diff --git a/android/app/build.gradle b/android/app/build.gradle index ecbd793..ac884c2 100644 --- a/android/app/build.gradle +++ b/android/app/build.gradle @@ -48,7 +48,7 @@ android { applicationId "com.example.konectar_events" // You can update the following values to match your application needs. // For more information, see: https://docs.flutter.dev/deployment/android#reviewing-the-gradle-build-configuration. - minSdkVersion flutter.minSdkVersion + minSdkVersion 21 targetSdkVersion flutter.targetSdkVersion versionCode flutterVersionCode.toInteger() versionName flutterVersionName diff --git a/assets/contact.json b/assets/contact.json new file mode 100644 index 0000000..42c6679 --- /dev/null +++ b/assets/contact.json @@ -0,0 +1,300 @@ +[ + { + "uid": 1, + "id": 1447203401, + "Salutation": "Dr.", + "First Name": "Roxana", + "Middle Name": "", + "Last Name": "Mehran", + "name": "Dr. Roxana Mehran", + "p_suffix": "MD,FACC,FACP,FCCP,FESC,FAHA,FSCAI", + "speciality": "Cardiovascular Disease (Cardiology)", + "sub_speciality": "", + "OrgName": "Icahn School of Medicine at Mount Sinai", + "Division": "", + "Title": "", + "License #": "NY: 185790", + "NPI Number": 1447203401, + "Profile Type": "Basic Profile", + "Url": "", + "Org ID": 256884, + "summarry": "• 41 Years of experience\n• Studied in New York University, St. George's University Medical School\n• Icahn School Of Medicine At Mount Sinai, Medstar Washington Hospital Center and 111 other affiliations\n• Speaker in 442 sessions in conferences\n• 909 Publications with 274 articles as lead author\n• Investigator in 23 clinical studies\n• Received payments from Abbott Laboratories, Amgen Inc., Astrazeneca Pharmaceuticals Lp and 23 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None", + "phone_no": "+12127317822", + "Fax": "+12127317822", + "email": "roxana.mehran@mountsinai.org", + "Address1": "1 Gustave L Levy Pl", + "Address2": "", + "City": "New York", + "State": "New York", + "PostalCode": 10029, + "Country": "United States", + "img_path": "", + "event_topics": "Heart Failure | Heart Diseases | Heart Failure, Systolic", + "pub_topics": "Heart Failure | Diabetes Mellitus, Type 2 | Cardiovascular Diseases", + "products_discussed": "VERQUVO | JARDIANCE | JARDIANCE", + "disease_conditions": "", + "drugs": "", + "topdata": [ + { + "title": "Top Event Topics", + "name1": "Heart Failure", + "name2": "Heart Diseases", + "name3": "Heart Failure, Systolic" + }, + { + "title": "Top Publication Topics", + "name1": "Heart Failure", + "name2": "Diabetes Mellitus, Type 2", + "name3": "Cardiovascular Diseases" + }, + { + "title": "Top Products Discussed", + "name1": "VERQUVO", + "name2": "JARDIANCE", + "name3": "JARDIANCE" + } + ] + }, + { + "uid": 2, + "id": 1639100928, + "Salutation": "Dr.", + "First Name": "Javed", + "Middle Name": "", + "Last Name": "Butler", + "name": "Dr. Javed Butler", + "p_suffix": "MD,MPH,MBA,FACC,FAHA", + "speciality": "Cardiovascular Disease (Cardiology)", + "sub_speciality": "Advanced Heart Failure And Transplant Cardiology", + "OrgName": "Baylor Scott & White Health", + "Division": "", + "Title": "", + "License #": "MS: 26174,TN: 31361", + "NPI Number": 1639100928, + "Profile Type": "Basic Profile", + "Url": "", + "Org ID": 23726, + "summarry": "• 34 Years of experience\n• Studied in Emory University Goizueta Business School, Harvard T.h. Chan School Of Public Health\n• Baylor Scott & White Health, University Of Mississippi Medical Center and 38 other affiliations\n• Speaker in 209 sessions in conferences\n• 1087 Publications with 299 articles as lead author\n• Investigator in 10 clinical studies\n• Received payments from Abbott Laboratories, American Regent, Amgen Inc. and 61 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents", + "phone_no": "+12148202687", + "Fax": "+16316384170", + "email": "javed.butler@bswhealth.org", + "Address1": "3434 Live Oak St", + "Address2": "", + "City": "Dallas", + "State": "Texas", + "PostalCode": 75204, + "Country": "United States", + "img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1639100928.jpeg", + "event_topics": "Atherosclerosis | Coronary Artery Disease | Computed Tomography Angiography", + "pub_topics": "Coronary Artery Disease | Atherosclerosis | Vascular Calcification", + "products_discussed": "VERQUVO | FARXIGA | Rybelsus", + "disease_conditions": "Angina Pectoris | Coronary Artery Disease | Heart Diseases", + "drugs": "Amlodipine Besylate | Metoprolol Succinate | Atorvastatin Calcium", + "topdata": [ + { + "title": "Top Event Topics", + "name1": "Atherosclerosis", + "name2": "Coronary Artery Disease", + "name3": "Computed Tomography Angiography" + }, + { + "title": "Top Publication Topics", + "name1": "Coronary Artery Disease", + "name2": "Atherosclerosis", + "name3": "Vascular Calcification" + }, + { + "title": "Top Products Discussed", + "name1": "VERQUVO", + "name2": "FARXIGA", + "name3": "Rybelsus" + }, + { + "title": "Condition Treated", + "name1": "Angina Pectoris", + "name2": "Coronary Artery Disease", + "name3": "Heart Diseases" + }, + { + "title": "Drugs Prescribed", + "name1": "Amlodipine Besylate", + "name2": "Metoprolol Succinate", + "name3": "Atorvastatin Calcium" + } + ] + }, + { + "uid": 3, + "id": 1811967433, + "Salutation": "Dr.", + "First Name": "Matthew", + "Middle Name": "J", + "Last Name": "Budoff", + "name": "Dr. Matthew J Budoff", + "p_suffix": "MD,FACC,FAHA", + "speciality": "Cardiovascular Disease (Cardiology)", + "sub_speciality": "", + "OrgName": "UCLA Santa Monica Medical Center", + "Division": "", + "Title": "", + "License #": "CA: G72496", + "NPI Number": 1811967433, + "Profile Type": "Basic Profile", + "Url": "", + "Org ID": 20514, + "summarry": "• 34 Years of experience\n• Studied in George Washington University School Of Medicine And Health Sciences, University Of California, Riverside\n• UCLA Santa Monica Medical Center, Prairie Du Chien Memorial Hospital Association, Inc. and 32 other affiliations\n• Speaker in 179 sessions in conferences\n• 992 Publications with 306 articles as lead author\n• Investigator in 25 clinical studies\n• Received payments from Abbott Laboratories, Actelion Pharmaceuticals Us, Inc., Actelion Pharmaceuticals, Ltd and 44 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents", + "phone_no": "+16083572000", + "Fax": "+13102224107", + "email": "Budoff@ucla.edu", + "Address1": "10833 Le Conte Ave", + "Address2": "", + "City": "Los Angeles", + "State": "California", + "PostalCode": 90095, + "Country": "United States", + "img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1811967433.jpeg", + "event_topics": "Tricuspid Valve Insufficiency | Transcatheter Aortic Valve Replacement | Tricuspid Valve", + "pub_topics": "Aortic Valve Stenosis | Tricuspid Valve Insufficiency | Mitral Valve Insufficiency", + "products_discussed": "(9520) IGT Devices Undivided | VersaCross Access Solution | MITRACLIP", + "disease_conditions": "", + "drugs": "", + "topdata": [ + { + "title": "Top Event Topics", + "name1": "Tricuspid Valve Insufficiency", + "name2": "Transcatheter Aortic Valve Replacement", + "name3": "Tricuspid Valve" + }, + { + "title": "Top Publication Topics", + "name1": "Aortic Valve Stenosis", + "name2": "Tricuspid Valve Insufficiency", + "name3": "Mitral Valve Insufficiency" + }, + { + "title": "Top Products Discussed", + "name1": "(9520) IGT Devices Undivided", + "name2": "VersaCross Access Solution", + "name3": "MITRACLIP" + } + ] + }, + { + "uid": 4, + "id": 1497893077, + "Salutation": "Dr.", + "First Name": "Rebecca", + "Middle Name": "Tung", + "Last Name": "Hahn", + "name": "Dr. Rebecca Tung Hahn", + "p_suffix": "MD", + "speciality": "Cardiovascular Disease (Cardiology)", + "sub_speciality": "Internal Medicine", + "OrgName": "Columbia University Irving Medical Center", + "Division": "", + "Title": "", + "License #": "NY: 163707", + "NPI Number": 1497893077, + "Profile Type": "Basic Profile", + "Url": "", + "Org ID": 22909, + "summarry": "• 40 Years of experience\n• Studied in Washington University School Of Medicine In St. Louis, Harvard University\n• Columbia University Irving Medical Center, Newyork-presbyterian Queens Hospital and 23 other affiliations\n• Speaker in 549 sessions in conferences\n• 427 Publications with 136 articles as lead author\n• Investigator in 7 clinical studies\n• Received payments from Abbott Laboratories, Baylis Medical Company Inc, Boston Scientific Corporation and 5 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None", + "phone_no": "+12123420444", + "Fax": "", + "email": "rth2@cumc.columbia.edu", + "Address1": "161 Fort Washington Avenue", + "Address2": "", + "City": "New York", + "State": "New York", + "PostalCode": 10032, + "Country": "United States", + "img_path": "https://cardio-staging.konectar.io/images/kol_images/resized/1497893077.jpeg", + "event_topics": "", + "pub_topics": "", + "products_discussed": "", + "disease_conditions": "", + "drugs": "", + "topdata": [ + { + "title": "Top Event Topics", + "name1": "Tricuspid Valve Insufficiency", + "name2": "Transcatheter Aortic Valve Replacement", + "name3": "Tricuspid Valve" + }, + { + "title": "Top Publication Topics", + "name1": "Aortic Valve Stenosis", + "name2": "Tricuspid Valve Insufficiency", + "name3": "Mitral Valve Insufficiency" + } + ] + }, + { + "uid": 5, + "id": 1841382421, + "Salutation": "Dr.", + "First Name": "Andrea", + "Middle Name": "", + "Last Name": "Natale", + "name": "Dr. Andrea Natale", + "p_suffix": "MD", + "speciality": "Clinical Cardiac Electrophysiology", + "sub_speciality": "Cardiovascular Disease (Cardiology), Internal Medicine", + "OrgName": "Texas Cardiac Arrhythmia Institute", + "Division": "", + "Title": "", + "License #": "CA: C50726,TX: M9533,OH: 35076775N", + "NPI Number": 1841382421, + "Profile Type": "Basic Profile", + "Url": "", + "Org ID": 24328, + "summarry": "• 39 Years of experience\n• Studied in Università Degli Studi Di Firenze Facoltà Di Medicina E Chirurgia\n• Texas Cardiac Arrhythmia Institute, Golden State Providers, A Medical Corporation and 110 other affiliations\n• Speaker in 1091 sessions in conferences\n• 542 Publications with 213 articles as lead author\n• Investigator in 80 clinical studies\n• Received payments from Abbott Laboratories, Acclarent, Inc, Acutus Medical, Inc. and 32 other companies\n• Is Opioid Prescribing - No\n• Sanction(s): None\n• Patent(s): 1 Patents", + "phone_no": "+15128073150", + "Fax": "+15124587879", + "email": "andrea.natale@hcahealthcare.com", + "Address1": "3000 N. IH-35", + "Address2": "Suite 720", + "City": "Austin", + "State": "Texas", + "PostalCode": 78705, + "Country": "United States", + "img_path": "", + "event_topics": "Ablation Techniques | Atrial Fibrillation | Catheter Ablation", + "pub_topics": "Atrial Fibrillation | Recurrence | Tachycardia, Ventricular", + "products_discussed": "CARTO 3 | WATCHMAN Access System | ENSITE PRECISION", + "disease_conditions": "Angina Pectoris | Coronary Artery Disease | Hypertension", + "drugs": "Eliquis | Xarelto | Furosemide", + "topdata": [ + { + "title": "Top Event Topics", + "name1": "Ablation Techniques", + "name2": "Atrial Fibrillation", + "name3": "Catheter Ablation" + }, + { + "title": "Top Publication Topics", + "name1": "CARTO 3", + "name2": "WATCHMAN Access System", + "name3": "ENSITE PRECISION" + }, + { + "title": "Top Products Discussed", + "name1": "CARTO 3", + "name2": "WATCHMAN Access System", + "name3": "RybeENSITE PRECISIONlsus" + }, + { + "title": "Condition Treated", + "name1": "Angina Pectoris", + "name2": "Coronary Artery Disease", + "name3": "Hypertension" + }, + { + "title": "Drugs Prescribed", + "name1": "Eliquis", + "name2": "Xarelto", + "name3": "Furosemide" + } + ] + } +] \ No newline at end of file diff --git a/assets/interactionform.json b/assets/interactionform.json new file mode 100644 index 0000000..dde4f61 --- /dev/null +++ b/assets/interactionform.json @@ -0,0 +1,511 @@ +{ + "data": [ + { + "id": "Form1", + "name": "Interaction Form", + "form-fields": [ + { + "sectionName": "Interaction Details", + "multiple": false, + "sectionList": [ + { + "name": "Interaction Date", + "id": "intdate_1", + "depid": "", + "widget": "text", + "input": "Date", + "validation": { + "isRequired": true + } + }, + { + "name": "Interaction Location", + "param": "interactionLocation", + "id": "intlocation_1", + "selectedValue": [], + "depid": "", + "widget": "dropdown", + "input": "dropdown", + "inputList": [ + { + "id": "1", + "name": "In office" + }, + { + "id": "2", + "name": "some" + }, + { + "id": "3", + "name": "Internal meetings" + }, + { + "id": "4", + "name": "Internal meetings2" + }, + { + "id": "5", + "name": "Out of Office" + }, + { + "id": "6", + "name": "Virtual" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Interaction Type", + "id": "inttype_11", + "depid": "", + "widget": "dropdown", + "input": "dropdown", + "inputList": [ + { + "id": "11", + "name": "Face to Face" + }, + { + "id": "12", + "name": "Lecture" + }, + { + "id": "13", + "name": "Mailing" + }, + { + "id": "14", + "name": "Other" + }, + { + "id": "15", + "name": "Phone" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Interaction Category", + "id": "intcategory_21", + "depid": "", + "widget": "radio", + "input": "radio", + "inputList": [ + { + "id": "21", + "name": "One to One" + }, + { + "id": "22", + "name": "Group" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Number of Attendees", + "id": "intattendees_2", + "depid": "", + "widget": "text", + "input": "number", + "validation": { + "isRequired": true + } + }, + { + "name": "Employee name", + "id": "intempname_31", + "depid": "", + "widget": "dropdown", + "input": "dropdown", + "inputList": [ + { + "id": "31", + "name": "Sarepta Manager" + }, + { + "id": "32", + "name": "Todd Truesdale" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Interaction ", + "id": "intcheck_121", + "depid": "", + "widget": "checkbox", + "input": "checkbox", + "inputList": [ + { + "id": "121", + "name": "One to One" + }, + { + "id": "122", + "name": "Group" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Number of Attendees", + "id": "intrange_122", + "depid": "", + "widget": "rangeslider", + "max": "100", + "min": "20", + "validation": { + "isRequired": true + } + } + ] + }, + { + "sectionName": "Discussion Topic", + "multiple": true, + "sectionList": [ + { + "name": "Product", + "id": "discproduct_41", + "depid": "", + "param": "product", + "widget": "dropdown", + "input": "dropdown", + "inputList": [ + { + "id": "41", + "name": "Product1" + }, + { + "id": "42", + "name": "Product2" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Discussion Type", + "id": "disctype_51", + "depid": "", + "widget": "autocomplete", + "input": "autocomplete", + "inputList": [ + { + "id": "51", + "name": "Face to Face" + }, + { + "id": "52", + "name": "Lecture" + }, + { + "id": "53", + "name": "Mailing" + }, + { + "id": "54", + "name": "Other" + }, + { + "id": "55", + "name": "Phone" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "Discussion Topic", + "id": "disctopic_61", + "depid": "", + "widget": "multiselect", + "input": "multiselect", + "inputList": [ + { + "id": "61", + "name": "Face to Face" + }, + { + "id": "62", + "name": "Lecture" + }, + { + "id": "63", + "name": "Mailing" + }, + { + "id": "64", + "name": "Other" + }, + { + "id": "65", + "name": "Phone" + } + ], + "validation": { + "isRequired": true + } + } + ] + }, + { + "sectionName": "Attendees", + "multiple": true, + "sectionList": [ + { + "name": "HCP Name", + "id": "attendeeshcpname_3", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Speciality", + "id": "attendeeshcpspeciality_4", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Title", + "id": "attendeestitle_5", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + } + ] + }, + { + "sectionName": "Other", + "multiple": false, + "sectionList": [ + { + "name": "Address1", + "id": "otheraddress1_12", + "depid": "", + "widget": "text", + "input": "primary", + "validation": { + "isRequired": true + } + }, + { + "name": "Address2", + "id": "otheraddress2_13", + "depid": "", + "widget": "text", + "input": "Hubli", + "validation": { + "isRequired": true + } + }, + { + "name": "Postal code", + "id": "otherpostal_14", + "depid": "", + "widget": "text", + "input": "number", + "validation": { + "isRequired": true + } + }, + { + "name": "Country", + "id": "othercountry_15", + "depid": "", + "widget": "dropdown", + "inputList": [ + { + "name": "India", + "id": "1" + }, + { + "name": "USA", + "id": "2" + }, + { + "name": "Nepal", + "id": "3" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "State", + "id": "otherstate_16", + "depid": "othercountry_15", + "widget": "dropdown", + "inputList": [ + { + "name": "Karnataka", + "id": "1", + "pid": "1" + }, + { + "name": "Maharashtra", + "id": "2", + "pid": "1" + }, + { + "name": "Andhra Pradesh", + "id": "3", + "pid": "1" + }, + { + "name": "Karnataka", + "id": "4", + "pid": "1" + } + ], + "validation": { + "isRequired": true + } + }, + { + "name": "City", + "widget": "dropdown", + "id": "othercity_17", + "depid": "otherstate_16", + "inputList": [ + { + "name": "Hubli", + "id": "1", + "pid": "1" + }, + { + "name": "Bangalore", + "id": "2", + "pid": "1" + }, + { + "name": "Belgavi", + "id": "3", + "pid": "1" + } + ], + "validation": { + "isRequired": true + } + } + ] + }, + { + "sectionName": "Other Attendees", + "multiple": false, + "sectionList": [ + { + "name": "Attendee Name", + "id": "otherattendeename_18", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Speciality", + "id": "otherattendeespeciality_19", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Comments", + "id": "otherattendeecom_20", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + } + ] + }, + { + "sectionName": "Attach Document(s)", + "multiple": true, + "sectionList": [ + { + "name": "Document Name", + "id": "documentName_21", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Description", + "id": "documentDescription_21", + "depid": "", + "widget": "text", + "input": "text", + "validation": { + "isRequired": true + } + }, + { + "name": "Choose file", + "id": "chooseFile_22", + "depid": "", + "widget": "button", + "input": "chooseFile", + "validation": { + "isRequired": true, + "multipleFiles": true + } + } + ] + }, + { + "sectionName": "Notes", + "multiple": false, + "sectionList": [ + { + "name": "Comments", + "id": "notescomments_22", + "depid": "", + "widget": "text", + "input": "textArea", + "validation": { + "type": "maxchars", + "chars": "500", + "isRequired": true + } + } + ] + } + ] + } + ] +} \ No newline at end of file diff --git a/assets/section.json b/assets/section.json new file mode 100644 index 0000000..1ef797b --- /dev/null +++ b/assets/section.json @@ -0,0 +1,57395 @@ +{ + "Publications": [ + { + "id": 1, + "user_id": 1447203401, + "artical_title": "New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.", + "pmid": 30595357, + "journal_name": "International journal of cardiology", + "date": "2019-01-01", + "author": "Tanaka A,Giustino G,Briede I,Sawaya FJ,Daemen J,Kawamoto H,Meliga E,D'Ascenzo F,Cerrato E,Stefanini GG,Capodanno D,Mangiameli A,Templin C,Erglis A,Morice MC,Mehran R,Van Mieghem NM,Nakamura S,De Benedictis M,Pavani M,Varbella F,Pisaniello M,Sharma SK,Tamburino C,Tchetche D,Colombo A,Chieffo A", + "auth_pos": 16, + "meshterms": "Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery*, Drug-Eluting Stents, Drug-Eluting Stents/trends*, Female, Humans, Internationality*, Male, Middle Aged, Mortality, Mortality/trends, Percutaneous Coronary Intervention, Registries*, Retrospective Studies, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 2, + "user_id": 1447203401, + "artical_title": "Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.", + "pmid": 30607496, + "journal_name": "Clinical research in cardiology : official journal of the German Cardiac Society", + "date": "2019-01-05", + "author": "Moalem K,Baber U,Chandrasekhar J,Claessen BE,Sartori S,Aquino M,Dangas G,Iakovou I,Colombo A,Kini A,Gibson M,Krucoff M,Chieffo A,Moliterno D,Witzenbichler B,Pocock S,Mehran R", + "auth_pos": 17, + "meshterms": "Aged, Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects*, Drug Administration Schedule, Female, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/mortality, Humans, Incidence, Male, Medication Adherence*, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage*, Purinergic P2Y Receptor Antagonists/adverse effects*, Registries, Risk Assessment, Risk Factors, Stents, Time Factors, Treatment Outcome, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 3, + "user_id": 1447203401, + "artical_title": "Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.", + "pmid": 30606052, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2019-01-05", + "author": "Baber U,Leisman DE,Cohen DJ,Gibson CM,Henry TD,Dangas G,Moliterno D,Kini A,Krucoff M,Colombo A,Chieffo A,Sartori S,Witzenbichler B,Steg PG,Pocock SJ,Mehran R", + "auth_pos": 16, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/economics, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy*, Aged, Aged, 80 and over, Clinical Decision-Making, Clopidogrel, Clopidogrel/administration & dosage*, Clopidogrel/adverse effects, Clopidogrel/economics, Coronary Thrombosis, Coronary Thrombosis/economics, Coronary Thrombosis/epidemiology, Coronary Thrombosis/prevention & control*, Cost Savings, Cost-Benefit Analysis, Drug Costs, Drug-Eluting Stents, Europe, Europe/epidemiology, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/economics, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/economics, Myocardial Ischemia/epidemiology, Myocardial Ischemia/prevention & control*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/economics, Percutaneous Coronary Intervention/instrumentation, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/economics, Prasugrel Hydrochloride, Prasugrel Hydrochloride/administration & dosage*, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/economics, Registries, Risk Assessment, Risk Factors, Ticagrelor, Ticagrelor/administration & dosage*, Ticagrelor/adverse effects, Ticagrelor/economics, Time Factors, Treatment Outcome, United States, United States/epidemiology, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 4, + "user_id": 1447203401, + "artical_title": "Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.", + "pmid": 30612724, + "journal_name": "The American journal of cardiology", + "date": "2019-01-08", + "author": "Schoos M,Power D,Baber U,Sartori S,Claessen B,Camaj A,Steg P,Ariti C,Weisz G,Witzenbichler B,Henry T,Cohen D,Antoniucci D,Krucoff M,Hermiller J,Gibson C,Chieffo A,Moliterno D,Colombo A,Pocock S,Dangas G,Mehran R", + "auth_pos": 22, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy*, Acute Coronary Syndrome/surgery, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Postoperative Period, Prognosis, Prospective Studies, Risk Factors, Withholding Treatment*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 5, + "user_id": 1447203401, + "artical_title": "ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.", + "pmid": 30630640, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-01-12", + "author": "Doherty JU,Kort S,Mehran R,Schoenhagen P,Soman P,Dehmer GJ,Bashore TM,Bhave NM,Calnon DA,Carabello B,Conte J,Dickfeld T,Edmundowicz D,Ferrari VA,Hall ME,Ghoshhajra B,Mehrotra P,Naqvi TZ,Reece TB,Starling RC,Szerlip M,Tzou WS,Wong JB", + "auth_pos": 3, + "meshterms": "Cardiac Imaging Techniques*, Heart Diseases, Heart Diseases/diagnostic imaging*, Humans, Multimodal Imaging*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 6, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.", + "pmid": 30630354, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-01-12", + "author": "Guedeney P,Mehran R,Collet JP,Claessen BE,Ten Berg J,Dangas GD", + "auth_pos": 2, + "meshterms": "Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects, Clopidogrel, Clopidogrel/administration & dosage*, Clopidogrel/adverse effects, Drug Administration Schedule, Drug Therapy, Combination, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Practice Guidelines as Topic, Risk Assessment, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 7, + "user_id": 1447203401, + "artical_title": "ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.", + "pmid": 30635178, + "journal_name": "The Journal of thoracic and cardiovascular surgery", + "date": "2019-01-13", + "author": "Doherty JU,Kort S,Mehran R,Schoenhagen P,Soman P,Dehmer GJ,Bashore TM,Bhave NM,Calnon DA,Carabello B,Conte J,Dickfeld T,Edmundowicz D,Ferrari VA,Hall ME,Ghoshhajra B,Mehrotra P,Naqvi TZ,Reece TB,Starling RC,Szerlip M,Tzou WS,Wong JB,Bailey SR,Brown AS,Daugherty SL,Dean LS,Desai MY,Duvernoy CS,Gillam LD,Hendel RC,Kramer CM,Lindsay BD,Manning WJ,Patel MR,Sachdeva R,Wann LS,Winchester DE,Wolk MJ", + "auth_pos": 4, + "meshterms": "Cardiology, Cardiology/standards*, Consensus, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/surgery, Humans, Multimodal Imaging, Multimodal Imaging/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 8, + "user_id": 1447203401, + "artical_title": "Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.", + "pmid": 30656812, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-01-19", + "author": "Faggioni M,Baber U,Chandrasekhar J,Sartori S,Weintraub W,Rao SV,Vogel B,Claessen B,Kini A,Effron M,Ge Z,Keller S,Strauss C,Snyder C,Toma C,Weiss S,Aquino M,Baker B,Defranco A,Bansilal S,Muhlestein B,Kapadia S,Pocock S,Poddar KL,Henry TD,Mehran R", + "auth_pos": 26, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/mortality, Acute Coronary Syndrome/therapy*, African Americans*, Age Factors, Aged, Cause of Death, Clopidogrel, Clopidogrel/adverse effects, Clopidogrel/therapeutic use*, Comorbidity, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology*, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prevalence, Prospective Studies, Race Factors, Registries, Risk Assessment, Risk Factors, Sex Factors, Stroke, Stroke/ethnology, Stroke/mortality, Time Factors, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 9, + "user_id": 1447203401, + "artical_title": "Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training.", + "pmid": 30660463, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2019-01-21", + "author": "Yong CM,Abnousi F,Rzeszut AK,Douglas PS,Harrington RA,Mehran R,Grines C,Altin SE,Duvernoy CS", + "auth_pos": 6, + "meshterms": "Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires, Adult, Attitude of Health Personnel*, Cardiologists, Cardiologists/education*, Cardiologists/psychology*, Cardiology, Cardiology/education*, Career Choice*, Choice Behavior, Education, Medical, Graduate*, Female, Humans, Male, Physicians, Women, Physicians, Women/psychology*, Sex Factors, Specialization*, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 10, + "user_id": 1447203401, + "artical_title": "Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.", + "pmid": 30666784, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-01-23", + "author": "Guedeney P,Claessen BE,Mehran R,Kandzari DE,Aquino M,Davis S,Tamis L,Wang JC,Othman I,Gigliotti OS,Haghighat A,Singh S,Lopez M,Giugliano G,Horwitz PA,Sorrentino S,Underwood P,Allocco D,Meredith IT,Batchelor W", + "auth_pos": 3, + "meshterms": "Aged, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Cardiovascular Agents/adverse effects, Chromium*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/ethnology, Coronary Thrombosis/mortality, Drug-Eluting Stents*, Everolimus, Everolimus/administration & dosage*, Everolimus/adverse effects, Female, Health Status Disparities*, Humans, Male, Middle Aged, Minority Health*, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Observational Studies as Topic, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platinum*, Prosthesis Design, Race Factors, Registries, Retrospective Studies, Risk Factors, Sex Factors, Time Factors, Treatment Outcome, United States, United States/epidemiology, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 11, + "user_id": 1447203401, + "artical_title": "Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.", + "pmid": 29887476, + "journal_name": "International journal of cardiology", + "date": "2019-01-27", + "author": "Pasceri V,Pelliccia F,Bressi E,Mantione L,Gaudio C,Speciale G,Mehran R,Dangas GD,Patti G", + "auth_pos": 7, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Foramen Ovale, Patent, Foramen Ovale, Patent/diagnosis*, Foramen Ovale, Patent/epidemiology, Foramen Ovale, Patent/surgery*, Humans, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods*, Regression Analysis, Risk Factors, Stroke, Stroke/diagnosis*, Stroke/epidemiology, Stroke/surgery*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 12, + "user_id": 1447203401, + "artical_title": "Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.", + "pmid": 30681262, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-01-27", + "author": "Sharma SK,Bolduan RW,Patel MR,Martinsen BJ,Azemi T,Giugliano G,Resar JR,Mehran R,Cohen DJ,Popma JJ,Waksman R", + "auth_pos": 8, + "meshterms": "Aged, Aged, 80 and over, Atherectomy, Coronary, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy*, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 13, + "user_id": 1447203401, + "artical_title": "Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.", + "pmid": 30690854, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-01-29", + "author": "Huang X,Redfors B,Chen S,Gersh BJ,Mehran R,Zhang Y,McAndrew T,Ben-Yehuda O,Mintz GS,Stone GW", + "auth_pos": 5, + "meshterms": "Aged, Coronary Angiography, Electrocardiography, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality*, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/mortality*, ST Elevation Myocardial Infarction/therapy*, Stents, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 14, + "user_id": 1447203401, + "artical_title": "Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.", + "pmid": 30704287, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-02-02", + "author": "Kerneis M,Yee MK,Mehran R,Nafee T,Bode C,Halperin JL,Peterson ED,Verheugt FWA,Wildgoose P,van Eickels M,Lip GYH,Cohen M,Fox KAA,Gibson CM", + "auth_pos": 3, + "meshterms": "Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy*, Blood Coagulation, Blood Coagulation/drug effects*, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage*, Factor Xa Inhibitors/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, International Normalized Ratio*, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Predictive Value of Tests, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Rivaroxaban/adverse effects, Time Factors, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors, Warfarin, Warfarin/administration & dosage*, Warfarin/adverse effects, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 15, + "user_id": 1447203401, + "artical_title": "The link between anemia and adverse outcomes in patients with acute coronary syndrome.", + "pmid": 30712411, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2019-02-05", + "author": "Guedeney P,Sorrentino S,Claessen B,Mehran R", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 16, + "user_id": 1447203401, + "artical_title": "ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.", + "pmid": 30744922, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2019-02-13", + "author": "Doherty JU,Kort S,Mehran R,Schoenhagen P,Soman P,Dehmer GJ,Bashore TM,Bhave NM,Calnon DA,Carabello B,Conte J,Dickfeld T,Edmundowicz D,Ferrari VA,Hall ME,Ghoshhajra B,Mehrotra P,Naqvi TZ,Reece TB,Starling RC,Szerlip M,Tzou WS,Wong JB,Bailey SR,Brown AS,Daugherty SL,Dean LS,Desai MY,Duvernoy CS,Gillam LD,Hendel RC,Kramer CM,Lindsay BD,Manning WJ,Patel MR,Sachdeva R,Wann LS,Winchester DE,Wolk MJ", + "auth_pos": 4, + "meshterms": "Advisory Committees, Cardiology, Cardiology/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Humans, Multimodal Imaging, Multimodal Imaging/standards*, Societies, Medical, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 17, + "user_id": 1447203401, + "artical_title": "Residual angina in female patients after coronary revascularization.", + "pmid": 30745255, + "journal_name": "International journal of cardiology", + "date": "2019-02-13", + "author": "Vogel B,Goel R,Kunadian V,Kalkman DN,Chieffo A,Appelman Y,Mehran R", + "auth_pos": 7, + "meshterms": "Angina Pectoris, Angina Pectoris/epidemiology*, Angina Pectoris/etiology, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/physiopathology*, Endothelium, Vascular, Endothelium, Vascular/physiopathology*, Female, Global Health, Humans, Incidence, Myocardial Revascularization, Myocardial Revascularization/methods*, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/etiology, Prevalence, Sex Factors, Vasodilation, Vasodilation/physiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 18, + "user_id": 1447203401, + "artical_title": "Transcatheter Cardiovascular Therapeutics 2018.", + "pmid": 30768208, + "journal_name": "European heart journal", + "date": "2019-02-16", + "author": "Mintz GS,Stone GW,Granada JF,Mehran R,Kirtane A,Dangas G,Parikh SA,Leon MB", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 19, + "user_id": 1447203401, + "artical_title": "The Lancet Commission on women and cardiovascular disease: time for a shift in women's health.", + "pmid": 30765122, + "journal_name": "Lancet (London, England)", + "date": "2019-02-16", + "author": "Mehran R,Vogel B,Ortega R,Cooney R,Horton R", + "auth_pos": 1, + "meshterms": "Advisory Committees, Advisory Committees/organization & administration*, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/prevention & control*, Female, Health Policy, Healthcare Disparities*, Humans, Research Design, Sex Factors, Women's Health*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 20, + "user_id": 1447203401, + "artical_title": "Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).", + "pmid": 30826050, + "journal_name": "The American journal of cardiology", + "date": "2019-03-04", + "author": "Nijenhuis VJ,Ten Berg JM,Hengstenberg C,Lefèvre T,Windecker S,Hildick-Smith D,Kupatt C,Van Belle E,Tron C,Hink HU,Colombo A,Claessen B,Sartori S,Chandrasekhar J,Mehran R,Anthopoulos P,Deliargyris EN,Dangas G", + "auth_pos": 15, + "meshterms": "Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Clopidogrel, Clopidogrel/administration & dosage*, Dose-Response Relationship, Drug, Europe, Europe/epidemiology, Female, Follow-Up Studies, Humans, Incidence, Male, North America, North America/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Postoperative Complications/etiology, Postoperative Complications/prevention & control*, Preoperative Care, Preoperative Care/methods*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Risk Assessment, Risk Assessment/methods*, Risk Factors, Thromboembolism, Thromboembolism/epidemiology, Thromboembolism/etiology, Thromboembolism/prevention & control*, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 21, + "user_id": 1447203401, + "artical_title": "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.", + "pmid": 30826192, + "journal_name": "International journal of cardiology", + "date": "2019-03-04", + "author": "Colombo A,Chandrasekhar J,Aquino M,Ong TK,Sartori S,Baber U,Lee M,Iniguez A,Hajek P,Borisov B,Atzev B,Den Heijer P,Coufal Z,Hudec M,Mates M,Snyder C,Moalem K,Morrell D,Elmore F,Rowland S,Mehran R", + "auth_pos": 21, + "meshterms": "Bioengineering, Bioengineering/methods, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, Immunosuppressive Agents/pharmacology, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Product Surveillance, Postmarketing, Product Surveillance, Postmarketing/statistics & numerical data*, Prosthesis Design, Registries*, Retrospective Studies, Sirolimus, Sirolimus/pharmacology*, Time Factors, Treatment Outcome, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 22, + "user_id": 1447203401, + "artical_title": "Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention.", + "pmid": 30844810, + "journal_name": "Cardiorenal medicine", + "date": "2019-03-08", + "author": "Farhan S,Vogel B,Baber U,Sartori S,Aquino M,Chandrasekhar J,Sorrentino S,Giustino G,Sharma M,Guedeney P,Rohla M,Bhandari R,Barman N,Sweeny J,Dangas G,Mehran R,Kini A,Sharma S", + "auth_pos": 16, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/blood*, Acute Kidney Injury/etiology, Acute Kidney Injury/mortality, Aged, Cause of Death, Cause of Death/trends, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Creatinine, Creatinine/blood, Female, Follow-Up Studies, Humans, Male, Middle Aged, Osmolar Concentration, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Retrospective Studies, Risk Factors, Survival Rate, Survival Rate/trends, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 23, + "user_id": 1447203401, + "artical_title": "Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.", + "pmid": 30041804, + "journal_name": "International journal of cardiology", + "date": "2019-03-12", + "author": "Généreux P,Giustino G,Redfors B,Palmerini T,Witzenbichler B,Weisz G,Stuckey TD,Maehara A,Mehran R,Kirtane AJ,Stone GW", + "auth_pos": 9, + "meshterms": "Aged, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects, Drug-Eluting Stents/trends*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/trends*, Platelet Activation, Platelet Activation/drug effects, Platelet Activation/physiology*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Registries, Risk Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 24, + "user_id": 1447203401, + "artical_title": "Hope for the best, prepare for the worst: How to manage coronary perforations.", + "pmid": 30859726, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-03-13", + "author": "Claessen BE,Mehran R", + "auth_pos": 2, + "meshterms": "Angioplasty, Balloon, Coronary*, Coronary Vessels, Humans, Incidence, Percutaneous Coronary Intervention*, Retrospective Studies, Stents, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 25, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.", + "pmid": 30883055, + "journal_name": "The New England journal of medicine", + "date": "2019-03-19", + "author": "Lopes RD,Heizer G,Aronson R,Vora AN,Massaro T,Mehran R,Goodman SG,Windecker S,Darius H,Li J,Averkov O,Bahit MC,Berwanger O,Budaj A,Hijazi Z,Parkhomenko A,Sinnaeve P,Storey RF,Thiele H,Vinereanu D,Granger CB,Alexander JH", + "auth_pos": 6, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications*, Acute Coronary Syndrome/therapy, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy*, Double-Blind Method, Drug Therapy, Combination, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Pyrazoles, Pyrazoles/adverse effects, Pyrazoles/therapeutic use*, Pyridones, Pyridones/adverse effects, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 26, + "user_id": 1447203401, + "artical_title": "Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.", + "pmid": 30924052, + "journal_name": "Journal of thrombosis and thrombolysis", + "date": "2019-03-30", + "author": "Ge Z,Baber U,Claessen BE,Chandrasekhar J,Chandiramani R,Li SX,Sartori S,Kini AS,Rao SV,Weiss S,Henry TD,Kapadia S,Muhlestein B,Strauss C,Toma C,DeFranco A,Effron MB,Keller S,Baker BA,Pocock S,Dangas G,Mehran R", + "auth_pos": 22, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Angina, Unstable, Angina, Unstable/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Clopidogrel/therapeutic use*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/drug therapy, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Registries, Retrospective Studies, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, Treatment Outcome, United States, Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 27, + "user_id": 1447203401, + "artical_title": "Atrial fibrillation, with ACS and PCI: walking a tightrope.", + "pmid": 30957836, + "journal_name": "European heart journal", + "date": "2019-04-09", + "author": "Mehran R,Kalkman DN,Angiolillo DJ", + "auth_pos": 1, + "meshterms": "Acute Coronary Syndrome*, Atrial Fibrillation*, Clopidogrel, Dabigatran, Humans, Percutaneous Coronary Intervention*, Ticagrelor", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 28, + "user_id": 1447203401, + "artical_title": "Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration.", + "pmid": 30982549, + "journal_name": "International journal of cardiology", + "date": "2019-04-16", + "author": "Camaj A,Giustino G,Claessen BE,Baber U,Power DA,Sartori S,Aquino M,Stone GW,Windecker S,Dangas G,Mehran R", + "auth_pos": 11, + "meshterms": "Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology, Aged, Cause of Death, Cause of Death/trends, Coronary Angiography, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Prosthesis Design, Retrospective Studies, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 29, + "user_id": 1447203401, + "artical_title": "Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.", + "pmid": 30998384, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-04-19", + "author": "Faggioni M,Baber U,Sartori S,Chandrasekhar J,Cohen DJ,Henry TD,Claessen BE,Dangas GD,Gibson CM,Krucoff MW,Vogel B,Moliterno DJ,Sorrentino S,Colombo A,Chieffo A,Kini A,Farhan S,Ariti C,Witzenbichler B,Weisz G,Steg PG,Pocock S,Mehran R", + "auth_pos": 23, + "meshterms": "Aged, Anemia, Anemia/complications*, Anemia/diagnosis, Anemia/mortality, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug Therapy, Combination, Female, Hemoglobins, Hemoglobins/metabolism, Hemorrhage, Hemorrhage/chemically induced*, Humans, Male, Medication Adherence, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects*, Prospective Studies, Registries, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 30, + "user_id": 1447203401, + "artical_title": "Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women.", + "pmid": 30998393, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-04-19", + "author": "Mehran R,Chandrasekhar J,Davis S,Nathan S,Hill R,Hearne S,Vismara V,Pyo R,Gharib E,Hawa Z,Chrysant G,Kandzari D,Underwood P,Allocco DJ,Batchelor W", + "auth_pos": 1, + "meshterms": "African Americans*, Aged, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Cardiovascular Agents/adverse effects, Comorbidity, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug-Eluting Stents*, European Continental Ancestry Group*, Everolimus, Everolimus/administration & dosage*, Everolimus/adverse effects, Female, Health Status Disparities*, Hispanic Americans*, Humans, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Sex Factors, Social Determinants of Health, Social Determinants of Health/ethnology*, Time Factors, Treatment Outcome, United States, United States/epidemiology, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 31, + "user_id": 1447203401, + "artical_title": "Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention.", + "pmid": 31005238, + "journal_name": "The American journal of cardiology", + "date": "2019-04-22", + "author": "Mahajan AM,Claessen BE,Chandrasekhar J,Sartori S,Aquino M,Baber U,Dangas G,Kovacic JC,Krishnan P,Moreno P,Sweeny J,Barman N,Vijay P,Kini A,Mehran R,Sharma S", + "auth_pos": 15, + "meshterms": "Aged, Aged, 80 and over, Ethnic Groups, Ethnic Groups/statistics & numerical data*, Female, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology*, Myocardial Infarction/mortality, Myocardial Infarction/surgery*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/statistics & numerical data*, Prospective Studies, Reoperation, Sex Factors, Socioeconomic Factors, Survival Rate, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 32, + "user_id": 1447203401, + "artical_title": "Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study.", + "pmid": 31012851, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2019-04-24", + "author": "Kogame N,Modolo R,Tomaniak M,Cavalcante R,de Martino F,Tinoco J,Ribeiro EE,Mehran R,Campos CM,Onuma Y,Lemos PA,Serruys PW", + "auth_pos": 8, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/surgery*, Angina, Stable, Angina, Stable/surgery*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Pilot Projects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Postoperative Complications, Prasugrel Hydrochloride, Prasugrel Hydrochloride/administration & dosage, Prasugrel Hydrochloride/therapeutic use*, Stents*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 33, + "user_id": 1447203401, + "artical_title": "When Can Strut Thickness Really Matter in Percutaneous Coronary Intervention?", + "pmid": 31111869, + "journal_name": "JAMA cardiology", + "date": "2019-05-22", + "author": "Kirtane AJ,Mehran R", + "auth_pos": 2, + "meshterms": "Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 34, + "user_id": 1447203401, + "artical_title": "Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.", + "pmid": 31116908, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-05-23", + "author": "Power D,Schäfer U,Guedeney P,Claessen BE,Sartori S,Sorrentino S,Lefèvre T,Kupatt C,Tchetche D,Dumonteil N,Webb JG,Colombo A,Windecker S,Ten Berg JM,Hildick-Smith D,Boekstegers P,Linke A,Tron C,Van Belle E,Asgar AW,Jeger R,Sardella G,Hink U,Husser O,Grube E,Lechthaler I,Wijngaard P,Anthopoulos P,Deliargyris EN,Bernstein D,Hengstenberg C,Mehran R,Dangas GD", + "auth_pos": 32, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/etiology, Acute Kidney Injury/prevention & control, Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Canada, Equipment Design, Europe, Female, Hemorrhage, Hemorrhage/etiology, Hemorrhage/mortality, Hemorrhage/prevention & control*, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Hemostatic Techniques/instrumentation*, Hemostatic Techniques/mortality, Humans, Male, Randomized Controlled Trials as Topic, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Vascular Closure Devices*, Vascular Diseases, Vascular Diseases/etiology, Vascular Diseases/mortality, Vascular Diseases/prevention & control*, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 35, + "user_id": 1447203401, + "artical_title": "Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.", + "pmid": 31116032, + "journal_name": "Circulation", + "date": "2019-05-23", + "author": "Urban P,Mehran R,Colleran R,Angiolillo DJ,Byrne RA,Capodanno D,Cuisset T,Cutlip D,Eerdmans P,Eikelboom J,Farb A,Gibson CM,Gregson J,Haude M,James SK,Kim HS,Kimura T,Konishi A,Laschinger J,Leon MB,Magee PFA,Mitsutake Y,Mylotte D,Pocock S,Price MJ,Rao SV,Spitzer E,Stockbridge N,Valgimigli M,Varenne O,Windhoevel U,Yeh RW,Krucoff MW,Morice MC", + "auth_pos": 2, + "meshterms": "Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods, Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Congresses as Topic*, Congresses as Topic/trends, Consensus*, District of Columbia, Hemorrhage, Hemorrhage/diagnosis*, Hemorrhage/etiology*, Hemorrhage/prevention & control, Humans, Paris, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/trends, Risk Assessment, Risk Assessment/methods", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 36, + "user_id": 1447203401, + "artical_title": "Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.", + "pmid": 31116395, + "journal_name": "European heart journal", + "date": "2019-05-23", + "author": "Urban P,Mehran R,Colleran R,Angiolillo DJ,Byrne RA,Capodanno D,Cuisset T,Cutlip D,Eerdmans P,Eikelboom J,Farb A,Gibson CM,Gregson J,Haude M,James SK,Kim HS,Kimura T,Konishi A,Laschinger J,Leon MB,Magee PFA,Mitsutake Y,Mylotte D,Pocock S,Price MJ,Rao SV,Spitzer E,Stockbridge N,Valgimigli M,Varenne O,Windhoevel U,Yeh RW,Krucoff MW,Morice MC", + "auth_pos": 2, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Risk Assessment, Safety, Stents, Stents/adverse effects*, Thrombocytopenia, Thrombocytopenia/complications, Thrombocytopenia/epidemiology, Thrombocytopenia/physiopathology, Treatment Outcome, United States, United States/epidemiology, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/physiopathology, Aged, Aged, 80 and over, Anemia, Anemia/complications, Anemia/epidemiology, Anemia/physiopathology, Asia, Asia/epidemiology, Clinical Decision-Making, Clinical Trials as Topic, Consensus, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Europe, Europe/epidemiology, Fibrosis, Fibrosis/complications, Frailty, Frailty/complications, Frailty/epidemiology, Frailty/physiopathology, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Humans, Hypertension, Portal, Hypertension, Portal/epidemiology, Hypertension, Portal/physiopathology, Medication Adherence, Medication Adherence/statistics & numerical data, Metals, Percutaneous Coronary Intervention, Percut", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 37, + "user_id": 1447203401, + "artical_title": "Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.", + "pmid": 31122354, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2019-05-28", + "author": "Joyce LC,Baber U,Claessen BE,Sartori S,Chandrasekhar J,Cohen DJ,Henry TD,Ariti C,Dangas G,Faggioni M,Aoi S,Gibson CM,Aquino M,Krucoff MW,Vogel B,Moliterno DJ,Sorrentino S,Colombo A,Chieffo A,Kini A,Guedeney P,Witzenbichler B,Weisz G,Steg PG,Pocock S,Mehran R", + "auth_pos": 26, + "meshterms": "Age Factors, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/mortality, Cardiovascular Diseases/therapy, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Incidence, Male, Medication Adherence, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Registries, Risk Assessment, Risk Factors, Stents, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 38, + "user_id": 1447203401, + "artical_title": "Contrast-Associated Acute Kidney Injury.", + "pmid": 31141635, + "journal_name": "The New England journal of medicine", + "date": "2019-05-30", + "author": "Mehran R,Dangas GD,Weisbord SD", + "auth_pos": 1, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/chemically induced*, Acute Kidney Injury/physiopathology, Acute Kidney Injury/prevention & control, Contrast Media, Contrast Media/adverse effects*, Contrast Media/chemistry, Humans, Kidney, Kidney/drug effects, Kidney/pathology, Kidney/physiopathology, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 39, + "user_id": 1447203401, + "artical_title": "ST-segment elevation myocardial infarction.", + "pmid": 31171787, + "journal_name": "Nature reviews. Disease primers", + "date": "2019-06-07", + "author": "Vogel B,Claessen BE,Arnold SV,Chan D,Cohen DJ,Giannitsis E,Gibson CM,Goto S,Katus HA,Kerneis M,Kimura T,Kunadian V,Pinto DS,Shiomi H,Spertus JA,Steg PG,Mehran R", + "auth_pos": 17, + "meshterms": "Biomarkers, Biomarkers/analysis, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/physiopathology, Echocardiography, Echocardiography/methods, Electrocardiography, Electrocardiography/methods, Humans, Mass Screening, Mass Screening/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Risk Factors, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnosis*, ST Elevation Myocardial Infarction/physiopathology, ST Elevation Myocardial Infarction/therapy*, Treatment Outcome, Troponin I, Troponin I/analysis, Troponin I/blood", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 40, + "user_id": 1447203401, + "artical_title": "Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention.", + "pmid": 31186218, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2019-06-13", + "author": "Brener SJ,Leon MB,Serruys PW,Smits PC,von Birgelen C,Mehran R,Kirtane AJ,Witzenbichler B,Rinaldi MJ,Metzger DC,Mazzaferri EL,Zhang Z,Stone GW", + "auth_pos": 6, + "meshterms": "Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/mortality*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Predictive Value of Tests, Randomized Controlled Trials as Topic*, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 41, + "user_id": 1447203401, + "artical_title": "Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.", + "pmid": 31197962, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-06-15", + "author": "Chandiramani R,Chen H,Aoi S,Giustino G,Claessen B,Sartori S,Aquino M,Sorrentino S,Cao D,Goel R,Kini A,Rao S,Weintraub W,Henry TD,Kapadia S,DeFranco A,Muhlestein JB,Toma C,Effron MB,Keller S,Baker BA,Pocock S,Baber U,Mehran R", + "auth_pos": 24, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/mortality, Acute Coronary Syndrome/therapy*, Aged, Aged, 80 and over, Female, Hemorrhage, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/mortality, Myocardial Infarction/therapy*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality*, Recurrence, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Stroke, Stroke/diagnosis, Stroke/mortality*, Time Factors, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 42, + "user_id": 1447203401, + "artical_title": "Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1?month of dual antiplatelet therapy.", + "pmid": 31203158, + "journal_name": "American heart journal", + "date": "2019-06-17", + "author": "Kedhi E,Latib A,Abizaid A,Kandzari D,Kirtane AJ,Mehran R,Price MJ,Simon D,Worthley S,Zaman A,Brar S,Liu M,Stone GW,Windecker S", + "auth_pos": 6, + "meshterms": "Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use, Drug Therapy, Combination, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Hemorrhage, Hemorrhage/chemically induced*, Humans, Immunosuppressive Agents, Immunosuppressive Agents/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prospective Studies, Prosthesis Design, Receptors, Purinergic P2Y12, Research Design, Risk, Single-Blind Method, Sirolimus, Sirolimus/analogs & derivatives, Sirolimus/therapeutic use, Stents, Stents/adverse effects, Thrombosis, Thrombosis/prevention & control, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 43, + "user_id": 1447203401, + "artical_title": "Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.", + "pmid": 31202949, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2019-06-17", + "author": "Sibbing D,Aradi D,Alexopoulos D,Ten Berg J,Bhatt DL,Bonello L,Collet JP,Cuisset T,Franchi F,Gross L,Gurbel P,Jeong YH,Mehran R,Moliterno DJ,Neumann FJ,Pereira NL,Price MJ,Sabatine MS,So DYF,Stone GW,Storey RF,Tantry U,Trenk D,Valgimigli M,Waksman R,Angiolillo DJ", + "auth_pos": 13, + "meshterms": "Blood Platelets, Blood Platelets/drug effects*, Blood Platelets/metabolism, Clinical Decision-Making, Consensus, Coronary Thrombosis, Coronary Thrombosis/blood, Coronary Thrombosis/genetics, Coronary Thrombosis/prevention & control*, Cytochrome P-450 CYP2C9, Cytochrome P-450 CYP2C9/genetics*, Cytochrome P-450 CYP2C9/metabolism, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Humans, Patient Selection, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Pharmacogenomic Testing, Pharmacogenomic Testing/standards*, Pharmacogenomic Variants*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/pharmacokinetics, Platelet Function Tests, Platelet Function Tests/standards*, Precision Medicine, Precision Medicine/standards, Predictive Value of Tests, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage*, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/pharmacokinetics, Receptors, Purinergic P2Y12, Receptors, Purinergic P2Y12/drug effects*, Receptors, Purinergic P2Y12/metabolism, Risk Factors, Treatment Outcome, P2Y12 inhibitor*, TIMI bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 44, + "user_id": 1447203401, + "artical_title": "Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.", + "pmid": 31215979, + "journal_name": "JAMA cardiology", + "date": "2019-06-20", + "author": "Lopes RD,Hong H,Harskamp RE,Bhatt DL,Mehran R,Cannon CP,Granger CB,Verheugt FWA,Li J,Ten Berg JM,Sarafoff N,Gibson CM,Alexander JH", + "auth_pos": 5, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/complications, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Network Meta-Analysis, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 45, + "user_id": 1447203401, + "artical_title": "Corrigendum to \"Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry\" [Int. J. Cardiol. 283 (2019) 67-72].", + "pmid": 31227412, + "journal_name": "International journal of cardiology", + "date": "2019-06-23", + "author": "Colombo A,Chandrasekhar J,Aquino M,Ong TK,Sartori S,Baber U,Lee M,Iniguez A,Hajek P,Borisov B,Atzev B,Heijer PD,Coufal Z,Hudec M,Mates M,Snyder C,Moalem K,Morrell D,Elmore F,Rowland S,Mehran R", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 46, + "user_id": 1447203401, + "artical_title": "ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons.", + "pmid": 31250324, + "journal_name": "Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology", + "date": "2019-06-30", + "author": "Doherty JU,Kort S,Mehran R,Schoenhagen P,Soman P", + "auth_pos": 3, + "meshterms": "Cardiac Imaging Techniques*, Heart Diseases, Heart Diseases/diagnostic imaging*, Humans, Multimodal Imaging*, Patient Selection*, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 47, + "user_id": 1447203401, + "artical_title": "Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.", + "pmid": 31270529, + "journal_name": "European heart journal", + "date": "2019-07-05", + "author": "Guedeney P,Giustino G,Sorrentino S,Claessen BE,Camaj A,Kalkman DN,Vogel B,Sartori S,De Rosa S,Baber U,Indolfi C,Montalescot G,Dangas GD,Rosenson RS,Pocock SJ,Mehran R", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 48, + "user_id": 1447203401, + "artical_title": "Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.", + "pmid": 31272556, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-07-06", + "author": "Capodanno D,Huber K,Mehran R,Lip GYH,Faxon DP,Granger CB,Vranckx P,Lopes RD,Montalescot G,Cannon CP,Ten Berg J,Gersh BJ,Bhatt DL,Angiolillo DJ", + "auth_pos": 3, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/complications, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control*, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 49, + "user_id": 1447203401, + "artical_title": "Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.", + "pmid": 31313820, + "journal_name": "Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus", + "date": "2019-07-18", + "author": "Mitchell KG,Nelson DB,Corsini EM,Vaporciyan AA,Antonoff MB,Mehran RJ,Rice DC,Roth JA,Sepesi B,Walsh GL,Bhutani MS,Maru DM,Wu CC,Nguyen QN,Ajani JA,Swisher SG,Hofstetter WL", + "auth_pos": 6, + "meshterms": "Chemoradiotherapy*, Chemoradiotherapy/adverse effects, Chemoradiotherapy/methods, Combined Modality Therapy, Combined Modality Therapy/methods, Combined Modality Therapy/statistics & numerical data, Esophageal Neoplasms*, Esophageal Neoplasms/mortality, Esophageal Neoplasms/pathology, Esophageal Neoplasms/surgery, Esophageal Squamous Cell Carcinoma*, Esophageal Squamous Cell Carcinoma/mortality, Esophageal Squamous Cell Carcinoma/pathology, Esophageal Squamous Cell Carcinoma/surgery, Esophagectomy*, Esophagectomy/adverse effects, Esophagectomy/methods, Female, Humans, Male, Middle Aged, Neoplasm Staging, Outcome and Process Assessment, Health Care, Postoperative Complications*, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Salvage Therapy, Salvage Therapy/methods, Salvage Therapy/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 50, + "user_id": 1447203401, + "artical_title": "Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.", + "pmid": 31326681, + "journal_name": "American heart journal", + "date": "2019-07-22", + "author": "Mehta SR,Wood DA,Meeks B,Storey RF,Mehran R,Bainey KR,Nguyen H,Bangdiwala SI,Cairns JA", + "auth_pos": 5, + "meshterms": "Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery*, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prospective Studies, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnosis, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Thrombolytic Therapy, Thrombolytic Therapy/methods*, Time Factors, Treatment Outcome, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 51, + "user_id": 1447203401, + "artical_title": "Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.", + "pmid": 31365942, + "journal_name": "Thrombosis and haemostasis", + "date": "2019-08-01", + "author": "Vogel B,Chandrasekhar J,Baber U,Mastoris I,Sartori S,Aquino M,Krucoff MW,Moliterno DJ,Henry TD,Weisz G,Gibson CM,Iakovou I,Kini AS,Farhan S,Sorrentino S,Faggioni M,Colombo A,Steg PG,Witzenbichler B,Chieffo A,Cohen DJ,Stuckey T,Ariti C,Dangas GD,Pocock S,Mehran R", + "auth_pos": 26, + "meshterms": "Aged, Aspirin, Aspirin/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects, Europe, Female, Follow-Up Studies, Geography, Heart Valve Prosthesis, Hemorrhage, Humans, Male, Middle Aged, Myocardial Infarction, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Prospective Studies, Prosthesis Implantation, Registries, Risk Factors, Stents, United States, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 52, + "user_id": 1447203401, + "artical_title": "Complete Revascularization with Multivessel PCI for Myocardial Infarction.", + "pmid": 31475795, + "journal_name": "The New England journal of medicine", + "date": "2019-09-03", + "author": "Mehta SR,Wood DA,Storey RF,Mehran R,Bainey KR,Nguyen H,Meeks B,Di Pasquale G,López-Sendón J,Faxon DP,Mauri L,Rao SV,Feldman L,Steg PG,Avezum Á,Sheth T,Pinilla-Echeverri N,Moreno R,Campo G,Wrigley B,Kedev S,Sutton A,Oliver R,Rodés-Cabau J,Stankovi? G,Welsh R,Lavi S,Cantor WJ,Wang J,Nakamya J,Bangdiwala SI,Cairns JA", + "auth_pos": 4, + "meshterms": "Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Combined Modality Therapy, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/therapy*, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Recurrence, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/drug therapy, ST Elevation Myocardial Infarction/etiology, ST Elevation Myocardial Infarction/therapy*, Secondary Prevention, Stents", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 53, + "user_id": 1447203401, + "artical_title": "Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).", + "pmid": 31477234, + "journal_name": "The American journal of cardiology", + "date": "2019-09-04", + "author": "Redfors B,Chen S,Ben-Yehuda O,Huang X,Witzenbichler B,Weisz G,Liu Y,Brodie BR,Rinaldi MJ,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Mazzaferri EL,Mehran R,Stuckey TD,Kirtane AJ,Stone GW", + "auth_pos": 16, + "meshterms": "Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Hypertension, Hypertension/blood, Hypertension/complications*, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Platelet Aggregation, Platelet Aggregation/physiology*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/etiology, Postoperative Complications/prevention & control, Prospective Studies, Registries*, Risk Assessment, Risk Assessment/methods*, Risk Factors, Survival Rate, Survival Rate/trends, United States, United States/epidemiology, P2Y12 inhibitor*, Postoperative hypertension*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 54, + "user_id": 1447203401, + "artical_title": "Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative.", + "pmid": 31480872, + "journal_name": "European journal of preventive cardiology", + "date": "2019-09-05", + "author": "Farhan S,Baber U,Vogel B,Aquino M,Giustino G,Chandrasekhar J,Sorrentino S,Guedeney P,Manzanilla G,Bunal N,Rassouli M,Barman N,Sweeny J,Khan A,Dangas G,Mehran R,Kini A,Sharma SK", + "auth_pos": 16, + "meshterms": "Aged, Aged, 80 and over, Feasibility Studies, Female, Health Status*, Humans, Male, Middle Aged, Patient Reported Outcome Measures*, Percutaneous Coronary Intervention*, Quality Improvement, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 55, + "user_id": 1447203401, + "artical_title": "Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.", + "pmid": 31490029, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-09-07", + "author": "Plitt A,Claessen BE,Sartori S,Baber U,Chandrasekhar J,Aquino M,Vijay P,Elsayed S,Kovacic JC,Sweeny J,Barman N,Moreno P,Krishnan P,Demopoulos A,Dangas G,Kini AS,Mehran R,Sharma SK", + "auth_pos": 17, + "meshterms": "Aged, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug-Eluting Stents*, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Prosthesis Design, Registries, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 56, + "user_id": 1447203401, + "artical_title": "The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.", + "pmid": 31489742, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-09-07", + "author": "Haude M,Lee SWL,Worthley SG,Silber S,Verheye S,Rosli MA,Botelho R,Sim KH,Abizaid A,Mehran R", + "auth_pos": 10, + "meshterms": "Aged, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Cardiovascular Agents/adverse effects, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/pathology, Coronary Artery Disease/therapy*, Coronary Restenosis, Coronary Restenosis/etiology, Coronary Thrombosis, Coronary Thrombosis/etiology, Drug-Eluting Stents*, Endothelial Progenitor Cells, Endothelial Progenitor Cells/pathology*, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Prospective Studies, Risk Factors, Sirolimus, Sirolimus/administration & dosage*, Sirolimus/adverse effects, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 57, + "user_id": 1447203401, + "artical_title": "Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization.", + "pmid": 31493829, + "journal_name": "The American journal of cardiology", + "date": "2019-09-09", + "author": "Redfors B,Chen S,Généreux P,Witzenbichler B,Weisz G,Stuckey TD,Maehara A,McAndrew T,Mehran R,Ben-Yehuda O,Kirtane AJ,Stone GW", + "auth_pos": 9, + "meshterms": "Animals, Coronary Stenosis, Coronary Stenosis/diagnosis, Coronary Stenosis/surgery*, Coronary Thrombosis, Coronary Thrombosis/blood, Coronary Thrombosis/epidemiology, Coronary Thrombosis/etiology*, Female, Follow-Up Studies, Germany, Germany/epidemiology, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Platelet Aggregation, Platelet Aggregation/physiology*, Postoperative Complications*, Prospective Studies, Registries, Risk Assessment, Risk Assessment/methods*, Stents, Stents/adverse effects*, Survival Rate, Survival Rate/trends, United States, United States/epidemiology, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 58, + "user_id": 1447203401, + "artical_title": "Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.", + "pmid": 31521648, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2019-09-16", + "author": "Almendarez M,Gurm HS,Mariani J,Montorfano M,Brilakis ES,Mehran R,Azzalini L", + "auth_pos": 6, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Coronary Angiography, Coronary Angiography/adverse effects*, Humans, Incidence, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Protective Factors, Radiography, Interventional, Radiography, Interventional/adverse effects*, Risk Assessment, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 59, + "user_id": 1447203401, + "artical_title": "Minding the Microcirculation: Is it Worth the Effort?", + "pmid": 31525079, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-09-17", + "author": "Claessen BE,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "Coronary Artery Disease*, Coronary Circulation, Humans, Microcirculation, Percutaneous Coronary Intervention*, Prognosis", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 60, + "user_id": 1447203401, + "artical_title": "Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.", + "pmid": 31553201, + "journal_name": "Circulation", + "date": "2019-09-26", + "author": "Vora AN,Alexander JH,Wojdyla DM,Aronson R,Granger CB,Darius H,Windecker S,Mehran R,Averkov O,Budaj A,Kong DF,Kobalava Z,Mehta RH,Mirza Z,Guimaraes PO,Parkhomenko A,Quadros A,Thiele H,Goodman SG,Lopes RD", + "auth_pos": 8, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy*, Acute Coronary Syndrome/surgery, Aged, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Aspirin, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Combined Modality Therapy, Drug Therapy, Combination, Elective Surgical Procedures, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Length of Stay, Length of Stay/statistics & numerical data, Male, Middle Aged, Multicenter Studies as Topic, Multicenter Studies as Topic/statistics & numerical data, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Proportional Hazards Models, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use, Pyrazoles, Pyrazoles/therapeutic use*, Pyridones, Pyridones/therapeutic use*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Survival Analysis, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 61, + "user_id": 1447203401, + "artical_title": "Ticagrelor with or without Aspirin in High-Risk Patients after PCI.", + "pmid": 31556978, + "journal_name": "The New England journal of medicine", + "date": "2019-09-27", + "author": "Mehran R,Baber U,Sharma SK,Cohen DJ,Angiolillo DJ,Briguori C,Cha JY,Collier T,Dangas G,Dudek D,Džavík V,Escaned J,Gil R,Gurbel P,Hamm CW,Henry T,Huber K,Kastrati A,Kaul U,Kornowski R,Krucoff M,Kunadian V,Marx SO,Mehta SR,Moliterno D,Ohman EM,Oldroyd K,Sardella G,Sartori S,Shlofmitz R,Steg PG,Weisz G,Witzenbichler B,Han YL,Pocock S,Gibson CM", + "auth_pos": 1, + "meshterms": "Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Coronary Disease, Coronary Disease/drug therapy, Coronary Disease/therapy*, Double-Blind Method, Drug Therapy, Combination, Female, Hemorrhage, Hemorrhage/chemically induced*, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stroke, Stroke/epidemiology, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, P2Y12 inhibitor*, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 62, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.", + "pmid": 31557056, + "journal_name": "Circulation", + "date": "2019-09-27", + "author": "Windecker S,Lopes RD,Massaro T,Jones-Burton C,Granger CB,Aronson R,Heizer G,Goodman SG,Darius H,Jones WS,Aschermann M,Brieger D,Cura F,Engstrøm T,Fridrich V,Halvorsen S,Huber K,Kang HJ,Leiva-Pons JL,Lewis BS,Malaga G,Meneveau N,Merkely B,Milicic D,Morais J,Potpara TS,Raev D,Sabaté M,de Waha-Thiele S,Welsh RC,Xavier D,Mehran R,Alexander JH", + "auth_pos": 32, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy*, Acute Coronary Syndrome/surgery, Aged, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Aspirin, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Combined Modality Therapy, Disease Management, Drug Therapy, Combination, Elective Surgical Procedures, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Hospitalization, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Proportional Hazards Models, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use, Pyrazoles, Pyrazoles/therapeutic use*, Pyridones, Pyridones/therapeutic use*, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 63, + "user_id": 1447203401, + "artical_title": "Contrast-Associated Acute Kidney Injury. Reply.", + "pmid": 31553855, + "journal_name": "The New England journal of medicine", + "date": "2019-09-29", + "author": "Mehran R,Dangas GD,Weisbord SD", + "auth_pos": 1, + "meshterms": "Acute Kidney Injury*, Contrast Media, Humans", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 64, + "user_id": 1447203401, + "artical_title": "Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.", + "pmid": 31562798, + "journal_name": "The New England journal of medicine", + "date": "2019-09-29", + "author": "Stone GW,Kappetein AP,Sabik JF,Pocock SJ,Morice MC,Puskas J,Kandzari DE,Karmpaliotis D,Brown WM,Lembo NJ,Banning A,Merkely B,Horkay F,Boonstra PW,van Boven AJ,Ungi I,Bogáts G,Mansour S,Noiseux N,Sabaté M,Pomar J,Hickey M,Gershlick A,Buszman PE,Bochenek A,Schampaert E,Pagé P,Modolo R,Gregson J,Simonton CA,Mehran R,Kosmidou I,Généreux P,Crowley A,Dressler O,Serruys PW", + "auth_pos": 31, + "meshterms": "Aged, Coronary Artery Bypass*, Coronary Artery Disease, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Coronary Artery Disease/therapy*, Drug-Eluting Stents*, Everolimus, Everolimus/administration & dosage, Female, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Ischemia, Myocardial Ischemia/therapy, Odds Ratio, Percutaneous Coronary Intervention*, Stroke, Stroke/epidemiology, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 65, + "user_id": 1447203401, + "artical_title": "Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement.", + "pmid": 31562908, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-29", + "author": "Vlastra W,Chandrasekhar J,García Del Blanco B,Tchétché D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Baan J,Tijssen JGP,Moreno R,Dumonteil N,Tarasoutchi F,Sartori S,D'Errigo P,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Berenguer A,Modine T,Dangas G,Mehran R,Piek JJ,Delewi R", + "auth_pos": 25, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Catheterization, Peripheral, Catheterization, Peripheral/methods*, Europe, Europe/epidemiology, Female, Femoral Artery, Humans, Male, Postoperative Complications, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Postoperative hypertension*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 66, + "user_id": 1447203401, + "artical_title": "Non-atherosclerotic causes of acute coronary syndromes.", + "pmid": 31582839, + "journal_name": "Nature reviews. Cardiology", + "date": "2019-10-05", + "author": "Waterbury TM,Tarantini G,Vogel B,Mehran R,Gersh BJ,Gulati R", + "auth_pos": 4, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/etiology*, Humans", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 67, + "user_id": 1447203401, + "artical_title": "Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.", + "pmid": 30354629, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-10-30", + "author": "Brener SJ,Kirtane AJ,Rinaldi MJ,Stuckey TD,Witzenbichler B,Weisz G,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Mazzaferri EL,Gurbel PA,Brodie BR,Mehran R,McAndrew T,Stone GW", + "auth_pos": 15, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 68, + "user_id": 1447203401, + "artical_title": "The obesity paradox revisited: body mass index and -long-term outcomes after PCI from a large pooled patient-level database.", + "pmid": 31659983, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2019-10-30", + "author": "Wolny R,Maehara A,Liu Y,Zhang Z,Mintz GS,Redfors B,Madhavan MV,Smits PC,von Birgelen C,Serruys PW,Mehran R,Leon MB,Stone GW", + "auth_pos": 11, + "meshterms": "Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome, Body Mass Index, Coronary Artery Disease*, Humans, Obesity*, Overweight, Percutaneous Coronary Intervention*, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 69, + "user_id": 1447203401, + "artical_title": "Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty?", + "pmid": 31672178, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-02", + "author": "Mehran R,Cao D,Baber U", + "auth_pos": 1, + "meshterms": "Aspirin, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Ticagrelor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 70, + "user_id": 1447203401, + "artical_title": "Reply: \"Zero\": The New Superhero or Superhero in Training?", + "pmid": 31672197, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-02", + "author": "Mortensen MB,Fuster V,Mehran R,Baber U,Falk E", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 71, + "user_id": 1447203401, + "artical_title": "Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study.", + "pmid": 31672031, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-11-02", + "author": "Gupta R,Kirtane AJ,Liu Y,Crowley A,Witzenbichler B,Rinaldi MJ,Metzger DC,Weisz G,Stuckey TD,Brodie BR,Mehran R,Ben-Yehuda O,Stone GW", + "auth_pos": 11, + "meshterms": "Aged, Blood Platelets, Blood Platelets/drug effects*, Blood Platelets/metabolism, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/blood, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control*, Drug-Eluting Stents, Female, Humans, Male, Middle Aged, Non-Smokers, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Platelet Activation, Platelet Activation/drug effects*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage*, Purinergic P2Y Receptor Antagonists/adverse effects, Receptors, Purinergic P2Y12, Receptors, Purinergic P2Y12/blood, Receptors, Purinergic P2Y12/drug effects*, Registries, Risk Factors, Smokers, Smoking, Smoking/adverse effects*, Smoking/blood, Time Factors, Treatment Outcome, United States, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 72, + "user_id": 1447203401, + "artical_title": "Aortic Valve Stenosis Treatment Disparities in the Underserved: JACC Council Perspectives.", + "pmid": 31672188, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-02", + "author": "Batchelor W,Anwaruddin S,Ross L,Alli O,Young MN,Horne A,Cestoni A,Welt F,Mehran R", + "auth_pos": 9, + "meshterms": "Aortic Valve Stenosis, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology*, Aortic Valve Stenosis/therapy*, Health Status Disparities*, Healthcare Disparities*, Humans, Vulnerable Populations*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 73, + "user_id": 1447203401, + "artical_title": "Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis).", + "pmid": 30502047, + "journal_name": "The American journal of cardiology", + "date": "2019-11-07", + "author": "Korjian S,Daaboul Y,Laliberté F,Zhao Q,Mehran R,Bode C,Halperin J,Verheugt FWA,Lip GYH,Cohen M,Peterson ED,Fox KAA,Gibson CM,Pinto DS", + "auth_pos": 5, + "meshterms": "Aged, Anticoagulants, Anticoagulants/economics*, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/therapy*, Drug Monitoring, Drug Monitoring/economics, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/economics, Heart Failure/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, International Normalized Ratio, Male, Patient Readmission, Patient Readmission/economics*, Patient Readmission/statistics & numerical data, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/economics, Platelet Aggregation Inhibitors/therapeutic use, Rivaroxaban, Rivaroxaban/economics, Rivaroxaban/therapeutic use, Warfarin, Warfarin/economics, Warfarin/therapeutic use, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 74, + "user_id": 1447203401, + "artical_title": "Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.", + "pmid": 31693078, + "journal_name": "JAMA cardiology", + "date": "2019-11-07", + "author": "Chichareon P,Modolo R,Kerkmeijer L,Tomaniak M,Kogame N,Takahashi K,Chang CC,Komiyama H,Moccetti T,Talwar S,Colombo A,Maillard L,Barlis P,Wykrzykowska J,Piek JJ,Garg S,Hamm C,Steg PG,Jüni P,Valgimigli M,Windecker S,Onuma Y,Mehran R,Serruys PW", + "auth_pos": 23, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 75, + "user_id": 1447203401, + "artical_title": "Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.", + "pmid": 31707833, + "journal_name": "Circulation", + "date": "2019-11-12", + "author": "Lopes RD,Leonardi S,Wojdyla DM,Vora AN,Thomas L,Storey RF,Vinereanu D,Granger CB,Goodman SG,Aronson R,Windecker S,Thiele H,Valgimigli M,Mehran R,Alexander JH", + "auth_pos": 14, + "meshterms": "Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/diagnostic imaging, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Pyrazoles, Pyrazoles/adverse effects, Pyrazoles/therapeutic use*, Pyridones, Pyridones/adverse effects, Pyridones/therapeutic use*, Risk Factors, Stents*, Time Factors, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 76, + "user_id": 1447203401, + "artical_title": "Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.", + "pmid": 31707805, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-11-12", + "author": "Kerneis M,Yee MK,Mehran R,Nafee T,Bode C,Halperin JL,Peterson ED,Verheugt FWA,Wildgoose P,van Eickels M,Lip GYH,Cohen M,Fox KAA,Gibson CM", + "auth_pos": 3, + "meshterms": "Administration, Oral, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy*, Drug Therapy, Combination, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage*, Factor Xa Inhibitors/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Patient Readmission, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Rivaroxaban/adverse effects, Stents*, Time Factors, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors*, Warfarin, Warfarin/administration & dosage*, Warfarin/adverse effects, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 77, + "user_id": 1447203401, + "artical_title": "Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.", + "pmid": 31721430, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-11-14", + "author": "Rubin GA,Kirtane AJ,Chen S,Redfors B,Weisz G,Baber U,Zhang Y,Stuckey TD,Witzenbichler B,Rinaldi MJ,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Brodie BR,Mazzaferri EL,Mehran R,Ali ZA,Ben-Yehuda O,Stone GW", + "auth_pos": 18, + "meshterms": "Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clopidogrel, Clopidogrel/adverse effects, Clopidogrel/therapeutic use*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/mortality, Coronary Thrombosis/prevention & control, Drug-Eluting Stents, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Germany, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Platelet Function Tests, Prospective Studies, Registries, Renal Dialysis*, Renal Dialysis/adverse effects, Renal Dialysis/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/therapy*, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 78, + "user_id": 1447203401, + "artical_title": "Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.", + "pmid": 29976363, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2019-11-15", + "author": "Schmidt T,Leon MB,Mehran R,Kuck KH,Alu MC,Braumann RE,Kodali S,Kapadia SR,Linke A,Makkar R,Naber C,Romero ME,Virmani R,Frerker C", + "auth_pos": 3, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Embolic Protection Devices*, Female, Heart Valve Prosthesis*, Humans, Intracranial Embolism, Intracranial Embolism/etiology, Intracranial Embolism/pathology, Intracranial Embolism/prevention & control*, Male, Multicenter Studies as Topic, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 79, + "user_id": 1447203401, + "artical_title": "Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success.", + "pmid": 31738602, + "journal_name": "Circulation", + "date": "2019-11-19", + "author": "Ortega RF,Yancy CW,Mehran R,Batchelor W", + "auth_pos": 3, + "meshterms": "Age Factors, Biological Variation, Population*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Ethnic Groups, Health Status Disparities, Healthcare Disparities, Humans, Minority Groups, Patient Selection*, Race Factors, Research Subjects*, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 80, + "user_id": 1447203401, + "artical_title": "Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.", + "pmid": 30760427, + "journal_name": "The Canadian journal of cardiology", + "date": "2019-11-19", + "author": "Mehilli J,Chandrasekhar J,Sartori S,Chieffo A,Petronio AS,Lefèvre T,Presbitero P,Capranzano P,Tchetche D,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Jochheim D,Zadrozny M,Mikhail GW,Sharma S,Ferrer MC,Naber C,Kievit P,Moalem K,Baber U,Snyder C,Sharma M,Morice MC,Mehran R", + "auth_pos": 29, + "meshterms": "Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Europe, Europe/epidemiology, Female, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Incidence, North America, North America/epidemiology, Patient Discharge, Patient Discharge/trends*, Postoperative Complications, Postoperative Complications/epidemiology*, Prospective Studies, Registries*, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 81, + "user_id": 1447203401, + "artical_title": "Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.", + "pmid": 31779786, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-30", + "author": "Wood DA,Cairns JA,Wang J,Mehran R,Storey RF,Nguyen H,Meeks B,Kunadian V,Tanguay JF,Kim HH,Cheema A,Dehghani P,Natarajan MK,Jolly SS,Amerena J,Keltai M,James S,Hlinomaz O,Niemela K,AlHabib K,Lewis BS,Nguyen M,Sarma J,Dzavik V,Della Siega A,Mehta SR", + "auth_pos": 4, + "meshterms": "Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery*, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnosis, ST Elevation Myocardial Infarction/surgery*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 82, + "user_id": 1447203401, + "artical_title": "Examining the role of diabetes mellitus in ST-elevation myocardial infarction.", + "pmid": 31793178, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-12-04", + "author": "Chandiramani R,Mehran R", + "auth_pos": 2, + "meshterms": "Diabetes Mellitus*, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, ST Elevation Myocardial Infarction*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 83, + "user_id": 1447203401, + "artical_title": "Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.", + "pmid": 31808295, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-12-07", + "author": "Zilberszac R,Chandiramani R,Hengstenberg C,Sartori S,Cao D,Chandrasekhar J,Schafer U,Tchetche D,Violini R,Jeger R,Van Belle E,Boekstegers P,Hambrecht R,Tron C,Dumenteil N,Linke A,Ten Berg JM,Deliargyris EN,Anthopoulos P,Mehran R,Dangas G", + "auth_pos": 20, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Catheterization, Peripheral*, Catheterization, Peripheral/adverse effects, Catheterization, Peripheral/mortality, Cerebrovascular Disorders, Cerebrovascular Disorders/etiology, Cerebrovascular Disorders/mortality, Europe, Female, Femoral Artery*, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/mortality, Heparin, Heparin/adverse effects, Heparin/therapeutic use*, Hirudins, Hirudins/adverse effects, Hospital Mortality, Humans, Male, Myocardial Infarction, Myocardial Infarction/etiology, Myocardial Infarction/mortality, North America, Peptide Fragments, Peptide Fragments/adverse effects, Peptide Fragments/therapeutic use*, Peripheral Arterial Disease, Peripheral Arterial Disease/complications*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/mortality, Punctures, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/adverse effects, Recombinant Proteins/therapeutic use, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 84, + "user_id": 1447203401, + "artical_title": "Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.", + "pmid": 31809479, + "journal_name": "Coronary artery disease", + "date": "2019-12-07", + "author": "Huang X,Chen S,Redfors B,Zhang Y,Souza CF,Mehran R,Bansilal S,Kirtane AJ,Brener SJ,Feite F,Dangas GD,Ben-Yehuda O,Stone GW", + "auth_pos": 6, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/blood, Acute Coronary Syndrome/therapy*, Aged, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/therapeutic use*, Creatine Kinase, MB Form, Creatine Kinase, MB Form/blood*, Enoxaparin, Enoxaparin/therapeutic use, Female, Hirudins, Humans, Male, Middle Aged, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/blood, Non-ST Elevated Myocardial Infarction/therapy*, Partial Thromboplastin Time, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Platelet Glycoprotein GPIIb-IIIa Complex, Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Troponin, Troponin/blood*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 85, + "user_id": 1447203401, + "artical_title": "Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).", + "pmid": 31813530, + "journal_name": "The American journal of cardiology", + "date": "2019-12-10", + "author": "Giannini C,Petronio AS,Mehilli J,Sartori S,Chandrasekhar J,Faggioni M,Lefèvre T,Presbitero P,Capranzano P,Tchetche D,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail GW,Ferrer MC,Naber C,Kievit P,Sorrentino S,Morice MC,Chieffo A,Mehran R", + "auth_pos": 25, + "meshterms": "Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Bioprosthesis*, Cause of Death, Cause of Death/trends, Europe, Europe/epidemiology, Female, Humans, Incidence, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology*, Prosthesis Design, Registries*, Risk Factors, Survival Rate, Survival Rate/trends, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, United States, United States/epidemiology, Postoperative hypertension*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 86, + "user_id": 1447203401, + "artical_title": "Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.", + "pmid": 31820428, + "journal_name": "Thrombosis and haemostasis", + "date": "2019-12-11", + "author": "Bikdeli B,McAndrew T,Crowley A,Chen S,Mehdipoor G,Redfors B,Liu Y,Zhang Z,Liu M,Zhang Y,Francese DP,Erlinge D,James SK,Han Y,Li Y,Kastrati A,Schüpke S,Stables RH,Shahzad A,Steg PG,Goldstein P,Frigoli E,Mehran R,Valgimigli M,Stone GW", + "auth_pos": 23, + "meshterms": "Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome, Algorithms, Anticoagulants, Anticoagulants/therapeutic use*, Data Interpretation, Statistical*, Databases, Factual, Drug Administration Schedule, Heparin, Heparin/therapeutic use*, Hirudins, Humans, Medical Informatics, Myocardial Infarction, Myocardial Infarction/drug therapy*, Outcome Assessment, Health Care, Peptide Fragments, Peptide Fragments/therapeutic use*, Percutaneous Coronary Intervention*, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Risk, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 87, + "user_id": 1447203401, + "artical_title": "Trends and Outcomes of Intravascular Imaging-guided Percutaneous Coronary Intervention in the United States.", + "pmid": 31895248, + "journal_name": "Critical pathways in cardiology", + "date": "2020-01-03", + "author": "Lemor A,Patel N,Jain T,Baber U,Hernandez G,Villablanca P,Basir MB,Alaswad K,Mehran R,Dangas G,Sharma SK,Kini A", + "auth_pos": 9, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/epidemiology, Adolescent, Adult, Aged, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Hospital Costs, Hospital Mortality*, Humans, Length of Stay, Male, Middle Aged, Odds Ratio, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Percutaneous Coronary Intervention/trends, Postoperative Complications, Postoperative Complications/epidemiology*, Propensity Score, Shock, Cardiogenic, Shock, Cardiogenic/epidemiology, Surgery, Computer-Assisted, Surgery, Computer-Assisted/methods*, Surgery, Computer-Assisted/trends, Tomography, Optical Coherence, Tomography, Optical Coherence/methods, Tomography, Optical Coherence/trends, Ultrasonography, Interventional, Ultrasonography, Interventional/methods, Ultrasonography, Interventional/trends, United States, Young Adult", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 88, + "user_id": 1447203401, + "artical_title": "Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.", + "pmid": 31915997, + "journal_name": "Clinical research in cardiology : official journal of the German Cardiac Society", + "date": "2020-01-10", + "author": "Chandrasekhar J,Baber U,Sartori S,Aquino M,Moalem K,Kini AS,Rao SV,Weintraub W,Henry TD,Vogel B,Ge Z,Muhlestein JB,Weiss S,Strauss C,Toma C,DeFranco A,Claessen BE,Keller S,Baker BA,Effron MB,Pocock S,Dangas G,Kapadia S,Mehran R", + "auth_pos": 24, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/physiopathology, Acute Coronary Syndrome/therapy*, Aged, Coronary Angiography, Electrocardiography, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Complications, Postoperative Complications/epidemiology*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use*, Preoperative Care, Preoperative Care/methods*, Prospective Studies, Survival Rate, Survival Rate/trends, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 89, + "user_id": 1447203401, + "artical_title": "Gender differences in industry payments among cardiologists.", + "pmid": 31926591, + "journal_name": "American heart journal", + "date": "2020-01-14", + "author": "Raber I,McCarthy CP,Al Rifai M,Vaduganathan M,Michos ED,Wood MJ,Smyth YM,Ibrahim NE,DeFaria Yeh D,Asnani A,Mehran R,McEvoy JW", + "auth_pos": 11, + "meshterms": "Cardiology, Cardiology/statistics & numerical data*, Cross-Sectional Studies, Female, Humans, Male, Medicaid, Medicare, Physicians, Women, Physicians, Women/statistics & numerical data*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/statistics & numerical data*, Sex Distribution, Sex Factors, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 90, + "user_id": 1447203401, + "artical_title": "Comparison of Age (<75 Years Vs ?75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).", + "pmid": 31926634, + "journal_name": "The American journal of cardiology", + "date": "2020-01-14", + "author": "Faggioni M,Redfors B,Crowley A,Claessen BE,Farhan S,Mastoris I,Witzenbichler B,Maehara A,Weisz G,Généreux P,Ben-Yehuda O,Mehran R,Kirtane AJ,Stone GW", + "auth_pos": 12, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/therapy*, Adult, Age Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/therapeutic use, Cause of Death, Clopidogrel, Clopidogrel/therapeutic use*, Drug-Eluting Stents, Graft Occlusion, Vascular, Graft Occlusion, Vascular/epidemiology, Hemorrhage, Hemorrhage/epidemiology*, Humans, Middle Aged, Mortality, Multivariate Analysis, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/therapy*, Percutaneous Coronary Intervention*, Platelet Activation*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Proportional Hazards Models, Prospective Studies, Recurrence, Thrombosis, Thrombosis/epidemiology*, Young Adult, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 91, + "user_id": 1447203401, + "artical_title": "The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.", + "pmid": 31943717, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-01-17", + "author": "Camaj A,Claessen BE,Mehran R,Yudi MB,Power D,Baber U,Hengstenberg C,Lefevre T,Van Belle E,Giustino G,Guedeney P,Sorrentino S,Kupatt C,Webb JG,Hildick-Smith D,Hink HU,Deliargyris EN,Anthopoulos P,Sharma SK,Kini A,Sartori S,Chandrasekhar J,Dangas GD", + "auth_pos": 3, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/therapeutic use, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Clinical Decision-Making*, Decision Support Techniques*, Female, Hemodynamics, Heparin, Heparin/therapeutic use, Hirudins, Humans, Male, Patient Care Team*, Patient Selection, Peptide Fragments, Peptide Fragments/therapeutic use, Postoperative Complications, Postoperative Complications/etiology, Predictive Value of Tests, Randomized Controlled Trials as Topic, Recombinant Proteins, Recombinant Proteins/therapeutic use, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 92, + "user_id": 1447203401, + "artical_title": "Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.", + "pmid": 31953535, + "journal_name": "Nature reviews. Cardiology", + "date": "2020-01-19", + "author": "Capodanno D,Bhatt DL,Eikelboom JW,Fox KAA,Geisler T,Michael Gibson C,Gonzalez-Juanatey JR,James S,Lopes RD,Mehran R,Montalescot G,Patel M,Steg PG,Storey RF,Vranckx P,Weitz JI,Welsh R,Zeymer U,Angiolillo DJ", + "auth_pos": 10, + "meshterms": "Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications, Drug Therapy, Combination, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Factor Xa Inhibitors/therapeutic use*, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage, Fibrinolytic Agents/therapeutic use*, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/therapeutic use*, Thrombosis, Thrombosis/etiology, Thrombosis/prevention & control*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 93, + "user_id": 1447203401, + "artical_title": "Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.", + "pmid": 31954680, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-01-20", + "author": "Giustino G,Serruys PW,Sabik JF,Mehran R,Maehara A,Puskas JD,Simonton CA,Lembo NJ,Kandzari DE,Morice MC,Taggart DP,Gershlick AH,Ragosta M,Kron IL,Liu Y,Zhang Z,McAndrew T,Dressler O,Généreux P,Ben-Yehuda O,Pocock SJ,Kappetein AP,Stone GW", + "auth_pos": 4, + "meshterms": "Aged, Coronary Angiography, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/mortality*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug-Eluting Stents, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality*, Reoperation, Reoperation/adverse effects, Reoperation/mortality*, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 94, + "user_id": 1447203401, + "artical_title": "Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.", + "pmid": 31475907, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-01-23", + "author": "Chang CC,Kogame N,Onuma Y,Byrne RA,Capodanno D,Windecker S,Morel MA,Cutlip DE,Krucoff MW,Stone GW,Lansky AJ,Mehran R,Spitzer E,Fraser AG,Baumbach A,Serruys PW", + "auth_pos": 12, + "meshterms": "Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Reproducibility of Results, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 95, + "user_id": 1447203401, + "artical_title": "The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.", + "pmid": 31977142, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-01-25", + "author": "Bandyopadhyay D,Sartori S,Baber U,Cao D,Chandiramani R,Tchétché D,Petronio AS,Mehilli J,Lefèvre T,Presbitero P,Capranzaro P,Sardella G,Van Mieghem NM,Chandrasekhar J,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail GW,Naber C,Kini A,Morice MC,Claessen BE,Chieffo A,Mehran R", + "auth_pos": 24, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 96, + "user_id": 1447203401, + "artical_title": "Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.", + "pmid": 31992063, + "journal_name": "Circulation", + "date": "2020-01-30", + "author": "Sorrentino S,Claessen BE,Chandiramani R,Guedeney P,Vogel B,Baber U,Rau V,Wang J,Krucoff M,Kozuma K,Ge J,Seth A,Makkar R,Liu Y,Bangalore S,Bhatt DL,Angiolillo DJ,Saito S,Neumann FJ,Hermiller J,Valgimigli M,Mehran R", + "auth_pos": 22, + "meshterms": "Aged, Aged, 80 and over, Cause of Death, Chromium, Cobalt, Comorbidity, Coronary Restenosis, Coronary Restenosis/epidemiology, Coronary Restenosis/etiology, Coronary Stenosis, Coronary Stenosis/complications, Coronary Stenosis/therapy*, Coronary Thrombosis, Coronary Thrombosis/epidemiology, Coronary Thrombosis/etiology*, Drug Therapy, Combination, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Everolimus, Everolimus/administration & dosage, Everolimus/adverse effects*, Everolimus/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology*, Hemorrhagic Disorders, Hemorrhagic Disorders/epidemiology, Humans, Kaplan-Meier Estimate, Male, Metabolic Syndrome, Metabolic Syndrome/epidemiology, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/instrumentation*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Polymers, Prevalence, Proportional Hazards Models, Prospective Studies, Registries, Smoking, Smoking/epidemiology, Treatment Outcome, TIMI bleeding*, GUSTO bleeding*, Thrombolysis*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 97, + "user_id": 1447203401, + "artical_title": "Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.", + "pmid": 30955866, + "journal_name": "The American journal of cardiology", + "date": "2020-01-30", + "author": "Guedeney P,Claessen BE,Baber U,Camaj A,Sorrentino S,Aquino M,Blum M,Chandiramani R,Goel R,Elsayed S,Kovacic JC,Sweeny J,Barman N,Moreno P,Dangas GD,Kini A,Sharma S,Mehran R", + "auth_pos": 18, + "meshterms": "Aged, Cholesterol, Cholesterol/blood*, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/surgery*, Drug Prescriptions, Drug Prescriptions/statistics & numerical data*, Female, Follow-Up Studies, Guideline Adherence, Guideline Adherence/statistics & numerical data*, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Percutaneous Coronary Intervention*, Prospective Studies, Risk Assessment, Risk Factors, Time Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 98, + "user_id": 1447203401, + "artical_title": "A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.", + "pmid": 31733180, + "journal_name": "The New England journal of medicine", + "date": "2020-01-31", + "author": "Dangas GD,Tijssen JGP,Wöhrle J,Søndergaard L,Gilard M,Möllmann H,Makkar RR,Herrmann HC,Giustino G,Baldus S,De Backer O,Guimarães AHC,Gullestad L,Kini A,von Lewinski D,Mack M,Moreno R,Schäfer U,Seeger J,Tchétché D,Thomitzek K,Valgimigli M,Vranckx P,Welsh RC,Wildgoose P,Volkl AA,Zazula A,van Amsterdam RGM,Mehran R,Windecker S", + "auth_pos": 29, + "meshterms": "Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Clopidogrel, Clopidogrel/adverse effects, Clopidogrel/therapeutic use*, Drug Therapy, Combination, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Heart Valve Prosthesis, Hemorrhage, Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Rivaroxaban, Rivaroxaban/adverse effects, Rivaroxaban/therapeutic use*, Thromboembolism, Thromboembolism/mortality, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 99, + "user_id": 1447203401, + "artical_title": "Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.", + "pmid": 31733182, + "journal_name": "The New England journal of medicine", + "date": "2020-01-31", + "author": "De Backer O,Dangas GD,Jilaihawi H,Leipsic JA,Terkelsen CJ,Makkar R,Kini AS,Veien KT,Abdel-Wahab M,Kim WK,Balan P,Van Mieghem N,Mathiassen ON,Jeger RV,Arnold M,Mehran R,Guimarães AHC,Nørgaard BL,Kofoed KF,Blanke P,Windecker S,Søndergaard L", + "auth_pos": 16, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/drug effects, Aortic Valve/pathology, Aortic Valve/physiopathology*, Aspirin, Aspirin/adverse effects, Aspirin/pharmacology*, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Clopidogrel, Clopidogrel/adverse effects, Clopidogrel/pharmacology*, Clopidogrel/therapeutic use, Drug Therapy, Combination, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/pharmacology*, Factor Xa Inhibitors/therapeutic use, Female, Four-Dimensional Computed Tomography, Heart Valve Prosthesis*, Hemorrhage, Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Male, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/pharmacology*, Platelet Aggregation Inhibitors/therapeutic use, Rivaroxaban, Rivaroxaban/adverse effects, Rivaroxaban/pharmacology*, Rivaroxaban/therapeutic use, Thromboembolism, Thromboembolism/etiology, Thromboembolism/mortality, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 100, + "user_id": 1447203401, + "artical_title": "SCAI multi-society position statement on occupational health hazards of the catheterization laboratory: Shifting the paradigm for Healthcare Workers' Protection.", + "pmid": 32043834, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-02-12", + "author": "Klein LW,Goldstein JA,Haines D,Chambers C,Mehran R,Kort S,Valentine CM,Cox D", + "auth_pos": 5, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/standards*, Consensus, Humans, Musculoskeletal Diseases, Musculoskeletal Diseases/epidemiology, Musculoskeletal Diseases/prevention & control*, Occupational Exposure, Occupational Exposure/adverse effects, Occupational Exposure/prevention & control*, Occupational Health, Occupational Health/standards*, Protective Factors, Radiation Exposure, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control*, Radiation Injuries, Radiation Injuries/epidemiology, Radiation Injuries/prevention & control*, Radiography, Interventional, Radiography, Interventional/adverse effects, Radiography, Interventional/standards*, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 101, + "user_id": 1447203401, + "artical_title": "Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.", + "pmid": 30897527, + "journal_name": "American heart journal", + "date": "2020-02-13", + "author": "Finn MT,Redfors B,Karmpaliotis D,Kirtane AJ,Green P,McAndrew T,Liu M,Cloney MB,Witzenbichler B,Weisz G,Stuckey TD,Brodie BR,Rinaldi MJ,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Mazzaferri EL,Mehran R,Stone GW", + "auth_pos": 20, + "meshterms": "Aged, Aspirin, Aspirin/therapeutic use, Blood Platelets, Blood Platelets/physiology*, Coronary Occlusion, Coronary Occlusion/blood*, Coronary Occlusion/surgery*, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Humans, Male, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/etiology*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Complications, Prospective Studies, Prosthesis Design, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 102, + "user_id": 1447203401, + "artical_title": "Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.", + "pmid": 32057371, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-02-15", + "author": "Baber U,Zafar MU,Dangas G,Escolar G,Angiolillo DJ,Sharma SK,Kini AS,Sartori S,Joyce L,Vogel B,Farhan S,Gurbel P,Gibson CM,Fuster V,Mehran R,Badimon JJ", + "auth_pos": 15, + "meshterms": "Aged, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Blood, Blood/drug effects, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use*, Postoperative Complications, Postoperative Complications/prevention & control*, Thrombosis, Thrombosis/prevention & control*, Ticagrelor, Ticagrelor/pharmacology, Ticagrelor/therapeutic use*, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 103, + "user_id": 1447203401, + "artical_title": "Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.", + "pmid": 32057373, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-02-15", + "author": "Madhavan MV,Kirtane AJ,Redfors B,Généreux P,Ben-Yehuda O,Palmerini T,Benedetto U,Biondi-Zoccai G,Smits PC,von Birgelen C,Mehran R,McAndrew T,Serruys PW,Leon MB,Pocock SJ,Stone GW", + "auth_pos": 11, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/etiology, Stents, Stents/adverse effects*, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 104, + "user_id": 1447203401, + "artical_title": "Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.", + "pmid": 32087000, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-02-23", + "author": "Aoi S,Baber U,Kovacic JC,Mehran R,Aquino M,Dangas G,Sweeny J,Vijay P,Shah S,Barman N,Moreno P,Kini AS,Sharma SK", + "auth_pos": 4, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Databases, Factual, Female, Humans, Inflammation, Inflammation/blood, Inflammation/complications*, Inflammation/diagnosis, Inflammation/mortality, Inflammation Mediators, Inflammation Mediators/blood, Male, Myocardial Infarction, Myocardial Infarction/diagnosis, Myocardial Infarction/etiology*, Myocardial Infarction/mortality, New York City, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Vascular Calcification/therapy*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 105, + "user_id": 1447203401, + "artical_title": "Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.", + "pmid": 30947913, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-02-25", + "author": "Milojevic M,Serruys PW,Sabik JF,Kandzari DE,Schampaert E,van Boven AJ,Horkay F,Ungi I,Mansour S,Banning AP,Taggart DP,Sabaté M,Gershlick AH,Bochenek A,Pomar J,Lembo NJ,Noiseux N,Puskas JD,Crowley A,Kosmidou I,Mehran R,Ben-Yehuda O,Généreux P,Pocock SJ,Simonton CA,Stone GW,Kappetein AP", + "auth_pos": 21, + "meshterms": "Aged, Coronary Artery Bypass, Coronary Artery Bypass/mortality*, Coronary Artery Disease, Coronary Artery Disease/complications*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Diabetes Complications, Diabetes Complications/mortality*, Diabetes Complications/surgery, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/mortality*, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 106, + "user_id": 1447203401, + "artical_title": "Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.", + "pmid": 32101251, + "journal_name": "JAMA cardiology", + "date": "2020-02-27", + "author": "Lopes RD,Hong H,Harskamp RE,Bhatt DL,Mehran R,Cannon CP,Granger CB,Verheugt FWA,Li J,Ten Berg JM,Sarafoff N,Vranckx P,Goette A,Gibson CM,Alexander JH", + "auth_pos": 5, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, Atrial Fibrillation, Atrial Fibrillation/complications*, Dose-Response Relationship, Drug, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/therapy*, Network Meta-Analysis*, Percutaneous Coronary Intervention*, Stroke, Stroke/etiology, Stroke/prevention & control*, P2Y12 inhibitor*, TIMI bleeding*, Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 107, + "user_id": 1447203401, + "artical_title": "1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.", + "pmid": 32111358, + "journal_name": "International journal of cardiology", + "date": "2020-03-01", + "author": "Chandrasekhar J,Kalkman DN,Aquino MB,Sartori S,Hájek P,Atzev B,Hudec M,Ong TK,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iñiguez A,Coufal Z,Khashaba A,Schee A,Munawar M,Gerber RT,Yan BP,Tejedor P,Kala P,Liew HB,Lee M,Baber U,Vogel B,Dangas GD,Colombo A,de Winter RJ,Mehran R", + "auth_pos": 30, + "meshterms": "P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 108, + "user_id": 1447203401, + "artical_title": "Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy.", + "pmid": 32154750, + "journal_name": "Expert review of medical devices", + "date": "2020-03-11", + "author": "Blum M,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "Clinical Trials as Topic, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Humans, Prosthesis Design, Sirolimus, Sirolimus/adverse effects, Sirolimus/analogs & derivatives*, Sirolimus/therapeutic use, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 109, + "user_id": 1447203401, + "artical_title": "Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.", + "pmid": 32162781, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-03-13", + "author": "Chandrasekhar J,Dangas G,Baber U,Sartori S,Qadeer A,Aquino M,Vogel B,Faggioni M,Vijay P,Claessen BE,Goel R,Moreno P,Krishnan P,Kovacic JC,Kini A,Mehran R,Sharma S", + "auth_pos": 16, + "meshterms": "Aged, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Databases, Factual, Diabetes Mellitus, Diabetes Mellitus/diagnosis, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/mortality, Female, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Hypoglycemic Agents/therapeutic use*, Insulin, Insulin/adverse effects, Insulin/therapeutic use*, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 110, + "user_id": 1447203401, + "artical_title": "Ticagrelor with or without Aspirin after PCI. Reply.", + "pmid": 32160679, + "journal_name": "The New England journal of medicine", + "date": "2020-03-17", + "author": "Baber U,Dangas G,Mehran R", + "auth_pos": 3, + "meshterms": "Aspirin*, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists, Ticagrelor", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 111, + "user_id": 1447203401, + "artical_title": "Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trial.", + "pmid": 32199152, + "journal_name": "American heart journal", + "date": "2020-03-22", + "author": "Marquis-Gravel G,Huang Z,Zelenkofske SL,Lincoff AM,Mehran R,Steg PG,Bode C,Alexander JH,Povsic TJ", + "auth_pos": 5, + "meshterms": "Aged, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology*, Humans, Male, Middle Aged, Multicenter Studies as Topic, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Postoperative Complications, Postoperative Complications/chemically induced, Postoperative Complications/epidemiology*, Radial Artery, Randomized Controlled Trials as Topic, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 112, + "user_id": 1447203401, + "artical_title": "Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.", + "pmid": 32198837, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-03-22", + "author": "Chandrasekhar J,Kerkmeijer LS,Kalkman DN,Sartori S,Aquino MB,Woudstra P,Beijk MA,Tijssen JG,Koch KT,Hájek P,Atzev B,Hudec M,Ong TK,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iñiguez A,Coufal Z,Khashaba A,Munawar M,Gerber RT,Yan BP,Lee M,Baber U,Dangas GD,Colombo A,de Winter RJ,Mehran R", + "auth_pos": 30, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Drug-Eluting Stents*, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Sex Characteristics, Stents, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 113, + "user_id": 1447203401, + "artical_title": "Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke.", + "pmid": 30871358, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-03-24", + "author": "Vlastra W,Jimenez-Quevedo P,Tchétché D,Chandrasekhar J,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Baan J,Tijssen JGP,De la Torre Hernandez JM,Dumonteil N,Sarmento-Leite R,Sartori S,Rosato S,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Hernandez-Antolin R,Modine T,Dangas G,Mehran R,Piek JJ,Delewi R", + "auth_pos": 25, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Catheterization, Peripheral, Catheterization, Peripheral/adverse effects*, Catheterization, Peripheral/mortality, Clinical Trials as Topic, Female, Femoral Artery*, Humans, Incidence, Male, Punctures, Registries, Risk Assessment, Risk Factors, Stroke, Stroke/diagnosis, Stroke/epidemiology*, Stroke/mortality, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 114, + "user_id": 1447203401, + "artical_title": "Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.", + "pmid": 30732736, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-03-26", + "author": "Ghare MI,Chandrasekhar J,Mehran R,Ng V,Grines C,Lansky A", + "auth_pos": 3, + "meshterms": "Attitude of Health Personnel, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/physiopathology, Cardiovascular Diseases/therapy*, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Female, Health Knowledge, Attitudes, Practice, Health Status Disparities*, Healthcare Disparities*, Humans, Male, Patient Education as Topic, Patient Selection*, Research Subjects*, Sex Factors, Stakeholder Participation", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 115, + "user_id": 1447203401, + "artical_title": "Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.", + "pmid": 32211813, + "journal_name": "JAMA cardiology", + "date": "2020-03-27", + "author": "Tahhan AS,Vaduganathan M,Greene SJ,Alrohaibani A,Raad M,Gafeer M,Mehran R,Fonarow GC,Douglas PS,Bhatt DL,Butler J", + "auth_pos": 7, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/ethnology*, Acute Coronary Syndrome/therapy, Clinical Trials as Topic*, Continental Population Groups*, Ethnic Groups*, Female, Humans, Male, Minority Groups*, Patient Selection*, Sex Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 116, + "user_id": 1447203401, + "artical_title": "Effect of Baseline Anemia on Outcomes After Left Main Coronary Revascularization.", + "pmid": 32216919, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-03-29", + "author": "Gaba P,Serruys PW,Sabik JF,Kappetein AP,Chen S,Morice MC,Kandzari DE,Crowley A,Mehran R,Stone GW", + "auth_pos": 9, + "meshterms": "Anemia, Anemia/blood, Anemia/mortality, Anemia/surgery*, Coronary Artery Bypass, Coronary Artery Bypass/mortality, Coronary Artery Bypass/trends*, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/trends*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 117, + "user_id": 1447203401, + "artical_title": "Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.", + "pmid": 32216472, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-03-29", + "author": "Sorrentino S,Sartori S,Baber U,Claessen BE,Giustino G,Chandrasekhar J,Chandiramani R,Cohen DJ,Henry TD,Guedeney P,Ariti C,Dangas G,Gibson CM,Krucoff MW,Moliterno DJ,Colombo A,Vogel B,Chieffo A,Kini AS,Witzenbichler B,Weisz G,Steg PG,Pocock S,Urban P,Mehran R", + "auth_pos": 25, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/diagnostic imaging, Coronary Thrombosis/mortality, Coronary Thrombosis/prevention & control*, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Female, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/mortality, Humans, Incidence, Male, Medication Adherence, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects*, Prevalence, Prospective Studies, Registries, Risk Assessment, Risk Factors, Stents, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 118, + "user_id": 1447203401, + "artical_title": "Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.", + "pmid": 31097159, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-03-31", + "author": "Guedeney P,Claessen BE,Kalkman DN,Aquino M,Sorrentino S,Giustino G,Farhan S,Vogel B,Sartori S,Montalescot G,Sweeny J,Kovacic JC,Krishnan P,Barman N,Dangas G,Kini A,Baber U,Sharma S,Mehran R", + "auth_pos": 19, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis*, Cholesterol, LDL, Cholesterol, LDL/blood, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/complications, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Female, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis*, Inflammation/etiology, Inflammation/mortality, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Registries, Retrospective Studies, Risk Factors, Stroke, Stroke/blood, Stroke/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 119, + "user_id": 1447203401, + "artical_title": "Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.", + "pmid": 32223396, + "journal_name": "Journal of the American Heart Association", + "date": "2020-04-01", + "author": "Chandiramani R,Cao D,Claessen BE,Sorrentino S,Guedeney P,Blum M,Goel R,Roumeliotis A,Krucoff M,Kozuma K,Ge J,Seth A,Makkar R,Bangalore S,Bhatt DL,Angiolillo DJ,Ruster K,Wang J,Saito S,Neumann FJ,Hermiller J,Valgimigli M,Mehran R", + "auth_pos": 23, + "meshterms": "Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug-Eluting Stents, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/mortality, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology*, Hemorrhage/mortality, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/mortality, Prevalence, Recurrence, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Sex Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 120, + "user_id": 1447203401, + "artical_title": "Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.", + "pmid": 32223444, + "journal_name": "Circulation", + "date": "2020-04-01", + "author": "Alexander JH,Wojdyla D,Vora AN,Thomas L,Granger CB,Goodman SG,Aronson R,Windecker S,Mehran R,Lopes RD", + "auth_pos": 9, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/therapy*, Aged, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use*, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy*, Coronary Thrombosis, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Fibrinolytic Agents/therapeutic use*, Hemorrhage, Hemorrhage/chemically induced, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Pyrazoles, Pyrazoles/adverse effects, Pyrazoles/therapeutic use*, Pyridones, Pyridones/adverse effects, Pyridones/therapeutic use*, Randomized Controlled Trials as Topic, Recurrence, Retrospective Studies, Risk Assessment, Risk Factors, Stroke, Stroke/etiology, Stroke/prevention & control, Time Factors, Treatment Outcome, Vitamin K, Vitamin K/antagonists & inhibitors, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 121, + "user_id": 1447203401, + "artical_title": "Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.", + "pmid": 32050061, + "journal_name": "The New England journal of medicine", + "date": "2020-04-02", + "author": "Windecker S,Latib A,Kedhi E,Kirtane AJ,Kandzari DE,Mehran R,Price MJ,Abizaid A,Simon DI,Worthley SG,Zaman A,Hudec M,Poliacikova P,Abdul Ghapar AKB,Selvaraj K,Petrov I,Mylotte D,Pinar E,Moreno R,Fabbiocchi F,Pasupati S,Kim HS,Aminian A,Tie C,Wlodarczak A,Hur SH,Marx SO,Jankovic I,Brar S,Bousquette L,Liu M,Stone GW", + "auth_pos": 6, + "meshterms": "Coronary Artery Disease, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/etiology, Coronary Thrombosis/mortality, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Heart Diseases, Heart Diseases/mortality, Hemorrhage, Hemorrhage/chemically induced, Humans, Immunosuppressive Agents, Immunosuppressive Agents/administration & dosage*, Kaplan-Meier Estimate, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Polymers*, Prosthesis Design, Single-Blind Method, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 122, + "user_id": 1447203401, + "artical_title": "Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention.", + "pmid": 32240760, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-03", + "author": "Angiolillo DJ,Baber U,Sartori S,Briguori C,Dangas G,Cohen DJ,Mehta SR,Gibson CM,Chandiramani R,Huber K,Kornowski R,Weisz G,Kunadian V,Oldroyd KG,Ya-Ling H,Kaul U,Witzenbichler B,Dudek D,Sardella G,Escaned J,Sharma S,Shlofmitz RA,Collier T,Pocock S,Mehran R", + "auth_pos": 25, + "meshterms": "Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/surgery*, Double-Blind Method, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/trends*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Postoperative Complications, Postoperative Complications/chemically induced, Postoperative Complications/epidemiology, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Ticagrelor, Ticagrelor/administration & dosage*, Ticagrelor/adverse effects, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 123, + "user_id": 1447203401, + "artical_title": "Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis.", + "pmid": 32240761, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-03", + "author": "Dangas G,Baber U,Sharma S,Giustino G,Mehta S,Cohen D,Angiolillo D,Sartori S,Chandiramani R,Briguori C,Dudek D,Escaned J,Huber K,Collier T,Kornowski R,Kunadian V,Kaul U,Oldroyd K,Sardella G,Shlofmitz R,Witzenbichler B,Ya-Ling H,Pocock S,Gibson CM,Mehran R", + "auth_pos": 25, + "meshterms": "Aged, Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects, Double-Blind Method, Drug Therapy, Combination, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/trends*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Postoperative Complications, Postoperative Complications/chemically induced, Postoperative Complications/epidemiology, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/administration & dosage*, Ticagrelor/adverse effects, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 124, + "user_id": 1447203401, + "artical_title": "Clinical features and prognosis of patients with spontaneous coronary artery dissection.", + "pmid": 32245641, + "journal_name": "International journal of cardiology", + "date": "2020-04-05", + "author": "Krittanawong C,Kumar A,Wang Z,Johnson KW,Baber U,Palazzo A,Mehran R,Bhatt DL", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 125, + "user_id": 1447203401, + "artical_title": "The Conundrum and Opportunity of Gender Equity For Evidence Generators.", + "pmid": 32267464, + "journal_name": "JAMA cardiology", + "date": "2020-04-09", + "author": "Ortega RF,Mehran R,Douglas PS", + "auth_pos": 2, + "meshterms": "Biomedical Research*, Decision Making*, Female, Gender Equity*, Health Knowledge, Attitudes, Practice*, Humans, Leadership*, Male, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 126, + "user_id": 1447203401, + "artical_title": "Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention.", + "pmid": 32273029, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-11", + "author": "Kosmidou I,Leon MB,Zhang Y,Serruys PW,von Birgelen C,Smits PC,Ben-Yehuda O,Redfors B,Madhavan MV,Maehara A,Mehran R,Stone GW", + "auth_pos": 11, + "meshterms": "Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/physiopathology, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Heart Disease Risk Factors, Humans, Long Term Adverse Effects*, Long Term Adverse Effects/diagnosis, Long Term Adverse Effects/mortality, Male, Middle Aged, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/methods, Risk Assessment, Risk Assessment/methods, Risk Factors, Severity of Illness Index, Ischemia-driven revascularization*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 127, + "user_id": 1447203401, + "artical_title": "SCAI Multi-Society Position Statement on Occupational Health Hazards of the Catheterization Laboratory: Shifting the Paradigm for Healthcare Workers' Protection.", + "pmid": 32273037, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-11", + "author": "Klein LW,Goldstein JA,Haines D,Chambers C,Mehran R,Kort S,Valentine CM,Cox D", + "auth_pos": 5, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiology Service, Hospital, Cardiology Service, Hospital/standards*, Fluoroscopy, Fluoroscopy/adverse effects, Fluoroscopy/methods, Health Personnel*, Humans, Laboratories, Hospital, Laboratories, Hospital/standards*, Occupational Diseases*, Occupational Diseases/etiology, Occupational Diseases/prevention & control, Occupational Health, Occupational Health/standards*, Radiation Monitoring, Safety Management, Safety Management/methods, Safety Management/organization & administration", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 128, + "user_id": 1447203401, + "artical_title": "1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.", + "pmid": 32273094, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-04-11", + "author": "Chandrasekhar J,Kok MM,Kalkman DN,Aquino MB,Zocca P,Woudstra P,Beijk MA,Kerkmeijer LS,Sartori S,Baber U,Tijssen JG,Koch KT,Dangas GD,Colombo A,Pocock S,von Birgelen C,Mehran R,de Winter RJ", + "auth_pos": 17, + "meshterms": "Absorbable Implants*, Aged, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Cardiovascular Agents/adverse effects, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/etiology, Databases, Factual, Drug-Eluting Stents*, Europe, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Polymers, Polymers/chemistry*, Propensity Score, Prosthesis Design, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage*, Sirolimus/adverse effects, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 129, + "user_id": 1447203401, + "artical_title": "Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis.", + "pmid": 32275743, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2020-04-11", + "author": "Guedeney P,Sorrentino S,Giustino G,Chapelle C,Laporte S,Claessen BE,Ollier E,Camaj A,Kalkman DN,Vogel B,De Rosa S,Indolfi C,Lattuca B,Zeitouni M,Kerneis M,Silvain J,Collet JP,Mehran R,Montalescot G", + "auth_pos": 18, + "meshterms": "Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Humanized/adverse effects*, Humans, Network Meta-Analysis, PCSK9 Inhibitors, Proprotein Convertase 9*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 130, + "user_id": 1447203401, + "artical_title": "Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials.", + "pmid": 32279561, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-04-14", + "author": "Madhavan MV,Redfors B,Ali ZA,Prasad M,Shahim B,Smits PC,von Birgelen C,Zhang Z,Mehran R,Serruys PW,Maehara A,Leon MB,Kirtane AJ,Stone GW", + "auth_pos": 9, + "meshterms": "Aged, Drug-Eluting Stents*, Female, Humans, Male, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/mortality, Myocardial Ischemia/therapy*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Prosthesis Design, Randomized Controlled Trials as Topic, Recurrence, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 131, + "user_id": 1447203401, + "artical_title": "Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.", + "pmid": 32306797, + "journal_name": "Journal of the American Heart Association", + "date": "2020-04-21", + "author": "Franchi F,Rollini F,Faz G,Rivas JR,Rivas A,Agarwal M,Briceno M,Wali M,Nawaz A,Silva G,Shaikh Z,Maaliki N,Fahmi K,Been L,Pineda AM,Suryadevara S,Soffer D,Zenni MM,Baber U,Mehran R,Jennings LK,Bass TA,Angiolillo DJ", + "auth_pos": 20, + "meshterms": "Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome, Aged, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/mortality, Female, Florida, Hemorrhage, Hemorrhage/chemically induced, Humans, Lactones, Lactones/adverse effects, Lactones/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/blood, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Platelet Aggregation, Platelet Aggregation/drug effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Prasugrel Hydrochloride/therapeutic use*, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thrombosis, Thrombosis/blood, Thrombosis/etiology, Thrombosis/prevention & control, Ticagrelor, Ticagrelor/adverse effects, Ticagrelor/therapeutic use*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 132, + "user_id": 1447203401, + "artical_title": "High Rates of Off-label Prescribing and the Urgent Need for a Randomized Clinical Trial.", + "pmid": 32319997, + "journal_name": "JAMA cardiology", + "date": "2020-04-23", + "author": "Navar AM,Mehran R", + "auth_pos": 2, + "meshterms": "Anticoagulants, Health Knowledge, Attitudes, Practice, Humans, Off-Label Use*, Warfarin*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 133, + "user_id": 1447203401, + "artical_title": "Gender-related differences after acute myocardial infarction: A major global health challenge.", + "pmid": 32331906, + "journal_name": "International journal of cardiology", + "date": "2020-04-26", + "author": "Pelliccia F,Rosano GMC,Mehran R", + "auth_pos": 3, + "meshterms": "Female, Global Health*, Humans, Male, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/epidemiology, Myocardial Infarction/therapy, Sex Factors, Survivors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 134, + "user_id": 1447203401, + "artical_title": "Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.", + "pmid": 32362133, + "journal_name": "Circulation", + "date": "2020-05-05", + "author": "Mehta LS,Warnes CA,Bradley E,Burton T,Economy K,Mehran R,Safdar B,Sharma G,Wood M,Valente AM,Volgman AS", + "auth_pos": 6, + "meshterms": "American Heart Association*, Delivery, Obstetric, Delivery, Obstetric/methods, Delivery, Obstetric/standards*, Female, Humans, Postnatal Care, Postnatal Care/methods, Postnatal Care/standards*, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnosis, Pregnancy Complications, Cardiovascular/epidemiology*, Pregnancy Complications, Cardiovascular/therapy*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 135, + "user_id": 1447203401, + "artical_title": "Abluminus DES+ for the treatment of coronary artery disease in patients with diabetes mellitus.", + "pmid": 32390471, + "journal_name": "Future cardiology", + "date": "2020-05-12", + "author": "Goel R,Chandiramani R,Mehran R", + "auth_pos": 3, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 136, + "user_id": 1447203401, + "artical_title": "Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial.", + "pmid": 32406492, + "journal_name": "Cardiovascular research", + "date": "2020-05-15", + "author": "Angiolillo DJ,Baber U,Mehran R", + "auth_pos": 3, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 137, + "user_id": 1447203401, + "artical_title": "SCAI Expert Consensus Statement on Out of Hospital Cardiac Arrest.", + "pmid": 32406999, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-05-15", + "author": "Lotfi A,Klein LW,Hira RS,Mallidi J,Mehran R,Messenger JC,Pinto DS,Mooney MR,Rab T,Yannopoulos D,van Diepen S", + "auth_pos": 5, + "meshterms": "Algorithms, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/standards*, Cardiology, Cardiology/standards*, Clinical Decision-Making, Consensus, Coronary Angiography, Coronary Angiography/standards, Decision Support Techniques, Heart-Assist Devices, Heart-Assist Devices/standards, Hemodynamics, Humans, Out-of-Hospital Cardiac Arrest, Out-of-Hospital Cardiac Arrest/diagnosis, Out-of-Hospital Cardiac Arrest/mortality, Out-of-Hospital Cardiac Arrest/physiopathology, Out-of-Hospital Cardiac Arrest/therapy*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards*, Predictive Value of Tests, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 138, + "user_id": 1447203401, + "artical_title": "Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.", + "pmid": 32406998, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-05-15", + "author": "Baber U,Chandiramani R,Mehta SR,Sartori S,Zhang Z,Claessen BE,Briguori C,Sharma S,Dangas G,Mehran R", + "auth_pos": 10, + "meshterms": "Absorbable Implants, Drug-Eluting Stents*, Everolimus, Everolimus/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Polymers, Sirolimus, Stents, Treatment Outcome, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 139, + "user_id": 1447203401, + "artical_title": "Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?", + "pmid": 32411779, + "journal_name": "Annals of translational medicine", + "date": "2020-05-16", + "author": "Chandiramani R,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 140, + "user_id": 1447203401, + "artical_title": "Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies.", + "pmid": 32411301, + "journal_name": "Cardiovascular therapeutics", + "date": "2020-05-16", + "author": "Gil RJ,Bil J,Kern A,Iñigo-Garcia LA,Formuszewicz R,Dobrzycki S,Vassilev D,Mehran R", + "auth_pos": 8, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy*, Aged, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy*, Coronary Restenosis, Coronary Restenosis/diagnostic imaging*, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Female, Humans, Male, Middle Aged, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/epidemiology, Non-ST Elevated Myocardial Infarction/therapy*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Poland, Poland/epidemiology, Predictive Value of Tests, Prevalence, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 141, + "user_id": 1447203401, + "artical_title": "Stent Expansion and Endothelial Shear Stress in Bifurcation Lesions.", + "pmid": 31195824, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-05-19", + "author": "Okamoto N,Vengrenyuk Y,Bhatheja S,Chamaria S,Khan A,Gupta E,Kapur V,Barman N,Hasan C,Sweeny J,Baber U,Mehran R,Narula J,Sharma SK,Kini AS", + "auth_pos": 12, + "meshterms": "Angioplasty, Balloon, Coronary, Angioplasty, Balloon, Coronary/adverse effects, Angioplasty, Balloon, Coronary/instrumentation*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy*, Coronary Circulation*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology*, Endothelium, Vascular, Endothelium, Vascular/diagnostic imaging, Endothelium, Vascular/physiopathology*, Hemodynamics*, Humans, Hydrodynamics, Models, Cardiovascular, Patient-Specific Modeling, Prosthesis Design, Retrospective Studies, Stents*, Stress, Mechanical, Tomography, Optical Coherence, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 142, + "user_id": 1447203401, + "artical_title": "The Implications of Acute Clinical Care Responsibilities on the Contemporary Practice of Interventional Cardiology.", + "pmid": 30898257, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-05-19", + "author": "Klein LW,Rab T,Anderson HV,Lotfi A,Truesdell AG,Duffy PL,Welt F,Mehran R,Kleiman NS", + "auth_pos": 8, + "meshterms": "Cardiologists*, Cardiologists/economics, Cardiologists/education, Cardiology*, Cardiology/economics, Cardiology/education, Clinical Competence, Education, Medical, Graduate, Fee-for-Service Plans, Health Services Needs and Demand, Heart Diseases, Heart Diseases/diagnostic imaging, Heart Diseases/economics, Heart Diseases/therapy*, Humans, Job Description, Leadership, Needs Assessment, Physician's Role*, Radiologists*, Radiologists/economics, Radiologists/education, Radiology, Interventional*, Radiology, Interventional/economics, Radiology, Interventional/education, Specialization, Workload", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 143, + "user_id": 1447203401, + "artical_title": "Comparison of One-Year Outcomes in Patients >75 Versus ?75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).", + "pmid": 32418717, + "journal_name": "The American journal of cardiology", + "date": "2020-05-19", + "author": "Chandrasekhar J,Sartori S,Aquino MB,Baber U,Hájek P,Atzev B,Hudec M,Ong TK,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iniguez A,Coufal Z,Khashaba A,Schee A,Munawar M,Gerber RT,Yan BP,Tejedor P,Kala P,Liew HB,Lee M,Kalkman DN,Dangas GD,de Winter RJ,Colombo A,Mehran R", + "auth_pos": 29, + "meshterms": "Absorbable Implants*, Aged, Aged, 80 and over, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery*, Drug-Eluting Stents*, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Polymers*, Postoperative Complications, Postoperative Complications/epidemiology*, Prospective Studies, Prosthesis Design, Registries*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 144, + "user_id": 1447203401, + "artical_title": "Panta rhei, also drug eluting stent technology.", + "pmid": 32421244, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-05-19", + "author": "Chiarito M,Mehran R", + "auth_pos": 2, + "meshterms": "Drug-Eluting Stents*, Everolimus, Humans, Percutaneous Coronary Intervention*, Prospective Studies, Sirolimus, Sirolimus/analogs & derivatives, Stents, Technology, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 145, + "user_id": 1447203401, + "artical_title": "The urgent need for integrated science to fight COVID-19 pandemic and beyond.", + "pmid": 32430070, + "journal_name": "Journal of translational medicine", + "date": "2020-05-21", + "author": "Moradian N,Ochs HD,Sedikies C,Hamblin MR,Camargo CA,Martinez JA,Biamonte JD,Abdollahi M,Torres PJ,Nieto JJ,Ogino S,Seymour JF,Abraham A,Cauda V,Gupta S,Ramakrishna S,Sellke FW,Sorooshian A,Wallace Hayes A,Martinez-Urbistondo M,Gupta M,Azadbakht L,Esmaillzadeh A,Kelishadi R,Esteghamati A,Emam-Djomeh Z,Majdzadeh R,Palit P,Badali H,Rao I,Saboury AA,Jagan Mohan Rao L,Ahmadieh H,Montazeri A,Fadini GP,Pauly D,Thomas S,Moosavi-Movahed AA,Aghamohammadi A,Behmanesh M,Rahimi-Movaghar V,Ghavami S,Mehran R,Uddin LQ,Von Herrath M,Mobasher B,Rezaei N", + "auth_pos": 43, + "meshterms": "Betacoronavirus, Betacoronavirus/pathogenicity, Biomedical Research, Biomedical Research/methods, Biomedical Research/organization & administration*, COVID-19, Coronavirus Infections, Coronavirus Infections/epidemiology*, Coronavirus Infections/therapy, Coronavirus Infections/virology, Delivery of Health Care, Integrated, Delivery of Health Care, Integrated/methods, Delivery of Health Care, Integrated/organization & administration*, Emergencies*, Health Services Needs and Demand*, History, 21st Century, Humans, Interdisciplinary Communication, Interdisciplinary Studies, Pandemics*, Pneumonia, Viral, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/therapy, Pneumonia, Viral/virology, Public Health, Public Health/history, Public Health/standards, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 146, + "user_id": 1447203401, + "artical_title": "Negative Risk Markers for Cardiovascular Events in the Elderly.", + "pmid": 31272534, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-05-21", + "author": "Mortensen MB,Fuster V,Muntendam P,Mehran R,Baber U,Sartori S,Falk E", + "auth_pos": 4, + "meshterms": "Age Factors, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Coronary Disease, Coronary Disease/diagnosis, Coronary Disease/epidemiology, Female, Humans, Male, Middle Aged, Patient Selection, Prospective Studies, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 147, + "user_id": 1447203401, + "artical_title": "Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.", + "pmid": 32432651, + "journal_name": "JAMA cardiology", + "date": "2020-05-21", + "author": "Bainey KR,Engstrøm T,Smits PC,Gershlick AH,James SK,Storey RF,Wood DA,Mehran R,Cairns JA,Mehta SR", + "auth_pos": 8, + "meshterms": "Coronary Vessels, Coronary Vessels/pathology, Coronary Vessels/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/pathology, ST Elevation Myocardial Infarction/surgery*, Coronary Vessels, Coronary Vessels/pathology, Coronary Vessels/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/pathology, ST Elevation Myocardial Infarction/surgery*, Coronary Vessels, Coronary Vessels/pathology, Coronary Vessels/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/pathology, ST Elevation Myocardial Infarction/surgery*, Coronary Vessels, Coronary Vessels/pathology, Coronary Vessels/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/pathology, ST Elevation Myocardial Infarction/surgery*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 148, + "user_id": 1447203401, + "artical_title": "Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial.", + "pmid": 32432718, + "journal_name": "JAMA cardiology", + "date": "2020-05-21", + "author": "Mehran R,Chandrasekhar J,Urban P,Lang IM,Windhoevel U,Spaulding C,Copt S,Stoll HP,Morice MC", + "auth_pos": 1, + "meshterms": "Aged, Blood Vessel Prosthesis, Blood Vessel Prosthesis/adverse effects, Double-Blind Method, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects, Female, Hemorrhage, Hemorrhage/etiology*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects*, Risk Factors, Sex Factors, Stents, Stents/adverse effects, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 149, + "user_id": 1447203401, + "artical_title": "Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?", + "pmid": 31439345, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-05-23", + "author": "Joyce L,Baber U,Mehran R", + "auth_pos": 3, + "meshterms": "Aged, Cardiovascular Diseases*, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Registries, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 150, + "user_id": 1447203401, + "artical_title": "Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.", + "pmid": 31288561, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-05-27", + "author": "Baber U,Stefanini GG,Giustino G,Stone GW,Leon MB,Sartori S,Aquino M,Steg PG,Windecker S,Wijns W,Serruys PW,Valgimigli M,Morice MC,Camenzind E,Weisz G,Smits PC,Kandzari DE,von Birgelen C,Dangas GD,Galatius S,Jeger RV,Kimura T,Mikhail GW,Itchhaporia D,Mehta L,Ortega R,Kim HS,Kastrati A,Chieffo A,Mehran R", + "auth_pos": 30, + "meshterms": "Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Coronary Thrombosis, Coronary Thrombosis/mortality, Coronary Thrombosis/therapy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Diabetes Mellitus, Type 1/mortality, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/mortality, Drug-Eluting Stents*, Female, Humans, Middle Aged, Myocardial Infarction, Myocardial Infarction/mortality, Myocardial Infarction/therapy, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sex Factors, Time Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 151, + "user_id": 1447203401, + "artical_title": "Sleep Duration and Cardiovascular Health in a Representative Community Population (from NHANES, 2005 to 2016).", + "pmid": 32466847, + "journal_name": "The American journal of cardiology", + "date": "2020-05-30", + "author": "Krittanawong C,Kumar A,Wang Z,Jneid H,Baber U,Mehran R,Tang WHW,Bhatt DL", + "auth_pos": 6, + "meshterms": "Body Mass Index, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/physiopathology*, Cross-Sectional Studies, Female, Health Status*, Humans, Male, Middle Aged, Nutrition Surveys*, Prevalence, Retrospective Studies, Risk Factors, Sleep, Sleep/physiology*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 152, + "user_id": 1447203401, + "artical_title": "Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.", + "pmid": 32466887, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-05-30", + "author": "Cao D,Mehran R,Dangas G,Baber U,Sartori S,Chandiramani R,Stefanini GG,Angiolillo DJ,Capodanno D,Urban P,Morice MC,Krucoff M,Goel R,Roumeliotis A,Sweeny J,Sharma SK,Kini A", + "auth_pos": 2, + "meshterms": "Aged, Aged, 80 and over, Female, Hemorrhage, Hemorrhage/etiology*, Humans, Male, Middle Aged, Patient Selection, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Prognosis, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 153, + "user_id": 1447203401, + "artical_title": "Implications of Kidney Disease in the Cardiac Patient.", + "pmid": 32471668, + "journal_name": "Interventional cardiology clinics", + "date": "2020-05-31", + "author": "Nicolas J,Claessen B,Mehran R", + "auth_pos": 3, + "meshterms": "Aged, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/physiopathology, Cardiovascular Diseases/therapy, Contrast Media, Contrast Media/adverse effects*, Drug Combinations, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacokinetics, Female, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Prevalence, Prognosis, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications*, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 154, + "user_id": 1447203401, + "artical_title": "One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.", + "pmid": 32478459, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-06-02", + "author": "Azzalini L,Baber U,Johal GS,Farhan S,Barman N,Kapur V,Hasan C,Vijay P,Jhaveri V,Mehran R,Kini AS,Sharma SK", + "auth_pos": 10, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Drug-Eluting Stents*, Everolimus, Everolimus/adverse effects, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 155, + "user_id": 1447203401, + "artical_title": "1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.", + "pmid": 32507695, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2020-06-09", + "author": "Chandrasekhar J,Zeebregts D,Kalkman DN,Sartori S,Roumeliotis A,Aquino MB,de Wilde P,de Winter VC,Baber U,Woudstra P,Beijk MA,Hájek P,Atzev B,Hudec M,Ong TK,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iniguez A,Lee M,Tijssen JG,Koch KT,Dangas GD,Colombo A,Mehran R,de Winter RJ", + "auth_pos": 27, + "meshterms": "Coronary Artery Disease*, Female, Humans, Percutaneous Coronary Intervention*, Prosthesis Design, Risk Factors, Stents*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 156, + "user_id": 1447203401, + "artical_title": "Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single-center registry study.", + "pmid": 32521116, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-06-11", + "author": "Murphy JL,Patel N,Vengrenyuk Y,Okamoto N,Barman N,Sweeny J,Kapur V,Hasan C,Krishnan P,Vijay P,Jhaveri V,Dangas G,Mehran R,Aquino M,Baber U,Sharma SK,Kini AS", + "auth_pos": 13, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 157, + "user_id": 1447203401, + "artical_title": "Ticagrelor in Patients With Cancer: 2 Birds With 1 Stone.", + "pmid": 34396234, + "journal_name": "JACC. CardioOncology", + "date": "2020-06-16", + "author": "Mehran R,Cao D,Baber U", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 158, + "user_id": 1447203401, + "artical_title": "Heroism in the Face of the COVID-19 Pandemic.", + "pmid": 32558909, + "journal_name": "JAMA cardiology", + "date": "2020-06-20", + "author": "Kirtane AJ,Mehran R,Navar AM,Bonow RO", + "auth_pos": 2, + "meshterms": "COVID-19*, Courage*, Humans, New York City, Out-of-Hospital Cardiac Arrest*, Pandemics, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 159, + "user_id": 1447203401, + "artical_title": "Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.", + "pmid": 32558218, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-06-20", + "author": "Yasumura K,Benhuri B,Vengrenyuk Y,Petrov A,Barman N,Sweeny J,Kapur V,Suleman J,Baber U,Mehran R,Stone GW,Kini AS,Sharma SK", + "auth_pos": 10, + "meshterms": "Atherectomy, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Coronary Angiography, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Retrospective Studies, Stents, Treatment Outcome, Coronary stent*, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 160, + "user_id": 1447203401, + "artical_title": "Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.", + "pmid": 32579195, + "journal_name": "JAMA network open", + "date": "2020-06-25", + "author": "Deftereos SG,Giannopoulos G,Vrachatis DA,Siasos GD,Giotaki SG,Gargalianos P,Metallidis S,Sianos G,Baltagiannis S,Panagopoulos P,Dolianitis K,Randou E,Syrigos K,Kotanidou A,Koulouris NG,Milionis H,Sipsas N,Gogos C,Tsoukalas G,Olympios CD,Tsagalou E,Migdalis I,Gerakari S,Angelidis C,Alexopoulos D,Davlouros P,Hahalis G,Kanonidis I,Katritsis D,Kolettis T,Manolis AS,Michalis L,Naka KK,Pyrgakis VN,Toutouzas KP,Triposkiadis F,Tsioufis K,Vavouranakis E,Martinèz-Dolz L,Reimers B,Stefanini GG,Cleman M,Goudevenos J,Tsiodras S,Tousoulis D,Iliodromitis E,Mehran R,Dangas G,Stefanadis C", + "auth_pos": 47, + "meshterms": "Aged, Aged, 80 and over, Betacoronavirus, C-Reactive Protein, C-Reactive Protein/metabolism*, COVID-19, Cause of Death, Colchicine, Colchicine/therapeutic use*, Coronavirus Infections, Coronavirus Infections/drug therapy*, Coronavirus Infections/metabolism, Diarrhea, Diarrhea/chemically induced, Disease Progression, Female, Fibrin Fibrinogen Degradation Products, Fibrin Fibrinogen Degradation Products/metabolism*, Greece, Hospitalization, Humans, Inflammation, Inflammation/metabolism, Kaplan-Meier Estimate, Male, Middle Aged, Mortality, Pandemics, Pneumonia, Viral, Pneumonia, Viral/drug therapy*, Pneumonia, Viral/metabolism, Respiration, Artificial, Respiration, Artificial/statistics & numerical data, SARS-CoV-2, Time Factors, Treatment Outcome, Troponin, Troponin/metabolism*, Tubulin Modulators, Tubulin Modulators/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 161, + "user_id": 1447203401, + "artical_title": "An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.", + "pmid": 32624456, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-07-07", + "author": "Kunadian V,Chieffo A,Camici PG,Berry C,Escaned J,Maas A,Prescott E,Karam N,Appelman Y,Fraccaro C,Buchanan GL,Manzo-Silberman S,Al-Lamee R,Regar E,Lansky A,Abbott JD,Badimon L,Duncker DJ,Mehran R,Capodanno D,Baumbach A", + "auth_pos": 19, + "meshterms": "Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*, Cardiology*, Consensus, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 162, + "user_id": 1447203401, + "artical_title": "An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.", + "pmid": 32626906, + "journal_name": "European heart journal", + "date": "2020-07-07", + "author": "Kunadian V,Chieffo A,Camici PG,Berry C,Escaned J,Maas AHEM,Prescott E,Karam N,Appelman Y,Fraccaro C,Louise Buchanan G,Manzo-Silberman S,Al-Lamee R,Regar E,Lansky A,Abbott JD,Badimon L,Duncker DJ,Mehran R,Capodanno D,Baumbach A", + "auth_pos": 19, + "meshterms": "Cardiology*, Consensus, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Female, Humans, Ischemia, Male, Microcirculation, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 163, + "user_id": 1447203401, + "artical_title": "Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial.", + "pmid": 31763982, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-07-09", + "author": "Kini AS,Dangas GD,Baber U,Vengrenyuk Y,Kandzari DE,Leon MB,Morice MC,Serruys PW,Kappetein AP,Sabik JF,Dressler O,Mehran R,Sharma SK,Stone GW", + "auth_pos": 12, + "meshterms": "Comparative Effectiveness Research, Coronary Artery Bypass*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery*, Coronary Vessels, Coronary Vessels/pathology*, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Everolimus, Everolimus/therapeutic use*, Humans, Myocardial Infarction, Myocardial Infarction/pathology, Myocardial Infarction/therapy*, Percutaneous Coronary Intervention*, Postoperative Complications, Postoperative Complications/epidemiology, Postoperative Complications/etiology, Stroke, Stroke/pathology, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 164, + "user_id": 1447203401, + "artical_title": "Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.", + "pmid": 31630816, + "journal_name": "International journal of cardiology", + "date": "2020-07-11", + "author": "Goel R,Power D,Tchetche D,Chandiramani R,Guedeney P,Claessen BE,Sartori S,Cao D,Meneveau N,Tron C,Dumonteil N,Widder JD,Hengstenberg C,Ferrari M,Violini R,Stella PR,Jeger R,Anthopoulos P,Deliargyris EN,Mehran R,Dangas GD", + "auth_pos": 20, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/complications*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Humans, Male, Postoperative Complications, Postoperative Complications/epidemiology*, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 165, + "user_id": 1447203401, + "artical_title": "Nonculprit Lesion Plaque Morphology in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys.", + "pmid": 32646305, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-07-11", + "author": "Pinilla-Echeverri N,Mehta SR,Wang J,Lavi S,Schampaert E,Cantor WJ,Bainey KR,Welsh RC,Kassam S,Mehran R,Storey RF,Nguyen H,Meeks B,Wood DA,Cairns JA,Sheth T", + "auth_pos": 10, + "meshterms": "Aged, Canada, Canada/epidemiology, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Fibrosis, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Plaque, Atherosclerotic*, Predictive Value of Tests, Prevalence, Prospective Studies, Randomized Controlled Trials as Topic, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging*, ST Elevation Myocardial Infarction/epidemiology, ST Elevation Myocardial Infarction/therapy, Tomography, Optical Coherence*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 166, + "user_id": 1447203401, + "artical_title": "Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials.", + "pmid": 32646701, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-07-11", + "author": "Golomb M,Redfors B,Crowley A,Smits PC,Serruys PW,von Birgelen C,Madhavan MV,Ben-Yehuda O,Mehran R,Leon MB,Stone GW", + "auth_pos": 9, + "meshterms": "African Americans*, Aged, Asian Americans, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, European Continental Ancestry Group, Female, Hispanic Americans, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/therapy*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Race Factors, Randomized Controlled Trials as Topic, Recurrence, Risk Assessment, Risk Factors, Stents*, Time Factors, Treatment Outcome, United States, United States/epidemiology, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 167, + "user_id": 1447203401, + "artical_title": "Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.", + "pmid": 31122347, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-07-14", + "author": "Vlastra W,Chandrasekhar J,Vendrik J,Gutierrez-Ibanes E,Tchétché D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Baan J,Tijssen JGP,Pan M,Dumonteil N,Mangione JA,Sartori S,D'Errigo P,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Sanchez Gila J,Modine T,Dangas G,Mehran R,Piek JJ,Delewi R", + "auth_pos": 26, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Catheterization, Peripheral*, Catheterization, Peripheral/adverse effects, Catheterization, Peripheral/mortality, Female, Femoral Artery*, Hemodynamics, Humans, Male, Postoperative Complications, Postoperative Complications/etiology, Punctures, Randomized Controlled Trials as Topic, Recovery of Function, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Trauma Severity Indices, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 168, + "user_id": 1447203401, + "artical_title": "Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation.", + "pmid": 32667846, + "journal_name": "Journal of women's health (2002)", + "date": "2020-07-16", + "author": "Yu J,Park K,Chandrasekhar J,Kalkman DN,Johnson JA,Wild RA,Dobies D,Thomas L,Skelding KA,Ahmed B,Barber KR,Mungee S,Mehran R", + "auth_pos": 13, + "meshterms": "Adult, Ambulatory Care Facilities, Ambulatory Care Facilities/statistics & numerical data*, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control*, Feasibility Studies, Female, Gynecology*, Health Knowledge, Attitudes, Practice*, Heart Disease Risk Factors*, Humans, Mass Screening, Mass Screening/methods*, Middle Aged, Obstetrics, Pregnancy, Risk Factors, United States, United States/epidemiology, Women's Health", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 169, + "user_id": 1447203401, + "artical_title": "2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.", + "pmid": 32680646, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-07-19", + "author": "Tomaselli GF,Mahaffey KW,Cuker A,Dobesh PP,Doherty JU,Eikelboom JW,Florido R,Gluckman TJ,Hucker WJ,Mehran R,Messé SR,Perino AC,Rodriguez F,Sarode R,Siegal DM,Wiggins BS", + "auth_pos": 11, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Cardiology*, Consensus*, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Societies, Medical*, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 170, + "user_id": 1447203401, + "artical_title": "Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review.", + "pmid": 32703515, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-07-25", + "author": "Marquis-Gravel G,Moliterno DJ,Francis DP,Jüni P,Rosenberg YD,Claessen BE,Mentz RJ,Mehran R,Cutlip DE,Chauhan C,Quella S,Zannad F,Goodman SG", + "auth_pos": 8, + "meshterms": "Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design, Coronary Artery Disease, Coronary Artery Disease/surgery*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Quality Improvement, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Randomized Controlled Trials as Topic/standards*, Research Design", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 171, + "user_id": 1447203401, + "artical_title": "Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management.", + "pmid": 32759962, + "journal_name": "Nature reviews. Cardiology", + "date": "2020-08-08", + "author": "Cao D,Chandiramani R,Capodanno D,Berger JS,Levin MA,Hawn MT,Angiolillo DJ,Mehran R", + "auth_pos": 8, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/mortality, Coronary Artery Disease/physiopathology, Humans, Preoperative Care, Risk Assessment, Risk Factors, Surgical Procedures, Operative*, Surgical Procedures, Operative/adverse effects, Surgical Procedures, Operative/mortality, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 172, + "user_id": 1447203401, + "artical_title": "Drug-eluting stents in diabetic patients: Are we still treading water?", + "pmid": 32797749, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-08-17", + "author": "Chiarito M,Mehran R", + "auth_pos": 2, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Prospective Studies, Registries, Sirolimus, Stents, Treatment Outcome, Water, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 173, + "user_id": 1447203401, + "artical_title": "Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.", + "pmid": 32805186, + "journal_name": "Journal of the American Heart Association", + "date": "2020-08-18", + "author": "Capodanno D,Di Maio M,Greco A,Bhatt DL,Gibson CM,Goette A,Lopes RD,Mehran R,Vranckx P,Angiolillo DJ", + "auth_pos": 8, + "meshterms": "Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*, Anticoagulants, Anticoagulants/therapeutic use, Antithrombins, Antithrombins/adverse effects, Antithrombins/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/complications*, Bayes Theorem, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cause of Death, Drug Therapy, Combination, Drug Therapy, Combination/methods, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control*, Humans, Kaplan-Meier Estimate, Network Meta-Analysis, Percutaneous Coronary Intervention*, Publication Bias, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Purinergic P2Y Receptor Antagonists/therapeutic use*, Randomized Controlled Trials as Topic, Thrombosis, Thrombosis/prevention & control*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 174, + "user_id": 1447203401, + "artical_title": "Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.", + "pmid": 32814108, + "journal_name": "International journal of cardiology", + "date": "2020-08-20", + "author": "Goel R,Sartori S,Cao D,Claessen BE,Baber U,Chandiramani R,Nicolas J,Roumeliotis A,Power D,Chandrasekhar J,Tchetche D,Petronio AS,Mehilli J,Lefevre T,Presbitero P,Capranzano P,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail GW,Ferrer-Gracia MC,Naber C,Sharma S,Morice MC,Dangas GD,Chieffo A,Mehran R", + "auth_pos": 31, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Female, Humans, Registries, Risk Assessment, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 175, + "user_id": 1447203401, + "artical_title": "Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients.", + "pmid": 32830645, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-08-25", + "author": "Marquis-Gravel G,Urban P,Copt S,Capodanno D,Pocock SJ,Sadozai Slama S,Stoll HP,Tanguay JF,Mehran R,Leon MB,Rao SV,Morice MC,Krucoff MW", + "auth_pos": 9, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 176, + "user_id": 1447203401, + "artical_title": "Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.", + "pmid": 32859453, + "journal_name": "Journal of cardiology", + "date": "2020-08-30", + "author": "Mehran R,Vogel B,Levy P", + "auth_pos": 1, + "meshterms": "Anticoagulants, Anticoagulants/economics*, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/economics, Atrial Fibrillation/therapy*, Combined Modality Therapy, Combined Modality Therapy/economics, Cost of Illness, Health Care Costs, Health Care Costs/statistics & numerical data*, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/economics*, Percutaneous Coronary Intervention/methods, Postoperative Complications, Postoperative Complications/economics, Postoperative Complications/prevention & control, Randomized Controlled Trials as Topic, Stents, Stents/economics*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 177, + "user_id": 1447203401, + "artical_title": "Women and Cardiology: The Value of Diversity.", + "pmid": 32863112, + "journal_name": "Heart, lung & circulation", + "date": "2020-08-31", + "author": "Burgess S,Morice MC,Alasnag M,Grines C,Mehran R,Zaman S", + "auth_pos": 5, + "meshterms": "Cardiology*, Female, Humans, Physicians, Women, Physicians, Women/statistics & numerical data*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 178, + "user_id": 1447203401, + "artical_title": "Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry.", + "pmid": 32865860, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-09-01", + "author": "Panoulas VF,Chandrasekhar J,Busi G,Ruparelia N,Zhang Z,Mehilli J,Sartori S,Lefèvre T,Presbitero P,Capranzano P,Tchetche D,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Sharma S,Ferrer-Gracia MC,Naber CK,Kievit PC,Snyder C,Sutaria N,Sen S,Malik IS,Morice MC,Nihoyannopoulos P,Petronio AS,Mehran R,Chieffo A,Mikhail GW", + "auth_pos": 30, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Postoperative Complications, Prevalence, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 179, + "user_id": 1447203401, + "artical_title": "Reply: P2Y Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent.", + "pmid": 32883424, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-09-05", + "author": "Angiolillo DJ,Baber U,Dangas GD,Mehran R", + "auth_pos": 4, + "meshterms": "Aspirin, Diabetes Mellitus*, Humans, Percutaneous Coronary Intervention*, Purinergic P2Y Receptor Antagonists, Ticagrelor, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 180, + "user_id": 1447203401, + "artical_title": "Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.", + "pmid": 32912441, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-09-12", + "author": "Sheth T,Pinilla-Echeverri N,Moreno R,Wang J,Wood DA,Storey RF,Mehran R,Bainey KR,Bossard M,Bangalore S,Schwalm JD,Velianou JL,Valettas N,Sibbald M,Rodés-Cabau J,Ducas J,Cohen EA,Bagai A,Rinfret S,Newby DE,Feldman L,Laster SB,Lang IM,Mills JD,Cairns JA,Mehta SR", + "auth_pos": 7, + "meshterms": "Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/trends*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends*, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery*, Severity of Illness Index*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 181, + "user_id": 1447203401, + "artical_title": "Coronary artery disease in the young in the US population-based cohort.", + "pmid": 32923100, + "journal_name": "American journal of cardiovascular disease", + "date": "2020-09-15", + "author": "Krittanawong C,Kumar A,Wang Z,Narasimhan B,Mahtta D,Jneid H,Baber U,Mehran R,Tang W,Ballantyne CM,Virani SS", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 182, + "user_id": 1447203401, + "artical_title": "Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions.", + "pmid": 32928716, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-09-16", + "author": "Zimarino M,Angiolillo DJ,Dangas G,Capodanno D,Barbato E,Hahn JY,Giustino G,Watanabe H,Costa F,Cuisset T,Rossini R,Sibbing D,Burzotta F,Louvard Y,Shehab A,Renda G,Kimura T,Gwon HC,Chen SL,Costa RA,Koo BK,Storey RF,Valgimigli M,Mehran R,Stankovic G", + "auth_pos": 24, + "meshterms": "Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Europe, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 183, + "user_id": 1447203401, + "artical_title": "Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.", + "pmid": 32943165, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-09-19", + "author": "Capodanno D,Morice MC,Angiolillo DJ,Bhatt DL,Byrne RA,Colleran R,Cuisset T,Cutlip D,Eerdmans P,Eikelboom J,Farb A,Gibson CM,Gregson J,Haude M,James SK,Kim HS,Kimura T,Konishi A,Leon MB,Magee PFA,Mitsutake Y,Mylotte D,Pocock SJ,Rao SV,Spitzer E,Stockbridge N,Valgimigli M,Varenne O,Windhovel U,Krucoff MW,Urban P,Mehran R", + "auth_pos": 32, + "meshterms": "Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*, Clinical Trials as Topic*, Hemorrhage*, Humans, Outcome Assessment, Health Care, Percutaneous Coronary Intervention*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 184, + "user_id": 1447203401, + "artical_title": "1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry.", + "pmid": 32953969, + "journal_name": "International journal of cardiology. Heart & vasculature", + "date": "2020-09-22", + "author": "Chandrasekhar J,Baber U,Sartori S,Aquino MB,Hájek P,Atzev B,Hudec M,Kiam Ong T,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iniguez A,Coufal Z,Khashaba A,Munawar M,Gerber RT,Yan BP,Tejedor P,Kala P,Bang Liew H,Lee M,Kalkman DN,Dangas GD,de Winter RJ,Colombo A,Mehran R", + "auth_pos": 28, + "meshterms": "BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 185, + "user_id": 1447203401, + "artical_title": "One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration.", + "pmid": 32964556, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-09-24", + "author": "Chandrasekhar J,Kalkman DN,Sartori S,Baber U,Blum M,Aquino MB,Woudstra P,Beijk MA,Tijssen JG,Koch KT,Dangas GD,Colombo A,de Winter RJ,Mehran R", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 186, + "user_id": 1447203401, + "artical_title": "Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort.", + "pmid": 32995474, + "journal_name": "International journal of cardiology. Heart & vasculature", + "date": "2020-10-01", + "author": "Krittanawong C,Liu Y,Mahtta D,Narasimhan B,Wang Z,Jneid H,Tamis-Holland JE,Mahboob A,Baber U,Mehran R,Wilson Tang WH,Ballantyne CM,Virani SS", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 187, + "user_id": 1447203401, + "artical_title": "Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.", + "pmid": 33002465, + "journal_name": "The American journal of cardiology", + "date": "2020-10-02", + "author": "Roumeliotis A,Claessen B,Dangas G,Torguson R,Sartori S,Reisman A,Cao D,Chandiramani R,Nicolas J,Goel R,Chiarito M,Sharma M,Bandyopadhyay D,Baber U,Sweeny J,Barman N,Sharma S,Kini A,Mehran R", + "auth_pos": 19, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/epidemiology, Coronary Artery Disease/surgery*, Drug-Eluting Stents*, Female, Follow-Up Studies, Humans, Incidence, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Male, Middle Aged, New York, New York/epidemiology, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Prognosis, Registries*, Retrospective Studies, Risk Factors, Survival Rate, Survival Rate/trends, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 188, + "user_id": 1447203401, + "artical_title": "Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry.", + "pmid": 33002302, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-10-02", + "author": "Nicolas J,Claessen BE,Cao D,Sartori S,Baber U,Power D,Chiarito M,Goel R,Roumeliotis A,Chandiramani R,Chen S,Chandrasekhar J,Tchetche D,Petronio AS,Mehilli J,Lefèvre T,Presbitero P,Capranzano P,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail G,Ferrer-Gracia MC,Naber C,Sharma S,Morice MC,Dangas GD,Chieffo A,Mehran R", + "auth_pos": 33, + "meshterms": "Anemia*, Anemia/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 189, + "user_id": 1447203401, + "artical_title": "Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.", + "pmid": 33017862, + "journal_name": "European journal of heart failure", + "date": "2020-10-06", + "author": "Abraham WT,Psotka MA,Fiuzat M,Filippatos G,Lindenfeld J,Mehran R,Ambardekar AV,Carson PE,Jacob R,Januzzi JL,Konstam MA,Krucoff MW,Lewis EF,Piccini JP,Solomon SD,Stockbridge N,Teerlink JR,Unger EF,Zeitler EP,Anker SD,O'Connor CM", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 190, + "user_id": 1447203401, + "artical_title": "Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent.", + "pmid": 33031789, + "journal_name": "American heart journal", + "date": "2020-10-09", + "author": "Valgimigli M,Cao D,Makkar RR,Bangalore S,Bhatt DL,Angiolillo DJ,Saito S,Ge J,Neumann FJ,Hermiller J,Picon H,Toelg R,Maksoud A,Chehab BM,Wang LJ,Wang J,Mehran R", + "auth_pos": 17, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/administration & dosage, Aspirin/adverse effects, Canada, Cause of Death, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus*, Everolimus/administration & dosage, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Immunosuppressive Agents*, Immunosuppressive Agents/administration & dosage, Myocardial Infarction*, Myocardial Infarction/prevention & control, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists*, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Stroke, Thrombosis, United States, Multicenter Studies as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 191, + "user_id": 1447203401, + "artical_title": "Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID-FFR study.", + "pmid": 33034419, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-10-10", + "author": "Kini AS,Okamoto N,Barman N,Vengrenyuk Y,Yasumura K,Chamaria S,Bhatheja S,Kapur V,Hasan C,Sweeny J,Baber U,Mehran R,Stone GW,Sharma S", + "auth_pos": 12, + "meshterms": "Coronary Angiography, Coronary Artery Disease*, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Fractional Flow Reserve, Myocardial*, Humans, Treatment Outcome, Thrombolysis*, Coronary stent*, Balloon Catheters*, Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 192, + "user_id": 1447203401, + "artical_title": "Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.", + "pmid": 33038061, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-10-11", + "author": "Goel R,Cao D,Chandiramani R,Roumeliotis A,Blum M,Bhatt DL,Angiolillo DJ,Ge J,Seth A,Saito S,Krucoff M,Kozuma K,Makkar RM,Bangalore S,Wang L,Koo K,Neumann FJ,Hermiller J,Stefanini G,Valgimigli M,Mehran R", + "auth_pos": 21, + "meshterms": "Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Everolimus, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Stents, Treatment Outcome, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Everolimus, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Stents, Treatment Outcome, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Everolimus, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Stents, Treatment Outcome, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Everolimus, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Stents, Treatment Outcome, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Everolimus, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Stents, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 193, + "user_id": 1447203401, + "artical_title": "Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.", + "pmid": 33065120, + "journal_name": "American heart journal", + "date": "2020-10-17", + "author": "Gibson CM,Kastelein JJP,Phillips AT,Aylward PE,Yee MK,Tendera M,Nicholls SJ,Pocock S,Goodman SG,Alexander JH,Lincoff AM,Bode C,Duffy D,Heise M,Berman G,Mears SJ,Tricoci P,Deckelbaum LI,Steg PG,Ridker P,Mehran R", + "auth_pos": 21, + "meshterms": "Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic, Aged, Humans, Brain Ischemia, Brain Ischemia/prevention & control, Cholesterol, Cholesterol/metabolism, Coronary Artery Disease, Coronary Artery Disease/metabolism, Diabetes Mellitus, Diabetes Mellitus/drug therapy, Double-Blind Method, Drug Administration Schedule, Hospitalization, Hospitalization/statistics & numerical data, Ischemia, Ischemia/prevention & control, Lipoproteins, HDL*, Lipoproteins, HDL/administration & dosage, Lipoproteins, HDL/adverse effects, Lipoproteins, HDL/therapeutic use, Liver, Liver/metabolism, Myocardial Infarction*, Myocardial Infarction/prevention & control, Myocardial Infarction/therapy, Myocardial Ischemia, Myocardial Ischemia/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Placebos, Placebos/therapeutic use, Plaque, Atherosclerotic, Plaque, Atherosclerotic/metabolism, Stroke, Stroke/prevention & control, Time Factors, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 194, + "user_id": 1447203401, + "artical_title": "Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.", + "pmid": 33085967, + "journal_name": "European heart journal", + "date": "2020-10-22", + "author": "Baber U,Dangas G,Angiolillo DJ,Cohen DJ,Sharma SK,Nicolas J,Briguori C,Cha JY,Collier T,Dudek D,Džavik V,Escaned J,Gil R,Gurbel P,Hamm CW,Henry T,Huber K,Kastrati A,Kaul U,Kornowski R,Krucoff M,Kunadian V,Marx SO,Mehta S,Moliterno D,Ohman EM,Oldroyd K,Sardella G,Sartori S,Shlofmitz R,Steg PG,Weisz G,Witzenbichler B,Han YL,Pocock S,Gibson CM,Mehran R", + "auth_pos": 37, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 195, + "user_id": 1447203401, + "artical_title": "Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines?", + "pmid": 33095164, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-10-24", + "author": "Baber U,Mehran R", + "auth_pos": 2, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Time", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 196, + "user_id": 1447203401, + "artical_title": "Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: A systematic review.", + "pmid": 33118664, + "journal_name": "European journal of heart failure", + "date": "2020-10-30", + "author": "Whitelaw S,Sullivan K,Eliya Y,Alruwayeh M,Thabane L,Yancy CW,Mehran R,Mamas MA,Van Spall HG", + "auth_pos": 7, + "meshterms": "Adult, Asia, Europe, Female, Heart Failure*, Humans, Male, Middle Aged, North America, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 197, + "user_id": 1447203401, + "artical_title": "Characterization of Myocardial Injury in Patients With COVID-19.", + "pmid": 33121710, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-10-31", + "author": "Giustino G,Croft LB,Stefanini GG,Bragato R,Silbiger JJ,Vicenzi M,Danilov T,Kukar N,Shaban N,Kini A,Camaj A,Bienstock SW,Rashed ER,Rahman K,Oates CP,Buckley S,Elbaum LS,Arkonac D,Fiter R,Singh R,Li E,Razuk V,Robinson SE,Miller M,Bier B,Donghi V,Pisaniello M,Mantovani R,Pinto G,Rota I,Baggio S,Chiarito M,Fazzari F,Cusmano I,Curzi M,Ro R,Malick W,Kamran M,Kohli-Seth R,Bassily-Marcus AM,Neibart E,Serrao G,Perk G,Mancini D,Reddy VY,Pinney SP,Dangas G,Blasi F,Sharma SK,Mehran R,Condorelli G,Stone GW,Fuster V,Lerakis S,Goldman ME", + "auth_pos": 50, + "meshterms": "Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Echocardiography, Electrocardiography, Female, Heart, Heart/diagnostic imaging*, Heart/physiopathology, Humans, Italy, Italy/epidemiology, Male, Middle Aged, Myocardium, Myocardium/pathology*, New York City, New York City/epidemiology, Pandemics, Pneumonia, Viral, Pneumonia, Viral/blood, Pneumonia, Viral/complications, Pneumonia, Viral/diagnostic imaging*, Pneumonia, Viral/mortality, Retrospective Studies, SARS-CoV-2, Ventricular Dysfunction, Ventricular Dysfunction/virology*, Aged, Betacoronavirus, Biomarkers, Biomarkers/blood, COVID-19, Coronary Angiography, Coronavirus Infections, Coronavirus Infections/blood, Coronavirus Infections/complications, Coronavirus Infections/diagnostic imaging*, Coronavirus Infections/drug therapy, C", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 198, + "user_id": 1447203401, + "artical_title": "NT-proBNP Levels and Cardiopulmonary Function in Children with Sickle Cell Disease.", + "pmid": 33151019, + "journal_name": "Pediatric pulmonology", + "date": "2020-11-06", + "author": "Feld L,Fiorino EK,Aygun B,Appiah-Kubi A,Mitchell EC,Jackson S,Mehran R,Fishbein J,Santiago MT", + "auth_pos": 7, + "meshterms": "Adolescent, Anemia, Sickle Cell, Anemia, Sickle Cell/blood*, Anemia, Sickle Cell/physiopathology*, Biomarkers, Biomarkers/blood, Child, Echocardiography, Female, Hemolysis, Humans, Male, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Respiratory Function Tests, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 199, + "user_id": 1447203401, + "artical_title": "Transcatheter aortic valve replacement in patients with end-stage renal disease: Is \"better than nothing\" good enough?", + "pmid": 33156966, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-11-07", + "author": "Chiarito M,Mehran R", + "auth_pos": 2, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/diagnosis, Kidney Failure, Chronic/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 200, + "user_id": 1447203401, + "artical_title": "One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.", + "pmid": 33167705, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-11-11", + "author": "Kandzari DE,Kirtane AJ,Windecker S,Latib A,Kedhi E,Mehran R,Price MJ,Abizaid A,Simon DI,Worthley SG,Zaman A,Choi JW,Caputo R,Kanitkar M,McLaurin B,Potluri S,Smith T,Spriggs D,Tolleson T,Nazif T,Parke M,Lee LC,Lung TH,Stone GW", + "auth_pos": 6, + "meshterms": "Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Percutaneous Coronary Intervention/mortality, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sirolimus, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives*, Time Factors, Treatment Outcome, United States, Aged, Aged, 80 and over, Cardiovascular Agents, Cardiovascular Agents/administration & dosage*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug Administration Schedule, Drug-Eluting Stents*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention,", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 201, + "user_id": 1447203401, + "artical_title": "Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium.", + "pmid": 33199251, + "journal_name": "JACC. Heart failure", + "date": "2020-11-18", + "author": "Abraham WT,Psotka MA,Fiuzat M,Filippatos G,Lindenfeld J,Mehran R,Ambardekar AV,Carson PE,Jacob R,Januzzi JL,Konstam MA,Krucoff MW,Lewis EF,Piccini JP,Solomon SD,Stockbridge N,Teerlink JR,Unger EF,Zeitler EP,Anker SD,O'Connor CM", + "auth_pos": 6, + "meshterms": "Cardiac Catheterization, Consensus, Endpoint Determination, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Humans, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 202, + "user_id": 1447203401, + "artical_title": "Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.", + "pmid": 33232583, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-11-25", + "author": "Ojeda S,Azzalini L,Suárez de Lezo J,Johal GS,González R,Barman N,Hidalgo F,Bellera N,Dangas G,Jurado-Román A,Kini A,Romero M,Moreno R,Garcia Del Blanco B,Mehran R,Sharma SK,Pan M", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 203, + "user_id": 1447203401, + "artical_title": "Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.", + "pmid": 33236497, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-11-26", + "author": "Blum M,Cao D,Chandiramani R,Goel R,Roumeliotis A,Sartori S,Beyhoff N,Kelle S,Kovacic JC,Krishnan P,Sweeny J,Barman N,Baber U,Dangas GD,Kini A,Sharma SK,Mehran R", + "auth_pos": 17, + "meshterms": "C-Reactive Protein*, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prevalence, Prognosis, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 204, + "user_id": 1447203401, + "artical_title": "TEMPORARY REMOVAL: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.", + "pmid": 33250267, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-12-01", + "author": "Kumbhani DJ,Cannon CP,Beavers CJ,Bhatt DL,Cuker A,Gluckman TJ,Marine JE,Mehran R,Messe SR,Patel NS,Peterson BE,Rosenfield K,Spinler SA,Thourani VH", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/therapy*, Cardiology*, Cardiovascular Diseases, Cardiovascular Diseases/therapy, Consensus*, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Societies, Medical*, United States, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 205, + "user_id": 1447203401, + "artical_title": "A sex paradox in clinical outcomes following complex percutaneous coronary intervention.", + "pmid": 33278415, + "journal_name": "International journal of cardiology", + "date": "2020-12-06", + "author": "Nicolas J,Claessen BE,Cao D,Chiarito M,Sartori S,Qiu H,Goel R,Nardin M,Roumeliotis A,Vogel B,Turfah A,Chandiramani R,Baber U,Barman N,Sweeny J,Krishnan P,Kini A,Sharma SK,Dangas GD,Mehran R", + "auth_pos": 20, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Drug-Eluting Stents*, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Retrospective Studies, Risk Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 206, + "user_id": 1447203401, + "artical_title": "Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials.", + "pmid": 33284979, + "journal_name": "European heart journal", + "date": "2020-12-08", + "author": "Giacoppo D,Matsuda Y,Fovino LN,D'Amico G,Gargiulo G,Byrne RA,Capodanno D,Valgimigli M,Mehran R,Tarantini G", + "auth_pos": 9, + "meshterms": "Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Randomized Controlled Trials as Topic, Treatment Outcome, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 207, + "user_id": 1447203401, + "artical_title": "Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.", + "pmid": 33289416, + "journal_name": "Journal of the American Heart Association", + "date": "2020-12-09", + "author": "Claessen BE,Guedeney P,Gibson CM,Angiolillo DJ,Cao D,Lepor N,Mehran R", + "auth_pos": 7, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Acute Coronary Syndrome/prevention & control, Adult, Aged, Aged, 80 and over, Anticholesteremic Agents, Anticholesteremic Agents/therapeutic use, Cholesterol, LDL, Cholesterol, LDL/blood, Cost-Benefit Analysis, Cost-Benefit Analysis/economics, Dicarboxylic Acids, Dicarboxylic Acids/therapeutic use, Eicosapentaenoic Acid, Eicosapentaenoic Acid/therapeutic use, Ezetimibe, Ezetimibe/therapeutic use, Fatty Acids, Fatty Acids/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Hypolipidemic Agents, Hypolipidemic Agents/therapeutic use, Lipids, Lipids/adverse effects, Lipids/blood*, Male, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/epidemiology*, Myocardial Ischemia/mortality, Practice Guidelines as Topic, Proprotein Convertase 9, Proprotein Convertase 9/antagonists & inhibitors, RNA, Small Interfering, RNA, Small Interfering/therapeutic use, Risk Reduction Behavior, Secondary Prevention", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 208, + "user_id": 1447203401, + "artical_title": "Towards a standardized classification of cardiogenic shock: Will the new SCAI staging system translate into better clinical practice and research?", + "pmid": 33306881, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-12-12", + "author": "Nicolas J,Mehran R", + "auth_pos": 2, + "meshterms": "Humans, Prospective Studies, Shock, Cardiogenic*, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 209, + "user_id": 1447203401, + "artical_title": "Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation.", + "pmid": 32553329, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-12-15", + "author": "Guedeney P,Claessen BE,Mehran R,Mintz GS,Liu M,Sorrentino S,Giustino G,Farhan S,Leon MB,Serruys PW,Smits PC,von Birgelen C,Ali ZA,Généreux P,Redfors B,Madhavan MV,Ben-Yehuda O,Stone GW", + "auth_pos": 3, + "meshterms": "Aged, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Drug-Eluting Stents*, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation*, Prosthesis Design, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Vascular Calcification/therapy*, Ischemia-driven revascularization*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 210, + "user_id": 1447203401, + "artical_title": "Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease.", + "pmid": 33332434, + "journal_name": "PloS one", + "date": "2020-12-18", + "author": "Okamoto N,Vengrenyuk Y,Fuster V,Samady H,Yasumura K,Baber U,Barman N,Suleman J,Sweeny J,Krishnan P,Mehran R,Sharma SK,Narula J,Kini AS", + "auth_pos": 11, + "meshterms": "Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Female, Hemodynamics*, Humans, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Tomography, Optical Coherence, Tomography, Optical Coherence/methods*, Tunica Intima, Tunica Intima/diagnostic imaging, Tunica Intima/pathology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 211, + "user_id": 1447203401, + "artical_title": "Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention.", + "pmid": 33359778, + "journal_name": "American heart journal", + "date": "2020-12-29", + "author": "Malik AO,Amin A,Kennedy K,Qintar M,Shafiq A,Mehran R,Spertus JA", + "auth_pos": 6, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Age Factors, Aged, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Diabetes Complications, Diabetes Complications/prevention & control, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/complications, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Risk Factors, Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Age Factors, Aged, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Diabetes Complications, Diabetes Complications/prevention & control, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/complications, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Risk Factors, Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Age Factors, Aged, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Diabetes Complications, Diabetes Complications/prevention & control, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/complications, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Risk Factors, Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Age Factors, Aged, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Diabetes Complications, Diabetes Complications/prevention & control, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/complications, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Risk Factors, Acute Kidney Injury, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/prevention & control*, Age Factors, Aged, Contrast Media, Contrast Media/administration & dosage, Contrast Media/adverse effects*, Diabetes Complications, Diabetes Complications/prevention & control, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/complications, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 212, + "user_id": 1447203401, + "artical_title": "Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.", + "pmid": 33367641, + "journal_name": "European heart journal", + "date": "2020-12-29", + "author": "Cao D,Chandiramani R,Chiarito M,Claessen BE,Mehran R", + "auth_pos": 5, + "meshterms": "Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Drug Therapy, Combination, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 213, + "user_id": 1447203401, + "artical_title": "Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI.", + "pmid": 33357526, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-12-29", + "author": "Beyhoff N,Cao D,Mehran R,Dangas G,Baber U,Sartori S,Blum M,Roumeliotis A,Chandiramani R,Goel R,Zhang Z,Kovacic J,Krishnan P,Barman N,Kapur V,Sweeny J,Sharma SK,Kini A", + "auth_pos": 3, + "meshterms": "Body Mass Index, C-Reactive Protein, C-Reactive Protein/analysis, Humans, Percutaneous Coronary Intervention*, Prognosis, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 214, + "user_id": 1447203401, + "artical_title": "The 70/30 Rule Between Men and Women-Disparity or Opportunity?-Reply.", + "pmid": 33377914, + "journal_name": "JAMA cardiology", + "date": "2020-12-31", + "author": "Chandrasekhar J,Morice MC,Mehran R", + "auth_pos": 3, + "meshterms": "Female, Humans, Male, Risk Factors*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 215, + "user_id": 1447203401, + "artical_title": "Impact of Atrial Fibrillation on Acute Coronary Syndrome--Analysis of In-Hospital Outcomes and 30-Day Readmissions.", + "pmid": 33385750, + "journal_name": "Current problems in cardiology", + "date": "2021-01-02", + "author": "Narasimhan B,Patel N,Chakraborty S,Bandyopadhyay D,Sreenivasan J,Hajra A,Amgai B,Rai D,Krittanawong C,Kaul R,Ho KS,Mehran R,Naidu SS,Mehta D", + "auth_pos": 12, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Female, Hospitals, Humans, Male, Patient Readmission, Percutaneous Coronary Intervention*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 216, + "user_id": 1447203401, + "artical_title": "Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model.", + "pmid": 33404627, + "journal_name": "JAMA cardiology", + "date": "2021-01-07", + "author": "Urban P,Gregson J,Owen R,Mehran R,Windecker S,Valgimigli M,Varenne O,Krucoff M,Saito S,Baber U,Chevalier B,Capodanno D,Morice MC,Pocock S", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Blood Vessel Prosthesis*, Blood Vessel Prosthesis/adverse effects, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis Implantation/adverse effects*, Female, Humans, Male, Models, Statistical, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/methods, Postoperative Hemorrhage, Postoperative Hemorrhage/etiology*, Risk Factors, Stents*, Stents/adverse effects, Thrombosis, Thrombosis/etiology*, Aged, Aged, 80 and over, Blood Vessel Prosthesis*, Blood Vessel Prosthesis/adverse effects, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis Implantation/adverse effects*, Female, Humans, Male, Models, Statistical, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/methods, Postoperative Hemorrhage, Postoperative Hemorrhage/etiology*, Risk Factors, Stents*, Stents/adverse effects, Thrombosis, Thrombosis/etiology*, Aged, Aged, 80 and over, Blood Vessel Prosthesis*, Blood Vessel Prosthesis/adverse effects, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis Implantation/adverse effects*, Female, Humans, Male, Models, Statistical, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/methods, Postoperative Hemorrhage, Postoperative Hemorrhage/etiology*, Risk Factors, Stents*, Stents/adverse effects, Thrombosis, Thrombosis/etiology*, Aged, Aged, 80 and over, Blood Vessel Prosthesis*, Blood Vessel Prosthesis/adverse effects, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis Implantation/adverse effects*, Female, Humans, Male, Models, Statistical, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/methods, Postoperative Hemorrhage, Postoperative Hemorrhage/etiology*, Risk Factors, Stents*, Stents/adverse effects, Thrombosis, Thrombosis/etiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 217, + "user_id": 1447203401, + "artical_title": "Relationship between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary syndromes: an analysis from the PROSPECT study.", + "pmid": 33413366, + "journal_name": "Cardiovascular diabetology", + "date": "2021-01-09", + "author": "Farhan S,Redfors B,Maehara A,McAndrew T,Ben-Yehuda O,De Bruyne B,Mehran R,Vogel B,Giustino G,Serruys PW,Mintz GS,Stone GW", + "auth_pos": 7, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/mortality, Acute Coronary Syndrome/therapy*, Aged, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy*, Diabetes Mellitus, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Disease Progression, Europe, Europe/epidemiology, Female, Humans, Insulin Resistance*, Male, Middle Aged, Patient Readmission, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Plaque, Atherosclerotic*, Prevalence, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Ultrasonography, Interventional, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 218, + "user_id": 1447203401, + "artical_title": "Pregnancy during cardiology training: a call to action.", + "pmid": 33431423, + "journal_name": "Heart (British Cardiac Society)", + "date": "2021-01-13", + "author": "Birkhoelzer SM,Gardner FJE,Ortega RF,Mehran R", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 219, + "user_id": 1447203401, + "artical_title": "Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.", + "pmid": 33461308, + "journal_name": "Circulation", + "date": "2021-01-20", + "author": "Hijazi Z,Alexander JH,Li Z,Wojdyla DM,Mehran R,Granger CB,Parkhomenko A,Bahit MC,Windecker S,Aronson R,Berwanger O,Halvorsen S,de Waha-Thiele S,Sinnaeve P,Darius H,Storey RF,Lopes RD", + "auth_pos": 5, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use*, Female, Humans, Kidney, Kidney/pathology*, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Pyrazoles, Pyrazoles/pharmacology, Pyrazoles/therapeutic use*, Pyridones, Pyridones/pharmacology, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use*, Female, Humans, Kidney, Kidney/pathology*, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Pyrazoles, Pyrazoles/pharmacology, Pyrazoles/therapeutic use*, Pyridones, Pyridones/pharmacology, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use*, Female, Humans, Kidney, Kidney/pathology*, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Pyrazoles, Pyrazoles/pharmacology, Pyrazoles/therapeutic use*, Pyridones, Pyridones/pharmacology, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use*, Female, Humans, Kidney, Kidney/pathology*, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Pyrazoles, Pyrazoles/pharmacology, Pyrazoles/therapeutic use*, Pyridones, Pyridones/pharmacology, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome, Acute Coronary Syndrome/drug therapy*, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/pharmacology, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*, Aspirin, Aspirin/pharmacology, Aspirin/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/pharmacology, Factor Xa Inhibitors/therapeutic use*, Female, Humans, Kidney, Kidney/pathology*, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Pyrazoles, Pyrazoles/pharmacology, Pyrazoles/therapeutic use*, Pyridones, Pyridones/pharmacology, Pyridones/therapeutic use*, Vitamin K, Vitamin K/antagonists & inhibitors*, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 220, + "user_id": 1447203401, + "artical_title": "Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.", + "pmid": 33507598, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-01-29", + "author": "Chiarito M,Cao D,Nicolas J,Roumeliotis A,Power D,Chandiramani R,Sartori S,Camaj A,Goel R,Claessen BE,Stefanini GG,Mehran R,Dangas G", + "auth_pos": 12, + "meshterms": "Catheterization, Peripheral*, Catheterization, Peripheral/adverse effects, Femoral Artery, Femoral Artery/diagnostic imaging, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Radial Artery, Radial Artery/diagnostic imaging, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 221, + "user_id": 1447203401, + "artical_title": "One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.", + "pmid": 33515411, + "journal_name": "Cardiovascular drugs and therapy", + "date": "2021-01-31", + "author": "Chandrasekhar J,de Winter VC,Kalkman DN,Sartori S,Chandiramani R,Aquino MB,de Wilde P,Zeebregts D,Woudstra P,Beijk MA,Hájek P,Atzev B,Hudec M,Ong TK,Mates M,Borisov B,Warda HM,den Heijer P,Wojcik J,Iniguez A,Coufal Z,Lee M,Tijssen JG,Koch KT,Baber U,Dangas GD,Colombo A,de Winter RJ,Mehran R", + "auth_pos": 29, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 222, + "user_id": 1447203401, + "artical_title": "Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES.", + "pmid": 33516690, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-02-01", + "author": "Chau KH,Kirtane AJ,Easterwood RM,Redfors B,Zhang Z,Witzenbichler B,Weisz G,Stuckey TD,Brodie BR,Rinaldi MJ,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Mazzaferri EL,Mehran R,Stone GW", + "auth_pos": 17, + "meshterms": "Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/epidemiology, Thrombosis/etiology, Treatment Outcome, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 223, + "user_id": 1447203401, + "artical_title": "Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.", + "pmid": 33523728, + "journal_name": "Circulation", + "date": "2021-02-02", + "author": "Ybarra LF,Rinfret S,Brilakis ES,Karmpaliotis D,Azzalini L,Grantham JA,Kandzari DE,Mashayekhi K,Spratt JC,Wijeysundera HC,Ali ZA,Buller CE,Carlino M,Cohen DJ,Cutlip DE,De Martini T,Di Mario C,Farb A,Finn AV,Galassi AR,Gibson CM,Hanratty C,Hill JM,Jaffer FA,Krucoff MW,Lombardi WL,Maehara A,Magee PFA,Mehran R,Moses JW,Nicholson WJ,Onuma Y,Sianos G,Sumitsuji S,Tsuchikane E,Virmani R,Walsh SJ,Werner GS,Yamane M,Stone GW", + "auth_pos": 29, + "meshterms": "Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male, Clinical Trials as Topic, Coronary Occlusion, Coronary Occlusion/therapy*, Coronary Vessels, Coronary Vessels/physiology*, Female, Humans, Male", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 224, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.", + "pmid": 33555916, + "journal_name": "Circulation", + "date": "2021-02-09", + "author": "Angiolillo DJ,Bhatt DL,Cannon CP,Eikelboom JW,Gibson CM,Goodman SG,Granger CB,Holmes DR,Lopes RD,Mehran R,Moliterno DJ,Price MJ,Saw J,Tanguay JF,Faxon DP", + "auth_pos": 10, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Administration, Oral, Anticoagulants, Anticoagulants/pharmacology, Anticoagulants/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, History, 21st Century, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 225, + "user_id": 1447203401, + "artical_title": "Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost.", + "pmid": 33559475, + "journal_name": "Journal of the American Heart Association", + "date": "2021-02-10", + "author": "Cao D,Dangas G,Mehran R", + "auth_pos": 3, + "meshterms": "Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Ticagrelor, Ticagrelor/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 226, + "user_id": 1447203401, + "artical_title": "Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences.", + "pmid": 33587663, + "journal_name": "Circulation", + "date": "2021-02-16", + "author": "Yong CM,Balasubramanian S,Douglas PS,Agarwal P,Birgersdotter-Green U,Gummidipundi S,Batchelor W,Duvernoy CS,Harrington RA,Mehran R", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 227, + "user_id": 1447203401, + "artical_title": "Hemoglobin A and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry.", + "pmid": 33602435, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-02-20", + "author": "Baber U,Azzalini L,Masoomi R,Johal G,Barman N,Sweeny J,Krishnan P,Dangas G,Vijay P,Jahveri VB,Mehran R,Fuster V,Kini AS,Sharma SK", + "auth_pos": 11, + "meshterms": "Glycated Hemoglobin A, Hemoglobin, Sickle, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Registries, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 228, + "user_id": 1447203401, + "artical_title": "Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.", + "pmid": 33602441, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-02-20", + "author": "Valgimigli M,Mehran R,Franzone A,da Costa BR,Baber U,Piccolo R,McFadden EP,Vranckx P,Angiolillo DJ,Leonardi S,Cao D,Dangas GD,Mehta SR,Serruys PW,Gibson CM,Steg GP,Sharma SK,Hamm C,Shlofmitz R,Liebetrau C,Briguori C,Janssens L,Huber K,Ferrario M,Kunadian V,Cohen DJ,Zurakowski A,Oldroyd KG,Yaling H,Dudek D,Sartori S,Kirkham B,Escaned J,Heg D,Windecker S,Pocock S,Jüni P", + "auth_pos": 2, + "meshterms": "Drug Therapy, Combination, Dual Anti-Platelet Therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 229, + "user_id": 1447203401, + "artical_title": "Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE).", + "pmid": 33608239, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2021-02-21", + "author": "Colleran R,Joner M,Cutlip D,Urban P,Maeng M,Jauhar R,Barakat M,Michel JM,Mehran R,Kirtane AJ,Maillard L,Kastrati A,Byrne RA", + "auth_pos": 9, + "meshterms": "Brain Ischemia*, Brain Ischemia/etiology, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Stents, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Brain Ischemia*, Brain Ischemia/etiology, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Stents, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Brain Ischemia*, Brain Ischemia/etiology, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Stents, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Brain Ischemia*, Brain Ischemia/etiology, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Stents, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 230, + "user_id": 1447203401, + "artical_title": "Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention.", + "pmid": 33615365, + "journal_name": "European heart journal", + "date": "2021-02-23", + "author": "Cao D,Baber U,Mehran R", + "auth_pos": 3, + "meshterms": "Aspirin, Dual Anti-Platelet Therapy, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 231, + "user_id": 1447203401, + "artical_title": "Gender Issues in Italian Catheterization Laboratories: The Gender-CATH Study.", + "pmid": 33618540, + "journal_name": "Journal of the American Heart Association", + "date": "2021-02-24", + "author": "Bernelli C,Cerrato E,Ortega R,Piccaluga E,Ricottini E,Chieffo A,Masiero G,Mattesini A,La Manna A,Musumeci G,Tarantini G,Mehran R", + "auth_pos": 12, + "meshterms": "Adaptation, Psychological*, Adult, Cardiac Catheterization, Cardiac Catheterization/psychology, Cardiac Catheterization/statistics & numerical data*, Cardiologists, Cardiologists/psychology*, Female, Humans, Interpersonal Relations, Italy, Laboratories, Laboratories/statistics & numerical data*, Male, Retrospective Studies, Sex Factors, Adaptation, Psychological*, Adult, Cardiac Catheterization, Cardiac Catheterization/psychology, Cardiac Catheterization/statistics & numerical data*, Cardiologists, Cardiologists/psychology*, Female, Humans, Interpersonal Relations, Italy, Laboratories, Laboratories/statistics & numerical data*, Male, Retrospective Studies, Sex Factors, Adaptation, Psychological*, Adult, Cardiac Catheterization, Cardiac Catheterization/psychology, Cardiac Catheterization/statistics & numerical data*, Cardiologists, Cardiologists/psychology*, Female, Humans, Interpersonal Relations, Italy, Laboratories, Laboratories/statistics & numerical data*, Male, Retrospective Studies, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 232, + "user_id": 1447203401, + "artical_title": "Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.", + "pmid": 33636137, + "journal_name": "American heart journal", + "date": "2021-02-27", + "author": "Batchelor WB,Damluji AA,Yong C,Fiuzat M,Barnett SD,Kandzari DE,Sherwood MW,Epps KC,Tehrani BN,Allocco DJ,Meredith IT,Lindenfeld J,O'Connor CM,Mehran R", + "auth_pos": 14, + "meshterms": "Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*, Clinical Trials as Topic, Clinical Trials as Topic/methods, Clinical Trials as Topic/statistics & numerical data, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/surgery, Drug-Eluting Stents, Female, Health Services Accessibility, Humans, Male, Middle Aged, Minority Groups, Minority Groups/classification, Minority Groups/statistics & numerical data, Minority Health, Minority Health/statistics & numerical data*, Outcome Assessment, Health Care, Patient Selection*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/instrumentation, Percutaneous Coronary Intervention/methods, Registries, Registries/statistics & numerical data, United States, United States/epidemiology, Women's Health, Women's Health/statistics & numerical data*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 233, + "user_id": 1447203401, + "artical_title": "Meta-Analysis of Anticoagulation Therapy for the Prevention of Cardiovascular Events in Patients with Peripheral Arterial Disease.", + "pmid": 33667437, + "journal_name": "The American journal of cardiology", + "date": "2021-03-06", + "author": "Kamran H,Malhotra R,Farhan S,Masoomi R,Garg A,Hooda A,Lascano R,Han D,Tadros R,Tarricone A,Baber U,Mehran R,Huber K,Krishnan P", + "auth_pos": 12, + "meshterms": "Amputation, Amputation/statistics & numerical data*, Anticoagulants, Anticoagulants/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology*, Peripheral Arterial Disease, Peripheral Arterial Disease/drug therapy*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Randomized Controlled Trials as Topic, Stroke, Stroke/epidemiology*, Vascular Surgical Procedures, Vascular Surgical Procedures/statistics & numerical data*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 234, + "user_id": 1447203401, + "artical_title": "Gender and Disparity in First Authorship in Cardiology Randomized Clinical Trials.", + "pmid": 33687441, + "journal_name": "JAMA network open", + "date": "2021-03-10", + "author": "Mehran R,Kumar A,Bansal A,Shariff M,Gulati M,Kalra A", + "auth_pos": 1, + "meshterms": "Authorship*, Cardiology*, Cross-Sectional Studies, Follow-Up Studies, Humans, Randomized Controlled Trials as Topic*, Retrospective Studies, Sex Factors, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 235, + "user_id": 1447203401, + "artical_title": "Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.", + "pmid": 33709255, + "journal_name": "Journal of thrombosis and thrombolysis", + "date": "2021-03-13", + "author": "Kuno T,Claessen B,Cao D,Chandiramani R,Guedeney P,Sorrentino S,Krucoff M,Kozuma K,Ge J,Seth A,Makkar R,Bangalore S,Bhatt DL,Angiolillo DJ,Saito S,Neumann FJ,Hermiller J,Rau V,Ruster K,Wang J,Valgimigli M,Mehran R", + "auth_pos": 22, + "meshterms": "ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, ErbB Receptors, Female, Hemorrhage, Hemorrhage/etiology, Humans, Kidney, Kidney/physiology, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 236, + "user_id": 1447203401, + "artical_title": "Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.", + "pmid": 33728965, + "journal_name": "Future cardiology", + "date": "2021-03-18", + "author": "Nicolas J,Razuk V,Giustino G,Mehran R", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 237, + "user_id": 1447203401, + "artical_title": "Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantation.", + "pmid": 36003588, + "journal_name": "JTCVS open", + "date": "2021-03-23", + "author": "van Nieuwkerk AC,Santos RB,Sartori S,Regueiro A,Tchétché D,Mehran R,Delewi R", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 238, + "user_id": 1447203401, + "artical_title": "Corrigendum to \"Gender-related differences after acute myocardial infarction: A major global health challenge\" [International Journal of Cardiology Volume 311 (2020), 18-19 / DOI: https://doi.org/10.1016/j.ijcard.2020.04.023].", + "pmid": 33757659, + "journal_name": "International journal of cardiology", + "date": "2021-03-25", + "author": "Pelliccia F,Rosano GMC,Mehran R", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 239, + "user_id": 1447203401, + "artical_title": "Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.", + "pmid": 33839885, + "journal_name": "Clinical research in cardiology : official journal of the German Cardiac Society", + "date": "2021-04-12", + "author": "Chandrasekhar J,Sartori S,Mehran R,Aquino M,Vogel B,Asgar AW,Webb JG,Tchetche D,Dumonteil N,Colombo A,Windecker S,Claessen BE,Ten Berg JM,Hildick-Smith D,Wijngaard P,Lefèvre T,Deliargyris EN,Hengstenberg C,Anthopoulos P,Dangas GD", + "auth_pos": 3, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/epidemiology*, Acute Kidney Injury/etiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Antithrombins, Antithrombins/administration & dosage, Antithrombins/adverse effects, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Heparin, Heparin/administration & dosage, Heparin/adverse effects, Hirudins, Hirudins/administration & dosage, Hirudins/adverse effects, Humans, Incidence, Male, Peptide Fragments, Peptide Fragments/administration & dosage, Peptide Fragments/adverse effects, Postoperative Complications, Postoperative Complications/epidemiology*, Recombinant Proteins, Recombinant Proteins/administration & dosage, Recombinant Proteins/adverse effects, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 240, + "user_id": 1447203401, + "artical_title": "Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?", + "pmid": 33851785, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-04-15", + "author": "Nicolas J,Mehran R", + "auth_pos": 2, + "meshterms": "Heparin*, Heparin/adverse effects, Hirudins, Hirudins/adverse effects, Humans, Peptide Fragments, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Recombinant Proteins, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 241, + "user_id": 1447203401, + "artical_title": "Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.", + "pmid": 33871579, + "journal_name": "European heart journal", + "date": "2021-04-20", + "author": "Généreux P,Piazza N,Alu MC,Nazif T,Hahn RT,Pibarot P,Bax JJ,Leipsic JA,Blanke P,Blackstone EH,Finn MT,Kapadia S,Linke A,Mack MJ,Makkar R,Mehran R,Popma JJ,Reardon M,Rodes-Cabau J,Van Mieghem NM,Webb JG,Cohen DJ,Leon MB", + "auth_pos": 17, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 242, + "user_id": 1447203401, + "artical_title": "Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.", + "pmid": 33888385, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-04-24", + "author": "Généreux P,Piazza N,Alu MC,Nazif T,Hahn RT,Pibarot P,Bax JJ,Leipsic JA,Blanke P,Blackstone EH,Finn MT,Kapadia S,Linke A,Mack MJ,Makkar R,Mehran R,Popma JJ,Reardon M,Rodes-Cabau J,Van Mieghem NM,Webb JG,Cohen DJ,Leon MB", + "auth_pos": 17, + "meshterms": "Aortic Valve Disease, Aortic Valve Disease/mortality, Aortic Valve Disease/surgery*, Cardiology, Cardiology/standards*, Clinical Studies as Topic, Clinical Studies as Topic/standards*, Humans, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 243, + "user_id": 1447203401, + "artical_title": "Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.", + "pmid": 33904638, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-04-28", + "author": "Abizaid A,Campos CM,Guimarães PO,Costa JR,Falcão BAA,Mangione F,Caixeta A,Lemos PA,S de Brito F,Cavalcante R,Bezerra CG,Cortes L,Ribeiro HB,de Souza FR,Huemer N,do Val RM,Caramelli B,Calderaro D,Lima FG,Hajjar LA,Mehran R,Filho RK", + "auth_pos": 21, + "meshterms": "COVID-19*, COVID-19 Testing, Coronary Angiography, Hospital Mortality, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Percutaneous Coronary Intervention*, Prospective Studies, SARS-CoV-2, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 244, + "user_id": 1447203401, + "artical_title": "Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.", + "pmid": 33909348, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-04-29", + "author": "Razuk V,Camaj A,Cao D,Nicolas J,Hengstenberg C,Sartori S,Zhang Z,Power D,Beerkens F,Chiarito M,Meneveau N,Tron C,Dumonteil N,Widder JD,Ferrari M,Violini R,Stella PR,Jeger R,Anthopoulos P,Mehran R,Dangas GD", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 245, + "user_id": 1447203401, + "artical_title": "Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace.", + "pmid": 33985685, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-15", + "author": "Sharma G,Douglas PS,Hayes SN,Mehran R,Rzeszut A,Harrington RA,Poppas A,Walsh MN,Singh T,Parekh R,Blumenthal RS,Mehta LS", + "auth_pos": 4, + "meshterms": "Adult, Aged, Asia, Asia/epidemiology, Cardiology*, Female, Hostility*, Humans, Job Satisfaction, Male, Middle Aged, Middle East, Middle East/epidemiology, Physicians, Women, Physicians, Women/psychology*, Prevalence, Sexual Harassment, Sexual Harassment/psychology*, Sexual Harassment/statistics & numerical data*, South America, South America/epidemiology, Surveys and Questionnaires*, Workplace, Workplace/psychology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 246, + "user_id": 1447203401, + "artical_title": "Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.", + "pmid": 33985688, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-15", + "author": "Parikh PB,Bhatt DL,Bhasin V,Anker SD,Skopicki HA,Claessen BE,Fonarow GC,Hernandez AF,Mehran R,Petrie MC,Butler J", + "auth_pos": 9, + "meshterms": "Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Heart Failure, Heart Failure/complications*, Heart Failure/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 247, + "user_id": 1447203401, + "artical_title": "Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.", + "pmid": 33991416, + "journal_name": "JAMA cardiology", + "date": "2021-05-16", + "author": "Vogel B,Baber U,Cohen DJ,Sartori S,Sharma SK,Angiolillo DJ,Farhan S,Goel R,Zhang Z,Briguori C,Collier T,Dangas G,Dudek D,Escaned J,Gil R,Han YL,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Mehta SR,Moliterno D,Ohman EM,Sardella G,Witzenbichler B,Gibson CM,Pocock S,Huber K,Mehran R", + "auth_pos": 29, + "meshterms": "Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment, Aged, Aspirin, Aspirin/therapeutic use*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/surgery*, Drug Therapy, Combination, Female, Global Health, Humans, Incidence, Male, Middle Aged, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Care, Postoperative Care/methods*, Postoperative Hemorrhage, Postoperative Hemorrhage/epidemiology*, Sex Distribution, Sex Factors, Survival Rate, Survival Rate/trends, Ticagrelor, Ticagrelor/therapeutic use*, Withholding Treatment", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 248, + "user_id": 1447203401, + "artical_title": "Impact of Chronic Kidney Disease on Revascularization and Outcomes in Patients with ST-Elevation Myocardial Infarction.", + "pmid": 34006375, + "journal_name": "The American journal of cardiology", + "date": "2021-05-20", + "author": "Panchal HB,Zheng S,Devani K,White CJ,Leinaar EF,Mukherjee D,Mamas M,Banerjee S,Bhatt DL,Jneid H,Samady H,Mehran R,Gharacholou SM,Paul TK", + "auth_pos": 12, + "meshterms": "Acute Kidney Injury, Acute Kidney Injury/etiology, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Hospital Costs, Hospital Costs/statistics & numerical data, Hospital Mortality, Humans, Length of Stay, Length of Stay/statistics & numerical data, Male, Middle Aged, Myocardial Revascularization*, Percutaneous Coronary Intervention*, Prognosis, Renal Dialysis, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications*, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/therapy, ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction/mortality, ST Elevation Myocardial Infarction/surgery*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 249, + "user_id": 1447203401, + "artical_title": "White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial.", + "pmid": 34010180, + "journal_name": "Coronary artery disease", + "date": "2021-05-20", + "author": "Claessen BE,Ben-Yehuda O,Mehran R,Sorrentino S,Guedeney P,Chen S,Dressler O,Kini AS,Sharma SK,Mansour S,Noiseux N,Li D,Kappetein AP,Sabik JF,Serruys PW,Stone GW", + "auth_pos": 3, + "meshterms": "Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Aged, Coronary Vessels, Coronary Vessels/physiopathology*, Female, Humans, Leukocyte Count, Leukocyte Count/methods, Leukocyte Count/statistics & numerical data*, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Myocardial Revascularization/statistics & numerical data, Outcome Assessment, Health Care, Outcome Assessment, Health Care/methods, Outcome Assessment, Health Care/statistics & numerical data*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/standards, Percutaneous Coronary Intervention/statistics & numerical data, Risk Factors, Treatment Outcome, Ischemia-driven revascularization*, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 250, + "user_id": 1447203401, + "artical_title": "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.", + "pmid": 34010613, + "journal_name": "Lancet (London, England)", + "date": "2021-05-20", + "author": "Vogel B,Acevedo M,Appelman Y,Bairey Merz CN,Chieffo A,Figtree GA,Guerrero M,Kunadian V,Lam CSP,Maas AHEM,Mihailidou AS,Olszanecka A,Poole JE,Saldarriaga C,Saw J,Zühlke L,Mehran R", + "auth_pos": 17, + "meshterms": "Awareness, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Cost of Illness*, Female, Goals*, Humans, Internationality*, Risk Factors, Socioeconomic Factors, Women's Health*, Women's Health/statistics & numerical data, Women's Health/trends, Awareness, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Cost of Illness*, Female, Goals*, Humans, Internationality*, Risk Factors, Socioeconomic Factors, Women's Health*, Women's Health/statistics & numerical data, Women's Health/trends, Awareness, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Cost of Illness*, Female, Goals*, Humans, Internationality*, Risk Factors, Socioeconomic Factors, Women's Health*, Women's Health/statistics & numerical data, Women's Health/trends, Awareness, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/mortality, Cost of Illness*, Female, Goals*, Humans, Internationality*, Risk Factors, Socioeconomic Factors, Women's Health*, Women's Health/statistics & numerical data, Women's Health/trends", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 251, + "user_id": 1447203401, + "artical_title": "Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.", + "pmid": 34032363, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-05-26", + "author": "Roumeliotis A,Claessen BE,Sartori S,Cao D,Qiu H,Camaj A,Nicolas J,Chandiramani R,Goel R,Chiarito M,Torguson R,Sweeny J,Barman N,Krishnan P,Kini A,Sharma SK,Dangas G,Mehran R", + "auth_pos": 18, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/surgery, Adolescent, Drug-Eluting Stents*, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 252, + "user_id": 1447203401, + "artical_title": "Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).", + "pmid": 34059914, + "journal_name": "European heart journal", + "date": "2021-06-02", + "author": "Bulluck H,Paradies V,Barbato E,Baumbach A,Bøtker HE,Capodanno D,De Caterina R,Cavallini C,Davidson SM,Feldman DN,Ferdinandy P,Gili S,Gyöngyösi M,Kunadian V,Ooi SY,Madonna R,Marber M,Mehran R,Ndrepepa G,Perrino C,Schüpke S,Silvain J,Sluijter JPG,Tarantini G,Toth GG,Van Laake LW,von Birgelen C,Zeitouni M,Jaffe AS,Thygesen K,Hausenloy DJ", + "auth_pos": 18, + "meshterms": "Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Biomarkers, Consensus, Coronary Artery Disease*, Heart Injuries*, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 253, + "user_id": 1447203401, + "artical_title": "Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.", + "pmid": 34095952, + "journal_name": "The British journal of surgery", + "date": "2021-06-08", + "author": "Zhou N,Mitchell KG,Corsini EM,Truong VTT,Antonoff MB,Mehran RJ,Rajaram R,Rice DC,Roth JA,Sepesi B,Swisher SG,Vaporciyan AA,Walsh GL,Ajani JA,Hofstetter WL", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 254, + "user_id": 1447203401, + "artical_title": "Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.", + "pmid": 34098740, + "journal_name": "Journal of the American Heart Association", + "date": "2021-06-09", + "author": "Spirito A,Gragnano F,Corpataux N,Vaisnora L,Galea R,Svab S,Gargiulo G,Siontis GCM,Praz F,Lanz J,Billinger M,Hunziker L,Stortecky S,Pilgrim T,Capodanno D,Urban P,Pocock S,Mehran R,Heg D,Windecker S,Räber L,Valgimigli M", + "auth_pos": 18, + "meshterms": "Aged, Aged, 80 and over, Female, Health Status Disparities, Hemorrhage, Hemorrhage/etiology*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Prospective Studies, Registries, Risk Assessment, Risk Factors, Sex Factors, Switzerland, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 255, + "user_id": 1447203401, + "artical_title": "Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved.", + "pmid": 34107569, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-06-10", + "author": "Nicolas J,Mehran R", + "auth_pos": 2, + "meshterms": "Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Rome, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 256, + "user_id": 1447203401, + "artical_title": "Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition.", + "pmid": 34105513, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-06-10", + "author": "Gragnano F,Spirito A,Corpataux N,Vaisnora L,Galea R,Gargiulo G,Siontis GCM,Praz F,Lanz J,Billinger M,Hunziker L,Stortecky S,Pilgrim T,Bär S,Ueki Y,Capodanno D,Urban P,Pocock SJ,Mehran R,Heg D,Windecker S,Räber L,Valgimigli M", + "auth_pos": 19, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/surgery, Hemorrhage, Hemorrhage/etiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Risk Assessment, Risk Factors, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/surgery, Hemorrhage, Hemorrhage/etiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Risk Assessment, Risk Factors, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/surgery, Hemorrhage, Hemorrhage/etiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Risk Assessment, Risk Factors, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/surgery, Hemorrhage, Hemorrhage/etiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Risk Assessment, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 257, + "user_id": 1447203401, + "artical_title": "Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy.", + "pmid": 34110420, + "journal_name": "European heart journal", + "date": "2021-06-11", + "author": "Crea F,Collet JP,Thiele H,Giannitsis E,Sibbing D,Barthélémy O,Bauersachs J,Bhatt DL,Dendale P,Dorobantu M,Edvardsen T,Folliguet T,Gale CP,Gilard M,Jobs A,Jüni P,Lambrinou E,Lewis BS,Mehilli J,Meliga E,Merkely B,Mueller C,Roffi M,Rutten FH,Siontis GCM,Barbato E,Hamm CW,Böhm M,Cornel JH,Ferreiro JL,Frey N,Huber K,Kubica J,Navarese EP,Mehran R,Morais J,Storey RF,Valgimigli M,Vranckx P,James S", + "auth_pos": 35, + "meshterms": "Clopidogrel, Humans, Percutaneous Coronary Intervention*, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Purinergic P2Y Receptor Antagonists, Ticagrelor, Ticagrelor/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 258, + "user_id": 1447203401, + "artical_title": "Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.", + "pmid": 34112322, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-06-12", + "author": "Van Spall HGC,Lala A,Deering TF,Casadei B,Zannad F,Kaul P,Mehran R,Pearson GD,Shah MR,Gulati M,Grines C,Volgman AS,Revkin JH,Piña I,Lam CSP,Hochman JS,Simon T,Walsh MN,Bozkurt B", + "auth_pos": 7, + "meshterms": "Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States, Cardiology*, Clinical Trials as Topic, Clinical Trials as Topic/organization & administration*, Female, Humans, Leadership*, Male, Periodicals as Topic*, Physicians, Women, Physicians, Women/organization & administration*, Sexism, Sexism/ethnology*, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 259, + "user_id": 1447203401, + "artical_title": "Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.", + "pmid": 34117817, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-06-13", + "author": "Nicolas J,Guedeney P,Claessen BE,Mehilli J,Petronio AS,Sartori S,Lefèvre T,Presbitero P,Capranzano P,Iadanza A,Cao D,Chiarito M,Goel R,Roumeliotis A,Chandiramani R,Chen S,Sardella G,Van Mieghem NM,Sorrentino S,Meliga E,Tchétché D,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail GW,Ferrer-Gracia MC,Naber C,Kievit PC,Baber U,Sharma SK,Morice MC,Dangas GD,Chandrasekhar J,Chieffo A,Mehran R", + "auth_pos": 35, + "meshterms": "Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 260, + "user_id": 1447203401, + "artical_title": "P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.", + "pmid": 34135011, + "journal_name": "BMJ (Clinical research ed.)", + "date": "2021-06-18", + "author": "Valgimigli M,Gragnano F,Branca M,Franzone A,Baber U,Jang Y,Kimura T,Hahn JY,Zhao Q,Windecker S,Gibson CM,Kim BK,Watanabe H,Song YB,Zhu Y,Vranckx P,Mehta S,Hong SJ,Ando K,Gwon HC,Serruys PW,Dangas GD,McFadden EP,Angiolillo DJ,Heg D,Jüni P,Mehran R", + "auth_pos": 27, + "meshterms": "Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control, Aged, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/surgery, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects*, Dual Anti-Platelet Therapy/methods, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects*, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/standards, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects*, Purinergic P2Y Receptor Antagonists/therapeutic use, Randomized Controlled Trials as Topic, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/prevention & control, Thrombosis, Thrombosis/drug therapy, Thrombosis/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 261, + "user_id": 1447203401, + "artical_title": "Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials.", + "pmid": 34142118, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2021-06-19", + "author": "Benz AP,Johansson I,Dewilde WJM,Lopes RD,Mehran R,Sartori S,Sarafoff N,Yasuda S,McIntyre WF,Healey JS,Shoamanesh A,Eikelboom JW,Connolly SJ", + "auth_pos": 5, + "meshterms": "Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/chemically induced, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Brain Ischemia*, Hemorrhage, Hemorrhage/chemically induced, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Randomized Controlled Trials as Topic, Stroke*, Stroke/diagnosis, Stroke/prevention & control, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 262, + "user_id": 1447203401, + "artical_title": "Stick to the guidelines or clinical judgment: A toss up?", + "pmid": 34147555, + "journal_name": "International journal of cardiology", + "date": "2021-06-21", + "author": "Nicolas J,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "Dual Anti-Platelet Therapy*, Humans, Judgment*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Humans, Judgment*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 263, + "user_id": 1447203401, + "artical_title": "Invasive Management of Coronary Artery Disease in Advanced Renal Disease.", + "pmid": 34169192, + "journal_name": "Kidney international reports", + "date": "2021-06-26", + "author": "Karimi Galougahi K,Chadban S,Mehran R,Bangalore S,Chertow GM,Ali ZA", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 264, + "user_id": 1447203401, + "artical_title": "Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial.", + "pmid": 34170842, + "journal_name": "The Journal of invasive cardiology", + "date": "2021-06-26", + "author": "Kuno T,Claessen BE,Guedeney P,Serruys PW,Sabik JF,Simonton CA,Kandzari DE,Morice MC,Zhang Z,Dressler O,Mehran R,Ben-Yehuda O,Kappetein AP,Stone GW", + "auth_pos": 11, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/surgery, Femoral Artery, Femoral Artery/surgery, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Vascular Closure Devices*, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 265, + "user_id": 1447203401, + "artical_title": "Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.", + "pmid": 34238553, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-07-10", + "author": "Angiolillo DJ,Cao D,Baber U,Sartori S,Zhang Z,Dangas G,Mehta S,Briguori C,Cohen DJ,Collier T,Dudek D,Escaned J,Gibson CM,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Moliterno DJ,Ohman EM,Oldroyd K,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Pocock S,Mehran R", + "auth_pos": 29, + "meshterms": "Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, Age Factors, Aged, Aspirin, Aspirin/adverse effects, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor*, Ticagrelor/adverse effects, Treatment Outcome, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 266, + "user_id": 1447203401, + "artical_title": "Performance of Prediction Models for Contrast-Induced Acute Kidney Injury after Transcutaneous Aortic Valve Replacement.", + "pmid": 34261063, + "journal_name": "Cardiorenal medicine", + "date": "2021-07-15", + "author": "Rosa VEE,Campos CM,Bacelar A,Abizaid AAC,Mangione JA,Lemos PA,Esteves V,Caramori P,Sampaio RO,Tarasoutchi F,Mehran R,Brito FS", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 267, + "user_id": 1447203401, + "artical_title": "The Opportunity of Women as One.", + "pmid": 34317103, + "journal_name": "JACC. Case reports", + "date": "2021-07-29", + "author": "Ortega RF,Mehran R,Morice MC", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 268, + "user_id": 1447203401, + "artical_title": "Sexual Harassment, Victim Blaming, and the Potential Impact on Women in Cardiology.", + "pmid": 34319305, + "journal_name": "JACC. Case reports", + "date": "2021-07-29", + "author": "Mansour C,Tamirisa KP,Lundberg G,Sharma G,Mehta LS,Mehran R,Volgman AS,Parwani P", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 269, + "user_id": 1447203401, + "artical_title": "Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE Trial.", + "pmid": 34320839, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-07-30", + "author": "Dehghani P,Cantor WJ,Wang J,Wood DA,Storey RF,Mehran R,Bainey KR,Welsh RC,Rodés-Cabau J,Rao S,Lavi S,Velianou JL,Natarajan MK,Ziakas A,Guiducci V,Fernández-Avilés F,Cairns JA,Mehta SR", + "auth_pos": 6, + "meshterms": "Humans, Myocardial Revascularization, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/surgery, Thrombolytic Therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 270, + "user_id": 1447203401, + "artical_title": "Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.", + "pmid": 34347202, + "journal_name": "Journal of thrombosis and thrombolysis", + "date": "2021-08-05", + "author": "Nicolas J,Beerkens F,Cao D,Sartori S,Pivato CA,Qiu H,Giustino G,Chiarito M,Claessen BE,Zhang Z,Nardin M,Razuk V,Jones D,Camaj A,Power D,Banashefski B,Sweeny J,Baber U,Dangas G,Sharma SK,Kini A,Mehran R", + "auth_pos": 22, + "meshterms": "Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 271, + "user_id": 1447203401, + "artical_title": "The importance of achieving sex- and gender-based equity in clinical trials: a call to action.", + "pmid": 34352884, + "journal_name": "European heart journal", + "date": "2021-08-06", + "author": "van Diemen J,Verdonk P,Chieffo A,Regar E,Mauri F,Kunadian V,Sharma G,Mehran R,Appelman Y", + "auth_pos": 8, + "meshterms": "Clinical Trials as Topic, Gender Equity*, Humans, Sex Factors, Sexism*, Clinical Trials as Topic, Gender Equity*, Humans, Sex Factors, Sexism*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 272, + "user_id": 1447203401, + "artical_title": "Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.", + "pmid": 34370836, + "journal_name": "European heart journal", + "date": "2021-08-10", + "author": "Dangas G,Nicolas J,Mehran R", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 273, + "user_id": 1447203401, + "artical_title": "Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives.", + "pmid": 34384555, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-08-14", + "author": "Cho L,Vest AR,O'Donoghue ML,Ogunniyi MO,Sarma AA,Denby KJ,Lau ES,Poole JE,Lindley KJ,Mehran R", + "auth_pos": 10, + "meshterms": "Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors, Animals, Female, Humans, Male, Pregnancy, Ageism, Cardiology*, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Leadership, Patient Participation*, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 274, + "user_id": 1447203401, + "artical_title": "Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.", + "pmid": 34386899, + "journal_name": "Journal of thrombosis and thrombolysis", + "date": "2021-08-14", + "author": "Cao D,Levin MA,Sartori S,Claessen B,Roumeliotis A,Zhang Z,Nicolas J,Chandiramani R,Bedekar R,Waseem Z,Goel R,Chiarito M,Lupo B,Jhang J,Dangas GD,Baber U,Bhatt DL,Sharma SK,Kini AS,Mehran R", + "auth_pos": 20, + "meshterms": "Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 275, + "user_id": 1447203401, + "artical_title": "Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.", + "pmid": 34423374, + "journal_name": "European heart journal", + "date": "2021-08-24", + "author": "Stefanini GG,Briguori C,Cao D,Baber U,Sartori S,Zhang Z,Dangas G,Angiolillo DJ,Mehta S,Cohen DJ,Collier T,Dudek D,Escaned J,Gibson CM,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Moliterno DJ,Ohman EM,Oldroyd KG,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Pocock S,Mehran R", + "auth_pos": 30, + "meshterms": "BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 276, + "user_id": 1447203401, + "artical_title": "Bleeding avoidance strategies in percutaneous coronary intervention.", + "pmid": 34426673, + "journal_name": "Nature reviews. Cardiology", + "date": "2021-08-25", + "author": "Capodanno D,Bhatt DL,Gibson CM,James S,Kimura T,Mehran R,Rao SV,Steg PG,Urban P,Valgimigli M,Windecker S,Angiolillo DJ", + "auth_pos": 6, + "meshterms": "Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome, Anticoagulants, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 277, + "user_id": 1447203401, + "artical_title": "Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.", + "pmid": 34449183, + "journal_name": "The New England journal of medicine", + "date": "2021-08-28", + "author": "Van Mieghem NM,Unverdorben M,Hengstenberg C,Möllmann H,Mehran R,López-Otero D,Nombela-Franco L,Moreno R,Nordbeck P,Thiele H,Lang I,Zamorano JL,Shawl F,Yamamoto M,Watanabe Y,Hayashida K,Hambrecht R,Meincke F,Vranckx P,Jin J,Boersma E,Rodés-Cabau J,Ohlmann P,Capranzano P,Kim HS,Pilgrim T,Anderson R,Baber U,Duggal A,Laeis P,Lanz H,Chen C,Valgimigli M,Veltkamp R,Saito S,Dangas GD", + "auth_pos": 5, + "meshterms": "4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*, 4-Hydroxycoumarins, 4-Hydroxycoumarins/adverse effects, 4-Hydroxycoumarins/therapeutic use*, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use*, Female, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/chemically induced, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Mortality, Phenindione, Phenindione/analogs & derivatives, Phenindione/therapeutic use, Postoperative Complications, Postoperative Complications/prevention & control, Pyridines, Pyridines/adverse effects, Pyridines/therapeutic use*, Thiazoles, Thiazoles/adverse effects, Thiazoles/therapeutic use*, Thromboembolism, Thromboembolism/prevention & control, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Vitamin K, Vitamin K/antagonists & inhibitors*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 278, + "user_id": 1447203401, + "artical_title": "Types of myocardial injury and mid-term outcomes in patients with COVID-19.", + "pmid": 34458912, + "journal_name": "European heart journal. Quality of care & clinical outcomes", + "date": "2021-08-31", + "author": "Kini A,Cao D,Nardin M,Sartori S,Zhang Z,Pivato CA,Chiarito M,Nicolas J,Vengrenyuk Y,Krishnamoorthy P,Sharma SK,Dangas G,Fuster V,Mehran R", + "auth_pos": 14, + "meshterms": "Acute Disease, Acute Disease/epidemiology, Acute Disease/mortality, Adult, Aged, Aged, 80 and over, COVID-19, COVID-19/complications*, COVID-19/diagnosis, COVID-19/epidemiology, COVID-19/virology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/mortality, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Artery Disease/mortality, Female, Heart Failure, Heart Failure/epidemiology, Humans, Male, Middle Aged, Mortality, Mortality/trends, Myocardial Infarction, Myocardial Infarction/blood*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology*, Myocardial Infarction/mortality, New York City, New York City/epidemiology, Outcome Assessment, Health Care, Prognosis, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology, Retrospective Studies, SARS-CoV-2, SARS-CoV-2/genetics, Troponin, Troponin/analysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 279, + "user_id": 1447203401, + "artical_title": "Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis.", + "pmid": 34459481, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2021-08-31", + "author": "Tavenier AH,Mehran R,Chiarito M,Cao D,Pivato CA,Nicolas J,Beerkens F,Nardin M,Sartori S,Baber U,Angiolillo DJ,Capodanno D,Valgimigli M,Hermanides RS,van 't Hof AWJ,Ten Berg JM,Chang K,Kini AS,Sharma SK,Dangas G", + "auth_pos": 2, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 280, + "user_id": 1447203401, + "artical_title": "Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria.", + "pmid": 34474588, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-09-04", + "author": "Nardin M,Cao D,Mehran R,Chandiramani R,Chiarito M,Sartori S,Qiu H,Zhang Z,Golani E,Nicolas J,Baber U,Dangas G,De Luca G,Stefanini GG,Sweeny J,Sharma SK,Kini A", + "auth_pos": 3, + "meshterms": "Hemorrhage, Hemorrhage/epidemiology, Humans, Percutaneous Coronary Intervention*, Prevalence, Prognosis, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 281, + "user_id": 1447203401, + "artical_title": "Evaluation of Cerebral Thromboembolism After Transcatheter Aortic Valve Replacement (EARTH TAVR): A Serial Magnetic Resonance Imaging Evaluation as Substudy of the GALILEO Trial.", + "pmid": 34474587, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-09-04", + "author": "Fröhlich GM,Endres M,Falk V,Steinbeck L,Erbay A,Stangl V,Wöhrle J,Rudolph TK,Geisler T,Dreger H,Leistner DM,Nolte CH,Unbehaun A,Linke A,Fiebach JB,Majoie C,Knapp G,Georg Haeusler K,Mehran R,Windecker S,Dangas GD,Landmesser U", + "auth_pos": 19, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Humans, Magnetic Resonance Imaging, Risk Factors, Stroke*, Thromboembolism*, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 282, + "user_id": 1447203401, + "artical_title": "Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.", + "pmid": 34478235, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-09-04", + "author": "Beerkens FJ,Singh R,Cao D,Claessen BE,Nicolas J,Sartori S,Snyder C,Camaj A,Giustino G,Power D,Razuk V,Jones D,Tavenier AH,Pivato CA,Nardin M,Chiarito M,Krishnan P,Barman N,Baber U,Sweeny J,Dangas G,Sharma SK,Mehran R,Kini A", + "auth_pos": 23, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 283, + "user_id": 1447203401, + "artical_title": "Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.", + "pmid": 34478233, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-09-04", + "author": "Kandzari DE,Kirtane AJ,Mehran R,Price MJ,Simon DI,Latib A,Kedhi E,Abizaid A,Worthley SG,Zaman A,Hudec M,Stoler R,Choi JW,Kanitkar M,Conradie A,Tam CF,Walton A,Gruberg L,Ando K,Lee LC,Lung TH,Windecker S,Stone GW", + "auth_pos": 3, + "meshterms": "Coronary stent*, Large vessel occlusion*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 284, + "user_id": 1447203401, + "artical_title": "Gender Differences in Medicare Payments Among Cardiologists.", + "pmid": 34495296, + "journal_name": "JAMA cardiology", + "date": "2021-09-09", + "author": "Raber I,Al Rifai M,McCarthy CP,Vaduganathan M,Michos ED,Wood MJ,Smyth YM,Ibrahim NE,Asnani A,Mehran R,McEvoy JW", + "auth_pos": 10, + "meshterms": "Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States, Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States, Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States, Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States, Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States, Cardiologists, Cardiologists/economics*, Cross-Sectional Studies, Databases, Factual, Female, Humans, Male, Medicare, Medicare/economics*, Reimbursement Mechanisms, Reimbursement Mechanisms/economics*, Salaries and Fringe Benefits, Salaries and Fringe Benefits/trends*, Sex Factors, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 285, + "user_id": 1447203401, + "artical_title": "Sex disparities continue to characterise the management of non-ST-elevation acute coronary syndrome.", + "pmid": 34499361, + "journal_name": "The Medical journal of Australia", + "date": "2021-09-10", + "author": "Pivato CA,Vogel B,Mehran R", + "auth_pos": 3, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Humans, Non-ST Elevated Myocardial Infarction*, ST Elevation Myocardial Infarction*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 286, + "user_id": 1447203401, + "artical_title": "Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort.", + "pmid": 34501454, + "journal_name": "Journal of clinical medicine", + "date": "2021-09-11", + "author": "van Nieuwkerk AC,Santos RB,Andraka L,Tchetche D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Ten F,Dumonteil N,Baan J,Piek JJ,Abizaid A,Sartori S,D'Errigo P,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Nogales-Asensio JM,Ghattas A,Dangas G,Mehran R,Delewi R", + "auth_pos": 25, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 287, + "user_id": 1447203401, + "artical_title": "3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.", + "pmid": 34503737, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-09-11", + "author": "Mehran R,Cao D,Angiolillo DJ,Bangalore S,Bhatt DL,Ge J,Hermiller J,Makkar RR,Neumann FJ,Saito S,Picon H,Toelg R,Maksoud A,Chehab BM,De la Torre Hernandez JM,Kunadian V,Sardella G,Thiele H,Varenne O,Vranckx P,Windecker S,Zhou Y,Krucoff MW,Ruster K,Wang J,Valgimigli M", + "auth_pos": 1, + "meshterms": "Drug Therapy, Combination, Drug-Eluting Stents*, Everolimus, Everolimus/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Treatment Outcome, P2Y12 inhibitor*, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 288, + "user_id": 1447203401, + "artical_title": "First and recurrent events in the ISCHEMIA trial: two sides of the same coin.", + "pmid": 34514507, + "journal_name": "European heart journal", + "date": "2021-09-14", + "author": "Cao D,Pepine CJ,Mehran R", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 289, + "user_id": 1447203401, + "artical_title": "Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.", + "pmid": 34519777, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2021-09-15", + "author": "Ortega-Paz L,Galli M,Capodanno D,Franchi F,Rollini F,Bikdeli B,Mehran R,Montalescot G,Gibson CM,Lopes RD,Andreotti F,Angiolillo DJ", + "auth_pos": 7, + "meshterms": "Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Anticoagulants, COVID-19*, Hemorrhage, Hemorrhage/chemically induced, Humans, Randomized Controlled Trials as Topic, Venous Thromboembolism*, Venous Thromboembolism/drug therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 290, + "user_id": 1447203401, + "artical_title": "Rationale and Design of the Small Annuli Randomized to Evolut or SAPIEN Trial (SMART Trial).", + "pmid": 34587510, + "journal_name": "American heart journal", + "date": "2021-09-30", + "author": "Herrmann HC,Abdel-Wahab M,Attizzani GF,Batchelor W,Bleiziffer S,Verdoliva S,Chang Y,Gada H,Gillam L,Guerrero M,Mahoney PD,Petronio AS,Rogers T,Rovin J,Szerlip M,Whisenant B,Mehran R,Tchetche D", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 291, + "user_id": 1447203401, + "artical_title": "Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization.", + "pmid": 34611327, + "journal_name": "Nature reviews. Cardiology", + "date": "2021-10-07", + "author": "Beerkens FJ,Claessen BE,Mahan M,Gaudino MFL,Tam DY,Henriques JPS,Mehran R,Dangas GD", + "auth_pos": 7, + "meshterms": "Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Saphenous Vein, Saphenous Vein/transplantation, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Saphenous Vein, Saphenous Vein/transplantation, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Saphenous Vein, Saphenous Vein/transplantation, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Saphenous Vein, Saphenous Vein/transplantation, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Saphenous Vein, Saphenous Vein/transplantation, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 292, + "user_id": 1447203401, + "artical_title": "Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.", + "pmid": 34620413, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-09", + "author": "Sullivan AE,Nanna MG,Wang TY,Bhatt DL,Angiolillo DJ,Mehran R,Banerjee S,Cantrell S,Jones WS,Rymer JA,Washam JB,Rao SV,Ohman EM", + "auth_pos": 6, + "meshterms": "Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, Adenosine Monophosphate, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Eptifibatide, Eptifibatide/therapeutic use, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Risk Factors, Stents, Thromboembolism, Thromboembolism/prevention & control, Tirofiban, Tirofiban/therapeutic use, P2Y12 inhibitor*, Coronary stent*, Bridging Stents*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 293, + "user_id": 1447203401, + "artical_title": "Sex Differences in Cardiovascular Research: A Scientometric Analysis.", + "pmid": 34632817, + "journal_name": "Journal of the American Heart Association", + "date": "2021-10-12", + "author": "Millenaar D,Dillmann M,Fehlmann T,Flohr A,Mehran R,Al-Lamee R,Lauder L,Ukena C,Böhm M,Keller A,Mahfoud F", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 294, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease.", + "pmid": 34662163, + "journal_name": "Circulation", + "date": "2021-10-19", + "author": "Calabrò P,Gragnano F,Niccoli G,Marcucci R,Zimarino M,Spaccarotella C,Renda G,Patti G,Andò G,Moscarella E,Mancone M,Cesaro A,Giustino G,De Caterina R,Mehran R,Capodanno D,Valgimigli M,Windecker S,Dangas GD,Indolfi C,Angiolillo DJ", + "auth_pos": 15, + "meshterms": "Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, Heart Diseases, Heart Diseases/drug therapy*, Heart Diseases/surgery, Humans, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, Heart Diseases, Heart Diseases/drug therapy*, Heart Diseases/surgery, Humans, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, Heart Diseases, Heart Diseases/drug therapy*, Heart Diseases/surgery, Humans, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, Heart Diseases, Heart Diseases/drug therapy*, Heart Diseases/surgery, Humans, Fibrinolytic Agents, Fibrinolytic Agents/pharmacology, Fibrinolytic Agents/therapeutic use*, Heart Diseases, Heart Diseases/drug therapy*, Heart Diseases/surgery, Humans", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 295, + "user_id": 1447203401, + "artical_title": "Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.", + "pmid": 34662382, + "journal_name": "European heart journal", + "date": "2021-10-19", + "author": "Escaned J,Cao D,Baber U,Nicolas J,Sartori S,Zhang Z,Dangas G,Angiolillo DJ,Briguori C,Cohen DJ,Collier T,Dudek D,Gibson M,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Mehta S,Moliterno DJ,Ohman EM,Oldroyd KG,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Pocock S,Mehran R", + "auth_pos": 30, + "meshterms": "BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 296, + "user_id": 1447203401, + "artical_title": "Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.", + "pmid": 34758252, + "journal_name": "The New England journal of medicine", + "date": "2021-11-11", + "author": "Pfeffer MA,Claggett B,Lewis EF,Granger CB,Køber L,Maggioni AP,Mann DL,McMurray JJV,Rouleau JL,Solomon SD,Steg PG,Berwanger O,Cikes M,De Pasquale CG,East C,Fernandez A,Jering K,Landmesser U,Mehran R,Merkely B,Vaghaiwalla Mody F,Petrie MC,Petrov I,Schou M,Senni M,Sim D,van der Meer P,Lefkowitz M,Zhou Y,Gong J,Braunwald E", + "auth_pos": 19, + "meshterms": "Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Aged, Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Double-Blind Method, Drug Combinations, Female, Heart Failure, Heart Failure/prevention & control*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Proportional Hazards Models, Ramipril, Ramipril/adverse effects, Ramipril/therapeutic use*, Stroke Volume, Valsartan, Valsartan/adverse effects, Valsartan/therapeutic use*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/etiology, Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 297, + "user_id": 1447203401, + "artical_title": "Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.", + "pmid": 34763774, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-11-13", + "author": "Palmerini T,Bruno AG,Redfors B,Valgimigli M,Taglieri N,Feres F,Abizaid A,Costa R,Gilard M,Morice MC,Hong MK,Kim BK,Jang Y,Kim HS,Park KW,Colombo A,Chieffo A,Nakamura M,Kotinkaduwa LN,Nardi E,Saia F,Gasparini M,Rizzello G,Weisz G,Kirtane AJ,Mehran R,Witzenbichler B,Galiè N,Stone GW", + "auth_pos": 26, + "meshterms": "Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome, Aged, Decision Making, Drug-Eluting Stents, Drug-Eluting Stents/adverse effects*, Female, Hemorrhage*, Humans, International Cooperation, Ischemia, Ischemia/physiopathology*, Kaplan-Meier Estimate, Male, Middle Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Randomized Controlled Trials as Topic, Registries, Risk, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 298, + "user_id": 1447203401, + "artical_title": "A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.", + "pmid": 34793743, + "journal_name": "Lancet (London, England)", + "date": "2021-11-19", + "author": "Mehran R,Owen R,Chiarito M,Baber U,Sartori S,Cao D,Nicolas J,Pivato CA,Nardin M,Krishnan P,Kini A,Sharma S,Pocock S,Dangas G", + "auth_pos": 1, + "meshterms": "Coronary slow flow*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 299, + "user_id": 1447203401, + "artical_title": "Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI.", + "pmid": 34794650, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-11-20", + "author": "Chiarito M,Kini A,Roumeliotis A,Cao D,Power D,Sartori S,Reisman A,Zhang Z,Mtisi T,Nicolas J,Nardin M,Stefanini G,Baber U,Giustino G,Sweeny J,Mehran R,Sharma S,Dangas G", + "auth_pos": 16, + "meshterms": "Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 300, + "user_id": 1447203401, + "artical_title": "Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.", + "pmid": 34794687, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-11-20", + "author": "Valgimigli M,Cao D,Angiolillo DJ,Bangalore S,Bhatt DL,Ge J,Hermiller J,Makkar RR,Neumann FJ,Saito S,Picon H,Toelg R,Maksoud A,Chehab BM,Choi JW,Campo G,De la Torre Hernandez JM,Kunadian V,Sardella G,Thiele H,Varenne O,Vranckx P,Windecker S,Zhou Y,Krucoff MW,Ruster K,Zheng Y,Mehran R", + "auth_pos": 28, + "meshterms": "Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, Aged, Aged, 80 and over, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/chemically induced*, Hemorrhage/diagnosis, Hemorrhage/prevention & control*, Humans, Male, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/administration & dosage*, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/administration & dosage, Purinergic P2Y Receptor Antagonists/adverse effects, Risk Factors, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 301, + "user_id": 1447203401, + "artical_title": "Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease.", + "pmid": 34823840, + "journal_name": "The American journal of cardiology", + "date": "2021-11-27", + "author": "Hahn J,Virk HUH,Al-Azzam F,Greason K,Yue B,El Hachem K,Lee M,Sharma S,Palazzo A,Mehran R,Alam M,Jneid H,Krittanawong C", + "auth_pos": 10, + "meshterms": "Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome, Aortic Valve Stenosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/epidemiology, Comorbidity, Female, Heart Failure, Heart Failure/epidemiology, Hospital Mortality*, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/epidemiology*, Logistic Models, Male, Mitral Valve Stenosis, Mitral Valve Stenosis/epidemiology, Multivariate Analysis, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/epidemiology, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Transcatheter Aortic Valve Replacement, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 302, + "user_id": 1447203401, + "artical_title": "Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.", + "pmid": 34873913, + "journal_name": "Journal of the American Heart Association", + "date": "2021-12-08", + "author": "Fudim M,Wojdyla DM,Alexander JH,Goodman SG,Mehran R,Windecker S,Aronson R,Vinereanu D,Halvorsen S,Bahit MC,Granger CB,Lopes RD", + "auth_pos": 5, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Clinical Trials as Topic, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Heart Failure*, Heart Failure/epidemiology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/statistics & numerical data, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 303, + "user_id": 1447203401, + "artical_title": "Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study.", + "pmid": 34881696, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-12-10", + "author": "Dangas G,Baber U,Sharma SK,Giustino G,Sartori S,Nicolas J,Goel R,Mehta SR,Cohen DJ,Angiolillo DJ,Zhang Z,Camaj A,Cao D,Briguori C,Dudek D,Escaned J,Huber K,Collier T,Kornowski R,Kunadian V,Moliterno DJ,Ohman EM,Weisz G,Gil RJ,Krucoff MW,Kaul U,Oldroyd KG,Sardella G,Shlofmitz RA,Witzenbichler B,Kastrati A,Han Y,Steg PG,Pocock SJ,Gibson CM,Mehran R", + "auth_pos": 36, + "meshterms": "Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome, Drug-Eluting Stents*, Everolimus, Everolimus/pharmacology, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Stents, Ticagrelor, Ticagrelor/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 304, + "user_id": 1447203401, + "artical_title": "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.", + "pmid": 34882435, + "journal_name": "Circulation", + "date": "2021-12-10", + "author": "Lawton JS,Tamis-Holland JE,Bangalore S,Bates ER,Beckie TM,Bischoff JM,Bittl JA,Cohen MG,DiMaio JM,Don CW,Fremes SE,Gaudino MF,Goldberger ZD,Grant MC,Jaswal JB,Kurlansky PA,Mehran R,Metkus TS,Nnacheta LC,Rao SV,Sellke FW,Sharma G,Yong CM,Zwischenberger BA", + "auth_pos": 17, + "meshterms": "Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States, Humans, American Heart Association, American Heart Association/organization & administration, Cardiology*, Cardiology/standards, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels*, Coronary Vessels/surgery, Guidelines as Topic, Guidelines as Topic/standards, Myocardial Revascularization*, Myocardial Revascularization/standards, Research Report, Research Report/standards, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 305, + "user_id": 1447203401, + "artical_title": "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.", + "pmid": 34882436, + "journal_name": "Circulation", + "date": "2021-12-10", + "author": "Lawton JS,Tamis-Holland JE,Bangalore S,Bates ER,Beckie TM,Bischoff JM,Bittl JA,Cohen MG,DiMaio JM,Don CW,Fremes SE,Gaudino MF,Goldberger ZD,Grant MC,Jaswal JB,Kurlansky PA,Mehran R,Metkus TS,Nnacheta LC,Rao SV,Sellke FW,Sharma G,Yong CM,Zwischenberger BA", + "auth_pos": 17, + "meshterms": "American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, American Heart Association, American Heart Association/organization & administration, Cardiology, Cardiology/standards*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Coronary Artery Bypass/standards*, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/surgery, Humans, Myocardial Revascularization, Myocardial Revascularization/standards*, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/standards*, United States, Vascular Surgical Procedures, Vascular Surgical Procedures/methods, Vascular Surgical Procedures/standards*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 306, + "user_id": 1447203401, + "artical_title": "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.", + "pmid": 34895950, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-12-14", + "author": "Lawton JS,Tamis-Holland JE,Bangalore S,Bates ER,Beckie TM,Bischoff JM,Bittl JA,Cohen MG,DiMaio JM,Don CW,Fremes SE,Gaudino MF,Goldberger ZD,Grant MC,Jaswal JB,Kurlansky PA,Mehran R,Metkus TS,Nnacheta LC,Rao SV,Sellke FW,Sharma G,Yong CM,Zwischenberger BA", + "auth_pos": 18, + "meshterms": "American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States, American Heart Association, Cardiology, Cardiology/standards*, Coronary Artery Disease, Coronary Artery Disease/therapy*, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 307, + "user_id": 1447203401, + "artical_title": "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.", + "pmid": 34895951, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-12-14", + "author": "Lawton JS,Tamis-Holland JE,Bangalore S,Bates ER,Beckie TM,Bischoff JM,Bittl JA,Cohen MG,DiMaio JM,Don CW,Fremes SE,Gaudino MF,Goldberger ZD,Grant MC,Jaswal JB,Kurlansky PA,Mehran R,Metkus TS,Nnacheta LC,Rao SV,Sellke FW,Sharma G,Yong CM,Zwischenberger BA", + "auth_pos": 18, + "meshterms": "Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States, Algorithms, American Heart Association, Coronary Artery Disease, Coronary Artery Disease/therapy*, Decision Making, Shared, Diabetes Mellitus, Dual Anti-Platelet Therapy, Humans, Myocardial Revascularization, Myocardial Revascularization/methods, Myocardial Revascularization/standards*, Patient Care Team, Risk Assessment, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 308, + "user_id": 1447203401, + "artical_title": "Patient partnership in cardiovascular clinical trials.", + "pmid": 34897413, + "journal_name": "European heart journal", + "date": "2021-12-14", + "author": "Zannad F,Chauhan C,Gee PO,Hartshorne-Evans N,Hernandez AF,Mann MK,Martinez R,Mehran R", + "auth_pos": 8, + "meshterms": "Humans, Patient Participation*, Quality of Life*, Research Personnel, Humans, Patient Participation*, Quality of Life*, Research Personnel, Humans, Patient Participation*, Quality of Life*, Research Personnel, Humans, Patient Participation*, Quality of Life*, Research Personnel", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 309, + "user_id": 1447203401, + "artical_title": "Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.", + "pmid": 34918066, + "journal_name": "European heart journal", + "date": "2021-12-18", + "author": "Galli M,Benenati S,Franchi F,Rollini F,Capodanno D,Biondi-Zoccai G,Vescovo GM,Cavallari LH,Bikdeli B,Ten Berg J,Mehran R,Gibson CM,Crea F,Pereira NL,Sibbing D,Angiolillo DJ", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 310, + "user_id": 1447203401, + "artical_title": "The year in cardiovascular medicine: interventional cardiology.", + "pmid": 34974613, + "journal_name": "European heart journal", + "date": "2022-01-03", + "author": "Escaned J,Jaffer FA,Mehilli J,Mehran R", + "auth_pos": 4, + "meshterms": "COVID-19*, Cardiology*, Humans, Pandemics, Percutaneous Coronary Intervention*, SARS-CoV-2, COVID-19*, Cardiology*, Humans, Pandemics, Percutaneous Coronary Intervention*, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 311, + "user_id": 1447203401, + "artical_title": "Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018.", + "pmid": 34973948, + "journal_name": "American heart journal", + "date": "2022-01-03", + "author": "Sharma A,Mahaffey KW,Gibson CM,Hicks KA,Alexander KP,Ali M,Chaitman BR,Held C,Hlatky M,Jones WS,Mehran R,Menon V,Rockhold FW,Seltzer J,Spitzer E,Wilson M,Lopes RD", + "auth_pos": 11, + "meshterms": "Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans, Artificial Intelligence*, Humans", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 312, + "user_id": 1447203401, + "artical_title": "Sex Difference in Bleeding Risk With P2Y12 Inhibitor Agents After Percutaneous Coronary Intervention-Reply.", + "pmid": 34985499, + "journal_name": "JAMA cardiology", + "date": "2022-01-06", + "author": "Vogel B,Huber K,Mehran R", + "auth_pos": 3, + "meshterms": "Aspirin*, Aspirin/adverse effects, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Sex Characteristics, Ticagrelor, Ticagrelor/therapeutic use, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 313, + "user_id": 1447203401, + "artical_title": "Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome.", + "pmid": 34994506, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-01-08", + "author": "Spirito A,Mehran R", + "auth_pos": 2, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/drug therapy, Clopidogrel, Clopidogrel/therapeutic use, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 314, + "user_id": 1447203401, + "artical_title": "SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.", + "pmid": 35021205, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-01-13", + "author": "Razuk V,Chiarito M,Cao D,Nicolas J,Pivato CA,Camaj A,Power D,Beerkens F,Jones D,Alter A,Mathew A,Spirito A,Contreras JP,Dangas GD,Mehran R", + "auth_pos": 15, + "meshterms": "Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Cardiovascular System*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 315, + "user_id": 1447203401, + "artical_title": "Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents.", + "pmid": 35031109, + "journal_name": "The American journal of cardiology", + "date": "2022-01-16", + "author": "Roumeliotis A,Claessen B,Sartori S,Cao D,Koh WJ,Qiu H,Nicolas J,Chandiramani R,Goel R,Chiarito M,Sweeny J,Barman N,Krishnan P,Kini A,Sharma SK,Dangas G,Mehran R", + "auth_pos": 17, + "meshterms": "Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Acute Coronary Syndrome*, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/etiology, Angina, Unstable/surgery, Drug-Eluting Stents*, Ethnicity, Humans, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/etiology, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 316, + "user_id": 1447203401, + "artical_title": "Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.", + "pmid": 35033468, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-01-17", + "author": "Chiarito M,Baber U,Cao D,Sharma SK,Dangas G,Angiolillo DJ,Briguori C,Cohen DJ,Dudek D,Džavík V,Escaned J,Gil R,Hamm CW,Henry T,Huber K,Kastrati A,Kaul U,Kornowski R,Krucoff M,Kunadian V,Mehta SR,Moliterno D,Ohman EM,Oldroyd K,Sardella G,Zhongjie Z,Sartori S,Stefanini G,Shlofmitz R,Steg PG,Weisz G,Witzenbichler B,Han YL,Pocock S,Gibson CM,Mehran R", + "auth_pos": 36, + "meshterms": "Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, Drug Therapy, Combination, Drug-Eluting Stents*, Humans, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Ticagrelor, Treatment Outcome, BARC bleeding*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 317, + "user_id": 1447203401, + "artical_title": "Individualizing dual antiplatelet therapy (DAPT) duration based on bleeding risk, ischemic risk, or both: An analysis from the DAPT Study.", + "pmid": 35045941, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2022-01-21", + "author": "Mihatov N,Secemsky EA,Kereiakes DJ,Steg PG,Cutlip DE,Kirtane AJ,Mehran R,Zhao B,Song Y,Gibson CM,Yeh RW", + "auth_pos": 7, + "meshterms": "Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Dinucleoside Phosphates, Drug Therapy, Combination, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Hemorrhage, Hemorrhage/etiology, Humans, Ischemia, Ischemia/diagnosis, Ischemia/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 318, + "user_id": 1447203401, + "artical_title": "Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation.", + "pmid": 35060092, + "journal_name": "Clinical pharmacokinetics", + "date": "2022-01-22", + "author": "Angiolillo DJ,Prats J,Deliargyris EN,Schneider DJ,Scheiman J,Kimmelstiel C,Steg PG,Alberts M,Rosengart T,Mehran R,Bhatt DL", + "auth_pos": 10, + "meshterms": "Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated, Aspirin*, Aspirin/pharmacology, Blood Platelets, Humans, Phospholipids*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Platelet Aggregation Inhibitors/therapeutic use, Tablets, Enteric-Coated", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 319, + "user_id": 1447203401, + "artical_title": "Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris.", + "pmid": 35058052, + "journal_name": "The American journal of cardiology", + "date": "2022-01-22", + "author": "Camaj A,Giustino G,Kocovic N,Cao D,Claessen BE,Sartori S,Zhang Z,Qiu H,Nicolas J,Hinohara T,Baber U,Power DA,Barman N,Sweeny J,Dangas G,Kini A,Sharma SK,Mehran R", + "auth_pos": 18, + "meshterms": "Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Angina Pectoris, Angina Pectoris/etiology, C-Reactive Protein*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 320, + "user_id": 1447203401, + "artical_title": "Evidence base for the management of women with non-ST elevation acute coronary syndrome.", + "pmid": 35064048, + "journal_name": "Heart (British Cardiac Society)", + "date": "2022-01-23", + "author": "Jackson J,Alkhalil M,Ratcovich H,Wilkinson C,Mehran R,Kunadian V", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 321, + "user_id": 1447203401, + "artical_title": "Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.", + "pmid": 35068227, + "journal_name": "Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis", + "date": "2022-01-25", + "author": "Cryer MJ,Farhan S,Kaufmann CC,Jäger B,Garg A,Krishnan P,Mehran R,Huber K", + "auth_pos": 7, + "meshterms": "Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Biomarkers, Biomarkers/blood, Blood Coagulation, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/drug therapy, Critical Illness, Heart Disease Risk Factors, Hospitalization, Humans, Pandemics, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2*, Thrombosis, Thrombosis/epidemiology, Thrombosis/etiology*, Thrombosis/prevention & control, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Biomarkers, Biomarkers/blood, Blood Coagulation, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/drug therapy, Critical Illness, Heart Disease Risk Factors, Hospitalization, Humans, Pandemics, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2*, Thrombosis, Thrombosis/epidemiology, Thrombosis/etiology*, Thrombosis/prevention & control, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Biomarkers, Biomarkers/blood, Blood Coagulation, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/drug therapy, Critical Illness, Heart Disease Risk Factors, Hospitalization, Humans, Pandemics, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2*, Thrombosis, Thrombosis/epidemiology, Thrombosis/etiology*, Thrombosis/prevention & control, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Biomarkers, Biomarkers/blood, Blood Coagulation, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/drug therapy, Critical Illness, Heart Disease Risk Factors, Hospitalization, Humans, Pandemics, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2*, Thrombosis, Thrombosis/epidemiology, Thrombosis/etiology*, Thrombosis/prevention & control, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Biomarkers, Biomarkers/blood, Blood Coagulation, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/drug therapy, Critical Illness, Heart Disease Risk Factors, Hospitalization, Humans, Pandemics, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2*, Thrombosis, Thrombosis/epidemiology, Thrombosis/etiology*, Thrombosis/prevention & control, Venous Thromboembolism, Venous Thromboembolism/etiology, Venous Thromboembolism/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 322, + "user_id": 1447203401, + "artical_title": "Perspectives of Female Cardiology Trainees on Interventional Cardiology Training and Careers: A Canadian Nationwide Survey.", + "pmid": 35074415, + "journal_name": "The Canadian journal of cardiology", + "date": "2022-01-26", + "author": "Barker M,Mehran R,Wong GC,Nair P,Chou A,Aymong E,Butler C,Chen-Tournoux A,Coverett K,DeJong P,Essadiqi B,Froeschl M,Hazra S,Huitema A,Kass M,Kavanagh K,Khoo C,Korley V,Ly H,Moeller A,Morin J,Sibbald M,Gin K,Sathananthan J", + "auth_pos": 2, + "meshterms": "Canada, Cardiology*, Cardiology/education, Fellowships and Scholarships, Female, Humans, Surveys and Questionnaires, Canada, Cardiology*, Cardiology/education, Fellowships and Scholarships, Female, Humans, Surveys and Questionnaires, Canada, Cardiology*, Cardiology/education, Fellowships and Scholarships, Female, Humans, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 323, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.", + "pmid": 35115097, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-02-05", + "author": "Harskamp RE,Fanaroff AC,Lopes RD,Wojdyla DM,Goodman SG,Thomas LE,Aronson R,Windecker S,Mehran R,Granger CB,Alexander JH", + "auth_pos": 9, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome, Acute Coronary Syndrome, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/therapy*, Aged, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/etiology, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents, Fibrinolytic Agents/administration & dosage*, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 324, + "user_id": 1447203401, + "artical_title": "Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes.", + "pmid": 35144783, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-02-12", + "author": "Laudani C,Greco A,Occhipinti G,Ingala S,Calderone D,Scalia L,Agnello F,Legnazzi M,Mauro MS,Rochira C,Buccheri S,Mehran R,James S,Angiolillo DJ,Capodanno D", + "auth_pos": 12, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Bayes Theorem, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Bayes Theorem, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Dual Anti-Platelet Therapy/methods, Humans, Percutaneous Coronary Intervention*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/administration & dosage, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 325, + "user_id": 1447203401, + "artical_title": "Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing PCI.", + "pmid": 35151783, + "journal_name": "The Canadian journal of cardiology", + "date": "2022-02-14", + "author": "Pivato CA,Jones D,Cao D,Sartori S,Chiarito M,Nicolas J,Zhang Z,Beerkens F,Nardin M,Qiu H,Razuk V,Feldman D,Kumaraguru V,Stefanini GG,Sweeny J,Baber U,Dangas G,Sharma SK,Kini A,Mehran R", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 326, + "user_id": 1447203401, + "artical_title": "Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.", + "pmid": 35172988, + "journal_name": "Open heart", + "date": "2022-02-18", + "author": "Welsh RC,Dehghani P,Lopes R,Wojdyla DM,Aronson R,Granger CB,Windecker S,Vora AN,Vinereanu D,Halvorsen S,Parkhomenko A,Mehran R,Alexander JH,Goodman S", + "auth_pos": 12, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Factor Xa Inhibitors, Factor Xa Inhibitors/adverse effects, Factor Xa Inhibitors/therapeutic use, Female, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control, Male, Medication Therapy Management, Middle Aged, Outcome and Process Assessment, Health Care, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Preoperative Period*, Pyrazoles*, Pyrazoles/adverse effects, Pyrazoles/therapeutic use, Pyridones*, Pyridones/adverse effects, Pyridones/therapeutic use, Vitamin K, Vitamin K/antagonists & inhibitors*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 327, + "user_id": 1447203401, + "artical_title": "Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.", + "pmid": 35189691, + "journal_name": "Journal of the American Heart Association", + "date": "2022-02-23", + "author": "Moroni F,Beneduce A,Giustino G,Briede I,Park SJ,Daemen J,Claude Morice M,Nakamura S,Meliga E,Cerrato E,Makkar RR,D'Ascenzo F,Lucarelli C,Capranzano P,Tchetche D,Templin C,Kirtane A,Buzman P,Alfieri O,Valgimigli M,Mehran R,Colombo A,Montorfano M,Chieffo A", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 328, + "user_id": 1447203401, + "artical_title": "The Heart Team for Coronary Revascularization Decisions: 2 Illustrative Cases.", + "pmid": 35199000, + "journal_name": "JACC. Case reports", + "date": "2022-02-25", + "author": "Metkus TS,Beckie TM,Cohen MG,Fremes SE,Mehran R,Sellke FW,Lawton JS,Tamis Holland JE", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 329, + "user_id": 1447203401, + "artical_title": "Revascularization or optimal medical therapy for stable ischemic heart disease: A Bayesian meta-analysis of contemporary trials.", + "pmid": 35210188, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2022-02-26", + "author": "Kumar A,Doshi R,Khan SU,Shariff M,Baby J,Majmundar M,Kanaa'N A,Hedrick DP,Puri R,Reed G,Mehran R,Kapadia S,Khot UN,Kalra A", + "auth_pos": 11, + "meshterms": "Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Angina Pectoris, Angina, Unstable, Bayes Theorem, Coronary Artery Disease*, Drug-Eluting Stents*, Humans, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*, Stroke*, Stroke/therapy, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 330, + "user_id": 1447203401, + "artical_title": "Women leaders: transforming the culture in cardiology.", + "pmid": 35228269, + "journal_name": "Open heart", + "date": "2022-03-02", + "author": "Eshtehardi P,Bullock-Palmer RP,Bravo-Jaimes K,Bozkurt B,Dorbala S,Gillam LD,Grines CL,Mehran R,Mieres JH,Singh T,Wenger NK", + "auth_pos": 8, + "meshterms": "Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation, Cardiology*, Female, Humans, Organizational Innovation", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 331, + "user_id": 1447203401, + "artical_title": "Endothelial progenitor cells in coronary atherosclerosis and percutaneous coronary intervention: A systematic review and meta-analysis.", + "pmid": 35246408, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2022-03-06", + "author": "Pelliccia F,Pasceri V,Zimarino M,De Luca G,De Caterina R,Mehran R,Dangas G", + "auth_pos": 6, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Endothelial Progenitor Cells*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Endothelial Progenitor Cells*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Endothelial Progenitor Cells*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Risk Factors, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 332, + "user_id": 1447203401, + "artical_title": "Inclusion of women in cardiovascular clinical trials: A path forward.", + "pmid": 35259540, + "journal_name": "Contemporary clinical trials", + "date": "2022-03-09", + "author": "Vogel B,Mehran R", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Clinical Trials as Topic*, Female, Humans, Patient Participation*, Women's Health", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 333, + "user_id": 1447203401, + "artical_title": "Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review.", + "pmid": 35272796, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-03-12", + "author": "Camaj A,Fuster V,Giustino G,Bienstock SW,Sternheim D,Mehran R,Dangas GD,Kini A,Sharma SK,Halperin J,Dweck MR,Goldman ME", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 334, + "user_id": 1447203401, + "artical_title": "Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.", + "pmid": 35286164, + "journal_name": "Circulation", + "date": "2022-03-15", + "author": "Kandzari DE,Mahfoud F,Weber MA,Townsend R,Parati G,Fisher NDL,Lobo MD,Bloch M,Böhm M,Sharp ASP,Schmieder RE,Azizi M,Schlaich MP,Papademetriou V,Kirtane AJ,Daemen J,Pathak A,Ukena C,Lurz P,Grassi G,Myers M,Finn AV,Morice MC,Mehran R,Jüni P,Stone GW,Krucoff MW,Whelton PK,Tsioufis K,Cutlip DE,Spitzer E", + "auth_pos": 24, + "meshterms": "Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy, Clinical Trials as Topic, Consensus, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 335, + "user_id": 1447203401, + "artical_title": "Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention.", + "pmid": 35294730, + "journal_name": "Current cardiology reports", + "date": "2022-03-17", + "author": "Alkhalil M,Džavík V,Bhatt DL,Mehran R,Mehta SR", + "auth_pos": 4, + "meshterms": "Aspirin, Aspirin/therapeutic use, Clopidogrel, Clopidogrel/therapeutic use, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/drug therapy, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Clopidogrel, Clopidogrel/therapeutic use, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/drug therapy, Hemorrhage/prevention & control, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Treatment Outcome, P2Y12 inhibitor*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 336, + "user_id": 1447203401, + "artical_title": "Independence of Clinical Events Committees: A Consensus Statement from Clinical Research Organizations.", + "pmid": 35296411, + "journal_name": "American heart journal", + "date": "2022-03-18", + "author": "Spitzer E,Fanaroff AC,Gibson CM,Seltzer J,McFadden E,Ali M,Wilson M,Menon V,Mehran R,Held C,Mahaffey KW,Lopes RD", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 337, + "user_id": 1447203401, + "artical_title": "Childbearing Among Women Cardiologists: The Interface of Experience, Impact, and the Law.", + "pmid": 35300820, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-03-19", + "author": "Gulati M,Korn RM,Wood MJ,Sarma A,Douglas PS,Singh T,Merz NB,Lee J,Mehran R,Andrews OA,Williams JC", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 338, + "user_id": 1447203401, + "artical_title": "Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.", + "pmid": 35305904, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-03-21", + "author": "Mohebi R,Karimi Galougahi K,Garcia JJ,Horst J,Ben-Yehuda O,Radhakrishnan J,Chertow GM,Jeremias A,Cohen DJ,Maehara A,Mintz GS,Chen S,Redfors B,Leon MB,Stuckey TD,Rinaldi MJ,Weisz G,Witzenbichler B,Kirtane AJ,Mehran R,Dangas GD,Stone GW,Ali ZA", + "auth_pos": 21, + "meshterms": "Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Contrast Media, Contrast Media/adverse effects, Drug-Eluting Stents*, Female, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Myocardial Infarction*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Thrombosis*, Thrombosis/etiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 339, + "user_id": 1447203401, + "artical_title": "Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.", + "pmid": 35317615, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2022-03-24", + "author": "Han Y,Claessen BE,Chen SL,Chunguang Q,Zhou Y,Xu Y,Hailong L,Chen J,Qiang W,Zhang R,Luo S,Li Y,Zhu J,Zhao X,Cheng X,Wang J,Su X,Tao J,Sun Y,Wang G,Li Y,Bian L,Goel R,Sartori S,Zhang Z,Angiolillo DJ,Cohen DJ,Gibson CM,Kastrati A,Krucoff M,Mehta SR,Ohman EM,Steg PG,Liu Y,Dangas G,Sharma S,Baber U,Mehran R", + "auth_pos": 38, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 340, + "user_id": 1447203401, + "artical_title": "Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD.", + "pmid": 35325085, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-03-25", + "author": "Dehghani P,Cao D,Baber U,Nicolas J,Sartori S,Pivato CA,Zhang Z,Dangas G,Angiolillo DJ,Briguori C,Cohen DJ,Collier T,Dudek D,Gibson M,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Mehta S,Moliterno DJ,Ohman EM,Escaned J,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Pocock S,Mehran R", + "auth_pos": 31, + "meshterms": "Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/therapy, Stroke, Stroke/epidemiology, Ticagrelor*, Ticagrelor/adverse effects, BARC bleeding*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 341, + "user_id": 1447203401, + "artical_title": "Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease.", + "pmid": 35347566, + "journal_name": "Current cardiology reports", + "date": "2022-03-30", + "author": "Molenaar MA,Selder JL,Nicolas J,Claessen BE,Mehran R,Bescós JO,Schuuring MJ,Bouma BJ,Verouden NJ,Chamuleau SAJ", + "auth_pos": 5, + "meshterms": "Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 342, + "user_id": 1447203401, + "artical_title": "Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation.", + "pmid": 35351288, + "journal_name": "The American journal of cardiology", + "date": "2022-03-31", + "author": "van Nieuwkerk AC,Santos RB,Fernandez-Nofrerias E,Tchétché D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Mainar V,Dumonteil N,Baan J,Abizaid A,Sartori S,D'Errigo P,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Larraya GL,Ghattas A,Dangas G,Mehran R,Delewi R", + "auth_pos": 24, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Male, Prosthesis Design, Stroke*, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Balloon Guide*, Balloon Guide*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 343, + "user_id": 1447203401, + "artical_title": "Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.", + "pmid": 35361351, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-04-02", + "author": "Mehran R,Cao D,Vogel B", + "auth_pos": 1, + "meshterms": "Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Humans, Kidney, Kidney/physiology, Percutaneous Coronary Intervention*, Renal Insufficiency*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 344, + "user_id": 1447203401, + "artical_title": "Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI.", + "pmid": 35389474, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-04-08", + "author": "Cao D,Swain JA,Sartori S,Nardin M,Zhang Z,Roumeliotis A,Nicolas J,Chiarito M,Chandiramani R,Pivato CA,Spirito A,Giustino G,Stefanini GG,Dangas GD,Baber U,Bhatt DL,Adams DH,Sharma SK,Kini AS,Mehran R", + "auth_pos": 20, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Hemorrhage, Hemorrhage/chemically induced, Cardiac Surgical Procedures*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 345, + "user_id": 1447203401, + "artical_title": "Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group.", + "pmid": 35393110, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-04-09", + "author": "Cutlip DE,Mehran R,Spitzer E,Morice MC,Krucoff MW", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 346, + "user_id": 1447203401, + "artical_title": "Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7.", + "pmid": 35393022, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-04-09", + "author": "Solola Nussbaum S,Henry S,Yong CM,Daugherty SL,Mehran R,Poppas A", + "auth_pos": 5, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Female, Humans, Male, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Myocardial Ischemia/therapy, Risk Factors, Sex Characteristics, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 347, + "user_id": 1447203401, + "artical_title": "Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.", + "pmid": 35393023, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-04-09", + "author": "Gaudino M,Di Franco A,Cao D,Giustino G,Bairey Merz CN,Fremes SE,Kirtane AJ,Kunadian V,Lawton JS,Masterson Creber RM,Sandner S,Vogel B,Zwischenberger BA,Dangas GD,Mehran R", + "auth_pos": 15, + "meshterms": "Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome, Coronary Artery Bypass, Coronary Artery Disease*, Coronary Artery Disease/surgery, Female, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Sex Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 348, + "user_id": 1447203401, + "artical_title": "Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75).", + "pmid": 35431050, + "journal_name": "The American journal of cardiology", + "date": "2022-04-19", + "author": "Krittanawong C,Yue B,Mahtta D,Narasimhan B,Kumar A,Wang Z,Sharma SK,Tamis-Holland JE,Brar SS,Mehran R,Alam M,Jneid H,Virani SS", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 349, + "user_id": 1447203401, + "artical_title": "Elderly patients with acute myocardial infarction: Targeted or complete revascularization?", + "pmid": 35441816, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-04-21", + "author": "Spirito A,Mehran R", + "auth_pos": 2, + "meshterms": "Aged, Humans, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Revascularization, Myocardial Revascularization/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 350, + "user_id": 1447203401, + "artical_title": "Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention.", + "pmid": 35450679, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-04-23", + "author": "Redfors B,Kirtane AJ,Liu M,Musikantow DR,Witzenbichler B,Rinaldi MJ,Metzger DC,Weisz G,Stuckey TD,Brodie BR,Ben-Yehuda O,Mehran R,Stone GW", + "auth_pos": 12, + "meshterms": "Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/therapy, Drug Therapy, Combination, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 351, + "user_id": 1447203401, + "artical_title": "Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry).", + "pmid": 35461697, + "journal_name": "The American journal of cardiology", + "date": "2022-04-25", + "author": "Pivato CA,Cao D,Spirito A,Sartori S,Nicolas J,Chiarito M,Snyder C,Mehilli J,Lefèvre T,Stefanini GG,Presbitero P,Capranzano P,Tchetche D,Iadanza A,Vogel B,Sardella G,Van Mieghem NM,Nardin M,Tavenier AH,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail G,Sharma S,Ferrer MC,Naber C,Kievit P,Baber U,Petronio AS,Morice MC,Chieffo A,Dangas G,Mehran R", + "auth_pos": 34, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Registries, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 352, + "user_id": 1447203401, + "artical_title": "The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.", + "pmid": 35466365, + "journal_name": "European heart journal", + "date": "2022-04-26", + "author": "Thiele H,Collet JP,Leon M,Mehran R", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiology*, Cardiology/standards, Humans, Thoracic Surgery*, Transcatheter Aortic Valve Replacement*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiology*, Cardiology/standards, Humans, Thoracic Surgery*, Transcatheter Aortic Valve Replacement*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiology*, Cardiology/standards, Humans, Thoracic Surgery*, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 353, + "user_id": 1447203401, + "artical_title": "Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention.", + "pmid": 35504744, + "journal_name": "The American journal of cardiology", + "date": "2022-05-04", + "author": "Krittanawong C,Virk HUH,Isath A,Wang Z,Naidu SS,Mehran R,Birnbaum Y,Levine GN,Jneid H", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 354, + "user_id": 1447203401, + "artical_title": "Timing of Stent Thrombosis After 1-Month Discontinuation of Dual Antiplatelet Therapy.", + "pmid": 35550693, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-14", + "author": "Thangam M,Nazif TM,Parke M,Kandzari DE,Windecker S,Latib A,Kedhi E,Mehran R,Stone GW,Kirtane AJ", + "auth_pos": 8, + "meshterms": "Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control, Coronary Thrombosis*, Coronary Thrombosis/etiology, Coronary Thrombosis/prevention & control, Drug Therapy, Combination, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Dual Anti-Platelet Therapy, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Thrombosis*, Thrombosis/drug therapy, Thrombosis/etiology, Thrombosis/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 355, + "user_id": 1447203401, + "artical_title": "A Biomarker-Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy.", + "pmid": 35574956, + "journal_name": "Journal of the American Heart Association", + "date": "2022-05-17", + "author": "Mohebi R,van Kimmenade R,McCarthy C,Gaggin H,Mehran R,Dangas G,Januzzi JL", + "auth_pos": 5, + "meshterms": "Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Acute Kidney Injury/epidemiology, Angiography, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Contrast Media, Contrast Media/adverse effects, Cystatin C, Heart Disease Risk Factors, Humans, Interleukin-18, Osteopontin, Risk Factors, Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 356, + "user_id": 1447203401, + "artical_title": "Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.", + "pmid": 35597684, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-22", + "author": "Lunardi M,Louvard Y,Lefèvre T,Stankovic G,Burzotta F,Kassab GS,Lassen JF,Darremont O,Garg S,Koo BK,Holm NR,Johnson TW,Pan M,Chatzizisis YS,Banning A,Chieffo A,Dudek D,Hildick-Smith D,Garot J,Henry TD,Dangas G,Stone GW,Krucoff MW,Cutlip D,Mehran R,Wijns W,Sharif F,Serruys PW,Onuma Y", + "auth_pos": 25, + "meshterms": "Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology, Asia, Cardiac Catheterization, Cardiac Catheterization/methods, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/therapy, Europe, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 357, + "user_id": 1447203401, + "artical_title": "Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.", + "pmid": 35612866, + "journal_name": "JAMA cardiology", + "date": "2022-05-26", + "author": "Bahit MC,Vora AN,Li Z,Wojdyla DM,Thomas L,Goodman SG,Aronson R,Jordan JD,Kolls BJ,Dombrowski KE,Vinereanu D,Halvorsen S,Berwanger O,Windecker S,Mehran R,Granger CB,Alexander JH,Lopes RD", + "auth_pos": 15, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Anticoagulants, Aspirin, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Hemorrhage/epidemiology, Humans, Ischemic Attack, Transient*, Percutaneous Coronary Intervention*, Prospective Studies, Pyrazoles, Pyridones, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/chemically induced, Warfarin, Warfarin/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 358, + "user_id": 1447203401, + "artical_title": "Becoming a Parent During Cardiovascular Training.", + "pmid": 35618349, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-27", + "author": "Oliveros E,Burgess S,Nadella N,Davidson L,Brailovsky Y,Reza N,Squeri E,Mehran R,DeFaria Yeh D,Park K", + "auth_pos": 8, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Fellowships and Scholarships, Female, Humans, Internship and Residency*, Parental Leave, Parents, Pregnancy, United States", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 359, + "user_id": 1447203401, + "artical_title": "Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope.", + "pmid": 39077183, + "journal_name": "Reviews in cardiovascular medicine", + "date": "2022-06-01", + "author": "Jones D,Nicolas J,Beerkens F,Satish M,Feldman D,Cao D,Spirito A,Mehran R", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 360, + "user_id": 1447203401, + "artical_title": "Depression and ischemic heart disease.", + "pmid": 35643217, + "journal_name": "International journal of cardiology", + "date": "2022-06-02", + "author": "Pivato CA,Chandiramani R,Petrovic M,Nicolas J,Spirito A,Cao D,Mehran R", + "auth_pos": 7, + "meshterms": "Atherosclerosis*, Autonomic Nervous System, Autonomic Nervous System/physiology, Depression, Depression/complications, Depression/diagnosis, Depression/epidemiology, Humans, Inflammation, Inflammation/epidemiology, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Atherosclerosis*, Autonomic Nervous System, Autonomic Nervous System/physiology, Depression, Depression/complications, Depression/diagnosis, Depression/epidemiology, Humans, Inflammation, Inflammation/epidemiology, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology, Atherosclerosis*, Autonomic Nervous System, Autonomic Nervous System/physiology, Depression, Depression/complications, Depression/diagnosis, Depression/epidemiology, Humans, Inflammation, Inflammation/epidemiology, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/diagnosis, Myocardial Ischemia/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 361, + "user_id": 1447203401, + "artical_title": "Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.", + "pmid": 35648414, + "journal_name": "JAMA cardiology", + "date": "2022-06-02", + "author": "Bikdeli B,Zahedi Tajrishi F,Sadeghipour P,Talasaz AH,Fanikos J,Lippi G,Siegal DM,Eikelboom JW,Monreal M,Jimenez D,Connors JM,Ageno W,Barnes GD,Piazza G,Angiolillo DJ,Parikh SA,Kirtane AJ,Lopes RD,Bhatt DL,Weitz JI,Mehran R,Krumholz HM,Goldhaber SZ,Lip GYH", + "auth_pos": 21, + "meshterms": "Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control, Administration, Oral, Anticoagulants, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/therapeutic use, Humans, Rivaroxaban, Rivaroxaban/therapeutic use, Stroke*, Stroke/complications, Venous Thromboembolism*, Venous Thromboembolism/complications, Venous Thromboembolism/drug therapy, Venous Thromboembolism/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 362, + "user_id": 1447203401, + "artical_title": "Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry.", + "pmid": 35656720, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2022-06-04", + "author": "Chandrasekhar J,Baber U,Sartori S,Goel R,Nicolas J,Vogel B,Snyder C,Kini A,Briguori C,Witzenbichler B,Iakovou I,Sardella G,Marzo K,DeFranco A,Stuckey T,Chieffo A,Colombo A,Shlofmitz R,Capodanno D,Dangas G,Pocock S,Mehran R", + "auth_pos": 22, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Female, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Humans, Male, Middle Aged, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Registries, Stroke, Stroke/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 363, + "user_id": 1447203401, + "artical_title": "Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.", + "pmid": 35680195, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-06-10", + "author": "Windecker S,Latib A,Kedhi E,Kirtane AJ,Kandzari DE,Mehran R,Price MJ,Abizaid A,Simon DI,Worthley SG,Zaman A,Hudec M,Poliacikova P,Kahar Bin Abdul Ghapar A,Selvaraj K,Petrov I,Mylotte D,Pinar E,Moreno R,Fabbiocchi F,Pasupati S,Kim HS,Aminian A,Tie C,Wlodarczak A,Hur SH,Marx SO,Ali ZA,Parke M,Lung TH,Stone GW", + "auth_pos": 6, + "meshterms": "P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 364, + "user_id": 1447203401, + "artical_title": "P2Y inhibitor monotherapy in patients undergoing percutaneous coronary intervention.", + "pmid": 35697777, + "journal_name": "Nature reviews. Cardiology", + "date": "2022-06-14", + "author": "Capodanno D,Baber U,Bhatt DL,Collet JP,Dangas G,Franchi F,Gibson CM,Gwon HC,Kastrati A,Kimura T,Lemos PA,Lopes RD,Mehran R,O'Donoghue ML,Rao SV,Rollini F,Serruys PW,Steg PG,Storey RF,Valgimigli M,Vranckx P,Watanabe H,Windecker S,Angiolillo DJ", + "auth_pos": 13, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dual Anti-Platelet Therapy, Aspirin, Aspirin/therapeutic use, Drug Therapy, Combination, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 365, + "user_id": 1447203401, + "artical_title": "Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non-ST-Segment-Elevation Myocardial Infarction.", + "pmid": 35713283, + "journal_name": "Journal of the American Heart Association", + "date": "2022-06-18", + "author": "Majmundar M,Ibarra G,Kumar A,Doshi R,Shah P,Mehran R,Reed GW,Puri R,Kapadia SR,Bangalore S,Kalra A", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 366, + "user_id": 1447203401, + "artical_title": "Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI.", + "pmid": 35716933, + "journal_name": "International journal of cardiology", + "date": "2022-06-19", + "author": "Koshy AN,Cao D,Levin MA,Sartori S,Giustino G,Kyaw H,Claessen B,Zhang Z,Nicolas J,Camaj A,Roumeliotis A,Chandiramani R,Bedekar R,Waseem Z,Bagga S,Kini A,Sharma SK,Mehran R", + "auth_pos": 18, + "meshterms": "Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, Aspirin, Aspirin/therapeutic use, Drug-Eluting Stents*, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Prasugrel Hydrochloride, Treatment Outcome, P2Y12 inhibitor*, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 367, + "user_id": 1447203401, + "artical_title": "Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis.", + "pmid": 35770326, + "journal_name": "ESC heart failure", + "date": "2022-07-01", + "author": "Chiarito M,Sanz-Sanchez J,Pighi M,Cannata F,Rubbio AP,Munafò A,Cao D,Roccasalva F,Pini D,Pagnotta PA,Ettori F,Petronio AS,Tamburino C,Reimers B,Colombo A,Di Mario C,Grasso C,Mehran R,Godino C,Stefanini GG", + "auth_pos": 18, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Mitral Valve, Mitral Valve/surgery, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 368, + "user_id": 1447203401, + "artical_title": "Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.", + "pmid": 35789263, + "journal_name": "European heart journal", + "date": "2022-07-06", + "author": "Spirito A,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "Angina, Stable*, Angina, Stable/therapy, Coronary Artery Disease*, Exercise Test, Humans, Moon, Myocardial Ischemia*, Myocardial Ischemia/therapy, Percutaneous Coronary Intervention*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 369, + "user_id": 1447203401, + "artical_title": "Coronary In-Stent Restenosis: JACC State-of-the-Art Review.", + "pmid": 35863852, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-22", + "author": "Giustino G,Colombo A,Camaj A,Yasumura K,Mehran R,Stone GW,Kini A,Sharma SK", + "auth_pos": 5, + "meshterms": "Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stents, Stents/adverse effects, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 370, + "user_id": 1447203401, + "artical_title": "Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women.", + "pmid": 35934563, + "journal_name": "The American journal of cardiology", + "date": "2022-08-08", + "author": "Wöhrle J,Gilard M,Didier R,Kini A,Tavenier AH,Tijssen JGP,Sartori S,Snyder C,Nicolas J,Seeger J,Landmesser U,Tarantini G,Asgar A,Möllmann H,Thiele H,Capranzano P,Reimers B,Stefanini G,Moreno R,Petronio AS,Mikhail G,Kapadia S,Hildick-Smith D,Hengstenberg C,Mehran R,Windecker S,Dangas GD", + "auth_pos": 25, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Female, Hemorrhage, Hemorrhage/etiology, Humans, Male, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Thrombosis*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 371, + "user_id": 1447203401, + "artical_title": "Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.", + "pmid": 35943473, + "journal_name": "JAMA", + "date": "2022-08-10", + "author": "Sandner S,Redfors B,Angiolillo DJ,Audisio K,Fremes SE,Janssen PWA,Kulik A,Mehran R,Peper J,Ruel M,Saw J,Soletti GJ,Starovoytov A,Ten Berg JM,Willemsen LM,Zhao Q,Zhu Y,Gaudino M", + "auth_pos": 8, + "meshterms": "Aged, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Female, Graft Occlusion, Vascular, Graft Occlusion, Vascular/etiology, Graft Occlusion, Vascular/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/etiology, Humans, Male, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Randomized Controlled Trials as Topic, Saphenous Vein*, Saphenous Vein/transplantation, Ticagrelor*, Ticagrelor/adverse effects, Ticagrelor/therapeutic use, Treatment Outcome, Aged, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Female, Graft Occlusion, Vascular, Graft Occlusion, Vascular/etiology, Graft Occlusion, Vascular/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/etiology, Humans, Male, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Randomized Controlled Trials as Topic, Saphenous Vein*, Saphenous Vein/transplantation, Ticagrelor*, Ticagrelor/adverse effects, Ticagrelor/therapeutic use, Treatment Outcome, Aged, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Female, Graft Occlusion, Vascular, Graft Occlusion, Vascular/etiology, Graft Occlusion, Vascular/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/etiology, Humans, Male, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Randomized Controlled Trials as Topic, Saphenous Vein*, Saphenous Vein/transplantation, Ticagrelor*, Ticagrelor/adverse effects, Ticagrelor/therapeutic use, Treatment Outcome, Aged, Aspirin*, Aspirin/adverse effects, Aspirin/therapeutic use, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/methods, Female, Graft Occlusion, Vascular, Graft Occlusion, Vascular/etiology, Graft Occlusion, Vascular/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/etiology, Humans, Male, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Randomized Controlled Trials as Topic, Saphenous Vein*, Saphenous Vein/transplantation, Ticagrelor*, Ticagrelor/adverse effects, Ticagrelor/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 372, + "user_id": 1447203401, + "artical_title": "Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom.", + "pmid": 35956061, + "journal_name": "Journal of clinical medicine", + "date": "2022-08-13", + "author": "Chiarito M,Spirito A,Nicolas J,Selberg A,Stefanini G,Colombo A,Reimers B,Kini A,Sharma SK,Dangas GD,Mehran R", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 373, + "user_id": 1447203401, + "artical_title": "Medication Nonadherence: A Challenging Conundrum for Clinical Trials, Patients, and Clinicians.", + "pmid": 35981822, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-08-19", + "author": "Baber U,Blaha MJ,Mehran R", + "auth_pos": 3, + "meshterms": "Humans, Medication Adherence*, Humans, Medication Adherence*, Humans, Medication Adherence*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 374, + "user_id": 1447203401, + "artical_title": "Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.", + "pmid": 35979636, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2022-08-19", + "author": "Sardella G,Beerkens FJ,Dangas G,Cao D,Baber U,Sartori S,Cohen DJ,Briguori C,Gil R,Nicolas J,Zhang Z,Dudek D,Kunadian V,Kornowski R,Weisz G,Claessen B,Marx SO,Escaned J,Huber K,Collier T,Moliterno DJ,Ohman EM,Krucoff MW,Kastrati A,Steg PG,Angiolillo DJ,Mehta SR,Shlofmitz R,Sharma S,Pocock S,Gibson CM,Mehran R", + "auth_pos": 32, + "meshterms": "Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome, Humans, Ticagrelor, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Drug Therapy, Combination, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/drug therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 375, + "user_id": 1447203401, + "artical_title": "ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike.", + "pmid": 35983744, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2022-08-20", + "author": "Krucoff MW,Cao D,Mehran R", + "auth_pos": 3, + "meshterms": "Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Assessment, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Assessment, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 376, + "user_id": 1447203401, + "artical_title": "Best Practices for Designing Informative Trials Including Women.", + "pmid": 36018472, + "journal_name": "Current atherosclerosis reports", + "date": "2022-08-27", + "author": "Nicolas J,Edens M,Vogel B,Mehran R", + "auth_pos": 4, + "meshterms": "Biomedical Research*, Clinical Trials as Topic, Female, Humans, Patient Selection, Biomedical Research*, Clinical Trials as Topic, Female, Humans, Patient Selection", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 377, + "user_id": 1447203401, + "artical_title": "Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.", + "pmid": 36040717, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-08-31", + "author": "Okuno T,Dangas GD,Hengstenberg C,Sartori S,Herrmann HC,de Winter R,Gilard M,Tchétché D,Möllmann H,Makkar RR,Baldus S,De Backer O,Bendz B,Kini A,von Lewinski D,Mack M,Moreno R,Schäfer U,Wöhrle J,Seeger J,Snyder C,Nicolas J,Tijssen JGP,Welsh RC,Vranckx P,Valgimigli M,Mehran R,Kapadia S,Sondergaard L,Windecker S", + "auth_pos": 27, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Female, Heart Valve Prosthesis*, Hemoglobins, Humans, Male, Prosthesis Design, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 378, + "user_id": 1447203401, + "artical_title": "Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.", + "pmid": 36054266, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-09-03", + "author": "Greco A,Sciahbasi A,Abizaid A,Mehran R,Rigattieri S,de la Torre Hernandez JM,Alfonso F,Cortese B", + "auth_pos": 4, + "meshterms": "Cardiovascular Agents*, Cardiovascular Agents/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus, Everolimus/adverse effects, Humans, Paclitaxel, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Sirolimus, Sirolimus/adverse effects, Stents, Stents/adverse effects, Treatment Outcome, Cardiovascular Agents*, Cardiovascular Agents/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Everolimus, Everolimus/adverse effects, Humans, Paclitaxel, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prosthesis Design, Sirolimus, Sirolimus/adverse effects, Stents, Stents/adverse effects, Treatment Outcome, Coronary stent*, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 379, + "user_id": 1447203401, + "artical_title": "SACUBITRIL/VALSARTAN VERSUS RAMIPRIL FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: WIN-RATIO ANALYSIS OF THE PARADISE-MI TRIAL.", + "pmid": 36054480, + "journal_name": "European journal of heart failure", + "date": "2022-09-03", + "author": "Berwanger O,Pfeffer M,Claggett B,Jering KS,Maggioni AP,Steg PG,Mehran R,Lewis EF,Zhou Y,van der Meer P,De Pasquale C,Merkely B,Filippatos G,McMurray JJV,Granger CB,Solomon SD,Braunwald E", + "auth_pos": 7, + "meshterms": "Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications, Humans, Ramipril, Ramipril/therapeutic use, Ramipril/pharmacology, Stroke Volume, Angiotensin Receptor Antagonists, Neprilysin, Tetrazoles, Tetrazoles/therapeutic use, Heart Failure*, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/complications", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 380, + "user_id": 1447203401, + "artical_title": "Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed?", + "pmid": 36056727, + "journal_name": "Journal of the American Heart Association", + "date": "2022-09-04", + "author": "Spirito A,Cohen R,Mehran R", + "auth_pos": 3, + "meshterms": "Biomarkers, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Troponin I, Troponin T, Biomarkers, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Troponin I, Troponin T, Biomarkers, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Troponin I, Troponin T, Biomarkers, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Troponin I, Troponin T", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 381, + "user_id": 1447203401, + "artical_title": "Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials.", + "pmid": 36102667, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-09-15", + "author": "Patti G,Spinoni EG,Grisafi L,Mehran R,Mennuni M", + "auth_pos": 4, + "meshterms": "Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Cholesterol, LDL, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/chemically induced, Randomized Controlled Trials as Topic, Cholesterol", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 382, + "user_id": 1447203401, + "artical_title": "Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes.", + "pmid": 36104217, + "journal_name": "Heart (British Cardiac Society)", + "date": "2022-09-15", + "author": "Balasubramanian RN,Mills GB,Wilkinson C,Mehran R,Kunadian V", + "auth_pos": 4, + "meshterms": "Humans, Female, Aged, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Risk Assessment, Prognosis, Troponin, Humans, Female, Aged, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Risk Assessment, Prognosis, Troponin", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 383, + "user_id": 1447203401, + "artical_title": "Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.", + "pmid": 36129696, + "journal_name": "JAMA cardiology", + "date": "2022-09-22", + "author": "Mehta SR,Wang J,Wood DA,Spertus JA,Cohen DJ,Mehran R,Storey RF,Steg PG,Pinilla-Echeverri N,Sheth T,Bainey KR,Bangalore S,Cantor WJ,Faxon DP,Feldman LJ,Jolly SS,Kunadian V,Lavi S,Lopez-Sendon J,Madan M,Moreno R,Rao SV,Rodés-Cabau J,Stankovic G,Bangdiwala SI,Cairns JA", + "auth_pos": 6, + "meshterms": "Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery, Humans, Male, Middle Aged, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/surgery, ST Elevation Myocardial Infarction/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Quality of Life, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/surgery, Angina Pectoris, Angina Pectoris/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 384, + "user_id": 1447203401, + "artical_title": "The Smart(est) Choice for Dual Antiplatelet Therapy is a Patient-Directed One.", + "pmid": 36169952, + "journal_name": "JAMA cardiology", + "date": "2022-09-29", + "author": "Kirtane AJ,Mehran R", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 385, + "user_id": 1447203401, + "artical_title": "Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.", + "pmid": 36202563, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-10-07", + "author": "Kunadian V,Baber U,Pivato CA,Cao D,Dangas G,Sartori S,Zhang Z,Angiolillo DJ,Briguori C,Cohen DJ,Collier T,Dudek D,Gibson M,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Dehghani P,Mehta S,Moliterno DJ,Ohman EM,Escaned J,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Džavík V,Gurbel P,Hamm CW,Henry T,Kastrati A,Marx SO,Oldroyd K,Steg PG,Pocock S,Mehran R", + "auth_pos": 38, + "meshterms": "Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Aspirin, Aspirin/adverse effects, Body Mass Index, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Humans, Obesity, Obesity/complications, Obesity/diagnosis, Overweight, Overweight/chemically induced, Overweight/complications, Overweight/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 386, + "user_id": 1447203401, + "artical_title": "Representation of Women in Internal Medicine Specialties in North America, the United Kingdom, and Australasia: Cardiology's Outlier Status and the Importance of Diversity.", + "pmid": 36216603, + "journal_name": "The American journal of cardiology", + "date": "2022-10-11", + "author": "Zaman S,Shaw E,Ellenberger K,Rosa M,Leung M,Kwan V,Liang R,Banerjee S,Bastiany A,Gulati M,Hayes S,Grines C,Mehran R,Burgess S", + "auth_pos": 13, + "meshterms": "Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America, Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America, Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America, Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America, Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America, Male, United States, Humans, Female, Internal Medicine, Workforce, Physicians*, Cardiology*, North America", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 387, + "user_id": 1447203401, + "artical_title": "Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention.", + "pmid": 36243487, + "journal_name": "Interventional cardiology clinics", + "date": "2022-10-16", + "author": "Spirito A,Cangialosi P,Cao D,Nicolas J,Mehran R", + "auth_pos": 5, + "meshterms": "Drug-Eluting Stents*, Dual Anti-Platelet Therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 388, + "user_id": 1447203401, + "artical_title": "The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.", + "pmid": 36270496, + "journal_name": "International journal of cardiology", + "date": "2022-10-22", + "author": "Nardin M,Pivato CA,Cao D,Sartori S,Zhang Z,Vogel B,Nicolas J,Chiarito M,Qiu H,Chandrasekhar J,Spirito A,Abizaid A,Christiansen EH,Colombo A,de Winter RJ,Haude M,Jakobsen L,Jensen LO,Krucoff MW,Landmesser U,Saito S,Suryapranata H,De Luca G,Dangas G,Mehran R", + "auth_pos": 25, + "meshterms": "Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*, Humans, Female, Middle Aged, Aged, Male, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Prosthesis Design, Risk Factors, Treatment Outcome, Time Factors, Myocardial Infarction*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 389, + "user_id": 1447203401, + "artical_title": "The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.", + "pmid": 36321459, + "journal_name": "Circulation", + "date": "2022-11-03", + "author": "Mehran R,Steg PG,Pfeffer MA,Jering K,Claggett B,Lewis EF,Granger C,Køber L,Maggioni A,Mann DL,McMurray JJV,Rouleau JL,Solomon SD,Ducrocq G,Berwanger O,De Pasquale CG,Landmesser U,Petrie M,Leng DSK,van der Meer P,Lefkowitz M,Zhou Y,Braunwald E", + "auth_pos": 1, + "meshterms": "Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Humans, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensins, Biphenyl Compounds, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Neprilysin, Neprilysin/antagonists & inhibitors, Prospective Studies, Ramipril, Ramipril/therapeutic use, Receptors, Angiotensin, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 390, + "user_id": 1447203401, + "artical_title": "Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis.", + "pmid": 36384656, + "journal_name": "Cardiovascular diabetology", + "date": "2022-11-18", + "author": "van Nieuwkerk AC,Santos RB,Mata RB,Tchétché D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Baan J,Oteo-Dominguez J,Dumonteil N,Abizaid A,Sartori S,D'Errigo P,Tarantini G,Lunardi M,Orvin K,Pagnesi M,Ghattas A,Amat-Santos I,Dangas G,Mehran R,Delewi R", + "auth_pos": 24, + "meshterms": "Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Diabetes Mellitus/etiology, Propensity Score, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Multicenter Studies as Topic, Registries", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 391, + "user_id": 1447203401, + "artical_title": "Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention.", + "pmid": 36423970, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-11-25", + "author": "Koshy AN,Giustino G,Sartori S,Kyaw H,Yadav M,Zhang Z,Hooda A,Farooq A,Krishnamoorthy P,Sweeny JM,Khera S,Serrao GW,Sharma R,Suleman J,Dangas G,Kini AS,Mehran R,Sharma SK", + "auth_pos": 17, + "meshterms": "Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology, Humans, Female, Male, Prasugrel Hydrochloride, Prasugrel Hydrochloride/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Stroke*, Stroke/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 392, + "user_id": 1447203401, + "artical_title": "Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.", + "pmid": 36455701, + "journal_name": "International journal of cardiology", + "date": "2022-12-02", + "author": "van Bergeijk KH,Wykrzykowska JJ,Sartori S,Snyder C,Vogel B,Tchetche D,Petronio AS,Mehilli J,Lefèvre T,Presbitero P,Capranzano P,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail G,Ferrer-Gracia MC,Naber C,Kievit P,Sharma SK,Morice MC,Dangas GD,Chieffo A,Voors AA,Mehran R", + "auth_pos": 28, + "meshterms": "Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology, Humans, Female, Aged, Aged, 80 and over, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Anticoagulants, Anticoagulants/adverse effects, Treatment Outcome, Risk Factors, Heart Failure*, Heart Failure/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 393, + "user_id": 1447203401, + "artical_title": "Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications.", + "pmid": 36455906, + "journal_name": "Expert review of clinical pharmacology", + "date": "2022-12-02", + "author": "Galli M,Franchi F,Rollini F,Ortega-Paz L,D'Amario D,De Caterina R,Mehran R,Gibson CM,Angiolillo DJ", + "auth_pos": 7, + "meshterms": "Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination, Humans, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Atherosclerosis*, Atherosclerosis/complications, Hemorrhage, Hemorrhage/chemically induced, Rivaroxaban, Drug Therapy, Combination", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 394, + "user_id": 1447203401, + "artical_title": "Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies.", + "pmid": 36477493, + "journal_name": "JAMA cardiology", + "date": "2022-12-09", + "author": "Nathan AS,Reddy KP,Yang L,Eberly LA,Dayoub EJ,Khatana SAM,Julien HM,Desai ND,Szeto WY,Herrmann HC,Kobayashi TJ,Fiorilli P,Batchelor WB,Mehran R,Alkhouli MA,Giri J,Groeneveld PW,Fanaroff AC", + "auth_pos": 14, + "meshterms": "Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery, Aged, Humans, United States, United States/epidemiology, Tricuspid Valve*, Tricuspid Valve/surgery, Cohort Studies, Ethnicity, Cross-Sectional Studies, Medicare, Minority Groups, Heart Valve Diseases*, Heart Valve Diseases/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 395, + "user_id": 1447203401, + "artical_title": "Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.", + "pmid": 36477292, + "journal_name": "European heart journal", + "date": "2022-12-09", + "author": "Costa F,Montalto C,Branca M,Hong SJ,Watanabe H,Franzone A,Vranckx P,Hahn JY,Gwon HC,Feres F,Jang Y,De Luca G,Kedhi E,Cao D,Steg PG,Bhatt DL,Stone GW,Micari A,Windecker S,Kimura T,Hong MK,Mehran R,Valgimigli M", + "auth_pos": 22, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Randomized Controlled Trials as Topic, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Randomized Controlled Trials as Topic, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Randomized Controlled Trials as Topic, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Randomized Controlled Trials as Topic, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Drug Therapy, Combination, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 396, + "user_id": 1447203401, + "artical_title": "New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention.", + "pmid": 36493579, + "journal_name": "The American journal of cardiology", + "date": "2022-12-10", + "author": "Spirito A,Sharma A,Cao D,Sartori S,Zhang Z,Nicolas J,Pivato CA,Cohen R,Baber U,Sweeny J,Sharma SK,Dangas G,Kini A,Brener SJ,Mehran R", + "auth_pos": 15, + "meshterms": "Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications, Humans, Aged, 80 and over, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Stroke Volume, Ventricular Function, Left, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Hemorrhage, Hemorrhage/etiology, Hemorrhage/complications, Treatment Outcome, Risk Factors, Coronary Artery Disease*, Coronary Artery Disease/complications", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 397, + "user_id": 1447203401, + "artical_title": "Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials.", + "pmid": 36515253, + "journal_name": "Journal of the American Heart Association", + "date": "2022-12-15", + "author": "Konigstein M,Redfors B,Zhang Z,Kotinkaduwa LN,Mintz GS,Smits PC,Serruys PW,von Birgelen C,Madhavan MV,Golomb M,Ben-Yehuda O,Mehran R,Leon MB,Stone GW", + "auth_pos": 12, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology, Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology, Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology, Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology, Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology, Humans, Male, Middle Aged, Aged, Female, Drug-Eluting Stents*, Treatment Outcome, Prospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Cardiology*, Prosthesis Design, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 398, + "user_id": 1447203401, + "artical_title": "Dear colleagues: enough with the men-only author panels.", + "pmid": 36545226, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2022-12-23", + "author": "Van Spall HGC,Mehran R,Januzzi JL", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 399, + "user_id": 1447203401, + "artical_title": "On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES.", + "pmid": 36565189, + "journal_name": "Journal of the American Heart Association", + "date": "2022-12-25", + "author": "Shahim B,Redfors B,Stuckey TD,Liu M,Zhou Z,Witzenbichler B,Weisz G,Rinaldi MJ,Neumann FJ,Metzger DC,Henry TD,Cox DA,Duffy PL,Brodie BR,Srdanovic I,Madhavan MV,Mazzaferri EL,Mehran R,Ben-Yehuda O,Kirtane AJ,Stone GW", + "auth_pos": 18, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Risk Factors, Blood Platelets, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/pharmacology, Ischemia, Ischemia/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/complications, Diabetes Mellitus*, Diabetes Mellitus/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 400, + "user_id": 1447203401, + "artical_title": "Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists.", + "pmid": 36585350, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-12-31", + "author": "Sharma G,Rao SJ,Douglas PS,Rzeszut A,Itchhaporia D,Wood MJ,Nasir K,Blumenthal RS,Poppas A,Kuvin J,Miller AP,Mehran R,Valentine M,Summers RF,Mehta LS", + "auth_pos": 12, + "meshterms": "Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*, Male, Humans, Female, United States, United States/epidemiology, Middle Aged, Mental Health, Cardiologists*, Cardiologists/psychology, Prevalence, Mental Disorders*, Mental Disorders/epidemiology, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 401, + "user_id": 1447203401, + "artical_title": "Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.", + "pmid": 36583436, + "journal_name": "Journal of the American Heart Association", + "date": "2022-12-31", + "author": "Marquis-Gravel G,Boivin-Proulx LA,Huang Z,Zelenkofske SL,Lincoff AM,Mehran R,Steg PG,Bode C,Alexander JH,Povsic TJ", + "auth_pos": 6, + "meshterms": "Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking, Female, Humans, Femoral Artery, Hemorrhage, Hemorrhage/etiology, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Treatment Outcome, Vascular Closure Devices*, Vascular Closure Devices/adverse effects, Walking", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 402, + "user_id": 1447203401, + "artical_title": "Representation of Women in Cardiology Academic Faculty Ranks.", + "pmid": 36608436, + "journal_name": "The American journal of cardiology", + "date": "2023-01-07", + "author": "Altin SE,Parikh PB,Squeri E,Douglas PS,Wang DD,Mehran R", + "auth_pos": 6, + "meshterms": "Humans, Female, United States, United States/epidemiology, Faculty, Academic Medical Centers, Cardiology*, Cardiovascular System*, Humans, Female, United States, United States/epidemiology, Faculty, Academic Medical Centers, Cardiology*, Cardiovascular System*, Humans, Female, United States, United States/epidemiology, Faculty, Academic Medical Centers, Cardiology*, Cardiovascular System*, Humans, Female, United States, United States/epidemiology, Faculty, Academic Medical Centers, Cardiology*, Cardiovascular System*, Humans, Female, United States, United States/epidemiology, Faculty, Academic Medical Centers, Cardiology*, Cardiovascular System*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 403, + "user_id": 1447203401, + "artical_title": "Determinants of Seattle Angina Questionnaire in multivessel disease patients undergoing percutaneous coronary intervention: Insights from a single-center study.", + "pmid": 36624012, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2023-01-10", + "author": "Iruvanti S,Blumfield A,Farhan S,Snyder C,Johal G,Sartori S,Vogel B,Giustino G,Melarcode-Krishnamoorthy P,Kyaw H,Dangas G,Mehran R,Kini A,Sharma SK", + "auth_pos": 12, + "meshterms": "Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Quality of Life, Angina Pectoris, Angina Pectoris/therapy, Angina Pectoris/surgery, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Surveys and Questionnaires, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 404, + "user_id": 1447203401, + "artical_title": "British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK.", + "pmid": 36644622, + "journal_name": "Interventional cardiology (London, England)", + "date": "2023-01-17", + "author": "Noc M,Mehran R", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 405, + "user_id": 1447203401, + "artical_title": "Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes.", + "pmid": 36660810, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2023-01-21", + "author": "Koshy AN,Giustino G,Sartori S,Hooda A,Feng Y,Snyder C,Dasgupta S,Kumar KR,Krishnamoorthy-Melarcode P,Sweeny J,Khera S,Serrao GW,Sharma R,Dangas G,Kini AS,Mehran R,Sharma SK", + "auth_pos": 16, + "meshterms": "Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 406, + "user_id": 1447203401, + "artical_title": "Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.", + "pmid": 36691863, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2023-01-25", + "author": "Chen H,Spirito A,Sartori S,Nicolas J,Cao D,Zhang Z,Baber U,Kamaleldin K,Guthrie J,Vogel B,Sweeny J,Krishnan P,Sharma SK,Kini A,Dangas G,Mehran R", + "auth_pos": 16, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 407, + "user_id": 1447203401, + "artical_title": "Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials.", + "pmid": 36697143, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-01-26", + "author": "Yong C,Suvarna A,Harrington R,Gummidipundi S,Krumholz HM,Mehran R,Heidenreich P", + "auth_pos": 6, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Male, Female, Clinical Trials as Topic, Patients*, Patients/statistics & numerical data, Research Personnel*, Research Personnel/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 408, + "user_id": 1447203401, + "artical_title": "Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease.", + "pmid": 36697136, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-01-26", + "author": "Farhan S,Enzmann FK,Bjorkman P,Kamran H,Zhang Z,Sartori S,Vogel B,Tarricone A,Linni K,Venermo M,van der Veen D,Moussalli H,Mehran R,Reijnen MMPJ,Bosiers M,Krishnan P", + "auth_pos": 13, + "meshterms": "Humans, Female, Middle Aged, Aged, Male, Treatment Outcome, Risk Factors, Vascular Surgical Procedures, Vascular Surgical Procedures/adverse effects, Peripheral Arterial Disease*, Femoral Artery, Femoral Artery/surgery, Endovascular Procedures*, Endovascular Procedures/adverse effects, Retrospective Studies, Limb Salvage, Vascular Patency, Randomized Controlled Trials as Topic, Humans, Female, Middle Aged, Aged, Male, Treatment Outcome, Risk Factors, Vascular Surgical Procedures, Vascular Surgical Procedures/adverse effects, Peripheral Arterial Disease*, Femoral Artery, Femoral Artery/surgery, Endovascular Procedures*, Endovascular Procedures/adverse effects, Retrospective Studies, Limb Salvage, Vascular Patency, Randomized Controlled Trials as Topic, Humans, Female, Middle Aged, Aged, Male, Treatment Outcome, Risk Factors, Vascular Surgical Procedures, Vascular Surgical Procedures/adverse effects, Peripheral Arterial Disease*, Femoral Artery, Femoral Artery/surgery, Endovascular Procedures*, Endovascular Procedures/adverse effects, Retrospective Studies, Limb Salvage, Vascular Patency, Randomized Controlled Trials as Topic, Humans, Female, Middle Aged, Aged, Male, Treatment Outcome, Risk Factors, Vascular Surgical Procedures, Vascular Surgical Procedures/adverse effects, Peripheral Arterial Disease*, Femoral Artery, Femoral Artery/surgery, Endovascular Procedures*, Endovascular Procedures/adverse effects, Retrospective Studies, Limb Salvage, Vascular Patency, Randomized Controlled Trials as Topic, Humans, Female, Middle Aged, Aged, Male, Treatment Outcome, Risk Factors, Vascular Surgical Procedures, Vascular Surgical Procedures/adverse effects, Peripheral Arterial Disease*, Femoral Artery, Femoral Artery/surgery, Endovascular Procedures*, Endovascular Procedures/adverse effects, Retrospective Studies, Limb Salvage, Vascular Patency, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 409, + "user_id": 1447203401, + "artical_title": "Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.", + "pmid": 36747244, + "journal_name": "Cardiovascular diabetology", + "date": "2023-02-08", + "author": "Chiarito M,Sanz-Sanchez J,Piccolo R,Condello F,Liccardo G,Maurina M,Avvedimento M,Regazzoli D,Pagnotta P,Garcia-Garcia HM,Mehran R,Federici M,Condorelli G,Diez Gil JL,Reimers B,Ferrante G,Stefanini G", + "auth_pos": 11, + "meshterms": "Humans, Acidosis, Lactic*, Acidosis, Lactic/chemically induced, Acidosis, Lactic/diagnosis, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Diabetes Mellitus*, Diabetes Mellitus/chemically induced, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Lactates, Metformin*, Metformin/adverse effects, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 410, + "user_id": 1447203401, + "artical_title": "Prevention and Management of Stroke After Transcatheter Aortic Valve Replacement: The Mount Sinai Stroke Initiative.", + "pmid": 36752233, + "journal_name": "Journal of the American Heart Association", + "date": "2023-02-09", + "author": "Khera S,Koshy AN,Tang GHL,Moreno P,Mehran R,Dangas GD,Bronster D,Kini AS,Fara M,Sharma SK", + "auth_pos": 5, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Stroke*, Stroke/etiology, Stroke/prevention & control, Ischemic Attack, Transient*, Ischemic Attack, Transient/prevention & control, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 411, + "user_id": 1447203401, + "artical_title": "P2Y Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.", + "pmid": 36754514, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-02-09", + "author": "Gragnano F,Mehran R,Branca M,Franzone A,Baber U,Jang Y,Kimura T,Hahn JY,Zhao Q,Windecker S,Gibson CM,Kim BK,Watanabe H,Song YB,Zhu Y,Vranckx P,Mehta S,Hong SJ,Ando K,Gwon HC,Calabrò P,Serruys PW,Dangas GD,McFadden EP,Angiolillo DJ,Heg D,Valgimigli M", + "auth_pos": 2, + "meshterms": "Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome, Humans, Platelet Aggregation Inhibitors*, Aspirin, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Purinergic P2Y Receptor Antagonists, Dual Anti-Platelet Therapy, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Drug Therapy, Combination, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 412, + "user_id": 1447203401, + "artical_title": "Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation.", + "pmid": 36848691, + "journal_name": "The American journal of cardiology", + "date": "2023-02-28", + "author": "Edens M,Watanabe Y,Nicolas J,Sartori S,Snyder C,Vogel B,Spirito A,Tchetche D,Petronio AS,Mehilli J,Lefèvre T,Presbitero P,Capranzano P,Selberg A,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Dumonteil N,Fraccaro C,Trabattoni D,Mikhail G,Ferrer-Gracia MC,Naber C,Sharma S,Morice MC,Dangas GD,Chieffo A,Mehran R", + "auth_pos": 29, + "meshterms": "Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery, Humans, Female, Middle Aged, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Prospective Studies, Risk Factors, Treatment Outcome, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Menopause, Aortic Valve, Aortic Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 413, + "user_id": 1447203401, + "artical_title": "Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR.", + "pmid": 38938310, + "journal_name": "JACC. Advances", + "date": "2023-03-08", + "author": "Mehran R,Spirito A,Jin J,Chen C,Seeger J,Mascherbauer J,Vranckx P,Moreno R,Lang IM,Duggal A,Watanabe Y,Capranzano P,Kini AS,Veulemans V,Tessitore E,Hayashida K,Unverdorben M,Van Mieghem NM,Hengstenberg C,Dangas GD", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 414, + "user_id": 1447203401, + "artical_title": "ROMA-Women: Innovative Approaches for the First Cardiac Surgery Trial in Women.", + "pmid": 37009730, + "journal_name": "Circulation", + "date": "2023-04-04", + "author": "Gaudino M,Fremes SE,Mehran R,Bairey Merz N", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 415, + "user_id": 1447203401, + "artical_title": "Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis.", + "pmid": 36564015, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-04-11", + "author": "Nicolas J,Dangas G,Chiarito M,Pivato CA,Spirito A,Cao D,Giustino G,Beerkens F,Camaj A,Vogel B,Sartori S,Yamamoto K,Kimura T,Kim BK,Baber U,Mehran R", + "auth_pos": 16, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Aspirin, Aspirin/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/chemically induced, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 416, + "user_id": 1447203401, + "artical_title": "Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).", + "pmid": 36869784, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-04-11", + "author": "Navarese EP,Landi A,Oliva A,Piccolo R,Aboyans V,Angiolillo D,Atar D,Capodanno D,Fox KAA,Halvorsen S,James S,Jüni P,Kunadian V,Leonardi S,Mehran R,Montalescot G,Niebauer J,Price S,Storey RF,Völler H,Vranckx P,Windecker S,Valgimigli M", + "auth_pos": 15, + "meshterms": "Humans, Ticagrelor, Ticagrelor/adverse effects, Coronary Artery Disease*, Clopidogrel, Clopidogrel/therapeutic use, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Rivaroxaban, Rivaroxaban/adverse effects, Network Meta-Analysis, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Aspirin, Stroke*, Stroke/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Cardiology*, Humans, Ticagrelor, Ticagrelor/adverse effects, Coronary Artery Disease*, Clopidogrel, Clopidogrel/therapeutic use, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Rivaroxaban, Rivaroxaban/adverse effects, Network Meta-Analysis, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Aspirin, Stroke*, Stroke/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Cardiology*, Humans, Ticagrelor, Ticagrelor/adverse effects, Coronary Artery Disease*, Clopidogrel, Clopidogrel/therapeutic use, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Rivaroxaban, Rivaroxaban/adverse effects, Network Meta-Analysis, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Aspirin, Stroke*, Stroke/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Cardiology*, Humans, Ticagrelor, Ticagrelor/adverse effects, Coronary Artery Disease*, Clopidogrel, Clopidogrel/therapeutic use, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Rivaroxaban, Rivaroxaban/adverse effects, Network Meta-Analysis, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Aspirin, Stroke*, Stroke/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Cardiology*, Humans, Ticagrelor, Ticagrelor/adverse effects, Coronary Artery Disease*, Clopidogrel, Clopidogrel/therapeutic use, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Rivaroxaban, Rivaroxaban/adverse effects, Network Meta-Analysis, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Aspirin, Stroke*, Stroke/prevention & control, Hemorrhage, Hemorrhage/chemically induced, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 417, + "user_id": 1447203401, + "artical_title": "Clinical Pharmacokinetics and Pharmacodynamics of CSL112.", + "pmid": 36928983, + "journal_name": "Clinical pharmacokinetics", + "date": "2023-04-12", + "author": "Ortega-Paz L,Giordano S,Capodanno D,Mehran R,Gibson CM,Angiolillo DJ", + "auth_pos": 4, + "meshterms": "Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development, Humans, Lipoproteins, HDL*, Lipoproteins, HDL/pharmacology, Lipoproteins, HDL/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/chemically induced, Apolipoprotein A-I, Apolipoprotein A-I/pharmacokinetics, Apolipoprotein A-I/therapeutic use, Drug Development", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 418, + "user_id": 1447203401, + "artical_title": "Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes.", + "pmid": 37045495, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-04-14", + "author": "Paradies V,Banning A,Cao D,Chieffo A,Daemen J,Diletti R,Hildick-Smith D,Kandzari DE,Kirtane AJ,Mehran R,Park DW,Tarantini G,Smits PC,Van Mieghem NM", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 419, + "user_id": 1447203401, + "artical_title": "Trends in Vascular Access Site Use and Outcomes in Patients Undergoing PCI.", + "pmid": 36989603, + "journal_name": "The American journal of cardiology", + "date": "2023-04-25", + "author": "Giustino G,Kyaw H,Sartori S,Farhan S,Dangas G,Sweeny J,Mehran R,Kini A,Sharma SK", + "auth_pos": 7, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Femoral Artery, Radial Artery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 420, + "user_id": 1447203401, + "artical_title": "Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside.", + "pmid": 35788828, + "journal_name": "Cardiovascular research", + "date": "2023-05-04", + "author": "Nicolas J,Pivato CA,Chiarito M,Beerkens F,Cao D,Mehran R", + "auth_pos": 6, + "meshterms": "Humans, Drug-Eluting Stents*, Prosthesis Design, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Stents, Humans, Drug-Eluting Stents*, Prosthesis Design, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Stents, Humans, Drug-Eluting Stents*, Prosthesis Design, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/therapy, Stents", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 421, + "user_id": 1447203401, + "artical_title": "Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.", + "pmid": 37036268, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2023-05-11", + "author": "Feldman D,Cao D,Sartori S,Zhang Z,Hengstenberg C,Tron C,Anthopoulos P,Widder JD,Meneveau N,Stella PR,Ferrari M,Jeger R,Violini R,Dumonteil N,Chen S,Yan R,Nicolas J,Razuk V,Spirito A,Vogel B,Mehran R,Dangas G", + "auth_pos": 21, + "meshterms": "Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects, Humans, Heparin, Heparin/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Antithrombins, Antithrombins/adverse effects, Treatment Outcome, Hirudins, Hirudins/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Peptide Fragments, Peptide Fragments/adverse effects, Recombinant Proteins, Recombinant Proteins/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 422, + "user_id": 1447203401, + "artical_title": "Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population.", + "pmid": 37164597, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-05-12", + "author": "Khandelwal G,Spirito A,Tanner R,Koshy AN,Sartori S,Salehi N,Giustino G,Dhulipala V,Zhang Z,Gonzalez J,Hooda A,Vinayak M,Shaikh A,Mehran R,Kini AS,Sharma SK", + "auth_pos": 14, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, United Kingdom", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 423, + "user_id": 1447203401, + "artical_title": "Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: an EAPCI position statement in collaboration with EHRA, EACVI, the ESC Regulatory Affairs Committee and Women as One.", + "pmid": 36411964, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2023-05-15", + "author": "Manzo-Silberman S,Velázquez M,Burgess S,Sahni S,Best P,Mehran R,Piccaluga E,Vitali-Serdoz L,Sarma A,Barbash IM,Mauri J,Szyma?ski P,Hinterbuchner L,Stefanini G,Gimelli A,Maurovich-Horvat P,Boersma L,Buchanan GL,Pontone G,Holmvang L,Karam N,Neylon A,Morice MC,Leclercq C,Tarantini G,Dudek D,Chieffo A", + "auth_pos": 6, + "meshterms": "Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care, Pregnancy, Humans, Female, Radiation Protection*, Laboratories, Cardiology*, Catheterization, Delivery of Health Care", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 424, + "user_id": 1447203401, + "artical_title": "Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects.", + "pmid": 37073647, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2023-05-16", + "author": "Chandiramani R,Spirito A,Johnson JW,Mehta A,Vogel B,Faillace RT,Mehran R", + "auth_pos": 7, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Coronary Artery Disease*, Coronary Artery Disease/therapy, Aspirin, Aspirin/therapeutic use, Anticoagulants, Anticoagulants/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Drug Therapy, Combination, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Humans, Platelet Aggregation Inhibitors, Coronary Artery Disease*, Coronary Artery Disease/therapy, Aspirin, Aspirin/therapeutic use, Anticoagulants, Anticoagulants/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Drug Therapy, Combination, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Humans, Platelet Aggregation Inhibitors, Coronary Artery Disease*, Coronary Artery Disease/therapy, Aspirin, Aspirin/therapeutic use, Anticoagulants, Anticoagulants/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Drug Therapy, Combination, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Humans, Platelet Aggregation Inhibitors, Coronary Artery Disease*, Coronary Artery Disease/therapy, Aspirin, Aspirin/therapeutic use, Anticoagulants, Anticoagulants/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Drug Therapy, Combination, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 425, + "user_id": 1447203401, + "artical_title": "PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.", + "pmid": 37187289, + "journal_name": "Journal of cardiology", + "date": "2023-05-16", + "author": "Jones D,Spirito A,Sartori S,Smith KF,Pivato CA,Chiarito M,Cao D,Nicolas J,Beerkens F,Edens M,Pileggi B,Sen A,Zhang Z,Vogel B,Sweeny J,Baber U,Dangas G,Sharma SK,Kini A,Mehran R", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 426, + "user_id": 1447203401, + "artical_title": "Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.", + "pmid": 36988155, + "journal_name": "European heart journal", + "date": "2023-05-22", + "author": "Cao D,Amabile N,Chiarito M,Lee VT,Angiolillo DJ,Capodanno D,Bhatt DL,Mack MJ,Storey RF,Schmoeckel M,Gibson CM,Deliargyris EN,Mehran R", + "auth_pos": 13, + "meshterms": "Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Anticoagulants, Anticoagulants/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 427, + "user_id": 1447203401, + "artical_title": "Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis.", + "pmid": 36841245, + "journal_name": "Thrombosis and haemostasis", + "date": "2023-05-25", + "author": "Galli M,Laborante R,Ortega-Paz L,Franchi F,Rollini F,D'Amario D,Capodanno D,Tremoli E,Gibson CM,Mehran R,Angiolillo DJ", + "auth_pos": 10, + "meshterms": "Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants, Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants, Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants, Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants, Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants, Humans, Enoxaparin*, Factor XI*, Platelet Aggregation Inhibitors, Anticoagulants", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 428, + "user_id": 1447203401, + "artical_title": "Reply: DAPT Shortening After Complex PCI: Examining the Fine Print.", + "pmid": 37257959, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-06-02", + "author": "Gragnano F,Mehran R,Calabrò P,Valgimigli M", + "auth_pos": 2, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Dual Anti-Platelet Therapy, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/drug therapy, Treatment Outcome, Drug Therapy, Combination", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 429, + "user_id": 1447203401, + "artical_title": "Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial.", + "pmid": 36649694, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-06-05", + "author": "Spirito A,Kastrati A,Cao D,Baber U,Sartori S,Angiolillo DJ,Briguori C,Cohen DJ,Dangas G,Dudek D,Escaned J,Gibson CM,Zhang Z,Huber K,Kaul U,Kornowski R,Kunadian V,Han YL,Mehta SR,Sardella G,Sharma S,Shlofmitz RA,Vogel B,Collier T,Pocock S,Mehran R", + "auth_pos": 26, + "meshterms": "Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced, Male, Humans, Female, Ticagrelor, Ticagrelor/adverse effects, Aspirin, Aspirin/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Hemorrhage, Hemorrhage/chemically induced, Anemia*, Anemia/diagnosis, Anemia/epidemiology, Anemia/chemically induced", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 430, + "user_id": 1447203401, + "artical_title": "Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight.", + "pmid": 37080466, + "journal_name": "International journal of cardiology", + "date": "2023-06-05", + "author": "Spirito A,Valgimigli M,Cao D,Baber U,Mehta SR,Gibson CM,Steg GP,Sharma SK,Goel R,Huber K,Kunadian V,Escaned J,Franzone A,Yaling H,Collier T,Kaul U,Kornowski R,Krucoff M,Moliterno D,Sartori S,Owen R,Zhang Z,Dangas GD,Kastrati A,Angiolillo DJ,Cohen DJ,Vranckx P,Windecker S,Pocock S,Mehran R", + "auth_pos": 30, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Sirolimus, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Ticagrelor, Treatment Outcome, Stents, Polymers, Absorbable Implants", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 431, + "user_id": 1447203401, + "artical_title": "Biological basis and proposed mechanism of action of CSL112 (Apolipoprotein A-I [Human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction.", + "pmid": 36787889, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-06-05", + "author": "Korjian S,Kazmi SHA,Chi G,Kalayci A,Lee JJ,Talib U,Wright SD,Duffy D,Kingwell BA,Mehran R,Ridker PM,Gibson CM", + "auth_pos": 10, + "meshterms": "Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control, Humans, Cholesterol, Apolipoprotein A-I, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Lipoproteins, HDL, Lipoproteins, HDL/adverse effects, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 432, + "user_id": 1447203401, + "artical_title": "Correction to: Clinical Pharmacokinetics and Pharmacodynamics of CSL112.", + "pmid": 37314681, + "journal_name": "Clinical pharmacokinetics", + "date": "2023-06-14", + "author": "Ortega-Paz L,Giordano S,Capodanno D,Mehran R,Gibson CM,Angiolillo DJ", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 433, + "user_id": 1447203401, + "artical_title": "Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.", + "pmid": 37335828, + "journal_name": "Circulation", + "date": "2023-06-21", + "author": "Capodanno D,Mehran R,Krucoff MW,Baber U,Bhatt DL,Capranzano P,Collet JP,Cuisset T,De Luca G,De Luca L,Farb A,Franchi F,Gibson CM,Hahn JY,Hong MK,James S,Kastrati A,Kimura T,Lemos PA,Lopes RD,Magee A,Matsumura R,Mochizuki S,O'Donoghue ML,Pereira NL,Rao SV,Rollini F,Shirai Y,Sibbing D,Smits PC,Steg PG,Storey RF,Ten Berg J,Valgimigli M,Vranckx P,Watanabe H,Windecker S,Serruys PW,Yeh RW,Morice MC,Angiolillo DJ", + "auth_pos": 2, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Hemorrhage, Hemorrhage/etiology, Blood Platelets, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Thrombosis*, Thrombosis/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Carotid Stents*, Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 434, + "user_id": 1447203401, + "artical_title": "The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study.", + "pmid": 37365618, + "journal_name": "Diabetology & metabolic syndrome", + "date": "2023-06-27", + "author": "Feitosa MPM,Lima EG,Abizaid AAC,Mehran R,Lopes NHM,de Assis Fischer Ramos T,Hideo-Kajita A,Filho RK,Junior CVS", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 435, + "user_id": 1447203401, + "artical_title": "Timing and Predictors of Myocardial Infarction or Stent Thrombosis in High-Bleeding Risk Patients Undergoing PCI.", + "pmid": 37380247, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-06-30", + "author": "Spirito A,Pitaro N,Sartori S,Nicolas J,Baber U,Vogel B,Kini A,Sharma SK,Dangas G,Mehran R", + "auth_pos": 10, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Thrombosis*, Stents", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 436, + "user_id": 1447203401, + "artical_title": "[Female Presence in Interventional Cardiology: Yes we can!]", + "pmid": 39093187, + "journal_name": "Revista médica de Chile", + "date": "2023-07-01", + "author": "Cataldo P,Mehran R", + "auth_pos": 2, + "meshterms": "Humans, Female, Physicians, Women*, Physicians, Women/statistics & numerical data, Cardiology*, Male, Chile", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 437, + "user_id": 1447203401, + "artical_title": "Artificial Intelligence - Advisory or Adversary?", + "pmid": 37398874, + "journal_name": "Interventional cardiology (London, England)", + "date": "2023-07-03", + "author": "Nicolas J,Pitaro NL,Vogel B,Mehran R", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 438, + "user_id": 1447203401, + "artical_title": "P2Y Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.", + "pmid": 37407118, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-07-07", + "author": "Gragnano F,Cao D,Pirondini L,Franzone A,Kim HS,von Scheidt M,Pettersen AR,Zhao Q,Woodward M,Chiarito M,McFadden EP,Park KW,Kastrati A,Seljeflot I,Zhu Y,Windecker S,Kang J,Schunkert H,Arnesen H,Bhatt DL,Steg PG,Calabrò P,Pocock S,Mehran R,Valgimigli M", + "auth_pos": 24, + "meshterms": "Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Humans, Aspirin, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/prevention & control, Coronary Artery Disease/chemically induced, Secondary Prevention, Purinergic P2Y Receptor Antagonists, Platelet Aggregation Inhibitors, Myocardial Infarction*, Myocardial Infarction/etiology, Hemorrhage, Hemorrhage/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 439, + "user_id": 1447203401, + "artical_title": "Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.", + "pmid": 37220640, + "journal_name": "The Journal of invasive cardiology", + "date": "2023-07-10", + "author": "Freitas RAP,Tanajura LF,Mehran R,Chamié D,Chaves A,Centemero M,Braga S,Costa R,Cao D,Sousa A,Feres F,Costa JR", + "auth_pos": 3, + "meshterms": "Aged, Humans, Contrast Media, Contrast Media/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Creatinine, Ioxaglic Acid*, Ioxaglic Acid/adverse effects, Kidney Diseases*, Kidney Diseases/chemically induced, Risk Factors, Triiodobenzoic Acids, Triiodobenzoic Acids/adverse effects, Aged, Humans, Contrast Media, Contrast Media/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Creatinine, Ioxaglic Acid*, Ioxaglic Acid/adverse effects, Kidney Diseases*, Kidney Diseases/chemically induced, Risk Factors, Triiodobenzoic Acids, Triiodobenzoic Acids/adverse effects, Aged, Humans, Contrast Media, Contrast Media/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Creatinine, Ioxaglic Acid*, Ioxaglic Acid/adverse effects, Kidney Diseases*, Kidney Diseases/chemically induced, Risk Factors, Triiodobenzoic Acids, Triiodobenzoic Acids/adverse effects, Aged, Humans, Contrast Media, Contrast Media/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Creatinine, Ioxaglic Acid*, Ioxaglic Acid/adverse effects, Kidney Diseases*, Kidney Diseases/chemically induced, Risk Factors, Triiodobenzoic Acids, Triiodobenzoic Acids/adverse effects, Aged, Humans, Contrast Media, Contrast Media/adverse effects, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Creatinine, Ioxaglic Acid*, Ioxaglic Acid/adverse effects, Kidney Diseases*, Kidney Diseases/chemically induced, Risk Factors, Triiodobenzoic Acids, Triiodobenzoic Acids/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 440, + "user_id": 1447203401, + "artical_title": "Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).", + "pmid": 37354778, + "journal_name": "The American journal of cardiology", + "date": "2023-07-10", + "author": "Beerkens FJ,Cao D,Batchelor W,Sartori S,Kandzari DE,Davis S,Tamis L,Wang JC,Othman I,Vogel B,Spirito A,Subramaniam V,Gigliotti OS,Haghighat A,Feng Y,Singh S,Lopez M,Giugliano G,Horwitz PA,Dangas G,Mehran R", + "auth_pos": 21, + "meshterms": "Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic, Female, Humans, Male, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/complications, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platinum, Registries, Risk Factors, Treatment Outcome, Clinical Studies as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 441, + "user_id": 1447203401, + "artical_title": "TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design.", + "pmid": 37438037, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-07-14", + "author": "Nuyens P,De Backer O,Sathananthan J,Højsgaard Jørgensen T,Treede H,Leipsic JA,Bax JJ,Webb JG,Mehran R,Chen M,Reardon M,Leon MB,Søndergaard L", + "auth_pos": 9, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 442, + "user_id": 1447203401, + "artical_title": "Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease.", + "pmid": 37456769, + "journal_name": "European cardiology", + "date": "2023-07-17", + "author": "Sambola A,Del Blanco BG,Kunadian V,Vogel B,Chieffo A,Vidal M,Ratcovich H,Botti G,Wilkinson C,Mehran R", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 443, + "user_id": 1447203401, + "artical_title": "Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry).", + "pmid": 37465632, + "journal_name": "Postepy w kardiologii interwencyjnej = Advances in interventional cardiology", + "date": "2023-07-19", + "author": "Dziewierz A,Vogel B,Zdzierak B,Kuleta M,Malinowski KP,Rakowski T,Piotrowska A,Mehran R,Siudak Z", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 444, + "user_id": 1447203401, + "artical_title": "Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC).", + "pmid": 37120728, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-07-31", + "author": "Valgimigli M,Aboyans V,Angiolillo D,Atar D,Capodanno D,Halvorsen S,James S,Jüni P,Kunadian V,Landi A,Leonardi S,Mehran R,Montalescot G,Navarese EP,Niebauer J,Oliva A,Piccolo R,Price S,Storey RF,Völler H,Vranckx P,Windecker S,Fox KAA", + "auth_pos": 12, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Blood Coagulation", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 445, + "user_id": 1447203401, + "artical_title": "Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention.", + "pmid": 37393727, + "journal_name": "The American journal of cardiology", + "date": "2023-07-31", + "author": "Farooq A,Koshy AN,Giustino G,Sartori S,Snyder C,Hooda A,Farhan S,Kyaw H,Khan M,Vinayak M,Arora A,Dhulipala V,Suleman J,Krishnamoorthy P,Khera S,Sweeny J,Mehran R,Kini AS,Sharma SK", + "auth_pos": 17, + "meshterms": "Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy, Humans, Atherectomy, Coronary*, Atherectomy, Coronary/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/diagnosis, Non-ST Elevated Myocardial Infarction/surgery, Non-ST Elevated Myocardial Infarction/etiology, Treatment Outcome, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/etiology, Angina, Unstable, Angina, Unstable/epidemiology, Angina, Unstable/surgery, Angina, Unstable/drug therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 446, + "user_id": 1447203401, + "artical_title": "Gender Disparity in Citations and Altmetric Attention Scores in High-Impact Cardiology Journals.", + "pmid": 37532427, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-08-03", + "author": "Brown KN,Goel R,Soman S,Khan E,Ya'Qoub L,Calsavara V,Wang DD,Velagapudi P,Mehran R,Gulati M", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 447, + "user_id": 1447203401, + "artical_title": "Migraine and cardiovascular disease: what cardiologists should know.", + "pmid": 37345664, + "journal_name": "European heart journal", + "date": "2023-08-09", + "author": "Kalkman DN,Couturier EGM,El Bouziani A,Dahdal J,Neefs J,Woudstra J,Vogel B,Trabattoni D,MaassenVanDenBrink A,Mehran R,de Winter RJ,Appelman Y", + "auth_pos": 10, + "meshterms": "Male, Humans, Female, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Migraine with Aura*, Migraine with Aura/complications, Migraine with Aura/epidemiology, Brain Ischemia*, Brain Ischemia/complications, Calcitonin Gene-Related Peptide Receptor Antagonists, Cardiologists*, Stroke*, Stroke/etiology, Stroke/complications, Migraine Disorders*, Migraine Disorders/complications, Migraine Disorders/epidemiology, Foramen Ovale, Patent*, Foramen Ovale, Patent/complications, Male, Humans, Female, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Migraine with Aura*, Migraine with Aura/complications, Migraine with Aura/epidemiology, Brain Ischemia*, Brain Ischemia/complications, Calcitonin Gene-Related Peptide Receptor Antagonists, Cardiologists*, Stroke*, Stroke/etiology, Stroke/complications, Migraine Disorders*, Migraine Disorders/complications, Migraine Disorders/epidemiology, Foramen Ovale, Patent*, Foramen Ovale, Patent/complications", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 448, + "user_id": 1447203401, + "artical_title": "Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry.", + "pmid": 37094668, + "journal_name": "American heart journal", + "date": "2023-08-14", + "author": "Spirito A,Koh WJ,Sartori S,Vogel B,Feng Y,Baber U,Nicolas J,Snyder C,Kamaleldin K,Pileggi B,Rezvanizadeh V,Sweeny J,Sharma SK,Kini A,Pocock SJ,Dangas G,Mehran R", + "auth_pos": 17, + "meshterms": "Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Patient Selection, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Registries, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 449, + "user_id": 1447203401, + "artical_title": "Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.", + "pmid": 37587580, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-08-18", + "author": "Mendieta G,Mehta S,Baber U,Angiolillo DJ,Briguori C,Cohen D,Collier T,Dangas G,Dudek D,Escaned J,Gil R,Vogel B,Cao D,Spirito A,Huber K,Kastrati A,Kaul U,Kornowski R,Krucoff MW,Kunadian V,Moliterno DJ,Ohman EM,Sardella G,Sartori S,Sharma S,Shlofmitz R,Steg PG,Han YL,Pocock S,Gibson CM,Mehran R", + "auth_pos": 31, + "meshterms": "Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Humans, Aspirin, Aspirin/adverse effects, Heart, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Ticagrelor, Ticagrelor/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 450, + "user_id": 1447203401, + "artical_title": "Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.", + "pmid": 37587595, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-08-18", + "author": "Landi A,Chiarito M,Branca M,Frigoli E,Gagnor A,Calabrò P,Briguori C,Andò G,Repetto A,Limbruno U,Sganzerla P,Lupi A,Cortese B,Ausiello A,Ierna S,Esposito G,Ferrante G,Santarelli A,Sardella G,Varbella F,Heg D,Mehran R,Valgimigli M", + "auth_pos": 22, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/diagnosis, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 451, + "user_id": 1447203401, + "artical_title": "Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI.", + "pmid": 37382924, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2023-08-23", + "author": "Spirito A,Itchhaporia D,Sartori S,Camenzind E,Chieffo A,Dangas GD,Galatius S,Jeger RV,Kandzari DE,Kastrati A,Kim HS,Kimura T,Leon MB,Mehta LS,Mikhail GW,Morice MC,Nicolas J,Pileggi B,Serruys PW,Smits PC,Steg PG,Stone GW,Valgimigli M,Vogel B,von Birgelen C,Weisz G,Wijns W,Windecker S,Mehran R", + "auth_pos": 29, + "meshterms": "Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic, Female, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Risk Factors, Treatment Outcome, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 452, + "user_id": 1447203401, + "artical_title": "2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.", + "pmid": 37632766, + "journal_name": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery", + "date": "2023-08-28", + "author": "Byrne RA,Fremes S,Capodanno D,Czerny M,Doenst T,Emberson JR,Falk V,Gaudino M,McMurray JJV,Mehran R,Milojevic M,Uva MS", + "auth_pos": 10, + "meshterms": "Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*, Humans, Cardiology*, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Myocardial Infarction*, Percutaneous Coronary Intervention*, Thoracic Surgery*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 453, + "user_id": 1447203401, + "artical_title": "Nonadherence to dual antiplatelet therapy: old problems without new solutions.", + "pmid": 37659651, + "journal_name": "Revista española de cardiología (English ed.)", + "date": "2023-09-03", + "author": "Ortega-Paz L,Mehran R,Angiolillo DJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 454, + "user_id": 1447203401, + "artical_title": "Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI.", + "pmid": 37609931, + "journal_name": "Journal of the American Heart Association", + "date": "2023-09-06", + "author": "Wang X,Jering KS,Cikes M,Tokmakova MP,Mehran R,Han Y,East C,Mody FV,Wang Y,Lewis EF,Claggett B,McMurray JJV,Granger CB,Pfeffer MA,Solomon SD", + "auth_pos": 5, + "meshterms": "Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use, Female, Humans, Male, Ramipril, Sex Characteristics, Stroke Volume, Ventricular Function, Left, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Valsartan, Valsartan/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 455, + "user_id": 1447203401, + "artical_title": "Significance of Kidney Disease in Cardiovascular Disease Patients.", + "pmid": 37673491, + "journal_name": "Interventional cardiology clinics", + "date": "2023-09-08", + "author": "Mehta A,Chandiramani R,Spirito A,Vogel B,Mehran R", + "auth_pos": 5, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardio-Renal Syndrome*, Kidney, Heart Diseases*, Heart Failure*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardio-Renal Syndrome*, Kidney, Heart Diseases*, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 456, + "user_id": 1447203401, + "artical_title": "Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.", + "pmid": 37494015, + "journal_name": "JAMA cardiology", + "date": "2023-09-14", + "author": "Reddy KP,Faggioni M,Eberly LA,Halaby R,Sanghavi M,Lewey J,Mehran R,Coylewright M,Herrmann HC,Giri J,Fanaroff AC,Nathan AS", + "auth_pos": 7, + "meshterms": "Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*, Adult, Humans, Female, Aged, Ethnicity*, Minority Groups, Ethnic and Racial Minorities, Hispanic or Latino, Heart Valve Diseases*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 457, + "user_id": 1447203401, + "artical_title": "Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.", + "pmid": 37609850, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2023-09-21", + "author": "Kuno T,Watanabe A,Shoji S,Fujisaki T,Ueyama H,Takagi H,Deharo P,Cuisset T,Bangalore S,Mehran R,Stone GW,Kohsaka S,Bhatt DL", + "auth_pos": 10, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Network Meta-Analysis, Clopidogrel, Clopidogrel/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Network Meta-Analysis, Clopidogrel, Clopidogrel/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Network Meta-Analysis, Clopidogrel, Clopidogrel/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Network Meta-Analysis, Clopidogrel, Clopidogrel/adverse effects, Ticagrelor, Ticagrelor/adverse effects, Treatment Outcome, Carotid Stents*, Balloon Guide*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 458, + "user_id": 1447203401, + "artical_title": "Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial.", + "pmid": 37725677, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2023-09-21", + "author": "Oqab Z,Kunadian V,Wood DA,Storey RF,Rao SV,Mehran R,Pinilla-Echeverri N,Mani T,Boone RH,Kassam S,Bossard M,Mansour S,Ball W,Sibbald M,Valettas N,Moreno R,Steg PG,Cairns JA,Mehta SR", + "auth_pos": 6, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Myocardial Infarction*, Myocardial Infarction/therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/diagnostic imaging, ST Elevation Myocardial Infarction/therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 459, + "user_id": 1447203401, + "artical_title": "Prevalence and Outcomes of Patients With Acute Ischemic Stroke and Concomitant Non-ST-Elevation Myocardial Infarction (Results from the National Inpatient Sample 2016 to 2019).", + "pmid": 37639760, + "journal_name": "The American journal of cardiology", + "date": "2023-09-22", + "author": "Mehta S,Mehran R,Hassan S,Kaur J,Sule A,Arsene C,Krishnamoorthy G,Szklo M", + "auth_pos": 2, + "meshterms": "Humans, Female, Aged, Male, Inpatients, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/complications, Non-ST Elevated Myocardial Infarction/epidemiology, Prevalence, Ischemic Stroke*, Ischemic Stroke/epidemiology, Percutaneous Coronary Intervention*, Anterior Wall Myocardial Infarction*, Intracranial Hemorrhages, ST Elevation Myocardial Infarction*, Humans, Female, Aged, Male, Inpatients, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/complications, Non-ST Elevated Myocardial Infarction/epidemiology, Prevalence, Ischemic Stroke*, Ischemic Stroke/epidemiology, Percutaneous Coronary Intervention*, Anterior Wall Myocardial Infarction*, Intracranial Hemorrhages, ST Elevation Myocardial Infarction*, Humans, Female, Aged, Male, Inpatients, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/complications, Non-ST Elevated Myocardial Infarction/epidemiology, Prevalence, Ischemic Stroke*, Ischemic Stroke/epidemiology, Percutaneous Coronary Intervention*, Anterior Wall Myocardial Infarction*, Intracranial Hemorrhages, ST Elevation Myocardial Infarction*, Humans, Female, Aged, Male, Inpatients, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/complications, Non-ST Elevated Myocardial Infarction/epidemiology, Prevalence, Ischemic Stroke*, Ischemic Stroke/epidemiology, Percutaneous Coronary Intervention*, Anterior Wall Myocardial Infarction*, Intracranial Hemorrhages, ST Elevation Myocardial Infarction*, Humans, Female, Aged, Male, Inpatients, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/complications, Non-ST Elevated Myocardial Infarction/epidemiology, Prevalence, Ischemic Stroke*, Ischemic Stroke/epidemiology, Percutaneous Coronary Intervention*, Anterior Wall Myocardial Infarction*, Intracranial Hemorrhages, ST Elevation Myocardial Infarction*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 460, + "user_id": 1447203401, + "artical_title": "Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.", + "pmid": 37730292, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-09-22", + "author": "Figtree GA,Vernon ST,Harmer JA,Gray MP,Arnott C,Bachour E,Barsha G,Brieger D,Brown A,Celermajer DS,Channon KM,Chew NWS,Chong JJH,Chow CK,Cistulli PA,Ellinor PT,Grieve SM,Guzik TJ,Hagström E,Jenkins A,Jennings G,Keech AC,Kott KA,Kritharides L,Mamas MA,Mehran R,Meikle PJ,Natarajan P,Negishi K,O'Sullivan J,Patel S,Psaltis PJ,Redfern J,Steg PG,Sullivan DR,Sundström J,Vogel B,Wilson A,Wong D,Bhatt DL,Kovacic JC,Nicholls SJ", + "auth_pos": 26, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Critical Pathways, Myocardial Infarction*, Atherosclerosis*, Heart Disease Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 461, + "user_id": 1447203401, + "artical_title": "Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.", + "pmid": 37742213, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-09-24", + "author": "Spirito A,Cao D,Sartori S,Sharma A,Smith KF,Vogel B,Kamaleldin K,Koshy AN,Feng Y,Power D,Baber U,Melarcode-Krishnamoorthy P,Sharma SK,Kini A,Dangas G,Mehran R", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 462, + "user_id": 1447203401, + "artical_title": "Thrombotic Risk in Patients with Acute Coronary Syndromes Discharged on Prasugrel or Clopidogrel: Results From the PROMETHEUS Study.", + "pmid": 37459570, + "journal_name": "European heart journal. Acute cardiovascular care", + "date": "2023-09-27", + "author": "Chiarito M,Cao D,Sartori S,Zhang Z,Vogel B,Spirito A,Smith KF,Weintraub W,Strauss C,Toma C,DeFranco A,Effron MB,Stefanini G,Keller S,Kapadia S,Rao SV,Henry TD,Pocock S,Sharma S,Dangas G,Kini A,Baber U,Mehran R", + "auth_pos": 23, + "meshterms": "Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control, Humans, Clopidogrel, Clopidogrel/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Acute Coronary Syndrome/complications, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Prospective Studies, Patient Discharge, Treatment Outcome, Thrombosis*, Thrombosis/epidemiology, Thrombosis/etiology, Thrombosis/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 463, + "user_id": 1447203401, + "artical_title": "1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.", + "pmid": 37804290, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-10-07", + "author": "Valgimigli M,Spirito A,Sartori S,Angiolillo DJ,Vranckx P,de la Torre Hernandez JM,Krucoff MW,Bangalore S,Bhatt DL,Campo G,Cao D,Chehab BM,Choi JW,Feng Y,Ge J,Hermiller J,Kunadian V,Lupo S,Makkar RR,Maksoud A,Neumann FJ,Picon H,Saito S,Sardella G,Thiele H,Toelg R,Varenne O,Vogel B,Zhou Y,Windecker S,Mehran R", + "auth_pos": 31, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 464, + "user_id": 1447203401, + "artical_title": "The Heart-Brain Connection in Myocardial Infarction in Women: A Dilemma to Tackle.", + "pmid": 37852695, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-10-23", + "author": "Mehran R,Vogel B", + "auth_pos": 1, + "meshterms": "Humans, Female, Myocardial Infarction*, Coronary Artery Disease*, Heart, Brain, Coronary Angiography, Coronary Vessels, Risk Factors, Humans, Female, Myocardial Infarction*, Coronary Artery Disease*, Heart, Brain, Coronary Angiography, Coronary Vessels, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 465, + "user_id": 1447203401, + "artical_title": "Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.", + "pmid": 37746717, + "journal_name": "Circulation", + "date": "2023-10-23", + "author": "Bikdeli B,Erlinge D,Valgimigli M,Kastrati A,Han Y,Steg PG,Stables RH,Mehran R,James SK,Frigoli E,Goldstein P,Li Y,Shahzad A,Schüpke S,Mehdipoor G,Chen S,Redfors B,Crowley A,Zhou Z,Stone GW", + "auth_pos": 8, + "meshterms": "Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome, Humans, Heparin, Heparin/adverse effects, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Randomized Controlled Trials as Topic, Hirudins, Hirudins/adverse effects, Peptide Fragments, Peptide Fragments/adverse effects, Myocardial Infarction*, Hemorrhage, Hemorrhage/etiology, Thrombosis*, Thrombosis/etiology, Recombinant Proteins, Recombinant Proteins/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 466, + "user_id": 1447203401, + "artical_title": "Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.", + "pmid": 37879803, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-10-27", + "author": "Angiolillo DJ,Cao D,Sartori S,Baber U,Dangas G,Zhang Z,Vogel B,Kunadian V,Briguori C,Cohen DJ,Collier T,Dudek D,Gibson M,Gil R,Huber K,Kaul U,Kornowski R,Krucoff MW,Ielasi A,Stefanini GG,Pivato CA,Mehta S,Moliterno DJ,Ohman EM,Escaned J,Sardella G,Sharma SK,Shlofmitz R,Weisz G,Witzenbichler B,Steg PG,Pocock S,Mehran R", + "auth_pos": 33, + "meshterms": "Humans, Ticagrelor, Platelet Aggregation Inhibitors*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Treatment Outcome, Drug Therapy, Combination, Aspirin, Dyspnea, Dyspnea/chemically induced, Dyspnea/diagnosis, Dyspnea/drug therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 467, + "user_id": 1447203401, + "artical_title": "Women in Cardiovascular Imaging: A Call for Action to Address Ongoing Challenges.", + "pmid": 37409644, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2023-10-30", + "author": "Joshi SS,Kadavath S,Mandoli GE,Gimelli A,Gulati M,Thamman R,Lundberg G,Mehran R,Mulvagh SL,Sade LE,Shivalkar B,Shaw LJ,Hristova K,Dweck MR,Almeida AG,Julia G", + "auth_pos": 8, + "meshterms": "Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires, Child, Humans, Female, Pregnancy, Prospective Studies, Sexual Harassment*, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 468, + "user_id": 1447203401, + "artical_title": "Gender-Based Differences in Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions (Insights from a Large Single-Center Registry).", + "pmid": 37734299, + "journal_name": "The American journal of cardiology", + "date": "2023-11-06", + "author": "Kyaw H,Giustino G,Kumar S,Sartori S,Qiu H,Feng Y,Iruvanti S,Kini A,Mehran R,Sharma SK", + "auth_pos": 9, + "meshterms": "Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors, Male, Humans, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Coronary Occlusion*, Coronary Occlusion/epidemiology, Coronary Occlusion/surgery, Coronary Occlusion/etiology, Myocardial Infarction*, Myocardial Infarction/complications, Registries, New York, Chronic Disease, Treatment Outcome, Coronary Angiography, Coronary Angiography/adverse effects, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 469, + "user_id": 1447203401, + "artical_title": "Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation.", + "pmid": 37741105, + "journal_name": "The American journal of cardiology", + "date": "2023-11-06", + "author": "Yamamoto M,Hayashida K,Hengstenberg C,Watanabe Y,Van Mieghem NM,Jin J,Saito S,Valgimigli M,Nicolas J,Mehran R,Moreno R,Kimura T,Chen C,Unverdorben M,Dangas GD", + "auth_pos": 10, + "meshterms": "Aged, Humans, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hemorrhage, Hemorrhage/etiology, Hypertension*, Hypertension/complications, Prospective Studies, Risk Factors, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Male, Female, Aged, Humans, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hemorrhage, Hemorrhage/etiology, Hypertension*, Hypertension/complications, Prospective Studies, Risk Factors, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Male, Female, Aged, Humans, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hemorrhage, Hemorrhage/etiology, Hypertension*, Hypertension/complications, Prospective Studies, Risk Factors, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Male, Female, Aged, Humans, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hemorrhage, Hemorrhage/etiology, Hypertension*, Hypertension/complications, Prospective Studies, Risk Factors, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Male, Female, Aged, Humans, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hemorrhage, Hemorrhage/etiology, Hypertension*, Hypertension/complications, Prospective Studies, Risk Factors, Stroke*, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Male, Female", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 470, + "user_id": 1447203401, + "artical_title": "2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.", + "pmid": 37632756, + "journal_name": "European heart journal", + "date": "2023-11-07", + "author": "Byrne RA,Fremes S,Capodanno D,Czerny M,Doenst T,Emberson JR,Falk V,Gaudino M,McMurray JJV,Mehran R,Milojevic M,Sousa Uva M", + "auth_pos": 10, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome, Humans, Coronary Artery Disease*, Coronary Artery Disease/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Thoracic Surgery*, Coronary Artery Bypass, Coronary Artery Bypass/methods, Cardiology*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 471, + "user_id": 1447203401, + "artical_title": "Bivalirudin plus a high-dose infusion versus Heparin in patients with acute coronary syndrome.", + "pmid": 37081774, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2023-11-08", + "author": "Galli M,Gargiulo G,Benenati S,Mehran R,Angiolillo DJ", + "auth_pos": 4, + "meshterms": "Humans, Heparin*, Acute Coronary Syndrome*, Hirudins, Peptide Fragments, Recombinant Proteins, Humans, Heparin*, Acute Coronary Syndrome*, Hirudins, Peptide Fragments, Recombinant Proteins", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 472, + "user_id": 1447203401, + "artical_title": "Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review.", + "pmid": 37941790, + "journal_name": "Pharmacogenomics and personalized medicine", + "date": "2023-11-09", + "author": "Oliva A,Cao D,Spirito A,Nicolas J,Pileggi B,Kamaleldin K,Vogel B,Mehran R", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 473, + "user_id": 1447203401, + "artical_title": "Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.", + "pmid": 37866281, + "journal_name": "The American journal of cardiology", + "date": "2023-11-13", + "author": "Spirito A,Nussbaum J,Sartori S,Vogel B,Abizaid A,Cao D,Christiansen EH,Colombo A,de Winter RJ,Haude M,Kamaleldin K,Jakobsen L,Jensen LO,Krucoff MW,Landmesser U,Nardin M,Saito S,Smith KF,Suryapranata H,De Luca G,Dangas G,Mehran R", + "auth_pos": 22, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design, Humans, Percutaneous Coronary Intervention*, Coronary Artery Disease*, Coronary Artery Disease/surgery, Sirolimus, Stents, Treatment Outcome, Risk Factors, Prosthesis Design", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 474, + "user_id": 1447203401, + "artical_title": "Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.", + "pmid": 37806185, + "journal_name": "The American journal of cardiology", + "date": "2023-11-13", + "author": "Baber U,Spirito A,Sartori S,Angiolillo DJ,Briguori C,Cohen DJ,Collier T,Dangas G,Dudek D,Escaned J,Gibson CM,Han YL,Huber K,Kastrati A,Kaul U,Kornowski R,Krucoff M,Kunadian V,Vogel B,Mehta SR,Moliterno D,Sardella G,Shlofmitz RA,Sharma S,Steg PG,Pocock S,Mehran R", + "auth_pos": 27, + "meshterms": "Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome, Humans, Ticagrelor, Ticagrelor/therapeutic use, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Drug Therapy, Combination, Aspirin, Myocardial Infarction*, Myocardial Infarction/therapy, Stroke*, Stroke/epidemiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 475, + "user_id": 1447203401, + "artical_title": "Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.", + "pmid": 37995152, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-11-27", + "author": "Kuno T,Kiyohara Y,Maehara A,Ueyama HA,Kampaktsis PN,Takagi H,Mehran R,Stone GW,Bhatt DL,Mintz GS,Bangalore S", + "auth_pos": 7, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Coronary Angiography, Coronary Angiography/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Treatment Outcome, Myocardial Infarction*, Myocardial Infarction/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/etiology, Thrombosis*, Thrombosis/etiology, Ultrasonography, Interventional, Ultrasonography, Interventional/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 476, + "user_id": 1447203401, + "artical_title": "Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.", + "pmid": 37696359, + "journal_name": "International journal of cardiology", + "date": "2023-12-04", + "author": "van Wely M,van Nieuwkerk AC,Rooijakkers M,van der Wulp K,Gehlmann H,Verkroost M,van Garsse L,Geuzebroek G,Baz JA,Tchétché D,De Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Dangas G,Mehran R,Delewi R,van Royen N", + "auth_pos": 18, + "meshterms": "Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Heart Valve Prosthesis*, Pacemaker, Artificial*, Propensity Score, Aortic Valve, Aortic Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 477, + "user_id": 1447203401, + "artical_title": "Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.", + "pmid": 35583108, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2023-12-06", + "author": "Lunardi M,Louvard Y,Lefèvre T,Stankovic G,Burzotta F,Kassab GS,Lassen JF,Darremont O,Garg S,Koo BK,Holm NR,Johnson TW,Pan M,Chatzizisis YS,Banning AP,Chieffo A,Dudek D,Hildick-Smith D,Garot J,Henry TD,Dangas G,Stone G,Krucoff MW,Cutlip D,Mehran R,Wijns W,Sharif F,Serruys PW,Onuma Y", + "auth_pos": 25, + "meshterms": "Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography, Humans, United States, Heart, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Europe, Asia, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Treatment Outcome, Coronary Angiography", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 478, + "user_id": 1447203401, + "artical_title": "Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).", + "pmid": 37871781, + "journal_name": "American heart journal", + "date": "2023-12-17", + "author": "Bainey KR,Wood DA,Bossard M,Campo G,Cantor WJ,Lavi S,Madan M,Mehran R,Pinilla-Echeverri N,Rao S,Sarma J,Sheth T,Stankovic G,Steg PG,Storey RF,Tanguay JF,Velianou JL,Welsh RC,Mani T,Cairns JA,Mehta SR", + "auth_pos": 8, + "meshterms": "Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged, Aged, Humans, Coronary Artery Disease*, Coronary Artery Disease/therapy, Myocardial Infarction*, Myocardial Infarction/surgery, Myocardial Infarction/etiology, Myocardial Revascularization, Myocardial Revascularization/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 479, + "user_id": 1447203401, + "artical_title": "US County-Level Variation in Preterm Birth Rates, 2007-2019.", + "pmid": 38064212, + "journal_name": "JAMA network open", + "date": "2023-12-17", + "author": "Khan SS,Vaughan AS,Harrington K,Seegmiller L,Huang X,Pool LR,Davis MM,Allen NB,Capewell S,O'Flaherty M,Miller GE,Mehran R,Vogel B,Kershaw KN,Lloyd-Jones DM,Grobman WA", + "auth_pos": 12, + "meshterms": "Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England, Female, Humans, Infant, Newborn, Infant, Premature Birth*, Premature Birth/epidemiology, Cross-Sectional Studies, Bayes Theorem, New England", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 480, + "user_id": 1447203401, + "artical_title": "Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.", + "pmid": 37550123, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2023-12-25", + "author": "Toth GG,Kandzari DE,Kirtane AJ,Windecker S,Latib A,Kedhi E,Mehran R,Price MJ,Choi JW,Caputo R,Troquay R,Diderholm E,Singh S,Brar SS,Loussararian A,Chetcuti S,Tulli M,Stone GW,Lung TH,Mylotte D", + "auth_pos": 7, + "meshterms": "Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies, Humans, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Treatment Outcome, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 481, + "user_id": 1447203401, + "artical_title": "Bleeding in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, Clinical Outcomes, and Predictors.", + "pmid": 38151309, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-12-29", + "author": "van Nieuwkerk AC,Aarts HM,Hemelrijk KI,Cantón T,Tchétché D,de Brito FS,Barbanti M,Kornowski R,Latib A,D'Onofrio A,Ribichini F,Maneiro Melón N,Dumonteil N,Abizaid A,Sartori S,D'Errigo P,Tarantini G,Fabroni M,Orvin K,Pagnesi M,Vicaino Arellano M,Dangas G,Mehran R,Voskuil M,Delewi R", + "auth_pos": 23, + "meshterms": "Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors, Humans, Female, Aged, Aged, 80 and over, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Incidence, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Treatment Outcome, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/etiology, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 482, + "user_id": 1447203401, + "artical_title": "Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial.", + "pmid": 38165112, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2024-01-03", + "author": "Sharma SK,Mehran R,Vogel B,Hooda A,Sartori S,Hanstein R,Feng Y,Shlofmitz RA,Jeremias A,Spirito A,Cao D,Shlofmitz E,Ali ZA,Yasumura K,Minatoguchi S,Vengrenyuk Y,Kini A,Moses JW", + "auth_pos": 2, + "meshterms": "Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology, Humans, Female, Middle Aged, Aged, Aged, 80 and over, Male, Atherectomy, Coronary*, Atherectomy, Coronary/methods, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Prospective Studies, Coronary Angiography, Coronary Angiography/adverse effects, Treatment Outcome, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Stents, Stents/adverse effects, Myocardial Infarction*, Myocardial Infarction/etiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 483, + "user_id": 1447203401, + "artical_title": "Reply: Unconvinced by Data or Resistance to Change?", + "pmid": 38171714, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-01-04", + "author": "Gragnano F,Calabrò P,Mehran R,Valgimigli M", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 484, + "user_id": 1447203401, + "artical_title": "Closing the gap: cardiovascular disease in women.", + "pmid": 38174697, + "journal_name": "Climacteric : the journal of the International Menopause Society", + "date": "2024-01-04", + "author": "Nathani M,Vogel B,Mehran R", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 485, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.", + "pmid": 38171713, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-01-05", + "author": "Di Biase L,Lakkireddy DJ,Marazzato J,Velasco A,Diaz JC,Navara R,Chrispin J,Rajagopalan B,Natale A,Mohanty S,Zhang X,Della Rocca D,Dalal A,Park K,Wiley J,Batchelor W,Cheung JW,Dangas G,Mehran R,Romero J", + "auth_pos": 19, + "meshterms": "Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 486, + "user_id": 1447203401, + "artical_title": "Primary prevention of cardiovascular disease in women.", + "pmid": 38197424, + "journal_name": "Climacteric : the journal of the International Menopause Society", + "date": "2024-01-10", + "author": "Gray MP,Vogel B,Mehran R,Leopold JA,Figtree GA", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 487, + "user_id": 1447203401, + "artical_title": "When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.", + "pmid": 38233019, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-01-19", + "author": "Bejjani A,Khairani CD,Assi A,Piazza G,Sadeghipour P,Talasaz AH,Fanikos J,Connors JM,Siegal DM,Barnes GD,Martin KA,Angiolillo DJ,Kleindorfer D,Monreal M,Jimenez D,Middeldorp S,Elkind MSV,Ruff CT,Goldhaber SZ,Krumholz HM,Mehran R,Cushman M,Eikelboom JW,Lip GYH,Weitz JI,Lopes RD,Bikdeli B", + "auth_pos": 21, + "meshterms": "Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic, Humans, Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Thrombosis*, Thrombosis/drug therapy, Venous Thromboembolism*, Venous Thromboembolism/drug therapy, Venous Thrombosis*, Venous Thrombosis/drug therapy, Vitamin K, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 488, + "user_id": 1447203401, + "artical_title": "Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.", + "pmid": 38173300, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-01-31", + "author": "Jones D,Spirito A,Sartori S,Vogel B,Edens M,Kamaleldin K,Pileggi B,Baber U,Dangas G,Sharma SK,Kini A,Mehran R", + "auth_pos": 12, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prognosis, Overweight, Overweight/complications, Coronary Restenosis*, Coronary Restenosis/diagnostic imaging, Coronary Restenosis/etiology, Coronary Restenosis/therapy, Risk Factors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Obesity, Obesity/complications, Obesity/diagnosis, Coronary Angiography, Coronary Angiography/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 489, + "user_id": 1447203401, + "artical_title": "Antithrombotic Therapy in Patients with Acute Coronary Syndrome: Similarities and Differences between a European Expert Consensus Document and the 2023 European Society of Cardiology Guidelines.", + "pmid": 38170562, + "journal_name": "European heart journal. Acute cardiovascular care", + "date": "2024-02-09", + "author": "Landi A,Aboyans V,Angiolillo DJ,Atar D,Capodanno D,Fox KAA,Halvorsen S,James S,Jüni P,Leonardi S,Mehran R,Montalescot G,Navarese EP,Niebauer J,Oliva A,Piccolo R,Price S,Storey RF,Völler H,Vranckx P,Windecker S,Valgimigli M", + "auth_pos": 11, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/drug therapy, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use, Consensus, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 490, + "user_id": 1447203401, + "artical_title": "North American Perspective on the 2023 ESC Guidelines for the Management of ACS.", + "pmid": 38092517, + "journal_name": "European heart journal. Acute cardiovascular care", + "date": "2024-02-10", + "author": "Ortega-Paz L,Mehran R,Angiolillo DJ", + "auth_pos": 2, + "meshterms": "Humans, United States, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Cardiology*, Platelet Aggregation Inhibitors, North America, North America/epidemiology, Humans, United States, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Cardiology*, Platelet Aggregation Inhibitors, North America, North America/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 491, + "user_id": 1447203401, + "artical_title": "Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.", + "pmid": 38314901, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-02-11", + "author": "Spirito A,Cohen R,Sartori S,Vogel B,Baber U,Pileggi B,Smith K,Nicosia D,Kamaleldin K,Farhan S,Kini A,Sharma SK,Dangas G,Mehran R", + "auth_pos": 14, + "meshterms": "Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Humans, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/therapy, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 492, + "user_id": 1447203401, + "artical_title": "Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.", + "pmid": 38355276, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-02-16", + "author": "Angiolillo DJ,Cao D,Baber U,Mehran R", + "auth_pos": 4, + "meshterms": "Humans, Ticagrelor, Ticagrelor/adverse effects, Sleep Apnea, Central*, Treatment Outcome, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dyspnea, Dyspnea/diagnosis, Dyspnea/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Humans, Ticagrelor, Ticagrelor/adverse effects, Sleep Apnea, Central*, Treatment Outcome, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dyspnea, Dyspnea/diagnosis, Dyspnea/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Humans, Ticagrelor, Ticagrelor/adverse effects, Sleep Apnea, Central*, Treatment Outcome, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/adverse effects, Dyspnea, Dyspnea/diagnosis, Dyspnea/etiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 493, + "user_id": 1447203401, + "artical_title": "Impact of Bleeding Risk and Inflammation on Cardiovascular Outcomes After Percutaneous Coronary Intervention.", + "pmid": 38355263, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-02-16", + "author": "Vinayak M,Cao D,Tanner R,Koshy AN,Farhan S,Vogel B,Sartori S,Feng Y,Dhulipala V,Arora A,Dangas GD,Kini AS,Sharma SK,Mehran R", + "auth_pos": 14, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, C-Reactive Protein, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Risk Factors, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Inflammation, Inflammation/chemically induced, Inflammation/complications", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 494, + "user_id": 1447203401, + "artical_title": "Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.", + "pmid": 38360097, + "journal_name": "International journal of cardiology", + "date": "2024-02-16", + "author": "Tanner R,Farhan S,Giustino G,Sartori S,Feng Y,Hooda A,Vinayak M,Dangas G,Mehran R,Kini AS,Sharma SK", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 495, + "user_id": 1447203401, + "artical_title": "Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.", + "pmid": 37870970, + "journal_name": "Circulation", + "date": "2024-02-22", + "author": "Baber U,Jang Y,Oliva A,Cao D,Vogel B,Dangas G,Sartori S,Spirito A,Smith KF,Branca M,Collier T,Pocock S,Valgimigli M,Kim BK,Hong MK,Mehran R", + "auth_pos": 16, + "meshterms": "Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome, Humans, Female, Middle Aged, Male, Ticagrelor, Ticagrelor/adverse effects, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/drug therapy, Acute Coronary Syndrome/surgery, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Drug Therapy, Combination, Randomized Controlled Trials as Topic, Aspirin, Aspirin/adverse effects, Myocardial Infarction*, Myocardial Infarction/therapy, Hemorrhage, Hemorrhage/epidemiology, Stroke*, Stroke/epidemiology, Biomarkers, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 496, + "user_id": 1447203401, + "artical_title": "Reply: The ROTA-CUT randomised trial: push the button harder.", + "pmid": 38389476, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2024-02-23", + "author": "Sharma SK,Vogel B,Mehran R,Moses JW", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 497, + "user_id": 1447203401, + "artical_title": "Impact of Ethnicity on Antiplatelet Treatment Regimens for Bleeding Reduction in Acute Coronary Syndromes: A Systematic Review and Pre-specified Subgroup Meta-analysis.", + "pmid": 37960983, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2024-02-26", + "author": "Galli M,Laborante R,Occhipinti G,Zito A,Spadafora L,Biondi-Zoccai G,Nerla R,Castriota F,D'Amario D,Capodanno D,Jeong YH,Kimura T,Mehran R,Angiolillo DJ", + "auth_pos": 13, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/ethnology, Acute Coronary Syndrome/therapy, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/mortality, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Hemorrhage*, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Risk Factors, Risk Assessment, Randomized Controlled Trials as Topic*, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/adverse effects, Female, Male, Race Factors, Middle Aged, Aged, Asian People, Time Factors, Healthcare Disparities, Healthcare Disparities/ethnology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 498, + "user_id": 1447203401, + "artical_title": "1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program.", + "pmid": 38185438, + "journal_name": "The American journal of cardiology", + "date": "2024-02-26", + "author": "Sardella G,Spirito A,Sartori S,Angiolillo DJ,Vranckx P,Hernandez JMT,Krucoff MW,Bangalore S,Bhatt DL,Campo G,Cao D,Chehab BM,Choi JW,Feng Y,Ge J,Godfrey K,Hermiller J,Kunadian V,Makkar RR,Maksoud A,Neumann FJ,Picon H,Saito S,Thiele H,Toelg R,Varenne O,Vogel B,Zhou Y,Valgimigli M,Windecker S,Mehran R", + "auth_pos": 31, + "meshterms": "Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome, Humans, Aged, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Drug-Eluting Stents*, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Prospective Studies, Drug Therapy, Combination, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/drug therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 499, + "user_id": 1447203401, + "artical_title": "Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.", + "pmid": 38418004, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-03-01", + "author": "Mann DL,Nicolas J,Claggett B,Miao ZM,Granger CB,Kerkar P,Køber L,Lewis EF,McMurray JJV,Maggioni AP,Núñez J,Ntsekhe M,Rouleau JL,Sim D,Solomon SD,Steg PG,van der Meer P,Braunwald E,Pfeffer MA,Mehran R", + "auth_pos": 20, + "meshterms": "Humans, Neprilysin, Ramipril, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/drug therapy, Non-ST Elevated Myocardial Infarction*, Non-ST Elevated Myocardial Infarction/drug therapy, Angiotensins, Receptors, Angiotensin, Prospective Studies, Tetrazoles, Tetrazoles/pharmacology, Treatment Outcome, Valsartan, Heart Failure*, Aminobutyrates, Aminobutyrates/pharmacology, Biphenyl Compounds, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 500, + "user_id": 1447203401, + "artical_title": "One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.", + "pmid": 38436365, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2024-03-05", + "author": "Sandner S,Gaudino M,Redfors B,Angiolillo DJ,Ben-Yehuda O,Bhatt DL,Fremes SE,Lamy A,Marano R,Mehran R,Pocock S,Rao SV,Spertus JA,Weinsaft JW,Wells G,Ruel M", + "auth_pos": 10, + "meshterms": "Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Ticagrelor, Ticagrelor/therapeutic use, Aspirin, Aspirin/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Prospective Studies, Coronary Artery Bypass, Coronary Artery Bypass/adverse effects, Myocardial Infarction*, Stroke*, Stroke/etiology, Stroke/prevention & control", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 501, + "user_id": 1447203401, + "artical_title": "Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous Coronary Intervention.", + "pmid": 38463683, + "journal_name": "JACC. Asia", + "date": "2024-03-11", + "author": "Chen Y,Gao L,Vogel B,Tian F,Jin Q,Guo J,Sun Z,Yang W,Jin Z,Yu B,Fu G,Pu J,Qu X,Zhang Q,Zhao Y,Yu L,Guan C,Tu S,Qiao S,Xu B,Mehran R,Song L", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 502, + "user_id": 1447203401, + "artical_title": "Influence of Race/Ethnicity and Sex on Coronary Stent Outcomes in Diabetic Patients.", + "pmid": 38469035, + "journal_name": "Journal of the Society for Cardiovascular Angiography & Interventions", + "date": "2024-03-12", + "author": "Epps K,Goel R,Mehran R,Kandzari D,Damluji A,Tehrani B,Sherwood M,Truesdell A,Davis S,Wang JC,Lopez M,Singh S,Underwood P,Allocco D,Batchelor W", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 503, + "user_id": 1447203401, + "artical_title": "ROMA:Women - a trial dedicated to women to improve coronary bypass outcomes.", + "pmid": 37330205, + "journal_name": "The Journal of thoracic and cardiovascular surgery", + "date": "2024-03-15", + "author": "Gaudino M,Bairey Merz CN,Sandner S,Creber RM,Ballman KV,O'Brien SM,Harik L,Perezgrovas-Olaria R,Mehran R,Safford MM,Fremes SE", + "auth_pos": 9, + "meshterms": "Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome, Adult, Female, Humans, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Disease*, Coronary Artery Disease/surgery, Randomized Controlled Trials as Topic, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 504, + "user_id": 1447203401, + "artical_title": "Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.", + "pmid": 37923124, + "journal_name": "The Canadian journal of cardiology", + "date": "2024-03-18", + "author": "Petrovic M,Spirito A,Sartori S,Vogel B,Tchetche D,Petronio AS,Mehilli J,Lefevre T,Presbitero P,Capranzano P,Pileggi B,Iadanza A,Sardella G,Van Mieghem NM,Meliga E,Feng Y,Dumonteil N,Cohen R,Fraccaro C,Trabattoni D,Mikhail G,Ferrer-Gracia MC,Naber C,Sharma SK,Watanabe Y,Morice MC,Dangas GD,Chieffo A,Mehran R", + "auth_pos": 29, + "meshterms": "Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery, Humans, Female, Male, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Frailty*, Frailty/complications, Frailty/epidemiology, Frailty/diagnosis, Prognosis, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Risk Assessment, Prospective Studies, Treatment Outcome, Hemorrhage, Hemorrhage/etiology, Registries, Aortic Valve, Aortic Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 505, + "user_id": 1447203401, + "artical_title": "Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis.", + "pmid": 38510285, + "journal_name": "JACC. CardioOncology", + "date": "2024-03-21", + "author": "Fujisaki T,Sueta D,Yamamoto E,Buckley C,Sacchi de Camargo Correia G,Aronson J,Tallón de Lara P,Fujisue K,Usuku H,Matsushita K,Mehran R,Dangas GD,Tsujita K", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 506, + "user_id": 1447203401, + "artical_title": "Real-World Comparison of Clopidogrel with Ticagrelor and Prasugrel In Patients with Chronic Coronary Disease Undergoing Atherectomy.", + "pmid": 38401658, + "journal_name": "The American journal of cardiology", + "date": "2024-04-03", + "author": "Khan MR,Koshy AN,Tanner R,Farhan S,Vinayak M,Farooq A,Sartori S,Feng Y,Spirito A,Arora A,Dhulipala V,Kapur V,Suleman J,Sharma R,Mehran R,Kini A,Sharma SK", + "auth_pos": 15, + "meshterms": "Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome, Humans, Clopidogrel, Clopidogrel/therapeutic use, Ticagrelor, Ticagrelor/therapeutic use, Prasugrel Hydrochloride, Prasugrel Hydrochloride/therapeutic use, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Heart Diseases*, Atherectomy, Coronary Disease*, Percutaneous Coronary Intervention*, Acute Coronary Syndrome*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 507, + "user_id": 1447203401, + "artical_title": "Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.", + "pmid": 38366821, + "journal_name": "European heart journal", + "date": "2024-04-03", + "author": "Windecker S,Gilard M,Achenbach S,Cribier A,Delgado V,Deych N,Drossart I,Eltchaninoff H,Fraser AG,Goncalves A,Hindricks G,Holborow R,Kappetein AP,Kilmartin J,Kurucova J,Lüscher TF,Mehran R,O'Connor DB,Perkins M,Samset E,von Bardeleben RS,Weidinger F", + "auth_pos": 17, + "meshterms": "Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*, Humans, Artificial Intelligence, Cardiology*, Diagnostic Imaging, Cardiac Imaging Techniques, Thoracic Surgical Procedures*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 508, + "user_id": 1447203401, + "artical_title": "Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement.", + "pmid": 38533944, + "journal_name": "Journal of the American Heart Association", + "date": "2024-04-03", + "author": "Pasceri V,Pelliccia F,Mehran R,Dangas G,Porto I,Radico F,Biancari F,D'Ascenzo F,Saia F,Luzi G,Bedogni F,Amat Santos IJ,De Marzo V,Dimagli A,Mäkikallio T,Stabile E,Blasco-Turrión S,Testa L,Barbanti M,Tamburino C,Fabiocchi F,Chilmeran A,Conrotto F,Costa G,Stefanini G,Spaccarotella C,Macchione A,La Torre M,Bendandi F,Juvonen T,Wańha W,Wojakowski W,Benedetto U,Indolfi C,Hildick-Smith D,Zimarino M", + "auth_pos": 3, + "meshterms": "Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Diabetes Mellitus*, Registries, Renal Dialysis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Multicenter Studies as Topic", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 509, + "user_id": 1447203401, + "artical_title": "2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.", + "pmid": 38484039, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2024-04-18", + "author": "Jneid H,Chikwe J,Arnold SV,Bonow RO,Bradley SM,Chen EP,Diekemper RL,Fugar S,Johnston DR,Kumbhani DJ,Mehran R,Misra A,Patel MR,Sweis RN,Szerlip M", + "auth_pos": 11, + "meshterms": "Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Heart Diseases*, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 510, + "user_id": 1447203401, + "artical_title": "Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention.", + "pmid": 38626078, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2024-04-18", + "author": "Spirito A,Krishnan SL,Capodanno D,Angiolillo DJ,Mehran R", + "auth_pos": 5, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Humans, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Treatment Outcome, Clopidogrel, Clopidogrel/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 511, + "user_id": 1447203401, + "artical_title": "Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials.", + "pmid": 38626080, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2024-04-18", + "author": "Campos CM,Mehran R,Capodanno D,Owen R,Windecker S,Varenne O,Stone GW,Valgimigli M,Hajjar LA,Kalil Filho R,Oldroyd K,Morice MC,Urban P,Abizaid A", + "auth_pos": 2, + "meshterms": "Humans, Platelet Aggregation Inhibitors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/etiology, Drug Therapy, Combination, Neoplasms*, Neoplasms/diagnosis, Neoplasms/epidemiology, Neoplasms/therapy, Humans, Platelet Aggregation Inhibitors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/etiology, Drug Therapy, Combination, Neoplasms*, Neoplasms/diagnosis, Neoplasms/epidemiology, Neoplasms/therapy, Humans, Platelet Aggregation Inhibitors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/etiology, Drug Therapy, Combination, Neoplasms*, Neoplasms/diagnosis, Neoplasms/epidemiology, Neoplasms/therapy, Humans, Platelet Aggregation Inhibitors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/etiology, Drug Therapy, Combination, Neoplasms*, Neoplasms/diagnosis, Neoplasms/epidemiology, Neoplasms/therapy, Humans, Platelet Aggregation Inhibitors, Drug-Eluting Stents*, Drug-Eluting Stents/adverse effects, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Treatment Outcome, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Myocardial Infarction*, Myocardial Infarction/etiology, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/etiology, Drug Therapy, Combination, Neoplasms*, Neoplasms/diagnosis, Neoplasms/epidemiology, Neoplasms/therapy", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 512, + "user_id": 1447203401, + "artical_title": "2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.", + "pmid": 38493389, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-04-19", + "author": "Jneid H,Chikwe J,Arnold SV,Bonow RO,Bradley SM,Chen EP,Diekemper RL,Fugar S,Johnston DR,Kumbhani DJ,Mehran R,Misra A,Patel MR,Sweis RN,Szerlip M", + "auth_pos": 12, + "meshterms": "Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*, Adult, United States, Humans, Quality Indicators, Health Care, American Heart Association, Cardiology*, Heart Diseases*, Cardiovascular System*", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 513, + "user_id": 1447203401, + "artical_title": "Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.", + "pmid": 38493833, + "journal_name": "International journal of cardiology", + "date": "2024-04-27", + "author": "Beerkens FJ,Küçük IT,van Veelen A,de Lind van Wijngaarden RAF,Timmermans MJC,Mehran R,Dangas G,Klautz R,Henriques JPS,Claessen BEPM", + "auth_pos": 6, + "meshterms": "Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends, Percutaneous Coronary Intervention/adverse effects, Female, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/trends, Netherlands, Netherlands/epidemiology, Registries*, Aged, Middle Aged, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/surgery, Treatment Outcome, Follow-Up Studies, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends, Percutaneous Coronary Intervention/adverse effects, Female, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/trends, Netherlands, Netherlands/epidemiology, Registries*, Aged, Middle Aged, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/surgery, Treatment Outcome, Follow-Up Studies, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends, Percutaneous Coronary Intervention/adverse effects, Female, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/trends, Netherlands, Netherlands/epidemiology, Registries*, Aged, Middle Aged, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/surgery, Treatment Outcome, Follow-Up Studies, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/trends, Percutaneous Coronary Intervention/adverse effects, Female, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Coronary Artery Bypass/trends, Netherlands, Netherlands/epidemiology, Registries*, Aged, Middle Aged, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Vessels, Coronary Vessels/surgery, Treatment Outcome, Follow-Up Studies", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 514, + "user_id": 1447203401, + "artical_title": "Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.", + "pmid": 38587254, + "journal_name": "The New England journal of medicine", + "date": "2024-05-02", + "author": "Gibson CM,Duffy D,Korjian S,Bahit MC,Chi G,Alexander JH,Lincoff AM,Heise M,Tricoci P,Deckelbaum LI,Mears SJ,Nicolau JC,Lopes RD,Merkely B,Lewis BS,Cornel JH,Trebacz J,Parkhomenko A,Libby P,Sacks FM,Povsic TJ,Bonaca M,Goodman SG,Bhatt DL,Tendera M,Steg PG,Ridker PM,Aylward P,Kastelein JJP,Bode C,Mahaffey KW,Nicholls SJ,Pocock SJ,Mehran R,Harrington RA", + "auth_pos": 34, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors, Aged, Female, Humans, Male, Middle Aged, Apolipoprotein A-I*, Apolipoprotein A-I/administration & dosage, Apolipoprotein A-I/blood, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/metabolism, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Double-Blind Method, Infusions, Intravenous, Kaplan-Meier Estimate, Lipoproteins, HDL*, Lipoproteins, HDL/blood, Lipoproteins, HDL/metabolism, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/metabolism, Myocardial Infarction/mortality, Recurrence, Secondary Prevention, Stroke, Stroke/prevention & control, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 515, + "user_id": 1447203401, + "artical_title": "Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.", + "pmid": 38458371, + "journal_name": "American heart journal", + "date": "2024-05-06", + "author": "Krucoff M,Spirito A,Baber U,Sartori S,Angiolillo DJ,Briguori C,Cohen DJ,Collier T,Dangas G,Dudek D,Escaned J,Gibson CM,Han YL,Huber K,Kastrati A,Kaul U,Kornowski R,Kunadian V,Vogel B,Mehta SR,Moliterno D,Sardella G,Shlofmitz RA,Sharma S,Steg PG,Pocock S,Mehran R", + "auth_pos": 27, + "meshterms": "Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Humans, Ticagrelor*, Ticagrelor/therapeutic use, Aspirin*, Aspirin/therapeutic use, Aspirin/administration & dosage, Peripheral Arterial Disease*, Peripheral Arterial Disease/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Male, Female, Aged, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Middle Aged, Drug Therapy, Combination, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Dual Anti-Platelet Therapy, Dual Anti-Platelet Therapy/methods, Myocardial Infarction, Myocardial Infarction/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 516, + "user_id": 1447203401, + "artical_title": "Patient-physician sex concordance and outcomes in cardiovascular disease: a systematic review.", + "pmid": 38551446, + "journal_name": "European heart journal", + "date": "2024-05-07", + "author": "Harik L,Yamamoto K,Kimura T,Rong LQ,Vogel B,Mehran R,Bairey-Merz CN,Gaudino M", + "auth_pos": 6, + "meshterms": "Humans, Cardiovascular Diseases*, Female, Male, Physician-Patient Relations*, Sex Factors, Treatment Outcome, Humans, Cardiovascular Diseases*, Female, Male, Physician-Patient Relations*, Sex Factors, Treatment Outcome, Humans, Cardiovascular Diseases*, Female, Male, Physician-Patient Relations*, Sex Factors, Treatment Outcome, Humans, Cardiovascular Diseases*, Female, Male, Physician-Patient Relations*, Sex Factors, Treatment Outcome, Humans, Cardiovascular Diseases*, Female, Male, Physician-Patient Relations*, Sex Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 517, + "user_id": 1447203401, + "artical_title": "Moving Beyond Conventional Guesstimation to Guide PCI.", + "pmid": 38477911, + "journal_name": "JAMA cardiology", + "date": "2024-05-08", + "author": "Kirtane AJ,Mehran R", + "auth_pos": 2, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Angiography, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Angiography", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 518, + "user_id": 1447203401, + "artical_title": "Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.", + "pmid": 38506796, + "journal_name": "JAMA cardiology", + "date": "2024-05-08", + "author": "Valgimigli M,Gragnano F,Branca M,Franzone A,da Costa BR,Baber U,Kimura T,Jang Y,Hahn JY,Zhao Q,Windecker S,Gibson CM,Watanabe H,Kim BK,Song YB,Zhu Y,Vranckx P,Mehta S,Ando K,Hong SJ,Gwon HC,Serruys PW,Dangas GD,McFadden EP,Angiolillo DJ,Heg D,Calabrò P,Jüni P,Mehran R", + "auth_pos": 29, + "meshterms": "Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced, Ticagrelor*, Ticagrelor/therapeutic use, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Humans, Clopidogrel*, Clopidogrel/therapeutic use, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Purinergic P2Y Receptor Antagonists, Purinergic P2Y Receptor Antagonists/therapeutic use, Hemorrhage, Hemorrhage/chemically induced", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 519, + "user_id": 1447203401, + "artical_title": "Beyond the GRACE ACS Score: Do We Need a Different Model for Men and Women after STEMI?", + "pmid": 38716988, + "journal_name": "Arquivos brasileiros de cardiologia", + "date": "2024-05-08", + "author": "Silva JSN,Barros IML,Guimarães JAN,Cao D,Martins SM,Carvalho TXM,Farias RS,Lemke V,Mehran R,Pedrosa R", + "auth_pos": 9, + "meshterms": "Humans, Female, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/mortality, Male, Hospital Mortality*, Middle Aged, Retrospective Studies, Sex Factors, Aged, Risk Assessment, Risk Assessment/methods, Risk Factors, Acute Coronary Syndrome, Acute Coronary Syndrome/mortality, Acute Coronary Syndrome/therapy, Logistic Models, Percutaneous Coronary Intervention", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 520, + "user_id": 1447203401, + "artical_title": "Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.", + "pmid": 38726720, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2024-05-10", + "author": "Garot P,Morice MC,Angiolillo DJ,Cabau JR,Park DW,Van Mieghem NM,Collet JP,Leon MB,Sengottuvelu G,Neylon A,Ten Berg JM,Mylotte D,Tchétché D,Krucoff MW,Reardon MJ,Piazza N,Mack MJ,Généreux P,Makkar R,Hayashida K,Ohno Y,Mochizuki S,Shirai Y,Matsumara R,Jin Y,Webb JG,Cutlip DE,Chen M,Spitzer E,Mehran R,Capodanno D", + "auth_pos": 30, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Consensus*, Risk Factors, Hemorrhage*, Hemorrhage/etiology, Risk Assessment, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 521, + "user_id": 1447203401, + "artical_title": "Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention.", + "pmid": 38771910, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2024-05-21", + "author": "Nicolas J,Pitaro N,Sartori S,Spirito A,Smith KF,Vogel B,Kini A,Dangas G,Sharma SK,Mehran R", + "auth_pos": 10, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Acute Kidney Injury/therapy, Contrast Media*, Contrast Media/adverse effects, Incidence, Risk Factors, Male, Hemorrhage*, Hemorrhage/chemically induced, Aged, Female, Risk Assessment, Middle Aged, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 522, + "user_id": 1447203401, + "artical_title": "GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis.", + "pmid": 38252145, + "journal_name": "Clinical research in cardiology : official journal of the German Cardiac Society", + "date": "2024-05-21", + "author": "Villaschi A,Ferrante G,Cannata F,Pini D,Pagnesi M,Corrada E,Reimers B,Mehran R,Federici M,Savarese G,Metra M,Condorelli G,Stefanini GG,Chiarito M", + "auth_pos": 8, + "meshterms": "Humans, Heart Failure*, Heart Failure/epidemiology, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hospitalization, Hospitalization/statistics & numerical data, Randomized Controlled Trials as Topic, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Treatment Outcome, Humans, Heart Failure*, Heart Failure/epidemiology, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hospitalization, Hospitalization/statistics & numerical data, Randomized Controlled Trials as Topic, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 523, + "user_id": 1447203401, + "artical_title": "One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.", + "pmid": 38776146, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2024-05-22", + "author": "Cao D,Vranckx P,Valgimigli M,Sartori S,Angiolillo DJ,Bangalore S,Bhatt DL,Feng Y,Ge J,Hermiller J,Makkar RR,Neumann FJ,Saito S,Picon H,Toelg R,Maksoud A,Chehab BM,Choi JW,Campo G,De la Torre Hernandez JM,Krucoff MW,Kunadian V,Sardella G,Spirito A,Thiele H,Varenne O,Vogel B,Zhou Y,Windecker S,Mehran R", + "auth_pos": 30, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/methods, Percutaneous Coronary Intervention/instrumentation, Acute Coronary Syndrome*, Acute Coronary Syndrome/therapy, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/administration & dosage, Male, Middle Aged, Aged, Female, Hemorrhage*, Hemorrhage/chemically induced, Drug-Eluting Stents*, Treatment Outcome, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Prospective Studies, Time Factors, Risk Factors, Non-ST Elevated Myocardial Infarction, Non-ST Elevated Myocardial Infarction/therapy, Non-ST Elevated Myocardial Infarction/mortality", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 524, + "user_id": 1447203401, + "artical_title": "Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.", + "pmid": 38588930, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-05-30", + "author": "Povsic TJ,Korjian S,Bahit MC,Chi G,Duffy D,Alexander JH,Vinereanu D,Tricoci P,Mears SJ,Deckelbaum LI,Bonaca M,Ridker PM,Goodman SG,Cornel JH,Lewis BS,Parkhomenko A,Lopes RD,Aylward P,Lincoff AM,Heise M,Sacks F,Nicolau JC,Merkely B,Trebacz J,Libby P,Nicholls SJ,Pocock S,Bhatt DL,Kastelein J,Bode C,Mahaffey KW,Steg PG,Tendera M,Bainey KR,Harrington RA,Mehran R,Duerschmied D,Kingwell BA,Gibson CM", + "auth_pos": 36, + "meshterms": "Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL, Humans, Male, Female, Double-Blind Method, Myocardial Infarction*, Myocardial Infarction/epidemiology, Apolipoprotein A-I*, Middle Aged, Aged, Recurrence, Infusions, Intravenous, Lipoproteins, HDL", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 525, + "user_id": 1447203401, + "artical_title": "Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification.", + "pmid": 38817323, + "journal_name": "Nature cardiovascular research", + "date": "2024-05-31", + "author": "de Vries PS,Conomos MP,Singh K,Nicholson CJ,Jain D,Hasbani NR,Jiang W,Lee S,Cardenas CLL,Lutz SM,Wong D,Guo X,Yao J,Young EP,Tcheandjieu C,Hilliard AT,Bis JC,Bielak LF,Brown MR,Musharoff S,Clarke SL,Terry JG,Palmer ND,Yanek LR,Xu H,Heard-Costa N,Wessel J,Selvaraj MS,Li RH,Sun X,Turner AW,Stilp AM,Khan A,Newman AB,Rasheed A,Freedman BI,Kral BG,McHugh CP,Hodonsky C,Saleheen D,Herrington DM,Jacobs DR,Nickerson DA,Boerwinkle E,Wang FF,Heiss G,Jun G,Kinney GL,Sigurslid HH,Doddapaneni H,Hall IM,Bensenor IM,Broome J,Crapo JD,Wilson JG,Smith JA,Blangero J,Vargas JD,Mosquera JV,Smith JD,Viaud-Martinez KA,Ryan KA,Young KA,Taylor KD,Lange LA,Emery LS,Bittencourt MS,Budoff MJ,Montasser ME,Yu M,Mahaney MC,Mahamdeh MS,Fornage M,Franceschini N,Lotufo PA,Natarajan P,Wong Q,Mathias RA,Gibbs RA,Do R,Mehran R,Tracy RP,Kim RW,Nelson SC,Damrauer SM,Kardia SLR,Rich SS,Fuster V,Napolioni V,Zhao W,Tian W,Yin X,Min YI,Manning AK,Peloso G,Kelly TN,O'Donnell CJ,Morrison AC,Curran JE,Zapol WM,Bowden DW,Becker LC,Correa A,Mitchell BD,Psaty BM,Carr JJ,Pereira AC,Assimes TL,Stitziel NO,Hokanson JE,Laurie CA,Rotter JI,Vasan RS,Post WS,Peyser PA,Miller CL,Malhotra R", + "auth_pos": 81, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 526, + "user_id": 1447203401, + "artical_title": "Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians.", + "pmid": 38639154, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-06-03", + "author": "Spirito A,Gao M,Sartori S,Vogel B,Pentousis P,Singh R,Jiang Y,Dangas G,Kini A,Sharma SK,Mehran R", + "auth_pos": 11, + "meshterms": "Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage, Humans, Male, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Percutaneous Coronary Intervention/mortality, Percutaneous Coronary Intervention/instrumentation, Female, Aged, 80 and over, Treatment Outcome, Age Factors, Prevalence, Time Factors, Coronary Artery Disease*, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Coronary Artery Disease/diagnostic imaging, Risk Assessment, Risk Factors, Retrospective Studies, Stents, New York, New York/epidemiology, Hemorrhage", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 527, + "user_id": 1447203401, + "artical_title": "Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery.", + "pmid": 38818962, + "journal_name": "Journal of the American Heart Association", + "date": "2024-06-04", + "author": "Koshy AN,Stone GW,Sartori S,Dhulipala V,Giustino G,Spirito A,Farhan S,Smith KF,Feng Y,Vinayak M,Salehi N,Tanner R,Hooda A,Krishnamoorthy P,Sweeny JM,Khera S,Dangas G,Filsoufi F,Mehran R,Kini AS,Fuster V,Sharma SK", + "auth_pos": 19, + "meshterms": "Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making, Humans, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Male, Coronary Artery Bypass*, Coronary Artery Bypass/adverse effects, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/mortality, Middle Aged, Treatment Outcome, Retrospective Studies, Risk Factors, Risk Assessment, Patient Selection, Clinical Decision-Making", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 528, + "user_id": 1447203401, + "artical_title": "Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.", + "pmid": 38587261, + "journal_name": "The New England journal of medicine", + "date": "2024-06-05", + "author": "Herrmann HC,Mehran R,Blackman DJ,Bailey S,Möllmann H,Abdel-Wahab M,Ben Ali W,Mahoney PD,Ruge H,Wood DA,Bleiziffer S,Ramlawi B,Gada H,Petronio AS,Resor CD,Merhi W,Garcia Del Blanco B,Attizzani GF,Batchelor WB,Gillam LD,Guerrero M,Rogers T,Rovin JD,Szerlip M,Whisenant B,Deeb GM,Grubb KJ,Padang R,Fan MT,Althouse AD,Tchétché D", + "auth_pos": 2, + "meshterms": "Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Aged, Aged, 80 and over, Female, Humans, Male, Aortic Valve*, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/complications, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Failure, Heart Valve Prosthesis*, Kaplan-Meier Estimate, Postoperative Complications, Postoperative Complications/etiology, Prosthesis Design, Prosthesis Failure, Stroke, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 529, + "user_id": 1447203401, + "artical_title": "Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.", + "pmid": 38705341, + "journal_name": "American heart journal", + "date": "2024-06-13", + "author": "Nicholls SJ,Nelson AJ,Ditmarsch M,Kastelein JJP,Ballantyne CM,Ray KK,Navar AM,Nissen SE,Golberg AC,Brunham LR,Curcio D,Wuerdeman E,Neild A,Kling D,Hsieh A,Dicklin MR,Ference BA,Laufs U,Banach M,Mehran R,Catapano AL,Davidson MH", + "auth_pos": 20, + "meshterms": "Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Anticholesteremic Agents*, Anticholesteremic Agents/therapeutic use, Anticholesteremic Agents/administration & dosage, Double-Blind Method, Cholesterol, LDL*, Cholesterol, LDL/blood, Male, Female, Cholesterol Ester Transfer Proteins, Cholesterol Ester Transfer Proteins/antagonists & inhibitors, Cholesterol, HDL, Cholesterol, HDL/blood, Hyperlipoproteinemia Type II, Hyperlipoproteinemia Type II/drug therapy, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/complications, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoprotein(a), Lipoprotein(a)/blood, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 530, + "user_id": 1447203401, + "artical_title": "Geographic Mapping of Gender Disparities in Authorship of Cardiovascular Literature.", + "pmid": 38866449, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-06-13", + "author": "Goel R,Sartori S,Vogel B,Okoli K,Franklin-Bedel K,Ortega R,Wang DD,Douglas PS,Wang TY,Mehran R", + "auth_pos": 10, + "meshterms": "Authorship*, Humans, Female, Cardiology*, Cardiology/statistics & numerical data, Male, Sexism, Sexism/statistics & numerical data, Periodicals as Topic, Periodicals as Topic/statistics & numerical data, Physicians, Women, Physicians, Women/statistics & numerical data, Sex Factors, Authorship*, Humans, Female, Cardiology*, Cardiology/statistics & numerical data, Male, Sexism, Sexism/statistics & numerical data, Periodicals as Topic, Periodicals as Topic/statistics & numerical data, Physicians, Women, Physicians, Women/statistics & numerical data, Sex Factors, Authorship*, Humans, Female, Cardiology*, Cardiology/statistics & numerical data, Male, Sexism, Sexism/statistics & numerical data, Periodicals as Topic, Periodicals as Topic/statistics & numerical data, Physicians, Women, Physicians, Women/statistics & numerical data, Sex Factors, Authorship*, Humans, Female, Cardiology*, Cardiology/statistics & numerical data, Male, Sexism, Sexism/statistics & numerical data, Periodicals as Topic, Periodicals as Topic/statistics & numerical data, Physicians, Women, Physicians, Women/statistics & numerical data, Sex Factors, Authorship*, Humans, Female, Cardiology*, Cardiology/statistics & numerical data, Male, Sexism, Sexism/statistics & numerical data, Periodicals as Topic, Periodicals as Topic/statistics & numerical data, Physicians, Women, Physicians, Women/statistics & numerical data, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 531, + "user_id": 1447203401, + "artical_title": "Impact of Polyvascular Disease in Patients undergoing unprotected Left Main Percutaneous Coronary Intervention.", + "pmid": 38697455, + "journal_name": "The American journal of cardiology", + "date": "2024-06-14", + "author": "Bay B,Sharma R,Roumeliotis A,Power D,Sartori S,Murphy J,Vogel B,Smith KF,Oliva A,Hooda A,Sweeny J,Dangas G,Kini A,Krishnan P,Sharma SK,Mehran R", + "auth_pos": 16, + "meshterms": "Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Humans, Male, Female, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Coronary Artery Disease*, Coronary Artery Disease/surgery, Retrospective Studies, Middle Aged, Cerebrovascular Disorders, Cerebrovascular Disorders/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/surgery, Peripheral Arterial Disease/epidemiology, Cause of Death, Cause of Death/trends, Risk Factors, Myocardial Infarction, Myocardial Infarction/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 532, + "user_id": 1447203401, + "artical_title": "Antithrombotic Strategies According to Age: Insights From the AUGUSTUS Trial.", + "pmid": 38876331, + "journal_name": "The American journal of medicine", + "date": "2024-06-15", + "author": "Guimarães PO,Lopes RD,Wojdyla DM,Alexander JH,Goodman SG,Aronson R,Halvorsen S,Sinnaeve P,Vinereanu D,Storey RF,Berwanger O,Windecker S,Mehran R,Granger CB,Alexander KP", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 533, + "user_id": 1447203401, + "artical_title": "Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence.", + "pmid": 38294774, + "journal_name": "Future cardiology", + "date": "2024-06-26", + "author": "Goel R,Spirito A,Gao M,Vogel B,N Kalkman D,Mehran R", + "auth_pos": 6, + "meshterms": "Humans, Drug-Eluting Stents*, Everolimus*, Everolimus/pharmacology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/therapy, Immunosuppressive Agents, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Prosthesis Design, Treatment Outcome, Humans, Drug-Eluting Stents*, Everolimus*, Everolimus/pharmacology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/therapy, Immunosuppressive Agents, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Prosthesis Design, Treatment Outcome, Humans, Drug-Eluting Stents*, Everolimus*, Everolimus/pharmacology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/therapy, Immunosuppressive Agents, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Prosthesis Design, Treatment Outcome, Humans, Drug-Eluting Stents*, Everolimus*, Everolimus/pharmacology, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Disease/therapy, Immunosuppressive Agents, Immunosuppressive Agents/pharmacology, Immunosuppressive Agents/therapeutic use, Prosthesis Design, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 534, + "user_id": 1447203401, + "artical_title": "Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure.", + "pmid": 38938863, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Shaw LJ,Patel K,Lala-Trindade A,Feltovich H,Vieira L,Kontorovich A,Ananth C,Taqueti VR,Mitrani L,Stern T,DeBolt C,Kase N,Smith RT,Narula J,Mehran R,Bianco A,Bhatt DL,Stone JL", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 535, + "user_id": 1447203401, + "artical_title": "Transcatheter or Surgical Aortic Valve Replacement in Women with Small Annuli at Low or Intermediate Surgical Risk.", + "pmid": 38641189, + "journal_name": "The American journal of cardiology", + "date": "2024-07-01", + "author": "Modine T,Forrest JK,Van Mieghem NM,Deeb GM,Yakubov SJ,Ali WB,Tchétché D,Lam KY,Oh JK,Huang J,Mehran R,Reardon MJ", + "auth_pos": 11, + "meshterms": "Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis, Humans, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aged, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/diagnostic imaging, Prospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Risk Factors, Severity of Illness Index, Risk Assessment, Risk Assessment/methods, Postoperative Complications, Postoperative Complications/epidemiology, Tomography, X-Ray Computed, Heart Valve Prosthesis", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 536, + "user_id": 1447203401, + "artical_title": "Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.", + "pmid": 38961226, + "journal_name": "Nature medicine", + "date": "2024-07-04", + "author": "Chertow GM,Chang AM,Felker GM,Heise M,Velkoska E,Fellström B,Charytan DM,Clementi R,Gibson CM,Goodman SG,Jardine M,Levin A,Lokhnygina Y,Mears J,Mehran R,Stenvinkel P,Wang AY,Wheeler DC,Zoccali C,Ridker PM,Mahaffey KW,Tricoci P,Wolf M", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 537, + "user_id": 1447203401, + "artical_title": "Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel.", + "pmid": 39007455, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-07-15", + "author": "Kuno T,Weisz G,Généreux P,Claessen BE,Shechter M,Alexander KP,James SK,Ohman EM,Dressler O,Mehran R,Ben-Yehuda O,Stone GW", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 538, + "user_id": 1447203401, + "artical_title": "Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.", + "pmid": 38509244, + "journal_name": "Nature reviews. Cardiology", + "date": "2024-07-19", + "author": "Talasaz AH,Sadeghipour P,Ortega-Paz L,Kakavand H,Aghakouchakzadeh M,Beavers C,Fanikos J,Eikelboom JW,Siegal DM,Monreal M,Jimenez D,Vaduganathan M,Castellucci LA,Cuker A,Barnes GD,Connors JM,Secemsky EA,Van Tassell BW,De Caterina R,Kurlander JE,Aminian A,Piazza G,Goldhaber SZ,Moores L,Middeldorp S,Kirtane AJ,Elkind MSV,Angiolillo DJ,Konstantinides S,Lip GYH,Stone GW,Cushman M,Krumholz HM,Mehran R,Bhatt DL,Bikdeli B", + "auth_pos": 34, + "meshterms": "Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity, Humans, Fibrinolytic Agents*, Fibrinolytic Agents/therapeutic use, Fibrinolytic Agents/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Gastrointestinal Diseases*, Gastrointestinal Diseases/chemically induced, Gastrointestinal Diseases/drug therapy, Gastrointestinal Hemorrhage*, Gastrointestinal Hemorrhage/chemically induced, Gastrointestinal Hemorrhage/prevention & control, Risk Assessment, Risk Factors, Comorbidity", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 539, + "user_id": 1447203401, + "artical_title": "Risk Factors of Ischemic Stroke in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation from the Randomized ENVISAGE-TAVI AF Trial.", + "pmid": 39032588, + "journal_name": "The American journal of cardiology", + "date": "2024-07-21", + "author": "Hengstenberg C,Unverdorben M,Möllmann H,Van Mieghem NM,Thiele H,Nordbeck P,Rassaf T,Moreno R,Mehran R,Jin J,Lang I,Veltkamp R,Dangas GD", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 540, + "user_id": 1447203401, + "artical_title": "Mortality After Procedural or Spontaneous Myocardial Infarction.", + "pmid": 39048279, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-26", + "author": "Spirito A,Sartori S,Koshy AN,Feng Y,Vogel B,Baber U,Sweeny J,Khera S,Kini AS,Windecker S,Dangas G,Sharma SK,Mehran R", + "auth_pos": 13, + "meshterms": "Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood, Humans, Male, Female, Myocardial Infarction*, Myocardial Infarction/mortality, Myocardial Infarction/blood, Percutaneous Coronary Intervention*, Aged, Middle Aged, Troponin I, Troponin I/blood, Prognosis, Troponin, Troponin/blood", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 541, + "user_id": 1447203401, + "artical_title": "P2Y12 Inhibitor Monotherapy After Short DAPT in Acute Coronary Syndrome: A Systematic Review and Meta-analysis.", + "pmid": 39054275, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2024-07-26", + "author": "Galli M,Laudani C,Occhipinti G,Spagnolo M,Gragnano F,D'Amario D,Navarese EP,Mehran R,Valgimigli M,Capodanno D,Angiolillo DJ", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 542, + "user_id": 1447203401, + "artical_title": "A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.", + "pmid": 39084827, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-08-01", + "author": "Hummel J,Houmsse M,Tomassoni G,Nair D,Romero J,Hargrove J,Mathews K,Thakkar AB,Ullery S,Eapen ZJ,Kumar UN,Mehran R,Butler J", + "auth_pos": 12, + "meshterms": "Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 543, + "user_id": 1447203401, + "artical_title": "One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.", + "pmid": 38871156, + "journal_name": "The American journal of cardiology", + "date": "2024-08-01", + "author": "Mankerious N,Toelg R,Vogel B,Sartori S,Angiolillo DJ,Vranckx P,Feng Y,Hernandez JMT,Krucoff MW,Bhatt DL,Spirito A,Cao D,Chehab BM,Kunadian V,Maksoud A,Picon H,Sardella G,Thiele H,Varenne O,Windecker S,Richardt G,Valgimigli M,Mehran R", + "auth_pos": 23, + "meshterms": "Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors, Humans, Male, Female, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/methods, Aged, Drug-Eluting Stents*, Platelet Aggregation Inhibitors*, Platelet Aggregation Inhibitors/therapeutic use, Platelet Aggregation Inhibitors/administration & dosage, Middle Aged, Prospective Studies, Dual Anti-Platelet Therapy*, Dual Anti-Platelet Therapy/methods, Hemorrhage, Hemorrhage/epidemiology, Hemorrhage/chemically induced, Coronary Artery Disease, Coronary Artery Disease/surgery, Coronary Artery Disease/complications, Time Factors, Clopidogrel, Clopidogrel/therapeutic use, Clopidogrel/administration & dosage, Aspirin, Aspirin/administration & dosage, Aspirin/therapeutic use, Myocardial Infarction, Myocardial Infarction/epidemiology, Cause of Death, Cause of Death/trends, Drug Administration Schedule, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 544, + "user_id": 1447203401, + "artical_title": "The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees.", + "pmid": 39110447, + "journal_name": "JAMA cardiology", + "date": "2024-08-07", + "author": "Navar AM,Khan SS,Patton KK,Day SM,Mehran R", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 545, + "user_id": 1447203401, + "artical_title": "Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis.", + "pmid": 38795109, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-08-08", + "author": "Adrichem R,Hokken TW,Bouwmeester S,Abdelkarim O,Vogel B,Blusztein DI,Veulemans V,Kuneman JH,Geleijnse ML,Verhemel S,Van den Dorpel MMP,Kardys I,Tonino PAL,Chang SM,Faza NN,Jou S,Ueyama HA,Bartkowiak J,Zeus T,Bax JJ,Bertrand PB,Hahn RT,Kodali SK,Lerakis S,Mehran R,Little SH,Houthuizen P,Van Mieghem NM", + "auth_pos": 25, + "meshterms": "Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 546, + "user_id": 1447203401, + "artical_title": "Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.", + "pmid": 39119987, + "journal_name": "Journal of the American Heart Association", + "date": "2024-08-09", + "author": "Oliva A,Ioppolo AM,Chiarito M,Cremonesi A,Azzano A,Miccichè E,Mangiameli A,Ariano F,Ferrante G,Reimers B,Garot P,Amabile N,Mehran R,Condorelli G,Stefanini G,Cao D", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 547, + "user_id": 1447203401, + "artical_title": "Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention.", + "pmid": 39152795, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-08-17", + "author": "Roumeliotis A,Siasos G,Dangas G,Power D,Sartori S,Vavouranakis M,Tsioufis K,Leone PP,Vogel B,Cao D,Oliva A,Oikonomou E,Smith KF,Sweeny J,Krishnan P,Kini A,Sharma S,Mehran R", + "auth_pos": 18, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 548, + "user_id": 1447203401, + "artical_title": "IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.", + "pmid": 38796655, + "journal_name": "Nature medicine", + "date": "2024-08-20", + "author": "Chertow GM,Chang AM,Felker GM,Heise M,Velkoska E,Fellström B,Charytan DM,Clementi R,Gibson CM,Goodman SG,Jardine M,Levin A,Lokhnygina Y,Mears J,Mehran R,Stenvinkel P,Wang A,Wheeler DC,Zoccali C,Ridker PM,Mahaffey KW,Tricoci P,Wolf M", + "auth_pos": 15, + "meshterms": "Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome, Humans, Antibodies, Monoclonal, Humanized*, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/administration & dosage, Renal Dialysis*, Male, Female, Interleukin-6*, Interleukin-6/antagonists & inhibitors, Interleukin-6/blood, Middle Aged, C-Reactive Protein*, C-Reactive Protein/metabolism, Aged, Adult, Antibodies, Monoclonal, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal/adverse effects, Double-Blind Method, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Roxana Mehran" + }, + { + "id": 549, + "user_id": 1639100928, + "artical_title": "Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.", + "pmid": 30615507, + "journal_name": "Circulation", + "date": "2019-01-08", + "author": "Greene SJ,Butler J", + "auth_pos": 2, + "meshterms": "Biomarkers, Biomarkers/blood, Blood Glucose, Blood Glucose/drug effects, Blood Glucose/metabolism, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/prevention & control*, Humans, Practice Guidelines as Topic, Primary Prevention, Primary Prevention/methods*, Primary Prevention/standards, Protective Factors, Risk Assessment, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 550, + "user_id": 1639100928, + "artical_title": "Cardiomyopathy and Heart Failure in Patients With HIV Infection.", + "pmid": 30621958, + "journal_name": "The Canadian journal of cardiology", + "date": "2019-01-10", + "author": "Savvoulidis P,Butler J,Kalogeropoulos A", + "auth_pos": 2, + "meshterms": "Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Antiretroviral Therapy, Highly Active/methods, Cardiomyopathies*, Cardiomyopathies/etiology, Cardiomyopathies/immunology, Cardiomyopathies/physiopathology, Cardiomyopathies/prevention & control, HIV Infections, HIV Infections/complications*, HIV Infections/drug therapy, Heart Failure*, Heart Failure/etiology, Heart Failure/immunology, Heart Failure/physiopathology, Heart Failure/prevention & control, Humans, Prognosis, Secondary Prevention", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 551, + "user_id": 1639100928, + "artical_title": "Redefining biomarkers in heart failure.", + "pmid": 29511896, + "journal_name": "Heart failure reviews", + "date": "2019-01-18", + "author": "Correale M,Monaco I,Brunetti ND,Di Biase M,Metra M,Nodari S,Butler J,Gheorghiade M", + "auth_pos": 7, + "meshterms": "Biomarkers, Biomarkers/blood*, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology, Humans, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 552, + "user_id": 1639100928, + "artical_title": "Updates on Device-Based Therapies for Patients with Heart Failure.", + "pmid": 29455273, + "journal_name": "Current heart failure reports", + "date": "2019-01-19", + "author": "Al Danaf J,Butler J,Yehya A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 553, + "user_id": 1639100928, + "artical_title": "Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical Trials.", + "pmid": 29476326, + "journal_name": "Current heart failure reports", + "date": "2019-01-19", + "author": "Singh P,Vijayakumar S,Kalogeroupoulos A,Butler J", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 554, + "user_id": 1639100928, + "artical_title": "Cigarette Smoking and Subclinical Peripheral Arterial Disease in Blacks of the Jackson Heart Study.", + "pmid": 30672360, + "journal_name": "Journal of the American Heart Association", + "date": "2019-01-24", + "author": "Clark D,Cain LR,Blaha MJ,DeFilippis AP,Mentz RJ,Kamimura D,White WB,Butler KR,Robertson RM,Bhatnagar A,Butler J,Correa A,Benjamin EJ,Hall ME", + "auth_pos": 11, + "meshterms": "Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult, Adult, Aged, Aged, 80 and over, Ankle Brachial Index, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/prevention & control, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Peripheral Arterial Disease, Peripheral Arterial Disease/ethnology*, Peripheral Arterial Disease/prevention & control, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Self Report*, Smoking Cessation, Smoking Cessation/methods*, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 555, + "user_id": 1639100928, + "artical_title": "The other serelaxin in acute heart failure study: lessons from a pragmatic clinical trial.", + "pmid": 30688399, + "journal_name": "European journal of heart failure", + "date": "2019-01-29", + "author": "Kalogeropoulos AP,Butler J", + "auth_pos": 2, + "meshterms": "Acute Disease, Heart Failure*, Humans, Recombinant Proteins, Relaxin*, Standard of Care", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 556, + "user_id": 1639100928, + "artical_title": "A new educational program in heart failure drug development: the Brescia international master program.", + "pmid": 29952846, + "journal_name": "Journal of cardiovascular medicine (Hagerstown, Md.)", + "date": "2019-01-31", + "author": "Dungen HD,Petroni R,Correale M,Coiro S,Monitillo F,Triggiani M,Leone M,Antohi EL,Ishihara S,Sarwar CMS,Sabbah HN,Memo M,Metra M,Butler J,Nodari S,Gheorghiade M", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 557, + "user_id": 1639100928, + "artical_title": "Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.", + "pmid": 30700141, + "journal_name": "Circulation", + "date": "2019-02-01", + "author": "Piccini JP,Xu H,Cox M,Matsouaka RA,Fonarow GC,Butler J,Curtis AB,Desai N,Fang M,McCabe PJ,Page Ii RL,Turakhia M,Russo AM,Knight BP,Sidhu M,Hurwitz JL,Ellenbogen KA,Lewis WR", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 558, + "user_id": 1639100928, + "artical_title": "Commentary: Failure predicting failure: The right ventricle after left ventricular assist device implantation.", + "pmid": 30709670, + "journal_name": "The Journal of thoracic and cardiovascular surgery", + "date": "2019-02-03", + "author": "Chikwe J,Anyanwu A,Butler J,McLarty A", + "auth_pos": 3, + "meshterms": "Cluster Analysis, Echocardiography, Heart Ventricles, Heart-Assist Devices*, Humans, Ventricular Dysfunction, Right*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 559, + "user_id": 1639100928, + "artical_title": "Epirubicin and long-term heart failure risk in breast cancer survivors.", + "pmid": 29972283, + "journal_name": "European journal of heart failure", + "date": "2019-02-06", + "author": "Mahmood SS,Patel RB,Butler J,Vaduganathan M", + "auth_pos": 3, + "meshterms": "Antibiotics, Antineoplastic, Breast Neoplasms, Cancer Survivors, Epirubicin*, Female, Heart Failure*, Humans, Incidence", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 560, + "user_id": 1639100928, + "artical_title": "Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.", + "pmid": 30738978, + "journal_name": "JACC. Heart failure", + "date": "2019-02-11", + "author": "Peri-Okonny PA,Mi X,Khariton Y,Patel KK,Thomas L,Fonarow GC,Sharma PP,Duffy CI,Albert NM,Butler J,Hernandez AF,McCague K,Williams FB,DeVore AD,Patterson JH,Spertus JA", + "auth_pos": 10, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/administration & dosage*, Adult, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/administration & dosage*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/administration & dosage*, Blood Pressure, Blood Pressure/drug effects*, Blood Pressure/physiology, Cross-Sectional Studies, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/trends, Humans, Male, Middle Aged, Prospective Studies, Registries*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 561, + "user_id": 1639100928, + "artical_title": "Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?", + "pmid": 30819383, + "journal_name": "JACC. Heart failure", + "date": "2019-03-02", + "author": "Vaduganathan M,Tahhan AS,Alrohaibani A,Greene SJ,Fonarow GC,Vardeny O,Lindenfeld J,Jessup M,Fiuzat M,O'Connor CM,Butler J", + "auth_pos": 11, + "meshterms": "Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome, Clinical Trials as Topic*, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Research Design, Research Report, Sex Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 562, + "user_id": 1639100928, + "artical_title": "Early Treatment in Emergency Department Patients with Acute Heart Failure: Does Time Matter?", + "pmid": 30828762, + "journal_name": "Current heart failure reports", + "date": "2019-03-05", + "author": "Chang AM,Pang PS,Butler J,Storrow AB,Levy PD,Lindenfeld J,Collins SP", + "auth_pos": 3, + "meshterms": "Acute Disease, Diuretics, Diuretics/therapeutic use*, Emergency Service, Hospital*, Global Health, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Morbidity, Morbidity/trends, Survival Rate, Survival Rate/trends, Time Factors, Treatment Outcome, Vasodilator Agents, Vasodilator Agents/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 563, + "user_id": 1639100928, + "artical_title": "Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.", + "pmid": 30837801, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2019-03-07", + "author": "Vijayakumar S,Butler J,Bakris GL", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 564, + "user_id": 1639100928, + "artical_title": "New treatments for hyperkalaemia: clinical use in cardiology.", + "pmid": 30837804, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2019-03-07", + "author": "Vijayakumar S,Butler J,Anker SD", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 565, + "user_id": 1639100928, + "artical_title": "Therapeutic Advances in the Management of Acute Decompensated Heart Failure.", + "pmid": 30839371, + "journal_name": "American journal of therapeutics", + "date": "2019-03-07", + "author": "Antohi EL,Ambrosy AP,Collins SP,Ahmed A,Iliescu VA,Cotter G,Pang PS,Butler J,Chioncel O", + "auth_pos": 8, + "meshterms": "Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Acute Disease, Disease Management*, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 566, + "user_id": 1639100928, + "artical_title": "Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.", + "pmid": 30844480, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-03-08", + "author": "Greene SJ,Fonarow GC,DeVore AD,Sharma PP,Vaduganathan M,Albert NM,Duffy CI,Hill CL,McCague K,Patterson JH,Spertus JA,Thomas L,Williams FB,Hernandez AF,Butler J", + "auth_pos": 15, + "meshterms": "Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*, Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 567, + "user_id": 1639100928, + "artical_title": "Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.", + "pmid": 30855996, + "journal_name": "Circulation", + "date": "2019-03-12", + "author": "Savarese G,Sattar N,Januzzi J,Verma S,Lund LH,Fitchett D,Zeller C,George JT,Brueckmann M,Ofstad AP,Inzucchi SE,Wanner C,Zinman B,Butler J", + "auth_pos": 14, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cause of Death, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/mortality, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/diagnosis, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/prevention & control*, Humans, Patient Readmission*, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 568, + "user_id": 1639100928, + "artical_title": "Mobile health applications in cardiovascular research.", + "pmid": 29921516, + "journal_name": "International journal of cardiology", + "date": "2019-03-12", + "author": "Sarwar CMS,Vaduganathan M,Anker SD,Coiro S,Papadimitriou L,Saltz J,Schoenfeld ER,Clark RL,Dinh W,Kramer F,Gheorghiade M,Fonarow GC,Butler J", + "auth_pos": 13, + "meshterms": "Biomedical Research, Biomedical Research/methods, Biomedical Research/trends*, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/therapy*, Humans, Observational Studies as Topic, Observational Studies as Topic/methods, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods, Telemedicine, Telemedicine/methods, Telemedicine/trends*, Text Messaging, Text Messaging/trends*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 569, + "user_id": 1639100928, + "artical_title": "Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).", + "pmid": 30876658, + "journal_name": "The American journal of cardiology", + "date": "2019-03-17", + "author": "Patel RB,Vaduganathan M,Felker GM,Butler J,Redfield MM,Shah SJ", + "auth_pos": 4, + "meshterms": "Accelerometry, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/physiopathology*, Biomarkers, Biomarkers/blood, Cross-Over Studies, Double-Blind Method, Exercise*, Exercise Tolerance, Exercise Tolerance/physiology*, Female, Follow-Up Studies, Heart Failure, Heart Failure/blood, Heart Failure/complications, Heart Failure/physiopathology*, Humans, Isosorbide Dinitrate, Isosorbide Dinitrate/analogs & derivatives, Isosorbide Dinitrate/therapeutic use, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Prognosis, Protein Precursors, Quality of Life*, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 570, + "user_id": 1639100928, + "artical_title": "Mihai Gheorghiade, MD-Life and Concepts.", + "pmid": 29916855, + "journal_name": "American journal of therapeutics", + "date": "2019-03-20", + "author": "Pang PS,Collins SP,Butler J,Chioncel O", + "auth_pos": 3, + "meshterms": "Acute Disease, Acute Disease/therapy, Cardiology, Cardiology/history, Cardiotonic Agents, Cardiotonic Agents/therapeutic use*, Digoxin, Digoxin/therapeutic use*, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hemodynamics, Hemodynamics/physiology, History, 21st Century, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 571, + "user_id": 1639100928, + "artical_title": "Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology.", + "pmid": 29943879, + "journal_name": "European journal of heart failure", + "date": "2019-03-21", + "author": "Patel RB,Vaduganathan M,Greene SJ,Butler J", + "auth_pos": 4, + "meshterms": "Disease Progression, Heart Failure*, Heart Failure/classification, Heart Failure/diagnosis, Heart Failure/physiopathology, Humans, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Terminology as Topic*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 572, + "user_id": 1639100928, + "artical_title": "Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial.", + "pmid": 30415473, + "journal_name": "European journal of heart failure", + "date": "2019-03-28", + "author": "Greene SJ,Fonarow GC,Solomon SD,Subacius HP,Vaduganathan M,Ambrosy AP,Fudim M,Böhm M,Maggioni AP,Lewis EF,Zannad F,Butler J", + "auth_pos": 12, + "meshterms": "Acute Disease, Amides, Amides/therapeutic use*, Fumarates, Fumarates/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Hospitalization*, Humans, Inpatients*, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 573, + "user_id": 1639100928, + "artical_title": "Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF.", + "pmid": 30953792, + "journal_name": "Journal of cardiac failure", + "date": "2019-04-07", + "author": "Grodin JL,Liebo MJ,Butler J,Metra M,Felker GM,Hernandez AF,Voors AA,McMurray JJ,Armstrong PW,O'Connor C,Starling RC,Troughton RW,Tang WHW", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 574, + "user_id": 1639100928, + "artical_title": "The continuous heart failure spectrum: moving beyond an ejection fraction classification.", + "pmid": 30957868, + "journal_name": "European heart journal", + "date": "2019-04-09", + "author": "Triposkiadis F,Butler J,Abboud FM,Armstrong PW,Adamopoulos S,Atherton JJ,Backs J,Bauersachs J,Burkhoff D,Bonow RO,Chopra VK,de Boer RA,de Windt L,Hamdani N,Hasenfuss G,Heymans S,Hulot JS,Konstam M,Lee RT,Linke WA,Lunde IG,Lyon AR,Maack C,Mann DL,Mebazaa A,Mentz RJ,Nihoyannopoulos P,Papp Z,Parissis J,Pedrazzini T,Rosano G,Rouleau J,Seferovic PM,Shah AM,Starling RC,Tocchetti CG,Trochu JN,Thum T,Zannad F,Brutsaert DL,Segers VF,De Keulenaer GW", + "auth_pos": 2, + "meshterms": "Comorbidity, Disease Progression, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Heart Failure, Heart Failure/classification*, Heart Failure/pathology, Heart Failure/physiopathology, Humans, Myocytes, Cardiac, Myocytes, Cardiac/physiology, Reference Values, Stroke Volume*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/physiopathology, Ventricular Remodeling", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 575, + "user_id": 1639100928, + "artical_title": "Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis).", + "pmid": 30967285, + "journal_name": "The American journal of cardiology", + "date": "2019-04-11", + "author": "Watson M,Dardari Z,Kianoush S,Hall ME,DeFilippis AP,Keith RJ,Benjamin EJ,Rodriguez CJ,Bhatnagar A,Lima JA,Butler J,Blaha MJ,Rifai MA", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications, Atherosclerosis/ethnology*, Cigarette Smoking, Cigarette Smoking/epidemiology*, Cohort Studies, Ethnicity, Ethnicity/statistics & numerical data*, Female, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Middle Aged, Proportional Hazards Models, Stroke Volume, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 576, + "user_id": 1639100928, + "artical_title": "Novel potassium binders as enabling therapy in heart failure.", + "pmid": 30993820, + "journal_name": "European journal of heart failure", + "date": "2019-04-18", + "author": "Butler J,Khan MS,Anker SD", + "auth_pos": 1, + "meshterms": "Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects*, Deprescriptions, Heart Failure, Heart Failure/drug therapy*, Humans, Hyperkalemia, Hyperkalemia/chemically induced, Hyperkalemia/drug therapy*, Ion Exchange Resins, Ion Exchange Resins/therapeutic use*, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects*, Polymers, Polymers/therapeutic use*, Renin-Angiotensin System, Silicates, Silicates/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 577, + "user_id": 1639100928, + "artical_title": "Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.", + "pmid": 31034476, + "journal_name": "PLoS medicine", + "date": "2019-04-30", + "author": "Bajaj NS,Vaduganathan M,Qamar A,Gupta K,Gupta A,Golwala H,Butler J,Goldhaber SZ,Mehra MR", + "auth_pos": 7, + "meshterms": "Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*, Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Chemoprevention, Chemoprevention/adverse effects, Chemoprevention/methods*, Chemoprevention/statistics & numerical data, Cohort Studies, Drug Administration Schedule, Female, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Male, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data, Venous Thromboembolism, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 578, + "user_id": 1639100928, + "artical_title": "Heart failure prevention with sodium-glucose cotransporter 2 inhibitors.", + "pmid": 31044514, + "journal_name": "Journal of diabetes", + "date": "2019-05-03", + "author": "Khan MS,Butler J", + "auth_pos": 2, + "meshterms": "Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Prognosis, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 579, + "user_id": 1639100928, + "artical_title": "Heart Failure in Pregnancy: A Problem Hiding in Plain Sight.", + "pmid": 31057025, + "journal_name": "Journal of the American Heart Association", + "date": "2019-05-07", + "author": "Stergiopoulos K,Lima FV,Butler J", + "auth_pos": 3, + "meshterms": "Cardiovascular System, Cardiovascular System/physiopathology*, Female, Heart Failure*, Heart Failure/diagnosis, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy, Hemodynamics*, Humans, Maternal Mortality, Pregnancy, Pregnancy Complications, Cardiovascular*, Pregnancy Complications, Cardiovascular/diagnosis, Pregnancy Complications, Cardiovascular/mortality, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy, Pregnancy Outcome, Prognosis, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 580, + "user_id": 1639100928, + "artical_title": "Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.", + "pmid": 31089966, + "journal_name": "PharmacoEconomics", + "date": "2019-05-16", + "author": "Bounthavong M,Butler J,Dolan CM,Dunn JD,Fisher KA,Oestreicher N,Pitt B,Hauptman PJ,Veenstra DL", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 581, + "user_id": 1639100928, + "artical_title": "Rationale and Design of the VITALITY-HFpEF Trial.", + "pmid": 31096775, + "journal_name": "Circulation. Heart failure", + "date": "2019-05-18", + "author": "Butler J,Lam CSP,Anstrom KJ,Ezekowitz J,Hernandez AF,O'Connor CM,Pieske B,Ponikowski P,Shah SJ,Solomon SD,Voors AA,Wu Y,Carvalho F,Bamber L,Blaustein RO,Roessig L,Armstrong PW", + "auth_pos": 1, + "meshterms": "Activities of Daily Living, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Dose-Response Relationship, Drug, Exercise Tolerance, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 2-Ring/therapeutic use*, Humans, Middle Aged, Pyrimidines, Pyrimidines/therapeutic use*, Quality of Life, Randomized Controlled Trials as Topic, Research Design, Stroke Volume, Treatment Outcome, Walk Test*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 582, + "user_id": 1639100928, + "artical_title": "Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.", + "pmid": 31104495, + "journal_name": "Circulation. Heart failure", + "date": "2019-05-21", + "author": "Ferreira JP,Verdonschot J,Collier T,Wang P,Pizard A,Bär C,Björkman J,Boccanelli A,Butler J,Clark A,Cleland JG,Delles C,Diez J,Girerd N,González A,Hazebroek M,Huby AC,Jukema W,Latini R,Leenders J,Levy D,Mebazaa A,Mischak H,Pinet F,Rossignol P,Sattar N,Sever P,Staessen JA,Thum T,Vodovar N,Zhang ZY,Heymans S,Zannad F", + "auth_pos": 9, + "meshterms": "Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics, Aged, Biomarkers, Biomarkers/blood*, Case-Control Studies, Disease Progression, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology*, Humans, Male, Proteome, Proteome/analysis*, Proteomics", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 583, + "user_id": 1639100928, + "artical_title": "Assessment of Heart Failure in Diabetes Cardiovascular Outcomes Trials: Is What We Are Currently Capturing Adequate?", + "pmid": 31127397, + "journal_name": "Current diabetes reports", + "date": "2019-05-28", + "author": "Bowes CD,Lien LF,Butler J", + "auth_pos": 3, + "meshterms": "Cardiovascular Diseases*, Diabetes Mellitus, Type 2*, Dipeptidyl-Peptidase IV Inhibitors*, Heart Failure*, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 584, + "user_id": 1639100928, + "artical_title": "Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.", + "pmid": 31134861, + "journal_name": "Journal of managed care & specialty pharmacy", + "date": "2019-05-29", + "author": "McGee BT,Phillips V,Higgins MK,Butler J", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Cost Sharing, Cost Sharing/economics, Cost Sharing/statistics & numerical data, Female, Health Expenditures, Health Expenditures/statistics & numerical data*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/economics, Humans, Male, Medicare Part D, Medicare Part D/economics*, Medicare Part D/statistics & numerical data, Medication Adherence, Medication Adherence/statistics & numerical data*, Prescription Drugs, Prescription Drugs/economics*, Prescription Drugs/therapeutic use, United States, Aged, Aged, 80 and over, Cost Sharing, Cost Sharing/economics, Cost Sharing/statistics & numerical data, Female, Health Expenditures, Health Expenditures/statistics & numerical data*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/economics, Humans, Male, Medicare Part D, Medicare Part D/economics*, Medicare Part D/statistics & numerical data, Medication Adherence, Medication Adherence/statistics & numerical data*, Prescription Drugs, Prescription Drugs/economics*, Prescription Drugs/therapeutic use, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 585, + "user_id": 1639100928, + "artical_title": "Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure.", + "pmid": 31163986, + "journal_name": "Circulation. Heart failure", + "date": "2019-06-06", + "author": "Butler J,Zannad F,Fitchett D,Zinman B,Koitka-Weber A,von Eynatten M,Zwiener I,George J,Brueckmann M,Cheung AK,Wanner C", + "auth_pos": 1, + "meshterms": "Adult, Aged, Albuminuria, Albuminuria/drug therapy*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney, Kidney/drug effects, Male, Middle Aged, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 586, + "user_id": 1639100928, + "artical_title": "Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.", + "pmid": 31176672, + "journal_name": "JACC. Heart failure", + "date": "2019-06-10", + "author": "Thomas M,Khariton Y,Fonarow GC,Arnold SV,Hill L,Nassif ME,Sharma PP,Butler J,Thomas L,Duffy CI,DeVore AD,Hernandez A,Albert NM,Patterson JH,Williams FB,McCague K,Spertus JA", + "auth_pos": 8, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Diuretics, Diuretics/therapeutic use, Female, Health Status, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology*, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Neprilysin/antagonists & inhibitors, Quality of Life*, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 587, + "user_id": 1639100928, + "artical_title": "The Limitations of Symptom-based Heart Failure Management.", + "pmid": 31179015, + "journal_name": "Cardiac failure review", + "date": "2019-06-11", + "author": "Papadimitriou L,Moore CK,Butler J,Long RC", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 588, + "user_id": 1639100928, + "artical_title": "Predictors of heart failure development in type 2 diabetes: a practical approach.", + "pmid": 31219877, + "journal_name": "Current opinion in cardiology", + "date": "2019-06-21", + "author": "Verma S,Sharma A,Kanumilli N,Butler J", + "auth_pos": 4, + "meshterms": "Atherosclerosis, Atherosclerosis/epidemiology, Canada, Canada/epidemiology, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Heart Failure, Heart Failure/epidemiology*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 589, + "user_id": 1639100928, + "artical_title": "Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial.", + "pmid": 31230825, + "journal_name": "The Canadian journal of cardiology", + "date": "2019-06-25", + "author": "Greene SJ,Felker GM,Giczewska A,Kalogeropoulos AP,Ambrosy AP,Chakraborty H,DeVore AD,Fudim M,McNulty SE,Mentz RJ,Vaduganathan M,Hernandez AF,Butler J", + "auth_pos": 13, + "meshterms": "Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Creatinine, Creatinine/blood, Dose-Response Relationship, Drug, Drug Resistance*, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Prospective Studies, Renal Insufficiency, Renal Insufficiency/blood, Renal Insufficiency/complications*, Renal Insufficiency/physiopathology, Risk Factors, Spironolactone, Spironolactone/administration & dosage*, Stroke Volume, Stroke Volume/physiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 590, + "user_id": 1639100928, + "artical_title": "Clinical aspects of heart failure in individuals with diabetes.", + "pmid": 31342083, + "journal_name": "Diabetologia", + "date": "2019-07-26", + "author": "Bowes CD,Lien LF,Butler J", + "auth_pos": 3, + "meshterms": "Algorithms, Diabetes Mellitus, Diabetes Mellitus/blood*, Diabetes Mellitus/physiopathology, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology*, Female, Heart Failure, Heart Failure/blood, Heart Failure/etiology*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects*, Male", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 591, + "user_id": 1639100928, + "artical_title": "Mid-regional pro-atrial natriuretic peptide for diagnosis of heart failure in non-acute settings: biomarkers plus clinical sense make good sense.", + "pmid": 31373140, + "journal_name": "European journal of heart failure", + "date": "2019-08-03", + "author": "Chioncel O,Butler J", + "auth_pos": 2, + "meshterms": "Atrial Natriuretic Factor*, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 592, + "user_id": 1639100928, + "artical_title": "Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week.", + "pmid": 31395131, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-08-10", + "author": "Triposkiadis F,Xanthopoulos A,Butler J", + "auth_pos": 3, + "meshterms": "Aged, Aging*, Cardiovascular System, Cardiovascular System/physiopathology*, Disease Progression, Heart Failure, Heart Failure/physiopathology*, Humans, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 593, + "user_id": 1639100928, + "artical_title": "Design of a \"Lean\" Case Report Form for Heart Failure Therapeutic Development.", + "pmid": 31401097, + "journal_name": "JACC. Heart failure", + "date": "2019-08-12", + "author": "Psotka MA,Fiuzat M,Carson PE,Kao DP,Cerkvenik J,Schaber DE,Verta P,Kazmierski RT,Shinnar M,Stockbridge N,Unger EF,Zuckerman B,Butler J,Felker GM,Konstam MA,Lindenfeld J,Solomon SD,Teerlink JR,O'Connor CM,Abraham WT", + "auth_pos": 13, + "meshterms": "Forms as Topic*, Heart Failure, Heart Failure/diagnosis*, Heart Failure/therapy*, Humans, Medical Records*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 594, + "user_id": 1639100928, + "artical_title": "Dying is not what it used to be! Impact of evolving epidemiology and treatment on mode of death in heart failure.", + "pmid": 31410990, + "journal_name": "European journal of heart failure", + "date": "2019-08-15", + "author": "Patel RB,Nohria A,Butler J,Vaduganathan M", + "auth_pos": 3, + "meshterms": "Cause of Death, Death, Sudden, Heart Failure*, Humans, Neoplasms*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 595, + "user_id": 1639100928, + "artical_title": "Salt, No Salt, or Less Salt for Patients With Heart Failure?", + "pmid": 31419422, + "journal_name": "The American journal of medicine", + "date": "2019-08-17", + "author": "Khan MS,Jones DW,Butler J", + "auth_pos": 3, + "meshterms": "Blood Pressure*, Diet, Sodium-Restricted*, Heart Failure, Heart Failure/diet therapy*, Heart Failure/metabolism, Humans, Hypertension, Hypertrophy, Left Ventricular, Practice Guidelines as Topic, Renin-Angiotensin System*, Sodium Chloride, Dietary", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 596, + "user_id": 1639100928, + "artical_title": "Timely Management of New-Onset Heart Failure.", + "pmid": 31424994, + "journal_name": "Circulation", + "date": "2019-08-20", + "author": "Gracia E,Hamid A,Butler J", + "auth_pos": 3, + "meshterms": "Heart Failure, Heart Failure/diagnosis, Heart Failure/mortality, Heart Failure/therapy*, Humans, Insurance, Health, Reimbursement, Patient Readmission, Practice Guidelines as Topic, Precision Medicine, Survival Analysis, Time Factors*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 597, + "user_id": 1639100928, + "artical_title": "Why Clinicians Should Care About the Cardiac Interstitium.", + "pmid": 31422140, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-08-20", + "author": "Schelbert EB,Butler J,Diez J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 598, + "user_id": 1639100928, + "artical_title": "Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial.", + "pmid": 31452311, + "journal_name": "European journal of heart failure", + "date": "2019-08-28", + "author": "Blumer V,Greene SJ,Sun JL,Bart BA,Ambrosy AP,Butler J,DeVore AD,Fudim M,Hernandez AF,McNulty SE,Felker GM,Mentz RJ", + "auth_pos": 6, + "meshterms": "Acute Disease, Aged, Cardio-Renal Syndrome, Cardio-Renal Syndrome/blood, Cardio-Renal Syndrome/therapy*, Comorbidity, Female, Heart Failure, Heart Failure/blood, Heart Failure/therapy*, Hematocrit*, Hemofiltration*, Hemoglobinometry*, Hospitalization, Humans, Kidney Function Tests, Male, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 599, + "user_id": 1639100928, + "artical_title": "Diagnosis and Prevention of Hypertensive Heart Failure.", + "pmid": 31472879, + "journal_name": "Heart failure clinics", + "date": "2019-09-02", + "author": "Kalogeropoulos AP,Goulbourne C,Butler J", + "auth_pos": 3, + "meshterms": "Antihypertensive Agents*, Antihypertensive Agents/classification, Antihypertensive Agents/therapeutic use, Disease Progression, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/prevention & control, Humans, Hypertension*, Hypertension/complications, Hypertension/physiopathology, Hypertrophy, Left Ventricular*, Hypertrophy, Left Ventricular/diagnosis, Hypertrophy, Left Ventricular/etiology, Preventive Health Services*, Preventive Health Services/methods, Preventive Health Services/organization & administration, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 600, + "user_id": 1639100928, + "artical_title": "Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.", + "pmid": 31475295, + "journal_name": "JAMA", + "date": "2019-09-03", + "author": "Januzzi JL,Prescott MF,Butler J,Felker GM,Maisel AS,McCague K,Camacho A,Piña IL,Rocha RA,Shah AM,Williamson KM,Solomon SD", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 601, + "user_id": 1639100928, + "artical_title": "Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.", + "pmid": 30025570, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-05", + "author": "Greene SJ,Butler J,Albert NM,DeVore AD,Sharma PP,Duffy CI,Hill CL,McCague K,Mi X,Patterson JH,Spertus JA,Thomas L,Williams FB,Hernandez AF,Fonarow GC", + "auth_pos": 2, + "meshterms": "Adrenergic beta-Antagonists*, Adrenergic beta-Antagonists/administration & dosage, Adrenergic beta-Antagonists/therapeutic use, Age Factors, Aged, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/administration & dosage, Angiotensin Receptor Antagonists/therapeutic use, Dose-Response Relationship, Drug*, Drug Utilization, Drug Utilization/statistics & numerical data*, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists*, Mineralocorticoid Receptor Antagonists/administration & dosage, Mineralocorticoid Receptor Antagonists/therapeutic use, Practice Guidelines as Topic, Quality Improvement, Registries, Registries/statistics & numerical data, Severity of Illness Index, Socioeconomic Factors, Stroke Volume, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 602, + "user_id": 1639100928, + "artical_title": "Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.", + "pmid": 31488284, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-07", + "author": "Greene SJ,Fonarow GC,Butler J", + "auth_pos": 3, + "meshterms": "Heart Failure*, Humans, Machine Learning, Patient-Centered Care, Stroke Volume, Ventricular Dysfunction, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 603, + "user_id": 1639100928, + "artical_title": "De novo heart failure: where the journey begins.", + "pmid": 31496006, + "journal_name": "European journal of heart failure", + "date": "2019-09-10", + "author": "Myhre PL,Januzzi JL,Butler J,Vaduganathan M", + "auth_pos": 3, + "meshterms": "Cohort Studies, Emergency Service, Hospital, Heart Failure*, Hospitalization, Humans, Patient Readmission", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 604, + "user_id": 1639100928, + "artical_title": "Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.", + "pmid": 30409566, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-13", + "author": "Vaduganathan M,Sathiyakumar V,Singh A,McCarthy CP,Qamar A,Januzzi JL,Scirica BM,Butler J,Cannon CP,Bhatt DL", + "auth_pos": 8, + "meshterms": "Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Drug Labeling, Drug Labeling/legislation & jurisprudence, Drug Labeling/trends*, Drug Prescriptions*, Female, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Male, Middle Aged, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Tertiary Care Centers, Tertiary Care Centers/legislation & jurisprudence, Tertiary Care Centers/trends, United States, United States Food and Drug Administration, United States Food and Drug Administration/legislation & jurisprudence, United States Food and Drug Administration/trends*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 605, + "user_id": 1639100928, + "artical_title": "Redefining Heart Failure With a Reduced Ejection Fraction.", + "pmid": 31517955, + "journal_name": "JAMA", + "date": "2019-09-14", + "author": "Butler J,Anker SD,Packer M", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 606, + "user_id": 1639100928, + "artical_title": "Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.", + "pmid": 31519694, + "journal_name": "Diabetes care", + "date": "2019-09-15", + "author": "Segar MW,Vaduganathan M,Patel KV,McGuire DK,Butler J,Fonarow GC,Basit M,Kannan V,Grodin JL,Everett B,Willett D,Berry J,Pandey A", + "auth_pos": 5, + "meshterms": "Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors, Aged, Clinical Trials as Topic, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Female, Follow-Up Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Incidence, Machine Learning*, Male, Middle Aged, Outpatients, Predictive Value of Tests, Reproducibility of Results, Risk Assessment, Risk Assessment/methods*, Risk Factors, Time Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 607, + "user_id": 1639100928, + "artical_title": "Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.", + "pmid": 31521679, + "journal_name": "JACC. Heart failure", + "date": "2019-09-16", + "author": "Khariton Y,Fonarow GC,Arnold SV,Hellkamp A,Nassif ME,Sharma PP,Butler J,Thomas L,Duffy CI,DeVore AD,Albert NM,Patterson JH,Williams FB,McCague K,Spertus JA", + "auth_pos": 7, + "meshterms": "Aged, Aminobutyrates, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Cohort Studies, Drug Combinations, Female, Health Status, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology*, Humans, Male, Middle Aged, Neprilysin, Neprilysin/antagonists & inhibitors*, Stroke Volume*, Tetrazoles, Tetrazoles/therapeutic use*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 608, + "user_id": 1639100928, + "artical_title": "Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial.", + "pmid": 31523892, + "journal_name": "European journal of heart failure", + "date": "2019-09-17", + "author": "Voors AA,Bax JJ,Hernandez AF,Wirtz AB,Pap AF,Ferreira AC,Senni M,van der Laan M,Butler J", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 609, + "user_id": 1639100928, + "artical_title": "Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.", + "pmid": 31523904, + "journal_name": "European journal of heart failure", + "date": "2019-09-17", + "author": "Anker SD,Butler J,Filippatos GS,Jamal W,Salsali A,Schnee J,Kimura K,Zeller C,George J,Brueckmann M,Zannad F,Packer M", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use*, Chronic Disease, Glucosides, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality*, Humans, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 610, + "user_id": 1639100928, + "artical_title": "2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.", + "pmid": 31526538, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-19", + "author": "Hollenberg SM,Warner Stevenson L,Ahmad T,Amin VJ,Bozkurt B,Butler J,Davis LL,Drazner MH,Kirkpatrick JN,Peterson PN,Reed BN,Roy CL,Storrow AB", + "auth_pos": 6, + "meshterms": "Cardiology, Cardiology/methods, Cardiology/organization & administration*, Comorbidity, Consensus, Continuity of Patient Care, Decision Making, Diuretics, Diuretics/therapeutic use, Heart Failure, Heart Failure/diagnosis*, Heart Failure/therapy*, Hospitalization, Humans, Palliative Care, Patient Discharge, Practice Guidelines as Topic, Risk Assessment, Risk Assessment/methods*, Societies, Medical, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 611, + "user_id": 1639100928, + "artical_title": "Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.", + "pmid": 31536660, + "journal_name": "Diabetic medicine : a journal of the British Diabetic Association", + "date": "2019-09-20", + "author": "Sharma A,Butler J,Zieroth S,Giannetti N,Verma S", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/mortality, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Hospitalization, Humans, Randomized Controlled Trials as Topic, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/mortality, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Hospitalization, Humans, Randomized Controlled Trials as Topic, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 612, + "user_id": 1639100928, + "artical_title": "Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.", + "pmid": 31545830, + "journal_name": "PloS one", + "date": "2019-09-24", + "author": "Chang TE,Park S,Yang Q,Loustalot F,Butler J,Ritchey MD", + "auth_pos": 5, + "meshterms": "Adolescent, Adult, Age Factors, Female, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/prevention & control, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Medication Adherence, Medication Adherence/statistics & numerical data*, Middle Aged, Practice Guidelines as Topic*, Practice Patterns, Physicians'*, Risk Factors, Time Factors, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 613, + "user_id": 1639100928, + "artical_title": "Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.", + "pmid": 31566649, + "journal_name": "JAMA internal medicine", + "date": "2019-10-01", + "author": "Sumarsono A,Everett BM,McGuire DK,Fonarow GC,Butler J,Pandey A,Vaduganathan M", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 614, + "user_id": 1639100928, + "artical_title": "Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial.", + "pmid": 31584231, + "journal_name": "European journal of heart failure", + "date": "2019-10-05", + "author": "Packer M,Butler J,Filippatos GS,Jamal W,Salsali A,Schnee J,Kimura K,Zeller C,George J,Brueckmann M,Anker SD,Zannad F", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 615, + "user_id": 1639100928, + "artical_title": "Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.", + "pmid": 31606362, + "journal_name": "JACC. Heart failure", + "date": "2019-10-14", + "author": "Greene SJ,DeVore AD,Sheng S,Fonarow GC,Butler J,Califf RM,Hernandez AF,Matsouaka RA,Samman Tahhan A,Thomas KL,Vaduganathan M,Yancy CW,Peterson ED,O'Connor CM,Mentz RJ", + "auth_pos": 5, + "meshterms": "African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*, African Americans, African Americans/statistics & numerical data*, Aged, Aged, 80 and over, Female, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Natriuretic Agents, Natriuretic Agents/therapeutic use*, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use*, Patient Selection*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Sex Distribution, Whites, Whites/statistics & numerical data*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 616, + "user_id": 1639100928, + "artical_title": "Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.", + "pmid": 31646707, + "journal_name": "European journal of heart failure", + "date": "2019-10-28", + "author": "Rachwan RJ,Butler J,Collins SP,Cotter G,Davison BA,Senger S,Ezekowitz JA,Filippatos G,Levy PD,Metra M,Ponikowski P,Teerlink JR,Voors AA,de Boer RA,Soergel DG,Felker GM,Pang PS", + "auth_pos": 2, + "meshterms": "Acute Disease, Aged, Biomarkers, Biomarkers/blood, Blood Pressure, Blood Pressure/physiology*, Cause of Death, Cause of Death/trends, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, Heart Failure, Heart Failure/blood*, Heart Failure/mortality, Heart Failure/physiopathology, Humans, Male, Renin, Renin/blood*, Retrospective Studies, Survival Rate, Survival Rate/trends, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 617, + "user_id": 1639100928, + "artical_title": "Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF).", + "pmid": 31679641, + "journal_name": "The American journal of cardiology", + "date": "2019-11-05", + "author": "Giblin EM,Adams KF,Hill L,Fonarow GC,Williams FB,Sharma PP,Albert NM,Butler J,DeVore AD,Duffy CI,Hernandez AF,McCague K,Spertus JA,Thomas L,Patterson JH", + "auth_pos": 8, + "meshterms": "African Americans, African Americans/statistics & numerical data*, Aged, Aminobutyrates, Aminobutyrates/administration & dosage, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Cohort Studies, Drug Combinations, Drug Utilization, Female, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/ethnology*, Humans, Hydralazine, Hydralazine/therapeutic use*, Male, Middle Aged, Neprilysin, Neprilysin/therapeutic use*, Prognosis, Registries*, Retrospective Studies, Risk Assessment, Stroke Volume, Stroke Volume/drug effects, Survival Rate, Tetrazoles, Tetrazoles/administration & dosage, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 618, + "user_id": 1639100928, + "artical_title": "SGLT-2 inhibitors in heart failure: a new therapeutic avenue.", + "pmid": 31700170, + "journal_name": "Nature medicine", + "date": "2019-11-09", + "author": "Vaduganathan M,Butler J", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use*, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control*, Glucosides, Glucosides/therapeutic use*, Heart Failure, Heart Failure/prevention & control*, Humans, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/genetics, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 619, + "user_id": 1639100928, + "artical_title": "Serum ST2 and hospitalization rates in Caucasian and African American outpatients with heart failure.", + "pmid": 31706624, + "journal_name": "International journal of cardiology", + "date": "2019-11-11", + "author": "Savvoulidis P,Snider JV,Rawal S,Morris AA,Butler J,Georgiopoulou VV,Kalogeropoulos AP", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 620, + "user_id": 1639100928, + "artical_title": "Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.", + "pmid": 31707797, + "journal_name": "Circulation", + "date": "2019-11-12", + "author": "Pandey A,Patel KV,Vongpatanasin W,Ayers C,Berry JD,Mentz RJ,Blaha MJ,McEvoy JW,Muntner P,Vaduganathan M,Correa A,Butler J,Shimbo D,Nambi V,deFilippi C,Seliger SL,Ballantyne CM,Selvin E,de Lemos JA,Joshi PH", + "auth_pos": 12, + "meshterms": "Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology, Adult, Aged, American Heart Association*, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiology, Cardiology/standards*, Cohort Studies, Female, Humans, Hypertension, Hypertension/blood*, Hypertension/drug therapy*, Hypertension/epidemiology, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Prospective Studies, Risk Assessment, Troponin T, Troponin T/blood, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 621, + "user_id": 1639100928, + "artical_title": "Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.", + "pmid": 31727426, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-16", + "author": "Vaduganathan M,Fonarow GC,Greene SJ,DeVore AD,Albert NM,Duffy CI,Hill CL,Spertus JA,Thomas LE,Butler J", + "auth_pos": 10, + "meshterms": "Aged, Diabetes Complications, Diabetes Complications/psychology*, Heart Failure, Heart Failure/complications*, Heart Failure/psychology, Humans, Middle Aged, Quality of Life*, Registries*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 622, + "user_id": 1639100928, + "artical_title": "Promise, Innovation, Potency, and Efficacy: The PIPE Dream of Sodium-Glucose Co-Transporter 2 Inhibitors.", + "pmid": 31741434, + "journal_name": "The American journal of cardiology", + "date": "2019-11-20", + "author": "Butler J", + "auth_pos": 1, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Diabetic Angiopathies, Diabetic Angiopathies/etiology, Diabetic Angiopathies/prevention & control*, Heart Failure, Heart Failure/prevention & control, Humans, Myocardial Infarction, Myocardial Infarction/prevention & control, Peripheral Vascular Diseases, Peripheral Vascular Diseases/prevention & control, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke, Stroke/prevention & control", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 623, + "user_id": 1639100928, + "artical_title": "Variation in Placebo Effect on Health-Related Quality of Life in Heart Failure (from the TOPCAT Trial).", + "pmid": 31748125, + "journal_name": "The American journal of cardiology", + "date": "2019-11-22", + "author": "Khan MS,Kalogeropoulos AP,Butler J", + "auth_pos": 3, + "meshterms": "Aged, Double-Blind Method, Female, Follow-Up Studies, Health Status*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Placebo Effect, Quality of Life*, Spironolactone, Spironolactone/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Stroke Volume/physiology*, Surveys and Questionnaires, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 624, + "user_id": 1639100928, + "artical_title": "Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF.", + "pmid": 31770656, + "journal_name": "American heart journal", + "date": "2019-11-27", + "author": "DeVore AD,Granger BB,Fonarow GC,Al-Khalidi HR,Albert NM,Lewis EF,Butler J,Piña IL,Heidenreich PA,Allen LA,Yancy CW,Cooper LB,Felker GM,Kaltenbach LA,McRae AT,Lanfear DE,Harrison RW,Kociol RD,Disch M,Ariely D,Miller JM,Granger CB,Hernandez AF", + "auth_pos": 7, + "meshterms": "Aftercare, Aftercare/standards*, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization*, Humans, Mobile Applications, Patient Compliance, Practice Guidelines as Topic*, Prospective Studies, Quality Improvement*, Quality of Health Care*, Research Design, Self Care, Self Care/methods, Stroke Volume, Stroke Volume/physiology, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 625, + "user_id": 1639100928, + "artical_title": "Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes.", + "pmid": 31768274, + "journal_name": "Cardiac failure review", + "date": "2019-11-27", + "author": "Khan MS,Butler J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 626, + "user_id": 1639100928, + "artical_title": "Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.", + "pmid": 31797490, + "journal_name": "European journal of heart failure", + "date": "2019-12-05", + "author": "Bhatt AS,Vaduganathan M,Patel RB,Fonarow GC,Subacius HP,Konstam MA,Zannad F,Butler J,Greene SJ", + "auth_pos": 8, + "meshterms": "Aftercare, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Benzazepines, Female, Heart Failure*, Heart Failure/therapy, Hemodilution, Hospitalization, Humans, Male, Middle Aged, Patient Discharge*, Stroke Volume, Tolvaptan, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 627, + "user_id": 1639100928, + "artical_title": "Acutely decompensated versus acute heart failure: two different entities.", + "pmid": 31802377, + "journal_name": "Heart failure reviews", + "date": "2019-12-06", + "author": "Xanthopoulos A,Butler J,Parissis J,Polyzogopoulou E,Skoularigis J,Triposkiadis F", + "auth_pos": 2, + "meshterms": "Acute Disease, Disease Management*, Heart Failure, Heart Failure/physiopathology*, Heart Failure/therapy, Humans, Registries*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 628, + "user_id": 1639100928, + "artical_title": "Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.", + "pmid": 31806281, + "journal_name": "International journal of cardiology", + "date": "2019-12-07", + "author": "Barutaut M,Fournier P,Peacock WF,Evaristi MF,Caubère C,Turkieh A,Desmoulin F,Eurlings LWM,van Wijk S,Rocca HB,Butler J,Koukoui F,Dambrin C,Mazeres S,Le Page S,Delmas C,Galinier M,Jung C,Smih F,Rouet P", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Cohort Studies, Female, Follow-Up Studies, France, France/epidemiology, Georgia, Georgia/epidemiology, Heart Failure, Heart Failure/blood*, Heart Failure/diagnosis, Heart Failure/mortality*, Humans, Insulin-Like Growth Factor Binding Protein 2, Insulin-Like Growth Factor Binding Protein 2/blood*, Internationality*, Male, Middle Aged, Mortality, Mortality/trends, Netherlands, Netherlands/epidemiology, Prognosis, Prospective Studies, Retrospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 629, + "user_id": 1639100928, + "artical_title": "Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.", + "pmid": 31820546, + "journal_name": "European journal of heart failure", + "date": "2019-12-11", + "author": "Pieske B,Patel MJ,Westerhout CM,Anstrom KJ,Butler J,Ezekowitz J,Hernandez AF,Koglin J,Lam CSP,Ponikowski P,Roessig L,Voors AA,O'Connor CM,Armstrong PW", + "auth_pos": 5, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Female, Follow-Up Studies, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/physiopathology, Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 2-Ring/therapeutic use*, Humans, Male, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Prospective Studies, Protein Precursors, Pyrimidines, Pyrimidines/therapeutic use*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 630, + "user_id": 1639100928, + "artical_title": "Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong.", + "pmid": 31840351, + "journal_name": "European journal of heart failure", + "date": "2019-12-17", + "author": "Bhatt AS,Vaduganathan M,Butler J", + "auth_pos": 3, + "meshterms": "Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensins, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Neprilysin*, Tetrazoles, Valsartan", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 631, + "user_id": 1639100928, + "artical_title": "Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.", + "pmid": 31841369, + "journal_name": "Circulation", + "date": "2019-12-17", + "author": "Butler J,Packer M,Greene SJ,Fiuzat M,Anker SD,Anstrom KJ,Carson PE,Cooper LB,Fonarow GC,Hernandez AF,Januzzi JL,Jessup M,Kalyani RR,Kaul S,Kosiborod M,Lindenfeld J,McGuire DK,Sabatine MS,Solomon SD,Teerlink JR,Vaduganathan M,Yancy CW,Stockbridge N,O'Connor CM", + "auth_pos": 1, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Cardiovascular Diseases, Cardiovascular Diseases/blood, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Endpoint Determination, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/epidemiology, Humans, Research Report, Research Report/standards, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 632, + "user_id": 1639100928, + "artical_title": "Biomarker Profile of Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial.", + "pmid": 31857197, + "journal_name": "Journal of cardiac failure", + "date": "2019-12-21", + "author": "Patel RB,Alenezi F,Sun JL,Alhanti B,Vaduganathan M,Oh JK,Redfield MM,Butler J,Hernandez AF,Velazquez EJ,Shah SJ", + "auth_pos": 8, + "meshterms": "Atrial Function, Left, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Muscular Diseases*, Natriuretic Peptide, Brain, Peptide Fragments, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 633, + "user_id": 1639100928, + "artical_title": "Emerging therapies in transthyretin amyloidosis - a new wave of hope after years of stagnancy?", + "pmid": 31912620, + "journal_name": "European journal of heart failure", + "date": "2020-01-09", + "author": "Müller ML,Butler J,Heidecker B", + "auth_pos": 2, + "meshterms": "Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/drug therapy, Heart Failure, Humans, Prealbumin, Rare Diseases", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 634, + "user_id": 1639100928, + "artical_title": "Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.", + "pmid": 31919960, + "journal_name": "European journal of heart failure", + "date": "2020-01-11", + "author": "Khan MS,Memon MM,Murad MH,Vaduganathan M,Greene SJ,Hall M,Triposkiadis F,Lam CSP,Shah AM,Butler J,Shah SJ", + "auth_pos": 10, + "meshterms": "Atrial Function, Left*, Heart Failure*, Heart Failure/epidemiology, Humans, Prognosis, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 635, + "user_id": 1639100928, + "artical_title": "Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure.", + "pmid": 31926059, + "journal_name": "European journal of heart failure", + "date": "2020-01-12", + "author": "Butler J,Handelsman Y,Bakris G,Verma S", + "auth_pos": 1, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Glucose, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 636, + "user_id": 1639100928, + "artical_title": "Prescription drug spending and hospital use among Medicare beneficiaries with heart failure.", + "pmid": 31953113, + "journal_name": "Research in social & administrative pharmacy : RSAP", + "date": "2020-01-19", + "author": "McGee BT,Higgins MK,Phillips V,Butler J", + "auth_pos": 4, + "meshterms": "Aged, Health Expenditures, Heart Failure*, Heart Failure/drug therapy, Hospitals, Humans, Medicare Part D*, Prescription Drugs*, Retrospective Studies, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 637, + "user_id": 1639100928, + "artical_title": "Growing Mismatch Between Evidence Generation and Implementation in Heart Failure.", + "pmid": 31958429, + "journal_name": "The American journal of medicine", + "date": "2020-01-21", + "author": "Bhatt AS,Vaduganathan M,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 638, + "user_id": 1639100928, + "artical_title": "Low- Versus Moderate-Sodium Diet in Patients With Recent Hospitalization for Heart Failure: The PROHIBIT (Prevent Adverse Outcomes in Heart Failure by Limiting Sodium) Pilot Study.", + "pmid": 31959014, + "journal_name": "Circulation. Heart failure", + "date": "2020-01-22", + "author": "Kalogeropoulos A,Papadimitriou L,Georgiopoulou VV,Dunbar SB,Skopicki H,Butler J", + "auth_pos": 6, + "meshterms": "Aged, Female, Heart Failure, Heart Failure/metabolism*, Heart Failure/physiopathology*, Heart Failure/prevention & control, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/metabolism, Peptide Fragments, Peptide Fragments/metabolism, Pilot Projects, Quality of Life, Sodium, Sodium/metabolism*, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 639, + "user_id": 1639100928, + "artical_title": "Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease.", + "pmid": 30765039, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-01-23", + "author": "Valero-Elizondo J,Khera R,Saxena A,Grandhi GR,Virani SS,Butler J,Samad Z,Desai NR,Krumholz HM,Nasir K", + "auth_pos": 6, + "meshterms": "Adult, Atherosclerosis, Atherosclerosis/diagnosis, Atherosclerosis/economics*, Atherosclerosis/therapy, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/economics*, Cardiovascular Diseases/therapy, Cost of Illness*, Health Expenditures*, Humans, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 640, + "user_id": 1639100928, + "artical_title": "Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.", + "pmid": 30819362, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-01-24", + "author": "Butler J,Yang M,Manzi MA,Hess GP,Patel MJ,Rhodes T,Givertz MM", + "auth_pos": 1, + "meshterms": "Adolescent, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use*, Adult, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Disease Progression, Female, Follow-Up Studies, Heart Failure, Heart Failure/drug therapy, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hospitalization, Hospitalization/trends, Humans, Incidence, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use*, Prognosis, Registries*, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Survival Rate, Survival Rate/trends, United States, United States/epidemiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 641, + "user_id": 1639100928, + "artical_title": "Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.", + "pmid": 31984682, + "journal_name": "ESC heart failure", + "date": "2020-01-28", + "author": "Anand IS,Konstam MA,Klein HU,Mann DL,Ardell JL,Gregory DD,Massaro JM,Libbus I,DiCarlo LA,Udelson JJE,Butler J,Parker JD,Teerlink JR", + "auth_pos": 11, + "meshterms": "Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/therapy, Humans, Male, Middle Aged, Plant Nectar, Stroke Volume, Treatment Outcome, Vagus Nerve Stimulation*, Ventricular Function, Left, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/therapy, Humans, Male, Middle Aged, Plant Nectar, Stroke Volume, Treatment Outcome, Vagus Nerve Stimulation*, Ventricular Function, Left, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/therapy, Humans, Male, Middle Aged, Plant Nectar, Stroke Volume, Treatment Outcome, Vagus Nerve Stimulation*, Ventricular Function, Left, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/therapy, Humans, Male, Middle Aged, Plant Nectar, Stroke Volume, Treatment Outcome, Vagus Nerve Stimulation*, Ventricular Function, Left, Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/therapy, Humans, Male, Middle Aged, Plant Nectar, Stroke Volume, Treatment Outcome, Vagus Nerve Stimulation*, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 642, + "user_id": 1639100928, + "artical_title": "Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes.", + "pmid": 31998851, + "journal_name": "JACC. Basic to translational science", + "date": "2020-01-31", + "author": "Iborra-Egea O,Santiago-Vacas E,Yurista SR,Lupón J,Packer M,Heymans S,Zannad F,Butler J,Pascual-Figal D,Lax A,Núñez J,de Boer RA,Bayés-Genís A", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 643, + "user_id": 1639100928, + "artical_title": "Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial.", + "pmid": 32068002, + "journal_name": "Journal of cardiac failure", + "date": "2020-02-19", + "author": "Butler J,Khan MS,Anker SD,Fonarow GC,Kim RJ,Nodari S,O'Connor CM,Pieske B,Pieske-Kraigher E,Sabbah HN,Senni M,Voors AA,Udelson JE,Carr J,Gheorghiade M,Filippatos G", + "auth_pos": 1, + "meshterms": "Aged, Female, Heart Failure*, Heart Failure/drug therapy, Humans, Middle Aged, Oligopeptides, Stroke Volume, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 644, + "user_id": 1639100928, + "artical_title": "Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life.", + "pmid": 32154649, + "journal_name": "European journal of heart failure", + "date": "2020-03-11", + "author": "Khan MS,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "Heart Failure*, Heart Failure/therapy, Humans, Obesity, Patient Reported Outcome Measures, Quality of Life*, Sedentary Behavior, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 645, + "user_id": 1639100928, + "artical_title": "Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper.", + "pmid": 32171762, + "journal_name": "JACC. Heart failure", + "date": "2020-03-17", + "author": "Ibrahim NE,Burnett JC,Butler J,Camacho A,Felker GM,Fiuzat M,O'Connor C,Solomon SD,Vaduganathan M,Zile MR,Januzzi JL", + "auth_pos": 3, + "meshterms": "Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume, Biomarkers, Heart Failure*, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptides, Peptide Fragments, Prognosis, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 646, + "user_id": 1639100928, + "artical_title": "Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.", + "pmid": 32211813, + "journal_name": "JAMA cardiology", + "date": "2020-03-27", + "author": "Tahhan AS,Vaduganathan M,Greene SJ,Alrohaibani A,Raad M,Gafeer M,Mehran R,Fonarow GC,Douglas PS,Bhatt DL,Butler J", + "auth_pos": 11, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/ethnology*, Acute Coronary Syndrome/therapy, Clinical Trials as Topic*, Continental Population Groups*, Ethnic Groups*, Female, Humans, Male, Minority Groups*, Patient Selection*, Sex Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 647, + "user_id": 1639100928, + "artical_title": "The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF.", + "pmid": 32212297, + "journal_name": "European journal of heart failure", + "date": "2020-03-27", + "author": "Bhatt AS,Ambrosy AP,Dunning A,DeVore AD,Butler J,Reed S,Voors A,Starling R,Armstrong PW,Ezekowitz JA,Metra M,Hernandez AF,O'Connor CM,Mentz RJ", + "auth_pos": 5, + "meshterms": "Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome, Acute Disease, Aged, Angiotensin Receptor Antagonists*, Comorbidity, Cost of Illness, Female, Health Care Costs, Heart Failure*, Heart Failure/economics, Heart Failure/epidemiology, Heart Failure/physiopathology, Heart Failure/therapy, Hospitalization, Hospitalization/economics, Hospitalization/statistics & numerical data, Humans, Length of Stay, Length of Stay/economics, Length of Stay/statistics & numerical data, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke Volume, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 648, + "user_id": 1639100928, + "artical_title": "Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction.", + "pmid": 32216011, + "journal_name": "European journal of heart failure", + "date": "2020-03-28", + "author": "Kramer F,Voss S,Roessig L,Igl BW,Butler J,Lam CSP,Maggioni AP,Shah SJ,Pieske B", + "auth_pos": 5, + "meshterms": "Aged, C-Reactive Protein, Female, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Humans, Male, Middle Aged, Pyrimidines, Stroke Volume, Uric Acid, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 649, + "user_id": 1639100928, + "artical_title": "Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.", + "pmid": 32222134, + "journal_name": "The New England journal of medicine", + "date": "2020-03-30", + "author": "Armstrong PW,Pieske B,Anstrom KJ,Ezekowitz J,Hernandez AF,Butler J,Lam CSP,Ponikowski P,Voors AA,Jia G,McNulty SE,Patel MJ,Roessig L,Koglin J,O'Connor CM", + "auth_pos": 6, + "meshterms": "Administration, Oral, Aged, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Chronic Disease, Double-Blind Method, Female, Follow-Up Studies, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 2-Ring/adverse effects, Heterocyclic Compounds, 2-Ring/therapeutic use*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Hypotension, Hypotension/chemically induced, Incidence, Male, Middle Aged, Pyrimidines, Pyrimidines/adverse effects, Pyrimidines/therapeutic use*, Soluble Guanylyl Cyclase, Soluble Guanylyl Cyclase/metabolism, Stroke Volume, Syncope, Syncope/chemically induced, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 650, + "user_id": 1639100928, + "artical_title": "Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.", + "pmid": 32227432, + "journal_name": "Diabetes, obesity & metabolism", + "date": "2020-04-01", + "author": "Verma S,Sharma A,Zinman B,Ofstad AP,Fitchett D,Brueckmann M,Wanner C,Zwiener I,George JT,Inzucchi SE,Butler J,Mazer CD", + "auth_pos": 11, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/prevention & control, Hospitalization, Humans, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Risk Factors, Thrombolytic Therapy, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/prevention & control, Hospitalization, Humans, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Risk Factors, Thrombolytic Therapy, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/prevention & control, Hospitalization, Humans, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Risk Factors, Thrombolytic Therapy, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/prevention & control, Hospitalization, Humans, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Risk Factors, Thrombolytic Therapy, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/prevention & control, Hospitalization, Humans, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Risk Factors, Thrombolytic Therapy, Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 651, + "user_id": 1639100928, + "artical_title": "Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial.", + "pmid": 32237012, + "journal_name": "European journal of heart failure", + "date": "2020-04-03", + "author": "de Denus S,Leclair G,Dubé MP,St-Jean I,Zada YF,Oussaïd E,Jutras M,Givertz MM,Mentz RJ,Tang WHW,Ferreira JP,Rouleau J,Butler J,Kalogeropoulos AP", + "auth_pos": 13, + "meshterms": "Aged, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Female, Heart Failure*, Heart Failure/drug therapy, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Spironolactone, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 652, + "user_id": 1639100928, + "artical_title": "Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fraction.", + "pmid": 32239794, + "journal_name": "European journal of heart failure", + "date": "2020-04-03", + "author": "Butler J,Khan MS,Mori C,Filippatos GS,Ponikowski P,Comin-Colet J,Roubert B,Spertus JA,Anker SD", + "auth_pos": 1, + "meshterms": "Aged, Female, Health Status, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Male, Middle Aged, Minimal Clinically Important Difference, Patient Reported Outcome Measures*, Quality of Life*, Randomized Controlled Trials as Topic, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 653, + "user_id": 1639100928, + "artical_title": "Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy.", + "pmid": 32243706, + "journal_name": "Diabetes, obesity & metabolism", + "date": "2020-04-04", + "author": "Butler J,Januzzi JL,Rosenstock J", + "auth_pos": 1, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 654, + "user_id": 1639100928, + "artical_title": "Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk.", + "pmid": 32245636, + "journal_name": "The American journal of cardiology", + "date": "2020-04-05", + "author": "Vaduganathan M,Singh A,Sharma A,Januzzi JL,Scirica BM,Butler J,Zannad F,McGuire DK,Cannon CP,Bhatt DL", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 655, + "user_id": 1639100928, + "artical_title": "Endpoints in Heart Failure Drug Development: History and Future.", + "pmid": 32278679, + "journal_name": "JACC. Heart failure", + "date": "2020-04-13", + "author": "Fiuzat M,Lowy N,Stockbridge N,Sbolli M,Latta F,Lindenfeld J,Lewis EF,Abraham WT,Teerlink J,Walsh M,Heidenreich P,Bozkurt B,Starling RC,Solomon S,Felker GM,Butler J,Yancy C,Stevenson LW,O'Connor C,Unger E,Temple R,McMurray J", + "auth_pos": 16, + "meshterms": "Cardiovascular Agents, Cardiovascular Agents/history*, Cardiovascular Agents/pharmacology, Drug Approval, Drug Approval/history, Drug Development, Drug Development/history*, Health Status*, Heart Failure, Heart Failure/drug therapy, Heart Failure/history*, History, 20th Century, History, 21st Century, Humans, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 656, + "user_id": 1639100928, + "artical_title": "Trends in prevalence of comorbidities in heart failure clinical trials.", + "pmid": 32293090, + "journal_name": "European journal of heart failure", + "date": "2020-04-16", + "author": "Khan MS,Samman Tahhan A,Vaduganathan M,Greene SJ,Alrohaibani A,Anker SD,Vardeny O,Fonarow GC,Butler J", + "auth_pos": 9, + "meshterms": "Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology, Chronic Disease, Chronic Disease/epidemiology, Chronic Disease/trends, Clinical Trials as Topic, Clinical Trials as Topic/statistics & numerical data*, Comorbidity, Comorbidity/trends*, Heart Failure*, Heart Failure/epidemiology, Humans, Prevalence, Prognosis, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 657, + "user_id": 1639100928, + "artical_title": "From PARADIGM to PARAGON further evidence supporting continuous heart failure spectrum.", + "pmid": 32294294, + "journal_name": "European journal of heart failure", + "date": "2020-04-16", + "author": "Triposkiadis F,Xanthopoulos A,Butler J", + "auth_pos": 3, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Drug Combinations, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Tetrazoles", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 658, + "user_id": 1639100928, + "artical_title": "With great power comes great… reliability.", + "pmid": 32301141, + "journal_name": "European journal of heart failure", + "date": "2020-04-18", + "author": "Ziaeian B,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Heart Failure*, Humans, Reproducibility of Results, Heart Failure*, Humans, Reproducibility of Results", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 659, + "user_id": 1639100928, + "artical_title": "Istaroxime in acute heart failure: the holy grail is at HORIZON?", + "pmid": 32374050, + "journal_name": "European journal of heart failure", + "date": "2020-05-07", + "author": "Chioncel O,Collins SP,Butler J", + "auth_pos": 3, + "meshterms": "Cardiotonic Agents, Cardiotonic Agents/therapeutic use, Etiocholanolone, Etiocholanolone/analogs & derivatives, Heart Failure*, Heart Failure/drug therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 660, + "user_id": 1639100928, + "artical_title": "The real world of de novo heart failure: the next frontier for heart failure clinical trials?", + "pmid": 32374051, + "journal_name": "European journal of heart failure", + "date": "2020-05-07", + "author": "Khan MS,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "Chronic Disease, Cohort Studies, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Readmission*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 661, + "user_id": 1639100928, + "artical_title": "Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.", + "pmid": 32387066, + "journal_name": "JACC. Heart failure", + "date": "2020-05-11", + "author": "Vaduganathan M,Fonarow GC,Greene SJ,DeVore AD,Kavati A,Sikirica S,Albert NM,Duffy CI,Hill CL,Patterson JH,Spertus JA,Thomas LE,Williams FB,Hernandez AF,Butler J", + "auth_pos": 15, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use*, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Female, Follow-Up Studies, Guideline Adherence, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use*, Outpatients, Outpatients/statistics & numerical data, Prospective Studies, Registries, Stroke Volume, Stroke Volume/physiology*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 662, + "user_id": 1639100928, + "artical_title": "Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic.", + "pmid": 32405232, + "journal_name": "Journal of cardiac failure", + "date": "2020-05-15", + "author": "Hall ME,Vaduganathan M,Khan MS,Papadimitriou L,Long RC,Hernandez GA,Moore CK,Lennep BW,McMullan MR,Butler J", + "auth_pos": 10, + "meshterms": "Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States, Betacoronavirus, COVID-19, Coronavirus*, Coronavirus Infections*, Heart Failure*, Hospitalization, Humans, Pandemics*, Pneumonia, Viral*, SARS-CoV-2, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 663, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects.", + "pmid": 32410463, + "journal_name": "Circulation", + "date": "2020-05-16", + "author": "Griffin M,Rao VS,Ivey-Miranda J,Fleming J,Mahoney D,Maulion C,Suda N,Siwakoti K,Ahmad T,Jacoby D,Riello R,Bellumkonda L,Cox Z,Collins S,Jeon S,Turner JM,Wilson FP,Butler J,Inzucchi SE,Testani JM", + "auth_pos": 18, + "meshterms": "Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/pharmacokinetics, Diabetes Complications*, Diabetes Complications/drug therapy, Diabetes Complications/urine, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/urine, Diuretics*, Diuretics/administration & dosage, Diuretics/pharmacokinetics, Double-Blind Method, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/pharmacokinetics, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Heart Failure/urine, Humans, Male, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 664, + "user_id": 1639100928, + "artical_title": "Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.", + "pmid": 32427023, + "journal_name": "Journal of the American Heart Association", + "date": "2020-05-20", + "author": "Khan MS,Shahid I,Siddiqi TJ,Khan SU,Warraich HJ,Greene SJ,Butler J,Michos ED", + "auth_pos": 7, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/ethnology, Clinical Trials as Topic*, Drug Approval*, Female, Health Status Disparities*, Healthcare Disparities, Healthcare Disparities/ethnology, Healthcare Disparities/trends*, Humans, Male, Metabolic Diseases, Metabolic Diseases/drug therapy*, Metabolic Diseases/ethnology, Minority Groups*, Patient Selection*, Race Factors, Sex Factors, Time Factors, United States, United States Food and Drug Administration, United States Food and Drug Administration/trends*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 665, + "user_id": 1639100928, + "artical_title": "Epicardial prestrained confinement and residual stresses: a newly observed heart ventricle confinement interface.", + "pmid": 30862283, + "journal_name": "Journal of the Royal Society, Interface", + "date": "2020-05-21", + "author": "Shi X,Liu Y,Copeland KM,McMahan SR,Zhang S,Butler JR,Hong Y,Cho M,Bajona P,Gao H,Liao J", + "auth_pos": 6, + "meshterms": "Animals, Heart Ventricles*, Models, Cardiovascular*, Myocardial Contraction, Myocardial Contraction/physiology, Myocardium*, Pericardium, Pericardium/physiology*, Stress, Mechanical*, Swine, Ventricular Function*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 666, + "user_id": 1639100928, + "artical_title": "N8-Acetylspermidine: A Polyamine Biomarker in Ischemic Cardiomyopathy With Reduced Ejection Fraction.", + "pmid": 32458724, + "journal_name": "Journal of the American Heart Association", + "date": "2020-05-28", + "author": "Nayak A,Liu C,Mehta A,Ko YA,Tahhan AS,Dhindsa DS,Uppal K,Jones DP,Butler J,Morris AA,Quyyumi AA", + "auth_pos": 9, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnosis, Cardiomyopathies/mortality, Cardiomyopathies/physiopathology, Case-Control Studies, Female, Heart Failure, Heart Failure/blood, Heart Failure/mortality, Heart Failure/physiopathology, Humans, Incidence, Male, Metabolomics, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/blood*, Myocardial Ischemia/diagnosis, Myocardial Ischemia/mortality, Myocardial Ischemia/physiopathology, Predictive Value of Tests, Prevalence, Prognosis, Prospective Studies, Reproducibility of Results, Risk Assessment, Risk Factors, Spermidine, Spermidine/analogs & derivatives*, Spermidine/blood, Spermine, Spermine/analogs & derivatives, Spermine/blood*, Stroke Volume*, Up-Regulation, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 667, + "user_id": 1639100928, + "artical_title": "Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology.", + "pmid": 32463543, + "journal_name": "European journal of heart failure", + "date": "2020-05-29", + "author": "Zhang Y,Coats AJS,Zheng Z,Adamo M,Ambrosio G,Anker SD,Butler J,Xu D,Mao J,Khan MS,Bai L,Mebazaa A,Ponikowski P,Tang Q,Ruschitzka F,Seferovic P,Tschöpe C,Zhang S,Gao C,Zhou S,Senni M,Zhang J,Metra M", + "auth_pos": 7, + "meshterms": "Betacoronavirus*, COVID-19, Cardiology*, China, Comorbidity, Coronavirus Infections, Coronavirus Infections/epidemiology*, Coronavirus Infections/therapy, Disease Management*, Europe, Heart Failure, Heart Failure/epidemiology, Heart Failure/therapy*, Humans, Pandemics*, Pneumonia, Viral, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/therapy, SARS-CoV-2, Societies, Medical*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 668, + "user_id": 1639100928, + "artical_title": "Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis.", + "pmid": 32469156, + "journal_name": "European journal of heart failure", + "date": "2020-05-30", + "author": "Kalogeropoulos AP,Thankachen J,Butler J,Fang JC", + "auth_pos": 3, + "meshterms": "Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Spironolactone, Stroke Volume, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 669, + "user_id": 1639100928, + "artical_title": "Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan.", + "pmid": 32482089, + "journal_name": "Circulation. Heart failure", + "date": "2020-06-03", + "author": "Januzzi JL,Camacho A,Piña IL,Rocha R,Williamson KM,Maisel AS,Felker GM,Prescott MF,Butler J,Solomon SD", + "auth_pos": 9, + "meshterms": "Aminobutyrates, Aminobutyrates/adverse effects, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Disease Progression, Drug Combinations, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/drug therapy*, Heart Failure/mortality, Heart Failure/physiopathology, Hospitalization, Humans, Neprilysin, Neprilysin/antagonists & inhibitors, Protease Inhibitors, Protease Inhibitors/adverse effects, Protease Inhibitors/therapeutic use*, Recovery of Function, Tetrazoles, Tetrazoles/adverse effects, Tetrazoles/therapeutic use*, Time Factors, Treatment Outcome, Ventricular Function, Left, Ventricular Function, Left/drug effects*, Ventricular Remodeling, Ventricular Remodeling/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 670, + "user_id": 1639100928, + "artical_title": "Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk.", + "pmid": 32482088, + "journal_name": "Circulation. Heart failure", + "date": "2020-06-03", + "author": "Greene SJ,Fonarow GC,Butler J", + "auth_pos": 3, + "meshterms": "Disease Progression, Heart Failure, Heart Failure/diagnosis*, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Predictive Value of Tests, Prognosis, Risk Assessment, Risk Factors, Terminology as Topic*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 671, + "user_id": 1639100928, + "artical_title": "Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).", + "pmid": 32498081, + "journal_name": "European heart journal", + "date": "2020-06-05", + "author": "Anker SD,Butler J,Khan MS,Abraham WT,Bauersachs J,Bocchi E,Bozkurt B,Braunwald E,Chopra VK,Cleland JG,Ezekowitz J,Filippatos G,Friede T,Hernandez AF,Lam CSP,Lindenfeld J,McMurray JJV,Mehra M,Metra M,Packer M,Pieske B,Pocock SJ,Ponikowski P,Rosano GMC,Teerlink JR,Tsutsui H,Van Veldhuisen DJ,Verma S,Voors AA,Wittes J,Zannad F,Zhang J,Seferovic P,Coats AJS", + "auth_pos": 2, + "meshterms": "Betacoronavirus*, COVID-19, Clinical Trials as Topic, Clinical Trials as Topic/ethics, Clinical Trials as Topic/methods*, Clinical Trials as Topic/standards, Coronavirus Infections*, Europe, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Humans, Informed Consent, Informed Consent/ethics, Informed Consent/standards, Pandemics*, Patient Safety, Patient Selection, Patient Selection/ethics, Pneumonia, Viral*, Research Design, Research Design/standards*, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 672, + "user_id": 1639100928, + "artical_title": "Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.", + "pmid": 32498812, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-06-06", + "author": "Ferreira JP,Butler J,Rossignol P,Pitt B,Anker SD,Kosiborod M,Lund LH,Bakris GL,Weir MR,Zannad F", + "auth_pos": 2, + "meshterms": "Gastrointestinal Diseases, Gastrointestinal Diseases/blood, Gastrointestinal Diseases/diagnosis, Heart Failure, Heart Failure/blood*, Heart Failure/diagnosis, Humans, Hyperkalemia, Hyperkalemia/blood*, Hyperkalemia/diagnosis, Hypokalemia, Hypokalemia/blood*, Hypokalemia/diagnosis, Potassium, Potassium/blood*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 673, + "user_id": 1639100928, + "artical_title": "Cigarette Smoking and Incident Stroke in Blacks of the Jackson Heart Study.", + "pmid": 32517526, + "journal_name": "Journal of the American Heart Association", + "date": "2020-06-11", + "author": "Oshunbade AA,Yimer WK,Valle KA,Clark D,Kamimura D,White WB,DeFilippis AP,Blaha MJ,Benjamin EJ,O'Brien EC,Mentz RJ,Fox ER,O'Mara CS,Butler J,Correa A,Hall ME", + "auth_pos": 14, + "meshterms": "Adult, African Americans*, Aged, Aged, 80 and over, Cigarette Smoking, Cigarette Smoking/adverse effects*, Cigarette Smoking/ethnology*, Cigarette Smoking/mortality, Disease-Free Survival, Ex-Smokers, Female, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Non-Smokers, Prospective Studies, Risk Assessment, Risk Factors, Smokers, Stroke, Stroke/diagnosis, Stroke/ethnology*, Stroke/mortality, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 674, + "user_id": 1639100928, + "artical_title": "Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers.", + "pmid": 32524327, + "journal_name": "Heart failure reviews", + "date": "2020-06-12", + "author": "Triposkiadis F,Xanthopoulos A,Parissis J,Butler J,Farmakis D", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 675, + "user_id": 1639100928, + "artical_title": "Sodium-glucose co-transporter 2 inhibitors: 'a tale of two sisters', diabetes and heart failure.", + "pmid": 32533724, + "journal_name": "European journal of heart failure", + "date": "2020-06-14", + "author": "Farmakis D,Butler J,Filippatos G", + "auth_pos": 2, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 676, + "user_id": 1639100928, + "artical_title": "Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.", + "pmid": 32540922, + "journal_name": "Diabetes care", + "date": "2020-06-17", + "author": "Segar MW,Patel KV,Vaduganathan M,Caughey MC,Butler J,Fonarow GC,Grodin JL,McGuire DK,Pandey A", + "auth_pos": 5, + "meshterms": "Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Aged, Blood Glucose, Blood Glucose/metabolism*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Diabetic Angiopathies, Diabetic Angiopathies/blood, Diabetic Angiopathies/epidemiology, Female, Follow-Up Studies, Glycated Hemoglobin A, Glycated Hemoglobin A/analysis, Glycated Hemoglobin A/metabolism, Glycemic Control, Glycemic Control/statistics & numerical data, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology*, Heart Failure/etiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 677, + "user_id": 1639100928, + "artical_title": "Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design.", + "pmid": 31722536, + "journal_name": "Circulation. Heart failure", + "date": "2020-06-17", + "author": "Konstam MA,Udelson JE,Butler J,Klein HU,Parker JD,Teerlink JR,Wedge PM,Saville BR,Ardell JL,Libbus I,DiCarlo LA", + "auth_pos": 3, + "meshterms": "Autonomic Nervous System, Autonomic Nervous System/physiopathology*, Cardiovascular Agents, Cardiovascular Agents/adverse effects, Cardiovascular Agents/therapeutic use*, Combined Modality Therapy, Disease Progression, Europe, Heart, Heart/innervation*, Heart Failure, Heart Failure/diagnosis, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Humans, Multicenter Studies as Topic, North America, Randomized Controlled Trials as Topic, Recovery of Function, Time Factors, Treatment Outcome, Vagus Nerve Stimulation*, Vagus Nerve Stimulation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 678, + "user_id": 1639100928, + "artical_title": "Antihyperglycemic Therapies with Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns within an Academic Medical Center.", + "pmid": 32569016, + "journal_name": "Journal of cardiovascular pharmacology", + "date": "2020-06-23", + "author": "Hamid A,Vaduganathan M,Oshunbade A,Ayyalasomayajula KK,Kalogeropoulos AP,Lien LF,Shafi T,Hall M,Butler J", + "auth_pos": 9, + "meshterms": "Academic Medical Centers, Academic Medical Centers/trends*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Approval*, Drug Utilization, Drug Utilization/trends, Electronic Health Records, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Incretins, Incretins/adverse effects, Incretins/therapeutic use*, Male, Middle Aged, Practice Patterns, Physicians', Practice Patterns, Physicians'/trends*, Retrospective Studies, Risk Assessment, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Time Factors, Treatment Outcome, United States, United States/epidemiology, United States Food and Drug Administration*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 679, + "user_id": 1639100928, + "artical_title": "Hypertensive diseases in pregnancy, cardiac structure and function later in life: Insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.", + "pmid": 32570153, + "journal_name": "Pregnancy hypertension", + "date": "2020-06-23", + "author": "Oshunbade AA,Hamid A,Lirette ST,Gbadamosi SO,Yimer WK,Orimoloye OA,Clark D,Kamimura D,Grado SD,Lutz EA,Mentz RJ,Fox ER,Butler J,Gwen Windham B,Butler KR,Mosley TH,Hall ME", + "auth_pos": 13, + "meshterms": "African Americans, African Americans/statistics & numerical data, Aged, Case-Control Studies, Echocardiography, Female, Humans, Hypertension, Hypertension/epidemiology*, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Surveys and Questionnaires, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/epidemiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 680, + "user_id": 1639100928, + "artical_title": "Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.", + "pmid": 32580657, + "journal_name": "Circulation. Heart failure", + "date": "2020-06-26", + "author": "DeVore AD,Hellkamp AS,Thomas L,Albert NM,Butler J,Patterson JH,Spertus JA,Williams FB,Duffy CI,Hernandez AF,Fonarow GC", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 681, + "user_id": 1639100928, + "artical_title": "Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.", + "pmid": 32635768, + "journal_name": "Circulation. Heart failure", + "date": "2020-07-09", + "author": "Morris AA,Nayak A,Ko YA,D'Souza M,Felker GM,Redfield MM,Tang WHW,Testani JM,Butler J", + "auth_pos": 9, + "meshterms": "Acute Disease, African Americans*, Aged, Aged, 80 and over, Continental Population Groups, Diuretics, Diuretics/pharmacology, Diuretics/therapeutic use, Female, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/ethnology*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Randomized Controlled Trials as Topic, Renin, Renin/blood, Renin-Angiotensin System, Renin-Angiotensin System/drug effects, Renin-Angiotensin System/physiology, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 682, + "user_id": 1639100928, + "artical_title": "Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities.", + "pmid": 32654354, + "journal_name": "European journal of heart failure", + "date": "2020-07-13", + "author": "Quarta G,Gori M,Iorio A,D'Elia E,Moon JC,Iacovoni A,Burocchi S,Schelbert EB,Brambilla P,Sironi S,Caravita S,Parati G,Gavazzi A,Maisel AS,Butler J,Lam CSP,Senni M", + "auth_pos": 15, + "meshterms": "Comorbidity, Heart Failure*, Heart Failure/diagnostic imaging, Humans, Magnetic Resonance Spectroscopy, Muscle Cells, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 683, + "user_id": 1639100928, + "artical_title": "Recognizing the Significance of Outpatient Worsening Heart Failure.", + "pmid": 32662304, + "journal_name": "Journal of the American Heart Association", + "date": "2020-07-15", + "author": "Khan MS,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "Diuretics, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Outpatients*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 684, + "user_id": 1639100928, + "artical_title": "Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic.", + "pmid": 32470516, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-07-25", + "author": "Bhatt AS,Moscone A,McElrath EE,Varshney AS,Claggett BL,Bhatt DL,Januzzi JL,Butler J,Adler DS,Solomon SD,Vaduganathan M", + "auth_pos": 8, + "meshterms": "Aged, Aged, 80 and over, Betacoronavirus, COVID-19, Cardiovascular Diseases*, Coronavirus Infections*, Female, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Pandemics*, Pneumonia, Viral*, Retrospective Studies, SARS-CoV-2, Tertiary Care Centers, Tertiary Care Centers/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 685, + "user_id": 1639100928, + "artical_title": "Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials.", + "pmid": 32757645, + "journal_name": "Circulation. Heart failure", + "date": "2020-08-08", + "author": "Reza N,Tahhan AS,Mahmud N,DeFilippis EM,Alrohaibani A,Vaduganathan M,Greene SJ,Ho AH,Fonarow GC,Butler J,O'Connor C,Fiuzat M,Vardeny O,Piña IL,Lindenfeld J,Jessup M", + "auth_pos": 10, + "meshterms": "Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*, Authorship*, Cardiology*, Europe, Female, Humans, Manuscripts, Medical as Topic*, Publishing, Publishing/statistics & numerical data*, United States, Women*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 686, + "user_id": 1639100928, + "artical_title": "Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event.", + "pmid": 32761552, + "journal_name": "Advances in therapy", + "date": "2020-08-08", + "author": "Butler J,Djatche LM,Sawhney B,Chakladar S,Yang L,Brady JE,Yang M", + "auth_pos": 1, + "meshterms": "Chronic Disease, Chronic Disease/economics*, Chronic Disease/therapy*, Cost of Illness*, Female, Heart Failure, Heart Failure/economics*, Heart Failure/epidemiology, Heart Failure/therapy*, Hospitalization, Hospitalization/economics*, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 687, + "user_id": 1639100928, + "artical_title": "Disparities in discharge disposition after hospitalizations for decompensated heart failure.", + "pmid": 32798116, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2020-08-17", + "author": "Khan MZ,Khan SU,Khan MS,Butler J,Alkhouli M", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 688, + "user_id": 1639100928, + "artical_title": "Heart Failure Prevention for All: Treatment Is Good, Prevention Is Better.", + "pmid": 32805347, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-08-18", + "author": "Butler J,Khan MS", + "auth_pos": 1, + "meshterms": "Biomarkers, Cardiovascular Diseases*, Female, Heart Disease Risk Factors, Heart Failure*, Heart Failure/prevention & control, Humans, Hypertension*, Male, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 689, + "user_id": 1639100928, + "artical_title": "?-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications.", + "pmid": 31957469, + "journal_name": "Circulation. Heart failure", + "date": "2020-08-19", + "author": "Düngen HD,Dordevic A,Felix SB,Pieske B,Voors AA,McMurray JJV,Butler J", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 690, + "user_id": 1639100928, + "artical_title": "Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology.", + "pmid": 32833519, + "journal_name": "Circulation", + "date": "2020-08-25", + "author": "Psotka MA,Fiuzat M,Solomon SD,Chauhan C,Felker GM,Butler J,Teerlink JR,Sinha SS,O'Connor CM,Konstam MA", + "auth_pos": 6, + "meshterms": "Cardiology, Cardiology/economics, Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/economics, Cost-Benefit Analysis, Drug Costs*, Humans, Insurance, Pharmaceutical Services*, Pharmaceutical Preparations, Pharmaceutical Preparations/economics*, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 691, + "user_id": 1639100928, + "artical_title": "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.", + "pmid": 32865377, + "journal_name": "The New England journal of medicine", + "date": "2020-09-01", + "author": "Packer M,Anker SD,Butler J,Filippatos G,Pocock SJ,Carson P,Januzzi J,Verma S,Tsutsui H,Brueckmann M,Jamal W,Kimura K,Schnee J,Zeller C,Cotton D,Bocchi E,Böhm M,Choi DJ,Chopra V,Chuquiure E,Giannetti N,Janssens S,Zhang J,Gonzalez Juanatey JR,Kaul S,Brunner-La Rocca HP,Merkely B,Nicholls SJ,Perrone S,Pina I,Ponikowski P,Sattar N,Senni M,Seronde MF,Spinar J,Squire I,Taddei S,Wanner C,Zannad F", + "auth_pos": 3, + "meshterms": "Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Aged, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Disease Progression, Double-Blind Method, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glucosides, Glucosides/adverse effects, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Proportional Hazards Models, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 692, + "user_id": 1639100928, + "artical_title": "Clinical Associations of Vascular Stiffness, Microvascular Dysfunction, and Prevalent Cardiovascular Disease in a Black Cohort: The Jackson Heart Study.", + "pmid": 32873113, + "journal_name": "Journal of the American Heart Association", + "date": "2020-09-03", + "author": "Cooper LL,Musani SK,Moore JA,Clarke VA,Yano Y,Cobbs K,Tsao CW,Butler J,Hall ME,Hamburg NM,Benjamin EJ,Vasan RS,Mitchell GF,Fox ER", + "auth_pos": 8, + "meshterms": "African Americans, African Americans/statistics & numerical data*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/physiopathology, Cross-Sectional Studies, Female, Humans, Male, Manometry, Microcirculation*, Mississippi, Mississippi/epidemiology, Prevalence, Pulse Wave Analysis, Risk Factors, Vascular Stiffness*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 693, + "user_id": 1639100928, + "artical_title": "Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications.", + "pmid": 32875490, + "journal_name": "Heart failure reviews", + "date": "2020-09-03", + "author": "Triposkiadis F,Starling RC,Xanthopoulos A,Butler J,Boudoulas H", + "auth_pos": 4, + "meshterms": "Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects*, Angiotensin-Converting Enzyme Inhibitors/pharmacology, COVID-19, COVID-19/chemically induced*, Humans, Renin-Angiotensin System, Renin-Angiotensin System/drug effects*, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects*, Angiotensin-Converting Enzyme Inhibitors/pharmacology, COVID-19, COVID-19/chemically induced*, Humans, Renin-Angiotensin System, Renin-Angiotensin System/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 694, + "user_id": 1639100928, + "artical_title": "SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.", + "pmid": 32877652, + "journal_name": "Lancet (London, England)", + "date": "2020-09-03", + "author": "Zannad F,Ferreira JP,Pocock SJ,Anker SD,Butler J,Filippatos G,Brueckmann M,Ofstad AP,Pfarr E,Jamal W,Packer M", + "auth_pos": 5, + "meshterms": "Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects*, Benzhydryl Compounds/therapeutic use, Body Mass Index, Case-Control Studies, Cause of Death, Cause of Death/trends, Clinical Trials as Topic, Death, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Drug Therapy, Combination, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Glomerular Filtration Rate/physiology, Glucosides, Glucosides/adverse effects*, Glucosides/therapeutic use, Heart Failure, Heart Failure/classification, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Neprilysin, Neprilysin/antagonists & inhibitors, Patient Outcome Assessment, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 695, + "user_id": 1639100928, + "artical_title": "Medicaid Expansion and Utilization of Antihyperglycemic Therapies.", + "pmid": 32887711, + "journal_name": "Diabetes care", + "date": "2020-09-06", + "author": "Sumarsono A,Buckley LF,Machado SR,Wadhera RK,Warraich HJ,Desai RJ,Everett BM,McGuire DK,Fonarow GC,Butler J,Pandey A,Vaduganathan M", + "auth_pos": 10, + "meshterms": "Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology, Adult, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/epidemiology, Drug Utilization, Drug Utilization/economics*, Female, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Humans, Male, Medicaid, Medicaid/economics*, Patient Protection and Affordable Care Act, Poverty, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/economics*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 696, + "user_id": 1639100928, + "artical_title": "Relation of Low Normal Left Ventricular Ejection Fraction to Heart Failure Hospitalization in Blacks (From the Jackson Heart Study).", + "pmid": 32910930, + "journal_name": "The American journal of cardiology", + "date": "2020-09-11", + "author": "Kamimura D,Valle KA,Blackshear C,Mentz RJ,Yeboah J,Rodriguez CJ,Herrington DM,Suzuki T,Clark ?D,Fox ER,Shah AM,Stacey RB,Hundley WG,Correa A,Butler J,Hall ME", + "auth_pos": 15, + "meshterms": "Adult, African Americans, African Americans/statistics & numerical data*, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Longitudinal Studies, Male, Middle Aged, Mississippi, Mississippi/epidemiology, Prospective Studies, Risk Assessment, Stroke Volume*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 697, + "user_id": 1639100928, + "artical_title": "Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials.", + "pmid": 32909376, + "journal_name": "ESC heart failure", + "date": "2020-09-11", + "author": "Savarese G,Schrage B,Cosentino F,Lund LH,Rosano GMC,Seferovic P,Butler J", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 698, + "user_id": 1639100928, + "artical_title": "Totality of evidence in trials of sodium-glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice.", + "pmid": 32935133, + "journal_name": "European heart journal", + "date": "2020-09-17", + "author": "Butler J,Zannad F,Filippatos G,Anker SD,Packer M", + "auth_pos": 1, + "meshterms": "Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 699, + "user_id": 1639100928, + "artical_title": "Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.", + "pmid": 32941789, + "journal_name": "American heart journal", + "date": "2020-09-18", + "author": "Shaikh A,Ochani RK,Khan MS,Riaz H,Khan SU,Sreenivasan J,Mookadam F,Doukky R,Butler J,Michos ED,Kalra A,Krasuski RA", + "auth_pos": 9, + "meshterms": "Angina Pectoris, Angina Pectoris/epidemiology, Angina Pectoris/mortality, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cardiovascular Diseases/therapy, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Journal Impact Factor, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Periodicals as Topic, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/statistics & numerical data*, Risk, Stroke, Stroke/epidemiology, Stroke/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 700, + "user_id": 1639100928, + "artical_title": "Sex-Based Differences in Biomarkers, Health Status, and Reverse Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan.", + "pmid": 32946164, + "journal_name": "European journal of heart failure", + "date": "2020-09-19", + "author": "Ibrahim NE,Piña IL,Camacho A,Bapat D,Felker GM,Maisel AS,Butler J,Prescott MF,Abbas CA,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "Aged, Aminobutyrates*, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Biomarkers, Biomarkers/metabolism, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Drug Combinations, Female, Health Status, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Heart Failure/pathology, Humans, Male, Middle Aged, Prospective Studies, Valsartan*, Valsartan/therapeutic use, Ventricular Remodeling, Ventricular Remodeling/drug effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 701, + "user_id": 1639100928, + "artical_title": "Ten lessons from the EMPEROR-Reduced trial.", + "pmid": 32949160, + "journal_name": "European journal of heart failure", + "date": "2020-09-20", + "author": "Butler J,Zannad F,Filippatos G,Anker SD,Packer M", + "auth_pos": 1, + "meshterms": "Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Humans, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2/metabolism, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 702, + "user_id": 1639100928, + "artical_title": "Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.", + "pmid": 32955939, + "journal_name": "Circulation", + "date": "2020-09-22", + "author": "Khan MS,Fonarow GC,McGuire DK,Hernandez AF,Vaduganathan M,Rosenstock J,Handelsman Y,Verma S,Anker SD,McMurray JJV,Kosiborod MN,Butler J", + "auth_pos": 12, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists*, Glucagon-Like Peptide-1 Receptor/metabolism, Glucosides, Glucosides/therapeutic use*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Humans, Practice Guidelines as Topic, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 703, + "user_id": 1639100928, + "artical_title": "Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.", + "pmid": 33016100, + "journal_name": "Circulation. Heart failure", + "date": "2020-10-06", + "author": "Ibrahim NE,Piña IL,Camacho A,Bapat D,Felker GM,Maisel AS,Butler J,Prescott MF,Abbas CA,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "African Americans, Aged, Aminobutyrates, Aminobutyrates/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Drug Combinations, European Continental Ancestry Group, Female, Health Status Disparities*, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/ethnology, Heart Failure/physiopathology, Hispanic Americans, Humans, Longitudinal Studies, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Prospective Studies, Race Factors, Recovery of Function, Risk Assessment, Risk Factors, Stroke Volume, Stroke Volume/drug effects*, Tetrazoles, Tetrazoles/therapeutic use*, Time Factors, Treatment Outcome, United States, United States/epidemiology, Ventricular Function, Left, Ventricular Function, Left/drug effects*, Ventricular Remodeling, Ventricular Remodeling/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 704, + "user_id": 1639100928, + "artical_title": "N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.", + "pmid": 33039447, + "journal_name": "JACC. Heart failure", + "date": "2020-10-12", + "author": "Ezekowitz JA,O'Connor CM,Troughton RW,Alemayehu WG,Westerhout CM,Voors AA,Butler J,Lam CSP,Ponikowski P,Emdin M,Patel MJ,Pieske B,Roessig L,Hernandez AF,Armstrong PW", + "auth_pos": 7, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Female, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/physiopathology, Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 2-Ring/therapeutic use*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Prognosis, Protein Precursors, Pyrimidines, Pyrimidines/therapeutic use*, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 705, + "user_id": 1639100928, + "artical_title": "Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.", + "pmid": 33079152, + "journal_name": "JAMA", + "date": "2020-10-21", + "author": "Armstrong PW,Lam CSP,Anstrom KJ,Ezekowitz J,Hernandez AF,O'Connor CM,Pieske B,Ponikowski P,Shah SJ,Solomon SD,Voors AA,She L,Vlajnic V,Carvalho F,Bamber L,Blaustein RO,Roessig L,Butler J", + "auth_pos": 18, + "meshterms": "Administration, Oral, Aged, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects*, Female, Guanylate Cyclase, Guanylate Cyclase/metabolism, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 2-Ring/administration & dosage, Heterocyclic Compounds, 2-Ring/adverse effects, Heterocyclic Compounds, 2-Ring/therapeutic use*, Hospitalization, Humans, Least-Squares Analysis, Male, Middle Aged, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/adverse effects, Pyrimidines/therapeutic use*, Quality of Life*, Stroke Volume, Treatment Failure, Walk Test", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 706, + "user_id": 1639100928, + "artical_title": "Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy.", + "pmid": 33083790, + "journal_name": "JACC. CardioOncology", + "date": "2020-10-22", + "author": "Vaduganathan M,Hirji SA,Qamar A,Bajaj N,Gupta A,Zaha V,Chandra A,Haykowsky M,Ky B,Moslehi J,Nohria A,Butler J,Pandey A", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 707, + "user_id": 1639100928, + "artical_title": "Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.", + "pmid": 33081531, + "journal_name": "Circulation", + "date": "2020-10-22", + "author": "Packer M,Anker SD,Butler J,Filippatos GS,Ferreira JP,Pocock S,Carson PE,Anand IS,Doehner W,Haass M,Komajda M,Miller AB,Pehrson S,Teerlink JR,Brueckmann M,Jamal W,Zeller C,Schnaidt S,Zannad F", + "auth_pos": 3, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 708, + "user_id": 1639100928, + "artical_title": "Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials.", + "pmid": 33083685, + "journal_name": "Digital biomarkers", + "date": "2020-10-22", + "author": "Kramer F,Butler J,Shah SJ,Jung C,Nodari S,Rosenkranz S,Senni M,Bamber L,Cichos S,Dori C,Karakoyun T,Köhler GJ,Patel K,Piraino P,Viethen T,Chennuru P,Paydar A,Sims J,Clark R,van Lummel R,Müller A,Gwaltney C,Smajlovic S,Düngen HD,Dinh W", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 709, + "user_id": 1639100928, + "artical_title": "Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial.", + "pmid": 33095032, + "journal_name": "Circulation", + "date": "2020-10-24", + "author": "Zannad F,Ferreira JP,Pocock SJ,Zeller C,Anker SD,Butler J,Filippatos G,Hauske SJ,Brueckmann M,Pfarr E,Schnee J,Wanner C,Packer M", + "auth_pos": 6, + "meshterms": "Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Kidney, Kidney/drug effects*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Kidney, Kidney/drug effects*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Kidney, Kidney/drug effects*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Kidney, Kidney/drug effects*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 710, + "user_id": 1639100928, + "artical_title": "Prediction of worsening heart failure events and all-cause mortality using an individualized risk stratification strategy.", + "pmid": 33118331, + "journal_name": "ESC heart failure", + "date": "2020-10-30", + "author": "Zile MR,Koehler J,Sarkar S,Butler J", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 711, + "user_id": 1639100928, + "artical_title": "Assessment of Heterogeneity in Heart Failure-Related Meta-Analyses.", + "pmid": 33131285, + "journal_name": "Circulation. Heart failure", + "date": "2020-11-03", + "author": "Khan MS,Li L,Yasmin F,Khan SU,Bajaj NS,Pandey A,Murad MH,Fonarow GC,Butler J,Vaduganathan M", + "auth_pos": 9, + "meshterms": "Data Accuracy, Data Interpretation, Statistical, Evidence-Based Medicine*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Meta-Analysis as Topic*, Reproducibility of Results, Research Design*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 712, + "user_id": 1639100928, + "artical_title": "Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study.", + "pmid": 33158949, + "journal_name": "Diabetes care", + "date": "2020-11-08", + "author": "Januzzi JL,Butler J,Sattar N,Xu J,Shaw W,Rosenthal N,Pfeifer M,Mahaffey KW,Neal B,Hansen MK", + "auth_pos": 2, + "meshterms": "Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Insulin-Like Growth Factor Binding Proteins, Insulin-Like Growth Factor Binding Proteins/blood*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Insulin-Like Growth Factor Binding Proteins, Insulin-Like Growth Factor Binding Proteins/blood*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Insulin-Like Growth Factor Binding Proteins, Insulin-Like Growth Factor Binding Proteins/blood*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 713, + "user_id": 1639100928, + "artical_title": "The Time Is Now for Sodium Glucose Co-Transporter 2 Inhibitors for Heart Failure: A Call to Overcome Clinical Inertia.", + "pmid": 33161728, + "journal_name": "Circulation. Heart failure", + "date": "2020-11-10", + "author": "Khan MS,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Glucose, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 714, + "user_id": 1639100928, + "artical_title": "Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP-HF registry.", + "pmid": 33170559, + "journal_name": "ESC heart failure", + "date": "2020-11-11", + "author": "Khariton Y,Fonarow GC,Hellkamp A,Thomas L,Nassif ME,Butler J,Duffy CI,Albert NM,Spertus JA", + "auth_pos": 6, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Biphenyl Compounds, Drug Combinations, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Quality of Life, Registries, Stroke Volume, Valsartan", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 715, + "user_id": 1639100928, + "artical_title": "Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.", + "pmid": 33175585, + "journal_name": "Circulation", + "date": "2020-11-12", + "author": "Anker SD,Butler J,Filippatos G,Khan MS,Marx N,Lam CSP,Schnaidt S,Ofstad AP,Brueckmann M,Jamal W,Bocchi E,Ponikowski P,Perrone SV,Januzzi JL,Verma S,Böhm M,Ferreira JP,Pocock SJ,Zannad F,Packer M", + "auth_pos": 2, + "meshterms": "Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Male, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 716, + "user_id": 1639100928, + "artical_title": "Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.", + "pmid": 33185662, + "journal_name": "JAMA cardiology", + "date": "2020-11-14", + "author": "Vaduganathan M,Greene SJ,Zhang S,Grau-Sepulveda M,DeVore AD,Butler J,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Fonarow GC", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 717, + "user_id": 1639100928, + "artical_title": "Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction.", + "pmid": 33189630, + "journal_name": "JACC. Heart failure", + "date": "2020-11-16", + "author": "Piña IL,Camacho A,Ibrahim NE,Felker GM,Butler J,Maisel AS,Prescott MF,Williamson KM,Claggett BL,Desai AS,Solomon SD,Januzzi JL", + "auth_pos": 5, + "meshterms": "Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Biphenyl Compounds, Cross-Sectional Studies, Drug Combinations, Female, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Male, Middle Aged, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 718, + "user_id": 1639100928, + "artical_title": "Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction.", + "pmid": 33189632, + "journal_name": "JACC. Heart failure", + "date": "2020-11-16", + "author": "Murphy SP,Prescott MF,Camacho A,Iyer SR,Maisel AS,Felker GM,Butler J,Piña IL,Ibrahim NE,Abbas C,Burnett JC,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Atrial Natriuretic Factor*, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Humans, Middle Aged, Prospective Studies, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Treatment Outcome, Valsartan, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 719, + "user_id": 1639100928, + "artical_title": "Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2.", + "pmid": 33189635, + "journal_name": "JACC. Heart failure", + "date": "2020-11-16", + "author": "Loungani RS,Teerlink JR,Metra M,Allen LA,Butler J,Carson PE,Chen CW,Cotter G,Davison BA,Eapen ZJ,Filippatos GS,Gimpelewicz C,Greenberg B,Holbro T,Januzzi JL,Lanfear DE,Pang PS,Piña IL,Ponikowski P,Miller AB,Voors AA,Felker GM", + "auth_pos": 5, + "meshterms": "Acute Disease, Cause of Death, Heart Failure*, Heart Failure/drug therapy, Humans, Recombinant Proteins, Relaxin*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 720, + "user_id": 1639100928, + "artical_title": "Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results.", + "pmid": 33191637, + "journal_name": "ESC heart failure", + "date": "2020-11-17", + "author": "Khan MS,Shahid I,Asad N,Greene SJ,Khan SU,Doukky R,Metra M,Anker SD,Filippatos GS,Fonarow GC,Butler J", + "auth_pos": 11, + "meshterms": "Cross-Sectional Studies, Heart Failure*, Heart Failure/therapy, Humans, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 721, + "user_id": 1639100928, + "artical_title": "Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.", + "pmid": 33197395, + "journal_name": "Lancet (London, England)", + "date": "2020-11-17", + "author": "Ponikowski P,Kirwan BA,Anker SD,McDonagh T,Dorobantu M,Drozdz J,Fabien V,Filippatos G,Göhring UM,Keren A,Khintibidze I,Kragten H,Martinez FA,Metra M,Milicic D,Nicolau JC,Ohlsson M,Parkhomenko A,Pascual-Figal DA,Ruschitzka F,Sim D,Skouri H,van der Meer P,Lewis BS,Comin-Colet J,von Haehling S,Cohen-Solal A,Danchin N,Doehner W,Dargie HJ,Motro M,Butler J,Friede T,Jensen KH,Pocock S,Jankowska EA", + "auth_pos": 32, + "meshterms": "Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left, Administration, Intravenous, Aged, Aged, 80 and over, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy*, Double-Blind Method, Female, Ferric Compounds, Ferric Compounds/administration & dosage, Ferric Compounds/therapeutic use*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/mortality, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Maltose, Maltose/administration & dosage, Maltose/analogs & derivatives*, Maltose/therapeutic use, Middle Aged, Patient Discharge, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 722, + "user_id": 1639100928, + "artical_title": "Benefit-Risk Tradeoffs in Assessment of New Drugs and Devices.", + "pmid": 33196311, + "journal_name": "Circulation", + "date": "2020-11-17", + "author": "Kaul S,Stockbridge N,Butler J", + "auth_pos": 3, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/metabolism, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy*, Diabetes Mellitus, Type 2/metabolism, Drug Discovery*, Embolism, Embolism/etiology, Embolism/metabolism, Embolism/prevention & control*, Equipment and Supplies*, Fibrinolytic Agents, Fibrinolytic Agents/therapeutic use*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Sodium-Glucose Transport Proteins, Sodium-Glucose Transport Proteins/antagonists & inhibitors, Sodium-Glucose Transport Proteins/metabolism, Stroke, Stroke/etiology, Stroke/metabolism, Stroke/prevention & control*, United States, United States Food and Drug Administration", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 723, + "user_id": 1639100928, + "artical_title": "Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical Trial.", + "pmid": 33206126, + "journal_name": "JAMA cardiology", + "date": "2020-11-19", + "author": "Collins SP,Liu D,Jenkins CA,Storrow AB,Levy PD,Pang PS,Chang AM,Char D,Diercks DJ,Fermann GJ,Han JH,Hiestand B,Hogan C,Kampe CJ,Khan Y,Lee S,Lindenfeld J,Martindale J,McNaughton CD,Miller KF,Miller-Reilly C,Moser K,Peacock WF,Robichaux C,Rothman R,Schrock J,Self WH,Singer AJ,Sterling SA,Ward MJ,Walsh C,Butler J", + "auth_pos": 32, + "meshterms": "Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine, Acute Disease, Aged, Ambulatory Care*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Emergency Service, Hospital*, Female, Heart Failure, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, House Calls, Humans, Male, Middle Aged, Patient Discharge*, Quality of Life*, Self Care, Self Care/methods*, Telemedicine", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 724, + "user_id": 1639100928, + "artical_title": "Regulation of Cardiovascular Therapies During the COVID-19 Public Health Emergency.", + "pmid": 33213730, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-11-21", + "author": "Vaduganathan M,Butler J,Krumholz HM,Itchhaporia D,Stecker EC,Bhatt DL", + "auth_pos": 2, + "meshterms": "COVID-19, Cardiovascular Diseases, Cardiovascular Diseases/therapy*, Emergencies, Health Services Accessibility*, Health Services Accessibility/legislation & jurisprudence, Humans, Public Health, United States, United States Food and Drug Administration", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 725, + "user_id": 1639100928, + "artical_title": "Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study.", + "pmid": 33222388, + "journal_name": "European journal of heart failure", + "date": "2020-11-23", + "author": "Anker MS,von Haehling S,Coats AJ,Riess H,Eucker J,Porthun J,Butler J,Karakas M,Haverkamp W,Landmesser U,Anker SD", + "auth_pos": 7, + "meshterms": "Carcinoma, Non-Small-Cell Lung*, Colon, Electrocardiography, Ambulatory, Heart Failure*, Humans, Lung, Lung Neoplasms*, Pancreatic Neoplasms*, Prospective Studies, Tachycardia, Ventricular*, Ventricular Premature Complexes*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 726, + "user_id": 1639100928, + "artical_title": "Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes.", + "pmid": 33237259, + "journal_name": "JAMA cardiology", + "date": "2020-11-26", + "author": "Honigberg MC,Patel RB,Pandey A,Fonarow GC,Butler J,McGuire DK,Vaduganathan M", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 727, + "user_id": 1639100928, + "artical_title": "Advanced cancer is also a heart failure syndrome - an hypothesis.", + "pmid": 33247608, + "journal_name": "European journal of heart failure", + "date": "2020-11-29", + "author": "Anker MS,Sanz AP,Zamorano JL,Mehra MR,Butler J,Riess H,Coats AJS,Anker SD", + "auth_pos": 5, + "meshterms": "Arrhythmias, Cardiac, Defibrillators, Implantable*, Heart Failure*, Humans, Neoplasms*, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 728, + "user_id": 1639100928, + "artical_title": "TEMPORARY NOTICE: 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).", + "pmid": 33250265, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-12-01", + "author": "Bozkurt B,Hershberger RE,Butler J,Isler ML,Grady KL,Kirklin JK,Heidenreich PA,Weintraub WS", + "auth_pos": 4, + "meshterms": "Advisory Committees, Advisory Committees/standards*, American Heart Association*, Cardiology, Cardiology/standards*, Cardiology/statistics & numerical data, Data Analysis, Databases, Factual, Databases, Factual/standards*, Databases, Factual/statistics & numerical data, Heart Failure, Heart Failure/epidemiology, Heart Failure/therapy*, Humans, Research Report, Research Report/standards*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 729, + "user_id": 1639100928, + "artical_title": "Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials.", + "pmid": 33254286, + "journal_name": "ESC heart failure", + "date": "2020-12-01", + "author": "Khan MS,Khan MAA,Irfan S,Siddiqi TJ,Greene SJ,Anker SD,Sreenivasan J,Friede T,Tahhan AS,Vaduganathan M,Fonarow GC,Butler J", + "auth_pos": 12, + "meshterms": "Heart Failure*, Heart Failure/therapy, Humans, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 730, + "user_id": 1639100928, + "artical_title": "Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial.", + "pmid": 33251670, + "journal_name": "European journal of heart failure", + "date": "2020-12-01", + "author": "Anker SD,Butler J,Filippatos G,Khan MS,Ferreira JP,Bocchi E,Böhm M,Rocca HPB,Choi DJ,Chopra V,Chuquiure E,Giannetti N,Gomez-Mesa JE,Janssens S,Januzzi JL,Gonzalez-Juanatey JR,Merkely B,Nicholls SJ,Perrone SV,Piña IL,Ponikowski P,Senni M,Seronde MF,Sim D,Spinar J,Squire I,Taddei S,Tsutsui H,Verma S,Vinereanu D,Zhang J,Jamal W,Schnaidt S,Schnee JM,Brueckmann M,Pocock SJ,Zannad F,Packer M", + "auth_pos": 2, + "meshterms": "Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use*, Biomarkers, Biomarkers/blood, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Female, Glucosides, Glucosides/therapeutic use*, Heart Failure*, Heart Failure/blood, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 731, + "user_id": 1639100928, + "artical_title": "Design of a Prospective Patient-Level Pooled Analysis of Two Parallel Trials of Empagliflozin in Patients With Established Heart Failure.", + "pmid": 33251659, + "journal_name": "European journal of heart failure", + "date": "2020-12-01", + "author": "Packer M,Butler J,Filippatos G,Zannad F,Ferreira JP,Zeller C,Brueckmann M,Jamal W,Pocock S,Anker SD", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 732, + "user_id": 1639100928, + "artical_title": "Temporal Trends in Risk Profiles Among Patients Hospitalized for Heart Failure.", + "pmid": 33264607, + "journal_name": "American heart journal", + "date": "2020-12-03", + "author": "Hamo CE,Fonarow GC,Greene SJ,Vaduganathan M,Yancy CW,Heidenreich P,Lu D,Matsouaka RA,DeVore AD,Butler J", + "auth_pos": 10, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People, Age Factors, Aged, Aged, 80 and over, Blood Pressure, Blood Urea Nitrogen, Comorbidity, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Heart Failure, Heart Failure/blood, Heart Failure/epidemiology, Heart Failure/physiopathology*, Heart Rate, Hispanic or Latino, Hospital Mortality, Hospital Mortality/trends*, Hospitalization, Humans, Logistic Models, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive, Risk Factors, Severity of Illness Index, Sex Factors, Sodium, Sodium/blood, Stroke Volume, White People", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 733, + "user_id": 1639100928, + "artical_title": "Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function.", + "pmid": 33274601, + "journal_name": "ESC heart failure", + "date": "2020-12-05", + "author": "Tschöpe C,Butler J,Farmakis D,Morley D,Rao I,Filippatos G", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 734, + "user_id": 1639100928, + "artical_title": "The role of sodium glucose co-transporter inhibitors in heart failure prevention.", + "pmid": 33280983, + "journal_name": "Journal of diabetes and its complications", + "date": "2020-12-08", + "author": "Garla V,Subauste A,Butler J,Lien LF", + "auth_pos": 3, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 735, + "user_id": 1639100928, + "artical_title": "Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF.", + "pmid": 33289458, + "journal_name": "Journal of the American Heart Association", + "date": "2020-12-09", + "author": "Fudim M,Brooksbank J,Giczewska A,Greene SJ,Grodin JL,Martens P,Ter Maaten JM,Sharma A,Verbrugge FH,Chakraborty H,Bart BA,Butler J,Hernandez AF,Felker GM,Mentz RJ", + "auth_pos": 12, + "meshterms": "Acute Disease, Aged, Aldosterone, Aldosterone/analysis, Creatinine, Creatinine/analysis, Female, Heart Failure, Heart Failure/complications, Heart Failure/physiopathology*, Heart Failure/therapy*, Hospitalization, Hospitalization/statistics & numerical data, Humans, Intention to Treat Analysis, Intention to Treat Analysis/methods, Kidney Diseases, Kidney Diseases/physiopathology*, Male, Middle Aged, Retrospective Studies, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Ultrafiltration, Ultrafiltration/adverse effects*, Ultrafiltration/methods", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 736, + "user_id": 1639100928, + "artical_title": "Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America.", + "pmid": 33289664, + "journal_name": "Journal of cardiac failure", + "date": "2020-12-09", + "author": "Greene SJ,Adusumalli S,Albert NM,Hauptman PJ,Rich MW,Heidenreich PA,Butler J", + "auth_pos": 7, + "meshterms": "Ambulatory Care Facilities, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 737, + "user_id": 1639100928, + "artical_title": "Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis.", + "pmid": 33300277, + "journal_name": "ESC heart failure", + "date": "2020-12-11", + "author": "Fudim M,Ashur N,Jones AD,Ambrosy AP,Bart BA,Butler J,Chen HH,Greene SJ,Reddy Y,Redfield MM,Sharma A,Hernandez AF,Felker GM,Borlaug BA,Mentz RJ", + "auth_pos": 6, + "meshterms": "Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left, Body Mass Index, Edema, Edema/epidemiology, Edema/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 738, + "user_id": 1639100928, + "artical_title": "Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.", + "pmid": 33301829, + "journal_name": "International journal of cardiology", + "date": "2020-12-11", + "author": "Volpe M,Bauersachs J,Bayés-Genís A,Butler J,Cohen-Solal A,Gallo G,Deichl AS,Khan MS,Battistoni A,Pieske B,Saito Y,Zieroth S", + "auth_pos": 4, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Stroke Volume, Tetrazoles, Valsartan", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 739, + "user_id": 1639100928, + "artical_title": "Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.", + "pmid": 33309579, + "journal_name": "JACC. Heart failure", + "date": "2020-12-15", + "author": "Srivastava PK,DeVore AD,Hellkamp AS,Thomas L,Albert NM,Butler J,Patterson JH,Spertus JA,Williams FB,Duffy CI,Hernandez AF,Fonarow GC", + "auth_pos": 6, + "meshterms": "Adult, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Patient Discharge, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 740, + "user_id": 1639100928, + "artical_title": "Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.", + "pmid": 33309582, + "journal_name": "JACC. Heart failure", + "date": "2020-12-15", + "author": "Bhatt AS,Abraham WT,Lindenfeld J,Bristow M,Carson PE,Felker GM,Fonarow GC,Greene SJ,Psotka MA,Solomon SD,Stockbridge N,Teerlink JR,Vaduganathan M,Wittes J,Fiuzat M,O'Connor CM,Butler J", + "auth_pos": 17, + "meshterms": "Heart Failure*, Heart Failure/drug therapy, Humans, Renin-Angiotensin System, Stroke Volume, Sympathetic Nervous System", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 741, + "user_id": 1639100928, + "artical_title": "Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes.", + "pmid": 33309581, + "journal_name": "JACC. Heart failure", + "date": "2020-12-15", + "author": "Khan MS,Felker GM,Piña IL,Camacho A,Bapat D,Ibrahim NE,Maisel AS,Prescott MF,Ward JH,Solomon SD,Januzzi JL,Butler J", + "auth_pos": 12, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Biphenyl Compounds, Cross-Sectional Studies, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Drug Combinations, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Prospective Studies, Stroke Volume, Valsartan, Valsartan/therapeutic use, Ventricular Function, Left, Ventricular Remodeling", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 742, + "user_id": 1639100928, + "artical_title": "Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.", + "pmid": 33351892, + "journal_name": "European heart journal", + "date": "2020-12-23", + "author": "Abraham WT,Lindenfeld J,Ponikowski P,Agostoni P,Butler J,Desai AS,Filippatos G,Gniot J,Fu M,Gullestad L,Howlett JG,Nicholls SJ,Redon J,Schenkenberger I,Silva-Cardoso J,Störk S,Krzysztof Wranicz J,Savarese G,Brueckmann M,Jamal W,Nordaby M,Peil B,Ritter I,Ustyugova A,Zeller C,Salsali A,Anker SD", + "auth_pos": 5, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 743, + "user_id": 1639100928, + "artical_title": "Major Depression and Anxiety Among Patients Hospitalized with Heart Failure.", + "pmid": 33383015, + "journal_name": "The American journal of cardiology", + "date": "2021-01-01", + "author": "Sreenivasan J,Khan MS,Ochani RK,Bhinder J,Usman MS,Anker SD,Fonarow GC,Butler J", + "auth_pos": 8, + "meshterms": "Anxiety Disorders, Anxiety Disorders/epidemiology*, Depressive Disorder, Major, Depressive Disorder, Major/epidemiology*, Female, Heart Failure, Heart Failure/epidemiology*, Hospitalization*, Humans, Inpatients, Inpatients/statistics & numerical data, Logistic Models, Male, Prevalence, Sex Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 744, + "user_id": 1639100928, + "artical_title": "Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.", + "pmid": 33420498, + "journal_name": "European heart journal", + "date": "2021-01-10", + "author": "Butler J,Anker SD,Filippatos G,Khan MS,Ferreira JP,Pocock SJ,Giannetti N,Januzzi JL,Piña IL,Lam CSP,Ponikowski P,Sattar N,Verma S,Brueckmann M,Jamal W,Vedin O,Peil B,Zeller C,Zannad F,Packer M", + "auth_pos": 1, + "meshterms": "Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Quality of Life*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 745, + "user_id": 1639100928, + "artical_title": "Challenges and the innovations in the care of advanced heart failure patients during COVID-19.", + "pmid": 33432419, + "journal_name": "Heart failure reviews", + "date": "2021-01-13", + "author": "Yehya A,Shah KS,Mitter SS,Ibrahim NE,Sperry B,Shah M,Chaudhry SP,Rajagopalan N,Hernandez-Montfort J,Mohan R,Alexander KM,Sinha S,Butler J,Kittleson MM", + "auth_pos": 13, + "meshterms": "COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2, COVID-19*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Heart-Assist Devices*, Humans, Pandemics, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 746, + "user_id": 1639100928, + "artical_title": "2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.", + "pmid": 33446410, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-01-16", + "author": "Maddox TM,Januzzi JL,Allen LA,Breathett K,Butler J,Davis LL,Fonarow GC,Ibrahim NE,Lindenfeld J,Masoudi FA,Motiwala SR,Oliveros E,Patterson JH,Walsh MN,Wasserman A,Yancy CW,Youmans QR", + "auth_pos": 6, + "meshterms": "Advisory Committees, Cardiology, Cardiology/standards, Disease Management*, Heart Failure, Heart Failure/therapy*, Humans, Stroke Volume*, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 747, + "user_id": 1639100928, + "artical_title": "The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Physiopathology and Clinical Implications.", + "pmid": 33454213, + "journal_name": "Heart, lung & circulation", + "date": "2021-01-18", + "author": "Triposkiadis F,Starling RC,Xanthopoulos A,Butler J,Boudoulas H", + "auth_pos": 4, + "meshterms": "Acute Lung Injury*, Acute Lung Injury/drug therapy, Acute Lung Injury/immunology, Angiotensin-Converting Enzyme 2, Angiotensin-Converting Enzyme 2/metabolism*, COVID-19*, COVID-19/metabolism, COVID-19/physiopathology, COVID-19/virology, Down-Regulation, Drug Discovery, Humans, Renin-Angiotensin System, Renin-Angiotensin System/immunology*, SARS-CoV-2, SARS-CoV-2/physiology, Signal Transduction*, Signal Transduction/drug effects, Signal Transduction/immunology, Acute Lung Injury*, Acute Lung Injury/drug therapy, Acute Lung Injury/immunology, Angiotensin-Converting Enzyme 2, Angiotensin-Converting Enzyme 2/metabolism*, COVID-19*, COVID-19/metabolism, COVID-19/physiopathology, COVID-19/virology, Down-Regulation, Drug Discovery, Humans, Renin-Angiotensin System, Renin-Angiotensin System/immunology*, SARS-CoV-2, SARS-CoV-2/physiology, Signal Transduction*, Signal Transduction/drug effects, Signal Transduction/immunology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 748, + "user_id": 1639100928, + "artical_title": "Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.", + "pmid": 33459776, + "journal_name": "European heart journal", + "date": "2021-01-19", + "author": "Packer M,Anker SD,Butler J,Filippatos G,Ferreira JP,Pocock SJ,Rocca HB,Janssens S,Tsutsui H,Zhang J,Brueckmann M,Jamal W,Cotton D,Iwata T,Schnee J,Zannad F", + "auth_pos": 3, + "meshterms": "Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Benzhydryl Compounds, Drug Combinations, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Neprilysin*, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 749, + "user_id": 1639100928, + "artical_title": "Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction.", + "pmid": 33471236, + "journal_name": "Heart failure reviews", + "date": "2021-01-21", + "author": "Greene SJ,Tan X,Yeh YC,Bernauer M,Zaidi O,Yang M,Butler J", + "auth_pos": 7, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Biphenyl Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Biphenyl Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 750, + "user_id": 1639100928, + "artical_title": "Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.", + "pmid": 33497697, + "journal_name": "American heart journal", + "date": "2021-01-27", + "author": "Albert NM,Tyson RJ,Hill CL,DeVore AD,Spertus JA,Duffy C,Butler J,Patterson JH,Hernandez AF,Williams FB,Thomas L,Fonarow GC", + "auth_pos": 7, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use*, Neprilysin, Neprilysin/antagonists & inhibitors*, Registries, Renin-Angiotensin System, Renin-Angiotensin System/drug effects*, Retrospective Studies, Stroke Volume, Stroke Volume/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 751, + "user_id": 1639100928, + "artical_title": "Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Sub-Study.", + "pmid": 33497809, + "journal_name": "Journal of cardiac failure", + "date": "2021-01-27", + "author": "Perez AL,Grodin JL,Chaikijurajai T,Wu Y,Hernandez AF,Butler J,Metra M,Michael Felker G,Voors AA,McMurray JJ,Armstrong PW,O'Connor C,Starling RC,Wilson Tang WH", + "auth_pos": 6, + "meshterms": "Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models, Acute Disease, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-6*, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Proportional Hazards Models", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 752, + "user_id": 1639100928, + "artical_title": "Impact of polyvascular disease with and without coexistent kidney dysfunction on cardiovascular outcomes in diabetes: a post-hoc analysis of EMPA-REG OUTCOME®.", + "pmid": 33502090, + "journal_name": "Diabetes, obesity & metabolism", + "date": "2021-01-28", + "author": "Verma S,Mazer CD,Inzucchi SE,Wanner C,Ofstad AP,Johansen OE,Zwiener I,George JT,Butler J,Zinman B", + "auth_pos": 9, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Kidney, Risk Factors, Treatment Outcome, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Kidney, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 753, + "user_id": 1639100928, + "artical_title": "Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction.", + "pmid": 33529619, + "journal_name": "The American journal of cardiology", + "date": "2021-02-03", + "author": "Salah HM,Fudim M,Al'Aref SJ,Khan MS,Almarzooq ZI,Devabhaktuni SR,Mentz RJ,Butler J,Greene SJ", + "auth_pos": 8, + "meshterms": "Aminobutyrates, Aminobutyrates/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Cause of Death, Drug Combinations, Heart Failure, Heart Failure/blood, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Humans, Mortality, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Severity of Illness Index, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 754, + "user_id": 1639100928, + "artical_title": "INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction.", + "pmid": 33527654, + "journal_name": "ESC heart failure", + "date": "2021-02-03", + "author": "Zile MR,Costanzo MRR,Ippolito EM,Zhang Y,Stapleton R,Sadhu A,Jimenez J,Hobbs J,Sharma V,Warman EN,Streeter L,Butler J", + "auth_pos": 12, + "meshterms": "Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume, Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume, Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume, Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume, Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume, Feasibility Studies, Heart Failure*, Heart Failure/drug therapy, Humans, Prospective Studies, Risk Assessment, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 755, + "user_id": 1639100928, + "artical_title": "Effect of Obesity on Response to Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction.", + "pmid": 33529620, + "journal_name": "The American journal of cardiology", + "date": "2021-02-03", + "author": "Elkholey K,Papadimitriou L,Butler J,Thadani U,Stavrakis S", + "auth_pos": 3, + "meshterms": "Aged, Comorbidity, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Obesity, Obesity/epidemiology*, Prevalence, Prognosis, Prospective Studies, Spironolactone, Spironolactone/therapeutic use*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome, United States, United States/epidemiology, Aged, Comorbidity, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Obesity, Obesity/epidemiology*, Prevalence, Prognosis, Prospective Studies, Spironolactone, Spironolactone/therapeutic use*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome, United States, United States/epidemiology, Aged, Comorbidity, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Obesity, Obesity/epidemiology*, Prevalence, Prognosis, Prospective Studies, Spironolactone, Spironolactone/therapeutic use*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome, United States, United States/epidemiology, Aged, Comorbidity, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/epidemiology, Heart Failure/physiopathology, Humans, Male, Obesity, Obesity/epidemiology*, Prevalence, Prognosis, Prospective Studies, Spironolactone, Spironolactone/therapeutic use*, Stroke Volume, Stroke Volume/physiology*, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 756, + "user_id": 1639100928, + "artical_title": "Standardizing the Standard: Reporting Health Status in Clinical Trials.", + "pmid": 33543813, + "journal_name": "European journal of heart failure", + "date": "2021-02-06", + "author": "Arnold SV,Butler J,Spertus JA", + "auth_pos": 2, + "meshterms": "Health Status, Heart Failure*, Humans, Research Design", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 757, + "user_id": 1639100928, + "artical_title": "Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.", + "pmid": 33586910, + "journal_name": "ESC heart failure", + "date": "2021-02-16", + "author": "Butler J,Usman MS,Khan MS,Greene SJ,Friede T,Vaduganathan M,Filippatos G,Coats AJS,Anker SD", + "auth_pos": 1, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 758, + "user_id": 1639100928, + "artical_title": "Use of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Heart Failure and Type 2 Diabetes Mellitus: Data from the Swedish Heart Failure Registry.", + "pmid": 33599357, + "journal_name": "European journal of heart failure", + "date": "2021-02-19", + "author": "Becher PM,Schrage B,Ferrannini G,Benson L,Butler J,Carrero JJ,Cosentino F,Dahlström U,Mellbin L,Rosano GM,Sinagra G,Stolfo D,Lund LH,Savarese G", + "auth_pos": 5, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Glucose, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Registries, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sweden, Sweden/epidemiology, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 759, + "user_id": 1639100928, + "artical_title": "A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure Consensus Conference.", + "pmid": 33605000, + "journal_name": "European journal of heart failure", + "date": "2021-02-20", + "author": "Bozkurt B,Coats AJS,Tsutsui H,Abdelhamid M,Adamopoulos S,Albert N,Anker SD,Atherton J,Böhm M,Butler J,Drazner MH,Felker GM,Filippatos G,Fiuzat M,Fonarow GC,Gomez-Mesa JE,Heidenreich P,Imamura T,Jankowska EA,Januzzi J,Khazanie P,Kinugawa K,Lam CSP,Matsue Y,Metra M,Ohtani T,Piepoli MF,Ponikowski P,Rosano GMC,Sakata Y,Seferovi? P,Starling RC,Teerlink JR,Vardeny O,Yamamoto K,Yancy C,Zhang J,Zieroth S", + "auth_pos": 11, + "meshterms": "Australia, Canada, Cardiology*, China, Heart Failure*, Humans, India, Japan, New Zealand, Prognosis, Stroke Volume, Ventricular Function, Left, Writing", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 760, + "user_id": 1639100928, + "artical_title": "Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial.", + "pmid": 33619896, + "journal_name": "ESC heart failure", + "date": "2021-02-24", + "author": "Khan MS,Siddiqi TJ,Butler J,Friede T,Levy WC,Witte KK,Lipiecki J,Sievert H,Coats AJS", + "auth_pos": 3, + "meshterms": "Humans, Incidence, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 761, + "user_id": 1639100928, + "artical_title": "Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials.", + "pmid": 33621540, + "journal_name": "American heart journal", + "date": "2021-02-24", + "author": "Shahzeb Khan M,Kristensen SL,Vaduganathan M,Kober L,Abraham WT,Desai AS,Solomon SD,Swedberg K,Dickstein K,Zile MR,Packer M,McMurray JJ,Butler J", + "auth_pos": 13, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Female, Heart Failure, Heart Failure/blood*, Heart Failure/physiopathology, Humans, Male, Middle Aged, Natriuretic Peptides, Natriuretic Peptides/blood*, Prognosis, Risk Assessment, Risk Assessment/methods*, Risk Factors, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 762, + "user_id": 1639100928, + "artical_title": "Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.", + "pmid": 33663906, + "journal_name": "Journal of cardiac failure", + "date": "2021-03-06", + "author": "Bozkurt B,Coats AJ,Tsutsui H,Abdelhamid M,Adamopoulos S,Albert N,Anker SD,Atherton J,Böhm M,Butler J,Drazner MH,Felker GM,Filippatos G,Fonarow GC,Fiuzat M,Gomez-Mesa JE,Heidenreich P,Imamura T,Januzzi J,Jankowska EA,Khazanie P,Kinugawa K,Lam CSP,Matsue Y,Metra M,Ohtani T,Francesco Piepoli M,Ponikowski P,Rosano GMC,Sakata Y,Seferovi? P,Starling RC,Teerlink JR,Vardeny O,Yamamoto K,Yancy C,Zhang J,Zieroth S", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 763, + "user_id": 1639100928, + "artical_title": "Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event.", + "pmid": 33689217, + "journal_name": "ESC heart failure", + "date": "2021-03-11", + "author": "Givertz MM,Yang M,Hess GP,Zhao B,Rai A,Butler J", + "auth_pos": 6, + "meshterms": "Cohort Studies, Heart Failure*, Heart Failure/therapy, Hospitalization, Humans, Retrospective Studies, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 764, + "user_id": 1639100928, + "artical_title": "Physical Activity, Inflammation, Coronary Artery Calcification, and Incident Coronary Heart Disease in African Americans: Insights From the Jackson Heart Study.", + "pmid": 33714604, + "journal_name": "Mayo Clinic proceedings", + "date": "2021-03-15", + "author": "Kamimura D,Cain-Shields LR,Clark D,Oshunbade AA,Ashley KE,Guild CS,Loprinzi PD,Newton R,Blaha MJ,Suzuki T,Butler J,Hall JE,Correa A,Hall ME", + "auth_pos": 11, + "meshterms": "Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Adult, Aged, Aged, 80 and over, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Exercise, Exercise/physiology*, Female, Humans, Incidence, Inflammation, Inflammation/epidemiology*, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Proportional Hazards Models, Risk Assessment, Risk Assessment/statistics & numerical data*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 765, + "user_id": 1639100928, + "artical_title": "Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future Direction.", + "pmid": 33714744, + "journal_name": "JACC. Heart failure", + "date": "2021-03-15", + "author": "Lin AY,Dinatolo E,Metra M,Sbolli M,Dasseni N,Butler J,Greenberg BH", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 766, + "user_id": 1639100928, + "artical_title": "Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.", + "pmid": 33714746, + "journal_name": "JACC. Heart failure", + "date": "2021-03-15", + "author": "Blumer V,Greene SJ,Wu A,Butler J,Ezekowitz JA,Lindenfeld J,Alhanti B,Hernandez AF,O'Connor CM,Mentz RJ", + "auth_pos": 4, + "meshterms": "Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome, Aftercare, Female, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Humans, Male, Patient Discharge, Patient Reported Outcome Measures, Quality of Life*, Sex Characteristics, Stroke Volume, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 767, + "user_id": 1639100928, + "artical_title": "Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry.", + "pmid": 33719492, + "journal_name": "Journal of the American Heart Association", + "date": "2021-03-16", + "author": "Chyou JY,Tay WT,Anand IS,Teng TK,Yap JJL,MacDonald MR,Chopra V,Loh SY,Shimizu W,Abidin IZ,Richards AM,Butler J,Lam CSP", + "auth_pos": 13, + "meshterms": "Cardiac Resynchronization Therapy, Cardiac Resynchronization Therapy/methods*, Echocardiography, Electrocardiography, Female, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology*, Heart Failure/therapy, Humans, Male, Middle Aged, Registries*, Risk Assessment, Risk Assessment/methods*, Risk Factors, Singapore, Singapore/epidemiology, Stroke Volume, Stroke Volume/physiology*, Survival Rate, Survival Rate/trends, Ventricular Function, Left, Ventricular Function, Left/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 768, + "user_id": 1639100928, + "artical_title": "Novel Trial Design: CHIEF-HF.", + "pmid": 33724883, + "journal_name": "Circulation. Heart failure", + "date": "2021-03-17", + "author": "Spertus JA,Birmingham MC,Butler J,Lingvay I,Lanfear DE,Abbate A,Kosiborod ML,Fawcett C,Burton P,Damaraju CV,Januzzi JL,Whang J", + "auth_pos": 3, + "meshterms": "Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects, Actigraphy, Actigraphy/instrumentation, Canagliflozin, Canagliflozin/adverse effects, Canagliflozin/therapeutic use*, Double-Blind Method, Exercise Tolerance, Exercise Tolerance/drug effects, Fitness Trackers, Heart Failure, Heart Failure/diagnosis, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Mobile Applications, Quality of Life, Randomized Controlled Trials as Topic, Recovery of Function, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Stroke Volume, Stroke Volume/drug effects, Telemedicine*, Telemedicine/instrumentation, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Function, Left/drug effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 769, + "user_id": 1639100928, + "artical_title": "Advanced cancer is also a heart failure syndrome: a hypothesis.", + "pmid": 33734609, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2021-03-19", + "author": "Anker MS,Sanz AP,Zamorano JL,Mehra MR,Butler J,Riess H,Coats AJS,Anker SD", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 770, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.", + "pmid": 33736819, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-03-20", + "author": "Packer M,Anker SD,Butler J,Filippatos G,Ferreira JP,Pocock SJ,Sattar N,Brueckmann M,Jamal W,Cotton D,Iwata T,Zannad F", + "auth_pos": 3, + "meshterms": "Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/adverse effects, Blood Volume, Blood Volume/drug effects, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy*, Diuretics, Diuretics/pharmacology, Drug Synergism, Female, Glomerular Filtration Rate, Glucosides*, Glucosides/administration & dosage, Glucosides/adverse effects, Heart Failure*, Heart Failure/blood, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy, Hematocrit, Humans, Male, Natriuretic Peptides, Natriuretic Peptides/blood, Outcome Assessment, Health Care, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/pharmacology*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Stroke Volume/drug effects, Water-Electrolyte Imbalance*, Water-Electrolyte Imbalance/physiopathology, Water-Electrolyte Imbalance/therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 771, + "user_id": 1639100928, + "artical_title": "Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.", + "pmid": 33736821, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-03-20", + "author": "Ferreira JP,Zannad F,Pocock SJ,Anker SD,Butler J,Filippatos G,Brueckmann M,Jamal W,Steubl D,Schueler E,Packer M", + "auth_pos": 5, + "meshterms": "Aged, Benzhydryl Compounds*, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/adverse effects, Drug Interactions, Drug Monitoring*, Drug Monitoring/methods, Drug Monitoring/statistics & numerical data, Drug Therapy, Combination, Drug Therapy, Combination/methods, Female, Glucosides*, Glucosides/administration & dosage, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hyperkalemia/diagnosis, Hyperkalemia/prevention & control, Kidney Function Tests, Kidney Function Tests/methods, Male, Mineralocorticoid Receptor Antagonists*, Mineralocorticoid Receptor Antagonists/administration & dosage, Mineralocorticoid Receptor Antagonists/adverse effects, Outcome and Process Assessment, Health Care, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Stroke Volume/drug effects, Withholding Treatment, Withholding Treatment/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 772, + "user_id": 1639100928, + "artical_title": "2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).", + "pmid": 33755495, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2021-03-24", + "author": "Bozkurt B,Hershberger RE,Butler J,Grady KL,Heidenreich PA,Isler ML,Kirklin JK,Weintraub WS", + "auth_pos": 3, + "meshterms": "Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing, Advisory Committees, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, United States, United States/epidemiology, Writing", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 773, + "user_id": 1639100928, + "artical_title": "Cigarette Smoking, Incident Coronary Heart Disease, and Coronary Artery Calcification in Black Adults: The Jackson Heart Study.", + "pmid": 33754833, + "journal_name": "Journal of the American Heart Association", + "date": "2021-03-24", + "author": "Oshunbade AA,Kassahun-Yimer W,Valle KA,Hamid A,Kipchumba RK,Kamimura D,Clark D,White WB,DeFilippis AP,Blaha MJ,Benjamin EJ,O'Brien EC,Mentz RJ,Rodriguez CJ,Fox ER,Butler J,Keith RJ,Bhatnagar A,Marie Robertson R,Correa A,Hall ME", + "auth_pos": 16, + "meshterms": "African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, African Americans, African Americans/psychology, African Americans/statistics & numerical data, Cigarette Smoking, Cigarette Smoking/epidemiology*, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology, Coronary Artery Disease/prevention & control, Coronary Artery Disease/psychology, Coronary Vessels, Coronary Vessels/pathology, Female, Heart Disease Risk Factors, Humans, Longitudinal Studies, Male, Middle Aged, Non-Smokers, Non-Smokers/statistics & numerical data, Risk Assessment, Smokers, Smokers/statistics & numerical data, United States, United States/epidemiology, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 774, + "user_id": 1639100928, + "artical_title": "Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.", + "pmid": 33760037, + "journal_name": "JAMA cardiology", + "date": "2021-03-25", + "author": "Greene SJ,Butler J,Spertus JA,Hellkamp AS,Vaduganathan M,DeVore AD,Albert NM,Duffy CI,Patterson JH,Thomas L,Williams FB,Hernandez AF,Fonarow GC", + "auth_pos": 2, + "meshterms": "Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy, Aged, Cause of Death, Female, Heart Failure, Heart Failure/classification, Heart Failure/physiopathology*, Heart Failure/therapy, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Mortality*, Patient Reported Outcome Measures, Proportional Hazards Models, Severity of Illness Index, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/classification, Ventricular Dysfunction, Left/physiopathology*, Ventricular Dysfunction, Left/therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 775, + "user_id": 1639100928, + "artical_title": "Etiology Of Heart Failure Is In The Eye Of The Beholder: Does It Even Matter?", + "pmid": 33768694, + "journal_name": "European journal of heart failure", + "date": "2021-03-27", + "author": "Khan MS,Usman MS,Butler J", + "auth_pos": 3, + "meshterms": "Heart Failure*, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 776, + "user_id": 1639100928, + "artical_title": "Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure.", + "pmid": 33775110, + "journal_name": "Circulation. Heart failure", + "date": "2021-03-30", + "author": "Blumer V,Mentz RJ,Sun JL,Butler J,Metra M,Voors AA,Hernandez AF,O'Connor CM,Greene SJ", + "auth_pos": 4, + "meshterms": "Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate, Aged, Chronic Disease, Disease Progression, Female, Heart Failure, Heart Failure/drug therapy, Heart Failure/mortality*, Hospital Mortality, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Agents/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Prognosis, Prospective Studies, Risk Factors, Stroke Volume*, Survival Rate", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 777, + "user_id": 1639100928, + "artical_title": "Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysis.", + "pmid": 33784028, + "journal_name": "ESC heart failure", + "date": "2021-03-31", + "author": "Khan MS,Friede T,Anker SD,Butler J", + "auth_pos": 4, + "meshterms": "Heart Valve Prosthesis Implantation*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Patient Reported Outcome Measures, Quality of Life, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 778, + "user_id": 1639100928, + "artical_title": "Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed.", + "pmid": 33787823, + "journal_name": "JAMA cardiology", + "date": "2021-04-01", + "author": "Greene SJ,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/administration & dosage, Adrenergic beta-Antagonists/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/administration & dosage, Angiotensin Receptor Antagonists/therapeutic use*, Drug Therapy, Combination, Drug Therapy, Combination/methods, Heart Failure, Heart Failure/drug therapy*, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Mineralocorticoid Receptor Antagonists/therapeutic use*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Time Factors, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/administration & dosage, Adrenergic beta-Antagonists/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/administration & dosage, Angiotensin Receptor Antagonists/therapeutic use*, Drug Therapy, Combination, Drug Therapy, Combination/methods, Heart Failure, Heart Failure/drug therapy*, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Mineralocorticoid Receptor Antagonists/therapeutic use*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Time Factors, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/administration & dosage, Adrenergic beta-Antagonists/therapeutic use*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/administration & dosage, Angiotensin Receptor Antagonists/therapeutic use*, Drug Therapy, Combination, Drug Therapy, Combination/methods, Heart Failure, Heart Failure/drug therapy*, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/administration & dosage, Mineralocorticoid Receptor Antagonists/therapeutic use*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Time Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 779, + "user_id": 1639100928, + "artical_title": "Reply: Improving Heart Failure Therapeutics: Thinking Outside the Pillbox?", + "pmid": 33795120, + "journal_name": "JACC. Heart failure", + "date": "2021-04-03", + "author": "Bhatt AS,Fiuzat M,Lindenfeld J,O'Connor CM,Butler J", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 780, + "user_id": 1639100928, + "artical_title": "Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multi-Cohort Analysis.", + "pmid": 33845593, + "journal_name": "Circulation", + "date": "2021-04-14", + "author": "Segar MW,Jaeger BC,Patel KV,Nambi V,Ndumele CE,Correa A,Butler J,Chandra A,Ayers C,Rao S,Lewis AA,Raffield LM,Rodriguez CJ,Michos ED,Ballantyne CM,Hall ME,Mentz RJ,de Lemos JA,Pandey A", + "auth_pos": 7, + "meshterms": "Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People, Aged, Cohort Studies, Electrocardiography, Female, Heart Failure, Heart Failure/diagnosis*, Heart Failure/epidemiology, Heart Failure/ethnology, Humans, Machine Learning*, Male, Middle Aged, Prevalence, Race Factors, Retrospective Studies, Risk Factors, Socioeconomic Factors, Troponin I, Troponin I/blood, White People", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 781, + "user_id": 1639100928, + "artical_title": "Trends in 30- and 90-Day Readmission Rates for Heart Failure.", + "pmid": 33866827, + "journal_name": "Circulation. Heart failure", + "date": "2021-04-20", + "author": "Khan MS,Sreenivasan J,Lateef N,Abougergi MS,Greene SJ,Ahmad T,Anker SD,Fonarow GC,Butler J", + "auth_pos": 9, + "meshterms": "Aged, Female, Heart Failure, Heart Failure/therapy*, Humans, Male, Medicare, Patient Readmission, Patient Readmission/trends*, Quality of Health Care, Retrospective Studies, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 782, + "user_id": 1639100928, + "artical_title": "Moving in the Right Direction but Not There Yet. The Utility, Measurement, and Analysis of Health Status in Heart Failure Trials.", + "pmid": 33880841, + "journal_name": "European journal of heart failure", + "date": "2021-04-22", + "author": "Nassif M,Butler J", + "auth_pos": 2, + "meshterms": "Health Status, Heart Failure*, Humans, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 783, + "user_id": 1639100928, + "artical_title": "Can we trust a smartwatch ECG? Potential and Limitations.", + "pmid": 33880842, + "journal_name": "European journal of heart failure", + "date": "2021-04-22", + "author": "Haverkamp W,Butler J,Anker SD", + "auth_pos": 2, + "meshterms": "Electrocardiography, Heart Failure*, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 784, + "user_id": 1639100928, + "artical_title": "Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.", + "pmid": 33888253, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-04-24", + "author": "Honka H,Solis-Herrera C,Triplitt C,Norton L,Butler J,DeFronzo RA", + "auth_pos": 5, + "meshterms": "Animals, Energy Metabolism, Energy Metabolism/drug effects, Energy Metabolism/physiology*, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptide-1 Receptor/metabolism, Heart Failure, Heart Failure/drug therapy, Heart Failure/metabolism*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/pharmacology, Hypoglycemic Agents/therapeutic use*, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Myocardium, Myocardium/metabolism*, Review Literature as Topic*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 785, + "user_id": 1639100928, + "artical_title": "Editorial Expression of Concern: Water and sodium in heart failure: a spotlight on congestion.", + "pmid": 33913077, + "journal_name": "Heart failure reviews", + "date": "2021-04-30", + "author": "Parrinello G,Greene SJ,Torres D,Alderman M,Bonventre JV,Pasquale PD,Gargani L,Nohria A,Fonarow GC,Vaduganathan M,Butler J,Paterna S,Stevenson LW,Gheorghiade M", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 786, + "user_id": 1639100928, + "artical_title": "Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials.", + "pmid": 33922085, + "journal_name": "Children (Basel, Switzerland)", + "date": "2021-05-01", + "author": "Das BB,Moskowitz WB,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 787, + "user_id": 1639100928, + "artical_title": "Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fraction.", + "pmid": 33932120, + "journal_name": "ESC heart failure", + "date": "2021-05-02", + "author": "Thomas M,Khariton Y,Fonarow GC,Arnold SV,Hill L,Nassif ME,Chan PS,Butler J,Thomas L,DeVore AD,Hernandez AF,Albert NM,Patterson JH,Williams FB,Spertus JA", + "auth_pos": 8, + "meshterms": "Aminobutyrates, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Biphenyl Compounds, Drug Combinations, Health Status, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Quality of Life, Stroke Volume, Valsartan", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 788, + "user_id": 1639100928, + "artical_title": "Heart Failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings.", + "pmid": 33932255, + "journal_name": "European journal of heart failure", + "date": "2021-05-02", + "author": "Hadzibegovic S,Lena A,Churchill TW,Ho JE,Potthoff S,Denecke C,Rösnick L,Heim KM,Kleinschmidt M,Sander LE,Witzenrath M,Suttorp N,Krannich A,Porthun J,Friede T,Butler J,Wilkenshoff U,Pieske B,Landmesser U,Anker SD,Lewis GD,Tschöpe C,Anker MS", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 789, + "user_id": 1639100928, + "artical_title": "Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress - not Problem.", + "pmid": 33939999, + "journal_name": "The American journal of medicine", + "date": "2021-05-04", + "author": "Rao VN,Fudim M,Savarese G,Butler J", + "auth_pos": 4, + "meshterms": "Aging, Aging/physiology*, Comorbidity, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Patient Selection*, Polypharmacology*, Polypharmacy*, Practice Guidelines as Topic, Professional Practice Gaps, Risk Assessment*, Stroke Volume, Aging, Aging/physiology*, Comorbidity, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Patient Selection*, Polypharmacology*, Polypharmacy*, Practice Guidelines as Topic, Professional Practice Gaps, Risk Assessment*, Stroke Volume, Aging, Aging/physiology*, Comorbidity, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Patient Selection*, Polypharmacology*, Polypharmacy*, Practice Guidelines as Topic, Professional Practice Gaps, Risk Assessment*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 790, + "user_id": 1639100928, + "artical_title": "SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives.", + "pmid": 33961133, + "journal_name": "Current cardiology reports", + "date": "2021-05-08", + "author": "Garla VV,Butler J,Lien LF", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 791, + "user_id": 1639100928, + "artical_title": "Hostile Work Environment: A Case of the Emperor's New Clothes.", + "pmid": 33985686, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-15", + "author": "Butler J,Piña IL", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 792, + "user_id": 1639100928, + "artical_title": "Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.", + "pmid": 33989713, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-15", + "author": "Patel RB,Fonarow GC,Greene SJ,Zhang S,Alhanti B,DeVore AD,Butler J,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Vaduganathan M", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 793, + "user_id": 1639100928, + "artical_title": "Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.", + "pmid": 33985688, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-15", + "author": "Parikh PB,Bhatt DL,Bhasin V,Anker SD,Skopicki HA,Claessen BE,Fonarow GC,Hernandez AF,Mehran R,Petrie MC,Butler J", + "auth_pos": 11, + "meshterms": "Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/surgery*, Heart Failure, Heart Failure/complications*, Heart Failure/surgery, Humans, Percutaneous Coronary Intervention, Percutaneous Coronary Intervention/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 794, + "user_id": 1639100928, + "artical_title": "Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement.", + "pmid": 33992567, + "journal_name": "JACC. Heart failure", + "date": "2021-05-17", + "author": "Anker SD,Starling RC,Khan MS,Friede T,Filippatos G,Lindenfeld J,Stephan von Bardeleben R,Coats AJS,Butler J", + "auth_pos": 9, + "meshterms": "Heart Failure*, Humans, Mitral Valve Annuloplasty*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 795, + "user_id": 1639100928, + "artical_title": "Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction.", + "pmid": 33998243, + "journal_name": "Circulation. Heart failure", + "date": "2021-05-18", + "author": "Murphy SP,Prescott MF,Maisel AS,Butler J,Piña IL,Felker GM,Ward JH,Williamson KM,Camacho A,Kandanelly RR,Solomon SD,Januzzi JL", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 796, + "user_id": 1639100928, + "artical_title": "Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF) Trial.", + "pmid": 33999486, + "journal_name": "European journal of heart failure", + "date": "2021-05-18", + "author": "Voors AA,Mulder H,Reyes E,Cowie MR,Lassus J,Hernandez AF,Ezekowitz JA,Butler J,O'Connor CM,Koglin J,Lam CSP,Pieske B,Roessig L,Ponikowski P,Anstrom KJ,Armstrong PW", + "auth_pos": 8, + "meshterms": "Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome, Aged, Female, Glomerular Filtration Rate, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring, Humans, Kidney, Kidney/physiology, Male, Pyrimidines, Stroke Volume, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 797, + "user_id": 1639100928, + "artical_title": "Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.", + "pmid": 34003690, + "journal_name": "Circulation. Heart failure", + "date": "2021-05-19", + "author": "Mentz RJ,Ambrosy AP,Ezekowitz JA,Lewis GD,Butler J,Wong YW,De Pasquale CG,Troughton RW,O'Meara E,Rockhold FW,Garg J,Samsky MD,Leloudis D,Dugan M,Mundy LM,Hernandez AF", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 798, + "user_id": 1639100928, + "artical_title": "Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.", + "pmid": 34015478, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-21", + "author": "Filippatos G,Bakris GL,Pitt B,Agarwal R,Rossing P,Ruilope LM,Butler J,Lam CSP,Kolkhof P,Roberts L,Tasto C,Joseph A,Anker SD", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 799, + "user_id": 1639100928, + "artical_title": "Dosing of losartan in men vs. women with HFrEF: the HEAAL trial.", + "pmid": 34050594, + "journal_name": "European journal of heart failure", + "date": "2021-05-30", + "author": "Ferreira JP,Konstam MA,McMurray JJV,Butler J,Girerd N,Rossignol P,Sharma A,Voors AA,Lam CSP,Packer M,Zannad F", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 800, + "user_id": 1639100928, + "artical_title": "Prefrailty, impairment in physical function, and risk of incident heart failure among older adults.", + "pmid": 34050919, + "journal_name": "Journal of the American Geriatrics Society", + "date": "2021-05-30", + "author": "Segar MW,Singh S,Goyal P,Hummel SL,Maurer MS,Forman DE,Butler J,Pandey A", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Frailty, Frailty/complications, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology, Heart Failure/physiopathology*, Humans, Incidence, Male, Prospective Studies, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 801, + "user_id": 1639100928, + "artical_title": "Treatment Patterns and Clinical Outcomes Among Patients <65?Years with a Worsening Heart Failure Event.", + "pmid": 34053163, + "journal_name": "European journal of heart failure", + "date": "2021-05-31", + "author": "Butler J,Yang M,Sawhney B,Chakladar S,Yang L,Djatche LM", + "auth_pos": 1, + "meshterms": "Aged, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Retrospective Studies, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 802, + "user_id": 1639100928, + "artical_title": "Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR-Reduced Trial.", + "pmid": 34053177, + "journal_name": "European journal of heart failure", + "date": "2021-05-31", + "author": "Packer M,Januzzi JL,Ferreira JP,Anker SD,Butler J,Filippatos G,Pocock SJ,Brueckmann M,Jamal W,Cotton D,Iwata T,Zannad F", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 803, + "user_id": 1639100928, + "artical_title": "What can heart failure trialists learn from oncology trialists?", + "pmid": 34076243, + "journal_name": "European heart journal", + "date": "2021-06-03", + "author": "Zannad F,Cotter G,Alonso Garcia A,George S,Davison B,Figtree G,Prasad K,Rockhold F,Schilsky RL,Stockbridge N,Pitt B,Butler J", + "auth_pos": 12, + "meshterms": "Cardiovascular Agents*, Cardiovascular Diseases*, Heart Failure*, Heart Failure/drug therapy, Humans, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 804, + "user_id": 1639100928, + "artical_title": "The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.", + "pmid": 34080008, + "journal_name": "European heart journal", + "date": "2021-06-04", + "author": "Jankowska EA,Kirwan BA,Kosiborod M,Butler J,Anker SD,McDonagh T,Dorobantu M,Drozdz J,Filippatos G,Keren A,Khintibidze I,Kragten H,Martinez FA,Metra M,Milicic D,Nicolau JC,Ohlsson M,Parkhomenko A,Pascual-Figal DA,Ruschitzka F,Sim D,Skouri H,van der Meer P,Lewis BS,Comin-Colet J,von Haehling S,Cohen-Solal A,Danchin N,Doehner W,Dargie HJ,Motro M,Friede T,Fabien V,Dorigotti F,Pocock S,Ponikowski P", + "auth_pos": 4, + "meshterms": "Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Iron/therapeutic use, Maltose, Maltose/therapeutic use, Quality of Life*, Stroke Volume, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 805, + "user_id": 1639100928, + "artical_title": "Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study.", + "pmid": 34097449, + "journal_name": "Circulation", + "date": "2021-06-08", + "author": "Felker GM,Butler J,Januzzi JL,Desai AS,McMurray JJV,Solomon SD", + "auth_pos": 2, + "meshterms": "Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Clinical Trials, Phase III as Topic, Drug Combinations, Heart Failure, Heart Failure/drug therapy*, Hospitalization, Hospitalization/statistics & numerical data*, Humans, Probability, Stroke Volume, Stroke Volume/drug effects, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 806, + "user_id": 1639100928, + "artical_title": "Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?", + "pmid": 34097173, + "journal_name": "Heart failure reviews", + "date": "2021-06-08", + "author": "Correale M,Petroni R,Coiro S,Antohi EL,Monitillo F,Leone M,Triggiani M,Ishihara S,Dungen HD,Sarwar CMS,Memo M,Sabbah HN,Metra M,Butler J,Nodari S", + "auth_pos": 14, + "meshterms": "Cardiologists*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Heart Failure*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/pharmacology, Hypoglycemic Agents/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Cardiologists*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Heart Failure*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/pharmacology, Hypoglycemic Agents/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Cardiologists*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Heart Failure*, Humans, Hypoglycemic Agents, Hypoglycemic Agents/pharmacology, Hypoglycemic Agents/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 807, + "user_id": 1639100928, + "artical_title": "Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing Disparities.", + "pmid": 34125562, + "journal_name": "Circulation", + "date": "2021-06-15", + "author": "Morris AA,Testani JM,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Healthcare Disparities*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/ethnology, Heart Failure/pathology, Hospitalization, Hospitalization/statistics & numerical data, Race Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Healthcare Disparities*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/ethnology, Heart Failure/pathology, Hospitalization, Hospitalization/statistics & numerical data, Race Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 808, + "user_id": 1639100928, + "artical_title": "Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism.", + "pmid": 34173305, + "journal_name": "European journal of heart failure", + "date": "2021-06-27", + "author": "Anker SD,Khan MS,Shahid I,Filippatos G,Coats AJS,Butler J", + "auth_pos": 6, + "meshterms": "Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 809, + "user_id": 1639100928, + "artical_title": "Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map.", + "pmid": 34173307, + "journal_name": "European journal of heart failure", + "date": "2021-06-27", + "author": "Khan MS,Khan F,Fonarow GC,Sreenivasan J,Greene SJ,Khan SU,Usman MS,Vaduganathan M,Fudim M,Anker SD,Butler J", + "auth_pos": 11, + "meshterms": "Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins, Dietary Supplements, Heart Failure*, Heart Failure/epidemiology, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Vitamin D, Vitamins", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 810, + "user_id": 1639100928, + "artical_title": "Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.", + "pmid": 34184057, + "journal_name": "European heart journal", + "date": "2021-06-30", + "author": "Lam CSP,Ferreira JP,Pfarr E,Sim D,Tsutsui H,Anker SD,Butler J,Filippatos G,Pocock SJ,Sattar N,Verma S,Brueckmann M,Schnee J,Cotton D,Zannad F,Packer M", + "auth_pos": 7, + "meshterms": "Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Ethnicity*, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 811, + "user_id": 1639100928, + "artical_title": "Vericiguat in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA trial.", + "pmid": 34191395, + "journal_name": "European journal of heart failure", + "date": "2021-07-01", + "author": "Ponikowski P,Alemayehu W,Oto A,Bahit MC,Noori E,Patel MJ,Butler J,Ezekowitz JA,Hernandez AF,Lam CSP,O'Connor CM,Pieske B,Roessig L,Voors AA,Westerhout C,Armstrong PW", + "auth_pos": 7, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heterocyclic Compounds, 2-Ring*, Humans, Pyrimidines, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 812, + "user_id": 1639100928, + "artical_title": "Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model.", + "pmid": 34216757, + "journal_name": "Journal of cardiac failure", + "date": "2021-07-04", + "author": "Mentz RJ,Mulder H,Mosterd A,Sweitzer NK,Senni M,Butler J,Ezekowitz JA,Lam CSP,Pieske B,Ponikowski P,Voors AA,Anstrom KJ,Armstrong PW,O'Connor CM", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 813, + "user_id": 1639100928, + "artical_title": "Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.", + "pmid": 34217593, + "journal_name": "Journal of cardiac failure", + "date": "2021-07-05", + "author": "Mentz RJ,Mulder H,Mosterd A,Sweitzer NK,Senni M,Butler J,Ezekowitz JA,Lam CSP,Pieske B,Ponikowski P,Voors AA,Anstrom KJ,Armstrong PW,O'connor CM,Hernandez AF", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 814, + "user_id": 1639100928, + "artical_title": "Trends in Substance Abuse Disorders Among Patients Hospitalized for Heart Failure in the United States.", + "pmid": 34233481, + "journal_name": "Circulation. Heart failure", + "date": "2021-07-09", + "author": "Khan MS,Sreenivasan J,Shahid I,Bhinder J,Fudim M,Greene SJ,Butler J", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 815, + "user_id": 1639100928, + "artical_title": "The Contribution of Thoracic Radiation Dose Volumes to Subsequent Development of Cardiovascular Disease in Cancer Survivors.", + "pmid": 34238842, + "journal_name": "The Journal of cardiovascular nursing", + "date": "2021-07-10", + "author": "Reilly CM,Higgins M,Butler J,Esiashvili N,Fei B,Flynn T,Dormer JD,Schreibmann E", + "auth_pos": 3, + "meshterms": "Cancer Survivors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/etiology, Humans, Neoplasms*, Neoplasms/complications, Neoplasms/radiotherapy, Pilot Projects, Radiation Dosage, Retrospective Studies, Cancer Survivors*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/etiology, Humans, Neoplasms*, Neoplasms/complications, Neoplasms/radiotherapy, Pilot Projects, Radiation Dosage, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 816, + "user_id": 1639100928, + "artical_title": "Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.", + "pmid": 34251893, + "journal_name": "Circulation", + "date": "2021-07-13", + "author": "Felker GM,Butler J,Ibrahim NE,Piña IL,Maisel A,Bapat D,Camacho A,Ward JH,Williamson KM,Solomon SD,Januzzi JL", + "auth_pos": 2, + "meshterms": "Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*, Aminobutyrates, Aminobutyrates/pharmacology, Aminobutyrates/therapeutic use*, Angiotensin II Type 1 Receptor Blockers, Angiotensin II Type 1 Receptor Blockers/pharmacology, Angiotensin II Type 1 Receptor Blockers/therapeutic use*, Biphenyl Compounds, Biphenyl Compounds/pharmacology, Biphenyl Compounds/therapeutic use*, Chronic Disease, Defibrillators, Implantable, Defibrillators, Implantable/standards*, Female, Heart Failure, Heart Failure/drug therapy*, Heart Failure/therapy*, Humans, Male, Valsartan, Valsartan/pharmacology, Valsartan/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 817, + "user_id": 1639100928, + "artical_title": "Maternal Heart Failure.", + "pmid": 34259013, + "journal_name": "Journal of the American Heart Association", + "date": "2021-07-15", + "author": "Bright RA,Lima FV,Avila C,Butler J,Stergiopoulos K", + "auth_pos": 4, + "meshterms": "Female, Global Health, Heart Failure, Heart Failure/epidemiology*, Humans, Infant, Newborn, Morbidity, Morbidity/trends, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/epidemiology*, Pregnancy Outcome, Risk Assessment, Risk Assessment/methods*, Risk Factors, Neonatal Morbidity*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 818, + "user_id": 1639100928, + "artical_title": "Another Reason to Embrace Quadruple Medical Therapy for Heart Failure: Medications Enabling Tolerance of the Others.", + "pmid": 34263507, + "journal_name": "European journal of heart failure", + "date": "2021-07-16", + "author": "Greene SJ,Butler J,Metra M", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 819, + "user_id": 1639100928, + "artical_title": "Simultaneous or rapid sequence initiation of medical therapies for heart failure: seeking to avoid the case of 'too little, too late'.", + "pmid": 34286897, + "journal_name": "European journal of heart failure", + "date": "2021-07-22", + "author": "Khan MS,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 820, + "user_id": 1639100928, + "artical_title": "Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial).", + "pmid": 34284862, + "journal_name": "The American journal of cardiology", + "date": "2021-07-22", + "author": "Chow C,Greene SJ,North R,Blumer V,Truby LK,Alhanti B,Butler J,Ezekowitz JA,Starling RC,Mentz RJ", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Case-Control Studies, Cause of Death*, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology*, Female, Heart Failure, Heart Failure/mortality*, Heart Failure/physiopathology, Hospitalization, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/mortality*, Pulmonary Embolism, Pulmonary Embolism/mortality, Sex Distribution, Sex Factors, Stroke, Stroke/mortality, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/physiopathology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 821, + "user_id": 1639100928, + "artical_title": "Improving Exercise Tolerance & Quality of Life in Heart Failure with Preserved Ejection Fraction Time to Think Outside the Heart.", + "pmid": 34296493, + "journal_name": "European journal of heart failure", + "date": "2021-07-24", + "author": "Pandey A,Butler J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 822, + "user_id": 1639100928, + "artical_title": "Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial.", + "pmid": 34313687, + "journal_name": "JAMA", + "date": "2021-07-28", + "author": "DeVore AD,Granger BB,Fonarow GC,Al-Khalidi HR,Albert NM,Lewis EF,Butler J,Piña IL,Allen LA,Yancy CW,Cooper LB,Felker GM,Kaltenbach LA,McRae AT,Lanfear DE,Harrison RW,Disch M,Ariely D,Miller JM,Granger CB,Hernandez AF", + "auth_pos": 7, + "meshterms": "Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome, Aftercare, Aged, Female, Follow-Up Studies, Heart Failure, Heart Failure/mortality, Heart Failure/physiopathology, Heart Failure/therapy*, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Patient Readmission/statistics & numerical data, Quality Improvement*, Quality Indicators, Health Care, Stroke Volume, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 823, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.", + "pmid": 34364665, + "journal_name": "Journal of cardiac failure", + "date": "2021-08-09", + "author": "Savarese G,Uijl A,Lund LH,Anker SD,Asselbergs F,Fitchett D,Inzucchi SE,Koudstaal S,Ofstad AP,Schrage B,Vedin O,Wanner C,Zannad F,Zwiener I,Butler J", + "auth_pos": 15, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Humans, Prognosis, Risk Factors, Stroke Volume, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Humans, Prognosis, Risk Factors, Stroke Volume, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Humans, Prognosis, Risk Factors, Stroke Volume, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Humans, Prognosis, Risk Factors, Stroke Volume, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Humans, Prognosis, Risk Factors, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 824, + "user_id": 1639100928, + "artical_title": "Transmethylamine-N-Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV.", + "pmid": 34365799, + "journal_name": "Journal of the American Heart Association", + "date": "2021-08-10", + "author": "Colaco NA,Wang TS,Ma Y,Scherzer R,Ilkayeva OR,Desvigne-Nickens P,Braunwald E,Hernandez AF,Butler J,Shah SH,Shah SJ,Hsue PY", + "auth_pos": 9, + "meshterms": "Aged, Anti-HIV Agents, Anti-HIV Agents/therapeutic use, Bacteria, Bacteria/metabolism*, Biomarkers, Biomarkers/blood, Cardiomyopathies, Cardiomyopathies/blood, Cardiomyopathies/epidemiology, Cardiomyopathies/microbiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Female, Fibrosis, Gastrointestinal Microbiome*, HIV Infections, HIV Infections/blood, HIV Infections/drug therapy, HIV Infections/epidemiology, HIV Infections/microbiology*, HIV Long-Term Survivors*, Humans, Male, Methylamines, Methylamines/blood*, Middle Aged, Myocardium, Myocardium/pathology, Predictive Value of Tests, Risk Assessment, Risk Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 825, + "user_id": 1639100928, + "artical_title": "Target Trial Emulations: Bridging the Gap Between Clinical Trial and Real-World Data.", + "pmid": 34383997, + "journal_name": "European journal of heart failure", + "date": "2021-08-13", + "author": "Usman MS,Pitt B,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 826, + "user_id": 1639100928, + "artical_title": "CARDIOVASCULAR EFFECTS OF NON-INSULIN GLUCOSE-LOWERING AGENTS: A COMPREHENSIVE REVIEW OF TRIAL EVIDENCE AND POTENTIAL CARDIOPROTECTIVE MECHANISMS.", + "pmid": 34390570, + "journal_name": "Cardiovascular research", + "date": "2021-08-15", + "author": "Savarese G,Butler J,Lund LH,Bhatt DL,Anker SD", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/complications, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/complications, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/complications, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Heart Failure/complications, Humans, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 827, + "user_id": 1639100928, + "artical_title": "Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.", + "pmid": 34423361, + "journal_name": "European heart journal", + "date": "2021-08-24", + "author": "Pocock SJ,Ferreira JP,Gregson J,Anker SD,Butler J,Filippatos G,Gollop ND,Iwata T,Brueckmann M,Januzzi JL,Voors AA,Zannad F,Packer M", + "auth_pos": 5, + "meshterms": "Biomarkers, Heart Failure*, Humans, Morbidity, Natriuretic Peptide, Brain, Peptide Fragments, Prognosis, Stroke Volume, Troponin T", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 828, + "user_id": 1639100928, + "artical_title": "Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors over Time in Heart Failure with Reduced Ejection Fraction.", + "pmid": 34428591, + "journal_name": "Journal of cardiac failure", + "date": "2021-08-25", + "author": "Vaduganathan M,Fonarow GC,Greene SJ,DeVore AD,Albert NM,Duffy CI,Hill CL,Patterson JH,Spertus JA,Thomas LE,Williams FB,Hernandez AF,Butler J", + "auth_pos": 13, + "meshterms": "Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume, Aldosterone, Aldosterone/pharmacology, Aldosterone/therapeutic use, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Angiotensins, Angiotensins/pharmacology, Angiotensins/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Humans, Renin, Renin/pharmacology, Renin/therapeutic use, Renin-Angiotensin System, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 829, + "user_id": 1639100928, + "artical_title": "Hemoglobin and Clinical Outcomes in the VerICiguaT Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).", + "pmid": 34432985, + "journal_name": "Circulation", + "date": "2021-08-26", + "author": "Ezekowitz JA,Zheng Y,Cohen-Solal A,Melenovský V,Escobedo J,Butler J,Hernandez AF,Lam CSP,O'Connor CM,Pieske B,Ponikowski P,Voors AA,deFilippi C,Westerhout CM,McMullan C,Roessig L,Armstrong PW", + "auth_pos": 6, + "meshterms": "Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization, Aged, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/therapy*, Hemoglobins, Hemoglobins/metabolism*, Humans, Male, Stroke Volume, Treatment Outcome, World Health Organization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 830, + "user_id": 1639100928, + "artical_title": "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.", + "pmid": 34447992, + "journal_name": "European heart journal", + "date": "2021-08-28", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,?elutkien? J,Chioncel O,Cleland JGF,Coats AJS,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Francesco Piepoli M,Price S,Rosano GMC,Ruschitzka F,Kathrine Skibelund A", + "auth_pos": 8, + "meshterms": "Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume, Cardiac Resynchronization Therapy*, Chronic Disease, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 831, + "user_id": 1639100928, + "artical_title": "Empagliflozin and Major Renal Outcomes in Heart Failure.", + "pmid": 34449179, + "journal_name": "The New England journal of medicine", + "date": "2021-08-28", + "author": "Packer M,Butler J,Zannad F,Pocock SJ,Filippatos G,Ferreira JP,Brueckmann M,Jamal W,Zeller C,Wanner C,Anker SD", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage, Benzhydryl Compounds/adverse effects*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/administration & dosage, Glucosides/adverse effects*, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Kidney Diseases, Kidney Diseases/etiology*, Renal Replacement Therapy, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage, Sodium-Glucose Transporter 2 Inhibitors/adverse effects*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 832, + "user_id": 1639100928, + "artical_title": "Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.", + "pmid": 34446165, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-08-28", + "author": "Fudim M,Abraham WT,von Bardeleben RS,Lindenfeld J,Ponikowski PP,Salah HM,Khan MS,Sievert H,Stone GW,Anker SD,Butler J", + "auth_pos": 11, + "meshterms": "Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States, Device Approval, Equipment Design, Equipment Design/trends*, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Heart-Assist Devices, Heart-Assist Devices/classification, Heart-Assist Devices/standards, Humans, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 833, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Heart Failure with a Preserved Ejection Fraction.", + "pmid": 34449189, + "journal_name": "The New England journal of medicine", + "date": "2021-08-28", + "author": "Anker SD,Butler J,Filippatos G,Ferreira JP,Bocchi E,Böhm M,Brunner-La Rocca HP,Choi DJ,Chopra V,Chuquiure-Valenzuela E,Giannetti N,Gomez-Mesa JE,Janssens S,Januzzi JL,Gonzalez-Juanatey JR,Merkely B,Nicholls SJ,Perrone SV,Piña IL,Ponikowski P,Senni M,Sim D,Spinar J,Squire I,Taddei S,Tsutsui H,Verma S,Vinereanu D,Zhang J,Carson P,Lam CSP,Marx N,Zeller C,Sattar N,Jamal W,Schnaidt S,Schnee JM,Brueckmann M,Pocock SJ,Zannad F,Packer M", + "auth_pos": 2, + "meshterms": "Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*, Adult, Benzhydryl Compounds, Benzhydryl Compounds/administration & dosage*, Benzhydryl Compounds/adverse effects, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Chronic Disease, Double-Blind Method, Female, Glucosides, Glucosides/administration & dosage*, Glucosides/adverse effects, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Hospitalization, Hospitalization/statistics & numerical data, Humans, Male, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/administration & dosage*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 834, + "user_id": 1639100928, + "artical_title": "Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.", + "pmid": 34459076, + "journal_name": "European journal of heart failure", + "date": "2021-08-31", + "author": "Packer M,Zannad F,Butler J,Filippatos G,Ferreira JP,Pocock SJ,Brueckmann M,Zeller C,Hauske S,Anker SD", + "auth_pos": 3, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/therapeutic use, Heart Failure*, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 835, + "user_id": 1639100928, + "artical_title": "Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial.", + "pmid": 34459213, + "journal_name": "Circulation", + "date": "2021-08-31", + "author": "Packer M,Butler J,Zannad F,Filippatos G,Ferreira JP,Pocock SJ,Carson P,Anand I,Doehner W,Haass M,Komajda M,Miller A,Pehrson S,Teerlink JR,Schnaidt S,Zeller C,Schnee JM,Anker SD", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Heart Failure/drug therapy*, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 836, + "user_id": 1639100928, + "artical_title": "Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure.", + "pmid": 34460024, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2021-08-31", + "author": "Maffeis C,Inciardi RM,Khan MS,Tafciu E,Bergamini C,Benfari G,Setti M,Ribichini FL,Cicoira M,Butler J,Rossi A", + "auth_pos": 10, + "meshterms": "Female, Heart Atria, Heart Atria/diagnostic imaging, Heart Failure*, Heart Failure/diagnostic imaging, Humans, Male, Predictive Value of Tests, Stroke Volume, Ventricular Function, Left*, Female, Heart Atria, Heart Atria/diagnostic imaging, Heart Failure*, Heart Failure/diagnostic imaging, Humans, Male, Predictive Value of Tests, Stroke Volume, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 837, + "user_id": 1639100928, + "artical_title": "Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial.", + "pmid": 34463409, + "journal_name": "Diabetes, obesity & metabolism", + "date": "2021-09-01", + "author": "Vaduganathan M,Inzucchi SE,Sattar N,Fitchett DH,Ofstad AP,Brueckmann M,George JT,Verma S,Mattheus M,Wanner C,Zinman B,Butler J", + "auth_pos": 12, + "meshterms": "Benzhydryl Compounds, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Glucosides, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Insulin, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Benzhydryl Compounds, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Glucosides, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Insulin, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Benzhydryl Compounds, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Glucosides, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Insulin, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 838, + "user_id": 1639100928, + "artical_title": "Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.", + "pmid": 34503685, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-09-11", + "author": "Pandey A,Shah SJ,Butler J,Kellogg DL,Lewis GD,Forman DE,Mentz RJ,Borlaug BA,Simon MA,Chirinos JA,Fielding RA,Volpi E,Molina AJA,Haykowsky MJ,Sam F,Goodpaster BH,Bertoni AG,Justice JN,White JP,Ding J,Hummel SL,LeBrasseur NK,Taffet GE,Pipinos II,Kitzman D", + "auth_pos": 3, + "meshterms": "Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans, Aging, Aging/physiology, Animals, Exercise Tolerance*, Heart Failure, Diastolic, Heart Failure, Diastolic/physiopathology*, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 839, + "user_id": 1639100928, + "artical_title": "Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department.", + "pmid": 34555929, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2021-09-25", + "author": "Stubblefield WB,Jenkins CA,Liu D,Storrow AB,Spertus JA,Pang PS,Levy PD,Butler J,Chang AM,Char D,Diercks DB,Fermann GJ,Han JH,Hiestand BC,Hogan CJ,Khan Y,Lee S,Lindenfeld JM,McNaughton CD,Miller K,Peacock WF,Schrock JW,Self WH,Singer AJ,Sterling SA,Collins SP", + "auth_pos": 8, + "meshterms": "Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome, Cardiomyopathies*, Emergency Service, Hospital, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Kansas, Middle Aged, Patient Discharge, Quality of Life, Self Care, Surveys and Questionnaires, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 840, + "user_id": 1639100928, + "artical_title": "Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.", + "pmid": 34556318, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-09-25", + "author": "Januzzi JL,Zannad F,Anker SD,Butler J,Filippatos G,Pocock SJ,Ferreira JP,Sattar N,Verma S,Vedin O,Schnee J,Iwata T,Cotton D,Packer M", + "auth_pos": 4, + "meshterms": "Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/blood, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/blood, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/blood, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/blood, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Female, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/blood, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood*, Peptide Fragments, Peptide Fragments/blood*, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 841, + "user_id": 1639100928, + "artical_title": "Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.", + "pmid": 34556320, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-09-25", + "author": "Böhm M,Anker SD,Butler J,Filippatos G,Ferreira JP,Pocock SJ,Mahfoud F,Brueckmann M,Jamal W,Ofstad AP,Schüler E,Ponikowski P,Wanner C,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Blood Pressure, Blood Pressure/drug effects*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Blood Pressure, Blood Pressure/drug effects*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Blood Pressure, Blood Pressure/drug effects*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Blood Pressure, Blood Pressure/drug effects*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome, Aged, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Benzhydryl Compounds/therapeutic use*, Blood Pressure, Blood Pressure/drug effects*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Glucosides, Glucosides/pharmacology, Glucosides/therapeutic use*, Heart Failure, Systolic, Heart Failure, Systolic/drug therapy*, Humans, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 842, + "user_id": 1639100928, + "artical_title": "Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study.", + "pmid": 34565606, + "journal_name": "Mayo Clinic proceedings", + "date": "2021-09-28", + "author": "Oshunbade AA,Lirette ST,Windham BG,Shafi T,Hamid A,Gbadamosi SO,Tin A,Yimer WK,Tibuakuu M,Clark D,Kamimura D,Lutz EA,Mentz RJ,Fox ER,Butler J,Butler KR,Garovic VD,Turner ST,Mosley TH,Hall ME", + "auth_pos": 15, + "meshterms": "Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires, Aged, Causality, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Hypertension, Pregnancy-Induced, Hypertension, Pregnancy-Induced/epidemiology*, Middle Aged, Pregnancy, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology*, Risk Assessment, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 843, + "user_id": 1639100928, + "artical_title": "Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights.", + "pmid": 34618015, + "journal_name": "European heart journal", + "date": "2021-10-08", + "author": "Sattar N,Anker SD,Butler J,Verma S", + "auth_pos": 3, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Obesity, Obesity/complications, Sodium-Glucose Transporter 2, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Obesity, Obesity/complications, Sodium-Glucose Transporter 2, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Obesity, Obesity/complications, Sodium-Glucose Transporter 2", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 844, + "user_id": 1639100928, + "artical_title": "Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.", + "pmid": 34615366, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2021-10-08", + "author": "Tran AT,Fonarow GC,Arnold SV,Jones PG,Thomas LE,Hill CL,DeVore AD,Butler J,Albert NM,Spertus JA", + "auth_pos": 8, + "meshterms": "Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology, Aged, Female, Health Status, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Male, Quality of Life, Registries, Risk Adjustment*, Stroke Volume, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 845, + "user_id": 1639100928, + "artical_title": "Investigator-Reported Versus Adjudicated Clinical Events: 2 Versions of the Truth?", + "pmid": 34620411, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-09", + "author": "Greene SJ,Butler J", + "auth_pos": 2, + "meshterms": "Humans, Myocardial Infarction*, Platelet Aggregation Inhibitors*, Research Personnel, Humans, Myocardial Infarction*, Platelet Aggregation Inhibitors*, Research Personnel", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 846, + "user_id": 1639100928, + "artical_title": "Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.", + "pmid": 34649282, + "journal_name": "European heart journal", + "date": "2021-10-15", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,?elutkien? J,Chioncel O,Cleland JGF,Coats AJS,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Francesco Piepoli M,Price S,Rosano GMC,Ruschitzka F,Kathrine Skibelund A", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 847, + "user_id": 1639100928, + "artical_title": "Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.", + "pmid": 34649696, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-16", + "author": "Segar MW,Khan MS,Patel KV,Butler J,Tang WHW,Vaduganathan M,Lam CSP,Verma S,McGuire DK,Pandey A", + "auth_pos": 4, + "meshterms": "Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis, Age Factors, Aged, Blood Glucose, Blood Glucose/analysis, Body Mass Index, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/epidemiology*, Female, Glomerular Filtration Rate, Heart Failure, Heart Failure/epidemiology*, Humans, Male, Models, Cardiovascular, Prevalence, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 848, + "user_id": 1639100928, + "artical_title": "'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.", + "pmid": 34655282, + "journal_name": "ESC heart failure", + "date": "2021-10-17", + "author": "Abdin A,Anker SD,Butler J,Coats AJS,Kindermann I,Lainscak M,Lund LH,Metra M,Mullens W,Rosano G,Slawik J,Wintrich J,Böhm M", + "auth_pos": 3, + "meshterms": "Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Prognosis, Risk Factors, Time-to-Treatment*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Prognosis, Risk Factors, Time-to-Treatment*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Prognosis, Risk Factors, Time-to-Treatment*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Prognosis, Risk Factors, Time-to-Treatment*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Prognosis, Risk Factors, Time-to-Treatment*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 849, + "user_id": 1639100928, + "artical_title": "Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.", + "pmid": 34674536, + "journal_name": "Circulation. Heart failure", + "date": "2021-10-23", + "author": "Khan MS,Greene SJ,Hellkamp AS,DeVore AD,Shen X,Albert NM,Patterson JH,Spertus JA,Thomas LE,Williams FB,Hernandez AF,Fonarow GC,Butler J", + "auth_pos": 13, + "meshterms": "Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase Inhibitors/therapeutic use*, Delivery of Health Care, Delivery of Health Care/statistics & numerical data*, Diuretics, Diuretics/therapeutic use*, Furosemide, Furosemide/therapeutic use, Heart Failure, Heart Failure/drug therapy*, Heart Failure/mortality, Humans, Male, Middle Aged, Outpatients, Outpatients/statistics & numerical data, Stroke Volume, Stroke Volume/drug effects*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 850, + "user_id": 1639100928, + "artical_title": "Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations.", + "pmid": 34718518, + "journal_name": "European heart journal", + "date": "2021-11-01", + "author": "Butler J,Anker SD,Filippatos G,Usman MS,Ferreira JP,Zannad F,Packer M", + "auth_pos": 1, + "meshterms": "Diabetes Mellitus, Type 2*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*, Diabetes Mellitus, Type 2*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*, Diabetes Mellitus, Type 2*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*, Diabetes Mellitus, Type 2*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*, Diabetes Mellitus, Type 2*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 851, + "user_id": 1639100928, + "artical_title": "Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia.", + "pmid": 34730265, + "journal_name": "European journal of heart failure", + "date": "2021-11-04", + "author": "Segar MW,Khan MS,Patel KV,Vaduganathan M,Kannan V,Willett D,Peterson E,Tang WHW,Butler J,Everett BM,Fonarow GC,Wang TJ,McGuire DK,Pandey A", + "auth_pos": 9, + "meshterms": "Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors, Adult, Cohort Studies, Glucose Metabolism Disorders, Glucose Metabolism Disorders/epidemiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Natriuretic Peptides*, Risk Assessment, Risk Assessment/methods, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 852, + "user_id": 1639100928, + "artical_title": "In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.", + "pmid": 34763778, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-11-13", + "author": "Rao VN,Murray E,Butler J,Cooper LB,Cox ZL,Fiuzat M,Green JB,Lindenfeld J,McGuire DK,Nassif ME,O'Brien C,Pagidipati N,Sharma K,Vaduganathan M,Vardeny O,Fonarow GC,Mentz RJ,Greene SJ", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure, Hospitalization*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Patient Discharge, Patient Readmission*, Patient-Centered Care, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Risk, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 853, + "user_id": 1639100928, + "artical_title": "In-hospital initiation of quadruple medical therapy for heart failure: making the post-discharge vulnerable phase far less vulnerable.", + "pmid": 34779112, + "journal_name": "European journal of heart failure", + "date": "2021-11-16", + "author": "Greene SJ,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Aftercare, Heart Failure*, Heart Failure/drug therapy, Hospitals, Humans, Patient Discharge*, Stroke Volume, Aftercare, Heart Failure*, Heart Failure/drug therapy, Hospitals, Humans, Patient Discharge*, Stroke Volume, Aftercare, Heart Failure*, Heart Failure/drug therapy, Hospitals, Humans, Patient Discharge*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 854, + "user_id": 1639100928, + "artical_title": "Contextualizing Risk Among Patients With Heart Failure.", + "pmid": 34779819, + "journal_name": "JAMA", + "date": "2021-11-16", + "author": "Greene SJ,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Cardiotonic Agents, Cardiotonic Agents/therapeutic use*, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Drug Therapy, Combination, Guideline Adherence, Heart Failure, Heart Failure/drug therapy*, Humans, Practice Guidelines as Topic, Risk, Risk Assessment*, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Cardiotonic Agents, Cardiotonic Agents/therapeutic use*, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Drug Therapy, Combination, Guideline Adherence, Heart Failure, Heart Failure/drug therapy*, Humans, Practice Guidelines as Topic, Risk, Risk Assessment*, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Cardiotonic Agents, Cardiotonic Agents/therapeutic use*, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Drug Therapy, Combination, Guideline Adherence, Heart Failure, Heart Failure/drug therapy*, Humans, Practice Guidelines as Topic, Risk, Risk Assessment*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 855, + "user_id": 1639100928, + "artical_title": "Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.", + "pmid": 34779658, + "journal_name": "Circulation", + "date": "2021-11-16", + "author": "Butler J,Filippatos G,Jamal Siddiqi T,Brueckmann M,Böhm M,Chopra VK,Pedro Ferreira J,Januzzi JL,Kaul S,Piña IL,Ponikowski P,Shah SJ,Senni M,Vedin O,Verma S,Peil B,Pocock SJ,Zannad F,Packer M,Anker SD", + "auth_pos": 1, + "meshterms": "Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects, Aged, Aged, 80 and over, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology*, Female, Glucosides, Glucosides/pharmacology*, Health Status*, Heart Failure, Heart Failure/drug therapy*, Humans, Male, Middle Aged, Quality of Life*, Stroke Volume, Stroke Volume/drug effects*, Ventricular Function, Left, Ventricular Function, Left/drug effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 856, + "user_id": 1639100928, + "artical_title": "Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.", + "pmid": 34785402, + "journal_name": "Journal of cardiac failure", + "date": "2021-11-18", + "author": "Vaduganathan M,Greene SJ,Zhang S,Solomon N,Chiswell K,Devore AD,Butler J,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,Mcdermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Fonarow GC", + "auth_pos": 7, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Aftercare, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Male, Medicare, Patient Discharge, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, United States, United States/epidemiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 857, + "user_id": 1639100928, + "artical_title": "Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model.", + "pmid": 34791838, + "journal_name": "ESC heart failure", + "date": "2021-11-19", + "author": "DeVore AD,Hill CL,Thomas LE,Albert NM,Butler J,Patterson JH,Hernandez AF,Williams FB,Shen X,Spertus JA,Fonarow GC", + "auth_pos": 5, + "meshterms": "Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology, Health Status, Heart Failure*, Hospitalization, Humans, Quality of Life, Stroke Volume, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 858, + "user_id": 1639100928, + "artical_title": "Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.", + "pmid": 34793971, + "journal_name": "Journal of cardiac failure", + "date": "2021-11-19", + "author": "Greene SJ,Butler J,Hellkamp AS,Spertus JA,Vaduganathan M,DeVore AD,Albert NM,Herbert Patterson J,Thomas L,Williams FB,Hernandez AF,Fonarow GC", + "auth_pos": 2, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Neprilysin, Registries, Stroke Volume, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 859, + "user_id": 1639100928, + "artical_title": "Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.", + "pmid": 34800079, + "journal_name": "European journal of heart failure", + "date": "2021-11-21", + "author": "Butler J,Anker SD,Siddiqi TJ,Coats AJS,Dorigotti F,Filippatos G,Friede T,Göhring UM,Kosiborod MN,Lund LH,Metra M,Quinn CM,Piña IL,Pinto FJ,Rossignol P,Szecsödy P,der Meer PV,Weir M,Pitt B", + "auth_pos": 1, + "meshterms": "Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/etiology, Polymers, Potassium, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renin-Angiotensin System, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 860, + "user_id": 1639100928, + "artical_title": "Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis.", + "pmid": 34808706, + "journal_name": "ESC heart failure", + "date": "2021-11-23", + "author": "Mujaj B,Zhang ZY,Yang WY,Thijs L,Wei FF,Verhamme P,Delles C,Butler J,Sever P,Latini R,Gf Cleland J,Zannad F,Staessen JA", + "auth_pos": 8, + "meshterms": "Aged, Aspirin, Aspirin/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Incidence, Male, Middle Aged, Observational Studies as Topic, Risk Factors, Aged, Aspirin, Aspirin/adverse effects, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Humans, Incidence, Male, Middle Aged, Observational Studies as Topic, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 861, + "user_id": 1639100928, + "artical_title": "Changes in inferior vena cava area represent a more sensitive metric than change in filling pressures during experimental manipulation of intravascular volume and tone.", + "pmid": 34837447, + "journal_name": "European journal of heart failure", + "date": "2021-11-28", + "author": "Ivey-Miranda JB,Wetterling F,Gaul R,Sheridan S,Asher JL,Rao VS,Maulion C,Mahoney D,Mebazaa A,Gray AP,Burkhoff D,Cowie MR,Cox ZL,Butler J,Fudim M,McDonald K,Damman K,Borlaug BA,Testani JM", + "auth_pos": 14, + "meshterms": "Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Animals, Cardiac Catheterization, Central Venous Pressure, Heart Diseases*, Heart Failure*, Humans, Sheep, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 862, + "user_id": 1639100928, + "artical_title": "Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI Cohorts.", + "pmid": 34860539, + "journal_name": "Circulation", + "date": "2021-12-04", + "author": "Patel KV,Segar MW,Lavie CJ,Kondamudi N,Neeland IJ,Almandoz JP,Martin CK,Carbone S,Butler J,Powell-Wiley TM,Pandey A", + "auth_pos": 9, + "meshterms": "Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States, Aged, Cohort Studies, Diabetes Mellitus, Diabetes Mellitus/etiology*, Diabetes Mellitus/physiopathology, Female, Heart Failure, Heart Failure/complications*, Humans, Male, National Heart, Lung, and Blood Institute (U.S.), Obesity, Obesity/complications*, Risk Factors, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 863, + "user_id": 1639100928, + "artical_title": "Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.", + "pmid": 34861154, + "journal_name": "The lancet. Diabetes & endocrinology", + "date": "2021-12-04", + "author": "Verma S,Dhingra NK,Butler J,Anker SD,Ferreira JP,Filippatos G,Januzzi JL,Lam CSP,Sattar N,Peil B,Nordaby M,Brueckmann M,Pocock SJ,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/pharmacology, Adrenergic beta-Antagonists/therapeutic use, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Benzhydryl Compounds, Double-Blind Method, Female, Glucosides, Heart Failure*, Heart Failure/drug therapy, Humans, Hypotension*, Hypotension/drug therapy, Male, Stroke Volume, Stroke Volume/drug effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 864, + "user_id": 1639100928, + "artical_title": "Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.", + "pmid": 34878502, + "journal_name": "European heart journal", + "date": "2021-12-09", + "author": "Butler J,Packer M,Filippatos G,Ferreira JP,Zeller C,Schnee J,Brueckmann M,Pocock SJ,Zannad F,Anker SD", + "auth_pos": 1, + "meshterms": "Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*, Benzhydryl Compounds, Glucosides, Glucosides/therapeutic use, Heart Failure*, Hospitalization, Humans, Stroke Volume, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 865, + "user_id": 1639100928, + "artical_title": "Ejection fraction in heart failure: just become Emperor's new clothes?", + "pmid": 34894037, + "journal_name": "European journal of heart failure", + "date": "2021-12-12", + "author": "Pagnesi M,Butler J,Metra M", + "auth_pos": 2, + "meshterms": "Heart Failure*, Heart Failure/therapy, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/therapy, Humans, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 866, + "user_id": 1639100928, + "artical_title": "Sodium-glucose co-transporter 2 inhibitors as an early, first line therapy in patients with heart failure and reduced ejection fraction.", + "pmid": 34894038, + "journal_name": "European journal of heart failure", + "date": "2021-12-12", + "author": "Tomasoni D,Fonarow GC,Adamo M,Anker SD,Butler J,Coats AJ,Filippatos G,Greene SJ,McDonagh TA,Ponikowski P,Rosano G,Seferovic P,Vaduganathan M,Voors AA,Metra M", + "auth_pos": 5, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glucose, Heart Failure*, Humans, Quality of Life, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Stroke Volume/physiology, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 867, + "user_id": 1639100928, + "artical_title": "Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.", + "pmid": 34895861, + "journal_name": "JACC. Heart failure", + "date": "2021-12-14", + "author": "Khan MS,Solomon N,DeVore AD,Sharma A,Felker GM,Hernandez AF,Heidenreich PA,Matsouaka RA,Green JB,Butler J,Yancy CW,Peterson PN,Fonarow GC,Greene SJ", + "auth_pos": 10, + "meshterms": "Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology, Adult, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Medicare, Metformin*, Metformin/therapeutic use, Middle Aged, Stroke Volume, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 868, + "user_id": 1639100928, + "artical_title": "Impact of Anemia and the Effect of Empagliflozin in HFrEF: findings from EMPEROR-Reduced.", + "pmid": 34957660, + "journal_name": "European journal of heart failure", + "date": "2021-12-28", + "author": "Ferreira JP,Anker S,Butler J,Filippatos G,Iwata T,Salsali A,Zeller C,Pocock SJ,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Anemia*, Anemia/drug therapy, Anemia/etiology, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/chemically induced, Heart Failure/complications, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 869, + "user_id": 1639100928, + "artical_title": "Kidney function assessment and endpoint ascertainment in clinical trials.", + "pmid": 34966917, + "journal_name": "European heart journal", + "date": "2021-12-31", + "author": "Khan MS,Bakris GL,Packer M,Shahid I,Anker SD,Fonarow GC,Wanner C,Weir MR,Zannad F,Butler J", + "auth_pos": 10, + "meshterms": "Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Albuminuria, Albuminuria/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Humans, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 870, + "user_id": 1639100928, + "artical_title": "Cost and Value in Contemporary Heart Failure Clinical Guidance Documents.", + "pmid": 34969491, + "journal_name": "JACC. Heart failure", + "date": "2022-01-01", + "author": "Ostrominski JW,Hirji S,Bhatt AS,Butler J,Fiuzat M,Fonarow GC,Heidenreich PA,Januzzi JL,Lam CSP,Maddox TM,O'Connor CM,Vaduganathan M", + "auth_pos": 4, + "meshterms": "Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans, Health Care Costs, Heart Failure*, Heart Failure/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 871, + "user_id": 1639100928, + "artical_title": "Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.", + "pmid": 34985495, + "journal_name": "JAMA cardiology", + "date": "2022-01-06", + "author": "Khan MS,Bakris GL,Shahid I,Weir MR,Butler J", + "auth_pos": 5, + "meshterms": "Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Biomarkers, Creatinine, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/therapy, Male, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 872, + "user_id": 1639100928, + "artical_title": "Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial.", + "pmid": 34989083, + "journal_name": "European journal of heart failure", + "date": "2022-01-07", + "author": "Butler J,Siddiqi TJ,Filippatos G,Ferreira JP,Pocock SJ,Zannad F,Anker SD", + "auth_pos": 1, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 873, + "user_id": 1639100928, + "artical_title": "Emergency Department Visits Versus Hospital Readmissions Among Patients Hospitalized for Heart Failure.", + "pmid": 34987009, + "journal_name": "Journal of cardiac failure", + "date": "2022-01-07", + "author": "Shah A,Mentz RJ,Sun JL,Rao VN,Alhanti B,Blumer V,Starling R,Butler J,Greene SJ", + "auth_pos": 8, + "meshterms": "Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies, Aftercare, Creatinine, Emergency Service, Hospital, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Patient Discharge, Patient Readmission*, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 874, + "user_id": 1639100928, + "artical_title": "Robustness of outcomes in trials evaluating sodium-glucose co-transporter 2 inhibitors for heart failure.", + "pmid": 35029056, + "journal_name": "ESC heart failure", + "date": "2022-01-15", + "author": "Usman MS,Khan MS,Fonarow GC,Greene SJ,Friede T,Vaduganathan M,Filippatos G,Coats AJS,Anker SD,Butler J", + "auth_pos": 10, + "meshterms": "Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*, Glucose, Heart Failure*, Heart Failure/drug therapy, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Symporters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 875, + "user_id": 1639100928, + "artical_title": "Annals for Hospitalists Inpatient Notes - Clinical Pearls-Stopping, Starting, and Optimizing Guideline-Directed Medical Therapy in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.", + "pmid": 35038400, + "journal_name": "Annals of internal medicine", + "date": "2022-01-18", + "author": "Greene SJ,Fonarow GC,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 876, + "user_id": 1639100928, + "artical_title": "Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.", + "pmid": 35083485, + "journal_name": "European journal of preventive cardiology", + "date": "2022-01-28", + "author": "Piepoli MF,Adamo M,Barison A,Bestetti RB,Biegus J,Böhm M,Butler J,Carapetis J,Ceconi C,Chioncel O,Coats A,Crespo-Leiro MG,de Simone G,Drexel H,Emdin M,Farmakis D,Halle M,Heymans S,Jaarsma T,Jankowska E,Lainscak M,Lam CSP,Løchen ML,Lopatin Y,Maggioni A,Matrone B,Metra M,Noonan K,Pina I,Prescott E,Rosano G,Seferovic PM,Sliwa K,Stewart S,Uijl A,Vaartjes I,Vermeulen R,Verschuren WM,Volterrani M,Von Haehling S,Hoes A", + "auth_pos": 7, + "meshterms": "Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors, Cardiology*, Consensus, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Patient Readmission, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 877, + "user_id": 1639100928, + "artical_title": "Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.", + "pmid": 35083829, + "journal_name": "European journal of heart failure", + "date": "2022-01-28", + "author": "Piepoli MF,Adamo M,Barison A,Bestetti RB,Biegus J,Böhm M,Butler J,Carapetis J,Ceconi C,Chioncel O,Coats A,Crespo-Leiro MG,de Simone G,Drexel H,Emdin M,Farmakis D,Halle M,Heymans S,Jaarsma T,Jankowska E,Lainscak M,Lam CSP,Løchen ML,Lopatin Y,Maggioni A,Matrone B,Metra M,Noonan K,Pina I,Prescott E,Rosano G,Seferovic PM,Sliwa K,Stewart S,Uijl A,Vaartjes I,Vermeulen R,Monique Verschuren WM,Volterrani M,von Heahling S,Hoes A", + "auth_pos": 7, + "meshterms": "Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors, Cardiology*, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/prevention & control, Humans, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 878, + "user_id": 1639100928, + "artical_title": "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.", + "pmid": 35083827, + "journal_name": "European journal of heart failure", + "date": "2022-01-28", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,?elutkien? J,Chioncel O,Cleland JGF,Coats AJS,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Francesco Piepoli M,Price S,Rosano GMC,Ruschitzka F,Kathrine Skibelund A", + "auth_pos": 9, + "meshterms": "Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States, Bayes Theorem, Cardiology*, Chronic Disease, Europe, France, Germany, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Italy, United Kingdom, United States", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 879, + "user_id": 1639100928, + "artical_title": "Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.", + "pmid": 35115099, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-02-05", + "author": "Vaduganathan M,Sattar N,Xu J,Butler J,Mahaffey KW,Neal B,Shaw W,Rosenthal N,Pfeifer M,Hansen MK,Januzzi JL", + "auth_pos": 4, + "meshterms": "Adult, Biomarkers, Biomarkers/blood, Canagliflozin, Canagliflozin/therapeutic use*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Female, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Kidney, Kidney/metabolism*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Troponin T, Troponin T/blood*, Adult, Biomarkers, Biomarkers/blood, Canagliflozin, Canagliflozin/therapeutic use*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Female, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Kidney, Kidney/metabolism*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Troponin T, Troponin T/blood*, Adult, Biomarkers, Biomarkers/blood, Canagliflozin, Canagliflozin/therapeutic use*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Female, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Kidney, Kidney/metabolism*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Troponin T, Troponin T/blood*, Adult, Biomarkers, Biomarkers/blood, Canagliflozin, Canagliflozin/therapeutic use*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Female, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Kidney, Kidney/metabolism*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Troponin T, Troponin T/blood*, Adult, Biomarkers, Biomarkers/blood, Canagliflozin, Canagliflozin/therapeutic use*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Female, Heart Failure, Heart Failure/complications, Heart Failure/drug therapy*, Humans, Kidney, Kidney/metabolism*, Male, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Troponin T, Troponin T/blood*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 880, + "user_id": 1639100928, + "artical_title": "Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.", + "pmid": 35115106, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-02-05", + "author": "Fiuzat M,Hamo CE,Butler J,Abraham WT,DeFilippis EM,Fonarow GC,Lindenfeld J,Mentz RJ,Psotka MA,Solomon SD,Teerlink JR,Vaduganathan M,Vardeny O,McMurray JJV,O'Connor CM", + "auth_pos": 3, + "meshterms": "Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Clinical Trials as Topic*, Heart Failure, Heart Failure/drug therapy*, Heart Failure/physiopathology, Humans, Periodicals as Topic*, Stroke Volume, Stroke Volume/physiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 881, + "user_id": 1639100928, + "artical_title": "The Enabling Potential of Device Therapy for Heart Failure.", + "pmid": 35172221, + "journal_name": "Journal of cardiac failure", + "date": "2022-02-17", + "author": "Sunny Varshney A,Butler J,Vaduganathan M", + "auth_pos": 2, + "meshterms": "Defibrillators, Implantable*, Heart Failure*, Heart Failure/therapy, Heart-Assist Devices*, Humans, Defibrillators, Implantable*, Heart Failure*, Heart Failure/therapy, Heart-Assist Devices*, Humans, Defibrillators, Implantable*, Heart Failure*, Heart Failure/therapy, Heart-Assist Devices*, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 882, + "user_id": 1639100928, + "artical_title": "Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure.", + "pmid": 35191586, + "journal_name": "European journal of heart failure", + "date": "2022-02-23", + "author": "Ferreira JP,Packer M,Butler J,Zannad F", + "auth_pos": 3, + "meshterms": "Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 883, + "user_id": 1639100928, + "artical_title": "The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.", + "pmid": 35228753, + "journal_name": "Nature medicine", + "date": "2022-03-02", + "author": "Spertus JA,Birmingham MC,Nassif M,Damaraju CV,Abbate A,Butler J,Lanfear DE,Lingvay I,Kosiborod MN,Januzzi JL", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 884, + "user_id": 1639100928, + "artical_title": "Vericiguat in Patients with Coronary Artery Disease and Heart Failure with Reduced Ejection Fraction.", + "pmid": 35239245, + "journal_name": "European journal of heart failure", + "date": "2022-03-04", + "author": "Saldarriaga C,Atar D,Stebbins A,Lewis BS,Zainal Abidin I,Blaustein RO,Butler J,Ezekowitz JA,Hernandez AF,Lam CSP,O'Connor CM,Pieske B,Ponikowski P,Roessig L,Voors AA,Anstrom KJ,Armstrong PW", + "auth_pos": 7, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/therapeutic use, Humans, Male, Pyrimidines, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/therapeutic use, Humans, Male, Pyrimidines, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/therapeutic use, Humans, Male, Pyrimidines, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/therapeutic use, Humans, Male, Pyrimidines, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/therapeutic use, Humans, Male, Pyrimidines, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 885, + "user_id": 1639100928, + "artical_title": "Defining Changes in Physical Limitation from the Patient Perspective: Insights from the VITALITY-HFpEF Randomized Trial.", + "pmid": 35274420, + "journal_name": "European journal of heart failure", + "date": "2022-03-12", + "author": "Butler J,Spertus JA,Bamber L,Khan MS,Roessig L,Vlajnic V,Norquist JM,Anstrom KJ,Blaustein RO,Lam CSP,Armstrong PW", + "auth_pos": 1, + "meshterms": "Heart Failure*, Humans, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Quality of Life, Stroke Volume, Stroke Volume/physiology, Heart Failure*, Humans, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Quality of Life, Stroke Volume, Stroke Volume/physiology, Heart Failure*, Humans, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Quality of Life, Stroke Volume, Stroke Volume/physiology, Heart Failure*, Humans, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Quality of Life, Stroke Volume, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 886, + "user_id": 1639100928, + "artical_title": "Health Status Improvement with Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency.", + "pmid": 35279929, + "journal_name": "European journal of heart failure", + "date": "2022-03-14", + "author": "Butler J,Khan MS,Friede T,Jankowska EA,Fabien V,Goehring UM,Dorigotti F,Metra M,Piña IL,Coats AJ,Rosano G,Comin-Colet J,Van Veldhuisen DJ,Filippatos GS,Anker SD,Ponikowski P", + "auth_pos": 1, + "meshterms": "Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology, Ferric Compounds, Ferric Compounds/therapeutic use, Health Status, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Quality of Life, Stroke Volume, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 887, + "user_id": 1639100928, + "artical_title": "The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF.", + "pmid": 35293088, + "journal_name": "European journal of heart failure", + "date": "2022-03-17", + "author": "DeVore AD,Hellkamp AS,Thomas L,Albert NM,Butler J,Patterson JH,Spertus JA,Williams FB,Shen X,Hernandez AF,Fonarow GC", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 888, + "user_id": 1639100928, + "artical_title": "Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.", + "pmid": 35293087, + "journal_name": "European journal of heart failure", + "date": "2022-03-17", + "author": "Vaduganathan M,Piccini JP,Camm AJ,Crijns HJGM,Anker SD,Butler J,Stewart J,Braceras R,Albuquerque APA,Wieloch M,Hohnloser SH", + "auth_pos": 6, + "meshterms": "Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Aged, Aged, 80 and over, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Flutter*, Atrial Flutter/complications, Dronedarone, Dronedarone/therapeutic use, Female, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Male, Middle Aged, Prognosis, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 889, + "user_id": 1639100928, + "artical_title": "Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease; implications for clinical practice.", + "pmid": 35297132, + "journal_name": "European journal of heart failure", + "date": "2022-03-18", + "author": "Cleland JG,Butler J,Januzzi JL,Pellicori P,McDonagh T", + "auth_pos": 2, + "meshterms": "Atrial Natriuretic Factor, Cardiovascular Diseases*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Female, Heart Failure*, Humans, Kidney Diseases*, Male, Natriuretic Peptide, Brain, Natriuretic Peptides, Atrial Natriuretic Factor, Cardiovascular Diseases*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Female, Heart Failure*, Humans, Kidney Diseases*, Male, Natriuretic Peptide, Brain, Natriuretic Peptides, Atrial Natriuretic Factor, Cardiovascular Diseases*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Female, Heart Failure*, Humans, Kidney Diseases*, Male, Natriuretic Peptide, Brain, Natriuretic Peptides, Atrial Natriuretic Factor, Cardiovascular Diseases*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Female, Heart Failure*, Humans, Kidney Diseases*, Male, Natriuretic Peptide, Brain, Natriuretic Peptides, Atrial Natriuretic Factor, Cardiovascular Diseases*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Female, Heart Failure*, Humans, Kidney Diseases*, Male, Natriuretic Peptide, Brain, Natriuretic Peptides", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 890, + "user_id": 1639100928, + "artical_title": "Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.", + "pmid": 35331406, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-03-26", + "author": "Ferreira JP,Butler J,Zannad F,Filippatos G,Schueler E,Steubl D,Zeller C,Januzzi JL,Pocock S,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume, Benzhydryl Compounds, Chronic Disease, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/pharmacology, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 891, + "user_id": 1639100928, + "artical_title": "Responder analysis for improvement in six-minute walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.", + "pmid": 35334136, + "journal_name": "European journal of heart failure", + "date": "2022-03-26", + "author": "Anker SD,Ponikowski P,Khan MS,Friede T,Jankowska EA,Fabien V,Goehring UM,Metra M,Piña IL,Coats AJ,Rosano G,Dorigotti F,Comin-Colet J,Van Veldhuisen DJ,Filippatos GS,Butler J", + "auth_pos": 16, + "meshterms": "Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Ferric Compounds, Heart Failure*, Heart Failure/drug therapy, Humans, Iron, Iron/therapeutic use, Iron Deficiencies*, Maltose, Maltose/analogs & derivatives, Maltose/therapeutic use, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Walk Test", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 892, + "user_id": 1639100928, + "artical_title": "The Updated Heart Failure Guidelines: Time for a Refresh.", + "pmid": 35363535, + "journal_name": "Circulation", + "date": "2022-04-02", + "author": "Morris AA,Butler J", + "auth_pos": 2, + "meshterms": "Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 893, + "user_id": 1639100928, + "artical_title": "Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.", + "pmid": 35361446, + "journal_name": "JACC. Heart failure", + "date": "2022-04-02", + "author": "Khan MS,Segar MW,Usman MS,Singh S,Greene SJ,Fonarow GC,Anker SD,Felker GM,Januzzi JL,Butler J,Pandey A", + "auth_pos": 10, + "meshterms": "Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Frailty*, Frailty/complications, Frailty/epidemiology, Heart Failure*, Heart Failure/drug therapy, Humans, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 894, + "user_id": 1639100928, + "artical_title": "Comparing and contrasting risk factors for Heart failure in patients with and without history of myocardial infarction: Data from HOMAGE and the UK Biobank.", + "pmid": 35365899, + "journal_name": "European journal of heart failure", + "date": "2022-04-03", + "author": "Rastogi T,Ho FK,Rossignol P,Merkling T,Butler J,Clark A,Collier T,Delles C,Jukema JW,Heymans S,Latini R,Mebazaa A,Pellicori P,Sever P,Staessen JA,Thijs L,Cleland JG,Sattar N,Zannad F,Girerd N", + "auth_pos": 5, + "meshterms": "Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology, Biological Specimen Banks, Diabetes Mellitus*, Heart Failure*, Heart Failure/complications, Humans, Hypertension*, Hypertension/epidemiology, Male, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, United Kingdom, United Kingdom/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 895, + "user_id": 1639100928, + "artical_title": "Uptitrating versus adding heart failure with reduced ejection fraction medications: bring more players to the game.", + "pmid": 35417086, + "journal_name": "European journal of heart failure", + "date": "2022-04-14", + "author": "Kalogeropoulos AP,Butler J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 896, + "user_id": 1639100928, + "artical_title": "Troponin is unrelated to outcomes in heart failure patients discharged from the emergency department.", + "pmid": 35434709, + "journal_name": "Journal of the American College of Emergency Physicians open", + "date": "2022-04-19", + "author": "Fermann GJ,Schrock JW,Levy PD,Pang P,Butler J,Chang AM,Char D,Diercks D,Han JH,Hiestand B,Hogan C,Jenkins CA,Kampe C,Khan Y,Kumar VA,Lee S,Lindenfeld J,Liu D,Miller KF,Peacock WF,Reilly CM,Robichaux C,Rothman RL,Self WH,Singer AJ,Sterling SA,Storrow AB,Stubblefield WB,Walsh C,Wilburn J,Collins SP", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 897, + "user_id": 1639100928, + "artical_title": "Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial.", + "pmid": 35462033, + "journal_name": "Journal of cardiac failure", + "date": "2022-04-25", + "author": "Granger BB,Kaltenbach LA,Fonarow GC,Allen LA,Lanfear DE,Albert NM,Al-Khalidi HR,Butler J,Cooper LB,Dewald T,Felker GM,Heidenreich P,Kottam A,Lewis EF,Piña IL,Yancy CW,Granger CB,Hernandez AF,Devore AD", + "auth_pos": 8, + "meshterms": "Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume, Aftercare, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Patient Discharge, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 898, + "user_id": 1639100928, + "artical_title": "Assessing Health Status After Discharge for Decompensated Heart Failure: A Patient-Centered Priority.", + "pmid": 35481937, + "journal_name": "European journal of heart failure", + "date": "2022-04-29", + "author": "Reza N,Butler J", + "auth_pos": 2, + "meshterms": "Health Status, Heart Failure*, Heart Failure/epidemiology, Humans, Natriuretic Peptide, Brain, Patient Discharge, Patient Readmission, Health Status, Heart Failure*, Heart Failure/epidemiology, Humans, Natriuretic Peptide, Brain, Patient Discharge, Patient Readmission, Health Status, Heart Failure*, Heart Failure/epidemiology, Humans, Natriuretic Peptide, Brain, Patient Discharge, Patient Readmission", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 899, + "user_id": 1639100928, + "artical_title": "Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.", + "pmid": 35483801, + "journal_name": "JACC. Heart failure", + "date": "2022-04-29", + "author": "Khan MS,DeVore AD,Felker GM,Butler J,Fonarow GC,Greene SJ", + "auth_pos": 4, + "meshterms": "Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left, Heart Failure*, Heart Failure/drug therapy, Humans, Metformin*, Metformin/therapeutic use, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 900, + "user_id": 1639100928, + "artical_title": "Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018.", + "pmid": 35483798, + "journal_name": "JACC. Heart failure", + "date": "2022-04-29", + "author": "Jain V,Minhas AMK,Khan SU,Greene SJ,Pandey A,Van Spall HGC,Fonarow GC,Mentz RJ,Butler J,Khan MS", + "auth_pos": 9, + "meshterms": "Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hispanic or Latino, Hospital Mortality, Hospitalization, Humans, Inpatients, United States, United States/epidemiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 901, + "user_id": 1639100928, + "artical_title": "Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure.", + "pmid": 35530511, + "journal_name": "Frontiers in physiology", + "date": "2022-05-10", + "author": "Konstam MA,Mann DL,Udelson JJE,Ardell JL,De Ferrari GM,Cowie MR,Klein HU,Gregory DD,Massaro JM,Libbus I,DiCarlo LA,Butler J,Parker JD,Teerlink JR", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 902, + "user_id": 1639100928, + "artical_title": "Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.", + "pmid": 35589167, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-20", + "author": "Udell JA,Jones WS,Petrie MC,Harrington J,Anker SD,Bhatt DL,Hernandez AF,Butler J", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 903, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.", + "pmid": 35595091, + "journal_name": "American heart journal", + "date": "2022-05-21", + "author": "Harrington J,Udell JA,Jones WS,Anker SD,Bhatt DL,Petrie MC,Vedin O,Sumin M,Zwiener I,Hernandez AF,Butler J", + "auth_pos": 11, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/etiology, Humans, Myocardial Infarction*, Myocardial Infarction/chemically induced, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 904, + "user_id": 1639100928, + "artical_title": "Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions.", + "pmid": 35604680, + "journal_name": "European journal of heart failure", + "date": "2022-05-24", + "author": "Anker SD,Siddiqi TJ,Filippatos G,Zannad F,Ferreira JP,Pocock SJ,Brueckmann M,Zeller C,Packer M,Butler J", + "auth_pos": 10, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/pharmacology, Glucosides, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 905, + "user_id": 1639100928, + "artical_title": "Prognostic Value of the MAGGIC Score, HFPEF Score, and HFA-PEFF Algorithm in Patients with Exertional Dyspnea and the Incremental Value of Exercise Echocardiography.", + "pmid": 35605894, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2022-05-24", + "author": "Przewlocka-Kosmala M,Butler J,Donal E,Ponikowski P,Kosmala W", + "auth_pos": 2, + "meshterms": "Aged, Algorithms, Chronic Disease, Dyspnea*, Dyspnea/diagnostic imaging, Dyspnea/etiology, Echocardiography, Echocardiography/methods, Heart Failure*, Heart Failure/complications, Heart Failure/diagnostic imaging, Humans, Middle Aged, Prognosis, Retrospective Studies, Stroke Volume, Ventricular Function, Left, Aged, Algorithms, Chronic Disease, Dyspnea*, Dyspnea/diagnostic imaging, Dyspnea/etiology, Echocardiography, Echocardiography/methods, Heart Failure*, Heart Failure/complications, Heart Failure/diagnostic imaging, Humans, Middle Aged, Prognosis, Retrospective Studies, Stroke Volume, Ventricular Function, Left, Aged, Algorithms, Chronic Disease, Dyspnea*, Dyspnea/diagnostic imaging, Dyspnea/etiology, Echocardiography, Echocardiography/methods, Heart Failure*, Heart Failure/complications, Heart Failure/diagnostic imaging, Humans, Middle Aged, Prognosis, Retrospective Studies, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 906, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.", + "pmid": 35613034, + "journal_name": "The New England journal of medicine", + "date": "2022-05-26", + "author": "Anker SD,Butler J,Packer M", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 907, + "user_id": 1639100928, + "artical_title": "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.", + "pmid": 35636830, + "journal_name": "Revista española de cardiología (English ed.)", + "date": "2022-06-01", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,?elutkien? J,Chioncel O,Cleland JGF,Coats AJS,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Piepoli MF,Price S,Rosano GMC,Ruschitzka F,Skibelund AK", + "auth_pos": 8, + "meshterms": "Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Cardiology*, Chronic Disease, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 908, + "user_id": 1639100928, + "artical_title": "Contemporary Outpatient Management of Patients with Worsening Heart Failure with Reduced Ejection Fraction: Rationale and Design of the CHART-HF Study.", + "pmid": 35640728, + "journal_name": "American heart journal", + "date": "2022-06-01", + "author": "Greene SJ,Lautsch D,Gaggin HK,Djatche LM,Zhou M,Song Y,Signorovitch J,Stevenson AS,Blaustein RO,Butler J", + "auth_pos": 10, + "meshterms": "Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Outpatients, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Outpatients, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Outpatients, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 909, + "user_id": 1639100928, + "artical_title": "Current Emergency Department Disposition of Patients with Acute Heart Failure: An Opportunity for Improvement.", + "pmid": 35649474, + "journal_name": "Journal of cardiac failure", + "date": "2022-06-02", + "author": "Sax DR,Mark DG,Rana JS,Reed ME,Lindenfeld J,Stevenson LW,Storrow AB,Butler J,Pang PS,Collins SP", + "auth_pos": 8, + "meshterms": "Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment, Acute Disease, Emergency Service, Hospital, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Hospitalization, Humans, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 910, + "user_id": 1639100928, + "artical_title": "Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome.", + "pmid": 35654525, + "journal_name": "JACC. Heart failure", + "date": "2022-06-03", + "author": "Harrington J,Jones WS,Udell JA,Hannan K,Bhatt DL,Anker SD,Petrie MC,Vedin O,Butler J,Hernandez AF", + "auth_pos": 9, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Female, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Longitudinal Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 911, + "user_id": 1639100928, + "artical_title": "Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.", + "pmid": 35656822, + "journal_name": "Circulation. Heart failure", + "date": "2022-06-04", + "author": "Butler J,Stebbins A,Melenovský V,Sweitzer NK,Cowie MR,Stehlik J,Khan MS,Blaustein RO,Ezekowitz JA,Hernandez AF,Lam CSP,Nkulikiyinka R,O'Connor CM,Pieske BM,Ponikowski P,Spertus JA,Voors AA,Anstrom KJ,Armstrong PW", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 912, + "user_id": 1639100928, + "artical_title": "Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?", + "pmid": 35663626, + "journal_name": "JACC. Basic to translational science", + "date": "2022-06-07", + "author": "Sharma A,Verma S,Bhatt DL,Connelly KA,Swiggum E,Vaduganathan M,Zieroth S,Butler J", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 913, + "user_id": 1639100928, + "artical_title": "Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.", + "pmid": 35670067, + "journal_name": "JACC. Heart failure", + "date": "2022-06-08", + "author": "Januzzi JL,Butler J,Zannad F,Filippatos G,Ferreira JP,Pocock SJ,Sattar N,Verma S,Vedin O,Iwata T,Brueckmann M,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T, Biomarkers, Chronic Disease, Clinical Trials as Topic, Heart Failure*, Heart Failure/drug therapy, Humans, Natriuretic Peptide, Brain*, Peptide Fragments, Prognosis, Troponin T", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 914, + "user_id": 1639100928, + "artical_title": "Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.", + "pmid": 35687107, + "journal_name": "European heart journal", + "date": "2022-06-11", + "author": "Ferreira JP,Zannad F,Butler J,Filipattos G,Ritter I,Schüler E,Kraus BJ,Pocock SJ,Anker SD,Packer M", + "auth_pos": 3, + "meshterms": "Aminobutyrates, Benzhydryl Compounds, Biphenyl Compounds, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hypokalemia*, Hypokalemia/complications, Potassium, Stroke Volume, Ventricular Function, Left, Aminobutyrates, Benzhydryl Compounds, Biphenyl Compounds, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hypokalemia*, Hypokalemia/complications, Potassium, Stroke Volume, Ventricular Function, Left, Aminobutyrates, Benzhydryl Compounds, Biphenyl Compounds, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hypokalemia*, Hypokalemia/complications, Potassium, Stroke Volume, Ventricular Function, Left, Aminobutyrates, Benzhydryl Compounds, Biphenyl Compounds, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hypokalemia*, Hypokalemia/complications, Potassium, Stroke Volume, Ventricular Function, Left, Aminobutyrates, Benzhydryl Compounds, Biphenyl Compounds, Glucosides, Heart Failure*, Humans, Hyperkalemia*, Hyperkalemia/chemically induced, Hypokalemia*, Hypokalemia/complications, Potassium, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 915, + "user_id": 1639100928, + "artical_title": "Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: findings from the HF-ACTION trial.", + "pmid": 35688408, + "journal_name": "Journal of cardiac failure", + "date": "2022-06-11", + "author": "Pierce JB,Mentz RJ,Sun JL,Alhanti B,Whellan DJ,Kraus WE,Piña IL,Fiuzat M,O'Connor CM,Greene SJ", + "auth_pos": 8, + "meshterms": "Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Discharge, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 916, + "user_id": 1639100928, + "artical_title": "Longitudinal changes in cardiac troponin and risk of heart failure among Black adults.", + "pmid": 35690315, + "journal_name": "Journal of cardiac failure", + "date": "2022-06-12", + "author": "Saha A,Patel KV,Ayers C,Ballantyne CM,Correa A,deFilippi C,Hall ME,Mentz RJ,Seliger SL,Yimer W,Butler J,Berry JD,de Lemos JA,Pandey A", + "auth_pos": 11, + "meshterms": "Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis, Humans, Adult, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Stroke Volume, Troponin I, Biomarkers, Longitudinal Studies, Cardiovascular Diseases*, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 917, + "user_id": 1639100928, + "artical_title": "Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.", + "pmid": 35711093, + "journal_name": "European journal of heart failure", + "date": "2022-06-18", + "author": "Zannad F,Ferreira JP,Gregson J,Kraus BJ,Mattheus M,Hauske SJ,Butler J,Filippatos G,Wanner C,Anker SD,Pocock SJ,Packer M", + "auth_pos": 7, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Heart Failure/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Heart Failure/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Heart Failure/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Heart Failure/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Glomerular Filtration Rate, Heart Failure*, Heart Failure/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 918, + "user_id": 1639100928, + "artical_title": "Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.", + "pmid": 35713973, + "journal_name": "European heart journal", + "date": "2022-06-18", + "author": "Pandey AK,Bhatt DL,Cosentino F,Marx N,Rotstein O,Pitt B,Pandey A,Butler J,Verma S", + "auth_pos": 8, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Humans, Hypertension, Renal, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoids, Mineralocorticoids/therapeutic use, Naphthyridines, Naphthyridines/pharmacology, Naphthyridines/therapeutic use, Nephritis, Receptors, Mineralocorticoid, Receptors, Mineralocorticoid/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 919, + "user_id": 1639100928, + "artical_title": "Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.", + "pmid": 35722989, + "journal_name": "Journal of the American Heart Association", + "date": "2022-06-21", + "author": "Chapman B,Hellkamp AS,Thomas LE,Albert NM,Butler J,Patterson JH,Hernandez AF,Williams FB,Shen X,Spertus JA,Fonarow GC,DeVore AD", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 920, + "user_id": 1639100928, + "artical_title": "Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy.", + "pmid": 35726617, + "journal_name": "Circulation. Heart failure", + "date": "2022-06-22", + "author": "Butler J,Talha KM,Aktas MK,Zareba W,Goldenberg I", + "auth_pos": 1, + "meshterms": "Death, Sudden, Cardiac, Death, Sudden, Cardiac/etiology, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Heart Failure*, Humans, Stroke Volume, Ventricular Function, Left, Death, Sudden, Cardiac, Death, Sudden, Cardiac/etiology, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Heart Failure*, Humans, Stroke Volume, Ventricular Function, Left, Death, Sudden, Cardiac, Death, Sudden, Cardiac/etiology, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Heart Failure*, Humans, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 921, + "user_id": 1639100928, + "artical_title": "Side effects and treatment initiation barriers of SGLT2 inhibitors in heart failure: A systematic review and meta-analysis.", + "pmid": 35730422, + "journal_name": "European journal of heart failure", + "date": "2022-06-23", + "author": "Vukadinovi? D,Abdin A,Anker SD,Rosano GM,Mahfoud F,Packer M,Butler J,Böhm M", + "auth_pos": 7, + "meshterms": "Humans, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Heart Failure*, Heart Failure/complications, Hypotension*, Hypotension/chemically induced, Hypotension/epidemiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Humans, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Heart Failure*, Heart Failure/complications, Hypotension*, Hypotension/chemically induced, Hypotension/epidemiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Humans, Acute Kidney Injury*, Acute Kidney Injury/chemically induced, Acute Kidney Injury/epidemiology, Heart Failure*, Heart Failure/complications, Hypotension*, Hypotension/chemically induced, Hypotension/epidemiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 922, + "user_id": 1639100928, + "artical_title": "Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.", + "pmid": 35762322, + "journal_name": "Circulation", + "date": "2022-06-29", + "author": "Filippatos G,Butler J,Farmakis D,Zannad F,Pernille Ofstad A,Pedro Ferreira J,Green JB,Rosenstock J,Schnaidt S,Brueckmann M,Pocock SJ,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucosides, Heart Failure*, Heart Failure/chemically induced, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 923, + "user_id": 1639100928, + "artical_title": "Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study.", + "pmid": 35772859, + "journal_name": "JACC. Heart failure", + "date": "2022-07-01", + "author": "Huynh K,Ayers C,Butler J,Neeland I,Kritchevsky S,Pandey A,Barton G,Berry JD", + "auth_pos": 3, + "meshterms": "Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh, Aged, Body Composition, Body Composition/physiology, Female, Heart Failure*, Humans, Male, Muscle, Skeletal, Muscle, Skeletal/diagnostic imaging, Obesity, Obesity/complications, Risk Factors, Stroke Volume, Stroke Volume/physiology, Thigh", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 924, + "user_id": 1639100928, + "artical_title": "Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.", + "pmid": 35772911, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-01", + "author": "Böhm M,Butler J,Filippatos G,Ferreira JP,Pocock SJ,Abdin A,Mahfoud F,Brueckmann M,Gollop ND,Iwata T,Ponikowski P,Wanner C,Zannad F,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Aged, Aged, 80 and over, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Chronic Disease, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Middle Aged, Stroke Volume, Stroke Volume/physiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 925, + "user_id": 1639100928, + "artical_title": "Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF.", + "pmid": 35780032, + "journal_name": "JACC. Heart failure", + "date": "2022-07-03", + "author": "Butler J,Shahzeb Khan M,Lindenfeld J,Abraham WT,Savarese G,Salsali A,Zeller C,Peil B,Filippatos G,Ponikowski P,Anker SD", + "auth_pos": 1, + "meshterms": "Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume, Health Status, Heart Failure*, Humans, Patient Reported Outcome Measures, Prognosis, Quality of Life, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 926, + "user_id": 1639100928, + "artical_title": "Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.", + "pmid": 35788657, + "journal_name": "European heart journal", + "date": "2022-07-06", + "author": "Doehner W,Anker SD,Butler J,Zannad F,Filippatos G,Ferreira JP,Salsali A,Kaempfer C,Brueckmann M,Pocock SJ,Januzzi JL,Packer M", + "auth_pos": 3, + "meshterms": "Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid, Benzhydryl Compounds, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Glucose, Glucose/therapeutic use, Glucosides, Heart Failure*, Humans, Hyperuricemia*, Hyperuricemia/complications, Hyperuricemia/drug therapy, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Uric Acid", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 927, + "user_id": 1639100928, + "artical_title": "Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction.", + "pmid": 35789018, + "journal_name": "Clinical cardiology", + "date": "2022-07-06", + "author": "Talha KM,Butler J", + "auth_pos": 2, + "meshterms": "Cardiovascular Agents*, Cardiovascular Agents/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/physiopathology, Humans, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/diagnosis, Ventricular Dysfunction, Left/drug therapy, Ventricular Dysfunction, Left/physiopathology, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 928, + "user_id": 1639100928, + "artical_title": "Efficacy and Safety of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan: Insights from the VICTORIA Trial.", + "pmid": 35791083, + "journal_name": "European journal of heart failure", + "date": "2022-07-07", + "author": "Senni M,Alemayehu WG,Sim D,Edelmann F,Butler J,Ezekowitz J,Hernandez AF,Lam CSP,O'Connor CM,Pieske B,Ponikowski P,Roessig L,Voors AA,Westerhout CM,McMullan C,Armstrong PW", + "auth_pos": 5, + "meshterms": "Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Humans, Hyperkalemia, Hyperkalemia/epidemiology, Hypotension, Hypotension/epidemiology, Pyrimidines*, Pyrimidines/adverse effects, Stroke Volume, Stroke Volume/physiology, Treatment Outcome, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 929, + "user_id": 1639100928, + "artical_title": "The Importance of Worsening Heart Failure: Hiding in Plain Sight.", + "pmid": 35798446, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-08", + "author": "Januzzi JL,Butler J", + "auth_pos": 2, + "meshterms": "Heart Failure*, Heart Failure/diagnosis, Humans, Heart Failure*, Heart Failure/diagnosis, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 930, + "user_id": 1639100928, + "artical_title": "Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.", + "pmid": 35796209, + "journal_name": "European journal of heart failure", + "date": "2022-07-08", + "author": "Pocock SJ,Ferreira JP,Packer M,Zannad F,Filippatos G,Kondo T,McMurray JJV,Solomon SD,Januzzi JL,Iwata T,Salsali A,Butler J,Anker SD", + "auth_pos": 12, + "meshterms": "Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use, Humans, Heart Failure*, Stroke Volume, Prognosis, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Peptide Fragments/therapeutic use, Biomarkers, Chronic Disease, Pulmonary Disease, Chronic Obstructive*, Insulins*, Insulins/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 931, + "user_id": 1639100928, + "artical_title": "Heart Failure Specific Versus All-Cause Endpoints in Heart Failure Clinical Trials.", + "pmid": 35843491, + "journal_name": "Journal of cardiac failure", + "date": "2022-07-18", + "author": "Khan MS,Butler J,Vaduganathan M,Greene SJ", + "auth_pos": 2, + "meshterms": "Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans, Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans, Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans, Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans, Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans, Endpoint Determination, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 932, + "user_id": 1639100928, + "artical_title": "Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.", + "pmid": 35869741, + "journal_name": "European journal of heart failure", + "date": "2022-07-24", + "author": "Metra M,Jankowska EA,Pagnesi M,Anker SD,Butler J,Dorigotti F,Fabien V,Filippatos G,Kirwan BA,Macdougall IC,Rosano G,Ruschitzka F,Tomasoni D,van der Meer P,Ponikowski P", + "auth_pos": 5, + "meshterms": "Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds, Humans, Male, Iron Deficiencies*, Quality of Life, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Maltose, Ferric Compounds", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 933, + "user_id": 1639100928, + "artical_title": "SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy.", + "pmid": 35877834, + "journal_name": "Circulation", + "date": "2022-07-26", + "author": "Anker SD,Usman MS,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 934, + "user_id": 1639100928, + "artical_title": "Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials.", + "pmid": 35876414, + "journal_name": "Journal of the American Heart Association", + "date": "2022-07-26", + "author": "Hamid A,Anker MS,Ruckdeschel JC,Khan MS,Tharwani A,Oshunbade AA,Kipchumba RK,Thigpen SC,Anker SD,Fonarow GC,Hall ME,Butler J", + "auth_pos": 12, + "meshterms": "Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin, Breast Neoplasms*, Breast Neoplasms/drug therapy, Female, Humans, Troponin", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 935, + "user_id": 1639100928, + "artical_title": "Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019.", + "pmid": 35895048, + "journal_name": "JAMA cardiology", + "date": "2022-07-28", + "author": "Jain V,Minhas AMK,Morris AA,Greene SJ,Pandey A,Khan SS,Fonarow GC,Mentz RJ,Butler J,Khan MS", + "auth_pos": 9, + "meshterms": "Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult, Cohort Studies, Ethnicity, Female, Heart Failure*, Hispanic or Latino, Humans, Male, Retrospective Studies, United States, United States/epidemiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 936, + "user_id": 1639100928, + "artical_title": "Spatial distribution and network morphology of epicardial, endocardial, interstitial, and Purkinje cell-associated elastin fibers in porcine left ventricle.", + "pmid": 35892002, + "journal_name": "Bioactive materials", + "date": "2022-07-28", + "author": "Shi X,Zhang S,Liu Y,Brazile B,Cooley J,Butler JR,McMahan SR,Perez KL,Xu J,Eastep T,Nguyen KT,Bajona P,Peltz M,Gao H,Hong Y,Liao J", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 937, + "user_id": 1639100928, + "artical_title": "Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey.", + "pmid": 35901855, + "journal_name": "Current problems in cardiology", + "date": "2022-07-29", + "author": "Minhas AMK,Jain V,Maqsood MH,Pandey A,Khan SS,Fudim M,Fonarow GC,Butler J,Khan MS", + "auth_pos": 8, + "meshterms": "Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors, Adult, Male, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Nutrition Surveys, Coronary Artery Disease*, Heart Failure*, Heart Failure/epidemiology, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 938, + "user_id": 1639100928, + "artical_title": "Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.", + "pmid": 35900838, + "journal_name": "European heart journal", + "date": "2022-07-29", + "author": "Butler J,Anker SD,Lund LH,Coats AJS,Filippatos G,Siddiqi TJ,Friede T,Fabien V,Kosiborod M,Metra M,Piña IL,Pinto F,Rossignol P,van der Meer P,Bahit C,Belohlavek J,Böhm M,Brugts JJ,Cleland JGF,Ezekowitz J,Bayes-Genis A,Gotsman I,Goudev A,Khintibidze I,Lindenfeld J,Mentz RJ,Merkely B,Montes EC,Mullens W,Nicolau JC,Parkhomenko A,Ponikowski P,Seferovic PM,Senni M,Shlyakhto E,Cohen-Solal A,Szecsödy P,Jensen K,Dorigotti F,Weir MR,Pitt B", + "auth_pos": 1, + "meshterms": "Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium, Humans, Hyperkalemia*, Hyperkalemia/drug therapy, Hyperkalemia/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Stroke Volume, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Renin-Angiotensin System, Potassium", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 939, + "user_id": 1639100928, + "artical_title": "How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?", + "pmid": 35905826, + "journal_name": "International journal of cardiology", + "date": "2022-07-30", + "author": "Cowie MR,Bozkurt B,Butler J,Briggs A,Kubin M,Jonas A,Adler AI,Patrick-Lake B,Zannad F", + "auth_pos": 3, + "meshterms": "Humans, Quality of Life*, Technology Assessment, Biomedical*, Humans, Quality of Life*, Technology Assessment, Biomedical*, Humans, Quality of Life*, Technology Assessment, Biomedical*, Humans, Quality of Life*, Technology Assessment, Biomedical*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 940, + "user_id": 1639100928, + "artical_title": "Vitamin D Levels in Black Americans and the Association with Left Ventricular Remodeling and.", + "pmid": 35905866, + "journal_name": "Journal of cardiac failure", + "date": "2022-07-30", + "author": "Kamimura D,Yimer WK,Shah AM,Mentz RJ,Oshunbade A,Hamid A,Suzuki T,Clark ? D,Waller J,Fox ER,Correa A,Butler J,Hall ME", + "auth_pos": 12, + "meshterms": "Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis, Humans, Heart Failure*, Ventricular Function, Left, Stroke Volume, Vitamin D, Ventricular Remodeling, Prospective Studies, Longitudinal Studies, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 941, + "user_id": 1639100928, + "artical_title": "The Association of Digital Health Application Use with Heart Failure Care and Outcomes: Insights from CONNECT-HF.", + "pmid": 35905867, + "journal_name": "Journal of cardiac failure", + "date": "2022-07-30", + "author": "Rao VN,Kaltenbach LA,Granger BB,Fonarow GC,Al-Khalidi HR,Albert NM,Butler J,Allen LA,Lanfear DE,Ariely D,Miller JM,Brodsky MA,Lalonde TA,Lafferty JC,Granger CB,Hernandez AF,Devore AD", + "auth_pos": 7, + "meshterms": "Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Hospitalization, Humans, Prospective Studies, Stroke Volume, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 942, + "user_id": 1639100928, + "artical_title": "Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now.", + "pmid": 35926930, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-08-05", + "author": "Kalogeropoulos AP,Butler J", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Forecasting, Humans, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 943, + "user_id": 1639100928, + "artical_title": "Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies).", + "pmid": 35933224, + "journal_name": "The American journal of cardiology", + "date": "2022-08-07", + "author": "Davison BA,Takagi K,Edwards C,Adams KF,Butler J,Collins SP,Dorobantu MI,Ezekowitz JA,Filippatos G,Greenberg BH,Levy PD,Masip J,Metra M,Pang PS,Ponikowski P,Severin TM,Teerlink JR,Teichman SL,Voors AA,Werdan K,Cotter G", + "auth_pos": 5, + "meshterms": "Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome, Acute Disease, Biomarkers, Double-Blind Method, Heart Failure*, Humans, Lymphocytes, Neutrophils, Relaxin*, Renal Insufficiency*, Renal Insufficiency/complications, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 944, + "user_id": 1639100928, + "artical_title": "Pragmatism in clinical trials: essential, not optional.", + "pmid": 35938357, + "journal_name": "European heart journal", + "date": "2022-08-09", + "author": "Usman MS,Butler J,Khan MS", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 945, + "user_id": 1639100928, + "artical_title": "DCRM Multispecialty Recommendations in Patients with Heart Failure: For Special Issue on Cardio-Renal-Metabolism.", + "pmid": 35973620, + "journal_name": "Journal of cardiac failure", + "date": "2022-08-17", + "author": "Hamid A,Handelsman Y,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Specialization, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Specialization, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Specialization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 946, + "user_id": 1639100928, + "artical_title": "Stability of Changes in Health Status: Next Step in Comprehensively Assessing Patient-Reported Outcomes.", + "pmid": 35980698, + "journal_name": "JAMA", + "date": "2022-08-19", + "author": "Khan MS,Butler J", + "auth_pos": 2, + "meshterms": "Health Status*, Humans, Patient Reported Outcome Measures*, Health Status*, Humans, Patient Reported Outcome Measures*, Health Status*, Humans, Patient Reported Outcome Measures*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 947, + "user_id": 1639100928, + "artical_title": "Investigating the Transient Regenerative Potential of Cardiac Muscle Using a Neonatal Pig Partial Apical Resection Model.", + "pmid": 36004926, + "journal_name": "Bioengineering (Basel, Switzerland)", + "date": "2022-08-26", + "author": "Copeland KM,Brazile BL,Butler JR,Cooley J,Brinkman-Ferguson E,Claude A,Lin S,Rais-Rohani S,Welch B,McMahan SR,Nguyen KT,Hong Y,Ramaswamy S,Liu ZP,Bajona P,Peltz M,Liao J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 948, + "user_id": 1639100928, + "artical_title": "Machine Learning to Define Phenotypes and Outcomes of Patients Hospitalized for Heart Failure with Preserved Ejection Fraction: Findings from ASCEND-HF.", + "pmid": 36007566, + "journal_name": "American heart journal", + "date": "2022-08-26", + "author": "Murray EM,Greene SJ,Rao VN,Sun JL,Alhanti BA,Blumer V,Butler J,Ahmad T,Mentz RJ", + "auth_pos": 7, + "meshterms": "Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic, Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic, Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic, Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic, Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic, Female, Humans, Atrial Fibrillation*, Heart Failure*, Machine Learning, Obesity, Prognosis, Stroke Volume, Stroke Volume/physiology, Male, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 949, + "user_id": 1639100928, + "artical_title": "Effect of Empagliflozin on Circulating Proteomics in Heart Failure: Mechanistic Insights from the EMPEROR Program.", + "pmid": 36017745, + "journal_name": "European heart journal", + "date": "2022-08-27", + "author": "Zannad F,Ferreira JP,Butler J,Filippatos G,Januzzi JL,Sumin M,Zwick M,Saadati M,Pocock SJ,Sattar N,Anker SD,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/metabolism, Inflammation, Inflammation/drug therapy, Proteomics, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Somatomedins*, Somatomedins/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 950, + "user_id": 1639100928, + "artical_title": "'Normal Weight' Is Really Not Normal in Chronic Disease.", + "pmid": 36029317, + "journal_name": "European heart journal", + "date": "2022-08-28", + "author": "Anker SD,Usman MS,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Body Mass Index, Body Weight, Chronic Disease, Heart Failure*, Humans, Body Mass Index, Body Weight, Chronic Disease, Heart Failure*, Humans, Body Mass Index, Body Weight, Chronic Disease, Heart Failure*, Humans, Body Mass Index, Body Weight, Chronic Disease, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 951, + "user_id": 1639100928, + "artical_title": "Putting the Puzzle Together: SGLT2 Inhibitors from Prevention to Treatment of Heart Failure.", + "pmid": 36036745, + "journal_name": "European heart journal", + "date": "2022-08-30", + "author": "Harrington J,Anker S,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Glucosides, Heart Failure*, Heart Failure/drug therapy, Heart Failure/prevention & control, Myocardial Infarction*, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Glucosides, Heart Failure*, Heart Failure/drug therapy, Heart Failure/prevention & control, Myocardial Infarction*, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Glucosides, Heart Failure*, Heart Failure/drug therapy, Heart Failure/prevention & control, Myocardial Infarction*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 952, + "user_id": 1639100928, + "artical_title": "Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review.", + "pmid": 36044233, + "journal_name": "JAMA cardiology", + "date": "2022-09-01", + "author": "Harrington J,Petrie MC,Anker SD,Bhatt DL,Jones SW,Udell JA,Hernandez AF,Butler J", + "auth_pos": 8, + "meshterms": "Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Aminobutyrates, Biphenyl Compounds, Heart Failure*, Heart Failure/chemically induced, Heart Failure/drug therapy, Humans, Myocardial Infarction*, Myocardial Infarction/drug therapy, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Valsartan, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 953, + "user_id": 1639100928, + "artical_title": "Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat.", + "pmid": 36049817, + "journal_name": "JACC. Heart failure", + "date": "2022-09-02", + "author": "Armstrong PW,Zheng Y,Troughton RW,Lund LH,Zhang J,Lam CSP,Westerhout CM,Blaustein RO,Butler J,Hernandez AF,Roessig L,O'Connor CM,Voors AA,Ezekowitz JA", + "auth_pos": 9, + "meshterms": "Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume, Biomarkers, Heart Failure*, Heart Failure/drug therapy, Heterocyclic Compounds, 2-Ring, Hospitalization, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/therapeutic use, Peptide Fragments, Prognosis, Pyrimidines, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 954, + "user_id": 1639100928, + "artical_title": "Reporting and Definition of Kidney Death in Heart Failure Clinical Trials.", + "pmid": 36055437, + "journal_name": "Current problems in cardiology", + "date": "2022-09-03", + "author": "Khan MS,Shahid I,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/complications, Kidney, Renal Insufficiency*, Clinical Trials as Topic, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/complications, Kidney, Renal Insufficiency*, Clinical Trials as Topic, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/complications, Kidney, Renal Insufficiency*, Clinical Trials as Topic, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/complications, Kidney, Renal Insufficiency*, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 955, + "user_id": 1639100928, + "artical_title": "Biomarkers in Heart Failure Clinical Trials. A review from the Biomarkers Working Group of the Heart Failure Association of the ESC.", + "pmid": 36073112, + "journal_name": "European journal of heart failure", + "date": "2022-09-09", + "author": "Bayes-Genis A,Aimo A,Jhund P,Richards AM,de Boer RA,Arfsten H,Fabiani I,Lupón J,Anker SD,González A,Castiglione V,Metra M,Mueller C,Núñez J,Rossignol P,Barison A,Butler J,Teerlink J,Filippatos G,Ponikowski P,Vergaro G,Zannad F,Seferovic P,Rosano G,Coats AJ,Emdin M,Januzzi JL", + "auth_pos": 17, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Valsartan/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Biomarkers, Drug Combinations, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 956, + "user_id": 1639100928, + "artical_title": "Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action.", + "pmid": 36082670, + "journal_name": "Hypertension (Dallas, Tex. : 1979)", + "date": "2022-09-10", + "author": "Díez J,Butler J", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/etiology, Heart Diseases*, Hypertension*, Hypertension/complications, Hypertension/diagnosis, Hypertension/drug therapy, Fibrosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 957, + "user_id": 1639100928, + "artical_title": "Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial.", + "pmid": 36087309, + "journal_name": "European journal of heart failure", + "date": "2022-09-11", + "author": "Böhm M,Butler J,Mahfoud F,Filippatos G,Ferreira JP,Pocock SJ,Slawik J,Brueckmann M,Linetzky B,Schüler E,Wanner C,Zannad F,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Humans, Heart Failure*, Stroke Volume, Heart Rate, Ventricular Function, Left, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 958, + "user_id": 1639100928, + "artical_title": "Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial.", + "pmid": 36088540, + "journal_name": "European journal of heart failure", + "date": "2022-09-12", + "author": "Butler J,Siddiqi TJ,Anker SD", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Hyperkalemia*, Hyperkalemia/chemically induced, Polymers, Polymers/therapeutic use, Potassium, Renal Insufficiency, Chronic*, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Hyperkalemia*, Hyperkalemia/chemically induced, Polymers, Polymers/therapeutic use, Potassium, Renal Insufficiency, Chronic*, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Hyperkalemia*, Hyperkalemia/chemically induced, Polymers, Polymers/therapeutic use, Potassium, Renal Insufficiency, Chronic*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 959, + "user_id": 1639100928, + "artical_title": "SGLT2 Inhibitors for Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Time to Deliver Implementation.", + "pmid": 36097872, + "journal_name": "European journal of heart failure", + "date": "2022-09-14", + "author": "Greene SJ,Fonarow GC,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium, Glucose, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium, Glucose, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium, Glucose", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 960, + "user_id": 1639100928, + "artical_title": "Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.", + "pmid": 36098051, + "journal_name": "Circulation", + "date": "2022-09-14", + "author": "Butler J,Filippatos G,Jamal Siddiqi T,Pedro Ferreira J,Brueckmann M,Bocchi E,Böhm M,Chopra VK,Giannetti N,Iwata T,Januzzi JL,Kaul S,Piña IL,Ponikowski P,Rauch-Kröhnert U,Shah SJ,Senni M,Sumin M,Verma S,Zhang J,Pocock SJ,Zannad F,Packer M,Anker SD", + "auth_pos": 1, + "meshterms": "Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left, Benzhydryl Compounds, Cardiomyopathies*, Cardiomyopathies/complications, Female, Glucosides, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Male, Stroke Volume, Uric Acid, Uric Acid/pharmacology, Uric Acid/therapeutic use, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 961, + "user_id": 1639100928, + "artical_title": "Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction.", + "pmid": 36122820, + "journal_name": "Journal of cardiac failure", + "date": "2022-09-20", + "author": "Mohebi R,Liu Y,Felker GM,Prescott MF,Ward JH,Piña IL,Butler J,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*, Humans, Natriuretic Peptide, Brain, Stroke Volume, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Ventricular Remodeling, Interleukin-1 Receptor-Like 1 Protein, Troponin T, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Tetrazoles, Tetrazoles/therapeutic use, Ventricular Function, Left, Aminobutyrates, Aminobutyrates/therapeutic use, Valsartan, Biphenyl Compounds, Drug Combinations, Biomarkers, Cardiomyopathies*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 962, + "user_id": 1639100928, + "artical_title": "Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction.", + "pmid": 36122819, + "journal_name": "Journal of cardiac failure", + "date": "2022-09-20", + "author": "Talha KM,Anker SD,Burkhoff D,Filippatos G,Lam CSP,Stone GW,Wazni O,Butler J", + "auth_pos": 8, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Heart Failure*, Heart Failure/therapy, Stroke Volume, Stroke Volume/physiology, Myocardial Contraction, Myocardial Contraction/physiology, Cardiac Resynchronization Therapy*, Prognosis, Ventricular Function, Left, Ventricular Function, Left/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 963, + "user_id": 1639100928, + "artical_title": "Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.", + "pmid": 36129693, + "journal_name": "JAMA cardiology", + "date": "2022-09-22", + "author": "Ferreira JP,Zannad F,Butler J,Filippatos G,Pocock SJ,Brueckmann M,Steubl D,Schueler E,Anker SD,Packer M", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 964, + "user_id": 1639100928, + "artical_title": "Accelerating therapeutic discoveries for heart failure: a new public-private partnership.", + "pmid": 36175548, + "journal_name": "Nature reviews. Drug discovery", + "date": "2022-09-30", + "author": "Shah SJ,Butler J,Shah SH,Kamphaus TN,Sachdev V", + "auth_pos": 2, + "meshterms": "Humans, Public-Private Sector Partnerships*, Heart Failure*, Humans, Public-Private Sector Partnerships*, Heart Failure*, Humans, Public-Private Sector Partnerships*, Heart Failure*, Humans, Public-Private Sector Partnerships*, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 965, + "user_id": 1639100928, + "artical_title": "Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study.", + "pmid": 36183276, + "journal_name": "Circulation", + "date": "2022-10-03", + "author": "Januzzi JL,Omar AMS,Liu Y,Murphy S,Butler J,Felker GM,Piña IL,Ward J,Solomon S,Contreras J", + "auth_pos": 5, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/drug therapy, Aminobutyrates, Aminobutyrates/adverse effects, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/adverse effects, Tetrazoles, Tetrazoles/adverse effects, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 966, + "user_id": 1639100928, + "artical_title": "Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.", + "pmid": 36194680, + "journal_name": "European journal of heart failure", + "date": "2022-10-05", + "author": "Filippatos G,Anker SD,Butler J,Farmakis D,Ferreira JP,Gollop ND,Brueckmann M,Iwata T,Pocock S,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 967, + "user_id": 1639100928, + "artical_title": "Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry study.", + "pmid": 36224725, + "journal_name": "ESC heart failure", + "date": "2022-10-14", + "author": "Zhang Y,Gao C,Greene SJ,Greenberg BH,Butler J,Yu J,Zheng Z,Ma G,Wang L,Yang P,Ji X,Xu D,Wang J,Zhang Y,Liu Y,Zhao Y,Qi H,Zhai M,Feng J,Huang Y,Zhou Q,Zhang J", + "auth_pos": 5, + "meshterms": "Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries, Humans, United States, Quality Indicators, Health Care*, Hospitalization, Heart Failure*, Heart Failure/epidemiology, Hospitals, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 968, + "user_id": 1639100928, + "artical_title": "Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.", + "pmid": 36229089, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-10-14", + "author": "Mohebi R,Liu Y,Piña IL,Prescott MF,Butler J,Felker GM,Ward JH,Solomon SD,Januzzi JL", + "auth_pos": 5, + "meshterms": "Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology, Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology, Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology, Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology, Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology, Aminobutyrates*, Aminobutyrates/therapeutic use, Atrial Natriuretic Factor, Biomarkers, Biphenyl Compounds*, Biphenyl Compounds/therapeutic use, Dose-Response Relationship, Drug, Guanosine Monophosphate, Guanosine Monophosphate/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Humans, Interleukin-1 Receptor-Like 1 Protein, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Stroke Volume, Stroke Volume/physiology, Troponin T, Valsartan*, Valsartan/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Ventricular Remodeling, Ventricular Remodeling/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 969, + "user_id": 1639100928, + "artical_title": "Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review.", + "pmid": 36243339, + "journal_name": "Journal of cardiac failure", + "date": "2022-10-16", + "author": "Khan MS,Ahmed A,Greene SJ,Fiuzat M,Kittleson MM,Butler J,Bakris GL,Fonarow GC", + "auth_pos": 6, + "meshterms": "Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors, Humans, Renal Dialysis, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Kidney Failure, Chronic*, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 970, + "user_id": 1639100928, + "artical_title": "Soluble Guanylate Cyclase Stimulators in Patients with Heart Failure with Reduced Ejection Fraction Across the Risk Spectrum.", + "pmid": 36250238, + "journal_name": "European journal of heart failure", + "date": "2022-10-18", + "author": "Butler J,Usman MS,Anstrom KJ,Blaustein RO,Bonaca MP,Ezekowitz JA,Freitas C,Lam CS,Lewis EF,Lindenfeld J,McMullan CJ,Mentz RJ,O'Connor C,Rosano GM,Saldarriaga CI,Senni M,Udelson J,Voors AA,Zannad F", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume, Humans, Heart Failure*, Heart Failure/drug therapy, Soluble Guanylyl Cyclase, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 971, + "user_id": 1639100928, + "artical_title": "Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease.", + "pmid": 36251465, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-10-18", + "author": "Filippatos G,Anker SD,Pitt B,McGuire DK,Rossing P,Ruilope LM,Butler J,Jankowska EA,Michos ED,Farmakis D,Farjat AE,Kolkhof P,Scalise A,Joseph A,Bakris GL,Agarwal R", + "auth_pos": 7, + "meshterms": "Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy, Humans, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 972, + "user_id": 1639100928, + "artical_title": "Iron deficiency and cardiovascular disease.", + "pmid": 36282723, + "journal_name": "European heart journal", + "date": "2022-10-26", + "author": "Savarese G,von Haehling S,Butler J,Cleland JG,Ponikowski P,Anker SD", + "auth_pos": 3, + "meshterms": "Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications, Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications, Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications, Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications, Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications, Humans, Female, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/etiology, Heart Failure*, Heart Failure/complications, Heart Failure/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Quality of Life, Stroke Volume, Iron Deficiencies*, Anemia*, Anemia/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 973, + "user_id": 1639100928, + "artical_title": "Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.", + "pmid": 36314126, + "journal_name": "Circulation. Heart failure", + "date": "2022-11-01", + "author": "Cosiano MF,Vista A,Sun JL,Alhanti B,Harrington J,Butler J,Starling R,Mentz RJ,Greene SJ", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, New York, Treatment Outcome, Patient Reported Outcome Measures, Quality of Life, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, New York, Treatment Outcome, Patient Reported Outcome Measures, Quality of Life, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, New York, Treatment Outcome, Patient Reported Outcome Measures, Quality of Life, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, New York, Treatment Outcome, Patient Reported Outcome Measures, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 974, + "user_id": 1639100928, + "artical_title": "Weight Change and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from EMPEROR-Reduced.", + "pmid": 36325584, + "journal_name": "European journal of heart failure", + "date": "2022-11-04", + "author": "Anker SD,Khan MS,Butler J,Ofstad AP,Peil B,Pfarr E,Doehner W,Sattar N,Coats AJS,Filippatos G,Ferreira JP,Zannad F,Pocock S,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*, Humans, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Body Mass Index, Weight Loss*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 975, + "user_id": 1639100928, + "artical_title": "Trends in Heart Failure-Related Mortality Among Older Adults in the United States From 1999-2019.", + "pmid": 36328654, + "journal_name": "JACC. Heart failure", + "date": "2022-11-04", + "author": "Siddiqi TJ,Khan Minhas AM,Greene SJ,Van Spall HGC,Khan SS,Pandey A,Mentz RJ,Fonarow GC,Butler J,Khan MS", + "auth_pos": 9, + "meshterms": "Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual, Male, Humans, United States, United States/epidemiology, Female, Aged, Heart Failure*, Ethnicity, Centers for Disease Control and Prevention, U.S., Databases, Factual", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 976, + "user_id": 1639100928, + "artical_title": "Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US.", + "pmid": 36334258, + "journal_name": "JAMA cardiology", + "date": "2022-11-06", + "author": "Talha KM,Butler J,Greene SJ,Aggarwal R,Anker SD,Claggett BL,Solomon SD,McMurray JJV,Vaduganathan M,Fonarow GC", + "auth_pos": 2, + "meshterms": "Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left, Adult, Aged, Female, Humans, Male, Chronic Disease, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 977, + "user_id": 1639100928, + "artical_title": "Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.", + "pmid": 36335517, + "journal_name": "Circulation", + "date": "2022-11-07", + "author": "Connelly KA,Mazer CD,Puar P,Teoh H,Wang CH,Mason T,Akhavein F,Chang CW,Liu MH,Yang NI,Chen WS,Juan YH,Opingari E,Salyani Y,Barbour W,Pasricha A,Ahmed S,Kosmopoulos A,Verma R,Moroney M,Bakbak E,Krishnaraj A,Bhatt DL,Butler J,Kosiborod MN,Lam CSP,Hess DA,Rizzi Coelho-Filho O,Lafreniere-Roula M,Thorpe KE,Quan A,Leiter LA,Yan AT,Verma S", + "auth_pos": 24, + "meshterms": "Aged, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Sodium, Stroke Volume, Ventricular Remodeling, Female, Aged, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Sodium, Stroke Volume, Ventricular Remodeling, Female, Aged, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Sodium, Stroke Volume, Ventricular Remodeling, Female, Aged, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Sodium, Stroke Volume, Ventricular Remodeling, Female, Aged, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose, Heart Failure*, Sodium, Stroke Volume, Ventricular Remodeling, Female", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 978, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled.", + "pmid": 36342827, + "journal_name": "Circulation", + "date": "2022-11-08", + "author": "Verma S,Dhingra NK,Butler J,Anker SD,Pedro Ferreira J,Filippatos G,Januzzi JL,Lam CSP,Sattar N,Pfarr E,Nordaby M,Brueckmann M,Pocock SJ,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Heart Failure/drug therapy, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Stroke Volume, Diabetes Mellitus, Type 2*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 979, + "user_id": 1639100928, + "artical_title": "Duration of Heart Failure, In-hospital Clinical Trajectory, and Post-discharge Outcomes Among Patients Hospitalized for Heart Failure.", + "pmid": 36351495, + "journal_name": "Journal of cardiac failure", + "date": "2022-11-10", + "author": "Pierce JB,Maqsood MH,Khan MS,Minhas AMK,Butler J,Felker GM,Greene SJ", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Aftercare, Patient Discharge, Hospitalization, Hospitals", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 980, + "user_id": 1639100928, + "artical_title": "Neighborhood Household Income and Trends in 30-Day Readmission for Patients With Heart Failure.", + "pmid": 36357301, + "journal_name": "JACC. Heart failure", + "date": "2022-11-11", + "author": "Aliyev N,Almani MU,Qudrat-Ullah M,Harrington J,Fonarow GC,Butler J,Pandey A,Khan MS,Greene SJ", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 981, + "user_id": 1639100928, + "artical_title": "Rationale and Design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in Patients with High-Risk Diabetic Cardiomyopathy.", + "pmid": 36372245, + "journal_name": "American heart journal", + "date": "2022-11-14", + "author": "Januzzi JL,Butler J,Prato SD,Ezekowitz JA,Ibrahim NE,Lam CS,Lewis GD,Marwick TH,Rosenstock J,Tang WW,Zannad F,Lawson F,Perfetti R,Urbinati A", + "auth_pos": 2, + "meshterms": "Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method, Animals, Humans, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Aldehyde Reductase, Aldehyde Reductase/metabolism, Aldehyde Reductase/therapeutic use, Exercise Tolerance, Diabetes Complications*, Diabetes Complications/drug therapy, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 982, + "user_id": 1639100928, + "artical_title": "Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high-risk heart failure patients (Confirm-AF trial).", + "pmid": 36436199, + "journal_name": "Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc", + "date": "2022-11-28", + "author": "Aktas MK,Zareba W,Butler J,Younis A,McNitt S,Brown MW,Rao N,Rao N,Steinberg J,Chen L,Alexis JD,Vidula H,Goldenberg I", + "auth_pos": 3, + "meshterms": "Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Humans, United States, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Prospective Studies, Stroke Volume, Electrocardiography, Electrocardiography, Ambulatory, Electrocardiography, Ambulatory/methods, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 983, + "user_id": 1639100928, + "artical_title": "Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status.", + "pmid": 36456072, + "journal_name": "JACC. Heart failure", + "date": "2022-12-02", + "author": "Murphy SP,Ward JH,Piña IL,Felker GM,Butler J,Maisel AS,Meng X,Prescott MF,Solomon SD,Januzzi JL", + "auth_pos": 5, + "meshterms": "Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Ventricular Remodeling, Ventricular Function, Left, Valsartan, Biomarkers, Health Status, Heart Atria", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 984, + "user_id": 1639100928, + "artical_title": "Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.", + "pmid": 36471037, + "journal_name": "Nature medicine", + "date": "2022-12-06", + "author": "Anker SD,Butler J,Usman MS,Filippatos G,Ferreira JP,Bocchi E,Böhm M,Rocca HPB,Choi DJ,Chopra V,Chuquiure E,Giannetti N,Gomez-Mesa JE,Janssens S,Januzzi JL,González-Juanatey JR,Merkely B,Nicholls SJ,Perrone SV,Piña IL,Ponikowski P,Senni M,Sim D,Spinar J,Squire I,Taddei S,Tsutsui H,Verma S,Vinereanu D,Zhang J,Iwata T,Schnee JM,Brueckmann M,Pocock SJ,Zannad F", + "auth_pos": 2, + "meshterms": "Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left, Humans, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 985, + "user_id": 1639100928, + "artical_title": "Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.", + "pmid": 36478225, + "journal_name": "European heart journal", + "date": "2022-12-09", + "author": "Bhm M,Anker S,Mahfoud F,Lauder L,Filippatos G,Ferreira JP,Pocock SJ,Brueckmann M,Saloustros I,Schler E,Wanner C,Zannad F,Packer M,Butler J", + "auth_pos": 14, + "meshterms": "Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Humans, Blood Pressure, Heart Failure*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 986, + "user_id": 1639100928, + "artical_title": "Mechanisms of current therapeutic strategies for heart failure: more questions than answers?", + "pmid": 36536991, + "journal_name": "Cardiovascular research", + "date": "2022-12-21", + "author": "Khan MS,Shahid I,Greene SJ,Mentz RJ,DeVore AD,Butler J", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Phenotype, Stroke Volume, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 987, + "user_id": 1639100928, + "artical_title": "The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?", + "pmid": 36545228, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2022-12-23", + "author": "Docherty KF,Bayes-Genis A,Butler J,Coats AJS,Drazner MH,Joyce E,Lam CSP", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 988, + "user_id": 1639100928, + "artical_title": "Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure.", + "pmid": 36561085, + "journal_name": "Methodist DeBakey cardiovascular journal", + "date": "2022-12-24", + "author": "Talha KM,Fonarow GC,Virani SS,Butler J", + "auth_pos": 4, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Glucose/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Pharmaceutical Preparations, Randomized Controlled Trials as Topic, Observational Studies as Topic, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Glucose/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Pharmaceutical Preparations, Randomized Controlled Trials as Topic, Observational Studies as Topic, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Glucose, Glucose/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Pharmaceutical Preparations, Randomized Controlled Trials as Topic, Observational Studies as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 989, + "user_id": 1639100928, + "artical_title": "Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.", + "pmid": 36565199, + "journal_name": "Journal of the American Heart Association", + "date": "2022-12-25", + "author": "Khan MS,Butler J,Anker SD,Filippatos G,Ferreira JP,Pocock SJ,Januzzi JL,Piña IL,Böhm M,Ponikowski P,Verma S,Brueckmann M,Vedin O,Zeller C,Zannad F,Packer M", + "auth_pos": 2, + "meshterms": "Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/chemically induced, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/chemically induced", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 990, + "user_id": 1639100928, + "artical_title": "Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure.", + "pmid": 36592843, + "journal_name": "Current problems in cardiology", + "date": "2023-01-03", + "author": "Jain V,Maqsood MH,Siddiqi TJ,Siddiqi AK,Baloch ZQ,Kittleson MM,Fudim M,Michael Felker G,Greene SJ,Butler J,Khan MS", + "auth_pos": 10, + "meshterms": "Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*, Humans, Young Adult, Aged, Middle Aged, Stroke Volume, Aftercare*, Patient Discharge, Ventricular Function, Left, Acute Disease, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 991, + "user_id": 1639100928, + "artical_title": "Little at a time: trying to understand the battery of benefits of SGLT2 inhibitors in heart failure.", + "pmid": 36597825, + "journal_name": "European journal of heart failure", + "date": "2023-01-05", + "author": "von Haehling S,Sato R,Butler J,Anker SD", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Glucose, Sodium, Hypoglycemic Agents, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Glucose, Sodium, Hypoglycemic Agents, Diabetes Mellitus, Type 2*, Humans, Heart Failure*, Glucose, Sodium, Hypoglycemic Agents, Diabetes Mellitus, Type 2*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 992, + "user_id": 1639100928, + "artical_title": "Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan.", + "pmid": 36599549, + "journal_name": "JACC. Heart failure", + "date": "2023-01-05", + "author": "Mohebi R,Liu Y,Felker GM,Prescott MF,Piña IL,Butler J,Ward JH,Solomon SD,Januzzi JL", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 993, + "user_id": 1639100928, + "artical_title": "Albuminuria and Heart Failure: JACC State-of-the-Art Review.", + "pmid": 36653095, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-01-19", + "author": "Khan MS,Shahid I,Anker SD,Fonarow GC,Fudim M,Hall ME,Hernandez A,Morris AA,Shafi T,Weir MR,Zannad F,Bakris GL,Butler J", + "auth_pos": 13, + "meshterms": "Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors, Humans, Albuminuria, Albuminuria/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Heart Failure*, Heart Failure/epidemiology, Cardiovascular Diseases*, Glomerular Filtration Rate, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 994, + "user_id": 1639100928, + "artical_title": "Management of Heart Failure with Reduced Ejection Fraction.", + "pmid": 36681212, + "journal_name": "Current problems in cardiology", + "date": "2023-01-22", + "author": "Rashid AM,Khan MS,Fudim M,DeWald TA,DeVore A,Butler J", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 995, + "user_id": 1639100928, + "artical_title": "Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.", + "pmid": 36697141, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-01-26", + "author": "Greene SJ,Bauersachs J,Brugts JJ,Ezekowitz JA,Lam CSP,Lund LH,Ponikowski P,Voors AA,Zannad F,Zieroth S,Butler J", + "auth_pos": 11, + "meshterms": "Humans, Acute Disease, Disease Progression, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/history, Heart Failure/therapy, Hospitalization, Humans, Acute Disease, Disease Progression, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/history, Heart Failure/therapy, Hospitalization, Humans, Acute Disease, Disease Progression, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/history, Heart Failure/therapy, Hospitalization, Humans, Acute Disease, Disease Progression, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/history, Heart Failure/therapy, Hospitalization, Humans, Acute Disease, Disease Progression, Diuretics, Diuretics/therapeutic use, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/history, Heart Failure/therapy, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 996, + "user_id": 1639100928, + "artical_title": "Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum.", + "pmid": 36702610, + "journal_name": "European heart journal", + "date": "2023-01-27", + "author": "Filbey L,Zhu JW,D'Angelo F,Thabane L,Khan MS,Lewis E,Patel MR,Powell-Wiley T,Miranda JJ,Zuhlke L,Butler J,Zannad F,Van Spall HGC", + "auth_pos": 11, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/therapy, Patient Selection*, Randomized Controlled Trials as Topic, Healthcare Disparities*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 997, + "user_id": 1639100928, + "artical_title": "Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States.", + "pmid": 36754528, + "journal_name": "JACC. Heart failure", + "date": "2023-02-09", + "author": "Khan MS,Xu H,Fonarow GC,Lautsch D,Hilkert R,Allen LA,DeVore AD,Alhanti B,Yancy CW,Albert NM,Butler J,Greene SJ", + "auth_pos": 11, + "meshterms": "Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume, Aged, Humans, Female, United States, United States/epidemiology, Heart Failure*, Heart Failure/therapy, Aftercare, Medicare, Patient Discharge, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 998, + "user_id": 1639100928, + "artical_title": "Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study.", + "pmid": 36802884, + "journal_name": "Circulation", + "date": "2023-02-22", + "author": "Felker GM,North R,Mulder H,Jones WS,Anstrom KJ,Patel MJ,Butler J,Ezekowitz JA,Lam C,O'Connor CM,Roessig L,Hernandez AF,Armstrong PW", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 999, + "user_id": 1639100928, + "artical_title": "A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study.", + "pmid": 36809039, + "journal_name": "Circulation. Heart failure", + "date": "2023-02-23", + "author": "Johansen ND,Vaduganathan M,Zahir D,Fiuzat M,DeFilippis EM,Januzzi JL,Butler J,O'Connor CM,Abraham WT,Psotka MA,McMurray JJV,Dewan P,Claggett BL,Solomon SD,Modin D,Butt JH,Jensen JUS,Schou M,Torp-Pedersen C,Køber L,Gislason GH,Biering-Sørensen T", + "auth_pos": 7, + "meshterms": "Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/therapy, Cohort Studies, Retrospective Studies, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1000, + "user_id": 1639100928, + "artical_title": "Impact of Diabetes and Hypertension on Left Ventricular Structure and Function: The Jackson Heart Study.", + "pmid": 36880997, + "journal_name": "Journal of the American Heart Association", + "date": "2023-03-08", + "author": "Hamid A,Yimer WK,Oshunbade AA,Kamimura D,Clark D,Fox ER,Min YI,Muntner P,Shimbo D,Pandey A,Shah AM,Mentz RJ,Jones DW,Bertoni AG,Hall JE,Correa A,Butler J,Hall ME", + "auth_pos": 17, + "meshterms": "Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling, Adult, Humans, Female, Middle Aged, Male, Cross-Sectional Studies, Natriuretic Peptide, Brain, Hypertension*, Hypertension/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Longitudinal Studies, Ventricular Function, Left, Ventricular Remodeling", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1001, + "user_id": 1639100928, + "artical_title": "Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure.", + "pmid": 36752485, + "journal_name": "JACC. Heart failure", + "date": "2023-03-30", + "author": "Zile MR,Kahwash R,Sarkar S,Koehler J,Butler J", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Defibrillators, Implantable*, Cardiac Resynchronization Therapy*, Hospitalization, Cardiac Resynchronization Therapy Devices, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/therapy, Atrial Fibrillation/diagnosis, Humans, Heart Failure*, Defibrillators, Implantable*, Cardiac Resynchronization Therapy*, Hospitalization, Cardiac Resynchronization Therapy Devices, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/therapy, Atrial Fibrillation/diagnosis, Humans, Heart Failure*, Defibrillators, Implantable*, Cardiac Resynchronization Therapy*, Hospitalization, Cardiac Resynchronization Therapy Devices, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/therapy, Atrial Fibrillation/diagnosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1002, + "user_id": 1639100928, + "artical_title": "Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.", + "pmid": 36881394, + "journal_name": "JACC. Heart failure", + "date": "2023-04-07", + "author": "Kaul P,Rathwell S,Lam CSP,Westerhout CM,Spertus JA,Anstrom KJ,Blaustein RO,Ezekowitz JA,Pieske B,Roessig L,Butler J,Armstrong PW", + "auth_pos": 11, + "meshterms": "Humans, Female, Male, Heart Failure*, Quality of Life, Stroke Volume, Frailty*, Functional Status, Patient Reported Outcome Measures, Humans, Female, Male, Heart Failure*, Quality of Life, Stroke Volume, Frailty*, Functional Status, Patient Reported Outcome Measures, Humans, Female, Male, Heart Failure*, Quality of Life, Stroke Volume, Frailty*, Functional Status, Patient Reported Outcome Measures", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1003, + "user_id": 1639100928, + "artical_title": "Medication-Attributable Adverse Events in Heart Failure Trials.", + "pmid": 36881395, + "journal_name": "JACC. Heart failure", + "date": "2023-04-07", + "author": "Harrington J,Fonarow GC,Khan MS,Hernandez A,Anker S,Böhm M,Greene SJ,Felker GM,Vaduganathan M,Butler J", + "auth_pos": 10, + "meshterms": "Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Heart Failure*, Heart Failure/therapy, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1004, + "user_id": 1639100928, + "artical_title": "Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.", + "pmid": 36881400, + "journal_name": "JACC. Heart failure", + "date": "2023-04-07", + "author": "Carson P,Teerlink JR,Komajda M,Anand I,Anker SD,Butler J,Doehner W,Ferreira JP,Filippatos G,Haass M,Miller A,Pehrson S,Pocock SJ,Schnaidt S,Schnee JM,Zannad F,Packer M", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis, Humans, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1005, + "user_id": 1639100928, + "artical_title": "Challenges and opportunities for increasing patient involvement in heart failure self-care programs and self-care in the post-hospital discharge period.", + "pmid": 37046357, + "journal_name": "Research involvement and engagement", + "date": "2023-04-13", + "author": "Butler J,Petrie MC,Bains M,Bawtinheimer T,Code J,Levitch T,Malvolti E,Monteleone P,Stevens P,Vafeiadou J,Lam CSP", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1006, + "user_id": 1639100928, + "artical_title": "Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.", + "pmid": 36634811, + "journal_name": "Journal of cardiac failure", + "date": "2023-04-18", + "author": "Defilippi CR,Alemayehu WG,Voors AA,Kaye D,Blaustein RO,Butler J,Ezekowitz JA,Hernandez AF,Lam CSP,Roessig L,Seliger S,Shah P,Westerhout CM,Armstrong PW,O'Connor CM", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Cystatin C, Interleukin-6, Biomarkers, Inflammation, Ventricular Dysfunction, Left*, Natriuretic Peptide, Brain, Kidney, Kidney/physiology, Growth Differentiation Factors, Troponin T, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1007, + "user_id": 1639100928, + "artical_title": "Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure.", + "pmid": 37042286, + "journal_name": "Journal of the American Heart Association", + "date": "2023-04-19", + "author": "Mohebi R,Liu Y,Felker GM,Ward JH,Piña IL,Butler J,Solomon SD,Januzzi JL", + "auth_pos": 6, + "meshterms": "Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Valsartan, Heart Failure*, Heart Failure/drug therapy, Biphenyl Compounds, Drug Combinations, Stroke Volume, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1008, + "user_id": 1639100928, + "artical_title": "STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With Care.", + "pmid": 37068130, + "journal_name": "Circulation", + "date": "2023-04-19", + "author": "Butler J,Talha KM,Fonarow GC", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1009, + "user_id": 1639100928, + "artical_title": "Vericiguat for the treatment of heart failure with reduced ejection fraction.", + "pmid": 36881733, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2023-04-19", + "author": "Siddiqi AK,Greene SJ,Fudim M,Mentz RJ,Butler J,Khan MS", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Treatment Outcome, Heterocyclic Compounds, 2-Ring*, Heterocyclic Compounds, 2-Ring/adverse effects, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1010, + "user_id": 1639100928, + "artical_title": "Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.", + "pmid": 37076211, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-04-21", + "author": "Lena A,Wilkenshoff U,Hadzibegovic S,Porthun J,Rösnick L,Fröhlich AK,Zeller T,Karakas M,Keller U,Ahn J,Bullinger L,Riess H,Rosen SD,Lyon AR,Lüscher TF,Totzeck M,Rassaf T,Burkhoff D,Mehra MR,Bax JJ,Butler J,Edelmann F,Haverkamp W,Anker SD,Packer M,Coats AJS,von Haehling S,Landmesser U,Anker MS", + "auth_pos": 21, + "meshterms": "Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Cachexia, Cachexia/diagnosis, Cachexia/etiology, Prognosis, Heart, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Neoplasms*, Neoplasms/complications, Ventricular Function, Left, Ventricular Function, Left/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1011, + "user_id": 1639100928, + "artical_title": "Efficacy of sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors for heart failure in black patients: a systematic review and meta-analysis of randomized controlled trials.", + "pmid": 36919580, + "journal_name": "European journal of heart failure", + "date": "2023-04-28", + "author": "Pandey AK,Dhingra NK,Pandey A,Puar P,Ahmed S,Verma R,Mazer CD,Butler J,Badiwala M,Yau TM,Yanagawa B,Bhatt DL,Verma S", + "auth_pos": 8, + "meshterms": "Humans, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Neprilysin, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Neprilysin, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Neprilysin, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Neprilysin, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1012, + "user_id": 1639100928, + "artical_title": "Time to reconsider the perception and management of hypertensive heart disease.", + "pmid": 36823787, + "journal_name": "European journal of heart failure", + "date": "2023-04-28", + "author": "Díez J,Rosano GMC,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Hypertension*, Hypertension/therapy, Heart Diseases*, Perception", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1013, + "user_id": 1639100928, + "artical_title": "CDC-WONDER Database Analysis of COVID-19 and Cardiovascular Disease-Related Mortality.", + "pmid": 37100492, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-04-28", + "author": "Maqsood MH,Talha KM,Minhas AMK,Fudim M,Khan SS,Butler J,Khan MS", + "auth_pos": 6, + "meshterms": "Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S., Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S., Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S., Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S., Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S., Humans, United States, United States/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, COVID-19*, Cardiovascular System*, Public Health, Centers for Disease Control and Prevention, U.S.", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1014, + "user_id": 1639100928, + "artical_title": "PATIENT REPORTED OUTCOME MEASURES AND PATIENT ENGAGEMENT IN HEART FAILURE CLINICAL TRIALS: MULTI-STAKEHOLDER PERSPECTIVES.", + "pmid": 36924142, + "journal_name": "European journal of heart failure", + "date": "2023-04-28", + "author": "Zannad F,Alikhaani J,Alikhaani S,Butler J,Gordon J,Jensen K,Khatib R,Mantovani L,Martinez R,Moore WF,Murakami M,Roessig L,Stockbridge N,Van Spall HGC,Yancy C,Spertus JA", + "auth_pos": 4, + "meshterms": "Humans, Quality of Life*, Heart Failure*, Heart Failure/therapy, Patient Participation, Patient Reported Outcome Measures, Caregivers, Humans, Quality of Life*, Heart Failure*, Heart Failure/therapy, Patient Participation, Patient Reported Outcome Measures, Caregivers, Humans, Quality of Life*, Heart Failure*, Heart Failure/therapy, Patient Participation, Patient Reported Outcome Measures, Caregivers, Humans, Quality of Life*, Heart Failure*, Heart Failure/therapy, Patient Participation, Patient Reported Outcome Measures, Caregivers, Humans, Quality of Life*, Heart Failure*, Heart Failure/therapy, Patient Participation, Patient Reported Outcome Measures, Caregivers", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1015, + "user_id": 1639100928, + "artical_title": "Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration.", + "pmid": 37100553, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-04-28", + "author": "Adamo M,Tomasoni D,Stolz L,Stocker TJ,Pancaldi E,Koell B,Karam N,Besler C,Giannini C,Sampaio F,Praz F,Ruf T,Pechmajou L,Neuss M,Iliadis C,Baldus S,Butter C,Kalbacher D,Lurz P,Melica B,Petronio AS,Stephan von Bardeleben R,Windecker S,Butler J,Fonarow GC,Hausleiter J,Metra M", + "auth_pos": 24, + "meshterms": "Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications, Humans, Heart Failure*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Retrospective Studies, Treatment Outcome, Stroke Volume, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1016, + "user_id": 1639100928, + "artical_title": "Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?", + "pmid": 36943697, + "journal_name": "European heart journal", + "date": "2023-05-02", + "author": "Packer M,Siddiqi TJ,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Diabetic Nephropathies*, Diabetic Nephropathies/drug therapy, Diabetic Nephropathies/prevention & control, Kidney, Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/prevention & control, Disease Progression, Kidney Failure, Chronic*, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Humans, Diabetic Nephropathies*, Diabetic Nephropathies/drug therapy, Diabetic Nephropathies/prevention & control, Kidney, Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/prevention & control, Disease Progression, Kidney Failure, Chronic*, Diabetes Mellitus*, Diabetes Mellitus/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1017, + "user_id": 1639100928, + "artical_title": "The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.", + "pmid": 37023862, + "journal_name": "International journal of cardiology", + "date": "2023-05-05", + "author": "Eder M,Griffin M,Moreno-Villagomez J,Bellumkonda L,Maulion C,Asher J,Wilson FP,Cox ZL,Ivey-Miranda JB,Rao VS,Butler J,Borlaug BA,McCallum W,Ramos-Mastache D,Testani JM", + "auth_pos": 11, + "meshterms": "Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Humans, Stroke Volume, Sodium Potassium Chloride Symporter Inhibitors, Sodium Potassium Chloride Symporter Inhibitors/adverse effects, Hyperemia*, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Heart Failure/complications, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1018, + "user_id": 1639100928, + "artical_title": "Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.", + "pmid": 37137660, + "journal_name": "JACC. Heart failure", + "date": "2023-05-05", + "author": "Butler J,Zheng Y,Khan MS,Bonderman D,Lund LH,deFilippi CR,Blaustein RO,Ezekowitz JA,Freitas C,Hernandez AF,O'Connor CM,Voors AA,Westerhout CM,Lam CSP,Armstrong PW", + "auth_pos": 1, + "meshterms": "Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Function, Left, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, C-Reactive Protein, Interleukin-6, Interleukin-6/pharmacology, Interleukin-6/therapeutic use, Ventricular Dysfunction, Left*, Biomarkers", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1019, + "user_id": 1639100928, + "artical_title": "Rapid Sequence Initiation of Device Therapy in Heart Failure.", + "pmid": 38939577, + "journal_name": "JACC. Advances", + "date": "2023-05-10", + "author": "Salah HM,Butler J,Fudim M", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1020, + "user_id": 1639100928, + "artical_title": "Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.", + "pmid": 37164523, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-05-12", + "author": "Butler J,Packer M,Siddiqi TJ,Böhm M,Brueckmann M,Januzzi JL,Verma S,Gergei I,Iwata T,Wanner C,Ferreira JP,Pocock SJ,Filippatos G,Anker SD,Zannad F", + "auth_pos": 1, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/epidemiology, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1021, + "user_id": 1639100928, + "artical_title": "Biomarkers for the diagnosis of heart failure in people with diabetes: A consensus report from diabetes technology society.", + "pmid": 37178991, + "journal_name": "Progress in cardiovascular diseases", + "date": "2023-05-14", + "author": "Yeung AM,Huang J,Pandey A,Hashim IA,Kerr D,Pop-Busui R,Rhee CM,Shah VN,Bally L,Bayes-Genis A,Bee YM,Bergenstal R,Butler J,Fleming GA,Gilbert G,Greene SJ,Kosiborod MN,Leiter LA,Mankovsky B,Martens TW,Mathieu C,Mohan V,Patel KV,Peters A,Rhee EJ,Rosano GMC,Sacks DB,Sandoval Y,Seley JJ,Schnell O,Umpierrez G,Waki K,Wright EE,Wu AHB,Klonoff DC", + "auth_pos": 13, + "meshterms": "Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Humans, Adult, Natriuretic Peptide, Brain, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 1*, Consensus, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1022, + "user_id": 1639100928, + "artical_title": "SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence.", + "pmid": 37180562, + "journal_name": "International journal of heart failure", + "date": "2023-05-14", + "author": "Talha KM,Anker SD,Butler J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1023, + "user_id": 1639100928, + "artical_title": "Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.", + "pmid": 37117140, + "journal_name": "Journal of cardiac failure", + "date": "2023-05-15", + "author": "Tsutsui H,Albert NM,Coats AJS,Anker SD,Bayes-Genis A,Butler J,Chioncel O,Defilippi CR,Drazner MH,Felker GM,Filippatos G,Fiuzat M,Ide T,Januzzi JL,Kinugawa K,Kuwahara K,Matsue Y,Mentz RJ,Metra M,Pandey A,Rosano G,Saito Y,Sakata Y,Sato N,Seferovic PM,Teerlink J,Yamamoto K,Yoshimura M", + "auth_pos": 6, + "meshterms": "Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides*, Peptide Fragments, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1024, + "user_id": 1639100928, + "artical_title": "Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.", + "pmid": 36332897, + "journal_name": "Journal of cardiac failure", + "date": "2023-05-15", + "author": "Khan MS,Anker SD,Friede T,Jankowska EA,Metra M,Piña IL,Coats AJ,Rosano G,Roubert B,Goehring UM,Dorigotti F,Comin-Colet J,Vanveldhuisen DJ,Filippatos GS,Ponikowski P,Butler J", + "auth_pos": 16, + "meshterms": "Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*, Humans, Walk Test, Heart Failure*, Heart Failure/diagnosis, Heart Failure/complications, Stroke Volume, Minimal Clinically Important Difference, Iron Deficiencies*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1025, + "user_id": 1639100928, + "artical_title": "Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.", + "pmid": 37192292, + "journal_name": "Circulation. Heart failure", + "date": "2023-05-18", + "author": "Girerd N,Levy D,Duarte K,Ferreira JP,Ballantyne C,Collier T,Pizard A,Björkman J,Butler J,Clark A,Cleland JG,Delles C,Diez J,González A,Hazebroek M,Ho J,Huby AC,Hwang SJ,Latini R,Mariottoni B,Mebazaa A,Pellicori P,Sattar N,Sever P,Staessen JA,Verdonschot J,Heymans S,Rossignol P,Zannad F", + "auth_pos": 9, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Biomarkers, Longitudinal Studies, Risk Factors, Aging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Natriuretic Peptide, Brain, Peptide Fragments", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1026, + "user_id": 1639100928, + "artical_title": "Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes.", + "pmid": 37199909, + "journal_name": "Diabetes therapy : research, treatment and education of diabetes and related disorders", + "date": "2023-05-18", + "author": "Kanumilli N,Butler J,Makrilakis K,Rydén L,Vallis M,Wanner C,Zieroth S,Alhussein A,Cheng A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1027, + "user_id": 1639100928, + "artical_title": "Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study.", + "pmid": 36924023, + "journal_name": "ESC heart failure", + "date": "2023-05-19", + "author": "Correale M,Antohi EL,Inciardi RM,Mazzeo P,Coiro S,Ishihara S,Petroni R,Monitillo F,Leone M,Triggiani M,Sarwar CMS,Dungen HD,Talha KM,Brunetti ND,Butler J,Nodari S", + "auth_pos": 15, + "meshterms": "Humans, Adult, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Prospective Studies, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Chronic Disease, Glucose, Humans, Adult, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Prospective Studies, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Chronic Disease, Glucose, Humans, Adult, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Prospective Studies, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Chronic Disease, Glucose, Humans, Adult, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Prospective Studies, Ventricular Function, Left, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Chronic Disease, Glucose", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1028, + "user_id": 1639100928, + "artical_title": "Sodium-Glucose Cotransporter-2 Inhibitors as Enablers of Chronic Glucocorticoid Therapy.", + "pmid": 38938258, + "journal_name": "JACC. Advances", + "date": "2023-05-24", + "author": "Kahwash R,Butler J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1029, + "user_id": 1639100928, + "artical_title": "Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.", + "pmid": 37051919, + "journal_name": "Circulation", + "date": "2023-06-01", + "author": "Filippatos G,Ponikowski P,Farmakis D,Anker SD,Butler J,Fabien V,Kirwan BA,Macdougall IC,Metra M,Rosano G,Ruschitzka F,van der Meer P,Waechter S,Jankowska EA", + "auth_pos": 5, + "meshterms": "Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome, Male, Humans, Female, Quality of Life, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Iron, Maltose, Maltose/adverse effects, Anemia*, Anemia/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/complications, Hemoglobins, Hemoglobins/metabolism, Ferritins, Transferrins, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1030, + "user_id": 1639100928, + "artical_title": "Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global survey.", + "pmid": 37254075, + "journal_name": "BMC public health", + "date": "2023-06-01", + "author": "Lam CSP,Harding E,Bains M,Chin A,Kanumilli N,Petrie MC,Pohja-Hutchison P,Yang J,Butler J", + "auth_pos": 9, + "meshterms": "Humans, Quality of Life*, Heart Failure*, Heart Failure/etiology, Surveys and Questionnaires, Hospitalization, Humans, Quality of Life*, Heart Failure*, Heart Failure/etiology, Surveys and Questionnaires, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1031, + "user_id": 1639100928, + "artical_title": "Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.", + "pmid": 37098746, + "journal_name": "European heart journal", + "date": "2023-06-02", + "author": "Khan MS,Usman MS,Talha KM,Van Spall HGC,Greene SJ,Vaduganathan M,Khan SS,Mills NL,Ali ZA,Mentz RJ,Fonarow GC,Rao SV,Spertus JA,Roe MT,Anker SD,James SK,Butler J,McGuire DK", + "auth_pos": 17, + "meshterms": "Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*, Humans, Electronic Health Records*, Cardiovascular Diseases*, Randomized Controlled Trials as Topic, Routinely Collected Health Data*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1032, + "user_id": 1639100928, + "artical_title": "Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled Analysis.", + "pmid": 36872213, + "journal_name": "JACC. Heart failure", + "date": "2023-06-09", + "author": "Ferreira JP,Zannad F,Butler J,Filippatos G,Pocock S,Iwata T,Sumin M,Zeller C,Januzzi JL,Anker SD,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, Humans, Heart Failure*, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1033, + "user_id": 1639100928, + "artical_title": "Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.", + "pmid": 37211049, + "journal_name": "International journal of cardiology", + "date": "2023-06-15", + "author": "Angélico-Gonçalves A,Leite AR,Neves JS,Saraiva F,Brochado L,Oliveira AC,Butler J,Packer M,Zannad F,Vasques-Nóvoa F,Leite-Moreira A,Ferreira JP", + "auth_pos": 7, + "meshterms": "Humans, Health Status, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization, Outcome Assessment, Health Care, Quality of Life*, Humans, Health Status, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization, Outcome Assessment, Health Care, Quality of Life*, Humans, Health Status, Heart Failure*, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization, Outcome Assessment, Health Care, Quality of Life*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1034, + "user_id": 1639100928, + "artical_title": "Interaction of Natriuretic Peptide Levels and Ejection Fraction on Outcomes with Dapagliflozin and Empagliflozin in Heart Failure.", + "pmid": 37038319, + "journal_name": "European journal of heart failure", + "date": "2023-06-19", + "author": "Butler J,Siddiqi TJ,Zannad F,Ferreira JP,Fillipatos G,Anker SD,Packer M", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Natriuretic Peptides, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Natriuretic Peptides, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Natriuretic Peptides, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Natriuretic Peptides, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1035, + "user_id": 1639100928, + "artical_title": "Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.", + "pmid": 37098791, + "journal_name": "European journal of heart failure", + "date": "2023-06-19", + "author": "Tsutsui H,Albert NM,Coats AJS,Anker SD,Bayes-Genis A,Butler J,Chioncel O,Defilippi CR,Drazner MH,Felker GM,Filippatos G,Fiuzat M,Ide T,Januzzi JL,Kinugawa K,Kuwahara K,Matsue Y,Mentz RJ,Metra M,Pandey A,Rosano G,Saito Y,Sakata Y,Sato N,Seferovic PM,Teerlink J,Yamamoto K,Yoshimura M", + "auth_pos": 6, + "meshterms": "Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis, Humans, Biomarkers, Cardiology*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/therapeutic use, Natriuretic Peptides, Peptide Fragments, Peptide Fragments/therapeutic use, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1036, + "user_id": 1639100928, + "artical_title": "High-Intensity Interval Training Versus Moderate Continuous Training in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-analysis.", + "pmid": 36967072, + "journal_name": "Current problems in cardiology", + "date": "2023-06-19", + "author": "Siddiqi TJ,Rashid AM,Javaid SS,Siddiqi AK,Usman MS,Hervir O,Kamimura D,Lavie CJ,Mentz RJ,Butler J,Hall ME", + "auth_pos": 10, + "meshterms": "Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance, Humans, Stroke Volume, High-Intensity Interval Training*, Carbon Dioxide, Exercise Test, Heart Failure*, Heart Failure/therapy, Exercise Tolerance", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1037, + "user_id": 1639100928, + "artical_title": "Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled.", + "pmid": 37199158, + "journal_name": "Arteriosclerosis, thrombosis, and vascular biology", + "date": "2023-06-23", + "author": "Verma S,Dhingra NK,Bonaca MP,Butler J,Anker SD,Ferreira JP,Filippatos G,Januzzi JL,Lam CSP,Sattar N,Iwata T,Nordaby M,Brueckmann M,Pocock SJ,Packer M", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume, Humans, Heart Failure*, Heart Failure/etiology, Heart Failure/complications, Peripheral Arterial Disease*, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/complications, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1038, + "user_id": 1639100928, + "artical_title": "Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.", + "pmid": 37344038, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-06-23", + "author": "Usman MS,Siddiqi TJ,Anker SD,Bakris GL,Bhatt DL,Filippatos G,Fonarow GC,Greene SJ,Januzzi JL,Khan MS,Kosiborod MN,McGuire DK,Piña IL,Rosenstock J,Vaduganathan M,Verma S,Zieroth S,Butler J", + "auth_pos": 18, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Heart Failure*, Heart Failure/complications, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1039, + "user_id": 1639100928, + "artical_title": "Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan.", + "pmid": 37115131, + "journal_name": "JACC. Heart failure", + "date": "2023-07-07", + "author": "Mohebi R,Liu Y,Myhre PL,Felker GM,Prescott MF,Piña IL,Butler J,Ward JH,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain, Humans, Heart Failure*, Heart Failure/drug therapy, Valsartan, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Drug Combinations, Natriuretic Peptides, Phenotype, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Tetrazoles, Tetrazoles/therapeutic use, Natriuretic Peptide, Brain", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1040, + "user_id": 1639100928, + "artical_title": "Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk.", + "pmid": 37227388, + "journal_name": "JACC. Heart failure", + "date": "2023-07-07", + "author": "Khan MS,Segar MW,Usman MS,Patel KV,Van Spall HGC,DeVore AD,Vaduganathan M,Lam CSP,Zannad F,Verma S,Butler J,Tang WHW,Pandey A", + "auth_pos": 11, + "meshterms": "Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Heart Failure*, Heart Failure/drug therapy, Hospitalization, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1041, + "user_id": 1639100928, + "artical_title": "An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure.", + "pmid": 37295177, + "journal_name": "The American journal of cardiology", + "date": "2023-07-10", + "author": "Akhtar KH,Maqsood MH,Ansari SA,Siddiqi TJ,Arshad MS,Greene SJ,Butler J,Khan MS", + "auth_pos": 7, + "meshterms": "Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications, Humans, Stroke Volume, Ventricular Function, Left, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Cardiomyopathies*, Cardiomyopathies/complications, Cardiomyopathies/therapy, Myocardial Ischemia*, Myocardial Ischemia/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1042, + "user_id": 1639100928, + "artical_title": "Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.", + "pmid": 37208936, + "journal_name": "European journal of heart failure", + "date": "2023-07-12", + "author": "Metra M,Tomasoni D,Adamo M,Bayes-Genis A,Filippatos G,Abdelhamid M,Adamopoulos S,Anker SD,Antohi L,Böhm M,Braunschweig F,Gal TB,Butler J,Cleland JGF,Cohen-Solal A,Damman K,Gustafsson F,Hill L,Jankowska EA,Lainscak M,Lund LH,McDonagh T,Mebazaa A,Moura B,Mullens W,Piepoli M,Ponikowski P,Rakisheva A,Ristic A,Savarese G,Seferovic P,Sharma R,Tocchetti CG,Yılmaz MB,Vitale C,Volterrani M,von Haehling S,Chioncel O,Coats AJS,Rosano G", + "auth_pos": 13, + "meshterms": "Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/prevention & control, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Quality of Life, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Chronic Disease, Cardiology*, Diuretics, Diuretics/therapeutic use, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1043, + "user_id": 1639100928, + "artical_title": "Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry.", + "pmid": 37212192, + "journal_name": "JAMA cardiology", + "date": "2023-07-14", + "author": "Pierce JB,Vaduganathan M,Fonarow GC,Ikeaba U,Chiswell K,Butler J,DeVore AD,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,Linganathan KK,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Greene SJ", + "auth_pos": 6, + "meshterms": "Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Stroke Volume, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/drug therapy, Registries, Glucose, Glucose/pharmacology, Glucose/therapeutic use, Sodium", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1044, + "user_id": 1639100928, + "artical_title": "Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial.", + "pmid": 37223933, + "journal_name": "JAMA cardiology", + "date": "2023-07-14", + "author": "Butler J,Usman MS,Filippatos G,Ferreira JP,Böhm M,Brueckmann M,Januzzi JL,Kaul S,Piña IL,Ponikowski P,Senni M,Sumin M,Verma S,Zaremba-Pechmann L,Pocock SJ,Packer M,Anker S", + "auth_pos": 1, + "meshterms": "Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/physiopathology, Stroke Volume, Diuretics, Diuretics/therapeutic use, Double-Blind Method, Ventricular Function, Left, Kidney, Kidney/physiopathology, Glucose, Glucose/therapeutic use, Sodium", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1045, + "user_id": 1639100928, + "artical_title": "Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial.", + "pmid": 37438734, + "journal_name": "Cardiovascular diabetology", + "date": "2023-07-14", + "author": "Mohebi R,Liu Y,Hansen MK,Yavin Y,Sattar N,Pollock CA,Butler J,Jardine M,Masson S,Heerspink HJL,Januzzi JL", + "auth_pos": 7, + "meshterms": "Humans, Insulin, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Canagliflozin, Humans, Insulin, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Canagliflozin, Humans, Insulin, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Canagliflozin", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1046, + "user_id": 1639100928, + "artical_title": "Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America.", + "pmid": 37137386, + "journal_name": "Journal of cardiac failure", + "date": "2023-07-17", + "author": "Beavers CJ,Ambrosy AP,Butler J,Davidson BT,Gale SE,Piña IL,Mastoris I,Reza N,Mentz RJ,Lewis GD", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/epidemiology, Iron Deficiencies*, Iron", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1047, + "user_id": 1639100928, + "artical_title": "Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.", + "pmid": 37191040, + "journal_name": "Circulation", + "date": "2023-07-19", + "author": "Gupta K,Spertus JA,Birmingham M,Gosch KL,Husain M,Kitzman DW,Pitt B,Shah SJ,Januzzi JL,Lingvay I,Butler J,Kosiborod M,Lanfear DE", + "auth_pos": 11, + "meshterms": "Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic, Humans, Quality of Life*, Race Factors, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Glucose, Sodium, Stroke Volume, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1048, + "user_id": 1639100928, + "artical_title": "Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.", + "pmid": 37532426, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-08-03", + "author": "Greene SJ,Bauersachs J,Brugts JJ,Ezekowitz JA,Filippatos G,Gustafsson F,Lam CSP,Lund LH,Mentz RJ,Pieske B,Ponikowski P,Senni M,Skopicki N,Voors AA,Zannad F,Zieroth S,Butler J", + "auth_pos": 17, + "meshterms": "Humans, Stroke Volume, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/complications, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1049, + "user_id": 1639100928, + "artical_title": "Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3.", + "pmid": 37532424, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-08-04", + "author": "Patolia H,Khan MS,Fonarow GC,Butler J,Greene SJ", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hospitalization, Ventricular Dysfunction, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1050, + "user_id": 1639100928, + "artical_title": "Kidney function in cachexia and sarcopenia: Facts and numbers.", + "pmid": 37222019, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2023-08-07", + "author": "Okamura M,Konishi M,Butler J,Kalantar-Zadeh K,von Haehling S,Anker SD", + "auth_pos": 3, + "meshterms": "Humans, Cachexia, Cachexia/etiology, Cachexia/complications, Cystatin C, Sarcopenia*, Sarcopenia/etiology, Sarcopenia/complications, Creatinine, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Kidney, Humans, Cachexia, Cachexia/etiology, Cachexia/complications, Cystatin C, Sarcopenia*, Sarcopenia/etiology, Sarcopenia/complications, Creatinine, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Kidney, Humans, Cachexia, Cachexia/etiology, Cachexia/complications, Cystatin C, Sarcopenia*, Sarcopenia/etiology, Sarcopenia/complications, Creatinine, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Kidney, Humans, Cachexia, Cachexia/etiology, Cachexia/complications, Cystatin C, Sarcopenia*, Sarcopenia/etiology, Sarcopenia/complications, Creatinine, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Kidney", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1051, + "user_id": 1639100928, + "artical_title": "Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.", + "pmid": 37222009, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2023-08-07", + "author": "Anker MS,Lena A,Roeland EJ,Porthun J,Schmitz S,Hadzibegovic S,Sikorski P,Wilkenshoff U,Fröhlich AK,Ramer LV,Rose M,Eucker J,Rassaf T,Totzeck M,Lehmann LH,von Haehling S,Coats AJS,Friede T,Butler J,Anker SD,Riess H,Landmesser U,Bullinger L,Keller U,Ahn J", + "auth_pos": 19, + "meshterms": "Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy, Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy, Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy, Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy, Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy, Humans, Female, Male, Walking*, Prospective Studies, Walking Speed, Regression Analysis, Hand Strength, Neoplasms*, Neoplasms/therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1052, + "user_id": 1639100928, + "artical_title": "Cardiac Reverse Remodeling with Vericiguat: Victory or No Victory?", + "pmid": 37191077, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Khan MS,Grayburn PA,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines, Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines, Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines, Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines, Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines, Humans, Heart Failure*, Heart, Heterocyclic Compounds, 2-Ring*, Pyrimidines", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1053, + "user_id": 1639100928, + "artical_title": "Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.", + "pmid": 37062866, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Filippatos G,Farmakis D,Butler J,Zannad F,Ferreira JP,Ofstad AP,Iwata T,Brueckmann M,Pocock SJ,Packer M,Anker SD", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1054, + "user_id": 1639100928, + "artical_title": "Potential Global Impact of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure.", + "pmid": 37062865, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Talha KM,Butler J,Greene SJ,Aggarwal R,Anker SD,Claggett BL,Docherty KF,Solomon SD,McMurray JJV,Januzzi JL,Vaduganathan M,Fonarow GC", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/chemically induced, Nutrition Surveys, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1055, + "user_id": 1639100928, + "artical_title": "Effect of Intravenous Iron Replacement on Recurrent Heart Failure Hospitalizations and Cardiovascular Mortality in Patients with Heart Failure and Iron Deficiency: A Bayesian Meta-Analysis.", + "pmid": 37062867, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Anker SD,Shahzeb Khan M,Butler J,von Haehling S,Jankowska EA,Ponikowski P,Friede T", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Bayes Theorem, Stroke Volume, Iron Deficiencies*, Hospitalization, Iron, Iron/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1056, + "user_id": 1639100928, + "artical_title": "Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.", + "pmid": 37461163, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Anker SD,Usman MS,Anker MS,Butler J,Böhm M,Abraham WT,Adamo M,Chopra VK,Cicoira M,Cosentino F,Filippatos G,Jankowska EA,Lund LH,Moura B,Mullens W,Pieske B,Ponikowski P,Gonzalez-Juanatey JR,Rakisheva A,Savarese G,Seferovic P,Teerlink JR,Tschöpe C,Volterrani M,von Haehling S,Zhang J,Zhang Y,Bauersachs J,Landmesser U,Zieroth S,Tsioufis K,Bayes-Genis A,Chioncel O,Andreotti F,Agabiti-Rosei E,Merino JL,Metra M,Coats AJS,Rosano GMC", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left, Humans, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Hypertension*, Hypertension/drug therapy, Cardiology*, Phenotype, Decision Making, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1057, + "user_id": 1639100928, + "artical_title": "Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC.", + "pmid": 37448210, + "journal_name": "European journal of heart failure", + "date": "2023-08-09", + "author": "Metra M,Adamo M,Tomasoni D,Mebazaa A,Bayes-Genis A,Abdelhamid M,Adamopoulos S,Anker SD,Bauersachs J,Belenkov Y,Böhm M,Gal TB,Butler J,Cohen-Solal A,Filippatos G,Gustafsson F,Hill L,Jaarsma T,Jankowska EA,Lainscak M,Lopatin Y,Lund LH,McDonagh T,Milicic D,Moura B,Mullens W,Piepoli M,Polovina M,Ponikowski P,Rakisheva A,Ristic A,Savarese G,Seferovic P,Sharma R,Thum T,Tocchetti CG,Van Linthout S,Vitale C,Von Haehling S,Volterrani M,Coats AJS,Chioncel O,Rosano G", + "auth_pos": 13, + "meshterms": "Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission, Humans, Patient Discharge*, Heart Failure*, Heart Failure/drug therapy, Aftercare, Hospitalization, Patient Readmission", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1058, + "user_id": 1639100928, + "artical_title": "Reducing Ischemic Stroke in Diabetes: The Role of GLP-1 RAs.", + "pmid": 37549420, + "journal_name": "The Journal of family practice", + "date": "2023-08-09", + "author": "Anderson JE,Butler J,Alexandrov AV", + "auth_pos": 2, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Ischemic Stroke*, Ischemic Stroke/complications, Ischemic Stroke/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1059, + "user_id": 1639100928, + "artical_title": "Vascular Disease Burden, Outcomes, and Benefit with Empagliflozin in Heart Failure: Insights from the EMPEROR-Reduced Trial.", + "pmid": 37558088, + "journal_name": "Journal of cardiac failure", + "date": "2023-08-10", + "author": "Khan MS,Anker SD,Filippatos G,Ferreira JP,Pocock SJ,Januzzi JL,Chopra VK,Piña IL,Böhm M,Ponikowski P,Verma S,Brueckmann M,Vedin O,Peil B,Zannad F,Packer M,Butler J", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1060, + "user_id": 1639100928, + "artical_title": "Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs.", + "pmid": 37204363, + "journal_name": "JACC. Heart failure", + "date": "2023-08-11", + "author": "Hussain A,Ramsey D,Lee M,Mahtta D,Khan MS,Nambi V,Ballantyne CM,Petersen LA,Walker AD,Kayani WT,Butler J,Slipczuk L,Rogers JG,Bozkurt B,Navaneethan SD,Virani SS", + "auth_pos": 11, + "meshterms": "Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy, Male, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Veterans*, Atherosclerosis*, Atherosclerosis/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1061, + "user_id": 1639100928, + "artical_title": "Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.", + "pmid": 37294245, + "journal_name": "JACC. Heart failure", + "date": "2023-08-11", + "author": "Kosiborod MN,Abildstrøm SZ,Borlaug BA,Butler J,Christensen L,Davies M,Hovingh KG,Kitzman DW,Lindegaard ML,Møller DV,Shah SJ,Treppendahl MB,Verma S,Petrie MC", + "auth_pos": 4, + "meshterms": "Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Obesity, Obesity/complications, Diuretics, Diuretics/therapeutic use, Phenotype, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1062, + "user_id": 1639100928, + "artical_title": "Classification of Heart Failure Events by Severity: Insights from the VICTORIA Trial.", + "pmid": 37331690, + "journal_name": "Journal of cardiac failure", + "date": "2023-08-14", + "author": "Felker GM,North R,Mulder H,Jones WS,Anstrom KJ,Patel MJ,Butler J,Ezekowitz JA,Lam CSP,O'Connor CM,Roessig L,Hernandez AF,Armstrong PW", + "auth_pos": 7, + "meshterms": "Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy, Humans, Aftercare, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/epidemiology, Patient Discharge, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left*, Ventricular Dysfunction, Left/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1063, + "user_id": 1639100928, + "artical_title": "Carat, clarity, colour, and cut: grading the DIAMOND trial.", + "pmid": 37583291, + "journal_name": "European heart journal", + "date": "2023-08-16", + "author": "Butler J,Budden J,Pitt B,Anker S", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1064, + "user_id": 1639100928, + "artical_title": "Frailty and heart failure: State-of-the-art review.", + "pmid": 37586848, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2023-08-17", + "author": "Talha KM,Pandey A,Fudim M,Butler J,Anker SD,Khan MS", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1065, + "user_id": 1639100928, + "artical_title": "Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.", + "pmid": 37592272, + "journal_name": "Cardiovascular diabetology", + "date": "2023-08-21", + "author": "Rosano G,Ponikowski P,Vitale C,Anker SD,Butler J,Fabien V,Filippatos G,Kirwan BA,Macdougall IC,Metra M,Ruschitzka F,Kumpeson V,Goehring UM,van der Meer P,Jankowska EA", + "auth_pos": 5, + "meshterms": "Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life, Humans, Male, Diabetes Mellitus*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Iron, Iron Deficiencies*, Quality of Life", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1066, + "user_id": 1639100928, + "artical_title": "The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter.", + "pmid": 37610399, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-08-23", + "author": "Butler J,Khan MS,Fonarow GC", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1067, + "user_id": 1639100928, + "artical_title": "Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial.", + "pmid": 37603600, + "journal_name": "Circulation", + "date": "2023-08-23", + "author": "Januzzi JL,Mohebi R,Liu Y,Sattar N,Heerspink HJL,Tefera E,Vaduganathan M,Butler J,Yavin Y,Li J,Pollock CA,Perkovic V,Neal B,Hansen MK", + "auth_pos": 8, + "meshterms": "Humans, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/drug therapy, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Albuminuria, Troponin T, Biomarkers, Growth Differentiation Factors, Humans, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/drug therapy, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Albuminuria, Troponin T, Biomarkers, Growth Differentiation Factors, Humans, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/drug therapy, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Albuminuria, Troponin T, Biomarkers, Growth Differentiation Factors, Humans, Diabetic Nephropathies*, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/drug therapy, Canagliflozin, Canagliflozin/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Albuminuria, Troponin T, Biomarkers, Growth Differentiation Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1068, + "user_id": 1639100928, + "artical_title": "Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartan.", + "pmid": 37632309, + "journal_name": "ESC heart failure", + "date": "2023-08-26", + "author": "Mohebi R,Liu Y,Butler J,Felker GM,Ward JH,Prescott MF,Piña IL,Solomon SD,Januzzi JL", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1069, + "user_id": 1639100928, + "artical_title": "Heart Failure Hospitalizations Versus Cardiovascular Mortality in Heart Failure Trials.", + "pmid": 37558550, + "journal_name": "The American journal of cardiology", + "date": "2023-08-28", + "author": "Kaul S,Siddiqi TJ,Anker SD,Butler J", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Cardiovascular System*, Heart, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Cardiovascular System*, Heart, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Cardiovascular System*, Heart, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Cardiovascular System*, Heart", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1070, + "user_id": 1639100928, + "artical_title": "A big STEP for treatment of heart failure with preserved ejection fraction.", + "pmid": 37643614, + "journal_name": "Cell metabolism", + "date": "2023-08-30", + "author": "Verma S,Borlaug BA,Butler J,Davies MJ,Kitzman DW,Petrie MC,Shah SJ,Dhingra NK,Kosiborod MN", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1071, + "user_id": 1639100928, + "artical_title": "Heart Failure after Myocardial Infarction: Glass Emptier Than Full.", + "pmid": 37462280, + "journal_name": "European journal of heart failure", + "date": "2023-08-31", + "author": "Harrington J,Butler J", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Myocardial Infarction*, Myocardial Infarction/complications, Humans, Heart Failure*, Heart Failure/therapy, Myocardial Infarction*, Myocardial Infarction/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1072, + "user_id": 1639100928, + "artical_title": "Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial.", + "pmid": 37062851, + "journal_name": "European journal of heart failure", + "date": "2023-08-31", + "author": "Sharma A,Ferreira JP,Zannad F,Pocock SJ,Filippatos G,Pfarr E,Petrini M,Kraus BJ,Wanner C,Packer M,Butler J,Anker SD", + "auth_pos": 11, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Kidney, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1073, + "user_id": 1639100928, + "artical_title": "Eligibility for vericiguat in a real-world heart failure population according to trial, guidelines, and label criteria: Data from the Swedish Heart Failure Registry.", + "pmid": 37323078, + "journal_name": "European journal of heart failure", + "date": "2023-08-31", + "author": "Nguyen NV,Lindberg F,Benson L,Ferrannini G,Imbalzano E,Mol PGM,Dahlström U,Rosano GMC,Ezekowitz J,Butler J,Lund LH,Savarese G", + "auth_pos": 10, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Sweden, Sweden/epidemiology, Stroke Volume, Ventricular Dysfunction, Left*, Registries, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Sweden, Sweden/epidemiology, Stroke Volume, Ventricular Dysfunction, Left*, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1074, + "user_id": 1639100928, + "artical_title": "Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.", + "pmid": 37278451, + "journal_name": "European journal of heart failure", + "date": "2023-08-31", + "author": "Böhm M,Butler J,Krawczyk M,Mahfoud F,Haring B,Filippatos G,Ferreira JP,Pocock SJ,Brueckmann M,Ofstad AP,Schüler E,Wanner C,Verma S,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Liver Function Tests, Stroke Volume, Liver, Humans, Heart Failure*, Liver Function Tests, Stroke Volume, Liver, Humans, Heart Failure*, Liver Function Tests, Stroke Volume, Liver, Humans, Heart Failure*, Liver Function Tests, Stroke Volume, Liver, Humans, Heart Failure*, Liver Function Tests, Stroke Volume, Liver", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1075, + "user_id": 1639100928, + "artical_title": "Changes in Mid-regional Pro-adrenomedullin during treatment with Sacubitril/Valsartan.", + "pmid": 37401523, + "journal_name": "European journal of heart failure", + "date": "2023-08-31", + "author": "Myhre PL,Liu Y,Kulac IJ,Claggett BL,Prescott MF,Felker GM,Butler J,Piña IL,Rouleau JL,Zile MR,McMurray JJV,Ward JH,Solomon SD,Januzzi JL", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations, Humans, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/drug therapy, Adrenomedullin, Neprilysin, Microcirculation, Tetrazoles, Tetrazoles/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Stroke Volume, Stroke Volume/physiology, Valsartan, Valsartan/therapeutic use, Aminobutyrates, Aminobutyrates/therapeutic use, Biphenyl Compounds, Biphenyl Compounds/therapeutic use, Drug Combinations", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1076, + "user_id": 1639100928, + "artical_title": "Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol.", + "pmid": 37674806, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-09-07", + "author": "Lee V,Zheng Q,Toh DF,Pua CJ,Bryant JA,Lee CH,Cook SA,Butler J,Díez J,Richards AM,Le TT,Chin CWL", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1077, + "user_id": 1639100928, + "artical_title": "Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.", + "pmid": 37382961, + "journal_name": "Clinical journal of the American Society of Nephrology : CJASN", + "date": "2023-09-11", + "author": "Macdougall IC,Ponikowski P,Stack AG,Wheeler DC,Anker SD,Butler J,Filippatos G,Göhring UM,Kirwan BA,Kumpeson V,Metra M,Rosano G,Ruschitzka F,van der Meer P,Wächter S,Jankowska EA", + "auth_pos": 6, + "meshterms": "Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology, Adult, Humans, Female, Male, Iron, Stroke Volume, Quality of Life, Ventricular Function, Left, Ferric Compounds, Ferric Compounds/adverse effects, Iron Deficiencies*, Renal Insufficiency*, Renal Insufficiency/complications, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Kidney, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/etiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1078, + "user_id": 1639100928, + "artical_title": "Ferric Carboxymaltose in Heart Failure with Iron Deficiency.", + "pmid": 37632463, + "journal_name": "The New England journal of medicine", + "date": "2023-09-15", + "author": "Mentz RJ,Garg J,Rockhold FW,Butler J,De Pasquale CG,Ezekowitz JA,Lewis GD,O'Meara E,Ponikowski P,Troughton RW,Wong YW,She L,Harrington J,Adamczyk R,Blackman N,Hernandez AF", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Iron Deficiencies*, Iron Deficiencies/complications, Iron Deficiencies/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Ferric Compounds*, Ferric Compounds/administration & dosage, Ferric Compounds/adverse effects, Ferric Compounds/therapeutic use, Double-Blind Method, Administration, Intravenous, Ambulatory Care", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1079, + "user_id": 1639100928, + "artical_title": "Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.", + "pmid": 37635157, + "journal_name": "Nature medicine", + "date": "2023-09-18", + "author": "Borlaug BA,Kitzman DW,Davies MJ,Rasmussen S,Barros E,Butler J,Einfeldt MN,Hovingh GK,Møller DV,Petrie MC,Shah SJ,Verma S,Abhayaratna W,Ahmed FZ,Chopra V,Ezekowitz J,Fu M,Ito H,Lelonek M,Melenovsky V,Núñez J,Perna E,Schou M,Senni M,van der Meer P,Von Lewinski D,Wolf D,Kosiborod MN", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein, Humans, Heart Failure*, Stroke Volume, Body Weight, Weight Loss, Obesity, Obesity/complications, Obesity/drug therapy, C-Reactive Protein", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1080, + "user_id": 1639100928, + "artical_title": "Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial.", + "pmid": 37417824, + "journal_name": "Circulation. Heart failure", + "date": "2023-09-21", + "author": "Ezekowitz JA,McMullan CJ,Westerhout CM,Piña IL,Lopez-Sendon J,Anstrom KJ,Hernandez AF,Lam CSP,O'Connor CM,Pieske B,Ponikowski P,Roessig L,Voors AA,Koglin J,Armstrong PW,Butler J", + "auth_pos": 16, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Heart Failure/chemically induced, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/adverse effects, Neprilysin, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Angiotensins", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1081, + "user_id": 1639100928, + "artical_title": "Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.", + "pmid": 37622681, + "journal_name": "The New England journal of medicine", + "date": "2023-09-22", + "author": "Kosiborod MN,Abildstrøm SZ,Borlaug BA,Butler J,Rasmussen S,Davies M,Hovingh GK,Kitzman DW,Lindegaard ML,Møller DV,Shah SJ,Treppendahl MB,Verma S,Abhayaratna W,Ahmed FZ,Chopra V,Ezekowitz J,Fu M,Ito H,Lelonek M,Melenovsky V,Merkely B,Núñez J,Perna E,Schou M,Senni M,Sharma K,Van der Meer P,von Lewinski D,Wolf D,Petrie MC", + "auth_pos": 4, + "meshterms": "Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume, Humans, Glucagon-Like Peptides*, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Heart Failure/physiopathology, Obesity*, Obesity/complications, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1082, + "user_id": 1639100928, + "artical_title": "Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment.", + "pmid": 37743075, + "journal_name": "Cardiology clinics", + "date": "2023-09-26", + "author": "Talha KM,Greene SJ,Butler J,Khan MS", + "auth_pos": 3, + "meshterms": "Humans, Frailty*, Frailty/complications, Heart Failure*, Heart Failure/therapy, Quality of Life, Stroke Volume, Prognosis, Humans, Frailty*, Frailty/complications, Heart Failure*, Heart Failure/therapy, Quality of Life, Stroke Volume, Prognosis, Humans, Frailty*, Frailty/complications, Heart Failure*, Heart Failure/therapy, Quality of Life, Stroke Volume, Prognosis, Humans, Frailty*, Frailty/complications, Heart Failure*, Heart Failure/therapy, Quality of Life, Stroke Volume, Prognosis, Humans, Frailty*, Frailty/complications, Heart Failure*, Heart Failure/therapy, Quality of Life, Stroke Volume, Prognosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1083, + "user_id": 1639100928, + "artical_title": "2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.", + "pmid": 37622666, + "journal_name": "European heart journal", + "date": "2023-10-03", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,Čelutkienė J,Chioncel O,Cleland JGF,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Francesco Piepoli M,Price S,Rosano GMC,Ruschitzka F,Skibelund AK", + "auth_pos": 8, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1084, + "user_id": 1639100928, + "artical_title": "Hospital at Home as a Novel Care Strategy for Worsening Heart Failure.", + "pmid": 37115128, + "journal_name": "JACC. Heart failure", + "date": "2023-10-23", + "author": "Haywood HB,Fonarow GC,Khan MS,Nassif ME,Butler J,Greene SJ", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Patient Readmission, Hospitals", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1085, + "user_id": 1639100928, + "artical_title": "Implementation of SGLT2 Inhibitors for Heart Failure with Reduced Ejection Fraction: Where We Are Versus Where We Need To Be.", + "pmid": 37581237, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Pierce JB,Butler J,Greene SJ", + "auth_pos": 2, + "meshterms": "Humans, Glucose, Heart Failure*, Heart Failure/drug therapy, Sodium, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Glucose, Heart Failure*, Heart Failure/drug therapy, Sodium, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Glucose, Heart Failure*, Heart Failure/drug therapy, Sodium, Stroke Volume, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1086, + "user_id": 1639100928, + "artical_title": "Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.", + "pmid": 37621153, + "journal_name": "Circulation", + "date": "2023-10-23", + "author": "Packer M,Butler J,Zeller C,Pocock SJ,Brueckmann M,Ferreira JP,Filippatos G,Usman MS,Zannad F,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1087, + "user_id": 1639100928, + "artical_title": "Residual risk in heart failure and the need for simultaneous implementation and innovation.", + "pmid": 37608604, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Fatima K,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1088, + "user_id": 1639100928, + "artical_title": "Health status across major subgroups of patients with heart failure and preserved ejection fraction.", + "pmid": 36974746, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Siddiqi TJ,Anker SD,Filippatos G,Ferreira JP,Pocock SJ,Böhm M,Brueckmann M,Chopra VK,Iwata T,Januzzi J,Piña IL,Ponikowski P,Senni M,Vedin O,Verma S,Zhang Y,Zannad F,Packer M,Butler J", + "auth_pos": 19, + "meshterms": "Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*, Humans, Female, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/diagnosis, Quality of Life, Stroke Volume, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Health Status, Diabetes Mellitus*, Renal Insufficiency, Chronic*, Anemia*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1089, + "user_id": 1639100928, + "artical_title": "Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.", + "pmid": 37369985, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Anker MS,Potthoff SK,Lena A,Porthun J,Hadzibegovic S,Evertz R,Denecke C,Fröhlich AK,Sonntag F,Regitz-Zagrosek V,Rosen SD,Lyon AR,Lüscher TF,Spertus JA,Anker SD,Karakas M,Bullinger L,Keller U,Landmesser U,Butler J,von Haehling S", + "auth_pos": 20, + "meshterms": "Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires, Humans, Quality of Life, Quality of Life/psychology, Prospective Studies, Stroke Volume, Ventricular Function, Left, Heart Failure*, Neoplasms*, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1090, + "user_id": 1639100928, + "artical_title": "Similarities and Distinctions Between Acetazolamide and SGLT2 Inhibitors in Patients With Acute Heart Failure: Key Insights Into ADVOR and EMPULSE.", + "pmid": 37403655, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Packer M,Butler J", + "auth_pos": 2, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Acetazolamide, Acetazolamide/therapeutic use, Sodium-Hydrogen Exchanger 3, Diuretics, Diuretics/therapeutic use, Sodium, Body Weight, Glucose, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Heart Failure*, Heart Failure/drug therapy, Acetazolamide, Acetazolamide/therapeutic use, Sodium-Hydrogen Exchanger 3, Diuretics, Diuretics/therapeutic use, Sodium, Body Weight, Glucose, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1091, + "user_id": 1639100928, + "artical_title": "Artificial Intelligence and Heart Failure: A State-of-the-Art Review.", + "pmid": 37560778, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Khan MS,Arshad MS,Greene SJ,Van Spall HGC,Pandey A,Vemulapalli S,Perakslis E,Butler J", + "auth_pos": 8, + "meshterms": "Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype, Humans, Artificial Intelligence*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Algorithms, Clinical Decision-Making, Phenotype", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1092, + "user_id": 1639100928, + "artical_title": "Baseline characteristics of patients enrolled in the EMPACT-MI trial.", + "pmid": 37622416, + "journal_name": "European journal of heart failure", + "date": "2023-10-23", + "author": "Harrington J,Udell JA,Jones WS,Anker SD,Bhatt DL,Petrie MC,Andersen KR,Sumin M,Zwiener I,Hernandez AF,Butler J", + "auth_pos": 11, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume, Humans, Male, Middle Aged, Aged, Female, Heart Failure*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Myocardial Infarction*, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1093, + "user_id": 1639100928, + "artical_title": "Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat.", + "pmid": 37503602, + "journal_name": "Circulation. Heart failure", + "date": "2023-10-23", + "author": "Armstrong PW,Zheng Y,Lund LH,Butler J,Troughton RW,Emdin M,Lam CSP,Ponikowski P,Blaustein RO,O'Connor CM,Roessig L,Voors AA,Ezekowitz JA,Westerhout CM", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers, Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers, Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers, Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers, Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers, Humans, Heart Failure*, Heart Failure/diagnosis, Natriuretic Peptide, Brain, Stroke Volume, Prognosis, Peptide Fragments, Ventricular Dysfunction, Left*, Biomarkers", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1094, + "user_id": 1639100928, + "artical_title": "Hospital at Home as a Treatment Strategy for Worsening Heart Failure.", + "pmid": 37646170, + "journal_name": "Circulation. Heart failure", + "date": "2023-10-23", + "author": "Haywood HB,Fonarow GC,Khan MS,Van Spall HGC,Morris AA,Nassif ME,Kittleson MM,Butler J,Greene SJ", + "auth_pos": 8, + "meshterms": "Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals, Aged, Humans, United States, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Medicare, Hospitalization, Hospitals", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1095, + "user_id": 1639100928, + "artical_title": "Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020.", + "pmid": 37755728, + "journal_name": "JAMA cardiology", + "date": "2023-11-09", + "author": "Ostrominski JW,Arnold SV,Butler J,Fonarow GC,Hirsch JS,Palli SR,Donato BMK,Parrinello CM,O'Connell T,Collins EB,Woolley JJ,Kosiborod MN,Vaduganathan M", + "auth_pos": 3, + "meshterms": "Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Adult, Humans, Male, Female, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/epidemiology, Nutrition Surveys, Cohort Studies, Prevalence, Cross-Sectional Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1096, + "user_id": 1639100928, + "artical_title": "Improved Decongestion With Devices in Decompensated Heart Failure: Does the End Justify the Means?", + "pmid": 37940218, + "journal_name": "JACC. Heart failure", + "date": "2023-11-10", + "author": "Testani JM,Butler J,Packer M", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Diuretics, Acute Disease, Humans, Heart Failure*, Heart Failure/therapy, Diuretics, Acute Disease", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1097, + "user_id": 1639100928, + "artical_title": "Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.", + "pmid": 37115133, + "journal_name": "JACC. Heart failure", + "date": "2023-11-10", + "author": "Khan MS,Singh S,Segar MW,Usman MS,Keshvani N,Ambrosy AP,Fiuzat M,Van Spall HGC,Fonarow GC,Zannad F,Felker GM,Januzzi JL,O'Connor C,Butler J,Pandey A", + "auth_pos": 14, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Humans, Heart Failure*, Heart Failure/drug therapy, Polypharmacy, Stroke Volume, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Ventricular Dysfunction, Left*, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1098, + "user_id": 1639100928, + "artical_title": "Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure.", + "pmid": 37498273, + "journal_name": "JACC. Heart failure", + "date": "2023-11-10", + "author": "Golbus JR,Gosch K,Birmingham MC,Butler J,Lingvay I,Lanfear DE,Abbate A,Kosiborod ML,Damaraju CV,Januzzi JL,Spertus J,Nallamothu BK", + "auth_pos": 4, + "meshterms": "Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume, Humans, Female, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/diagnosis, Quality of Life, Canagliflozin, Health Status, Patient Reported Outcome Measures, Wearable Electronic Devices*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1099, + "user_id": 1639100928, + "artical_title": "The In- and Out-(Patient) Context of Omecamtiv Merbarbil Initiation: Assuaging Concerns and Opening Opportunities.", + "pmid": 37972704, + "journal_name": "Journal of cardiac failure", + "date": "2023-11-17", + "author": "Denfeld QE,Butler J", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1100, + "user_id": 1639100928, + "artical_title": "Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.", + "pmid": 37996192, + "journal_name": "The lancet. Diabetes & endocrinology", + "date": "2023-11-27", + "author": "Ahmed A,Anker SD,Butler J,Bakris GL,Bhatt DL,Fonarow GC,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Glucose*, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1101, + "user_id": 1639100928, + "artical_title": "Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency: HEART-FID Trial.", + "pmid": 37598795, + "journal_name": "American heart journal", + "date": "2023-11-27", + "author": "Harrington J,Mentz RJ,Rockhold FW,Garg J,Butler J,De Pasquale CG,Ezekowitz JA,Lewis GD,O'Meara E,Ponikowski P,Troughton RW,Wong YW,Adamczyk R,Blackman N,Hernandez AF", + "auth_pos": 5, + "meshterms": "Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Female, Aged, Male, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Iron Deficiencies*, Iron, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1102, + "user_id": 1639100928, + "artical_title": "Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.", + "pmid": 37993201, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-11-27", + "author": "Butler J,Abildstrøm SZ,Borlaug BA,Davies MJ,Kitzman DW,Petrie MC,Shah SJ,Verma S,Abhayaratna WP,Chopra V,Ezekowitz JA,Fu M,Ito H,Lelonek M,Núñez J,Perna E,Schou M,Senni M,van der Meer P,von Lewinski D,Wolf D,Altschul RL,Rasmussen S,Kosiborod MN", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Obesity, Obesity/complications, Obesity/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1103, + "user_id": 1639100928, + "artical_title": "Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral Diuretics.", + "pmid": 38011247, + "journal_name": "Circulation", + "date": "2023-11-29", + "author": "Greene SJ,Butler J", + "auth_pos": 2, + "meshterms": "Humans, Outpatients*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Humans, Outpatients*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1104, + "user_id": 1639100928, + "artical_title": "Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease.", + "pmid": 37871362, + "journal_name": "Seminars in nephrology", + "date": "2023-12-04", + "author": "Khan MS,Rashid AM,Shafi T,Ferreira JP,Butler J", + "auth_pos": 5, + "meshterms": "Humans, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Angiotensins, Angiotensins/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Angiotensins, Angiotensins/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Angiotensins, Angiotensins/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Angiotensins, Angiotensins/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Angiotensins, Angiotensins/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1105, + "user_id": 1639100928, + "artical_title": "Endpoint adjudication in cardiovascular clinical trials.", + "pmid": 37935635, + "journal_name": "European heart journal", + "date": "2023-12-11", + "author": "Khan MS,Usman MS,Van Spall HGC,Greene SJ,Baqal O,Felker GM,Bhatt DL,Januzzi JL,Butler J", + "auth_pos": 9, + "meshterms": "Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable, Humans, Myocardial Infarction*, Myocardial Infarction/etiology, Ischemic Attack, Transient*, Ischemic Attack, Transient/complications, Hemorrhage, Hemorrhage/complications, Heart Failure*, Heart Failure/complications, Angina, Unstable", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1106, + "user_id": 1639100928, + "artical_title": "Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management.", + "pmid": 38084597, + "journal_name": "Hypertension (Dallas, Tex. : 1979)", + "date": "2023-12-12", + "author": "González A,López B,Ravassa S,San José G,Latasa I,Butler J,Díez J", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1107, + "user_id": 1639100928, + "artical_title": "Morbidity and Mortality Associated with Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of Four Clinical Trials.", + "pmid": 37479054, + "journal_name": "Journal of cardiac failure", + "date": "2023-12-17", + "author": "Goodwin NP,Clare RM,Harrington JL,Badjatiya A,Wojdyla DM,Udell JA,Butler J,Januzzi JL,Parikh PB,James S,Alexander JH,Lopes RD,Wallentin L,Ohman EM,Hernandez AF,Jones WS", + "auth_pos": 7, + "meshterms": "Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic, Humans, Acute Coronary Syndrome*, Acute Coronary Syndrome/complications, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Heart Failure*, Heart Failure/drug therapy, Incidence, Myocardial Infarction*, Myocardial Infarction/complications, Stroke*, Stroke/etiology, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1108, + "user_id": 1639100928, + "artical_title": "Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC.", + "pmid": 37712339, + "journal_name": "European journal of heart failure", + "date": "2023-12-17", + "author": "Bayes-Genis A,Doherty KF,Petrie MC,Januzzi JL,Mueller C,Andreson L,Bozkurt B,Butler J,Chioncel O,Cleland JG,Christodorescu R,Del Prato S,Gustafsson F,Lam CSP,Moura B,Pop-Busui R,Seferovic P,Volterrani M,Vaduganathan M,Metra M,Rosano G", + "auth_pos": 8, + "meshterms": "Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis, Humans, Natriuretic Peptide, Brain, Heart Failure*, Heart Failure/diagnosis, Heart Diseases*, Peptide Fragments, Biomarkers, Early Diagnosis", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1109, + "user_id": 1639100928, + "artical_title": "Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.", + "pmid": 38127122, + "journal_name": "Diabetologia", + "date": "2023-12-21", + "author": "Savarese G,Lindberg F,Filippatos G,Butler J,Anker SD", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1110, + "user_id": 1639100928, + "artical_title": "Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.", + "pmid": 37632415, + "journal_name": "European heart journal", + "date": "2023-12-22", + "author": "Ponikowski P,Mentz RJ,Hernandez AF,Butler J,Khan MS,van Veldhuisen DJ,Roubert B,Blackman N,Friede T,Jankowska EA,Anker SD", + "auth_pos": 4, + "meshterms": "Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Humans, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/complications, Stroke Volume, Ventricular Function, Left, Iron Deficiencies*, Ferric Compounds, Ferric Compounds/therapeutic use, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1111, + "user_id": 1639100928, + "artical_title": "The cardiovascular effects of novel weight loss therapies.", + "pmid": 37966486, + "journal_name": "European heart journal", + "date": "2023-12-22", + "author": "Usman MS,Davies M,Hall ME,Verma S,Anker SD,Rosenstock J,Butler J", + "auth_pos": 7, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/therapy, Diabetes Mellitus, Type 2/drug therapy, Overweight, Obesity, Obesity/complications, Obesity/therapy, Weight Loss, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Glucose, Glucose/therapeutic use, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1112, + "user_id": 1639100928, + "artical_title": "Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines.", + "pmid": 38138937, + "journal_name": "Journal of personalized medicine", + "date": "2023-12-23", + "author": "Bhagat AA,Kalogeropoulos AP,Baer L,Lacey M,Kort S,Skopicki HA,Butler J,Bloom MW", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1113, + "user_id": 1639100928, + "artical_title": "Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure.", + "pmid": 37409733, + "journal_name": "The Journal of clinical endocrinology and metabolism", + "date": "2023-12-25", + "author": "Ferreira JP,Sharma A,Butler J,Packer M,Zannad F,Vasques-Nóvoa F,Leite-Moreira A,Neves JS", + "auth_pos": 3, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/chemically induced, Glucagon-Like Peptide 1, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Heart Failure*, Heart Failure/diagnosis, Hypoglycemic Agents, Hypoglycemic Agents/adverse effects, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1114, + "user_id": 1639100928, + "artical_title": "A Novel Heart Failure Diagnostic Risk Score Using a Minimally Invasive Subcutaneous Insertable Cardiac Monitor.", + "pmid": 37943225, + "journal_name": "JACC. Heart failure", + "date": "2024-01-08", + "author": "Zile MR,Kahwash R,Sarkar S,Koehler J,Zielinski T,Mehra MR,Fonarow GC,Gulati S,Butler J", + "auth_pos": 9, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic, Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic, Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic, Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic, Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic, Aged, Female, Humans, Male, Middle Aged, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Heart Failure*, Heart Failure/complications, Heart Failure/diagnosis, Heart Rate, Monitoring, Physiologic, Risk Factors, Observational Studies as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1115, + "user_id": 1639100928, + "artical_title": "Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper.", + "pmid": 38069997, + "journal_name": "JACC. Heart failure", + "date": "2024-01-08", + "author": "Lala A,Hamo CE,Bozkurt B,Fiuzat M,Blumer V,Bukhoff D,Butler J,Costanzo MR,Felker GM,Filippatos G,Konstam MA,McMurray JJV,Mentz RJ,Metra M,Psotka MA,Solomon SD,Teerlink J,Abraham WT,O'Connor CM", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Heart Valve Prosthesis Implantation*, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1116, + "user_id": 1639100928, + "artical_title": "Efficacy and Safety of Empagliflozin According to Background Diuretic Use in Heart Failure With Reduced Ejection Fraction: Post-Hoc Analysis of EMPEROR-Reduced.", + "pmid": 37715769, + "journal_name": "JACC. Heart failure", + "date": "2024-01-08", + "author": "Dhingra NK,Verma S,Butler J,Anker SD,Ferreira JP,Filippatos G,Januzzi JL,Lam CSP,Sattar N,Zaremba-Pechmann L,Böhm M,Nordaby M,Brueckmann M,Pocock SJ,Zannad F,Packer M", + "auth_pos": 3, + "meshterms": "Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*, Humans, Benzhydryl Compounds, Benzhydryl Compounds/adverse effects, Chronic Disease, Diuretics, Diuretics/therapeutic use, Heart Failure*, Stroke Volume, Ventricular Dysfunction, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1117, + "user_id": 1639100928, + "artical_title": "Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure.", + "pmid": 38184323, + "journal_name": "The American journal of medicine", + "date": "2024-01-08", + "author": "Greene SJ,Butler J,Kosiborod MN", + "auth_pos": 2, + "meshterms": "United States, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Symporters*, Glucose, Sodium, United States, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Symporters*, Glucose, Sodium, United States, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Quality of Life, Stroke Volume, Ventricular Function, Left, Symporters*, Glucose, Sodium", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1118, + "user_id": 1639100928, + "artical_title": "Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes.", + "pmid": 37994632, + "journal_name": "Future cardiology", + "date": "2024-01-15", + "author": "Butler J,Filippatos G", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Cardiovascular Diseases*, Stroke Volume, Diabetes Mellitus*, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Cardiovascular Diseases*, Stroke Volume, Diabetes Mellitus*, Benzhydryl Compounds*, Glucosides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1119, + "user_id": 1639100928, + "artical_title": "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.", + "pmid": 37952180, + "journal_name": "Circulation", + "date": "2024-01-18", + "author": "Kosiborod MN,Verma S,Borlaug BA,Butler J,Davies MJ,Jon Jensen T,Rasmussen S,Erlang Marstrand P,Petrie MC,Shah SJ,Ito H,Schou M,Melenovský V,Abhayaratna W,Kitzman DW", + "auth_pos": 4, + "meshterms": "Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*, Humans, Quality of Life*, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Stroke Volume, Obesity, Obesity/drug therapy, Inflammation, Glucagon-Like Peptides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1120, + "user_id": 1639100928, + "artical_title": "SGLT2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: any incremental effect?", + "pmid": 37846611, + "journal_name": "European journal of heart failure", + "date": "2024-01-24", + "author": "Savarese G,Butler J,Ponikowki P,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Glucose, Iron Deficiencies*, Sodium, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/drug therapy, Iron, Glucose, Iron Deficiencies*, Sodium, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1121, + "user_id": 1639100928, + "artical_title": "Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: a Pooled Cohort Analysis.", + "pmid": 37950893, + "journal_name": "Circulation", + "date": "2024-01-24", + "author": "Patel KV,Segar MW,Klonoff DC,Khan MS,Usman MS,Lam CSP,Verma S,DeFilippis AP,Nasir K,Bakker SJL,Westenbrink BD,Dullaart RPF,Butler J,Vaduganathan M,Pandey A", + "auth_pos": 13, + "meshterms": "Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T, Adult, Humans, Female, Male, Cardiovascular Diseases*, Biomarkers, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/prevention & control, Diabetes Mellitus*, Cohort Studies, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/prevention & control, Peptide Fragments, Natriuretic Peptide, Brain, Troponin T", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1122, + "user_id": 1639100928, + "artical_title": "SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know.", + "pmid": 38157160, + "journal_name": "American journal of cardiovascular drugs : drugs, devices, and other interventions", + "date": "2024-01-24", + "author": "Greene SJ,Fonarow GC,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalists*, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalists*, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Diabetes Mellitus, Type 2*, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalists*, Heart Failure*, Heart Failure/drug therapy, Stroke Volume, Diabetes Mellitus, Type 2*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1123, + "user_id": 1639100928, + "artical_title": "Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial.", + "pmid": 37985002, + "journal_name": "ESC heart failure", + "date": "2024-01-24", + "author": "Butler J,Khan MS,Gasior T,Erickson TR,Vlajnic V,Kramer F,Blaustein RO,Goldsbury D,Roessig L,Lam CSP,Anstrom KJ,Armstrong PW", + "auth_pos": 1, + "meshterms": "Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume, Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume, Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume, Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume, Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume, Humans, Accelerometry, Health Status, Heart Failure*, Quality of Life, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1124, + "user_id": 1639100928, + "artical_title": "Creation of next generation of diverse cardiovascular physician-scientists from developing countries: insights from Research Council of Pakistan.", + "pmid": 37571853, + "journal_name": "European heart journal", + "date": "2024-01-29", + "author": "Khan MS,Fatima K,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart, Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart, Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart, Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart, Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart, Humans, Developing Countries, Pakistan, Physicians*, Cardiovascular System*, Heart", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1125, + "user_id": 1639100928, + "artical_title": "Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects.", + "pmid": 38073038, + "journal_name": "Journal of the American Society of Nephrology : JASN", + "date": "2024-02-02", + "author": "Rao VS,Ivey-Miranda JB,Cox ZL,Moreno-Villagomez J,Maulion C,Bellumkonda L,Chang J,Field MP,Wiederin DR,Butler J,Collins SP,Turner JM,Wilson FP,Inzucchi SE,Wilcox CS,Ellison DH,Testani JM", + "auth_pos": 10, + "meshterms": "Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*, Humans, Sodium, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Lithium, Cross-Over Studies, Nephrons, Heart Failure*, Heart Failure/drug therapy, Diuretics, Glucose, Benzhydryl Compounds*, Glucosides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1126, + "user_id": 1639100928, + "artical_title": "Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.", + "pmid": 38158636, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2024-02-05", + "author": "Coats AJS,Butler J,Tsutsui H,Doehner W,Filippatos G,Ferreira JP,Böhm M,Chopra VK,Verma S,Nordaby M,Iwata T,Nitta D,Ponikowski P,Zannad F,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*, Humans, Female, Heart Failure*, Heart Failure/drug therapy, Frailty*, Frailty/epidemiology, Quality of Life, Stroke Volume, Benzhydryl Compounds*, Glucosides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1127, + "user_id": 1639100928, + "artical_title": "Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.", + "pmid": 38302936, + "journal_name": "Cardiovascular diabetology", + "date": "2024-02-05", + "author": "Januzzi JL,Del Prato S,Rosenstock J,Butler J,Ezekowitz J,Ibrahim NE,Lam CSP,Marwick T,Wilson Tang WH,Liu Y,Mohebi R,Urbinati A,Zannad F,Perfetti R", + "auth_pos": 4, + "meshterms": "Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left, Humans, Female, Aged, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/etiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Hypertrophy, Left Ventricular, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1128, + "user_id": 1639100928, + "artical_title": "Cardiac Biomarkers in Dyspnea Hospitalizations - Still Breathing Not Predictively.", + "pmid": 37883930, + "journal_name": "Cardiology", + "date": "2024-02-06", + "author": "Agarwal MA,AlMahmeed W,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Dyspnea*, Dyspnea/etiology, Biomarkers, Natriuretic Peptide, Brain*, Peptide Fragments, Troponin T", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1129, + "user_id": 1639100928, + "artical_title": "How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?", + "pmid": 38321579, + "journal_name": "Cardio-oncology (London, England)", + "date": "2024-02-07", + "author": "Hamid A,Fonarow GC,Butler J,Hall ME", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1130, + "user_id": 1639100928, + "artical_title": "Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure.", + "pmid": 38325995, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-02-09", + "author": "Fudim M,Butler J,Kittipibul V", + "auth_pos": 2, + "meshterms": "Humans, Pulmonary Artery, Prostheses and Implants, Hemodynamic Monitoring*, Hemodynamics, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Defibrillators, Implantable*, Humans, Pulmonary Artery, Prostheses and Implants, Hemodynamic Monitoring*, Hemodynamics, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Defibrillators, Implantable*, Humans, Pulmonary Artery, Prostheses and Implants, Hemodynamic Monitoring*, Hemodynamics, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Defibrillators, Implantable*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1131, + "user_id": 1639100928, + "artical_title": "Medical Therapy Before, During, and After Hospitalization in Medicare Beneficiaries with Heart Failure and Diabetes: The Get With The Guidelines - Heart Failure Registry.", + "pmid": 37757995, + "journal_name": "Journal of cardiac failure", + "date": "2024-02-19", + "author": "Bhatt AS,Fonarow GC,Greene SJ,Holmes DN,Alhanti B,DeVore AD,Butler J,Heidenreich PA,Huang JC,Kittleson MM,Linganathan K,Joynt Maddox KE,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Vaduganathan M", + "auth_pos": 7, + "meshterms": "Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use, Humans, Female, Aged, United States, United States/epidemiology, Male, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Aftercare, Patient Discharge, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Stroke Volume, Medicare, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Hospitalization, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Registries, Metformin*, Metformin/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1132, + "user_id": 1639100928, + "artical_title": "Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation.", + "pmid": 38191996, + "journal_name": "European journal of heart failure", + "date": "2024-02-20", + "author": "Khan MS,Sperry BW,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Creatinine, Prealbumin, Heart Failure*, Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/complications, Kidney, Cardiomyopathies*, Humans, Creatinine, Prealbumin, Heart Failure*, Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/complications, Kidney, Cardiomyopathies*, Humans, Creatinine, Prealbumin, Heart Failure*, Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/complications, Kidney, Cardiomyopathies*, Humans, Creatinine, Prealbumin, Heart Failure*, Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/complications, Kidney, Cardiomyopathies*, Humans, Creatinine, Prealbumin, Heart Failure*, Amyloid Neuropathies, Familial*, Amyloid Neuropathies, Familial/complications, Kidney, Cardiomyopathies*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1133, + "user_id": 1639100928, + "artical_title": "GDF-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program.", + "pmid": 37964408, + "journal_name": "European journal of heart failure", + "date": "2024-02-20", + "author": "Ferreira JP,Packer M,Butler J,Filippatos G,Pocock SJ,Januzzi JL,Sattar N,Maldonado SG,Panova-Noeva M,Sumin M,Masson S,Anker SD,Zannad F", + "auth_pos": 3, + "meshterms": "Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*, Male, Humans, Aged, Heart Failure*, Growth Differentiation Factor 15, AMP-Activated Protein Kinases, AMP-Activated Protein Kinases/therapeutic use, Stroke Volume, Stroke Volume/physiology, Metformin*, Metformin/therapeutic use, Benzhydryl Compounds*, Glucosides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1134, + "user_id": 1639100928, + "artical_title": "2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.", + "pmid": 38169072, + "journal_name": "European journal of heart failure", + "date": "2024-02-20", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,Čelutkienė J,Chioncel O,Cleland JGF,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Francesco Piepoli M,Price S,Rosano GMC,Ruschitzka F,Skibelund AK", + "auth_pos": 9, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Poland, United Kingdom, Spain, Cardiology*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1135, + "user_id": 1639100928, + "artical_title": "Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth Substudy.", + "pmid": 38205653, + "journal_name": "Circulation. Heart failure", + "date": "2024-02-22", + "author": "Diamond JE,Kaltenbach LA,Granger BB,Fonarow GC,Al-Khalidi HR,Albert NM,Butler J,Allen LA,Lanfear DE,Thibodeau JT,Granger CB,Hernandez AF,Ariely D,DeVore AD", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Digital Divide*, Mobile Applications*, Telemedicine*, Patients", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1136, + "user_id": 1639100928, + "artical_title": "Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial.", + "pmid": 38250799, + "journal_name": "Circulation. Heart failure", + "date": "2024-02-22", + "author": "Harrington J,Mentz RJ,Rockhold FW,Garg J,Butler J,De Pasquale CG,Ezekowitz JA,Lewis GD,O'Meara E,Ponikowski P,Troughton RW,Wong YW,Adamczyk R,Storie T,Blackman N,Hernandez AF", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Treatment Outcome, Ferric Compounds, Hospitalization, Stroke Volume, Randomized Controlled Trials as Topic, Maltose, Maltose/analogs & derivatives*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1137, + "user_id": 1639100928, + "artical_title": "Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity.", + "pmid": 38275114, + "journal_name": "Circulation. Heart failure", + "date": "2024-02-22", + "author": "Mentias A,Desai MY,Aminian A,Patel KV,Keshvani N,Verma S,Cho L,Jacob M,Alvarez P,Lincoff AM,Van Spall HGC,Lam CSP,Butler J,Nissen SE,Pandey A", + "auth_pos": 13, + "meshterms": "Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies, Male, Humans, Aged, United States, United States/epidemiology, Middle Aged, Female, Heart Failure*, Heart Failure/etiology, Liraglutide, Medicare, Obesity, Obesity/complications, Obesity/surgery, Bariatric Surgery*, Bariatric Surgery/adverse effects, Weight Loss, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1138, + "user_id": 1639100928, + "artical_title": "The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan.", + "pmid": 38073194, + "journal_name": "European heart journal", + "date": "2024-02-23", + "author": "Mehra MR,Castagna F,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Heart-Assist Devices*, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Registries, Humans, Heart-Assist Devices*, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Registries, Humans, Heart-Assist Devices*, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1139, + "user_id": 1639100928, + "artical_title": "Aldosterone and Aldosterone Synthase Inhibitors in Cardiorenal Disease.", + "pmid": 38133623, + "journal_name": "American journal of physiology. Heart and circulatory physiology", + "date": "2024-02-23", + "author": "Verma S,Pandey A,Pandey AK,Butler J,Lee JS,Teoh H,Mazer CD,Kosiborod MN,Cosentino F,D Anker S,Connelly KA,Bhatt DL", + "auth_pos": 4, + "meshterms": "Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*, Humans, Cytochrome P-450 CYP11B2, Cytochrome P-450 CYP11B2/genetics, Cytochrome P-450 CYP11B2/metabolism, Aldosterone, Aldosterone/pharmacology, Hypothalamo-Hypophyseal System, Hypothalamo-Hypophyseal System/metabolism, Pituitary-Adrenal System, Pituitary-Adrenal System/metabolism, Hypertension, Renal*, Hypertension, Renal/drug therapy, Renin-Angiotensin System, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists/pharmacology, Heart Diseases*, Heart Diseases/drug therapy, Nephritis*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1140, + "user_id": 1639100928, + "artical_title": "[2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].", + "pmid": 38410903, + "journal_name": "Giornale italiano di cardiologia (2006)", + "date": "2024-02-27", + "author": "McDonagh TA,Metra M,Adamo M,Gardner RS,Baumbach A,Böhm M,Burri H,Butler J,Čelutkienė J,Chioncel O,Cleland JGF,Coats AJS,Crespo-Leiro MG,Farmakis D,Gilard M,Heymans S,Hoes AW,Jaarsma T,Jankowska EA,Lainscak M,Lam CSP,Lyon AR,McMurray JJV,Mebazaa A,Mindham R,Muneretto C,Piepoli MF,Price S,Rosano GMC,Ruschitzka F,Skibelund AK", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1141, + "user_id": 1639100928, + "artical_title": "Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies.", + "pmid": 38429011, + "journal_name": "European journal of preventive cardiology", + "date": "2024-03-02", + "author": "Bertero E,Carmisciano L,Jonasson C,Butler J,Maack C,Ameri P", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1142, + "user_id": 1639100928, + "artical_title": "A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure.", + "pmid": 38099890, + "journal_name": "JACC. Heart failure", + "date": "2024-03-08", + "author": "Segar MW,Khan MS,Patel KV,Butler J,Ravichandran AK,Walsh MN,Willett D,Fonarow GC,Drazner MH,Mentz RJ,Hall J,Farr MA,Hedayati SS,Yancy C,Allen LA,Tang WHW,Pandey A", + "auth_pos": 4, + "meshterms": "Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease, Humans, Diuretics*, Diuretics/therapeutic use, Heart Failure*, Furosemide, Furosemide/therapeutic use, Creatinine, Natriuretic Peptides, Acute Disease", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1143, + "user_id": 1639100928, + "artical_title": "Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping.", + "pmid": 38099892, + "journal_name": "JACC. Heart failure", + "date": "2024-03-08", + "author": "Dimond MG,Ibrahim NE,Fiuzat M,McMurray JJV,Lindenfeld J,Ahmad T,Bozkurt B,Bristow MR,Butler J,Carson PE,Felker GM,Jessup M,Murillo J,Kondo T,Solomon SD,Abraham WT,O'Connor CM,Psotka MA", + "auth_pos": 9, + "meshterms": "Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors, Humans, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left*, Ventricular Function, Left/physiology, Heart Failure*, Prognosis, Time Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1144, + "user_id": 1639100928, + "artical_title": "Drug development for major chronic health conditions - aligning with growing public health needs: Proceedings from a multi-stakeholder think tank.", + "pmid": 38242417, + "journal_name": "American heart journal", + "date": "2024-03-18", + "author": "Krychtiuk KA,Andersson TL,Bodesheim U,Butler J,Curtis LH,Elkind M,Hernandez AF,Hornik C,Lyman GH,Khatri P,Mbagwu M,Murakami M,Nichols G,Roessig L,Young AQ,Schilsky RL,Pagidipati N", + "auth_pos": 4, + "meshterms": "Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry, Humans, Public Health*, Delivery of Health Care, Drug Development, Neoplasms*, Drug Industry", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1145, + "user_id": 1639100928, + "artical_title": "The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.", + "pmid": 38242191, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-03-19", + "author": "Akhtar KH,Khan MS,Baron SJ,Zieroth S,Estep J,Burkhoff D,Butler J,Fudim M", + "auth_pos": 7, + "meshterms": "Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy, Humans, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/etiology, Shock, Cardiogenic/therapy, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/therapy, Myocardial Infarction/complications, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Heart Failure/therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1146, + "user_id": 1639100928, + "artical_title": "Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.", + "pmid": 38244825, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-03-19", + "author": "Shahid I,Khan MS,Fonarow GC,Butler J,Greene SJ", + "auth_pos": 4, + "meshterms": "Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance, Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance, Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance, Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance, Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance, Humans, Stroke Volume, Heart Failure*, Heart Failure/diagnosis, Heart Failure/drug therapy, Hospitalization, Patient Compliance", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1147, + "user_id": 1639100928, + "artical_title": "Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?", + "pmid": 38235943, + "journal_name": "European journal of heart failure", + "date": "2024-03-27", + "author": "Greene SJ,Khan MS,Butler J", + "auth_pos": 3, + "meshterms": "Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Dysfunction, Left*, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Dysfunction, Left*, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Dysfunction, Left*, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Dysfunction, Left*, Humans, Stroke Volume, Heart Failure*, Heart Failure/drug therapy, Ventricular Dysfunction, Left*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1148, + "user_id": 1639100928, + "artical_title": "Effects of empaglifozin on collagen biomarkers in patients with Heart Failure. Findings from the EMPEROR trials.", + "pmid": 38037709, + "journal_name": "European journal of heart failure", + "date": "2024-03-27", + "author": "Ferreira JP,Butler J,Anker SD,Januzzi JL,Panova-Noeva M,Reese-Petersen AL,Sattar N,Schueler E,Pocock SJ,Filippatos G,Packer M,Sumin M,Zannad F", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*, Humans, Heart Failure*, Collagen Type III, Collagen Type III/therapeutic use, Complement C3, Complement C3/therapeutic use, Collagen, Collagen/metabolism, Collagen/therapeutic use, Biomarkers, Stroke Volume, Stroke Volume/physiology, Benzhydryl Compounds*, Glucosides*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1149, + "user_id": 1639100928, + "artical_title": "Transcatheter aortic valve replacement in heart failure.", + "pmid": 38297972, + "journal_name": "European journal of heart failure", + "date": "2024-03-27", + "author": "Parikh PB,Mack M,Stone GW,Anker SD,Gilchrist IC,Kalogeropoulos AP,Packer M,Skopicki HA,Butler J", + "auth_pos": 9, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left, Humans, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/surgery, Quality of Life, Heart Failure*, Heart Failure/complications, Heart Failure/surgery, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Risk Factors, Severity of Illness Index, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1150, + "user_id": 1639100928, + "artical_title": "The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.", + "pmid": 38235936, + "journal_name": "European journal of heart failure", + "date": "2024-03-27", + "author": "Usman MS,Januzzi JL,Anker SD,Salman A,Parikh PB,Adamo M,Filippatos G,Khan MS,Lala A,Verma S,Metra M,Butler J", + "auth_pos": 12, + "meshterms": "Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium, Humans, Heart Failure*, Stroke Volume, Ventricular Function, Left, Ventricular Remodeling, Ventricular Dysfunction, Left*, Glucose, Sodium", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1151, + "user_id": 1639100928, + "artical_title": "Is Reducing Heart Failure Hospitalization Associated With Reducing Mortality in Heart Failure Trials?", + "pmid": 37943226, + "journal_name": "JACC. Heart failure", + "date": "2024-04-05", + "author": "Sayed A,Awad K,ElRefaei M,Salah HM,Abushouk AI,Kapadia S,Butler J,Anker SD,Fudim M,Savarese G", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization, Humans, Heart Failure*, Heart Failure/therapy, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1152, + "user_id": 1639100928, + "artical_title": "Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.", + "pmid": 37656079, + "journal_name": "JACC. Heart failure", + "date": "2024-04-05", + "author": "Zafeiropoulos S,Farmakis IT,Milioglou I,Doundoulakis I,Gorodeski EZ,Konstantinides SV,Cooper L,Zanos S,Stavrakis S,Giamouzis G,Butler J,Giannakoulas G", + "auth_pos": 11, + "meshterms": "Humans, Angiotensin Receptor Antagonists, Digoxin, Digoxin/therapeutic use, Heart Failure*, Network Meta-Analysis, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Randomized Controlled Trials as Topic, Humans, Angiotensin Receptor Antagonists, Digoxin, Digoxin/therapeutic use, Heart Failure*, Network Meta-Analysis, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Randomized Controlled Trials as Topic, Humans, Angiotensin Receptor Antagonists, Digoxin, Digoxin/therapeutic use, Heart Failure*, Network Meta-Analysis, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Randomized Controlled Trials as Topic, Humans, Angiotensin Receptor Antagonists, Digoxin, Digoxin/therapeutic use, Heart Failure*, Network Meta-Analysis, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Randomized Controlled Trials as Topic, Humans, Angiotensin Receptor Antagonists, Digoxin, Digoxin/therapeutic use, Heart Failure*, Network Meta-Analysis, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1153, + "user_id": 1639100928, + "artical_title": "Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin.", + "pmid": 38385941, + "journal_name": "JACC. Heart failure", + "date": "2024-04-05", + "author": "Mohebi R,Jones PG,Spertus JA,Lingvay I,Lanfear DE,Gosch KL,Birmingham M,Kosiborod MN,Butler J,Januzzi JL", + "auth_pos": 9, + "meshterms": "Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status, Humans, Heart Failure*, Quality of Life, Canagliflozin, Canagliflozin/therapeutic use, Stroke Volume, Health Status", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1154, + "user_id": 1639100928, + "artical_title": "Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.", + "pmid": 38586479, + "journal_name": "EClinicalMedicine", + "date": "2024-04-08", + "author": "Lamy A,Chertow GM,Jessen M,Collar A,Brown CD,Mack CA,Marzouk M,Scavo V,Washburn TB,Savage D,Smith J,Bennetts J,Assi R,Shults C,Arghami A,Butler J,Devereaux PJ,Zager R,Wang C,Snapinn S,Browne A,Rodriguez J,Ruiz S,Singh B", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1155, + "user_id": 1639100928, + "artical_title": "Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer.", + "pmid": 38587563, + "journal_name": "Clinical research in cardiology : official journal of the German Cardiac Society", + "date": "2024-04-08", + "author": "Fröhlich AK,Porthun J,Talha KM,Lena A,Hadzibegovic S,Wilkenshoff U,Sonntag F,Nikolski A,Ramer LV,Zeller T,Keller U,Bullinger L,Anker SD,Haverkamp W,von Haehling S,Doehner W,Rauch U,Skurk C,Cleland JGF,Butler J,Coats AJS,Landmesser U,Karakas M,Anker MS", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1156, + "user_id": 1639100928, + "artical_title": "Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points.", + "pmid": 38099944, + "journal_name": "Clinical journal of the American Society of Nephrology : CJASN", + "date": "2024-04-11", + "author": "Mohebi R,Liu Y,Hansen MK,Yavin Y,Sattar N,Pollock CA,Butler J,Jardine M,Masson S,Heerspink HJL,Januzzi JL", + "auth_pos": 7, + "meshterms": "Humans, Angiopoietin-2*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications, Diabetic Nephropathies, Diabetic Nephropathies/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Vascular Endothelial Growth Factor A*, Humans, Angiopoietin-2*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications, Diabetic Nephropathies, Diabetic Nephropathies/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Vascular Endothelial Growth Factor A*, Humans, Angiopoietin-2*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications, Diabetic Nephropathies, Diabetic Nephropathies/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Vascular Endothelial Growth Factor A*, Humans, Angiopoietin-2*, Canagliflozin, Canagliflozin/therapeutic use, Cardiovascular Diseases, Cardiovascular Diseases/complications, Diabetic Nephropathies, Diabetic Nephropathies/complications, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Vascular Endothelial Growth Factor A*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1157, + "user_id": 1639100928, + "artical_title": "Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF.", + "pmid": 38599459, + "journal_name": "Journal of cardiac failure", + "date": "2024-04-11", + "author": "Shoji S,Kaltenbach LA,Granger BB,Fonarow GC,Al-Khalidi HR,Albert NM,Butler J,Allen LA,Felker GM,Harrison RW,Fudim M,Nelson AJ,Granger CB,Hernandez AF,Devore AD", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1158, + "user_id": 1639100928, + "artical_title": "2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.", + "pmid": 38466244, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-04-12", + "author": "Maddox TM,Januzzi JL,Allen LA,Breathett K,Brouse S,Butler J,Davis LL,Fonarow GC,Ibrahim NE,Lindenfeld J,Masoudi FA,Motiwala SR,Oliveros E,Walsh MN,Wasserman A,Yancy CW,Youmans QR", + "auth_pos": 7, + "meshterms": "United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume, United States, Humans, Consensus, Cardiology*, Heart Failure*, Heart Failure/therapy, Cardiovascular System*, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1159, + "user_id": 1639100928, + "artical_title": "Natriuretic Peptides and Prognosis in Patients with Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events.", + "pmid": 38614444, + "journal_name": "Journal of cardiac failure", + "date": "2024-04-14", + "author": "Khan MS,Januzzi JL,Liu Y,Xu J,Shaw W,Sattar N,Mahaffey KW,Neal B,Hansen MK,Butler J", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1160, + "user_id": 1639100928, + "artical_title": "Thinner is better: Intentional weight loss and cardiovascular risk.", + "pmid": 38614070, + "journal_name": "Med (New York, N.Y.)", + "date": "2024-04-15", + "author": "Abraham J,Butler J,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Overweight, Risk Factors, Heart Disease Risk Factors, Weight Loss, Obesity, Obesity/epidemiology, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Overweight, Risk Factors, Heart Disease Risk Factors, Weight Loss, Obesity, Obesity/epidemiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1161, + "user_id": 1639100928, + "artical_title": "Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.", + "pmid": 38587233, + "journal_name": "The New England journal of medicine", + "date": "2024-04-19", + "author": "Kosiborod MN,Petrie MC,Borlaug BA,Butler J,Davies MJ,Hovingh GK,Kitzman DW,Møller DV,Treppendahl MB,Verma S,Jensen TJ,Liisberg K,Lindegaard ML,Abhayaratna W,Ahmed FZ,Ben-Gal T,Chopra V,Ezekowitz JA,Fu M,Ito H,Lelonek M,Melenovský V,Merkely B,Núñez J,Perna E,Schou M,Senni M,Sharma K,van der Meer P,Von Lewinski D,Wolf D,Shah SJ", + "auth_pos": 4, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/etiology, Double-Blind Method, Glucagon-Like Peptides*, Glucagon-Like Peptides/administration & dosage, Glucagon-Like Peptides/adverse effects, Glucagon-Like Peptides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/etiology, Obesity*, Obesity/complications, Obesity/drug therapy, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1162, + "user_id": 1639100928, + "artical_title": "GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.", + "pmid": 38426865, + "journal_name": "American journal of physiology. Heart and circulatory physiology", + "date": "2024-04-23", + "author": "Park B,Bakbak E,Teoh H,Krishnaraj A,Dennis F,Quan A,Rotstein OD,Butler J,Hess DA,Verma S", + "auth_pos": 8, + "meshterms": "Animals, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Endothelium, Vascular*, Endothelium, Vascular/drug effects, Endothelium, Vascular/physiopathology, Incretins, Incretins/therapeutic use, Signal Transduction, Animals, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Endothelium, Vascular*, Endothelium, Vascular/drug effects, Endothelium, Vascular/physiopathology, Incretins, Incretins/therapeutic use, Signal Transduction, Animals, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Endothelium, Vascular*, Endothelium, Vascular/drug effects, Endothelium, Vascular/physiopathology, Incretins, Incretins/therapeutic use, Signal Transduction, Animals, Humans, Atherosclerosis*, Atherosclerosis/drug therapy, Atherosclerosis/prevention & control, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Endothelium, Vascular*, Endothelium, Vascular/drug effects, Endothelium, Vascular/physiopathology, Incretins, Incretins/therapeutic use, Signal Transduction", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1163, + "user_id": 1639100928, + "artical_title": "Empagliflozin after Acute Myocardial Infarction.", + "pmid": 38587237, + "journal_name": "The New England journal of medicine", + "date": "2024-04-24", + "author": "Butler J,Jones WS,Udell JA,Anker SD,Petrie MC,Harrington J,Mattheus M,Zwiener I,Amir O,Bahit MC,Bauersachs J,Bayes-Genis A,Chen Y,Chopra VK,Figtree G,Ge J,Goodman SG,Gotcheva N,Goto S,Gasior T,Jamal W,Januzzi JL,Jeong MH,Lopatin Y,Lopes RD,Merkely B,Parikh PB,Parkhomenko A,Ponikowski P,Rossello X,Schou M,Simic D,Steg PG,Szachniewicz J,van der Meer P,Vinereanu D,Zieroth S,Brueckmann M,Sumin M,Bhatt DL,Hernandez AF", + "auth_pos": 1, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds, Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Double-Blind Method, Follow-Up Studies, Glucosides, Glucosides/therapeutic use, Glucosides/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/prevention & control, Hospitalization, Kaplan-Meier Estimate, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome, Heart Disease Risk Factors", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1164, + "user_id": 1639100928, + "artical_title": "Vascular Endothelial Growth Factors and Risk of Cardio-renal Events: Results from the CREDENCE trial.", + "pmid": 38401646, + "journal_name": "American heart journal", + "date": "2024-04-25", + "author": "Januzzi JL,Liu Y,Sattar N,Yavin Y,Pollock CA,Butler J,Jardine M,Heerspink HJ,Masson S,Breyer M,Hansen MK", + "auth_pos": 6, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood, Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood, Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood, Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood, Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood, Aged, Female, Humans, Male, Middle Aged, Biomarkers*, Biomarkers/blood, Canagliflozin*, Canagliflozin/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/blood, Diabetic Nephropathies, Diabetic Nephropathies/blood, Diabetic Nephropathies/epidemiology, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/blood, Placenta Growth Factor*, Placenta Growth Factor/blood, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Vascular Endothelial Growth Factor A*, Vascular Endothelial Growth Factor A/blood, Vascular Endothelial Growth Factor Receptor-1*, Vascular Endothelial Growth Factor Receptor-1/blood", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1165, + "user_id": 1639100928, + "artical_title": "Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.", + "pmid": 38599221, + "journal_name": "Lancet (London, England)", + "date": "2024-04-28", + "author": "Butler J,Shah SJ,Petrie MC,Borlaug BA,Abildstrøm SZ,Davies MJ,Hovingh GK,Kitzman DW,Møller DV,Verma S,Einfeldt MN,Lindegaard ML,Rasmussen S,Abhayaratna W,Ahmed FZ,Ben-Gal T,Chopra V,Ezekowitz JA,Fu M,Ito H,Lelonek M,Melenovský V,Merkely B,Núñez J,Perna E,Schou M,Senni M,Sharma K,van der Meer P,Von Lewinski D,Wolf D,Kosiborod MN", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides/administration & dosage, Male, Stroke Volume*, Stroke Volume/drug effects, Female, Aged, Middle Aged, Double-Blind Method, Obesity*, Obesity/complications, Obesity/drug therapy, Treatment Outcome, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1166, + "user_id": 1639100928, + "artical_title": "Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction.", + "pmid": 38363272, + "journal_name": "JACC. Heart failure", + "date": "2024-05-09", + "author": "Mentz RJ,Stebbins A,Butler J,Chiang CE,Ezekowitz JA,Hernandez AF,Hilkert R,Lam CSP,McDonald K,O'Connor CM,Pieske B,Ponikowski P,Roessig L,Sweitzer NK,Voors AA,Anstrom KJ,Armstrong PW", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Male, Female, Aged, Pyrimidines*, Pyrimidines/therapeutic use, Middle Aged, Hospitalization*, Hospitalization/statistics & numerical data, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Double-Blind Method, Treatment Outcome, Heterocyclic Compounds, 2-Ring", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1167, + "user_id": 1639100928, + "artical_title": "Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical Trials.", + "pmid": 38739696, + "journal_name": "Circulation", + "date": "2024-05-13", + "author": "Butler J,Stockbridge N,Packer M", + "auth_pos": 1, + "meshterms": "Humans, Clinical Trials as Topic*, Clinical Trials as Topic/standards, Evidence-Based Medicine, Evidence-Based Medicine/standards, Research Design, Research Design/standards, Humans, Clinical Trials as Topic*, Clinical Trials as Topic/standards, Evidence-Based Medicine, Evidence-Based Medicine/standards, Research Design, Research Design/standards, Humans, Clinical Trials as Topic*, Clinical Trials as Topic/standards, Evidence-Based Medicine, Evidence-Based Medicine/standards, Research Design, Research Design/standards", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1168, + "user_id": 1639100928, + "artical_title": "Role of telemedicine in the management of obesity: State-of-the-art review.", + "pmid": 38528833, + "journal_name": "Obesity reviews : an official journal of the International Association for the Study of Obesity", + "date": "2024-05-13", + "author": "Shariq K,Siddiqi TJ,Van Spall H,Greene SJ,Fudim M,DeVore AD,Pandey A,Butler J,Khan MS", + "auth_pos": 8, + "meshterms": "Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2, Humans, Telemedicine*, Telemedicine/methods, Obesity*, Obesity/therapy, COVID-19*, COVID-19/epidemiology, COVID-19/therapy, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1169, + "user_id": 1639100928, + "artical_title": "Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.", + "pmid": 38739118, + "journal_name": "European heart journal", + "date": "2024-05-13", + "author": "Shah SJ,Sharma K,Borlaug BA,Butler J,Davies M,Kitzman DW,Petrie MC,Verma S,Patel S,Chinnakondepalli KM,Einfeldt MN,Jensen TJ,Rasmussen S,Asleh R,Ben-Gal T,Kosiborod MN", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1170, + "user_id": 1639100928, + "artical_title": "Iron replacement therapy in heart failure: Contextualizing the results of the HEART-FID trial.", + "pmid": 38439623, + "journal_name": "European journal of heart failure", + "date": "2024-05-16", + "author": "Butler J,Mentz RJ,Hernandez AF", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy, Iron, Iron/therapeutic use, Iron/administration & dosage, Treatment Outcome, Ferric Compounds, Ferric Compounds/therapeutic use, Ferric Compounds/administration & dosage, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy, Iron, Iron/therapeutic use, Iron/administration & dosage, Treatment Outcome, Ferric Compounds, Ferric Compounds/therapeutic use, Ferric Compounds/administration & dosage, Randomized Controlled Trials as Topic, Humans, Heart Failure*, Heart Failure/drug therapy, Anemia, Iron-Deficiency, Anemia, Iron-Deficiency/drug therapy, Iron, Iron/therapeutic use, Iron/administration & dosage, Treatment Outcome, Ferric Compounds, Ferric Compounds/therapeutic use, Ferric Compounds/administration & dosage, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1171, + "user_id": 1639100928, + "artical_title": "Use of natriuretic peptides and echocardiography for diagnosing heart failure.", + "pmid": 38378966, + "journal_name": "European journal of heart failure", + "date": "2024-05-16", + "author": "Talha KM,Januzzi JL,Meng T,Greene SJ,Vaduganathan M,Janicijevic TK,John A,Bayes-Genis A,Butler J", + "auth_pos": 9, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/blood, Male, Female, Echocardiography*, Echocardiography/methods, Echocardiography/statistics & numerical data, Aged, Natriuretic Peptides, Natriuretic Peptides/blood, Middle Aged, United States, United States/epidemiology, Biomarkers, Biomarkers/blood, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/blood, Male, Female, Echocardiography*, Echocardiography/methods, Echocardiography/statistics & numerical data, Aged, Natriuretic Peptides, Natriuretic Peptides/blood, Middle Aged, United States, United States/epidemiology, Biomarkers, Biomarkers/blood, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/blood, Male, Female, Echocardiography*, Echocardiography/methods, Echocardiography/statistics & numerical data, Aged, Natriuretic Peptides, Natriuretic Peptides/blood, Middle Aged, United States, United States/epidemiology, Biomarkers, Biomarkers/blood, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/blood, Male, Female, Echocardiography*, Echocardiography/methods, Echocardiography/statistics & numerical data, Aged, Natriuretic Peptides, Natriuretic Peptides/blood, Middle Aged, United States, United States/epidemiology, Biomarkers, Biomarkers/blood", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1172, + "user_id": 1639100928, + "artical_title": "Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.", + "pmid": 38450878, + "journal_name": "European journal of heart failure", + "date": "2024-05-16", + "author": "Ezekowitz J,Alemayehu W,Edelmann F,Ponikowski P,Lam CSP,O'Connor CM,Butler J,Corda S,McMullan CJ,Westerhout CM,Voors AA,Mentz RJ,Armstrong PW", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Sodium Potassium Chloride Symporter Inhibitors*, Sodium Potassium Chloride Symporter Inhibitors/administration & dosage, Sodium Potassium Chloride Symporter Inhibitors/therapeutic use, Middle Aged, Treatment Outcome, Furosemide, Furosemide/administration & dosage, Furosemide/therapeutic use, Dose-Response Relationship, Drug, Hospitalization, Hospitalization/statistics & numerical data, Pyrimidines, Pyrimidines/administration & dosage, Pyrimidines/therapeutic use, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1173, + "user_id": 1639100928, + "artical_title": "Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study.", + "pmid": 37816446, + "journal_name": "Journal of cardiac failure", + "date": "2024-05-17", + "author": "Omar AMS,Murphy S,Felker GM,Piña I,Butler J,Liu Y,Mohebi R,Bhatia K,Ward JH,Williamson KM,Solomon SD,Januzzi JL,Contreras J", + "auth_pos": 5, + "meshterms": "Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies, Humans, Valsartan*, Female, Drug Combinations*, Aminobutyrates*, Aminobutyrates/therapeutic use, Aminobutyrates/pharmacology, Male, Middle Aged, Biphenyl Compounds*, Stroke Volume*, Stroke Volume/physiology, Stroke Volume/drug effects, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/diagnostic imaging, Aged, Tetrazoles*, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, Treatment Outcome, Myocardial Contraction, Myocardial Contraction/drug effects, Myocardial Contraction/physiology, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/administration & dosage, Ventricular Function, Left, Ventricular Function, Left/drug effects, Ventricular Function, Left/physiology, Echocardiography, Doppler, Echocardiography, Doppler/methods, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1174, + "user_id": 1639100928, + "artical_title": "Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.", + "pmid": 38581389, + "journal_name": "Circulation", + "date": "2024-05-20", + "author": "Hernandez AF,Udell JA,Jones WS,Anker SD,Petrie MC,Harrington J,Mattheus M,Seide S,Zwiener I,Amir O,Bahit MC,Bauersachs J,Bayes-Genis A,Chen Y,Chopra VK,Figtree G,Ge J,Goodman S,Gotcheva N,Goto S,Gasior T,Jamal W,Januzzi JL,Jeong MH,Lopatin Y,Lopes RD,Merkely B,Parikh PB,Parkhomenko A,Ponikowski P,Rossello X,Schou M,Simic D,Steg PG,Szachniewicz J,van der Meer P,Vinereanu D,Zieroth S,Brueckmann M,Sumin M,Bhatt DL,Butler J", + "auth_pos": 42, + "meshterms": "Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Myocardial Infarction/complications, Aged, Middle Aged, Double-Blind Method, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Hospitalization*, Treatment Outcome, Stroke Volume, Stroke Volume/drug effects", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1175, + "user_id": 1639100928, + "artical_title": "Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study.", + "pmid": 38766664, + "journal_name": "International journal of cardiology. Cardiovascular risk and prevention", + "date": "2024-05-20", + "author": "Gaggin HK,Greene SJ,Zhou M,Lautsch D,Bash LD,Djatche L,Song Y,Signorovitch J,Stevenson AS,Blaustein RO,Butler J", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1176, + "user_id": 1639100928, + "artical_title": "Generalizable Approach to Quantifying Guideline-Directed Medical Therapy.", + "pmid": 38742418, + "journal_name": "Circulation. Heart failure", + "date": "2024-05-21", + "author": "Khan MS,Chan PS,Sherrod CF,Ikemura N,Sauer AJ,Jones PG,Fonarow GC,Butler J,DeVore AD,Lund LH,Spertus JA", + "auth_pos": 8, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome, Humans, Heart Failure*, Heart Failure/drug therapy, Practice Guidelines as Topic*, Practice Guidelines as Topic/standards, Angiotensin-Converting Enzyme Inhibitors*, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Female, Male, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Mineralocorticoid Receptor Antagonists, Mineralocorticoid Receptor Antagonists/therapeutic use, Guideline Adherence, Guideline Adherence/standards, Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Middle Aged, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1177, + "user_id": 1639100928, + "artical_title": "Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.", + "pmid": 38247160, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Rastogi T,Ferreira JP,Butler J,Kraus BJ,Mattheus M,Brueckmann M,Filippatos G,Wanner C,Pocock SJ,Packer M,Anker SD,Zannad F", + "auth_pos": 3, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Double-Blind Method, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Glucosides*, Glucosides/therapeutic use, Glucosides/pharmacology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume, Stroke Volume/physiology, Stroke Volume/drug effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1178, + "user_id": 1639100928, + "artical_title": "Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.", + "pmid": 38587259, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Ferreira JP,Packer M,Sattar N,Butler J,González Maldonado S,Panova-Noeva M,Sumin M,Masson S,Pocock SJ,Anker SD,Zannad F,Januzzi JL", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/blood, Heart Failure/metabolism, Male, Female, Biomarkers*, Biomarkers/blood, Insulin-Like Growth Factor Binding Proteins*, Insulin-Like Growth Factor Binding Proteins/blood, Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Middle Aged, Glucosides*, Glucosides/therapeutic use, Prognosis, Stroke Volume, Stroke Volume/physiology, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1179, + "user_id": 1639100928, + "artical_title": "Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial.", + "pmid": 38558521, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Sattar N,Butler J,Lee MMY,Harrington J,Sharma A,Zannad F,Filippatos G,Verma S,Januzzi JL,Ferreira JP,Pocock SJ,Pfarr E,Ofstad AP,Brueckmann M,Packer M,Anker SD", + "auth_pos": 2, + "meshterms": "Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome, Humans, Body Mass Index*, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Heart Failure/mortality, Glomerular Filtration Rate, Stroke Volume, Stroke Volume/physiology, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Middle Aged, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1180, + "user_id": 1639100928, + "artical_title": "Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.", + "pmid": 38439582, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Ferreira JP,Packer M,Sattar N,Butler J,Pocock SJ,Anker SD,Maldonado SG,Panova-Noeva M,Sumin M,Masson S,Zannad F,Januzzi JL", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/blood, CA-125 Antigen*, CA-125 Antigen/blood, Male, Female, Stroke Volume*, Stroke Volume/physiology, Aged, Biomarkers*, Biomarkers/blood, Middle Aged, Prognosis, Hospitalization, Hospitalization/statistics & numerical data, Chronic Disease", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1181, + "user_id": 1639100928, + "artical_title": "Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.", + "pmid": 38439585, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Ferreira JP,Zannad F,Packer M,Filippatos G,Pocock SJ,Vasques-Nóvoa F,Böhm M,Butler J,Anker S", + "auth_pos": 8, + "meshterms": "Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Follow-Up Studies, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Incidence, Prognosis, Respiratory Tract Infections*, Respiratory Tract Infections/epidemiology, Respiratory Tract Infections/drug therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Double-Blind Method, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Follow-Up Studies, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Incidence, Prognosis, Respiratory Tract Infections*, Respiratory Tract Infections/epidemiology, Respiratory Tract Infections/drug therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Double-Blind Method, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Follow-Up Studies, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Incidence, Prognosis, Respiratory Tract Infections*, Respiratory Tract Infections/epidemiology, Respiratory Tract Infections/drug therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Double-Blind Method, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Follow-Up Studies, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Incidence, Prognosis, Respiratory Tract Infections*, Respiratory Tract Infections/epidemiology, Respiratory Tract Infections/drug therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Double-Blind Method, Aged, Female, Humans, Male, Middle Aged, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Follow-Up Studies, Glucosides*, Glucosides/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Incidence, Prognosis, Respiratory Tract Infections*, Respiratory Tract Infections/epidemiology, Respiratory Tract Infections/drug therapy, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume*, Stroke Volume/physiology, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1182, + "user_id": 1639100928, + "artical_title": "Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial design.", + "pmid": 38654139, + "journal_name": "European journal of heart failure", + "date": "2024-05-30", + "author": "Anker SD,Friede T,von Bardeleben RS,Butler J,Fatima K,Diek M,Heinrich J,Hasenfuß G,Schillinger W,Ponikowski P", + "auth_pos": 4, + "meshterms": "Female, Humans, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Prospective Studies, Treatment Outcome, Female, Humans, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Prospective Studies, Treatment Outcome, Female, Humans, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Prospective Studies, Treatment Outcome, Female, Humans, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/physiopathology, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Prospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1183, + "user_id": 1639100928, + "artical_title": "Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes.", + "pmid": 38641191, + "journal_name": "The American journal of cardiology", + "date": "2024-06-01", + "author": "Edmonston D,Mulder H,Lydon E,Chiswell K,Lampron Z,Shay C,Marsolo K,Jones WS,Butler J,Shah RC,Chamberlain AM,Ford DE,Gordon HS,Hwang W,Chang A,Rao A,Bosworth HB,Pagidipati N", + "auth_pos": 9, + "meshterms": "Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Dipeptidyl-Peptidase IV Inhibitors*, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Male, Female, Middle Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Glomerular Filtration Rate, Aged, Cardiovascular Diseases, Kidney Failure, Chronic, Kidney Failure, Chronic/complications, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1184, + "user_id": 1639100928, + "artical_title": "Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.", + "pmid": 38583093, + "journal_name": "Circulation", + "date": "2024-06-03", + "author": "Patel SM,Kang YM,Im K,Neuen BL,Anker SD,Bhatt DL,Butler J,Cherney DZI,Claggett BL,Fletcher RA,Herrington WG,Inzucchi SE,Jardine MJ,Mahaffey KW,McGuire DK,McMurray JJV,Neal B,Packer M,Perkovic V,Solomon SD,Staplin N,Vaduganathan M,Wanner C,Wheeler DC,Zannad F,Zhao Y,Heerspink HJL,Sabatine MS,Wiviott SD", + "auth_pos": 7, + "meshterms": "Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/mortality, Renal Insufficiency, Chronic/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/complications, Female, Male, Treatment Outcome, Aged, Carotid Stents*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1185, + "user_id": 1639100928, + "artical_title": "Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.", + "pmid": 38558314, + "journal_name": "Diabetes, obesity & metabolism", + "date": "2024-06-04", + "author": "Talha KM,Green J,Filippatos G,Pocock S,Zannad F,Brueckmann M,Schueler E,Ofstad AP,Ferreira JP,Anker SD,Butler J,Rosenstock J,Packer M", + "auth_pos": 11, + "meshterms": "Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome, Humans, Glucosides*, Glucosides/therapeutic use, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Heart Failure*, Heart Failure/drug therapy, Heart Failure/complications, Male, Female, Insulin*, Insulin/therapeutic use, Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Middle Aged, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1186, + "user_id": 1639100928, + "artical_title": "Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors.", + "pmid": 38839134, + "journal_name": "JACC. Heart failure", + "date": "2024-06-06", + "author": "Butler J,Rich J", + "auth_pos": 1, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/epidemiology, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Cardiotonic Agents, Cardiotonic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/epidemiology, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Cardiotonic Agents, Cardiotonic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Heart Failure*, Heart Failure/epidemiology, Heart Failure/drug therapy, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Cardiotonic Agents, Cardiotonic Agents/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1187, + "user_id": 1639100928, + "artical_title": "Summary and Panel Discussion.", + "pmid": 38839135, + "journal_name": "JACC. Heart failure", + "date": "2024-06-06", + "author": "Butler J,Rich J,Pessah-Pollack R,Anderson JE", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Heart Failure*, Heart Failure/drug therapy, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1188, + "user_id": 1639100928, + "artical_title": "Use of SGLT2 Inhibitors in Patients With HF With and Without Type 2 Diabetes: An Endocrinologist's Perspective.", + "pmid": 38839136, + "journal_name": "JACC. Heart failure", + "date": "2024-06-06", + "author": "Butler J,Pessah-Pollack R", + "auth_pos": 1, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Heart Failure*, Heart Failure/drug therapy, Endocrinologists, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1189, + "user_id": 1639100928, + "artical_title": "Managing Patients on SGLT2 Inhibitors in Primary Care.", + "pmid": 38839137, + "journal_name": "JACC. Heart failure", + "date": "2024-06-06", + "author": "Butler J,Anderson JE", + "auth_pos": 1, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Primary Health Care*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Heart Failure/drug therapy, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1190, + "user_id": 1639100928, + "artical_title": "Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.", + "pmid": 38588929, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-06-06", + "author": "Udell JA,Petrie MC,Jones WS,Anker SD,Harrington J,Mattheus M,Seide S,Amir O,Bahit MC,Bauersachs J,Bayes-Genis A,Chen Y,Chopra VK,Figtree G,Ge J,Goodman SG,Gotcheva N,Goto S,Gasior T,Jamal W,Januzzi JL,Jeong MH,Lopatin Y,Lopes RD,Merkely B,Martinez-Traba M,Parikh PB,Parkhomenko A,Ponikowski P,Rossello X,Schou M,Simic D,Steg PG,Szachniewicz J,van der Meer P,Vinereanu D,Zieroth S,Brueckmann M,Sumin M,Bhatt DL,Hernandez AF,Butler J", + "auth_pos": 42, + "meshterms": "Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies, Humans, Benzhydryl Compounds*, Benzhydryl Compounds/therapeutic use, Glucosides*, Glucosides/therapeutic use, Male, Female, Myocardial Infarction*, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Middle Aged, Aged, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Ventricular Function, Left*, Ventricular Function, Left/drug effects, Stroke Volume, Stroke Volume/drug effects, Hospitalization, Hospitalization/statistics & numerical data, Double-Blind Method, Follow-Up Studies", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1191, + "user_id": 1639100928, + "artical_title": "Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial.", + "pmid": 38561962, + "journal_name": "Journal of cachexia, sarcopenia and muscle", + "date": "2024-06-06", + "author": "Pandey A,Patel KV,Segar MW,Ayers C,Linge J,Leinhard OD,Anker SD,Butler J,Verma S,Joshi PH,Neeland IJ", + "auth_pos": 8, + "meshterms": "Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method, Humans, Liraglutide*, Liraglutide/therapeutic use, Liraglutide/pharmacology, Female, Male, Obesity*, Obesity/drug therapy, Middle Aged, Overweight*, Overweight/drug therapy, Overweight/complications, Body Composition, Body Composition/drug effects, Adult, Muscle, Skeletal, Muscle, Skeletal/drug effects, Thigh, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1192, + "user_id": 1639100928, + "artical_title": "MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials.", + "pmid": 38738988, + "journal_name": "Journal of internal medicine", + "date": "2024-06-11", + "author": "Zannad F,Sanyal AJ,Butler J,Ferreira JP,Girerd N,Miller V,Pandey A,Parikh CR,Ratziu V,Younossi ZM,Harrison SA", + "auth_pos": 3, + "meshterms": "Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Humans, Clinical Trials as Topic*, Cardiovascular Diseases, Fatty Liver, Fatty Liver/therapy, Biomarkers, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1193, + "user_id": 1639100928, + "artical_title": "Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021.", + "pmid": 38656398, + "journal_name": "JAMA cardiology", + "date": "2024-06-12", + "author": "Sayed A,Abramov D,Fonarow GC,Mamas MA,Kobo O,Butler J,Fudim M", + "auth_pos": 6, + "meshterms": "Humans, Heart Failure*, Heart Failure/mortality, United States, United States/epidemiology, Male, Female, Aged, Mortality, Mortality/trends, Middle Aged, Humans, Heart Failure*, Heart Failure/mortality, United States, United States/epidemiology, Male, Female, Aged, Mortality, Mortality/trends, Middle Aged, Humans, Heart Failure*, Heart Failure/mortality, United States, United States/epidemiology, Male, Female, Aged, Mortality, Mortality/trends, Middle Aged, Humans, Heart Failure*, Heart Failure/mortality, United States, United States/epidemiology, Male, Female, Aged, Mortality, Mortality/trends, Middle Aged, Humans, Heart Failure*, Heart Failure/mortality, United States, United States/epidemiology, Male, Female, Aged, Mortality, Mortality/trends, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1194, + "user_id": 1639100928, + "artical_title": "Sex-related similarities and differences in responses to heart failure therapies.", + "pmid": 38459252, + "journal_name": "Nature reviews. Cardiology", + "date": "2024-06-19", + "author": "Chyou JY,Qin H,Butler J,Voors AA,Lam CSP", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Female, Sex Factors, Male, Treatment Outcome, Cardiovascular Agents, Cardiovascular Agents/therapeutic use, Cardiovascular Agents/adverse effects, Cardiac Rehabilitation, Cardiac Rehabilitation/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Female, Sex Factors, Male, Treatment Outcome, Cardiovascular Agents, Cardiovascular Agents/therapeutic use, Cardiovascular Agents/adverse effects, Cardiac Rehabilitation, Cardiac Rehabilitation/methods", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1195, + "user_id": 1639100928, + "artical_title": "Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.", + "pmid": 38768620, + "journal_name": "The lancet. Diabetes & endocrinology", + "date": "2024-06-21", + "author": "Usman MS,Bhatt DL,Hameed I,Anker SD,Cheng AYY,Hernandez AF,Jones WS,Khan MS,Petrie MC,Udell JA,Friede T,Butler J", + "auth_pos": 12, + "meshterms": "Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/mortality, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Cardiovascular Diseases*, Cardiovascular Diseases/mortality, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/mortality, Hospitalization, Hospitalization/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1196, + "user_id": 1639100928, + "artical_title": "Subclinical association of aortic stiffness with cardiac structure and function in African-Americans: The Jackson Heart Study.", + "pmid": 38909092, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2024-06-23", + "author": "Jha M,Musani S,McCarthy I,Hundley WG,Carr JJ,Terry JG,Oshunbade A,Vasan RS,Butler J,Hall M,Mitchell GF,Fox E,Tsao CW", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1197, + "user_id": 1639100928, + "artical_title": "Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials.", + "pmid": 38913003, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-06-24", + "author": "Verma S,Butler J,Borlaug BA,Davies M,Kitzman DW,Shah SJ,Petrie MC,Barros E,Rönnbäck C,Vestergaard LS,Schou M,Ezekowitz JA,Sharma K,Patel S,Chinnakondepalli KM,Kosiborod MN", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1198, + "user_id": 1639100928, + "artical_title": "Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday versus Weekend Hospital Admissions for Heart Failure.", + "pmid": 37244294, + "journal_name": "Journal of cardiac failure", + "date": "2024-06-25", + "author": "Aliyev N,Almani MU,Qudrat-Ullah M,Butler J,Khan MS,Greene SJ", + "auth_pos": 4, + "meshterms": "Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Humans, Patient Readmission*, Patient Readmission/statistics & numerical data, Patient Readmission/trends, Male, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Female, Retrospective Studies, Aged, Middle Aged, Time Factors, United States, United States/epidemiology, Aged, 80 and over, Cardiac Surgical Procedures, Inpatients, Hospitalization, Hospitalization/statistics & numerical data, Hospitalization/trends, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1199, + "user_id": 1639100928, + "artical_title": "Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.", + "pmid": 38922613, + "journal_name": "JAMA network open", + "date": "2024-06-26", + "author": "Edmonston D,Lydon E,Mulder H,Chiswell K,Lampron Z,Marsolo K,Goss A,Ayoub I,Shah RC,Chang AR,Ford DE,Jones WS,Fonesca V,Machineni S,Fort D,Butler J,Hunt KJ,Pitlosh M,Rao A,Ahmad FS,Gordon HS,Hung AM,Hwang W,Bosworth HB,Pagidipati NJ", + "auth_pos": 16, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Female, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Retrospective Studies, Aged, Guideline Adherence*, Guideline Adherence/statistics & numerical data, Practice Guidelines as Topic, Mass Screening, Mass Screening/methods, Mass Screening/standards, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, United States, United States/epidemiology, Glomerular Filtration Rate", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1200, + "user_id": 1639100928, + "artical_title": "Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial.", + "pmid": 38934967, + "journal_name": "JACC. Heart failure", + "date": "2024-06-27", + "author": "Khan MS,Butler J,Young R,Lewis BS,Escobedo J,Refsgaard J,Reyes E,Roessig L,Blaustein RO,Lam CSP,Voors AA,Ponikowski P,Anstrom KJ,Armstrong PW", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1201, + "user_id": 1639100928, + "artical_title": "Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria.", + "pmid": 38623814, + "journal_name": "European journal of heart failure", + "date": "2024-06-27", + "author": "Jalloh MB,Bot VA,Borjaille CZ,Thabane L,Li G,Butler J,Zannad F,Granger CB,Van Spall HGC", + "auth_pos": 6, + "meshterms": "Humans, Randomized Controlled Trials as Topic*, Randomized Controlled Trials as Topic/standards, Heart Failure*, Heart Failure/therapy, Guideline Adherence*, Research Design, Research Design/standards, Humans, Randomized Controlled Trials as Topic*, Randomized Controlled Trials as Topic/standards, Heart Failure*, Heart Failure/therapy, Guideline Adherence*, Research Design, Research Design/standards, Humans, Randomized Controlled Trials as Topic*, Randomized Controlled Trials as Topic/standards, Heart Failure*, Heart Failure/therapy, Guideline Adherence*, Research Design, Research Design/standards, Humans, Randomized Controlled Trials as Topic*, Randomized Controlled Trials as Topic/standards, Heart Failure*, Heart Failure/therapy, Guideline Adherence*, Research Design, Research Design/standards", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1202, + "user_id": 1639100928, + "artical_title": "Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.", + "pmid": 38727791, + "journal_name": "European journal of heart failure", + "date": "2024-06-27", + "author": "Packer M,Anker SD,Butler J,Cleland JGF,Kalra PR,Mentz RJ,Ponikowski P,Talha KM", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease, Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease, Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease, Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease, Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease, Humans, Heart Failure*, Heart Failure/blood, Heart Failure/drug therapy, Heart Failure/complications, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Anemia, Iron-Deficiency/diagnosis, Iron*, Iron/blood, Iron/administration & dosage, Ferritins*, Ferritins/blood, Iron Deficiencies, Transferrin, Transferrin/metabolism, Transferrin/analysis, Chronic Disease", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1203, + "user_id": 1639100928, + "artical_title": "Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial.", + "pmid": 38733160, + "journal_name": "European journal of heart failure", + "date": "2024-06-27", + "author": "Greene SJ,Chambers R,Lerman JB,Harrington J,deFilippi CR,Wendell DC,Kim HW,Green CL,Butler J,Felker GM", + "auth_pos": 9, + "meshterms": "Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood, Humans, Biphenyl Compounds*, Aminobutyrates*, Aminobutyrates/therapeutic use, Valsartan*, Drug Combinations*, Male, Female, COVID-19*, COVID-19/complications, COVID-19/blood, Biomarkers*, Biomarkers/blood, Double-Blind Method, Middle Aged, Aged, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Angiotensin Receptor Antagonists*, Angiotensin Receptor Antagonists/therapeutic use, Peptide Fragments*, Peptide Fragments/blood, Tetrazoles, Tetrazoles/therapeutic use, Tetrazoles/administration & dosage, SARS-CoV-2, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Troponin T, Troponin T/blood, Interleukin-1 Receptor-Like 1 Protein, Interleukin-1 Receptor-Like 1 Protein/blood", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1204, + "user_id": 1639100928, + "artical_title": "Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.", + "pmid": 38819334, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-06-27", + "author": "Petrie MC,Borlaug BA,Butler J,Davies MJ,Kitzman DW,Shah SJ,Verma S,Jensen TJ,Einfeldt MN,Liisberg K,Perna E,Sharma K,Ezekowitz JA,Fu M,Melenovský V,Ito H,Lelonek M,Kosiborod MN", + "auth_pos": 3, + "meshterms": "Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Heart Failure*, Heart Failure/drug therapy, Heart Failure/blood, Heart Failure/physiopathology, Peptide Fragments*, Peptide Fragments/blood, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Male, Female, Double-Blind Method, Aged, Obesity*, Obesity/blood, Obesity/complications, Obesity/drug therapy, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Middle Aged, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1205, + "user_id": 1639100928, + "artical_title": "Global epidemiology of heart failure.", + "pmid": 38926611, + "journal_name": "Nature reviews. Cardiology", + "date": "2024-06-27", + "author": "Khan MS,Shahid I,Bennis A,Rakisheva A,Metra M,Butler J", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1206, + "user_id": 1639100928, + "artical_title": "Sacubitril/Valsartan and Cognitive Outcomes in Heart Failure With Reduced Ejection Fraction.", + "pmid": 38938237, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Grewal PK,Abboud A,Myserlis EP,Goldschmidt ME,Butler J,Skopicki HA,Kalogeropoulos AP", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1207, + "user_id": 1639100928, + "artical_title": "Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.", + "pmid": 38597864, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-04", + "author": "Januzzi JL,Butler J,Del Prato S,Ezekowitz JA,Ibrahim NE,Lam CSP,Lewis GD,Marwick TH,Perfetti R,Rosenstock J,Solomon SD,Tang WHW,Zannad F", + "auth_pos": 2, + "meshterms": "Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug, Humans, Female, Male, Aged, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/drug therapy, Middle Aged, Aldehyde Reductase*, Aldehyde Reductase/antagonists & inhibitors, Double-Blind Method, Exercise Test, Oxygen Consumption, Oxygen Consumption/drug effects, Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Exercise Tolerance, Exercise Tolerance/drug effects, Enzyme Inhibitors, Enzyme Inhibitors/therapeutic use, Dose-Response Relationship, Drug", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1208, + "user_id": 1639100928, + "artical_title": "Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.", + "pmid": 38960514, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-04", + "author": "Hahn RT,Lindenfeld J,Böhm M,Edelmann F,Lund LH,Lurz P,Metra M,Tedford RJ,Butler J,Borlaug BA", + "auth_pos": 9, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1209, + "user_id": 1639100928, + "artical_title": "Redefining Iron Deficiency in Patients With Chronic Heart Failure.", + "pmid": 38733252, + "journal_name": "Circulation", + "date": "2024-07-08", + "author": "Packer M,Anker SD,Butler J,Cleland JGF,Kalra PR,Mentz RJ,Ponikowski P,Talha KM", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood, Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood, Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood, Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood, Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood, Humans, Heart Failure*, Heart Failure/blood, Ferritins*, Ferritins/blood, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/diagnosis, Anemia, Iron-Deficiency/drug therapy, Anemia, Iron-Deficiency/blood, Chronic Disease, Iron Deficiencies, Iron, Iron/metabolism, Iron/blood", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1210, + "user_id": 1639100928, + "artical_title": "Identification of three mechanistic pathways for iron-deficient heart failure.", + "pmid": 38733250, + "journal_name": "European heart journal", + "date": "2024-07-09", + "author": "Packer M,Anker SD,Butler J,Cleland JGF,Kalra PR,Mentz RJ,Ponikowski P", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism, Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism, Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism, Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism, Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism, Humans, Heart Failure*, Heart Failure/metabolism, Heart Failure/physiopathology, Iron*, Iron/metabolism, Myocytes, Cardiac*, Myocytes, Cardiac/metabolism, Muscle, Skeletal*, Muscle, Skeletal/metabolism, Anemia, Iron-Deficiency*, Anemia, Iron-Deficiency/metabolism, Myocardium, Myocardium/metabolism, Iron Deficiencies, Erythropoiesis, Erythropoiesis/physiology, Erythroblasts, Erythroblasts/metabolism", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1211, + "user_id": 1639100928, + "artical_title": "GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?", + "pmid": 38809399, + "journal_name": "Current atherosclerosis reports", + "date": "2024-07-10", + "author": "Hayat J,Shah NP,Agarwala A,Khan MS,Butler J", + "auth_pos": 5, + "meshterms": "Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Humans, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1212, + "user_id": 1639100928, + "artical_title": "Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure.", + "pmid": 38809567, + "journal_name": "JAMA cardiology", + "date": "2024-07-10", + "author": "Ostrominski JW,Greene SJ,Patel RB,Solomon NC,Chiswell K,DeVore AD,Butler J,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,Linganathan KK,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Fonarow GC,Vaduganathan M", + "auth_pos": 7, + "meshterms": "Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries, Humans, Heart Failure*, Heart Failure/therapy, Heart Failure/epidemiology, Male, Female, United States, United States/epidemiology, Aged, Hospitalization*, Hospitalization/statistics & numerical data, Medicare*, Retrospective Studies, Aged, 80 and over, Glomerular Filtration Rate*, Acute Kidney Injury*, Acute Kidney Injury/therapy, Acute Kidney Injury/epidemiology, Renal Dialysis, Renal Dialysis/statistics & numerical data, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1213, + "user_id": 1639100928, + "artical_title": "Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.", + "pmid": 38986667, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-11", + "author": "Lopez J,Liu Y,Butler J,Del Prato S,Ezekowitz JA,Lam CSP,Marwick TH,Rosenstock J,Tang WHW,Perfetti R,Urbinati A,Zannad F,Januzzi JL,Ibrahim NE", + "auth_pos": 3, + "meshterms": "Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy, Humans, Female, Male, Diabetic Cardiomyopathies*, Diabetic Cardiomyopathies/ethnology, Diabetic Cardiomyopathies/epidemiology, Aged, Middle Aged, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/ethnology, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Exercise Tolerance, Exercise Tolerance/physiology, Hispanic or Latino, Hispanic or Latino/statistics & numerical data, Echocardiography, Exercise Test, Heart Failure, Heart Failure/ethnology, Heart Failure/physiopathology, Heart Failure/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1214, + "user_id": 1639100928, + "artical_title": "Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does Not Enhance Decongestion.", + "pmid": 38986838, + "journal_name": "Journal of cardiac failure", + "date": "2024-07-11", + "author": "Natov PS,Ivey-Miranda JB,Cox ZL,Rao VS,Butler J,Konstam MA,Kiernan MS,Kapur NK,Testani JM", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1215, + "user_id": 1639100928, + "artical_title": "Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program.", + "pmid": 38913004, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-11", + "author": "Schou M,Petrie MC,Borlaug BA,Butler J,Davies MJ,Kitzman DW,Shah SJ,Verma S,Patel S,Chinnakondepalli KM,Harring S,Abildstrøm SZ,Liisberg K,Kosiborod MN", + "auth_pos": 4, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Glucagon-Like Peptides*, Glucagon-Like Peptides/therapeutic use, Stroke Volume*, Stroke Volume/drug effects, Stroke Volume/physiology, Male, Female, Obesity*, Obesity/complications, Obesity/drug therapy, Aged, Double-Blind Method, Middle Aged, Treatment Outcome, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1216, + "user_id": 1639100928, + "artical_title": "Body Mass Index Distribution Among Patients with Heart Failure and Reduced Ejection Fraction: Implication for Future Trials.", + "pmid": 38636936, + "journal_name": "Journal of cardiac failure", + "date": "2024-07-12", + "author": "Butler J,Nair A,Shahzeb Khan M", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods, Humans, Heart Failure*, Heart Failure/physiopathology, Stroke Volume*, Stroke Volume/physiology, Body Mass Index*, Female, Male, Aged, Middle Aged, Clinical Trials as Topic, Clinical Trials as Topic/methods", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1217, + "user_id": 1639100928, + "artical_title": "Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries.", + "pmid": 38632048, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2024-07-16", + "author": "Wallner M,Biber ME,Stolfo D,Sinagra G,Benson L,Dahlström U,Gudbjörnsdottir S,Cosentino F,Mol PGM,Rosano GMC,Butler J,Metra M,Lund LH,Ferrannini G,Savarese G", + "auth_pos": 11, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Sweden, Sweden/epidemiology, Heart Failure*, Heart Failure/mortality, Heart Failure/epidemiology, Heart Failure/diagnosis, Registries*, Male, Female, Aged, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Incretins*, Incretins/adverse effects, Incretins/therapeutic use, Treatment Outcome, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Middle Aged, Risk Factors, Risk Assessment, Time Factors, Aged, 80 and over, Blood Glucose, Blood Glucose/drug effects, Blood Glucose/metabolism, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/mortality, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/complications, Sweden, Sweden/epidemiology, Heart Failure*, Heart Failure/mortality, Heart Failure/epidemiology, Heart Failure/diagnosis, Registries*, Male, Female, Aged, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Incretins*, Incretins/adverse effects, Incretins/therapeutic use, Treatment Outcome, Hypoglycemic Agents*, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Middle Aged, Risk Factors, Risk Assessment, Time Factors, Aged, 80 and over, Blood Glucose, Blood Glucose/drug effects, Blood Glucose/metabolism", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1218, + "user_id": 1639100928, + "artical_title": "Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF Registry.", + "pmid": 39045701, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2024-07-24", + "author": "El-Zein RS,Mohammed M,Nguyen DD,Hill CL,Thomas L,Nassif M,DeVore AD,Albert NM,Butler J,Patterson JH,Williams FB,Hernandez A,Fonarow GC,Spertus JA", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1219, + "user_id": 1639100928, + "artical_title": "Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials.", + "pmid": 38991584, + "journal_name": "The lancet. Diabetes & endocrinology", + "date": "2024-07-26", + "author": "Apperloo EM,Neuen BL,Fletcher RA,Jongs N,Anker SD,Bhatt DL,Butler J,Cherney DZI,Herrington WG,Inzucchi SE,Jardine MJ,Liu CC,Mahaffey KW,McGuire DK,McMurray JJV,Neal B,Packer M,Perkovic V,Sabatine MS,Solomon SD,Staplin N,Szarek M,Vaduganathan M,Wanner C,Wheeler DC,Wiviott SD,Zannad F,Heerspink HJL", + "auth_pos": 7, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Randomized Controlled Trials as Topic*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/epidemiology, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Hypoglycemic Agents/adverse effects, Treatment Outcome, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1220, + "user_id": 1639100928, + "artical_title": "Global hypokinesis in resting transthoracic echocardiography diagnosis of heart failure and coronary artery disease.", + "pmid": 39052513, + "journal_name": "The Journal of invasive cardiology", + "date": "2024-07-26", + "author": "Hatfield J,Woods MD,Hammonds K,Wahab L,Nguyen V,Hassan OA,Butler J,Widmer RJ", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1221, + "user_id": 1639100928, + "artical_title": "Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.", + "pmid": 38847420, + "journal_name": "European journal of heart failure", + "date": "2024-07-26", + "author": "Anker SD,Friede T,von Bardeleben RS,Butler J,Khan MS,Diek M,Heinrich J,Geyer M,Placzek M,Ferrari R,Abraham WT,Alfieri O,Auricchio A,Bayes-Genis A,Cleland JGF,Filippatos G,Gustafsson F,Haverkamp W,Kelm M,Kuck KH,Landmesser U,Maggioni AP,Metra M,Ninios V,Petrie MC,Rassaf T,Ruschitzka F,Schäfer U,Schulze PC,Spargias K,Vahanian A,Zamorano JL,Zeiher A,Karakas M,Koehler F,Lainscak M,Öner A,Mezilis N,Theofilogiannakos EK,Ninios I,Chrissoheris M,Kourkoveli P,Papadopoulos K,Smolka G,Wojakowski W,Reczuch K,Pinto FJ,Zmudka K,Kalarus Z,Adamo M,Santiago-Vacas E,Ruf TF,Gross M,Tongers J,Hasenfuß G,Schillinger W,Ponikowski P", + "auth_pos": 4, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/complications, Female, Male, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Heart Failure/complications, Aged, Severity of Illness Index*, Prospective Studies, Stroke Volume*, Stroke Volume/physiology, Treatment Outcome, Middle Aged, Peptide Fragments, Peptide Fragments/blood, Mitral Valve, Mitral Valve/surgery, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Ventricular Function, Left, Ventricular Function, Left/physiology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1222, + "user_id": 1639100928, + "artical_title": "Treatment patterns of patients with worsening heart failure with reduced ejection fraction.", + "pmid": 38639469, + "journal_name": "ESC heart failure", + "date": "2024-07-30", + "author": "Greene SJ,Gaggin HK,Zhou M,Bash LD,Lautsch D,Djatche L,Song Y,Signorovitch J,Stevenson AS,Blaustein RO,Butler J", + "auth_pos": 11, + "meshterms": "Humans, Stroke Volume*, Stroke Volume/physiology, Male, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Retrospective Studies, Disease Progression*, Aged, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Follow-Up Studies, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Middle Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume*, Stroke Volume/physiology, Male, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Retrospective Studies, Disease Progression*, Aged, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Follow-Up Studies, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Middle Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Humans, Stroke Volume*, Stroke Volume/physiology, Male, Female, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Retrospective Studies, Disease Progression*, Aged, Adrenergic beta-Antagonists, Adrenergic beta-Antagonists/therapeutic use, Follow-Up Studies, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Middle Aged, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1223, + "user_id": 1639100928, + "artical_title": "A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.", + "pmid": 39084827, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-08-01", + "author": "Hummel J,Houmsse M,Tomassoni G,Nair D,Romero J,Hargrove J,Mathews K,Thakkar AB,Ullery S,Eapen ZJ,Kumar UN,Mehran R,Butler J", + "auth_pos": 13, + "meshterms": "Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance, Humans, Death, Sudden, Cardiac*, Death, Sudden, Cardiac/prevention & control, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Male, Middle Aged, Prospective Studies, Wearable Electronic Devices*, Defibrillators*, Aged, Tachycardia, Ventricular, Tachycardia, Ventricular/therapy, Ventricular Fibrillation, Ventricular Fibrillation/therapy, Equipment Design, Adult, Patient Compliance", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1224, + "user_id": 1639100928, + "artical_title": "Individualized Risk for CKD Progression among US Adults.", + "pmid": 38749547, + "journal_name": "Journal of the American Society of Nephrology : JASN", + "date": "2024-08-01", + "author": "Tio MC,Butler J,Zhu X,Obi Y,Yen TE,Kalantar-Zadeh K,Streja E,Dossabhoy NR,Hall ME,Shafi T", + "auth_pos": 2, + "meshterms": "Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate, Humans, Disease Progression*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, United States, United States/epidemiology, Adult, Risk Assessment, Risk Factors, Glomerular Filtration Rate", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1225, + "user_id": 1639100928, + "artical_title": "Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.", + "pmid": 39095808, + "journal_name": "Cardiovascular diabetology", + "date": "2024-08-03", + "author": "Gouda P,Liu Y,Butler J,Del Prato S,Ibrahim NE,Lam CSP,Marwick T,Rosenstock J,Tang W,Zannad F,Januzzi J,Ezekowitz J", + "auth_pos": 3, + "meshterms": "Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method, Humans, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Peptide Fragments*, Peptide Fragments/blood, Male, Female, Biomarkers*, Biomarkers/blood, Middle Aged, Aged, Ventricular Function, Left*, Predictive Value of Tests*, Exercise Tolerance*, Asymptomatic Diseases*, Functional Status, Diabetic Cardiomyopathies, Diabetic Cardiomyopathies/physiopathology, Diabetic Cardiomyopathies/diagnostic imaging, Diabetic Cardiomyopathies/blood, Diabetic Cardiomyopathies/etiology, Double-Blind Method", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1226, + "user_id": 1639100928, + "artical_title": "Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core Principles.", + "pmid": 39102475, + "journal_name": "Circulation", + "date": "2024-08-05", + "author": "Greene SJ,Butler J,Fonarow GC", + "auth_pos": 2, + "meshterms": "Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Practice Guidelines as Topic*, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Practice Guidelines as Topic*, Humans, Heart Failure*, Heart Failure/drug therapy, Heart Failure/therapy, Practice Guidelines as Topic*", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1227, + "user_id": 1639100928, + "artical_title": "Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction.", + "pmid": 39115518, + "journal_name": "JACC. Heart failure", + "date": "2024-08-08", + "author": "Rao VN,Hellkamp AS,Thomas LE,Fonarow GC,Fiuzat M,O'Connor CM,Spertus JA,Desai AS,Albert NM,Butler J,Hernandez AF,DeVore AD", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1228, + "user_id": 1639100928, + "artical_title": "Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?", + "pmid": 39115523, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-08-08", + "author": "Neves JS,Zannad F,Butler J,Packer M,Ferreira JP", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1229, + "user_id": 1639100928, + "artical_title": "Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy.", + "pmid": 38727651, + "journal_name": "JACC. Heart failure", + "date": "2024-08-08", + "author": "Kittipibul V,Vaduganathan M,Ikeaba U,Chiswell K,Butler J,DeVore AD,Heidenreich PA,Huang JC,Kittleson MM,Joynt Maddox KE,Linganathan KK,McDermott JJ,Owens AT,Peterson PN,Solomon SD,Vardeny O,Yancy CW,Fonarow GC,Greene SJ", + "auth_pos": 5, + "meshterms": "Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries, Humans, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/economics, Heart Failure*, Heart Failure/economics, Heart Failure/therapy, Heart Failure/drug therapy, Hospitalization*, Hospitalization/economics, Aged, Female, Male, United States, Health Care Costs*, Health Care Costs/statistics & numerical data, Medicare*, Medicare/economics, Stroke Volume, Stroke Volume/physiology, Aged, 80 and over, Registries", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1230, + "user_id": 1639100928, + "artical_title": "Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey.", + "pmid": 39118004, + "journal_name": "BMC primary care", + "date": "2024-08-09", + "author": "Campos C,Magwire M,Butler J,Hoovler A,Sabharwal A,Shah SJ", + "auth_pos": 3, + "meshterms": "Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Obesity*, Obesity/epidemiology, Obesity/therapy, Obesity/diagnosis, Male, Female, Stroke Volume*, Stroke Volume/physiology, Middle Aged, Aged, Physicians, Primary Care, Internet, Surveys and Questionnaires, Adult, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Obesity*, Obesity/epidemiology, Obesity/therapy, Obesity/diagnosis, Male, Female, Stroke Volume*, Stroke Volume/physiology, Middle Aged, Aged, Physicians, Primary Care, Internet, Surveys and Questionnaires, Adult, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Obesity*, Obesity/epidemiology, Obesity/therapy, Obesity/diagnosis, Male, Female, Stroke Volume*, Stroke Volume/physiology, Middle Aged, Aged, Physicians, Primary Care, Internet, Surveys and Questionnaires, Adult, Humans, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/epidemiology, Heart Failure/physiopathology, Obesity*, Obesity/epidemiology, Obesity/therapy, Obesity/diagnosis, Male, Female, Stroke Volume*, Stroke Volume/physiology, Middle Aged, Aged, Physicians, Primary Care, Internet, Surveys and Questionnaires, Adult", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1231, + "user_id": 1639100928, + "artical_title": "Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study.", + "pmid": 39119707, + "journal_name": "Circulation. Heart failure", + "date": "2024-08-09", + "author": "Hamid A,Yimer WK,Oshunbade AA,Khan MS,Kamimura D,Kipchumba RK,Pandey A,Clark Iii D,Mentz RJ,Fox ER,Berry JD,Stacey RB,Shah A,Correa A,Virani SS,Butler J,Hall ME", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1232, + "user_id": 1639100928, + "artical_title": "Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.", + "pmid": 39142723, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-08-15", + "author": "Edmonston D,Mulder H,Lydon E,Chiswell K,Lampron Z,Shay C,Marsolo K,Shah RC,Jones WS,Gordon H,Hwang W,Ayoub I,Ford D,Chamberlain A,Rao A,Fonseca V,Chang A,Ahmad F,Hung A,Hunt K,Butler J,Bosworth HB,Pagidipati N", + "auth_pos": 21, + "meshterms": "Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists, Humans, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors*, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Male, Female, Glucagon-Like Peptide-1 Receptor*, Glucagon-Like Peptide-1 Receptor/agonists, Middle Aged, Aged, Glomerular Filtration Rate*, Glomerular Filtration Rate/drug effects, Cardiovascular Diseases, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Kidney Failure, Chronic, Glucagon-Like Peptide-1 Receptor Agonists", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1233, + "user_id": 1639100928, + "artical_title": "Estimating the Proportion of Heart Failure Admissions Potentially Eligible for Hospital at Home.", + "pmid": 38588859, + "journal_name": "Journal of cardiac failure", + "date": "2024-08-16", + "author": "Haywood HB,Graham AJ,Chermak D,Achanta A,Butler J,Fonarow GC,Greene SJ", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Home Care Services, Hospital-Based, Aged, 80 and over, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Home Care Services, Hospital-Based, Aged, 80 and over, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Home Care Services, Hospital-Based, Aged, 80 and over, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Home Care Services, Hospital-Based, Aged, 80 and over, Humans, Heart Failure*, Heart Failure/epidemiology, Heart Failure/therapy, Male, Female, Aged, Hospitalization, Hospitalization/statistics & numerical data, Patient Admission, Patient Admission/trends, Patient Admission/statistics & numerical data, Home Care Services, Hospital-Based, Aged, 80 and over", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1234, + "user_id": 1639100928, + "artical_title": "Role of anti-obesity drugs in heart failure regardless of ejection fraction.", + "pmid": 38752355, + "journal_name": "European journal of heart failure", + "date": "2024-08-19", + "author": "Butler J,Arshad MS,Khan MS", + "auth_pos": 1, + "meshterms": "Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology, Humans, Stroke Volume*, Stroke Volume/physiology, Heart Failure*, Heart Failure/drug therapy, Heart Failure/physiopathology, Anti-Obesity Agents*, Anti-Obesity Agents/therapeutic use, Anti-Obesity Agents/pharmacology, Obesity, Obesity/complications, Obesity/physiopathology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1235, + "user_id": 1639100928, + "artical_title": "Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials.", + "pmid": 38795231, + "journal_name": "Current heart failure reports", + "date": "2024-08-19", + "author": "Hamid A,Greene SJ,Mehta A,Butler J,Khan MS", + "auth_pos": 4, + "meshterms": "Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology, Humans, Glomerular Filtration Rate*, Glomerular Filtration Rate/physiology, Heart Failure*, Heart Failure/physiopathology, Clinical Trials as Topic*, Clinical Trials as Topic/methods, Kidney Failure, Chronic, Kidney Failure, Chronic/physiopathology, Kidney Failure, Chronic/therapy, Biomarkers, Disease Progression, Endpoint Determination, Cardiovascular Diseases, Cardiovascular Diseases/physiopathology", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1236, + "user_id": 1639100928, + "artical_title": "Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.", + "pmid": 39159624, + "journal_name": "American journal of nephrology", + "date": "2024-08-20", + "author": "Weir MR,Rossignol P,Pitt B,Lund LH,Coats AJS,Filippatos G,Perrin A,Waechter S,Budden J,Kosiborod M,Metra M,Boehm M,Ezekowitz JA,Bayes-Genis A,Mentz RJ,Ponikowski P,Senni M,Castro-Montes E,Nicolau JC,Parkhomenko A,Seferovic P,Cohen-Solal A,Anker SD,Butler J", + "auth_pos": 24, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Javed Butler" + }, + { + "id": 1237, + "user_id": 1811967433, + "artical_title": "Prognostic value of age adjusted segment involvement score as measured by coronary computed tomography: a potential marker of vascular age.", + "pmid": 29797058, + "journal_name": "Heart and vessels", + "date": "2019-01-03", + "author": "Ayoub C,Kritharides L,Yam Y,Chen L,Hossain A,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Cury RC,Delago A,Dunning A,Feuchtner G,Gomez M,Gransar H,Hadamitzky M,Hausleiter J,Hindoyan N,Kaufmann PA,Kim YJ,Leipsic J,Maffei E,Marques H,Pontone G,Raff G,Rubinshtein R,Shaw LJ,Villines TC,Min JK,Chow BJW", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1238, + "user_id": 1811967433, + "artical_title": "Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 30600075, + "journal_name": "Atherosclerosis", + "date": "2019-01-03", + "author": "Zhao Y,Evans MA,Allison MA,Bertoni AG,Budoff MJ,Criqui MH,Malik S,Ouyang P,Polak JF,Wong ND", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies, Aged, Aged, 80 and over, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/epidemiology*, Calcium, Calcium/blood, Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology*, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Diabetes Complications, Diabetes Complications/epidemiology*, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Female, Humans, Male, Metabolic Syndrome, Metabolic Syndrome/complications*, Metabolic Syndrome/epidemiology*, Middle Aged, Prognosis, Proportional Hazards Models, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1239, + "user_id": 1811967433, + "artical_title": "Risk of peripheral artery disease in human immunodeficiency virus infected individuals.", + "pmid": 30613621, + "journal_name": "Annals of translational medicine", + "date": "2019-01-08", + "author": "Belgrave K,Shaikh K,Budoff MJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1240, + "user_id": 1811967433, + "artical_title": "Incidence and Progression of Coronary Artery Calcium in South Asians Compared With 4 Race/Ethnic Groups.", + "pmid": 30630376, + "journal_name": "Journal of the American Heart Association", + "date": "2019-01-12", + "author": "Kanaya AM,Vittinghoff E,Lin F,Kandula NR,Herrington D,Liu K,Blaha M,Budoff MJ", + "auth_pos": 8, + "meshterms": "Adult, Aged, Aged, 80 and over, Asia, Asia/ethnology, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Ethnicity*, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prevalence, Prospective Studies, Racial Groups*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/etiology*, Vascular Calcification/metabolism, Adult, Aged, Aged, 80 and over, Asia, Asia/ethnology, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Ethnicity*, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prevalence, Prospective Studies, Racial Groups*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/etiology*, Vascular Calcification/metabolism, Adult, Aged, Aged, 80 and over, Asia, Asia/ethnology, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Ethnicity*, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prevalence, Prospective Studies, Racial Groups*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/etiology*, Vascular Calcification/metabolism, Adult, Aged, Aged, 80 and over, Asia, Asia/ethnology, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Ethnicity*, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prevalence, Prospective Studies, Racial Groups*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/etiology*, Vascular Calcification/metabolism, Adult, Aged, Aged, 80 and over, Asia, Asia/ethnology, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Ethnicity*, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prevalence, Prospective Studies, Racial Groups*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/etiology*, Vascular Calcification/metabolism", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1241, + "user_id": 1811967433, + "artical_title": "Effect of statins on atherosclerotic plaque.", + "pmid": 30642643, + "journal_name": "Trends in cardiovascular medicine", + "date": "2019-01-16", + "author": "Almeida SO,Budoff M", + "auth_pos": 2, + "meshterms": "Animals, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/mortality, Coronary Artery Disease/pathology, Disease Progression, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/drug therapy*, Dyslipidemias/mortality, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipids, Lipids/blood*, Plaque, Atherosclerotic*, Risk Assessment, Risk Factors, Rupture, Spontaneous, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1242, + "user_id": 1811967433, + "artical_title": "The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET Registry.", + "pmid": 30653377, + "journal_name": "Journal of women's health (2002)", + "date": "2019-01-18", + "author": "Gul B,Lansky A,Budoff MJ,Sharp D,Maniet B,Herman L,Kuo JZ,Huang L,Monane M,Ladapo JA", + "auth_pos": 3, + "meshterms": "Adult, Aged, Aged, 80 and over, Clinical Decision-Making, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/genetics, Female, Follow-Up Studies, Gene Expression Profiling, Gene Expression Profiling/methods*, Hematologic Tests, Hematologic Tests/methods, Humans, Middle Aged, Precision Medicine, Precision Medicine/methods*, Prospective Studies, Registries, Sex Characteristics, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1243, + "user_id": 1811967433, + "artical_title": "Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography.", + "pmid": 30657884, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-01-19", + "author": "Won KB,Lee SE,Lee BK,Park HB,Heo R,Rizvi A,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,Leipsic JA,Shin S,Choi JH,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Chang HJ", + "auth_pos": 13, + "meshterms": "Aged, Body Mass Index*, Computed Tomography Angiography*, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Longitudinal Studies, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Radiographic Image Interpretation, Computer-Assisted, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1244, + "user_id": 1811967433, + "artical_title": "Superior Risk Stratification With Coronary Computed Tomography Angiography Using a Comprehensive Atherosclerotic Risk Score.", + "pmid": 30660516, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-21", + "author": "van Rosendael AR,Shaw LJ,Xie JX,Dimitriu-Leen AC,Smit JM,Scholte AJ,van Werkhoven JM,Callister TQ,DeLago A,Berman DS,Hadamitzky M,Hausleiter J,Al-Mallah MH,Budoff MJ,Kaufmann PA,Raff G,Chinnaiyan K,Cademartiri F,Maffei E,Villines TC,Kim YJ,Feuchtner G,Lin FY,Jones EC,Pontone G,Andreini D,Marques H,Rubinshtein R,Achenbach S,Dunning A,Gomez M,Hindoyan N,Gransar H,Leipsic J,Narula J,Min JK,Bax JJ", + "auth_pos": 14, + "meshterms": "Adult, Aged, Computed Tomography Angiography*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Coronary Stenosis, Coronary Stenosis/complications, Coronary Stenosis/diagnostic imaging*, Coronary Stenosis/mortality, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Myocardial Infarction, Myocardial Infarction/etiology, Myocardial Infarction/mortality, Plaque, Atherosclerotic, Predictive Value of Tests, Progression-Free Survival, Reproducibility of Results, Risk Assessment, Risk Factors, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1245, + "user_id": 1811967433, + "artical_title": "Associations between lipids and subclinical coronary atherosclerosis.", + "pmid": 30664005, + "journal_name": "AIDS (London, England)", + "date": "2019-01-22", + "author": "Whelton SP,Deal JA,Zikusoka M,Jacobson LP,Sarkar S,Palella FJ,Kingsley L,Budoff M,Witt MD,Brown TT,Post WS", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1246, + "user_id": 1811967433, + "artical_title": "Comparison of Whole Heart Computed Tomography Scanners for Image Quality Lower Radiation Dosing in Coronary Computed Tomography Angiography: The CONVERGE Registry.", + "pmid": 30683612, + "journal_name": "Academic radiology", + "date": "2019-01-27", + "author": "Patel N,Li D,Nakanishi R,Fatima B,Andreini D,Pontone G,Conte E,O'Rourke R,Jayawardena E,Hamilton-Craig C,Nimmagadda M,Budoff MJ", + "auth_pos": 12, + "meshterms": "Artifacts*, Computed Tomography Angiography, Computed Tomography Angiography/instrumentation*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Radiation Dosage, Radiation Exposure, Radiation Exposure/prevention & control*, Registries*, Tomography Scanners, X-Ray Computed*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1247, + "user_id": 1811967433, + "artical_title": "A case of isolated right coronary ostial atresia.", + "pmid": 30702506, + "journal_name": "Coronary artery disease", + "date": "2019-02-01", + "author": "Shekar C,Cherukuri L,Dailing C,Budoff MJ,Roy SK", + "auth_pos": 4, + "meshterms": "Computed Tomography Angiography*, Coronary Angiography*, Coronary Vessel Anomalies, Coronary Vessel Anomalies/diagnostic imaging*, Humans, Male, Middle Aged, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1248, + "user_id": 1811967433, + "artical_title": "The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 30716566, + "journal_name": "Atherosclerosis", + "date": "2019-02-05", + "author": "Ezeigwe A,Fashanu OE,Zhao D,Budoff MJ,Otvos JD,Thomas IC,Mora S,Tibuakuu M,Michos ED", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*, Aged, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/pathology*, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnosis, Biomarkers, Biomarkers/blood*, Cross-Sectional Studies, Disease Progression, Female, Follow-Up Studies, Glycosylation, Heart Valves, Heart Valves/pathology*, Humans, Inflammation, Linear Models, Male, Middle Aged, Poisson Distribution, Prevalence, Risk Factors, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/pathology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1249, + "user_id": 1811967433, + "artical_title": "A cross-sectional survey of coronary plaque composition in individuals on non-statin lipid lowering drug therapies and undergoing coronary computed tomography angiography.", + "pmid": 30745132, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-02-13", + "author": "Al'Aref SJ,Su A,Gransar H,van Rosendael AR,Rizvi A,Berman DS,Callister TQ,DeLago A,Hadamitzky M,Hausleiter J,Al-Mallah MH,Budoff MJ,Kaufmann PA,Raff GL,Chinnaiyan K,Cademartiri F,Maffei E,Villines TC,Kim YJ,Leipsic J,Feuchtner G,Pontone G,Andreini D,Marques H,de Araújo Gonçalves P,Rubinshtein R,Achenbach S,Chang HJ,Chow BJW,Cury R,Lu Y,Bax JJ,Jones EC,Peña JM,Shaw LJ,Min JK,Lin FY", + "auth_pos": 12, + "meshterms": "Aged, Asia, Asia/epidemiology, Biomarkers, Biomarkers/blood, Computed Tomography Angiography*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/pathology, Coronary Artery Disease/prevention & control, Coronary Stenosis, Coronary Stenosis/diagnostic imaging*, Coronary Stenosis/epidemiology, Coronary Stenosis/pathology, Coronary Stenosis/prevention & control, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/pathology, Cross-Sectional Studies, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Dyslipidemias/epidemiology, Europe, Europe/epidemiology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypolipidemic Agents, Hypolipidemic Agents/therapeutic use*, Lipids, Lipids/blood*, Male, Middle Aged, North America, North America/epidemiology, Plaque, Atherosclerotic*, Predictive Value of Tests, Prevalence, Registries, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1250, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Progression Among the US and Japanese Men.", + "pmid": 30755051, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2019-02-14", + "author": "Hisamatsu T,Liu K,Chan C,Krefman AE,Fujiyoshi A,Budoff MJ,Miura K,Lloyd-Jones DM,Ueshima H", + "auth_pos": 6, + "meshterms": "African Americans, Aged, Asian Americans, Computed Tomography Angiography, Continental Population Groups*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Disease Progression, European Continental Ancestry Group, Health Status Disparities*, Hispanic Americans, Humans, Incidence, Japan, Japan/epidemiology, Longitudinal Studies, Male, Middle Aged, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1251, + "user_id": 1811967433, + "artical_title": "Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study.", + "pmid": 30768487, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2019-02-16", + "author": "Polanka BM,Kundu S,So-Armah KA,Freiberg MS,Gupta SK,Bedimo RJ,Budoff MJ,Butt AA,Chang CH,Gottlieb SS,Marconi VC,Womack JA,Stewart JC", + "auth_pos": 7, + "meshterms": "Adult, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Female, HIV Infections, HIV Infections/complications*, Humans, Male, Middle Aged, Risk Factors, Sleep Initiation and Maintenance Disorders, Sleep Initiation and Maintenance Disorders/complications*, United States, Veterans, Veterans/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1252, + "user_id": 1811967433, + "artical_title": "Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study.", + "pmid": 30789215, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-02-23", + "author": "Lee SE,Sung JM,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Kumar A,Lee BK,Leipsic JA,Maffei E,Marques H,Pontone G,Raff G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 4, + "meshterms": "Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/chemically induced*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/chemically induced*, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Prospective Studies, Registries, Vascular Calcification, Vascular Calcification/chemically induced*, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1253, + "user_id": 1811967433, + "artical_title": "Double chambered right ventricle diagnosed on cardiac CTA: A case series.", + "pmid": 30850276, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-03-10", + "author": "Shaikh K,Jayawerdena E,Budoff M,Pillutla P", + "auth_pos": 3, + "meshterms": "Adult, Cardiac Surgical Procedures, Computed Tomography Angiography*, Coronary Angiography*, Female, Heart Septal Defects, Ventricular, Heart Septal Defects, Ventricular/diagnostic imaging*, Heart Septal Defects, Ventricular/physiopathology, Heart Septal Defects, Ventricular/surgery, Heart Ventricles, Heart Ventricles/abnormalities, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Heart Ventricles/surgery, Humans, Male, Middle Aged, Predictive Value of Tests, Ventricular Outflow Obstruction, Ventricular Outflow Obstruction/diagnostic imaging*, Ventricular Outflow Obstruction/etiology, Ventricular Outflow Obstruction/physiopathology, Ventricular Outflow Obstruction/surgery", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1254, + "user_id": 1811967433, + "artical_title": "The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.", + "pmid": 30878435, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-18", + "author": "Budoff M,Backlund JC,Bluemke DA,Polak J,Bebu I,Schade D,Strowig S,Raskin P,Lachin JM", + "auth_pos": 1, + "meshterms": "Adolescent, Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Predictive Value of Tests, Prognosis, Risk Factors, Time Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Young Adult, Adolescent, Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Predictive Value of Tests, Prognosis, Risk Factors, Time Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Young Adult, Adolescent, Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Predictive Value of Tests, Prognosis, Risk Factors, Time Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Young Adult, Adolescent, Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Predictive Value of Tests, Prognosis, Risk Factors, Time Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Young Adult, Adolescent, Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/diagnosis, Diabetes Mellitus, Type 1/epidemiology*, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Predictive Value of Tests, Prognosis, Risk Factors, Time Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1255, + "user_id": 1811967433, + "artical_title": "Role of Coronary Artery Calcium for Stratifying Cardiovascular Risk in Adults With Hypertension.", + "pmid": 30879359, + "journal_name": "Hypertension (Dallas, Tex. : 1979)", + "date": "2019-03-19", + "author": "Uddin SMI,Mirbolouk M,Kianoush S,Orimoloye OA,Dardari Z,Whelton SP,Miedema MD,Nasir K,Rumberger JA,Shaw LJ,Berman DS,Budoff MJ,McEvoy JW,Matsushita K,Blaha MJ,Graham G", + "auth_pos": 12, + "meshterms": "Aged, Blood Pressure, Blood Pressure/physiology*, Calcinosis, Calcinosis/diagnosis*, Calcinosis/epidemiology, Calcinosis/metabolism, Calcium, Calcium/metabolism*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Female, Follow-Up Studies, Humans, Hypertension, Hypertension/complications*, Hypertension/epidemiology, Hypertension/physiopathology, Incidence, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Survival Rate, Survival Rate/trends, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1256, + "user_id": 1811967433, + "artical_title": "Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study.", + "pmid": 30924577, + "journal_name": "HIV medicine", + "date": "2019-03-30", + "author": "So-Armah K,Gupta SK,Kundu S,Stewart JC,Goulet JL,Butt AA,Sico JJ,Marconi VC,Crystal S,Rodriguez-Barradas MC,Budoff M,Gibert CL,Chang CC,Bedimo R,Freiberg MS", + "auth_pos": 11, + "meshterms": "Adult, Case-Control Studies, Depressive Disorder, Major, Depressive Disorder, Major/epidemiology*, Female, HIV Infections, HIV Infections/mortality*, HIV Infections/psychology, Humans, Longitudinal Studies, Male, Middle Aged, Mortality, Prospective Studies, United States, United States/epidemiology, Veterans, Veterans/psychology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1257, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium scoring in low risk patients with family history of coronary heart disease: Validation of the SCCT guideline approach in the coronary artery calcium consortium.", + "pmid": 30935842, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-04-03", + "author": "Dudum R,Dzaye O,Mirbolouk M,Dardari ZA,Orimoloye OA,Budoff MJ,Berman DS,Rozanski A,Miedema MD,Nasir K,Rumberger JA,Shaw L,Whelton SP,Graham G,Blaha MJ", + "auth_pos": 6, + "meshterms": "Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy, Adult, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/genetics, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Databases, Factual, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Pedigree, Phenotype, Practice Guidelines as Topic, Practice Guidelines as Topic/standards*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/genetics, Vascular Calcification/mortality, Vascular Calcification/therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1258, + "user_id": 1811967433, + "artical_title": "The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?", + "pmid": 30939537, + "journal_name": "Menopause (New York, N.Y.)", + "date": "2019-04-03", + "author": "", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1259, + "user_id": 1811967433, + "artical_title": "Associations between lipids and subclinical coronary atherosclerosis.", + "pmid": 30946159, + "journal_name": "AIDS (London, England)", + "date": "2019-04-05", + "author": "Whelton SP,Deal JA,Zikusoka M,Jacobson LP,Sarkar S,Palella FJ,Kingsley L,Budoff M,Witt MD,Brown TT,Post WS", + "auth_pos": 8, + "meshterms": "Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed, Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed, Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed, Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed, Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed, Adult, Asymptomatic Diseases*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, HIV Infections, HIV Infections/complications*, Humans, Lipids, Lipids/blood*, Male, Middle Aged, Prevalence, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1260, + "user_id": 1811967433, + "artical_title": "Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): Dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium.", + "pmid": 30952612, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-04-07", + "author": "Dzaye O,Dudum R,Mirbolouk M,Orimoloye OA,Osei AD,Dardari ZA,Berman DS,Miedema MD,Shaw L,Rozanski A,Holdhoff M,Nasir K,Rumberger JA,Budoff MJ,Al-Mallah MH,Blankstein R,Blaha MJ", + "auth_pos": 14, + "meshterms": "Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Databases, Factual, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Radiology Information Systems*, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1261, + "user_id": 1811967433, + "artical_title": "The association between left main coronary artery calcium and cardiovascular-specific and total mortality: The Coronary Artery Calcium Consortium.", + "pmid": 30954247, + "journal_name": "Atherosclerosis", + "date": "2019-04-08", + "author": "Lahti SJ,Feldman DI,Dardari Z,Mirbolouk M,Orimoloye OA,Osei AD,Graham G,Rumberger J,Shaw L,Budoff MJ,Rozanski A,Miedema MD,Al-Mallah MH,Berman D,Nasir K,Blaha MJ", + "auth_pos": 10, + "meshterms": "Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/etiology*, Cardiovascular Diseases/mortality*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1262, + "user_id": 1811967433, + "artical_title": "Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.", + "pmid": 30987601, + "journal_name": "BMC gastroenterology", + "date": "2019-04-17", + "author": "Torgersen J,So-Armah K,Freiberg MS,Goetz MB,Budoff MJ,Lim JK,Taddei T,Butt AA,Rodriguez-Barradas MC,Justice AC,Kostman JR,Lo Re V", + "auth_pos": 5, + "meshterms": "Comorbidity, Cross-Sectional Studies, Fatty Liver, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology*, Female, HIV Infections, HIV Infections/epidemiology*, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Factors, Severity of Illness Index, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1263, + "user_id": 1811967433, + "artical_title": "Long-term prognostic utility of computed tomography coronary angiography in older populations.", + "pmid": 30993334, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-04-18", + "author": "Gnanenthiran SR,Naoum C,Leipsic JA,Achenbach S,Al-Mallah MH,Andreini D,Bax JJ,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufman PA,Kim YJ,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Shaw LJ,Villines TC,Gransar H,Lu Y,Jones EC,Peña JM,Lin FY,Kritharides L,Min JK", + "auth_pos": 9, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality*, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1264, + "user_id": 1811967433, + "artical_title": "Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial).", + "pmid": 31002997, + "journal_name": "American heart journal", + "date": "2019-04-20", + "author": "Win TT,Nakanishi R,Osawa K,Li D,Susaria SS,Jayawardena E,Hamal S,Kim M,Broersen A,Kitslaar PH,Dailing C,Budoff MJ", + "auth_pos": 12, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/administration & dosage, Atherosclerosis, Atherosclerosis/drug therapy*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Humans, Male, Middle Aged, Pyrazoles, Pyrazoles/administration & dosage*, Pyridones, Pyridones/administration & dosage*, Randomized Controlled Trials as Topic, Randomized Controlled Trials as Topic/methods*, Vascular Calcification, Vascular Calcification/drug therapy*, Warfarin, Warfarin/administration & dosage*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1265, + "user_id": 1811967433, + "artical_title": "Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ?1,000: Results From the CAC Consortium.", + "pmid": 31005541, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-04-22", + "author": "Peng AW,Mirbolouk M,Orimoloye OA,Osei AD,Dardari Z,Dzaye O,Budoff MJ,Shaw L,Miedema MD,Rumberger J,Berman DS,Rozanski A,Al-Mallah MH,Nasir K,Blaha MJ", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Asymptomatic Diseases, Cause of Death, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality*, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1266, + "user_id": 1811967433, + "artical_title": "Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 31048102, + "journal_name": "Atherosclerosis", + "date": "2019-05-03", + "author": "Bortnick AE,Xu S,Kim RS,Kestenbaum B,Ix JH,Jenny NS,de Boer IH,Michos ED,Thanassoulis G,Siscovick DS,Budoff MJ,Kizer JR", + "auth_pos": 11, + "meshterms": "Adult, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/blood*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/metabolism, Atherosclerosis, Atherosclerosis/blood*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Atherosclerosis/metabolism, Biomarkers, Biomarkers/blood, Calcinosis, Calcinosis/blood*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/metabolism, Disease Progression, Ethnic Groups, Female, Fibroblast Growth Factors, Fibroblast Growth Factors/blood*, Heart Valve Diseases, Heart Valve Diseases/blood*, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Heart Valve Diseases/metabolism, Humans, Incidence, Male, Middle Aged, Minerals, Minerals/metabolism, Mitral Valve*, Mitral Valve/diagnostic imaging, Prospective Studies, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1267, + "user_id": 1811967433, + "artical_title": "HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study.", + "pmid": 31044604, + "journal_name": "AIDS research and human retroviruses", + "date": "2019-05-03", + "author": "Hutchins E,Wang R,Rahmani S,Nakanishi R,Haberlen S,Kingsley L,Witt MD,Palella FJ,Jacobson L,Budoff MJ,Post WS", + "auth_pos": 10, + "meshterms": "Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/drug therapy, Acquired Immunodeficiency Syndrome/physiopathology*, Adult, Aged, Anti-Retroviral Agents, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Antiretroviral Therapy, Highly Active/adverse effects, Atrial Fibrillation, Atrial Fibrillation/epidemiology*, Atrial Fibrillation/physiopathology, CD4 Lymphocyte Count, Cardiomyopathies, Cardiomyopathies/epidemiology*, Cardiomyopathies/pathology, Cross-Sectional Studies, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Risk Factors, Ventricular Function, Left, Ventricular Function, Left/physiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1268, + "user_id": 1811967433, + "artical_title": "Applications of Cardiac Computed Tomography in the Cardio-Oncology Population.", + "pmid": 31056717, + "journal_name": "Current treatment options in oncology", + "date": "2019-05-06", + "author": "Layoun ME,Yang EH,Herrmann J,Iliescu CA,Lopez-Mattei JC,Marmagkiolis K,Budoff MJ,Ferencik M", + "auth_pos": 7, + "meshterms": "Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards, Animals, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cardiotoxicity, Cardiotoxicity/diagnosis, Cardiotoxicity/epidemiology, Cardiotoxicity/etiology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/epidemiology, Heart Diseases/etiology*, Humans, Monitoring, Physiologic, Neoplasms, Neoplasms/complications*, Neoplasms/epidemiology, Neoplasms/therapy, Peripheral Arterial Disease, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/epidemiology, Peripheral Arterial Disease/etiology, Population Surveillance, Radiotherapy, Radiotherapy/adverse effects, Radiotherapy/methods, Risk Assessment, Risk Factors, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Tomography, X-Ray Computed/standards", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1269, + "user_id": 1811967433, + "artical_title": "Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study.", + "pmid": 31078511, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-05-13", + "author": "Jayawardena E,Li D,Nakanishi R,Dey D,Dailing C,Qureshi A,Dickens B,Hathiramani N,Kim M,Flores F,Kearns AE,Lui LY,Black D,Budoff MJ", + "auth_pos": 14, + "meshterms": "Adipose Tissue, Adipose Tissue/diagnostic imaging*, Adiposity*, Female, Healthy Volunteers, Humans, Menopause*, Middle Aged, Observer Variation, Pericardium, Pericardium/diagnostic imaging*, Predictive Value of Tests, Radiographic Image Interpretation, Computer-Assisted, Radiography, Thoracic*, Reproducibility of Results, Retrospective Studies, Tomography, X-Ray Computed*, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1270, + "user_id": 1811967433, + "artical_title": "Risks of High Coronary Artery Calcium.", + "pmid": 31090871, + "journal_name": "JAMA cardiology", + "date": "2019-05-16", + "author": "Shaikh K,Budoff MJ", + "auth_pos": 2, + "meshterms": "Calcium*, Coronary Angiography, Coronary Artery Disease*, Exercise, Humans", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1271, + "user_id": 1811967433, + "artical_title": "Lung Function, Coronary Artery Disease, and Mortality in HIV.", + "pmid": 31113229, + "journal_name": "Annals of the American Thoracic Society", + "date": "2019-05-23", + "author": "Chandra D,Gupta A,Fitzpatrick M,Haberlen SA,Neupane M,Leader JK,Kingsley LA,Kleerup E,Budoff MJ,Witt M,Sciurba FC,Post WS,Morris A", + "auth_pos": 9, + "meshterms": "Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load, Adult, CD4 Lymphocyte Count, Carbon Monoxide, Case-Control Studies, Comorbidity, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Endothelin-1, Endothelin-1/blood, Female, Forced Expiratory Volume, HIV Infections, HIV Infections/epidemiology*, Humans, Intercellular Adhesion Molecule-1, Intercellular Adhesion Molecule-1/blood, Lung, Lung/diagnostic imaging, Lung/physiopathology, Male, Middle Aged, Mortality*, Odds Ratio, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology, Smoking, Smoking/epidemiology, Spirometry, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Viral Load", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1272, + "user_id": 1811967433, + "artical_title": "Significance of Coronary Artery Calcium Found on Non-Electrocardiogram-Gated Computed Tomography During Preoperative Evaluation for Liver Transplant.", + "pmid": 31122618, + "journal_name": "The American journal of cardiology", + "date": "2019-05-28", + "author": "West BH,Low CG,Bista BB,Yang EH,Vorobiof G,Busuttil RW,Budoff MJ,Elashoff D,Tobis JM,Honda HM", + "auth_pos": 7, + "meshterms": "Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism, Aged, Algorithms, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Electrocardiography, End Stage Liver Disease, End Stage Liver Disease/complications, End Stage Liver Disease/metabolism, End Stage Liver Disease/surgery, Female, Follow-Up Studies, Humans, Liver Transplantation*, Male, Middle Aged, Predictive Value of Tests, Preoperative Care, Preoperative Care/methods*, Reproducibility of Results, Retrospective Studies, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1273, + "user_id": 1811967433, + "artical_title": "Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.", + "pmid": 31135582, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2019-05-29", + "author": "Crane HM,Nance RM,Heckbert SR,Ritchings C,Rosenblatt L,Budoff M,Wood BR,Tirschwell DL,Kim HN,Mathews WC,Geng E,Moore RD,Hunt PW,Eron JJ,Burkholder GA,Drozd DR,Chow FC,Becker KJ,Zunt JR,Ho EL,Kalani R,Huffer A,Whitney BM,Saag MS,Kitahata MM,Delaney JAC", + "auth_pos": 6, + "meshterms": "Adult, Atazanavir Sulfate, Atazanavir Sulfate/adverse effects, Atazanavir Sulfate/therapeutic use*, Bilirubin, Bilirubin/blood*, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology, HIV Protease Inhibitors, HIV Protease Inhibitors/adverse effects, HIV Protease Inhibitors/therapeutic use*, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1274, + "user_id": 1811967433, + "artical_title": "Endogenous Sex Hormones and Endothelial Function in Postmenopausal Women and Men: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 31170017, + "journal_name": "Journal of women's health (2002)", + "date": "2019-06-07", + "author": "Mathews L,Subramanya V,Zhao D,Ouyang P,Vaidya D,Guallar E,Yeboah J,Herrington D,Hays AG,Budoff MJ,Michos ED", + "auth_pos": 10, + "meshterms": "Aged, Androgens, Androgens/blood, Atherosclerosis, Atherosclerosis/epidemiology*, Brachial Artery, Brachial Artery/physiology, Cross-Sectional Studies, Dehydroepiandrosterone, Dehydroepiandrosterone/blood, Endothelium, Vascular, Endothelium, Vascular/physiology*, Estradiol, Estradiol/blood, Ethnic Groups, Ethnic Groups/statistics & numerical data, Female, Gonadal Steroid Hormones, Gonadal Steroid Hormones/blood*, Humans, Male, Middle Aged, Postmenopause, Postmenopause/blood*, Sex Hormone-Binding Globulin, Testosterone, Testosterone/blood, Vasodilation", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1275, + "user_id": 1811967433, + "artical_title": "Ambient air pollution and pulmonary vascular volume on computed tomography: the MESA Air Pollution and Lung cohort studies.", + "pmid": 31167881, + "journal_name": "The European respiratory journal", + "date": "2019-06-07", + "author": "Aaron CP,Hoffman EA,Kawut SM,Austin JHM,Budoff M,Michos ED,Hinckley Stukovsky K,Sack C,Szpiro AA,Watson KD,Kaufman JD,Barr RG", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Air Pollutants, Air Pollutants/adverse effects*, Air Pollutants/analysis, Air Pollution, Air Pollution/adverse effects*, Air Pollution/analysis, Carbon, Carbon/adverse effects, Carbon/analysis, Disease Progression, Environmental Exposure, Environmental Exposure/adverse effects, Female, Humans, Linear Models, Lung, Lung/diagnostic imaging, Lung/physiology*, Male, Middle Aged, Nitrogen Oxides, Nitrogen Oxides/adverse effects, Nitrogen Oxides/analysis, Ozone, Ozone/adverse effects, Ozone/analysis, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Prospective Studies, Pulmonary Emphysema, Pulmonary Emphysema/epidemiology*, Pulmonary Emphysema/physiopathology*, Respiratory Function Tests, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1276, + "user_id": 1811967433, + "artical_title": "Subjects with diffuse idiopathic skeletal hyperostosis have an increased burden of coronary artery disease: An evaluation in the COPDGene cohort.", + "pmid": 31181416, + "journal_name": "Atherosclerosis", + "date": "2019-06-11", + "author": "Oudkerk SF,Mohamed Hoesein FAA,PThM Mali W,Öner FC,Verlaan JJ,de Jong PA,Kinney GL,Hokanson J,Lynch D,Silverman EK,Budoff MJ,Regan EA", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*, Aged, Aged, 80 and over, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology*, Female, Follow-Up Studies, Humans, Hyperostosis, Hyperostosis/complications*, Hyperostosis/diagnosis, Hyperostosis/epidemiology, Incidence, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Vascular Calcification/etiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1277, + "user_id": 1811967433, + "artical_title": "Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.", + "pmid": 31189617, + "journal_name": "BMJ (Clinical research ed.)", + "date": "2019-06-14", + "author": "Haase R,Schlattmann P,Gueret P,Andreini D,Pontone G,Alkadhi H,Hausleiter J,Garcia MJ,Leschka S,Meijboom WB,Zimmermann E,Gerber B,Schoepf UJ,Shabestari AA,Nørgaard BL,Meijs MFL,Sato A,Ovrehus KA,Diederichsen ACP,Jenkins SMM,Knuuti J,Hamdan A,Halvorsen BA,Mendoza-Rodriguez V,Rochitte CE,Rixe J,Wan YL,Langer C,Bettencourt N,Martuscelli E,Ghostine S,Buechel RR,Nikolaou K,Mickley H,Yang L,Zhang Z,Chen MY,Halon DA,Rief M,Sun K,Hirt-Moch B,Niinuma H,Marcus RP,Muraglia S,Jakamy R,Chow BJ,Kaufmann PA,Tardif JC,Nomura C,Kofoed KF,Laissy JP,Arbab-Zadeh A,Kitagawa K,Laham R,Jinzaki M,Hoe J,Rybicki FJ,Scholte A,Paul N,Tan SY,Yoshioka K,Röhle R,Schuetz GM,Schueler S,Coenen MH,Wieske V,Achenbach S,Budoff MJ,Laule M,Newby DE,Dewey M", + "auth_pos": 68, + "meshterms": "Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability, Angina Pectoris, Angina Pectoris/diagnostic imaging*, Angina Pectoris/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Feasibility Studies, Humans, Predictive Value of Tests, Probability", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1278, + "user_id": 1811967433, + "artical_title": "Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.", + "pmid": 31203233, + "journal_name": "Journal of lipid research", + "date": "2019-06-17", + "author": "Basu A,Bebu I,Jenkins AJ,Stoner JA,Zhang Y,Klein RL,Lopes-Virella MF,Garvey WT,Budoff MJ,Alaupovic P,Lyons TJ", + "auth_pos": 9, + "meshterms": "Adult, Apolipoproteins, Apolipoproteins/blood*, Cardiovascular Diseases, Cardiovascular Diseases/blood*, Diabetes Complications, Diabetes Complications/blood*, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 1/blood*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1279, + "user_id": 1811967433, + "artical_title": "Association of Estimated Long-term Exposure to Air Pollution and Traffic Proximity With a Marker for Coronary Atherosclerosis in a Nationwide Study in China.", + "pmid": 31251382, + "journal_name": "JAMA network open", + "date": "2019-06-30", + "author": "Wang M,Hou ZH,Xu H,Liu Y,Budoff MJ,Szpiro AA,Kaufman JD,Vedal S,Lu B", + "auth_pos": 5, + "meshterms": "Adult, Aged, Aged, 80 and over, Air Pollution, Air Pollution/adverse effects*, Air Pollution/analysis, Beijing, Beijing/epidemiology, Biomarkers, Biomarkers/metabolism, China, China/epidemiology, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/etiology, Cross-Sectional Studies, Environmental Exposure, Environmental Exposure/adverse effects, Environmental Exposure/analysis, Female, Humans, Male, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/adverse effects, Ozone, Ozone/adverse effects, Ozone/analysis, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Residence Characteristics, Residence Characteristics/statistics & numerical data, Traffic-Related Pollution, Traffic-Related Pollution/adverse effects*, Traffic-Related Pollution/analysis, Vascular Calcification, Vascular Calcification/epidemiology*, Vascular Calcification/etiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1280, + "user_id": 1811967433, + "artical_title": "Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis).", + "pmid": 31262497, + "journal_name": "The American journal of cardiology", + "date": "2019-07-03", + "author": "Oni E,Budoff MJ,Zeb I,Li D,Veledar E,Polak JF,Blankstein R,Wong ND,Blaha MJ,Agatston A,Blumenthal RS,Nasir K", + "auth_pos": 2, + "meshterms": "African Americans, African Americans/statistics & numerical data, Aged, Asymptomatic Diseases, Atherosclerosis, Atherosclerosis/epidemiology*, Carotid Artery Diseases, Carotid Artery Diseases/epidemiology*, Carotid Artery, Common, Carotid Artery, Common/diagnostic imaging, Carotid Artery, Common/physiopathology, Carotid Artery, Internal, Carotid Artery, Internal/diagnostic imaging, Carotid Artery, Internal/physiopathology, Carotid Intima-Media Thickness*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Elastic Modulus, European Continental Ancestry Group, European Continental Ancestry Group/statistics & numerical data, Female, Hispanic Americans, Hispanic Americans/statistics & numerical data, Humans, Linear Models, Logistic Models, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/epidemiology*, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Vascular Stiffness*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1281, + "user_id": 1811967433, + "artical_title": "Is waist-to-height ratio better than body mass index as a predictive indicator of coronary atherosclerosis disease? A cohort study.", + "pmid": 31279694, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-07-08", + "author": "Hou ZH,Lu B,Li ZN,An YQ,Gao Y,Yin WH,Budoff MJ", + "auth_pos": 7, + "meshterms": "Body Mass Index*, China, China/epidemiology, Computed Tomography Angiography*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, Humans, Obesity, Obesity/diagnosis*, Obesity/epidemiology, Predictive Value of Tests, Prevalence, Prospective Studies, Risk Factors, Waist-Height Ratio*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1282, + "user_id": 1811967433, + "artical_title": "How accurate is atherosclerosis imaging by coronary computed tomography angiography?", + "pmid": 31302029, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-07-16", + "author": "Nakanishi R,Motoyama S,Leipsic J,Budoff MJ", + "auth_pos": 4, + "meshterms": "Computed Tomography Angiography*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1283, + "user_id": 1811967433, + "artical_title": "Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults.", + "pmid": 31322693, + "journal_name": "JAMA network open", + "date": "2019-07-20", + "author": "Miedema MD,Dardari ZA,Nasir K,Blankstein R,Knickelbine T,Oberembt S,Shaw L,Rumberger J,Michos ED,Rozanski A,Berman DS,Budoff MJ,Blaha MJ", + "auth_pos": 12, + "meshterms": "Adult, Cardiovascular Diseases, Cardiovascular Diseases/etiology, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/etiology, Coronary Artery Disease/mortality*, Female, Humans, Male, Middle Aged, Prevalence, Proportional Hazards Models, Regression Analysis, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/mortality*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1284, + "user_id": 1811967433, + "artical_title": "Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes.", + "pmid": 31334442, + "journal_name": "Hepatology communications", + "date": "2019-07-25", + "author": "Barata L,Feitosa MF,Bielak LF,Halligan B,Baldridge AS,Guo X,Yerges-Armstrong LM,Smith AV,Yao J,Palmer ND,VanWagner LB,Carr JJ,Chen YI,Allison M,Budoff MJ,Handelman SK,Kardia SLR,Mosley TH,Ryan K,Harris TB,Launer LJ,Gudnason V,Rotter JI,Fornage M,Rasmussen-Torvik LJ,Borecki IB,O'Connell JR,Peyser PA,Speliotes EK,Province MA", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1285, + "user_id": 1811967433, + "artical_title": "Identifying Smoking-Related Disease on Lung Cancer Screening CT Scans: Increasing the Value.", + "pmid": 31342730, + "journal_name": "Chronic obstructive pulmonary diseases (Miami, Fla.)", + "date": "2019-07-26", + "author": "Regan EA,Lowe KE,Make BJ,Lynch DA,Kinney GL,Budoff MJ,Mao SS,Dyer D,Curtis JL,Bowler RP,Han MK,Beaty TH,Hokanson JE,Kern E,Humphries S,Curran-Everett D,van Beek EJR,Silverman EK,Crapo JD,Finigan JH", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1286, + "user_id": 1811967433, + "artical_title": "Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).", + "pmid": 31362721, + "journal_name": "BMC medicine", + "date": "2019-08-01", + "author": "Feinstein MJ,Nance RM,Delaney JAC,Heckbert SR,Budoff MJ,Drozd DR,Burkholder GA,Willig JH,Mugavero MJ,Mathews WC,Moore RD,Eron JJ,Napravnik S,Hunt PW,Geng E,Hsue P,Peter I,Lober WB,Crothers K,Grunfeld C,Saag MS,Kitahata MM,Lloyd-Jones DM,Crane HM", + "auth_pos": 5, + "meshterms": "Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/epidemiology, Acquired Immunodeficiency Syndrome/mortality, Adult, Aged, Cohort Studies, Community Networks, Comorbidity, Female, HIV Infections, HIV Infections/complications, HIV Infections/epidemiology, HIV Infections/mortality*, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Myocardial Infarction/mortality*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/mortality, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1287, + "user_id": 1811967433, + "artical_title": "Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation.", + "pmid": 31411812, + "journal_name": "Journal of diabetes", + "date": "2019-08-15", + "author": "Beverly JK,Budoff MJ", + "auth_pos": 2, + "meshterms": "Atherosclerosis, Atherosclerosis/etiology*, Humans, Hyperglycemia, Hyperglycemia/complications*, Hyperlipidemias, Hyperlipidemias/complications*, Inflammation, Inflammation/complications*, Insulin Resistance*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1288, + "user_id": 1811967433, + "artical_title": "Computed tomography shows high fracture prevalence among physically active forager-horticulturalists with high fertility.", + "pmid": 31418688, + "journal_name": "eLife", + "date": "2019-08-17", + "author": "Stieglitz J,Trumble BC,Finch CE,Li D,Budoff MJ,Kaplan H,Gurven MD", + "auth_pos": 6, + "meshterms": "Adult, Aged, Aged, 80 and over, Bolivia, Bone Density*, Ethnic Groups*, Feeding Behavior*, Female, Fractures, Bone, Fractures, Bone/diagnostic imaging, Fractures, Bone/epidemiology*, Humans, Male, Middle Aged, Prevalence, Reproductive Behavior*, Sex Factors, Tomography, X-Ray Computed, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1289, + "user_id": 1811967433, + "artical_title": "Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA).", + "pmid": 31416591, + "journal_name": "The American journal of cardiology", + "date": "2019-08-17", + "author": "Arps K,Rifai MA,Blaha MJ,Michos ED,Nasir K,Yeboah J,Budoff MJ,Blumenthal RS,Bittencourt MS,McEvoy JW", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Aged, 80 and over, Atherosclerosis, Atherosclerosis/complications*, Atherosclerosis/drug therapy, Atherosclerosis/ethnology, Calcium, Calcium/metabolism*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Dose-Response Relationship, Drug, Ethnicity*, Factor Xa Inhibitors, Factor Xa Inhibitors/administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Primary Prevention, Primary Prevention/methods*, Prognosis, Prospective Studies, Risk Assessment, Risk Assessment/methods, Risk Factors, Rivaroxaban, Rivaroxaban/administration & dosage*, Survival Rate, Survival Rate/trends, Thrombosis, Thrombosis/ethnology, Thrombosis/etiology, Thrombosis/prevention & control*, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1290, + "user_id": 1811967433, + "artical_title": "Associations Between Subcutaneous Fat Density and Systemic Inflammation Differ by HIV Serostatus and Are Independent of Fat Quantity.", + "pmid": 31430720, + "journal_name": "European journal of endocrinology", + "date": "2019-08-21", + "author": "Lake JE,Debroy P,Ng D,Erlandson K,Kingsley LA,Palella FJ,Budoff MJ,Post WS,Brown TT", + "auth_pos": 7, + "meshterms": "Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*, Adiposity, Adiposity/physiology*, Biomarkers, Biomarkers/blood, Cohort Studies, Cross-Sectional Studies, HIV Infections, HIV Infections/blood, HIV Infections/diagnosis, HIV Seropositivity, HIV Seropositivity/blood*, HIV Seropositivity/diagnosis*, HIV Seropositivity/immunology, HIV-1, HIV-1/immunology, HIV-1/metabolism*, Humans, Inflammation, Inflammation/blood, Inflammation/diagnosis, Inflammation/virology, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/metabolism*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1291, + "user_id": 1811967433, + "artical_title": "The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?", + "pmid": 31453973, + "journal_name": "Menopause (New York, N.Y.)", + "date": "2019-08-28", + "author": "Miller VM,Naftolin F,Asthana S,Black DM,Brinton EA,Budoff MJ,Cedars MI,Dowling NM,Gleason CE,Hodis HN,Jayachandran M,Kantarci K,Lobo RA,Manson JE,Pal L,Santoro NF,Taylor HS,Harman SM", + "auth_pos": 6, + "meshterms": "Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Carotid Intima-Media Thickness, Coronary Artery Disease, Coronary Artery Disease/physiopathology, Coronary Artery Disease/prevention & control*, Estrogen Replacement Therapy*, Female, Humans, Menopause*, Middle Aged, Randomized Controlled Trials as Topic, Vasomotor Symptoms*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1292, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium as a predictor of coronary heart disease, cardiovascular disease, and all-cause mortality in Asian-Americans: The Coronary Artery Calcium Consortium.", + "pmid": 31486775, + "journal_name": "Coronary artery disease", + "date": "2019-09-06", + "author": "Orimoloye OA,Banga S,Dardari ZA,Uddin SMI,Budoff MJ,Berman DS,Rozanski A,Shaw LJ,Rumberger JA,Nasir K,Miedema MD,Blumenthal RS,Blaha MJ,Mirbolouk M", + "auth_pos": 5, + "meshterms": "Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality, Adult, Aged, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Race Factors, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology*, Vascular Calcification/mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1293, + "user_id": 1811967433, + "artical_title": "Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.", + "pmid": 31513271, + "journal_name": "European heart journal", + "date": "2019-09-13", + "author": "Al'Aref SJ,Maliakal G,Singh G,van Rosendael AR,Ma X,Xu Z,Alawamlh OAH,Lee B,Pandey M,Achenbach S,Al-Mallah MH,Andreini D,Bax JJ,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,Gonçalves PA,Pontone G,Raff GL,Rubinshtein R,Villines TC,Gransar H,Lu Y,Jones EC,Peña JM,Lin FY,Min JK,Shaw LJ", + "auth_pos": 15, + "meshterms": "Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*, Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prospective Studies, ROC Curve, Registries*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1294, + "user_id": 1811967433, + "artical_title": "Point of Care Clinical Risk Score to Improve the Negative Diagnostic Utility of an Agatston Score of Zero: Averting the Need for Coronary Computed Tomography Angiography.", + "pmid": 31526300, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2019-09-19", + "author": "Alshahrani AM,Mahmood H,Wells GA,Hossain A,Rybicki FJ,Achenbach S,Al-Mallah MH,Andreini D,Bax JJ,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,Pontone G,Raff G,Rubinshtein R,Shaw LJ,Villines TC,Lin FY,Min JK,Chow BJ", + "auth_pos": 11, + "meshterms": "Algorithms, Computed Tomography Angiography*, Coronary Stenosis, Coronary Stenosis/diagnostic imaging*, Female, Humans, Male, Middle Aged, Point-of-Care Systems*, Predictive Value of Tests, Registries, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Unnecessary Procedures*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1295, + "user_id": 1811967433, + "artical_title": "Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis.", + "pmid": 31532064, + "journal_name": "Arthritis & rheumatology (Hoboken, N.J.)", + "date": "2019-09-19", + "author": "Wu J,Chen HY,Luo MQ,Tiwary CS,Li W,Ajayan PM,Zhang Y,Wu Y", + "auth_pos": 4, + "meshterms": "Aged, Antirheumatic Agents, Antirheumatic Agents/therapeutic use*, Arthritis, Rheumatoid, Arthritis, Rheumatoid/complications*, Arthritis, Rheumatoid/drug therapy, Arthritis, Rheumatoid/pathology, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/etiology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Female, Humans, Incidence, Inflammation, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/epidemiology*, Plaque, Atherosclerotic/etiology, Risk Factors, Time Factors*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1296, + "user_id": 1811967433, + "artical_title": "Associations between QT interval subcomponents, HIV serostatus, and inflammation.", + "pmid": 31538387, + "journal_name": "Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc", + "date": "2019-09-21", + "author": "Wu KC,Bhondoekhan F,Haberlen SA,Ashikaga H,Brown TT,Budoff MJ,D'Souza G,Magnani JW,Kingsley LA,Palella FJ,Margolick JB,Martínez-Maza O,Altekruse SF,Soliman EZ,Post WS", + "auth_pos": 6, + "meshterms": "Adult, Aged, Biomarkers, Biomarkers/blood, Electrocardiography*, HIV Infections*, Humans, Inflammation*, Long QT Syndrome, Long QT Syndrome/complications*, Long QT Syndrome/physiopathology*, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1297, + "user_id": 1811967433, + "artical_title": "Reliability of CAC Scoring on Nongated Compared With Gated Cardiac CT Scans From MESA.", + "pmid": 31542523, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-09-23", + "author": "Almeida SO,Honoris L,Defranco A,Port S,Li D,Nasir K,Kronmal R,Barr RG,Budoff M", + "auth_pos": 9, + "meshterms": "Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology, Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology, Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology, Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology, Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology, Aged, Cardiac-Gated Imaging Techniques*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/ethnology, Electrocardiography, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/ethnology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1298, + "user_id": 1811967433, + "artical_title": "Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]).", + "pmid": 31547994, + "journal_name": "The American journal of cardiology", + "date": "2019-09-25", + "author": "Han D,Beecy A,Anchouche K,Gransar H,Dunham PC,Lee JH,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Bax JJ,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Villines TC,Lu Y,Peña JM,Shaw LJ,Min JK,Lin FY", + "auth_pos": 12, + "meshterms": "American Heart Association, Biomarkers, Biomarkers/blood, Cause of Death, Cause of Death/trends, Cholesterol, Cholesterol/blood, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/classification*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Global Health, Humans, Incidence, Male, Middle Aged, Practice Guidelines as Topic*, Registries*, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Societies, Medical, Survival Rate, Survival Rate/trends, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1299, + "user_id": 1811967433, + "artical_title": "A novel density-volume calcium score by non-contrast CT predicts coronary plaque burden on coronary CT angiography: Results from the MACS (Multicenter AIDS cohort study).", + "pmid": 31564631, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-10-01", + "author": "Nakanishi R,Delaney JA,Post WS,Dailing C,Blaha MJ,Palella F,Witt M,Brown TT,Kingsley LA,Osawa K,Ceponiene I,Nezarat N,Rahmani S,Kanisawa M,Jacobson L,Budoff MJ", + "auth_pos": 16, + "meshterms": "Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Disease, Coronary Disease/diagnostic imaging*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1300, + "user_id": 1811967433, + "artical_title": "Implications of serial coronary computed tomography angiography in the evaluation of coronary plaque progression.", + "pmid": 31592788, + "journal_name": "Current opinion in lipidology", + "date": "2019-10-09", + "author": "Yaxley JW,Varma M", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1301, + "user_id": 1811967433, + "artical_title": "Lower Radiation Dosing in Cardiac Computed Tomographic Angiography: the CONVERGE Registry.", + "pmid": 31604891, + "journal_name": "Journal of nuclear medicine technology", + "date": "2019-10-13", + "author": "Madaj P,Li D,Nakanishi R,Andreini D,Pontone G,Conte E,O'Rourke R,Hamilton-Craig C,Nimmagadda M,Kim N,Fatima B,Dailing C,Budoff M", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1302, + "user_id": 1811967433, + "artical_title": "Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.", + "pmid": 31652073, + "journal_name": "Journal of the American Heart Association", + "date": "2019-10-28", + "author": "El Khoudary SR,Zhao Q,Venugopal V,Manson JE,Brooks MM,Santoro N,Black DM,Harman SM,Cedars MI,Hopkins PN,Kearns AE,Miller VM,Taylor HS,Budoff MJ", + "auth_pos": 14, + "meshterms": "Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*, Adipose Tissue, Adipose Tissue/drug effects*, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Disease Progression, Estradiol, Estradiol/pharmacology*, Estradiol/therapeutic use*, Estrogen Replacement Therapy*, Estrogens, Estrogens/pharmacology*, Estrogens/therapeutic use*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/pharmacology*, Estrogens, Conjugated (USP)/therapeutic use*, Female, Humans, Middle Aged, Pericardium, Pericardium/pathology*, Vascular Calcification, Vascular Calcification/drug therapy*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1303, + "user_id": 1811967433, + "artical_title": "Association of High-Sensitivity Troponin with Cardiac CT Angiography Evidence of Myocardial and Coronary Disease in a Primary Prevention Cohort of Men: Results from MACS.", + "pmid": 31659073, + "journal_name": "The journal of applied laboratory medicine", + "date": "2019-10-30", + "author": "Rahman F,Zhang Z,Zhao D,Budoff MJ,Palella FJ,Witt MD,Evans RW,Jacobson LP,Korley FK,Guallar E,Post WS,McEvoy JW", + "auth_pos": 4, + "meshterms": "Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood, Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood, Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood, Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood, Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood, Aged, Biomarkers, Cardiomyopathies, Cardiomyopathies/blood*, Cardiomyopathies/diagnostic imaging*, Cardiomyopathies/epidemiology, Comorbidity, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, HIV Infections, Humans, Male, Middle Aged, Odds Ratio, Sensitivity and Specificity, Troponin, Troponin/blood*, Troponin C, Troponin C/blood, Troponin T, Troponin T/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1304, + "user_id": 1811967433, + "artical_title": "HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype.", + "pmid": 31659325, + "journal_name": "Nature genetics", + "date": "2019-10-30", + "author": "Malhotra R,Mauer AC,Lino Cardenas CL,Guo X,Yao J,Zhang X,Wunderer F,Smith AV,Wong Q,Pechlivanis S,Hwang SJ,Wang J,Lu L,Nicholson CJ,Shelton G,Buswell MD,Barnes HJ,Sigurslid HH,Slocum C,Rourke CO,Rhee DK,Bagchi A,Nigwekar SU,Buys ES,Campbell CY,Harris T,Budoff M,Criqui MH,Rotter JI,Johnson AD,Song C,Franceschini N,Debette S,Hoffmann U,Kälsch H,Nöthen MM,Sigurdsson S,Freedman BI,Bowden DW,Jöckel KH,Moebus S,Erbel R,Feitosa MF,Gudnason V,Thanassoulis G,Zapol WM,Lindsay ME,Bloch DB,Post WS,O'Donnell CJ", + "auth_pos": 27, + "meshterms": "Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*, Aged, Animals, Aorta, Aorta/metabolism, Aorta/pathology, Atherosclerosis, Atherosclerosis/genetics, Atherosclerosis/metabolism, Atherosclerosis/pathology*, Cohort Studies, Female, GTPase-Activating Proteins, GTPase-Activating Proteins/genetics, GTPase-Activating Proteins/metabolism, Genetic Predisposition to Disease*, Genome-Wide Association Study, Histone Deacetylases, Histone Deacetylases/genetics, Histone Deacetylases/metabolism*, Histone Deacetylases/physiology*, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Muscle Contraction*, Muscle, Smooth, Vascular, Muscle, Smooth, Vascular/metabolism, Muscle, Smooth, Vascular/pathology*, Phenotype, Polymorphism, Single Nucleotide, Repressor Proteins, Repressor Proteins/genetics, Repressor Proteins/metabolism*, Repressor Proteins/physiology*, Vascular Calcification, Vascular Calcification/genetics, Vascular Calcification/metabolism, Vascular Calcification/pathology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1305, + "user_id": 1811967433, + "artical_title": "Associations of recreational and non-recreational physical activity with coronary artery calcium density vs. volume and cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 31670763, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-11-02", + "author": "Thomas IC,Takemoto ML,Forbang NI,Larsen BA,Michos ED,McClelland RL,Allison MA,Budoff MJ,Criqui MH", + "auth_pos": 8, + "meshterms": "Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Exercise, Humans, Prospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1306, + "user_id": 1811967433, + "artical_title": "Peripheral arterial disease and statin therapy, what do we know after all these years?", + "pmid": 31679955, + "journal_name": "Trends in cardiovascular medicine", + "date": "2019-11-05", + "author": "Onuegbu A,Roy S,Budoff M", + "auth_pos": 3, + "meshterms": "Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Peripheral Arterial Disease*, Practice Patterns, Physicians', Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1307, + "user_id": 1811967433, + "artical_title": "Intermittent Nonhabitual Coffee Consumption and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 31687073, + "journal_name": "Journal of atrial fibrillation", + "date": "2019-11-07", + "author": "Xu J,Fan W,Budoff MJ,Heckbert SR,Amsterdam EA,Alonso A,Wong ND", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1308, + "user_id": 1811967433, + "artical_title": "REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States.", + "pmid": 31707829, + "journal_name": "Circulation", + "date": "2019-11-12", + "author": "Bhatt DL,Miller M,Brinton EA,Jacobson TA,Steg PG,Ketchum SB,Doyle RT,Juliano RA,Jiao L,Granowitz C,Tardif JC,Olshansky B,Chung MK,Gibson CM,Giugliano RP,Budoff MJ,Ballantyne CM", + "auth_pos": 16, + "meshterms": "Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/drug therapy*, Myocardial Infarction/mortality, Risk Factors, Stroke, Stroke/drug therapy*, Stroke/mortality, United States, Aged, Cholesterol, LDL, Cholesterol, LDL/drug effects*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Eicosapentaenoic Acid/pharmacology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Myo", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1309, + "user_id": 1811967433, + "artical_title": "COPDGene 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.", + "pmid": 31710793, + "journal_name": "Chronic obstructive pulmonary diseases (Miami, Fla.)", + "date": "2019-11-12", + "author": "Lowe KE,Regan EA,Anzueto A,Austin E,Austin JHM,Beaty TH,Benos PV,Benway CJ,Bhatt SP,Bleecker ER,Bodduluri S,Bon J,Boriek AM,Boueiz AR,Bowler RP,Budoff M,Casaburi R,Castaldi PJ,Charbonnier JP,Cho MH,Comellas A,Conrad D,Costa Davis C,Criner GJ,Curran-Everett D,Curtis JL,DeMeo DL,Diaz AA,Dransfield MT,Dy JG,Fawzy A,Fleming M,Flenaugh EL,Foreman MG,Fortis S,Gebrekristos H,Grant S,Grenier PA,Gu T,Gupta A,Han MK,Hanania NA,Hansel NN,Hayden LP,Hersh CP,Hobbs BD,Hoffman EA,Hogg JC,Hokanson JE,Hoth KF,Hsiao A,Humphries S,Jacobs K,Jacobson FL,Kazerooni EA,Kim V,Kim WJ,Kinney GL,Koegler H,Lutz SM,Lynch DA,MacIntye NR,Make BJ,Marchetti N,Martinez FJ,Maselli DJ,Mathews AM,McCormack MC,McDonald MN,McEvoy CE,Moll M,Molye SS,Murray S,Nath H,Newell JD,Occhipinti M,Paoletti M,Parekh T,Pistolesi M,Pratte KA,Putcha N,Ragland M,Reinhardt JM,Rennard SI,Rosiello RA,Ross JC,Rossiter HB,Ruczinski I,San Jose Estepar R,Sciurba FC,Sieren JC,Singh H,Soler X,Steiner RM,Strand MJ,Stringer WW,Tal-Singer R,Thomashow B,Vegas Sánchez-Ferrero G,Walsh JW,Wan ES,Washko GR,Michael Wells J,Wendt CH,Westney G,Wilson A,Wise RA,Yen A,Young K,Yun J,Silverman EK,Crapo JD", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1310, + "user_id": 1811967433, + "artical_title": "HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS).", + "pmid": 31707799, + "journal_name": "Circulation", + "date": "2019-11-12", + "author": "Heravi AS,Etzkorn LH,Urbanek JK,Crainiceanu CM,Punjabi NM,Ashikaga H,Brown TT,Budoff MJ,D'Souza G,Magnani JW,Palella FJ,Berger RD,Wu KC,Post WS", + "auth_pos": 8, + "meshterms": "Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load, Adult, Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/physiopathology*, Electrocardiography*, HIV Infections, HIV Infections/physiopathology*, HIV-1*, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Middle Aged, Viral Load", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1311, + "user_id": 1811967433, + "artical_title": "Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progressiontrial.", + "pmid": 31724966, + "journal_name": "Coronary artery disease", + "date": "2019-11-15", + "author": "", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1312, + "user_id": 1811967433, + "artical_title": "Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.", + "pmid": 31729142, + "journal_name": "HIV medicine", + "date": "2019-11-16", + "author": "Brusca RM,Hanna DB,Wada NI,Blankson JN,Witt MD,Jacobson LP,Kingsley L,Palella FJ,Budoff M,Brown TT,Anastos K,Lazar JM,Mack WJ,Bacchetti P,Tien PC,Golzar Y,Plankey M,Golub E,Kaplan RC,Post WS", + "auth_pos": 9, + "meshterms": "Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data*, Humans, Lipopolysaccharide Receptors, Lipopolysaccharide Receptors/blood, Male, Middle Aged, Multicenter Studies as Topic, Observational Studies as Topic, Receptors, Cell Surface, Receptors, Cell Surface/blood, Tomography, X-Ray Computed, Young Adult, Adult, Antigens, CD, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Antigens, Differentiation, Myelomonocytic/blood, Biomarkers, Biomarkers/blood*, CD4 Lymphocyte Count, Calcium, Calcium/metabolism, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Artery Diseases/etiology, Carotid Artery Diseases/immunology, Carotid Intima-Media Thickness, Cohort Studies, Female, HIV Infections, HIV Infections/blood, HIV Infections/complications*, HIV Infections/immunology, HIV Long-Term Survivors, HIV Long-Term Survivors/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1313, + "user_id": 1811967433, + "artical_title": "Interplay of Coronary Artery Calcium and Risk Factors for Predicting CVD/CHD Mortality: The CAC Consortium.", + "pmid": 31734198, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-11-18", + "author": "Grandhi GR,Mirbolouk M,Dardari ZA,Al-Mallah MH,Rumberger JA,Shaw LJ,Blankstein R,Miedema MD,Berman DS,Budoff MJ,Krumholz HM,Blaha MJ,Nasir K", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1314, + "user_id": 1811967433, + "artical_title": "Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA.", + "pmid": 31734214, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-11-18", + "author": "Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Shin S,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1315, + "user_id": 1811967433, + "artical_title": "Valvular calcification and risk of peripheral artery disease: the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 31740939, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-11-20", + "author": "Garg PK,Buzkova P,Meyghani Z,Budoff MJ,Lima J,Criqui M,Cushman M,Allison M", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1316, + "user_id": 1811967433, + "artical_title": "Primary outcomes should be of primary interest to readers.", + "pmid": 31759457, + "journal_name": "American heart journal", + "date": "2019-11-25", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "Prospective Studies, Pyrazoles, Pyridones*, Warfarin*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1317, + "user_id": 1811967433, + "artical_title": "Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.", + "pmid": 31761548, + "journal_name": "Nutrition, metabolism, and cardiovascular diseases : NMCD", + "date": "2019-11-26", + "author": "El Khoudary SR,Samargandy S,Zeb I,Foster T,de Boer IH,Li D,Budoff MJ", + "auth_pos": 7, + "meshterms": "African Americans*, Aged, Aged, 80 and over, Asian Americans*, Biomarkers, Biomarkers/blood, Comorbidity, Cross-Sectional Studies, European Continental Ancestry Group*, Female, Health Status Disparities, Hispanic Americans*, Humans, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/diagnostic imaging, Non-alcoholic Fatty Liver Disease/ethnology*, Prevalence, Prospective Studies, Race Factors, Risk Assessment, Risk Factors, Smoking, Smoking/adverse effects, Smoking/ethnology, United States, United States/epidemiology, Vitamin D, Vitamin D/analogs & derivatives*, Vitamin D/blood, Vitamin D Deficiency, Vitamin D Deficiency/blood, Vitamin D Deficiency/diagnosis, Vitamin D Deficiency/ethnology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1318, + "user_id": 1811967433, + "artical_title": "All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium.", + "pmid": 31784032, + "journal_name": "Atherosclerosis", + "date": "2019-12-01", + "author": "Blaha MJ,Cainzos-Achirica M,Dardari Z,Blankstein R,Shaw LJ,Rozanski A,Rumberger JA,Dzaye O,Michos ED,Berman DS,Budoff MJ,Miedema MD,Blumenthal RS,Nasir K", + "auth_pos": 11, + "meshterms": "Aged, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/mortality*, Female, Humans, Male, Middle Aged, Prevalence, Retrospective Studies, Risk Assessment, Severity of Illness Index, Survival Rate, Vascular Calcification, Vascular Calcification/diagnosis*, Vascular Calcification/mortality*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1319, + "user_id": 1811967433, + "artical_title": "Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography.", + "pmid": 31825484, + "journal_name": "Cardiovascular research", + "date": "2019-12-12", + "author": "Lakshmanan S,Shekar C,Kinninger A,Dahal S,Onuegbu A,Cai AN,Hamal S,Birudaraju D,Roy SK,Nelson JR,Budoff MJ,Bhatt DL", + "auth_pos": 11, + "meshterms": "Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/drug effects, Coronary Vessels/pathology, Disease Progression, Female, Humans, Male, Middle Aged, Mineral Oil, Mineral Oil/administration & dosage*, Mineral Oil/adverse effects, Placebos*, Plaque, Atherosclerotic*, Predictive Value of Tests, Randomized Controlled Trials as Topic, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1320, + "user_id": 1811967433, + "artical_title": "Coronary atherosclerosis scoring with semiquantitative CCTA risk scores for prediction of major adverse cardiac events: Propensity score-based analysis of diabetic and non-diabetic patients.", + "pmid": 31836415, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-12-15", + "author": "van den Hoogen IJ,van Rosendael AR,Lin FY,Lu Y,Dimitriu-Leen AC,Smit JM,Scholte AJHA,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Villines TC,Gransar H,Jones EC,Peña JM,Shaw LJ,Min JK,Bax JJ", + "auth_pos": 12, + "meshterms": "Aged, Case-Control Studies, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology, Coronary Stenosis, Coronary Stenosis/diagnostic imaging*, Coronary Stenosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Disease Progression, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Predictive Value of Tests, Prognosis, Propensity Score, Registries, Risk Assessment, Risk Factors, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1321, + "user_id": 1811967433, + "artical_title": "Power of zero stronger than \"soft\" plaque.", + "pmid": 31848076, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2019-12-19", + "author": "Eisenbarth W,Zhang X,Guo X,Lehane C,Wang B,Johnson A,Wang X,Wittich W", + "auth_pos": 1, + "meshterms": "Humans, Plaque, Atherosclerotic*, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1322, + "user_id": 1811967433, + "artical_title": "Low-dose ionizing radiation and cancer risk: not so easy to tell.", + "pmid": 31929978, + "journal_name": "Quantitative imaging in medicine and surgery", + "date": "2020-01-14", + "author": "Dahal S,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1323, + "user_id": 1811967433, + "artical_title": "The association of coronary artery calcium score and mortality risk among smokers: The coronary artery calcium consortium.", + "pmid": 31951880, + "journal_name": "Atherosclerosis", + "date": "2020-01-18", + "author": "Mirbolouk M,Kianoush S,Dardari Z,Miedema MD,Shaw LJ,Rumberger JA,Berman DS,Budoff MJ,Rozanski A,Al-Mallah MH,McEvoy JW,Nasir K,Blaha MJ", + "auth_pos": 8, + "meshterms": "Adult, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications*, Coronary Artery Disease/mortality*, Early Detection of Cancer, Female, Humans, Lung Neoplasms, Lung Neoplasms/diagnosis, Lung Neoplasms/epidemiology*, Male, Middle Aged, Patient Selection, Risk Factors, Severity of Illness Index, Smoking, Smoking/adverse effects*, Survival Rate, Vascular Calcification, Vascular Calcification/complications*, Vascular Calcification/mortality*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1324, + "user_id": 1811967433, + "artical_title": "Comparing Risk Scores in the Prediction of Coronary and Cardiovascular Deaths: Coronary Artery Calcium Consortium.", + "pmid": 31954640, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-01-20", + "author": "Blaha MJ,Whelton SP,Al Rifai M,Dardari Z,Shaw LJ,Al-Mallah MH,Matsushita K,Rozanski A,Rumberger JA,Berman DS,Budoff MJ,Miedema MD,Nasir K,Cainzos-Achirica M", + "auth_pos": 11, + "meshterms": "Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Aged, Calcium, Coronary Artery Disease*, Coronary Vessels, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1325, + "user_id": 1811967433, + "artical_title": "The Predictive Value of Coronary Artery Calcium Scoring for Major Adverse Cardiac Events According to Renal Function (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter [CONFIRM] Registry).", + "pmid": 30850210, + "journal_name": "The American journal of cardiology", + "date": "2020-01-21", + "author": "Lee JH,Rizvi A,Hartaigh BÓ,Han D,Park MW,Roudsari HM,Stuijfzand WJ,Gransar H,Lu Y,Callister TQ,Berman DS,DeLago A,Hadamitzky M,Hausleiter J,Al-Mallah MH,Budoff MJ,Kaufmann PA,Raff GL,Chinnaiyan K,Cademartiri F,Maffei E,Villines TC,Kim YJ,Leipsic J,Feuchtner G,Pontone G,Andreini D,Marques H,de Araújo Gonçalves P,Rubinshtein R,Achenbach S,Shaw LJ,Chow BJW,Cury RC,Bax JJ,Chang HJ,Jones EC,Lin FY,Min JK,Peña JM", + "auth_pos": 16, + "meshterms": "Calcium, Calcium/metabolism*, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/mortality, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Global Health, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, Humans, Male, Middle Aged, Multidetector Computed Tomography, Multidetector Computed Tomography/methods, Predictive Value of Tests, Prognosis, Registries, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/physiopathology*, Risk Assessment, Risk Factors, Survival Rate, Survival Rate/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis*, Vascular Calcification/metabolism", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1326, + "user_id": 1811967433, + "artical_title": "Association of High-Density Calcified 1K Plaque With Risk of Acute Coronary Syndrome.", + "pmid": 31968065, + "journal_name": "JAMA cardiology", + "date": "2020-01-23", + "author": "van Rosendael AR,Narula J,Lin FY,van den Hoogen IJ,Gianni U,Al Hussein Alawamlh O,Dunham PC,Peña JM,Lee SE,Andreini D,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,Hadamitzky M,Kim YJ,Leipsic J,Maffei E,Marques H,de Araújo Gonçalves P,Plank F,Pontone G,Raff GL,Villines TC,Weirich HG,Al'Aref SJ,Baskaran L,Cho I,Danad I,Han D,Heo R,Lee JH,Rivzi A,Stuijfzand WJ,Gransar H,Lu Y,Sung JM,Park HB,Samady H,Stone PH,Virmani R,Budoff MJ,Berman DS,Chang HJ,Bax JJ,Min JK,Shaw LJ", + "auth_pos": 44, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnosis*, Case-Control Studies, Cohort Studies, Computed Tomography Angiography, Coronary Stenosis, Coronary Stenosis/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging*, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1327, + "user_id": 1811967433, + "artical_title": "Anomalous coronary sinus communication to the left atrium.", + "pmid": 31969939, + "journal_name": "Journal of cardiology cases", + "date": "2020-01-24", + "author": "Shafter AM,Almeida SO,Syed U,Shaikh K,Budoff MJ", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1328, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis).", + "pmid": 31980142, + "journal_name": "The American journal of cardiology", + "date": "2020-01-26", + "author": "Rifai MA,Blaha MJ,Patel J,Xiaoming J,Cainzos-Achirica M,Greenland P,Budoff M,Yeboah J,Nasir K,Al-Mallah MH,Virani SS", + "auth_pos": 7, + "meshterms": "Aged, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Cross-Cultural Comparison, Ethnic Groups*, Female, Follow-Up Studies, Guideline Adherence, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Multivariate Analysis, Prognosis, Risk Factors, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1329, + "user_id": 1811967433, + "artical_title": "Increased long-term mortality in women with high left ventricular ejection fraction: data from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) long-term registry.", + "pmid": 31985803, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-01-28", + "author": "Gebhard C,Maredziak M,Messerli M,Buechel RR,Lin F,Gransar H,Achenbach S,Al-Mallah MH,Andreini D,Bax JJ,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kim YJ,Leipsic J,Maffei E,Marques H,Gonçalves PA,Pontone G,Raff GL,Rubinshtein R,Shaw LJ,Villines TC,Lu Y,Jones EC,Peña JM,Min JK,Kaufmann PA", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1330, + "user_id": 1811967433, + "artical_title": "A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.", + "pmid": 31987113, + "journal_name": "Clinical nutrition ESPEN", + "date": "2020-01-29", + "author": "Birudaraju D,Cherukuri L,Kinninger A,Chaganti BT,Shaikh K,Hamal S,Flores F,Roy SK,Budoff MJ", + "auth_pos": 9, + "meshterms": "Adolescent, Adult, Aged, Biomarkers, Biomarkers/blood, Blood Pressure, Blood Pressure/drug effects*, C-Reactive Protein, Cardiovascular Diseases, Coronary Artery Disease, Dietary Supplements, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage*, Endothelium, Fatty Acids, Omega-3, Fatty Acids, Omega-3/administration & dosage, Female, Healthy Volunteers, Humans, Hypertension, Interleukin-6, Male, Middle Aged, Xanthophylls, Xanthophylls/administration & dosage*, Young Adult, gamma-Linolenic Acid, gamma-Linolenic Acid/administration & dosage*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1331, + "user_id": 1811967433, + "artical_title": "Short-term impact of aged garlic extract on endothelial function in diabetes: A randomized, double-blind, placebo-controlled trial.", + "pmid": 32010327, + "journal_name": "Experimental and therapeutic medicine", + "date": "2020-02-06", + "author": "Hamal S,Cherukuri L,Birudaraju D,Matsumoto S,Kinninger A,Chaganti BT,Flores F,Shaikh K,Roy SK,Budoff MJ", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1332, + "user_id": 1811967433, + "artical_title": "Association Between Homocysteine and Vascular Calcification Incidence, Prevalence, and Progression in the MESA Cohort.", + "pmid": 32013703, + "journal_name": "Journal of the American Heart Association", + "date": "2020-02-06", + "author": "Karger AB,Steffen BT,Nomura SO,Guan W,Garg PK,Szklo M,Budoff MJ,Tsai MY", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Disease Progression, Female, Homocysteine, Homocysteine/blood*, Humans, Hyperhomocysteinemia, Hyperhomocysteinemia/blood, Hyperhomocysteinemia/diagnosis, Hyperhomocysteinemia/epidemiology*, Incidence, Male, Middle Aged, Prevalence, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Up-Regulation, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1333, + "user_id": 1811967433, + "artical_title": "Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: A randomized, double-blind, placebo-controlled study.", + "pmid": 32010322, + "journal_name": "Experimental and therapeutic medicine", + "date": "2020-02-06", + "author": "Shaikh K,Kinninger A,Cherukuri L,Birudaraju D,Nakanishi R,Almeida S,Jayawardena E,Shekar C,Flores F,Hamal S,Sheikh MS,Johanis A,Cu B,Budoff MJ", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1334, + "user_id": 1811967433, + "artical_title": "Aged garlic extract reduces left ventricular myocardial mass in patients with diabetes: A prospective randomized controlled double-blind study.", + "pmid": 32010324, + "journal_name": "Experimental and therapeutic medicine", + "date": "2020-02-06", + "author": "Almeida S,Jayawardena E,Shekar C,Flores F,Hamal S,Sheikh S,Johanis A,Cu B,Trad G,Budoff MJ,Goldberg JK,Lively CM,Sternlieb SR,Pintel G,Hare JD,Morrissey MB,Delph LF", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1335, + "user_id": 1811967433, + "artical_title": "Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.", + "pmid": 32015261, + "journal_name": "Menopause (New York, N.Y.)", + "date": "2020-02-06", + "author": "El Khoudary SR,Venugopal V,Manson JE,Brooks MM,Santoro N,Black DM,Harman M,Naftolin F,Hodis HN,Brinton EA,Miller VM,Taylor HS,Budoff MJ", + "auth_pos": 13, + "meshterms": "Administration, Cutaneous, Administration, Oral, Atherosclerosis, Atherosclerosis/etiology, Atherosclerosis/prevention & control*, Carotid Artery Diseases, Carotid Artery Diseases/etiology, Carotid Artery Diseases/prevention & control*, Carotid Intima-Media Thickness, Disease Progression, Estradiol, Estradiol/administration & dosage*, Estrogen Replacement Therapy, Estrogen Replacement Therapy/methods*, Estrogens, Estrogens/administration & dosage*, Estrogens, Conjugated (USP), Estrogens, Conjugated (USP)/administration & dosage*, Female, Humans, Middle Aged, Myocardium, Myocardium/pathology, Postmenopause, Postmenopause/drug effects, Treatment Outcome, Menopause Hormone Therapy*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1336, + "user_id": 1811967433, + "artical_title": "Age- and gender-adjusted percentiles for number of calcified plaques in coronary artery calcium scanning.", + "pmid": 30598344, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-02-11", + "author": "Wang F,Rozanski A,Dey D,Arnson Y,Gransar H,Friedman J,Hayes SW,Thomson LEJ,Tamarappoo B,Shaw LJ,Min JK,Rumberger JA,Budoff MJ,Miedema MD,Blaha MJ,Berman DS", + "auth_pos": 13, + "meshterms": "Adult, Age Distribution, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/epidemiology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography, Nomograms*, Plaque, Atherosclerotic*, Predictive Value of Tests, Prevalence, Prognosis, Risk Factors, Sex Distribution, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/epidemiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1337, + "user_id": 1811967433, + "artical_title": "Percent atheroma volume: Optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study.", + "pmid": 32063545, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-02-18", + "author": "van Rosendael AR,Lin FY,Ma X,van den Hoogen IJ,Gianni U,Al Hussein O,Al'Aref SJ,Peña JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Raff GL,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Virmani R,Samady H,Stone PH,Narula J,Bax JJ,Shaw LJ,Min JK,Chang HJ", + "auth_pos": 11, + "meshterms": "Aged, Body Surface Area, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Registries, Severity of Illness Index, Sex Factors, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1338, + "user_id": 1811967433, + "artical_title": "Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry.", + "pmid": 32065624, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-02-18", + "author": "van Rosendael AR,Bax AM,Smit JM,van den Hoogen IJ,Ma X,Al'Aref S,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Villines TC,Gransar H,Lu Y,Peña JM,Lin FY,Shaw LJ,Min JK,Bax JJ", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1339, + "user_id": 1811967433, + "artical_title": "FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.", + "pmid": 32068085, + "journal_name": "Progress in cardiovascular diseases", + "date": "2020-02-19", + "author": "So-Armah KA,Lim JK,Lo Re V,Tate JP,Chang CH,Butt AA,Gibert CL,Rimland D,Marconi VC,Goetz MB,Ramachandran V,Brittain E,Long M,Nguyen KL,Rodriguez-Barradas MC,Budoff MJ,Tindle HA,Samet JH,Justice AC,Freiberg MS", + "auth_pos": 16, + "meshterms": "Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load, Adult, Anti-HIV Agents, Anti-HIV Agents/adverse effects, Anti-HIV Agents/therapeutic use*, Female, HIV Infections, HIV Infections/diagnosis, HIV Infections/drug therapy*, HIV Infections/epidemiology, HIV Long-Term Survivors*, Health Status, Heart Failure, Heart Failure/diagnosis, Heart Failure/epidemiology*, Heart Failure/physiopathology, Hepatitis C, Hepatitis C/diagnosis, Hepatitis C/epidemiology*, Hepatitis C/virology, Humans, Incidence, Liver Cirrhosis, Liver Cirrhosis/diagnosis, Liver Cirrhosis/epidemiology*, Liver Cirrhosis/virology, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Time Factors, United States, United States/epidemiology, Ventricular Function, Left*, Veterans Health, Viral Load", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1340, + "user_id": 1811967433, + "artical_title": "Machine Learning Framework to Identify Individuals at Risk of Rapid Progression of Coronary Atherosclerosis: From the PARADIGM Registry.", + "pmid": 32089046, + "journal_name": "Journal of the American Heart Association", + "date": "2020-02-25", + "author": "Han D,Kolli KK,Al'Aref SJ,Baskaran L,van Rosendael AR,Gransar H,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Raff GL,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Virmani R,Samady H,Stone P,Narula J,Berman DS,Bax JJ,Shaw LJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 8, + "meshterms": "Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Diagnosis, Computer-Assisted*, Disease Progression, Female, Humans, Machine Learning*, Male, Middle Aged, Multidetector Computed Tomography*, Plaque, Atherosclerotic, Predictive Value of Tests, Prospective Studies, Radiographic Image Interpretation, Computer-Assisted*, Registries, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1341, + "user_id": 1811967433, + "artical_title": "N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).", + "pmid": 32106929, + "journal_name": "The American journal of cardiology", + "date": "2020-02-29", + "author": "Nguyen K,Fan W,Bertoni A,Budoff MJ,Defilippi C,Lombardo D,Maisel A,Szklo M,Wong ND", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Angina Pectoris, Angina Pectoris/epidemiology, Angina Pectoris/metabolism, Blood Glucose, Blood Glucose/metabolism*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/metabolism, Coronary Disease, Coronary Disease/metabolism, Coronary Disease/mortality, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/metabolism*, Female, Heart Failure, Heart Failure/epidemiology, Heart Failure/metabolism*, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Infarction/metabolism, Myocardial Ischemia, Myocardial Ischemia/epidemiology, Myocardial Ischemia/metabolism*, Myocardial Ischemia/mortality, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/metabolism*, Peptide Fragments, Peptide Fragments/metabolism*, Prediabetic State, Prediabetic State/metabolism*, Risk Assessment, Stroke, Stroke/epidemiology, Stroke/metabolism*, Stroke/mortality, Troponin T, Troponin T/metabolism*, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1342, + "user_id": 1811967433, + "artical_title": "Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men.", + "pmid": 32128321, + "journal_name": "Open forum infectious diseases", + "date": "2020-03-05", + "author": "Price JC,Wang R,Seaberg EC,Brown TT,Budoff MJ,Kingsley LA,Palella FJ,Witt MD,Post WS,Lake JE,Thio CL", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1343, + "user_id": 1811967433, + "artical_title": "Lower Radiation Dosing in Cardiac CT Angiography: The CONVERGE Registry.", + "pmid": 32144159, + "journal_name": "Journal of nuclear medicine technology", + "date": "2020-03-08", + "author": "Madaj P,Li D,Nakanishi R,Andreini D,Pontone G,Conte E,O'Rourke Franzcr R,Hamilton-Craig C,Nimmagadda M,Kim N,Fatima B,Dailing C,Budoff MJ", + "auth_pos": 13, + "meshterms": "Aged, Body Mass Index, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Contrast Media, Contrast Media/administration & dosage*, Contrast Media/chemistry*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Heart, Humans, Male, Middle Aged, Radiation Dosage, Registries, Risk Assessment, Risk Assessment/legislation & jurisprudence, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1344, + "user_id": 1811967433, + "artical_title": "Quantification of atherosclerotic plaque volume in coronary arteries by computed tomographic angiography in subjects with and without diabetes.", + "pmid": 32149765, + "journal_name": "Chinese medical journal", + "date": "2020-03-10", + "author": "Hou ZH,Lu B,Li ZN,An YQ,Gao Y,Yin WH,Budoff MJ", + "auth_pos": 7, + "meshterms": "Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1345, + "user_id": 1811967433, + "artical_title": "Novel use of coronary artery calcium scoring.", + "pmid": 32168043, + "journal_name": "Coronary artery disease", + "date": "2020-03-14", + "author": "Golub I,Dahal S,Calicchio F,Budoff MJ", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1346, + "user_id": 1811967433, + "artical_title": "Relationship between cardio-ankle vascular index and obstructive coronary artery disease.", + "pmid": 32168051, + "journal_name": "Coronary artery disease", + "date": "2020-03-14", + "author": "Birudaraju D,Cherukuri L,Kinninger A,Chaganti BT,Haroun P,Pidikiti S,Lakshmanan S,Hamal S,Flores F,Dailing C,Shaikh K,Roy SK,Budoff MJ", + "auth_pos": 13, + "meshterms": "Ankle, Ankle/blood supply*, Coronary Angiography, Coronary Occlusion, Coronary Occlusion/diagnosis, Coronary Occlusion/physiopathology*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology*, Female, Humans, Male, Middle Aged, Odds Ratio, ROC Curve, Risk Assessment*, Risk Factors, Tomography, X-Ray Computed, Vascular Stiffness, Vascular Stiffness/physiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1347, + "user_id": 1811967433, + "artical_title": "Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis.", + "pmid": 32186652, + "journal_name": "JAMA cardiology", + "date": "2020-03-19", + "author": "Chen HY,Cairns BJ,Small AM,Burr HA,Ambikkumar A,Martinsson A,Thériault S,Munter HM,Steffen B,Zhang R,Levinson RT,Shaffer CM,Rong J,Sonestedt E,Dufresne L,Ljungberg J,Näslund U,Johansson B,Ranatunga DK,Whitmer RA,Budoff MJ,Nguyen A,Vasan RS,Larson MG,Harris WS,Damrauer SM,Stark KD,Boekholdt SM,Wareham NJ,Pibarot P,Arsenault BJ,Mathieu P,Gudnason V,O'Donnell CJ,Rotter JI,Tsai MY,Post WS,Clarke R,Söderberg S,Bossé Y,Wells QS,Smith JG,Rader DJ,Lathrop M,Engert JC,Thanassoulis G", + "auth_pos": 21, + "meshterms": "Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*, Aged, Alleles, Aortic Valve Stenosis, Aortic Valve Stenosis/genetics*, Aortic Valve Stenosis/metabolism, Case-Control Studies, DNA, DNA/genetics*, Delta-5 Fatty Acid Desaturase, Fatty Acid Desaturases, Fatty Acid Desaturases/genetics*, Fatty Acid Desaturases/metabolism, Fatty Acids, Unsaturated, Fatty Acids, Unsaturated/genetics*, Fatty Acids, Unsaturated/metabolism, Female, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, Male, Polymorphism, Single Nucleotide*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1348, + "user_id": 1811967433, + "artical_title": "Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease.", + "pmid": 32220662, + "journal_name": "Atherosclerosis", + "date": "2020-03-30", + "author": "Tucker B,McClelland RL,Allison MA,Budoff MJ,Wu BJ,Barter PJ,Rye KA,Ong KL", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Cross-Sectional Studies, Female, Fibroblast Growth Factors, Fibroblast Growth Factors/blood*, Humans, Inflammation Mediators, Inflammation Mediators/blood*, Interleukin-6, Interleukin-6/blood*, Lipoproteins, Lipoproteins/blood*, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/blood*, Non-alcoholic Fatty Liver Disease/diagnostic imaging, Non-alcoholic Fatty Liver Disease/ethnology, Prognosis, Prospective Studies, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1349, + "user_id": 1811967433, + "artical_title": "Something Old Predicting Something New.", + "pmid": 31195820, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2020-04-01", + "author": "Lakshmanan S,Budoff MJ", + "auth_pos": 2, + "meshterms": "Calcium*, Coronary Vessels*, Heart Ventricles", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1350, + "user_id": 1811967433, + "artical_title": "Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.", + "pmid": 32238811, + "journal_name": "Nature communications", + "date": "2020-04-03", + "author": "Zekavat SM,Ruotsalainen S,Handsaker RE,Alver M,Bloom J,Poterba T,Seed C,Ernst J,Chaffin M,Engreitz J,Peloso GM,Manichaikul A,Yang C,Ryan KA,Fu M,Johnson WC,Tsai M,Budoff M,Vasan RS,Cupples LA,Rotter JI,Rich SS,Post W,Mitchell BD,Correa A,Metspalu A,Wilson JG,Salomaa V,Kellis M,Daly MJ,Neale BM,McCarroll S,Surakka I,Esko T,Ganna A,Ripatti S,Kathiresan S,Natarajan P", + "auth_pos": 18, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1351, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis).", + "pmid": 32233663, + "journal_name": "Circulation", + "date": "2020-04-03", + "author": "Cainzos-Achirica M,Miedema MD,McEvoy JW,Al Rifai M,Greenland P,Dardari Z,Budoff M,Blumenthal RS,Yeboah J,Duprez DA,Mortensen MB,Dzaye O,Hong J,Nasir K,Blaha MJ", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality, Aged, Aged, 80 and over, Aspirin, Aspirin/adverse effects, Aspirin/therapeutic use*, Clinical Decision-Making, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Coronary Artery Disease/ethnology, Coronary Artery Disease/mortality, Female, Heart Disease Risk Factors, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/ethnology, Hemorrhage/mortality, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/ethnology, Myocardial Infarction/mortality, Myocardial Infarction/prevention & control, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/adverse effects, Platelet Aggregation Inhibitors/therapeutic use*, Primary Prevention*, Prospective Studies, Risk Assessment, Stroke, Stroke/ethnology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/drug therapy*, Vascular Calcification/ethnology, Vascular Calcification/mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1352, + "user_id": 1811967433, + "artical_title": "Failed ISCHEMIA Trial or Failed Ischemia Testing?", + "pmid": 32234969, + "journal_name": "The Journal of invasive cardiology", + "date": "2020-04-03", + "author": "Dahal S,Budoff MJ", + "auth_pos": 2, + "meshterms": "Clinical Trials as Topic, Coronary Angiography, Coronary Artery Disease*, Exercise Test, Fractional Flow Reserve, Myocardial*, Humans, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnosis, Tomography, X-Ray Computed, Treatment Failure", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1353, + "user_id": 1811967433, + "artical_title": "Incidence of New Coronary Calcification: Time to Conversion From CAC = 0.", + "pmid": 32241379, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-04", + "author": "Dzaye O,Sun L,Xiao L,Dardari ZA,Liu Y,Barrowman N,Cainzos-Achirica M,Nishio N,Zhao Y,Momoli F,Kido A,Rahim FF,Murto K,Blankstein R,Abdulrahman SA,Bromwich M,Szklo M,Kurata Y,Kader Maideen SF,Proulx F,Budoff MJ,Minami M,Katz SL,Lima JAC,Tokunaga K,Rashid A,Blumenthal RS,Honda M,Lee CYD,Sung HL,Nasir K,Mandai M,Yang XW,Sengupta A,Togashi K,Yancy CW,Nesbitt D,Blaha MJ", + "auth_pos": 6, + "meshterms": "Aged, Calcinosis, Calcinosis/epidemiology*, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Time Factors, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1354, + "user_id": 1811967433, + "artical_title": "Computed tomography angiogram: Diagnosing device placement failure.", + "pmid": 32249194, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-04-07", + "author": "Golub I,Lakshmanan S,Calicchio F,Budoff MJ", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1355, + "user_id": 1811967433, + "artical_title": "Age-specific competing risk of cardiovascular versus cancer mortality as a function of coronary artery calcium: The Coronary Artery Calcium Consortium.", + "pmid": 32268145, + "journal_name": "The American journal of medicine", + "date": "2020-04-09", + "author": "Whelton SP,Rifai MA,Marshall CH,Dardari Z,Shaw LJ,Al-Mallah MH,Rozanski A,Mortensen MB,Dzaye O,Bazzano L,Kelly TN,Matsushita K,Rumberger JA,Berman DS,Budoff MJ,Miedema MD,Nasir K,Blaha MJ", + "auth_pos": 15, + "meshterms": "Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Aged, Cardiac-Gated Imaging Techniques, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/mortality*, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1356, + "user_id": 1811967433, + "artical_title": "Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial.", + "pmid": 32271261, + "journal_name": "Coronary artery disease", + "date": "2020-04-10", + "author": "Hamal S,Cherukuri L,Shaikh K,Kinninger A,Doshi J,Birudaraju D,Budoff MJ", + "auth_pos": 7, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Disease Progression, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Incretins, Incretins/therapeutic use*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging*, Randomized Controlled Trials as Topic, Treatment Outcome, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Disease Progression, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Incretins, Incretins/therapeutic use*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging*, Randomized Controlled Trials as Topic, Treatment Outcome, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Disease Progression, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Incretins, Incretins/therapeutic use*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging*, Randomized Controlled Trials as Topic, Treatment Outcome, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy*, Disease Progression, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Incretins, Incretins/therapeutic use*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging*, Randomized Controlled Trials as Topic, Treatment Outcome, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1357, + "user_id": 1811967433, + "artical_title": "Association of psychosocial traits with coronary artery calcium development and progression: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 32280016, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-04-14", + "author": "Abdulla AG,Buzkova P,Nakanishi R,Budoff MJ", + "auth_pos": 4, + "meshterms": "Affect, Aged, Aged, 80 and over, Anger, Anxiety, Anxiety/diagnosis, Anxiety/ethnology, Anxiety/psychology*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Coronary Artery Disease/psychology*, Databases, Factual, Depression, Depression/diagnosis, Depression/ethnology, Depression/psychology*, Disease Progression, Emotions*, Female, Hostility, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/psychology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1358, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium as a Synergistic Tool for the Age- and Sex-Specific Risk of Cardiovascular and Cancer Mortality: The Coronary Artery Calcium Consortium.", + "pmid": 32310025, + "journal_name": "Journal of the American Heart Association", + "date": "2020-04-21", + "author": "Dzaye O,Al Rifai M,Dardari Z,Shaw LJ,Al-Mallah MH,Handy Marshall C,Rozanski A,Mortensen MB,Duebgen M,Matsushita K,Rumberger JA,Berman DS,Budoff MJ,Miedema MD,Nasir K,Blaha MJ,Whelton SP", + "auth_pos": 13, + "meshterms": "Adult, Age Factors, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/mortality*, Cause of Death, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Neoplasms, Neoplasms/diagnosis, Neoplasms/mortality*, Predictive Value of Tests, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Factors, Time Factors, United States, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1359, + "user_id": 1811967433, + "artical_title": "Relation of Plasma Renin Activity to Subclinical Peripheral and Coronary Artery Disease (from the Multiethnic Study of Atherosclerosis).", + "pmid": 32307090, + "journal_name": "The American journal of cardiology", + "date": "2020-04-21", + "author": "Unkart JT,Allison MA,Abdelmalek JA,Jenny NS,McClelland RL,Budoff M,Ix JH,Rifkin DE", + "auth_pos": 6, + "meshterms": "Aldosterone, Aldosterone/blood, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/blood*, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood*, Female, Humans, Inflammation, Inflammation/blood, Kidney Function Tests, Male, Peripheral Vascular Diseases, Peripheral Vascular Diseases/blood*, Renin, Renin/blood*, Risk Factors, Vascular Calcification, Vascular Calcification/blood, Aldosterone, Aldosterone/blood, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/blood*, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood*, Female, Humans, Inflammation, Inflammation/blood, Kidney Function Tests, Male, Peripheral Vascular Diseases, Peripheral Vascular Diseases/blood*, Renin, Renin/blood*, Risk Factors, Vascular Calcification, Vascular Calcification/blood, Aldosterone, Aldosterone/blood, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/blood*, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood*, Female, Humans, Inflammation, Inflammation/blood, Kidney Function Tests, Male, Peripheral Vascular Diseases, Peripheral Vascular Diseases/blood*, Renin, Renin/blood*, Risk Factors, Vascular Calcification, Vascular Calcification/blood, Aldosterone, Aldosterone/blood, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/blood*, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood*, Female, Humans, Inflammation, Inflammation/blood, Kidney Function Tests, Male, Peripheral Vascular Diseases, Peripheral Vascular Diseases/blood*, Renin, Renin/blood*, Risk Factors, Vascular Calcification, Vascular Calcification/blood, Aldosterone, Aldosterone/blood, Ankle Brachial Index, Atherosclerosis, Atherosclerosis/blood*, Biomarkers, Biomarkers/blood, Coronary Artery Disease, Coronary Artery Disease/blood*, Female, Humans, Inflammation, Inflammation/blood, Kidney Function Tests, Male, Peripheral Vascular Diseases, Peripheral Vascular Diseases/blood*, Renin, Renin/blood*, Risk Factors, Vascular Calcification, Vascular Calcification/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1360, + "user_id": 1811967433, + "artical_title": "Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high-risk lesions.", + "pmid": 32319221, + "journal_name": "Arthritis & rheumatology (Hoboken, N.J.)", + "date": "2020-04-23", + "author": "Karpouzas GA,Kim J,Ormseth SR,Lee SH,Rha KH,Hernandez E,Ham WS,Budoff MJ", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1361, + "user_id": 1811967433, + "artical_title": "Predictors of coronary artery calcium among 20-30-year-olds: The Coronary Artery Calcium Consortium.", + "pmid": 32330692, + "journal_name": "Atherosclerosis", + "date": "2020-04-25", + "author": "Osei AD,Uddin SMI,Dzaye O,Achirica MC,Dardari ZA,Obisesan OH,Kianoush S,Mirbolouk M,Orimoloye OA,Shaw L,Rumberger JA,Berman D,Rozanski A,Miedema MD,Budoff MJ,Vasan RS,Nasir K,Blaha MJ", + "auth_pos": 15, + "meshterms": "Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Calcium, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1362, + "user_id": 1811967433, + "artical_title": "Role of Coronary Artery and Thoracic Aortic Calcium as Risk Modifiers to Guide Antihypertensive Therapy in Stage 1 Hypertension (From the Multiethnic Study of Atherosclerosis).", + "pmid": 32359719, + "journal_name": "The American journal of cardiology", + "date": "2020-05-04", + "author": "Elshazly MB,Abdellatif A,Dargham SR,Rifai MA,Quispe R,Cainzos-Achirica M,Martin SS,Yeboah J,Psaty BM,Post WS,Nasir K,Budoff MJ,Blumenthal RS,Blaha MJ,McEvoy JW", + "auth_pos": 12, + "meshterms": "Aged, Antihypertensive Agents, Antihypertensive Agents/therapeutic use*, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging*, Cohort Studies, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Female, Humans, Hypertension, Hypertension/drug therapy*, Male, Middle Aged, Multidetector Computed Tomography, Risk Assessment, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1363, + "user_id": 1811967433, + "artical_title": "Automatic segmentation of multiple cardiovascular structures from cardiac computed tomography angiography images using deep learning.", + "pmid": 32374784, + "journal_name": "PloS one", + "date": "2020-05-07", + "author": "Baskaran L,Al'Aref SJ,Maliakal G,Lee BC,Xu Z,Choi JW,Lee SE,Sung JM,Lin FY,Dunham S,Mosadegh B,Kim YJ,Gottlieb I,Lee BK,Chun EJ,Cademartiri F,Maffei E,Marques H,Shin S,Choi JH,Chinnaiyan K,Hadamitzky M,Conte E,Andreini D,Pontone G,Budoff MJ,Leipsic JA,Raff GL,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Bax JJ,Chang HJ,Min JK,Shaw LJ", + "auth_pos": 26, + "meshterms": "Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Deep Learning*, Female, Heart, Heart/diagnostic imaging*, Heart Atria, Heart Atria/diagnostic imaging, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Male, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1364, + "user_id": 1811967433, + "artical_title": "Association of flow mediated vasodilation and burden of subclinical atherosclerosis by coronary CTA.", + "pmid": 32413792, + "journal_name": "Atherosclerosis", + "date": "2020-05-16", + "author": "Lakshmanan S,Shekar C,Kinninger A,Birudaraju D,Dahal S,Onuegbu A,Cherukuri L,Hamal S,Flores F,Dailing C,Roy SK,Budoff M", + "auth_pos": 12, + "meshterms": "Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Brachial Artery, Brachial Artery/diagnostic imaging, Coronary Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Retrospective Studies, Risk Factors, Vasodilation*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1365, + "user_id": 1811967433, + "artical_title": "Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.", + "pmid": 32520334, + "journal_name": "JAMA cardiology", + "date": "2020-06-11", + "author": "Whelton SP,McEvoy JW,Shaw L,Psaty BM,Lima JAC,Budoff M,Nasir K,Szklo M,Blumenthal RS,Blaha MJ", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1366, + "user_id": 1811967433, + "artical_title": "Myocardial crypt, diverticulum, or aneurysm? CTA as an adjudicator.", + "pmid": 32524243, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2020-06-12", + "author": "Golub I,Lakshmanan S,Budoff MJ", + "auth_pos": 3, + "meshterms": "Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/diagnostic imaging*, Cardiomyopathy, Hypertrophic/pathology, Computed Tomography Angiography*, Coronary Angiography*, Diagnosis, Differential, Diverticulum, Diverticulum/diagnostic imaging*, Female, Heart Aneurysm, Heart Aneurysm/diagnostic imaging*, Heart Defects, Congenital, Heart Defects, Congenital/diagnostic imaging*, Heart Defects, Congenital/pathology, Humans, Myocardium, Myocardium/pathology*, Predictive Value of Tests, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1367, + "user_id": 1811967433, + "artical_title": "Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.", + "pmid": 32530466, + "journal_name": "American journal of hypertension", + "date": "2020-06-13", + "author": "Itano S,Yano Y,Nagasu H,Tomiyama H,Kanegae H,Makino H,Higashi Y,Kobayashi Y,Sogawa Y,Satoh M,Suzuki K,Townsend RR,Budoff M,Bakris G,Kashihara N", + "auth_pos": 13, + "meshterms": "Ankle Brachial Index, Ankle Brachial Index/methods*, Ankle Brachial Index/statistics & numerical data, Disease Progression, Female, Glomerular Filtration Rate, Humans, Hypertension*, Hypertension/diagnosis, Hypertension/physiopathology, Japan, Japan/epidemiology, Kidney, Kidney/physiopathology, Kidney Function Tests, Kidney Function Tests/methods, Kidney Function Tests/statistics & numerical data, Male, Medical Records, Problem-Oriented, Medical Records, Problem-Oriented/statistics & numerical data, Middle Aged, Prognosis, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/prevention & control, Retrospective Studies, Risk Assessment, Vascular Stiffness*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1368, + "user_id": 1811967433, + "artical_title": "Non-obstructive high-risk plaques increase the risk of future culprit lesions comparable to obstructive plaques without high-risk features: the ICONIC study.", + "pmid": 32535636, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-06-15", + "author": "Ferraro RA,van Rosendael AR,Lu Y,Andreini D,Al-Mallah MH,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,de Araújo Gonçalves P,Hadamitzky M,Kim YJ,Leipsic J,Maffei E,Marques H,Plank F,Pontone G,Raff GL,Villines TC,Lee SE,Al'Aref SJ,Baskaran L,Cho I,Danad I,Gransar H,Budoff MJ,Samady H,Stone PH,Virmani R,Narula J,Berman DS,Chang HJ,Bax JJ,Min JK,Shaw LJ,Lin FY", + "auth_pos": 28, + "meshterms": "Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors, Acute Coronary Syndrome*, Aged, Case-Control Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Retrospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1369, + "user_id": 1811967433, + "artical_title": "Feasibility of measuring pericoronary fat from precontrast scans: Effect of iodinated contrast on pericoronary fat attenuation.", + "pmid": 32576456, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-06-25", + "author": "Almeida S,Pelter M,Shaikh K,Cherukuri L,Birudaraju D,Kim K,Modi J,Shekar C,Sheikh M,Kinninger A,Hill E,Mutchler C,Tabb L,Falk R,Dey D,Gonzalez J,Karlsberg R,Wesbey G,Budoff M", + "auth_pos": 19, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1370, + "user_id": 1811967433, + "artical_title": "Predicting Left Atrial Appendage Thrombus from Left Atrial Volume and Confirmation by Computed Tomography with Delayed Enhancement.", + "pmid": 32603460, + "journal_name": "Texas Heart Institute journal", + "date": "2020-07-01", + "author": "Osawa K,Nakanishi R,Ceponiene I,Nezarat N,French WJ,Budoff MJ", + "auth_pos": 6, + "meshterms": "Aged, Atrial Appendage*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Cardiac Volume, Cardiac Volume/physiology*, Female, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/physiopathology, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Humans, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Thrombosis, Thrombosis/diagnosis*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1371, + "user_id": 1811967433, + "artical_title": "Rebuttal to \"The ISCHEMIA Algorithm or the FAME-2 Algorithm to Detect Ischemia?", + "pmid": 32610283, + "journal_name": "The Journal of invasive cardiology", + "date": "2020-07-02", + "author": "Dahal S,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1372, + "user_id": 1811967433, + "artical_title": "Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: A prospective, placebo-controlled randomized trial (EVAPORATE): Interim Results.", + "pmid": 32609331, + "journal_name": "Cardiovascular research", + "date": "2020-07-02", + "author": "Budoff MJ,Muhlestein JB,Bhatt DL,Le Pa VT,May HT,Shaikh K,Shekar C,Kinninger A,Lakshmanan S,Roy S,Tayek J,Nelson JR", + "auth_pos": 1, + "meshterms": "Adult, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipid Regulating Agents, Lipid Regulating Agents/adverse effects, Lipid Regulating Agents/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Plaque, Atherosclerotic*, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Triglycerides/blood*, Adult, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipid Regulating Agents, Lipid Regulating Agents/adverse effects, Lipid Regulating Agents/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Plaque, Atherosclerotic*, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Triglycerides/blood*, Adult, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipid Regulating Agents, Lipid Regulating Agents/adverse effects, Lipid Regulating Agents/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Plaque, Atherosclerotic*, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Triglycerides/blood*, Adult, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipid Regulating Agents, Lipid Regulating Agents/adverse effects, Lipid Regulating Agents/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Plaque, Atherosclerotic*, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Triglycerides/blood*, Adult, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy*, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Dyslipidemias, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy*, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Lipid Regulating Agents, Lipid Regulating Agents/adverse effects, Lipid Regulating Agents/therapeutic use*, Male, Middle Aged, Multidetector Computed Tomography, Plaque, Atherosclerotic*, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Triglycerides/blood*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1373, + "user_id": 1811967433, + "artical_title": "Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial.", + "pmid": 32615321, + "journal_name": "Atherosclerosis", + "date": "2020-07-03", + "author": "Lakshmanan S,Shekar C,Kinninger A,Dahal S,Onuegbu A,Cai AN,Hamal S,Birudaraju D,Cherukuri L,Flores F,Dailing C,Roy SK,Bhatt DL,Nelson JR,Budoff MJ", + "auth_pos": 15, + "meshterms": "Cholesterol, HDL, Cholesterol, HDL/blood*, Cholesterol, LDL, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Plaque, Atherosclerotic*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1374, + "user_id": 1811967433, + "artical_title": "Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 32620506, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-07-06", + "author": "Garg PK,Guan W,Karger AB,Steffen BT,Budoff M,Tsai MY", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Aorta, Thoracic*, Aorta, Thoracic/diagnostic imaging, Aortic Diseases, Aortic Diseases/blood*, Aortic Diseases/diagnostic imaging, Aortic Diseases/ethnology, Biomarkers, Biomarkers/blood, Calcinosis, Calcinosis/blood*, Calcinosis/diagnostic imaging, Calcinosis/ethnology, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Cross-Sectional Studies, Female, Heart Valve Diseases, Heart Valve Diseases/blood*, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/ethnology, Humans, Incidence, Lipoprotein(a), Lipoprotein(a)/blood*, Male, Middle Aged, Mitral Valve*, Mitral Valve/diagnostic imaging, Prevalence, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Aged, Aged, 80 and over, Aorta, Thoracic*, Aorta, Thoracic/diagnostic imaging, Aortic Diseases, Aortic Diseases/blood*, Aortic Diseases/diagnostic imaging, Aortic Diseases/ethnology, Biomarkers, Biomarkers/blood, Calcinosis, Calcinosis/blood*, Calcinosis/diagnostic imaging, Calcinosis/ethnology, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Cross-Sectional Studies, Female, Heart Valve Diseases, Heart Valve Diseases/blood*, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/ethnology, Humans, Incidence, Lipoprotein(a), Lipoprotein(a)/blood*, Male, Middle Aged, Mitral Valve*, Mitral Valve/diagnostic imaging, Prevalence, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Aged, Aged, 80 and over, Aorta, Thoracic*, Aorta, Thoracic/diagnostic imaging, Aortic Diseases, Aortic Diseases/blood*, Aortic Diseases/diagnostic imaging, Aortic Diseases/ethnology, Biomarkers, Biomarkers/blood, Calcinosis, Calcinosis/blood*, Calcinosis/diagnostic imaging, Calcinosis/ethnology, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Cross-Sectional Studies, Female, Heart Valve Diseases, Heart Valve Diseases/blood*, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/ethnology, Humans, Incidence, Lipoprotein(a), Lipoprotein(a)/blood*, Male, Middle Aged, Mitral Valve*, Mitral Valve/diagnostic imaging, Prevalence, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/blood*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1375, + "user_id": 1811967433, + "artical_title": "Association of Body Mass Index With Coronary Artery Calcium and Subsequent Cardiovascular Mortality: The Coronary Artery Calcium Consortium.", + "pmid": 32660258, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2020-07-15", + "author": "Jensen JC,Dardari ZA,Blaha MJ,White S,Shaw LJ,Rumberger J,Rozanski A,Berman DS,Budoff MJ,Nasir K,Miedema MD", + "auth_pos": 9, + "meshterms": "Adult, Aged, Body Mass Index*, Cause of Death, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology*, Coronary Artery Disease/mortality, Female, Humans, Male, Middle Aged, Obesity, Obesity/diagnosis, Obesity/epidemiology*, Obesity/mortality, Prevalence, Prognosis, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology*, Vascular Calcification/mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1376, + "user_id": 1811967433, + "artical_title": "A Boosted Ensemble Algorithm for Determination of Plaque Stability in High-Risk Patients on Coronary CTA.", + "pmid": 32682719, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-07-20", + "author": "Al'Aref SJ,Singh G,Choi JW,Xu Z,Maliakal G,van Rosendael AR,Lee BC,Fatima Z,Andreini D,Bax JJ,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,Hadamitzky M,Kim YJ,Lee SE,Leipsic JA,Maffei E,Marques H,Plank F,Pontone G,Raff GL,Villines TC,Weirich HG,Cho I,Danad I,Han D,Heo R,Lee JH,Rizvi A,Stuijfzand WJ,Gransar H,Lu Y,Sung JM,Park HB,Berman DS,Budoff MJ,Samady H,Stone PH,Virmani R,Narula J,Chang HJ,Lin FY,Baskaran L,Shaw LJ,Min JK", + "auth_pos": 40, + "meshterms": "Algorithms, Case-Control Studies, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Stenosis, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1377, + "user_id": 1811967433, + "artical_title": "Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry.", + "pmid": 32682451, + "journal_name": "Cardiovascular diabetology", + "date": "2020-07-20", + "author": "Won KB,Lee BK,Park HB,Heo R,Lee SE,Rizvi A,Lin FY,Kumar A,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,de Araújo Gonçalves P,Leipsic JA,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Raff GL,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Chang HJ", + "auth_pos": 15, + "meshterms": "Aged, Biomarkers, Biomarkers/blood, Blood Glucose, Blood Glucose/analysis*, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/blood*, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography*, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Time Factors, Triglycerides, Triglycerides/blood*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1378, + "user_id": 1811967433, + "artical_title": "Association of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs With Vertebral Trabecular Bone: Data From Multiethnic Study of Atherosclerosis, a Population-Based Multicenter Cohort Study.", + "pmid": 32697527, + "journal_name": "Journal of computer assisted tomography", + "date": "2020-07-23", + "author": "Ahmad K,Budoff MJ,Delaney JA,Mao S,Gao Y,Nasir K,Tracy R,Li D", + "auth_pos": 2, + "meshterms": "Aged, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects, Bone Density, Bone Density/drug effects, Cancellous Bone, Cancellous Bone/diagnostic imaging*, Cancellous Bone/drug effects, Cross-Sectional Studies, Female, Fractures, Bone, Fractures, Bone/diagnostic imaging, Fractures, Bone/epidemiology*, Humans, Lumbar Vertebrae, Lumbar Vertebrae/diagnostic imaging*, Lumbar Vertebrae/drug effects, Male, Middle Aged, Prospective Studies, Thoracic Vertebrae, Thoracic Vertebrae/diagnostic imaging*, Thoracic Vertebrae/drug effects, Tomography, X-Ray Computed, United States, United States/ethnology, Aged, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Aspirin, Aspirin/administration & dosage*, Aspirin/adverse effects, Bone Density, Bone Density/drug effects, Cancellous Bone, Cancellous Bone/diagnostic imaging*, Cancellous Bone/drug effects, Cross-Sectional Studies, Female, Fractures, Bone, Fractures, Bone/diagnostic imaging, Fractures, Bone/epidemiology*, Humans, Lumbar Vertebrae, Lumbar Vertebrae/diagnostic imaging*, Lumbar Vertebrae/drug effects, Male, Middle Aged, Prospective Studies, Thoracic Vertebrae, Thoracic Vertebrae/diagnostic imaging*, Thoracic Vertebrae/drug effects, Tomography, X-Ray Computed, United States, United States/ethnology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1379, + "user_id": 1811967433, + "artical_title": "Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults.", + "pmid": 32698652, + "journal_name": "Journal of the American Heart Association", + "date": "2020-07-24", + "author": "Gore MO,Ayers CR,Khera A,deFilippi CR,Wang TJ,Seliger SL,Nambi V,Selvin E,Berry JD,Hundley WG,Budoff M,Greenland P,Drazner MH,Ballantyne CM,Levine BD,de Lemos JA", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood, Aged, Aged, 80 and over, Biomarkers, Biomarkers/blood, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/etiology*, Carotid Intima-Media Thickness, Electrocardiography, Female, Humans, Male, Middle Aged, Natriuretic Peptide, Brain, Natriuretic Peptide, Brain/blood, Peptide Fragments, Peptide Fragments/blood, Risk Assessment, Risk Factors, Troponin T, Troponin T/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1380, + "user_id": 1811967433, + "artical_title": "Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.", + "pmid": 32706382, + "journal_name": "JAMA network open", + "date": "2020-07-25", + "author": "Han D,Berman DS,Miller RJH,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic J,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Virmani R,Samady H,Stone P,Narula J,Bax JJ,Shaw LJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "Aged, Brazil, Brazil/epidemiology, Cardiovascular Diseases, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/physiopathology*, Cohort Studies, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/statistics & numerical data*, Coronary Artery Disease, Coronary Artery Disease/classification*, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology, Disease Progression, Female, Humans, Male, Middle Aged, Portugal, Portugal/epidemiology, Prospective Studies, Quebec, Quebec/epidemiology, Registries, Registries/statistics & numerical data, Republic of Korea, Republic of Korea/epidemiology, Risk Factors*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1381, + "user_id": 1811967433, + "artical_title": "High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index.", + "pmid": 32723810, + "journal_name": "Lupus science & medicine", + "date": "2020-07-30", + "author": "Stojan G,Li J,Budoff M,Arbab-Zadeh A,Petri MA", + "auth_pos": 3, + "meshterms": "Adult, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Female, Humans, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/etiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1382, + "user_id": 1811967433, + "artical_title": "Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 32738574, + "journal_name": "Atherosclerosis", + "date": "2020-08-02", + "author": "Fashanu OE,Bizanti A,Al-Abdouh A,Zhao D,Budoff MJ,Thomas IC,Longstreth WT,Michos ED", + "auth_pos": 5, + "meshterms": "Aged, Aortic Valve Stenosis*, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnosis, Calcinosis/epidemiology, Ethnic Groups, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Male, Middle Aged, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1383, + "user_id": 1811967433, + "artical_title": "Cystatin C based estimation of glomerular filtration rate and association with atherosclerosis imaging markers in people living with HIV.", + "pmid": 32740375, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2020-08-03", + "author": "Mcclean M,Buzkova P,Budoff M,Estrella M,Freiberg M,Hodis HN,Palella F,Shikuma C,Post WS,Gupta S", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1384, + "user_id": 1811967433, + "artical_title": "Per-lesion versus per-patient analysis of coronary artery disease in predicting the development of obstructive lesions: the Progression of AtheRosclerotic PlAque DetermIned by Computed TmoGraphic Angiography Imaging (PARADIGM) study.", + "pmid": 32779077, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2020-08-12", + "author": "Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Stenosis, Coronary Stenosis/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Disease Progression, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Registries, Risk Assessment, Rupture, Spontaneous, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1385, + "user_id": 1811967433, + "artical_title": "Age- and sex-related features of atherosclerosis from coronary computed tomography angiography in patients prior to acute coronary syndrome: results from the ICONIC study.", + "pmid": 32793985, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-08-15", + "author": "Conte E,Dwivedi A,Mushtaq S,Pontone G,Lin FY,Hollenberg EJ,Lee SE,Bax J,Cademartiri F,Chinnaiyan K,Chow BJW,Cury RC,Feuchtner G,Hadamitzky M,Kim YJ,Baggiano A,Leipsic J,Maffei E,Marques H,Plank F,Raff GL,van Rosendael AR,Villines TC,Weirich HG,Al'Aref SJ,Baskaran L,Cho I,Danad I,Han D,Heo R,Lee JH,Stuijfzand WJ,Gransar H,Lu Y,Sung JM,Park HB,Al-Mallah MH,de Araújo Gonçalves P,Berman DS,Budoff MJ,Samady H,Shaw LJ,Stone PH,Virmani R,Narula J,Min JK,Chang HJ,Andreini D", + "auth_pos": 40, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Aged, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1386, + "user_id": 1811967433, + "artical_title": "Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium.", + "pmid": 32816996, + "journal_name": "Diabetes care", + "date": "2020-08-21", + "author": "Wong ND,Cordola Hsu AR,Rozanski A,Shaw LJ,Whelton SP,Budoff MJ,Nasir K,Miedema MD,Rumberger J,Blaha MJ,Berman DS", + "auth_pos": 6, + "meshterms": "Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult, Adult, Aged, Aged, 80 and over, Calcium, Calcium/blood, Calcium/metabolism, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/etiology, Cause of Death, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology*, Diabetes Mellitus/mortality, Diabetic Angiopathies, Diabetic Angiopathies/epidemiology*, Diabetic Angiopathies/mortality, Female, Humans, Male, Middle Aged, Mortality, Risk Assessment, Risk Factors, Severity of Illness Index, Sex Characteristics, Time Factors, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/epidemiology*, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1387, + "user_id": 1811967433, + "artical_title": "Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.", + "pmid": 32819467, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-08-21", + "author": "Kagiyama N,Piccirilli M,Yanamala N,Shrestha S,Farjo PD,Casaclang-Verzosa G,Tarhuni WM,Nezarat N,Budoff MJ,Narula J,Sengupta PP", + "auth_pos": 9, + "meshterms": "Early Diagnosis, Echocardiography, Echocardiography/methods*, Female, Heart Failure, Diastolic, Heart Failure, Diastolic/diagnosis, Heart Failure, Diastolic/physiopathology, Humans, Machine Learning*, Male, Middle Aged, Myocardial Contraction, Myocardial Contraction/physiology*, Predictive Value of Tests, ROC Curve, Signal Processing, Computer-Assisted, Stroke Volume*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/diagnosis, Ventricular Dysfunction, Left/physiopathology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1388, + "user_id": 1811967433, + "artical_title": "Cardiovascular and All-Cause Mortality Risk by Coronary Artery Calcium Scores and Percentiles Among Older Adult Males and Females.", + "pmid": 32822664, + "journal_name": "The American journal of medicine", + "date": "2020-08-22", + "author": "Wang FM,Rozanski A,Arnson Y,Budoff MJ,Miedema MD,Nasir K,Shaw LJ,Rumberger JA,Blumenthal RS,Matsushita K,Blaha MJ,Berman DS", + "auth_pos": 4, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Calcium, Calcium/analysis*, Cardiovascular Diseases, Cardiovascular Diseases/mortality*, Cause of Death, Cohort Studies, Coronary Vessels, Coronary Vessels/chemistry*, Female, Heart Disease Risk Factors, Humans, Male, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1389, + "user_id": 1811967433, + "artical_title": "Sex Differences in Compositional Plaque Volume Progression in Patients With Coronary Artery Disease.", + "pmid": 32828763, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-08-24", + "author": "Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Vessels, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Risk Factors, Sex Characteristics", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1390, + "user_id": 1811967433, + "artical_title": "Association Between Cardiovascular Risk Factors and the Diameter of the Thoracic Aorta in an Asymptomatic Population in the Central Appalachian Region.", + "pmid": 32828521, + "journal_name": "The American journal of the medical sciences", + "date": "2020-08-24", + "author": "Paul TK,Alamin AE,Subedi P,Alamian A,Wang L,Blackwell G,Budoff M,Mamudu HM", + "auth_pos": 7, + "meshterms": "Aged, Aorta, Thoracic, Aorta, Thoracic/anatomy & histology*, Aorta, Thoracic/diagnostic imaging, Appalachian Region, Body Mass Index, Female, Heart Disease Risk Factors*, Humans, Hypertension, Male, Middle Aged, Smoking, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1391, + "user_id": 1811967433, + "artical_title": "Ambient air pollution, traffic proximity and coronary atherosclerotic phenotype in China.", + "pmid": 32846635, + "journal_name": "Environmental research", + "date": "2020-08-28", + "author": "Wang M,Hou ZH,Xu H,Budoff MJ,Szpiro AA,Vedal S,Kaufman JD,Lu B", + "auth_pos": 4, + "meshterms": "Aged, Air Pollutants*, Air Pollutants/analysis, Air Pollutants/toxicity, Air Pollution*, Air Pollution/adverse effects, Air Pollution/analysis, Atherosclerosis*, China, China/epidemiology, Environmental Exposure, Environmental Exposure/adverse effects, Environmental Exposure/analysis, Humans, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/toxicity, Particulate Matter, Particulate Matter/analysis, Particulate Matter/toxicity, Phenotype, Traffic-Related Pollution*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1392, + "user_id": 1811967433, + "artical_title": "Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.", + "pmid": 32860032, + "journal_name": "European heart journal", + "date": "2020-08-30", + "author": "Budoff MJ,Bhatt DL,Kinninger A,Lakshmanan S,Muhlestein JB,Le VT,May HT,Shaikh K,Shekar C,Roy SK,Tayek J,Nelson JR", + "auth_pos": 1, + "meshterms": "Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1393, + "user_id": 1811967433, + "artical_title": "Prognostic significance of subtle coronary calcification in patients with zero coronary artery calcium score: From the CONFIRM registry.", + "pmid": 32862086, + "journal_name": "Atherosclerosis", + "date": "2020-08-31", + "author": "Han D,Klein E,Friedman J,Gransar H,Achenbach S,Al-Mallah MH,Budoff MJ,Cademartiri F,Maffei E,Callister TQ,Chinnaiyan K,Chow BJW,DeLago A,Hadamitzky M,Hausleiter J,Kaufmann PA,Villines TC,Kim YJ,Leipsic J,Feuchtner G,Cury RC,Pontone G,Andreini D,Marques H,Rubinshtein R,Chang HJ,Lin FY,Shaw LJ,Min JK,Berman DS", + "auth_pos": 7, + "meshterms": "Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1394, + "user_id": 1811967433, + "artical_title": "Where ISCHEMIA fails, coronary CTA shines.", + "pmid": 32871187, + "journal_name": "International journal of cardiology", + "date": "2020-09-02", + "author": "Lakshmanan S,Budoff MJ", + "auth_pos": 2, + "meshterms": "Conservative Treatment, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Fractional Flow Reserve, Myocardial*, Humans, Ischemia", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1395, + "user_id": 1811967433, + "artical_title": "Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review.", + "pmid": 32883417, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-09-05", + "author": "Abdelrahman KM,Chen MY,Dey AK,Virmani R,Finn AV,Khamis RY,Choi AD,Min JK,Williams MC,Buckler AJ,Taylor CA,Rogers C,Samady H,Antoniades C,Shaw LJ,Budoff MJ,Hoffmann U,Blankstein R,Narula J,Mehta NN", + "auth_pos": 16, + "meshterms": "Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Biomedical Technology, Biomedical Technology/trends*, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Computed Tomography Angiography/trends*, Coronary Angiography, Coronary Angiography/methods, Coronary Angiography/trends*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging*, Humans, Review Literature as Topic, Risk Assessment, Risk Assessment/methods, Risk Assessment/trends, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1396, + "user_id": 1811967433, + "artical_title": "ISCHEMIA trial - Failed intervention or failed stratification?", + "pmid": 32888878, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-09-06", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Vessels, Humans, Ischemia, Plaque, Atherosclerotic*, Predictive Value of Tests, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1397, + "user_id": 1811967433, + "artical_title": "The evolving pandemic of COVID-19 and increasing role of cardiac computed tomography.", + "pmid": 32897900, + "journal_name": "Coronary artery disease", + "date": "2020-09-09", + "author": "Chaganti BT,Cherukuri L,Birudaraju D,Roy SK,Budoff MJ", + "auth_pos": 5, + "meshterms": "COVID-19, COVID-19/prevention & control*, COVID-19/transmission, COVID-19/virology, Equipment Contamination, Equipment Contamination/prevention & control, Fractional Flow Reserve, Myocardial, Humans, Infection Control, Infectious Disease Transmission, Patient-to-Professional, Infectious Disease Transmission, Patient-to-Professional/prevention & control, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging*, Myocardial Ischemia/physiopathology, Myocardial Ischemia/virology, Occupational Exposure, Occupational Exposure/prevention & control, Occupational Health, Predictive Value of Tests, Risk Assessment, Risk Factors, SARS-CoV-2, SARS-CoV-2/pathogenicity*, Tomography Scanners, X-Ray Computed, Tomography Scanners, X-Ray Computed/virology, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/adverse effects, Tomography, X-Ray Computed/instrumentation, COVID-19, COVID-19/prevention & control*, COVID-19/transmission, COVID-19/virology, Equipment Contamination, Equipment Contamination/prevention & control, Fractional Flow Reserve, Myocardial, Humans, Infection Control, Infectious Disease Transmission, Patient-to-Professional, Infectious Disease Transmission, Patient-to-Professional/prevention & control, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging*, Myocardial Ischemia/physiopathology, Myocardial Ischemia/virology, Occupational Exposure, Occupational Exposure/prevention & control, Occupational Health, Predictive Value of Tests, Risk Assessment, Risk Factors, SARS-CoV-2, SARS-CoV-2/pathogenicity*, Tomography Scanners, X-Ray Computed, Tomography Scanners, X-Ray Computed/virology, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/adverse effects, Tomography, X-Ray Computed/instrumentation, COVID-19, COVID-19/prevention & control*, COVID-19/transmission, COVID-19/virology, Equipment Contamination, Equipment Contamination/prevention & control, Fractional Flow Reserve, Myocardial, Humans, Infection Control, Infectious Disease Transmission, Patient-to-Professional, Infectious Disease Transmission, Patient-to-Professional/prevention & control, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging*, Myocardial Ischemia/physiopathology, Myocardial Ischemia/virology, Occupational Exposure, Occupational Exposure/prevention & control, Occupational Health, Predictive Value of Tests, Risk Assessment, Risk Factors, SARS-CoV-2, SARS-CoV-2/pathogenicity*, Tomography Scanners, X-Ray Computed, Tomography Scanners, X-Ray Computed/virology, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/adverse effects, Tomography, X-Ray Computed/instrumentation", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1398, + "user_id": 1811967433, + "artical_title": "Effect of Progression of Valvular Calcification on Left Ventricular Structure and Frequency of Incident Heart Failure (from the Multiethnic Study of Atherosclerosis).", + "pmid": 32917344, + "journal_name": "The American journal of cardiology", + "date": "2020-09-13", + "author": "Fashanu OE,Upadhrasta S,Zhao D,Budoff MJ,Pandey A,Lima JAC,Michos ED", + "auth_pos": 4, + "meshterms": "Aged, Aortic Valve, Aortic Valve/diagnostic imaging*, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology*, Cardiac-Gated Imaging Techniques, Disease Progression, Female, Heart Failure, Heart Failure/epidemiology*, Heart Failure/physiopathology, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology*, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Humans, Incidence, Male, Middle Aged, Mitral Valve, Mitral Valve/diagnostic imaging*, Proportional Hazards Models, Stroke Volume, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1399, + "user_id": 1811967433, + "artical_title": "The relationship between coronary artery calcium density and optical coherence tomography-derived plaque characteristics.", + "pmid": 32919282, + "journal_name": "Atherosclerosis", + "date": "2020-09-13", + "author": "Okubo R,Nakanishi R,Dailing C,Yabe T,Noike R,Matsumoto S,Aikawa H,Okamura Y,Hashimoto H,Amano H,Toda M,Maehara A,Budoff MJ,Ikeda T", + "auth_pos": 13, + "meshterms": "Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, Optical Coherence", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1400, + "user_id": 1811967433, + "artical_title": "Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.", + "pmid": 32936272, + "journal_name": "JAMA cardiology", + "date": "2020-09-17", + "author": "Whelton SP,McEvoy JW,Shaw L,Psaty BM,Lima JAC,Budoff M,Nasir K,Szklo M,Blumenthal RS,Blaha MJ", + "auth_pos": 6, + "meshterms": "Blood Pressure, Blood Pressure/physiology*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/physiopathology*, Female, Global Health, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Systole", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1401, + "user_id": 1811967433, + "artical_title": "Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk Among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines.", + "pmid": 32941817, + "journal_name": "The American journal of cardiology", + "date": "2020-09-18", + "author": "Rajan T,Rozanski A,Cainzos-Achirica M,Grandhi GR,Dardari ZA,Al-Mallah MH,Blankstein R,Miedema MD,Shaw LJ,Rumberger JA,Budoff MJ,Blaha MJ,Berman D,Nasir K", + "auth_pos": 11, + "meshterms": "Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/complications, Cardiovascular Diseases/mortality*, Cardiovascular Diseases/prevention & control*, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/complications, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Practice Guidelines as Topic, Primary Prevention, Retrospective Studies, Risk Assessment, Vascular Calcification, Vascular Calcification/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1402, + "user_id": 1811967433, + "artical_title": "Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome.", + "pmid": 31983575, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-09-30", + "author": "Almeida SO,Dai X,Ram RJ,Liu Y,Kinninger A,Zheng M,Xing F,Budoff MJ", + "auth_pos": 4, + "meshterms": "Acute Coronary Syndrome, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/drug therapy*, Acute Coronary Syndrome/physiopathology, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/drug effects*, Adipose Tissue/physiopathology, Adiposity, Adiposity/drug effects*, Anti-Inflammatory Agents, Anti-Inflammatory Agents/adverse effects, Anti-Inflammatory Agents/therapeutic use*, Canada, Computed Tomography Angiography, Double-Blind Method, Female, Humans, Hydroxyurea, Hydroxyurea/adverse effects, Hydroxyurea/analogs & derivatives*, Hydroxyurea/therapeutic use, Lipoxygenase Inhibitors, Lipoxygenase Inhibitors/adverse effects, Lipoxygenase Inhibitors/therapeutic use*, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging, Pericardium/drug effects*, Pericardium/physiopathology, Prospective Studies, Time Factors, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1403, + "user_id": 1811967433, + "artical_title": "Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups.", + "pmid": 33002750, + "journal_name": "Atherosclerosis", + "date": "2020-10-02", + "author": "Makshood M,Joshi PH,Kanaya AM,Ayers C,Budoff M,Tsai MY,Blaha M,Michos ED,Post WS", + "auth_pos": 5, + "meshterms": "Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors, Aortic Valve, Calcium*, Hispanic or Latino, Humans, Lipoprotein(a)*, Prevalence, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1404, + "user_id": 1811967433, + "artical_title": "Impact of age on coronary artery plaque progression and clinical outcome: A PARADIGM substudy.", + "pmid": 33032975, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-10-10", + "author": "Kim M,Lee SP,Kwak S,Yang S,Kim YJ,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Raff GL,Shin S,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Lin FY,Virmani R,Samady H,Stone PH,Narula J,Bax JJ,Shaw LJ,Min JK,Chang HJ", + "auth_pos": 8, + "meshterms": "Adult, Age Factors, Aged, Computed Tomography Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Progression, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Assessment, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1405, + "user_id": 1811967433, + "artical_title": "Multidetector computed tomography in transcatheter aortic valve replacement: an update on technological developments and clinical applications.", + "pmid": 33063552, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2020-10-17", + "author": "Abd Alamir M,Nazir S,Alani A,Golub I,Gilchrist IC,Aslam F,Dhawan P,Changal K,Ostra C,Soni R,Elzanaty A,Budoff M", + "auth_pos": 12, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Heart Valve Prosthesis, Humans, Multidetector Computed Tomography, Multidetector Computed Tomography/methods*, Prosthesis Design, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1406, + "user_id": 1811967433, + "artical_title": "Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.", + "pmid": 33061866, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2020-10-17", + "author": "Olshansky B,Chung MK,Budoff MJ,Philip S,Jiao L,Doyle RT,Copland C,Giaquinto A,Juliano RA,Bhatt DL", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1407, + "user_id": 1811967433, + "artical_title": "Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.", + "pmid": 33061864, + "journal_name": "European heart journal supplements : journal of the European Society of Cardiology", + "date": "2020-10-17", + "author": "O'Connell TD,Mason RP,Budoff MJ,Navar AM,Shearer GC", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1408, + "user_id": 1811967433, + "artical_title": "A Revolution in Omega-3 Fatty Acid Research.", + "pmid": 33121717, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-10-31", + "author": "Bhatt DL,Budoff MJ,Mason RP", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1409, + "user_id": 1811967433, + "artical_title": "Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.", + "pmid": 33121743, + "journal_name": "Atherosclerosis", + "date": "2020-10-31", + "author": "Osei AD,Mirbolouk M,Berman D,Budoff MJ,Miedema MD,Rozanski A,Rumberger JA,Shaw L,Al Rifai M,Dzaye O,Graham GN,Banach M,Blumenthal RS,Dardari ZA,Nasir K,Blaha MJ", + "auth_pos": 4, + "meshterms": "Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Adult, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1410, + "user_id": 1811967433, + "artical_title": "Predicting Long-Term Absence of Coronary Artery Calcium in Metabolic Syndrome and Diabetes: The MESA Study.", + "pmid": 33129732, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-11-02", + "author": "Razavi AC,Wong N,Budoff M,Bazzano LA,Kelly TN,He J,Fernandez C,Lima J,Polak JF,Mongraw-Chaffin M,deFilippi C,Szklo M,Bertoni AG,Blumenthal RS,Blaha MJ,Whelton SP", + "auth_pos": 3, + "meshterms": "Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification, Calcium, Coronary Artery Disease*, Coronary Vessels, Diabetes Mellitus, Type 2, Female, Humans, Male, Metabolic Syndrome*, Middle Aged, Predictive Value of Tests, Risk Factors, Vascular Calcification", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1411, + "user_id": 1811967433, + "artical_title": "Warranty Period of a Calcium Score of Zero: Comprehensive Analysis From the Multiethnic Study of Atherosclerosis.", + "pmid": 33129734, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-11-02", + "author": "Dzaye O,Dardari ZA,Cainzos-Achirica M,Blankstein R,Agatston AS,Duebgen M,Yeboah J,Szklo M,Budoff MJ,Lima JAC,Blumenthal RS,Nasir K,Blaha MJ", + "auth_pos": 9, + "meshterms": "Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Aged, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1412, + "user_id": 1811967433, + "artical_title": "Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths.", + "pmid": 33129741, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-11-02", + "author": "Nakanishi R,Slomka PJ,Rios R,Betancur J,Blaha MJ,Nasir K,Miedema MD,Rumberger JA,Gransar H,Shaw LJ,Rozanski A,Budoff MJ,Berman DS", + "auth_pos": 12, + "meshterms": "Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests, Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests, Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests, Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests, Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests, Adult, Aged, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Machine Learning, Male, Middle Aged, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1413, + "user_id": 1811967433, + "artical_title": "Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.", + "pmid": 33136746, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2020-11-03", + "author": "McClean M,Buzkova P,Budoff M,Estrella M,Freiberg M,Hodis HN,Palella F,Shikuma C,Post WS,Gupta S", + "auth_pos": 3, + "meshterms": "Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged, Adult, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Biomarkers, Calcium, Carotid Intima-Media Thickness, Coronary Vessels, Coronary Vessels/pathology, Cross-Sectional Studies, Cystatin C, Cystatin C/blood*, Cystatin C/metabolism, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/physiology*, HIV Infections, HIV Infections/blood*, HIV Infections/complications*, HIV-1*, Humans, Male, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1414, + "user_id": 1811967433, + "artical_title": "Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 33142714, + "journal_name": "Journal of clinical medicine", + "date": "2020-11-05", + "author": "Morze J,Koch M,Aroner SA,Budoff M,McClelland RL,Mukamal KJ,Jensen MK", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1415, + "user_id": 1811967433, + "artical_title": "Reduction in Revascularization with Icosapent Ethyl: Insights from REDUCE-IT REVASC.", + "pmid": 33148016, + "journal_name": "Circulation", + "date": "2020-11-06", + "author": "Peterson BE,Bhatt DL,Steg PG,Miller M,Brinton EA,Jacobson TA,Ketchum SB,Juliano RA,Jiao L,Doyle RT,Granowitz C,Gibson CM,Pinto D,Giugliano RP,Budoff MJ,Tardif JC,Verma S,Ballantyne CM", + "auth_pos": 15, + "meshterms": "Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revascularization, Myocardial Revascularization/methods*, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/therapeutic use*, Aged, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy*, Cardiovascular Diseases/physiopathology, Diabetes Mellitus, Diabetes Mellitus/drug therapy*, Diabetes Mellitus/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Male, Middle Aged, Myocardial Revasculariza", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1416, + "user_id": 1811967433, + "artical_title": "The Story of Wall Shear Stress in Coronary Artery Atherosclerosis: Biochemical Transport and Mechanotransduction.", + "pmid": 33156343, + "journal_name": "Journal of biomechanical engineering", + "date": "2020-11-07", + "author": "Mahmoudi M,Farghadan A,McConnell D,Barker AJ,Wentzel JJ,Budoff MJ,Arzani A", + "auth_pos": 6, + "meshterms": "Mechanotransduction, Cellular*, Coronary Artery Disease*, Coronary Artery Disease/metabolism, Coronary Artery Disease/physiopathology, Stress, Mechanical*, Humans, Shear Strength*, Biological Transport, Coronary Vessels, Coronary Vessels/metabolism, Coronary Vessels/physiopathology, Hydrodynamics, Atherosclerosis, Atherosclerosis/metabolism, Atherosclerosis/physiopathology, Models, Cardiovascular", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1417, + "user_id": 1811967433, + "artical_title": "Effect of a plant-based bioequivalent inorganic nitrate (NO) complex with vitamins, antioxidants and phytophenol rich food extracts in hypertensive individuals - A randomized, double-blind, placebo-controlled study.", + "pmid": 33183558, + "journal_name": "Clinical nutrition ESPEN", + "date": "2020-11-14", + "author": "Cherukuri L,Birudaraju D,Kinninger A,Chaganti BT,Shekar C,Hamal S,Shaikh K,Flores F,Roy SK,Sotka W,Green SJ,Budoff MJ", + "auth_pos": 12, + "meshterms": "Antioxidants, Beta vulgaris*, Humans, Infant, Newborn, Nitrates, Nitric Oxide*, Vitamins", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1418, + "user_id": 1811967433, + "artical_title": "Coronary Artery Disease in Patients with HIV Infection: An Update.", + "pmid": 33184766, + "journal_name": "American journal of cardiovascular drugs : drugs, devices, and other interventions", + "date": "2020-11-14", + "author": "Patel AA,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1419, + "user_id": 1811967433, + "artical_title": "The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.", + "pmid": 33186224, + "journal_name": "Current opinion in nephrology and hypertension", + "date": "2020-11-14", + "author": "Streja E,Norris KC,Budoff MJ,Hashemi L,Akbilgic O,Kalantar-Zadeh K", + "auth_pos": 3, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/etiology, Cardiovascular Diseases/therapy, Comorbidity, Humans, Machine Learning, Models, Cardiovascular*, Predictive Value of Tests, Renal Dialysis, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Risk Assessment*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1420, + "user_id": 1811967433, + "artical_title": "Comparative differences in the atherosclerotic disease burden between the epicardial coronary arteries: quantitative plaque analysis on coronary computed tomography angiography.", + "pmid": 33215192, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-11-21", + "author": "Bax AM,van Rosendael AR,Ma X,van den Hoogen IJ,Gianni U,Tantawy SW,Hollenberg EJ,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Virmani R,Samady H,Stone PH,Berman DS,Min JK,Narula J,Lin FY,Chang HJ,Shaw LJ", + "auth_pos": 10, + "meshterms": "Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cost of Illness, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1421, + "user_id": 1811967433, + "artical_title": "Use of Advanced CT Technology to Evaluate Left Atrial Indices in Patients with a High Heart Rate or with Heart Rate Variability: The Converge Registry.", + "pmid": 33219160, + "journal_name": "Journal of nuclear medicine technology", + "date": "2020-11-22", + "author": "Cherukuri L,Birudaraju D,Kinninger A,Chaganti BT,Pidikiti S,Pozon RG,Pozon ACG,Lakshmanan S,Dahal S,Hamal S,Flores F,Christopher D,Andreini D,Pontone G,Conte E,Nakanishi R,O'Rourke R,Hamilton-Craig C,Nasir K,Roy SK,Mao SS,Budoff MJ", + "auth_pos": 22, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1422, + "user_id": 1811967433, + "artical_title": "The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease.", + "pmid": 33221216, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-11-23", + "author": "Jin HY,Weir-McCall JR,Leipsic JA,Son JW,Sellers SL,Shao M,Blanke P,Ahmadi A,Hadamitzky M,Kim YJ,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Lee BK,Chun EJ,Cademartiri F,Maffei E,Marques H,de Araujo Goncalves P,Shin S,Choi JH,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Chinnaiyan K,Raff G,Al-Mallah MH,Lin FY,Min JK,Sung JM,Lee SE,Chang HJ", + "auth_pos": 14, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Vessels, Disease Progression, Humans, Plaque, Atherosclerotic, Predictive Value of Tests, Risk Factors, Vascular Calcification", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1423, + "user_id": 1811967433, + "artical_title": "Prediction of coronary artery calcium scoring from surface electrocardiogram in atherosclerotic cardiovascular disease: a pilot study.", + "pmid": 37056293, + "journal_name": "European heart journal. Digital health", + "date": "2020-11-23", + "author": "Farjo PD,Yanamala N,Kagiyama N,Patel HB,Casaclang-Verzosa G,Nezarat N,Budoff MJ,Sengupta PP", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1424, + "user_id": 1811967433, + "artical_title": "Community-Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV.", + "pmid": 33222591, + "journal_name": "Journal of the American Heart Association", + "date": "2020-11-24", + "author": "Zifodya JS,Duncan MS,So-Armah KA,Attia EF,Akgün KM,Rodriguez-Barradas MC,Marconi VC,Budoff MJ,Bedimo RJ,Alcorn CW,Soo Hoo GW,Butt AA,Kim JW,Sico JJ,Tindle HA,Huang L,Tate JP,Justice AC,Freiberg MS,Crothers K", + "auth_pos": 8, + "meshterms": "Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*, Adult, Aged, Cardiovascular Diseases, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology*, Cardiovascular Diseases/therapy, Cohort Studies, Community-Acquired Infections, Community-Acquired Infections/diagnosis, Community-Acquired Infections/epidemiology*, Community-Acquired Infections/therapy, Female, HIV Infections, HIV Infections/complications*, HIV Infections/therapy, Hospitalization, Humans, Incidence, Male, Middle Aged, Pneumonia, Pneumonia/diagnosis, Pneumonia/epidemiology*, Pneumonia/therapy, Survival Rate, United States, Veterans, Veterans/statistics & numerical data*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1425, + "user_id": 1811967433, + "artical_title": "Discrete subaortic stenosis characterized with ECG-gated cardiac CT: A case series.", + "pmid": 33229303, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-11-25", + "author": "Cai AN,Budoff MJ,Pillutla P", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1426, + "user_id": 1811967433, + "artical_title": "A noncoding variant near PPP1R3B promotes liver glycogen storage and MetS, but protects against myocardial infarction.", + "pmid": 33231259, + "journal_name": "The Journal of clinical endocrinology and metabolism", + "date": "2020-11-25", + "author": "Kahali B,Chen Y,Feitosa MF,Bielak LF,O'Connell JR,Musani SK,Hegde Y,Chen Y,Stetson LC,Guo X,Fu YP,Smith AV,Ryan KA,Eiriksdottir G,Cohain AT,Allison M,Bakshi A,Bowden DW,Budoff MJ,Carr JJ,Carskadon S,Chen YI,Correa A,Crudup BF,Du X,Harris TB,Yang J,Kardia SLR,Launer LJ,Liu J,Mosley TH,Norris JM,Terry JG,Palanisamy N,Schadt EE,O'Donnell CJ,Yerges-Armstrong LM,Rotter JI,Wagenknecht LE,Handelman SK,Gudnason V,Province MA,Peyser PA,Halligan B,Palmer ND,Speliotes EK", + "auth_pos": 19, + "meshterms": "Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*, Adult, Aged, Biomarkers, Biomarkers/analysis, Female, Follow-Up Studies, Glycogen Storage Disease, Glycogen Storage Disease/etiology*, Glycogen Storage Disease/metabolism, Glycogen Storage Disease/pathology, Humans, Liver Glycogen, Liver Glycogen/metabolism*, Male, Metabolic Syndrome, Metabolic Syndrome/etiology*, Metabolic Syndrome/metabolism, Metabolic Syndrome/pathology, Middle Aged, Myocardial Infarction, Myocardial Infarction/genetics, Myocardial Infarction/pathology, Myocardial Infarction/prevention & control*, Polymorphism, Single Nucleotide*, Prognosis, Prospective Studies, Protein Phosphatase 1, Protein Phosphatase 1/genetics*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1427, + "user_id": 1811967433, + "artical_title": "COVID-19 IgG/IgM antibody testing in Los Angeles County, California.", + "pmid": 33241444, + "journal_name": "European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology", + "date": "2020-11-27", + "author": "Ahmad K,Rezvanizadeh V,Dahal S,Kinninger A,Ghanem AK,Lakshmanan S,Hamal S,Flores F,Dailing C,Roy SK,Budoff MJ", + "auth_pos": 11, + "meshterms": "Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibodies, Viral/blood*, COVID-19, COVID-19/diagnosis*, COVID-19 Testing, Female, Humans, Immunoglobulin G, Immunoglobulin G/blood*, Immunoglobulin M, Immunoglobulin M/blood*, Male, Middle Aged, SARS-CoV-2, SARS-CoV-2/immunology*, Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibodies, Viral/blood*, COVID-19, COVID-19/diagnosis*, COVID-19 Testing, Female, Humans, Immunoglobulin G, Immunoglobulin G/blood*, Immunoglobulin M, Immunoglobulin M/blood*, Male, Middle Aged, SARS-CoV-2, SARS-CoV-2/immunology*, Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibodies, Viral/blood*, COVID-19, COVID-19/diagnosis*, COVID-19 Testing, Female, Humans, Immunoglobulin G, Immunoglobulin G/blood*, Immunoglobulin M, Immunoglobulin M/blood*, Male, Middle Aged, SARS-CoV-2, SARS-CoV-2/immunology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1428, + "user_id": 1811967433, + "artical_title": "To stress or not to stress: a new approach for diagnosing coronary heart disease.", + "pmid": 33269238, + "journal_name": "Quantitative imaging in medicine and surgery", + "date": "2020-12-04", + "author": "Mikielski K,Budoff M", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1429, + "user_id": 1811967433, + "artical_title": "Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV.", + "pmid": 33270338, + "journal_name": "HIV medicine", + "date": "2020-12-04", + "author": "Hiremath PG,Bhondoekhan F,Haberlen SA,Ashikaga H,Palella FJ,D'Souza G,Budoff MJ,Kingsley LA,Dobs AS,Post WS,Soliman EZ,Brown TT,Wu KC", + "auth_pos": 7, + "meshterms": "Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone, Cohort Studies, Electrocardiography, Electrocardiography/adverse effects, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Homosexuality, Male, Humans, Long QT Syndrome*, Long QT Syndrome/chemically induced, Long QT Syndrome/complications, Longitudinal Studies, Male, Prospective Studies, Sexual and Gender Minorities*, Testosterone", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1430, + "user_id": 1811967433, + "artical_title": "Association of Coronary Calcium, Carotid Wall Thickness, and Carotid Plaque Progression with Low Density Lipoprotein and High Density Lipoprotein Particle Concentration Measured by Ion Mobility (From Multiethnic Study of Atherosclerosis [MESA]).", + "pmid": 33278360, + "journal_name": "The American journal of cardiology", + "date": "2020-12-06", + "author": "Ceponiene I,Li D,Khoudary SRE,Nakanishi R,Stein JH,Wong ND,Nezarat N,Kanisawa M,Rahmani S,Osawa K,Tattersall M,Budoff MJ", + "auth_pos": 12, + "meshterms": "Aged, Carotid Arteries, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Intima-Media Thickness, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Ion Mobility Spectrometry, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Lipoproteins, LDL, Lipoproteins, LDL/blood*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/blood, Plaque, Atherosclerotic/diagnostic imaging*, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging*, Aged, Carotid Arteries, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Intima-Media Thickness, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Ion Mobility Spectrometry, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Lipoproteins, LDL, Lipoproteins, LDL/blood*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/blood, Plaque, Atherosclerotic/diagnostic imaging*, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging*, Aged, Carotid Arteries, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Intima-Media Thickness, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Ion Mobility Spectrometry, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Lipoproteins, LDL, Lipoproteins, LDL/blood*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/blood, Plaque, Atherosclerotic/diagnostic imaging*, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging*, Aged, Carotid Arteries, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Intima-Media Thickness, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Ion Mobility Spectrometry, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Lipoproteins, LDL, Lipoproteins, LDL/blood*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/blood, Plaque, Atherosclerotic/diagnostic imaging*, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging*, Aged, Carotid Arteries, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases, Carotid Artery Diseases/blood, Carotid Artery Diseases/diagnostic imaging*, Carotid Intima-Media Thickness, Cohort Studies, Coronary Artery Disease, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging*, Female, Humans, Ion Mobility Spectrometry, Lipoproteins, HDL, Lipoproteins, HDL/blood*, Lipoproteins, LDL, Lipoproteins, LDL/blood*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/blood, Plaque, Atherosclerotic/diagnostic imaging*, Tomography, X-Ray Computed, Vascular Calcification, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1431, + "user_id": 1811967433, + "artical_title": "Life's Simple 7 and Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 33285128, + "journal_name": "The American journal of medicine", + "date": "2020-12-08", + "author": "Oni E,Ogunmoroti O,Allen N,A-Mallah MH,Blankstein R,Martin SS,Zeb I,Cushman M,Joshi PH,Budoff MJ,Blaha MJ,Blumenthal RS,Veledar E,Nasir K", + "auth_pos": 10, + "meshterms": "Aged, Atherosclerosis, Atherosclerosis/ethnology*, Atherosclerosis/etiology*, Cohort Studies, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/complications*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1432, + "user_id": 1811967433, + "artical_title": "Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging - Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque.", + "pmid": 33303383, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2020-12-12", + "author": "Shaw LJ,Blankstein R,Bax JJ,Ferencik M,Bittencourt MS,Min JK,Berman DS,Leipsic J,Villines TC,Dey D,Al'Aref S,Williams MC,Lin F,Baskaran L,Litt H,Litmanovich D,Cury R,Gianni U,van den Hoogen I,R van Rosendael A,Budoff M,Chang HJ,E Hecht H,Feuchtner G,Ahmadi A,Ghoshajra BB,Newby D,Chandrashekhar YS,Narula J", + "auth_pos": 21, + "meshterms": "Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index, Computed Tomography Angiography, Computed Tomography Angiography/standards*, Consensus, Coronary Angiography, Coronary Angiography/standards*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Prognosis, Reproducibility of Results, Risk Assessment, Risk Factors, Rupture, Spontaneous, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1433, + "user_id": 1811967433, + "artical_title": "Comprehensive plaque assessment with serial coronary CT angiography: translation to bedside.", + "pmid": 32307630, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2020-12-15", + "author": "Li P,Robinson-Papp J,Neyret P,Lakshmanan S,Lindow T,Servien E,Rezvanizadeh V,Gu H,Lustig S,Budoff MJ,Dong RE,Smith SW", + "auth_pos": 3, + "meshterms": "Animals, Cardiovascular Agents, Cardiovascular Agents/therapeutic use, Computed Tomography Angiography*, Coronary Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/drug therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/drug effects, Disease Progression, Humans, Plaque, Atherosclerotic*, Predictive Value of Tests, Translational Medical Research, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1434, + "user_id": 1811967433, + "artical_title": "Use of Coronary Computed Tomography for Calcium Screening of Atherosclerosis.", + "pmid": 36276503, + "journal_name": "Heart international", + "date": "2020-12-17", + "author": "Beverly J,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1435, + "user_id": 1811967433, + "artical_title": "Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies.", + "pmid": 33333344, + "journal_name": "Atherosclerosis", + "date": "2020-12-18", + "author": "Al Rifai M,Kanaya AM,Kandula NR,Cainzos-Achirica M,Patel J,Budoff M,Criqui MH,Blaha MJ,Virani SS", + "auth_pos": 6, + "meshterms": "Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors, Atherosclerosis*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Prevalence, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1436, + "user_id": 1811967433, + "artical_title": "Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium.", + "pmid": 33331631, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-12-18", + "author": "Han D,Cordoso R,Whelton S,Rozanski A,Budoff MJ,Miedema MD,Nasir K,Shaw LJ,Rumberger JA,Gransar H,Dardari Z,Blumenthal RS,Blaha MJ,Berman DS", + "auth_pos": 5, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Humans, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1437, + "user_id": 1811967433, + "artical_title": "The Quantification of Total Coronary Atheroma Burden - A Major Step Forward.", + "pmid": 36276513, + "journal_name": "Heart international", + "date": "2020-12-23", + "author": "Foult JM,Pranesh S,Budoff MJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1438, + "user_id": 1811967433, + "artical_title": "Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis.", + "pmid": 33360226, + "journal_name": "Seminars in arthritis and rheumatism", + "date": "2020-12-29", + "author": "Karpouzas GA,Ormseth SR,Hernandez E,Bui VL,Budoff MJ", + "auth_pos": 5, + "meshterms": "Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/diagnostic imaging, Coronary Angiography, Glycoproteins, Humans, Immunoglobulin A, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1439, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium score and risk of cardiovascular events without established coronary artery disease: a systemic review and meta-analysis.", + "pmid": 33417339, + "journal_name": "Coronary artery disease", + "date": "2021-01-09", + "author": "Abuzaid A,Saad M,Addoumieh A,Ha LD,Elbadawi A,Mahmoud AN,Elgendy A,Abdelaziz HK,Barakat AF,Mentias A,Adeola O,Elgendy IY,Qasim A,Budoff M", + "auth_pos": 14, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Cardiovascular Diseases, Cardiovascular Diseases/epidemiology, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Humans, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Risk Assessment*, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1440, + "user_id": 1811967433, + "artical_title": "New carotid plaque, but not the progression of intima-media thickness, predicts the progression of high-risk coronary plaque.", + "pmid": 33417340, + "journal_name": "Coronary artery disease", + "date": "2021-01-09", + "author": "Chao CJ,Lakshmanan S,Ceponiene I,Luo Y,Nakanishi R,Nezarat N,Kanisawa M,Budoff MJ", + "auth_pos": 8, + "meshterms": "Carotid Intima-Media Thickness*, Computed Tomography Angiography, Coronary Angiography, Disease Progression, Female, Garlic, Heart Disease Risk Factors*, Humans, Male, Middle Aged, Plant Extracts, Plant Extracts/pharmacology, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology*, Ultrasonography, Carotid Intima-Media Thickness*, Computed Tomography Angiography, Coronary Angiography, Disease Progression, Female, Garlic, Heart Disease Risk Factors*, Humans, Male, Middle Aged, Plant Extracts, Plant Extracts/pharmacology, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology*, Ultrasonography, Carotid Intima-Media Thickness*, Computed Tomography Angiography, Coronary Angiography, Disease Progression, Female, Garlic, Heart Disease Risk Factors*, Humans, Male, Middle Aged, Plant Extracts, Plant Extracts/pharmacology, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology*, Ultrasonography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1441, + "user_id": 1811967433, + "artical_title": "Prevalence of normal coronary arteries by coronary computed tomography angiography (CCTA) in patients with type 2 diabetes mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) trial.", + "pmid": 33419635, + "journal_name": "Journal of diabetes and its complications", + "date": "2021-01-10", + "author": "Birudaraju D,Cherukuri L,Kinninger A,Dahal S,Lakshmanan S,Rezvanizadeh V,Ghanem AK,Flores F,Hamal S,Pozon RG,Adudodla N,Tayek JA,Roy SK,Budoff MJ", + "auth_pos": 14, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/diagnostic imaging, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Female, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Prevalence, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/diagnostic imaging, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Female, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Prevalence, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/diagnostic imaging, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Female, Glucagon-Like Peptides, Glucagon-Like Peptides/therapeutic use*, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/epidemiology, Predictive Value of Tests, Prevalence", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1442, + "user_id": 1811967433, + "artical_title": "The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction.", + "pmid": 33419719, + "journal_name": "Journal of clinical lipidology", + "date": "2021-01-10", + "author": "Orringer CE,Blaha MJ,Blankstein R,Budoff MJ,Goldberg RB,Gill EA,Maki KC,Mehta L,Jacobson TA", + "auth_pos": 4, + "meshterms": "Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors, Humans, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Coronary Vessels/drug effects, Calcium*, Calcium/metabolism, Calcium/analysis, Coronary Artery Disease, Coronary Artery Disease/prevention & control, Atherosclerosis, Atherosclerosis/prevention & control, Risk Reduction Behavior, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1443, + "user_id": 1811967433, + "artical_title": "Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.", + "pmid": 33433123, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2021-01-13", + "author": "Crane HM,Nance RM,Whitney BM,Heckbert SR,Budoff M,High K,Landay A,Feinstein M,Moore RD,Mathews WC,Christopoulos K,Saag MS,Willig A,Eron JJ,Kitahata MM,Delaney JAC", + "auth_pos": 5, + "meshterms": "Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications, Adult, Aged, Aging*, Cohort Studies, Female, HIV Infections, HIV Infections/complications*, HIV Infections/epidemiology*, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Myocardial Infarction, Myocardial Infarction/epidemiology*, Plaque, Atherosclerotic, Plaque, Atherosclerotic/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1444, + "user_id": 1811967433, + "artical_title": "Progression of whole-heart Atherosclerosis by coronary CT and major adverse cardiovascular events.", + "pmid": 33451974, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2021-01-17", + "author": "van Rosendael AR,Lin FY,van den Hoogen IJ,Ma X,Gianni U,Al Hussein Alawamlh O,Al'Aref SJ,Peña JM,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic J,Maffei E,Pontone G,Raff GL,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Han D,Berman DS,Virmani R,Samady H,Stone P,Narula J,Bax JJ,Shaw LJ,Min JK,Chang HJ", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1445, + "user_id": 1811967433, + "artical_title": "Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.", + "pmid": 33454249, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-01-18", + "author": "Mancini GBJ,Leipsic J,Budoff MJ,Hague CJ,Min JK,Stevens SR,Reynolds HR,O'Brien SM,Shaw LJ,Manjunath CN,Mavromatis K,Demkow M,Lopez-Sendon JL,Chernavskiy AM,Gosselin G,Schuchlenz H,Devlin GP,Chauhan A,Bangalore S,Hochman JS,Maron DJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1446, + "user_id": 1811967433, + "artical_title": "Topological Data Analysis of Coronary Plaques Demonstrates the Natural History of Coronary Atherosclerosis.", + "pmid": 33454260, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-01-18", + "author": "Hwang D,Kim HJ,Lee SP,Lim S,Koo BK,Kim YJ,Kook W,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Raff GL,Shin S,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Lin FY,Virmani R,Samady H,Stone PH,Narula J,Bax JJ,Shaw LJ,Min JK,Chang HJ", + "auth_pos": 10, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Data Analysis, Exercise, Humans, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1447, + "user_id": 1811967433, + "artical_title": "Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 33461306, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2021-01-20", + "author": "Shea S,Navas-Acien A,Shimbo D,Brown ER,Budoff M,Bancks MP,Barr RG,Kronmal R", + "auth_pos": 5, + "meshterms": "Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology, Aged, Atherosclerosis, Atherosclerosis/diagnosis*, Atherosclerosis/ethnology, Atherosclerosis/metabolism, Calcium, Calcium/metabolism*, Coronary Angiography, Coronary Angiography/methods*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Coronary Artery Disease/ethnology, Coronary Artery Disease/metabolism, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism*, Ethnicity*, Female, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Assessment/methods*, Tomography, X-Ray Computed, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1448, + "user_id": 1811967433, + "artical_title": "Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.", + "pmid": 33471721, + "journal_name": "Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists", + "date": "2021-01-21", + "author": "Handelsman Y,Jellinger PS,Guerin CK,Bloomgarden ZT,Brinton EA,Budoff MJ,Davidson MH,Einhorn D,Fazio S,Fonseca VA,Garber AJ,Grunberger G,Krauss RM,Mechanick JI,Rosenblit PD,Smith DA,Wyne KL", + "auth_pos": 6, + "meshterms": "Algorithms, Anticholesteremic Agents*, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Consensus, Dyslipidemias*, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Endocrinologists, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Factors, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1449, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium score: pivotal role as a predictor for detecting coronary artery disease in symptomatic patients.", + "pmid": 33471470, + "journal_name": "Coronary artery disease", + "date": "2021-01-21", + "author": "Cherukuri L,Birudaraju D,Budoff MJ", + "auth_pos": 3, + "meshterms": "Biomarkers, Biomarkers/blood, Calcium, Calcium/blood*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Humans, Predictive Value of Tests, Risk Assessment, Severity of Illness Index, Vascular Calcification, Vascular Calcification/diagnosis*, Biomarkers, Biomarkers/blood, Calcium, Calcium/blood*, Coronary Artery Disease, Coronary Artery Disease/diagnosis*, Humans, Predictive Value of Tests, Risk Assessment, Severity of Illness Index, Vascular Calcification, Vascular Calcification/diagnosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1450, + "user_id": 1811967433, + "artical_title": "Anatomic burden mostly outperforms ischemic burden: From COURAGE to ISCHEMIA.", + "pmid": 33528866, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-02-03", + "author": "Dahal S,Budoff MJ", + "auth_pos": 2, + "meshterms": "Coronary Artery Disease*, Courage*, Humans, Ischemia, Myocardial Ischemia*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1451, + "user_id": 1811967433, + "artical_title": "Associations between dyspnoea, coronary atherosclerosis, and cardiovascular outcomes: results from the long-term follow-up CONFIRM registry.", + "pmid": 33538308, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2021-02-05", + "author": "van Rosendael AR,Bax AM,van den Hoogen IJ,Smit JM,Al'Aref SJ,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Villines TC,Gransar H,Lu Y,Peña JM,Lin FY,Shaw LJ,Narula J,Min JK,Bax JJ", + "auth_pos": 10, + "meshterms": "Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors, Aged, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Dyspnea, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Registries, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1452, + "user_id": 1811967433, + "artical_title": "Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study.", + "pmid": 33561176, + "journal_name": "PloS one", + "date": "2021-02-10", + "author": "Polanka BM,Kundu S,So-Armah KA,Freiberg MS,Gupta SK,Zapolski TCB,Hirsh AT,Bedimo RJ,Budoff MJ,Butt AA,Chang CH,Gottlieb SS,Marconi VC,Womack JA,Stewart JC", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1453, + "user_id": 1811967433, + "artical_title": "Epicardial adipose tissue volume is a marker of subclinical coronary atherosclerosis in Rheumatoid arthritis.", + "pmid": 33586363, + "journal_name": "Arthritis & rheumatology (Hoboken, N.J.)", + "date": "2021-02-16", + "author": "Karpouzas GA,Rezaeian P,Ormseth SR,Hollan I,Budoff MJ", + "auth_pos": 5, + "meshterms": "Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Arthritis, Rheumatoid, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/pathology*, Atherosclerosis, Atherosclerosis/diagnostic imaging*, Atherosclerosis/etiology, Biomarkers, Biomarkers/analysis, C-Reactive Protein, C-Reactive Protein/analysis, Case-Control Studies, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/etiology, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Obesity, Obesity/complications, Obesity/pathology, Pericardium, Pericardium/diagnostic imaging, Pericardium/pathology, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/etiology, Prednisone, Prednisone/therapeutic use, Time Factors, Tumor Necrosis Factor Inhibitors, Tumor Necrosis Factor Inhibitors/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1454, + "user_id": 1811967433, + "artical_title": "Very High Coronary Artery Calcium (?1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA.", + "pmid": 33650435, + "journal_name": "Circulation", + "date": "2021-03-03", + "author": "Peng AW,Dardari ZA,Blumenthal RS,Dzaye O,Obisesan OH,Iftekhar Uddin SM,Nasir K,Blankstein R,Budoff MJ,Bødtker Mortensen M,Joshi PH,Page J,Blaha MJ", + "auth_pos": 9, + "meshterms": "Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome, Aged, Aged, 80 and over, Calcium, Calcium/adverse effects*, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/physiopathology*, Female, Humans, Male, Middle Aged, Survival Analysis, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1455, + "user_id": 1811967433, + "artical_title": "Thoracic Aortic Calcium For The Prediction Of Stroke Mortality (From The Coronary Artery Calcium Consortium).", + "pmid": 33667445, + "journal_name": "The American journal of cardiology", + "date": "2021-03-06", + "author": "Obisesan OH,Osei AD,Berman D,Dardari ZA,Uddin SMI,Dzaye O,Orimoloye OA,Budoff MJ,Miedema MD,Rumberger J,Mirbolouk M,Boakye E,Johansen MC,Rozanski A,Shaw LJ,Han D,Nasir K,Blaha MJ", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1456, + "user_id": 1811967433, + "artical_title": "Comparison of the Relation of Carotid Intima-Media Thickness with Incident Heart Failure with Reduced Versus Preserved Ejection Fraction (From the Multi-Ethnic Study of Atherosclerosis [MESA]).", + "pmid": 33667446, + "journal_name": "The American journal of cardiology", + "date": "2021-03-06", + "author": "Aladin AI,Soliman EZ,Kitzman DW,Dardari Z,Rasool SH,Yeboah J,Budoff MJ,Psaty BM,Ouyang P,Polak JF,Blumenthal RS,McEvoy JW,Gandhi SK,Herrington DM", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1457, + "user_id": 1811967433, + "artical_title": "A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.", + "pmid": 33677498, + "journal_name": "European heart journal", + "date": "2021-03-08", + "author": "Jacobsen AP,Al Rifai M,Arps K,Whelton SP,Budoff MJ,Nasir K,Blaha MJ,Psaty BM,Blumenthal RS,Post WS,McEvoy JW", + "auth_pos": 5, + "meshterms": "Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States, Aged, Blood Pressure, Cardiovascular Diseases*, Cohort Studies, Humans, Hypertension*, Hypertension/epidemiology, Middle Aged, Risk Factors, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1458, + "user_id": 1811967433, + "artical_title": "Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study.", + "pmid": 33705543, + "journal_name": "The Journal of clinical endocrinology and metabolism", + "date": "2021-03-12", + "author": "Goldberg RB,Tripputi MT,Boyko EJ,Budoff M,Chen ZZ,Clark JM,Dabelea DM,Edelstein SL,Gerszten RE,Horton E,Mather KJ,Perreault L,Temprosa M,Wallia A,Watson K,Zeb I", + "auth_pos": 4, + "meshterms": "Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology, Aged, Biomarkers, Biomarkers/blood*, Blood Glucose, Blood Glucose/analysis, Body Mass Index*, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Diabetes Mellitus, Type 2/etiology, Diabetes Mellitus, Type 2/prevention & control, Fatty Liver, Fatty Liver/complications*, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use*, Insulin Resistance*, Male, Middle Aged, Outcome Assessment, Health Care, Prediabetic State, Prediabetic State/epidemiology*, Prediabetic State/etiology, Prediabetic State/prevention & control, Prognosis, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1459, + "user_id": 1811967433, + "artical_title": "Effects of chronic kidney disease and declining renal function on coronary atherosclerotic plaque progression: a PARADIGM substudy.", + "pmid": 33709096, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2021-03-13", + "author": "Huang AL,Leipsic JA,Zekry SB,Sellers S,Ahmadi AA,Blanke P,Hadamitzky M,Kim YJ,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Lee BK,Chun EJ,Cademartiri F,Maffei E,Marques H,Shin S,Choi JH,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Chang HJ", + "auth_pos": 12, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Humans, Kidney, Kidney/physiology, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1460, + "user_id": 1811967433, + "artical_title": "Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV.", + "pmid": 33721213, + "journal_name": "Diabetes therapy : research, treatment and education of diabetes and related disorders", + "date": "2021-03-16", + "author": "Budoff MJ,Davis TME,Palmer AG,Frederich R,Lawrence DE,Liu J,Gantz I,Derosa G", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1461, + "user_id": 1811967433, + "artical_title": "Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.", + "pmid": 33724260, + "journal_name": "AIDS (London, England)", + "date": "2021-03-17", + "author": "Feinstein MJ,Haberlen SA,Ashikaga H,Palella FJ,Magnani JW,Budoff M,Berlacher K,D'Souza G,Brown T,Post WS,Wu KC", + "auth_pos": 6, + "meshterms": "Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Humans, Ventricular Premature Complexes*, Viral Load, Viremia, Viremia/drug therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1462, + "user_id": 1811967433, + "artical_title": "Rationale and Design of the Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Trial.", + "pmid": 33745898, + "journal_name": "American heart journal", + "date": "2021-03-23", + "author": "Handberg EM,Merz CNB,Cooper-Dehoff R,Wei J,Conlon M,Lo MC,Boden W,Frayne SM,Villines T,Spertus JA,Weintraub W,O'Malley P,Chaitman B,Shaw LJ,Budoff M,Rogatko A,Pepine CJ", + "auth_pos": 15, + "meshterms": "Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use*, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/prevention & control*, Female, Follow-Up Studies, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Incidence, Middle Aged, Myocardial Ischemia, Myocardial Ischemia/epidemiology, Myocardial Ischemia/etiology, Myocardial Ischemia/prevention & control*, Prognosis, Prospective Studies, Quality of Life, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1463, + "user_id": 1811967433, + "artical_title": "Associations Between HIV Serostatus and Cardiac Structure and Function Evaluated by 2-Dimensional Echocardiography in the Multicenter AIDS Cohort Study.", + "pmid": 33749311, + "journal_name": "Journal of the American Heart Association", + "date": "2021-03-23", + "author": "Doria de Vasconcellos H,Post WS,Ervin AM,Haberlen SA,Budoff M,Malvestutto C,Magnani JW,Feinstein MJ,Brown TT,Lima JAC,Wu KC", + "auth_pos": 5, + "meshterms": "Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome/complications, Acquired Immunodeficiency Syndrome/physiopathology, Aged, Cross-Sectional Studies, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, HIV, HIV/immunology*, HIV Antibodies, HIV Antibodies/immunology*, Heart Failure, Heart Failure/complications, Heart Failure/diagnosis, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Prospective Studies, Stroke Volume, Stroke Volume/physiology*, Ventricular Function, Left, Ventricular Function, Left/physiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1464, + "user_id": 1811967433, + "artical_title": "Coronary Computed Tomography Angiography (CCTA) vs Functional Imaging in the Evaluation of Stable Ischemic Heart Disease.", + "pmid": 33771938, + "journal_name": "The Journal of invasive cardiology", + "date": "2021-03-28", + "author": "Patel VI,Roy SK,Budoff MJ", + "auth_pos": 3, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Humans, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Randomized Controlled Trials as Topic, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1465, + "user_id": 1811967433, + "artical_title": "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors.", + "pmid": 33813155, + "journal_name": "Atherosclerosis", + "date": "2021-04-05", + "author": "Won KB,Heo R,Park HB,Lee BK,Lin FY,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,de Araújo Gonçalves P,Leipsic JA,Lee SE,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Chang HJ", + "auth_pos": 12, + "meshterms": "Adult, Atherosclerosis*, Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Plaque, Atherosclerotic*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1466, + "user_id": 1811967433, + "artical_title": "Epigenome-wide analysis of long-term air pollution exposure and DNA methylation in monocytes: results from the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 33818294, + "journal_name": "Epigenetics", + "date": "2021-04-06", + "author": "C Chi G,Liu Y,MacDonald JW,M Reynolds L,Enquobahrie DA,L Fitzpatrick A,Kerr KF,J Budoff M,Lee SI,Siscovick D,D Kaufman J", + "auth_pos": 8, + "meshterms": "Adult, Air Pollutants*, Air Pollutants/toxicity, Air Pollution*, Air Pollution/analysis, Air Pollution/statistics & numerical data, Antigens, Neoplasm, Antigens, Neoplasm/analysis, Atherosclerosis*, Atherosclerosis/chemically induced, Atherosclerosis/genetics, DNA Methylation, Environmental Exposure, Environmental Exposure/analysis, Environmental Exposure/statistics & numerical data, Epigenome, Humans, Monocytes, Neoplasm Proteins, Particulate Matter, Particulate Matter/toxicity, Adult, Air Pollutants*, Air Pollutants/toxicity, Air Pollution*, Air Pollution/analysis, Air Pollution/statistics & numerical data, Antigens, Neoplasm, Antigens, Neoplasm/analysis, Atherosclerosis*, Atherosclerosis/chemically induced, Atherosclerosis/genetics, DNA Methylation, Environmental Exposure, Environmental Exposure/analysis, Environmental Exposure/statistics & numerical data, Epigenome, Humans, Monocytes, Neoplasm Proteins, Particulate Matter, Particulate Matter/toxicity, Adult, Air Pollutants*, Air Pollutants/toxicity, Air Pollution*, Air Pollution/analysis, Air Pollution/statistics & numerical data, Antigens, Neoplasm, Antigens, Neoplasm/analysis, Atherosclerosis*, Atherosclerosis/chemically induced, Atherosclerosis/genetics, DNA Methylation, Environmental Exposure, Environmental Exposure/analysis, Environmental Exposure/statistics & numerical data, Epigenome, Humans, Monocytes, Neoplasm Proteins, Particulate Matter, Particulate Matter/toxicity", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1467, + "user_id": 1811967433, + "artical_title": "Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.", + "pmid": 33824003, + "journal_name": "Atherosclerosis", + "date": "2021-04-08", + "author": "Razavi AC,Kelly TN,Budoff MJ,Bazzano LA,He J,Fernandez C,Lima J,Nasir K,Blumenthal RS,Blaha MJ,Whelton SP", + "auth_pos": 3, + "meshterms": "Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Aging, Atherosclerosis*, Cardiovascular Diseases*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1468, + "user_id": 1811967433, + "artical_title": "Quantitative Analysis of Adipose Depots by Using Chest CT and Associations with All-Cause Mortality in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis from MESArthritis Ancillary Study.", + "pmid": 33825508, + "journal_name": "Radiology", + "date": "2021-04-08", + "author": "Pishgar F,Shabani M,Quinaglia A C Silva T,Bluemke DA,Budoff M,Barr RG,Allison MA,Post WS,Lima JAC,Demehri S", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1469, + "user_id": 1811967433, + "artical_title": "Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification: The MESA.", + "pmid": 33827231, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2021-04-09", + "author": "Mehta A,Rigdon J,Tattersall MC,German CA,Barringer TA,Joshi PH,Sperling LS,Budoff MJ,Bertoni A,Michos ED,Blaha MJ,Stein JH,Shapiro MD", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1470, + "user_id": 1811967433, + "artical_title": "Allele Specific Variation at APOE Increases Non-alcoholic Fatty Liver Disease and Obesity but Decreases Risk of Alzheimer's Disease and Myocardial Infarction.", + "pmid": 33856023, + "journal_name": "Human molecular genetics", + "date": "2021-04-16", + "author": "Palmer ND,Kahali B,Kuppa A,Chen Y,Du X,Feitosa MF,Bielak LF,O'Connell JR,Musani SK,Guo X,Smith AV,Ryan KA,Eirksdottir G,Allison MA,Bowden DW,Budoff MJ,Carr JJ,Chen YI,Taylor KD,Correa A,Crudup BF,Halligan B,Yang J,Kardia SLR,Launer LJ,Fu YP,Mosley TH,Norris JM,Terry JG,O'Donnell CJ,Rotter JI,Wagenknecht LE,Gudnason V,Province MA,Peyser PA,Speliotes EK", + "auth_pos": 16, + "meshterms": "Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides, Alanine Transaminase, Alleles, Alzheimer Disease, Alzheimer Disease/genetics, Apolipoproteins E, Apolipoproteins E/genetics*, Apolipoproteins E/metabolism, Databases, Genetic, Exome, Exome/genetics, Gene Frequency, Gene Frequency/genetics, Genome-Wide Association Study, Genome-Wide Association Study/methods, Humans, Liver, Liver Cirrhosis, Liver Cirrhosis/genetics, Myocardial Infarction, Myocardial Infarction/genetics, Non-alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease/genetics*, Non-alcoholic Fatty Liver Disease/metabolism, Obesity, Obesity/genetics*, Obesity/metabolism, Phenotype, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Prognosis, Risk Factors, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1471, + "user_id": 1811967433, + "artical_title": "Relation between Retinopathy and Progression of Coronary Artery Calcium in Individuals with Versus Without Diabetes Mellitus (From the Multi-Ethnic Study of Atherosclerosis).", + "pmid": 33892913, + "journal_name": "The American journal of cardiology", + "date": "2021-04-25", + "author": "Khazai B,Adabifirouzjaei F,Guo M,Ipp E,Klein R,Klein B,Cotch MF,Wong TY,Swerdloff R,Wang C,Surampudi P,Kaufman J,Park C,Hendel R,Budoff MJ", + "auth_pos": 15, + "meshterms": "Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*, Case-Control Studies, Coronary Artery Disease, Coronary Artery Disease/epidemiology*, Coronary Disease, Coronary Disease/epidemiology, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetic Retinopathy, Diabetic Retinopathy/epidemiology*, Diabetic Retinopathy/etiology, Diabetic Retinopathy/pathology, Disease Progression, Female, Humans, Incidence, Male, Middle Aged, Retinal Diseases, Retinal Diseases/epidemiology*, Retinal Diseases/pathology, Retinal Vessels, Retinal Vessels/pathology, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/epidemiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1472, + "user_id": 1811967433, + "artical_title": "EPA's pleiotropic mechanisms of action: a narrative review.", + "pmid": 33900135, + "journal_name": "Postgraduate medicine", + "date": "2021-04-27", + "author": "Nelson JR,Budoff MJ,Wani OR,Le V,Patel DK,Nelson A,Nemiroff RL", + "auth_pos": 2, + "meshterms": "Anti-Inflammatory Agents, Anti-Inflammatory Agents/pharmacology, Atherosclerosis*, Atherosclerosis/immunology, Atherosclerosis/pathology, Atherosclerosis/prevention & control, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/pharmacology, Humans, Lipid Regulating Agents, Lipid Regulating Agents/pharmacology, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/metabolism, Platelet Aggregation Inhibitors, Platelet Aggregation Inhibitors/pharmacology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1473, + "user_id": 1811967433, + "artical_title": "The role of cardiovascular CT in occupational health assessment for coronary heart disease: An expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT).", + "pmid": 33926854, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2021-05-01", + "author": "Slim AM,Fentanes E,Cheezum MK,Parsons IT,Maroules C,Chen B,Abbara S,Branch K,Nagpal P,Shah NR,Thomas DM,Villines TC,Blankstein R,Shaw LJ,Budoff M,Nicol E", + "auth_pos": 16, + "meshterms": "Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed, Consensus, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Disease*, Humans, Occupational Health*, Predictive Value of Tests, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1474, + "user_id": 1811967433, + "artical_title": "Effect of body mass index on bone mineral density is age-specific.", + "pmid": 33934946, + "journal_name": "Nutrition, metabolism, and cardiovascular diseases : NMCD", + "date": "2021-05-04", + "author": "Cherukuri L,Kinninger A,Birudaraju D,Lakshmanan S,Li D,Flores F,Mao SS,Budoff MJ", + "auth_pos": 8, + "meshterms": "Adult, Age Factors, Aged, Aged, 80 and over, Body Mass Index*, Bone Density*, Female, Humans, Male, Middle Aged, Multidetector Computed Tomography, Obesity, Obesity/complications, Obesity/diagnosis, Obesity/physiopathology*, Osteoporosis, Osteoporosis/diagnostic imaging, Osteoporosis/etiology, Osteoporosis/physiopathology*, Retrospective Studies, Risk Assessment, Risk Factors, Sex Factors, Thoracic Vertebrae, Thoracic Vertebrae/diagnostic imaging, Thoracic Vertebrae/physiopathology*, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1475, + "user_id": 1811967433, + "artical_title": "The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl.", + "pmid": 33970207, + "journal_name": "European heart journal", + "date": "2021-05-11", + "author": "Budoff M,Lakshmanan S,Bhatt DL", + "auth_pos": 1, + "meshterms": "Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hypertriglyceridemia*, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1476, + "user_id": 1811967433, + "artical_title": "The Association between Lung Hyperinflation and Coronary Artery Disease in Smokers.", + "pmid": 33971144, + "journal_name": "Chest", + "date": "2021-05-11", + "author": "Chandra D,Gupta A,Kinney GL,Fuhrman CR,Leader JK,Diaz AA,Bon J,Barr RG,Washko G,Budoff M,Hokanson J,Sciurba FC", + "auth_pos": 10, + "meshterms": "Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Airway Obstruction*, Airway Obstruction/diagnosis, Airway Obstruction/physiopathology, Airway Remodeling, Asymptomatic Diseases, Asymptomatic Diseases/epidemiology, Biological Variation, Population, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Humans, Lung*, Lung/diagnostic imaging, Lung/pathology, Lung/physiopathology, Male, Middle Aged, Organ Size, Plethysmography, Plethysmography/methods, Pulmonary Emphysema*, Pulmonary Emphysema/diagnostic imaging, Pulmonary Emphysema/physiopathology, Respiratory Function Tests, Respiratory Function Tests/methods, Risk Factors, Smoking, Smoking/epidemiology*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, United States, United States/epidemiology, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1477, + "user_id": 1811967433, + "artical_title": "Association between Aortic Valve Calcification Progression and Coronary Atherosclerotic Plaque Volume Progression in the PARADIGM Registry.", + "pmid": 33973837, + "journal_name": "Radiology", + "date": "2021-05-12", + "author": "Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1478, + "user_id": 1811967433, + "artical_title": "Utilizing coronary artery calcium to guide statin use.", + "pmid": 34000565, + "journal_name": "Atherosclerosis", + "date": "2021-05-18", + "author": "Golub I,Lakshmanan S,Dahal S,Budoff MJ", + "auth_pos": 4, + "meshterms": "Calcium, Coronary Artery Disease*, Coronary Vessels, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Risk Assessment, Risk Factors, Vascular Calcification*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1479, + "user_id": 1811967433, + "artical_title": "Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA.", + "pmid": 34041918, + "journal_name": "Journal of the American Heart Association", + "date": "2021-05-28", + "author": "Kapoor K,Alfaddagh A,Al Rifai M,Bhatt DL,Budoff MJ,Nasir K,Miller M,Welty FK,McEvoy JW,Dardari Z,Shapiro MD,Blumenthal RS,Tsai MY,Blaha MJ", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Fibrillation/blood, Atrial Fibrillation/complications*, Atrial Fibrillation/ethnology, Biomarkers, Biomarkers/blood, Ethnicity*, Fatty Acids, Omega-3, Fatty Acids, Omega-3/blood*, Female, Follow-Up Studies, Hemorrhage, Hemorrhage/blood*, Hemorrhage/etiology, Humans, Incidence, Male, Middle Aged, Prospective Studies, United States, United States/epidemiology, Carotid Stents*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1480, + "user_id": 1811967433, + "artical_title": "Pericardial Fat and the Risk of Heart Failure.", + "pmid": 34045020, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-05-29", + "author": "Kenchaiah S,Ding J,Carr JJ,Allison MA,Budoff MJ,Tracy RP,Burke GL,McClelland RL,Arai AE,Bluemke DA", + "auth_pos": 5, + "meshterms": "Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed, Adiposity*, Aged, Aged, 80 and over, Cardiac Imaging Techniques, Cohort Studies, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/etiology*, Humans, Male, Middle Aged, Pericardium, Pericardium/diagnostic imaging*, Risk, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1481, + "user_id": 1811967433, + "artical_title": "Automated coronary calcium scoring using deep learning with multicenter external validation.", + "pmid": 34075194, + "journal_name": "NPJ digital medicine", + "date": "2021-06-03", + "author": "Eng D,Chute C,Khandwala N,Rajpurkar P,Long J,Shleifer S,Khalaf MH,Sandhu AT,Rodriguez F,Maron DJ,Seyyedi S,Marin D,Golub I,Budoff M,Kitamura F,Takahashi MS,Filice RW,Shah R,Mongan J,Kallianos K,Langlotz CP,Lungren MP,Ng AY,Patel BN", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1482, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium is associated with increased risk for lung and colorectal cancer in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 34086883, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2021-06-05", + "author": "Dzaye O,Berning P,Dardari ZA,Mortensen MB,Marshall CH,Nasir K,Budoff MJ,Blumenthal RS,Whelton SP,Blaha MJ", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1483, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium: An Equal Opportunity Predictor.", + "pmid": 36338356, + "journal_name": "JACC. Asia", + "date": "2021-06-15", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1484, + "user_id": 1811967433, + "artical_title": "The Multidimensionality of Coronary Artery Disease: Combining, Conflating and Changing.", + "pmid": 36338361, + "journal_name": "JACC. Asia", + "date": "2021-06-15", + "author": "Min JK,Budoff MJ,Bax JJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1485, + "user_id": 1811967433, + "artical_title": "Elevated serum thyrotropin levels and endothelial dysfunction in a prospective hemodialysis cohort.", + "pmid": 34231302, + "journal_name": "Hemodialysis international. International Symposium on Home Hemodialysis", + "date": "2021-07-08", + "author": "You AS,Budoff M,Zeb I,Ahmadi N,Novoa A,Flores F,Hamal S,Kinninger A,Dailing C,Nakata T,Kovesdy CP,Nguyen DV,Brent GA,Kalantar-Zadeh K,Rhee CM", + "auth_pos": 2, + "meshterms": "Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*, Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*, Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*, Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*, Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*, Cohort Studies, Humans, Hypothyroidism*, Hypothyroidism/epidemiology, Prospective Studies, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Vascular Diseases*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1486, + "user_id": 1811967433, + "artical_title": "Multiethnic Genome-wide Association Study of Subclinical Atherosclerosis in Individuals with Type 2 Diabetes.", + "pmid": 34241534, + "journal_name": "Circulation. Genomic and precision medicine", + "date": "2021-07-10", + "author": "Lu Y,Dimitrov L,Chen SH,Bielak LF,Bis JC,Feitosa MF,Lu L,Kavousi M,Raffield LM,Smith AV,Wang L,Weiss S,Yao J,Zhu J,Gudmundsson EF,Gudmundsdottir V,Bos D,Ghanbari M,Ikram MA,Hwang SJ,Taylor KD,Budoff MJ,Gíslason GK,O'Donnell CJ,An P,Franceschini N,Freedman BI,Fu YP,Guo X,Heiss G,Kardia SLR,Wilson JG,Langefeld CD,Schminke U,Uitterlinden AG,Lange LA,Peyser PA,Gudnason VG,Psaty BM,Rotter JI,Bowden DW,Ng MCY", + "auth_pos": 22, + "meshterms": "Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*, Atherosclerosis, Atherosclerosis/genetics*, Diabetes Complications, Diabetes Complications/genetics*, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/genetics*, Genetic Loci*, Genetic Predisposition to Disease*, Genome-Wide Association Study, Humans, White People, White People/genetics*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1487, + "user_id": 1811967433, + "artical_title": "Temporal change in inflammatory biomarkers and risk of cardiovascular events: the Multi-ethnic Study of Atherosclerosis.", + "pmid": 34240828, + "journal_name": "ESC heart failure", + "date": "2021-07-10", + "author": "Shabani M,Bakhshi H,Ostovaneh MR,Ma X,Wu CO,Ambale-Venkatesh B,Blaha MJ,Allison MA,Budoff MJ,Cushman M,Tracy RP,Herrington DM,Szklo M,Cox C,Bluemke DA,Lima JAC", + "auth_pos": 9, + "meshterms": "Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged, Atherosclerosis*, Biomarkers, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Ethnicity, Female, Humans, Male, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1488, + "user_id": 1811967433, + "artical_title": "Adipose tissue biomarkers and type 2 diabetes incidence in normoglycemic participants in the MESArthritis Ancillary Study: A cohort study.", + "pmid": 34242221, + "journal_name": "PLoS medicine", + "date": "2021-07-10", + "author": "Pishgar F,Shabani M,Quinaglia A C Silva T,Bluemke DA,Budoff M,Barr RG,Allison MA,Bertoni AG,Post WS,Lima JAC,Demehri S", + "auth_pos": 5, + "meshterms": "Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed, Adipose Tissue, Adipose Tissue/diagnostic imaging*, Aged, Cohort Studies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 2/epidemiology*, Female, Humans, Incidence, Male, Middle Aged, Subcutaneous Fat, Subcutaneous Fat/diagnostic imaging*, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1489, + "user_id": 1811967433, + "artical_title": "The Evolving Role of Omega 3 Fatty Acids in Cardiovascular Disease: Is Icosapent Ethyl the Answer?", + "pmid": 36277323, + "journal_name": "Heart international", + "date": "2021-07-15", + "author": "Lakshmanan S,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1490, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Scoring for Adults at Borderline 10-Year ASCVD Risk: The CAC Consortium.", + "pmid": 34325843, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-07-31", + "author": "Uddin SMI,Osei AD,Obisesan O,Dzaye O,Dardari Z,Miedema MD,Rumberger JA,Berman DS,Budoff MJ,Blaha MJ", + "auth_pos": 9, + "meshterms": "Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors, Atherosclerosis, Atherosclerosis/epidemiology*, Calcium, Calcium/analysis*, Coronary Vessels, Coronary Vessels/chemistry*, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1491, + "user_id": 1811967433, + "artical_title": "Risk Markers for Limited Coronary Artery Calcium in Persons With Significant Aortic Valve Calcium (From the Multi-ethnic Study of Atherosclerosis).", + "pmid": 34325879, + "journal_name": "The American journal of cardiology", + "date": "2021-07-31", + "author": "Razavi AC,Cardoso R,Dzaye O,Budoff M,Thanassoulis G,Post WS,Shah S,Berman DS,Nasir K,Blaha MJ,Whelton SP", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/metabolism, Aortic Valve/pathology*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/ethnology*, Calcinosis, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/ethnology*, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/ethnology*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Ethnicity*, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Tomography, X-Ray Computed, United States, United States/epidemiology, Vascular Calcification, Vascular Calcification/complications, Vascular Calcification/diagnosis, Vascular Calcification/ethnology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1492, + "user_id": 1811967433, + "artical_title": "20-Year trend of high prevalence of zero coronary artery calcium in beach cities of Southern California: A blue zone?", + "pmid": 34327474, + "journal_name": "American journal of preventive cardiology", + "date": "2021-07-31", + "author": "Lakshmanan S,Kinninger A,Golub I,Dahal S,Birudaraju D,Ahmad K,Ghanem AK,Rezvanizadeh V,Roy SK,Budoff MJ", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1493, + "user_id": 1811967433, + "artical_title": "Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium.", + "pmid": 34327479, + "journal_name": "American journal of preventive cardiology", + "date": "2021-07-31", + "author": "Wang FM,Reiter-Brennan C,Dardari Z,Marshall CH,Nasir K,Miedema MD,Berman DS,Rozanski A,Rumberger JA,Budoff MJ,Dzaye O,Blaha MJ", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1494, + "user_id": 1811967433, + "artical_title": "Ten things to know about ten imaging studies: A preventive cardiology perspective (\"ASPC top ten imaging\").", + "pmid": 34327499, + "journal_name": "American journal of preventive cardiology", + "date": "2021-07-31", + "author": "Bays HE,Khera A,Blaha MJ,Budoff MJ,Toth PP", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1495, + "user_id": 1811967433, + "artical_title": "Current methods to assess mitral annular calcification and its risk factors.", + "pmid": 34348555, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2021-08-06", + "author": "Birudaraju D,Cherukuri L,Pranesh S,Budoff MJ", + "auth_pos": 4, + "meshterms": "Calcinosis*, Calcinosis/diagnostic imaging, Echocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Risk Factors, Calcinosis*, Calcinosis/diagnostic imaging, Echocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Risk Factors, Calcinosis*, Calcinosis/diagnostic imaging, Echocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1496, + "user_id": 1811967433, + "artical_title": "The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis.", + "pmid": 34373923, + "journal_name": "Rheumatology (Oxford, England)", + "date": "2021-08-11", + "author": "Karpouzas GA,Ormseth SR,Hernandez E,Budoff MJ", + "auth_pos": 4, + "meshterms": "Arthritis, Rheumatoid*, Arthritis, Rheumatoid/chemically induced, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Calcinosis*, Calcinosis/complications, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Cardiovascular Diseases/prevention & control, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/etiology, Disease Progression, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Inflammation, Inflammation/complications, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/chemically induced, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Calcinosis*, Calcinosis/complications, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Cardiovascular Diseases/prevention & control, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/etiology, Disease Progression, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Inflammation, Inflammation/complications, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/chemically induced, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Calcinosis*, Calcinosis/complications, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Cardiovascular Diseases/prevention & control, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/etiology, Disease Progression, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Inflammation, Inflammation/complications, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/chemically induced, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Calcinosis*, Calcinosis/complications, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Cardiovascular Diseases/prevention & control, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/etiology, Disease Progression, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Inflammation, Inflammation/complications, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1497, + "user_id": 1811967433, + "artical_title": "Imaging in Coronary Artery Disease Risk Stratification.", + "pmid": 34379929, + "journal_name": "The New England journal of medicine", + "date": "2021-08-12", + "author": "Kadire SR,Udelson J,Budoff MJ", + "auth_pos": 3, + "meshterms": "Chest Pain, Chest Pain/etiology, Computed Tomography Angiography*, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Middle Aged, Myocardial Perfusion Imaging*, Radionuclide Imaging, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1498, + "user_id": 1811967433, + "artical_title": "Identification and Predictors for Cardiovascular Disease Risk Equivalents among Adults With Diabetes Mellitus.", + "pmid": 34380703, + "journal_name": "Diabetes care", + "date": "2021-08-13", + "author": "Zhao Y,Malik S,Budoff MJ,Correa A,Ashley KE,Selvin E,Watson KE,Wong ND", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1499, + "user_id": 1811967433, + "artical_title": "Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.", + "pmid": 34384260, + "journal_name": "AIDS research and human retroviruses", + "date": "2021-08-14", + "author": "Sarkar S,Haberlen S,Post W,Kelesidis T,Wiley D,Kingsley L,Kim EY,Palella FJ,Witt MD,Budoff M,Rodriguez A,Brown TT", + "auth_pos": 10, + "meshterms": "Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein, Acquired Immunodeficiency Syndrome*, Antigens, CD, Antigens, CD/genetics, Antigens, CD/metabolism, Cohort Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, HIV Infections*, HIV Infections/complications, Humans, Lymphocyte Activation, Male, Lymphocyte Activation Gene 3 Protein", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1500, + "user_id": 1811967433, + "artical_title": "Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.", + "pmid": 34398665, + "journal_name": "Journal of the American Heart Association", + "date": "2021-08-17", + "author": "Lee Y,Nemet I,Wang Z,Lai HTM,de Oliveira Otto MC,Lemaitre RN,Fretts AM,Sotoodehnia N,Budoff M,DiDonato JA,McKnight B,Tang WHW,Psaty BM,Siscovick DS,Hazen SL,Mozaffarian D", + "auth_pos": 9, + "meshterms": "Aged, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Biomarkers, Biomarkers/blood, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Humans, Methylamines, Methylamines/blood*, Middle Aged, Prospective Studies, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Biomarkers, Biomarkers/blood, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Humans, Methylamines, Methylamines/blood*, Middle Aged, Prospective Studies, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Biomarkers, Biomarkers/blood, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Humans, Methylamines, Methylamines/blood*, Middle Aged, Prospective Studies, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Biomarkers, Biomarkers/blood, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Humans, Methylamines, Methylamines/blood*, Middle Aged, Prospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1501, + "user_id": 1811967433, + "artical_title": "Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition.", + "pmid": 34406326, + "journal_name": "JAMA cardiology", + "date": "2021-08-19", + "author": "van Rosendael AR,van den Hoogen IJ,Gianni U,Ma X,Tantawy SW,Bax AM,Lu Y,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Virmani R,Samady H,Sato Y,Stone PH,Berman DS,Narula J,Blankstein R,Min JK,Lin FY,Shaw LJ,Bax JJ,Chang HJ", + "auth_pos": 10, + "meshterms": "Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed, Calcium, Calcium/metabolism*, Coronary Artery Disease, Coronary Artery Disease/diagnosis, Coronary Artery Disease/drug therapy*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/metabolism, Disease Progression, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnosis, Plaque, Atherosclerotic/drug therapy*, Risk Factors, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1502, + "user_id": 1811967433, + "artical_title": "Association of Tube Voltage With Plaque Composition on Coronary CT Angiography: Results From Paradigm Registry.", + "pmid": 34419398, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-08-23", + "author": "Takagi H,Leipsic JA,Indraratna P,Gulsin G,Khasanova E,Tzimas G,Lin FY,Shaw LJ,Lee SE,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Bax JJ,Chang HJ", + "auth_pos": 12, + "meshterms": "Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1503, + "user_id": 1811967433, + "artical_title": "Differential progression of coronary atherosclerosis according to plaque composition: a cluster analysis of PARADIGM registry data.", + "pmid": 34429500, + "journal_name": "Scientific reports", + "date": "2021-08-26", + "author": "Yoon YE,Baskaran L,Lee BC,Pandey MK,Goebel B,Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Narula J,Bax JJ,Lin FY,Shaw L,Chang HJ", + "auth_pos": 10, + "meshterms": "Aged, Cluster Analysis, Coronary Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Coronary Artery Disease/pathology, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic, Plaque, Atherosclerotic/classification, Plaque, Atherosclerotic/diagnostic imaging*, Plaque, Atherosclerotic/pathology, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Vascular Calcification/pathology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1504, + "user_id": 1811967433, + "artical_title": "Plaque Character and Progression According to the Location of Coronary Atherosclerotic Plaque.", + "pmid": 34465463, + "journal_name": "The American journal of cardiology", + "date": "2021-09-02", + "author": "Bax AM,Yoon YE,Gianni U,Ma X,Lu Y,Lee BC,Goebel B,Han D,Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,Gonçalves PA,Pontone G,Shin S,Narula J,Lin FY,Shaw LJ,Chang HJ", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1505, + "user_id": 1811967433, + "artical_title": "Implication of thoracic aortic calcification over coronary calcium score regarding the 2018 ACC/AHA Multisociety cholesterol guideline: results from the CAC Consortium.", + "pmid": 34467259, + "journal_name": "American journal of preventive cardiology", + "date": "2021-09-02", + "author": "Han D,Kuronuma K,Rozanski A,Budoff MJ,Miedema MD,Nasir K,Shaw LJ,Rumberger JA,Gransar H,Blumenthal RS,Blaha MJ,Berman DS", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1506, + "user_id": 1811967433, + "artical_title": "Measurement of compensatory arterial remodelling over time with serial coronary computed tomography angiography and 3D metrics.", + "pmid": 34468717, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2021-09-02", + "author": "van den Hoogen IJ,van Rosendael AR,Lin FY,Gianni U,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Hyun Choi J,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic J,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Virmani R,Samady H,Stone PH,Narula J,Chang HJ,Min JK,Shaw LJ,Bax JJ", + "auth_pos": 7, + "meshterms": "Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1507, + "user_id": 1811967433, + "artical_title": "HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium.", + "pmid": 34471076, + "journal_name": "AIDS (London, England)", + "date": "2021-09-03", + "author": "Sarkar S,Haberlen S,Metkus TS,Kingsley L,Budoff M,Witt MD,Palella FJ,Post WS,Brown TT", + "auth_pos": 5, + "meshterms": "Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Humans, Male, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1508, + "user_id": 1811967433, + "artical_title": "Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 34511241, + "journal_name": "Atherosclerosis", + "date": "2021-09-14", + "author": "Massera D,Buzkova P,Bortnick AE,Owens DS,Mao S,Li D,De Boer IH,Kestenbaum BR,Budoff MJ,Kizer JR", + "auth_pos": 9, + "meshterms": "Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male, Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Bone Density, Calcinosis*, Calcinosis/diagnostic imaging, Female, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Humans, Male", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1509, + "user_id": 1811967433, + "artical_title": "Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.", + "pmid": 34542321, + "journal_name": "AIDS research and human retroviruses", + "date": "2021-09-21", + "author": "Sarkar S,Haberlen S,Post WS,Kelesidis T,Wiley D,Kingsley L,Kim EY,Palella FJ,Witt MD,Budoff MJ,Rodriguez A,Brown TT", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1510, + "user_id": 1811967433, + "artical_title": "Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.", + "pmid": 34608042, + "journal_name": "AIDS (London, England)", + "date": "2021-10-06", + "author": "Shaikh K,Bhondoekhan F,Haberlen S,Nakanishi R,Roy SK,Alla VM,Brown TT,Lee J,Osawa K,Almeida S,Rahmani S,Nezarat N,Sheidaee N,Kim M,Jayawardena E,Kim N,Hathiramani N,Palella FJ,Witt M,Ahmad K,Kingsley L,Post WS,Budoff MJ", + "auth_pos": 23, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cohort Studies, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, HIV Infections*, HIV Infections/complications, Heart Disease Risk Factors, Humans, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1511, + "user_id": 1811967433, + "artical_title": "The Miami Heart Study (MiHeart) at Baptist Health South Florida, A prospective study of subclinical cardiovascular disease and emerging cardiovascular risk factors in asymptomatic young and middle-aged adults: The Miami Heart Study: Rationale and Design.", + "pmid": 34611641, + "journal_name": "American journal of preventive cardiology", + "date": "2021-10-07", + "author": "Nasir K,Ziffer JA,Cainzos-Achirica M,Ali SS,Feldman DI,Arias L,Saxena A,Feldman T,Cury R,Budoff MJ,Fialkow J", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1512, + "user_id": 1811967433, + "artical_title": "Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.", + "pmid": 34620417, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-09", + "author": "Kenchaiah S,Budoff MJ,Ding J,Carr JJ,Bluemke DA", + "auth_pos": 2, + "meshterms": "Adipose Tissue, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Incidence, Pericardium*, Pericardium/diagnostic imaging, Prognosis, Adipose Tissue, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Incidence, Pericardium*, Pericardium/diagnostic imaging, Prognosis, Adipose Tissue, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Incidence, Pericardium*, Pericardium/diagnostic imaging, Prognosis, Adipose Tissue, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Incidence, Pericardium*, Pericardium/diagnostic imaging, Prognosis, Adipose Tissue, Heart Failure*, Heart Failure/diagnosis, Heart Failure/epidemiology, Humans, Incidence, Pericardium*, Pericardium/diagnostic imaging, Prognosis", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1513, + "user_id": 1811967433, + "artical_title": "Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.", + "pmid": 34620410, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-09", + "author": "Gaba P,Bhatt DL,Giugliano RP,Steg PG,Miller M,Brinton EA,Jacobson TA,Ketchum SB,Juliano RA,Jiao L,Doyle RT,Granowitz C,Tardif JC,Ballantyne CM,Pinto DS,Budoff MJ,Gibson CM", + "auth_pos": 16, + "meshterms": "Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology, Aged, Angina, Unstable, Angina, Unstable/epidemiology, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives*, Eicosapentaenoic Acid/therapeutic use, Endpoint Determination*, Female, Humans, Hypertriglyceridemia, Hypertriglyceridemia/drug therapy, Lipid Regulating Agents, Lipid Regulating Agents/therapeutic use, Male, Myocardial Infarction, Myocardial Infarction/epidemiology, Myocardial Revascularization, Myocardial Revascularization/statistics & numerical data, Stroke, Stroke/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1514, + "user_id": 1811967433, + "artical_title": "LDL receptor and pathogen processes: Functions beyond normal lipids.", + "pmid": 34645587, + "journal_name": "Journal of clinical lipidology", + "date": "2021-10-15", + "author": "Aldana-Bitar J,Moore J,Budoff MJ", + "auth_pos": 3, + "meshterms": "Animals, Binding Sites, Cholesterol, LDL, Cholesterol, LDL/metabolism, Hepacivirus, Hepacivirus/metabolism*, Hepacivirus/physiology, Humans, Lipoproteins, LDL, Lipoproteins, LDL/metabolism*, Mice, Protein Binding, Protozoan Infections, Protozoan Infections/metabolism, Protozoan Infections/parasitology, Receptors, LDL, Receptors, LDL/metabolism*, Toxoplasma, Toxoplasma/metabolism*, Toxoplasma/physiology, Trypanosoma cruzi, Trypanosoma cruzi/metabolism*, Trypanosoma cruzi/physiology, Vesicular stomatitis Indiana virus, Vesicular stomatitis Indiana virus/metabolism*, Vesicular stomatitis Indiana virus/physiology, Virus Diseases, Virus Diseases/metabolism, Virus Diseases/virology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1515, + "user_id": 1811967433, + "artical_title": "Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.", + "pmid": 34649694, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-10-16", + "author": "Dzaye O,Razavi AC,Dardari ZA,Shaw LJ,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rozanski A,Rumberger JA,Orringer CE,Smith SC,Blankstein R,Whelton SP,Mortensen MB,Blaha MJ", + "auth_pos": 6, + "meshterms": "Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*, Adult, Cohort Studies, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/diagnostic imaging*, Disease Susceptibility, Female, Humans, Male, Middle Aged, Models, Cardiovascular*, Retrospective Studies, Risk Assessment*, Risk Factors, Vascular Calcification, Vascular Calcification/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1516, + "user_id": 1811967433, + "artical_title": "Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.", + "pmid": 34710343, + "journal_name": "Circulation", + "date": "2021-10-29", + "author": "Verma S,Bhatt DL,Steg PG,Miller M,Brinton EA,Jacobson TA,Dhingra NK,Ketchum SB,Juliano RA,Jiao L,Doyle RT,Granowitz C,Gibson CM,Pinto D,Giugliano RP,Budoff MJ,Mason RP,Tardif JC,Ballantyne CM", + "auth_pos": 16, + "meshterms": "Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors, Aged, Coronary Artery Bypass*, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/analogs & derivatives*, Female, Humans, Ischemia, Ischemia/etiology, Ischemia/prevention & control*, Male, Middle Aged, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1517, + "user_id": 1811967433, + "artical_title": "Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.", + "pmid": 34706555, + "journal_name": "Circulation", + "date": "2021-10-29", + "author": "Majithia A,Bhatt DL,Friedman AN,Miller M,Steg PG,Brinton EA,Jacobson TA,Ketchum SB,Juliano RA,Jiao L,Doyle RT,Granowitz C,Budoff M,Preston Mason R,Tardif JC,Boden WE,Ballantyne CM", + "auth_pos": 13, + "meshterms": "Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control, Aged, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/physiopathology, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/administration & dosage, Eicosapentaenoic Acid/adverse effects, Eicosapentaenoic Acid/analogs & derivatives*, Female, Glomerular Filtration Rate, Glomerular Filtration Rate/drug effects*, Humans, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/etiology, Renal Insufficiency, Chronic/physiopathology, Renal Insufficiency, Chronic/prevention & control", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1518, + "user_id": 1811967433, + "artical_title": "Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans.", + "pmid": 34729994, + "journal_name": "Journal of the American Heart Association", + "date": "2021-11-04", + "author": "Soohoo M,Hashemi L,Hsiung JT,Moradi H,Budoff MJ,Kovesdy CP,Kalantar-Zadeh K,Streja E", + "auth_pos": 5, + "meshterms": "Aged, Atherosclerosis*, Atherosclerosis/blood, Atherosclerosis/epidemiology, Atherosclerosis/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/therapy, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/pathology, Risk Assessment, Triglycerides*, Triglycerides/blood, United States, United States/epidemiology, Veterans, Veterans/statistics & numerical data, Aged, Atherosclerosis*, Atherosclerosis/blood, Atherosclerosis/epidemiology, Atherosclerosis/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/therapy, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/pathology, Risk Assessment, Triglycerides*, Triglycerides/blood, United States, United States/epidemiology, Veterans, Veterans/statistics & numerical data, Aged, Atherosclerosis*, Atherosclerosis/blood, Atherosclerosis/epidemiology, Atherosclerosis/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/blood, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/therapy, Hospitalization*, Hospitalization/statistics & numerical data, Humans, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/pathology, Risk Assessment, Triglycerides*, Triglycerides/blood, United States, United States/epidemiology, Veterans, Veterans/statistics & numerical data", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1519, + "user_id": 1811967433, + "artical_title": "Comparison of coronary atherosclerotic plaque progression in East Asians and Caucasians by serial coronary computed tomographic angiography: A PARADIGM substudy.", + "pmid": 34736879, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2021-11-06", + "author": "Ben Zekry S,Sreedharan S,Han D,Sellers S,Ahmadi AA,Blanke P,Hadamitzky M,Kim YJ,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Lee BK,Chun EJ,Cademartiri F,Maffei E,Marques H,Shin S,Choi JH,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Leipsic J,Chang HJ", + "auth_pos": 12, + "meshterms": "Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Aged, Asians, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1520, + "user_id": 1811967433, + "artical_title": "Deep neural survival networks for cardiovascular risk prediction: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 34749095, + "journal_name": "Computers in biology and medicine", + "date": "2021-11-09", + "author": "Hathaway QA,Yanamala N,Budoff MJ,Sengupta PP,Zeb I", + "auth_pos": 3, + "meshterms": "Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Ethnicity, Heart Disease Risk Factors, Humans, Risk Assessment, Risk Factors, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Coronary Artery Disease*, Ethnicity, Heart Disease Risk Factors, Humans, Risk Assessment, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1521, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.", + "pmid": 34756729, + "journal_name": "Atherosclerosis", + "date": "2021-11-11", + "author": "Dzaye O,Berning P,Dardari ZA,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rozanski A,Rumberger JA,Shaw LJ,Mortensen MB,Whelton SP,Blaha MJ", + "auth_pos": 5, + "meshterms": "Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Aged, Calcium, Cause of Death, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Lung Neoplasms/diagnostic imaging, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1522, + "user_id": 1811967433, + "artical_title": "Associations of adipokine levels with the prevalence and extent of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 34785427, + "journal_name": "Atherosclerosis", + "date": "2021-11-18", + "author": "Sweeney T,Ogunmoroti O,Ndumele CE,Zhao D,Varma B,Allison MA,Budoff MJ,Fashanu OE,Sharma A,Bertoni AG,Michos ED", + "auth_pos": 7, + "meshterms": "Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Adipokines, Adult, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1523, + "user_id": 1811967433, + "artical_title": "Associations of endogenous sex hormone levels with the prevalence and progression of valvular and thoracic aortic calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 34785061, + "journal_name": "Atherosclerosis", + "date": "2021-11-18", + "author": "Sharma A,Ogunmoroti O,Fashanu OE,Zhao D,Ouyang P,Budoff MJ,Thomas IC,Michos ED", + "auth_pos": 6, + "meshterms": "Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Female, Gonadal Steroid Hormones, Humans, Male, Prevalence, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1524, + "user_id": 1811967433, + "artical_title": "Clinical Applications Measuring Arterial Stiffness: An Expert Consensus for the Application of Cardio-Ankle Vascular Index (CAVI).", + "pmid": 34791038, + "journal_name": "American journal of hypertension", + "date": "2021-11-19", + "author": "Budoff MJ,Alpert B,Chirinos JA,Fernhall B,Hamburg N,Kario K,Kullo I,Matsushita K,Miyoshi T,Tanaka H,Townsend R,Valensi P", + "auth_pos": 1, + "meshterms": "Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*, Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*, Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*, Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*, Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*, Ankle, Consensus, Humans, Pulse Wave Analysis, Vascular Stiffness*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1525, + "user_id": 1811967433, + "artical_title": "Prognostic significance of plaque location in non-obstructive coronary artery disease: from the CONFIRM registry.", + "pmid": 34791117, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2021-11-19", + "author": "Han D,Chen B,Gransar H,Achenbach S,Al-Mallah MH,Budoff MJ,Cademartiri F,Maffei E,Callister TQ,Chinnaiyan K,Chow BJW,DeLago A,Hadamitzky M,Hausleiter J,Kaufmann PA,Villines TC,Kim YJ,Leipsic J,Feuchtner G,Cury RC,Pontone G,Andreini D,Marques H,Rubinshtein R,Chang HJ,Lin FY,Shaw LJ,Min JK,Berman DS", + "auth_pos": 6, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Prognosis, Registries, Risk Assessment, Risk Assessment/methods, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1526, + "user_id": 1811967433, + "artical_title": "Mean Versus Peak Coronary Calcium Density on Non-Contrast CT: Calcium Scoring and ASCVD Risk Prediction.", + "pmid": 34801452, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-11-22", + "author": "Dzaye O,Razavi AC,Dardari ZA,Berman DS,Budoff MJ,Miedema MD,Obisesan OH,Boakye E,Nasir K,Rozanski A,Rumberger JA,Shaw LJ,Mortensen MB,Whelton SP,Blaha MJ", + "auth_pos": 5, + "meshterms": "Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult, Adult, Atherosclerosis*, Calcium, Calcium/analysis, Coronary Disease*, Female, Humans, Male, Plaque, Atherosclerotic*, Predictive Value of Tests, Tomography, X-Ray Computed, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1527, + "user_id": 1811967433, + "artical_title": "De-risking primary prevention: role of imaging.", + "pmid": 34821189, + "journal_name": "Therapeutic advances in cardiovascular disease", + "date": "2021-11-26", + "author": "Shafter AM,Shaikh K,Johanis A,Budoff MJ", + "auth_pos": 4, + "meshterms": "Atherosclerosis*, Coronary Artery Disease*, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Male, Risk Assessment, Risk Factors, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1528, + "user_id": 1811967433, + "artical_title": "Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis.", + "pmid": 34826751, + "journal_name": "Atherosclerosis", + "date": "2021-11-27", + "author": "Zeb I,Jorgensen NW,Blumenthal RS,Burke GL,Lloyd-Jones D,Blaha MJ,Wong ND,Nasir K,Budoff MJ", + "auth_pos": 9, + "meshterms": "Atherosclerosis*, Atherosclerosis/diagnosis, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Lipoproteins, Longitudinal Studies, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Lipoproteins, Longitudinal Studies, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Lipoproteins, Longitudinal Studies, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Lipoproteins, Longitudinal Studies, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Lipoproteins, Longitudinal Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1529, + "user_id": 1811967433, + "artical_title": "Trends in utilization of Coronary CT Angiography in patients presenting with acute chest pain in United States: An analysis of the National Emergency Database.", + "pmid": 34844899, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2021-12-01", + "author": "Shaikh KA,Walters RW,Aboeata A,Thandra A,Anugula D,Urja P,Alla VM,Budoff MJ", + "auth_pos": 8, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography*, Coronary Angiography, Emergency Service, Hospital, Humans, Predictive Value of Tests, Tomography, X-Ray Computed, United States, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography*, Coronary Angiography, Emergency Service, Hospital, Humans, Predictive Value of Tests, Tomography, X-Ray Computed, United States, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/therapy, Chest Pain, Chest Pain/diagnostic imaging, Chest Pain/etiology, Computed Tomography Angiography*, Coronary Angiography, Emergency Service, Hospital, Humans, Predictive Value of Tests, Tomography, X-Ray Computed, United States", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1530, + "user_id": 1811967433, + "artical_title": "The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV.", + "pmid": 34870934, + "journal_name": "AIDS (London, England)", + "date": "2021-12-07", + "author": "Sarkar S,Bhondoekhan F,Haberlen S,Palella FJ,Kingsley LA,Budoff M,Witt MD,Post WS,Brown TT", + "auth_pos": 6, + "meshterms": "Adipose Tissue, Coronary Angiography, Coronary Artery Disease*, HIV Infections*, HIV Infections/complications, Humans, Male, Risk Factors, Adipose Tissue, Coronary Angiography, Coronary Artery Disease*, HIV Infections*, HIV Infections/complications, Humans, Male, Risk Factors, Adipose Tissue, Coronary Angiography, Coronary Artery Disease*, HIV Infections*, HIV Infections/complications, Humans, Male, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1531, + "user_id": 1811967433, + "artical_title": "Coronary lumen volume in diabetes.", + "pmid": 34919059, + "journal_name": "Coronary artery disease", + "date": "2021-12-18", + "author": "Beroukhim Afrahimi S,Williams A,Shaikh K,Kinninger A,Roy S,Budoff M", + "auth_pos": 6, + "meshterms": "Coronary Angiography, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Ultrasonography, Interventional, Coronary Angiography, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Ultrasonography, Interventional, Coronary Angiography, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Ultrasonography, Interventional", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1532, + "user_id": 1811967433, + "artical_title": "DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.", + "pmid": 34922811, + "journal_name": "Journal of diabetes and its complications", + "date": "2021-12-20", + "author": "Handelsman Y,Anderson JE,Bakris GL,Ballantyne CM,Beckman JA,Bhatt DL,Bloomgarden ZT,Bozkurt B,Budoff MJ,Butler J,Dagogo-Jack S,de Boer IH,DeFronzo RA,Eckel RH,Einhorn D,Fonseca VA,Green JB,Grunberger G,Guerin C,Inzucchi SE,Jellinger PS,Kosiborod MN,Kushner P,Lepor N,Mende CW,Michos ED,Plutzky J,Taub PR,Umpierrez GE,Vaduganathan M,Weir MR", + "auth_pos": 9, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular System*, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/epidemiology, Diabetes Mellitus, Type 2/therapy, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/epidemiology, Renal Insufficiency, Chronic/therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1533, + "user_id": 1811967433, + "artical_title": "Cardiovascular risk score associations with frailty in men and women with or at risk for HIV.", + "pmid": 34934019, + "journal_name": "AIDS (London, England)", + "date": "2021-12-23", + "author": "Kuniholm MH,Vásquez E,Appleton AA,Kingsley L,Palella FJ,Budoff M,Michos ED,Fox E,Jones D,Adimora AA,Ofotokun I,D'souza G,Weber KM,Tien PC,Plankey M,Sharma A,Gustafson DR", + "auth_pos": 6, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cohort Studies, Female, Frailty*, Frailty/complications, Frailty/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Heart Disease Risk Factors, Humans, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1534, + "user_id": 1811967433, + "artical_title": "Machine learning enables new insights into genetic contributions to liver fat accumulation.", + "pmid": 34957434, + "journal_name": "Cell genomics", + "date": "2021-12-28", + "author": "Haas ME,Pirruccello JP,Friedman SN,Wang M,Emdin CA,Ajmera VH,Simon TG,Homburger JR,Guo X,Budoff M,Corey KE,Zhou AY,Philippakis A,Ellinor PT,Loomba R,Batra P,Khera AV", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1535, + "user_id": 1811967433, + "artical_title": "Association of Quantified Costal Cartilage Calcification and Long-Term Cumulative Blood Glucose Exposure: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 34966360, + "journal_name": "Frontiers in endocrinology", + "date": "2021-12-31", + "author": "Shabani M,Pishgar F,Akhtarkhavari S,Quinaglia T,Budoff MJ,Bluemke DA,Barr GR,Post WS,Wu CO,Arbab-Zadeh A,Sidhaye A,Lima JAC,Demehri S", + "auth_pos": 5, + "meshterms": "Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1536, + "user_id": 1811967433, + "artical_title": "Aortic Arch Calcification in Ungated Lung Computed Tomography Scans as Predictors of Atherosclerotic Cardiovascular Disease: Methodology and Reproducibility in a Multi-Ethnic Study of Atherosclerosis.", + "pmid": 36874906, + "journal_name": "Journal of coronary artery disease", + "date": "2022-01-01", + "author": "Golub I,Sheppard JP,Lakshmanan S,Dahal S,Kinninger A,Allison M,Barr G,McClelland R,Blaha MJ,Roy SK,Budoff MJ", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1537, + "user_id": 1811967433, + "artical_title": "Cardiac Computed Tomography in Cardio-Oncology: Primer.", + "pmid": 34988472, + "journal_name": "JACC. CardioOncology", + "date": "2022-01-07", + "author": "Lopez-Mattei JC,Yang EH,Ferencik M,Baldassarre LA,Dent S,Budoff MJ", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1538, + "user_id": 1811967433, + "artical_title": "Association of Coronary Artery Calcium Density and Volume with Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study.", + "pmid": 34999157, + "journal_name": "Current problems in cardiology", + "date": "2022-01-10", + "author": "Rifai MA,Kanaya AM,Kandula NR,Patel J,Al-Mallah MH,Budoff M,Cainzos-Achirica M,Criqui MH,Virani SS", + "auth_pos": 6, + "meshterms": "Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged, Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged, Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged, Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged, Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged, Female, Humans, Male, Middle Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Calcium, Cardiometabolic Risk Factors, Cardiovascular Diseases*, Coronary Artery Disease*, Risk Assessment, Risk Factors, South Asian People, Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1539, + "user_id": 1811967433, + "artical_title": "Insomnia and Risk of Myocardial Infarction Among People with HIV.", + "pmid": 35001042, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2022-01-11", + "author": "Luu BR,Nance RM,Delaney JAC,Ruderman SA,Heckbert SR,Budoff MJ,Mathews WC,Moore RD,Feinstein MJ,Burkholder GA,Eron JJ,Mugavero MJ,Saag MS,Kitahata MM,Crane HM,Whitney BM", + "auth_pos": 6, + "meshterms": "Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, HIV Infections*, HIV Infections/complications, Humans, Longitudinal Studies, Myocardial Infarction*, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Sleep Initiation and Maintenance Disorders*, Sleep Initiation and Maintenance Disorders/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1540, + "user_id": 1811967433, + "artical_title": "Association of coronary artery calcification and thoracic aortic calcification with incident peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 35005719, + "journal_name": "European heart journal open", + "date": "2022-01-11", + "author": "Bakhshi H,Bagchi P,Meyghani Z,Tehrani B,Qian X,Garg PK,Ambale-Venkatesh B,Bhatia HS,Ohyama Y,Wu CO,Budoff M,Allison M,Criqui MH,Bluemke DA,Lima JAC,deFilippi CR", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1541, + "user_id": 1811967433, + "artical_title": "Evaluation of the Value of Waist Circumference and Metabolomics in the Estimation of Visceral Adipose Tissue.", + "pmid": 35015809, + "journal_name": "American journal of epidemiology", + "date": "2022-01-12", + "author": "Boone SC,van Smeden M,Rosendaal FR,le Cessie S,Groenwold RHH,Jukema JW,van Dijk KW,Lamb HJ,Greenland P,Neeland IJ,Allison MA,Criqui MH,Budoff MJ,Lind LL,Kullberg J,Ahlström H,Mook-Kanamori DO,de Mutsert R", + "auth_pos": 13, + "meshterms": "Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference, Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference, Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference, Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference, Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference, Adipose Tissue, Body Mass Index, Humans, Intra-Abdominal Fat*, Metabolomics, Middle Aged, Obesity*, Obesity/epidemiology, Prospective Studies, Waist Circumference", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1542, + "user_id": 1811967433, + "artical_title": "Relationship between genomic risk scores (GRS) and coronary artery calcium (CAC) score: A pilot study.", + "pmid": 35063217, + "journal_name": "Clinical nutrition ESPEN", + "date": "2022-01-23", + "author": "Chaganti BT,Kinninger A,Cherukuri L,Birudaraju D,Lakshmanan S,Hamal S,Flores F,Dailing C,Ahmad K,Trine R,Krishnamoorthy S,Gibson G,Budoff MJ", + "auth_pos": 13, + "meshterms": "Calcium*, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Genomics, Humans, Male, Middle Aged, Pilot Projects, Risk Factors, Calcium*, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Genomics, Humans, Male, Middle Aged, Pilot Projects, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1543, + "user_id": 1811967433, + "artical_title": "Association of Plaque Location and Vessel Geometry Determined by Coronary Computed Tomographic Angiography With Future Acute Coronary Syndrome-Causing Culprit Lesions.", + "pmid": 35080587, + "journal_name": "JAMA cardiology", + "date": "2022-01-27", + "author": "Han D,Lin A,Kuronuma K,Tzolos E,Kwan AC,Klein E,Andreini D,Bax JJ,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,Hadamitzky M,Kim YJ,Leipsic JA,Maffei E,Marques H,Plank F,Pontone G,Villines TC,Al-Mallah MH,de Araújo Gonçalves P,Danad I,Gransar H,Lu Y,Lee JH,Lee SE,Baskaran L,Al'Aref SJ,Yoon YE,Van Rosendael A,Budoff MJ,Samady H,Stone PH,Virmani R,Achenbach S,Narula J,Chang HJ,Min JK,Lin FY,Shaw LJ,Slomka PJ,Dey D,Berman DS", + "auth_pos": 34, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/etiology, Case-Control Studies, Coronary Angiography, Coronary Angiography/methods, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1544, + "user_id": 1811967433, + "artical_title": "Performance and Integration of Smartphone Wireless ECG Monitoring into the Enterprise Electronic Health Record: First Clinical Experience.", + "pmid": 35095284, + "journal_name": "Clinical medicine insights. Case reports", + "date": "2022-02-01", + "author": "Cho GW,Almeida SO,Gang ES,Elad Y,Duncan R,Budoff MJ,Karlsberg RP", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1545, + "user_id": 1811967433, + "artical_title": "Higher Leptin Levels Are Associated with Coronary Artery Calcium Progression: the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 35132401, + "journal_name": "Diabetes epidemiology and management", + "date": "2022-02-09", + "author": "Varma B,Ogunmoroti O,Ndumele CE,Zhao D,Szklo M,Sweeney T,Allison MA,Budoff MJ,Subramanya V,Bertoni AG,Michos ED", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1546, + "user_id": 1811967433, + "artical_title": "Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement.", + "pmid": 35146468, + "journal_name": "American journal of preventive cardiology", + "date": "2022-02-12", + "author": "Budoff MJ,Lakshmanan S,Toth PP,Hecht HS,Shaw LJ,Maron DJ,Michos ED,Williams KA,Nasir K,Choi AD,Chinnaiyan K,Min J,Blaha M", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1547, + "user_id": 1811967433, + "artical_title": "Radiation Doses in Patients Undergoing Computed Tomographic Coronary Artery Calcium Evaluation With a 64-Slice Scanner Versus a 256-Slice Scanner.", + "pmid": 35244722, + "journal_name": "Texas Heart Institute journal", + "date": "2022-03-05", + "author": "Madaj P,Li D,Nakanishi R,Andreini D,Pontone G,Conte E,O'Rourke R,Hamilton-Craig C,Nimmagadda M,Kim N,Fatima B,Dailing C,Shaikh K,Shekar C,Lee JH,Budoff MJ", + "auth_pos": 16, + "meshterms": "Calcium, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Male, Radiation Dosage, Calcium, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Male, Radiation Dosage, Calcium, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Male, Radiation Dosage, Calcium, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Male, Radiation Dosage, Calcium, Coronary Angiography, Coronary Angiography/adverse effects, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Early Detection of Cancer, Female, Humans, Lung Neoplasms*, Male, Radiation Dosage", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1548, + "user_id": 1811967433, + "artical_title": "Association of HIV Serostatus and Inflammation With Ascending Aortic Size.", + "pmid": 35253450, + "journal_name": "Journal of the American Heart Association", + "date": "2022-03-08", + "author": "Minhas AS,Post WS,Liu B,Doria De Vasconcellos H,Haberlen SA,Feinstein M,Stosor V,Budoff M,Chew KW,Magnani JW,Brown T,Lima JAC,Wu KC", + "auth_pos": 8, + "meshterms": "Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*, Aorta, Aorta/diagnostic imaging, Aorta/pathology, Cohort Studies, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, HIV Infections/epidemiology, Humans, Inflammation, Inflammation/pathology, Male, Reference Values, Tumor Necrosis Factor-alpha*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1549, + "user_id": 1811967433, + "artical_title": "Vessel-specific plaque features on coronary computed tomography angiography among patients of varying atherosclerotic cardiovascular disease risk.", + "pmid": 35253854, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2022-03-08", + "author": "Bax AM,Yoon YE,Gianni U,van Rosendael AR,Lu Y,Ma X,Goebel BP,Tantawy SW,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Narula J,Lin FY,Chang HJ,Shaw LJ", + "auth_pos": 10, + "meshterms": "Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies, Aged, Atherosclerosis*, Cardiovascular Diseases*, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1550, + "user_id": 1811967433, + "artical_title": "Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.", + "pmid": 35261279, + "journal_name": "Journal of the American Heart Association", + "date": "2022-03-10", + "author": "Peterson BE,Bhatt DL,Steg PG,Miller M,Brinton EA,Jacobson TA,Ketchum SB,Juliano RA,Jiao L,Doyle RT,Granowitz C,Gibson CM,Pinto D,Giugliano RP,Budoff MJ,Tardif JC,Verma S,Ballantyne CM", + "auth_pos": 15, + "meshterms": "Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides, Double-Blind Method, Eicosapentaenoic Acid, Eicosapentaenoic Acid/analogs & derivatives, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Ischemia, Ischemia/drug therapy, Myocardial Infarction*, Myocardial Infarction/drug therapy, Percutaneous Coronary Intervention*, Percutaneous Coronary Intervention/adverse effects, Risk Factors, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1551, + "user_id": 1811967433, + "artical_title": "Computed tomography angiography versus Agatston score for diagnosis of coronary artery disease in patients with stable chest pain: individual patient data meta-analysis of the international COME-CCT Consortium.", + "pmid": 35267094, + "journal_name": "European radiology", + "date": "2022-03-11", + "author": "Wieske V,Walther M,Dubourg B,Alkadhi H,Nørgard BL,Meijs MFL,Diederichsen ACP,Wan YL,Mickley H,Nikolaou K,Shabestari AA,Halvorsen BA,Martuscelli E,Sun K,Herzog BA,Marcus RP,Leschka S,Garcia MJ,Ovrehus KA,Knuuti J,Mendoza-Rodriguez V,Bettencourt N,Muraglia S,Buechel RR,Kaufmann PA,Zimmermann E,Tardif JC,Budoff MJ,Schlattmann P,Dewey M", + "auth_pos": 28, + "meshterms": "Calcium, Chest Pain, Chest Pain/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Predictive Value of Tests, Tomography, X-Ray Computed, Calcium, Chest Pain, Chest Pain/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Predictive Value of Tests, Tomography, X-Ray Computed, Calcium, Chest Pain, Chest Pain/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Humans, Predictive Value of Tests, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1552, + "user_id": 1811967433, + "artical_title": "Arterial stiffness and left ventricular structure assessed by cardiac computed tomography in a multiethnic population.", + "pmid": 35287157, + "journal_name": "Journal of cardiovascular medicine (Hagerstown, Md.)", + "date": "2022-03-15", + "author": "Calicchio F,Onuegbu A,Kinninger A,Shou MS,Golub I,Petronio AS,Tadic M,Budoff MJ", + "auth_pos": 8, + "meshterms": "Adult, Aged, Coronary Artery Disease*, Female, Heart Ventricles, Heart Ventricles/diagnostic imaging, Humans, Hypertension*, Male, Middle Aged, Tomography, Vascular Stiffness*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1553, + "user_id": 1811967433, + "artical_title": "Relation of Progression of Coronary Artery Calcium to Dementia (from the Multi-Ethnic Study of Atherosclerosis).", + "pmid": 35287946, + "journal_name": "The American journal of cardiology", + "date": "2022-03-16", + "author": "Huang GS,Hansen SL,McClelland RL,Fitzpatrick AL,Longstreth WT,Budoff M,Wong ND,Fujiyoshi A,Kwon Y,Hughes TM,Heckbert SR", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1554, + "user_id": 1811967433, + "artical_title": "Favorable Cardiovascular Health Is Associated With Lower Prevalence, Incidence, Extent, and Progression of Extracoronary Calcification: MESA.", + "pmid": 35290079, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2022-03-16", + "author": "Ogunmoroti O,Osibogun O,Mathews L,Esuruoso OA,Ndumele CE,Okunrintemi V,Burke GL,Blumenthal RS,Budoff MJ,Michos ED", + "auth_pos": 9, + "meshterms": "Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Female, Humans, Incidence, Male, Middle Aged, Prevalence, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Female, Humans, Incidence, Male, Middle Aged, Prevalence, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Female, Humans, Incidence, Male, Middle Aged, Prevalence, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Female, Humans, Incidence, Male, Middle Aged, Prevalence, Risk Factors, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Female, Humans, Incidence, Male, Middle Aged, Prevalence, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1555, + "user_id": 1811967433, + "artical_title": "Prognostic Value of Serial Coronary CT Angiography in Atherosclerotic Plaque Modification: What have we learnt?", + "pmid": 35300492, + "journal_name": "Current cardiovascular imaging reports", + "date": "2022-03-19", + "author": "Manubolu VS,Roy SK,Budoff MJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1556, + "user_id": 1811967433, + "artical_title": "Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).", + "pmid": 35300833, + "journal_name": "The American journal of cardiology", + "date": "2022-03-19", + "author": "Hashemi L,Hsiung JT,Arif Y,Soohoo M,Jackson N,Gosmanova EO,Budoff M,Kovesdy CP,Kalantar-Zadeh K,Streja E", + "auth_pos": 7, + "meshterms": "Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cholesterol, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Risk Factors, United States, United States/epidemiology, Veterans*, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cholesterol, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Risk Factors, United States, United States/epidemiology, Veterans*, Aged, Atherosclerosis*, Atherosclerosis/epidemiology, Cardiovascular Diseases*, Cholesterol, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/epidemiology, Risk Factors, United States, United States/epidemiology, Veterans*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1557, + "user_id": 1811967433, + "artical_title": "Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.", + "pmid": 35342890, + "journal_name": "American journal of preventive cardiology", + "date": "2022-03-29", + "author": "Wong ND,Budoff MJ,Ferdinand K,Graham IM,Michos ED,Reddy T,Shapiro MD,Toth PP", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1558, + "user_id": 1811967433, + "artical_title": "Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort.", + "pmid": 35343038, + "journal_name": "HIV medicine", + "date": "2022-03-29", + "author": "Luu B,Ruderman S,Nance R,Delaney JAC,Ma J,Hahn A,Heckbert SR,Budoff MJ,Crothers K,Mathews WC,Christopolous K,Hunt PW,Eron J,Moore R,Keruly J,Lober WB,Burkholder GA,Willig A,Chander G,McCaul ME,Cropsey K,O'Cleirigh C,Peter I,Feinstein M,Tsui JI,Lindstroem S,Saag M,Kitahata MM,Crane HM,Drumright LN,Whitney BM", + "auth_pos": 8, + "meshterms": "Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology, Binge Drinking*, Binge Drinking/complications, Binge Drinking/epidemiology, Ethanol, HIV Infections*, HIV Infections/complications, Humans, Proportional Hazards Models, Prospective Studies, Risk Factors, Tobacco Smoking, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/etiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1559, + "user_id": 1811967433, + "artical_title": "Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.", + "pmid": 35354153, + "journal_name": "Nephron", + "date": "2022-03-31", + "author": "Soohoo M,Hashemi L,Hsiung JT,Moradi H,Budoff MJ,Kovesdy CP,Kalantar-Zadeh K,Streja E", + "auth_pos": 5, + "meshterms": "Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney/physiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/etiology, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/therapy, Risk Factors, Triglycerides, Veterans*, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney/physiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/etiology, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/therapy, Risk Factors, Triglycerides, Veterans*, Disease Progression, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney/physiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/etiology, Male, Middle Aged, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/therapy, Risk Factors, Triglycerides, Veterans*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1560, + "user_id": 1811967433, + "artical_title": "Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.", + "pmid": 35366608, + "journal_name": "Journal of autoimmunity", + "date": "2022-04-03", + "author": "Karpouzas GA,Ormseth SR,Ronda N,Hernandez E,Budoff MJ", + "auth_pos": 5, + "meshterms": "Arthritis, Rheumatoid*, Atherosclerosis*, C-Reactive Protein, C-Reactive Protein/metabolism, Cholesterol, LDL, Humans, Interleukin-6, Lipoprotein(a), Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Proprotein Convertase 9, Tumor Necrosis Factor-alpha, Arthritis, Rheumatoid*, Atherosclerosis*, C-Reactive Protein, C-Reactive Protein/metabolism, Cholesterol, LDL, Humans, Interleukin-6, Lipoprotein(a), Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Proprotein Convertase 9, Tumor Necrosis Factor-alpha, Arthritis, Rheumatoid*, Atherosclerosis*, C-Reactive Protein, C-Reactive Protein/metabolism, Cholesterol, LDL, Humans, Interleukin-6, Lipoprotein(a), Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Proprotein Convertase 9, Tumor Necrosis Factor-alpha, Arthritis, Rheumatoid*, Atherosclerosis*, C-Reactive Protein, C-Reactive Protein/metabolism, Cholesterol, LDL, Humans, Interleukin-6, Lipoprotein(a), Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Proprotein Convertase 9, Tumor Necrosis Factor-alpha", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1561, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death: The Coronary Artery Calcium Consortium.", + "pmid": 35370113, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-04-05", + "author": "Razavi AC,Uddin SMI,Dardari ZA,Berman DS,Budoff MJ,Miedema MD,Osei AD,Obisesan OH,Nasir K,Rozanski A,Rumberger JA,Shaw LJ,Sperling LS,Whelton SP,Mortensen MB,Blaha MJ,Dzaye O", + "auth_pos": 5, + "meshterms": "Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology, Death, Sudden, Cardiac/etiology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Assessment, Risk Factors, Vascular Calcification*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1562, + "user_id": 1811967433, + "artical_title": "Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.", + "pmid": 35385529, + "journal_name": "PloS one", + "date": "2022-04-07", + "author": "Aneni EC,Saeed GJ,Bittencourt MS,Cainzos-Achirica M,Osondu CU,Budoff M,Parise ER,Santos RD,Nasir K", + "auth_pos": 6, + "meshterms": "Alcoholism*, Alcoholism/complications, Blood Glucose, Body Mass Index, C-Reactive Protein, Humans, Hypertension*, Hypertension/complications, Incidence, Inflammation, Inflammation/complications, Longitudinal Studies, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/metabolism, Risk Factors, Alcoholism*, Alcoholism/complications, Blood Glucose, Body Mass Index, C-Reactive Protein, Humans, Hypertension*, Hypertension/complications, Incidence, Inflammation, Inflammation/complications, Longitudinal Studies, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/metabolism, Risk Factors, Alcoholism*, Alcoholism/complications, Blood Glucose, Body Mass Index, C-Reactive Protein, Humans, Hypertension*, Hypertension/complications, Incidence, Inflammation, Inflammation/complications, Longitudinal Studies, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/metabolism, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1563, + "user_id": 1811967433, + "artical_title": "Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.", + "pmid": 35411785, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2022-04-13", + "author": "Bangalore S,Spertus JA,Stevens SR,Jones PG,Mancini GBJ,Leipsic J,Reynolds HR,Budoff MJ,Hague CJ,Min JK,Boden WE,O'Brien SM,Harrington RA,Berger JS,Senior R,Peteiro J,Pandit N,Bershtein L,de Belder MA,Szwed H,Doerr R,Monti L,Alfakih K,Hochman JS,Maron DJ", + "auth_pos": 8, + "meshterms": "Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome, Angina Pectoris, Angina Pectoris/diagnostic imaging, Angina Pectoris/therapy, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/therapy, Humans, Ischemia, Myocardial Infarction*, Myocardial Infarction/etiology, Myocardial Infarction/therapy, Quality of Life, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1564, + "user_id": 1811967433, + "artical_title": "Correction to: Computed tomography angiography versus Agatston score for diagnosis of coronary artery disease in patients with stable chest pain: individual patient data meta-analysis of the international COME-CCT Consortium.", + "pmid": 35467114, + "journal_name": "European radiology", + "date": "2022-04-26", + "author": "Wieske V,Walther M,Dubourg B,Alkadhi H,Nørgaard BL,Meijs MFL,Diederichsen ACP,Wan YL,Mickley H,Nikolaou K,Shabestari AA,Halvorsen BA,Martuscelli E,Sun K,Herzog BA,Marcus RP,Leschka S,Garcia MJ,Ovrehus KA,Knuuti J,Mendoza-Rodriguez V,Bettencourt N,Muraglia S,Buechel RR,Kaufmann PA,Zimmermann E,Tardif JC,Budoff MJ,Schlattmann P,Dewey M", + "auth_pos": 28, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1565, + "user_id": 1811967433, + "artical_title": "Achieving coronary plaque regression: a decades-long battle against coronary artery disease.", + "pmid": 35466832, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2022-04-26", + "author": "Manubolu VS,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1566, + "user_id": 1811967433, + "artical_title": "Marked variation in atherosclerotic plaque progression between the major epicardial coronary arteries.", + "pmid": 35471406, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2022-04-27", + "author": "Bax AM,Lin FY,van Rosendael AR,Ma X,Lu Y,van den Hoogen IJ,Gianni U,Tantawy SW,Andreini D,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Stone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Berman DS,Narula J,Chang HJ,Shaw LJ", + "auth_pos": 10, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*, Humans, Male, Middle Aged, Aged, Female, Coronary Vessels, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Atherosclerosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1567, + "user_id": 1811967433, + "artical_title": "Anti-Inflammatory Therapeutics and Coronary Artery Disease.", + "pmid": 35471811, + "journal_name": "Cardiology in review", + "date": "2022-04-27", + "author": "Eghtedari B,Roy SK,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Anti-Inflammatory Agents, Anti-Inflammatory Agents/therapeutic use, Atherosclerosis*, Atherosclerosis/drug therapy, Plaque, Atherosclerotic*, Humans, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Anti-Inflammatory Agents, Anti-Inflammatory Agents/therapeutic use, Atherosclerosis*, Atherosclerosis/drug therapy, Plaque, Atherosclerotic*, Humans, Coronary Artery Disease*, Coronary Artery Disease/drug therapy, Cardiovascular Diseases*, Cardiovascular Diseases/chemically induced, Anti-Inflammatory Agents, Anti-Inflammatory Agents/therapeutic use, Atherosclerosis*, Atherosclerosis/drug therapy, Plaque, Atherosclerotic*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1568, + "user_id": 1811967433, + "artical_title": "Case Report: Hypercholesterolemia \"Lean Mass Hyper-Responder\" Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet.", + "pmid": 35498420, + "journal_name": "Frontiers in endocrinology", + "date": "2022-05-03", + "author": "Norwitz NG,Soto-Mota A,Feldman D,Parpos S,Budoff M", + "auth_pos": 5, + "meshterms": "Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides, Carbohydrates, Cholesterol, LDL, Diet, Carbohydrate-Restricted, Humans, Hypercholesterolemia*, Hypercholesterolemia/etiology, Hyperlipidemias*, Male, Phenotype, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1569, + "user_id": 1811967433, + "artical_title": "Aspirin and Statin Therapy for Nonobstructive Coronary Artery Disease: Five-year Outcomes from the CONFIRM Registry.", + "pmid": 35506137, + "journal_name": "Radiology. Cardiothoracic imaging", + "date": "2022-05-05", + "author": "Indraratna P,Naoum C,Ben Zekry S,Gransar H,Blanke P,Sellers S,Achenbach S,Al-Mallah MH,Andreini D,Berman DS,Budoff MJ,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Maffei E,Marques H,Gonçalves PA,Pontone G,Raff GL,Rubinshtein R,Villines TC,Lin FY,Shaw LJ,Narula J,Bax JJ,Leipsic JA", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1570, + "user_id": 1811967433, + "artical_title": "Recent Advances in Coronary Computed Tomography Angiogram: The Ultimate Tool for Coronary Artery Disease.", + "pmid": 35507277, + "journal_name": "Current atherosclerosis reports", + "date": "2022-05-05", + "author": "Alalawi L,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1571, + "user_id": 1811967433, + "artical_title": "Serum Thyrotropin Elevation and Coronary Artery Calcification in Hemodialysis Patients.", + "pmid": 35551382, + "journal_name": "Cardiorenal medicine", + "date": "2022-05-14", + "author": "Rhee CM,Budoff M,Brent G,You AS,Stenvinkel P,Novoa A,Flores F,Hamal S,Dailing C,Kinninger A,Nakata T,Kovesdy CP,Nguyen DV,Kalantar-Zadeh K", + "auth_pos": 2, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Humans, Hypothyroidism*, Hypothyroidism/complications, Hypothyroidism/epidemiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Humans, Hypothyroidism*, Hypothyroidism/complications, Hypothyroidism/epidemiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Humans, Hypothyroidism*, Hypothyroidism/complications, Hypothyroidism/epidemiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Humans, Hypothyroidism*, Hypothyroidism/complications, Hypothyroidism/epidemiology, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Kidney Failure, Chronic/epidemiology, Kidney Failure, Chronic/therapy, Renal Dialysis, Renal Dialysis/adverse effects, Thyrotropin", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1572, + "user_id": 1811967433, + "artical_title": "Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old.", + "pmid": 35550683, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-14", + "author": "Javaid A,Dardari ZA,Mitchell JD,Whelton SP,Dzaye O,Lima JAC,Lloyd-Jones DM,Budoff M,Nasir K,Berman DS,Rumberger J,Miedema MD,Villines TC,Blaha MJ", + "auth_pos": 8, + "meshterms": "Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult, Adult, Atherosclerosis*, Calcium, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1573, + "user_id": 1811967433, + "artical_title": "Trimethylamine N-oxide and hip fracture and bone mineral density in older adults: The cardiovascular health study.", + "pmid": 35577327, + "journal_name": "Bone", + "date": "2022-05-17", + "author": "Elam RE,B?žková P,Barzilay JI,Wang Z,Nemet I,Budoff MJ,Cauley JA,Fink HA,Lee Y,Robbins JA,Wang M,Hazen SL,Mozaffarian D,Carbone LD", + "auth_pos": 6, + "meshterms": "Absorptiometry, Photon, Aged, Bone Density*, Female, Hip Fractures*, Hip Fractures/epidemiology, Humans, Male, Methylamines, Risk Factors, Absorptiometry, Photon, Aged, Bone Density*, Female, Hip Fractures*, Hip Fractures/epidemiology, Humans, Male, Methylamines, Risk Factors, Absorptiometry, Photon, Aged, Bone Density*, Female, Hip Fractures*, Hip Fractures/epidemiology, Humans, Male, Methylamines, Risk Factors, Absorptiometry, Photon, Aged, Bone Density*, Female, Hip Fractures*, Hip Fractures/epidemiology, Humans, Male, Methylamines, Risk Factors, Absorptiometry, Photon, Aged, Bone Density*, Female, Hip Fractures*, Hip Fractures/epidemiology, Humans, Male, Methylamines, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1574, + "user_id": 1811967433, + "artical_title": "Suboptimal HIV suppression is associated with progression of coronary artery stenosis: The Multicenter AIDS Cohort Study (MACS) longitudinal coronary CT angiography study.", + "pmid": 35577614, + "journal_name": "Atherosclerosis", + "date": "2022-05-17", + "author": "Post WS,Haberlen SA,Witt MD,Zhang L,Jacobson LP,Brown TT,Margolick JB,Kingsley L,Palella FJ,Budoff M", + "auth_pos": 10, + "meshterms": "Cohort Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Stenosis/complications, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, HIV Infections/epidemiology, Humans, Male, Middle Aged, Viremia, Cohort Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Stenosis/complications, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, HIV Infections/epidemiology, Humans, Male, Middle Aged, Viremia, Cohort Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Stenosis/complications, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, HIV Infections/epidemiology, Humans, Male, Middle Aged, Viremia, Cohort Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Stenosis*, Coronary Stenosis/complications, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/epidemiology, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, HIV Infections/epidemiology, Humans, Male, Middle Aged, Viremia", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1575, + "user_id": 1811967433, + "artical_title": "The Role of Cardiac Computed Tomography in Heart Failure.", + "pmid": 35588344, + "journal_name": "Current heart failure reports", + "date": "2022-05-20", + "author": "Kitchin SS,Manubolu VS,Roy SK,Budoff MJ", + "auth_pos": 4, + "meshterms": "Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Heart Failure*, Heart Failure/diagnostic imaging, Humans, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Heart Failure*, Heart Failure/diagnostic imaging, Humans, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1576, + "user_id": 1811967433, + "artical_title": "Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.", + "pmid": 35594043, + "journal_name": "JAMA network open", + "date": "2022-05-21", + "author": "Fretts AM,Hazen SL,Jensen P,Budoff M,Sitlani CM,Wang M,de Oliveira Otto MC,DiDonato JA,Lee Y,Psaty BM,Siscovick DS,Sotoodehnia N,Tang WHW,Lai H,Lemaitre RN,Mozaffarian D", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1577, + "user_id": 1811967433, + "artical_title": "Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.", + "pmid": 35603600, + "journal_name": "Circulation", + "date": "2022-05-24", + "author": "Goldberg RB,Orchard TJ,Crandall JP,Boyko EJ,Budoff M,Dabelea D,Gadde KM,Knowler WC,Lee CG,Nathan DM,Watson K,Temprosa M", + "auth_pos": 5, + "meshterms": "Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care, Diabetes Mellitus, Type 2*, Diabetes Mellitus, Type 2/diagnosis, Diabetes Mellitus, Type 2/drug therapy, Diabetes Mellitus, Type 2/epidemiology, Humans, Hypoglycemic Agents, Hypoglycemic Agents/therapeutic use, Life Style, Metformin*, Metformin/therapeutic use, Myocardial Infarction*, Myocardial Infarction/drug therapy, Outcome Assessment, Health Care", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1578, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.", + "pmid": 35618504, + "journal_name": "Atherosclerosis", + "date": "2022-05-27", + "author": "Bhatia HS,Lin F,Thomas IC,Denenberg J,Kandula NR,Budoff MJ,Criqui MH,Kanaya AM", + "auth_pos": 6, + "meshterms": "Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Calcium, Calcium, Dietary, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Incidence, Plaque, Atherosclerotic*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1579, + "user_id": 1811967433, + "artical_title": "The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets.", + "pmid": 35629964, + "journal_name": "Metabolites", + "date": "2022-05-29", + "author": "Norwitz NG,Soto-Mota A,Kaplan B,Ludwig DS,Budoff M,Kontush A,Feldman D", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1580, + "user_id": 1811967433, + "artical_title": "Hepatocyte growth factor is associated with greater risk of extracoronary calcification: results from the multiethnic study of atherosclerosis.", + "pmid": 35641100, + "journal_name": "Open heart", + "date": "2022-06-01", + "author": "Ogunmoroti O,Osibogun O,Ferraro RA,Ndunda PM,Larson NB,Decker PA,Bielinski SJ,Blumenthal RS,Budoff MJ,Michos ED", + "auth_pos": 9, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Calcinosis*, Female, Hepatocyte Growth Factor*, Hepatocyte Growth Factor/metabolism, Humans, Male, Middle Aged, Mitral Valve, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Calcinosis*, Female, Hepatocyte Growth Factor*, Hepatocyte Growth Factor/metabolism, Humans, Male, Middle Aged, Mitral Valve, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Calcinosis*, Female, Hepatocyte Growth Factor*, Hepatocyte Growth Factor/metabolism, Humans, Male, Middle Aged, Mitral Valve", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1581, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium and cardiovascular disease prediction by scanner type: the multi-ethnic study of atherosclerosis.", + "pmid": 35641338, + "journal_name": "Clinical radiology", + "date": "2022-06-01", + "author": "Bhatia HS,Thomas IC,Denenberg J,Allison M,McClelland RL,Budoff M,McVeigh ER,Criqui MH", + "auth_pos": 6, + "meshterms": "Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1582, + "user_id": 1811967433, + "artical_title": "A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.", + "pmid": 35654975, + "journal_name": "Nature genetics", + "date": "2022-06-03", + "author": "Vujkovic M,Ramdas S,Lorenz KM,Guo X,Darlay R,Cordell HJ,He J,Gindin Y,Chung C,Myers RP,Schneider CV,Park J,Lee KM,Serper M,Carr RM,Kaplan DE,Haas ME,MacLean MT,Witschey WR,Zhu X,Tcheandjieu C,Kember RL,Kranzler HR,Verma A,Giri A,Klarin DM,Sun YV,Huang J,Huffman JE,Townsend Creasy K,Hand NJ,Liu CT,Long MT,Yao J,Budoff M,Tan J,Li X,Lin HJ,Chen YI,Taylor KD,Chang RK,Krauss RM,Vilarinho S,Brancale J,Nielsen JB,Locke AE,Jones MB,Verweij N,Baras A,Reddy KR,Neuschwander-Tetri BA,Schwimmer JB,Sanyal AJ,Chalasani N,Ryan KA,Mitchell BD,Gill D,Wells AD,Manduchi E,Saiman Y,Mahmud N,Miller DR,Reaven PD,Phillips LS,Muralidhar S,DuVall SL,Lee JS,Assimes TL,Pyarajan S,Cho K,Edwards TL,Damrauer SM,Wilson PW,Gaziano JM,O'Donnell CJ,Khera AV,Grant SFA,Brown CD,Tsao PS,Saleheen D,Lotta LA,Bastarache L,Anstee QM,Daly AK,Meigs JB,Rotter JI,Lynch JA,Rader DJ,Voight BF,Chang KM", + "auth_pos": 35, + "meshterms": "Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/antagonists & inhibitors, Alanine Transaminase, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Genome-Wide Association Study*, Humans, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Lipase, Lipase/genetics, Membrane Proteins, Membrane Proteins/genetics, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Polymor", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1583, + "user_id": 1811967433, + "artical_title": "Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.", + "pmid": 35656990, + "journal_name": "Journal of the American Heart Association", + "date": "2022-06-04", + "author": "Obisesan OH,Kou M,Wang FM,Boakye E,Honda Y,Uddin SMI,Dzaye O,Osei AD,Orimoloye OA,Howard-Claudio CM,Coresh J,Blumenthal RS,Hoogeveen RC,Budoff MJ,Matsushita K,Ballantyne CM,Blaha MJ", + "auth_pos": 14, + "meshterms": "Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/etiology, Calcium, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Female, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/epidemiology, Humans, Lipoprotein(a), Male, Middle Aged, Risk Factors, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Vascular Calcification*, Vascular Calcification/complications, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1584, + "user_id": 1811967433, + "artical_title": "Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.", + "pmid": 35673995, + "journal_name": "Clinical cardiology", + "date": "2022-06-09", + "author": "Won KB,Park HB,Heo R,Lee BK,Lin FY,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,Gonçalves PA,Leipsic JA,Lee SE,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Berman DS,Narula J,Bax JJ,Min JK,Chang HJ", + "auth_pos": 12, + "meshterms": "Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Male, Blood Pressure, Cardiovascular Diseases*, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Disease Progression, Plaque, Atherosclerotic*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1585, + "user_id": 1811967433, + "artical_title": "Improving the Prediction of Major Clinical Cardiovascular Events With Cardiac Computed Tomographic Angiography.", + "pmid": 35680217, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-06-10", + "author": "Lavie CJ,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1586, + "user_id": 1811967433, + "artical_title": "Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection.", + "pmid": 35678187, + "journal_name": "Arteriosclerosis, thrombosis, and vascular biology", + "date": "2022-06-10", + "author": "Wang Z,Peters BA,Usyk M,Xing J,Hanna DB,Wang T,Post WS,Landay AL,Hodis HN,Weber K,French A,Golub ET,Lazar J,Gustafson D,Kassaye S,Aouizerat B,Haberlen S,Malvestutto C,Budoff M,Wolinsky SM,Sharma A,Anastos K,Clish CB,Kaplan RC,Burk RD,Qi Q", + "auth_pos": 19, + "meshterms": "Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology, Atherosclerosis*, Atherosclerosis/pathology, Carotid Arteries, Carotid Arteries/pathology, Carotid Artery Diseases*, Carotid Artery Diseases/pathology, Carotid Stenosis*, Carotid Stenosis/pathology, Cross-Sectional Studies, Female, Gastrointestinal Microbiome*, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Humans, Lysophosphatidylcholines, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/pathology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1587, + "user_id": 1811967433, + "artical_title": "Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease.", + "pmid": 35680215, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-06-10", + "author": "Hollenberg EJ,Lin F,Blaha MJ,Budoff MJ,van den Hoogen IJ,Gianni U,Lu Y,Bax AM,van Rosendael AR,Tantawy SW,Andreini D,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,de Araújo Gonçalves P,Hadamitzky M,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Gimelli A,Lee SE,Bax JJ,Berman DS,Sellers SL,Leipsic JA,Blankstein R,Narula J,Chang HJ,Shaw LJ", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1588, + "user_id": 1811967433, + "artical_title": "Age related compositional plaque burden by CT in patients with future ACS.", + "pmid": 35725722, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2022-06-21", + "author": "van Rosendael AR,van den Hoogen IJ,Lin FY,Gianni U,Lu Y,Andreini D,Al-Mallah MH,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,de Araújo Gonçalves P,Hadamitzky M,Kim YJ,Leipsic JA,Maffei E,Marques H,Plank F,Pontone G,Raff GL,Villines TC,Lee SE,Al'Aref SJ,Baskaran L,Cho I,Danad I,Gransar H,Budoff MJ,Samady H,Virmani R,Min JK,Narula J,Berman DS,Chang HJ,Shaw LJ,Bax JJ", + "auth_pos": 30, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1589, + "user_id": 1811967433, + "artical_title": "Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis.", + "pmid": 35730391, + "journal_name": "AIDS (London, England)", + "date": "2022-06-23", + "author": "Wang S,Pasca S,Post WS,Langan S,Pallavajjalla A,Haley L,Gocke C,Budoff M,Haberlen S,Brown TT,Ambinder RF,Margolick JB,Gondek LP", + "auth_pos": 8, + "meshterms": "Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/genetics, Biomarkers, Cohort Studies, Coronary Stenosis*, Cross-Sectional Studies, HIV Infections*, HIV Infections/complications, Humans, Leukocytes, Mononuclear, Male, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/genetics, Biomarkers, Cohort Studies, Coronary Stenosis*, Cross-Sectional Studies, HIV Infections*, HIV Infections/complications, Humans, Leukocytes, Mononuclear, Male, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/genetics, Biomarkers, Cohort Studies, Coronary Stenosis*, Cross-Sectional Studies, HIV Infections*, HIV Infections/complications, Humans, Leukocytes, Mononuclear, Male, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/genetics, Biomarkers, Cohort Studies, Coronary Stenosis*, Cross-Sectional Studies, HIV Infections*, HIV Infections/complications, Humans, Leukocytes, Mononuclear, Male, Acquired Immunodeficiency Syndrome*, Acquired Immunodeficiency Syndrome/complications, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/genetics, Biomarkers, Cohort Studies, Coronary Stenosis*, Cross-Sectional Studies, HIV Infections*, HIV Infections/complications, Humans, Leukocytes, Mononuclear, Male", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1590, + "user_id": 1811967433, + "artical_title": "Assessment of left main coronary artery disease: a comparison between invasive and noninvasive.", + "pmid": 35757932, + "journal_name": "Coronary artery disease", + "date": "2022-06-28", + "author": "Alalawi LH,Dookhan CM,Verghese D,Manubolu VS,Aldana-Bitar J,Lakshmanan S,Ahmad K,Shafter A,Alchokhachi Z,Ghanem A,Golub IS,Budoff M,Roy S", + "auth_pos": 12, + "meshterms": "Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans, Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans, Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans, Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans, Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans, Atherosclerosis*, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Humans", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1591, + "user_id": 1811967433, + "artical_title": "Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.", + "pmid": 35759823, + "journal_name": "Atherosclerosis", + "date": "2022-06-28", + "author": "Alfaddagh A,Kapoor K,Dardari ZA,Bhatt DL,Budoff MJ,Nasir K,Miller M,Welty FK,Miedema MD,Shapiro MD,Tsai MY,Blumenthal RS,Blaha MJ", + "auth_pos": 5, + "meshterms": "Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Disease Progression, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3*, Female, Humans, Male, Middle Aged, Primary Prevention, Risk Factors, Aged, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/prevention & control, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/prevention & control, Dise", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1592, + "user_id": 1811967433, + "artical_title": "Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.", + "pmid": 35760597, + "journal_name": "Mayo Clinic proceedings", + "date": "2022-06-28", + "author": "Zhou Z,Leung Ong K,Whelton SP,Allison MA,Curtis AJ,Blaha MJ,Breslin M,Tonkin A,Magnussen CG,Budoff M,Nelson MR", + "auth_pos": 10, + "meshterms": "Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Dyslipidemias*, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Glucose, Heart Disease Risk Factors, Humans, Lipids, Lipoproteins, Lipoproteins/therapeutic use, Middle Aged, Risk Factors, Triglycerides, Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Dyslipidemias*, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Glucose, Heart Disease Risk Factors, Humans, Lipids, Lipoproteins, Lipoproteins/therapeutic use, Middle Aged, Risk Factors, Triglycerides, Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Dyslipidemias*, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Glucose, Heart Disease Risk Factors, Humans, Lipids, Lipoproteins, Lipoproteins/therapeutic use, Middle Aged, Risk Factors, Triglycerides, Antihypertensive Agents, Antihypertensive Agents/therapeutic use, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cardiovascular Diseases/epidemiology, Cholesterol, Cholesterol, HDL, Cholesterol, LDL, Dyslipidemias*, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Glucose, Heart Disease Risk Factors, Humans, Lipids, Lipoproteins, Lipoproteins/therapeutic use, Middle Aged, Risk Factors, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1593, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 35769201, + "journal_name": "American journal of preventive cardiology", + "date": "2022-07-01", + "author": "Chu JH,Michos ED,Ouyang P,Vaidya D,Blumenthal RS,Budoff MJ,Blaha MJ,Whelton SP", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1594, + "user_id": 1811967433, + "artical_title": "Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio.", + "pmid": 35778256, + "journal_name": "Journal of clinical lipidology", + "date": "2022-07-02", + "author": "Manubolu VS,Verghese D,Lakshmanan S,Alalawi L,Kinninger A,Bitar JA,Calicchio F,Ahmad K,Ghanem A,Javier DA,Mangaoang C,Flores F,Dailing C,Roy SK,Budoff MJ", + "auth_pos": 15, + "meshterms": "Male, Humans, Middle Aged, Female, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Disease Progression, Cholesterol, HDL, Risk Factors, Coronary Angiography, Coronary Angiography/methods, Male, Humans, Middle Aged, Female, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Disease Progression, Cholesterol, HDL, Risk Factors, Coronary Angiography, Coronary Angiography/methods, Male, Humans, Middle Aged, Female, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Disease Progression, Cholesterol, HDL, Risk Factors, Coronary Angiography, Coronary Angiography/methods, Male, Humans, Middle Aged, Female, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Disease Progression, Cholesterol, HDL, Risk Factors, Coronary Angiography, Coronary Angiography/methods, Male, Humans, Middle Aged, Female, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Disease Progression, Cholesterol, HDL, Risk Factors, Coronary Angiography, Coronary Angiography/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1595, + "user_id": 1811967433, + "artical_title": "Serum cholesterol loading capacity on macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients.", + "pmid": 35809057, + "journal_name": "Rheumatology (Oxford, England)", + "date": "2022-07-10", + "author": "Karpouzas GA,Papotti B,Ormseth SR,Palumbo M,Hernandez E,Marchi C,Zimetti F,Budoff MJ,Ronda N", + "auth_pos": 8, + "meshterms": "Humans, Proprotein Convertase 9, C-Reactive Protein, C-Reactive Protein/metabolism, Cross-Sectional Studies, Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Arthritis, Rheumatoid*, Cholesterol, Cholesterol/metabolism, Macrophages, Macrophages/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Immunoglobulin G, Immunoglobulin G/metabolism, Humans, Proprotein Convertase 9, C-Reactive Protein, C-Reactive Protein/metabolism, Cross-Sectional Studies, Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Arthritis, Rheumatoid*, Cholesterol, Cholesterol/metabolism, Macrophages, Macrophages/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Immunoglobulin G, Immunoglobulin G/metabolism, Humans, Proprotein Convertase 9, C-Reactive Protein, C-Reactive Protein/metabolism, Cross-Sectional Studies, Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Arthritis, Rheumatoid*, Cholesterol, Cholesterol/metabolism, Macrophages, Macrophages/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Immunoglobulin G, Immunoglobulin G/metabolism, Humans, Proprotein Convertase 9, C-Reactive Protein, C-Reactive Protein/metabolism, Cross-Sectional Studies, Lipoproteins, LDL, Lipoproteins, LDL/metabolism, Arthritis, Rheumatoid*, Cholesterol, Cholesterol/metabolism, Macrophages, Macrophages/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Immunoglobulin G, Immunoglobulin G/metabolism", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1596, + "user_id": 1811967433, + "artical_title": "Quantitative plaque analysis with A.I.-augmented CCTA in end-stage renal disease and complex CAD.", + "pmid": 35835019, + "journal_name": "Clinical imaging", + "date": "2022-07-15", + "author": "Cho GW,Ghanem AK,Quesada CG,Crabtree TR,Jennings RS,Budoff MJ,Choi AD,Min JK,Karlsberg RP,Earls JP", + "auth_pos": 6, + "meshterms": "Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Stenosis*, Female, Humans, Kidney Failure, Chronic*, Kidney Failure, Chronic/complications, Male, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1597, + "user_id": 1811967433, + "artical_title": "Estimating the accuracy of dual energy chest radiography for coronary calcium detection with lateral or anteroposterior orientations.", + "pmid": 35848231, + "journal_name": "Medical physics", + "date": "2022-07-19", + "author": "Hsieh SS,Budoff MJ", + "auth_pos": 2, + "meshterms": "Adult, Aged, Calcium*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart, Humans, Middle Aged, Radiography, Reproducibility of Results, Sensitivity and Specificity, Adult, Aged, Calcium*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart, Humans, Middle Aged, Radiography, Reproducibility of Results, Sensitivity and Specificity", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1598, + "user_id": 1811967433, + "artical_title": "Discordance Between Coronary Artery Calcium Area and Density Predicts Long-Term Atherosclerotic Cardiovascular Disease Risk.", + "pmid": 35850937, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-07-20", + "author": "Razavi AC,van Assen M,De Cecco CN,Dardari ZA,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rozanski A,Rumberger JA,Shaw LJ,Sperling LS,Whelton SP,Mortensen MB,Blaha MJ,Dzaye O", + "auth_pos": 6, + "meshterms": "Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Vascular Calcification*, Calcium, Coronary Artery Disease*, Cardiovascular Diseases*, Cardiovascular Diseases/pathology, Risk Assessment, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Plaque, Atherosclerotic*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1599, + "user_id": 1811967433, + "artical_title": "CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI).", + "pmid": 35864070, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2022-07-22", + "author": "Cury RC,Leipsic J,Abbara S,Achenbach S,Berman D,Bittencourt M,Budoff M,Chinnaiyan K,Choi AD,Ghoshhajra B,Jacobs J,Koweek L,Lesser J,Maroules C,Rubin GD,Rybicki FJ,Shaw LJ,Williams MC,Williamson E,White CS,Villines TC,Blankstein R", + "auth_pos": 7, + "meshterms": "Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Cardiology*, Plaque, Atherosclerotic*, Radiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1600, + "user_id": 1811967433, + "artical_title": "Early versus late acute coronary syndrome risk patterns of coronary atherosclerotic plaque.", + "pmid": 35904766, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2022-07-30", + "author": "van den Hoogen IJ,Stuijfzand WJ,Gianni U,van Rosendael AR,Bax AM,Lu Y,Tantawy SW,Hollenberg EJ,Andreini D,Al-Mallah MH,Cademartiri F,Chinnaiyan K,Chow BJW,Conte E,Cury RC,Feuchtner G,Gonçalves PA,Hadamitzky M,Kim YJ,Leipsic J,Maffei E,Marques H,Plank F,Pontone G,Villines TC,Lee SE,Al'Aref SJ,Baskaran L,Danad I,Gransar H,Budoff MJ,Samady H,Virmani R,Berman DS,Chang HJ,Narula J,Min JK,Bax JJ,Lin FY,Shaw LJ", + "auth_pos": 31, + "meshterms": "Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnostic imaging, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/etiology, Aged, Computed Tomography Angiography, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/diagnostic imaging, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1601, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?", + "pmid": 35908457, + "journal_name": "Clinical imaging", + "date": "2022-08-01", + "author": "Cherukuri L,Kinninger A,Birudaraju D,Jayawardena E,Manubolu VS,Brinton EA,Black D,Miller V,Kearns AE,Manson JE,Budoff MJ,Roy SK", + "auth_pos": 11, + "meshterms": "Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause, Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause, Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause, Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause, Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause, Bone Density*, Calcium, Coronary Vessels, Estrogen Replacement Therapy*, Estrogens, Estrogens/therapeutic use, Female, Humans, Menopause", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1602, + "user_id": 1811967433, + "artical_title": "Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study.", + "pmid": 35912635, + "journal_name": "Arteriosclerosis, thrombosis, and vascular biology", + "date": "2022-08-02", + "author": "Wang M,Wang Z,Lee Y,Lai HTM,de Oliveira Otto MC,Lemaitre RN,Fretts A,Sotoodehnia N,Budoff M,DiDonato JA,McKnight B,Tang WHW,Psaty BM,Siscovick DS,Hazen SL,Mozaffarian D", + "auth_pos": 9, + "meshterms": "Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors, Animals, Atherosclerosis*, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Carnitine, Humans, Meat, Methylamines, Methylamines/metabolism, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1603, + "user_id": 1811967433, + "artical_title": "Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.", + "pmid": 35952728, + "journal_name": "Progress in cardiovascular diseases", + "date": "2022-08-12", + "author": "Al Rifai M,Yao J,Guo X,Post WS,Malik S,Blumenthal RS,Ballantyne CM,Budoff M,Taylor KD,Lin HJ,Rich SS,Hajek C,Greenland P,Rotter JI,Virani SS", + "auth_pos": 8, + "meshterms": "Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics, Female, Humans, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Artery Disease/genetics, Stroke*, Stroke/diagnosis, Stroke/epidemiology, Stroke/genetics, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/genetics", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1604, + "user_id": 1811967433, + "artical_title": "Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 35952903, + "journal_name": "Journal of lipid research", + "date": "2022-08-12", + "author": "Koska J,Furtado J,Hu Y,Sinari S,Budoff MJ,Billheimer D,Nedelkov D,McClelland RL,Reaven P", + "auth_pos": 5, + "meshterms": "Apolipoprotein C-II, Apolipoprotein C-III, Apolipoproteins*, Atherosclerosis*, Female, Humans, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1605, + "user_id": 1811967433, + "artical_title": "Potential Effects of Icosapent Ethyl on Cardiovascular Outcomes in Cigarette Smokers: REDUCE-IT Smoking.", + "pmid": 35953437, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2022-08-12", + "author": "Miller M,Bhatt DL,Steg PG,Brinton EA,Jacobson TA,Jiao L,Tardif JC,Ballantyne CM,Budoff M,Mason RP", + "auth_pos": 9, + "meshterms": "Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects, Humans, Eicosapentaenoic Acid, Eicosapentaenoic Acid/adverse effects, Myocardial Infarction*, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Tobacco Products*, Smoking, Smoking/adverse effects", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1606, + "user_id": 1811967433, + "artical_title": "Long term prognostic value for a normal CCTA.", + "pmid": 35963781, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2022-08-14", + "author": "Alalawi L,Budoff MJ", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1607, + "user_id": 1811967433, + "artical_title": "High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 35979837, + "journal_name": "Arteriosclerosis, thrombosis, and vascular biology", + "date": "2022-08-19", + "author": "Bortnick AE,Buzkova P,Otvos J,Jensen M,Tsai MY,Budoff M,Mackey R,El Khoudary SR,Favari E,Kim RS,Rodriguez CJ,Thanassoulis G,Kizer JR", + "auth_pos": 6, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Calcinosis, Cholesterol Ester Transfer Proteins, Cholesterol, HDL, Humans, Incidence, Lipoproteins, HDL, Male", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1608, + "user_id": 1811967433, + "artical_title": "Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.", + "pmid": 35994564, + "journal_name": "Circulation", + "date": "2022-08-23", + "author": "Greenland P,Maron DJ,Budoff MJ", + "auth_pos": 3, + "meshterms": "Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/prevention & control, Coronary Vessels, Humans, Insurance*, Primary Prevention, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/prevention & control, Coronary Vessels, Humans, Insurance*, Primary Prevention, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/prevention & control, Coronary Vessels, Humans, Insurance*, Primary Prevention, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Calcium, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/prevention & control, Coronary Vessels, Humans, Insurance*, Primary Prevention, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1609, + "user_id": 1811967433, + "artical_title": "Coronary Atherosclerosis in an Asymptomatic U.S. Population: Miami Heart Study at Baptist Health South Florida.", + "pmid": 36075621, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-09-09", + "author": "Nasir K,Cainzos-Achirica M,Valero-Elizondo J,Ali SS,Havistin R,Lakshman S,Blaha MJ,Blankstein R,Shapiro MD,Arias L,Saxena A,Feldman T,Budoff MJ,Ziffer JA,Fialkow J,Cury RC", + "auth_pos": 13, + "meshterms": "Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cross-Sectional Studies, Female, Florida, Florida/epidemiology, Humans, Male, Middle Aged, Obesity, Overweight, Plaque, Atherosclerotic*, Predictive Value of Tests, Protestantism, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1610, + "user_id": 1811967433, + "artical_title": "Obstructive coronary artery disease in symptomatic diabetics with zero coronary calcium score: are we missing something?", + "pmid": 36093966, + "journal_name": "Coronary artery disease", + "date": "2022-09-13", + "author": "Calicchio F,Manubolu VS,Dahal S,Kinninger A,Havistin R,Lakshmanan S,Ahmad K,Roy SK,Budoff MJ", + "auth_pos": 9, + "meshterms": "Middle Aged, Adult, Male, Humans, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Plaque, Atherosclerotic*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Predictive Value of Tests, Computed Tomography Angiography, Middle Aged, Adult, Male, Humans, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Plaque, Atherosclerotic*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Predictive Value of Tests, Computed Tomography Angiography, Middle Aged, Adult, Male, Humans, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Plaque, Atherosclerotic*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Predictive Value of Tests, Computed Tomography Angiography, Middle Aged, Adult, Male, Humans, Female, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Plaque, Atherosclerotic*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Predictive Value of Tests, Computed Tomography Angiography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1611, + "user_id": 1811967433, + "artical_title": "Testosterone: therapeutic or toxic for the cardiovascular health of men?", + "pmid": 36098311, + "journal_name": "The Lancet. Healthy longevity", + "date": "2022-09-14", + "author": "Michos ED,Budoff MJ", + "auth_pos": 2, + "meshterms": "Cardiovascular System*, Heart, Humans, Male, Mediastinum, Testosterone*, Testosterone/adverse effects, Testosterone Congeners, Cardiovascular System*, Heart, Humans, Male, Mediastinum, Testosterone*, Testosterone/adverse effects, Testosterone Congeners", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1612, + "user_id": 1811967433, + "artical_title": "Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis.", + "pmid": 36113961, + "journal_name": "RMD open", + "date": "2022-09-17", + "author": "Karpouzas GA,Papotti B,Ormseth S,Palumbo M,Hernandez E,Adorni MP,Zimetti F,Budoff M,Ronda N", + "auth_pos": 8, + "meshterms": "Antirheumatic Agents, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Biological Products, Biological Products/therapeutic use, Biomarkers, Cholesterol*, Cholesterol/blood, Cholesterol/chemistry, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/etiology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Lipoproteins, LDL/therapeutic use, Macrophages*, Macrophages/metabolism, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/drug therapy, Antirheumatic Agents, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Biological Products, Biological Products/therapeutic use, Biomarkers, Cholesterol*, Cholesterol/blood, Cholesterol/chemistry, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/etiology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Lipoproteins, LDL/therapeutic use, Macrophages*, Macrophages/metabolism, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/drug therapy, Antirheumatic Agents, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/drug therapy, Biological Products, Biological Products/therapeutic use, Biomarkers, Cholesterol*, Cholesterol/blood, Cholesterol/chemistry, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/etiology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Lipoproteins, LDL, Lipoproteins, LDL/therapeutic use, Macrophages*, Macrophages/metabolism, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Plaque, Atherosclerotic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1613, + "user_id": 1811967433, + "artical_title": "Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial.", + "pmid": 36115814, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-09-18", + "author": "Reynolds HR,Diaz A,Cyr DD,Shaw LJ,Mancini GBJ,Leipsic J,Budoff MJ,Min JK,Hague CJ,Berman DS,Chaitman BR,Picard MH,Hayes SW,Scherrer-Crosbie M,Kwong RY,Lopes RD,Senior R,Dwivedi SK,Miller TD,Chow BJW,de Silva R,Stone GW,Boden WE,Bangalore S,O'Brien SM,Hochman JS,Maron DJ", + "auth_pos": 7, + "meshterms": "Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests, Female, Humans, Male, Atherosclerosis*, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Coronary Vessels, Coronary Vessels/diagnostic imaging, Ischemia, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1614, + "user_id": 1811967433, + "artical_title": "CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI).", + "pmid": 36115815, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-09-18", + "author": "Cury RC,Leipsic J,Abbara S,Achenbach S,Berman D,Bittencourt M,Budoff M,Chinnaiyan K,Choi AD,Ghoshhajra B,Jacobs J,Koweek L,Lesser J,Maroules C,Rubin GD,Rybicki FJ,Shaw LJ,Williams MC,Williamson E,White CS,Villines TC,Blankstein R", + "auth_pos": 7, + "meshterms": "Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Computed Tomography Angiography, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/therapy, Cardiology*, Plaque, Atherosclerotic*, Radiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1615, + "user_id": 1811967433, + "artical_title": "Association Between Omega-3 Fatty Acid Levels and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).", + "pmid": 36127180, + "journal_name": "The American journal of cardiology", + "date": "2022-09-21", + "author": "Pisaniello AD,Alfaddagh A,Tibuakuu M,Whelton SP,Czarny MJ,Blaha MJ,Tsai MY,Budoff MJ,Shea S,Allison MA,Post WS", + "auth_pos": 8, + "meshterms": "Male, Humans, Middle Aged, Aged, Female, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Prospective Studies, Fatty Acids, Omega-3*, Risk Factors, Aortic Valve Stenosis*, Atherosclerosis*, Inflammation, Male, Humans, Middle Aged, Aged, Female, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Prospective Studies, Fatty Acids, Omega-3*, Risk Factors, Aortic Valve Stenosis*, Atherosclerosis*, Inflammation, Male, Humans, Middle Aged, Aged, Female, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Prospective Studies, Fatty Acids, Omega-3*, Risk Factors, Aortic Valve Stenosis*, Atherosclerosis*, Inflammation, Male, Humans, Middle Aged, Aged, Female, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Prospective Studies, Fatty Acids, Omega-3*, Risk Factors, Aortic Valve Stenosis*, Atherosclerosis*, Inflammation, Male, Humans, Middle Aged, Aged, Female, Aortic Valve, Aortic Valve/diagnostic imaging, Calcium, Prospective Studies, Fatty Acids, Omega-3*, Risk Factors, Aortic Valve Stenosis*, Atherosclerosis*, Inflammation", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1616, + "user_id": 1811967433, + "artical_title": "Serial Changes in Troponin I in COVID-19 Vaccine-Associated Myocarditis.", + "pmid": 36128420, + "journal_name": "Cardiology research", + "date": "2022-09-22", + "author": "Aldana-Bitar J,Ramirez NR,Jaffe AS,Manubolu VS,Verghese D,Hussein L,Anderson LR,Budoff MJ,Karlsberg RP", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1617, + "user_id": 1811967433, + "artical_title": "Risk Factors for Incident Coronary Artery Calcium in Younger (Age 32 to 45 Years) Versus Intermediate (46 to 64 Years) Versus Older (65 to 84 Years) Persons.", + "pmid": 36154968, + "journal_name": "The American journal of cardiology", + "date": "2022-09-27", + "author": "Razavi AC,Allen NB,Dzaye O,Michos ED,Budoff MJ,Lima JAC,Shikany JM,Liu K,Post WS,Blumenthal RS,Blaha MJ,Carr JJ,Whelton SP", + "auth_pos": 5, + "meshterms": "Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*, Middle Aged, Young Adult, Female, Humans, Aged, Aged, 80 and over, Adult, Male, Calcium, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Risk Factors, Risk Assessment, Atherosclerosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1618, + "user_id": 1811967433, + "artical_title": "Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 36180367, + "journal_name": "Journal of clinical lipidology", + "date": "2022-10-01", + "author": "Chevli PA,Islam T,Pokharel Y,Rodriguez F,Virani SS,Blaha MJ,Bertoni AG,Budoff M,Otvos JD,Shapiro MD", + "auth_pos": 8, + "meshterms": "Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors, Female, Humans, Middle Aged, Male, C-Reactive Protein, C-Reactive Protein/analysis, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Prospective Studies, Lipoproteins, Cholesterol, Atherosclerosis*, Atherosclerosis/complications, Hypercholesterolemia*, Hypercholesterolemia/complications, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1619, + "user_id": 1811967433, + "artical_title": "EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis: Meta-Analysis of Prospective Imaging Trials.", + "pmid": 36202462, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-10-07", + "author": "Sheppard JP,Lakshmanan S,Dahal S,Roy SK,Bhatt DL,Budoff MJ,Nelson JR", + "auth_pos": 6, + "meshterms": "Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Predictive Value of Tests, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Predictive Value of Tests, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Predictive Value of Tests, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Predictive Value of Tests, Prospective Studies, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Predictive Value of Tests, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1620, + "user_id": 1811967433, + "artical_title": "Association Between Changes in Perivascular Adipose Tissue Density and Plaque Progression.", + "pmid": 36202455, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2022-10-07", + "author": "Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Kitslaar PH,Reiber JHC,Stone PH,Samady H,Virmani R,Narula J,Berman DS,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 5, + "meshterms": "Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies, Adipose Tissue, Adipose Tissue/diagnostic imaging, Adipose Tissue/pathology, Aged, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Disease Progression, Female, Humans, Inflammation, Inflammation/pathology, Lipids, Male, Middle Aged, Plaque, Atherosclerotic*, Predictive Value of Tests, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1621, + "user_id": 1811967433, + "artical_title": "Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a \"cholesterol paradox?", + "pmid": 36272449, + "journal_name": "Progress in cardiovascular diseases", + "date": "2022-10-23", + "author": "Rozanski A,Han D,Blaha MJ,Gransar H,Friedman J,Hayes S,Thomson LEJ,Miedema MD,Nasir K,Budoff MJ,Shaw LJ,Rumberger JA,Blumenthal RS,Villines T,Lin F,Berman DS", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1622, + "user_id": 1811967433, + "artical_title": "Multimodality Imaging Trials Evaluating the Impact of Omega-3 Fatty Acids on Coronary Artery Plaque Characteristics and Burden.", + "pmid": 36275355, + "journal_name": "Heart international", + "date": "2022-10-25", + "author": "Manubolu VS,Budoff MJ,Lakshmanan S", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1623, + "user_id": 1811967433, + "artical_title": "Relationship of fibroblast growth factor 21 with the prevalence and progression of vascular and valvular calcification: Multi-ethnic study of atherosclerosis.", + "pmid": 36306948, + "journal_name": "International journal of cardiology", + "date": "2022-10-29", + "author": "Sayanthan S,Allison MA,Budoff MJ,Rye KA,Ong KL", + "auth_pos": 3, + "meshterms": "Humans, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Fibroblast Growth Factors, Prevalence, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Cardiovascular Diseases*, Humans, Risk Factors, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Fibroblast Growth Factors, Prevalence, Vascular Calcification*, Vascular Calcification/diagnosis, Vascular Calcification/epidemiology, Cardiovascular Diseases*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1624, + "user_id": 1811967433, + "artical_title": "Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine Learning Approach in the MESA Study.", + "pmid": 36314118, + "journal_name": "Circulation", + "date": "2022-11-01", + "author": "Inoue K,Seeman TE,Horwich T,Budoff MJ,Watson KE", + "auth_pos": 4, + "meshterms": "Adult, United States, United States/epidemiology, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Calcium, Cohort Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/chemistry, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Adult, United States, United States/epidemiology, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Calcium, Cohort Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/chemistry, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Adult, United States, United States/epidemiology, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Calcium, Cohort Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/chemistry, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1625, + "user_id": 1811967433, + "artical_title": "Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry.", + "pmid": 36336615, + "journal_name": "Heart, lung & circulation", + "date": "2022-11-07", + "author": "Lee J,Shaikh K,Nakanishi R,Gransar H,Achenbach S,Al-Mallah MH,Andreini D,Bax JJ,Berman DS,Cademartiri F,Callister TQ,Chang HJ,Chinnaiyan K,Chow BJW,Cury RC,DeLago A,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Rubinshtein R,Villines TC,Lu Y,Peña JM,Lin FY,Min JK,Shaw LJ,Budoff MJ", + "auth_pos": 34, + "meshterms": "Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries, Humans, Middle Aged, Aged, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Prognosis, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Proportional Hazards Models, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Risk Factors, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1626, + "user_id": 1811967433, + "artical_title": "Longitudinal Quantitative Assessment of Coronary Atherosclerotic Plaque Burden Related to Serum Hemoglobin Levels.", + "pmid": 36338409, + "journal_name": "JACC. Asia", + "date": "2022-11-08", + "author": "Won KB,Lee BK,Heo R,Park HB,Lin FY,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,de Araújo Gonçalves P,Leipsic JA,Lee SE,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Berman DS,Narula J,Bax JJ,Min JK,Chang HJ", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1627, + "user_id": 1811967433, + "artical_title": "CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI).", + "pmid": 36339062, + "journal_name": "Radiology. Cardiothoracic imaging", + "date": "2022-11-08", + "author": "Cury RC,Leipsic J,Abbara S,Achenbach S,Berman D,Bittencourt M,Budoff M,Chinnaiyan K,Choi AD,Ghoshhajra B,Jacobs J,Koweek L,Lesser J,Maroules C,Rubin GD,Rybicki FJ,Shaw LJ,Williams MC,Williamson E,White CS,Villines TC,Blankstein R", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1628, + "user_id": 1811967433, + "artical_title": "Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research.", + "pmid": 36351849, + "journal_name": "Journal of clinical lipidology", + "date": "2022-11-10", + "author": "Norwitz NG,Mindrum MR,Giral P,Kontush A,Soto-Mota A,Wood TR,D'Agostino DP,Manubolu VS,Budoff M,Krauss RM", + "auth_pos": 9, + "meshterms": "Humans, Diet, Ketogenic*, Diet, Carbohydrate-Restricted, Triglycerides, Cholesterol, Attention, Carbohydrates, Cholesterol, HDL, Humans, Diet, Ketogenic*, Diet, Carbohydrate-Restricted, Triglycerides, Cholesterol, Attention, Carbohydrates, Cholesterol, HDL", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1629, + "user_id": 1811967433, + "artical_title": "Physical Activity, Muscle Oxidative Capacity, and Coronary Artery Calcium in Smokers with and without COPD.", + "pmid": 36353139, + "journal_name": "International journal of chronic obstructive pulmonary disease", + "date": "2022-11-11", + "author": "Tiller NB,Kinninger A,Abbasi A,Casaburi R,Rossiter HB,Budoff MJ,Adami A", + "auth_pos": 6, + "meshterms": "Humans, Pulmonary Disease, Chronic Obstructive*, Smokers, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Retrospective Studies, Exercise, Muscles, Oxidative Stress, Coronary Artery Disease*, Coronary Artery Disease/etiology, Coronary Artery Disease/complications, Humans, Pulmonary Disease, Chronic Obstructive*, Smokers, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcium, Retrospective Studies, Exercise, Muscles, Oxidative Stress, Coronary Artery Disease*, Coronary Artery Disease/etiology, Coronary Artery Disease/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1630, + "user_id": 1811967433, + "artical_title": "Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry.", + "pmid": 36371222, + "journal_name": "Cardiovascular diabetology", + "date": "2022-11-13", + "author": "Won KB,Lee BK,Lin FY,Hadamitzky M,Kim YJ,Sung JM,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,de Araújo Gonçalves P,Leipsic JA,Lee SE,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Chang HJ", + "auth_pos": 10, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests, Humans, Male, Middle Aged, Aged, Female, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Retrospective Studies, Coronary Angiography, Coronary Angiography/methods, Case-Control Studies, Glycemic Control, Prospective Studies, Disease Progression, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Registries, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1631, + "user_id": 1811967433, + "artical_title": "Letter by Lakshmanan et al Regarding Article \"Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1?, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy\".", + "pmid": 36374969, + "journal_name": "Circulation", + "date": "2022-11-15", + "author": "Lakshmanan S,Budoff MJ,Nelson JR", + "auth_pos": 2, + "meshterms": "Humans, C-Reactive Protein*, C-Reactive Protein/metabolism, 1-Alkyl-2-acetylglycerophosphocholine Esterase*, Lipoprotein(a), Interleukin-6, Mineral Oil, Interleukin-1beta, Homocysteine, Cholesterol, Lipoproteins, LDL, Biomarkers, Humans, C-Reactive Protein*, C-Reactive Protein/metabolism, 1-Alkyl-2-acetylglycerophosphocholine Esterase*, Lipoprotein(a), Interleukin-6, Mineral Oil, Interleukin-1beta, Homocysteine, Cholesterol, Lipoproteins, LDL, Biomarkers, Humans, C-Reactive Protein*, C-Reactive Protein/metabolism, 1-Alkyl-2-acetylglycerophosphocholine Esterase*, Lipoprotein(a), Interleukin-6, Mineral Oil, Interleukin-1beta, Homocysteine, Cholesterol, Lipoproteins, LDL, Biomarkers", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1632, + "user_id": 1811967433, + "artical_title": "Mortality impact of low CAC density predominantly occurs in early atherosclerosis: explainable ML in the CAC consortium.", + "pmid": 36376147, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2022-11-15", + "author": "Lin FY,Goebel BP,Lee BC,Lu Y,Baskaran L,Yoon YE,Maliakal GT,Gianni U,Bax AM,Sengupta PP,Slomka PJ,Dey DS,Rozanski A,Han D,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rumberger J,Whelton SP,Blaha MJ,Shaw LJ", + "auth_pos": 16, + "meshterms": "Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment, Humans, Male, Middle Aged, Female, Coronary Artery Disease*, Coronary Angiography, Coronary Angiography/methods, Calcium, Risk Factors, Vascular Calcification*, Predictive Value of Tests, Atherosclerosis*, Coronary Vessels, Machine Learning, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1633, + "user_id": 1811967433, + "artical_title": "Performance of the Pooled Cohort Equations in Non-alcoholic Fatty Liver Disease: the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 36401810, + "journal_name": "Liver international : official journal of the International Association for the Study of the Liver", + "date": "2022-11-20", + "author": "Henson JB,Budoff MJ,Muir AJ", + "auth_pos": 2, + "meshterms": "Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Humans, Female, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1634, + "user_id": 1811967433, + "artical_title": "Contemporary use of coronary artery calcium for the allocation of aspirin in light of the 2022 USPSTF guideline recommendations.", + "pmid": 36407963, + "journal_name": "American journal of preventive cardiology", + "date": "2022-11-22", + "author": "Verghese D,Manubolu S,Budoff MJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1635, + "user_id": 1811967433, + "artical_title": "Coronary plaque progression is greater in systemic lupus erythematosus than rheumatoid arthritis.", + "pmid": 36421035, + "journal_name": "Coronary artery disease", + "date": "2022-11-25", + "author": "Moore J,Lakshmanan S,Manubolu VS,Kinninger A,Stojan G,Goldman DW,Petri M,Budoff M,Karpouzas GA", + "auth_pos": 8, + "meshterms": "Humans, Cardiovascular Diseases*, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Lupus Erythematosus, Systemic/diagnosis, Lupus Erythematosus, Systemic/epidemiology, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/epidemiology, Humans, Cardiovascular Diseases*, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Lupus Erythematosus, Systemic/diagnosis, Lupus Erythematosus, Systemic/epidemiology, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/epidemiology, Humans, Cardiovascular Diseases*, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Lupus Erythematosus, Systemic/diagnosis, Lupus Erythematosus, Systemic/epidemiology, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/epidemiology, Humans, Cardiovascular Diseases*, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Lupus Erythematosus, Systemic/diagnosis, Lupus Erythematosus, Systemic/epidemiology, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/epidemiology, Humans, Cardiovascular Diseases*, Lupus Erythematosus, Systemic*, Lupus Erythematosus, Systemic/complications, Lupus Erythematosus, Systemic/diagnosis, Lupus Erythematosus, Systemic/epidemiology, Arthritis, Rheumatoid*, Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1636, + "user_id": 1811967433, + "artical_title": "CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System.: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI).", + "pmid": 36436841, + "journal_name": "Journal of the American College of Radiology : JACR", + "date": "2022-11-28", + "author": "Cury RC,Leipsic J,Abbara S,Achenbach S,Berman D,Bittencourt M,Budoff M,Chinnaiyan K,Choi AD,Ghoshhajra B,Jacobs J,Koweek L,Lesser J,Maroules C,Rubin GD,Rybicki FJ,Shaw LJ,Williams MC,Williamson E,White CS,Villines TC,Blankstein R", + "auth_pos": 7, + "meshterms": "Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*, Humans, United States, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Consensus, Constriction, Pathologic, Artificial Intelligence, Predictive Value of Tests, Computed Tomography Angiography, Coronary Stenosis*, Cardiology*, North America, Radiology*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1637, + "user_id": 1811967433, + "artical_title": "Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development.", + "pmid": 36441819, + "journal_name": "Circulation", + "date": "2022-11-29", + "author": "Figtree GA,Adamson PD,Antoniades C,Blumenthal RS,Blaha M,Budoff M,Celermajer DS,Chan MY,Chow CK,Dey D,Dwivedi G,Giannotti N,Grieve SM,Hamilton-Craig C,Kingwell BA,Kovacic JC,Min JK,Newby DE,Patel S,Peter K,Psaltis PJ,Vernon ST,Wong DT,Nicholls SJ", + "auth_pos": 6, + "meshterms": "United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*, United States, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Heart, Drug Development, Cardiovascular Agents*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1638, + "user_id": 1811967433, + "artical_title": "Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry.", + "pmid": 36444796, + "journal_name": "Journal of diabetes and its complications", + "date": "2022-11-30", + "author": "Shaikh K,Ahmed A,Gransar H,Lee J,Leipsic J,Nakanishi R,Alla V,Bax JJ,Chow BJW,Berman DS,Maffei E,Lin FY,Ahmad A,DeLago A,Pontone G,Feuchtner G,Marques H,Min JK,Hausleiter J,Hadamitzky M,Kaufmann PA,de Araújo Gonçalves P,Cury RC,Kim YJ,Chang HJ,Rubinshtein R,Villines TC,Lu Y,Shaw LJ,Acenbach S,Al Mallah MH,Andreini D,Cademartiri F,Callister TQ,Budoff MJ", + "auth_pos": 35, + "meshterms": "Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries, Adult, Humans, Middle Aged, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Tomography, X-Ray Computed, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Atherosclerosis/drug therapy, Diabetes Mellitus*, Diabetes Mellitus/drug therapy, Diabetes Mellitus/epidemiology, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1639, + "user_id": 1811967433, + "artical_title": "Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA).", + "pmid": 36494811, + "journal_name": "BMC cardiovascular disorders", + "date": "2022-12-11", + "author": "Zhao Y,Malik S,Criqui MH,Allison MA,Budoff MJ,Sandfort V,Wong ND", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1640, + "user_id": 1811967433, + "artical_title": "Coronary Computed Tomography Angiography for Evaluation of Chest Pain in the Emergency Department.", + "pmid": 36511943, + "journal_name": "Texas Heart Institute journal", + "date": "2022-12-14", + "author": "Dahal S,Budoff MJ,Roy SK", + "auth_pos": 2, + "meshterms": "Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Chest Pain, Chest Pain/diagnosis, Chest Pain/etiology, Emergency Service, Hospital, Troponin, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Coronary Angiography, Coronary Angiography/methods, Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Chest Pain, Chest Pain/diagnosis, Chest Pain/etiology, Emergency Service, Hospital, Troponin, Acute Coronary Syndrome*, Acute Coronary Syndrome/diagnosis, Coronary Angiography, Coronary Angiography/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1641, + "user_id": 1811967433, + "artical_title": "Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.", + "pmid": 36580204, + "journal_name": "Current atherosclerosis reports", + "date": "2022-12-30", + "author": "Sherratt SCR,Libby P,Budoff MJ,Bhatt DL,Mason RP", + "auth_pos": 3, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypertriglyceridemia*, Hypertriglyceridemia/drug therapy, Fatty Acids, Omega-3*, Fatty Acids, Omega-3/therapeutic use, Docosahexaenoic Acids, Docosahexaenoic Acids/therapeutic use, Cholesterol, Atherosclerosis*, Atherosclerosis/drug therapy, Triglycerides, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypertriglyceridemia*, Hypertriglyceridemia/drug therapy, Fatty Acids, Omega-3*, Fatty Acids, Omega-3/therapeutic use, Docosahexaenoic Acids, Docosahexaenoic Acids/therapeutic use, Cholesterol, Atherosclerosis*, Atherosclerosis/drug therapy, Triglycerides, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypertriglyceridemia*, Hypertriglyceridemia/drug therapy, Fatty Acids, Omega-3*, Fatty Acids, Omega-3/therapeutic use, Docosahexaenoic Acids, Docosahexaenoic Acids/therapeutic use, Cholesterol, Atherosclerosis*, Atherosclerosis/drug therapy, Triglycerides, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypertriglyceridemia*, Hypertriglyceridemia/drug therapy, Fatty Acids, Omega-3*, Fatty Acids, Omega-3/therapeutic use, Docosahexaenoic Acids, Docosahexaenoic Acids/therapeutic use, Cholesterol, Atherosclerosis*, Atherosclerosis/drug therapy, Triglycerides, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypertriglyceridemia*, Hypertriglyceridemia/drug therapy, Fatty Acids, Omega-3*, Fatty Acids, Omega-3/therapeutic use, Docosahexaenoic Acids, Docosahexaenoic Acids/therapeutic use, Cholesterol, Atherosclerosis*, Atherosclerosis/drug therapy, Triglycerides, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1642, + "user_id": 1811967433, + "artical_title": "Behind the Age Cutoff in the Chest Pain Guidelines.", + "pmid": 36599562, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-05", + "author": "Havistin R,Lakshmanan S,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Predictive Value of Tests, Chest Pain*, Chest Pain/diagnostic imaging, Chest Pain/etiology, Humans, Predictive Value of Tests, Chest Pain*, Chest Pain/diagnostic imaging, Chest Pain/etiology, Humans, Predictive Value of Tests, Chest Pain*, Chest Pain/diagnostic imaging, Chest Pain/etiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1643, + "user_id": 1811967433, + "artical_title": "Major Global Coronary Artery Calcium Guidelines.", + "pmid": 36599573, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-05", + "author": "Golub IS,Termeie OG,Kristo S,Schroeder LP,Lakshmanan S,Shafter AM,Hussein L,Verghese D,Aldana-Bitar J,Manubolu VS,Budoff MJ", + "auth_pos": 11, + "meshterms": "Adult, United States, Humans, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/therapy, Coronary Artery Disease/drug therapy, Calcium, Prospective Studies, Canada, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Factors, Adult, United States, Humans, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/therapy, Coronary Artery Disease/drug therapy, Calcium, Prospective Studies, Canada, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Factors, Adult, United States, Humans, Cardiovascular Diseases*, Coronary Artery Disease*, Coronary Artery Disease/therapy, Coronary Artery Disease/drug therapy, Calcium, Prospective Studies, Canada, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1644, + "user_id": 1811967433, + "artical_title": "Virtual pathology: Reaching higher standards for noninvasive CTA tissue characterization capability by using histology as a truth standard.", + "pmid": 36603478, + "journal_name": "European journal of radiology", + "date": "2023-01-06", + "author": "Buckler AJ,Sakamoto A,Pierre SS,Virmani R,Budoff MJ", + "auth_pos": 5, + "meshterms": "Humans, Computed Tomography Angiography, Carotid Stenosis*, Carotid Stenosis/pathology, Angiography, Plaque, Atherosclerotic*, Hemorrhage, Calcinosis*, Reference Standards, Carotid Arteries, Carotid Arteries/pathology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1645, + "user_id": 1811967433, + "artical_title": "Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?", + "pmid": 36619296, + "journal_name": "American journal of preventive cardiology", + "date": "2023-01-10", + "author": "Piña P,Lorenzatti D,Paula R,Daich J,Schenone AL,Gongora C,Garcia MJ,Blaha MJ,Budoff MJ,Berman DS,Virani SS,Slipczuk L", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1646, + "user_id": 1811967433, + "artical_title": "Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians.", + "pmid": 36636123, + "journal_name": "American journal of preventive cardiology", + "date": "2023-01-14", + "author": "Agarwala A,Patel J,Blaha M,Cainzos-Achirica M,Nasir K,Budoff M", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1647, + "user_id": 1811967433, + "artical_title": "Association between coronary artery calcium and thoracic spine bone mineral density: Multiethnic Study of Atherosclerosis (MESA).", + "pmid": 36642601, + "journal_name": "Nutrition, metabolism, and cardiovascular diseases : NMCD", + "date": "2023-01-16", + "author": "Manubolu VS,Mao S,Kinninger A,Dahal S,Ahmad K,Havistin R,Gao Y,Dailing C,Carr JJ,Roy SK,Budoff MJ", + "auth_pos": 11, + "meshterms": "Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary, Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary, Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary, Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary, Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary, Humans, Female, Male, Middle Aged, Aged, Aged, 80 and over, Bone Density, Bone Density/physiology, Calcium, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cross-Sectional Studies, Osteoporosis*, Osteoporosis/diagnostic imaging, Osteoporosis/epidemiology, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Bone Diseases, Metabolic*, Risk Factors, Calcium, Dietary", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1648, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Dispersion and Cause-Specific Mortality.", + "pmid": 36645939, + "journal_name": "The American journal of cardiology", + "date": "2023-01-17", + "author": "Dudum R,Dardari ZA,Feldman DI,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rozanski A,Rumberger JA,Shaw L,Dzaye O,Caínzos-Achirica M,Patel J,Blaha MJ", + "auth_pos": 5, + "meshterms": "Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*, Humans, Female, Male, Coronary Artery Disease*, Calcium, Coronary Angiography, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Cause of Death, Retrospective Studies, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Cardiovascular Diseases*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1649, + "user_id": 1811967433, + "artical_title": "Lipoprotein(a) and Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 36648051, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-18", + "author": "Bhatia HS,Zheng KH,Garg PK,Guan W,Whelton SP,Budoff MJ,Tsai MY", + "auth_pos": 6, + "meshterms": "Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1650, + "user_id": 1811967433, + "artical_title": "Expert Consensus on the Clinical Use of Pulse Wave Velocity in Asia.", + "pmid": 36660436, + "journal_name": "Pulse (Basel, Switzerland)", + "date": "2023-01-21", + "author": "Park JB,Sharman JE,Li Y,Munakata M,Shirai K,Chen CH,Jae SY,Tomiyama H,Kosuge H,Bruno RM,Spronck B,Kario K,Lee HY,Cheng HM,Wang J,Budoff M,Townsend R,Avolio AP", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1651, + "user_id": 1811967433, + "artical_title": "Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry.", + "pmid": 36691990, + "journal_name": "Clinical cardiology", + "date": "2023-01-25", + "author": "Park HB,Lee J,Hong Y,Byungchang S,Kim W,Lee BK,Lin FY,Hadamitzky M,Kim YJ,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,Gonçalves PA,Leipsic JA,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Kook W,Chang HJ", + "auth_pos": 13, + "meshterms": "Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors, Humans, Angina Pectoris, Bayes Theorem, Coronary Angiography, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Machine Learning, Registries, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1652, + "user_id": 1811967433, + "artical_title": "Copd And The Risk For Myocardial Infarction By Type In People With Hiv.", + "pmid": 36728918, + "journal_name": "AIDS (London, England)", + "date": "2023-02-03", + "author": "Crothers K,Nance RM,Whitney BM,Harding BN,Heckbert SR,Budoff MJ,Mathews WC,Bamford L,Cachay ER,Eron JJ,Napravnik S,Moore RD,Keruly JC,Willig A,Burkholder G,Feinstein MJ,Saag MS,Kitahata MM,Crane HM,Delaney JAC", + "auth_pos": 6, + "meshterms": "Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Myocardial Infarction*, Myocardial Infarction/epidemiology, Pulmonary Disease, Chronic Obstructive*, Pulmonary Disease, Chronic Obstructive/complications, Smoking", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1653, + "user_id": 1811967433, + "artical_title": "Comparing the pooled cohort equations and coronary artery calcium scores in a symptomatic mixed Asian cohort.", + "pmid": 36733301, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-02-04", + "author": "Baskaran L,Lee JK,Ko MSM,Al'Aref SJ,Neo YP,Ho JS,Huang W,Yoon YE,Han D,Nakanishi R,Tan SY,Al-Mallah M,Budoff MJ,Shaw LJ", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1654, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Density and Cardiovascular Events by Volume Level: The MESA.", + "pmid": 36802448, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-02-22", + "author": "Bhatia HS,McClelland RL,Denenberg J,Budoff MJ,Allison MA,Criqui MH", + "auth_pos": 4, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prospective Studies, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prospective Studies, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prospective Studies, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prospective Studies, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prospective Studies, Myocardial Infarction*, Myocardial Infarction/complications, Risk Factors, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1655, + "user_id": 1811967433, + "artical_title": "Does Coronary Plaque Morphology Matter Beyond Plaque Burden?", + "pmid": 36808390, + "journal_name": "Current atherosclerosis reports", + "date": "2023-02-23", + "author": "Lorenzatti D,Piña P,Csecs I,Schenone AL,Gongora CA,Garcia MJ,Blaha MJ,Budoff MJ,Williams MC,Dey D,Berman DS,Virani SS,Slipczuk L", + "auth_pos": 8, + "meshterms": "Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging, Humans, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Myocardial Infarction*, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1656, + "user_id": 1811967433, + "artical_title": "Age and the power of zero CAC in cardiac risk assessment: overview of the literature and a cautionary case.", + "pmid": 36873724, + "journal_name": "The British journal of cardiology", + "date": "2023-03-07", + "author": "Sheppard JP,Lakshmanan S,Lichtenstein SJ,Budoff MJ,Roy SK", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1657, + "user_id": 1811967433, + "artical_title": "Vitamin D Metabolite Ratio and Coronary Artery Calcification in the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 36943910, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-03-22", + "author": "Ginsberg C,Hoofnagle AN,Katz R,Cheng JH,Hsu S,Budoff MJ,Kado DM,Kestenbaum B,Siscovick DS,Michos ED,Ix JH,de Boer IH", + "auth_pos": 6, + "meshterms": "Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Humans, Vitamin D, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1658, + "user_id": 1811967433, + "artical_title": "The association of sex-specific hormones with coronary artery plaque characteristics from Miami Heart (MiHeart) study.", + "pmid": 36950675, + "journal_name": "American journal of preventive cardiology", + "date": "2023-03-24", + "author": "Kwapong YA,Sharma G,Valero-Elizondo J,Achirica MC,Ali SS,Blaha MJ,Blankstein R,Shapiro MD,Arias L,Budoff MJ,Feldman T,Cury RC,Mehta L,Fialkow J,Nasir K", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1659, + "user_id": 1811967433, + "artical_title": "Associations of urinary isoprostanes with measures of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 36969704, + "journal_name": "Atherosclerosis plus", + "date": "2023-03-28", + "author": "Wallace RL,Ogunmoroti O,Zhao D,Vaidya D,Heravi A,Guallar E,Ndumele CE,Lima JAC,Ouyang P,Budoff MJ,Allison M,Thomas I,Fashanu OE,Hoogeveen R,Post WS,Michos ED", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1660, + "user_id": 1811967433, + "artical_title": "Clinical and Coronary Plaque Predictors of Atherosclerotic Nonresponse to Statin Therapy.", + "pmid": 36648046, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-04-07", + "author": "van Rosendael SE,van den Hoogen IJ,Lin FY,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Leipsic JA,Maffei E,Pontone G,Raff GL,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Lee SE,Virmani R,Samady H,Stone PH,Min JK,Narula J,Shaw LJ,Chang HJ,van Rosendael AR,Bax JJ", + "auth_pos": 6, + "meshterms": "Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods, Humans, Middle Aged, Aged, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Coronary Artery Disease*, Coronary Artery Disease/pathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/pathology, Prospective Studies, Disease Progression, Predictive Value of Tests, Atherosclerosis*, Atherosclerosis/pathology, Computed Tomography Angiography, Computed Tomography Angiography/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1661, + "user_id": 1811967433, + "artical_title": "Computed tomographic angiography in coronary artery disease.", + "pmid": 37025086, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2023-04-10", + "author": "Serruys PW,Kotoku N,Nørgaard BL,Garg S,Nieman K,Dweck MR,Bax JJ,Knuuti J,Narula J,Perera D,Taylor CA,Leipsic JA,Nicol ED,Piazza N,Schultz CJ,Kitagawa K,Bruyne B,Collet C,Tanaka K,Mushtaq S,Belmonte M,Dudek D,Zlahoda-Huzior A,Tu S,Wijns W,Sharif F,Budoff MJ,Mey J,Andreini D,Onuma Y", + "auth_pos": 27, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnosis, Fractional Flow Reserve, Myocardial*, Coronary Angiography, Coronary Angiography/methods, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/pathology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/surgery, Coronary Vessels/pathology, Coronary Stenosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1662, + "user_id": 1811967433, + "artical_title": "ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis.", + "pmid": 36996698, + "journal_name": "Journal of autoimmunity", + "date": "2023-04-12", + "author": "Karpouzas GA,Papotti B,Ormseth SR,Palumbo M,Hernandez E,Adorni MP,Zimetti F,Budoff MJ,Ronda N", + "auth_pos": 8, + "meshterms": "Animals, Cricetinae, Humans, Coronary Artery Disease*, Cardiovascular Diseases*, Prednisone, CHO Cells, Risk Factors, Cricetulus, Cholesterol, Arthritis, Rheumatoid*, Inflammation, Heart Disease Risk Factors, Membrane Transport Proteins, Adenosine Triphosphate, Animals, Cricetinae, Humans, Coronary Artery Disease*, Cardiovascular Diseases*, Prednisone, CHO Cells, Risk Factors, Cricetulus, Cholesterol, Arthritis, Rheumatoid*, Inflammation, Heart Disease Risk Factors, Membrane Transport Proteins, Adenosine Triphosphate, Animals, Cricetinae, Humans, Coronary Artery Disease*, Cardiovascular Diseases*, Prednisone, CHO Cells, Risk Factors, Cricetulus, Cholesterol, Arthritis, Rheumatoid*, Inflammation, Heart Disease Risk Factors, Membrane Transport Proteins, Adenosine Triphosphate, Animals, Cricetinae, Humans, Coronary Artery Disease*, Cardiovascular Diseases*, Prednisone, CHO Cells, Risk Factors, Cricetulus, Cholesterol, Arthritis, Rheumatoid*, Inflammation, Heart Disease Risk Factors, Membrane Transport Proteins, Adenosine Triphosphate", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1663, + "user_id": 1811967433, + "artical_title": "Native Bypass of the Left Coronary Artery in a Male Patient Aged 63 Years.", + "pmid": 36811870, + "journal_name": "JAMA cardiology", + "date": "2023-04-14", + "author": "Narang VK,Budoff M", + "auth_pos": 2, + "meshterms": "Humans, Male, Coronary Artery Disease*, Coronary Artery Disease/surgery, Coronary Artery Bypass", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1664, + "user_id": 1811967433, + "artical_title": "Current utility of the coronary calcium score for the initial evaluation of suspected coronary artery disease.", + "pmid": 36604165, + "journal_name": "Heart (British Cardiac Society)", + "date": "2023-04-14", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Coronary Angiography, Coronary Stenosis*, Cardiovascular System*, Computed Tomography Angiography, Multidetector Computed Tomography, Predictive Value of Tests, Coronary Vessels, Coronary Vessels/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1665, + "user_id": 1811967433, + "artical_title": "Dealing with calcification in the coronary arteries.", + "pmid": 36995725, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2023-04-19", + "author": "Aldana-Bitar J,Karlsberg RP,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcinosis*, Calcinosis/diagnostic imaging, Coronary Artery Disease*, Plaque, Atherosclerotic*, Vascular Calcification*, Humans, Coronary Vessels, Coronary Vessels/diagnostic imaging, Calcinosis*, Calcinosis/diagnostic imaging, Coronary Artery Disease*, Plaque, Atherosclerotic*, Vascular Calcification*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1666, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium progression and all-cause mortality.", + "pmid": 37102229, + "journal_name": "Coronary artery disease", + "date": "2023-04-28", + "author": "Eghtedari B,Kinninger A,Roy SK,Budoff MJ", + "auth_pos": 4, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Calcium, Risk Factors, Risk Assessment, Coronary Artery Disease*, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Coronary Angiography, Humans, Male, Middle Aged, Aged, Female, Calcium, Risk Factors, Risk Assessment, Coronary Artery Disease*, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Coronary Angiography, Humans, Male, Middle Aged, Aged, Female, Calcium, Risk Factors, Risk Assessment, Coronary Artery Disease*, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Coronary Angiography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1667, + "user_id": 1811967433, + "artical_title": "In-Hospital Cardiac Arrest Complicating ST-Elevation Myocardial Infarction: Temporal Trends and Outcomes Based on Management Strategy.", + "pmid": 36822461, + "journal_name": "Resuscitation", + "date": "2023-05-01", + "author": "Bhat AG,Verghese D,Harsha Patlolla S,Truesdell AG,Batchelor WB,Henry TD,Cubeddu RJ,Budoff M,Bui Q,Matthew Belford P,X Zhao D,Vallabhajosyula S", + "auth_pos": 8, + "meshterms": "Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality, Adult, Humans, ST Elevation Myocardial Infarction*, ST Elevation Myocardial Infarction/complications, ST Elevation Myocardial Infarction/therapy, Treatment Outcome, Shock, Cardiogenic, Shock, Cardiogenic/etiology, Heart Arrest*, Heart Arrest/therapy, Heart Arrest/complications, Percutaneous Coronary Intervention*, Hospitals, Hospital Mortality", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1668, + "user_id": 1811967433, + "artical_title": "Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.", + "pmid": 36883587, + "journal_name": "European heart journal", + "date": "2023-05-08", + "author": "Wang M,Li XS,Wang Z,de Oliveira Otto MC,Lemaitre RN,Fretts A,Sotoodehnia N,Budoff M,Nemet I,DiDonato JA,Tang WHW,Psaty BM,Siscovick DS,Hazen SL,Mozaffarian D", + "auth_pos": 8, + "meshterms": "Adult, Humans, Risk Factors, Biomarkers, Methylamines, Methylamines/metabolism, Cardiovascular Diseases*, Renal Insufficiency*, Renal Insufficiency/etiology, Atherosclerosis*, Atherosclerosis/complications, Neoplasms*, Neoplasms/complications, Dementia*, Adult, Humans, Risk Factors, Biomarkers, Methylamines, Methylamines/metabolism, Cardiovascular Diseases*, Renal Insufficiency*, Renal Insufficiency/etiology, Atherosclerosis*, Atherosclerosis/complications, Neoplasms*, Neoplasms/complications, Dementia*, Adult, Humans, Risk Factors, Biomarkers, Methylamines, Methylamines/metabolism, Cardiovascular Diseases*, Renal Insufficiency*, Renal Insufficiency/etiology, Atherosclerosis*, Atherosclerosis/complications, Neoplasms*, Neoplasms/complications, Dementia*, Adult, Humans, Risk Factors, Biomarkers, Methylamines, Methylamines/metabolism, Cardiovascular Diseases*, Renal Insufficiency*, Renal Insufficiency/etiology, Atherosclerosis*, Atherosclerosis/complications, Neoplasms*, Neoplasms/complications, Dementia*, Adult, Humans, Risk Factors, Biomarkers, Methylamines, Methylamines/metabolism, Cardiovascular Diseases*, Renal Insufficiency*, Renal Insufficiency/etiology, Atherosclerosis*, Atherosclerosis/complications, Neoplasms*, Neoplasms/complications, Dementia*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1669, + "user_id": 1811967433, + "artical_title": "Associations of Adipokine Levels with Levels of Remnant Cholesterol: the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 37162928, + "journal_name": "medRxiv : the preprint server for health sciences", + "date": "2023-05-10", + "author": "Quispe R,Sweeney T,Martin SS,Jones SR,Allison MA,Budoff MJ,Ndumele CE,Elshazly MB,Michos ED", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1670, + "user_id": 1811967433, + "artical_title": "The use of coronary artery calcium scoring in young adults.", + "pmid": 37198083, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2023-05-18", + "author": "Ichikawa K,Susarla S,Budoff MJ", + "auth_pos": 3, + "meshterms": "Middle Aged, Humans, Young Adult, United States, Calcium, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Atherosclerosis*, Atherosclerosis/epidemiology, Risk Assessment, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1671, + "user_id": 1811967433, + "artical_title": "Opportunistic AI-enabled automated bone mineral density measurements in lung cancer screening and coronary calcium scoring CT scans are equivalent.", + "pmid": 37214544, + "journal_name": "European journal of radiology open", + "date": "2023-05-22", + "author": "Naghavi M,De Oliveira I,Mao SS,Jaberzadeh A,Montoya J,Zhang C,Atlas K,Manubolu V,Montes M,Li D,Atlas T,Reeves A,Henschke C,Yankelevitz D,Budoff M", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1672, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events.", + "pmid": 37219552, + "journal_name": "JAMA", + "date": "2023-05-25", + "author": "Khan SS,Post WS,Guo X,Tan J,Zhu F,Bos D,Sedaghati-Khayat B,van Rooij J,Aday A,Allen NB,Bos MM,Uitterlinden AG,Budoff MJ,Lloyd-Jones DM,Mosley JD,Rotter JI,Greenland P,Kavousi M", + "auth_pos": 13, + "meshterms": "Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment, Aged, Humans, Middle Aged, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Calcium, Coronary Disease*, Coronary Disease/diagnostic imaging, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Risk Factors, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1673, + "user_id": 1811967433, + "artical_title": "Ruptured Sinus of Valsalva Aneurysm Diagnosed on Coronary Computed Tomography Angiography in a Patient With Trisomy 13 Syndrome.", + "pmid": 37231901, + "journal_name": "Texas Heart Institute journal", + "date": "2023-05-29", + "author": "Barforoshi S,Sheker C,Ullal AV,Manubolu V,Budoff MJ,Roy SK", + "auth_pos": 5, + "meshterms": "Humans, Trisomy 13 Syndrome, Trisomy 13 Syndrome/complications, Aortic Rupture*, Aortic Rupture/etiology, Aortic Rupture/genetics, Computed Tomography Angiography, Sinus of Valsalva*, Sinus of Valsalva/diagnostic imaging, Sinus of Valsalva/surgery, Aortic Aneurysm*, Aortic Aneurysm/complications, Aortic Aneurysm/diagnostic imaging, Aortic Aneurysm/genetics, Aneurysm, Ruptured*, Aneurysm, Ruptured/complications, Humans, Trisomy 13 Syndrome, Trisomy 13 Syndrome/complications, Aortic Rupture*, Aortic Rupture/etiology, Aortic Rupture/genetics, Computed Tomography Angiography, Sinus of Valsalva*, Sinus of Valsalva/diagnostic imaging, Sinus of Valsalva/surgery, Aortic Aneurysm*, Aortic Aneurysm/complications, Aortic Aneurysm/diagnostic imaging, Aortic Aneurysm/genetics, Aneurysm, Ruptured*, Aneurysm, Ruptured/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1674, + "user_id": 1811967433, + "artical_title": "Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.", + "pmid": 37038246, + "journal_name": "European heart journal", + "date": "2023-06-02", + "author": "Chen HY,Dina C,Small AM,Shaffer CM,Levinson RT,Helgadóttir A,Capoulade R,Munter HM,Martinsson A,Cairns BJ,Trudsø LC,Hoekstra M,Burr HA,Marsh TW,Damrauer SM,Dufresne L,Le Scouarnec S,Messika-Zeitoun D,Ranatunga DK,Whitmer RA,Bonnefond A,Sveinbjornsson G,Daníelsen R,Arnar DO,Thorgeirsson G,Thorsteinsdottir U,Gudbjartsson DF,Hólm H,Ghouse J,Olesen MS,Christensen AH,Mikkelsen S,Jacobsen RL,Dowsett J,Pedersen OBV,Erikstrup C,Ostrowski SR,O'Donnell CJ,Budoff MJ,Gudnason V,Post WS,Rotter JI,Lathrop M,Bundgaard H,Johansson B,Ljungberg J,Näslund U,Le Tourneau T,Smith JG,Wells QS,Söderberg S,Stefánsson K,Schott JJ,Rader DJ,Clarke R,Engert JC,Thanassoulis G", + "auth_pos": 40, + "meshterms": "Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics, Humans, Genome-Wide Association Study, Genome-Wide Association Study/methods, Adiposity, Adiposity/genetics, Genetic Predisposition to Disease, Aortic Valve Stenosis*, Aortic Valve Stenosis/genetics, Obesity, Risk Factors, Inflammation, Dyslipidemias*, Dyslipidemias/complications, Dyslipidemias/genetics, Apolipoproteins, Apolipoproteins/genetics, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Polymorphism, Single Nucleotide/genetics", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1675, + "user_id": 1811967433, + "artical_title": "Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.", + "pmid": 36855253, + "journal_name": "HIV medicine", + "date": "2023-06-09", + "author": "Drumright LN,Nance RM,Ruderman SA,Ma J,Whitney BM,Hahn A,Fredericksen RJ,Luu B,Lober WB,Moore RD,Budoff MJ,Keruly JC,Christopoulos K,Puryear S,Willig A,Cropsey K,Mathews WC,Cachay E,Bamford L,Eron JJ,Napravnik S,Mayer KH,O'Cleirigh C,Mccaul ME,Chander G,Feinstein MJ,Saag MS,Kitahata MM,Heckbert SR,Crane HM,Delaney JAC", + "auth_pos": 11, + "meshterms": "Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Myocardial Infarction/etiology, Risk Factors, Plaque, Atherosclerotic*, Tobacco Products*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1676, + "user_id": 1811967433, + "artical_title": "Role of Dual-Acquisition Noninvasive Cardiac CT Imaging for the Detection of Vasospastic Angina.", + "pmid": 37297948, + "journal_name": "Journal of clinical medicine", + "date": "2023-06-10", + "author": "Jin X,Kang EJ,Jin CD,Lee KM,Lim KH,Rha SW,Choi CU,Yong HS,Yun SC,Budoff MJ,Yu LH,Kim MH", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1677, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcification and One-Year Cardiovascular Disease Incidence in the 75-and-Older Population: The ARIC Study.", + "pmid": 37283057, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-06-22", + "author": "Mok Y,Honda Y,Wang FM,Howard CM,Folsom AR,Coresh J,Budoff M,Blaha MJ,Matsushita K", + "auth_pos": 7, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/complications, Incidence, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology, Heart, Risk Factors, Prevalence, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/complications, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/complications, Incidence, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology, Heart, Risk Factors, Prevalence, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/complications, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/complications, Incidence, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/etiology, Heart, Risk Factors, Prevalence, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1678, + "user_id": 1811967433, + "artical_title": "Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT.", + "pmid": 37082990, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2023-06-23", + "author": "Rabbat MG,Lakshmanan S,Benjamin MM,Doros G,Kinninger A,Budoff MJ,Bhatt DL", + "auth_pos": 6, + "meshterms": "Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/drug therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Predictive Value of Tests, Severity of Illness Index, Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/drug therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Predictive Value of Tests, Severity of Illness Index, Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/drug therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Predictive Value of Tests, Severity of Illness Index, Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/drug therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Predictive Value of Tests, Severity of Illness Index, Humans, Computed Tomography Angiography, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Coronary Stenosis/drug therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Predictive Value of Tests, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1679, + "user_id": 1811967433, + "artical_title": "Plasma interleukin-6 (IL-6), angiopoietin-2, and C-reactive protein levels predict subsequent type 1 myocardial infarction in persons with treated HIV infection.", + "pmid": 37018921, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2023-06-28", + "author": "Graham SM,Nance RM,Chen J,Wurfel MM,Hunt PW,Heckbert SR,Budoff MJ,Moore RD,Jacobson JM,Martin JN,Crane HM,López JA,Liles WC", + "auth_pos": 7, + "meshterms": "Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/drug therapy, Interleukin-6, C-Reactive Protein, Cohort Studies, Angiopoietin-2, Angiopoietin-2/therapeutic use, Case-Control Studies, Atherosclerosis*, Atherosclerosis/complications, Myocardial Infarction*, Myocardial Infarction/complications, Biomarkers", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1680, + "user_id": 1811967433, + "artical_title": "Massive Biventricular Thrombi in a Patient with Endometrial Adenocarcinoma Diagnosed on Computed Tomography Angiography.", + "pmid": 37377539, + "journal_name": "Clinical Medicine Insights. Cardiology", + "date": "2023-06-28", + "author": "Barforoshi S,Sharim J,Budoff MJ", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1681, + "user_id": 1811967433, + "artical_title": "Computed Tomography Assessment of Coronary Atherosclerosis: From Threshold-Based Evaluation to Histologically Validated Plaque Quantification.", + "pmid": 37115957, + "journal_name": "Journal of thoracic imaging", + "date": "2023-06-29", + "author": "Varga-Szemes A,Maurovich-Horvat P,Schoepf UJ,Zsarnoczay E,Pelberg R,Stone GW,Budoff MJ", + "auth_pos": 7, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Artificial Intelligence, Coronary Angiography, Coronary Angiography/methods, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Vessels, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1682, + "user_id": 1811967433, + "artical_title": "Editorial: Old habits die hard: from risk calculators and stenosis evaluation to phenotyping coronary atherosclerosis using cardiac CT.", + "pmid": 37424898, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-07-10", + "author": "Slipczuk L,Budoff MJ,Villines TC", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1683, + "user_id": 1811967433, + "artical_title": "The effect of icosapent ethyl on left atrial and left ventricular morphology.", + "pmid": 39144091, + "journal_name": "The British journal of cardiology", + "date": "2023-07-11", + "author": "Kitchin SS,Lakshmanan S,Kinninger A,Mao SS,Rabbat MG,Bhatt DL,Budoff MJ", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1684, + "user_id": 1811967433, + "artical_title": "Plaque Progression Differences Between Apixaban and Rivaroxaban in Patients With Atrial Fibrillation Measured With Cardiac Computed Tomography and Plaque Quantification.", + "pmid": 36731003, + "journal_name": "American journal of therapeutics", + "date": "2023-07-17", + "author": "Aldana-Bitar J,Moore J,Manubolu VS,Dahal S,Verghese D,Lakshmanan S,Hussein L,Crabtree T,Jonas R,Min JK,Earls JP,Budoff MJ", + "auth_pos": 12, + "meshterms": "Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications, Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications, Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications, Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications, Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications, Humans, Rivaroxaban, Rivaroxaban/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/complications, Prospective Studies, Pyridones, Pyridones/adverse effects, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Dabigatran, Stroke*, Stroke/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1685, + "user_id": 1811967433, + "artical_title": "Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.", + "pmid": 37484708, + "journal_name": "Journal of translational autoimmunity", + "date": "2023-07-24", + "author": "Karpouzas GA,Papotti B,Ormseth SR,Palumbo M,Hernandez E,Adorni MP,Zimetti F,Budoff MJ,Ronda N", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1686, + "user_id": 1811967433, + "artical_title": "ApoC-III Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.", + "pmid": 37317850, + "journal_name": "Arteriosclerosis, thrombosis, and vascular biology", + "date": "2023-07-28", + "author": "Sinari S,Koska J,Hu Y,Furtado J,Jensen MK,Budoff MJ,Nedelkov D,McClelland RL,Billheimer D,Reaven P", + "auth_pos": 6, + "meshterms": "Aged, Humans, Male, Apolipoprotein C-III, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cross-Sectional Studies, Heart Disease Risk Factors, Obesity, Risk Factors, Triglycerides, Aged, Humans, Male, Apolipoprotein C-III, Cardiovascular Diseases*, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/epidemiology, Cross-Sectional Studies, Heart Disease Risk Factors, Obesity, Risk Factors, Triglycerides", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1687, + "user_id": 1811967433, + "artical_title": "Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.", + "pmid": 37520890, + "journal_name": "Journal of translational autoimmunity", + "date": "2023-07-31", + "author": "Karpouzas GA,Papotti B,Ormseth SR,Palumbo M,Hernandez E,Adorni MP,Zimetti F,Budoff MJ,Ronda N", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1688, + "user_id": 1811967433, + "artical_title": "Encapsulated Calcified Hematoma Mimicking a Cardiac Tumor, Diagnosed 25 Years Post-Traumatic Injury.", + "pmid": 37545682, + "journal_name": "JACC. Case reports", + "date": "2023-08-07", + "author": "Anderson LR,Aldana-Bitar J,Manubolu VS,Verghese D,Alalawi L,Ramirez NR,Budoff MJ,Karlsberg RP", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1689, + "user_id": 1811967433, + "artical_title": "Artificial intelligence using a deep learning versus expert computed tomography human reading in calcium score and coronary artery calcium data and reporting system classification.", + "pmid": 37139562, + "journal_name": "Coronary artery disease", + "date": "2023-08-10", + "author": "Aldana-Bitar J,Cho GW,Anderson L,Karlsberg DW,Manubolu VS,Verghese D,Hussein L,Budoff MJ,Karlsberg RP", + "auth_pos": 8, + "meshterms": "Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Female, Middle Aged, Male, Coronary Vessels, Coronary Vessels/diagnostic imaging, Artificial Intelligence, Calcium, Coronary Angiography, Coronary Angiography/methods, Deep Learning*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1690, + "user_id": 1811967433, + "artical_title": "Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE.", + "pmid": 37600044, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-08-21", + "author": "Buckler AJ,Doros G,Kinninger A,Lakshmanan S,Le VT,Libby P,May HT,Muhlestein JB,Nelson JR,Nicolaou A,Roy SK,Shaikh K,Shekar C,Tayek JA,Zheng L,Bhatt DL,Budoff MJ", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1691, + "user_id": 1811967433, + "artical_title": "Mitral annular calcification as a predictor of stroke in the multiethnic study of atherosclerosis.", + "pmid": 37409651, + "journal_name": "Journal of cardiovascular medicine (Hagerstown, Md.)", + "date": "2023-08-23", + "author": "Onuegbu A,Calicchio F,Kinninger A,Nakanishi R,Carr JJ,Nasir K,Gottesman R,Budoff M", + "auth_pos": 8, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Calcium, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Stroke*, Stroke/etiology, Stroke/epidemiology, Calcinosis*, Calcinosis/complications, Calcinosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Calcium, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Stroke*, Stroke/etiology, Stroke/epidemiology, Calcinosis*, Calcinosis/complications, Calcinosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Calcium, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Stroke*, Stroke/etiology, Stroke/epidemiology, Calcinosis*, Calcinosis/complications, Calcinosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Risk Factors, Humans, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Calcium, Heart Valve Diseases*, Heart Valve Diseases/complications, Heart Valve Diseases/diagnostic imaging, Stroke*, Stroke/etiology, Stroke/epidemiology, Calcinosis*, Calcinosis/complications, Calcinosis/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1692, + "user_id": 1811967433, + "artical_title": "Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium.", + "pmid": 37534563, + "journal_name": "Obesity (Silver Spring, Md.)", + "date": "2023-08-23", + "author": "Boakye E,Grandhi GR,Dardari Z,Adhikari R,Soroosh G,Jha K,Dzaye O,Tasdighi E,Erhabor J,Kumar SJ,Whelton S,Blumenthal RS,Albert M,Rozanski A,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rumberger JA,Shaw LJ,Blaha M", + "auth_pos": 16, + "meshterms": "Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors, Male, Humans, Adult, Middle Aged, Female, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Calcium, Retrospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Factors, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/complications, Coronary Artery Disease*, Coronary Artery Disease/etiology, Obesity, Obesity/complications, Heart Disease Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1693, + "user_id": 1811967433, + "artical_title": "Sex and age-specific interactions of coronary atherosclerotic plaque onset and prognosis from coronary computed tomography.", + "pmid": 37165981, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2023-08-24", + "author": "van Rosendael SE,Bax AM,Lin FY,Achenbach S,Andreini D,Budoff MJ,Cademartiri F,Callister TQ,Chinnaiyan K,Chow BJW,Cury RC,DeLago AJ,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Kim YJ,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Raff GL,Rubinshtein R,Villines TC,Chang HJ,Berman DS,Min JK,Bax JJ,Shaw LJ,van Rosendael AR", + "auth_pos": 6, + "meshterms": "Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests, Humans, Male, Female, Child, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/complications, Coronary Stenosis*, Coronary Stenosis/therapy, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/therapy, Tomography, X-Ray Computed, Prognosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Age Factors, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1694, + "user_id": 1811967433, + "artical_title": "The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men.", + "pmid": 37656011, + "journal_name": "The Journal of clinical endocrinology and metabolism", + "date": "2023-09-01", + "author": "Lee HS,Han SH,Swerdloff R,Pak Y,Budoff M,Wang C", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1695, + "user_id": 1811967433, + "artical_title": "Association of apolipoproteins C-I and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis.", + "pmid": 37573768, + "journal_name": "Atherosclerosis", + "date": "2023-09-04", + "author": "Koska J,Hu Y,Furtado J,Billheimer D,Nedelkov D,Allison M,Budoff MJ,McClelland RL,Reaven P", + "auth_pos": 7, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Calcium/metabolism, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Calcium, Dietary, Apolipoproteins C, Apolipoproteins C/metabolism, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Calcium/metabolism, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Calcium, Dietary, Apolipoproteins C, Apolipoproteins C/metabolism, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Calcium/metabolism, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Calcium, Dietary, Apolipoproteins C, Apolipoproteins C/metabolism, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Calcium/metabolism, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Calcium, Dietary, Apolipoproteins C, Apolipoproteins C/metabolism, Risk Factors, Risk Assessment, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Calcium, Calcium/metabolism, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/metabolism, Atherosclerosis*, Atherosclerosis/metabolism, Calcium, Dietary, Apolipoproteins C, Apolipoproteins C/metabolism, Risk Factors, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1696, + "user_id": 1811967433, + "artical_title": "Association of Inflammation and Lipoprotein(a) With Aortic Valve Calcification.", + "pmid": 37052566, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-09-08", + "author": "Marrero N,Razavi AC,Boakye E,Anchouche K,Dardari Z,Dzaye O,Jha K,Budoff MJ,Tsai MY,Rotter JI,Blumenthal RS,Thanassoulis G,Post WS,Blaha MJ,Whelton SP", + "auth_pos": 8, + "meshterms": "Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging, Humans, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Lipoprotein(a), Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Inflammation, Inflammation/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1697, + "user_id": 1811967433, + "artical_title": "The True Power of Zero.", + "pmid": 37673479, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-09-08", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1698, + "user_id": 1811967433, + "artical_title": "When Does a Calcium Score Equates to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.", + "pmid": 37227328, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-09-08", + "author": "Budoff MJ,Kinninger A,Gransar H,Achenbach S,Al-Mallah M,Bax JJ,Berman DS,Cademartiri F,Callister TQ,Chang HJ,Chow BJW,Cury RC,Feuchtner G,Hadamitzky M,Hausleiter J,Kaufmann PA,Leipsic J,Lin FY,Kim YJ,Marques H,Pontone G,Rubinshtein R,Shaw LJ,Villines TC,Min JK", + "auth_pos": 1, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors, Humans, Male, Middle Aged, Aged, Female, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/therapy, Cohort Studies, Calcium, Secondary Prevention, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/therapy, Vascular Calcification/complications, Predictive Value of Tests, Myocardial Infarction*, Myocardial Infarction/diagnostic imaging, Myocardial Infarction/epidemiology, Myocardial Infarction/prevention & control, Atherosclerosis*, Disease Progression, Registries, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1699, + "user_id": 1811967433, + "artical_title": "The quantity and quality of cardiovascular fat at mid-life and future cognitive performance among women: The SWAN cardiovascular fat ancillary study.", + "pmid": 37212597, + "journal_name": "Alzheimer's & dementia : the journal of the Alzheimer's Association", + "date": "2023-09-15", + "author": "Qi M,Janssen I,Barinas-Mitchell E,Budoff M,Brooks MM,Karlamangla AS,Derby CA,Chang CH,Shields KJ,El Khoudary SR", + "auth_pos": 4, + "meshterms": "Female, Humans, Middle Aged, Adipose Tissue*, Adipose Tissue/diagnostic imaging, Risk Factors, Female, Humans, Middle Aged, Adipose Tissue*, Adipose Tissue/diagnostic imaging, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1700, + "user_id": 1811967433, + "artical_title": "Defining Demographic-Specific Coronary Artery Calcium Percentiles in the Population Aged ?75: The ARIC Study and MESA.", + "pmid": 37655462, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-09-21", + "author": "Wang FM,Cainzos-Achirica M,Ballew SH,Coresh J,Folsom AR,Howard CM,Post WS,Wagenknecht LE,Budoff MJ,Blaha MJ,Matsushita K", + "auth_pos": 9, + "meshterms": "Male, Female, Humans, Aged, Aged, 80 and over, Calcium*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Demography, Male, Female, Humans, Aged, Aged, 80 and over, Calcium*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Demography, Male, Female, Humans, Aged, Aged, 80 and over, Calcium*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Demography, Male, Female, Humans, Aged, Aged, 80 and over, Calcium*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Demography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1701, + "user_id": 1811967433, + "artical_title": "Letter by Aldana-Bitar et al Regarding Article, \"Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study\".", + "pmid": 37747953, + "journal_name": "Circulation", + "date": "2023-09-27", + "author": "Aldana-Bitar J,Karlsberg RP,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Artery Disease*, Antibodies, Monoclonal, Humanized, Hyperlipoproteinemia Type II*, Hyperlipoproteinemia Type II/complications, Hyperlipoproteinemia Type II/diagnosis, Hyperlipoproteinemia Type II/genetics, Humans, Coronary Artery Disease*, Antibodies, Monoclonal, Humanized, Hyperlipoproteinemia Type II*, Hyperlipoproteinemia Type II/complications, Hyperlipoproteinemia Type II/diagnosis, Hyperlipoproteinemia Type II/genetics", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1702, + "user_id": 1811967433, + "artical_title": "Evaluation of Image Quality for High Heart Rates for Coronary Computed Tomographic Angiography with Advancement in CT Technology: The CONVERGE Registry.", + "pmid": 37754833, + "journal_name": "Journal of cardiovascular development and disease", + "date": "2023-09-27", + "author": "Abdelkarim A,Roy SK,Kinninger A,Salek A,Baranski O,Andreini D,Pontone G,Conte E,O'Rourke R,Hamilton-Craig C,Budoff MJ", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1703, + "user_id": 1811967433, + "artical_title": "Association of diabetes with coronary artery calcium in South Asian adults and other race/ethnic groups: The multi-ethnic study of atherosclerosis and the mediators of atherosclerosis in South Asians living in America study.", + "pmid": 37795703, + "journal_name": "Diabetes & vascular disease research", + "date": "2023-10-05", + "author": "Premyodhin N,Fan W,Arora M,Budoff MJ,Kanaya AM,Kandula N,Palaniappan L,Rana JS,Younus M,Wong ND", + "auth_pos": 4, + "meshterms": "Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Adult, Ethnicity, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, South Asian People, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1704, + "user_id": 1811967433, + "artical_title": "Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.", + "pmid": 37709864, + "journal_name": "Nature genetics", + "date": "2023-10-11", + "author": "Chen Y,Du X,Kuppa A,Feitosa MF,Bielak LF,O'Connell JR,Musani SK,Guo X,Kahali B,Chen VL,Smith AV,Ryan KA,Eirksdottir G,Allison MA,Bowden DW,Budoff MJ,Carr JJ,Chen YI,Taylor KD,Oliveri A,Correa A,Crudup BF,Kardia SLR,Mosley TH,Norris JM,Terry JG,Rotter JI,Wagenknecht LE,Halligan BD,Young KA,Hokanson JE,Washko GR,Gudnason V,Province MA,Peyser PA,Palmer ND,Speliotes EK", + "auth_pos": 16, + "meshterms": "Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism, Humans, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/genetics, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/metabolism, Genome-Wide Association Study, Liver Cirrhosis, Liver Cirrhosis/genetics, Acyltransferases, Acyltransferases/genetics, Acyltransferases/metabolism, Phospholipases, Phospholipases/genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Liver, Liver/metabolism, Protein Serine-Threonine Kinases, Protein Serine-Threonine Kinases/genetics, Intracellular Signaling Peptides and Proteins, Intracellular Signaling Peptides and Proteins/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1705, + "user_id": 1811967433, + "artical_title": "Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.", + "pmid": 37769454, + "journal_name": "Atherosclerosis", + "date": "2023-10-23", + "author": "Williams C,Han D,Takagi H,Fordyce CB,Sellers S,Blanke P,Lin FY,Shaw LJ,Lee SE,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Conte E,Marques H,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Maffei E,Pontone G,Shin S,Kim YJ,Lee BK,Chun EJ,Sung JM,Virmani R,Samady H,Stone PH,Berman DS,Narula J,Bax JJ,Leipsic JA,Chang HJ", + "auth_pos": 12, + "meshterms": "Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/complications, Aldosterone, Renin, Prospective Studies, Renin-Angiotensin System, Coronary Vessels, Disease Progression, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/complications, Coronary Angiography, Computed Tomography Angiography, Registries, Angiotensins, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1706, + "user_id": 1811967433, + "artical_title": "Coronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida.", + "pmid": 37772409, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-10-23", + "author": "Patel KV,Budoff MJ,Valero-Elizondo J,Lahan S,Ali SS,Taha MB,Blaha MJ,Blankstein R,Shapiro MD,Pandey A,Arias L,Feldman T,Cury RC,Cainzos-Achirica M,Shah SH,Ziffer JA,Fialkow J,Nasir K", + "auth_pos": 2, + "meshterms": "Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors, Adult, Humans, Female, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Prediabetic State*, Prediabetic State/diagnosis, Prediabetic State/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Florida, Florida/epidemiology, Constriction, Pathologic, Constriction, Pathologic/complications, Protestantism, Coronary Angiography, Coronary Angiography/methods, Prospective Studies, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/epidemiology, Plaque, Atherosclerotic/complications, Atherosclerosis*, Diabetes Mellitus*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1707, + "user_id": 1811967433, + "artical_title": "Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 37517431, + "journal_name": "American heart journal", + "date": "2023-10-26", + "author": "Ichikawa K,Hansen S,Manubolu VS,Pourafkari L,Fazlalizadeh H,Aldana-Bitar J,VanWagner LB,Krishnan S,Budoff MJ", + "auth_pos": 9, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/diagnosis, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prognosis, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/diagnosis, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prognosis, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/diagnosis, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prognosis, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/complications, Non-alcoholic Fatty Liver Disease/diagnosis, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prognosis, Coronary Vessels, Coronary Vessels/diagnostic imaging, Atherosclerosis*, Atherosclerosis/complications, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Risk Assessment, Risk Assessment/methods, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1708, + "user_id": 1811967433, + "artical_title": "Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study.", + "pmid": 37232393, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2023-10-30", + "author": "Park HB,Arsanjani R,Sung JM,Heo R,Lee BK,Lin FY,Hadamitzky M,Kim YJ,Conte E,Andreini D,Pontone G,Budoff MJ,Gottlieb I,Chun EJ,Cademartiri F,Maffei E,Marques H,Gonçalves PA,Leipsic JA,Lee SE,Shin S,Choi JH,Virmani R,Samady H,Chinnaiyan K,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Min JK,Chang HJ", + "auth_pos": 12, + "meshterms": "Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests, Female, Humans, Male, Middle Aged, Computed Tomography Angiography, Constriction, Pathologic, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/drug therapy, Coronary Artery Disease/pathology, Coronary Vessels, Coronary Vessels/pathology, Disease Progression, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Plaque, Atherosclerotic/drug therapy, Plaque, Atherosclerotic/pathology, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1709, + "user_id": 1811967433, + "artical_title": "Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification.", + "pmid": 37770635, + "journal_name": "Nature genetics", + "date": "2023-10-30", + "author": "Kavousi M,Bos MM,Barnes HJ,Cardenas CLL,Wong D,Lu H,Hodonsky CJ,Landsmeer LPL,Turner AW,Kho M,Hasbani NR,de Vries PS,Bowden DW,Chopade S,Deelen J,Benavente ED,Guo X,Hofer E,Hwang SJ,Lutz SM,Lyytikäinen LP,Slenders L,Smith AV,Stanislawski MA,van Setten J,Wong Q,Yanek LR,Becker DM,Beekman M,Budoff MJ,Feitosa MF,Finan C,Hilliard AT,Kardia SLR,Kovacic JC,Kral BG,Langefeld CD,Launer LJ,Malik S,Hoesein FAAM,Mokry M,Schmidt R,Smith JA,Taylor KD,Terry JG,van der Grond J,van Meurs J,Vliegenthart R,Xu J,Young KA,Zilhão NR,Zweiker R,Assimes TL,Becker LC,Bos D,Carr JJ,Cupples LA,de Kleijn DPV,de Winther M,den Ruijter HM,Fornage M,Freedman BI,Gudnason V,Hingorani AD,Hokanson JE,Ikram MA,Išgum I,Jacobs DR,Kähönen M,Lange LA,Lehtimäki T,Pasterkamp G,Raitakari OT,Schmidt H,Slagboom PE,Uitterlinden AG,Vernooij MW,Bis JC,Franceschini N,Psaty BM,Post WS,Rotter JI,Björkegren JLM,O'Donnell CJ,Bielak LF,Peyser PA,Malhotra R,van der Laan SW,Miller CL", + "auth_pos": 30, + "meshterms": "Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics, Humans, Atherosclerosis*, Atherosclerosis/genetics, Coronary Artery Disease*, Coronary Artery Disease/genetics, Genome-Wide Association Study, Risk Factors, European People, European People/genetics", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1710, + "user_id": 1811967433, + "artical_title": "Reply: The Blurry Line Between Primary and Secondary Prevention: Should We Continue to Use These Terms?", + "pmid": 37793715, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-11-01", + "author": "Budoff MJ,Kinninger A", + "auth_pos": 1, + "meshterms": "Humans, Predictive Value of Tests, Primary Prevention*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1711, + "user_id": 1811967433, + "artical_title": "Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.", + "pmid": 37844316, + "journal_name": "Annals of internal medicine", + "date": "2023-11-01", + "author": "Budoff MJ,Nasir K,Blaha MJ", + "auth_pos": 1, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Coronary Angiography, Denmark, Denmark/epidemiology, Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Coronary Angiography, Denmark, Denmark/epidemiology, Risk Factors, Humans, Coronary Artery Disease*, Coronary Artery Disease/complications, Coronary Artery Disease/epidemiology, Myocardial Infarction*, Myocardial Infarction/epidemiology, Coronary Angiography, Denmark, Denmark/epidemiology, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1712, + "user_id": 1811967433, + "artical_title": "Predictive Value of Deep Learning-derived CT Pectoralis Muscle and Adipose Measurements for Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis.", + "pmid": 37908549, + "journal_name": "Radiology. Cardiothoracic imaging", + "date": "2023-11-01", + "author": "Hathaway Q,Ibad HA,Bluemke DA,Pishgar F,Kasaiean A,Klein JG,Cogswell R,Allison M,Budoff MJ,Barr RG,Post W,Bredella MA,Lima JAC,Demehri S", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1713, + "user_id": 1811967433, + "artical_title": "Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison.", + "pmid": 37908554, + "journal_name": "Radiology. Cardiothoracic imaging", + "date": "2023-11-01", + "author": "Hirschfeld CB,Dorbala S,Shaw LJ,Villines TC,Choi AD,Better N,Cerci RJ,Karthikeyan G,Vitola JV,Williams MC,Al-Mallah M,Berman DS,Bernheim A,Biederman RW,Bravo PE,Budoff MJ,Bullock-Palmer RP,Chen MY,DiLorenzo MP,Doukky R,Ferencik M,Geske JB,Hage FG,Hendel RC,Koweek L,Murthy VL,Narula J,Rodriguez Lozano PF,Shah NR,Shah A,Soman P,Thompson RC,Wolinsky D,Cohen YA,Malkovskiy E,Randazzo MJ,Lopez-Mattei J,Parwani P,Shetty M,Pascual TNB,Pynda Y,Dondi M,Paez D,Einstein AJ", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1714, + "user_id": 1811967433, + "artical_title": "Efficacy and Safety of Iodixanol in Computed Coronary Tomographic Angiography and Cardiac Catheterization.", + "pmid": 37998507, + "journal_name": "Journal of cardiovascular development and disease", + "date": "2023-11-24", + "author": "Budoff MJ,Lee HS,Roy SK,Shekar C", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1715, + "user_id": 1811967433, + "artical_title": "Inter- and intra-observer reproducibility of CT-Leaman score by an independent core lab.", + "pmid": 37875690, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2023-11-27", + "author": "Revaiah PC,Kageyama S,Masuda S,Ninomiya K,Kotoku N,Wang B,He X,Tsai TY,Garg S,Mushtaq S,Reiber JHC,Leaman DM,Bax JJ,Budoff MJ,Andreini D,Serruys PW,Onuma Y", + "auth_pos": 14, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Angiography, Coronary Angiography/methods, Reproducibility of Results, Predictive Value of Tests, Tomography, X-Ray Computed, Observer Variation", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1716, + "user_id": 1811967433, + "artical_title": "Predictors of non-calcified plaque presence and future adverse cardiovascular events in symptomatic rural Appalachian patients with a zero coronary artery calcium score.", + "pmid": 37543447, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2023-11-27", + "author": "Miller T,Hana D,Patel B,Conte J,Velu D,Avalon JC,Thyagaturu H,Sankaramangalam K,Shotwell M,Guzman DB,Kadiyala M,Balla S,Kim C,Zeb I,Patel B,Budoff M,Mills J,Hamirani YS", + "auth_pos": 16, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Predictive Value of Tests, Plaque, Atherosclerotic*, Coronary Angiography, Coronary Angiography/methods, Risk Factors, Hypertension*, Diabetes Mellitus*, Diabetes Mellitus/diagnosis, Diabetes Mellitus/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1717, + "user_id": 1811967433, + "artical_title": "Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia.", + "pmid": 37926153, + "journal_name": "Progress in cardiovascular diseases", + "date": "2023-12-05", + "author": "Piña P,Fernandez C,Lorenzatti D,Castagna F,Miles J,Kuno T,Scotti A,Arce J,Gongora CA,Schenone AL,Budoff MJ,Nasir K,Blankstein R,Blaha MJ,Dey D,Berman DS,Levsky JM,Virani SS,Garcia MJ,Slipczuk L", + "auth_pos": 11, + "meshterms": "Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed, Humans, Hypercholesterolemia*, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1718, + "user_id": 1811967433, + "artical_title": "Vendor Independent Coronary Calcium Scoring Improves Individual Risk Assessment: The Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 37318394, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-12-11", + "author": "van der Werf NR,Dobrolinska MM,Greuter MJW,Willemink MJ,Fleischmann D,Bos D,Slart RHJA,Budoff M,Leiner T", + "auth_pos": 8, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Predictive Value of Tests, Atherosclerosis*, Tomography, X-Ray Computed, Risk Factors, Risk Assessment, Coronary Vessels, Coronary Vessels/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Predictive Value of Tests, Atherosclerosis*, Tomography, X-Ray Computed, Risk Factors, Risk Assessment, Coronary Vessels, Coronary Vessels/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Predictive Value of Tests, Atherosclerosis*, Tomography, X-Ray Computed, Risk Factors, Risk Assessment, Coronary Vessels, Coronary Vessels/diagnostic imaging, Vascular Calcification*, Vascular Calcification/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1719, + "user_id": 1811967433, + "artical_title": "Thoracic Aortic Calcium Density and Area in Long-Term Atherosclerotic Cardiovascular Disease Risk Among Men Versus Women.", + "pmid": 38054290, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2023-12-21", + "author": "Razavi AC,Kim C,van Assen M,De Cecco CN,Berman DS,Budoff MJ,Quyyumi AA,Vaccarino V,Miedema MD,Nasir K,Rozanski A,Fernandez C,Rumberger JA,Shaw LJ,Bødtker Mortensen M,Wong ND,Blumenthal RS,Sperling LS,Whelton SP,Blaha MJ,Dzaye O", + "auth_pos": 6, + "meshterms": "Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications, Male, Humans, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/complications, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Assessment, Risk Assessment/methods, Atherosclerosis*, Atherosclerosis/diagnostic imaging, Atherosclerosis/epidemiology, Risk Factors, Vascular Calcification*, Vascular Calcification/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1720, + "user_id": 1811967433, + "artical_title": "How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial.", + "pmid": 37798157, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2023-12-22", + "author": "Cardoso R,Choi AD,Shiyovich A,Besser SA,Min JK,Earls J,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,de Araújo Gonçalves P,Pontone G,Lee SE,Sung JM,Virmani R,Samady H,Lin FY,Stone PH,Berman DS,Narula J,Shaw LJ,Bax JJ,Chang HJ,Blankstein R", + "auth_pos": 9, + "meshterms": "Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Humans, Male, Middle Aged, Female, Computed Tomography Angiography, Computed Tomography Angiography/methods, Retrospective Studies, Predictive Value of Tests, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Plaque, Atherosclerotic*, Atherosclerosis*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1721, + "user_id": 1811967433, + "artical_title": "Evaluation of stable angina by coronary computed tomographic angiography versus standard of care: A systematic review and meta-analysis.", + "pmid": 37541837, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2024-01-02", + "author": "Palicherla A,Ismayl M,Thandra A,Budoff M,Shaikh K", + "auth_pos": 4, + "meshterms": "Humans, Computed Tomography Angiography, Angina, Stable*, Angina, Stable/diagnostic imaging, Angina, Stable/therapy, Coronary Angiography, Coronary Angiography/methods, Standard of Care, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/complications, Myocardial Infarction*, Angina, Unstable, Humans, Computed Tomography Angiography, Angina, Stable*, Angina, Stable/diagnostic imaging, Angina, Stable/therapy, Coronary Angiography, Coronary Angiography/methods, Standard of Care, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/complications, Myocardial Infarction*, Angina, Unstable, Humans, Computed Tomography Angiography, Angina, Stable*, Angina, Stable/diagnostic imaging, Angina, Stable/therapy, Coronary Angiography, Coronary Angiography/methods, Standard of Care, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/complications, Myocardial Infarction*, Angina, Unstable, Humans, Computed Tomography Angiography, Angina, Stable*, Angina, Stable/diagnostic imaging, Angina, Stable/therapy, Coronary Angiography, Coronary Angiography/methods, Standard of Care, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Coronary Artery Disease/complications, Myocardial Infarction*, Angina, Unstable", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1722, + "user_id": 1811967433, + "artical_title": "Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis.", + "pmid": 37178073, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-01-08", + "author": "Whelton SP,Jha K,Dardari Z,Razavi AC,Boakye E,Dzaye O,Verghese D,Shah S,Budoff MJ,Matsushita K,Carr JJ,Vasan RS,Blumenthal RS,Anchouche K,Thanassoulis G,Guo X,Rotter JI,McClelland RL,Post WS,Blaha MJ", + "auth_pos": 9, + "meshterms": "Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology, Male, Humans, Female, Aortic Valve*, Aortic Valve/diagnostic imaging, Calcium, Prevalence, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1723, + "user_id": 1811967433, + "artical_title": "Can Noncalcified Plaques Contribute to Future Coronary Events?", + "pmid": 38019491, + "journal_name": "JAMA cardiology", + "date": "2024-01-11", + "author": "Erbay MI,Susarla S,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Plaque, Atherosclerotic*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1724, + "user_id": 1811967433, + "artical_title": "Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events.", + "pmid": 37940398, + "journal_name": "Atherosclerosis", + "date": "2024-01-15", + "author": "Acquah I,Cainzos-Achirica M,Taha MB,Lahan S,Blaha MJ,Al-Kindi SG,Khan SU,Sharma G,Budoff MJ,Nasir K", + "auth_pos": 9, + "meshterms": "Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Calcium, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Prospective Studies, Coronary Vessels, Coronary Vessels/diagnostic imaging, Risk Assessment, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Atherosclerosis*, Atherosclerosis/diagnosis, Atherosclerosis/epidemiology, Risk Factors, Calcium, Dietary", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1725, + "user_id": 1811967433, + "artical_title": "Venous thromboembolism among people with HIV: Design, implementation, and findings of a centralized adjudication system in clinical care sites across the United States.", + "pmid": 37988634, + "journal_name": "Journal of acquired immune deficiency syndromes (1999)", + "date": "2024-01-15", + "author": "Crane HM,Nance RM,Ruderman SA,Haidar L,Tenforde MW,Heckbert SR,Budoff MJ,Hahn AW,Drumright LN,Ma J,Mixson LS,Lober WB,Barnes GS,McReynolds J,Attia EF,Peter I,Moges T,Bamford L,Cachay E,Mathews WC,Christopolous K,Hunt PW,Napravnik S,Keruly J,Moore RD,Burkholder G,Willig AL,Lindstrom S,Whitney BM,Saag MS,Kitahata MM,Crothers KA,Delaney JA", + "auth_pos": 7, + "meshterms": "Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications, Humans, United States, United States/epidemiology, Venous Thromboembolism*, Venous Thromboembolism/epidemiology, Venous Thromboembolism/complications, Risk Factors, Viremia, Viremia/complications, HIV Infections*, HIV Infections/complications, Venous Thrombosis*, Venous Thrombosis/complications", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1726, + "user_id": 1811967433, + "artical_title": "Association between long-term exposure to ambient air pollution and lesion ischemia in patients with atherosclerosis.", + "pmid": 38118276, + "journal_name": "Atherosclerosis", + "date": "2024-01-15", + "author": "Xu M,Hou Z,Koyratty N,Huang C,Mu L,Zhu K,Yu G,LaMonte MJ,Budoff MJ,Kaufman JD,Wang M,Lu B", + "auth_pos": 9, + "meshterms": "Humans, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/adverse effects, Nitrogen Dioxide/analysis, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Air Pollution*, Air Pollution/adverse effects, Air Pollution/analysis, Atherosclerosis*, Atherosclerosis/etiology, Atherosclerosis/chemically induced, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/chemically induced, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Myocardial Ischemia/chemically induced, Ischemia, Environmental Exposure, Environmental Exposure/adverse effects, Humans, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/adverse effects, Nitrogen Dioxide/analysis, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Air Pollution*, Air Pollution/adverse effects, Air Pollution/analysis, Atherosclerosis*, Atherosclerosis/etiology, Atherosclerosis/chemically induced, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/chemically induced, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Myocardial Ischemia/chemically induced, Ischemia, Environmental Exposure, Environmental Exposure/adverse effects, Humans, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/adverse effects, Nitrogen Dioxide/analysis, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Air Pollution*, Air Pollution/adverse effects, Air Pollution/analysis, Atherosclerosis*, Atherosclerosis/etiology, Atherosclerosis/chemically induced, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/chemically induced, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Myocardial Ischemia/chemically induced, Ischemia, Environmental Exposure, Environmental Exposure/adverse effects, Humans, Middle Aged, Nitrogen Dioxide, Nitrogen Dioxide/adverse effects, Nitrogen Dioxide/analysis, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Air Pollution*, Air Pollution/adverse effects, Air Pollution/analysis, Atherosclerosis*, Atherosclerosis/etiology, Atherosclerosis/chemically induced, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/chemically induced, Particulate Matter, Particulate Matter/adverse effects, Particulate Matter/analysis, Myocardial Ischemia*, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/epidemiology, Myocardial Ischemia/chemically induced, Ischemia, Environmental Exposure, Environmental Exposure/adverse effects", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1727, + "user_id": 1811967433, + "artical_title": "Methods and Reproducibility of Liver Fat Measurement Using 3-Dimensional Liver Segmentation From Noncontrast Computed Tomography in EVAPORATE Cohort.", + "pmid": 37531634, + "journal_name": "Journal of computer assisted tomography", + "date": "2024-01-15", + "author": "Ding KR,Lakshmanan S,Holda M,Kinninger A,Manubolu VS,Joshi T,Golub I,Mao SS,Budoff MJ,Roy SK", + "auth_pos": 9, + "meshterms": "Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/diagnostic imaging, Reproducibility of Results, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Clinical Trials as Topic, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/diagnostic imaging, Reproducibility of Results, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Clinical Trials as Topic, Humans, Cardiovascular Diseases*, Cardiovascular Diseases/diagnostic imaging, Non-alcoholic Fatty Liver Disease*, Non-alcoholic Fatty Liver Disease/diagnostic imaging, Reproducibility of Results, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1728, + "user_id": 1811967433, + "artical_title": "Factors Associated With Myocardial Infarction in a Rural Population With Peripheral Arterial Diseases.", + "pmid": 38319736, + "journal_name": "Angiology", + "date": "2024-02-06", + "author": "Awujoola AO,Mokikan MT,Odebunmi OO,Mamudu HM,Stewart DW,Husari G,Singh K,Grant C,Budoff M,Paul TK", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1729, + "user_id": 1811967433, + "artical_title": "AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi-Ethnic Study of Atherosclerosis.", + "pmid": 38343816, + "journal_name": "medRxiv : the preprint server for health sciences", + "date": "2024-02-12", + "author": "Naghavi M,Yankelevitz D,Reeves AP,Budoff MJ,Li D,Atlas KC,Zhang C,Atlas TL,Lirette S,Wasserthal J,Henschke C,Defilippi C,Heckbert SR,Greenland P", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1730, + "user_id": 1811967433, + "artical_title": "Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study.", + "pmid": 38377236, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2024-02-22", + "author": "Fazlalizadeh H,Khan MS,Fox ER,Douglas PS,Adams D,Blaha MJ,Daubert MA,Dunn G,van den Heuvel E,Kelsey MD,Martin RP,Thomas JD,Thomas Y,Judd SE,Vasan RS,Budoff MJ,Bloomfield GS", + "auth_pos": 16, + "meshterms": "Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*, Humans, Longitudinal Studies, Rural Population*, Cohort Studies, Multimodal Imaging*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1731, + "user_id": 1811967433, + "artical_title": "Non-calcified plaque in asymptomatic patients with zero coronary artery calcium score: A systematic review and meta-analysis.", + "pmid": 37821352, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-02-26", + "author": "Sama C,Abdelhaleem A,Velu D,Ditah Chobufo M,Fongwen NT,Budoff MJ,Roberts M,Balla S,Mills JD,Njim TN,Greathouse M,Zeb I,Hamirani YS", + "auth_pos": 6, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult, Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Prevalence, Plaque, Atherosclerotic*, Coronary Angiography*, Computed Tomography Angiography*, Asymptomatic Diseases*, Predictive Value of Tests*, Male, Female, Risk Assessment, Middle Aged, Risk Factors, Severity of Illness Index*, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Prognosis, Adult", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1732, + "user_id": 1811967433, + "artical_title": "Association of urine biomarkers of kidney health with subclinical cardiovascular disease in a MACS substudy.", + "pmid": 37861689, + "journal_name": "AIDS (London, England)", + "date": "2024-02-29", + "author": "Lai M,Madden E,Shlipak MG,Scherzer R,Post WS,Vittinghoff E,Haberlen S,Brown TT,Wolinsky SM,Witt MD,Ho K,Abraham AG,Parikh CR,Budoff M,Estrella MM", + "auth_pos": 14, + "meshterms": "Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*, Male, Humans, Female, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Cardiovascular Diseases*, Cardiovascular Diseases/complications, Cohort Studies, Albuminuria, Cross-Sectional Studies, Constriction, Pathologic, Constriction, Pathologic/complications, Risk Factors, Kidney, Biomarkers, Plaque, Atherosclerotic*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1733, + "user_id": 1811967433, + "artical_title": "Reference intervals for cardiometabolic risk factors in China: a national multicenter cross-sectional study on an adult population sample.", + "pmid": 38434556, + "journal_name": "Cardiovascular diagnosis and therapy", + "date": "2024-03-04", + "author": "Fan X,Wang X,Zhao H,Xiong D,Hu M,Wang L,Pan A,Gabelli C,Budoff MJ,Yuan H", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1734, + "user_id": 1811967433, + "artical_title": "Coronary Artery Calcium Score Predicts Major Adverse Cardiovascular Events in Stable Chest Pain.", + "pmid": 38441097, + "journal_name": "Radiology", + "date": "2024-03-06", + "author": "Biavati F,Saba L,Boussoussou M,Kofoed KF,Benedek T,Donnelly P,Rodríguez-Palomares J,Erglis A,Štěchovský C,Šakalytė G,Čemerlić Ađić N,Gutberlet M,Dodd JD,Diez I,Davis G,Zimmermann E,Kępka C,Vidakovic R,Francone M,Ilnicka-Suckiel M,Plank F,Knuuti J,Faria R,Schröder S,Berry C,Ruzsics B,Rieckmann N,Kubiak C,Hansen KS,Müller-Nordhorn J,Maurovich-Horvat P,Sigvardsen PE,Benedek I,Orr C,Valente FX,Zvaigzne L,Suchánek V,Jankauskas A,Ađić F,Woinke M,Cadogan D,Lecumberri I,Thwaite E,Kruk M,Neskovic AN,Mancone M,Kuśmierz D,Feuchtner G,Pietilä M,Ribeiro VG,Drosch T,Delles C,Cau R,Fisher M,Merkely B,Kragelund C,Aurelian R,Kelly S,García Del Blanco B,Rubio A,Szilveszter B,Hove JD,Rodean I,Regan S,Cuéllar Calabria H,Édes IF,Larsen L,Hodas R,Napp AE,Haase R,Feger S,Mohamed M,Serna-Higuita LM,Neumann K,Dreger H,Rief M,Wieske V,Budoff MJ,Estrella M,Martus P,Bosserdt M,Dewey M", + "auth_pos": 78, + "meshterms": "Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*, Adult, Humans, Female, Middle Aged, Calcium, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Chest Pain, Chest Pain/diagnostic imaging, Myocardial Infarction*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1735, + "user_id": 1811967433, + "artical_title": "Risk stratifying individuals with zero, minimal, and mild coronary artery calcium for cardiovascular disease by determining coronary plaque burden.", + "pmid": 38097409, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-03-11", + "author": "Ansari S,Pourafkari L,Kinninger A,Manubolu V,Budoff MJ", + "auth_pos": 5, + "meshterms": "Humans, Female, Adult, Middle Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiovascular Diseases*, Prospective Studies, Coronary Angiography, Risk Factors, Tomography, X-Ray Computed, Predictive Value of Tests, Plaque, Atherosclerotic*, Diabetes Mellitus*, Risk Assessment, Hypertension*, Humans, Female, Adult, Middle Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Calcium, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiovascular Diseases*, Prospective Studies, Coronary Angiography, Risk Factors, Tomography, X-Ray Computed, Predictive Value of Tests, Plaque, Atherosclerotic*, Diabetes Mellitus*, Risk Assessment, Hypertension*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1736, + "user_id": 1811967433, + "artical_title": "Computed tomographic angiography measures of coronary plaque in clinical trials: .", + "pmid": 38500753, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2024-03-19", + "author": "Howden N,Branch K,Douglas P,Gray M,Budoff M,Dewey M,Newby DE,Nicholls SJ,Blankstein R,Fathieh S,Grieve SM,Figtree GA", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1737, + "user_id": 1811967433, + "artical_title": "Validation of Opportunistic Artificial Intelligence-based Bone Mineral Density Measurements in Coronary Artery Calcium Scans.", + "pmid": 37336431, + "journal_name": "Journal of the American College of Radiology : JACR", + "date": "2024-03-22", + "author": "Naghavi M,Atlas K,Jaberzadeh A,Zhang C,Manubolu V,Li D,Budoff M", + "auth_pos": 7, + "meshterms": "Humans, Male, Female, Middle Aged, Aged, Bone Density, Calcium, Coronary Vessels, Artificial Intelligence, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Osteoporosis*, Osteoporosis/diagnostic imaging, Absorptiometry, Photon, Atherosclerosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1738, + "user_id": 1811967433, + "artical_title": "Progression of non-obstructive coronary plaque: a practical CCTA-based risk score from the PARADIGM registry.", + "pmid": 37750979, + "journal_name": "European radiology", + "date": "2024-03-22", + "author": "Pontone G,Rossi A,Baggiano A,Andreini D,Conte E,Fusini L,Gebhard C,Rabbat MG,Guaricci A,Guglielmo M,Muscogiuri G,Mushtaq S,Al-Mallah MH,Berman DS,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,de Araújo Gonçalves P,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Lee SE,Maffei E,Marques H,Samady H,Shin S,Sung JM,van Rosendael A,Virmani R,Bax JJ,Leipsic JA,Lin FY,Min JK,Narula J,Shaw LJ,Chang HJ", + "auth_pos": 15, + "meshterms": "Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/diagnostic imaging, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Stenosis*, Coronary Angiography, Coronary Angiography/methods, Constriction, Pathologic, Risk Assessment, Risk Assessment/methods, Predictive Value of Tests, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Risk Factors, Disease Progression, Registries", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1739, + "user_id": 1811967433, + "artical_title": "Combination of computed tomography angiography with coronary artery calcium score for improved diagnosis of coronary artery disease: a collaborative meta-analysis of stable chest pain patients referred for invasive coronary angiography.", + "pmid": 37831139, + "journal_name": "European radiology", + "date": "2024-03-22", + "author": "Mohamed M,Bosserdt M,Wieske V,Dubourg B,Alkadhi H,Garcia MJ,Leschka S,Zimmermann E,Shabestari AA,Nørgaard BL,Meijs MFL,Øvrehus KA,Diederichsen ACP,Knuuti J,Halvorsen BA,Mendoza-Rodriguez V,Wan YL,Bettencourt N,Martuscelli E,Buechel RR,Mickley H,Sun K,Muraglia S,Kaufmann PA,Herzog BA,Tardif JC,Schütz GM,Laule M,Newby DE,Achenbach S,Budoff M,Haase R,Biavati F,Mézquita AV,Schlattmann P,Dewey M", + "auth_pos": 31, + "meshterms": "Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged, Female, Humans, Male, Calcium, Chest Pain, Chest Pain/diagnosis, Computed Tomography Angiography, Computed Tomography Angiography/methods, Coronary Angiography, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Stenosis*, Coronary Stenosis/diagnostic imaging, Predictive Value of Tests, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Middle Aged, Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1740, + "user_id": 1811967433, + "artical_title": "High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.", + "pmid": 38131623, + "journal_name": "The American journal of gastroenterology", + "date": "2024-04-05", + "author": "Price JC,Springer G,Seaberg EC,Budoff MJ,Koletar SL,Hawkins CA,Witt MD,Post WS,Thio CL", + "auth_pos": 4, + "meshterms": "Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects, Male, Humans, HIV Infections*, HIV Infections/complications, HIV Infections/epidemiology, Incidence, Prospective Studies, Fatty Liver*, Fatty Liver/diagnostic imaging, Fatty Liver/epidemiology, Fatty Liver/complications, Tomography, Tomography/adverse effects", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1741, + "user_id": 1811967433, + "artical_title": "Epicardial and intra-thoracic adipose tissue and cardiovascular calcifications in type 1 diabetes (T1D) in epidemiology of diabetes Interventions and Complications (EDIC): A pilot study.", + "pmid": 38584607, + "journal_name": "American journal of preventive cardiology", + "date": "2024-04-08", + "author": "Rezaeian P,Backlund JC,Zaveri M,Nakanishi R,Matsumoto S,Alani A,Razipour A,Lachin JM,Budoff M", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1742, + "user_id": 1811967433, + "artical_title": "Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 38596669, + "journal_name": "Frontiers in immunology", + "date": "2024-04-11", + "author": "Niedecker RW,Delaney JA,Doyle MF,Sparks AD,Sitlani CM,Buzkova P,Zeb I,Tracy RP,Psaty BM,Budoff MJ,Olson NC", + "auth_pos": 10, + "meshterms": "Humans, Monocytes, Cross-Sectional Studies, Fatty Liver*, Fatty Liver/diagnosis, T-Lymphocyte Subsets, Biomarkers, Atherosclerosis*, Humans, Monocytes, Cross-Sectional Studies, Fatty Liver*, Fatty Liver/diagnosis, T-Lymphocyte Subsets, Biomarkers, Atherosclerosis*, Humans, Monocytes, Cross-Sectional Studies, Fatty Liver*, Fatty Liver/diagnosis, T-Lymphocyte Subsets, Biomarkers, Atherosclerosis*", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1743, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium for stroke mortality prediction.", + "pmid": 38334053, + "journal_name": "Vascular medicine (London, England)", + "date": "2024-04-12", + "author": "Erhabor J,Boakye E,Dardari Z,Dzaye O,Soroosh G,Berman DS,Budoff MJ,Miedema MD,Nasir K,Rumberger JA,Shaw LJ,Johansen MC,Blaha MJ", + "auth_pos": 7, + "meshterms": "Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography, Humans, Calcium, Coronary Vessels, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Cardiovascular Diseases*, Stroke*, Stroke/diagnosis, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Risk Factors, Risk Assessment, Coronary Angiography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1744, + "user_id": 1811967433, + "artical_title": "Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.", + "pmid": 38631771, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-04-19", + "author": "Wong ND,Fan W,Hu X,Ballantyne C,Hoodgeveen RC,Tsai MY,Browne A,Budoff MJ", + "auth_pos": 8, + "meshterms": "Humans, Female, Male, Prospective Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Factors, Lipoprotein(a), Atherosclerosis*, Atherosclerosis/epidemiology, Heart Disease Risk Factors, Diabetes Mellitus*, Risk Assessment, Humans, Female, Male, Prospective Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Factors, Lipoprotein(a), Atherosclerosis*, Atherosclerosis/epidemiology, Heart Disease Risk Factors, Diabetes Mellitus*, Risk Assessment, Humans, Female, Male, Prospective Studies, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Risk Factors, Lipoprotein(a), Atherosclerosis*, Atherosclerosis/epidemiology, Heart Disease Risk Factors, Diabetes Mellitus*, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1745, + "user_id": 1811967433, + "artical_title": "Prediction of the development of new coronary atherosclerotic plaques with radiomics.", + "pmid": 38378314, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-04-30", + "author": "Lee SE,Hong Y,Hong J,Jung J,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Cademartiri F,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Maffei E,Marques H,Gonçalves PA,Pontone G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 8, + "meshterms": "Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography, Humans, Male, Plaque, Atherosclerotic*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Female, Predictive Value of Tests*, Computed Tomography Angiography*, Middle Aged, Coronary Angiography*, Aged, Registries*, Coronary Vessels*, Coronary Vessels/diagnostic imaging, Time Factors, Prospective Studies, Disease Progression, Risk Factors, Risk Assessment, Radiographic Image Interpretation, Computer-Assisted, Prognosis, Reproducibility of Results, Multidetector Computed Tomography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1746, + "user_id": 1811967433, + "artical_title": "A Leaky False Pouch: Left Ventricle Pseudoaneurysm with Active Hemopericardium Detected on Cardiac Computed Tomography Angiography.", + "pmid": 38686315, + "journal_name": "Clinical Medicine Insights. Cardiology", + "date": "2024-04-30", + "author": "Barforoshi S,Shekar C,Yu Z,Liu E,Manubolu V,Budoff MJ,Roy SK", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1747, + "user_id": 1811967433, + "artical_title": "Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood.", + "pmid": 38699360, + "journal_name": "medRxiv : the preprint server for health sciences", + "date": "2024-05-03", + "author": "Jakubek YA,Ma X,Stilp AM,Yu F,Bacon J,Wong JW,Aguet F,Ardlie K,Arnett D,Barnes K,Bis JC,Blackwell T,Becker LC,Boerwinkle E,Bowler RP,Budoff MJ,Carson AP,Chen J,Cho MH,Coresh J,Cox N,de Vries PS,DeMeo DL,Fardo DW,Fornage M,Guo X,Hall ME,Heard-Costa N,Hidalgo B,Irvin MR,Johnson AD,Kenny EE,Levy D,Li Y,Lima JA,Liu Y,Loos RJF,Machiela MJ,Mathias RA,Mitchell BD,Murabito J,Mychaleckyj JC,North K,Orchard P,Parker SC,Pershad Y,Peyser PA,Pratte KA,Psaty BM,Raffield LM,Redline S,Rich SS,Rotter JI,Shah SJ,Smith JA,Smith AP,Smith A,Taub M,Tiwari HK,Tracy R,Tuftin B,Bick AG,Sankaran VG,Reiner AP,Scheet P,Auer PL", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1748, + "user_id": 1811967433, + "artical_title": "Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis.", + "pmid": 37567791, + "journal_name": "Nutrition, metabolism, and cardiovascular diseases : NMCD", + "date": "2024-05-07", + "author": "Vazirian F,Sadeghi M,Kelesidis T,Budoff MJ,Zandi Z,Samadi S,Mohammadpour AH", + "auth_pos": 4, + "meshterms": "Humans, Lipoprotein(a)*, Lipoprotein(a)/blood, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Vascular Calcification*, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/diagnosis, Biomarkers*, Biomarkers/blood, Risk Assessment, Male, Female, Asymptomatic Diseases*, Predictive Value of Tests*, Middle Aged, Aged, Adult, Incidence, Prognosis, Risk Factors, Up-Regulation, Humans, Lipoprotein(a)*, Lipoprotein(a)/blood, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Vascular Calcification*, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/diagnosis, Biomarkers*, Biomarkers/blood, Risk Assessment, Male, Female, Asymptomatic Diseases*, Predictive Value of Tests*, Middle Aged, Aged, Adult, Incidence, Prognosis, Risk Factors, Up-Regulation, Humans, Lipoprotein(a)*, Lipoprotein(a)/blood, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Vascular Calcification*, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/diagnosis, Biomarkers*, Biomarkers/blood, Risk Assessment, Male, Female, Asymptomatic Diseases*, Predictive Value of Tests*, Middle Aged, Aged, Adult, Incidence, Prognosis, Risk Factors, Up-Regulation, Humans, Lipoprotein(a)*, Lipoprotein(a)/blood, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/epidemiology, Vascular Calcification*, Vascular Calcification/blood, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/diagnosis, Biomarkers*, Biomarkers/blood, Risk Assessment, Male, Female, Asymptomatic Diseases*, Predictive Value of Tests*, Middle Aged, Aged, Adult, Incidence, Prognosis, Risk Factors, Up-Regulation", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1749, + "user_id": 1811967433, + "artical_title": "Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.", + "pmid": 38527383, + "journal_name": "Atherosclerosis", + "date": "2024-05-13", + "author": "Berlot AA,Fu X,Shea MK,Tracy R,Budoff M,Kim RS,Naveed M,Booth SL,Kizer JR,Bortnick AE", + "auth_pos": 5, + "meshterms": "Humans, Extracellular Matrix Proteins*, Extracellular Matrix Proteins/blood, Calcium-Binding Proteins*, Calcium-Binding Proteins/blood, Male, Female, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/blood, Vascular Calcification/epidemiology, Incidence, Aged, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/ethnology, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnostic imaging, Disease Progression*, Aortic Diseases*, Aortic Diseases/ethnology, Aortic Diseases/blood, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, United States, United States/epidemiology, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Aorta, Thoracic/pathology, Time Factors, Biomarkers, Biomarkers/blood, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Risk Factors, Prospective Studies, Phosphorylation, Computed Tomography Angiography, Humans, Extracellular Matrix Proteins*, Extracellular Matrix Proteins/blood, Calcium-Binding Proteins*, Calcium-Binding Proteins/blood, Male, Female, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/blood, Vascular Calcification/epidemiology, Incidence, Aged, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/ethnology, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnostic imaging, Disease Progression*, Aortic Diseases*, Aortic Diseases/ethnology, Aortic Diseases/blood, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, United States, United States/epidemiology, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Aorta, Thoracic/pathology, Time Factors, Biomarkers, Biomarkers/blood, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Risk Factors, Prospective Studies, Phosphorylation, Computed Tomography Angiography, Humans, Extracellular Matrix Proteins*, Extracellular Matrix Proteins/blood, Calcium-Binding Proteins*, Calcium-Binding Proteins/blood, Male, Female, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/blood, Vascular Calcification/epidemiology, Incidence, Aged, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/ethnology, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnostic imaging, Disease Progression*, Aortic Diseases*, Aortic Diseases/ethnology, Aortic Diseases/blood, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, United States, United States/epidemiology, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Aorta, Thoracic/pathology, Time Factors, Biomarkers, Biomarkers/blood, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Risk Factors, Prospective Studies, Phosphorylation, Computed Tomography Angiography, Humans, Extracellular Matrix Proteins*, Extracellular Matrix Proteins/blood, Calcium-Binding Proteins*, Calcium-Binding Proteins/blood, Male, Female, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/blood, Vascular Calcification/epidemiology, Incidence, Aged, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/ethnology, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnostic imaging, Disease Progression*, Aortic Diseases*, Aortic Diseases/ethnology, Aortic Diseases/blood, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, United States, United States/epidemiology, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Aorta, Thoracic/pathology, Time Factors, Biomarkers, Biomarkers/blood, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Risk Factors, Prospective Studies, Phosphorylation, Computed Tomography Angiography, Humans, Extracellular Matrix Proteins*, Extracellular Matrix Proteins/blood, Calcium-Binding Proteins*, Calcium-Binding Proteins/blood, Male, Female, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Vascular Calcification/blood, Vascular Calcification/epidemiology, Incidence, Aged, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/ethnology, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnostic imaging, Disease Progression*, Aortic Diseases*, Aortic Diseases/ethnology, Aortic Diseases/blood, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, United States, United States/epidemiology, Aged, 80 and over, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Aorta, Thoracic/pathology, Time Factors, Biomarkers, Biomarkers/blood, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Risk Factors, Prospective Studies, Phosphorylation, Computed Tomography Angiography", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1750, + "user_id": 1811967433, + "artical_title": "Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a).", + "pmid": 38741703, + "journal_name": "American journal of preventive cardiology", + "date": "2024-05-14", + "author": "Razavi AC,Richardson LC,Coronado F,Dzaye O,Bhatia HS,Mehta A,Quyyumi AA,Vaccarino V,Budoff MJ,Nasir K,Tsimikas S,Whelton SP,Blaha MJ,Blumenthal RS,Sperling LS", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1751, + "user_id": 1811967433, + "artical_title": "Development and validation of a deep-learning model to predict 10-year atherosclerotic cardiovascular disease risk from retinal images using the UK Biobank and EyePACS 10K datasets.", + "pmid": 38765618, + "journal_name": "Cardiovascular digital health journal", + "date": "2024-05-20", + "author": "Vaghefi E,Squirrell D,Yang S,An S,Xie L,Durbin MK,Hou H,Marshall J,Shreibati J,McConnell MV,Budoff M", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1752, + "user_id": 1811967433, + "artical_title": "Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review.", + "pmid": 38777513, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-05-23", + "author": "Nielsen RV,Fuster V,Bundgaard H,Fuster JJ,Johri AM,Kofoed KF,Douglas PS,Diederichsen A,Shapiro MD,Nicholls SJ,Nordestgaard BG,Lindholt JS,MacRae C,Yuan C,Newby DE,Urbina EM,Bergström G,Ridderstråle M,Budoff MJ,Bøttcher M,Raitakari OT,Hansen TH,Näslund U,Sillesen H,Eldrup N,Ibanez B", + "auth_pos": 19, + "meshterms": "Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood, Humans, Atherosclerosis*, Atherosclerosis/diagnosis, Early Diagnosis*, Precision Medicine*, Precision Medicine/methods, Biomarkers, Biomarkers/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1753, + "user_id": 1811967433, + "artical_title": "Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.", + "pmid": 38519739, + "journal_name": "Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA", + "date": "2024-05-29", + "author": "Li D,Mao SS,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Bone Density*, Bone Density/physiology, Female, Male, Thoracic Vertebrae*, Thoracic Vertebrae/diagnostic imaging, Thoracic Vertebrae/physiopathology, Thoracic Vertebrae/injuries, Osteoporotic Fractures*, Osteoporotic Fractures/physiopathology, Osteoporotic Fractures/ethnology, Osteoporotic Fractures/diagnostic imaging, Osteoporotic Fractures/etiology, Aged, Spinal Fractures*, Spinal Fractures/physiopathology, Spinal Fractures/ethnology, Spinal Fractures/diagnostic imaging, Spinal Fractures/epidemiology, Spinal Fractures/etiology, Hip Fractures*, Hip Fractures/physiopathology, Hip Fractures/ethnology, Hip Fractures/diagnostic imaging, Hip Fractures/etiology, Hip Fractures/epidemiology, Middle Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Cancellous Bone*, Cancellous Bone/diagnostic imaging, Cancellous Bone/physiopathology, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Osteoporosis, Osteoporosis/ethnology, Osteoporosis/physiopathology, Osteoporosis/diagnostic imaging, Risk Assessment, Risk Assessment/methods, Incidence", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1754, + "user_id": 1811967433, + "artical_title": "Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.", + "pmid": 38358333, + "journal_name": "Cancer", + "date": "2024-05-30", + "author": "Wu S,Rhee JW,Iukuridze A,Bosworth A,Chen S,Atencio L,Manubolu V,Bhandari R,Jamal F,Mei M,Herrera A,Rodriguez F,Forman S,Nakamura R,Wong FL,Budoff M,Armenian SH", + "auth_pos": 16, + "meshterms": "Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence, Humans, Male, Female, Middle Aged, Hematopoietic Stem Cell Transplantation*, Hematopoietic Stem Cell Transplantation/adverse effects, Adult, Retrospective Studies, Aged, Lymphoma*, Lymphoma/therapy, Transplantation, Autologous*, Young Adult, Adolescent, Cardiovascular Diseases*, Cardiovascular Diseases/etiology, Cardiovascular Diseases/epidemiology, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/pathology, Coronary Vessels/metabolism, Risk Factors, Calcium, Calcium/metabolism, Coronary Artery Disease, Coronary Artery Disease/epidemiology, Incidence", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1755, + "user_id": 1811967433, + "artical_title": "Uncovering Subclinical Atherosclerosis: Assessment of Low-Attenuation Plaques in Low Risk Group.", + "pmid": 38819337, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-05-31", + "author": "Erbay MI,Susarla S,Lee D,Pourafkari L,Kinninger A,Bagheri M,Hamidi H,Khan MA,Bishay RN,Budoff MJ", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1756, + "user_id": 1811967433, + "artical_title": "Impact of Atherosclerosis Imaging-Quantitative Computed Tomography on Diagnostic Certainty, Downstream Testing, Coronary Revascularization and Medical Therapy: The CERTAIN Study.", + "pmid": 38270472, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2024-05-31", + "author": "Nurmohamed NS,Cole JH,Budoff M,Karlsberg RP,Gupta H,Sullenberger LE,Quesada CG,Rahban H,Woods KM,Uzzilia JR,Purga SL,Aquino M,Hoffmann U,Min JK,Earls JP,Choi AD", + "auth_pos": 3, + "meshterms": "Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Prospective Studies, Aged, Cross-Over Studies*, Myocardial Revascularization, Tomography, X-Ray Computed, Tomography, X-Ray Computed/methods", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1757, + "user_id": 1811967433, + "artical_title": "Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification.", + "pmid": 38817323, + "journal_name": "Nature cardiovascular research", + "date": "2024-05-31", + "author": "de Vries PS,Conomos MP,Singh K,Nicholson CJ,Jain D,Hasbani NR,Jiang W,Lee S,Cardenas CLL,Lutz SM,Wong D,Guo X,Yao J,Young EP,Tcheandjieu C,Hilliard AT,Bis JC,Bielak LF,Brown MR,Musharoff S,Clarke SL,Terry JG,Palmer ND,Yanek LR,Xu H,Heard-Costa N,Wessel J,Selvaraj MS,Li RH,Sun X,Turner AW,Stilp AM,Khan A,Newman AB,Rasheed A,Freedman BI,Kral BG,McHugh CP,Hodonsky C,Saleheen D,Herrington DM,Jacobs DR,Nickerson DA,Boerwinkle E,Wang FF,Heiss G,Jun G,Kinney GL,Sigurslid HH,Doddapaneni H,Hall IM,Bensenor IM,Broome J,Crapo JD,Wilson JG,Smith JA,Blangero J,Vargas JD,Mosquera JV,Smith JD,Viaud-Martinez KA,Ryan KA,Young KA,Taylor KD,Lange LA,Emery LS,Bittencourt MS,Budoff MJ,Montasser ME,Yu M,Mahaney MC,Mahamdeh MS,Fornage M,Franceschini N,Lotufo PA,Natarajan P,Wong Q,Mathias RA,Gibbs RA,Do R,Mehran R,Tracy RP,Kim RW,Nelson SC,Damrauer SM,Kardia SLR,Rich SS,Fuster V,Napolioni V,Zhao W,Tian W,Yin X,Min YI,Manning AK,Peloso G,Kelly TN,O'Donnell CJ,Morrison AC,Curran JE,Zapol WM,Bowden DW,Becker LC,Correa A,Mitchell BD,Psaty BM,Carr JJ,Pereira AC,Assimes TL,Stitziel NO,Hokanson JE,Laurie CA,Rotter JI,Vasan RS,Post WS,Peyser PA,Miller CL,Malhotra R", + "auth_pos": 68, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1758, + "user_id": 1811967433, + "artical_title": "The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline.", + "pmid": 38593157, + "journal_name": "Journal of the American Society of Nephrology : JASN", + "date": "2024-06-03", + "author": "Wang M,Tang WHW,Li XS,de Oliveira Otto MC,Lee Y,Lemaitre RN,Fretts A,Nemet I,Sotoodehnia N,Sitlani CM,Budoff M,DiDonato JA,Wang Z,Bansal N,Shlipak MG,Psaty BM,Siscovick DS,Sarnak MJ,Mozaffarian D,Hazen SL", + "auth_pos": 11, + "meshterms": "Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged, Methylamines*, Methylamines/metabolism, Humans, Gastrointestinal Microbiome*, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/metabolism, Male, Female, Glomerular Filtration Rate, Kidney, Kidney/metabolism, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1759, + "user_id": 1811967433, + "artical_title": "CT-derived pectoralis composition and incident pneumonia hospitalization using fully automated deep-learning algorithm: multi-ethnic study of atherosclerosis.", + "pmid": 37951855, + "journal_name": "European radiology", + "date": "2024-06-11", + "author": "Ibad HA,Hathaway QA,Bluemke DA,Kasaeian A,Klein JG,Budoff MJ,Barr RG,Allison M,Post WS,Lima JAC,Demehri S", + "auth_pos": 6, + "meshterms": "Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging, Humans, Female, Deep Learning*, Male, Aged, Tomography, X-Ray Computed*, Tomography, X-Ray Computed/methods, Pneumonia*, Pneumonia/diagnostic imaging, Hospitalization*, Hospitalization/statistics & numerical data, Pectoralis Muscles*, Pectoralis Muscles/diagnostic imaging, Algorithms, Pulmonary Disease, Chronic Obstructive, Pulmonary Disease, Chronic Obstructive/diagnostic imaging, Aged, 80 and over, Middle Aged, Incidence, Atherosclerosis, Atherosclerosis/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1760, + "user_id": 1811967433, + "artical_title": "The impact of carbohydrate restriction-induced elevations in low-density lipoprotein cholesterol on progression of coronary atherosclerosis: the ketogenic diet trial study design.", + "pmid": 38861193, + "journal_name": "Coronary artery disease", + "date": "2024-06-11", + "author": "Javier DAR,Manubolu VS,Norwitz NG,Kinninger A,Aldana-Bitar J,Ghanem A,Ahmad K,Vicuna WD,Hamidi H,Bagheri M,Elsayed T,Villanueva B,Ichikawa K,Flores F,Hamal S,Feldman D,Budoff MJ", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1761, + "user_id": 1811967433, + "artical_title": "Preventive medicine and cardiac CT- Their move into mainstream medicine.", + "pmid": 38762050, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-06-14", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "Humans, Preventive Medicine*, Preventive Medicine/methods, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/diagnostic imaging, Cardiovascular Diseases/therapy, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1762, + "user_id": 1811967433, + "artical_title": "Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.", + "pmid": 38547955, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-06-14", + "author": "Lakshmanan S,Wei J,Cook-Wiens G,Pepine CJ,Handberg EM,Shaw LJ,Budoff M,Merz CNB", + "auth_pos": 7, + "meshterms": "Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology, Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology, Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology, Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology, Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology, Humans, Female, Coronary Angiography*, Middle Aged, Aged, Computed Tomography Angiography*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/therapy, Risk Assessment, Prospective Studies, Predictive Value of Tests*, Myocardial Ischemia, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/diagnosis, Risk Factors, Heart Disease Risk Factors, Sex Factors, Time Factors, Prognosis, Women's Health, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1763, + "user_id": 1811967433, + "artical_title": "Colchicine and plaque: A focus on atherosclerosis imaging.", + "pmid": 38423236, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-06-14", + "author": "Aldana-Bitar J,Golub IS,Moore J,Krishnan S,Verghese D,Manubolu VS,Benzing T,Ichikawa K,Hamal S,Kianoush S,Anderson LR,Ramirez NR,Leipsic JA,Karlsberg RP,Budoff MJ", + "auth_pos": 15, + "meshterms": "Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Colchicine*, Colchicine/therapeutic use, Humans, Plaque, Atherosclerotic*, Plaque, Atherosclerotic/drug therapy, Anti-Inflammatory Agents*, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents/pharmacology, Atherosclerosis, Atherosclerosis/drug therapy, Atherosclerosis/diagnostic imaging, Atherosclerosis/diagnosis, Predictive Value of Tests, Animals, Treatment Outcome, Coronary Artery Disease, Coronary Artery Disease/drug therapy, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1764, + "user_id": 1811967433, + "artical_title": "Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.", + "pmid": 38423237, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-06-14", + "author": "Krishnan S,Aldana-Bitar J,Golub I,Ichikawa K,Shabir A,Bagheri M,Hamidi H,Benzing T,Kianoush S,Budoff MJ", + "auth_pos": 10, + "meshterms": "Humans, Testosterone*, Testosterone/adverse effects, Testosterone/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Male, Hypogonadism*, Hypogonadism/drug therapy, Hypogonadism/epidemiology, Hypogonadism/blood, Risk Assessment, Heart Disease Risk Factors*, Hormone Replacement Therapy*, Hormone Replacement Therapy/adverse effects, Aged, Age Factors, Middle Aged, Treatment Outcome, Risk Factors, Biomarkers, Biomarkers/blood, Humans, Testosterone*, Testosterone/adverse effects, Testosterone/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Male, Hypogonadism*, Hypogonadism/drug therapy, Hypogonadism/epidemiology, Hypogonadism/blood, Risk Assessment, Heart Disease Risk Factors*, Hormone Replacement Therapy*, Hormone Replacement Therapy/adverse effects, Aged, Age Factors, Middle Aged, Treatment Outcome, Risk Factors, Biomarkers, Biomarkers/blood, Humans, Testosterone*, Testosterone/adverse effects, Testosterone/therapeutic use, Cardiovascular Diseases*, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Male, Hypogonadism*, Hypogonadism/drug therapy, Hypogonadism/epidemiology, Hypogonadism/blood, Risk Assessment, Heart Disease Risk Factors*, Hormone Replacement Therapy*, Hormone Replacement Therapy/adverse effects, Aged, Age Factors, Middle Aged, Treatment Outcome, Risk Factors, Biomarkers, Biomarkers/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1765, + "user_id": 1811967433, + "artical_title": "Innovations in cardiac computed tomography: Imaging in coronary artery disease.", + "pmid": 38754532, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-06-14", + "author": "Manubolu VS,Ichikawa K,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/therapy, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Predictive Value of Tests*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology, Prognosis, Plaque, Atherosclerotic, Plaque, Atherosclerotic/diagnostic imaging, Diffusion of Innovation, Risk Assessment, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1766, + "user_id": 1811967433, + "artical_title": "Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.", + "pmid": 37532595, + "journal_name": "Atherosclerosis", + "date": "2024-06-15", + "author": "Barforoshi S,Manubolu VS,Wang R,McClelland RL,Budoff MJ", + "auth_pos": 5, + "meshterms": "Humans, Male, Female, Middle Aged, Aged, Incidence, Ankle Brachial Index*, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Risk Assessment, Predictive Value of Tests*, United States, United States/epidemiology, Coronary Artery Disease, Coronary Artery Disease/mortality, Coronary Artery Disease/blood, Coronary Artery Disease/epidemiology, Risk Factors, Vascular Calcification, Vascular Calcification/mortality, Vascular Calcification/diagnostic imaging, Vascular Calcification/blood, Vascular Calcification/epidemiology, Fasting, Fasting/blood, Aged, 80 and over, Time Factors, Atherosclerosis, Atherosclerosis/blood, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetes Mellitus/blood, Humans, Male, Female, Middle Aged, Aged, Incidence, Ankle Brachial Index*, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Risk Assessment, Predictive Value of Tests*, United States, United States/epidemiology, Coronary Artery Disease, Coronary Artery Disease/mortality, Coronary Artery Disease/blood, Coronary Artery Disease/epidemiology, Risk Factors, Vascular Calcification, Vascular Calcification/mortality, Vascular Calcification/diagnostic imaging, Vascular Calcification/blood, Vascular Calcification/epidemiology, Fasting, Fasting/blood, Aged, 80 and over, Time Factors, Atherosclerosis, Atherosclerosis/blood, Diabetes Mellitus, Diabetes Mellitus/epidemiology, Diabetes Mellitus/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1767, + "user_id": 1811967433, + "artical_title": "Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.", + "pmid": 38889215, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2024-06-18", + "author": "Marrero N,Jha K,Razavi AC,Boakye E,Anchouche K,Dzaye O,Budoff MJ,Tsai MY,Shah SJ,Rotter JI,Guo X,Yao J,Blumenthal RS,Thanassoulis G,Post WS,Blaha MJ,Whelton SP", + "auth_pos": 7, + "meshterms": "Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/blood, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/diagnostic imaging, Female, Lipoprotein(a)*, Lipoprotein(a)/blood, Male, Middle Aged, Cholesterol, LDL*, Cholesterol, LDL/blood, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Calcinosis*, Calcinosis/blood, Calcinosis/diagnostic imaging, Calcinosis/diagnosis, Calcinosis/epidemiology, Calcinosis/ethnology, Severity of Illness Index*, Aged, Biomarkers*, Biomarkers/blood, Risk Factors, Risk Assessment, Incidence, United States, United States/epidemiology, Aged, 80 and over, Predictive Value of Tests, Time Factors, Prospective Studies, Proportional Hazards Models, Tomography, X-Ray Computed, Prognosis", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1768, + "user_id": 1811967433, + "artical_title": "The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.", + "pmid": 38913124, + "journal_name": "Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA", + "date": "2024-06-24", + "author": "Barzilay JI,Buzkova P,Bielinski SJ,Cotch MF,Kestenbaum B,Austin TR,Carbone L,Mukamal KJ,Budoff MJ", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1769, + "user_id": 1811967433, + "artical_title": "Hemodynamic significance of coronary anomalies: Computed tomography-based fractional flow reserve (CT-FFR) as an Adjudicator.", + "pmid": 38652086, + "journal_name": "Coronary artery disease", + "date": "2024-06-25", + "author": "Golub I,Benzing T,Kianoush S,Krishnan S,Ichikawa K,Budoff MJ", + "auth_pos": 6, + "meshterms": "Humans, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Coronary Vessel Anomalies*, Coronary Vessel Anomalies/physiopathology, Coronary Vessel Anomalies/diagnostic imaging, Coronary Vessel Anomalies/complications, Hemodynamics, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology, Predictive Value of Tests, Humans, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Coronary Vessel Anomalies*, Coronary Vessel Anomalies/physiopathology, Coronary Vessel Anomalies/diagnostic imaging, Coronary Vessel Anomalies/complications, Hemodynamics, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology, Predictive Value of Tests, Humans, Fractional Flow Reserve, Myocardial*, Fractional Flow Reserve, Myocardial/physiology, Computed Tomography Angiography*, Computed Tomography Angiography/methods, Coronary Angiography*, Coronary Angiography/methods, Coronary Vessel Anomalies*, Coronary Vessel Anomalies/physiopathology, Coronary Vessel Anomalies/diagnostic imaging, Coronary Vessel Anomalies/complications, Hemodynamics, Coronary Vessels, Coronary Vessels/diagnostic imaging, Coronary Vessels/physiopathology, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1770, + "user_id": 1811967433, + "artical_title": "Thoracic versus coronary calcification for atherosclerotic cardiovascular disease events prediction.", + "pmid": 38627022, + "journal_name": "Heart (British Cardiac Society)", + "date": "2024-06-26", + "author": "Ichikawa K,Rui W,McClelland RL,Manubolu VS,Susarla S,Lee D,Pourafkari L,Fazlalizadeh H,Bitar JA,Robin R,Kinninger A,Roy S,Post WS,Budoff M", + "auth_pos": 14, + "meshterms": "Humans, Male, Female, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnosis, Prognosis, Middle Aged, Risk Assessment, Risk Assessment/methods, Computed Tomography Angiography, Predictive Value of Tests, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Risk Factors, Aortic Diseases, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, Aortic Diseases/diagnosis, ROC Curve, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiac-Gated Imaging Techniques, United States, United States/epidemiology, Electrocardiography, Incidence, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Atherosclerosis, Atherosclerosis/epidemiology, Atherosclerosis/diagnosis, Humans, Male, Female, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnosis, Prognosis, Middle Aged, Risk Assessment, Risk Assessment/methods, Computed Tomography Angiography, Predictive Value of Tests, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Risk Factors, Aortic Diseases, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, Aortic Diseases/diagnosis, ROC Curve, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiac-Gated Imaging Techniques, United States, United States/epidemiology, Electrocardiography, Incidence, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Atherosclerosis, Atherosclerosis/epidemiology, Atherosclerosis/diagnosis, Humans, Male, Female, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnosis, Prognosis, Middle Aged, Risk Assessment, Risk Assessment/methods, Computed Tomography Angiography, Predictive Value of Tests, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Risk Factors, Aortic Diseases, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, Aortic Diseases/diagnosis, ROC Curve, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiac-Gated Imaging Techniques, United States, United States/epidemiology, Electrocardiography, Incidence, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Atherosclerosis, Atherosclerosis/epidemiology, Atherosclerosis/diagnosis, Humans, Male, Female, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnosis, Prognosis, Middle Aged, Risk Assessment, Risk Assessment/methods, Computed Tomography Angiography, Predictive Value of Tests, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Risk Factors, Aortic Diseases, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, Aortic Diseases/diagnosis, ROC Curve, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiac-Gated Imaging Techniques, United States, United States/epidemiology, Electrocardiography, Incidence, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Atherosclerosis, Atherosclerosis/epidemiology, Atherosclerosis/diagnosis, Humans, Male, Female, Aged, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/epidemiology, Coronary Artery Disease/diagnosis, Prognosis, Middle Aged, Risk Assessment, Risk Assessment/methods, Computed Tomography Angiography, Predictive Value of Tests, Aorta, Thoracic, Aorta, Thoracic/diagnostic imaging, Risk Factors, Aortic Diseases, Aortic Diseases/diagnostic imaging, Aortic Diseases/epidemiology, Aortic Diseases/diagnosis, ROC Curve, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiac-Gated Imaging Techniques, United States, United States/epidemiology, Electrocardiography, Incidence, Coronary Angiography, Coronary Angiography/methods, Tomography, X-Ray Computed, Atherosclerosis, Atherosclerosis/epidemiology, Atherosclerosis/diagnosis", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1771, + "user_id": 1811967433, + "artical_title": "Testosterone Repletement: Is it the TRAVERSE Trial or a Travesty?", + "pmid": 38938483, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Budoff MJ", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1772, + "user_id": 1811967433, + "artical_title": "Vitamins to Treat Heart Disease: Can Coronary Calcium Progression Show Us the Path Forward?", + "pmid": 38938714, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Budoff M", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1773, + "user_id": 1811967433, + "artical_title": "Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons ?65 Years of Age.", + "pmid": 38939371, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Razavi AC,Dzaye O,Michos ED,Budoff MJ,Allen NB,Lima JAC,Polak JF,Post WS,Nasir K,Blumenthal RS,Sperling LS,Blaha MJ,Whelton SP", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1774, + "user_id": 1811967433, + "artical_title": "AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 38947043, + "journal_name": "Research square", + "date": "2024-07-01", + "author": "Naghavi M,Reeves A,Atlas K,Zhang C,Atlas T,Henschke C,Yankelevitz D,Budoff M,Li D,Roy S,Nasir K,Narula J,Kakadiaris I,Molloi S,Fayad Z,Maron D,McConnell M,Williams K,Levy D,Wong N", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1775, + "user_id": 1811967433, + "artical_title": "Improving the prognostic impact of computed tomography coronary angiography with physical activity, exercise and fitness.", + "pmid": 38582660, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-07-02", + "author": "Slipczuk L,Lavie CJ,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Coronary Angiography*, Computed Tomography Angiography*, Predictive Value of Tests*, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Exercise*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiorespiratory Fitness, Humans, Coronary Angiography*, Computed Tomography Angiography*, Predictive Value of Tests*, Prognosis, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Exercise*, Coronary Vessels, Coronary Vessels/diagnostic imaging, Cardiorespiratory Fitness", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1776, + "user_id": 1811967433, + "artical_title": "AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CAC) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: The multi-ethnic study of atherosclerosis.", + "pmid": 38653606, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-07-02", + "author": "Naghavi M,Yankelevitz D,Reeves AP,Budoff MJ,Li D,Atlas K,Zhang C,Atlas TL,Lirette S,Wasserthal J,Roy SK,Henschke C,Wong ND,Defilippi C,Heckbert SR,Greenland P", + "auth_pos": 4, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results, Humans, Atrial Fibrillation*, Atrial Fibrillation/ethnology, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/blood, Female, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Male, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Predictive Value of Tests*, Risk Factors, Risk Assessment, Aged, 80 and over, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Biomarkers*, Biomarkers/blood, Time Factors, Prognosis, United States, Coronary Angiography*, Artificial Intelligence, Computed Tomography Angiography, Heart Atria, Heart Atria/diagnostic imaging, Radiographic Image Interpretation, Computer-Assisted, Asymptomatic Diseases, Incidence, Reproducibility of Results", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1777, + "user_id": 1811967433, + "artical_title": "AI-enabled cardiac chambers volumetry in coronary artery calcium scans (AI-CAC) predicts heart failure and outperforms NT-proBNP: The multi-ethnic study of Atherosclerosis.", + "pmid": 38664073, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-07-02", + "author": "Naghavi M,Reeves A,Budoff M,Li D,Atlas K,Zhang C,Atlas T,Roy SK,Henschke CI,Wong ND,Defilippi C,Levy D,Yankelevitz DF", + "auth_pos": 3, + "meshterms": "Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases, Humans, Female, Male, Peptide Fragments*, Peptide Fragments/blood, Natriuretic Peptide, Brain*, Natriuretic Peptide, Brain/blood, Aged, Heart Failure*, Heart Failure/ethnology, Heart Failure/diagnostic imaging, Predictive Value of Tests*, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/ethnology, Middle Aged, Risk Factors, Biomarkers*, Biomarkers/blood, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/ethnology, Risk Assessment, Prognosis, United States, Time Factors, Incidence, Aged, 80 and over, Computed Tomography Angiography*, Artificial Intelligence*, Coronary Angiography*, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Multidetector Computed Tomography, Asymptomatic Diseases", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1778, + "user_id": 1811967433, + "artical_title": "Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.", + "pmid": 38954413, + "journal_name": "JAMA network open", + "date": "2024-07-02", + "author": "Hashemi L,Marijic Buljubasic A,Budoff MJ,Copeland LA,Jackson NJ,Jasuja GK,Gornbein J,Reue K", + "auth_pos": 3, + "meshterms": "Humans, Metabolic Syndrome*, Metabolic Syndrome/epidemiology, Transgender Persons*, Transgender Persons/statistics & numerical data, Male, Female, Veterans*, Veterans/statistics & numerical data, Retrospective Studies, Adult, Testosterone*, Testosterone/therapeutic use, Testosterone/blood, Longitudinal Studies, Middle Aged, Gender Dysphoria*, Gender Dysphoria/drug therapy, Gender Dysphoria/epidemiology, Estradiol, Estradiol/blood, Estradiol/therapeutic use, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1779, + "user_id": 1811967433, + "artical_title": "Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000.", + "pmid": 38385932, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-07-04", + "author": "Razavi AC,Shaw LJ,Berman DS,Budoff MJ,Wong ND,Vaccarino V,van Assen M,De Cecco CN,Quyyumi AA,Mehta A,Muntner P,Miedema MD,Rozanski A,Rumberger JA,Nasir K,Blumenthal RS,Sperling LS,Mortensen MB,Whelton SP,Blaha MJ,Dzaye O", + "auth_pos": 4, + "meshterms": "Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors, Humans, Female, Male, Vascular Calcification*, Vascular Calcification/diagnostic imaging, Vascular Calcification/mortality, Aged, Coronary Artery Disease*, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/mortality, Coronary Artery Disease/therapy, Middle Aged, Risk Assessment, Risk Factors, Time Factors, Predictive Value of Tests*, Diabetes Mellitus*, Diabetes Mellitus/epidemiology, Diabetes Mellitus/mortality, Prognosis, Coronary Angiography*, Computed Tomography Angiography, Asymptomatic Diseases, Severity of Illness Index, Coronary Vessels, Coronary Vessels/diagnostic imaging, Heart Disease Risk Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1780, + "user_id": 1811967433, + "artical_title": "Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men.", + "pmid": 38974987, + "journal_name": "Journal of the Endocrine Society", + "date": "2024-07-08", + "author": "Lake JE,Feng H,Hyatt AN,Miao H,Debroy P,Funderburg N,Ailstock K,Dobs A,Haberlen S,Magnani JW,Margolick JB,McGowan K,Palella FJ,Witt MD,Bhasin S,Budoff MJ,Post WS,Brown TT", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1781, + "user_id": 1811967433, + "artical_title": "Training and Verification Requirements for Interpretation of Cardiac CT and MRI: Expert Panel Narrative Review.", + "pmid": 38984783, + "journal_name": "AJR. American journal of roentgenology", + "date": "2024-07-10", + "author": "Rajiah PS,Budoff M,Ghoshhajra B,Morris MF,Ocazionez-Trujillo D,Ordovas K,Patel AR,Ranganath P,Vargas D,Woodard PK,Choi AD", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1782, + "user_id": 1811967433, + "artical_title": "Regression and stabilization of atherogenic plaques.", + "pmid": 37494987, + "journal_name": "Trends in cardiovascular medicine", + "date": "2024-07-13", + "author": "Aldana-Bitar J,Bhatt DL,Budoff MJ", + "auth_pos": 3, + "meshterms": "Humans, Plaque, Atherosclerotic*, Atherosclerosis, Atherosclerosis/diagnostic imaging, Disease Progression, Predictive Value of Tests, Treatment Outcome, Humans, Plaque, Atherosclerotic*, Atherosclerosis, Atherosclerosis/diagnostic imaging, Disease Progression, Predictive Value of Tests, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1783, + "user_id": 1811967433, + "artical_title": "Comparison of Coronary Artery Calcium and Quantitative Coronary Plaque in Predicting Obstructive Coronary Artery Disease: Subgroup Analysis of the CLARIFY Study.", + "pmid": 39006468, + "journal_name": "Heart international", + "date": "2024-07-15", + "author": "Manubolu VS,Dahal S,Lakshmanan S,Crabtree T,Kinninger A,Shafter AM,Bitar JA,Verghese D,Alalawi L,Dailing C,Earls JP,Budoff MJ", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1784, + "user_id": 1811967433, + "artical_title": "Exploring the relationship between epicardial fat and coronary plaque burden and characteristics: insights from cardiac ct imaging.", + "pmid": 39008195, + "journal_name": "The international journal of cardiovascular imaging", + "date": "2024-07-15", + "author": "Manubolu VS,Lu JY,Montano B,Kininger A,Bainiwal J,Verghese D,Alalawi L,Bitar JA,Pourafkari L,Fazlalizadeh H,Ichikawa K,Khadije A,Denise J,Ghanem A,Hamal S,Mao S,Budoff MJ,Roy SK", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1785, + "user_id": 1811967433, + "artical_title": "Lipoprotein(a) and Coronary Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida.", + "pmid": 39012945, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2024-07-16", + "author": "Mszar R,Cainzos-Achirica M,Valero-Elizondo J,Lahan S,Al-Kindi SG,Quispe R,Ali SS,Arias L,Saxena A,Shah SH,Cury RC,Budoff MJ,Blaha MJ,Shapiro MD,Sharma G,Santos RD,Blankstein R,Feldman T,Fialkow J,Nasir K", + "auth_pos": 12, + "meshterms": "Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood, Humans, Middle Aged, Female, Male, Plaque, Atherosclerotic*, Lipoprotein(a)*, Lipoprotein(a)/blood, Florida, Florida/epidemiology, Prospective Studies, Coronary Angiography*, Coronary Angiography/methods, Coronary Artery Disease*, Coronary Artery Disease/epidemiology, Coronary Artery Disease/blood, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/diagnosis, Adult, Computed Tomography Angiography*, Biomarkers*, Biomarkers/blood, Aged, Asymptomatic Diseases*, Risk Factors, Coronary Vessels, Coronary Vessels/diagnostic imaging, Up-Regulation, Predictive Value of Tests, Risk Assessment, Prevalence, Vascular Calcification, Vascular Calcification/diagnostic imaging, Vascular Calcification/epidemiology, Vascular Calcification/blood", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1786, + "user_id": 1811967433, + "artical_title": "Rapid Plaque Progression Is Independently Associated With Hyperglycemia and Low HDL Cholesterol in Patients With Stable Coronary Artery Disease: A PARADIGM Study.", + "pmid": 39012946, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2024-07-16", + "author": "Neglia D,Caselli C,Maffei E,Cademartiri F,Meloni A,Bossone E,Saba L,Lee SE,Sung JM,Andreini D,Al-Mallah MH,Budoff MJ,Chinnaiyan K,Choi JH,Chun EJ,Conte E,Gottlieb I,Hadamitzky M,Kim YJ,Lee BK,Leipsic JA,Marques H,de Araújo Gonçalves P,Pontone G,Shin S,Stone PH,Samady H,Virmani R,Narula J,Shaw LJ,Bax JJ,Lin FY,Min JK,Chang HJ", + "auth_pos": 12, + "meshterms": "Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests, Humans, Male, Female, Middle Aged, Coronary Artery Disease*, Coronary Artery Disease/blood, Coronary Artery Disease/diagnosis, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Plaque, Atherosclerotic*, Disease Progression*, Aged, Computed Tomography Angiography*, Coronary Angiography*, Coronary Angiography/methods, Cholesterol, HDL*, Cholesterol, HDL/blood, Hyperglycemia*, Hyperglycemia/blood, Hyperglycemia/complications, Time Factors, Blood Glucose*, Blood Glucose/metabolism, Blood Glucose/analysis, Biomarkers, Biomarkers/blood, Risk Assessment, Prognosis, Risk Factors, Prospective Studies, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1787, + "user_id": 1811967433, + "artical_title": "Relationship of apolipoprotein C-III proteoform composition with ankle-brachial index and peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis (MESA).", + "pmid": 38823352, + "journal_name": "Atherosclerosis", + "date": "2024-07-18", + "author": "Koska J,Hansen S,Hu Y,Jensen MC,Billheimer D,Nedelkov D,Budoff MJ,Allison M,McClelland RL,Reaven PD", + "auth_pos": 7, + "meshterms": "Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors, Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors, Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors, Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors, Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors, Humans, Peripheral Arterial Disease*, Peripheral Arterial Disease/blood, Peripheral Arterial Disease/ethnology, Peripheral Arterial Disease/diagnosis, Peripheral Arterial Disease/physiopathology, Male, Female, Ankle Brachial Index*, Apolipoprotein C-III*, Apolipoprotein C-III/blood, Middle Aged, Aged, United States, United States/epidemiology, Aged, 80 and over, Biomarkers, Biomarkers/blood, Risk Factors, Atherosclerosis, Atherosclerosis/blood, Atherosclerosis/ethnology, Atherosclerosis/diagnosis, Glycosylation, Risk Assessment, Time Factors", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1788, + "user_id": 1811967433, + "artical_title": "Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution.", + "pmid": 39029567, + "journal_name": "Progress in cardiovascular diseases", + "date": "2024-07-20", + "author": "Krishnan S,Aldana-Bitar J,Golub I,Kianoush S,Benzing T,Ichikawa K,Budoff MJ", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1789, + "user_id": 1811967433, + "artical_title": "Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients with STable CoROnary Artery Disease CoMpared to Placebo (EKSTROM) Trial - Rationale and Design.", + "pmid": 39029568, + "journal_name": "American heart journal", + "date": "2024-07-20", + "author": "Verghese D,Hamal S,Ghanem A,Kinninger A,Javier D,Ichikawa K,Benzing T,Krishnan S,Kianoush S,Hamidi H,Bagheri M,Abraham D,Deljavanghodrti M,Ghoto A,Aldana-Bitar J,Budoff M", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1790, + "user_id": 1811967433, + "artical_title": "Association of with Coronary Artery Calcium Differs by Sex and Cigarette Smoking.", + "pmid": 39057616, + "journal_name": "Journal of cardiovascular development and disease", + "date": "2024-07-26", + "author": "Voorhies K,Young K,Hsu FC,Palmer ND,McDonald MN,Lee S,Hahn G,Hecker J,Prokopenko D,Wu AC,Regan EA,DeMeo D,Kinney GL,Crapo JD,Cho MH,Silverman EK,Lange C,Budoff MJ,Hokanson JE,Lutz SM", + "auth_pos": 18, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1791, + "user_id": 1811967433, + "artical_title": "The Association of Mitral Annular Calcification with Cardiovascular and Non-Cardiovascular Outcomes: The Multi-Ethnic Study of Atherosclerosis.", + "pmid": 38914415, + "journal_name": "The American journal of cardiology", + "date": "2024-08-01", + "author": "Oni E,Boakye E,Pressman GS,Dardari Z,Jha K,Szklo M,Budoff M,Nasir K,Hughes TM,Blaha MJ", + "auth_pos": 7, + "meshterms": "Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends, Humans, Female, Male, Mitral Valve*, Mitral Valve/diagnostic imaging, Middle Aged, Aged, Calcinosis, Calcinosis/diagnostic imaging, Calcinosis/epidemiology, Calcinosis/ethnology, United States, United States/epidemiology, Atherosclerosis, Atherosclerosis/ethnology, Dementia, Dementia/epidemiology, Bone Density, Heart Valve Diseases, Heart Valve Diseases/epidemiology, Heart Valve Diseases/complications, Tomography, X-Ray Computed, Ethnicity, Ethnicity/statistics & numerical data, Renal Insufficiency, Renal Insufficiency/epidemiology, Cross-Sectional Studies, Risk Factors, Prevalence, Incidence, Walking Speed, Cardiovascular Diseases, Cardiovascular Diseases/ethnology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/epidemiology, Cause of Death, Cause of Death/trends", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1792, + "user_id": 1811967433, + "artical_title": "COPD Subtypes Are Differentially Associated with Cardiovascular Events and COPD Exacerbations.", + "pmid": 39094733, + "journal_name": "Chest", + "date": "2024-08-03", + "author": "Yang HM,Ryu MH,Carey VJ,Young K,Kinney GL,Dransfield MT,Wade RC,Wells JM,Budoff M,Castaldi PJ,Hersh CP,Silverman EK", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1793, + "user_id": 1811967433, + "artical_title": "Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.", + "pmid": 39101625, + "journal_name": "European heart journal", + "date": "2024-08-05", + "author": "Nurmohamed NS,Min JK,Anthopolos R,Reynolds HR,Earls JP,Crabtree T,Mancini GBJ,Leipsic J,Budoff MJ,Hague CJ,O'Brien SM,Stone GW,Berger JS,Donnino R,Sidhu MS,Newman JD,Boden WE,Chaitman BR,Stone PH,Bangalore S,Spertus JA,Mark DB,Shaw LJ,Hochman JS,Maron DJ", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1794, + "user_id": 1811967433, + "artical_title": "Lipoprotein(a) and Progression of Coronary Artery Calcification in a Pooled U.S. Cohort.", + "pmid": 39115504, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-08-08", + "author": "Wong ND,Fan W,Hu X,Ballantyne C,Hoogeveen R,Tsai MY,Browne A,Budoff MJ", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1795, + "user_id": 1811967433, + "artical_title": "Genetic Risk and Coronary Artery Calcium in Personalizing Antihypertensive Treatment: A Pooled Cohort Analysis.", + "pmid": 39115511, + "journal_name": "Mayo Clinic proceedings", + "date": "2024-08-08", + "author": "Shetty NS,Gaonkar M,Pampana A,Patel N,Irvin MR,Lin HJ,Guo X,Rich SS,Rotter JI,Budoff MJ,Li P,Arora G,Arora P", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1796, + "user_id": 1811967433, + "artical_title": "Trimethylamine -Oxide and Related Gut Microbe-Derived Metabolites and Incident Heart Failure Development in Community-Based Populations.", + "pmid": 39119698, + "journal_name": "Circulation. Heart failure", + "date": "2024-08-09", + "author": "Tang WHW,Lemaitre RN,Jensen PN,Wang M,Wang Z,Li XS,Nemet I,Lee Y,Lai HTM,de Oliveira Otto MC,Fretts AM,Sotoodehnia N,DiDonato JA,Bäckhed F,Psaty BM,Siscovick DS,Budoff MJ,Mozaffarian D,Hazen SL", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1797, + "user_id": 1811967433, + "artical_title": "Regional and socioeconomic disparities in calcium scans.", + "pmid": 39153865, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-08-18", + "author": "Sachs V,Scoma C,Shaikh K,Budoff M,Almeida S", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1798, + "user_id": 1811967433, + "artical_title": "Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.", + "pmid": 39154888, + "journal_name": "American journal of kidney diseases : the official journal of the National Kidney Foundation", + "date": "2024-08-19", + "author": "Tian L,Jaeger BC,Scialla JJ,Budoff MJ,Mehta RC,Jaar BG,Saab G,Dobre MA,Reilly MP,Rader DJ,Townsend RR,Lash JP,Greenland P,Isakova T,Bundy JD", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Matthew J Budoff" + }, + { + "id": 1799, + "user_id": 1497893077, + "artical_title": "Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement.", + "pmid": 30621987, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-10", + "author": "Pibarot P,Magne J,Leipsic J,Côté N,Blanke P,Thourani VH,Hahn R", + "auth_pos": 7, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Bioprosthesis*, Echocardiography*, Echocardiography, Doppler, Color, Echocardiography, Doppler, Pulsed, Echocardiography, Transesophageal, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography*, Multimodal Imaging, Postoperative Complications, Postoperative Complications/diagnostic imaging*, Postoperative Complications/etiology, Postoperative Complications/physiopathology, Predictive Value of Tests, Prosthesis Design, Prosthesis Implantation, Prosthesis Implantation/adverse effects, Prosthesis Implantation/instrumentation*, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome, Coronary stent*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1800, + "user_id": 1497893077, + "artical_title": "Moderate Aortic Stenosis and Heart Failure With Reduced Ejection Fraction: Can Imaging Guide Us to Therapy?", + "pmid": 30621989, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-10", + "author": "Pibarot P,Messika-Zeitoun D,Ben-Yehuda O,Hahn RT,Burwash IG,Van Mieghem NM,Spitzer E,Leon MB,Bax J,Otto CM", + "auth_pos": 4, + "meshterms": "Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging*, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/therapy, Clinical Decision-Making*, Echocardiography*, Echocardiography, Doppler, Echocardiography, Stress, Echocardiography, Three-Dimensional, Echocardiography, Transesophageal, Heart Failure, Heart Failure/diagnostic imaging*, Heart Failure/etiology, Heart Failure/physiopathology, Heart Failure/therapy, Humans, Magnetic Resonance Imaging, Multimodal Imaging, Patient Selection, Predictive Value of Tests, Prognosis, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke Volume*, Tomography, X-Ray Computed*, Ventricular Dysfunction, Left, Ventricular Dysfunction, Left/diagnostic imaging*, Ventricular Dysfunction, Left/etiology, Ventricular Dysfunction, Left/physiopathology, Ventricular Dysfunction, Left/therapy, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1801, + "user_id": 1497893077, + "artical_title": "Mitral Annulus Calcium Score.", + "pmid": 30636513, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2019-01-15", + "author": "Khalique OK,Hahn RT", + "auth_pos": 2, + "meshterms": "Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Calcium, Humans, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1802, + "user_id": 1497893077, + "artical_title": "Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation Is Associated With Right Ventricular Reverse Remodeling in Patients With Right-Sided Heart Failure.", + "pmid": 30660521, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-21", + "author": "Orban M,Braun D,Deseive S,Stolz L,Stocker TJ,Stark K,Stremmel C,Orban M,Hagl C,Massberg S,Hahn RT,Nabauer M,Hausleiter J", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Female, Heart Failure, Heart Failure/diagnostic imaging, Heart Failure/physiopathology*, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/methods*, Hemodynamics, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/physiopathology*, Ventricular Function, Right*, Ventricular Remodeling*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1803, + "user_id": 1497893077, + "artical_title": "The Tricuspid Valve Relationship With the Right Ventricle and Pulmonary Vasculature.", + "pmid": 30660539, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-21", + "author": "Hahn RT,Delhaas T,Denti P,Waxman AB", + "auth_pos": 1, + "meshterms": "Hemodynamics*, Humans, Prognosis, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Pulmonary Artery/physiopathology*, Pulmonary Circulation*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology*, Ventricular Function, Left, Ventricular Function, Right*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1804, + "user_id": 1497893077, + "artical_title": "Quantifying Tricuspid Regurgitation Severity: A Comparison of Proximal Isovelocity Surface Area and Novel Quantitative Doppler Methods.", + "pmid": 30660544, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-01-21", + "author": "Dahou A,Ong G,Hamid N,Avenatti E,Yao J,Hahn RT", + "auth_pos": 6, + "meshterms": "Echocardiography, Doppler*, Hemodynamics, Humans, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Severity of Illness Index, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve/physiopathology, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/physiopathology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1805, + "user_id": 1497893077, + "artical_title": "How Do We Reconcile Echocardiography, Computed Tomography, and Hybrid Imaging in Assessing Discordant Grading of Aortic Stenosis Severity?", + "pmid": 30732722, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-02-09", + "author": "Delgado V,Clavel MA,Hahn RT,Gillam L,Bax J,Sengupta PP,Pibarot P", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging*, Aortic Valve Stenosis/physiopathology, Echocardiography*, Humans, Multimodal Imaging, Multimodal Imaging/methods*, Predictive Value of Tests, Reproducibility of Results, Severity of Illness Index, Tomography, X-Ray Computed*, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1806, + "user_id": 1497893077, + "artical_title": "Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance.", + "pmid": 30797660, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2019-02-25", + "author": "Zoghbi WA,Asch FM,Bruce C,Gillam LD,Grayburn PA,Hahn RT,Inglessis I,Islam AM,Lerakis S,Little SH,Siegel RJ,Skubas N,Slesnick TC,Stewart WJ,Thavendiranathan P,Weissman NJ,Yasukochi S,Zimmerman KG", + "auth_pos": 6, + "meshterms": "Cardiac Catheterization, Coronary Angiography, Coronary Angiography/standards*, Echocardiography, Doppler, Echocardiography, Doppler/standards*, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/surgery*, Humans, Magnetic Resonance Imaging, Magnetic Resonance Imaging/standards*, Postoperative Complications, Postoperative Complications/diagnostic imaging*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1807, + "user_id": 1497893077, + "artical_title": "Anatomy and Physiology of the Tricuspid Valve.", + "pmid": 30846121, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-09", + "author": "Dahou A,Levin D,Reisman M,Hahn RT", + "auth_pos": 4, + "meshterms": "Hemodynamics*, Humans, Risk Factors, Tricuspid Valve, Tricuspid Valve/anatomy & histology*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiology*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/physiopathology*, Ventricular Function, Right*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1808, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation: A Voyage of Discovery.", + "pmid": 30846131, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-09", + "author": "Hahn RT,Chandrashekhar Y", + "auth_pos": 1, + "meshterms": "Hemodynamics, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1809, + "user_id": 1497893077, + "artical_title": "Imaging Assessment of Tricuspid Regurgitation Severity.", + "pmid": 30846122, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-09", + "author": "Hahn RT,Thomas JD,Khalique OK,Cavalcante JL,Praz F,Zoghbi WA", + "auth_pos": 1, + "meshterms": "Computed Tomography Angiography, Coronary Angiography, Echocardiography*, Echocardiography, Doppler, Color, Echocardiography, Doppler, Pulsed, Echocardiography, Three-Dimensional, Hemodynamics, Humans, Magnetic Resonance Imaging*, Predictive Value of Tests, Severity of Illness Index, Tomography, X-Ray Computed*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve/physiopathology, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/physiopathology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1810, + "user_id": 1497893077, + "artical_title": "Intraprocedural Imaging of Transcatheter Tricuspid Valve Interventions.", + "pmid": 30846126, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-09", + "author": "Hahn RT,Nabauer M,Zuber M,Nazif TM,Hausleiter J,Taramasso M,Pozzoli A,George I,Kodali S,Bapat V,Maisano F", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheters, Cardiac Valve Annuloplasty, Cardiac Valve Annuloplasty/instrumentation, Cardiac Valve Annuloplasty/methods*, Echocardiography*, Echocardiography/instrumentation, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/methods*, Humans, Radiography, Interventional*, Radiography, Interventional/instrumentation, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ultrasonography, Interventional*, Ultrasonography, Interventional/instrumentation", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1811, + "user_id": 1497893077, + "artical_title": "3-Dimensional Echocardiography in Imaging the Tricuspid Valve.", + "pmid": 30846124, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-03-09", + "author": "Muraru D,Hahn RT,Soliman OI,Faletra FF,Basso C,Badano LP", + "auth_pos": 2, + "meshterms": "Echocardiography, Three-Dimensional*, Echocardiography, Transesophageal*, Hemodynamics, Humans, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve/physiopathology, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/physiopathology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1812, + "user_id": 1497893077, + "artical_title": "Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.", + "pmid": 30883058, + "journal_name": "The New England journal of medicine", + "date": "2019-03-19", + "author": "Mack MJ,Leon MB,Thourani VH,Makkar R,Kodali SK,Russo M,Kapadia SR,Malaisrie SC,Cohen DJ,Pibarot P,Leipsic J,Hahn RT,Blanke P,Williams MR,McCabe JM,Brown DL,Babaliaros V,Goldman S,Szeto WY,Genereux P,Pershad A,Pocock SJ,Alu MC,Webb JG,Smith CR", + "auth_pos": 12, + "meshterms": "Aged, Aortic Valve, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Atrial Fibrillation, Atrial Fibrillation/etiology, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods*, Humans, Kaplan-Meier Estimate, Length of Stay, Male, Patient Readmission, Patient Readmission/statistics & numerical data*, Postoperative Complications, Postoperative Complications/epidemiology*, Prosthesis Design, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1813, + "user_id": 1497893077, + "artical_title": "Morphological Assessment of the Tricuspid Apparatus and Grading Regurgitation Severity in Patients With Functional Tricuspid Regurgitation: Thinking Outside the Box.", + "pmid": 30947907, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-04-06", + "author": "Badano LP,Hahn R,Rodríguez-Zanella H,Araiza Garaygordobil D,Ochoa-Jimenez RC,Muraru D", + "auth_pos": 2, + "meshterms": "Clinical Decision-Making, Echocardiography, Doppler*, Hemodynamics*, Humans, Predictive Value of Tests, Prognosis, Reproducibility of Results, Severity of Illness Index, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve/physiopathology, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1814, + "user_id": 1497893077, + "artical_title": "Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review.", + "pmid": 30994879, + "journal_name": "JAMA cardiology", + "date": "2019-04-18", + "author": "Hahn RT,Waxman AB,Denti P,Delhaas T", + "auth_pos": 1, + "meshterms": "Disease Progression, Echocardiography, Three-Dimensional, Echocardiography, Three-Dimensional/methods, Female, Heart Failure, Heart Failure/epidemiology, Heart Failure/etiology*, Heart Ventricles, Heart Ventricles/anatomy & histology*, Heart Ventricles/diagnostic imaging, Hemodynamics, Hemodynamics/physiology, Humans, Lung, Lung/blood supply, Lung/physiology*, Male, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/anatomy & histology*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/physiopathology*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1815, + "user_id": 1497893077, + "artical_title": "Transcatheter Aortic Valve Replacement: Role of Multimodality Imaging in Common and Complex Clinical Scenarios.", + "pmid": 31103575, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-05-20", + "author": "Bax JJ,Delgado V,Hahn RT,Leipsic J,Min JK,Grayburn P,Sondergaard L,Yoon SH,Windecker S", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Insufficiency, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/physiopathology, Aortic Valve Insufficiency/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Bioprosthesis, Clinical Decision-Making, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional, Echocardiography, Transesophageal, Heart Valve Prosthesis, Hemodynamics, Humans, Magnetic Resonance Imaging, Multidetector Computed Tomography, Multimodal Imaging*, Patient Selection, Predictive Value of Tests, Prosthesis Design, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1816, + "user_id": 1497893077, + "artical_title": "Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials.", + "pmid": 31179020, + "journal_name": "Cardiac failure review", + "date": "2019-06-11", + "author": "Spitzer E,Hahn RT,Pibarot P,de Vries T,Bax JJ,Leon MB,Van Mieghem NM", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1817, + "user_id": 1497893077, + "artical_title": "Imaging in patients with severe mitral annular calcification: insights from a multicentre experience using transatrial balloon-expandable valve replacement.", + "pmid": 31220240, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2019-06-21", + "author": "Praz F,Khalique OK,Lee R,Wu IY,Russell H,Guerrero M,Wang DD,Veeragandham R,Islam AM,Deaton DW,Kaneko T,Eudailey KW,Akkoc D,Kantor A,Wang C,Tang DCH,Park JS,Leung D,Nazif TM,Vahl TP,Hahn RT,Kodali SK,Leon MB,Takayama H,Bapat V,Borger MA,George I", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1818, + "user_id": 1497893077, + "artical_title": "2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee.", + "pmid": 31378259, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2019-08-06", + "author": "Wiegers SE,Ryan T,Arrighi JA,Brown SM,Canaday B,Damp JB,Diaz-Gomez JL,Figueredo VM,Garcia MJ,Gillam LD,Griffin BP,Kirkpatrick JN,Klarich KW,Lui GK,Maffett S,Naqvi TZ,Patel AR,Poulin MF,Rose GA,Swaminathan M,Mendes LA,Adams JE,Brush JE,Dec GW,Denktas A,Fernandes S,Freeman R,Hahn RT,Halperin JL,Housholder-Hughes SD,Khan SS,Lin CH,Marine JE,McPherson JA,Niazi K,Solomon MA,Spicer RL,Tam M,Wang A,Weissman G,Weitz HH,Williams ES", + "auth_pos": 31, + "meshterms": "Cardiology, Cardiology/education*, Clinical Competence, Consensus, Curriculum, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing*, Education, Medical, Graduate*, Educational Measurement, Educational Measurement/standards, Fellowships and Scholarships, Humans, Societies, Medical, Specialty Boards, United States, Cardiology, Cardiology/education*, Clinical Competence, Consensus, Curriculum, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing*, Education, Medical, Graduate*, Educational Measurement, Educational Measurement/standards, Fellowships and Scholarships, Humans, Societies, Medical, Specialty Boards, United States, Cardiology, Cardiology/education*, Clinical Competence, Consensus, Curriculum, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing*, Education, Medical, Graduate*, Educational Measurement, Educational Measurement/standards, Fellowships and Scholarships, Humans, Societies, Medical, Specialty Boards, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1819, + "user_id": 1497893077, + "artical_title": "Optimizing Cardiac CT Protocols for Comprehensive Acquisition Prior to Percutaneous MV and TV Repair/Replacement.", + "pmid": 31422136, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-08-20", + "author": "Pulerwitz TC,Khalique OK,Leb J,Hahn RT,Nazif TM,Leon MB,George I,Vahl TP,D'Souza B,Bapat VN,Dumeer S,Kodali SK,Einstein AJ", + "auth_pos": 4, + "meshterms": "Cardiac Catheterization, Heart Valve Prosthesis Implantation, Humans, Mitral Valve, Mitral Valve/diagnostic imaging*, Mitral Valve/physiopathology, Mitral Valve/surgery, Mitral Valve Annuloplasty, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging*, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/surgery, Predictive Value of Tests, Severity of Illness Index, Tomography, X-Ray Computed*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1820, + "user_id": 1497893077, + "artical_title": "Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach.", + "pmid": 31452322, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2019-08-28", + "author": "Eudailey KW,Olds A,Lewis CT,Nazif TN,Vahl T,Khalique OK,Hahn RT,Bapat V,Borger MA,Leon MB,Ahmed MI,Kodali S,George I", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Alabama, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Female, Hemodynamics, Humans, Male, New York City, Postoperative Complications, Postoperative Complications/etiology, Recovery of Function, Retrospective Studies, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1821, + "user_id": 1497893077, + "artical_title": "The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement.", + "pmid": 31466847, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2019-08-31", + "author": "Kiefer NJ,Salber GC,Burke GM,Chang JD,Guibone KA,Popma JJ,Hahn RT,Pinto DS,Strom JB", + "auth_pos": 7, + "meshterms": "Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery*, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Hypertrophic/complications, Cardiomyopathy, Hypertrophic/diagnosis*, Cardiomyopathy, Hypertrophic/physiopathology, Echocardiography, Female, Follow-Up Studies, Heart Septum, Heart Septum/diagnostic imaging*, Heart Valve Prosthesis*, Humans, Male, Retrospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1822, + "user_id": 1497893077, + "artical_title": "New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.", + "pmid": 31505615, + "journal_name": "European heart journal", + "date": "2019-09-11", + "author": "Nazif TM,Chen S,George I,Dizon JM,Hahn RT,Crowley A,Alu MC,Babaliaros V,Thourani VH,Herrmann HC,Smalling RW,Brown DL,Mack MJ,Kapadia S,Makkar R,Webb JG,Leon MB,Kodali SK", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Bundle-Branch Block, Bundle-Branch Block/etiology*, Cohort Studies, Female, Humans, Male, Postoperative Complications, Postoperative Complications/etiology*, Risk Assessment, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1823, + "user_id": 1497893077, + "artical_title": "Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review.", + "pmid": 31511897, + "journal_name": "European heart journal", + "date": "2019-09-13", + "author": "Chang CC,Veen KM,Hahn RT,Bogers AJJC,Latib A,Oei FBS,Abdelghani M,Modolo R,Ho SY,Abdel-Wahab M,Fattouch K,Bosmans J,Caliskan K,Taramasso M,Serruys PW,Bax JJ,van Mieghem NMDA,Takkenberg JJM,Lurz P,Modine T,Soliman O", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1824, + "user_id": 1497893077, + "artical_title": "Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.", + "pmid": 31525069, + "journal_name": "Circulation. Heart failure", + "date": "2019-09-17", + "author": "Furer A,Chen S,Redfors B,Elmariah S,Pibarot P,Herrmann HC,Hahn RT,Kodali S,Thourani VH,Douglas PS,Alu MC,Fearon WF,Passeri J,Malaisrie SC,Crowley A,McAndrew T,Genereux P,Ben-Yehuda O,Leon MB,Burkhoff D", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Female, Follow-Up Studies, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/physiopathology, Humans, Male, North America, North America/epidemiology, Postoperative Period, Prognosis, Recovery of Function*, Registries*, Stroke Volume, Stroke Volume/physiology*, Survival Rate, Survival Rate/trends, Time Factors, Transcatheter Aortic Valve Replacement*, Ventricular Function, Left, Ventricular Function, Left/physiology*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1825, + "user_id": 1497893077, + "artical_title": "Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation.", + "pmid": 31568868, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-10-01", + "author": "Taramasso M,Benfari G,van der Bijl P,Alessandrini H,Attinger-Toller A,Biasco L,Lurz P,Braun D,Brochet E,Connelly KA,de Bruijn S,Denti P,Deuschl F,Estevez-Loureiro R,Fam N,Frerker C,Gavazzoni M,Hausleiter J,Ho E,Juliard JM,Kaple R,Besler C,Kodali S,Kreidel F,Kuck KH,Latib A,Lauten A,Monivas V,Mehr M,Muntané-Carol G,Nazif T,Nickening G,Pedrazzini G,Philippon F,Pozzoli A,Praz F,Puri R,Rodés-Cabau J,Schäfer U,Schofer J,Sievert H,Tang GHL,Thiele H,Topilsky Y,Rommel KP,Delgado V,Vahanian A,Von Bardeleben RS,Webb JG,Weber M,Windecker S,Winkel M,Zuber M,Leon MB,Hahn RT,Bax JJ,Enriquez-Sarano M,Maisano F", + "auth_pos": 55, + "meshterms": "Aged, Aged, 80 and over, Cardiac Surgical Procedures, Cardiac Surgical Procedures/mortality*, Case-Control Studies, Echocardiography, Endovascular Procedures, Endovascular Procedures/mortality*, Europe, Europe/epidemiology, Female, Humans, Male, North America, North America/epidemiology, Registries*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/drug therapy, Tricuspid Valve Insufficiency/mortality, Tricuspid Valve Insufficiency/surgery*, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1826, + "user_id": 1497893077, + "artical_title": "Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States.", + "pmid": 31568867, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-10-01", + "author": "Chhatriwalla AK,Vemulapalli S,Szerlip M,Kodali S,Hahn RT,Saxon JT,Mack MJ,Ailawadi G,Rymer J,Manandhar P,Kosinski AS,Sorajja P", + "auth_pos": 5, + "meshterms": "Aged, Aged, 80 and over, Cardiac Surgical Procedures, Cardiac Surgical Procedures/adverse effects, Cardiac Surgical Procedures/instrumentation, Cardiac Surgical Procedures/statistics & numerical data*, Endovascular Procedures, Endovascular Procedures/adverse effects, Endovascular Procedures/instrumentation, Endovascular Procedures/statistics & numerical data*, Female, Humans, Learning Curve*, Male, Mitral Valve, Mitral Valve/surgery*, Mitral Valve Insufficiency, Mitral Valve Insufficiency/surgery, Registries*, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1827, + "user_id": 1497893077, + "artical_title": "Imaging in Structural Heart Disease: The Evolution of a New Subspecialty.", + "pmid": 34316851, + "journal_name": "JACC. Case reports", + "date": "2019-10-02", + "author": "Faza NN,Özden Tok Ö,Hahn RT", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1828, + "user_id": 1497893077, + "artical_title": "Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance.", + "pmid": 31601378, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-10-12", + "author": "Bax JJ,Debonnaire P,Lancellotti P,Ajmone Marsan N,Tops LF,Min JK,Piazza N,Leipsic J,Hahn RT,Delgado V", + "auth_pos": 9, + "meshterms": "Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Clinical Decision-Making*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Hemodynamics, Humans, Mitral Valve, Mitral Valve/diagnostic imaging*, Mitral Valve/physiopathology, Mitral Valve/surgery*, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Annuloplasty/instrumentation, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging*, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/surgery*, Multimodal Imaging*, Patient Selection*, Predictive Value of Tests, Risk Assessment, Risk Factors, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1829, + "user_id": 1497893077, + "artical_title": "Percutaneous Mitral Valve Repair: Multi-Modality Cardiac Imaging for Patient Selection and Intra-Procedural Guidance.", + "pmid": 31616674, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2019-10-17", + "author": "Khalique OK,Hahn RT", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1830, + "user_id": 1497893077, + "artical_title": "Assessment and procedural guidance with echocardiography for transcatheter tricuspid regurgitation devices.", + "pmid": 31669497, + "journal_name": "Progress in cardiovascular diseases", + "date": "2019-11-02", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods*, Echocardiography, Echocardiography/methods*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/methods, Humans, Tricuspid Valve*, Tricuspid Valve/anatomy & histology, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1831, + "user_id": 1497893077, + "artical_title": "Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials.", + "pmid": 31690104, + "journal_name": "Circulation", + "date": "2019-11-07", + "author": "Summers MR,Leon MB,Smith CR,Kodali SK,Thourani VH,Herrmann HC,Makkar RR,Pibarot P,Webb JG,Leipsic J,Alu MC,Crowley A,Hahn RT,Kapadia SR,Tuzcu EM,Svensson L,Cremer PC,Jaber WA", + "auth_pos": 13, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/surgery*, Endocarditis, Endocarditis/surgery*, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Male, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1832, + "user_id": 1497893077, + "artical_title": "Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.", + "pmid": 31708188, + "journal_name": "Lancet (London, England)", + "date": "2019-11-12", + "author": "Nickenig G,Weber M,Lurz P,von Bardeleben RS,Sitges M,Sorajja P,Hausleiter J,Denti P,Trochu JN,Näbauer M,Dahou A,Hahn RT", + "auth_pos": 12, + "meshterms": "Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Cardiac Catheterization/methods*, Female, Follow-Up Studies, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/methods*, Humans, Male, Postoperative Complications, Prospective Studies, Severity of Illness Index, Surgical Instruments, Treatment Outcome, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/surgery*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1833, + "user_id": 1497893077, + "artical_title": "Planning for Success: Pre-procedural Evaluation for Transcatheter Aortic Valve Replacement.", + "pmid": 31753169, + "journal_name": "Cardiology clinics", + "date": "2019-11-23", + "author": "Ng VG,Hahn RT,Nazif TM", + "auth_pos": 2, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging*, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging*, Aortic Valve Stenosis/surgery*, Balloon Valvuloplasty, Computed Tomography Angiography, Coronary Artery Disease, Coronary Artery Disease/complications, Coronary Artery Disease/diagnostic imaging, Coronary Artery Disease/surgery, Echocardiography, Heart Valve Prosthesis, Humans, Intraoperative Care, Multidetector Computed Tomography, Preoperative Care, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1834, + "user_id": 1497893077, + "artical_title": "Differences in Pressure Recovery Between Balloon Expandable and Self-expandable Transcatheter Aortic Valves.", + "pmid": 31792706, + "journal_name": "Annals of biomedical engineering", + "date": "2019-12-04", + "author": "Hatoum H,Hahn RT,Lilly S,Dasi LP", + "auth_pos": 2, + "meshterms": "Aortic Valve, Aortic Valve/pathology, Aortic Valve/surgery*, Female, Heart Valve Prosthesis*, Humans, Male, Models, Cardiovascular*, Transcatheter Aortic Valve Replacement*, Aortic Valve, Aortic Valve/pathology, Aortic Valve/surgery*, Female, Heart Valve Prosthesis*, Humans, Male, Models, Cardiovascular*, Transcatheter Aortic Valve Replacement*, Aortic Valve, Aortic Valve/pathology, Aortic Valve/surgery*, Female, Heart Valve Prosthesis*, Humans, Male, Models, Cardiovascular*, Transcatheter Aortic Valve Replacement*, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1835, + "user_id": 1497893077, + "artical_title": "Endpoints for tricuspid regurgitation trans-catheter therapy trials.", + "pmid": 31805295, + "journal_name": "Progress in cardiovascular diseases", + "date": "2019-12-06", + "author": "Hahn RT,Ben-Yehuda O,Leon MB", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods, Clinical Trials as Topic, Clinical Trials as Topic/methods*, Endpoint Determination, Endpoint Determination/methods*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1836, + "user_id": 1497893077, + "artical_title": "Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement.", + "pmid": 31806184, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2019-12-07", + "author": "Hahn RT,Mahmood F,Kodali S,Lang R,Monaghan M,Gillam LD,Swaminathan M,Bonow RO,von Bardeleben RS,Bax JJ,Grayburn P,Zoghbi WA,Sengupta PP,Chandrashekhar Y,Little SH", + "auth_pos": 1, + "meshterms": "Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results, Cardiology, Cardiology/education*, Certification, Certification/standards, Clinical Competence, Clinical Competence/standards*, Clinical Decision-Making, Consensus, Echocardiography, Echocardiography/standards*, Education, Medical, Continuing, Education, Medical, Continuing/standards*, Education, Medical, Graduate, Education, Medical, Graduate/standards*, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/physiopathology, Heart Diseases/therapy, Humans, Patient Selection, Predictive Value of Tests, Reproducibility of Results", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1837, + "user_id": 1497893077, + "artical_title": "Avoiding Mistakes of the Past with Tricuspid Regurgitation.", + "pmid": 31810512, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2019-12-08", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods*, Diagnostic Errors*, Echocardiography, Echocardiography/methods*, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnosis*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1838, + "user_id": 1497893077, + "artical_title": "Comparative quantification of primary mitral regurgitation by computer modeling and simulated echocardiography.", + "pmid": 31922890, + "journal_name": "American journal of physiology. Heart and circulatory physiology", + "date": "2020-01-11", + "author": "Mao W,Caballero A,Hahn RT,Sun W", + "auth_pos": 3, + "meshterms": "Blood Flow Velocity, Computer Simulation*, Echocardiography*, Humans, Image Interpretation, Computer-Assisted, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/physiopathology*, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/physiopathology*, Models, Cardiovascular*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1839, + "user_id": 1497893077, + "artical_title": "Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.", + "pmid": 30947905, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-01-14", + "author": "Addetia K,Harb SC,Hahn RT,Kapadia S,Lang RM", + "auth_pos": 3, + "meshterms": "Cardiac Catheterization, Defibrillators, Implantable, Defibrillators, Implantable/adverse effects*, Device Removal, Diuretics, Diuretics/therapeutic use, Echocardiography, Heart Valve Prosthesis Implantation, Hemodynamics*, Humans, Pacemaker, Artificial, Pacemaker, Artificial/adverse effects*, Prosthesis Design, Risk Factors, Severity of Illness Index, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1840, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease.", + "pmid": 30947904, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-01-14", + "author": "Taramasso M,Gavazzoni M,Pozzoli A,Dreyfus GD,Bolling SF,George I,Kapos I,Tanner FC,Zuber M,Maisano F,Hahn RT", + "auth_pos": 11, + "meshterms": "Cardiac Valve Annuloplasty*, Cardiac Valve Annuloplasty/adverse effects, Cardiac Valve Annuloplasty/mortality, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/mortality, Hemodynamics*, Humans, Postoperative Complications, Postoperative Complications/etiology, Recovery of Function, Recurrence, Risk Factors, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1841, + "user_id": 1497893077, + "artical_title": "Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.", + "pmid": 31954676, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-01-20", + "author": "Taramasso M,Gavazzoni M,Pozzoli A,Alessandrini H,Latib A,Attinger-Toller A,Biasco L,Braun D,Brochet E,Connelly KA,de Bruijn S,Denti P,Deuschl F,Estevez-Louriero R,Fam N,Frerker C,Ho E,Juliard JM,Kaple R,Kodali S,Kreidel F,Kuck KH,Lauten A,Lurz J,Monivas V,Mehr M,Nazif T,Nickening G,Pedrazzini G,Praz F,Puri R,Rodés-Cabau J,Schäfer U,Schofer J,Sievert H,Tang GHL,Khattab AA,Thiele H,Unterhuber M,Vahanian A,Von Bardeleben RS,Webb JG,Weber M,Windecker S,Winkel M,Zuber M,Hausleiter J,Lurz P,Maisano F,Leon MB,Hahn RT", + "auth_pos": 51, + "meshterms": "Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation*, Cardiac Catheterization/mortality, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/adverse effects, Cardiac Pacing, Artificial/mortality, Clinical Decision-Making, Defibrillators, Implantable*, Electric Countershock, Electric Countershock/adverse effects, Electric Countershock/instrumentation*, Electric Countershock/mortality, Europe, Feasibility Studies, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Heart Valve Prosthesis Implantation/mortality, Hemodynamics, Hospital Mortality, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/physiopathology, Mitral Valve/surgery*, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/mortality, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/surgery*, North America, Pacemaker, Artificial*, Postoperative Complications, Postoperative Complications/etiology, Postoperative Complications/mortality, Prosthesis Design, Recovery of Function, Registries, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1842, + "user_id": 1497893077, + "artical_title": "Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.", + "pmid": 31995682, + "journal_name": "The New England journal of medicine", + "date": "2020-01-30", + "author": "Makkar RR,Thourani VH,Mack MJ,Kodali SK,Kapadia S,Webb JG,Yoon SH,Trento A,Svensson LG,Herrmann HC,Szeto WY,Miller DC,Satler L,Cohen DJ,Dewey TM,Babaliaros V,Williams MR,Kereiakes DJ,Zajarias A,Greason KL,Whisenant BK,Hodson RW,Brown DL,Fearon WF,Russo MJ,Pibarot P,Hahn RT,Jaber WA,Rogers E,Xu K,Wheeler J,Alu MC,Smith CR,Leon MB", + "auth_pos": 27, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postoperative Complications/mortality, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Cohort Studies, Echocardiography, Female, Health Status, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Incidence, Intention to Treat Analysis, Kaplan-Meier Estimate, Male, Multivariate Analysis, Postoperative Complications, Postop", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1843, + "user_id": 1497893077, + "artical_title": "All that glitters is not gold: can videodensitometry replace echocardiography for the assessment of paravalvular aortic regurgitation?", + "pmid": 32044729, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-02-12", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Aortic Valve, Aortic Valve Insufficiency*, Echocardiography, Echocardiography, Transesophageal, Heart Valve Prosthesis*, Humans, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1844, + "user_id": 1497893077, + "artical_title": "Disproportionate Emphasis on Proportionate Mitral Regurgitation-Are There Better Measures of Regurgitant Severity?", + "pmid": 32074245, + "journal_name": "JAMA cardiology", + "date": "2020-02-20", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Humans, Echocardiography, Doppler, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1845, + "user_id": 1497893077, + "artical_title": "2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.", + "pmid": 32081473, + "journal_name": "Journal of cardiac failure", + "date": "2020-02-23", + "author": "Yancy CW,Drazner MH,Coffin ST,Cornwell W,Desai S,Erwin JP,Ginwalla M,Harshaw-Ellis KS,Horwich T,Kittleson M,Lala A,Lewsey SC,Marine JE,Martin C,Meehan K,Morrow DA,Schlendorf K,Smith JW,Stevens GR,Arrighi JA,Mendes LA,Adams JE,Brush JE,Dec GW,Denktas A,Fernandes S,Freeman R,Francis SA,Hahn RT,Halperin JL,Housholder-Hughes SD,Khan SS,Klarich K,Lin CH,McPherson JA,Niazi K,Ryan T,Solomon MA,Spicer RL,Tam M,Wang A,Weissman G,Weitz HH,Williams ES", + "auth_pos": 31, + "meshterms": "American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization, American Heart Association, Cardiology*, Heart Failure*, Heart Failure/therapy, Heart Transplantation*, Humans, Societies, Medical, Specialization", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1846, + "user_id": 1497893077, + "artical_title": "Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Secondary Mitral Regurgitation.", + "pmid": 32081284, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-02-23", + "author": "Namazi F,van der Bijl P,Hirasawa K,Kamperidis V,van Wijngaarden SE,Mertens B,Leon MB,Hahn RT,Stone GW,Narula J,Ajmone Marsan N,Delgado V,Bax JJ", + "auth_pos": 8, + "meshterms": "Aged, Echocardiography, Echocardiography/methods*, Female, Humans, Male, Middle Aged, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging*, Mitral Valve Insufficiency/mortality, Mitral Valve Insufficiency/physiopathology, Netherlands, Netherlands/epidemiology, Prognosis, Retrospective Studies, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1847, + "user_id": 1497893077, + "artical_title": "Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.", + "pmid": 32118351, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2020-03-03", + "author": "Murdoch DJ,Sathananthan J,Hensey M,Alu MC,Liu Y,Crowley A,Wood D,Cheung A,Ye J,Feldman T,Hahn RT,Jaber WA,Mack MJ,Malaisrie SC,Leon MB,Webb JG", + "auth_pos": 11, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Insufficiency, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/mortality, Aortic Valve Insufficiency/physiopathology, Aortic Valve Insufficiency/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Bioprosthesis*, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Heart Valve Prosthesis Implantation/mortality, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/physiopathology*, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/mortality, Mitral Valve Insufficiency/physiopathology*, Prosthesis Failure*, Recovery of Function, Registries, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1848, + "user_id": 1497893077, + "artical_title": "The Role of Multimodality Imaging in Transcatheter Aortic Valve Replacement.", + "pmid": 31324994, + "journal_name": "Current cardiology reports", + "date": "2020-03-05", + "author": "Liu Q,Hahn RT", + "auth_pos": 2, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/pathology, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery*, Cardiac Catheterization, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Humans, Multimodal Imaging, Multimodal Imaging/methods*, Surgery, Computer-Assisted, Surgery, Computer-Assisted/methods*, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1849, + "user_id": 1497893077, + "artical_title": "6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation.", + "pmid": 30999993, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-03-05", + "author": "Nickenig G,Weber M,Schueler R,Hausleiter J,Näbauer M,von Bardeleben RS,Sotiriou E,Schäfer U,Deuschl F,Kuck KH,Kreidel F,Juliard JM,Brochet E,Latib A,Agricola E,Baldus S,Friedrichs K,Vandrangi P,Verta P,Hahn RT,Maisano F", + "auth_pos": 20, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/methods*, Echocardiography, Doppler, Echocardiography, Doppler/methods, Female, Follow-Up Studies, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Heart Valve Prosthesis Implantation/mortality, Hospital Mortality, Hospital Mortality/trends*, Humans, Internationality, Male, Middle Aged, Minimally Invasive Surgical Procedures, Minimally Invasive Surgical Procedures/methods, Prospective Studies, Reconstructive Surgical Procedures, Reconstructive Surgical Procedures/methods, Reconstructive Surgical Procedures/mortality, Risk Assessment, Severity of Illness Index, Survival Rate, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/mortality, Tricuspid Valve Insufficiency/surgery*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1850, + "user_id": 1497893077, + "artical_title": "Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation.", + "pmid": 32176279, + "journal_name": "European heart journal", + "date": "2020-03-17", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Echocardiography, Humans, Hypertension, Pulmonary*, Hypertension, Pulmonary/diagnostic imaging, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Risk Assessment, Tricuspid Valve, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1851, + "user_id": 1497893077, + "artical_title": "Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.", + "pmid": 32192985, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-03-21", + "author": "Tang GHL,Zaid S,Fuchs A,Yamabe T,Yazdchi F,Gupta E,Ahmad H,Kofoed KF,Goldberg JB,Undemir C,Kaple RK,Shah PB,Kaneko T,Lansman SL,Khera S,Kovacic JC,Dangas GD,Lerakis S,Sharma SK,Kini A,Adams DH,Khalique OK,Hahn RT,Søndergaard L,George I,Kodali SK,De Backer O,Leon MB,Bapat VN", + "auth_pos": 23, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery*, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Female, Fluoroscopy, Heart Valve Prosthesis*, Humans, Male, Multidetector Computed Tomography*, Pilot Projects, Predictive Value of Tests, Prosthesis Design, Retrospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1852, + "user_id": 1497893077, + "artical_title": "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.", + "pmid": 32272848, + "journal_name": "Circulation", + "date": "2020-04-11", + "author": "Pibarot P,Salaun E,Dahou A,Avenatti E,Guzzetti E,Annabi MS,Toubal O,Bernier M,Beaudoin J,Ong G,Ternacle J,Krapf L,Thourani VH,Makkar R,Kodali SK,Russo M,Kapadia SR,Malaisrie SC,Cohen DJ,Leipsic J,Blanke P,Williams MR,McCabe JM,Brown DL,Babaliaros V,Goldman S,Szeto WY,Généreux P,Pershad A,Alu MC,Xu K,Rogers E,Webb JG,Smith CR,Mack MJ,Leon MB,Hahn RT", + "auth_pos": 37, + "meshterms": "Aged, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Insufficiency, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/physiopathology, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography*, Female, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Hemodynamics, Humans, Male, North America, Predictive Value of Tests, Prosthesis Design, Prosthesis Failure, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1853, + "user_id": 1497893077, + "artical_title": "The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic.", + "pmid": 32278716, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-13", + "author": "Chung CJ,Nazif TM,Wolbinski M,Hakemi E,Lebehn M,Brandwein R,Rezende CP,Doolittle J,Rabbani L,Uriel N,Schwartz A,Biviano A,Wan E,Hathaway L,Hahn R,Khalique O,Hamid N,Ng V,Patel A,Vahl T,Kirtane A,Bapat V,George I,Leon MB,Kodali SK", + "auth_pos": 15, + "meshterms": "Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2, Betacoronavirus, Betacoronavirus/isolation & purification, COVID-19, Comorbidity, Coronavirus Infections*, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Coronavirus Infections/therapy, Critical Pathways*, Critical Pathways/organization & administration, Critical Pathways/trends, Heart Diseases*, Heart Diseases/epidemiology, Heart Diseases/surgery, Humans, Infection Control, Infection Control/methods*, Organizational Innovation, Pandemics*, Pandemics/prevention & control, Pneumonia, Viral*, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/therapy, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1854, + "user_id": 1497893077, + "artical_title": "Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement.", + "pmid": 31466616, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-05-15", + "author": "Chakravarty T,Patel A,Kapadia S,Raschpichler M,Smalling RW,Szeto WY,Abramowitz Y,Cheng W,Douglas PS,Hahn RT,Herrmann HC,Kereiakes D,Svensson L,Yoon SH,Babaliaros VC,Kodali S,Thourani VH,Alu MC,Liu Y,McAndrew T,Mack M,Leon MB,Makkar RR", + "auth_pos": 10, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/pharmacology*, Anticoagulants/therapeutic use, Aortic Valve, Aortic Valve/drug effects*, Aortic Valve/physiology*, Aortic Valve/surgery, Bioprosthesis*, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods*, Hemodynamics, Hemodynamics/drug effects*, Humans, Male, Postoperative Period, Prospective Studies, Transcatheter Aortic Valve Replacement, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1855, + "user_id": 1497893077, + "artical_title": "Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.", + "pmid": 32408979, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-05-16", + "author": "Chau KH,Douglas PS,Pibarot P,Hahn RT,Khalique OK,Jaber WA,Cremer P,Weissman NJ,Asch FM,Zhang Y,Gertz ZM,Elmariah S,Clavel MA,Thourani VH,Daubert M,Alu MC,Leon MB,Lindman BR", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging*, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Female, Humans, Hypertrophy, Left Ventricular, Hypertrophy, Left Ventricular/diagnostic imaging*, Hypertrophy, Left Ventricular/mortality, Male, Mortality, Mortality/trends, Registries*, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/trends*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1856, + "user_id": 1497893077, + "artical_title": "Transcatheter Mitral Valve Replacement Guided by Echocardiographic-CT Scan Fusion: Early Human Clinical Experience.", + "pmid": 32417097, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-05-18", + "author": "Coisne A,Pontana F,Modine T,Sudre A,Lancellotti P,Hahn RT,Khalique OK,Granada JF,Montaigne D,Donal E", + "auth_pos": 6, + "meshterms": "Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Echocardiography, Three-Dimensional*, Echocardiography, Transesophageal*, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/physiopathology, Mitral Valve/surgery*, Multimodal Imaging, Predictive Value of Tests, Radiographic Image Interpretation, Computer-Assisted, Surgery, Computer-Assisted*, Surgery, Computer-Assisted/instrumentation, Tomography, X-Ray Computed*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1857, + "user_id": 1497893077, + "artical_title": "A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization.", + "pmid": 32417332, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2020-05-18", + "author": "Guerrero M,Wang DD,Pursnani A,Eleid M,Khalique O,Urena M,Salinger M,Kodali S,Kaptzan T,Lewis B,Kato N,Cajigas HM,Wendler O,Holzhey D,Pershad A,Witzke C,Alnasser S,Tang GHL,Grubb K,Reisman M,Blanke P,Leipsic J,Williamson E,Pellikka PA,Pislaru S,Crestanello J,Himbert D,Vahanian A,Webb J,Hahn RT,Leon M,George I,Bapat V,O'Neill W,Rihal C", + "auth_pos": 30, + "meshterms": "Aged, Aged, 80 and over, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve/surgery, Predictive Value of Tests, Retrospective Studies, Tomography, X-Ray Computed, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1858, + "user_id": 1497893077, + "artical_title": "Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions.", + "pmid": 32432125, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2020-05-21", + "author": "Winkel MG,Brugger N,Khalique OK,Gräni C,Huber A,Pilgrim T,Billinger M,Windecker S,Hahn RT,Praz F", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1859, + "user_id": 1497893077, + "artical_title": "Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries.", + "pmid": 32441856, + "journal_name": "European journal of heart failure", + "date": "2020-05-23", + "author": "Chen S,Redfors B,Crowley A,Ben-Yehuda O,Summers M,Hahn RT,Jaber WA,Pibarot P,Alu MC,Chau KH,Kapadia S,Nazif T,Vahl TP,Thourani V,Kodali S,Leon M", + "auth_pos": 6, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/epidemiology, Aortic Valve Stenosis/surgery, Heart Failure*, Heart Failure/epidemiology, Hospitalization, Humans, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1860, + "user_id": 1497893077, + "artical_title": "A Comprehensive Engineering Analysis of Left Heart Dynamics After MitraClip in a Functional Mitral Regurgitation Patient.", + "pmid": 32457650, + "journal_name": "Frontiers in physiology", + "date": "2020-05-28", + "author": "Caballero A,Mao W,McKay R,Hahn RT,Sun W", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1861, + "user_id": 1497893077, + "artical_title": "Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.", + "pmid": 32499024, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-06-06", + "author": "Gonzales H,Douglas PS,Pibarot P,Hahn RT,Khalique OK,Jaber WA,Cremer P,Weissman NJ,Asch FM,Zhang Y,Gertz ZM,Elmariah S,Clavel MA,Thourani VH,Daubert M,Alu MC,Leon MB,Lindman BR", + "auth_pos": 4, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Clinical Trials as Topic, Female, Humans, Hypertrophy, Left Ventricular, Hypertrophy, Left Ventricular/diagnostic imaging, Hypertrophy, Left Ventricular/mortality, Hypertrophy, Left Ventricular/physiopathology*, Male, Patient Readmission, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/therapy, Recovery of Function, Registries, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Ventricular Function, Left*, Ventricular Remodeling*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1862, + "user_id": 1497893077, + "artical_title": "Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Decision-Making in the Operating Room: A Surgery-Based Approach: From the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons.", + "pmid": 32503709, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2020-06-07", + "author": "Nicoara A,Skubas N,Ad N,Finley A,Hahn RT,Mahmood F,Mankad S,Nyman CB,Pagani F,Porter TR,Rehfeldt K,Stone M,Taylor B,Vegas A,Zimmerman KG,Zoghbi WA,Swaminathan M", + "auth_pos": 5, + "meshterms": "Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States, Anesthesiologists, Echocardiography, Echocardiography, Transesophageal*, Humans, Operating Rooms, Surgeons*, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1863, + "user_id": 1497893077, + "artical_title": "Global evaluation of echocardiography in patients with COVID-19.", + "pmid": 32556199, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-06-20", + "author": "Dweck MR,Bularga A,Hahn RT,Bing R,Lee KK,Chapman AR,White A,Salvo GD,Sade LE,Pearce K,Newby DE,Popescu BA,Donal E,Cosyns B,Edvardsen T,Mills NL,Haugaa K", + "auth_pos": 3, + "meshterms": "Age Factors, Aged, COVID-19, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging*, Cardiovascular Diseases/epidemiology*, Comorbidity, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Cross-Sectional Studies, Echocardiography, Echocardiography/methods*, Europe, Female, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/epidemiology*, Humans, Incidence, Internationality, Internet, Logistic Models, Male, Middle Aged, Multivariate Analysis, Pandemics, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Predictive Value of Tests, Prognosis, Prospective Studies, Sex Factors, Age Factors, Aged, COVID-19, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging*, Cardiovascular Diseases/epidemiology*, Comorbidity, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Cross-Sectional Studies, Echocardiography, Echocardiography/methods*, Europe, Female, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/epidemiology*, Humans, Incidence, Internationality, Internet, Logistic Models, Male, Middle Aged, Multivariate Analysis, Pandemics, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Predictive Value of Tests, Prognosis, Prospective Studies, Sex Factors, Age Factors, Aged, COVID-19, Cardiovascular Diseases, Cardiovascular Diseases/diagnostic imaging*, Cardiovascular Diseases/epidemiology*, Comorbidity, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Cross-Sectional Studies, Echocardiography, Echocardiography/methods*, Europe, Female, Heart Diseases, Heart Diseases/diagnostic imaging*, Heart Diseases/epidemiology*, Humans, Incidence, Internationality, Internet, Logistic Models, Male, Middle Aged, Multivariate Analysis, Pandemics, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Predictive Value of Tests, Prognosis, Prospective Studies, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1864, + "user_id": 1497893077, + "artical_title": "Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement.", + "pmid": 32610268, + "journal_name": "The Journal of invasive cardiology", + "date": "2020-07-02", + "author": "Lampert J,Finn MT,Kantor A,Akkoc D,Chen S,Brandwein R,Fidlow K,Liao M,Khalique O,Hahn RT,Vahl TP,George I,Kirtane A,Leon MB,Kodali SK,Nazif TM", + "auth_pos": 10, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Catheters, Indwelling, Catheters, Indwelling/adverse effects, Humans, Retrospective Studies, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Urinary Catheterization, Urinary Catheterization/adverse effects, Urinary Catheters", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1865, + "user_id": 1497893077, + "artical_title": "Comparison of Mitral Valve Replacement and Repair for Degenerative Mitral Regurgitation: a Meta-analysis and Implications for Transcatheter Mitral Procedures.", + "pmid": 32648008, + "journal_name": "Current cardiology reports", + "date": "2020-07-11", + "author": "Overtchouk P,Ben-Ali W,Prendergast B,Conradi L,Hahn R,Granada J,Modine T", + "auth_pos": 5, + "meshterms": "Aged, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Humans, Middle Aged, Mitral Valve, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1866, + "user_id": 1497893077, + "artical_title": "Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry.", + "pmid": 32674676, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-07-18", + "author": "Salaun E,Clavel MA,Hahn RT,Jaber WA,Asch FM,Rodriguez L,Weissman NJ,Gertz ZM,Herrmann HC,Dahou A,Annabi MS,Toubal O,Bernier M,Beaudoin J,Leipsic J,Blanke P,Ridard C,Ong G,Rodés-Cabau J,Webb JG,Zhang Y,Alu MC,Douglas PS,Makkar R,Miller DC,Lindman BR,Thourani VH,Leon MB,Pibarot P", + "auth_pos": 3, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Doppler, Female, Heart Failure, Heart Failure/etiology, Heart Failure/mortality, Heart Failure/therapy, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Hemodynamics*, Humans, Male, North America, Patient Readmission, Postoperative Complications, Postoperative Complications/etiology, Postoperative Complications/mortality, Recovery of Function, Registries, Risk Assessment, Risk Factors, Severity of Illness Index, Stroke, Stroke/etiology, Stroke/mortality, Time Factors, Treatment Outcome, Ventricular Function, Left*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1867, + "user_id": 1497893077, + "artical_title": "Determination of cannabinoids in plasma using salting-out-assisted liquid-liquid extraction followed by LC-MS/MS analysis.", + "pmid": 32706449, + "journal_name": "Biomedical chromatography : BMC", + "date": "2020-07-25", + "author": "da Silva CP,Dalpiaz LPP,Gerbase FE,Muller VV,Cezimbra da Silva A,Lizot LF,Hahn RZ,da Costa JL,Antunes MV,Linden R", + "auth_pos": 7, + "meshterms": "Adult, Cannabinoids, Cannabinoids/blood*, Cannabinoids/chemistry, Cannabinoids/isolation & purification, Chromatography, High Pressure Liquid, Chromatography, High Pressure Liquid/methods*, Humans, Linear Models, Liquid-Liquid Extraction, Liquid-Liquid Extraction/methods*, Reproducibility of Results, Sensitivity and Specificity, Tandem Mass Spectrometry, Tandem Mass Spectrometry/methods*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1868, + "user_id": 1497893077, + "artical_title": "Utility of Three-Dimensional Transesophageal Echocardiography for Mitral Annular Sizing in Transcatheter Mitral Valve Replacement Procedures: A Cardiac Computed Tomographic Comparative Study.", + "pmid": 32718722, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2020-07-29", + "author": "Coisne A,Pontana F,Aghezzaf S,Mouton S,Ridon H,Richardson M,Polge AS,Longère B,Silvestri V,Pagniez J,Bical A,Rousse N,Overtchouk P,Granada JF,Hahn RT,Modine T,Montaigne D", + "auth_pos": 15, + "meshterms": "Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Echocardiography, Three-Dimensional*, Echocardiography, Transesophageal, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Multidetector Computed Tomography, ROC Curve, Reproducibility of Results", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1869, + "user_id": 1497893077, + "artical_title": "Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.", + "pmid": 32729170, + "journal_name": "European journal of heart failure", + "date": "2020-07-31", + "author": "Rosenblum H,Masri A,Narotsky DL,Goldsmith J,Hamid N,Hahn RT,Kodali S,Vahl T,Nazif T,Khalique OK,Bokhari S,Soman P,Cavalcante JL,Maurer MS,Castaño A", + "auth_pos": 6, + "meshterms": "Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, 80 and over, Amyloidosis*, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Female, Heart Failure*, Humans, Male, Prealbumin, Prospective Studies, Risk Factors, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1870, + "user_id": 1497893077, + "artical_title": "Tricuspid regurgitation: finally unforgettable!", + "pmid": 31625575, + "journal_name": "European heart journal cardiovascular Imaging", + "date": "2020-08-01", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1871, + "user_id": 1497893077, + "artical_title": "Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review.", + "pmid": 32772772, + "journal_name": "Journal of the American Heart Association", + "date": "2020-08-11", + "author": "Alexis SL,Malik AH,George I,Hahn RT,Khalique OK,Seetharam K,Bhatt DL,Tang GHL", + "auth_pos": 4, + "meshterms": "Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Age Factors, Aortic Valve, Aortic Valve/surgery*, Endocarditis, Endocarditis/diagnosis, Endocarditis/epidemiology, Endocarditis/microbiology*, Endocarditis/therapy, Female, Heart Valve Diseases, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Heart Valve Diseases/microbiology*, Heart Valve Diseases/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Humans, Incidence, Male, Postoperative Complications, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/microbiology*, Postoperative Complications/therapy, Prognosis, Prosthesis-Related Infections, Prosthesis-Related Infections/diagnosis, Prosthesis-Related Infections/epidemiology, Prosthesis-Related Infections/microbiology*, Prosthesis-Related Infections/therapy, Risk Factors, Sex Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1872, + "user_id": 1497893077, + "artical_title": "Meta-analysis of Incidence, Predictors and Consequences of Clinical and Subclinical Bioprosthetic Leaflet Thrombosis After Transcatheter Aortic Valve Implantation.", + "pmid": 32773221, + "journal_name": "The American journal of cardiology", + "date": "2020-08-11", + "author": "Sannino A,Hahn RT,Leipsic J,Mack MJ,Grayburn PA", + "auth_pos": 2, + "meshterms": "Aortic Valve Stenosis, Aortic Valve Stenosis/surgery, Bioprosthesis, Bioprosthesis/adverse effects*, Global Health, Heart Diseases, Heart Diseases/epidemiology*, Heart Diseases/etiology, Humans, Incidence, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/etiology, Registries*, Risk Factors, Thrombosis, Thrombosis/epidemiology*, Thrombosis/etiology, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1873, + "user_id": 1497893077, + "artical_title": "Indications for and Findings on Transthoracic Echocardiography in COVID-19.", + "pmid": 32782131, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2020-08-13", + "author": "Jain SS,Liu Q,Raikhelkar J,Fried J,Elias P,Poterucha TJ,DeFilippis EM,Rosenblum H,Wang EY,Redfors B,Clerkin K,Griffin JM,Wan EY,Abdalla M,Bello NA,Hahn RT,Shimbo D,Weiner SD,Kirtane AJ,Kodali SK,Burkhoff D,Rabbani LE,Schwartz A,Leon MB,Homma S,Di Tullio MR,Sayer G,Uriel N,Anstey DE", + "auth_pos": 16, + "meshterms": "Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Betacoronavirus*, COVID-19, Coronavirus Infections, Coronavirus Infections/complications*, Coronavirus Infections/epidemiology, Echocardiography, Echocardiography/methods*, Female, Follow-Up Studies, Heart Diseases, Heart Diseases/diagnosis*, Heart Diseases/etiology, Heart Diseases/physiopathology, Heart Ventricles, Heart Ventricles/diagnostic imaging*, Heart Ventricles/physiopathology, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Pneumonia, Viral/complications*, Pneumonia, Viral/epidemiology, Reproducibility of Results, Retrospective Studies, SARS-CoV-2, Stroke Volume, Stroke Volume/physiology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology, Young Adult", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1874, + "user_id": 1497893077, + "artical_title": "Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms.", + "pmid": 30704832, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2020-08-14", + "author": "Esquitin KA,Khalique OK,Liu Q,Kodali SK,Marcoff L,Nazif TM,George I,Vahl TP,Leon MB,Hahn RT", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1875, + "user_id": 1497893077, + "artical_title": "Super-Responders and Nonresponders in the COAPT Trial: Not as Simple as Clip or No Clip.", + "pmid": 32854835, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-08-29", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Heart Valve Prosthesis Implantation*, Humans, Mitral Valve, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Surgical Instruments", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1876, + "user_id": 1497893077, + "artical_title": "Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.", + "pmid": 32912445, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-09-12", + "author": "Hahn RT,Asch F,Weissman NJ,Grayburn P,Kar S,Lim S,Ben-Yehuda O,Shahim B,Chen S,Liu M,Redfors B,Medvedofsky D,Puri R,Kapadia S,Sannino A,Lindenfeld J,Abraham WT,Mack MJ,Stone GW", + "auth_pos": 1, + "meshterms": "Aged, Aged, 80 and over, Echocardiography, Echocardiography/trends, Female, Follow-Up Studies, Heart Failure, Heart Failure/diagnostic imaging*, Heart Failure/epidemiology, Heart Failure/surgery*, Humans, Male, Middle Aged, Mitral Valve Insufficiency, Mitral Valve Insufficiency/diagnostic imaging*, Mitral Valve Insufficiency/epidemiology, Mitral Valve Insufficiency/surgery*, Surgical Instruments, Surgical Instruments/trends, Treatment Outcome, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1877, + "user_id": 1497893077, + "artical_title": "Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention.", + "pmid": 32912460, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-09-12", + "author": "Miura M,Alessandrini H,Alkhodair A,Attinger-Toller A,Biasco L,Lurz P,Braun D,Brochet E,Connelly KA,de Bruijn S,Denti P,Deuschl F,Estevez-Loureiro R,Fam N,Frerker C,Gavazzoni M,Hausleiter J,Himbert D,Ho E,Juliard JM,Kaple R,Besler C,Kodali S,Kreidel F,Kuck KH,Latib A,Lauten A,Monivas V,Mehr M,Muntané-Carol G,Nazif T,Nickenig G,Pedrazzini G,Philippon F,Pozzoli A,Praz F,Puri R,Rodés-Cabau J,Schäfer U,Schofer J,Sievert H,Tang GHL,Thiele H,Rommel KP,Vahanian A,Von Bardeleben RS,Webb JG,Weber M,Windecker S,Winkel M,Zuber M,Leon MB,Maisano F,Hahn RT,Taramasso M", + "auth_pos": 54, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Cardiac Catheterization/mortality, Disease Progression, Europe, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Humans, Male, North America, Patient Readmission, Recovery of Function, Registries, Retrospective Studies, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/mortality, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Retrieval Device*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1878, + "user_id": 1497893077, + "artical_title": "Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study.", + "pmid": 33046437, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2020-10-14", + "author": "Nickenig G,Weber M,Schüler R,Hausleiter J,Nabauer M,von Bardeleben RS,Sotiriou E,Schäfer U,Deuschl F,Alessandrini H,Kreidel F,Juliard JM,Brochet E,Latib A,Montorfano M,Agricola E,Baldus S,Friedrichs KP,Deo SH,Gilmore SY,Feldman T,Hahn RT,Maisano F", + "auth_pos": 22, + "meshterms": "Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Retrospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1879, + "user_id": 1497893077, + "artical_title": "Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.", + "pmid": 33059828, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-10-17", + "author": "Pibarot P,Ternacle J,Jaber WA,Salaun E,Dahou A,Asch FM,Weissman NJ,Rodriguez L,Xu K,Annabi MS,Guzzetti E,Beaudoin J,Bernier M,Leipsic J,Blanke P,Clavel MA,Rogers E,Alu MC,Douglas PS,Makkar R,Miller DC,Kapadia SR,Mack MJ,Webb JG,Kodali SK,Smith CR,Herrmann HC,Thourani VH,Leon MB,Hahn RT", + "auth_pos": 30, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Insufficiency, Aortic Valve Insufficiency/diagnosis*, Aortic Valve Insufficiency/physiopathology, Aortic Valve Insufficiency/surgery*, Bioprosthesis*, Bioprosthesis/trends, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis/trends, Humans, Male, Prosthesis Failure*, Prosthesis Failure/trends, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/instrumentation, Transcatheter Aortic Valve Replacement/methods*, Transcatheter Aortic Valve Replacement/trends", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1880, + "user_id": 1497893077, + "artical_title": "Response by Pibarot et al to Letter Regarding Article, \"Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial\".", + "pmid": 33136514, + "journal_name": "Circulation", + "date": "2020-11-03", + "author": "Pibarot P,Mack MJ,Leon MB,Hahn RT", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Heart Valve Prosthesis*, Humans", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1881, + "user_id": 1497893077, + "artical_title": "Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation.", + "pmid": 33153565, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-11-07", + "author": "Hahn RT,Kodali S,Fam N,Bapat V,Bartus K,Rodés-Cabau J,Dagenais F,Estevez-Loureiro R,Forteza A,Kapadia S,Latib A,Maisano F,McCarthy P,Navia J,Ong G,Peterson M,Petrossian G,Pozzoli A,Reinartz M,Ricciardi MJ,Robinson N,Sievert H,Taramasso M,Agarwal V,Bédard E,Tarantini G,Colli A", + "auth_pos": 1, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1882, + "user_id": 1497893077, + "artical_title": "Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.", + "pmid": 33243380, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-11-28", + "author": "Ben-Yehuda O,Shahim B,Chen S,Liu M,Redfors B,Hahn RT,Asch FM,Weissman NJ,Medvedofsky D,Puri R,Kapadia S,Sannino A,Grayburn P,Kar S,Lim S,Lindenfeld J,Abraham WT,Mack MJ,Stone GW", + "auth_pos": 6, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods*, Echocardiography, Echocardiography/methods, Female, Heart Failure*, Heart Failure/etiology, Heart Failure/physiopathology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Hypertension, Pulmonary/physiopathology, Male, Middle Aged, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/pathology, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/complications, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/physiopathology, Mitral Valve Insufficiency/surgery, Postoperative Complications*, Postoperative Complications/diagnosis, Postoperative Complications/mortality, Prognosis, Risk Assessment, Risk Assessment/methods, Risk Assessment/statistics & numerical data, Risk Factors, Severity of Illness Index, Treatment Outcome, Postoperative hypertension*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1883, + "user_id": 1497893077, + "artical_title": "Degenerative mitral stenosis: interpreting the meaning of mean gradient.", + "pmid": 33251546, + "journal_name": "European heart journal", + "date": "2020-12-01", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Calcinosis*, Heart Valve Diseases*, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Stenosis*, Mitral Valve Stenosis/diagnostic imaging, Mitral Valve Stenosis/surgery, Prognosis", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1884, + "user_id": 1497893077, + "artical_title": "Interventional Echocardiography: A New Specialty Interest Group for American Society of Echocardiography.", + "pmid": 33279018, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2020-12-07", + "author": "Hahn RT,Rubenson D,Mackensen GB,Saric M,Little SH,Mahmood F,Cole SP,Quader N", + "auth_pos": 1, + "meshterms": "Echocardiography*, Humans, Public Opinion*, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1885, + "user_id": 1497893077, + "artical_title": "Coronary protection in transcatheter aortic valve replacement: when, how and critical decision making.", + "pmid": 33312916, + "journal_name": "Annals of cardiothoracic surgery", + "date": "2020-12-15", + "author": "Hakemi EU,Wolbinski M,Hahn R,Kodali S,George I", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1886, + "user_id": 1497893077, + "artical_title": "Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.", + "pmid": 33334422, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-12-19", + "author": "Ong G,Pibarot P,Redfors B,Weissman NJ,Jaber WA,Makkar RR,Lerakis S,Gopal D,Khalique O,Kodali SK,Thourani VH,Anwaruddin S,McAndrew T,Zhang Y,Alu MC,Douglas PS,Hahn RT", + "auth_pos": 17, + "meshterms": "Aged, 80 and over, Aortic Valve Stenosis*, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery, Canada, Echocardiography, Echocardiography/methods, Echocardiography/statistics & numerical data, Female, Heart Failure, Diastolic*, Heart Failure, Diastolic/diagnosis, Heart Failure, Diastolic/etiology, Heart Failure, Diastolic/physiopathology, Humans, Male, Outcome and Process Assessment, Health Care, Patient Readmission, Patient Readmission/statistics & numerical data*, Postoperative Complications*, Postoperative Complications/diagnosis, Postoperative Complications/physiopathology, Prognosis, Survival Analysis, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects*, Transcatheter Aortic Valve Replacement/methods, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1887, + "user_id": 1497893077, + "artical_title": "Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes.", + "pmid": 33413863, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-01-09", + "author": "Davidson CJ,Lim DS,Smith RL,Kodali SK,Kipperman RM,Eleid MF,Reisman M,Whisenant B,Puthumana J,Abramson S,Fowler D,Grayburn P,Hahn RT,Koulogiannis K,Pislaru SV,Zwink T,Minder M,Dahou A,Deo SH,Vandrangi P,Deuschl F,Feldman TE,Gray WA", + "auth_pos": 13, + "meshterms": "Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Stroke Volume, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1888, + "user_id": 1497893077, + "artical_title": "Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.", + "pmid": 33478646, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-01-23", + "author": "Lurz P,Stephan von Bardeleben R,Weber M,Sitges M,Sorajja P,Hausleiter J,Denti P,Trochu JN,Nabauer M,Tang GHL,Biaggi P,Ying SW,Trusty PM,Dahou A,Hahn RT,Nickenig G", + "auth_pos": 15, + "meshterms": "Aged, Aged, 80 and over, Echocardiography, Endovascular Procedures, Endovascular Procedures/instrumentation*, Female, Humans, Male, Prospective Studies, Tricuspid Valve, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery*, Ventricular Remodeling", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1889, + "user_id": 1497893077, + "artical_title": "Hereditary angioedema patients would prefer newer-generation oral prophylaxis.", + "pmid": 33489436, + "journal_name": "Journal of drug assessment", + "date": "2021-01-26", + "author": "Geba D,Mohd Sani J,Gascon M,Hahn R,Aggarwal K,Rosselli J", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1890, + "user_id": 1497893077, + "artical_title": "Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.", + "pmid": 33509390, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-01-30", + "author": "Kodali S,Hahn RT,Eleid MF,Kipperman R,Smith R,Lim DS,Gray WA,Narang A,Pislaru SV,Koulogiannis K,Grayburn P,Fowler D,Hawthorne K,Dahou A,Deo SH,Vandrangi P,Deuschl F,Mack MJ,Leon MB,Feldman T,Davidson CJ", + "auth_pos": 2, + "meshterms": "Aged, Aged, 80 and over, Cardiac Valve Annuloplasty, Cardiac Valve Annuloplasty/instrumentation*, Cardiac Valve Annuloplasty/statistics & numerical data, Echocardiography, Endovascular Procedures, Endovascular Procedures/instrumentation*, Endovascular Procedures/statistics & numerical data, Feasibility Studies, Female, Humans, Male, Prospective Studies, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1891, + "user_id": 1497893077, + "artical_title": "Optimising a targeted test reduction intervention for patients admitted to the intensive care unit: The Targeted Intensive Care Test Ordering Cluster Trial intervention.", + "pmid": 33526330, + "journal_name": "Australian critical care : official journal of the Confederation of Australian Critical Care Nurses", + "date": "2021-02-03", + "author": "Litton E,Atkinson H,Anstey J,Anstey M,Campbell LT,Forbes A,Hahn R,Hooper K,Kasza J,Knapp S,McGain F,Ngyuen N,Pilcher D,Reddi B,Reid C,Robinson S,Thompson K,Webb S,Young P", + "auth_pos": 7, + "meshterms": "Critical Care*, Diagnostic Tests, Routine, Hospitalization, Humans, Intensive Care Units*, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1892, + "user_id": 1497893077, + "artical_title": "Reply: Looking for the Most Effective Transcatheter Treatment for Tricuspid Regurgitation: A Long Road.", + "pmid": 33541546, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-02-06", + "author": "Hahn RT,Kodali S,Fam N,Rodes-Cabau J", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1893, + "user_id": 1497893077, + "artical_title": "Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension: Insights From the TriValve Registry.", + "pmid": 33541097, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-02-06", + "author": "Muntané-Carol G,Taramasso M,Miura M,Gavazzoni M,Pozzoli A,Alessandrini H,Latib A,Attinger-Toller A,Biasco L,Braun D,Brochet E,Connelly KA,de Bruijn S,Denti P,Deuschl F,Lubos E,Ludwig S,Kalbacher D,Estevez-Loureiro R,Fam N,Frerker C,Ho E,Juliard JM,Kaple R,Kodali S,Kreidel F,Harr C,Lauten A,Lurz J,Monivas V,Mehr M,Nazif T,Nickening G,Pedrazzini G,Philippon F,Praz F,Puri R,Schäfer U,Schofer J,Sievert H,Tang GHL,Khattab AA,Andreas M,Russo M,Thiele H,Unterhuber M,Himbert D,Urena M,von Bardeleben RS,Webb JG,Weber M,Windecker S,Winkel M,Zuber M,Hausleiter J,Lurz P,Maisano F,Leon MB,Hahn RT,Rodés-Cabau J", + "auth_pos": 59, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Hypertension, Pulmonary*, Hypertension, Pulmonary/diagnosis, Hypertension, Pulmonary/etiology, Hypertension, Pulmonary/therapy, Male, New York, Registries, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/etiology, Ventricular Dysfunction, Right/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1894, + "user_id": 1497893077, + "artical_title": "Reply: TAVR Versus SAVR or Valve Versus Valve?", + "pmid": 33573753, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-02-13", + "author": "Ternacle J,Pibarot P,Hahn RT", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1895, + "user_id": 1497893077, + "artical_title": "Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation: Two Sides to Every Story.", + "pmid": 33582066, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-02-15", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/etiology, Mitral Valve Insufficiency/surgery, Predictive Value of Tests", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1896, + "user_id": 1497893077, + "artical_title": "Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience.", + "pmid": 33582084, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-02-15", + "author": "Fam NP,von Bardeleben RS,Hensey M,Kodali SK,Smith RL,Hausleiter J,Ong G,Boone R,Ruf T,George I,Szerlip M,Näbauer M,Ali FM,Moss R,Bapat V,Schnitzler K,Kreidel F,Ye J,Deva DP,Mack MJ,Grayburn PA,Peterson MD,Leon MB,Hahn RT,Webb JG", + "auth_pos": 24, + "meshterms": "Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1897, + "user_id": 1497893077, + "artical_title": "Transcatheter Tricuspid Valve Intervention in Patients with Previous Left Valve Surgery.", + "pmid": 33617978, + "journal_name": "The Canadian journal of cardiology", + "date": "2021-02-23", + "author": "Muntané-Carol G,Taramasso M,Miura M,Gavazzoni M,Pozzoli A,Alessandrini H,Latib A,Attinger-Toller A,Biasco L,Braun D,Brochet E,Connelly KA,Sievert H,Denti P,Lubos E,Ludwig S,Kalbacher D,Estevez-Loureiro R,Fam N,Frerker C,Ho E,Juliard JM,Kaple R,Kodali S,Kreidel F,Harr C,Lauten A,Lurz J,Kresoja KP,Monivas V,Mehr M,Nazif T,Nickening G,Pedrazzini G,Philippon F,Praz F,Puri R,Schäfer U,Schofer J,Tang GHL,Khattab AA,Andreas M,Russo M,Thiele H,Unterhuber M,Himbert D,Urena M,Stephan von Bardeleben R,Webb JG,Weber M,Winkel M,Zuber M,Hausleiter J,Lurz P,Maisano F,Leon MB,Hahn RT,Rodés-Cabau J", + "auth_pos": 57, + "meshterms": "Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects*, Cardiac Catheterization/methods, Cardiac Surgical Procedures, Cardiac Surgical Procedures/adverse effects, Female, Follow-Up Studies, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects*, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/statistics & numerical data, Humans, Male, Outcome Assessment, Health Care, Patient Readmission, Patient Readmission/statistics & numerical data, Registries, Registries/statistics & numerical data, Risk Assessment, Risk Factors, Severity of Illness Index, Survival Analysis, Tricuspid Valve, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/mortality, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnosis, Ventricular Dysfunction, Right/etiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1898, + "user_id": 1497893077, + "artical_title": "Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.", + "pmid": 33663731, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-03-06", + "author": "Leon MB,Mack MJ,Hahn RT,Thourani VH,Makkar R,Kodali SK,Alu MC,Madhavan MV,Chau KH,Russo M,Kapadia SR,Malaisrie SC,Cohen DJ,Blanke P,Leipsic JA,Williams MR,McCabe JM,Brown DL,Babaliaros V,Goldman S,Herrmann HC,Szeto WY,Genereux P,Pershad A,Lu M,Webb JG,Smith CR,Pibarot P", + "auth_pos": 3, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality*, Aortic Valve Stenosis/surgery*, Female, Follow-Up Studies, Humans, Male, Postoperative Complications, Postoperative Complications/diagnostic imaging, Postoperative Complications/mortality*, Risk Factors, Survival Rate, Survival Rate/trends, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/mortality*, Transcatheter Aortic Valve Replacement/trends*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1899, + "user_id": 1497893077, + "artical_title": "Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic Review.", + "pmid": 33728929, + "journal_name": "Journal of the American Heart Association", + "date": "2021-03-18", + "author": "Alexis SL,Malik AH,El-Eshmawi A,George I,Sengupta A,Kodali SK,Hahn RT,Khalique OK,Zaid S,Guerrero M,Bapat VN,Leon MB,Adams DH,Tang GHL", + "auth_pos": 7, + "meshterms": "Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome, Aged, Calcinosis*, Calcinosis/complications, Calcinosis/diagnosis, Calcinosis/physiopathology, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/etiology, Heart Valve Diseases/physiopathology, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Humans, Mitral Valve, Mitral Valve/pathology, Mitral Valve/surgery*, Postoperative Complications, Postoperative Complications/mortality*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1900, + "user_id": 1497893077, + "artical_title": "Reply: Entrapped Leads After Transcatheter Tricuspid Valve Replacement.", + "pmid": 33736786, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-03-20", + "author": "Hahn RT,Kodali S,Fam N,Rodés-Cabau J", + "auth_pos": 1, + "meshterms": "Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1901, + "user_id": 1497893077, + "artical_title": "Transcatheter Tricuspid Repair With the Use of 4-Dimensional Intracardiac Echocardiography.", + "pmid": 33744150, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-03-22", + "author": "Davidson CJ,Abramson S,Smith RL,Kodali SK,Kipperman RM,Eleid MF,Reisman M,Whisenant BK,Puthumana J,Fowler D,Grayburn PA,Hahn RT,Koulogiannis K,Pislaru SV,Zwink T,Minder M,Deuschl F,Feldman T,Gray WA,Lim DS", + "auth_pos": 12, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1902, + "user_id": 1497893077, + "artical_title": "Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature.", + "pmid": 33744134, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-03-22", + "author": "Hahn RT,Weckbach LT,Noack T,Hamid N,Kitamura M,Bae R,Lurz P,Kodali SK,Sorajja P,Hausleiter J,Nabauer M", + "auth_pos": 1, + "meshterms": "Aged, Aged, 80 and over, Echocardiography*, Europe, Female, Humans, Male, Predictive Value of Tests, Retrospective Studies, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1903, + "user_id": 1497893077, + "artical_title": "Anatomic classification of mitral annular calcification for surgical and transcatheter mitral valve replacement.", + "pmid": 33797788, + "journal_name": "Journal of cardiac surgery", + "date": "2021-04-03", + "author": "Alexis SL,Alzahrani TS,Akkoc D,Salna M,Khalique OK,El-Eshmawi A,Sengupta A,Hahn RT,Lerakis S,Kini A,Sharma SK,Dangas GD,Kodali SK,Leon MB,Adams DH,Bapat VB,George I,Tang GHL", + "auth_pos": 8, + "meshterms": "Cardiac Catheterization, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Treatment Outcome, Ventricular Outflow Obstruction*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1904, + "user_id": 1497893077, + "artical_title": "Prognostic Value of Feature-Tracking Right Ventricular Longitudinal Strain in Severe Functional Tricuspid Regurgitation: A Multicenter Study.", + "pmid": 33865769, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-04-19", + "author": "Romano S,Dell'atti D,Judd RM,Kim RJ,Weinsaft JW,Kim J,Heitner JF,Hahn RT,Farzaneh-Far A", + "auth_pos": 8, + "meshterms": "Heart Ventricles, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Heart Ventricles, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Heart Ventricles, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Heart Ventricles, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Heart Ventricles, Humans, Predictive Value of Tests, Prognosis, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1905, + "user_id": 1497893077, + "artical_title": "Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.", + "pmid": 33871579, + "journal_name": "European heart journal", + "date": "2021-04-20", + "author": "Généreux P,Piazza N,Alu MC,Nazif T,Hahn RT,Pibarot P,Bax JJ,Leipsic JA,Blanke P,Blackstone EH,Finn MT,Kapadia S,Linke A,Mack MJ,Makkar R,Mehran R,Popma JJ,Reardon M,Rodes-Cabau J,Van Mieghem NM,Webb JG,Cohen DJ,Leon MB", + "auth_pos": 6, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Cardiac Catheterization, Endpoint Determination, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Risk Assessment, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1906, + "user_id": 1497893077, + "artical_title": "Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes.", + "pmid": 33888229, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-04-24", + "author": "Guerrero M,Wang DD,Eleid MF,Pursnani A,Salinger M,Russell HM,Kodali SK,George I,Bapat VN,Dangas GD,Tang GHL,Inglesis I,Meduri CU,Palacios I,Reisman M,Whisenant BK,Jermihov A,Kaptzan T,Lewis BR,Tommaso C,Krause P,Thaden J,Oh JK,Douglas PS,Hahn RT,Leon MB,Rihal CS,Feldman T,O'Neill WW", + "auth_pos": 25, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Cardiac Catheterization, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Male, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1907, + "user_id": 1497893077, + "artical_title": "Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes.", + "pmid": 33888230, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-04-24", + "author": "Guerrero M,Wang DD,Pursnani A,Salinger M,Russell HM,Eleid M,Chakravarty T,Ng MH,Kodali SK,Meduri CU,Pershad A,Satler L,Waksman R,Palacios I,Smalling R,Reisman M,Gegenhuber M,Kaptzan T,Lewis B,Tommaso C,Krause P,Thaden J,Oh J,Douglas PS,Hahn RT,Kar S,Makkar R,Leon MB,Feldman T,Rihal C,O'Neill WW", + "auth_pos": 25, + "meshterms": "Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Annuloplasty*, Mitral Valve Annuloplasty/adverse effects, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Prospective Studies, Prosthesis Design, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1908, + "user_id": 1497893077, + "artical_title": "Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes.", + "pmid": 33888231, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-04-24", + "author": "Guerrero M,Pursnani A,Narang A,Salinger M,Wang DD,Eleid M,Kodali SK,George I,Satler L,Waksman R,Meduri CU,Rajagopal V,Inglessis I,Palacios I,Reisman M,Eng MH,Russell HM,Pershad A,Fang K,Kar S,Makkar R,Saucedo J,Pearson P,Bokhary U,Kaptzan T,Lewis B,Tommaso C,Krause P,Thaden J,Oh J,Lang RM,Hahn RT,Leon MB,O'Neill WW,Feldman T,Rihal C", + "auth_pos": 32, + "meshterms": "Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome, Aged, Aged, 80 and over, Bioprosthesis*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Mitral Valve Annuloplasty*, Prospective Studies, Prosthesis Design, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1909, + "user_id": 1497893077, + "artical_title": "Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.", + "pmid": 33888385, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-04-24", + "author": "Généreux P,Piazza N,Alu MC,Nazif T,Hahn RT,Pibarot P,Bax JJ,Leipsic JA,Blanke P,Blackstone EH,Finn MT,Kapadia S,Linke A,Mack MJ,Makkar R,Mehran R,Popma JJ,Reardon M,Rodes-Cabau J,Van Mieghem NM,Webb JG,Cohen DJ,Leon MB", + "auth_pos": 6, + "meshterms": "Aortic Valve Disease, Aortic Valve Disease/mortality, Aortic Valve Disease/surgery*, Cardiology, Cardiology/standards*, Clinical Studies as Topic, Clinical Studies as Topic/standards*, Humans, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1910, + "user_id": 1497893077, + "artical_title": "Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis.", + "pmid": 33956637, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-05-07", + "author": "Schlotter F,Miura M,Kresoja KP,Alushi B,Alessandrini H,Attinger-Toller A,Besler C,Biasco L,Braun D,Brochet E,Connelly KA,de Bruijn S,Denti P,Estevez-Loureiro R,Fam N,Gavazzoni M,Himbert D,Ho EC,Juliard JM,Kalbacher D,Kaple R,Kreidel F,Latib A,Lubos E,Ludwig S,Mehr M,Monivas V,Nazif TM,Nickenig G,Pedrazzini G,Pozzoli A,Praz F,Puri R,Rodés-Cabau J,Rommel KP,Schäfer U,Schofer J,Sievert H,Tang GHL,Thiele H,Unterhuber M,Vahanian A,von Bardeleben RS,von Roeder M,Webb JG,Weber M,Wild MG,Windecker S,Zuber M,Hausleiter J,Maisano F,Leon MB,Hahn RT,Lauten A,Taramasso M,Lurz P", + "auth_pos": 53, + "meshterms": "Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Ventricular Dysfunction, Right/therapy, Ventricular Function, Right", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1911, + "user_id": 1497893077, + "artical_title": "Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.", + "pmid": 33980327, + "journal_name": "Allergy and asthma proceedings", + "date": "2021-05-14", + "author": "Radojicic C,Riedl MA,Craig TJ,Best JM,Rosselli J,Hahn R,Banerji A", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1912, + "user_id": 1497893077, + "artical_title": "Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.", + "pmid": 33980328, + "journal_name": "Allergy and asthma proceedings", + "date": "2021-05-14", + "author": "Craig TJ,Banerji A,Riedl MA,Best JM,Rosselli J,Hahn R,Radojicic C", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1913, + "user_id": 1497893077, + "artical_title": "Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.", + "pmid": 33980329, + "journal_name": "Allergy and asthma proceedings", + "date": "2021-05-14", + "author": "Riedl MA,Craig TJ,Banerji A,Aggarwal K,Best JM,Rosselli J,Hahn R,Radojicic C", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1914, + "user_id": 1497893077, + "artical_title": "Real world outcomes using 20?mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29?mm)-a propensity matched analysis.", + "pmid": 33984182, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2021-05-14", + "author": "Eng MH,Abbas AE,Hahn RT,Lee J,Wang DD,Eleid MF,O'Neill WW", + "auth_pos": 3, + "meshterms": "Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1915, + "user_id": 1497893077, + "artical_title": "Treatment Goals for Transcatheter Edge-to-Edge Mitral Valve Repair: Are Optimal Results Always Optimum?", + "pmid": 33992548, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-05-17", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1916, + "user_id": 1497893077, + "artical_title": "Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study.", + "pmid": 34031021, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-05-26", + "author": "Nickenig G,Friedrichs KP,Baldus S,Arnold M,Seidler T,Hakmi S,Linke A,Schäfer U,Dreger H,Reinthaler M,von Bardeleben RS,Möllmann H,Weber M,Roder F,Körber MI,Landendinger M,Wolf F,Alessandrini H,Sveric K,Schewel D,Romero-Dorta E,Kasner M,Dahou A,Hahn RT,Windecker S", + "auth_pos": 24, + "meshterms": "Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Follow-Up Studies, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1917, + "user_id": 1497893077, + "artical_title": "Impact of Tricuspid Valve Morphology on Clinical Outcomes After Transcatheter Edge-to-Edge Repair.", + "pmid": 34052157, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-05-31", + "author": "Kitamura M,Kresoja KP,Besler C,Leontyev S,Kiefer P,Rommel KP,Otto W,Forner AF,Ender J,Holzhey DM,Abdel-Wahab M,Thiele H,Borger MA,Hahn RT,Lurz P,Noack T", + "auth_pos": 14, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1918, + "user_id": 1497893077, + "artical_title": "Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System.", + "pmid": 34112460, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-06-12", + "author": "Ruf TF,Hahn RT,Kreidel F,Beiras-Fernandez A,Hell M,Gerdes P,da Roche E Silva JG,Vosseler M,Geyer M,Tamm A,Münzel T,von Bardeleben RS", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1919, + "user_id": 1497893077, + "artical_title": "Inter-Ethnic Differences in Cardiovascular Disease: Impact on Therapies and Outcomes.", + "pmid": 36338373, + "journal_name": "JACC. Asia", + "date": "2021-06-15", + "author": "Hahn RT,Wan EY,Leon MB", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1920, + "user_id": 1497893077, + "artical_title": "Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement.", + "pmid": 34130476, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-06-17", + "author": "Herrmann HC,Cohen DJ,Hahn RT,Babaliaros VC,Yu X,Makkar R,McCabe J,Szerlip M,Kapadia S,Russo M,Malaisrie SC,Webb JG,Szeto WY,Kodali S,Thourani VH,Mack MJ,Leon MB", + "auth_pos": 3, + "meshterms": "Anesthesia, General, Anesthesia, General/adverse effects, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Conscious Sedation, Humans, Retrospective Studies, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1921, + "user_id": 1497893077, + "artical_title": "State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL Repair System.", + "pmid": 34136901, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2021-06-18", + "author": "Hahn RT,Kodali SK", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1922, + "user_id": 1497893077, + "artical_title": "Impact of Predilation During Transcatheter Aortic Valve Replacement: Insights From the PARTNER 3 Trial.", + "pmid": 34139864, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-06-19", + "author": "Ternacle J,Al-Azizi K,Szerlip M,Potluri S,Hamandi M,Blanke P,Leipsic J,Dahou A,Salaun E,Vincent F,Rogers E,Alu MC,Lu M,Yu X,Thourani VH,Hahn RT,Leon MB,Pibarot P,Mack MJ", + "auth_pos": 16, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1923, + "user_id": 1497893077, + "artical_title": "Topologic Data Analysis and Machine Learning: Defining the Aortic Valvular-Ventricular Disease Terrain.", + "pmid": 34147435, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2021-06-21", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1924, + "user_id": 1497893077, + "artical_title": "Transcatheter Left Atrial Appendage Closure Using Preprocedural Computed Tomography and Intraprocedural 4-Dimensional Intracardiac Echocardiography.", + "pmid": 34157847, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-06-24", + "author": "Ranard LS,Khalique OK,Donald E,Agarwal V,Hamid N,Hahn RT,Ng V,Brady M,Gurung A,Ali ZA,Leon MB,Sommer R,Vahl TP", + "auth_pos": 6, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal, Humans, Stroke*, Tomography, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1925, + "user_id": 1497893077, + "artical_title": "Computational analysis of virtual echocardiographic assessment of functional mitral regurgitation for validation of proximal isovelocity surface area (PISA) methods.", + "pmid": 34214636, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2021-07-03", + "author": "Qin T,Caballero A,Hahn RT,McKay R,Sun W", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1926, + "user_id": 1497893077, + "artical_title": "Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials.", + "pmid": 34217631, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-07-05", + "author": "Hahn RT,Douglas PS,Jaber WA,Leipsic J,Kapadia S,Thourani VH,Makkar R,Kodali S,Clavel MA,Khalique OK,Weissman NJ,Blanke P,Chen Y,Smith CR,Mack MJ,Leon MB,Pibarot P", + "auth_pos": 1, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1927, + "user_id": 1497893077, + "artical_title": "Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry.", + "pmid": 34238557, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-07-10", + "author": "Ternacle J,Pibarot P,Herrmann HC,Kodali S,Leipsic J,Blanke P,Jaber W,Mack MJ,Clavel MA,Salaun E,Guzzetti E,Annabi MS,Bernier M,Beaudoin J,Khalique OK,Weissman NJ,Douglas P,Bax J,Dahou A,Xu K,Alu M,Rogers E,Leon M,Thourani VH,Abbas AE,Hahn RT", + "auth_pos": 26, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prosthesis Design, Registries, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Lung Ultrasound Score*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1928, + "user_id": 1497893077, + "artical_title": "Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial.", + "pmid": 34266311, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-07-17", + "author": "Cremer PC,Wang TKM,Rodriguez LL,Lindman BR,Zhang Y,Zajarias A,Hahn RT,Lerakis S,Malaisrie SC,Douglas PS,Pibarot P,Svensson LG,Kapadia S,Leon MB,Jaber WA", + "auth_pos": 7, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Incidence, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1929, + "user_id": 1497893077, + "artical_title": "Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography.", + "pmid": 34280494, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2021-07-20", + "author": "Hahn R,Saric M,Faletra FF,Garg R,Gillam LD,Horton K,Khalique O,Little SH,Mackensen GB,Oh J,Quader N,Safi L,Scalia GM,Lang RM", + "auth_pos": 1, + "meshterms": "Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States, Cardiac Surgical Procedures*, Echocardiography, Echocardiography, Transesophageal*, Humans, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1930, + "user_id": 1497893077, + "artical_title": "Edge-to-Edge Tricuspid Valve Repair: Closing the Gap on Tricuspid Regurgitation.", + "pmid": 34317422, + "journal_name": "JACC. Case reports", + "date": "2021-07-29", + "author": "Lebehn M,Nikolou E,Grapsa J,Hahn RT", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1931, + "user_id": 1497893077, + "artical_title": "Treatment of Acute Aortic Insufficiency With a Dedicated Device.", + "pmid": 34317595, + "journal_name": "JACC. Case reports", + "date": "2021-07-29", + "author": "Ng VG,Khalique OK,Nazif T,Patel A,Hamid N,George I,Bapat V,Hahn R,Kodali S,Vahl TP", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1932, + "user_id": 1497893077, + "artical_title": "Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis.", + "pmid": 34376060, + "journal_name": "Journal of the American Heart Association", + "date": "2021-08-12", + "author": "Brener MI,Olds A,Nemeth S,Kurlansky P,Nazif TM,Vahl TP,Khalique OK,Hamid NB,Patel A,Ng VG,Chen S,Cahill TJ,Rahim HM,Hahn RT,Bapat V,Sarraf M,Ahmed MI,Leon MB,Kodali S,Eudailey KW,George I", + "auth_pos": 14, + "meshterms": "Aged, Aged, 80 and over, Alabama, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Brachiocephalic Trunk*, Brachiocephalic Trunk/diagnostic imaging, Catheterization, Peripheral*, Catheterization, Peripheral/adverse effects, Catheterization, Peripheral/mortality, Feasibility Studies, Female, Femoral Artery*, Femoral Artery/diagnostic imaging, Hospital Mortality, Humans, Male, New York City, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/therapy, Propensity Score, Prospective Studies, Punctures, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1933, + "user_id": 1497893077, + "artical_title": "Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.", + "pmid": 34387093, + "journal_name": "Journal of the American Heart Association", + "date": "2021-08-14", + "author": "Ogami T,Kurlansky P,Takayama H,Ning Y,Ali ZA,Nazif TM,Vahl TP,Khalique O,Patel A,Hamid N,Ng VG,Hahn RT,Avgerinos DV,Leon MB,Kodali SK,George I", + "auth_pos": 12, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery*, Databases, Factual, Female, Hospital Mortality, Humans, Kidney Failure, Chronic, Kidney Failure, Chronic/diagnosis, Kidney Failure, Chronic/epidemiology*, Kidney Failure, Chronic/mortality, Male, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1934, + "user_id": 1497893077, + "artical_title": "Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement.", + "pmid": 34387097, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2021-08-14", + "author": "Abbas AE,Ternacle J,Pibarot P,Xu K,Alu M,Rogers E,Hahn RT,Leon M,Thourani VH", + "auth_pos": 7, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Doppler, Pulsed, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Hemodynamics*, Humans, Male, Patient Readmission, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/physiopathology, Postoperative Complications/therapy, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Doppler, Pulsed, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Hemodynamics*, Humans, Male, Patient Readmission, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/physiopathology, Postoperative Complications/therapy, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Doppler, Pulsed, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Hemodynamics*, Humans, Male, Patient Readmission, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/physiopathology, Postoperative Complications/therapy, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/surgery*, Aortic Valve Stenosis, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/surgery*, Echocardiography, Doppler, Pulsed, Female, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation*, Hemodynamics*, Humans, Male, Patient Readmission, Postoperative Complications, Postoperative Complications/mortality, Postoperative Complications/physiopathology, Postoperative Complications/therapy, Randomized Controlled Trials as Topic, Registries, Risk Assessment, Risk Factors, Time Factors, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/instrumentation*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1935, + "user_id": 1497893077, + "artical_title": "Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States.", + "pmid": 34433290, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2021-08-27", + "author": "Nazif TM,Cahill TJ,Daniels D,McCabe JM,Reisman M,Chakravarty T,Makkar R,Krishnaswamy A,Kapadia S,Chehab BM,Wang J,Spies C,Rodriguez E,Kaneko T,Hahn RT,Leon MB,George I", + "auth_pos": 15, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1936, + "user_id": 1497893077, + "artical_title": "Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study.", + "pmid": 34483095, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-09-07", + "author": "Chau KH,Chen S,Crowley A,Redfors B,Li D,Hahn RT,Douglas PS,Alu MC,Finn MT,Kodali S,Jaber WA,Rodriguez LL,Thourani VH,Pibarot P,Leon MB", + "auth_pos": 6, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1937, + "user_id": 1497893077, + "artical_title": "Predicting Outcomes for Isolated Tricuspid Regurgitation: Multimodality Imaging and Clinical Assessment.", + "pmid": 34521211, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2021-09-16", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Heart Valve Prosthesis Implantation*, Humans, Multimodal Imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1938, + "user_id": 1497893077, + "artical_title": "Commissural Alignment After Transfemoral Transcatheter Aortic Valve Replacement With the JenaValve Trilogy System.", + "pmid": 34556282, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-09-25", + "author": "Hamid N,Ranard LS,Khalique OK,Hahn RT,Nazif TM,George I,Ng V,Leon MB,Kodali SK,Vahl TP", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1939, + "user_id": 1497893077, + "artical_title": "5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease.", + "pmid": 34556273, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-09-25", + "author": "Garcia S,Cubeddu RJ,Hahn RT,Ternacle J,Kapadia SR,Kodali SK,Thourani VH,Jaber WA,Asher CR,Elmariah S,Makkar R,Webb JG,Herrmann HC,Lu M,Devireddy CM,Malaisrie SC,Smith CR,Mack MJ,Sorajja P,Cavalcante JL,Goessl M,Shroff GR,Leon MB,Pibarot P", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Humans, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Risk Factors, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1940, + "user_id": 1497893077, + "artical_title": "Multimodality Imaging of the Anatomy of Tricuspid Valve.", + "pmid": 34564125, + "journal_name": "Journal of cardiovascular development and disease", + "date": "2021-09-27", + "author": "Schlossbauer SA,Faletra FF,Paiocchi VL,Leo LA,Franciosi G,Bonanni M,Angelini G,Pavon AG,Ferrari E,Ho SY,Hahn RT", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1941, + "user_id": 1497893077, + "artical_title": "Is it Time to Formalize Training for Interventional Echocardiography and Imaging for Structural Heart Disease Procedures?", + "pmid": 34607647, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2021-10-06", + "author": "Quader N,Hahn RT,Saric M,Little S", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1942, + "user_id": 1497893077, + "artical_title": "Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3.", + "pmid": 34620395, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-10-09", + "author": "Ihdayhid AR,Leipsic J,Hahn RT,Pibarot P,Thourani V,Makkar R,Kodali S,Russo M,Kapadia S,Chen Y,Mack M,Webb J,Bax J,Leon MB,Blanke P", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1943, + "user_id": 1497893077, + "artical_title": "Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial.", + "pmid": 34674862, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-10-23", + "author": "Brener MI,Grayburn P,Lindenfeld J,Burkhoff D,Liu M,Zhou Z,Alu MC,Medvedofsky DA,Asch FM,Weissman NJ,Bax J,Abraham W,Mack MJ,Stone GW,Hahn RT", + "auth_pos": 15, + "meshterms": "Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome, Echocardiography, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Hypertension, Pulmonary*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1944, + "user_id": 1497893077, + "artical_title": "Transcatheter treatment for tricuspid valve disease.", + "pmid": 34796878, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-11-20", + "author": "Praz F,Muraru D,Kreidel F,Lurz P,Hahn RT,Delgado V,Senni M,von Bardeleben RS,Nickenig G,Hausleiter J,Mangieri A,Zamorano JL,Prendergast BD,Maisano F", + "auth_pos": 5, + "meshterms": "Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left, Heart Valve Diseases*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Stroke Volume, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1945, + "user_id": 1497893077, + "artical_title": "Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve Interventions.", + "pmid": 34854068, + "journal_name": "Cardiovascular engineering and technology", + "date": "2021-12-03", + "author": "Khalique OK,Jelnin V,Hueske A,Lawlor M,Leon MB,Kodali SK,Akkoc D,Pettway E,Hahn RT,Hamid NB,George I,Patel A,Ng V,Vahl TP,Nazif TM,Siefert AW", + "auth_pos": 9, + "meshterms": "Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Computed Tomography Angiography, Computed Tomography Angiography/methods, Echocardiography, Hemodynamics, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1946, + "user_id": 1497893077, + "artical_title": "Standardised definitions of transcatheter edge-to-edge repair leaflet adverse events: identifying complications or complicating identification?", + "pmid": 34870599, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-12-07", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1947, + "user_id": 1497893077, + "artical_title": "Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations.", + "pmid": 34963308, + "journal_name": "Circulation. Heart failure", + "date": "2021-12-30", + "author": "Brener MI,Masoumi A,Ng VG,Tello K,Bastos MB,Cornwell WK,Hsu S,Tedford RJ,Lurz P,Rommel KP,Kresoja KP,Nagueh SF,Kanwar MK,Kapur NK,Hiremath G,Sarraf M,Van Den Enden AJM,Van Mieghem NM,Heerdt PM,Hahn RT,Kodali SK,Sayer GT,Uriel N,Burkhoff D", + "auth_pos": 20, + "meshterms": "Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*, Heart Failure, Heart Failure/physiopathology*, Heart Ventricles, Heart Ventricles/physiopathology, Hemodynamics, Hemodynamics/physiology, Humans, Stroke Volume, Stroke Volume/physiology*, Ventricular Dysfunction, Right, Ventricular Dysfunction, Right/physiopathology, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Function, Right, Ventricular Function, Right/physiology*, Ventricular Pressure, Ventricular Pressure/physiology*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1948, + "user_id": 1497893077, + "artical_title": "A Novel Approach to Quantification of Aortic Regurgitation in Left Ventricular Assist Device.", + "pmid": 35033438, + "journal_name": "Journal of cardiothoracic and vascular anesthesia", + "date": "2022-01-17", + "author": "Han H,Hong E,Tat E,Hahn RT,Cobey F", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/surgery, Heart Failure*, Heart-Assist Devices*, Humans, Treatment Outcome, Ventricular Function, Left, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/surgery, Heart Failure*, Heart-Assist Devices*, Humans, Treatment Outcome, Ventricular Function, Left, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/surgery, Heart Failure*, Heart-Assist Devices*, Humans, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1949, + "user_id": 1497893077, + "artical_title": "Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials.", + "pmid": 35041482, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2022-01-19", + "author": "Vincent F,Thourani VH,Ternacle J,Redfors B,Cohen DJ,Hahn RT,Li D,Crowley A,Webb JG,Mack MJ,Kapadia S,Russo M,Smith CR,Alu MC,Leon MB,Pibarot P", + "auth_pos": 6, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Humans, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1950, + "user_id": 1497893077, + "artical_title": "Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.", + "pmid": 35066989, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-01-24", + "author": "Lawlor MK,Hamid N,Kampaktsis P,Ning Y,Wang V,Akkoc D,Dershowitz L,Placheril E,Vahl TP,Nazif T,Khalique O,Ng V,Brener MI,Burkhoff D,Dickstein M,Kurlansky P,Leon MB,Hahn RT,Kodali S,George I", + "auth_pos": 18, + "meshterms": "Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Incidence, Retrospective Studies, Shock, Cardiogenic, Shock, Cardiogenic/diagnosis, Shock, Cardiogenic/epidemiology, Shock, Cardiogenic/therapy, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1951, + "user_id": 1497893077, + "artical_title": "Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.", + "pmid": 35084803, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-01-28", + "author": "Ranard LS,Vahl TP,Chung CJ,Sadri S,Khalique OK,Hamid N,Nazif T,George I,Ng V,Patel A,Rezende CP,Reisman M,Latib A,Hausleiter J,Sorajja P,Bapat VN,Tang GHL,Davidson CJ,Zahr F,Makkar R,Fam NP,Granada JF,Leon MB,Hahn RT,Kodali S", + "auth_pos": 24, + "meshterms": "Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging, Aged, Aged, 80 and over, Heart Valve Prosthesis Implantation*, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Vena Cava, Inferior, Vena Cava, Inferior/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1952, + "user_id": 1497893077, + "artical_title": "Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair.", + "pmid": 35115101, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-02-05", + "author": "Brener MI,Lurz P,Hausleiter J,Rodés-Cabau J,Fam N,Kodali SK,Rommel KP,Muntané-Carol G,Gavazzoni M,Nazif TM,Pozzoli A,Alessandrini H,Latib A,Biasco L,Braun D,Brochet E,Denti P,Lubos E,Ludwig S,Kalbacher D,Estevez-Loureiro R,Connelly KA,Frerker C,Ho EC,Juliard JM,Harr C,Monivas V,Nickenig G,Pedrazzini G,Philippon F,Praz F,Puri R,Schofer J,Sievert H,Tang GHL,Andreas M,Thiele H,Unterhuber M,Himbert D,Alcázar MU,Von Bardeleben RS,Windecker S,Wild MG,Maisano F,Leon MB,Taramasso M,Hahn RT", + "auth_pos": 47, + "meshterms": "Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*, Aged, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Male, Postoperative Period, Pulmonary Artery, Pulmonary Artery/physiopathology*, Pulmonary Wedge Pressure, Pulmonary Wedge Pressure/physiology*, Registries, Retrospective Studies, Stroke Volume, Stroke Volume/physiology*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery*, Tricuspid Valve Insufficiency, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/surgery*, Ventricular Function, Left, Ventricular Function, Right, Ventricular Function, Right/physiology*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1953, + "user_id": 1497893077, + "artical_title": "Reply: Pathophysiological Entity or Imaging-Based Risk Score?: A Controversial Interpretation of the Ratio.", + "pmid": 35144796, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-02-12", + "author": "Brener MI,Grayburn P,Mack MJ,Stone GW,Hahn RT", + "auth_pos": 5, + "meshterms": "Humans, Risk Factors, Treatment Outcome*, Humans, Risk Factors, Treatment Outcome*, Humans, Risk Factors, Treatment Outcome*, Humans, Risk Factors, Treatment Outcome*, Humans, Risk Factors, Treatment Outcome*, Humans, Risk Factors, Treatment Outcome*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1954, + "user_id": 1497893077, + "artical_title": "Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome.", + "pmid": 35157070, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2022-02-15", + "author": "Hahn RT,Badano LP,Bartko PE,Muraru D,Maisano F,Zamorano JL,Donal E", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/therapy, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/therapy, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/therapy, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/therapy, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Humans, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1955, + "user_id": 1497893077, + "artical_title": "Sex Differences and Similarities in Valvular Heart Disease.", + "pmid": 35175844, + "journal_name": "Circulation research", + "date": "2022-02-18", + "author": "DesJardin JT,Chikwe J,Hahn RT,Hung JW,Delling FN", + "auth_pos": 3, + "meshterms": "Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Heart Valve Diseases, Heart Valve Diseases/diagnostic imaging*, Heart Valve Diseases/physiopathology, Heart Valve Diseases/therapy*, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Humans, Male, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Cardiovascular/diagnostic imaging*, Pregnancy Complications, Cardiovascular/physiopathology, Pregnancy Complications, Cardiovascular/therapy*, Sex Characteristics*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1956, + "user_id": 1497893077, + "artical_title": "Unearthing the Tunnel.", + "pmid": 35199025, + "journal_name": "JACC. Case reports", + "date": "2022-02-25", + "author": "Nemshah Y,Sharma A,Hamid N,Rahim H,Ng V,George I,Nazif T,Vahl T,Kodali S,Hahn R,Khalique O", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1957, + "user_id": 1497893077, + "artical_title": "Tricuspid Valve Morphology and Outcome in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair.", + "pmid": 35272783, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-03-12", + "author": "Weckbach LT,Orban M,Kitamura M,Hamid N,Lurz P,Hahn RT,Sorajja P,Näbauer M,Noack T,Hausleiter J", + "auth_pos": 6, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Surgical Procedures*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1958, + "user_id": 1497893077, + "artical_title": "Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results.", + "pmid": 35272771, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-03-12", + "author": "Kodali S,Hahn RT,George I,Davidson CJ,Narang A,Zahr F,Chadderdon S,Smith R,Grayburn PA,O'Neill WW,Wang DD,Herrmann H,Silvestry F,Elmariah S,Inglessis I,Passeri J,Lim DS,Salerno M,Makar M,Mack MJ,Leon MB,Makkar R", + "auth_pos": 2, + "meshterms": "Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1959, + "user_id": 1497893077, + "artical_title": "Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience.", + "pmid": 35272772, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-03-12", + "author": "Webb JG,Chuang AM,Meier D,von Bardeleben RS,Kodali SK,Smith RL,Hausleiter J,Ong G,Boone R,Ruf T,George I,Szerlip M,Näbauer M,Ali FM,Moss R,Kreidel F,Bapat V,Schnitzler K,Ye J,Wild M,Akodad M,Deva DP,Chatfield AG,Mack MJ,Grayburn PA,Peterson MD,Makkar R,Leon MB,Hahn RT,Fam NP", + "auth_pos": 29, + "meshterms": "Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Aged, 80 and over, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Female, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Recovery of Function, Severity of Illness Index, Time Factors, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1960, + "user_id": 1497893077, + "artical_title": "The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.", + "pmid": 35272777, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-03-12", + "author": "Williams MR,Jilaihawi H,Makkar R,O'Neill WW,Guyton R,Malaisrie SC,Brown DL,Blanke P,Leipsic JA,Pibarot P,Hahn RT,Leon MB,Cohen DJ,Bax JJ,Kodali SK,Mack MJ,Lu M,Webb JG", + "auth_pos": 11, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/etiology, Aortic Valve Stenosis/surgery, Humans, Prospective Studies, Registries, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1961, + "user_id": 1497893077, + "artical_title": "Improved Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by Cardiac Computed Tomography Angiography at 45 Days Postimplant.", + "pmid": 35313734, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2022-03-23", + "author": "Ranard LS,Guber K,Khalique OK,Leb J,Hamid N,Donald E,Hahn RT,Forman J,Ng V,Leon MB,Sommer R,Vahl TP", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1962, + "user_id": 1497893077, + "artical_title": "Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.", + "pmid": 35353129, + "journal_name": "JAMA cardiology", + "date": "2022-03-31", + "author": "Zhou M,Ta S,Hahn RT,Hsi DH,Leon MB,Hu R,Zhang J,Zuo L,Li J,Wang J,Wang B,Zhu X,Liu J,Han Y,Li X,Xu B,Zhang L,Hou L,Han C,Liu J,Liu L", + "auth_pos": 3, + "meshterms": "Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome, Cardiomyopathy, Hypertrophic*, Female, Humans, Male, Middle Aged, Pericardial Effusion*, Radiofrequency Ablation*, Stroke*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1963, + "user_id": 1497893077, + "artical_title": "New ESC/EACTS Guideline Recommendations for Treatment of Secondary Mitral Regurgitation: Reflections on the Evidence.", + "pmid": 35385192, + "journal_name": "European journal of heart failure", + "date": "2022-04-07", + "author": "Frerker C,Karam N,Hahn RT,Thiele H,Stone GW,Treede H,Hausleiter J", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1964, + "user_id": 1497893077, + "artical_title": "5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses.", + "pmid": 35393102, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-04-09", + "author": "Hahn RT,Webb J,Pibarot P,Ternacle J,Herrmann HC,Suri RM,Dvir D,Leipsic J,Blanke P,Jaber WA,Kodali S,Kapadia S,Makkar R,Thourani V,Williams M,Salaun E,Vincent F,Xu K,Leon MB,Mack M", + "auth_pos": 1, + "meshterms": "Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnostic imaging, Aortic Valve Insufficiency/etiology, Aortic Valve Insufficiency/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Follow-Up Studies, Heart Valve Prosthesis*, Humans, Prosthesis Failure, Quality of Life, Registries, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1965, + "user_id": 1497893077, + "artical_title": "Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7.", + "pmid": 35422247, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-04-16", + "author": "Hahn RT,Clavel MA,Mascherbauer J,Mick SL,Asgar AW,Douglas PS", + "auth_pos": 1, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Female, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Hemodynamics, Humans, Male, Sex Factors, Aortic Valve, Aortic Valve/surgery, Female, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Hemodynamics, Humans, Male, Sex Factors, Aortic Valve, Aortic Valve/surgery, Female, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Hemodynamics, Humans, Male, Sex Factors, Aortic Valve, Aortic Valve/surgery, Female, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis Implantation*, Hemodynamics, Humans, Male, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1966, + "user_id": 1497893077, + "artical_title": "Transmitral Gradients Following Transcatheter Edge-to-Edge Repair: Are Mean Gradients Meaningful?", + "pmid": 35430172, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-04-18", + "author": "Hahn RT,Hausleiter J", + "auth_pos": 1, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Valve Prosthesis Implantation*, Humans, Mitral Valve, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1967, + "user_id": 1497893077, + "artical_title": "Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy.", + "pmid": 35446255, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2022-04-22", + "author": "Hahn RT,Muraru D,Lurz P,Hausleiter J,Maisano F,Praz F", + "auth_pos": 1, + "meshterms": "Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*, Heart*, Humans, Models, Anatomic*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1968, + "user_id": 1497893077, + "artical_title": "An Unusual Cause of Shortness of Breath: Pulmonary Vein Stenosis After Surgical Mitral Valve Replacement.", + "pmid": 35573843, + "journal_name": "JACC. Case reports", + "date": "2022-05-17", + "author": "Guber K,Ranard LS,Ng V,Hahn RT,Sommer R,Vahl TP", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1969, + "user_id": 1497893077, + "artical_title": "Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.", + "pmid": 35595203, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-21", + "author": "Généreux P,Pibarot P,Redfors B,Bax JJ,Zhao Y,Makkar RR,Kapadia S,Thourani VH,Mack MJ,Nazif TM,Lindman BR,Babaliaros V,Vincent F,Russo M,McCabe JM,Gillam LD,Alu MC,Hahn RT,Webb JG,Leon MB,Cohen DJ", + "auth_pos": 18, + "meshterms": "Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Prognosis, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1970, + "user_id": 1497893077, + "artical_title": "Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.", + "pmid": 35653690, + "journal_name": "European heart journal", + "date": "2022-06-03", + "author": "Hahn RT,Pibarot P,Otto CM", + "auth_pos": 1, + "meshterms": "Heart Valve Diseases*, Heart Valve Diseases/surgery, Humans, Transcatheter Aortic Valve Replacement*, Heart Valve Diseases*, Heart Valve Diseases/surgery, Humans, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1971, + "user_id": 1497893077, + "artical_title": "The Right Heart and Outcomes of Tricuspid Valve Surgery.", + "pmid": 35788829, + "journal_name": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery", + "date": "2022-07-06", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Cardiac Valve Annuloplasty*, Heart Failure*, Humans, Tricuspid Valve, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1972, + "user_id": 1497893077, + "artical_title": "Insights from a clinical heart valve center: characteristics and management of functional mitral regurgitation.", + "pmid": 35791723, + "journal_name": "European journal of heart failure", + "date": "2022-07-07", + "author": "Stanton LJ,Dershowitz LB,Lang KJ,Brandwein R,Hahn R,Uriel N,Kodali SK,George I", + "auth_pos": 5, + "meshterms": "Humans, Heart Failure*, Heart Valves, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Humans, Heart Failure*, Heart Valves, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Humans, Heart Failure*, Heart Valves, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Humans, Heart Failure*, Heart Valves, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Humans, Heart Failure*, Heart Valves, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1973, + "user_id": 1497893077, + "artical_title": "3D Intracardiac Echocardiography in Mitral Transcatheter Edge-to-Edge Repair: When TEE Is Hard to Stomach.", + "pmid": 35818605, + "journal_name": "JACC. Case reports", + "date": "2022-07-13", + "author": "Blusztein DI,Lehenbauer K,Sitticharoenchai P,Cahill T,Mihatov N,Ng V,Hamid N,George I,Kodali S,Hahn RT", + "auth_pos": 10, + "meshterms": "Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1974, + "user_id": 1497893077, + "artical_title": "Quantification of mitral regurgitation after transcatheter edge-to-edge repair: Comparison of echocardiography and patient-specific in silico models.", + "pmid": 35872413, + "journal_name": "Computers in biology and medicine", + "date": "2022-07-26", + "author": "Caballero A,Qin T,Hahn RT,McKay R,Sun W", + "auth_pos": 3, + "meshterms": "Computer Simulation, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional*, Hemodynamics, Humans, Mitral Valve Insufficiency*, Reproducibility of Results, Severity of Illness Index, Computer Simulation, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional*, Hemodynamics, Humans, Mitral Valve Insufficiency*, Reproducibility of Results, Severity of Illness Index, Computer Simulation, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional*, Hemodynamics, Humans, Mitral Valve Insufficiency*, Reproducibility of Results, Severity of Illness Index, Computer Simulation, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional*, Hemodynamics, Humans, Mitral Valve Insufficiency*, Reproducibility of Results, Severity of Illness Index, Computer Simulation, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional*, Hemodynamics, Humans, Mitral Valve Insufficiency*, Reproducibility of Results, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1975, + "user_id": 1497893077, + "artical_title": "Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review.", + "pmid": 35902177, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-29", + "author": "Herrmann HC,Pibarot P,Wu C,Hahn RT,Tang GHL,Abbas AE,Playford D,Ruel M,Jilaihawi H,Sathananthan J,Wood DA,De Paulis R,Bax JJ,Rodes-Cabau J,Cameron DE,Chen T,Del Nido PJ,Dweck MR,Kaneko T,Latib A,Moat N,Modine T,Popma JJ,Raben J,Smith RL,Tchetche D,Thomas MR,Vincent F,Yoganathan A,Zuckerman B,Mack MJ,Leon MB", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Echocardiography, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Hemodynamics, Humans, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1976, + "user_id": 1497893077, + "artical_title": "Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review.", + "pmid": 35902178, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-29", + "author": "Pibarot P,Herrmann HC,Wu C,Hahn RT,Otto CM,Abbas AE,Chambers J,Dweck MR,Leipsic JA,Simonato M,Rogers T,Sathananthan J,Guerrero M,Ternacle J,Wijeysundera HC,Sondergaard L,Barbanti M,Salaun E,Généreux P,Kaneko T,Landes U,Wood DA,Deeb GM,Sellers SL,Lewis J,Madhavan M,Gillam L,Reardon M,Bleiziffer S,O'Gara PT,Rodés-Cabau J,Grayburn PA,Lancellotti P,Thourani VH,Bax JJ,Mack MJ,Leon MB", + "auth_pos": 4, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Bioprosthesis/adverse effects, Heart Valve Diseases*, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prosthesis Design, Prosthesis Failure, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/methods, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1977, + "user_id": 1497893077, + "artical_title": "Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis.", + "pmid": 35898276, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2022-07-29", + "author": "Sannino A,Ilardi F,Hahn RT,Lancellotti P,Lurz P,Smith RL,Esposito G,Grayburn PA", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1978, + "user_id": 1497893077, + "artical_title": "Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.", + "pmid": 35926935, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-08-05", + "author": "Elias P,Poterucha TJ,Rajaram V,Moller LM,Rodriguez V,Bhave S,Hahn RT,Tison G,Abreau SA,Barrios J,Torres JN,Hughes JW,Perez MV,Finer J,Kodali S,Khalique O,Hamid N,Schwartz A,Homma S,Kumaraiah D,Cohen DJ,Maurer MS,Einstein AJ,Nazif T,Leon MB,Perotte AJ", + "auth_pos": 7, + "meshterms": "Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology, Aortic Valve Insufficiency*, Aortic Valve Insufficiency/diagnosis, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnosis, Deep Learning*, Electrocardiography, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/epidemiology, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/epidemiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1979, + "user_id": 1497893077, + "artical_title": "Gradient and pressure recovery of a self-expandable transcatheter aortic valve depends on ascending aorta size: In vitro study.", + "pmid": 36003461, + "journal_name": "JTCVS open", + "date": "2022-08-26", + "author": "Samaee M,Hatoum H,Biersmith M,Yeats B,Gooden SC,Thourani VH,Hahn RT,Lilly S,Yoganathan A,Dasi LP", + "auth_pos": 7, + "meshterms": "Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1980, + "user_id": 1497893077, + "artical_title": "Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation: Effective Therapy or Elusive Target?", + "pmid": 36075645, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-09-09", + "author": "Alkhouli M,Hahn RT,Petronio AS", + "auth_pos": 2, + "meshterms": "Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Atria, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1981, + "user_id": 1497893077, + "artical_title": "Functional Mitral Regurgitation Staging and its Relationship to Outcomes in the COAPT Trial.", + "pmid": 36075650, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-09-09", + "author": "Cavalcante JL,Asch FM,Garcia S,Weissman NJ,Sorajja P,Zhou Z,Hahn RT,Lindenfeld J,Abraham WT,Redfors B,Mack MJ,Stone GW", + "auth_pos": 7, + "meshterms": "Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome, Heart Failure*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1982, + "user_id": 1497893077, + "artical_title": "COVID-19 Serosurvey of Frontline Healthcare Workers in Western Australia.", + "pmid": 36131202, + "journal_name": "Journal of epidemiology and global health", + "date": "2022-09-22", + "author": "Ludewick H,Hahn R,Italiano C,Pereira L,Fatovich D,Saxton J,Hunt R,Ho KM,Boan P,Pavey W", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1983, + "user_id": 1497893077, + "artical_title": "Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial.", + "pmid": 36137685, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-09-23", + "author": "Cahill TJ,Pibarot P,Yu X,Babaliaros V,Blanke P,Clavel MA,Douglas PS,Khalique OK,Leipsic J,Makkar R,Alu MC,Kodali S,Mack MJ,Leon MB,Hahn RT", + "auth_pos": 15, + "meshterms": "Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/complications, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Ventricles, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Treatment Outcome, Ventricular Dysfunction, Right*, Ventricular Function, Right", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1984, + "user_id": 1497893077, + "artical_title": "Transvalvular Pressure Gradients and All-Cause Mortality Following TAVR: A Multicenter Echocardiographic and Invasive Registry.", + "pmid": 36137687, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-09-23", + "author": "Khalili H,Pibarot P,Hahn RT,Elmariah S,Pilgrim T,Bavry AA,Maini B,Okuno T,Al-Azizi K,Waggoner TE,Mack M,Rodès-Cabau J,Abbas AE", + "auth_pos": 3, + "meshterms": "Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Echocardiography, Humans, Registries, Retrospective Studies, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1985, + "user_id": 1497893077, + "artical_title": "1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study.", + "pmid": 36202561, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-10-07", + "author": "Gray WA,Abramson SV,Lim S,Fowler D,Smith RL,Grayburn PA,Kodali SK,Hahn RT,Kipperman RM,Koulogiannis KP,Eleid MF,Pislaru SV,Whisenant BK,McCabe JM,Liu J,Dahou A,Puthumana JJ,Davidson CJ", + "auth_pos": 8, + "meshterms": "Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Aged, Cardiac Catheterization, Feasibility Studies, Female, Heart Valve Prosthesis Implantation*, Humans, Male, Prospective Studies, Severity of Illness Index, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1986, + "user_id": 1497893077, + "artical_title": "Current Indications for Transcatheter Edge-to-Edge Repair in a Patient With Primary Mitral Regurgitation.", + "pmid": 36279415, + "journal_name": "Circulation", + "date": "2022-10-25", + "author": "Hahn RT,Chan V,Adams DH", + "auth_pos": 1, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Annuloplasty*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Cardiac Catheterization, Treatment Outcome, Echocardiography, Transesophageal", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1987, + "user_id": 1497893077, + "artical_title": "Economic Impact Analysis of Custom Pak on Cataract and Vitreoretinal Surgery in the United States.", + "pmid": 36389103, + "journal_name": "ClinicoEconomics and outcomes research : CEOR", + "date": "2022-11-18", + "author": "Ayres BD,Gupta OP,Davis JS,Hahn R,Hsiao CW,Kara R,Di Simplicio S", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1988, + "user_id": 1497893077, + "artical_title": "FEops HEARTguide Patient-Specific Computational Simulations for WATCHMAN FLX Left Atrial Appendage Closure: A Retrospective Study.", + "pmid": 38939468, + "journal_name": "JACC. Advances", + "date": "2022-11-30", + "author": "Ranard LS,Vahl TP,Sommer R,Ng V,Leb J,Lehenbauer K,Sitticharoenchai P,Khalique O,Hamid N,De Beule M,Bavo A,Hahn RT", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1989, + "user_id": 1497893077, + "artical_title": "Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.", + "pmid": 36445158, + "journal_name": "European heart journal", + "date": "2022-11-30", + "author": "Scotti A,Coisne A,Taramasso M,Granada JF,Ludwig S,Rodés-Cabau J,Lurz P,Hausleiter J,Fam N,Kodali SK,Rosiene J,Feinberg A,Pozzoli A,Alessandrini H,Biasco L,Brochet E,Denti P,Estevez-Loureiro R,Frerker C,Ho EC,Monivas V,Nickenig G,Praz F,Puri R,Sievert H,Tang GHL,Andreas M,Von Bardeleben RS,Rommel KP,Muntané-Carol G,Gavazzoni M,Braun D,Koell B,Kalbacher D,Connelly KA,Juliard JM,Harr C,Pedrazzini G,Russo G,Philippon F,Schofer J,Thiele H,Unterhuber M,Himbert D,Alcázar MU,Wild MG,Windecker S,Jorde U,Maisano F,Leon MB,Hahn RT,Latib A", + "auth_pos": 51, + "meshterms": "Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications, Male, Humans, Female, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Treatment Outcome, Registries, Heart Failure*, Heart Failure/complications", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1990, + "user_id": 1497893077, + "artical_title": "2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses.", + "pmid": 36456047, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-12-02", + "author": "Eleid MF,Wang DD,Pursnani A,Kodali SK,George I,Palacios I,Russell H,Makkar RR,Kar S,Satler LF,Rajagopal V,Dangas G,Tang GHL,McCabe JM,Whisenant BK,Fang K,Kaptzan T,Lewis B,Douglas P,Hahn R,Thaden J,Oh JK,Leon M,O'Neill W,Rihal CS,Guerrero ME", + "auth_pos": 20, + "meshterms": "Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery, Humans, Bioprosthesis*, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Prospective Studies, Quality of Life, Calcinosis*, Calcinosis/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1991, + "user_id": 1497893077, + "artical_title": "Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data.", + "pmid": 36596333, + "journal_name": "American heart journal", + "date": "2023-01-04", + "author": "Cubeddu RJ,Murphy SME,Asher CR,Garcia SA,Granada JF,Don CW,Patel S,Albaghdadi MS,Cavalcante JL,Coylewright M,Hahn RT,Genereux P,Yadav PK,Thourani VH,Leon MB", + "auth_pos": 11, + "meshterms": "Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors, Adult, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Angiotensin Receptor Antagonists, Angiotensin Receptor Antagonists/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors*, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Aortic Valve Stenosis*, Treatment Outcome, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Aortic Valve, Aortic Valve/surgery, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1992, + "user_id": 1497893077, + "artical_title": "The Authors Reply: Is it Too Early to Predict Effective Orifice Area in the Era of TAVR?", + "pmid": 36599564, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-05", + "author": "Akinmolayemi O,Ozdemir D,Pibarot P,Hahn RT", + "auth_pos": 4, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Predictive Value of Tests, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1993, + "user_id": 1497893077, + "artical_title": "Clinical and Echocardiographic Characteristics of Flow-Based Classification Following Balloon-Expandable Transcatheter Heart Valve in PARTNER Trials.", + "pmid": 36599555, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-05", + "author": "Akinmolayemi O,Ozdemir D,Pibarot P,Zhao Y,Leipsic J,Douglas PS,Jaber WA,Weissman NJ,Blanke P,Hahn RT", + "auth_pos": 10, + "meshterms": "Humans, Male, Aged, 80 and over, Female, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Stroke Volume, Heart Valve Prosthesis*, Treatment Outcome, Ventricular Function, Left, Predictive Value of Tests, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Echocardiography, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Hemodynamics, Prosthesis Design, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Aged, 80 and over, Female, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Stroke Volume, Heart Valve Prosthesis*, Treatment Outcome, Ventricular Function, Left, Predictive Value of Tests, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Echocardiography, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Hemodynamics, Prosthesis Design, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Aged, 80 and over, Female, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Stroke Volume, Heart Valve Prosthesis*, Treatment Outcome, Ventricular Function, Left, Predictive Value of Tests, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Echocardiography, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Hemodynamics, Prosthesis Design, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Aged, 80 and over, Female, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Stroke Volume, Heart Valve Prosthesis*, Treatment Outcome, Ventricular Function, Left, Predictive Value of Tests, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Echocardiography, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Hemodynamics, Prosthesis Design, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1994, + "user_id": 1497893077, + "artical_title": "Structural Heart Imaging Survey Highlights: Training, Challenges, and Practice Patterns in Interventional Imaging.", + "pmid": 36648041, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-01-18", + "author": "Lee JC,Geske JB,Narang A,Khalique OK,Choi AD,Sun YP,Cavalcante JL,Pinto DS,Gafoor SA,Jagasia DH,DiCarli MF,Villines TC,Little SH,Hahn RT,Wang DD", + "auth_pos": 14, + "meshterms": "Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians', Humans, Predictive Value of Tests, Surveys and Questionnaires, Heart*, Diagnostic Imaging*, Practice Patterns, Physicians'", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1995, + "user_id": 1497893077, + "artical_title": "Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion.", + "pmid": 36697147, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-01-26", + "author": "Sisinni A,Taramasso M,Praz F,Metra M,Agricola E,Margonato A,Fam N,Estevez-Loureiro R,Latib A,Messika-Zeitoun D,Conradi L,von Bardeleben RS,Sorajja P,Hahn RT,Caravita S,Maisano F,Adamo M,Godino C", + "auth_pos": 14, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Expert Testimony, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/adverse effects", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1996, + "user_id": 1497893077, + "artical_title": "Iatrogenic Atrial Septal Defects After Transseptal Transcatheter Mitral Valve Replacement With a Balloon-Expandable Valve.", + "pmid": 36764914, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-02-11", + "author": "Ranard LS,Lebehn M,Ng V,Nazif T,Hahn RT,George I,Leon MB,Granada JF,Kodali SK,Vahl TP", + "auth_pos": 5, + "meshterms": "Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease, Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Septal Defects, Atrial*, Iatrogenic Disease", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1997, + "user_id": 1497893077, + "artical_title": "Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.", + "pmid": 36792287, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-02-16", + "author": "Weckbach LT,Stolz L,Chatfield AG,Fam NP,Stephan von Bardeleben R,Davidson CJ,Hahn RT,Hausleiter J", + "auth_pos": 7, + "meshterms": "Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Surgical Procedures*, Heart Failure*, Heart Failure/surgery, Treatment Outcome, Cardiac Catheterization, Ventricular Remodeling, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Surgical Procedures*, Heart Failure*, Heart Failure/surgery, Treatment Outcome, Cardiac Catheterization, Ventricular Remodeling, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Surgical Procedures*, Heart Failure*, Heart Failure/surgery, Treatment Outcome, Cardiac Catheterization, Ventricular Remodeling", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1998, + "user_id": 1497893077, + "artical_title": "Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.", + "pmid": 36813373, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-02-23", + "author": "Généreux P,Cohen DJ,Pibarot P,Redfors B,Bax JJ,Zhao Y,Prince H,Makkar RR,Kapadia S,Thourani VH,Mack MJ,Nazif TM,Lindman BR,Babaliaros V,Russo M,McCabe JM,Gillam LD,Alu MC,Hahn RT,Webb JG,Leon MB,Arnold SV", + "auth_pos": 19, + "meshterms": "Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index, Humans, Aortic Valve, Aortic Valve/surgery, Quality of Life, Treatment Outcome, Health Status, Transcatheter Aortic Valve Replacement*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis Implantation*, Risk Factors, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 1999, + "user_id": 1497893077, + "artical_title": "Comprehensive Custom-Pak in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis.", + "pmid": 36883115, + "journal_name": "ClinicoEconomics and outcomes research : CEOR", + "date": "2023-03-09", + "author": "Punch D,Davis JS,Hahn R,Gill R,Hsiao CW,Kara R", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2000, + "user_id": 1497893077, + "artical_title": "New therapeutic approach for tricuspid regurgitation: Transcatheter tricuspid valve replacement or repair.", + "pmid": 36910541, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-03-14", + "author": "Blusztein DI,Hahn RT", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2001, + "user_id": 1497893077, + "artical_title": "Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-to-Edge Repair: Insights From the TriValve Registry.", + "pmid": 36948892, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-03-23", + "author": "Coisne A,Scotti A,Taramasso M,Granada JF,Ludwig S,Rodés-Cabau J,Lurz P,Hausleiter J,Fam N,Kodali SK,Pozzoli A,Alessandrini H,Biasco L,Brochet E,Denti P,Estevez-Loureiro R,Frerker C,Ho EC,Monivas V,Nickenig G,Praz F,Puri R,Sievert H,Tang GHL,Andreas M,Von Bardeleben RS,Rommel KP,Muntané-Carol G,Gavazzoni M,Braun D,Lubos E,Kalbacher D,Connelly KA,Juliard JM,Harr C,Pedrazzini G,Philippon F,Schofer J,Thiele H,Unterhuber M,Himbert D,Alcázar MU,Wild MG,Jorde U,Windecker S,Maisano F,Leon MB,Hahn RT,Latib A", + "auth_pos": 48, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2002, + "user_id": 1497893077, + "artical_title": "Recommendations for Special Competency in Echocardiographic Guidance of Structural Heart Disease Interventions: From the American Society of Echocardiography.", + "pmid": 36841670, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2023-04-07", + "author": "Little SH,Rigolin VH,Garcia-Sayan E,Hahn RT,Hung J,Mackensen GB,Mankad S,Quader N,Saric M", + "auth_pos": 4, + "meshterms": "Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical, Humans, United States, Echocardiography, Echocardiography/methods, Heart Diseases*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Cardiology*, Societies, Medical", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2003, + "user_id": 1497893077, + "artical_title": "Transcatheter Tricuspid Valve Replacement With Novel Self-Expanding Valve: Secure Fixation in Insecure Anatomy.", + "pmid": 37091056, + "journal_name": "JACC. Case reports", + "date": "2023-04-24", + "author": "Blusztein DI,Hahn RT,Godoy Rivas C,George I,Kodali SK", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2004, + "user_id": 1497893077, + "artical_title": "1-Year Outcomes of Transcatheter Tricuspid Valve Repair.", + "pmid": 37137586, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-05-05", + "author": "Kodali SK,Hahn RT,Davidson CJ,Narang A,Greenbaum A,Gleason P,Kapadia S,Miyasaka R,Zahr F,Chadderdon S,Smith RL,Grayburn P,Kipperman RM,Marcoff L,Whisenant B,Gonzales M,Makkar R,Makar M,O'Neill W,Wang DD,Gray WA,Abramson S,Hermiller J,Mitchel L,Lim DS,Fowler D,Williams M,Pislaru SV,Dahou A,Mack MJ,Leon MB,Eleid MF", + "auth_pos": 2, + "meshterms": "Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2005, + "user_id": 1497893077, + "artical_title": "Baseline Characteristics and Clinical Outcomes of a Tricuspid Regurgitation Referral Population.", + "pmid": 37058874, + "journal_name": "The American journal of cardiology", + "date": "2023-05-08", + "author": "Lawlor MK,Ng V,Ahmed S,Dershowitz L,Brener MI,Kampaktsis P,Pitts A,Vahl T,Nazif T,Leon M,George I,Hahn RT,Kodali S", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2006, + "user_id": 1497893077, + "artical_title": "Multimodality Imaging of Right Heart Function: JACC Scientific Statement.", + "pmid": 37164529, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-05-12", + "author": "Hahn RT,Lerakis S,Delgado V,Addetia K,Burkhoff D,Muraru D,Pinney S,Friedberg MK", + "auth_pos": 1, + "meshterms": "Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging, Humans, Magnetic Resonance Imaging, Cine, Magnetic Resonance Imaging, Cine/methods, Heart, Heart Ventricles, Heart Ventricles/diagnostic imaging, Multimodal Imaging, Multimodal Imaging/methods, Cardiovascular Diseases*, Ventricular Function, Right, Ventricular Function, Right/physiology, Ventricular Dysfunction, Right*, Ventricular Dysfunction, Right/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2007, + "user_id": 1497893077, + "artical_title": "Understanding the anatomy of the mitral valve: attitudinal is unnecessary.", + "pmid": 36585241, + "journal_name": "Heart (British Cardiac Society)", + "date": "2023-05-17", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Humans, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Prolapse*, Echocardiography, Transesophageal, Echocardiography, Three-Dimensional*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2008, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation.", + "pmid": 37195943, + "journal_name": "The New England journal of medicine", + "date": "2023-05-19", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Humans, Cardiac Catheterization, Echocardiography, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2009, + "user_id": 1497893077, + "artical_title": "Transcatheter Repair for Patients with Tricuspid Regurgitation.", + "pmid": 36876753, + "journal_name": "The New England journal of medicine", + "date": "2023-05-19", + "author": "Sorajja P,Whisenant B,Hamid N,Naik H,Makkar R,Tadros P,Price MJ,Singh G,Fam N,Kar S,Schwartz JG,Mehta S,Bae R,Sekaran N,Warner T,Makar M,Zorn G,Spinner EM,Trusty PM,Benza R,Jorde U,McCarthy P,Thourani V,Tang GHL,Hahn RT,Adams DH", + "auth_pos": 25, + "meshterms": "Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Aged, Female, Humans, Male, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/methods, Heart Failure, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2010, + "user_id": 1497893077, + "artical_title": "Valvular Heart Failure due to Tricuspid Regurgitation: Surgical and Transcatheter Management Options.", + "pmid": 37230648, + "journal_name": "Heart failure clinics", + "date": "2023-05-29", + "author": "Lebehn MA,Hahn RT", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Heart Failure*, Heart Failure/etiology, Heart Failure/therapy, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2011, + "user_id": 1497893077, + "artical_title": "Valvular Heart Disease Associated With Radiation Therapy: A Contemporary Review.", + "pmid": 37275597, + "journal_name": "Structural heart : the journal of the Heart Team", + "date": "2023-06-05", + "author": "Lee C,Hahn RT", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2012, + "user_id": 1497893077, + "artical_title": "Tricuspid Leaflet Gap-Reduction Maneuvers During Transcatheter Tricuspid Valve Repair.", + "pmid": 37283822, + "journal_name": "JACC. Case reports", + "date": "2023-06-07", + "author": "Godoy Rivas C,Agarwal V,Tomlinson S,Lebehn M,Kodali S,Hahn RT", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2013, + "user_id": 1497893077, + "artical_title": "Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study.", + "pmid": 37288125, + "journal_name": "Structural heart : the journal of the Heart Team", + "date": "2023-06-08", + "author": "Malaisrie SC,Zajarias A,Leon MB,Mack MJ,Pibarot P,Hahn RT,Brown D,Wong SC,Oldemeyer JB,Shang K,Leipsic J,Blanke P,Guerrero M", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2014, + "user_id": 1497893077, + "artical_title": "Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair.", + "pmid": 37288338, + "journal_name": "Structural heart : the journal of the Heart Team", + "date": "2023-06-08", + "author": "Chadderdon SM,Eleid MF,Thaden JJ,Makkar R,Nakamura M,Babaliaros V,Greenbaum A,Gleason P,Kodali S,Hahn RT,Koulogiannis KP,Marcoff L,Grayburn P,Smith RL,Song HK,Lim DS,Gray WA,Hawthorne K,Deuschl F,Narang A,Davidson C,Zahr FE", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2015, + "user_id": 1497893077, + "artical_title": "Managing Patients With Moderate Aortic Stenosis.", + "pmid": 36881428, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2023-06-09", + "author": "Stassen J,Ewe SH,Pio SM,Pibarot P,Redfors B,Leipsic J,Genereux P,Van Mieghem NM,Kuneman JH,Makkar R,Hahn RT,Playford D,Marsan NA,Delgado V,Ben-Yehuda O,Leon MB,Bax JJ", + "auth_pos": 11, + "meshterms": "Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left, Humans, Predictive Value of Tests, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/surgery, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2016, + "user_id": 1497893077, + "artical_title": "Zero-Contrast Left Atrial Appendage Occlusion Using a Hybrid Echocardiography-Fluoroscopy Technique Without Iodinated Contrast.", + "pmid": 37201232, + "journal_name": "The American journal of cardiology", + "date": "2023-06-13", + "author": "Blusztein DI,Gogia S,Hahn RT,Sommer RJ,Ng V,Forman J,Lebehn M,Ranard L,Vahl TP", + "auth_pos": 3, + "meshterms": "Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy, Humans, Echocardiography, Transesophageal, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Echocardiography, Contrast Media, Fluoroscopy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2017, + "user_id": 1497893077, + "artical_title": "2-Year Outcomes Following Transcatheter Tricuspid Valve Replacement Using the EVOQUE System.", + "pmid": 37191592, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-06-16", + "author": "Stolz L,Weckbach LT,Hahn RT,Chatfield AG,Fam NP,von Bardeleben RS,Davidson CJ,Grayburn PA,Zahr F,Hausleiter J", + "auth_pos": 3, + "meshterms": "Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Transcatheter Aortic Valve Replacement*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2018, + "user_id": 1497893077, + "artical_title": "Radioprotection for the imaging specialist during structural heart interventions: Not an option!", + "pmid": 37391341, + "journal_name": "Archives of cardiovascular diseases", + "date": "2023-07-01", + "author": "Ternacle J,Salaun E,Ruf T,Lafitte S,von Bardeleben RS,Modine T,Leroux L,Rodes-Cabau J,Kodali S,Leon M,Pibarot P,Hahn RT", + "auth_pos": 12, + "meshterms": "Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control, Humans, Radiation Injuries*, Radiation Injuries/etiology, Radiation Injuries/prevention & control, Radiation Protection*, Radiation Protection/methods, Echocardiography, Radiation Dosage, Radiation Exposure*, Radiation Exposure/adverse effects, Radiation Exposure/prevention & control", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2019, + "user_id": 1497893077, + "artical_title": "Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.", + "pmid": 37407110, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-07-07", + "author": "Madhavan MV,Kodali SK,Thourani VH,Makkar R,Mack MJ,Kapadia S,Webb JG,Cohen DJ,Herrmann HC,Williams M,Greason K,Pibarot P,Hahn RT,Jaber W,Xu K,Alu M,Smith CR,Leon MB", + "auth_pos": 13, + "meshterms": "Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Humans, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Heart Valve Prosthesis*, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/etiology, Treatment Outcome, Surgical Instruments, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2020, + "user_id": 1497893077, + "artical_title": "The (Heart and) Soul of a Human Creation: Designing Echocardiography for the Big Data Age.", + "pmid": 37191597, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2023-07-10", + "author": "Arnaout R,Hahn RT,Hung JW,Jone PN,Lester SJ,Little SH,Mackensen GB,Rigolin V,Sachdev V,Saric M,Sengupta PP,Strom JB,Taub CC,Thamman R,Abraham T", + "auth_pos": 2, + "meshterms": "Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography, Humans, Big Data*, Heart*, Echocardiography", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2021, + "user_id": 1497893077, + "artical_title": "Low-Cardiac Output Syndrome After Tricuspid Valve Repair: Insights From the TriValve Registry.", + "pmid": 37294229, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-07-14", + "author": "Rommel KP,Taramasso M,Ludwig S,Bonnet G,Thiele H,Leon MB,Maisano F,Burkhoff D,Hahn RT,Lurz P", + "auth_pos": 9, + "meshterms": "Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Registries, Cardiac Output", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2022, + "user_id": 1497893077, + "artical_title": "The association between intraoperative cardiopulmonary bypass power and complications after cardiac surgery.", + "pmid": 37442644, + "journal_name": "Perfusion", + "date": "2023-07-14", + "author": "Hui V,Ho KM,Hahn R,Wright B,Larbalestier R,Pavey W", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2023, + "user_id": 1497893077, + "artical_title": "Three-dimensional transoesophageal echocardiography: how to use and when to use-a clinical consensus statement from the European Association of Cardiovascular Imaging of the European Society of Cardiology.", + "pmid": 37259019, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2023-07-25", + "author": "Faletra FF,Agricola E,Flachskampf FA,Hahn R,Pepi M,Ajmone Marsan N,Wunderlich N,Elif Sade L,Donal E,Zamorano JL,Cosyns B,Vannan M,Edvardsen T,Berrebi A,Popescu BA,Lancellotti P,Lang R,Bäck M,Bertrand PB,Dweck M,Keenan N,Stankovic I", + "auth_pos": 4, + "meshterms": "Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Humans, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Three-Dimensional*, Echocardiography, Three-Dimensional/methods, Heart, Cardiovascular System*, Cardiology*, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2024, + "user_id": 1497893077, + "artical_title": "Multimodality imaging for transcatheter tricuspid valve repair and replacement.", + "pmid": 37502182, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-07-28", + "author": "Tomlinson S,Rivas CG,Agarwal V,Lebehn M,Hahn RT", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2025, + "user_id": 1497893077, + "artical_title": "Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.", + "pmid": 37393603, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2023-08-07", + "author": "Lang FM,Mihatov N,Kriegel J,Nazif TM,Vahl TP,Ng VG,Lebehn M,Blusztein D,Cahill TJ,Lehenbauer KR,Hahn RT,Leon M,Kodali SK,George I", + "auth_pos": 11, + "meshterms": "Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Humans, Middle Aged, Aged, Aged, 80 and over, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Heart Valve Prosthesis*, Treatment Outcome, Prosthesis Design, Transcatheter Aortic Valve Replacement*, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Bioprosthesis*, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2026, + "user_id": 1497893077, + "artical_title": "2023 ACC/AHA/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): A report of the ACC Competency Management Committee.", + "pmid": 37269254, + "journal_name": "The Journal of thoracic and cardiovascular surgery", + "date": "2023-08-14", + "author": "Bass TA,Abbott JD,Mahmud E,Parikh SA,Aboulhosn J,Ashwath ML,Baranowski B,Bergersen L,Chaudry HI,Coylewright M,Denktas AE,Gupta K,Gutierrez JA,Haft J,Hawkins BM,Herrmann HC,Kapur NK,Kilic S,Lesser J,Lin CH,Mendirichaga R,Nkomo VT,Park LG,Phoubandith DR,Quader N,Rich MW,Rosenfield K,Sabri SS,Shames ML,Shernan SK,Skelding KA,Tamis-Holland J,Thourani VH,Tremmel JA,Uretsky S,Wageman J,Welt F,Whisenant BK,White CJ,Yong CM,Mendes LA,Arrighi JA,Breinholt JP,Day J,Dec GW,Drajpuch D,Faza N,Francis SA,Hahn RT,Housholder-Hughes SD,Khan SS,Kondapaneni MD,Lee KS,Hussain Mahar J,McConnaughey S,Niazi K,Pearson DD,Punnoose LR,Reejhsinghani RS,Ryan T,Silvestry FE,Solomon MA,Spicer RL,Weissman G,Werns SW", + "auth_pos": 52, + "meshterms": "Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical, Humans, United States, Heart, Coronary Vessels, Cardiac Surgical Procedures*, Cardiology*, Cardiology/education, Clinical Competence, American Heart Association, Societies, Medical", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2027, + "user_id": 1497893077, + "artical_title": "Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial.", + "pmid": 37582170, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2023-08-17", + "author": "von Bardeleben RS,Lurz P,Sorajja P,Ruf T,Hausleiter J,Sitges M,Da Rocha E Silva J,Näbauer M,Weber M,Tang GHL,Heitkemper M,Ying SW,Trochu JN,Kar S,Hahn RT,Nickenig G", + "auth_pos": 15, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Heart Valve Prosthesis Implantation*, Prospective Studies, Cardiac Catheterization, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2028, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation Management for Heart Failure.", + "pmid": 37611990, + "journal_name": "JACC. Heart failure", + "date": "2023-08-25", + "author": "Hahn RT,Brener MI,Cox ZL,Pinney S,Lindenfeld J", + "auth_pos": 1, + "meshterms": "Humans, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Cardiovascular Diseases*, Hospital Mortality, Hospitalization, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Cardiovascular Diseases*, Hospital Mortality, Hospitalization, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Cardiovascular Diseases*, Hospital Mortality, Hospitalization, Humans, Heart Failure*, Heart Failure/complications, Heart Failure/therapy, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Cardiovascular Diseases*, Hospital Mortality, Hospitalization", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2029, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation and Right Heart Failure: The Role of Imaging in Defining Pathophysiology, Presentation, and Novel Management Strategies.", + "pmid": 37714590, + "journal_name": "Heart failure clinics", + "date": "2023-09-18", + "author": "Agarwal V,Hahn R", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Multimodal Imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2030, + "user_id": 1497893077, + "artical_title": "Contemporary Evaluation and Clinical Treatment Options for Aortic Regurgitation.", + "pmid": 37754793, + "journal_name": "Journal of cardiovascular development and disease", + "date": "2023-09-27", + "author": "Lebehn M,Vahl T,Kampaktsis P,Hahn RT", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2031, + "user_id": 1497893077, + "artical_title": "5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results.", + "pmid": 37758379, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-09-28", + "author": "Guerrero ME,Eleid MF,Wang DD,Pursnani A,Kodali SK,George I,Palacios I,Russell H,Makkar RR,Kar S,Satler LF,Rajagopal V,Dangas G,Tang GHL,McCabe JM,Whisenant BK,Fang K,Balan P,Smalling R,Kaptzan T,Lewis B,Douglas PS,Hahn RT,Thaden J,Oh JK,Leon M,O'Neill W,Rihal C", + "auth_pos": 23, + "meshterms": "Humans, Aged, Aged, 80 and over, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Heart Valve Prosthesis Implantation*, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Valve Diseases*, Heart Valve Diseases/diagnostic imaging, Heart Valve Diseases/surgery, Heart Valve Prosthesis*, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/etiology, Calcinosis*, Calcinosis/surgery, Vascular Diseases*, Vascular Diseases/etiology, Cardiomyopathies*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2032, + "user_id": 1497893077, + "artical_title": "Absence of Atrial Fibrillation Reduction in REDUCE LAP-HF II.", + "pmid": 37480878, + "journal_name": "JACC. Heart failure", + "date": "2023-10-23", + "author": "Hahn RT,Link MS", + "auth_pos": 1, + "meshterms": "Humans, Atrial Fibrillation*, Heart Failure*, Flavins, Luciferases, Stroke Volume, Humans, Atrial Fibrillation*, Heart Failure*, Flavins, Luciferases, Stroke Volume", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2033, + "user_id": 1497893077, + "artical_title": "Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.", + "pmid": 37804270, + "journal_name": "The Annals of thoracic surgery", + "date": "2023-11-01", + "author": "Hahn RT,Lawlor MK,Davidson CJ,Badhwar V,Sannino A,Spitzer E,Lurz P,Lindman BR,Topilsky Y,Baron SJ,Chadderdon S,Khalique OK,Tang GHL,Taramasso M,Grayburn PA,Badano L,Leipsic J,Lindenfeld J,Windecker S,Vemulapalli S,Redfors B,Alu MC,Cohen DJ,Rodés-Cabau J,Ailawadi G,Mack M,Ben-Yehuda O,Leon MB,Hausleiter J", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Treatment Outcome, Comorbidity, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2034, + "user_id": 1497893077, + "artical_title": "Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.", + "pmid": 37804294, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-11-01", + "author": "Hahn RT,Lawlor MK,Davidson CJ,Badhwar V,Sannino A,Spitzer E,Lurz P,Lindman BR,Topilsky Y,Baron SJ,Chadderdon S,Khalique OK,Tang GHL,Taramasso M,Grayburn PA,Badano L,Leipsic J,Lindenfeld J,Windecker S,Vemulapalli S,Redfors B,Alu MC,Cohen DJ,Rodés-Cabau J,Ailawadi G,Mack M,Ben-Yehuda O,Leon MB,Hausleiter J", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2035, + "user_id": 1497893077, + "artical_title": "Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.", + "pmid": 37793121, + "journal_name": "European heart journal", + "date": "2023-11-15", + "author": "Hahn RT,Lawlor MK,Davidson CJ,Badhwar V,Sannino A,Spitzer E,Lurz P,Lindman BR,Topilsky Y,Baron SJ,Chadderdon S,Khalique OK,Tang GHL,Taramasso M,Grayburn PA,Badano L,Leipsic J,Lindenfeld J,Windecker S,Vemulapalli S,Redfors B,Alu MC,Cohen DJ,Rodés-Cabau J,Ailawadi G,Mack M,Ben-Yehuda O,Leon MB,Hausleiter J", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Treatment Outcome, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2036, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation and Right Heart Failure: The Role of Imaging in Defining Pathophysiology, Presentation, and Novel Management Strategies.", + "pmid": 37980069, + "journal_name": "Interventional cardiology clinics", + "date": "2023-11-20", + "author": "Agarwal V,Hahn R", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnosis, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prognosis", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2037, + "user_id": 1497893077, + "artical_title": "Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.", + "pmid": 37874020, + "journal_name": "The New England journal of medicine", + "date": "2023-11-23", + "author": "Mack MJ,Leon MB,Thourani VH,Pibarot P,Hahn RT,Genereux P,Kodali SK,Kapadia SR,Cohen DJ,Pocock SJ,Lu M,White R,Szerlip M,Ternacle J,Malaisrie SC,Herrmann HC,Szeto WY,Russo MJ,Babaliaros V,Smith CR,Blanke P,Webb JG,Makkar R", + "auth_pos": 5, + "meshterms": "Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology, Humans, Aortic Valve, Aortic Valve/diagnostic imaging, Aortic Valve/surgery, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/mortality, Aortic Valve Stenosis/surgery, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/methods, Postoperative Complications, Postoperative Complications/etiology, Risk Factors, Stroke, Stroke/epidemiology, Stroke/etiology, Stroke/surgery, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Treatment Outcome, Follow-Up Studies, Patient Readmission, Heart Failure, Heart Failure/etiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2038, + "user_id": 1497893077, + "artical_title": "Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.", + "pmid": 37930776, + "journal_name": "European heart journal", + "date": "2023-12-11", + "author": "Kodali S,Hahn RT,Makkar R,Makar M,Davidson CJ,Puthumana JJ,Zahr F,Chadderdon S,Fam N,Ong G,Yadav P,Thourani V,Vannan MA,O'Neill WW,Wang DD,Tchétché D,Dumonteil N,Bonfils L,Lepage L,Smith R,Grayburn PA,Sharma RP,Haeffele C,Babaliaros V,Gleason PT,Elmariah S,Inglessis-Azuaje I,Passeri J,Herrmann HC,Silvestry FE,Lim S,Fowler D,Webb JG,Moss R,Modine T,Lafitte S,Latib A,Ho E,Goldberg Y,Shah P,Nyman C,Rodés-Cabau J,Bédard E,Brugger N,Sannino A,Mack MJ,Leon MB,Windecker S", + "auth_pos": 2, + "meshterms": "Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Severity of Illness Index, Humans, Female, Aged, Male, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Prospective Studies, Quality of Life, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/met", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2039, + "user_id": 1497893077, + "artical_title": "Using Machine Learning to Predict Bleeding after Cardiac Surgery.", + "pmid": 37669153, + "journal_name": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery", + "date": "2023-12-17", + "author": "Hui V,Litton E,Edibam C,Geldenhuys A,Hahn R,Larbalestier R,Wright B,Pavey W", + "auth_pos": 5, + "meshterms": "Humans, Australia, Australia/epidemiology, Machine Learning*, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/adverse effects, Hemorrhage, Heart, Retrospective Studies, Humans, Australia, Australia/epidemiology, Machine Learning*, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/adverse effects, Hemorrhage, Heart, Retrospective Studies, Humans, Australia, Australia/epidemiology, Machine Learning*, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/adverse effects, Hemorrhage, Heart, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2040, + "user_id": 1497893077, + "artical_title": "Degenerative mitral regurgitation.", + "pmid": 38062018, + "journal_name": "Nature reviews. Disease primers", + "date": "2023-12-17", + "author": "Delgado V,Ajmone Marsan N,Bonow RO,Hahn RT,Norris RA,Zühlke L,Borger MA", + "auth_pos": 4, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnosis, Mitral Valve Insufficiency/surgery, Mitral Valve, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Cardiac Surgical Procedures*, Cardiac Surgical Procedures/methods, Echocardiography, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2041, + "user_id": 1497893077, + "artical_title": "Multimodality assessment of high- vs. low-gradient aortic stenosis using echocardiography and cardiac CT.", + "pmid": 37806845, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2023-12-22", + "author": "Zeb I,Uqaily R,Gonuguntla K,Ludhwani D,Abdelhaleem A,Leipsic J,Hahn RT,Pibarot P,Sankaramangalam K,Kuzhandai D,Sattar Y,Raina S,Sudarshan B,Kawsara M,Hamirani Y,Daggubati R", + "auth_pos": 7, + "meshterms": "Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index, Humans, Retrospective Studies, Predictive Value of Tests, Aortic Valve Stenosis*, Echocardiography, Aortic Valve, Aortic Valve/diagnostic imaging, Tomography, X-Ray Computed, Stroke Volume, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2042, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation: From imaging to clinical trials to resolving the unmet need for treatment.", + "pmid": 37731368, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-01-08", + "author": "Grapsa J,Praz F,Sorajja P,Cavalcante JL,Sitges M,Taramasso M,Piazza N,Zeitoun DM,Michelena HI,Hamid N,Dreyfus J,Benfari G,Argulian E,Chieffo A,Tchetche D,Rudski L,Bax JJ,Von Bardeleben S,Patterson T,Redwood S,Bapat VN,Nickenig G,Lurz P,Hausleiter J,Kodali S,Hahn RT,Maisano F,Sarano ME", + "auth_pos": 26, + "meshterms": "Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic, Humans, Diagnostic Imaging, Heart Valve Prosthesis Implantation*, Predictive Value of Tests, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Clinical Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2043, + "user_id": 1497893077, + "artical_title": "Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography.", + "pmid": 38182282, + "journal_name": "Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography", + "date": "2024-01-08", + "author": "Zoghbi WA,Jone PN,Chamsi-Pasha MA,Chen T,Collins KA,Desai MY,Grayburn P,Groves DW,Hahn RT,Little SH,Kruse E,Sanborn D,Shah SB,Sugeng L,Swaminathan M,Thaden J,Thavendiranathan P,Tsang W,Weir-McCall JR,Gill E", + "auth_pos": 9, + "meshterms": "Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy, Adult, Humans, Heart*, Magnetic Resonance Imaging, Echocardiography, Prostheses and Implants, Heart Valve Diseases*, Heart Valve Diseases/diagnosis, Heart Valve Diseases/surgery, Magnetic Resonance Spectroscopy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2044, + "user_id": 1497893077, + "artical_title": "Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from TriValve Registry.", + "pmid": 37905381, + "journal_name": "European journal of heart failure", + "date": "2024-01-24", + "author": "Russo G,Badano LP,Adamo M,Alessandrini H,Andreas M,Braun D,Connelly KA,Denti P,Estevez-Loureiro R,Fam N,Gavazzoni M,Hahn RT,Harr C,Hausleiter J,Himbert D,Kalbacher D,Ho E,Latib A,Lubos E,Ludwig S,Lurz P,Monivas V,Nickenig G,Pedicino D,Pedrazzini G,Pozzoli A,Pires Marafon D,Pastorino R,Praz F,Rodes-Cabau J,Besler C,Schofer J,Scotti A,Piayda K,Sievert H,Tang GHL,Thiele H,Schlotter F,von Bardeleben RS,Webb J,Windecker S,Leon M,Maisano F,Metra M,Taramasso M", + "auth_pos": 12, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/complications, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Stroke Volume, Treatment Outcome, Cardiac Catheterization, Cardiac Catheterization/methods, Heart Failure*, Heart Failure/etiology, Ventricular Function, Left, Registries", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2045, + "user_id": 1497893077, + "artical_title": "Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve Replacement.", + "pmid": 38283566, + "journal_name": "Structural heart : the journal of the Heart Team", + "date": "2024-01-29", + "author": "El-Zein RS,Malik AO,Cohen DJ,Spertus JA,Saxon JT,Pibarot P,Hahn RT,Alu MC,Shang K,Kodali SK,Thourani VH,Leon MB,Mack MJ,Chhatriwalla AK", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2046, + "user_id": 1497893077, + "artical_title": "An attention-based deep learning method for right ventricular quantification using 2D echocardiography: Feasibility and accuracy.", + "pmid": 38126261, + "journal_name": "Echocardiography (Mount Kisco, N.Y.)", + "date": "2024-01-30", + "author": "Kampaktsis PN,Bohoran TA,Lebehn M,McLaughlin L,Leb J,Liu Z,Moustakidis S,Siouras A,Singh A,Hahn RT,McCann GP,Giannakidis A", + "auth_pos": 10, + "meshterms": "Adult, Female, Humans, Male, Middle Aged, Deep Learning*, Echocardiography, Feasibility Studies, Reproducibility of Results, Retrospective Studies, Stroke Volume, Ventricular Dysfunction, Right*, Ventricular Function, Right, Adult, Female, Humans, Male, Middle Aged, Deep Learning*, Echocardiography, Feasibility Studies, Reproducibility of Results, Retrospective Studies, Stroke Volume, Ventricular Dysfunction, Right*, Ventricular Function, Right, Adult, Female, Humans, Male, Middle Aged, Deep Learning*, Echocardiography, Feasibility Studies, Reproducibility of Results, Retrospective Studies, Stroke Volume, Ventricular Dysfunction, Right*, Ventricular Function, Right, Adult, Female, Humans, Male, Middle Aged, Deep Learning*, Echocardiography, Feasibility Studies, Reproducibility of Results, Retrospective Studies, Stroke Volume, Ventricular Dysfunction, Right*, Ventricular Function, Right", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2047, + "user_id": 1497893077, + "artical_title": "Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention.", + "pmid": 37890014, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2024-01-31", + "author": "Dershowitz L,Lawlor MK,Hamid N,Kampaktsis P,Ning Y,Vahl TP,Nazif T,Khalique O,Ng V,Kurlansky P,Leon M,Hahn R,Kodali S,George I", + "auth_pos": 12, + "meshterms": "Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy, Humans, Female, Aged, Aged, 80 and over, Male, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Retrospective Studies, Ventricular Remodeling, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Heart Failure*, Heart Failure/diagnostic imaging, Heart Failure/therapy", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2048, + "user_id": 1497893077, + "artical_title": "Tricuspid valve disease and cardiac implantable electronic devices.", + "pmid": 38096587, + "journal_name": "European heart journal", + "date": "2024-02-05", + "author": "Andreas M,Burri H,Praz F,Soliman O,Badano L,Barreiro M,Cavalcante JL,de Potter T,Doenst T,Friedrichs K,Hausleiter J,Karam N,Kodali S,Latib A,Marijon E,Mittal S,Nickenig G,Rinaldi A,Rudzinski P,Russo M,Starck C,von Bardeleben RS,Wunderlich N,Zamorano JL,Hahn RT,Maisano F,Leclercq C", + "auth_pos": 25, + "meshterms": "Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies, Humans, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/complications, Rheumatic Heart Disease*, Rheumatic Heart Disease/complications, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2049, + "user_id": 1497893077, + "artical_title": "Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.", + "pmid": 37827552, + "journal_name": "Heart (British Cardiac Society)", + "date": "2024-02-14", + "author": "Otto CM,Bartkowiak J,Hahn RT", + "auth_pos": 3, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Atrial Pressure, Echocardiography, Doppler, Pulmonary Artery, Pulmonary Artery/diagnostic imaging, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Atrial Pressure, Echocardiography, Doppler, Pulmonary Artery, Pulmonary Artery/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2050, + "user_id": 1497893077, + "artical_title": "Multimodality Cardiac Imaging and the Imaging Workforce in the United States: Diversity, Disparities, and Future Directions.", + "pmid": 38377238, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2024-02-22", + "author": "Bullock-Palmer RP,Flores Rosario K,Douglas PS,Hahn RT,Lang RM,Chareonthaitawee P,Srichai MB,Ordovas KG,Baldassarre LA,Burroughs MS,Henderson CS,Woodard PK,Pressoir K,Swaminathan M,Blankstein R,Daubert MA", + "auth_pos": 4, + "meshterms": "Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques, Humans, Female, United States, Workforce, Minority Groups*, Cardiovascular Diseases*, Multimodal Imaging, Cardiac Imaging Techniques", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2051, + "user_id": 1497893077, + "artical_title": "TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.", + "pmid": 37624856, + "journal_name": "European heart journal", + "date": "2024-02-23", + "author": "Dreyfus J,Galloo X,Taramasso M,Heitzinger G,Benfari G,Kresoja KP,Juarez-Casso F,Omran H,Bohbot Y,Iliadis C,Russo G,Topilsky Y,Weber M,Nombela-Franco L,Sala A,Eixerés-Esteve A,Iung B,Obadia JF,Estevez Loureiro R,Riant E,Donal E,Hausleiter J,Badano L,Le Tourneau T,Coisne A,Modine T,Latib A,Praz F,Windecker S,Zamorano JL,von Bardeleben RS,Tang GHL,Hahn R,Webb J,Muraru D,Nejjari M,Chan V,De Bonis M,Carnero-Alcazar M,Nickenig G,Pfister R,Tribouilloy C,Rudolph V,Crestanello J,Lurz P,Bartko P,Maisano F,Bax J,Enriquez-Sarano M,Messika-Zeitoun D", + "auth_pos": 33, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization, Humans, Tricuspid Valve Insufficiency*, Heart Valve Prosthesis Implantation*, Treatment Outcome, Cardiac Surgical Procedures*, Cardiac Catheterization", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2052, + "user_id": 1497893077, + "artical_title": "Mitral regurgitation mechanisms related to systolic anterior motion in hypertrophic cardiomyopathy.", + "pmid": 38410607, + "journal_name": "Journal of thoracic disease", + "date": "2024-02-27", + "author": "Hayashi H,Singh SK,Hahn RT,Akita K,Kurlansky P,Sun J,Vedula V,Leb JS,Shimada YJ,Weiner SD,Takayama H", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2053, + "user_id": 1497893077, + "artical_title": "Great debate: symptomatic moderate aortic stenosis should undergo intervention.", + "pmid": 38446449, + "journal_name": "European heart journal", + "date": "2024-03-18", + "author": "Bax JJ,Hahn RT,Marsan NA,Baumgartner H", + "auth_pos": 2, + "meshterms": "Humans, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Watchful Waiting, Severity of Illness Index, Aortic Valve, Aortic Valve/surgery, Humans, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Watchful Waiting, Severity of Illness Index, Aortic Valve, Aortic Valve/surgery, Humans, Heart Valve Prosthesis Implantation*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Watchful Waiting, Severity of Illness Index, Aortic Valve, Aortic Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2054, + "user_id": 1497893077, + "artical_title": "Transcatheter treatment of the tricuspid valve: current status and perspectives.", + "pmid": 38426859, + "journal_name": "European heart journal", + "date": "2024-03-18", + "author": "Maisano F,Hahn R,Sorajja P,Praz F,Lurz P", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Quality of Life, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Treatment Outcome, Humans, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Quality of Life, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Treatment Outcome, Humans, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Quality of Life, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Treatment Outcome, Humans, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Quality of Life, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Treatment Outcome, Humans, Tricuspid Valve, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Quality of Life, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2055, + "user_id": 1497893077, + "artical_title": "Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.", + "pmid": 38441886, + "journal_name": "European heart journal", + "date": "2024-03-18", + "author": "Muraru D,Badano LP,Hahn RT,Lang RM,Delgado V,Wunderlich NC,Donal E,Taramasso M,Duncan A,Lurz P,De Potter T,Zamorano Gómez JL,Bax JJ,von Bardeleben RS,Enriquez-Sarano M,Maisano F,Praz F,Sitges M", + "auth_pos": 3, + "meshterms": "Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*, Humans, Female, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/etiology, Tricuspid Valve Insufficiency/complications, Heart Atria, Heart Atria/diagnostic imaging, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/etiology, Atrial Fibrillation/therapy, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2056, + "user_id": 1497893077, + "artical_title": "Mitigating Intensive Care Unit Noise: Design-Led Modeling Solutions, Calculated Acoustic Outcomes, and Cost Implications.", + "pmid": 38512990, + "journal_name": "HERD", + "date": "2024-03-21", + "author": "Jonescu EE,Farrel B,Ramanayaka CE,White C,Costanzo G,Delaney L,Hahn R,Ferrier J,Litton E", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2057, + "user_id": 1497893077, + "artical_title": "New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention.", + "pmid": 38599687, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-04-12", + "author": "Welle GA,Hahn RT,Lindenfeld J,Lin G,Nkomo VT,Hausleiter J,Lurz PC,Pislaru SV,Davidson CJ,Eleid MF", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Quality of Life, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2058, + "user_id": 1497893077, + "artical_title": "Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE.", + "pmid": 38599688, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-04-12", + "author": "Adamo M,Russo G,Pagnesi M,Pancaldi E,Alessandrini H,Andreas M,Badano LP,Braun D,Connelly KA,Denti P,Estevez-Loureiro R,Fam N,Gavazzoni M,Hahn RT,Harr C,Hausleiter J,Himbert D,Kalbacher D,Ho E,Latib A,Lubos E,Ludwig S,Lupi L,Lurz P,Monivas V,Nickenig G,Pedicino D,Pedrazzini G,Pozzoli A,Marafon DP,Pastorino R,Praz F,Rodes-Cabau J,Besler C,Schöber AR,Schofer J,Scotti A,Piayda K,Sievert H,Tang GHL,Sticchi A,Messika-Zeitoun D,Thiele H,Schlotter F,von Bardeleben RS,Webb J,Dreyfus J,Windecker S,Leon M,Maisano F,Metra M,Taramasso M", + "auth_pos": 14, + "meshterms": "Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods, Humans, Tricuspid Valve, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Treatment Outcome, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Heart Failure/etiology, Cardiac Catheterization, Cardiac Catheterization/methods", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2059, + "user_id": 1497893077, + "artical_title": "Heart valve disease: at the threshold of a new era in patient management.", + "pmid": 38554723, + "journal_name": "Lancet (London, England)", + "date": "2024-04-22", + "author": "Hahn RT,Muraru D,Lindman BR,Delgado V,Dweck MR", + "auth_pos": 1, + "meshterms": "Humans, Heart Valve Diseases*, Heart Valve Diseases/therapy, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis*, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Heart Valve Diseases*, Heart Valve Diseases/therapy, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis*, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Heart Valve Diseases*, Heart Valve Diseases/therapy, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis*, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Heart Valve Diseases*, Heart Valve Diseases/therapy, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis*, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Humans, Heart Valve Diseases*, Heart Valve Diseases/therapy, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis*, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2060, + "user_id": 1497893077, + "artical_title": "Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.", + "pmid": 38437953, + "journal_name": "International journal of cardiology", + "date": "2024-04-27", + "author": "Russo G,Hahn RT,Alessandrini H,Andreas M,Badano LP,Braun D,Connelly KA,Denti P,Estevez-Loureiro R,Fam N,Gavazzoni M,Hausleiter J,Himbert D,Kalbacher D,Latib A,Lubos E,Ludwig S,Lurz P,Monivas V,Nickenig G,Pedicino D,Pedrazzini G,Pozzoli A,Praz F,Rodes-Cabau J,Rommel KP,Schofer J,Sievert H,Tang G,Thiele H,Unterhuber M,von Bardeleben RS,Webb J,Windecker S,Leon M,Maisano F,Taramasso M", + "auth_pos": 2, + "meshterms": "Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods, Humans, Registries*, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/diagnostic imaging, Cardiac Catheterization*, Cardiac Catheterization/methods, Aged, 80 and over, Treatment Outcome, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Middle Aged, Echocardiography, Echocardiography/methods", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2061, + "user_id": 1497893077, + "artical_title": "Computed tomography anatomic predictors of outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair.", + "pmid": 38383226, + "journal_name": "Journal of cardiovascular computed tomography", + "date": "2024-04-30", + "author": "Bartkowiak J,Vivekanantham H,Kassar M,Dernektsi C,Agarwal V,Lebehn M,Windecker S,Brugger N,Hahn RT,Praz F", + "auth_pos": 9, + "meshterms": "Humans, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Treatment Outcome, Predictive Value of Tests*, Risk Factors, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Retrospective Studies, Aged, 80 and over, Time Factors, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Recovery of Function, Tomography, X-Ray Computed, Risk Assessment, Middle Aged, Humans, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Treatment Outcome, Predictive Value of Tests*, Risk Factors, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Retrospective Studies, Aged, 80 and over, Time Factors, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Recovery of Function, Tomography, X-Ray Computed, Risk Assessment, Middle Aged, Humans, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Treatment Outcome, Predictive Value of Tests*, Risk Factors, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Retrospective Studies, Aged, 80 and over, Time Factors, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Recovery of Function, Tomography, X-Ray Computed, Risk Assessment, Middle Aged, Humans, Male, Female, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Tricuspid Valve/surgery, Aged, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Treatment Outcome, Predictive Value of Tests*, Risk Factors, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Retrospective Studies, Aged, 80 and over, Time Factors, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Recovery of Function, Tomography, X-Ray Computed, Risk Assessment, Middle Aged", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2062, + "user_id": 1497893077, + "artical_title": "Left and Right Ventricular Longitudinal Systolic Function Following Aortic Valve Replacement in the PARTNER 2 Trial And Registry.", + "pmid": 38693866, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2024-05-02", + "author": "Silva I,Ternacle J,Hahn RT,Salah-Annabi M,Dahou A,Krapf L,Salaun E,Guzzetti E,Xu K,Clavel MA,Bernier M,Beaudoin J,Cremer PC,Jaber W,Rodriguez L,Asch FM,Weismann NJ,Bax J,Ajmone N,Alu MC,Kallel F,Mack MJ,Webb JG,Kapadia S,Makkar R,Kodali S,Herrmann HC,Thourani V,Leon MB,Pibarot P", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2063, + "user_id": 1497893077, + "artical_title": "Echocardiographic Outcomes With Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients.", + "pmid": 38099912, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-05-09", + "author": "Marcoff L,Koulogiannis K,Aldaia L,Mediratta A,Chadderdon SM,Makar MM,Ruf TF,Gößler T,Zaroff JG,Leung GK,Ku IA,Nabauer M,Grayburn PA,Wang Z,Hawthorne KM,Fowler DE,Dal-Bianco JP,Vannan MA,Bevilacqua C,Meineri M,Ender J,Forner AF,Puthumana JJ,Mansoor AH,Lloyd DJ,Voskanian SJ,Ghobrial A,Hahn RT,Mahmood F,Haeffele C,Ong G,Schneider LM,Wang DD,Sekaran NK,Koss E,Mehla P,Harb S,Miyasaka R,Ivannikova M,Stewart-Dehner T,Mitchel L,Raissi SR,Kalbacher D,Biswas S,Ho EC,Goldberg Y,Smith RL,Hausleiter J,Lim DS,Gillam LD", + "auth_pos": 28, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Insufficiency/surgery, Mitral Valve Insufficiency/physiopathology, Male, Female, Mitral Valve*, Mitral Valve/diagnostic imaging, Mitral Valve/surgery, Mitral Valve/physiopathology, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/instrumentation, Cardiac Catheterization/adverse effects, Aged, Risk Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Time Factors, Predictive Value of Tests*, Aged, 80 and over, Recovery of Function*, Severity of Illness Index*, Heart Valve Prosthesis, Feasibility Studies, Risk Assessment, Prosthesis Design, Echocardiography, Three-Dimensional, Humans,", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2064, + "user_id": 1497893077, + "artical_title": "Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review.", + "pmid": 38749619, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-05-16", + "author": "Hahn RT,Wilkoff BL,Kodali S,Birgersdotter-Green UM,Ailawadi G,Addetia K,Andreas M,Auricchio A,Ehlert F,George I,Gupta A,Harrison R,Ho EC,Kusumoto F,Latib A,O'Gara P,Patton KK,Pinney S,Zeitler EP,Mack MJ,Leon MB,Epstein LM", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Severity of Illness Index", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2065, + "user_id": 1497893077, + "artical_title": "Transesophageal Echocardiographic Planning and Neo-Left Ventricular Outflow Tract Assessment for Transcatheter Mitral Valve Implantation Using Novel Software.", + "pmid": 38765629, + "journal_name": "CASE (Philadelphia, Pa.)", + "date": "2024-05-20", + "author": "Bartkowiak J,Lebehn MA,Kodali SK,George I,Hahn RT,Vahl TP", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2066, + "user_id": 1497893077, + "artical_title": "Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER Trials.", + "pmid": 38316377, + "journal_name": "The Annals of thoracic surgery", + "date": "2024-05-24", + "author": "Thourani VH,Abbas AE,Ternacle J,Hahn RT,Makkar R,Kodali SK,George I,Kapadia S,Svensson LG,Szeto WY,Herrmann HC,Ailawadi G,Leipsic J,Blanke P,Webb J,Jaber WA,Russo M,Malaisrie SC,Yadav P,Clavel MA,Khalique OK,Weissman NJ,Douglas P,Bax J,Dahou A,Xu K,Bapat V,Alu MC,Leon MB,Mack MJ,Pibarot P", + "auth_pos": 4, + "meshterms": "Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting, Humans, Female, Male, Aged, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Prospective Studies, Transcatheter Aortic Valve Replacement, Transcatheter Aortic Valve Replacement/methods, Transcatheter Aortic Valve Replacement/adverse effects, Aortic Valve, Aortic Valve/surgery, Postoperative Complications, Postoperative Complications/epidemiology, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/adverse effects, Prosthesis Design, Aged, 80 and over, Treatment Outcome, Prosthesis Fitting", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2067, + "user_id": 1497893077, + "artical_title": "Understanding Tricuspid Regurgitation Regression May Be the Key to Progression of the Field.", + "pmid": 38551532, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-06-06", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/physiopathology, Humans, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/physiopathology, Treatment Outcome, Hemodynamics, Disease Progression", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2068, + "user_id": 1497893077, + "artical_title": "Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement.", + "pmid": 38841078, + "journal_name": "Annals of cardiothoracic surgery", + "date": "2024-06-06", + "author": "Hahn RT,Pibarot P", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2069, + "user_id": 1497893077, + "artical_title": "Reply: Management of Isolated Tricuspid Regurgitation: 2 Sides of the Same Coin.", + "pmid": 38866465, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-06-13", + "author": "Welle GA,Hahn RT,Davidson CJ,Eleid MF", + "auth_pos": 2, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve*, Tricuspid Valve/physiopathology, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Risk Factors, Hemodynamics, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve*, Tricuspid Valve/physiopathology, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Risk Factors, Hemodynamics, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve*, Tricuspid Valve/physiopathology, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Risk Factors, Hemodynamics, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Treatment Outcome, Tricuspid Valve*, Tricuspid Valve/physiopathology, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/adverse effects, Risk Factors, Hemodynamics", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2070, + "user_id": 1497893077, + "artical_title": "Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.", + "pmid": 38866455, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-06-13", + "author": "Chen S,Dizon JM,Hahn RT,Pibarot P,George I,Zhao Y,Blanke P,Kapadia S,Babaliaros V,Szeto WY,Makkar R,Thourani VH,Webb JG,Mack MJ,Leon MB,Kodali S,Nazif TM", + "auth_pos": 3, + "meshterms": "Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology, Humans, Registries*, Male, Female, Transcatheter Aortic Valve Replacement*, Transcatheter Aortic Valve Replacement/adverse effects, Transcatheter Aortic Valve Replacement/mortality, Transcatheter Aortic Valve Replacement/instrumentation, Pacemaker, Artificial*, Risk Factors, Aged, Time Factors, Aged, 80 and over, Treatment Outcome, Cardiac Pacing, Artificial*, Heart Valve Prosthesis*, Aortic Valve Stenosis*, Aortic Valve Stenosis/surgery, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Aortic Valve Stenosis/mortality, Aortic Valve*, Aortic Valve/surgery, Aortic Valve/physiopathology, Aortic Valve/diagnostic imaging, Prosthesis Design*, Risk Assessment, Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/mortality, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2071, + "user_id": 1497893077, + "artical_title": "Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR).", + "pmid": 38881496, + "journal_name": "Circulation", + "date": "2024-06-17", + "author": "Long A,Haggerty CM,Finer J,Hartzel D,Jing L,Keivani A,Kelsey C,Rocha D,Ruhl J,vanMaanen D,Metser G,Duffy E,Mawson T,Maurer M,Einstein AJ,Beecy A,Kumaraiah D,Homma S,Liu Q,Agarwal V,Lebehn M,Leon M,Hahn R,Elias P,Poterucha TJ", + "auth_pos": 23, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2072, + "user_id": 1497893077, + "artical_title": "Transcatheter Therapy for the Tricuspid Valve: A Focused Review of Edge-to-Edge Repair and Orthotopic Valve Replacement.", + "pmid": 38884853, + "journal_name": "Current cardiology reports", + "date": "2024-06-25", + "author": "Madhavan MV,Agarwal V,Hahn RT", + "auth_pos": 3, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization*, Cardiac Catheterization/methods, Cardiac Catheterization/instrumentation, Tricuspid Valve*, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis, Treatment Outcome, Randomized Controlled Trials as Topic, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Cardiac Catheterization*, Cardiac Catheterization/methods, Cardiac Catheterization/instrumentation, Tricuspid Valve*, Tricuspid Valve/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis, Treatment Outcome, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2073, + "user_id": 1497893077, + "artical_title": "Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair.", + "pmid": 38752971, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-06-27", + "author": "Dreyfus J,Taramasso M,Kresoja KP,Omran H,Iliadis C,Russo G,Weber M,Nombela-Franco L,Estevez Loureiro R,Hausleiter J,Latib A,Stolz L,Praz F,Windecker S,Zamorano JL,von Bardeleben RS,Tang GHL,Hahn R,Lubos E,Webb J,Schofer J,Fam N,Lauten A,Pedrazzini G,Rodés-Cabau J,Nejjari M,Badano L,Alessandrini H,Himbert D,Sievert H,Piayda K,Donal E,Modine T,Nickenig G,Pfister R,Rudolph V,Bernick J,Wells GA,Bax J,Lurz P,Enriquez-Sarano M,Maisano F,Messika-Zeitoun D", + "auth_pos": 18, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Tricuspid Valve Insufficiency/surgery, Tricuspid Valve Insufficiency/physiopathology, Tricuspid Valve Insufficiency/mortality, Male, Female, Severity of Illness Index*, Tricuspid Valve*, Tricuspid Valve/diagnostic imaging, Tricuspid Valve/surgery, Tricuspid Valve/physiopathology, Aged, Treatment Outcome, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/mortality, Cardiac Catheterization/instrumentation, Time Factors, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/adverse effects, Heart Valve Prosthesis Implantation/instrumentation, Heart Valve Prosthesis Implantation/mortality, Risk Factors, Aged, 80 and over, Middle Aged, Risk Assessment, Registries", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2074, + "user_id": 1497893077, + "artical_title": "Characterization of Left Atrial Appendage Closure Device Protrusion and Implications for Transcatheter Mitral Valve Replacement.", + "pmid": 38938333, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Ranard LS,Guber K,Leb J,Lebehn M,Agarwal V,Hahn RT,Ng V,Leon MB,Sommer R,Vahl TP", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2075, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation: A New Transcatheter Therapy on the Block!", + "pmid": 38938710, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Velagapudi P,Hahn RT", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2076, + "user_id": 1497893077, + "artical_title": "Effect of Sex and Flow Status on Outcomes After Surgical or Transcatheter Aortic Valve Replacement.", + "pmid": 38938841, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Carter-Storch R,Hahn RT,Abbas AE,Daubert MA,Douglas PS,Elmariah S,Zhao Y,Mack MJ,Leon MB,Pibarot P,Clavel MA", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2077, + "user_id": 1497893077, + "artical_title": "First Experience With Augmented Reality Guidance for Cerebral Embolic Protection During TAVR.", + "pmid": 38938839, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Sadri S,Loeb GJ,Grinshpoon A,Elvezio C,Sun SH,Ng VG,Khalique O,Moses JW,Einstein AJ,Patel AJ,George I,Hahn RT,Nazif TM,Leon MB,Kirtane AJ,Kodali SK,Feiner SK,Vahl TP", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2078, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.", + "pmid": 38960514, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-07-04", + "author": "Hahn RT,Lindenfeld J,Böhm M,Edelmann F,Lund LH,Lurz P,Metra M,Tedford RJ,Butler J,Borlaug BA", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/physiopathology, Heart Failure*, Heart Failure/physiopathology, Heart Failure/therapy, Stroke Volume*, Stroke Volume/physiology", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2079, + "user_id": 1497893077, + "artical_title": "Structural Heart Imaging Using 3-Dimensional Intracardiac Echocardiography: JACC Cardiovascular Imaging Position Statement.", + "pmid": 38970594, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-07-06", + "author": "Tang GHL,Zaid S,Hahn RT,Aggarwal V,Alkhouli M,Aman E,Berti S,Chandrashekhar YS,Chadderdon SM,D'Agostino A,Fam NP,Ho EC,Kliger C,Kodali SK,Krishnamoorthy P,Latib A,Lerakis S,Lim DS,Mahadevan VS,Nair DG,Narula J,O'Gara PT,Packer DL,Praz F,Rogers JH,Ruf TF,Sanchez CE,Sharma A,Singh GD,van Mieghem NM,Vannan MA,Yadav PK,Ya'Qoub L,Zahr FE,von Bardeleben RS", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2080, + "user_id": 1497893077, + "artical_title": "Sex-related differences in degenerative mitral regurgitation: a call to action.", + "pmid": 38866496, + "journal_name": "European heart journal", + "date": "2024-07-09", + "author": "Hahn RT", + "auth_pos": 1, + "meshterms": "Humans, Mitral Valve Insufficiency*, Mitral Valve Insufficiency/physiopathology, Female, Male, Sex Factors", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2081, + "user_id": 1497893077, + "artical_title": "3-Dimensional Echocardiographic Prediction of Left Ventricular Outflow Tract Area Prior to Transcatheter Mitral Valve Replacement.", + "pmid": 39066744, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-07-28", + "author": "Bartkowiak J,Dernektsi C,Agarwal V,Lebehn MA,Williams TA,Brandwein RA,Brugger N,Gräni C,Windecker S,Vahl TP,Nazif TM,George I,Kodali SK,Praz F,Hahn RT", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2082, + "user_id": 1497893077, + "artical_title": "Tricuspid Regurgitation Severity Grades: Is More Always Better?", + "pmid": 38829783, + "journal_name": "European heart journal. Cardiovascular Imaging", + "date": "2024-07-31", + "author": "Hahn RT,Zamorano JL", + "auth_pos": 1, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/diagnostic imaging, Severity of Illness Index*, Female, Male, Echocardiography", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2083, + "user_id": 1497893077, + "artical_title": "TRISCEND II: Novel Randomized Trial Design for Transcatheter Tricuspid Valve Replacement.", + "pmid": 38897265, + "journal_name": "The American journal of cardiology", + "date": "2024-08-01", + "author": "Grayburn PA,Kodali SK,Hahn RT,Lurz P,Thourani VH,Kozorovitsky ER,Gilmore SY,Vinekar C,Zhang B,Boulware K,Krzmarzick AM,Nguyen D,Vu MT,Feldman T,Mack MJ,Leon MB", + "auth_pos": 3, + "meshterms": "Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome, Humans, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/surgery, Heart Valve Prosthesis Implantation*, Heart Valve Prosthesis Implantation/methods, Cardiac Catheterization*, Cardiac Catheterization/methods, Tricuspid Valve*, Tricuspid Valve/surgery, Prospective Studies, Heart Valve Prosthesis, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2084, + "user_id": 1497893077, + "artical_title": "Treatment of Aortic Regurgitation With a Novel Device: Results of the J-Valve Early Feasibility Study.", + "pmid": 39093242, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-08-02", + "author": "Garcia S,Kaneko T,Reardon M,Goel S,Cohen DJ,Cavalcante JL,Chuang ML,Hahn RT,Latib A,Waksman R,Rizik DG,Fail P,Gafoor SA,Kereiakes DJ", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2085, + "user_id": 1497893077, + "artical_title": "Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis.", + "pmid": 38795109, + "journal_name": "JACC. Cardiovascular imaging", + "date": "2024-08-08", + "author": "Adrichem R,Hokken TW,Bouwmeester S,Abdelkarim O,Vogel B,Blusztein DI,Veulemans V,Kuneman JH,Geleijnse ML,Verhemel S,Van den Dorpel MMP,Kardys I,Tonino PAL,Chang SM,Faza NN,Jou S,Ueyama HA,Bartkowiak J,Zeus T,Bax JJ,Bertrand PB,Hahn RT,Kodali SK,Lerakis S,Mehran R,Little SH,Houthuizen P,Van Mieghem NM", + "auth_pos": 22, + "meshterms": "Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics, Humans, Aortic Valve Stenosis*, Aortic Valve Stenosis/diagnostic imaging, Aortic Valve Stenosis/physiopathology, Female, Male, Aged, Aortic Valve*, Aortic Valve/diagnostic imaging, Aortic Valve/physiopathology, Aortic Valve/pathology, Calcinosis*, Calcinosis/diagnostic imaging, Calcinosis/physiopathology, Predictive Value of Tests*, Severity of Illness Index*, Multidetector Computed Tomography*, Aged, 80 and over, Echocardiography, Stress*, Reproducibility of Results, ROC Curve, Ventricular Function, Left, Area Under Curve, Stroke Volume, Hemodynamics", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2086, + "user_id": 1497893077, + "artical_title": "Strain assessment in patients with aortic regurgitation undergoing transcatheter aortic valve implantation: case series.", + "pmid": 39113778, + "journal_name": "European heart journal. Case reports", + "date": "2024-08-08", + "author": "Bartkowiak J,Agarwal V,Lebehn M,Nazif TM,George I,Kodali SK,Vahl TP,Hahn RT", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Rebecca Tung Hahn" + }, + { + "id": 2087, + "user_id": 1841382421, + "artical_title": "Cardiac Implantable Electronic Devices.", + "pmid": 29428147, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-01-03", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2088, + "user_id": 1841382421, + "artical_title": "Leadless Pacemakers: State of the Art and Future Perspectives.", + "pmid": 29428139, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-01-03", + "author": "Della Rocca DG,Gianni C,Di Biase L,Natale A,Al-Ahmad A", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2089, + "user_id": 1841382421, + "artical_title": "Localization of Ventricular Arrhythmias for Catheter Ablation: The Role of Surface Electrocardiogram.", + "pmid": 29784487, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-01-03", + "author": "Della Rocca DG,Gianni C,Mohanty S,Trivedi C,Di Biase L,Natale A", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2090, + "user_id": 1841382421, + "artical_title": "Ectopic Beats: Insights from Timing and Morphology.", + "pmid": 29784483, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-01-03", + "author": "Bagliani G,Della Rocca DG,De Ponti R,Capucci A,Padeletti M,Natale A", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2091, + "user_id": 1841382421, + "artical_title": "Ablation Index as a predictor of long-term efficacy in premature ventricular complex ablation: A regional target value analysis.", + "pmid": 30616020, + "journal_name": "Heart rhythm", + "date": "2019-01-08", + "author": "Casella M,Gasperetti A,Gianni C,Zucchelli G,Notarstefano P,Al-Ahmad A,Burkhardt JD,Soldati E,Della Rocca D,Catto V,Majocchi B,Carbucicchio C,Bongiorni MG,Dello Russo A,Natale A,Tondo C", + "auth_pos": 15, + "meshterms": "Adult, Body Surface Potential Mapping, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography, Female, Follow-Up Studies, Heart Ventricles, Heart Ventricles/physiopathology*, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Ventricular Premature Complexes, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/physiopathology, Ventricular Premature Complexes/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2092, + "user_id": 1841382421, + "artical_title": "The role of the Purkinje network in premature ventricular complex-triggered ventricular fibrillation.", + "pmid": 30066290, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-01-10", + "author": "Gianni C,Burkhardt JD,Trivedi C,Mohanty S,Natale A", + "auth_pos": 5, + "meshterms": "Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Humans, Male, Prognosis, Purkinje Fibers, Purkinje Fibers/physiopathology*, Recovery of Function, Risk Assessment, Treatment Outcome, Ventricular Fibrillation, Ventricular Fibrillation/diagnostic imaging, Ventricular Fibrillation/surgery*, Ventricular Premature Complexes, Ventricular Premature Complexes/diagnostic imaging*, Ventricular Premature Complexes/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2093, + "user_id": 1841382421, + "artical_title": "Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.", + "pmid": 30623500, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2019-01-10", + "author": "Gadiyaram VK,Mohanty S,Gianni C,Trivedi C,Al-Ahmad A,Burkhardt DJ,Gallinghouse JG,Hranitzky PM,Horton RP,Sanchez JE,Della Rocca DG,Di Biase L,Price MJ,Couts L,Gibson D,Natale A", + "auth_pos": 16, + "meshterms": "Aged, Anticoagulants, Anticoagulants/administration & dosage*, Anticoagulants/adverse effects, Atrial Appendage, Atrial Appendage/diagnostic imaging, Atrial Appendage/drug effects*, Atrial Appendage/physiopathology, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/mortality, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Cardiac Catheterization*, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation, Cardiac Catheterization/mortality, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/mortality, Drug Administration Schedule, Echocardiography, Doppler, Color, Echocardiography, Transesophageal, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Stroke, Stroke/diagnosis, Stroke/mortality, Stroke/physiopathology, Stroke/prevention & control*, Thromboembolism, Thromboembolism/diagnosis, Thromboembolism/mortality, Thromboembolism/physiopathology, Thromboembolism/prevention & control*, Time Factors, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2094, + "user_id": 1841382421, + "artical_title": "Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.", + "pmid": 30066291, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-01-11", + "author": "Briceño DF,Markman TM,Lupercio F,Romero J,Liang JJ,Villablanca PA,Birati EY,Garcia FC,Di Biase L,Natale A,Marchlinski FE,Santangeli P", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2095, + "user_id": 1841382421, + "artical_title": "[Leadless pacing: present and future of cardiac stimulation].", + "pmid": 30638213, + "journal_name": "Giornale italiano di cardiologia (2006)", + "date": "2019-01-15", + "author": "Piro A,Lavalle C,Della Rocca DG,Scarparo P,Mancone M,Maestrini V,Di Biase L,Natale A,Fedele F", + "auth_pos": 8, + "meshterms": "Arrhythmias, Cardiac, Arrhythmias, Cardiac/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Cardiac Resynchronization Therapy, Cardiac Resynchronization Therapy/methods, Equipment Design, Humans, Pacemaker, Artificial*, Prosthesis Implantation, Prosthesis Implantation/methods, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2096, + "user_id": 1841382421, + "artical_title": "Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.", + "pmid": 30678778, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2019-01-27", + "author": "Romero J,Cerrud-Rodriguez RC,Di Biase L,Diaz JC,Alviz I,Grupposo V,Cerna L,Avendano R,Tedrow U,Natale A,Tung R,Kumar S", + "auth_pos": 10, + "meshterms": "Aged, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Catheter Ablation/mortality, Female, Heart Diseases, Heart Diseases/complications*, Humans, Male, Middle Aged, Postoperative Complications, Postoperative Complications/epidemiology, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2097, + "user_id": 1841382421, + "artical_title": "Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.", + "pmid": 30678787, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2019-01-27", + "author": "Santangeli P,Tung R,Xue Y,Chung FP,Lin YJ,Di Biase L,Zhan X,Lin CY,Wei W,Mohanty S,Burkhardt DJ,Zado ES,Callans DJ,Marchlinski FE,Wu S,Chen SA,Natale A", + "auth_pos": 17, + "meshterms": "Adult, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Dysplasia/complications*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/mortality, Catheter Ablation/statistics & numerical data, Female, Humans, Male, Middle Aged, Registries, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2098, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30686083, + "journal_name": "Hypertension (Dallas, Tex. : 1979)", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Biomedical Research, Biomedical Research/ethics*, Communication*, Humans, Periodicals as Topic*, Scientific Misconduct, Scientific Misconduct/ethics*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2099, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30688079, + "journal_name": "Circulation. Heart failure", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Evidence-Based Medicine, Evidence-Based Medicine/education*, Health Communication*, Health Knowledge, Attitudes, Practice*, Humans, Information Dissemination*, Patient Education as Topic*, Patient Safety, Public Opinion, Risk Assessment, Social Media*, Truth Disclosure", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2100, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30688515, + "journal_name": "Circulation. Genomic and precision medicine", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/mortality, Cardiovascular Diseases/pathology, Communication*, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Risk Assessment", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2101, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30688516, + "journal_name": "Circulation. Cardiovascular imaging", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Evidence-Based Medicine, Evidence-Based Medicine/education*, Health Communication*, Health Knowledge, Attitudes, Practice*, Humans, Information Dissemination*, Patient Education as Topic*, Patient Safety, Public Opinion, Risk Assessment, Social Media*, Truth Disclosure", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2102, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30688519, + "journal_name": "Circulation. Cardiovascular quality and outcomes", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol C,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Access to Information*, Attitude of Health Personnel, Cardiologists, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control*, Health Communication, Health Knowledge, Attitudes, Practice, Humans, Information Dissemination*, Internet, Patient Education as Topic*, Patient Safety, Professional-Patient Relations, Risk Assessment, Social Media", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2103, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30688520, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Attitude of Health Personnel, Cardiologists, Cardiovascular Diseases, Cardiovascular Diseases/prevention & control*, Health Communication, Health Knowledge, Attitudes, Practice*, Humans, Information Dissemination*, Internet*, Patient Education as Topic*, Professional-Patient Relations, Risk Assessment, Social Media*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2104, + "user_id": 1841382421, + "artical_title": "Medical Misinformation: Vet the Message!", + "pmid": 30688522, + "journal_name": "Circulation", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol C,Grines C,Gropler RJ,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis AD,Vrints CJ", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2105, + "user_id": 1841382421, + "artical_title": "Medical Misinformation.", + "pmid": 30689419, + "journal_name": "Circulation", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Access to Information*, Attitude of Health Personnel*, Cardiologists, Cardiologists/psychology*, Health Communication*, Health Knowledge, Attitudes, Practice*, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Internet, Patient Acceptance of Health Care*, Patient Safety, Risk Assessment, Social Media", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2106, + "user_id": 1841382421, + "artical_title": "Medical misinformation: vet the message!", + "pmid": 30689762, + "journal_name": "Cardiovascular research", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2107, + "user_id": 1841382421, + "artical_title": "Medical Misinformation: Vet the Message!", + "pmid": 30689805, + "journal_name": "European heart journal", + "date": "2019-01-29", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 22, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2108, + "user_id": 1841382421, + "artical_title": "Medical misinformation: Vet the message!", + "pmid": 30703343, + "journal_name": "Heart rhythm", + "date": "2019-02-01", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Communication*, Consumer Health Information*, Health Knowledge, Attitudes, Practice*, Humans, Patient Education as Topic*, Social Media", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2109, + "user_id": 1841382421, + "artical_title": "Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.", + "pmid": 29680972, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-02-01", + "author": "Atti V,Vuddanda V,Turagam MK,Vemula P,Shah Z,Nagam H,Yandrapalli S,Jazayeri MA,Koerber S,Gonzalez JV,Natale A,Di Biase L,Lakkireddy DR", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2110, + "user_id": 1841382421, + "artical_title": "Closure of foramen ovale triggered by injury to tunnel surfaces of septum primum and secundum.", + "pmid": 30706256, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-02-02", + "author": "Di Biase L,Burkhardt JD,Horton R,Sanchez J,Mohanty P,Mohanty S,Bailey S,Gallinghouse GJ,Natale A,Krishnan SC", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery*, Atrial Septum, Atrial Septum/diagnostic imaging, Atrial Septum/injuries*, Atrial Septum/surgery*, Echocardiography, Doppler, Color, Female, Foramen Ovale, Patent, Foramen Ovale, Patent/diagnostic imaging, Foramen Ovale, Patent/surgery*, Humans, Male, Middle Aged, Pilot Projects, Radiofrequency Ablation, Radiofrequency Ablation/methods*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2111, + "user_id": 1841382421, + "artical_title": "Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter-defibrillator.", + "pmid": 30710741, + "journal_name": "Heart rhythm", + "date": "2019-02-03", + "author": "Sharma SP,Turagam M,Atkins D,Bommana S,Jeffrey C,Newton D,Nydegger C,Carroll H,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 10, + "meshterms": "Aged, Amiodarone, Amiodarone/administration & dosage*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/administration & dosage*, Atrial Fibrillation, Atrial Fibrillation/drug therapy*, Defibrillators, Implantable*, Female, Hospitalization, Humans, Male, Middle Aged, Phenethylamines, Phenethylamines/administration & dosage*, Retrospective Studies, Sulfonamides, Sulfonamides/administration & dosage*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2112, + "user_id": 1841382421, + "artical_title": "Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations.", + "pmid": 30712645, + "journal_name": "Heart rhythm", + "date": "2019-02-05", + "author": "Winkle RA,Mohanty S,Patrawala RA,Mead RH,Kong MH,Engel G,Salcedo J,Trivedi CG,Gianni C,Jais P,Natale A,Day JD", + "auth_pos": 11, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Burns, Electric, Burns, Electric/etiology, Burns, Electric/prevention & control, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Female, Humans, Intraoperative Complications*, Intraoperative Complications/etiology, Intraoperative Complications/prevention & control, Male, Middle Aged, Outcome and Process Assessment, Health Care, Postoperative Complications*, Postoperative Complications/diagnosis, Postoperative Complications/etiology, Postoperative Complications/prevention & control, Pulmonary Veins, Pulmonary Veins/surgery, Radio Waves, Radio Waves/adverse effects*, Time Factors, Postoperative hypertension*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2113, + "user_id": 1841382421, + "artical_title": "Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications.", + "pmid": 30726903, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2019-02-07", + "author": "Mohanty S,Trivedi C,Beheiry S,Al-Ahmad A,Horton R,Della Rocca DG,Gianni C,Gasperetti A,Abdul-Moheeth M,Turakhia M,Natale A", + "auth_pos": 11, + "meshterms": "Aged, Anticoagulants, Anticoagulants/administration & dosage*, Arrhythmias, Cardiac, Arrhythmias, Cardiac/surgery*, Atrial Appendage, Atrial Appendage/surgery*, Bed Rest, Catheter Ablation, Catheter Ablation/methods*, Equipment Design, Female, Hemostasis, Surgical, Hemostasis, Surgical/methods*, Humans, Male, Patient Satisfaction, Postoperative Complications, Postoperative Complications/etiology, Pressure, Punctures, Retrospective Studies, Urologic Diseases, Urologic Diseases/etiology, Vascular Closure Devices*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2114, + "user_id": 1841382421, + "artical_title": "Medical Misinformation: Vet the Message!", + "pmid": 30730472, + "journal_name": "Journal of cardiovascular pharmacology", + "date": "2019-02-08", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Access to Information*, Consumer Health Information*, Evidence-Based Medicine*, Health Communication*, Health Knowledge, Attitudes, Practice*, Humans, Internet, Patient Education as Topic*, Patient Safety, Risk Assessment, Risk Factors, Social Media", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2115, + "user_id": 1841382421, + "artical_title": "Sudden Cardiac Death: Back to the Future.", + "pmid": 29173419, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-02-15", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Cardiovascular Diseases, Cardiovascular Diseases/complications*, Cardiovascular Diseases/epidemiology, Death, Sudden, Cardiac, Death, Sudden, Cardiac/epidemiology*, Death, Sudden, Cardiac/etiology, Global Health, Humans, Incidence, Risk Assessment*, Risk Factors, Survival Rate, Survival Rate/trends", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2116, + "user_id": 1841382421, + "artical_title": "Evidence of relevant electrical connection between the left atrial appendage and the great cardiac vein during catheter ablation of atrial fibrillation.", + "pmid": 30763785, + "journal_name": "Heart rhythm", + "date": "2019-02-15", + "author": "Di Biase L,Romero J,Briceno D,Valderrabano M,Sanchez JE,Della Rocca DG,Mohanty P,Horton R,Gallinghouse GJ,Mohanty S,Trivedi C,Beheiry S,Gianni C,Elayi CS,Burkhardt JD,Natale A", + "auth_pos": 16, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies, Aged, Atrial Appendage, Atrial Appendage/innervation*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Coronary Sinus, Coronary Sinus/innervation*, Coronary Vessels, Coronary Vessels/innervation*, Female, Humans, Male, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2117, + "user_id": 1841382421, + "artical_title": "The Role of Collaboration Between Electrophysiologists and Surgeons in the Management of Complex Arrhythmia Patients.", + "pmid": 32494412, + "journal_name": "The Journal of innovations in cardiac rhythm management", + "date": "2019-02-15", + "author": "Gianni C,Trivedi C,Mohanty S,Natale A", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2118, + "user_id": 1841382421, + "artical_title": "Lead Management.", + "pmid": 30396584, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-03-05", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2119, + "user_id": 1841382421, + "artical_title": "Sex differences in complications of catheter ablation for atrial fibrillation: results on 85,977 patients.", + "pmid": 30062452, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-03-15", + "author": "Elayi CS,Darrat Y,Suffredini JM,Misumida N,Shah J,Morales G,Wilson W,Bidwell K,Czarapata M,Parrott K,Di Biase L,Natale A,Ogunbayo GO", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2120, + "user_id": 1841382421, + "artical_title": "Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience.", + "pmid": 30060879, + "journal_name": "Heart rhythm", + "date": "2019-03-21", + "author": "Aryana A,Baker JH,Espinosa Ginic MA,Pujara DK,Bowers MR,O'Neill PG,Ellenbogen KA,Di Biase L,d'Avila A,Natale A", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2121, + "user_id": 1841382421, + "artical_title": "Cardiac Resynchronization Therapy.", + "pmid": 30717858, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-04-05", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2122, + "user_id": 1841382421, + "artical_title": "Role of surface electrocardiogram in the era of high-resolution mapping and imaging systems-back to the future.", + "pmid": 30997205, + "journal_name": "Journal of thoracic disease", + "date": "2019-04-19", + "author": "Lavalle C,Mariani MV,Della Rocca DG,Natale A", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2123, + "user_id": 1841382421, + "artical_title": "Medical misinformation: vet the message!", + "pmid": 30689786, + "journal_name": "European heart journal. Cardiovascular pharmacotherapy", + "date": "2019-04-23", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Access to Information, Cardiovascular Diseases, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control*, Communications Media*, Conflict of Interest, Health Knowledge, Attitudes, Practice, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*, Information Dissemination, Information Dissemination/methods*, Marketing of Health Services, Patient Education as Topic*, Patient Safety, Risk Assessment, Risk Factors, Treatment Refusal*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2124, + "user_id": 1841382421, + "artical_title": "Mastering the art of epicardial access in cardiac electrophysiology.", + "pmid": 31015022, + "journal_name": "Heart rhythm", + "date": "2019-04-25", + "author": "Romero J,Shivkumar K,Di Biase L,Avendano R,Anderson RD,Natale A,Kumar S", + "auth_pos": 6, + "meshterms": "Cardiac Surgical Procedures*, Diagnostic Imaging, Electrophysiologic Techniques, Cardiac*, Epicardial Mapping, Heart Injuries, Heart Injuries/prevention & control, Humans, Insufflation, Pericardium*, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2125, + "user_id": 1841382421, + "artical_title": "Electrocardiographic Trilogy.", + "pmid": 31084859, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-05-16", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Electrocardiography*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2126, + "user_id": 1841382421, + "artical_title": "The Value of Baseline and Arrhythmic ECG in the Interpretation of Arrhythmic Mechanisms.", + "pmid": 31084848, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-05-16", + "author": "Chen Q,Gasperetti A,Della Rocca DG,Mohanty S,Gedikli O,Trivedi C,Chauca-Tapia A,Di Biase L,Natale A", + "auth_pos": 9, + "meshterms": "Arrhythmias, Cardiac*, Arrhythmias, Cardiac/classification, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Electrocardiography, Electrocardiography/classification*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2127, + "user_id": 1841382421, + "artical_title": "Medical misinformation: vet the message!", + "pmid": 30689789, + "journal_name": "European heart journal. Quality of care & clinical outcomes", + "date": "2019-05-22", + "author": "Hill JA,Agewall S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Rosenson RS,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Attitude*, Communication*, Humans, Medical Informatics*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2128, + "user_id": 1841382421, + "artical_title": "Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin.", + "pmid": 30128801, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-05-23", + "author": "Avendano R,Romero J,Lupercio F,Diaz JC,Quispe R,Golive A,Natale A,Garcia MJ,Krumerman AK,Di Biase L", + "auth_pos": 7, + "meshterms": "Administration, Oral, Aged, Amiodarone, Amiodarone/administration & dosage*, Amiodarone/adverse effects, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/administration & dosage*, Anti-Arrhythmia Agents/adverse effects, Atrial Fibrillation, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/drug therapy*, Atrial Fibrillation/mortality, Female, Humans, Male, Middle Aged, Prognosis, Randomized Controlled Trials as Topic, Risk Assessment, Severity of Illness Index, Stroke, Stroke/prevention & control*, Survival Rate, Thromboembolism, Thromboembolism/prevention & control, Treatment Outcome, Warfarin, Warfarin/administration & dosage*, Warfarin/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2129, + "user_id": 1841382421, + "artical_title": "Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up.", + "pmid": 30144981, + "journal_name": "American heart journal", + "date": "2019-06-21", + "author": "Mohanty S,Gianni C,Trivedi C,Metz T,Bai R,Al-Ahmad A,Bailey S,Burkhardt JD,Gallinghouse GJ,Horton R,Hranitzky PM,Sanchez JE,Di Biase L,Natale A", + "auth_pos": 14, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Body Surface Potential Mapping, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography, Ambulatory, Female, Follow-Up Studies, Heart Rate, Heart Rate/physiology*, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2130, + "user_id": 1841382421, + "artical_title": "Persistent left superior vena cava as an arrhythmogenic source in atrial fibrillation: results from a multicenter experience.", + "pmid": 30259306, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-06-30", + "author": "Turagam MK,Atoui M,Atkins D,Di Biase L,Shivkumar K,Jared Bunch T,Mohanty S,Gianni C,Natale A,Lakkireddy D", + "auth_pos": 9, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Cohort Studies, Electrocardiography, Electrocardiography/methods, Female, Follow-Up Studies, Heart Defects, Congenital, Heart Defects, Congenital/diagnostic imaging, Heart Defects, Congenital/surgery*, Humans, Male, Middle Aged, Pulmonary Veins, Pulmonary Veins/surgery, Quality of Life, Retrospective Studies, Treatment Outcome, Vena Cava, Superior, Vena Cava, Superior/abnormalities*, Vena Cava, Superior/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2131, + "user_id": 1841382421, + "artical_title": "Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.", + "pmid": 31257677, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2019-07-02", + "author": "Romero J,Cerrud-Rodriguez RC,Diaz JC,Rodriguez D,Arshad S,Alviz I,Cerna L,Rios S,Monhanty S,Natale A,Garcia MJ,Di Biase L", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2132, + "user_id": 1841382421, + "artical_title": "Association between prolonged P wave duration and left atrial scarring in patients with paroxysmal atrial fibrillation.", + "pmid": 31310407, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2019-07-17", + "author": "Chen Q,Mohanty S,Trivedi C,Gianni C,Della Rocca DG,Canpolat U,Burkhardt JD,Sanchez JE,Hranitzky P,Gallinghouse GJ,Al-Ahmad A,Horton R,Di Biase L,Natale A", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2133, + "user_id": 1841382421, + "artical_title": "An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience.", + "pmid": 31313089, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-07-18", + "author": "Casella M,Dello Russo A,Riva S,Catto V,Negro G,Sicuso R,Cellucci S,Gasperetti A,Zucchetti M,Ribatti V,Biagioli V,Fassini G,Di Biase L,Natale A,Tondo C", + "auth_pos": 14, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/standards*, Female, Humans, Male, Middle Aged, Propensity Score, Prospective Studies, Quality Improvement*, Quality Indicators, Health Care*, Reproducibility of Results, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2134, + "user_id": 1841382421, + "artical_title": "Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial.", + "pmid": 31320006, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2019-07-20", + "author": "Reddy VY,Grimaldi M,De Potter T,Vijgen JM,Bulava A,Duytschaever MF,Martinek M,Natale A,Knecht S,Neuzil P,Pürerfellner H", + "auth_pos": 8, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/instrumentation, Catheter Ablation/methods, Catheters, Catheters/adverse effects, Equipment Design, Female, Fluoroscopy, Humans, Male, Microelectrodes, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Therapeutic Irrigation, Therapeutic Irrigation/instrumentation, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2135, + "user_id": 1841382421, + "artical_title": "Medical Misinformation - Vet the Message!", + "pmid": 30694814, + "journal_name": "Anatolian journal of cardiology", + "date": "2019-07-23", + "author": "Hill JA,Agewal S,Baranchuk A,Booz GW,Borer JS,Camici PG,Chen PS,Dominiczak AF,Erol Ç,Grines CL,Gropler R,Guzik TJ,Heinemann MK,Iskandrian AE,Knight BP,London B,Lüscher TF,Metra M,Musunuru K,Nallamothu BK,Natale A,Saksena S,Picard MH,Rao SV,Remme WJ,Sweitzer NK,Timmis A,Vrints C", + "auth_pos": 21, + "meshterms": "Cardiovascular Diseases*, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/prevention & control, Communication*, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2136, + "user_id": 1841382421, + "artical_title": "Letter by Romero et al Regarding Article, \"Left Atrial Appendage Isolation in Patients Not Responding to Pulmonary Vein Isolation: Benefit and Risks\".", + "pmid": 31329484, + "journal_name": "Circulation", + "date": "2019-07-23", + "author": "Romero J,Natale A,Di Biase L", + "auth_pos": 2, + "meshterms": "Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation*, Humans, Pulmonary Veins, Pulmonary Veins/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2137, + "user_id": 1841382421, + "artical_title": "Personalized occluders for the left atrial appendage.", + "pmid": 31015660, + "journal_name": "Nature biomedical engineering", + "date": "2019-07-26", + "author": "Gianni C,Natale A", + "auth_pos": 2, + "meshterms": "Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/surgery*, Cardiac Surgical Procedures, Cardiac Surgical Procedures/instrumentation*, Cardiac Surgical Procedures/methods*, Humans, Precision Medicine, Precision Medicine/instrumentation*, Precision Medicine/methods, Printing, Three-Dimensional", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2138, + "user_id": 1841382421, + "artical_title": "Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results from a multicenter study.", + "pmid": 31400519, + "journal_name": "Heart rhythm", + "date": "2019-08-11", + "author": "Mohanty S,Gianni C,Trivedi C,Gadiyaram V,Della Rocca DG,MacDonald B,Horton R,Al-Ahmad A,Gibson DN,Price M,Krumerman AK,Palma EC,Di Biase L,Lakkireddy D,Natale A", + "auth_pos": 15, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Cardiac Catheterization, Cardiac Catheterization/methods*, Cardiac Surgical Procedures, Cardiac Surgical Procedures/methods*, Echocardiography, Doppler, Color, Echocardiography, Transesophageal, Female, Follow-Up Studies, Humans, Incidence, Ligation, Male, Retrospective Studies, Risk Assessment, Risk Assessment/methods*, Risk Factors, Thromboembolism, Thromboembolism/epidemiology, Thromboembolism/etiology, Thromboembolism/prevention & control*, Time Factors, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2139, + "user_id": 1841382421, + "artical_title": "Mapping the Heart.", + "pmid": 31400879, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-08-12", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Cardiac Imaging Techniques*, Electrocardiography*, Electrophysiologic Techniques, Cardiac*, Heart*, Heart/diagnostic imaging, Heart/physiology, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2140, + "user_id": 1841382421, + "artical_title": "Radiofrequency Balloon Devices for Atrial Fibrillation Ablation.", + "pmid": 31400873, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2019-08-12", + "author": "Gianni C,Chen Q,Della Rocca D,Canpolat U,Ayhan H,MacDonald B,Mohanty S,Trivedi C,Natale A,Al-Ahmad A", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/instrumentation*, Catheter Ablation/methods, Catheters, Equipment Design, Humans, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2141, + "user_id": 1841382421, + "artical_title": "Comparison of Complications of Catheter Ablation for Ventricular Arrhythmias in Adults With Versus Without Structural Heart Disease.", + "pmid": 30115423, + "journal_name": "The American journal of cardiology", + "date": "2019-08-23", + "author": "Ogunbayo GO,Charnigo R,Darrat Y,Shah J,Patel R,Suffredini J,Wilson W,Parrott K,Kusterer N,Biase LD,Natale A,Morales G,Elayi CS", + "auth_pos": 11, + "meshterms": "Adolescent, Adult, Aged, Aged, 80 and over, Catheter Ablation, Catheter Ablation/methods*, Female, Heart Diseases, Heart Diseases/complications*, Heart Diseases/mortality, Hospital Mortality, Humans, Length of Stay, Length of Stay/statistics & numerical data, Male, Middle Aged, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/mortality, Tachycardia, Ventricular, Tachycardia, Ventricular/mortality, Tachycardia, Ventricular/surgery*, Treatment Outcome, United States, United States/epidemiology, Ventricular Premature Complexes, Ventricular Premature Complexes/mortality, Ventricular Premature Complexes/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2142, + "user_id": 1841382421, + "artical_title": "Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.", + "pmid": 31439209, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-08-24", + "author": "Di Biase L,Mohanty S,Trivedi C,Romero J,Natale V,Briceno D,Gadiyaram V,Couts L,Gianni C,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Horton R,Hranitzky PM,Sanchez JE,Natale A", + "auth_pos": 16, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/diagnostic imaging*, Atrial Appendage/surgery*, Catheter Ablation, Catheter Ablation/adverse effects*, Catheter Ablation/trends, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Stroke, Stroke/diagnostic imaging*, Stroke/etiology*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2143, + "user_id": 1841382421, + "artical_title": "Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.", + "pmid": 30071993, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-08-29", + "author": "Zareba W,Daubert JP,Beck CA,Huang DT,Alexis JD,Brown MW,Pyykkonen K,McNitt S,Oakes D,Feng C,Aktas MK,Ayala-Parades F,Baranchuk A,Dubuc M,Haigney M,Mazur A,McPherson CA,Mitchell LB,Natale A,Piccini JP,Raitt M,Rashtian MY,Schuger C,Winters S,Worley SJ,Ziv O,Moss AJ", + "auth_pos": 19, + "meshterms": "Aged, Cardiovascular Agents, Cardiovascular Agents/therapeutic use*, Defibrillators, Implantable, Defibrillators, Implantable/adverse effects, Defibrillators, Implantable/trends*, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Ranolazine, Ranolazine/therapeutic use*, Risk Factors, Tachycardia, Ventricular, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/physiopathology, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/epidemiology, Ventricular Fibrillation/physiopathology, Ventricular Fibrillation/prevention & control*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2144, + "user_id": 1841382421, + "artical_title": "CABANA trial: \"beauty is in the eye of the beholder\".", + "pmid": 31493123, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-09-08", + "author": "Briceno D,Mohanty P,Di Biase L,Romero J,Rocca DGD,Trivedi C,Mohanty S,Natale A", + "auth_pos": 8, + "meshterms": "Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use*, Atrial Fibrillation, Atrial Fibrillation/mortality, Atrial Fibrillation/therapy*, Catheter Ablation*, Female, Heart Arrest, Heart Arrest/epidemiology, Hemorrhage, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Quality of Life*, Recurrence, Stroke, Stroke/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2145, + "user_id": 1841382421, + "artical_title": "Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.", + "pmid": 30213326, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-09-10", + "author": "Turagam MK,Vuddanda V,Verberkmoes N,Ohtsuka T,Akca F,Atkins D,Bommana S,Emmert MY,Gopinathannair R,Dunnington G,Rasekh A,Cheng J,Salzberg S,Natale A,Cox J,Lakkireddy DR", + "auth_pos": 14, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/therapy*, Cardiac Surgical Procedures, Cardiac Surgical Procedures/instrumentation, Creatinine, Creatinine/blood, Female, Humans, Hypertension, Hypertension/therapy*, Magnesium, Magnesium/blood, Male, Potassium, Potassium/blood, Prospective Studies, Sodium, Sodium/blood, Stroke, Stroke/prevention & control, Systole", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2146, + "user_id": 1841382421, + "artical_title": "Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients.", + "pmid": 30354288, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2019-09-10", + "author": "Hussein A,Das M,Riva S,Morgan M,Ronayne C,Sahni A,Shaw M,Todd D,Hall M,Modi S,Natale A,Dello Russo A,Snowdon R,Gupta D", + "auth_pos": 11, + "meshterms": "Action Potentials, Aged, Alcohol Drinking, Alcohol Drinking/adverse effects, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Body Mass Index, Catheter Ablation*, Catheter Ablation/adverse effects, Electrocardiography, Ambulatory, Europe, Female, Heart Rate, Humans, Male, Middle Aged, Progression-Free Survival, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Recurrence, Risk Factors, Time Factors", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2147, + "user_id": 1841382421, + "artical_title": "Safety of catheter ablation for atrial fibrillation in the octogenarian population.", + "pmid": 31506996, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2019-09-12", + "author": "Romero J,Ogunbayo G,Elayi SC,Darrat Y,Rios SA,Diaz JC,Alviz I,Cerna L,Gabr M,Chernobelsky E,Mohanty S,Trivedi CG,Della Rocca DG,Natale A,Di Biase L", + "auth_pos": 14, + "meshterms": "Age Factors, Aged, Aged, 80 and over, Anemia, Anemia/epidemiology, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/mortality, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/adverse effects*, Catheter Ablation/mortality, Catheter Ablation/trends, Databases, Factual, Female, Humans, Inpatients, Lung Diseases, Lung Diseases/epidemiology, Male, Middle Aged, Postoperative Complications, Postoperative Complications/epidemiology*, Postoperative Complications/mortality, Practice Patterns, Physicians', Practice Patterns, Physicians'/trends, Renal Insufficiency, Chronic, Renal Insufficiency, Chronic/epidemiology, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2148, + "user_id": 1841382421, + "artical_title": "Association of fragmented QRS with left atrial scarring in patients with persistent atrial fibrillation undergoing radiofrequency catheter ablation.", + "pmid": 31518722, + "journal_name": "Heart rhythm", + "date": "2019-09-14", + "author": "Canpolat U,Mohanty S,Trivedi C,Chen Q,Ayhan H,Gianni C,Della Rocca DG,MacDonald B,Burkhardt JD,Bassiouny M,Gallinghouse GJ,Al-Ahmad A,Horton R,Di Biase L,Natale A", + "auth_pos": 15, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Cicatrix, Cicatrix/physiopathology, Electrocardiography, Electrocardiography/methods*, Female, Follow-Up Studies, Heart Atria, Heart Atria/diagnostic imaging*, Heart Atria/physiopathology, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2149, + "user_id": 1841382421, + "artical_title": "Recurrent persistent atrial fibrillation after effective pulmonary vein isolation: What else?", + "pmid": 31535745, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2019-09-20", + "author": "Della Rocca DG,Natale A", + "auth_pos": 2, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Atria, Heart Atria/surgery, Humans, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2150, + "user_id": 1841382421, + "artical_title": "Simple electrocardiographic criteria for rapid identification of wide QRS complex tachycardia: The new limb lead algorithm.", + "pmid": 31546028, + "journal_name": "Heart rhythm", + "date": "2019-09-24", + "author": "Chen Q,Xu J,Gianni C,Trivedi C,Della Rocca DG,Bassiouny M,Canpolat U,Tapia AC,Burkhardt JD,Sanchez JE,Hranitzky P,Gallinghouse GJ,Al-Ahmad A,Horton R,Di Biase L,Mohanty S,Natale A", + "auth_pos": 17, + "meshterms": "Algorithms*, Diagnosis, Differential, Electrocardiography, Electrocardiography/methods*, Female, Follow-Up Studies, Heart Rate, Heart Rate/physiology*, Humans, Male, Middle Aged, Retrospective Studies, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis*, Tachycardia, Ventricular/physiopathology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2151, + "user_id": 1841382421, + "artical_title": "The quandary of study design in evaluating effectiveness of contact force sensing catheter in atrial fibrillation ablation.", + "pmid": 31625561, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2019-10-19", + "author": "Natale A,Boo LM,Verma A", + "auth_pos": 1, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheters, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2152, + "user_id": 1841382421, + "artical_title": "Mapping and localization of the left phrenic nerve during left atrial appendage electrical isolation to avoid inadvertent injury in patients undergoing catheter ablation of atrial fibrillation.", + "pmid": 31634618, + "journal_name": "Heart rhythm", + "date": "2019-10-22", + "author": "Romero J,Natale A,Lakkireddy D,Cerna L,Diaz JC,Alviz I,Cerrud-Rodriguez RC,Grupposo V,Rios SA,Chernobelsky E,Elsayed MG,Garcia M,Di Biase L", + "auth_pos": 2, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Body Surface Potential Mapping, Body Surface Potential Mapping/methods*, Catheter Ablation, Catheter Ablation/methods*, Echocardiography, Female, Follow-Up Studies, Humans, Male, Phrenic Nerve, Phrenic Nerve/diagnostic imaging*, Phrenic Nerve/physiopathology, Retrospective Studies, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2153, + "user_id": 1841382421, + "artical_title": "Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording.", + "pmid": 31646429, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-10-28", + "author": "Della Rocca DG,Albanese M,Placidi F,Forle GB,Di Biase L,Ribatti V,Santini L,Izzi F,Cicchini L,Lovecchio M,Valsecchi S,Lavalle C,Natale A,Mercuri NB,Romigi A", + "auth_pos": 13, + "meshterms": "Aged, Cardiography, Impedance, Defibrillators, Implantable*, Feasibility Studies, Female, Humans, Male, Pacemaker, Artificial*, Polysomnography*, Prospective Studies, Sleep Apnea Syndromes, Sleep Apnea Syndromes/diagnosis*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2154, + "user_id": 1841382421, + "artical_title": "Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.", + "pmid": 31672183, + "journal_name": "Journal of the American College of Cardiology", + "date": "2019-11-02", + "author": "Sharma SP,Turagam MK,Gopinathannair R,Reddy V,Kar S,Mohanty S,Cheng J,Holmes DR,Sondergaard L,Natale A,Lakkireddy D", + "auth_pos": 10, + "meshterms": "Aged, Atrial Appendage*, Atrial Fibrillation, Atrial Fibrillation/complications*, Atrial Fibrillation/therapy*, Electric Countershock*, Feasibility Studies, Female, Humans, Male, Middle Aged, Retrospective Studies, Septal Occluder Device*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2155, + "user_id": 1841382421, + "artical_title": "Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs direct oral anticoagulants.", + "pmid": 31732839, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-11-17", + "author": "Pillarisetti J,Maybrook R,Parikh V,Adabala N,Khalafi M,Reddy S,Bommana S,Lakkireddy P,Reddy MY,Gianni C,Gopinathannair R,Mohanty S,Di Biase L,Natale A,Saksena S,Lakkireddy D", + "auth_pos": 14, + "meshterms": "Administration, Oral, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Dabigatran, Dabigatran/adverse effects, Defibrillators, Implantable*, Female, Humans, Male, Middle Aged, Pyridones, Rivaroxaban, Rivaroxaban/adverse effects, Vitamin K, Warfarin, Warfarin/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2156, + "user_id": 1841382421, + "artical_title": "Differences in Transient Thermal Response of Commercial Esophageal Temperature Probes: Insights From an Experimental Study.", + "pmid": 31753433, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2019-11-23", + "author": "Turagam MK,Miller S,Sharma SP,Prakash P,Gopinathannair R,Lakkireddy P,Mohanty S,Cheng J,Natale A,Lakkireddy D", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Burns, Burns/etiology, Burns/prevention & control*, Catheter Ablation, Catheter Ablation/adverse effects, Equipment Design*, Equipment Failure*, Esophagus, Esophagus/injuries, Humans, In Vitro Techniques, Intraoperative Complications, Intraoperative Complications/etiology, Intraoperative Complications/prevention & control*, Monitoring, Intraoperative, Monitoring, Intraoperative/instrumentation*, Thermodynamics, Thermometers*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2157, + "user_id": 1841382421, + "artical_title": "Comparing rates of atrioesophageal fistula with contact force-sensing and non-contact force-sensing catheters: analysis of post-market safety surveillance data.", + "pmid": 31758505, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-11-24", + "author": "Calkins H,Natale A,Gomez T,Etlin A,Bishara M", + "auth_pos": 2, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheters, Fistula*, Humans, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2158, + "user_id": 1841382421, + "artical_title": "Ventriculoatrial conduction in patients without high-grade AV block: when is it present?", + "pmid": 31820272, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-12-11", + "author": "Elayi CS,Morales G,Butt M,Shah J,Ogunbayo G,Misumida N,Catanzaro J,Di Biase L,Natale A,Delisle B,Darrat Y", + "auth_pos": 9, + "meshterms": "Atrioventricular Block*, Atrioventricular Block/therapy, Atrioventricular Node, Atrioventricular Node/diagnostic imaging, Cardiac Pacing, Artificial, Electrocardiography, Heart Rate, Humans, Tachycardia, Atrioventricular Nodal Reentry*, Tachycardia, Atrioventricular Nodal Reentry/therapy, Tachycardia, Supraventricular*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2159, + "user_id": 1841382421, + "artical_title": "Pulmonary Vein Isolation With a Novel Multielectrode Radiofrequency Balloon Catheter That Allows Directionally Tailored Energy Delivery: Short-Term Outcomes From a Multicenter First-in-Human Study (RADIANCE).", + "pmid": 31826648, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2019-12-13", + "author": "Reddy VY,Schilling R,Grimaldi M,Horton R,Natale A,Riva S,Tondo C,Kuck KH,Neuzil P,McInnis K,Bishara M,Zhang B,Govari A,Abdelaal A,Mansour M", + "auth_pos": 5, + "meshterms": "Action Potentials, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation*, Cardiac Catheters*, Catheter Ablation, Catheter Ablation/adverse effects, Catheter Ablation/instrumentation*, Equipment Design, Europe, Female, Heart Rate*, Humans, Male, Middle Aged, Postoperative Complications, Postoperative Complications/etiology, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Recurrence, Time Factors, Treatment Outcome, United States, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2160, + "user_id": 1841382421, + "artical_title": "WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage.", + "pmid": 31833012, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-12-14", + "author": "Hucker WJ,Cohen JA,Gurol ME,Heist EK,Gianni C,Galvin J,Atkins D,Bommana S,Di Biase L,Ruskin J,Mohanty S,Horton R,Lakkireddy D,Natale A,Mansour M", + "auth_pos": 14, + "meshterms": "Anticoagulants, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Humans, Intracranial Hemorrhages, Retrospective Studies, Stroke*, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2161, + "user_id": 1841382421, + "artical_title": "Myocarditis Causing Premature Ventricular Contractions: Insights From the MAVERIC Registry.", + "pmid": 31838913, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2019-12-17", + "author": "Lakkireddy D,Turagam MK,Yarlagadda B,Dar T,Hamblin M,Krause M,Parikh V,Bommana S,Atkins D,Di Biase L,Mohanty S,Rosamond T,Carroll H,Nydegger C,Wetzel L,Gopinathannair R,Natale A", + "auth_pos": 17, + "meshterms": "Adult, Aged, Biopsy, Catheter Ablation, Female, Fluorodeoxyglucose F18, Fluorodeoxyglucose F18/administration & dosage, Heart Rate, Humans, Immunosuppressive Agents, Immunosuppressive Agents/therapeutic use, Magnetic Resonance Imaging, Male, Middle Aged, Myocarditis, Myocarditis/complications*, Myocarditis/diagnosis, Myocarditis/drug therapy, Myocarditis/physiopathology, Positron-Emission Tomography, Prospective Studies, Radiopharmaceuticals, Radiopharmaceuticals/administration & dosage, Recovery of Function, Registries, Risk Factors, Stroke Volume, Time Factors, Treatment Outcome, United States, Ventricular Function, Left, Ventricular Premature Complexes, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/etiology*, Ventricular Premature Complexes/physiopathology, Ventricular Premature Complexes/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2162, + "user_id": 1841382421, + "artical_title": "Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.", + "pmid": 31857038, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2019-12-21", + "author": "Romero J,Cerrud-Rodriguez RC,Alviz I,Diaz JC,Rodriguez D,Arshad S,Cerna L,Taveras J,Grupposo V,Natale A,Garcia M,Di Biase L", + "auth_pos": 10, + "meshterms": "Administration, Oral, Aged, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Catheter Ablation*, Female, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Stroke, Stroke/etiology, Stroke/prevention & control, Thromboembolism, Thromboembolism/drug therapy, Thromboembolism/etiology, Thromboembolism/prevention & control, Vitamin K, Vitamin K/antagonists & inhibitors*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2163, + "user_id": 1841382421, + "artical_title": "Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study).", + "pmid": 31863251, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2019-12-22", + "author": "Parikh V,Rasekh A,Mohanty S,Yarlagadda B,Atkins D,Bommana S,Turagam M,Jeffery C,Carroll H,Nydegger C,Jaeger M,Dar T,Cheng J,Gopinnathanair R,Dibiase L,Lee R,Horton R,Natale A,Lakkireddy D", + "auth_pos": 18, + "meshterms": "Aged, Atrial Appendage, Atrial Appendage/physiopathology, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Epicardial Mapping, Female, Humans, Ligation, Ligation/instrumentation, Male, Patient Safety, Pulmonary Veins, Pulmonary Veins/surgery, Radiofrequency Ablation, Radiofrequency Ablation/methods*, Retrospective Studies", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2164, + "user_id": 1841382421, + "artical_title": "Reply: LAA Electrical Isolation: A Tool to Achieve Superior Ablation Success Under Protection of Optimal Anticoagulation.", + "pmid": 31918827, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-01-11", + "author": "Di Biase L,Mohanty S,Romero J,Della Rocca DG,Natale A", + "auth_pos": 5, + "meshterms": "Anticoagulants, Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation*, Humans, Stroke*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2165, + "user_id": 1841382421, + "artical_title": "Long-term follow-up analysis of a highly characterized arrhythmogenic cardiomyopathy cohort with classical and non-classical phenotypes-a real-world assessment of a novel prediction model: does the subtype really matter.", + "pmid": 31942607, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2020-01-17", + "author": "Casella M,Gasperetti A,Gaetano F,Busana M,Sommariva E,Catto V,Sicuso R,Rizzo S,Conte E,Mushtaq S,Andreini D,Di Biase L,Carbucicchio C,Natale A,Basso C,Tondo C,Dello Russo A", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2166, + "user_id": 1841382421, + "artical_title": "First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.", + "pmid": 31954677, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2020-01-20", + "author": "Della Rocca DG,Horton RP,Di Biase L,Bassiouny M,Al-Ahmad A,Mohanty S,Gasperetti A,Natale VN,Trivedi C,Gianni C,Burkhardt JD,Gallinghouse GJ,Hranitzky P,Sanchez JE,Natale A", + "auth_pos": 15, + "meshterms": "Aged, Aged, 80 and over, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation*, Echocardiography, Doppler, Color, Echocardiography, Three-Dimensional, Echocardiography, Transesophageal, Embolization, Therapeutic, Embolization, Therapeutic/adverse effects, Embolization, Therapeutic/instrumentation*, Equipment Design, Feasibility Studies, Female, Humans, Male, Middle Aged, Risk Factors, Thromboembolism, Thromboembolism/diagnosis, Thromboembolism/etiology, Thromboembolism/prevention & control*, Time Factors, Treatment Outcome, Coil embolization*, Embolic Coils*, Specialty Coils*, Embolic Coils*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2167, + "user_id": 1841382421, + "artical_title": "Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial.", + "pmid": 31971899, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-01-24", + "author": "Natale A,Mohanty S,Liu PY,Mittal S,Al-Ahmad A,De Lurgio DB,Horton R,Spear W,Bailey S,Bunch J,Musat D,O'Neill P,Compton S,Turakhia MP", + "auth_pos": 1, + "meshterms": "Adult, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Early Ambulation, Female, Femoral Vein, Femoral Vein/surgery*, Humans, Male, Middle Aged, Patient Satisfaction, Vascular Closure Devices*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2168, + "user_id": 1841382421, + "artical_title": "Systematic Review of Contiguous Vessel and Valve Injury Associated with Endocardial Left Atrial Appendage Occlusion Devices.", + "pmid": 32002118, + "journal_name": "Journal of atrial fibrillation", + "date": "2020-02-01", + "author": "Sharma SP,Murtaza G,Madoukh B,Atkins D,Nydegger C,Jeffery C,Bommana S,Wang E,Gopinathannair R,Saw J,Natale A,Lakkireddy D", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2169, + "user_id": 1841382421, + "artical_title": "Left Atrial Appendage Occlusion.", + "pmid": 32067653, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-02-19", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2170, + "user_id": 1841382421, + "artical_title": "Epicardial versus Endocardial Closure: Is One Better than the Other?", + "pmid": 32067652, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-02-19", + "author": "Akella K,Yarlagadda B,Murtaza G,Della Rocca DG,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2171, + "user_id": 1841382421, + "artical_title": "Clinical Implications and Management Strategies for Left Atrial Appendage Leaks.", + "pmid": 32067651, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-02-19", + "author": "Sahore A,Della Rocca DG,Anannab A,Mohanty S,Akella K,Murtaza G,Trivedi C,Gianni C,Chen Q,Bassiouny M,Ahmadian-Tehrani A,Macdonald B,Al-Ahmad A,Tarantino N,Cirone D,Horton RP,Romero J,Lakkireddy D,Di Biase L,Natale A", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2172, + "user_id": 1841382421, + "artical_title": "Role of the Left Atrial Appendage in Systemic Homeostasis, Arrhythmogenesis, and Beyond.", + "pmid": 32067644, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-02-19", + "author": "Murtaza G,Yarlagadda B,Akella K,Della Rocca DG,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2173, + "user_id": 1841382421, + "artical_title": "Imaging Integration to Localize and Protect the Left Coronary Artery in Patients Undergoing LAAEI.", + "pmid": 32081217, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-02-23", + "author": "Romero J,Natale A,Cerna L,Lakkireddy D,Diaz JC,Alviz I,Grupposo V,Rios SA,Chernobelsky E,Lopez Cabanillas N,Garcia M,Di Biase L", + "auth_pos": 2, + "meshterms": "Aged, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation, Atrial Fibrillation/surgery*, Cardiac Imaging Techniques, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Coronary Vessels, Coronary Vessels/diagnostic imaging*, Coronary Vessels/injuries, Female, Humans, Male, Middle Aged, Retrospective Studies, Surgery, Computer-Assisted, Surgery, Computer-Assisted/methods*, Tomography, X-Ray Computed, Vascular System Injuries, Vascular System Injuries/etiology, Vascular System Injuries/prevention & control", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2174, + "user_id": 1841382421, + "artical_title": "Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.", + "pmid": 32078373, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-02-23", + "author": "Shoemaker MB,Husser D,Roselli C,Al Jazairi M,Chrispin J,Kühne M,Neumann B,Knight S,Sun H,Mohanty S,Shaffer C,Thériault S,Rinke LL,Siland JE,Crawford DM,Ueberham L,Zardkoohi O,Büttner P,Geelhoed B,Blum S,Aeschbacher S,Smith JD,Van Wagoner DR,Freudling R,Müller-Nurasyid M,Montgomery J,Yoneda Z,Wells Q,Issa T,Weeke P,Jacobs V,Van Gelder IC,Hindricks G,Barnard J,Calkins H,Darbar D,Michaud G,Kääb S,Ellinor P,Natale A,Chung M,Nazarian S,Cutler MJ,Sinner MF,Conen D,Rienstra M,Bollmann A,Roden DM,Lubitz S", + "auth_pos": 40, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/genetics*, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery, Body Surface Potential Mapping, Body Surface Potential Mapping/methods, Catheter Ablation*, Female, Follow-Up Studies, Genetic Predisposition to Disease*, Humans, Male, Middle Aged, Multifactorial Inheritance, Multifactorial Inheritance/genetics*, Polymorphism, Single Nucleotide*, Preoperative Period, Prognosis, Prospective Studies, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2175, + "user_id": 1841382421, + "artical_title": "Toward a Uniform Ablation Protocol for Paroxysmal, Persistent, and Permanent Atrial Fibrillation.", + "pmid": 31706479, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-03-10", + "author": "Della Rocca DG,Lavalle C,Gianni C,Mariani MV,Mohanty S,Trivedi C,Canpolat U,MacDonald B,Ayhan H,Piro A,Bassiouny M,Al-Ahmad A,Burkhardt JD,Gallinghouse JG,Horton RP,Sanchez J,Tarantino N,Di Biase L,Natale A", + "auth_pos": 19, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation*, Humans, Practice Guidelines as Topic", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2176, + "user_id": 1841382421, + "artical_title": "Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia.", + "pmid": 32151737, + "journal_name": "Heart rhythm", + "date": "2020-03-11", + "author": "Gianni C,Rivera D,Burkhardt JD,Pollard B,Gardner E,Maguire P,Zei PC,Natale A,Al-Ahmad A", + "auth_pos": 8, + "meshterms": "Aged, Catheter Ablation, Catheter Ablation/methods*, Cicatrix, Cicatrix/complications*, Cicatrix/physiopathology, Cicatrix/therapy, Feasibility Studies, Follow-Up Studies, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Radiosurgery, Radiosurgery/methods*, Recurrence, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology, Tachycardia, Ventricular/therapy*, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2177, + "user_id": 1841382421, + "artical_title": "Radiofrequency-Assisted Transseptal Access for Atrial Fibrillation Ablation Via a Superior Approach.", + "pmid": 32192677, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-03-21", + "author": "Liang JJ,Lin A,Mohanty S,Muser D,Briceno DF,Burkhardt JD,Supple GE,Callans DJ,Dixit S,Horton RP,Di Biase L,Marchlinski FE,Natale A,Santangeli P", + "auth_pos": 13, + "meshterms": "Adult, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery*, Atrial Septum, Atrial Septum/diagnostic imaging, Atrial Septum/surgery, Catheter Ablation, Catheter Ablation/adverse effects, Catheter Ablation/methods*, Echocardiography, Female, Humans, Male, Middle Aged, Retrospective Studies, Vena Cava, Inferior, Vena Cava, Inferior/abnormalities", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2178, + "user_id": 1841382421, + "artical_title": "Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy.", + "pmid": 32200046, + "journal_name": "Heart rhythm", + "date": "2020-03-23", + "author": "Gasperetti A,Russo AD,Busana M,Dessanai M,Pizzamiglio F,Saguner AM,Te Riele ASJM,Sommariva E,Vettor G,Bosman L,Duru F,Zeppilli P,Di Biase L,Natale A,Tondo C,Casella M", + "auth_pos": 14, + "meshterms": "Aged, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Dysplasia/physiopathology*, Athletes*, Electrocardiography*, Exercise, Exercise/physiology*, Female, Humans, Male, Reproducibility of Results, Stroke Volume, Stroke Volume/physiology*, Ventricular Function, Right, Ventricular Function, Right/physiology*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2179, + "user_id": 1841382421, + "artical_title": "Mapping the Heart.", + "pmid": 31706481, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-03-27", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Cardiac Imaging Techniques*, Electrocardiography*, Electrophysiologic Techniques, Cardiac*, Heart, Heart/diagnostic imaging, Heart/physiology, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2180, + "user_id": 1841382421, + "artical_title": "Use of a Multi-Electrode Radiofrequency Balloon Catheter to Achieve Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: Twelve-month outcomes of the RADIANCE Study.", + "pmid": 32250514, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-04-07", + "author": "Dhillon GS,Honarbakhsh S,Di Monaco A,Coling AE,Lenka K,Pizzamiglio F,Hunter RJ,Horton R,Mansour M,Natale A,Reddy V,Grimaldi M,Neuzil P,Tondo C,Schilling RJ", + "auth_pos": 10, + "meshterms": "Action Potentials, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Cardiac Catheters*, Catheter Ablation, Catheter Ablation/adverse effects, Catheter Ablation/instrumentation*, Disease-Free Survival, Electrodes*, Europe, Female, Heart Rate, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Recurrence, Registries, Time Factors, Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2181, + "user_id": 1841382421, + "artical_title": "Closure of the left atrial appendage using percutaneous transcatheter occlusion devices.", + "pmid": 32249473, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-04-07", + "author": "Gianni C,Anannab A,Salwan AS,Della Rocca DG,Natale A,Horton RP", + "auth_pos": 5, + "meshterms": "Administration, Oral, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2182, + "user_id": 1841382421, + "artical_title": "Atrial Fibrillation: JACC Council Perspectives.", + "pmid": 32273035, + "journal_name": "Journal of the American College of Cardiology", + "date": "2020-04-11", + "author": "Chung MK,Refaat M,Shen WK,Kutyifa V,Cha YM,Di Biase L,Baranchuk A,Lampert R,Natale A,Fisher J,Lakkireddy DR", + "auth_pos": 9, + "meshterms": "Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Anticoagulants, Anticoagulants/pharmacology*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/therapy, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/trends, Humans, Risk Assessment, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2183, + "user_id": 1841382421, + "artical_title": "Direct Thrombin Inhibitors as an Alternative to Heparin During Catheter Ablation: A Multicenter Experience.", + "pmid": 32276868, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-04-12", + "author": "Voskoboinik A,Butcher E,Sandhu A,Nguyen DT,Tzou W,Della Rocca DG,Natale A,Zado ES,Marchlinski FE,Aguilar M,Sauer W,Tedrow UB,Gerstenfeld EP", + "auth_pos": 7, + "meshterms": "Aged, Antithrombins, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Catheters, Female, Heparin*, Heparin/adverse effects, Humans, Male, Middle Aged, Stroke Volume, Ventricular Function, Left, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2184, + "user_id": 1841382421, + "artical_title": "Catheter Ablation is Preferred over Surgery for Persistent Atrial Fibrillation.", + "pmid": 32293063, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-04-16", + "author": "Anannab A,Gianni C,Della Rocca DG,Salwan AS,Natale A,Al-Ahmad A", + "auth_pos": 5, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Rate, Humans, Recurrence, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2185, + "user_id": 1841382421, + "artical_title": "Warfarin vs non-vitamin K oral anticoagulants for left atrial appendage thrombus: A meta-analysis.", + "pmid": 32323386, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-04-24", + "author": "Murtaza G,Turagam MK,Atti V,Garg J,Boda U,Velagapudi P,Akella K,Natale A,Gopinathannair R,Lakkireddy D", + "auth_pos": 8, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/diagnostic imaging, Humans, Stroke*, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Thrombosis/prevention & control, Treatment Outcome, Warfarin, Warfarin/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2186, + "user_id": 1841382421, + "artical_title": "Trigger-Based Versus Empirical Left Atrial Appendage Electrical Isolation in Atrial Fibrillation: Denying the Undeniable.", + "pmid": 32327081, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-04-25", + "author": "Romero J,Liu H,Wan Q,Natale A,Han X,Di Biase L", + "auth_pos": 2, + "meshterms": "Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation*, Humans, Incidence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2187, + "user_id": 1841382421, + "artical_title": "Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review.", + "pmid": 32327075, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-04-25", + "author": "Sharma SP,Cheng J,Turagam MK,Gopinathannair R,Horton R,Lam YY,Tarantini G,D'Amico G,Freixa Rofastes X,Lange M,Natale A,Lakkireddy DR", + "auth_pos": 11, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Feasibility Studies, Humans, Thrombosis*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2188, + "user_id": 1841382421, + "artical_title": "Modern Mapping and Ablation Techniques to Treat Ventricular Arrhythmias From the Left Ventricular Summit and Interventricular Septum.", + "pmid": 32333973, + "journal_name": "Heart rhythm", + "date": "2020-04-26", + "author": "Romero J,Shivkumar K,Valderrabano M,Diaz JC,Alviz I,Briceno D,Natale A,Di Biase L", + "auth_pos": 7, + "meshterms": "Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Electrophysiologic Techniques, Cardiac*, Heart Ventricles, Heart Ventricles/physiopathology, Humans, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology*, Tomography, X-Ray Computed, Ventricular Septum, Ventricular Septum/diagnostic imaging, Ventricular Septum/physiopathology*, Coil embolization*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2189, + "user_id": 1841382421, + "artical_title": "State of Fluoroless Procedures in Cardiac Electrophysiology Practice.", + "pmid": 32368376, + "journal_name": "The Journal of innovations in cardiac rhythm management", + "date": "2020-05-06", + "author": "Canpolat U,Faggioni M,Della Rocca DG,Chen Q,Ayhan H,Vu AA,Mohanty S,Trivedi C,Gianni C,Bassiouny M,Al-Ahmad A,Burkhardt JD,Sanchez JE,Gallinghouse GJ,Natale A,Horton RP", + "auth_pos": 15, + "meshterms": "Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2190, + "user_id": 1841382421, + "artical_title": "Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure.", + "pmid": 32377383, + "journal_name": "Cardiac failure review", + "date": "2020-05-08", + "author": "Faggioni M,Della Rocca DG,Mohanty S,Trivedi C,Canpolat U,Gianni C,Al-Ahmad A,Horton R,Gallinghouse GJ,Burkhardt JD,Natale A", + "auth_pos": 11, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2191, + "user_id": 1841382421, + "artical_title": "A Lattice-Tip Focal Ablation Catheter that Toggles Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation: A First-in-Human Trial.", + "pmid": 32383391, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-05-10", + "author": "Reddy VY,Ajani JA,Anter E,Bosset JF,Hannoun-Levi JM,Rackauskas G,Puyraveau M,Peichl P,Koruth JS,Chakravarthy AB,Petru J,Meadows H,Funasako M,Northover J,Minami K,Collette L,Natale A,Christiaens M,Maingon P,Jais P,Mercer C,Nakagawa H,Marinskis G,Bennett R,Aidietis A,Conghaile PÓ,Kautzner J,Rusling JF,Neuzil P,Leech D", + "auth_pos": 9, + "meshterms": "Action Potentials, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation*, Cardiac Catheters*, Catheter Ablation, Catheter Ablation/adverse effects, Catheter Ablation/instrumentation*, Czech Republic, Electrophysiologic Techniques, Cardiac, Equipment Design, Female, Heart Rate, Humans, Lithuania, Male, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Therapeutic Irrigation, Therapeutic Irrigation/adverse effects, Therapeutic Irrigation/instrumentation*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2192, + "user_id": 1841382421, + "artical_title": "HRS white paper on atrial fibrillation centers of excellence: Rationale, considerations, and goals.", + "pmid": 32387248, + "journal_name": "Heart rhythm", + "date": "2020-05-11", + "author": "Piccini JP,Allred J,Bunch TJ,Deering TF,Di Biase L,Hussein AA,Lewis WR,Mittal S,Natale A,Osorio J,Packer DL,Ruff C,Russo AM,Sanders P,Seiler A,Slotwiner D,Hills MT,Turakhia MP,Van Gelder IC,Varosy PD,Verma A,Volgman AS,Wood KA,Deneke T", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/standards*, Humans, Societies, Medical*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2193, + "user_id": 1841382421, + "artical_title": "Safety and Efficacy of Leadless Pacemaker for Cardio Inhibitory Vasovagal Syncope.", + "pmid": 32389681, + "journal_name": "Heart rhythm", + "date": "2020-05-12", + "author": "Turagam MK,Gopinathannair R,Park PH,Tummala RV,Vasamreddy C,Shah A,Koerber S,Krauthammer Y,Di Biase L,Murtaza G,Akella K,Atkins D,Bommana S,Kodwani N,Romero J,Al-Ahmad A,Lakkireddy P,Della Rocca DG,Mohanty S,Gwon Y,Natale A,Lakkireddy DR", + "auth_pos": 21, + "meshterms": "Adult, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Female, Follow-Up Studies, Humans, Male, Pacemaker, Artificial*, Recurrence, Retrospective Studies, Syncope, Vasovagal, Syncope, Vasovagal/diagnosis, Syncope, Vasovagal/physiopathology, Syncope, Vasovagal/therapy*, Tilt-Table Test, Treatment Outcome, Young Adult", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2194, + "user_id": 1841382421, + "artical_title": "Real-world safety of catheter ablation for atrial fibrillation with contact force or cryoballoon ablation.", + "pmid": 32390061, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-05-12", + "author": "Natale A,Mohanty S,Goldstein L,Gomez T,Hunter TD", + "auth_pos": 1, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Cryosurgery*, Cryosurgery/adverse effects, Equipment Design, Humans, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2195, + "user_id": 1841382421, + "artical_title": "Prevention, diagnosis, and management of atrioesophageal fistula.", + "pmid": 32400890, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2020-05-14", + "author": "Gianni C,Della Rocca DG,MacDonald BC,Mohanty S,Quintero Mayedo A,Sahore Salwan A,Trivedi C,Natale A", + "auth_pos": 8, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery, Burns, Burns/etiology*, Catheter Ablation, Esophageal Fistula, Esophageal Fistula/etiology*, Heart Atria, Heart Atria/surgery*, Humans, Postoperative Complications, Postoperative Complications/etiology*, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2196, + "user_id": 1841382421, + "artical_title": "A Lattice-Tip Temperature-Controlled Radiofrequency Ablation Catheter for Wide Thermal Lesions: First-in-Human Experience With Atrial Fibrillation.", + "pmid": 32439034, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-05-23", + "author": "Anter E,Neužil P,Rackauskas G,Peichl P,Aidietis A,Kautzner J,Nakagawa H,Jackman WM,Natale A,Reddy VY", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Catheters, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Temperature", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2197, + "user_id": 1841382421, + "artical_title": "Advances in Atrial Fibrillation Ablation.", + "pmid": 32451111, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-05-27", + "author": "Di Biase L,Marchlinski F,Natale A", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2198, + "user_id": 1841382421, + "artical_title": "Outcomes of junctional ectopic tachycardia ablation in adult population-a multicenter experience.", + "pmid": 32451798, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-05-27", + "author": "Dar T,Turagam MK,Yarlagadda B,Parikh V,Pillarisetti J,Gopinathannair R,Gianni C,Mohanty S,Mansour M,Di Biase L,Bunch TJ,Natale A,Lakkireddy D", + "auth_pos": 12, + "meshterms": "Adult, Atrioventricular Node, Atrioventricular Node/surgery, Catheter Ablation*, Cryosurgery*, Female, Humans, Infant, Newborn, Male, Retrospective Studies, Tachycardia, Atrioventricular Nodal Reentry*, Tachycardia, Atrioventricular Nodal Reentry/diagnostic imaging, Tachycardia, Atrioventricular Nodal Reentry/surgery, Tachycardia, Ectopic Junctional*, Tachycardia, Ectopic Junctional/diagnostic imaging, Tachycardia, Ectopic Junctional/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2199, + "user_id": 1841382421, + "artical_title": "Recurrent Atrial Fibrillation with Isolated Pulmonary Veins: What to Do.", + "pmid": 32451105, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-05-27", + "author": "Gianni C,Anannab A,Della Rocca DG,Salwan A,MacDonald B,Quintero Mayedo A,Mohanty S,Trivedi C,Di Biase L,Natale A", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2200, + "user_id": 1841382421, + "artical_title": "Provocation and ablation of non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: Role of the coronary sinus.", + "pmid": 32461886, + "journal_name": "HeartRhythm case reports", + "date": "2020-05-29", + "author": "Della Rocca DG,Gianni C,Gedikli O,Chen Q,Natale A,Al-Ahmad A", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2201, + "user_id": 1841382421, + "artical_title": "Long-term safety and effectiveness of paroxysmal atrial fibrillation ablation using a porous tip contact force-sensing catheter from the SMART SF trial.", + "pmid": 32462550, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-05-29", + "author": "Natale A,Monir G,Patel AM,Fishel RS,Marchlinski FE,Delaughter MC,Athill CA,Melby DP,Gonzalez MD,Hariharan R,Gidney B,Tan T,Chinitz LA", + "auth_pos": 1, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Catheters, Equipment Design, Humans, Male, Middle Aged, Porosity, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2202, + "user_id": 1841382421, + "artical_title": "Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.", + "pmid": 32478430, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-06-02", + "author": "Romero J,Patel K,Briceno D,Alviz I,Gabr M,Diaz JC,Trivedi C,Mohanty S,Della Rocca D,Al-Ahmad A,Yang R,Rios S,Cerna L,Du X,Tarantino N,Zhang XD,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 18, + "meshterms": "Adult, Arrhythmogenic Right Ventricular Dysplasia*, Arrhythmogenic Right Ventricular Dysplasia/complications, Arrhythmogenic Right Ventricular Dysplasia/diagnosis, Arrhythmogenic Right Ventricular Dysplasia/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Female, Humans, Male, Pericardium, Pericardium/surgery, Recurrence, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2203, + "user_id": 1841382421, + "artical_title": "COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.", + "pmid": 32494896, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-06-05", + "author": "Gopinathannair R,Merchant FM,Lakkireddy DR,Etheridge SP,Feigofsky S,Han JK,Kabra R,Natale A,Poe S,Saha SA,Russo AM", + "auth_pos": 8, + "meshterms": "Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/administration & dosage*, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnostic imaging*, Arrhythmias, Cardiac/drug therapy, Arrhythmias, Cardiac/epidemiology*, COVID-19, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Coronavirus Infections/epidemiology*, Cross-Sectional Studies, Electrocardiography, Electrocardiography/methods, Female, Humans, Incidence, Long QT Syndrome, Long QT Syndrome/diagnostic imaging, Long QT Syndrome/drug therapy, Long QT Syndrome/epidemiology, Male, Pandemics, Pandemics/prevention & control, Pandemics/statistics & numerical data*, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pneumonia, Viral/epidemiology*, Prognosis, Severity of Illness Index, Surveys and Questionnaires*, Survival Rate, Torsades de Pointes, Torsades de Pointes/diagnostic imaging, Torsades de Pointes/drug therapy, Torsades de Pointes/epidemiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2204, + "user_id": 1841382421, + "artical_title": "Epicardial Interventions: Impact of Liposomal Bupivacaine on Postprocedural Management (The EPI-LIBRE Study).", + "pmid": 32496820, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-06-05", + "author": "Sharma SP,Turagam MK,Mohanty S,Di Biase L,Burkhardt D,Horton R,Natale A,Lakkireddy D", + "auth_pos": 7, + "meshterms": "Aged, Anesthetics, Local, Anesthetics, Local/administration & dosage*, Anesthetics, Local/adverse effects, Atrial Appendage, Atrial Appendage/physiopathology, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Bupivacaine, Bupivacaine/administration & dosage*, Bupivacaine/adverse effects, Cardiac Surgical Procedures*, Catheter Ablation*, Catheter Ablation/adverse effects, Colchicine, Colchicine/administration & dosage, Female, Humans, Length of Stay, Ligation, Liposomes, Male, Middle Aged, Pain Measurement, Pain, Postoperative, Pain, Postoperative/diagnosis, Pain, Postoperative/etiology, Pain, Postoperative/prevention & control*, Pericardium, Pericardium/physiopathology, Pericardium/surgery*, Retrospective Studies, Risk Factors, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/physiopathology, Tachycardia, Ventricular/surgery*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2205, + "user_id": 1841382421, + "artical_title": "Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology.", + "pmid": 32530306, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-06-13", + "author": "Lakkireddy DR,Chung MK,Deering TF,Gopinathannair R,Albert CM,Epstein LM,Harding CV,Hurwitz JL,Jeffery CC,Krahn AD,Kusumoto FM,Lampert R,Mansour M,Natale A,Patton KK,Seiler A,Shah MJ,Wang PJ,Russo AM", + "auth_pos": 14, + "meshterms": "American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/surgery*, COVID-19, COVID-19 Testing, Cardiac Electrophysiology, Cardiac Imaging Techniques, Catheter Ablation, Catheter Ablation/methods, Catheter Ablation/statistics & numerical data, Clinical Laboratory Techniques, Clinical Laboratory Techniques/methods, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Elective Surgical Procedures, Elective Surgical Procedures/methods, Elective Surgical Procedures/statistics & numerical data*, Female, Humans, Infection Control, Infection Control/organization & administration*, Male, Outcome Assessment, Health Care, Pandemics, Pandemics/prevention & control, Pandemics/statistics & numerical data*, Pneumonia, Viral, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Practice Guidelines as Topic*, Societies, Medical, United States", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2206, + "user_id": 1841382421, + "artical_title": "Safety and efficacy of catheter ablation for atrial fibrillation in patients with percutaneous atrial septal closure device: Electrophysiology Collaborative Consortium for Meta-analysis-ELECTRAM Investigators.", + "pmid": 32530528, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-06-13", + "author": "Garg J,Shah K,Turagam MK,Janagam P,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Septal Defects, Atrial, Heart Septal Defects, Atrial/diagnostic imaging, Heart Septal Defects, Atrial/surgery, Humans, Punctures, Septal Occluder Device*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2207, + "user_id": 1841382421, + "artical_title": "Cavotricuspid isthmus line in patients undergoing catheter ablation of atrial fibrillation with or without history of typical atrial flutter: A meta-analysis.", + "pmid": 32530541, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-06-13", + "author": "Romero J,Patel K,Briceno D,Lakkireddy D,Gabr M,Diaz JC,Alviz I,Polanco D,Della Rocca DG,Mohanty P,Mohanty S,Trivedi C,Natale A,Di Biase L", + "auth_pos": 13, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Flutter*, Atrial Flutter/diagnosis, Atrial Flutter/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2208, + "user_id": 1841382421, + "artical_title": "Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology.", + "pmid": 32540298, + "journal_name": "Heart rhythm", + "date": "2020-06-17", + "author": "Lakkireddy DR,Chung MK,Deering TF,Gopinathannair R,Albert CM,Epstein LM,Harding CV,Hurwitz JL,Jeffery CC,Krahn AD,Kusumoto FM,Lampert R,Mansour M,Natale A,Patton KK,Seiler A,Shah MJ,Wang PJ,Russo AM", + "auth_pos": 14, + "meshterms": "Betacoronavirus*, COVID-19, Cardiac Electrophysiology, Cardiac Electrophysiology/organization & administration*, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control*, Humans, Infection Control, Infection Control/organization & administration*, Pandemics, Pandemics/prevention & control*, Patient Selection, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control*, SARS-CoV-2, Telemedicine", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2209, + "user_id": 1841382421, + "artical_title": "A Lattice-Tip Temperature-Controlled Radiofrequency Ablation Catheter: Durability of Pulmonary Vein Isolation and Linear Lesion Block.", + "pmid": 32553211, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-06-20", + "author": "Reddy VY,Neužil P,Peichl P,Rackauskas G,Anter E,Petru J,Funasako M,Minami K,Aidietis A,Marinskis G,Natale A,Nakagawa H,Jackman WM,Kautzner J", + "auth_pos": 11, + "meshterms": "Catheter Ablation*, Catheters, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/surgery, Temperature", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2210, + "user_id": 1841382421, + "artical_title": "Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation: A Meta-Analysis.", + "pmid": 32553216, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-06-20", + "author": "Atti V,Turagam MK,Garg J,Koerber S,Angirekula A,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 7, + "meshterms": "Axillary Vein*, Axillary Vein/diagnostic imaging, Axillary Vein/surgery, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Electronics, Humans, Subclavian Vein, Venous Cutdown, Venous Cutdown/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2211, + "user_id": 1841382421, + "artical_title": "Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: Implications of pathophysiology for catheter ablation.", + "pmid": 32583488, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-06-26", + "author": "Della Rocca DG,Tarantino N,Trivedi C,Mohanty S,Anannab A,Salwan AS,Gianni C,Bassiouny M,Al-Ahmad A,Romero J,Briceño DF,Burkhardt JD,Gallinghouse GJ,Horton RP,Di Biase L,Natale A", + "auth_pos": 16, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2212, + "user_id": 1841382421, + "artical_title": "Implantable loop recorders for cardiac dysrhythmia monitoring.", + "pmid": 32583678, + "journal_name": "Future cardiology", + "date": "2020-06-26", + "author": "Akella K,Murtaza G,Della Rocca DG,Kodwani N,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2213, + "user_id": 1841382421, + "artical_title": "Increasing atrial fibrillation: What is the cause?", + "pmid": 32602237, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-07-01", + "author": "Gianni C,Della Rocca DG,Kim J,Sahore Salwan A,Natale A,Al-Ahmad A", + "auth_pos": 5, + "meshterms": "Aged, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Pacing, Artificial, Female, Humans, Pacemaker, Artificial*, Sick Sinus Syndrome, Sick Sinus Syndrome/therapy", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2214, + "user_id": 1841382421, + "artical_title": "A simple method to detect leaks after left atrial appendage occlusion with Watchman.", + "pmid": 32596864, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-07-01", + "author": "Ayhan H,Mohanty S,Gedikli Ö,Trivedi C,Canpolat U,Tapia AC,Chen Q,Della Rocca DG,Gianni C,Salwan A,Annanab A,MacDonald B,Mayedo A,Burkhardt JD,Horton R,Gallinghouse GJ,Di Biase L,Al-Ahmad A,Natale A", + "auth_pos": 19, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Cardiac Catheterization, Echocardiography, Transesophageal, Humans, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2215, + "user_id": 1841382421, + "artical_title": "Meta-Analysis Comparing Watchman and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation.", + "pmid": 32656246, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2020-07-14", + "author": "Basu Ray I,Khanra D,Shah S,Char S,Jia X,Lam W,Mathuria N,Razavi M,Jain B,Lakkireddy D,Kar S,Natale A,Adeboye A,Jefferies JL,Bangalore S,Asirvatham S,Saeed M", + "auth_pos": 12, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2216, + "user_id": 1841382421, + "artical_title": "Authors' reply.", + "pmid": 32662147, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2020-07-15", + "author": "Gianni C,Natale A", + "auth_pos": 2, + "meshterms": "Fistula*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2217, + "user_id": 1841382421, + "artical_title": "Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter registry.", + "pmid": 32681991, + "journal_name": "Heart rhythm", + "date": "2020-07-19", + "author": "Patel K,Natale A,Yang R,Trivedi C,Romero J,Briceno D,Mohanty S,Alviz I,Natale V,Sanchez J,Della Rocca DG,Tarantino N,Zhang XD,Mohanty P,Horton R,Burkhardt D,Gopinathannair R,Joseph Gallinghouse G,Lakkireddy D,Di Biase L", + "auth_pos": 2, + "meshterms": "Aged, Anticoagulants, Anticoagulants/administration & dosage*, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods*, Female, Follow-Up Studies, Heart Rate, Heart Rate/physiology, Humans, Male, Preoperative Period, Prospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2218, + "user_id": 1841382421, + "artical_title": "Epicardial Interventions in Electrophysiology.", + "pmid": 32771196, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-08-11", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2219, + "user_id": 1841382421, + "artical_title": "Epicardial Ablation Complications.", + "pmid": 32771194, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-08-11", + "author": "Tarantino N,Della Rocca DG,Faggioni M,Zhang XD,Mohanty S,Anannab A,Canpolat U,Ayhan H,Bassiouny M,Sahore A,Aytemir K,Sarcon A,Forleo GB,Lavalle C,Horton RP,Trivedi C,Al-Ahmad A,Romero J,Burkhardt DJ,Gallinghouse JG,Di Biase L,Natale A", + "auth_pos": 22, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2220, + "user_id": 1841382421, + "artical_title": "Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies.", + "pmid": 32791857, + "journal_name": "Circulation", + "date": "2020-08-15", + "author": "Casella M,Dello Russo A,Bergonti M,Catto V,Conte E,Sommariva E,Gasperetti A,Vettor G,Tundo F,Sicuso R,Rizzo S,Mushtaq S,Della Rocca D,Pompilio G,Di Biase L,Andreini D,Natale A,Basso C,Tondo C", + "auth_pos": 17, + "meshterms": "Adult, Biopsy, Contrast Media, Contrast Media/administration & dosage*, Electrophysiologic Techniques, Cardiac*, Female, Gadolinium, Gadolinium/administration & dosage*, Heart Ventricles*, Heart Ventricles/diagnostic imaging, Heart Ventricles/physiopathology, Humans, Magnetic Resonance Imaging*, Male, Middle Aged, Myocardium*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2221, + "user_id": 1841382421, + "artical_title": "Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology.", + "pmid": 32819525, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-08-21", + "author": "Lakkireddy DR,Chung MK,Deering TF,Gopinathannair R,Albert CM,Epstein LM,Harding CV,Hurwitz JL,Jeffery CC,Krahn AD,Kusumoto FM,Lampert R,Mansour M,Natale A,Patton KK,Seiler A,Shah MJ,Wang PJ,Russo AM", + "auth_pos": 14, + "meshterms": "Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology, Ambulatory Care, American Heart Association, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis*, Arrhythmias, Cardiac/therapy*, Betacoronavirus, COVID-19, COVID-19 Testing, Cardiology*, Clinical Laboratory Techniques, Coronavirus Infections, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology*, Coronavirus Infections/prevention & control, Decision Making, Shared, Delivery of Health Care*, Electrophysiologic Techniques, Cardiac*, Health Personnel, Humans, Mass Screening, Organizational Policy, Pandemics, Pandemics/prevention & control, Patient Selection, Personal Protective Equipment, Personal Protective Equipment/supply & distribution, Pneumonia, Viral, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology*, Pneumonia, Viral/prevention & control, Return to Work, Risk Assessment, SARS-CoV-2, Telemedicine, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2222, + "user_id": 1841382421, + "artical_title": "Persistent Atrial Fibrillation Ablation With Contact Force-Sensing Catheter: The Prospective Multicenter PRECEPT Trial.", + "pmid": 32819531, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-08-21", + "author": "Mansour M,Calkins H,Osorio J,Pollak SJ,Melby D,Marchlinski FE,Athill CA,Delaughter C,Patel AM,Gentlesk PJ,DeVille B,Macle L,Ellenbogen KA,Dukkipati SR,Reddy VY,Natale A", + "auth_pos": 16, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Catheter Ablation*, Catheters, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/surgery, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2223, + "user_id": 1841382421, + "artical_title": "Coronary sinus diverticulum: Importance, function, and treatment.", + "pmid": 32815147, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2020-08-21", + "author": "Razeghian-Jahromi I,Natale A,Nikoo MH", + "auth_pos": 2, + "meshterms": "Cardiac Resynchronization Therapy, Catheter Ablation, Coronary Sinus, Coronary Sinus/abnormalities*, Diverticulum, Diverticulum/physiopathology*, Diverticulum/therapy*, Electrocardiography, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2224, + "user_id": 1841382421, + "artical_title": "Dizziness during atrial antitachycardia pacing: What is the cause.", + "pmid": 32864770, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-08-31", + "author": "Gianni C,Canby RC,Della Rocca DG,Natale A,Al-Ahmad A", + "auth_pos": 4, + "meshterms": "Aged, Atrial Fibrillation*, Atrial Fibrillation/therapy, Cardiac Pacing, Artificial, Dizziness, Dizziness/diagnosis, Dizziness/etiology, Heart Atria, Humans, Pacemaker, Artificial*, Sick Sinus Syndrome, Sick Sinus Syndrome/diagnosis, Sick Sinus Syndrome/therapy", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2225, + "user_id": 1841382421, + "artical_title": "Prophylactic Catheter Ablation of Ventricular Tachycardia in Ischemic Cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials Electrophysiology Collaborative Consortium for Metaanalysis - ELECTRAM Investigators.", + "pmid": 34950297, + "journal_name": "Journal of atrial fibrillation", + "date": "2020-08-31", + "author": "Shah K,Turagam M,Patel B,Natale A,Lakkireddy D,Garg J", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2226, + "user_id": 1841382421, + "artical_title": "Periprocedural and long-term safety and feasibility of direct oral anticoagulants in patients with biological valve undergoing radiofrequency catheter ablation for atrial fibrillation: a prospective multicenter study.", + "pmid": 32894399, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-09-08", + "author": "Di Biase L,Romero J,Briceno D,Lakkireddy D,Trivedi C,Mohanty P,Mohanty S,Horton R,Hranitzky P,Gallinghouse GJ,Alviz I,Turagam M,Gopinathannair R,Della Rocca DG,Beheiry S,Burkhardt JD,Viles-Gonzales J,Natale A", + "auth_pos": 18, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Catheter Ablation*, Feasibility Studies, Female, Humans, Male, Prospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2227, + "user_id": 1841382421, + "artical_title": "Perclose Proglide™ for vascular closure.", + "pmid": 32915065, + "journal_name": "Future cardiology", + "date": "2020-09-12", + "author": "Del Prete A,Della Rocca DG,Calcagno S,Di Pietro R,Del Prete G,Biondi-Zoccai G,Raponi M,Scappaticci M,Di Matteo A,Natale A,Versaci F", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2228, + "user_id": 1841382421, + "artical_title": "Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.", + "pmid": 32942913, + "journal_name": "Circulation. Cardiovascular interventions", + "date": "2020-09-19", + "author": "Della Rocca DG,Horton RP,Tarantino N,Van Niekerk CJ,Trivedi C,Chen Q,Mohanty S,Anannab A,Murtaza G,Akella K,Gianni C,Bassiouny M,Ahmadian-Tehrani A,Al-Ahmad A,Burkhardt JD,Natale VN,Price M,Gallinghouse GJ,Gibson DN,Lakkireddy D,Di Biase L,Natale A", + "auth_pos": 22, + "meshterms": "Aged, Aged, 80 and over, Atrial Appendage, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Atrial Function, Left*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cardiac Catheterization/instrumentation*, Clinical Decision-Making, Echocardiography, Doppler, Color, Echocardiography, Transesophageal, Feasibility Studies, Female, Heart Rate, Humans, Male, Middle Aged, Prospective Studies, Prosthesis Design, Risk Factors, Septal Occluder Device*, Thromboembolism, Thromboembolism/prevention & control*, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2229, + "user_id": 1841382421, + "artical_title": "Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.", + "pmid": 32954600, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-09-22", + "author": "Piro A,Magnocavallo M,Della Rocca DG,Neccia M,Manzi G,Mariani MV,Straito M,Bernardini A,Severino P,Iannucci G,Giunta G,Chimenti C,Natale A,Fedele F,Lavalle C", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2230, + "user_id": 1841382421, + "artical_title": "Long-Term Outcomes of Left Atrial Appendage Electrical Isolation in Patients With Nonparoxysmal Atrial Fibrillation: A Propensity Score-Matched Analysis.", + "pmid": 32998529, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-10-02", + "author": "Romero J,Di Biase L,Mohanty S,Trivedi C,Patel K,Parides M,Alviz I,Diaz JC,Natale V,Sanchez J,Della Rocca DG,Yang R,Mohanty P,Gianni C,Horton R,Burkhardt D,Al-Ahmad A,Lakkireddy D,Natale A", + "auth_pos": 19, + "meshterms": "Action Potentials, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage, Atrial Appendage/physiopathology, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation*, Catheter Ablation/adverse effects, Databases, Factual, Female, Heart Rate, Humans, Male, Middle Aged, Propensity Score, Prospective Studies, Recurrence, Registries, Risk Assessment, Risk Factors, Thromboembolism, Thromboembolism/etiology, Thromboembolism/prevention & control, Time Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2231, + "user_id": 1841382421, + "artical_title": "Long-term durability of posterior wall isolation using the cryoballoon in patients with persistent atrial fibrillation: a multicenter analysis of repeat catheter ablations.", + "pmid": 33000358, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-10-02", + "author": "Aryana A,Di Biase L,Pujara DK,Baker JH,Espinosa MA,de Asmundis C,Bowers MR,O'Neill PG,Ellenbogen KA,Brugada P,Chierchia GB,d'Avila A,Natale A", + "auth_pos": 13, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2232, + "user_id": 1841382421, + "artical_title": "Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience.", + "pmid": 33006086, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-10-03", + "author": "Mohanty S,Lakkireddy D,Trivedi C,MacDonald B,Quintero Mayedo A,Della Rocca DG,Atkins D,Park P,Shah A,Gopinathannair R,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Bassiouny M,Di Biase L,Kessler D,Tschopp D,Coffeen P,Horton R,Canby R,Natale A", + "auth_pos": 21, + "meshterms": "COVID-19*, Cardiac Electrophysiology, Health Personnel, Humans, SARS-CoV-2*, Workplace", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2233, + "user_id": 1841382421, + "artical_title": "Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design.", + "pmid": 33009645, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-10-04", + "author": "Aryana A,Pujara DK,Allen SL,Baker JH,Espinosa MA,Buch EF,Srivatsa U,Ellis E,Makati K,Kowalski M,Lee S,Tadros T,Baykaner T,Al-Ahmad A,d'Avila A,Di Biase L,Okishige K,Natale A", + "auth_pos": 18, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Catheter Ablation*, Cryosurgery*, Humans, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2234, + "user_id": 1841382421, + "artical_title": "Impact of Yoga on Cardiac Autonomic Function and Arrhythmias.", + "pmid": 33024508, + "journal_name": "Journal of atrial fibrillation", + "date": "2020-10-08", + "author": "Akella K,Kanuri SH,Murtaza G,G Della Rocca D,Kodwani N,K Turagam M,Shenthar J,Padmanabhan D,Basu Ray I,Natale A,Gopinathannair R,Lakkireddy D", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2235, + "user_id": 1841382421, + "artical_title": "Prospective use of ablation index for the ablation of right ventricle outflow tract premature ventricular contractions: a proof of concept study.", + "pmid": 33063099, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2020-10-17", + "author": "Gasperetti A,Sicuso R,Dello Russo A,Zucchelli G,Saguner AM,Notarstefano P,Soldati E,Bongiorni MG,Della Rocca DG,Mohanty S,Carbucicchio C,Duru F,Di Biase L,Natale A,Tondo C,Casella M", + "auth_pos": 14, + "meshterms": "Adult, Catheter Ablation*, Catheter Ablation/adverse effects, Electrocardiography, Female, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Male, Middle Aged, Proof of Concept Study, Prospective Studies, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2236, + "user_id": 1841382421, + "artical_title": "Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial.", + "pmid": 33107945, + "journal_name": "JAMA", + "date": "2020-10-28", + "author": "Valderrábano M,Peterson LE,Swarup V,Schurmann PA,Makkar A,Doshi RN,DeLurgio D,Athill CA,Ellenbogen KA,Natale A,Koneru J,Dave AS,Giorgberidze I,Afshar H,Guthrie ML,Bunge R,Morillo CA,Kleiman NS", + "auth_pos": 10, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Combined Modality Therapy, Combined Modality Therapy/methods, Ethanol, Ethanol/administration & dosage*, Female, Humans, Infusions, Intravenous, Infusions, Intravenous/adverse effects, Infusions, Intravenous/methods, Kaplan-Meier Estimate, Male, Single-Blind Method, Tachycardia, Tachycardia/therapy, Treatment Outcome, Vena Cava, Superior*, Vena Cava, Superior/embryology, Vena Cava, Superior/innervation", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2237, + "user_id": 1841382421, + "artical_title": "Clinical Outcomes of Catheter Ablation for VT in Patients With Chagasic Cardiomyopathy: Systematic Review.", + "pmid": 33121677, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-10-31", + "author": "Garg J,Shah K,Shah S,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Cardiomyopathies*, Catheter Ablation*, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2238, + "user_id": 1841382421, + "artical_title": "T-wave inversion as a manifestation of COVID-19 infection: a case series.", + "pmid": 33128658, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-11-01", + "author": "Romero J,Alviz I,Parides M,Diaz JC,Briceno D,Gabr M,Gamero M,Patel K,Braunstein ED,Purkayastha S,Polanco D,Valencia CR,Della Rocca D,Velasco A,Yang R,Tarantino N,Zhang XD,Mohanty S,Bello J,Natale A,Jorde UP,Garcia M,Di Biase L", + "auth_pos": 20, + "meshterms": "Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*, Aged, COVID-19, COVID-19/epidemiology, COVID-19/mortality, COVID-19/physiopathology*, Electrocardiography, Female, Humans, Male, New York City, New York City/epidemiology, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, Troponin, Troponin/blood, Ventricular Function*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2239, + "user_id": 1841382421, + "artical_title": "Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease.", + "pmid": 33156441, + "journal_name": "Journal of thrombosis and thrombolysis", + "date": "2020-11-07", + "author": "Della Rocca DG,Magnocavallo M,Lavalle C,Romero J,Forleo GB,Tarantino N,Chimenti C,Alviz I,Gamero MT,Garcia MJ,Di Biase L,Natale A", + "auth_pos": 12, + "meshterms": "Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Aged, COVID-19, COVID-19/blood, COVID-19/complications*, COVID-19/physiopathology, Cohort Studies, Endothelium, Vascular, Endothelium, Vascular/physiopathology, Erythrocytes, Erythrocytes/pathology*, Female, Humans, Inpatients, Inpatients/statistics & numerical data, Male, Middle Aged, Thrombosis, Thrombosis/virology*, Thrombolysis*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2240, + "user_id": 1841382421, + "artical_title": "Preexcitation Syndrome.", + "pmid": 33162006, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2020-11-10", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Electrocardiography, Humans, Pre-Excitation Syndromes*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2241, + "user_id": 1841382421, + "artical_title": "First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.", + "pmid": 33179155, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2020-11-13", + "author": "Briceño DF,Romero J,Patel K,Liaqat W,Zhang XD,Alviz I,Yang R,Rodriguez D,Lakkireddy D,Rocca DD,Tarantino N,Gopinathannair R,Natale A,Di Biase L", + "auth_pos": 13, + "meshterms": "Aged, Cardiomyopathies*, Cardiomyopathies/therapy, Catheter Ablation*, Defibrillators, Implantable*, Female, Humans, Male, Middle Aged, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/diagnostic imaging, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnostic imaging, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2242, + "user_id": 1841382421, + "artical_title": "Implantable cardioverter-defibrillators in cardiac transplant recipients: A systematic review from the Electrophysiology Collaborative Consortium for Meta-analysis-ELECTRAM investigators.", + "pmid": 33180346, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2020-11-13", + "author": "Garg J,Shah K,Turagam MK,Tzou W,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 6, + "meshterms": "Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control*, Defibrillators, Implantable*, Heart Transplantation*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2243, + "user_id": 1841382421, + "artical_title": "Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.", + "pmid": 33197325, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-11-17", + "author": "Casella M,Gasperetti A,Sicuso R,Conte E,Catto V,Sommariva E,Bergonti M,Vettor G,Rizzo S,Pompilio G,Andreini D,Saguner AM,Duru F,Natale A,Thiene G,Basso C,Dello Russo A,Tondo C", + "auth_pos": 14, + "meshterms": "Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Dysplasia/diagnosis*, Arrhythmogenic Right Ventricular Dysplasia/genetics, Arrhythmogenic Right Ventricular Dysplasia/pathology, Arrhythmogenic Right Ventricular Dysplasia/physiopathology, Biopsy, Desmoglein 2, Desmoglein 2/genetics*, Desmoplakins, Desmoplakins/genetics*, Electrocardiography, Electrophysiologic Techniques, Cardiac, Female, Genetic Predisposition to Disease, Genetic Testing, Genetic Variation*, Heart Rate*, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Myocardium, Myocardium/pathology*, Phenotype, Predictive Value of Tests, Registries", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2244, + "user_id": 1841382421, + "artical_title": "Prevalence of Undiagnosed Sleep Apnea in Patients With Atrial Fibrillation and its Impact on Therapy.", + "pmid": 33213809, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-11-21", + "author": "Shapira-Daniels A,Mohanty S,Contreras-Valdes FM,Tieu H,Thomas RJ,Natale A,Anter E", + "auth_pos": 6, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Humans, Male, Middle Aged, Polysomnography, Prevalence, Prospective Studies, Sleep Apnea Syndromes*, Sleep Apnea Syndromes/complications, Sleep Apnea Syndromes/diagnosis, Sleep Apnea Syndromes/epidemiology, Sleep Apnea, Obstructive*, Sleep Apnea, Obstructive/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2245, + "user_id": 1841382421, + "artical_title": "Results from the Prospective, Multicenter AMBULATE-CAP Trial: Reduced Use of Urinary Catheters and Protamine with Hemostasis via the Mid-Bore Venous Vascular Closure System (Vascade MVP) Following Multi-access Cardiac Ablation Procedures.", + "pmid": 33270306, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-12-04", + "author": "Al-Ahmad A,Mittal S,DeLurgio D,Joseph Gallinghouse G,Horton RP,Preminger MW,David Burkhardt J,Natale A", + "auth_pos": 8, + "meshterms": "Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*, Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*, Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*, Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*, Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*, Femoral Artery, Hemostasis, Hemostatic Techniques, Hemostatic Techniques/adverse effects, Humans, Prospective Studies, Protamines*, Protamines/adverse effects, Treatment Outcome, Urinary Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2246, + "user_id": 1841382421, + "artical_title": "Positive Clinical Benefit on Patient Care, Quality of Life and Symptoms After Contact-Force Guided Radiofrequency Ablation in Persistent Atrial Fibrillation: Analyses from Prospective Multicenter Study.", + "pmid": 33290093, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2020-12-09", + "author": "Natale A,Calkins H,Osorio J,Pollak SJ,Melby D,Marchlinski FE,Athill CA,Delaughter C,Patel AM,Gentlesk PJ,DeVille B,Macle L,Ellenbogen KA,Dukkipati SR,Reddy VY,Mansour M", + "auth_pos": 1, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography, Female, Follow-Up Studies, Heart Rate, Heart Rate/physiology*, Humans, Male, Postoperative Period, Prospective Studies, Quality of Life*, Recurrence, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2247, + "user_id": 1841382421, + "artical_title": "Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis.", + "pmid": 33324978, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2020-12-17", + "author": "Romero J,Gabr M,Patel K,Briceno D,Diaz JC,Alviz I,Trivedi C,Mohanty S,Polanco D,Della Rocca DG,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 12, + "meshterms": "Aged, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Female, Humans, Male, Middle Aged, Pulmonary Veins*, Recurrence, Thromboembolism*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2248, + "user_id": 1841382421, + "artical_title": "Direct Oral Anticoagulant Versus Warfarin for Watchman Left Atrial Appendage Occlusion-Systematic Review: Electram Investigators.", + "pmid": 33334455, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-12-19", + "author": "Garg J,Shah S,Shah K,Turagam MK,Tzou W,Natale A,Lakkireddy D", + "auth_pos": 6, + "meshterms": "Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects, Humans, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Warfarin, Warfarin/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2249, + "user_id": 1841382421, + "artical_title": "High-Dose Dobutamine for Inducibility of Atrial Arrhythmias During Atrial Fibrillation Ablation.", + "pmid": 33334450, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2020-12-19", + "author": "Gianni C,Sanchez JE,Mohanty S,Trivedi C,Della Rocca DG,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Hranitzky PM,Horton RP,Di Biase L,Natale A", + "auth_pos": 12, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Cross-Over Studies, Dobutamine, Dobutamine/adverse effects, Humans, Prospective Studies", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2250, + "user_id": 1841382421, + "artical_title": "Prior myocarditis and ventricular arrhythmias: the importance of scar pattern.", + "pmid": 33348060, + "journal_name": "Heart rhythm", + "date": "2020-12-22", + "author": "Casella M,Bergonti M,Narducci ML,Persampieri S,Gasperetti A,Conte E,Catto V,Carbucicchio C,Guerra F,Pontone G,Andreini D,Basso C,Di Biase L,Santangeli P,Natale A,Pelargonio G,Russo AD,Tondo C", + "auth_pos": 15, + "meshterms": "Adult, Body Surface Potential Mapping, Body Surface Potential Mapping/methods, Catheter Ablation, Cicatrix, Cicatrix/complications*, Cicatrix/diagnosis, Female, Humans, Magnetic Resonance Imaging, Cine, Male, Myocarditis, Myocarditis/complications*, Myocarditis/diagnosis, Retrospective Studies, Stroke Volume, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/etiology*, Tachycardia, Ventricular/surgery, Ventricular Function, Left, Ventricular Function, Left/physiology*, Ventricular Septum, Ventricular Septum/pathology*, Adult, Body Surface Potential Mapping, Body Surface Potential Mapping/methods, Catheter Ablation, Cicatrix, Cicatrix/complications*, Cicatrix/diagnosis, Female, Humans, Magnetic Resonance Imaging, Cine, Male, Myocarditis, Myocarditis/complications*, Myocarditis/diagnosis, Retrospective Studies, Stroke Volume, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/etiology*, Tachycardia, Ventricular/surgery, Ventricular Function, Left, Ventricular Function, Left/physiology*, Ventricular Septum, Ventricular Septum/pathology*, Adult, Body Surface Potential Mapping, Body Surface Potential Mapping/methods, Catheter Ablation, Cicatrix, Cicatrix/complications*, Cicatrix/diagnosis, Female, Humans, Magnetic Resonance Imaging, Cine, Male, Myocarditis, Myocarditis/complications*, Myocarditis/diagnosis, Retrospective Studies, Stroke Volume, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/etiology*, Tachycardia, Ventricular/surgery, Ventricular Function, Left, Ventricular Function, Left/physiology*, Ventricular Septum, Ventricular Septum/pathology*, Adult, Body Surface Potential Mapping, Body Surface Potential Mapping/methods, Catheter Ablation, Cicatrix, Cicatrix/complications*, Cicatrix/diagnosis, Female, Humans, Magnetic Resonance Imaging, Cine, Male, Myocarditis, Myocarditis/complications*, Myocarditis/diagnosis, Retrospective Studies, Stroke Volume, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/etiology*, Tachycardia, Ventricular/surgery, Ventricular Function, Left, Ventricular Function, Left/physiology*, Ventricular Septum, Ventricular Septum/pathology*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2251, + "user_id": 1841382421, + "artical_title": "Catheter ablation of ventricular tachycardia in patients with prior cardiac surgery: An analysis from the International VT Ablation Center Collaborative Group.", + "pmid": 33355965, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2020-12-29", + "author": "Aguilar M,Tedrow UB,Tzou WS,Tung R,Frankel DS,Santangeli P,Vaseghi M,Bunch TJ,Di Biase L,Tholakanahalli VN,Lakkireddy D,Dickfeld T,Weiss JP,Mathuria N,Vergara P,Nakahara S,Bradfield JS,Burkhardt JD,Stevenson WG,Callans DJ,Della Bella P,Natale A,Shivkumar K,Marchlinski FE,Sauer WH", + "auth_pos": 22, + "meshterms": "Cardiac Surgical Procedures*, Cardiac Surgical Procedures/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Pericardium, Pericardium/surgery, Recurrence, Stroke Volume, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2252, + "user_id": 1841382421, + "artical_title": "Interventional Treatment for Stroke Prevention.", + "pmid": 33377326, + "journal_name": "Korean circulation journal", + "date": "2020-12-31", + "author": "Gianni C,Della Rocca DG,Natale A,Horton RP", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2253, + "user_id": 1841382421, + "artical_title": "Half-normal saline versus normal saline for irrigation of open-irrigated radiofrequency catheters in atrial fibrillation ablation.", + "pmid": 33442937, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-01-15", + "author": "Gianni C,Gallinghouse GJ,Al-Ahmad A,Horton RP,Bailey SM,Burkhardt JD,Bassiouny MA,MacDonald BC,Quintero Mayedo A,Della Rocca DG,Mohanty S,Trivedi C,Di Biase L,Hranitzky PM,Sanchez JE,Natale A", + "auth_pos": 16, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheters, Equipment Design, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Saline Solution, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2254, + "user_id": 1841382421, + "artical_title": "Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial.", + "pmid": 33482387, + "journal_name": "Heart rhythm", + "date": "2021-01-23", + "author": "Lador A,Peterson LE,Swarup V,Schurmann PA,Makkar A,Doshi RN,DeLurgio D,Athill CA,Ellenbogen KA,Natale A,Koneru J,Dave AS,Giorgberidze I,Afshar H,Guthrie ML,Bunge R,Morillo CA,Kleiman NS,Valderrábano M", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2255, + "user_id": 1841382421, + "artical_title": "Atrial Fibrillation Risk Factors.", + "pmid": 33516413, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-02-01", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Atrial Fibrillation*, Humans, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2256, + "user_id": 1841382421, + "artical_title": "A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation.", + "pmid": 33516712, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-02-01", + "author": "Kautzner J,Albenque JP,Natale A,Maddox W,Cuoco F,Neuzil P,Poty H,Getman MK,Liu S,Starek Z,Dukkipati SR,Colley BJ,Al-Ahmad A,Sidney DS,McElderry HT", + "auth_pos": 3, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheters, Humans, Prospective Studies, Quality of Life, Temperature, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2257, + "user_id": 1841382421, + "artical_title": "In memoriam: John Joseph Gallagher MD: a founder and pioneer of modern clinical electrophysiology (March 3, 1943, to November 21, 2020).", + "pmid": 33521886, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2021-02-02", + "author": "Saksena S,Natale A", + "auth_pos": 2, + "meshterms": "Electrophysiology, Electrophysiology/history*, History, 20th Century, History, 21st Century, Humans, Electrophysiology, Electrophysiology/history*, History, 20th Century, History, 21st Century, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2258, + "user_id": 1841382421, + "artical_title": "Catheter Ablation of Ventricular Tachycardia in Ischemic Cardiomyopathy: Impact of Concomitant Amiodarone Therapy on Short and Long-Term Clinical Outcomes.", + "pmid": 33592323, + "journal_name": "Heart rhythm", + "date": "2021-02-17", + "author": "Di Biase L,Romero J,Du X,Mohanty S,Trivedi C,Della Rocca DG,Patel K,Sanchez J,Yang R,Alviz I,Mohanty P,Gianni C,Tarantino N,Zhang XD,Horton R,Al-Ahmad A,Lakkireddy D,Burkhardt DJ,Chen M,Natale A", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2259, + "user_id": 1841382421, + "artical_title": "Concomitant Pulmonary Vein and Posterior Wall Isolation Using Cryoballoon With Adjunct Radiofrequency in Persistent Atrial Fibrillation.", + "pmid": 33602399, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-02-20", + "author": "Aryana A,Allen SL,Pujara DK,Bowers MR,O'Neill PG,Yamauchi Y,Shigeta T,Vierra EC,Okishige K,Natale A", + "auth_pos": 10, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2260, + "user_id": 1841382421, + "artical_title": "Catheter Ablation of Life-Threatening Ventricular Arrhythmias in Athletes.", + "pmid": 33652714, + "journal_name": "Medicina (Kaunas, Lithuania)", + "date": "2021-03-04", + "author": "Tarantino N,Rocca DGD,Cruz NSL,Manheimer ED,Magnocavallo M,Lavalle C,Gianni C,Mohanty S,Trivedi C,Al-Ahmad A,Horton RP,Bassiouny M,Burkhardt JD,Gallinghouse GJ,Forleo GB,Biase LD,Natale A", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2261, + "user_id": 1841382421, + "artical_title": "Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review.", + "pmid": 33663741, + "journal_name": "Journal of the American College of Cardiology", + "date": "2021-03-06", + "author": "Romero J,Velasco A,Pisani CF,Alviz I,Briceno D,Díaz JC,Della Rocca DG,Natale A,de Lourdes Higuchi M,Scanavacca M,Di Biase L", + "auth_pos": 8, + "meshterms": "Autonomic Denervation, Autonomic Denervation/methods, Autonomic Denervation/trends*, Catheter Ablation, Catheter Ablation/methods, Catheter Ablation/trends*, Chagas Cardiomyopathy, Chagas Cardiomyopathy/diagnostic imaging, Chagas Cardiomyopathy/epidemiology*, Chagas Cardiomyopathy/therapy*, Defibrillators, Implantable, Defibrillators, Implantable/trends, Epicardial Mapping, Epicardial Mapping/methods, Epicardial Mapping/trends, Humans, Kidney, Kidney/innervation, Kidney/physiology, Review Literature as Topic, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnostic imaging, Tachycardia, Ventricular/epidemiology*, Tachycardia, Ventricular/therapy*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2262, + "user_id": 1841382421, + "artical_title": "Predictors of recurrent atrial fibrillation following catheter ablation.", + "pmid": 33678103, + "journal_name": "Expert review of cardiovascular therapy", + "date": "2021-03-09", + "author": "Mohanty S,Della Rocca DG,Gianni C,Trivedi C,Mayedo AQ,MacDonald B,Natale A", + "auth_pos": 7, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Heart Atria, Heart Atria/physiopathology, Humans, Recurrence, Risk Factors, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2263, + "user_id": 1841382421, + "artical_title": "Tumescent Local Anesthesia Versus General Anesthesia for Subcutaneous Implantable Cardioverter-Defibrillator Implantation.", + "pmid": 33684548, + "journal_name": "Heart rhythm", + "date": "2021-03-09", + "author": "Romero J,Bello J,Díaz JC,Grushko M,Velasco A,Zhang X,Briceno D,Gabr M,Purkayastha S,Alviz I,Polanco D,Della Rocca D,Krumerman A,Palma E,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2264, + "user_id": 1841382421, + "artical_title": "Thromboembolic Risk in Atrial Fibrillation Patients With Left Atrial Scar Post-Extensive Ablation: A Single-Center Experience.", + "pmid": 33736751, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-03-20", + "author": "Mohanty S,Trivedi C,Della Rocca DG,Baqai FM,Anannab A,Gianni C,MacDonald B,Quintero Mayedo A,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Al-Ahmad A,Di Biase L,Natale A", + "auth_pos": 15, + "meshterms": "Atrial Appendage*, Atrial Appendage/pathology, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Cicatrix, Cicatrix/epidemiology, Cicatrix/etiology, Cicatrix/pathology, Contrast Media, Gadolinium, Humans, Vena Cava, Superior", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2265, + "user_id": 1841382421, + "artical_title": "Arrhythmia profile and ablation-outcome in elderly women with atrial fibrillation undergoing first catheter ablation.", + "pmid": 33742711, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2021-03-21", + "author": "Natale V,Mohanty S,Trivedi C,Baqai FM,Gallinghouse J,Rocca DGD,Gianni C,MacDonald B,Mayedo A,Burkhardt JD,Gallinghouse GJ,Al-Ahmad A,Horton R,Bassiouny M,Biase LD,Natale A", + "auth_pos": 16, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Comorbidity, Echocardiography, Electrocardiography, Epicardial Mapping, Female, Humans, Middle Aged, Prospective Studies, Pulmonary Veins, Pulmonary Veins/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2266, + "user_id": 1841382421, + "artical_title": "Direct oral anticoagulants to treat left ventricular thrombus - A systematic review and meta-analysis: ELECTRAM investigators.", + "pmid": 33772939, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-03-28", + "author": "Shah S,Shah K,Turagam MK,Sharma A,Natale A,Lakkireddy D,Garg J", + "auth_pos": 5, + "meshterms": "Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*, Administration, Oral, Anticoagulants, Anticoagulants/adverse effects, Humans, Prospective Studies, Thrombosis*, Thrombosis/diagnostic imaging, Thrombosis/drug therapy, Vitamin K*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2267, + "user_id": 1841382421, + "artical_title": "Renal sympathetic denervation for the treatment of recurrent ventricular arrhythmias - ELECTRAM Investigators.", + "pmid": 33786832, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2021-04-01", + "author": "Garg J,Shah S,Shah K,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*, Defibrillators, Implantable, Humans, Kidney, Kidney/innervation*, Recurrence, Sympathectomy*, Tachycardia, Ventricular, Tachycardia, Ventricular/physiopathology*, Tachycardia, Ventricular/prevention & control*, Ventricular Fibrillation, Ventricular Fibrillation/physiopathology*, Ventricular Fibrillation/surgery*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2268, + "user_id": 1841382421, + "artical_title": "Focal Impulse and Rotor Modulation Guided Ablation Versus Pulmonary Vein Isolation for Atrial Fibrillation: A Meta-Analysis of Head-to-Head Comparative Studies.", + "pmid": 33844385, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-04-13", + "author": "Romero J,Gabr M,Alviz I,Briceno D,Diaz JC,Rodriguez D,Patel K,Polanco D,Trivedi C,Mohanty S,Della Rocca D,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 13, + "meshterms": "Aged, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2269, + "user_id": 1841382421, + "artical_title": "Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis.", + "pmid": 33866017, + "journal_name": "Indian pacing and electrophysiology journal", + "date": "2021-04-19", + "author": "Murtaza G,Turagam MK,Garg J,Boda U,Akella K,Velagapudi P,Natale A,Gopinathannair R,Lakkireddy D", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2270, + "user_id": 1841382421, + "artical_title": "Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation.", + "pmid": 33870705, + "journal_name": "Journal of the American Heart Association", + "date": "2021-04-20", + "author": "Mohanty S,Mohanty P,Trivedi C,Assadourian J,Mayedo AQ,MacDonald B,Della Rocca DG,Gianni C,Horton R,Al-Ahmad A,Bassiouny M,Burkhardt JD,Di Biase L,Gurol ME,Natale A", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2271, + "user_id": 1841382421, + "artical_title": "Surviving sudden cardiac arrest-successes, challenges, and opportunities.", + "pmid": 33909223, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2021-04-29", + "author": "Rajagopalan B,Shen WK,Patton K,Kutyifa V,Di Biase L,Al-Ahmad A,Natale A,Gopinathannair R,Lakkireddy D", + "auth_pos": 7, + "meshterms": "Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans, Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans, Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans, Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans, Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans, Artificial Intelligence, Cardiopulmonary Resuscitation*, Cardiopulmonary Resuscitation/education, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Emergency Medical Services*, Heart Arrest*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2272, + "user_id": 1841382421, + "artical_title": "Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach.", + "pmid": 33933407, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-05-03", + "author": "Bergonti M,Dello Russo A,Sicuso R,Ribatti V,Compagnucci P,Catto V,Gasperetti A,Zucchetti M,Cellucci S,Vettor G,Dessanai MA,Majocchi B,Moltrasio M,Russo E,Stronati G,Guerra F,Di Biase L,Natale A,Tondo C,Casella M", + "auth_pos": 18, + "meshterms": "Adult, Catheter Ablation*, Female, Fluoroscopy, Humans, Male, Middle Aged, Tachycardia, Supraventricular*, Tachycardia, Supraventricular/surgery, Tachycardia, Ventricular*, Treatment Outcome, Young Adult, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2273, + "user_id": 1841382421, + "artical_title": "Role of Immunosuppressive Therapy in the Management Refractory Post-Procedural Pericarditis.", + "pmid": 33942420, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-05-05", + "author": "Narasimhan B,Turagam MK,Garg J,G Della Rocca D,Gopinathannair R,Biase LD,Romero J,Mohanty S,Natale A,Lakkireddy D", + "auth_pos": 9, + "meshterms": "Humans, Immunosuppressive Agents*, Immunosuppressive Agents/adverse effects, Methotrexate, Methotrexate/adverse effects, Pericarditis*, Pericarditis/chemically induced, Pericarditis/diagnosis, Pericarditis/drug therapy, Prednisone, Prednisone/adverse effects, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2274, + "user_id": 1841382421, + "artical_title": "Gender Associated Disparities in Atrioventricular Nodal Reentrant Tachycardia: Review Article.", + "pmid": 33969588, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-05-11", + "author": "Etaee F,Elayi CS,Catanzarro J,Delisle B,Ogunbayo G,Di Biase L,Natale A,Darrat Y", + "auth_pos": 7, + "meshterms": "Arrhythmias, Cardiac, Catheter Ablation*, Female, Humans, Male, Recurrence, Tachycardia, Atrioventricular Nodal Reentry*, Tachycardia, Atrioventricular Nodal Reentry/diagnosis, Tachycardia, Atrioventricular Nodal Reentry/epidemiology, Tachycardia, Atrioventricular Nodal Reentry/surgery, Tachycardia, Ventricular*, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2275, + "user_id": 1841382421, + "artical_title": "Effects of permanent cardiac pacing on ventricular repolarization when compared to cardioneuroablation.", + "pmid": 33984570, + "journal_name": "Journal of electrocardiology", + "date": "2021-05-14", + "author": "Aksu T,Turagam M,Gautam S,Futyma P,Akella K,Baysal E,Bozyel S,Yalin K,Padmanabhan D,Shenthar J,Natale A,Lakkireddy D,Gopinathannair R", + "auth_pos": 11, + "meshterms": "Adult, Catheter Ablation*, Electrocardiography, Female, Heart Rate, Humans, Male, Middle Aged, Syncope, Vasovagal*, Syncope, Vasovagal/surgery, Tilt-Table Test", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2276, + "user_id": 1841382421, + "artical_title": "Intracardiac Echocardiography to Guide Catheter Ablation of Atrial Fibrillation.", + "pmid": 33990269, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-05-16", + "author": "Gianni C,Sanchez JE,Della Rocca DG,Al-Ahmad A,Horton RP,Di Biase L,Natale A", + "auth_pos": 7, + "meshterms": "Atrial Fibrillation, Atrial Fibrillation/surgery*, Catheter Ablation, Catheter Ablation/methods*, Echocardiography, Echocardiography/methods*, Humans, Surgery, Computer-Assisted, Surgery, Computer-Assisted/methods*, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2277, + "user_id": 1841382421, + "artical_title": "Real-Time 3D Intracardiac Echocardiography.", + "pmid": 33990280, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-05-16", + "author": "Gianni C,Della Rocca DG,Horton RP,Burkhardt JD,Natale A,Al-Ahmad A", + "auth_pos": 5, + "meshterms": "Echocardiography, Three-Dimensional*, Equipment Design, Heart, Heart/diagnostic imaging, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2278, + "user_id": 1841382421, + "artical_title": "Intracardiac Echocardiography.", + "pmid": 33990281, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-05-16", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Cardiac Catheterization, Catheter Ablation, Echocardiography*, Electrophysiologic Techniques, Cardiac, Heart, Heart/diagnostic imaging*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2279, + "user_id": 1841382421, + "artical_title": "Epicardial Access Complications During Electrophysiology Procedures.", + "pmid": 33993576, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-05-17", + "author": "Romero J,Patel K,Lakkireddy D,Alviz I,Velasco A,Rodriguez D,Karpenos J,Zhang XD,Natale A,Di Biase L", + "auth_pos": 9, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Cardiac Electrophysiology, Catheter Ablation*, Catheter Ablation/adverse effects, Epicardial Mapping, Humans, Pericardium, Pericardium/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/etiology, Tachycardia, Ventricular/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2280, + "user_id": 1841382421, + "artical_title": "Natural History of Arrhythmia After Successful Isolation of Pulmonary Veins, Left Atrial Posterior Wall, and Superior Vena Cava in Patients With Paroxysmal Atrial Fibrillation: A Multi-Center Experience.", + "pmid": 33998277, + "journal_name": "Journal of the American Heart Association", + "date": "2021-05-18", + "author": "Mohanty S,Trivedi C,Horton P,Della Rocca DG,Gianni C,MacDonald B,Mayedo A,Sanchez J,Gallinghouse GJ,Al-Ahmad A,Horton RP,Burkhardt JD,Dello Russo A,Casella M,Tondo C,Themistoclakis S,Forleo G,Di Biase L,Natale A", + "auth_pos": 19, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2281, + "user_id": 1841382421, + "artical_title": "Reply: Radiofrequency Is Not Always Necessary for Left Atrium Posterior Wall Isolation.", + "pmid": 34016397, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-05-22", + "author": "Aryana A,O'Neill PG,Okishige K,Natale A", + "auth_pos": 4, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Humans, Pulmonary Veins*, Pulmonary Veins/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2282, + "user_id": 1841382421, + "artical_title": "Tumescent local anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: An alternative for general anesthesia.", + "pmid": 34026517, + "journal_name": "HeartRhythm case reports", + "date": "2021-05-25", + "author": "Romero J,Diaz JC,Alviz I,Briceno D,Zhang X,Palma E,Vue E,Bello J,Natale A,Di Biase L", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2283, + "user_id": 1841382421, + "artical_title": "Fluoroless 3D mapping-guided pacemaker implant in a pregnant patient.", + "pmid": 34033130, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2021-05-26", + "author": "Gianni C,Della Rocca DG,Natale A,Horton RP", + "auth_pos": 3, + "meshterms": "Adult, Echocardiography, Three-Dimensional*, Electrocardiography, Epicardial Mapping, Female, Humans, Pacemaker, Artificial*, Pregnancy, Prosthesis Implantation, Prosthesis Implantation/methods*, Syncope, Syncope/diagnostic imaging*, Syncope/therapy*, Ultrasonography, Interventional*, Adult, Echocardiography, Three-Dimensional*, Electrocardiography, Epicardial Mapping, Female, Humans, Pacemaker, Artificial*, Pregnancy, Prosthesis Implantation, Prosthesis Implantation/methods*, Syncope, Syncope/diagnostic imaging*, Syncope/therapy*, Ultrasonography, Interventional*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2284, + "user_id": 1841382421, + "artical_title": "Early Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction.", + "pmid": 34103156, + "journal_name": "The American journal of cardiology", + "date": "2021-06-10", + "author": "Shah K,Shah S,Turagam MK,Bhardwaj R,Contractor T,Mandapati R,Natale A,Lakkireddy D,Garg J", + "auth_pos": 7, + "meshterms": "Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control*, Defibrillators, Implantable*, Early Medical Intervention, Humans, Myocardial Infarction, Myocardial Infarction/therapy*, Myocardial Revascularization, Prosthesis Implantation*, Randomized Controlled Trials as Topic", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2285, + "user_id": 1841382421, + "artical_title": "Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association.", + "pmid": 34129347, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2021-06-16", + "author": "Gopinathannair R,Chen LY,Chung MK,Cornwell WK,Furie KL,Lakkireddy DR,Marrouche NF,Natale A,Olshansky B,Joglar JA", + "auth_pos": 8, + "meshterms": "American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States, American Heart Association*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/pharmacology*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/physiopathology, Atrial Fibrillation/therapy*, Catheter Ablation, Catheter Ablation/methods*, Disease Management*, Heart Failure, Heart Failure/complications*, Heart Failure/physiopathology, Heart Rate, Humans, Stroke Volume, Stroke Volume/physiology*, United States", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2286, + "user_id": 1841382421, + "artical_title": "Laser-assisted lead extraction of a retained lead remnant in the femoral and iliac veins.", + "pmid": 34176172, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-06-28", + "author": "Gianni C,Canby RC,Della Rocca DG,Natale A,Al-Ahmad A", + "auth_pos": 4, + "meshterms": "Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Device Removal, Electrodes, Implanted, Humans, Iliac Vein, Iliac Vein/diagnostic imaging, Iliac Vein/surgery, Lasers, Pacemaker, Artificial*, Pacemaker, Artificial/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2287, + "user_id": 1841382421, + "artical_title": "Amplatzer PFO Occluder for treatment of incomplete LAA closure with AtriClip.", + "pmid": 34185340, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-06-30", + "author": "Gianni C,David Burkhardt J,Della Rocca DG,Natale A,Horton RP", + "auth_pos": 4, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Humans, Septal Occluder Device*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2288, + "user_id": 1841382421, + "artical_title": "Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy.", + "pmid": 34217665, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-07-05", + "author": "Della Rocca DG,Horton RP,Di Biase L,Gianni C,Trivedi C,Mohanty S,Anannab A,Magnocavallo M,Chen Q,Tarantino N,Bassiouny M,Lavalle C,Natale VN,Forleo GB,Del Prete A,Van Niekerk CJ,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Sanchez JE,Lakkireddy D,Gibson DN,Natale A", + "auth_pos": 23, + "meshterms": "Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics, Clopidogrel, Clopidogrel/adverse effects, Fibrinolytic Agents*, Genotype, Humans, Incidence, Thrombosis*, Thrombosis/drug therapy, Thrombosis/epidemiology, Thrombosis/genetics", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2289, + "user_id": 1841382421, + "artical_title": "Safety and Feasibility of Peri-device Leakage Closure after LAAO: An International, Multi-center Collaborative Study.", + "pmid": 34219662, + "journal_name": "EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology", + "date": "2021-07-06", + "author": "Piayda K,Sievert K,Della Rocca DG,Adeola OG,Alkhouli M,Yoo D,Benito-González T,Cruz-González I,Galea R,Skurk C,De Backer O,Nielsen-Kudsk JE,Grygier M,Beaty EH,Newton J,Pérez de Prado A,Räber L,Gibson D,Van Niekerk C,Ellis CR,Horton RP,Natale A,Grundwald I,Zeus T,Sievert H", + "auth_pos": 22, + "meshterms": "Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects, Feasibility Studies, Humans, Septal Occluder Device*, Septal Occluder Device/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2290, + "user_id": 1841382421, + "artical_title": "Clinical Presentation, Diagnosis, and Treatment of Atrioesophageal Fistula Resulting from Atrial Fibrillation Ablation.", + "pmid": 34260115, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-07-15", + "author": "Della Rocca DG,Magnocavallo M,Natale VN,Gianni C,Mohanty S,Trivedi C,Lavalle C,Forleo GB,Tarantino N,Romero J,Zhang X,Bassiouny M,Al-Ahmad A,David Burkhardt J,Joseph Gallinghouse G,Sanchez JE,Horton RP,Di Biase L,Natale A", + "auth_pos": 19, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Esophageal Fistula*, Esophageal Fistula/diagnostic imaging, Esophageal Fistula/etiology, Esophageal Fistula/surgery, Heart Atria, Heart Atria/surgery, Humans, Magnetic Resonance Imaging, Tomography, X-Ray Computed", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2291, + "user_id": 1841382421, + "artical_title": "The Subtle Journey of a Right Atrial Lead: Hemopneumothorax Due to Subacute Pacemaker Lead Perforation.", + "pmid": 34317378, + "journal_name": "JACC. Case reports", + "date": "2021-07-29", + "author": "Gianni C,Canby RC,Anannab A,Della Rocca DG,Natale A,Al-Ahmad A", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2292, + "user_id": 1841382421, + "artical_title": "Device-Based Arrhythmia Monitoring.", + "pmid": 34330382, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-08-01", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2293, + "user_id": 1841382421, + "artical_title": "Left Atrial Appendage Occlusion With New Watchman-FLX Device.", + "pmid": 34330451, + "journal_name": "The American journal of cardiology", + "date": "2021-08-01", + "author": "Garg J,Shah K,Shah S,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Atrial Appendage, Atrial Appendage/surgery*, Atrial Fibrillation, Atrial Fibrillation/complications, Atrial Fibrillation/surgery*, Humans, Ischemic Stroke, Ischemic Stroke/epidemiology, Ischemic Stroke/etiology, Ischemic Stroke/prevention & control*, Mortality, Pericardial Effusion, Pericardial Effusion/epidemiology, Postoperative Complications, Postoperative Complications/epidemiology, Thrombosis, Thrombosis/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2294, + "user_id": 1841382421, + "artical_title": "Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation: A Prospective, Multicenter Experience.", + "pmid": 34330671, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-08-01", + "author": "Della Rocca DG,Murtaza G,Di Biase L,Akella K,Krishnan SC,Magnocavallo M,Mohanty S,Gianni C,Trivedi C,Lavalle C,Forleo GB,Natale VN,Tarantino N,Romero J,Gopinathannair R,Patel PJ,Bassiouny M,Del Prete A,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Sanchez JE,Doshi SK,Horton RP,Lakkireddy D,Natale A", + "auth_pos": 26, + "meshterms": "Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cardiac Catheterization, Humans, Prospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2295, + "user_id": 1841382421, + "artical_title": "Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST Registry).", + "pmid": 34339847, + "journal_name": "Heart rhythm", + "date": "2021-08-03", + "author": "Lakkireddy D,Garg J,DeAsmundis C,LaMeier M,Romeya A,Vanmeetren J,Park P,Tummala R,Koerber S,Vasamreddy C,Shah A,Shivamurthy P,Frazier K,Awasthi Y,Chierchia GB,Atkins D,Bommana S,Di Biase L,Al-Ahmad A,Natale A,Gopinathannair R", + "auth_pos": 20, + "meshterms": "Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult, Catheter Ablation, Catheter Ablation/methods*, Epicardial Mapping, Female, Humans, Male, Postoperative Complications, Prospective Studies, Registries, Reoperation, Reoperation/statistics & numerical data, Tachycardia, Sinus, Tachycardia, Sinus/physiopathology, Tachycardia, Sinus/surgery*, Thoracoscopy*, Young Adult", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2296, + "user_id": 1841382421, + "artical_title": "Implantable Cardioverter Defibrillator in Patients with Spontaneous Coronary Artery Dissection presenting with Sudden Cardiac Arrest.", + "pmid": 34379349, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-08-12", + "author": "Garg J,Shah K,Shah S,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left, Adult, Coronary Vessels, Death, Sudden, Cardiac, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable*, Dissection, Female, Heart Arrest*, Heart Arrest/diagnosis, Heart Arrest/therapy, Humans, Male, Middle Aged, Pregnancy, Risk Assessment, Risk Factors, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2297, + "user_id": 1841382421, + "artical_title": "SafeTy and Efficacy of Direct Oral Anticoagulant versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT).", + "pmid": 34393085, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2021-08-17", + "author": "Lakkireddy D,Shenthar J,Garg J,Padmanabhan D,Gopinathannair R,Di Biase L,Romero J,Mohanty S,Burkhardt DJ,Al-Ahmad A,Atkins D,Bommana S,Natale A", + "auth_pos": 13, + "meshterms": "Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery, Anticoagulants, Aspirin, Aspirin/adverse effects, Catheter Ablation*, Catheter Ablation/adverse effects, Endocardium, Endocardium/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/epidemiology, Tachycardia, Ventricular/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2298, + "user_id": 1841382421, + "artical_title": "Decreased biventricular pacing with high burden PVCs, what is the cause?", + "pmid": 34405483, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-08-19", + "author": "Gianni C,Burkhardt JD,Natale A,Al-Ahmad A", + "auth_pos": 3, + "meshterms": "Atrial Flutter*, Cardiac Pacing, Artificial, Cardiac Resynchronization Therapy*, Electrocardiography, Humans, Ventricular Premature Complexes*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2299, + "user_id": 1841382421, + "artical_title": "Intracardiac echocardiography- vs transesophageal echocardiography-guided left atrial appendage occlusion with Watchman FLX.", + "pmid": 34411376, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-08-20", + "author": "Gianni C,Horton RP,Della Rocca DG,Mohanty S,Al-Ahmad A,Bassiouny MA,David Burkhardt J,Joseph Gallinghouse G,Hranitzky PM,Sanchez JE,Natale A", + "auth_pos": 11, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Cohort Studies, Echocardiography, Transesophageal, Humans, Treatment Outcome, Ultrasonography, Interventional", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2300, + "user_id": 1841382421, + "artical_title": "Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry.", + "pmid": 34417816, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2021-08-22", + "author": "Della Rocca DG,Di Biase L,Mohanty S,Trivedi C,Gianni C,Romero J,Tarantino N,Magnocavallo M,Bassiouny M,Natale VN,Mayedo AQ,Macdonald B,Lavalle C,Murtaza G,Akella K,Forleo GB,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Sanchez JE,Horton RP,Viles-Gonzalez JF,Lakkireddy D,Natale A", + "auth_pos": 24, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2301, + "user_id": 1841382421, + "artical_title": "Lessons learned from experimental models of cerebrovascular aneurysms to improve endocardial device occlusion of the left atrial appendage.", + "pmid": 34430948, + "journal_name": "Heart rhythm O2", + "date": "2021-08-26", + "author": "Krishnan SC,Natale A", + "auth_pos": 2, + "meshterms": "Coil embolization*, Embolic Coils*, Embolic Coils*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2302, + "user_id": 1841382421, + "artical_title": "Wide-area antral pulmonary vein and posterior wall isolation by way of segmental nonocclusive applications using a novel radiofrequency ablation balloon.", + "pmid": 34434698, + "journal_name": "HeartRhythm case reports", + "date": "2021-08-27", + "author": "Aryana A,Allen SL,Di Biase L,Bowers MR,O'Neill PG,Natale A", + "auth_pos": 6, + "meshterms": "Balloon Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2303, + "user_id": 1841382421, + "artical_title": "His-bundle pacing following transcatheter aortic valve replacement.", + "pmid": 34435679, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2021-08-27", + "author": "Garg J,Shah S,Shah K,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 5, + "meshterms": "Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*, Bundle of His, Bundle of His/physiopathology*, Bundle-Branch Block, Bundle-Branch Block/physiopathology*, Bundle-Branch Block/therapy*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods*, Humans, Postoperative Complications, Postoperative Complications/physiopathology*, Postoperative Complications/therapy*, Transcatheter Aortic Valve Replacement*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2304, + "user_id": 1841382421, + "artical_title": "Rhythm- Versus Rate-Control in Atrial Fibrillation-ELECTRAM Investigators.", + "pmid": 34491956, + "journal_name": "American journal of therapeutics", + "date": "2021-09-08", + "author": "Garg J,Shah K,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 4, + "meshterms": "Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2305, + "user_id": 1841382421, + "artical_title": "Ventricular Arrhythmias in Athletes: Role of a Comprehensive Diagnostic Workup.", + "pmid": 34536590, + "journal_name": "Heart rhythm", + "date": "2021-09-19", + "author": "Dello Russo A,Compagnucci P,Casella M,Gasperetti A,Riva S,Dessanai MA,Pizzamiglio F,Catto V,Guerra F,Stronati G,Andreini D,Pontone G,Bonomi A,Rizzo S,Di Biase L,Capucci A,Natale A,Basso C,Fiorentini C,Zeppilli P,Tondo C", + "auth_pos": 17, + "meshterms": "Adult, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Dysplasia/diagnosis*, Arrhythmogenic Right Ventricular Dysplasia/physiopathology, Athletes*, Biopsy, Electrophysiologic Techniques, Cardiac, Electrophysiologic Techniques, Cardiac/methods*, Female, Humans, Male, Retrospective Studies, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis*, Tachycardia, Ventricular/physiopathology, Adult, Arrhythmogenic Right Ventricular Dysplasia, Arrhythmogenic Right Ventricular Dysplasia/diagnosis*, Arrhythmogenic Right Ventricular Dysplasia/physiopathology, Athletes*, Biopsy, Electrophysiologic Techniques, Cardiac, Electrophysiologic Techniques, Cardiac/methods*, Female, Humans, Male, Retrospective Studies, Tachycardia, Ventricular, Tachycardia, Ventricular/diagnosis*, Tachycardia, Ventricular/physiopathology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2306, + "user_id": 1841382421, + "artical_title": "Evaluation of a Novel Cardiac Signal Processing System for Electrophysiology Procedures: The PURE EP 2.0 Study.", + "pmid": 34554634, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-09-24", + "author": "Al-Ahmad A,Knight B,Tzou W,Schaller R,Yasin O,Padmanabhan D,Zagrodzky J,Bassiouny M,David Burkhardt J,Joseph Gallinghouse G,Mansour M,McLeod C,Natale A", + "auth_pos": 13, + "meshterms": "Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Cardiac Electrophysiology*, Catheter Ablation*, Electrophysiologic Techniques, Cardiac, Heart, Humans, Prospective Studies, Signal Processing, Computer-Assisted, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2307, + "user_id": 1841382421, + "artical_title": "Endomyocardial Biopsy: The Forgotten Piece in the Arrhythmogenic Cardiomyopathy Puzzle.", + "pmid": 34569251, + "journal_name": "Journal of the American Heart Association", + "date": "2021-09-28", + "author": "Casella M,Bergonti M,Dello Russo A,Maragna R,Gasperetti A,Compagnucci P,Catto V,Trombara F,Frappampina A,Conte E,Fogante M,Sommariva E,Rizzo S,De Gaspari M,Giovagnoni A,Andreini D,Pompilio G,Di Biase L,Natale A,Basso C,Tondo C", + "auth_pos": 19, + "meshterms": "Arrhythmogenic Right Ventricular Dysplasia*, Arrhythmogenic Right Ventricular Dysplasia/diagnosis, Biopsy, Cardiac Catheterization, Humans, Myocardium*, Arrhythmogenic Right Ventricular Dysplasia*, Arrhythmogenic Right Ventricular Dysplasia/diagnosis, Biopsy, Cardiac Catheterization, Humans, Myocardium*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2308, + "user_id": 1841382421, + "artical_title": "Intraprocedural PRAETORIAN score for early assessment of S-ICD implantation: a proof-of-concept study.", + "pmid": 34582055, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2021-09-29", + "author": "Gasperetti A,Schiavone M,Biffi M,Casella M,Compagnucci P,Mitacchione G,Angeletti A,Vogler J,Proietti R,Ziacchi M,Russo AD,Natale A,Tilz RR,Forleo GB", + "auth_pos": 12, + "meshterms": "Cohort Studies, Defibrillators, Implantable*, Humans, Proof of Concept Study, Prosthesis Implantation, Prosthesis Implantation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2309, + "user_id": 1841382421, + "artical_title": "Recovery of Conduction Following High-Power Short-Duration Ablation in Patients With Atrial Fibrillation: A Single-Center Experience.", + "pmid": 34583523, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2021-09-30", + "author": "Mohanty S,Trivedi C,Della Rocca DG,Gianni C,MacDonald B,Quintero Mayedo A,Al-Ahmad A,Burkhardt JD,Bassiouny M,Gallinghouse GJ,Horton R,Di Biase L,Natale A", + "auth_pos": 13, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome, Aged, Atrial Fibrillation, Atrial Fibrillation/physiopathology*, Atrial Fibrillation/surgery, Catheter Ablation, Catheter Ablation/methods*, Electrocardiography*, Female, Follow-Up Studies, Heart Conduction System, Heart Conduction System/physiopathology*, Humans, Male, Middle Aged, Prospective Studies, Recovery of Function, Recovery of Function/physiology*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2310, + "user_id": 1841382421, + "artical_title": "Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion.", + "pmid": 34656496, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2021-10-18", + "author": "Della Rocca DG,Magnocavallo M,Di Biase L,Mohanty S,Trivedi C,Tarantino N,Gianni C,Lavalle C,Van Niekerk CJ,Romero J,Briceño DF,Bassiouny M,Al-Ahmad A,Burkhardt JD,Natale VN,Gallinghouse GJ,Del Prete A,Forleo GB,Sanchez J,Lakkireddy D,Horton RP,Gibson DN,Natale A", + "auth_pos": 23, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Female, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Humans, Male, Stroke*, Stroke/diagnosis, Stroke/etiology, Stroke/prevention & control, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2311, + "user_id": 1841382421, + "artical_title": "Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article.", + "pmid": 34674120, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2021-10-22", + "author": "Etaee F,Tobin M,Vuppala S,Komaki A,Delisle BP,Di Biase L,Catanzaro JN,Natale A,Elayi CS", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2312, + "user_id": 1841382421, + "artical_title": "New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation.", + "pmid": 34688719, + "journal_name": "International journal of cardiology", + "date": "2021-10-25", + "author": "Di Lullo L,Lavalle C,Magnocavallo M,Mariani MV,Della Rocca DG,Severino P,Di Iorio BR,Russo D,Summaria F,Forleo GB,Ronco C,Mancone M,Chimenti C,Miraldi F,Natale A,Bellasi A", + "auth_pos": 15, + "meshterms": "Anticoagulants*, Anticoagulants/adverse effects, Atrial Fibrillation*, Calcinosis*, Factor Xa Inhibitors, Heart Valves*, Heart Valves/pathology, Humans, Inflammation*, Inflammation/drug therapy, Kidney, Kidney/physiology, Prospective Studies, Rivaroxaban, Stroke*, Treatment Outcome, Warfarin, Warfarin/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2313, + "user_id": 1841382421, + "artical_title": "Cardiac Conduction System Disorders.", + "pmid": 34689902, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2021-10-26", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Arrhythmias, Cardiac*, Heart Conduction System*, Humans, Arrhythmias, Cardiac*, Heart Conduction System*, Humans", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2314, + "user_id": 1841382421, + "artical_title": "RETRACTED:B-PO04-095 ESOPHAGEAL TEMPERATURE MONITORING DURING ATRIAL FIBRILLATION ABLATION WITH THE PULSED FIELD ABLATION SYSTEM.", + "pmid": 34736718, + "journal_name": "Heart rhythm", + "date": "2021-11-06", + "author": "Natale A,Della Rocca DG,Gianni C,Trivedi CG,Al-Ahmad A,Bassiouny MA,Gallinghouse GJ,Horton RP,Burkhardt JD,Biase LD,Mohanty S", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2315, + "user_id": 1841382421, + "artical_title": "RETRACTED:B-AB03-04 CEREBRAL MICROEMBOLIC SIGNAL BURDEN DURING PULSED FILED ABLATION: PRELIMINARY RESULTS FROM ROBOTICALLY ASSISTED TRANSCRANIAL DOPPLER.", + "pmid": 34736719, + "journal_name": "Heart rhythm", + "date": "2021-11-06", + "author": "Natale A,Della Rocca DG,Gianni C,Trivedi CG,Horton RP,Bassiouny MA,Al-Ahmad A,Joseph Gallinghouse G,David Burkhardt J,Di Biase L,Mohanty S", + "auth_pos": 1, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2316, + "user_id": 1841382421, + "artical_title": "Cardiac Resynchronization Therapy in continuous flow Left Ventricular Assist Device Recipients: A Systematic Review and Meta-analysis from ELECTRAM Investigators.", + "pmid": 34950326, + "journal_name": "Journal of atrial fibrillation", + "date": "2021-12-25", + "author": "Shah K,Karpe V,K Turagam M,Shah M,Natale A,Gopinathannair R,Lakkireddy D,Garg J", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2317, + "user_id": 1841382421, + "artical_title": "Temperature-Controlled Catheter Ablation for Paroxysmal Atrial Fibrillation: the QDOT-MICRO Workflow Sttudy.", + "pmid": 34950350, + "journal_name": "Journal of atrial fibrillation", + "date": "2021-12-25", + "author": "Potter T,Grimaldi M,Jensen HK,Kautzner J,Neuzil P,Vijgen J,Natale A,Kristiansen SB,Lukac P,Peichl P,Y Reddy V", + "auth_pos": 7, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2318, + "user_id": 1841382421, + "artical_title": "Same Day versus Overnight Discharge in Patients Undergoing Ablation for Atrial Fibrillation (SODA) Study.", + "pmid": 34950374, + "journal_name": "Journal of atrial fibrillation", + "date": "2021-12-25", + "author": "Bailey SA,Subramanian K,Sanchez J,P Horton R,Natale A,Thambidorai S", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2319, + "user_id": 1841382421, + "artical_title": "First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial.", + "pmid": 34964367, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2021-12-30", + "author": "Verma A,Boersma L,Haines DE,Natale A,Marchlinski FE,Sanders P,Calkins H,Packer DL,Hummel J,Onal B,Rosen S,Kuck KH,Hindricks G,Wilsmore B", + "auth_pos": 4, + "meshterms": "Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States, Aged, Atrial Fibrillation, Atrial Fibrillation/diagnosis, Atrial Fibrillation/physiopathology, Atrial Fibrillation/surgery*, Australia, Canada, Catheter Ablation*, Catheter Ablation/adverse effects, Feasibility Studies, Female, Humans, Male, Middle Aged, Netherlands, Operative Time, Pilot Projects, Prospective Studies, Pulmonary Veins, Pulmonary Veins/physiopathology, Pulmonary Veins/surgery*, Time Factors, Treatment Outcome, United States", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2320, + "user_id": 1841382421, + "artical_title": "Implantable cardioverter-defibrillator-related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience.", + "pmid": 34988518, + "journal_name": "Heart rhythm O2", + "date": "2022-01-07", + "author": "Ravichandran A,Pothineni NVK,Trivedi JR,Roukoz H,Ahmed MM,Bhan A,Bhat G,Cowger J,Al Ahmad A,Natale A,Di Biase L,Slaughter MS,Lakkireddy D,Gopinathannair R", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2321, + "user_id": 1841382421, + "artical_title": "Reply: Half-Dose Direct Oral Anticoagulants after Left Atrial Appendage Occlusion.", + "pmid": 34991818, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-01-08", + "author": "Della Rocca DG,Natale A", + "auth_pos": 2, + "meshterms": "Anticoagulants, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/drug therapy, Humans, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2322, + "user_id": 1841382421, + "artical_title": "Racial and Ethnic Differences in the Management of Atrial Fibrillation.", + "pmid": 34993443, + "journal_name": "CJC open", + "date": "2022-01-08", + "author": "Tamirisa KP,Al-Khatib SM,Mohanty S,Han JK,Natale A,Gupta D,Russo AM,Al-Ahmad A,Gillis AM,Thomas KL", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2323, + "user_id": 1841382421, + "artical_title": "Left atrial appendage closure in patients with intracranial hemorrhage.", + "pmid": 35107719, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2022-02-03", + "author": "Garg J,Shah S,Shah K,Bhardwaj R,Contractor T,Mandapati R,Turagam MK,Natale A,Lakkireddy D", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2324, + "user_id": 1841382421, + "artical_title": "Impact of Catheter Ablation on Quality of Life and Healthcare Utilisation.", + "pmid": 35106178, + "journal_name": "Arrhythmia & electrophysiology review", + "date": "2022-02-03", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2325, + "user_id": 1841382421, + "artical_title": "Zero contrast left atrial appendage occlusion and peridevice leak closure in patients with advanced kidney disease.", + "pmid": 35124231, + "journal_name": "Heart rhythm", + "date": "2022-02-07", + "author": "Magnocavallo M,Della Rocca DG,Gianni C,Zagrodzky W,Lavalle C,Mohanty S,Chimenti C,Al-Ahmad A,Di Biase L,Horton RP,Natale A", + "auth_pos": 11, + "meshterms": "Anticoagulants, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Cardiac Catheterization, Echocardiography, Transesophageal, Humans, Kidney Diseases*, Septal Occluder Device*, Stroke*, Treatment Outcome, Anticoagulants, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Cardiac Catheterization, Echocardiography, Transesophageal, Humans, Kidney Diseases*, Septal Occluder Device*, Stroke*, Treatment Outcome, Anticoagulants, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Cardiac Catheterization, Echocardiography, Transesophageal, Humans, Kidney Diseases*, Septal Occluder Device*, Stroke*, Treatment Outcome, Anticoagulants, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Cardiac Catheterization, Echocardiography, Transesophageal, Humans, Kidney Diseases*, Septal Occluder Device*, Stroke*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2326, + "user_id": 1841382421, + "artical_title": "Cryoballoon Ablation of the Pulmonary Veins, the Posterior Wall, the Left Atrial Appendage, and the Mitral Isthmus Guided by Intracardiac Echocardiography-integrated and Three-dimensional Mapping.", + "pmid": 35127241, + "journal_name": "The Journal of innovations in cardiac rhythm management", + "date": "2022-02-08", + "author": "Aryana A,Lafortune P,Di Biase L,Natale A", + "auth_pos": 4, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2327, + "user_id": 1841382421, + "artical_title": "Reply: Half-Dose DOAC After Watchman Implantation.", + "pmid": 35144792, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-02-12", + "author": "Della Rocca DG,Natale A", + "auth_pos": 2, + "meshterms": "Atrial Appendage*, Atrial Fibrillation*, Humans, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2328, + "user_id": 1841382421, + "artical_title": "ORIGINAL ARTICLESCatheter Ablation For Papillary Muscle Arrhythmias A Systematic Review.", + "pmid": 35147225, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2022-02-12", + "author": "Mariani MV,Piro A,Magnocavallo M,Chimenti C,Della Rocca D,Santangeli P,Natale A,Fedele F,Lavalle C", + "auth_pos": 7, + "meshterms": "Catheter Ablation*, Catheter Ablation/methods, Heart Ventricles, Humans, Papillary Muscles, Papillary Muscles/surgery, Tachycardia, Ventricular*, Treatment Outcome, Ventricular Premature Complexes*, Catheter Ablation*, Catheter Ablation/methods, Heart Ventricles, Humans, Papillary Muscles, Papillary Muscles/surgery, Tachycardia, Ventricular*, Treatment Outcome, Ventricular Premature Complexes*, Catheter Ablation*, Catheter Ablation/methods, Heart Ventricles, Humans, Papillary Muscles, Papillary Muscles/surgery, Tachycardia, Ventricular*, Treatment Outcome, Ventricular Premature Complexes*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2329, + "user_id": 1841382421, + "artical_title": "Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis.", + "pmid": 35158089, + "journal_name": "Heart rhythm", + "date": "2022-02-15", + "author": "Della Rocca DG,Magnocavallo M,Gianni C,Mohanty S,Natale VN,Al-Ahmad A,Lavalle C,Horton RP,Biase LD,Natale A", + "auth_pos": 10, + "meshterms": "Atrial Appendage*, Atrial Fibrillation*, Cardiac Catheterization, Follow-Up Studies, Humans, Septal Occluder Device*, Stroke*, Treatment Outcome, Atrial Appendage*, Atrial Fibrillation*, Cardiac Catheterization, Follow-Up Studies, Humans, Septal Occluder Device*, Stroke*, Treatment Outcome, Atrial Appendage*, Atrial Fibrillation*, Cardiac Catheterization, Follow-Up Studies, Humans, Septal Occluder Device*, Stroke*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2330, + "user_id": 1841382421, + "artical_title": "Electrocardiographic Features of Patients with COVID-19: An Updated Review.", + "pmid": 35221086, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Romero J,Gabr M,Diaz JC,Purkayastha S,Gamero MT,Reynbakh O,Matias J,Alviz I,Velasco A,Della Rocca DG,Mohanty S,Lin A,Zou F,Natale A,Di Biase L", + "auth_pos": 14, + "meshterms": "COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2, COVID-19*, Electrocardiography, Humans, Myocardial Infarction*, Myocarditis*, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2331, + "user_id": 1841382421, + "artical_title": "Arrhythmic and Vascular Complications of Coronavirus Disease 2019.", + "pmid": 35221090, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Della Rocca DG,Forleo GB,Natale A", + "auth_pos": 3, + "meshterms": "COVID-19*, COVID-19/complications, Cardiovascular Diseases*, Humans, SARS-CoV-2", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2332, + "user_id": 1841382421, + "artical_title": "Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients.", + "pmid": 35221076, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Magnocavallo M,Vetta G,Della Rocca DG,Gianni C,Mohanty S,Bassiouny M,Di Lullo L,Del Prete A,Cirone D,Lavalle C,Chimenti C,Al-Ahmad A,Burkhardt JD,Gallinghouse GJ,Sanchez JE,Horton RP,Di Biase L,Natale A", + "auth_pos": 18, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2333, + "user_id": 1841382421, + "artical_title": "Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients.", + "pmid": 35221078, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Tarantino N,Della Rocca DG,Zou F,Lin A,Natale A,Di Biase L", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2334, + "user_id": 1841382421, + "artical_title": "Coronavirus Disease-19 Testing Strategies for Patients and Health Care Workers to Improve Workplace Safety.", + "pmid": 35221079, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Mohanty S,Garcia U,MacDonald B,Mayedo A,Della Rocca DG,Gianni C,Udenyi P,Zagrodzky W,Shetty S,Natale A", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2335, + "user_id": 1841382421, + "artical_title": "COVID-19, Acute Myocardial Injury, and Infarction.", + "pmid": 35221083, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-03-01", + "author": "Del Prete A,Conway F,Della Rocca DG,Biondi-Zoccai G,De Felice F,Musto C,Picichè M,Martuscelli E,Natale A,Versaci F", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2336, + "user_id": 1841382421, + "artical_title": "Leak closure following left atrial appendage exclusion procedures: A multicenter registry.", + "pmid": 35233927, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2022-03-03", + "author": "Killu AM,Gbolabo Adeola O,Della Rocca DG,Ellis C,Sugrue AM,Simard T,Friedman PA,Kawsara A,Horton RP,Natale A,Alkhouli M,Holmes DR", + "auth_pos": 10, + "meshterms": "Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Aged, Aged, 80 and over, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Cardiac Catheterization, Female, Humans, Male, Middle Aged, Registries, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Treatment Outcome, Embolic Coils*, Specialty Coils*, Embolic Coils*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2337, + "user_id": 1841382421, + "artical_title": "Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.", + "pmid": 35245370, + "journal_name": "European heart journal", + "date": "2022-03-05", + "author": "Roselli C,Yu M,Nauffal V,Georges A,Yang Q,Love K,Weng LC,Delling FN,Maurya SR,Schrölkamp M,Tfelt-Hansen J,Hagège A,Jeunemaitre X,Debette S,Amouyel P,Guan W,Muehlschlegel JD,Body SC,Shah S,Samad Z,Kyryachenko S,Haynes C,Rienstra M,Le Tourneau T,Probst V,Roussel R,Wijdh-Den Hamer IJ,Siland JE,Knowlton KU,Jacques Schott J,Levine RA,Benjamin EJ,Vasan RS,Horne BD,Muhlestein JB,Benfari G,Enriquez-Sarano M,Natale A,Mohanty S,Trivedi C,Shoemaker MB,Yoneda ZT,Wells QS,Baker MT,Farber-Eger E,Michelena HI,Lundby A,Norris RA,Slaugenhaupt SA,Dina C,Lubitz SA,Bouatia-Naji N,Ellinor PT,Milan DJ", + "auth_pos": 38, + "meshterms": "Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors, Adult, Genetic Loci, Genetic Loci/genetics, Genome-Wide Association Study, Humans, Latent TGF-beta Binding Proteins, Latent TGF-beta Binding Proteins/genetics, Mitral Valve Prolapse*, Mitral Valve Prolapse/genetics, Proteomics, Risk Factors", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2338, + "user_id": 1841382421, + "artical_title": "Endocardial Scar-Homogenization With Vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy.", + "pmid": 35246406, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2022-03-06", + "author": "Mohanty S,Trivedi C,Di Biase L,Burkhardt JD,Della Rocca DG,Gianni C,MacDonald B,Mayedo A,Shetty SS,Zagrodzky W,Baqai F,Bassiouny M,Gallinghouse GJ,Horton R,Al-Ahmad A,Natale A", + "auth_pos": 16, + "meshterms": "Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome, Cardiomyopathies*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Cicatrix/etiology, Endocardium, Endocardium/surgery, Humans, Myocardial Ischemia*, Myocardial Ischemia/complications, Myocardial Ischemia/surgery, Tachycardia, Ventricular*, Tachycardia, Ventricular/complications, Tachycardia, Ventricular/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2339, + "user_id": 1841382421, + "artical_title": "Higher Hospitalization Rate and Impaired Quality of Life in the Presence of Severe Tricuspid Regurgitation in Patients With Newly Diagnosed Atrial Fibrillation: Is the Risk Real?", + "pmid": 35383464, + "journal_name": "Journal of the American Heart Association", + "date": "2022-04-07", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Heart Atria, Hospitalization, Humans, Quality of Life, Tricuspid Valve Insufficiency*, Tricuspid Valve Insufficiency/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2340, + "user_id": 1841382421, + "artical_title": "Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study.", + "pmid": 35407408, + "journal_name": "Journal of clinical medicine", + "date": "2022-04-13", + "author": "Compagnucci P,Dello Russo A,Bergonti M,Anselmino M,Zucchelli G,Gasperetti A,Cipolletta L,Volpato G,Ascione C,Ferraris F,Valeri Y,Bongiorni MG,Natale A,Tondo C,De Ferrari GM,Casella M", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2341, + "user_id": 1841382421, + "artical_title": "Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers.", + "pmid": 35428582, + "journal_name": "Heart rhythm", + "date": "2022-04-17", + "author": "Sandhu RK,Seiler A,Johnson CJ,Bunch TJ,Deering TF,Deneke T,Kirchhof P,Natale A,Piccini JP,Russo AM,Hills MT,Varosy PD,Araia A,Smith AM,Freeman J", + "auth_pos": 8, + "meshterms": "Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires, Anticoagulants, Anticoagulants/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/complications, Hemorrhage, Hemorrhage/chemically induced, Humans, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Surveys and Questionnaires", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2342, + "user_id": 1841382421, + "artical_title": "Letter by Natale et al Regarding Article, \"Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial\".", + "pmid": 35467955, + "journal_name": "Circulation", + "date": "2022-04-26", + "author": "Natale A,Kar S,Holmes D", + "auth_pos": 1, + "meshterms": "Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control, Atrial Appendage*, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Humans, Septal Occluder Device*, Stroke*, Stroke/etiology, Stroke/prevention & control", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2343, + "user_id": 1841382421, + "artical_title": "Impact of digital monitoring on compliance and outcome of lifestyle-change measures in patients with coexistent atrial fibrillation and obesity.", + "pmid": 35493269, + "journal_name": "Cardiovascular digital health journal", + "date": "2022-05-03", + "author": "Mohanty S,Trivedi C,Della Rocca DG,Gianni C,MacDonald B,Mayedo A,Shetty S,Natale E,Burkhardt JD,Bassiouny M,Gallinghouse GJ,Horton R,Al-Ahmad A,Natale A", + "auth_pos": 14, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2344, + "user_id": 1841382421, + "artical_title": "In-vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed-field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications.", + "pmid": 35510408, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2022-05-06", + "author": "Hsu JC,Gibson D,Banker R,Doshi SK,Gidney B,Gomez T,Berman D,Datta K,Govari A,Natale A", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2345, + "user_id": 1841382421, + "artical_title": "The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.", + "pmid": 35550691, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-05-14", + "author": "Camm AJ,Naccarelli GV,Mittal S,Crijns HJGM,Hohnloser SH,Ma CS,Natale A,Turakhia MP,Kirchhof P", + "auth_pos": 7, + "meshterms": "Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Atrial Fibrillation/therapy, Atrial Remodeling*, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2346, + "user_id": 1841382421, + "artical_title": "Transesophageal Echocardiography Following Left Atrial Appendage Electrical Isolation: Diagnostic Pitfalls and Clinical Implications.", + "pmid": 35617267, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2022-05-27", + "author": "Gianni C,Sanchez JE,Chen Q,Della Rocca DG,Mohanty S,Trivedi C,Al-Ahmad A,Bassiouny MA,Burkhardt JD,Gallinghouse GJ,Horton RP,Hranitzky PM,Romero JE,Di Biase L,Garcia MJ,Natale A", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2347, + "user_id": 1841382421, + "artical_title": "Amiodarone Use and All-Cause Mortality in Patients With a Continuous-Flow Left Ventricular Assist Device.", + "pmid": 35656998, + "journal_name": "Journal of the American Heart Association", + "date": "2022-06-04", + "author": "Gopinathannair R,Pothineni NVK,Trivedi JR,Roukoz H,Cowger J,Ahmed MM,Bhan A,K Ravichandran A,Bhat G,Al Ahmad A,Natale A,Di Biase L,Slaughter MS,Lakkireddy D", + "auth_pos": 11, + "meshterms": "Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome, Amiodarone*, Amiodarone/adverse effects, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/therapy, Female, Heart Failure*, Heart-Assist Devices*, Heart-Assist Devices/adverse effects, Humans, Male, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2348, + "user_id": 1841382421, + "artical_title": "Advances in Physiologic Pacing.", + "pmid": 35715091, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2022-06-18", + "author": "Thakur RK,Natale A", + "auth_pos": 2, + "meshterms": "Cardiac Pacing, Artificial*, Humans, Pacemaker, Artificial*, Cardiac Pacing, Artificial*, Humans, Pacemaker, Artificial*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2349, + "user_id": 1841382421, + "artical_title": "Fluoroless Versus Conventional Mapping and Ablation of Ventricular Arrhythmias Arising From the Left Ventricular Summit and Interventricular Septum.", + "pmid": 35759380, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2022-06-28", + "author": "Romero J,Velasco A,Díaz JC,Alviz I,Briceno D,Grushko M,Palma E,Ferrick K,Parashar A,Bello J,Zhang X,Gabr M,Purkayastha S,Polanco D,Grupposo V,Della Rocca D,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 18, + "meshterms": "Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Treatment Outcome, Ventricular Septum*, Ventricular Septum/diagnostic imaging, Ventricular Septum/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2350, + "user_id": 1841382421, + "artical_title": "Improved Survival in Patients with Atrial Fibrillation and Heart Failure Undergoing Catheter Ablation Compared to Medical Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.", + "pmid": 35842804, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2022-07-18", + "author": "Romero J,Gabr M,Alviz I,Briceno D,Diaz JC,Rodriguez D,Patel K,Polanco D,Trivedi C,Mohanty S,Della Rocca D,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 13, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Stroke Volume, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Ventricular Function, Left, Treatment Outcome, Randomized Controlled Trials as Topic, Catheter Ablation*, Catheter Ablation/methods, Heart Failure*, Heart Failure/diagnosis, Heart Failure/therapy", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2351, + "user_id": 1841382421, + "artical_title": "Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.", + "pmid": 35902169, + "journal_name": "Journal of the American College of Cardiology", + "date": "2022-07-29", + "author": "Dukkipati SR,Holmes DR,Doshi SK,Kar S,Singh SM,Gibson D,Price MJ,Natale A,Mansour M,Sievert H,Houle VM,Allocco DJ,Reddy VY", + "auth_pos": 8, + "meshterms": "Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use, Aged, Aged, 80 and over, Anticoagulants, Anticoagulants/therapeutic use, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/surgery, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Echocardiography, Transesophageal/adverse effects, Embolism*, Embolism/epidemiology, Embolism/etiology, Embolism/prevention & control, Female, Humans, Male, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Thromboembolism*, Thromboembolism/etiology, Treatment Outcome, Warfarin, Warfarin/therapeutic use", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2352, + "user_id": 1841382421, + "artical_title": "Catheter Ablation for Atrial Fibrillation in Adult Congenital Heart Disease: An International Multicenter Registry Study.", + "pmid": 36074954, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2022-09-09", + "author": "Griffiths JR,Nussinovitch U,Liang JJ,Sims R,Yoneda ZT,Bernstein HM,Viswanathan MN,Khairy P,Srivatsa UN,Frankel DS,Marchlinski FE,Sandhu A,Shoemaker MB,Mohanty S,Burkhardt JD,Natale A,Lakireddy D,De Groot NMS,Gerstenfeld EP,Moore JP,Ávila P,Ernst S,Nguyen DT", + "auth_pos": 16, + "meshterms": "Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Adult, Aged, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Child, Female, Heart Defects, Congenital*, Heart Defects, Congenital/complications, Humans, Male, Middle Aged, Pulmonary Veins*, Pulmonary Veins/surgery, Registries, Retrospective Studies, Transposition of Great Vessels*, Treatment Outcome, Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2353, + "user_id": 1841382421, + "artical_title": "Composite Index Tagging for PVI in Paroxysmal AF: A Prospective, Multicenter Postapproval Study.", + "pmid": 36137711, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2022-09-23", + "author": "Di Biase L,Monir G,Melby D,Tabereaux P,Natale A,Manyam H,Athill C,Delaughter C,Patel A,Gentlesk P,Liu C,Arkles J,McElderry HT,Osorio J", + "auth_pos": 5, + "meshterms": "Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/methods, Humans, Prospective Studies, Reproducibility of Results, Tachycardia, Tachycardia/surgery, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2354, + "user_id": 1841382421, + "artical_title": "Anatomical considerations and clinical interpretation of the 12-lead ECG in the prone position: a prospective multicentre study.", + "pmid": 36196043, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2022-10-06", + "author": "Romero J,Garcia M,Diaz JC,Gabr M,Rodriguez-Taveras J,Braunstein ED,Purkayastha S,Gamero MT,Alviz I,Marín J,Aristizábal J,Reynbakh O,Peralta AO,Duque M,Dave KP,Rodriguez D,Nino C,Briceno D,Velasco A,Ferrick K,Slipczuk L,Natale A,Di Biase L", + "auth_pos": 22, + "meshterms": "Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart, Humans, Prone Position, Prospective Studies, Electrocardiography*, Electrocardiography/methods, Patient Positioning*, Heart", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2355, + "user_id": 1841382421, + "artical_title": "Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: a metanalysis.", + "pmid": 36214206, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2022-10-11", + "author": "Vetta G,Parlavecchio A,Magnocavallo M,Valente D,Caminiti R,Polselli M,Vetta F,Cirone D,Cauti FM,Crea P,Rossi P,Chierchia GB,Bianchi S,Asmundis C,Natale A,Rocca DGD", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2356, + "user_id": 1841382421, + "artical_title": "Catheter Ablation versus Medical Therapy of Atrial Fibrillation in Patients with Heart Failure: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.", + "pmid": 36233407, + "journal_name": "Journal of clinical medicine", + "date": "2022-10-15", + "author": "Magnocavallo M,Parlavecchio A,Vetta G,Gianni C,Polselli M,De Vuono F,Pannone L,Mohanty S,Cauti FM,Caminiti R,Miraglia V,Monaco C,Chierchia GB,Rossi P,Di Biase L,Bianchi S,de Asmundis C,Natale A,Della Rocca DG", + "auth_pos": 18, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2357, + "user_id": 1841382421, + "artical_title": "Contact force catheter ablation for the treatment of Persistent Atrial Fibrillation: Results from the Persist-End Study.", + "pmid": 36352771, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2022-11-11", + "author": "Lo M,Nair D,Mansour M,Calkins H,Reddy VY,Colley BJ,Tanaka-Esposito C,Sundaram S,DeLurgio DB,Sanders P,Khatib S,Bernard M,Olson N,Gibson D,Miller A,Li J,Natale A", + "auth_pos": 17, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Quality of Life, Prospective Studies, Heart Conduction System, Atrial Flutter*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Treatment Outcome, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2358, + "user_id": 1841382421, + "artical_title": "Evaluation of Multimodality LAA Leak Closure Methods Following Incomplete Occlusion: The LAA Leak Study.", + "pmid": 36357020, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2022-11-11", + "author": "Charate R,Ahmed A,Della Rocca DG,Bloom S,Garg J,Pothineni NVK,DiBiase L,Turagam M,Gopinathannair R,Horton R,Kar S,Fontana G,Doshi SK,Swarup V,Finn A,Reddy V,Natale A,Lakkireddy D", + "auth_pos": 17, + "meshterms": "Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Male, Humans, Middle Aged, Aged, Aged, 80 and over, Female, Atrial Appendage*, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Treatment Outcome, Septal Occluder Device*, Echocardiography, Transesophageal, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Embolic Coils*, Embolic Coils*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2359, + "user_id": 1841382421, + "artical_title": "Prevalence of atrial fibrillation and procedural outcome in patients undergoing catheter ablation for premature ventricular complexes.", + "pmid": 36378783, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2022-11-16", + "author": "Zou F,Di Biase L,Mohanty S,Zhang XD,Shetty SS,Gianni C,Della Rocca DG,Lin A,Arosio R,Schiavone M,Forleo G,Mayedo A,MacDonald B,Al-Ahmad A,Bassiouny M,Joseph Gallinghouse G,Horton R,Burkhardt JD,Natale A", + "auth_pos": 19, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Treatment Outcome, Prevalence, Stroke Volume, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/epidemiology, Ventricular Premature Complexes/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2360, + "user_id": 1841382421, + "artical_title": "3-Dimensional Intracardiac Echocardiography-Guided Percutaneous Closure of a Residual Leak via Radiofrequency Applications After LAAO.", + "pmid": 36543517, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2022-12-22", + "author": "Della Rocca DG,Gianni C,Magnocavallo M,Mohanty S,Al-Ahmad A,Tschopp DR,Burkhardt JD,Di Biase L,Horton RP,Natale A", + "auth_pos": 10, + "meshterms": "Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*, Humans, Heart, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Fibrillation*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2361, + "user_id": 1841382421, + "artical_title": "Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States.", + "pmid": 36589917, + "journal_name": "Heart rhythm O2", + "date": "2023-01-03", + "author": "Osorio J,Mansour M,Melby D,Imhoff RJ,Hunter TD,Maccioni S,Wei T,Natale A", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2362, + "user_id": 1841382421, + "artical_title": "Fatal Spontaneous Intercostal Artery Bleeding During Catheter Ablation for Atrial Fibrillation.", + "pmid": 36684031, + "journal_name": "JACC. Case reports", + "date": "2023-01-24", + "author": "Yoo D,Mohanty S,Natale A", + "auth_pos": 3, + "meshterms": "Intermediate Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2363, + "user_id": 1841382421, + "artical_title": "Takotsubo Syndrome Following Catheter Ablation for Atrial Fibrillation: A Single-Center Experience.", + "pmid": 36697192, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-01-26", + "author": "Mohanty S,Gianni C,Mayedo A,MacDonald B,Al-Ahmad A,Bassiouny M,Gallinghouse GJ,Horton R,Burkhardt JD,Natale A", + "auth_pos": 10, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/diagnostic imaging, Takotsubo Cardiomyopathy/etiology, Takotsubo Cardiomyopathy/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2364, + "user_id": 1841382421, + "artical_title": "Clinical, procedural and lead outcomes associated with different pacing techniques a network meta-analysis.", + "pmid": 36736670, + "journal_name": "International journal of cardiology", + "date": "2023-02-04", + "author": "Mariani MV,Piro A,Forleo GB,Rocca DGD,Natale A,Miraldi F,Vizza CD,Lavalle C", + "auth_pos": 5, + "meshterms": "Humans, Bundle of His*, Cardiac Pacing, Artificial, Cardiac Pacing, Artificial/methods, Network Meta-Analysis, Electrocardiography, Heart Conduction System, Cardiac Resynchronization Therapy*, Cardiac Resynchronization Therapy/methods, Treatment Outcome, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2365, + "user_id": 1841382421, + "artical_title": "Catheter Ablation of Left Ventricular Summit Arrhythmias from Adjacent Anatomic Vantage Points.", + "pmid": 36774134, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2023-02-12", + "author": "Romero J,Gamero M,Alviz I,Grushko M,Diaz JC,Lorente M,Gabr M,Toquica CC,Krishnan S,Velasco A,Lin A,Natale A,Zou F,Di Biase L", + "auth_pos": 12, + "meshterms": "Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Heart Ventricles, Heart Ventricles/surgery, Arrhythmias, Cardiac, Epicardial Mapping, Catheter Ablation*, Catheter Ablation/methods, Electrocardiography, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2366, + "user_id": 1841382421, + "artical_title": "Fluoroless Catheter Ablation of Left Ventricular Summit Arrhythmias: A Step-by-Step Approach.", + "pmid": 36774139, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2023-02-12", + "author": "Romero J,Diaz JC,Gamero M,Alviz I,Lorente M,Gabr M,Toquica CC,Krishnan S,Velasco A,Lin A,Natale A,Zou F,Di Biase L", + "auth_pos": 11, + "meshterms": "Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods, Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods, Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods, Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods, Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods, Humans, Treatment Outcome, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/diagnostic imaging, Arrhythmias, Cardiac/surgery, Heart Ventricles, Heart Ventricles/diagnostic imaging, Heart Ventricles/surgery, Heart, Catheter Ablation*, Catheter Ablation/methods", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2367, + "user_id": 1841382421, + "artical_title": "The Clinical Outcomes and Success of Posterior Wall Isolation Using a \"Box\" Approach.", + "pmid": 36858696, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-03-02", + "author": "Aryana A,Saad EB,d'Avila A,DiBiase L,Natale A", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2368, + "user_id": 1841382421, + "artical_title": "Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures.", + "pmid": 36858707, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-03-02", + "author": "Hsu JC,Darden D,Du C,Marine JE,Nichols S,Marcus GM,Natale A,Noseworthy PA,Selzman KA,Varosy P,Masoudi F,Freeman J,Curtis J,Akar J,Kowey PR", + "auth_pos": 7, + "meshterms": "Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries, Humans, Male, Middle Aged, Aged, Female, Atrial Fibrillation*, Hospital Mortality, Prospective Studies, Cardiovascular System*, Registries", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2369, + "user_id": 1841382421, + "artical_title": "Impact of Remote Cardiac Monitoring on Greenhouse Gas Emissions: Global Cardiovascular Carbon Footprint Project.", + "pmid": 38939591, + "journal_name": "JACC. Advances", + "date": "2023-03-03", + "author": "Bawa D,Ahmed A,Darden D,Kabra R,Garg J,Bansal S,Olsen E,Atkins D,Rahim A,Pham N,Gopinathannair R,Pothineni NVK,Park P,Tummala R,Koerber S,Natale A,Lakkireddy D", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2370, + "user_id": 1841382421, + "artical_title": "Nonthrombogenic Roles of the Left Atrial Appendage: JACC Review Topic of the Week.", + "pmid": 36922093, + "journal_name": "Journal of the American College of Cardiology", + "date": "2023-03-16", + "author": "Alkhouli M,Di Biase L,Natale A,Rihal CS,Holmes DR,Asirvatham S,Bartus K,Lakkireddy D,Friedman PA", + "auth_pos": 3, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Stroke*, Stroke/etiology, Stroke/prevention & control", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2371, + "user_id": 1841382421, + "artical_title": "Reply: Atrial Fibrillation Ablation and Takotsubo Syndrome: Prevention/Prognostication/Management?", + "pmid": 36990600, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-03-31", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/surgery, Takotsubo Cardiomyopathy*, Takotsubo Cardiomyopathy/surgery, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2372, + "user_id": 1841382421, + "artical_title": "Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics.", + "pmid": 36752480, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-03-31", + "author": "Casella M,Gasperetti A,Compagnucci P,Narducci ML,Pelargonio G,Catto V,Carbucicchio C,Bencardino G,Conte E,Schicchi N,Andreini D,Pontone G,Giovagnoni A,Rizzo S,Inzani F,Basso C,Natale A,Tondo C,Russo AD,Crea F", + "auth_pos": 17, + "meshterms": "Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation, Humans, Myocarditis*, Myocarditis/complications, Myocarditis/diagnosis, Contrast Media, Gadolinium, Myocardium, Myocardium/pathology, Arrhythmias, Cardiac, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/etiology, Inflammation", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2373, + "user_id": 1841382421, + "artical_title": "Peridevice Leak After Left Atrial Appendage Occlusion: Incidence, Mechanisms, Clinical Impact, and Management.", + "pmid": 36990553, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2023-03-31", + "author": "Alkhouli M,De Backer O,Ellis CR,Nielsen-Kudsk JE,Sievert H,Natale A,Lakkireddy D,Holmes DR", + "auth_pos": 6, + "meshterms": "Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Incidence, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/epidemiology, Cardiac Catheterization, Cardiac Catheterization/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2374, + "user_id": 1841382421, + "artical_title": "Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: A cost-effectiveness analysis.", + "pmid": 36563830, + "journal_name": "Heart rhythm", + "date": "2023-04-03", + "author": "Romero J,Rodriguez-Taveras J,Diaz JC,Lorente-Ros M,Braunstein ED,Alviz I,Parides M,Haroun MW,Papa L,Dave K,Rodriguez D,Krishnan S,Toquica C,Velasco A,Gabr M,Natale A,Di Biase L", + "auth_pos": 16, + "meshterms": "Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome, Humans, Anesthesia, Local, Defibrillators, Implantable*, Defibrillators, Implantable/adverse effects, Prospective Studies, Pain, Procedural*, Anesthesia, General, Anesthesia, General/adverse effects, Pain, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2375, + "user_id": 1841382421, + "artical_title": "Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation.", + "pmid": 37086226, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-04-22", + "author": "Mohanty S,Mohanty P,Kessler D,Gianni C,Baho KK,Morris T,Yildiz T,Quintero Mayedo A,MacDonald B,Della Rocca DG,Al-Ahmad A,Bassiouny M,Gallinghouse GJ,Horton R,Burkhardt JD,di Biase L,Natale A", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2376, + "user_id": 1841382421, + "artical_title": "Posterior Wall Electrical Isolation in Patients Undergoing Catheter Ablation for Paroxysmal and Nonparoxysmal Atrial Fibrillation.", + "pmid": 36752475, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-04-28", + "author": "Romero J,Polanco D,Gabr M,Alviz I,Diaz JC,Briceno D,Velasco A,Patel K,Natale A,Di Biase L", + "auth_pos": 9, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Catheter Ablation*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2377, + "user_id": 1841382421, + "artical_title": "Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY Trial.", + "pmid": 36752484, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-04-28", + "author": "Osorio J,Hussein AA,Delaughter MC,Monir G,Natale A,Dukkipati S,Oza S,Daoud E,Di Biase L,Mansour M,Fishel R,Valderrabano M,Ellenbogen K", + "auth_pos": 5, + "meshterms": "Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Temperature, Prospective Studies, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Radiofrequency Ablation*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2378, + "user_id": 1841382421, + "artical_title": "Feasibility and Safety of Intravenous Sotalol Loading in Adult Patients With Atrial Fibrillation (DASH-AF).", + "pmid": 37014289, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-04-28", + "author": "Lakkireddy D,Ahmed A,Atkins D,Bawa D,Garg J,Bush J,Charate R,Bommana S,Pothineni NVK,Kabra R,Darden D,Koreber S,Tummala R,Vasamreddy C,Park P,Mohanty S,Gopinathannair R,Seo BW,Natale A,Kennedy R", + "auth_pos": 19, + "meshterms": "Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies, Humans, Adult, Sotalol*, Sotalol/adverse effects, Atrial Fibrillation*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/adverse effects, Prospective Studies, Feasibility Studies", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2379, + "user_id": 1841382421, + "artical_title": "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.", + "pmid": 36877118, + "journal_name": "Circulation", + "date": "2023-05-10", + "author": "Verma A,Haines DE,Boersma LV,Sood N,Natale A,Marchlinski FE,Calkins H,Sanders P,Packer DL,Kuck KH,Hindricks G,Onal B,Cerkvenik J,Tada H,DeLurgio DB", + "auth_pos": 5, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Treatment Outcome, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Electrocardiography, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Pulmonary Veins*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2380, + "user_id": 1841382421, + "artical_title": "Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry.", + "pmid": 36924020, + "journal_name": "Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions", + "date": "2023-05-11", + "author": "Gallo F,Ronco F,D'Amico G,Della Rocca DG,Mazzone P,Bordignon S,Casu G,Giannini F,Berti S,Horton RP,D'Angelo G,Urbanek L,Merella P,Ruggiero R,Romeo MR,Bosica F,Schmidt B,Atzori E,Barbierato M,Natale A,Themistoclakis S", + "auth_pos": 20, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/diagnosis, Gastrointestinal Hemorrhage/etiology, Gastrointestinal Hemorrhage/prevention & control, Intracranial Hemorrhages, Intracranial Hemorrhages/etiology, Registries, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Logic, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/diagnosis, Gastrointestinal Hemorrhage/etiology, Gastrointestinal Hemorrhage/prevention & control, Intracranial Hemorrhages, Intracranial Hemorrhages/etiology, Registries, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Logic, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/diagnosis, Gastrointestinal Hemorrhage/etiology, Gastrointestinal Hemorrhage/prevention & control, Intracranial Hemorrhages, Intracranial Hemorrhages/etiology, Registries, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Logic, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Gastrointestinal Hemorrhage, Gastrointestinal Hemorrhage/diagnosis, Gastrointestinal Hemorrhage/etiology, Gastrointestinal Hemorrhage/prevention & control, Intracranial Hemorrhages, Intracranial Hemorrhages/etiology, Registries, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/therapy, Logic", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2381, + "user_id": 1841382421, + "artical_title": "Brief commentary : Regarding \"Posterior wall isolation in persistent atrial fibrillation. Long-term outcomes of a repeat procedure strategy.\" J Interv Card Electrophysiol, 2022 Nov 3. doi: 10.1007/s10840-022-01,402-x.", + "pmid": 36472750, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2023-05-12", + "author": "Aryana A,Saad EB,d'Avila A,DiBiase L,Natale A", + "auth_pos": 5, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Heart Atria/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Heart Atria, Heart Atria/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2382, + "user_id": 1841382421, + "artical_title": "Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: A dual-center experience.", + "pmid": 37087672, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-05-22", + "author": "Dello Russo A,Compagnucci P,Bergonti M,Cipolletta L,Parisi Q,Volpato G,Santarelli G,Colonnelli M,Saenen J,Valeri Y,Carboni L,Marchese P,Marini M,Sarkozy A,Natale A,Casella M", + "auth_pos": 15, + "meshterms": "Humans, Male, Aged, Female, Microelectrodes, Treatment Outcome, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Tachycardia, Ventricular/complications, Arrhythmias, Cardiac, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix, Humans, Male, Aged, Female, Microelectrodes, Treatment Outcome, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Tachycardia, Ventricular/complications, Arrhythmias, Cardiac, Arrhythmias, Cardiac/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Cicatrix", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2383, + "user_id": 1841382421, + "artical_title": "Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation in Persistent AF.", + "pmid": 37219558, + "journal_name": "JAMA", + "date": "2023-05-25", + "author": "Mohanty S,Mohanty P,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheter Ablation*, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Heart Atria*, Heart Atria/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2384, + "user_id": 1841382421, + "artical_title": "Best ablation strategy in patients with premature ventricular contractions with multiple morphology: a single-centre experience.", + "pmid": 36942834, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-05-31", + "author": "Mohanty S,Burkhardt JD,Di Biase L,Mohanty P,Shetty SS,Gianni C,Della Rocca DG,Baho KK,Morris T,Mayedo A,MacDonald B,Al-Ahmad A,Bassiouny M,Gallinghouse GJ,Horton R,Natale A", + "auth_pos": 16, + "meshterms": "Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stroke Volume, Stroke Volume/physiology, Ventricular Dysfunction, Left*, Ventricular Function, Left, Ventricular Function, Left/physiology, Ventricular Premature Complexes*, Ventricular Premature Complexes/diagnosis, Ventricular Premature Complexes/surgery, Ventricular Premature Complexes/complications", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2385, + "user_id": 1841382421, + "artical_title": "Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.", + "pmid": 37078691, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-06-01", + "author": "Saksena S,Slee A,Natale A,Lakkireddy DR,Shah D,Di Biase L,Lewalter T,Nagarakanti R,Santangeli P", + "auth_pos": 3, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Heart Failure*, Stroke Volume, Stroke Volume/physiology, Propensity Score, Comorbidity, Prognosis", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2386, + "user_id": 1841382421, + "artical_title": "Editorial: Stereotactic radioablation of cardiac arrhythmias: pros and cons.", + "pmid": 37408657, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-07-06", + "author": "Narducci ML,Cellini F,Natale A", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2387, + "user_id": 1841382421, + "artical_title": "A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study.", + "pmid": 37062040, + "journal_name": "European heart journal", + "date": "2023-07-17", + "author": "Tilz RR,Schmidt V,Pürerfellner H,Maury P,Chun KJ,Martinek M,Sohns C,Schmidt B,Mandel F,Gandjbakhch E,Laredo M,Gunawardene MA,Willems S,Beiert T,Borlich M,Iden L,Füting A,Spittler R,Gaspar T,Richter S,Schade A,Kuniss M,Neumann T,Francke A,Wunderlich C,Shin DI,Grosse Meininghaus D,Foresti M,Bonsels M,Reek D,Wiegand U,Bauer A,Metzner A,Eckardt L,Popescu SȘ,Krahnefeld O,Sticherling C,Kühne M,Nguyen DQ,Roten L,Saguner AM,Linz D,van der Voort P,Mulder BA,Vijgen J,Almorad A,Guenancia C,Fauchier L,Boveda S,De Greef Y,Da Costa A,Jais P,Derval N,Milhem A,Jesel L,Garcia R,Poty H,Khoueiry Z,Seitz J,Laborderie J,Mechulan A,Brigadeau F,Zhao A,Saludas Y,Piot O,Ahluwalia N,Martin C,Chen J,Antolic B,Leventopoulos G,Özcan EE,Yorgun H,Cay S,Yalin K,Botros MS,Mahmoud AT,Jędrzejczyk-Patej E,Inaba O,Okumura K,Ejima K,Khakpour H,Boyle N,Catanzaro JN,Reddy V,Mohanty S,Natale A,Blessberger H,Yang B,Stevens I,Sommer P,Veltmann C,Steven D,Vogler J,Kuck KH,Merino JL,Keelani A,Heeger CH", + "auth_pos": 86, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/epidemiology, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnosis, Treatment Outcome, Incidence, Risk Factors, Esophageal Fistula*, Esophageal Fistula/epidemiology, Esophageal Fistula/etiology, Esophageal Fistula/diagnosis, Prognosis, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2388, + "user_id": 1841382421, + "artical_title": "Impact of Catheter Ablation on Cognition in Atrial Fibrillation: Is the Glass Half-Empty or Half-Full?", + "pmid": 37495317, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-07-28", + "author": "Mohanty S,Natale A,Di Biase L", + "auth_pos": 2, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Cognition, Catheter Ablation*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2389, + "user_id": 1841382421, + "artical_title": "Feasibility of Three-Dimensional Artificial Intelligence Algorithm Integration with Intracardiac Echocardiography for Left Atrial Imaging During Atrial Fibrillation Catheter Ablation.", + "pmid": 37477946, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-08-07", + "author": "Di Biase L,Zou F,Lin AN,Grupposo V,Marazzato J,Tarantino N,Della Rocca D,Mohanty S,Natale A,Alhuarrat MAD,Haiman G,Haimovich D,Matthew RA,Alcazar J,Costa G,Urman R,Zhang X", + "auth_pos": 9, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Artificial Intelligence, Feasibility Studies, Echocardiography, Echocardiography/methods, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Imaging, Three-Dimensional, Imaging, Three-Dimensional/methods, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Algorithms, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Artificial Intelligence, Feasibility Studies, Echocardiography, Echocardiography/methods, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Imaging, Three-Dimensional, Imaging, Three-Dimensional/methods, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Algorithms, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Artificial Intelligence, Feasibility Studies, Echocardiography, Echocardiography/methods, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Imaging, Three-Dimensional, Imaging, Three-Dimensional/methods, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Algorithms, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Artificial Intelligence, Feasibility Studies, Echocardiography, Echocardiography/methods, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Imaging, Three-Dimensional, Imaging, Three-Dimensional/methods, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Algorithms, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Artificial Intelligence, Feasibility Studies, Echocardiography, Echocardiography/methods, Heart Atria, Heart Atria/diagnostic imaging, Heart Atria/surgery, Imaging, Three-Dimensional, Imaging, Three-Dimensional/methods, Pulmonary Veins*, Pulmonary Veins/diagnostic imaging, Pulmonary Veins/surgery, Algorithms, Catheter Ablation*, Catheter Ablation/methods", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2390, + "user_id": 1841382421, + "artical_title": "Novel streamlined technique for left atrial appendage closure using a radiofrequency wire-based large access system.", + "pmid": 37417961, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-08-10", + "author": "Asfour IK,Elchouemi M,Gianni C,Helmy R,Tschopp DR,Horton RP,Natale A,Al-Ahmad A", + "auth_pos": 7, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Retrospective Studies, Cardiac Catheterization, Heart Atria, Treatment Outcome, Stroke*, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Retrospective Studies, Cardiac Catheterization, Heart Atria, Treatment Outcome, Stroke*, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Retrospective Studies, Cardiac Catheterization, Heart Atria, Treatment Outcome, Stroke*, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Retrospective Studies, Cardiac Catheterization, Heart Atria, Treatment Outcome, Stroke*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2391, + "user_id": 1841382421, + "artical_title": "Function follows form\": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.", + "pmid": 37493490, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-08-10", + "author": "Magnocavallo M,Vetta G,Polselli M,Cauti FM,Parlavecchio A,Caminiti R,Crea P,Pannone L,Sorgente A,Chimenti C,Chierchia GB,Rossi P,Natale A,de Asmundis C,Bianchi S,Della Rocca DG", + "auth_pos": 13, + "meshterms": "Humans, Male, Middle Aged, Arrhythmias, Cardiac, Arrhythmias, Cardiac/etiology, Arrhythmias, Cardiac/complications, Contrast Media, Death, Sudden, Cardiac, Death, Sudden, Cardiac/etiology, Death, Sudden, Cardiac/epidemiology, Gadolinium, Magnetic Resonance Imaging, Cine, Magnetic Resonance Spectroscopy, Magnetic Resonance Spectroscopy/adverse effects, Myocarditis*, Myocarditis/complications, Prognosis, Risk Assessment, Risk Factors, Sarcoidosis*, Sarcoidosis/complications, Sarcoidosis/diagnostic imaging, Stroke Volume, Ventricular Function, Left", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2392, + "user_id": 1841382421, + "artical_title": "Axillary vein puncture versus cephalic vein cutdown for cardiac implantable electronic device implantation: A meta-analysis.", + "pmid": 37378419, + "journal_name": "Pacing and clinical electrophysiology : PACE", + "date": "2023-08-14", + "author": "Vetta G,Magnocavallo M,Parlavecchio A,Caminiti R,Polselli M,Sorgente A,Cauti FM,Crea P,Pannone L,Marcon L,Savio AL,Pistelli L,Vetta F,Chierchia GB,Rossi P,Bianchi S,Natale A,de Asmundis C,Rocca DGD", + "auth_pos": 17, + "meshterms": "Male, Humans, Middle Aged, Aged, Aged, 80 and over, Axillary Vein*, Axillary Vein/surgery, Venous Cutdown*, Venous Cutdown/methods, Subclavian Vein, Punctures, Punctures/methods, Heart", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2393, + "user_id": 1841382421, + "artical_title": "Identifying the prognostic significance of early arrhythmia recurrence during the blanking period: a pursuit to rediscover the past.", + "pmid": 37506253, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-08-15", + "author": "Mohanty S,Mansour M,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Prognosis, Atrial Fibrillation*, Treatment Outcome, Humans, Prognosis, Atrial Fibrillation*, Treatment Outcome, Humans, Prognosis, Atrial Fibrillation*, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2394, + "user_id": 1841382421, + "artical_title": "Enhanced Thromboresistance and Endothelialization of a Novel Fluoropolymer-Coated Left Atrial Appendage Closure Device.", + "pmid": 37204356, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-08-25", + "author": "Saliba WI,Kawai K,Sato Y,Kopesky E,Cheng Q,Ghosh SKB,Herbst TJ,Kawakami R,Konishi T,Virmani R,Jaber WA,Gibson DN,Shah M,Natale A,Gibson M,Holmes DR,Finn AV", + "auth_pos": 14, + "meshterms": "Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation, Animals, Dogs, Swine, Fluorocarbon Polymers, Prosthesis Design, Atrial Fibrillation*, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Thrombosis*, Thrombosis/complications, Inflammation", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2395, + "user_id": 1841382421, + "artical_title": "Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward.", + "pmid": 37622589, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-08-28", + "author": "Natale A,Zeppenfeld K,Della Bella P,Liu X,Sabbag A,Santangeli P,Sommer P,Sticherling C,Zhang X,Di Biase L", + "auth_pos": 1, + "meshterms": "Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Tachycardia, Ventricular*, Tachycardia, Ventricular/diagnosis, Tachycardia, Ventricular/surgery, Catheter Ablation*, Catheter Ablation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2396, + "user_id": 1841382421, + "artical_title": "Outcomes of catheter ablation of atrial tachyarrhythmia guided exclusively by activation mapping.", + "pmid": 36456653, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2023-08-28", + "author": "Zhang X,Li W,Lin A,Zou F,Marazzato J,Varrias D,Nagraj S,Wang YC,Seo J,Della Rocca DG,Levine E,Santangeli P,Lakkireddy D,Natale A,Di Biase L", + "auth_pos": 14, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Tachycardia, Tachycardia/surgery, Heart Atria, Heart Atria/surgery, Catheter Ablation*, Catheter Ablation/methods, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2397, + "user_id": 1841382421, + "artical_title": "QDOT MICRO™ versus THERMOCOOL SMARTTOUCH™ and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation.", + "pmid": 37584396, + "journal_name": "Journal of comparative effectiveness research", + "date": "2023-09-01", + "author": "Osorio J,Maccioni S,Sharma R,Patel L,Spin P,Natale A", + "auth_pos": 6, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Equipment Design, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Equipment Design, Radiofrequency Ablation*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Equipment Design, Radiofrequency Ablation*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2398, + "user_id": 1841382421, + "artical_title": "Influence of Monitoring and Atrial Arrhythmia Burden on Quality of Life and Healthcare Utilization in Patients Undergoing Pulsed Field Ablation: A Secondary Analysis of the PULSED AF Trial.", + "pmid": 37211146, + "journal_name": "Heart rhythm", + "date": "2023-09-01", + "author": "Verma A,Haines DE,Boersma LV,Sood N,Natale A,Marchlinski FE,Calkins H,Sanders P,Packer DL,Kuck KH,Hindricks G,Tada H,Hoyt RH,Irwin JM,Andrade J,Cerkvenik J,Selma J,DeLurgio DB", + "auth_pos": 5, + "meshterms": "Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery, Humans, Atrial Fibrillation*, Quality of Life, Treatment Outcome, Catheter Ablation*, Catheter Ablation/methods, Patient Acceptance of Health Care, Recurrence, Pulmonary Veins*, Pulmonary Veins/surgery", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2399, + "user_id": 1841382421, + "artical_title": "A Focal Ablation Catheter Toggling Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation.", + "pmid": 37227340, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-09-01", + "author": "Reddy VY,Peichl P,Anter E,Rackauskas G,Petru J,Funasako M,Minami K,Koruth JS,Natale A,Jais P,Marinskis G,Aidietis A,Kautzner J,Neuzil P", + "auth_pos": 9, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Catheters, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Ablation Techniques*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2400, + "user_id": 1841382421, + "artical_title": "The Antwerp score: is this the 'new hope on the horizon'?", + "pmid": 37387669, + "journal_name": "European heart journal", + "date": "2023-09-15", + "author": "Mohanty S,La Fazia VM,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Atrial Fibrillation*, Heart Failure*, Humans, Atrial Fibrillation*, Heart Failure*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2401, + "user_id": 1841382421, + "artical_title": "Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.", + "pmid": 37279840, + "journal_name": "American heart journal", + "date": "2023-09-18", + "author": "Kar S,Doshi SK,Alkhouli M,Camm AJ,Coylewright M,Gibson MC,Granger CB,Gurol ME,Huber K,Mansour M,Nair DG,Natale A,Pocock SJ,Reddy VR,Saliba W,Christen T,Allocco DJ,Ellenbogen KA,Leon MB", + "auth_pos": 12, + "meshterms": "Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control, Male, Humans, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Treatment Outcome, Follow-Up Studies, Atrial Appendage*, Atrial Appendage/surgery, Anticoagulants, Anticoagulants/therapeutic use, Stroke*, Stroke/etiology, Stroke/prevention & control, Stroke/epidemiology, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/complications, Aspirin, Aspirin/therapeutic use, Embolism*, Embolism/prevention & control", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2402, + "user_id": 1841382421, + "artical_title": "Association Between ?-thalassemia and Atrial Fibrillation: Insights from the United States National Inpatient Sample.", + "pmid": 37781720, + "journal_name": "The Journal of innovations in cardiac rhythm management", + "date": "2023-10-02", + "author": "Abdelmottaleb W,Maraey A,Ozbay M,Elsharnoby H,Khalil M,Natale A,Al Rawahi M", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2403, + "user_id": 1841382421, + "artical_title": "Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation.", + "pmid": 37829690, + "journal_name": "Frontiers in cardiovascular medicine", + "date": "2023-10-13", + "author": "Conti S,Verma A,Natale A,Tondo C", + "auth_pos": 3, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2404, + "user_id": 1841382421, + "artical_title": "Mechanism and Management of Leaks Arising after Left Atrial Appendage Closure (LAAC).", + "pmid": 36069138, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-10-23", + "author": "Charate R,Ahmed A,Aedma SK,Singh V,Garg J,Pothineni NVK,Della Rocca DG,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 9, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Treatment Outcome, Stroke*, Cardiac Catheterization, Cardiac Catheterization/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2405, + "user_id": 1841382421, + "artical_title": "Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation.", + "pmid": 37634148, + "journal_name": "The New England journal of medicine", + "date": "2023-11-03", + "author": "Reddy VY,Gerstenfeld EP,Natale A,Whang W,Cuoco FA,Patel C,Mountantonakis SE,Gibson DN,Harding JD,Ellis CR,Ellenbogen KA,DeLurgio DB,Osorio J,Achyutha AB,Schneider CW,Mugglin AS,Albrecht EM,Stein KM,Lehmann JW,Mansour M", + "auth_pos": 3, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/classification, Atrial Fibrillation/surgery, Bayes Theorem, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Single-Blind Method, Tachycardia, Tachycardia/etiology, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2406, + "user_id": 1841382421, + "artical_title": "Severity of Ischemic Stroke After Left Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants.", + "pmid": 37999669, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-11-24", + "author": "Turagam MK,Kawamura I,Neuzil P,Nair D,Doshi S,Valderrabano M,Hala P,Della Rocca D,Gibson D,Funasako M,Ha G,Lee B,Musikantow D,Yoo D,Flautt T,Dukkipati S,Natale A,Gurol ME,Halperin J,Mansour M,Reddy VY", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2407, + "user_id": 1841382421, + "artical_title": "Prognostic value of chronic kidney disease in patients undergoing left atrial appendage occlusion.", + "pmid": 37889200, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2023-11-27", + "author": "Della Rocca DG,Magnocavallo M,Van Niekerk CJ,Gilhofer T,Ha G,D'Ambrosio G,Mohanty S,Gianni C,Galvin J,Vetta G,Lavalle C,Di Biase L,Sorgente A,Chierchia GB,de Asmundis C,Urbanek L,Schmidt B,Geller JC,Lakkireddy DR,Mansour M,Saw J,Horton RP,Gibson D,Natale A", + "auth_pos": 24, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/surgery, Stroke*, Stroke/epidemiology, Stroke/etiology, Stroke/prevention & control, Prognosis, Treatment Outcome, Retrospective Studies, Hemorrhage, Hemorrhage/chemically induced, Renal Insufficiency, Chronic*, Renal Insufficiency, Chronic/complications, Renal Insufficiency, Chronic/diagnosis, Renal Insufficiency, Chronic/epidemiology, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Anticoagulants, Anticoagulants/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2408, + "user_id": 1841382421, + "artical_title": "Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular Tachyarrhythmias.", + "pmid": 38032582, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-11-30", + "author": "Krzowski B,Kutyifa V,Vloka M,Huang DT,Attari M,Aktas M,Shah AH,Musat D,Rosenthal L,McNitt S,Polonsky B,Schuger C,Natale A,Ziv O,Beck C,Daubert JP,Goldenberg I,Zareba W", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2409, + "user_id": 1841382421, + "artical_title": "Catheter ablation approach and outcome in HIV+ patients with recurrent atrial fibrillation.", + "pmid": 37746923, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-12-11", + "author": "La Fazia VM,Pierucci N,Mohanty S,Gianni C,Della Rocca DG,Compagnucci P,MacDonald B,Mayedo A,Torlapati PG,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Al-Ahmad A,Di Biase L,Natale A", + "auth_pos": 16, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Treatment Outcome, HIV Infections*, HIV Infections/complications, HIV Infections/diagnosis, Vena Cava, Superior, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2410, + "user_id": 1841382421, + "artical_title": "Paroxysmal atrial fibrillation ablation with a novel temperature-controlled CF-sensing catheter: Q-FFICIENCY clinical and healthcare utilization benefits.", + "pmid": 37870157, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2023-12-11", + "author": "Hussein AA,Delaughter MC,Monir G,Natale A,Dukkipati S,Oza S,Daoud E,Di Biase L,Mansour M,Fishel R,Valderrabano M,Ellenbogen K,Osorio J", + "auth_pos": 4, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Prospective Studies, Quality of Life, Temperature, Treatment Outcome, Catheters, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Pulmonary Veins*, Pulmonary Veins/surgery, Patient Acceptance of Health Care, Catheter Ablation*, Catheter Ablation/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2411, + "user_id": 1841382421, + "artical_title": "Point-by-Point Pulsed Field Ablation Using a Multimodality Generator and a Contact Force-Sensing Ablation Catheter: Comparison With Radiofrequency Ablation in a Remapped Chronic Swine Heart.", + "pmid": 37994554, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2023-12-21", + "author": "Di Biase L,Marazzato J,Zou F,Lin A,Grupposo V,Chowdhuri N,Maffre J,Farshchi-Heydari S,Sharma T,Beeckler C,Govari A,Bhardwaj R,Mohanty S,Natale A,Nakagawa H,Zhang X", + "auth_pos": 14, + "meshterms": "Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Animals, Atrial Fibrillation*, Catheter Ablation*, Catheters, Cicatrix, Pulmonary Veins*, Radiofrequency Ablation*, Swine, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2412, + "user_id": 1841382421, + "artical_title": "Inotropes to Differentiate Dense Spontaneous Echo Contrast From Thrombus in the Left Atrial Appendage.", + "pmid": 38032576, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2023-12-29", + "author": "Pandey AC,Shen CP,Chu E,Della Rocca D,Janczyk G,Pangborn K,Natale A,Price MJ,Gibson D,Reddy VY", + "auth_pos": 7, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Thrombosis*, Thrombosis/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2413, + "user_id": 1841382421, + "artical_title": "Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.", + "pmid": 38171713, + "journal_name": "Journal of the American College of Cardiology", + "date": "2024-01-05", + "author": "Di Biase L,Lakkireddy DJ,Marazzato J,Velasco A,Diaz JC,Navara R,Chrispin J,Rajagopalan B,Natale A,Mohanty S,Zhang X,Della Rocca D,Dalal A,Park K,Wiley J,Batchelor W,Cheung JW,Dangas G,Mehran R,Romero J", + "auth_pos": 9, + "meshterms": "Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Humans, Aged, Fibrinolytic Agents, Fibrinolytic Agents/adverse effects, Atrial Fibrillation*, Atrial Fibrillation/drug therapy, Anticoagulants, Anticoagulants/adverse effects, Hemorrhage, Hemorrhage/chemically induced, Stroke*, Stroke/drug therapy, Treatment Outcome, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2414, + "user_id": 1841382421, + "artical_title": "Cardiac contractility modulation in a patient with refractory systolic heart failure following orthotopic heart transplant.", + "pmid": 38264106, + "journal_name": "HeartRhythm case reports", + "date": "2024-01-24", + "author": "Pierucci N,La Fazia VM,Gianni C,Mohanty S,Lavalle C,Cishek MB,Canby RC,Natale A", + "auth_pos": 8, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2415, + "user_id": 1841382421, + "artical_title": "Inherited Arrhythmias in the Pediatric Population: An Updated Overview.", + "pmid": 38256355, + "journal_name": "Medicina (Kaunas, Lithuania)", + "date": "2024-01-24", + "author": "Mariani MV,Pierucci N,Fanisio F,Laviola D,Silvetti G,Piro A,La Fazia VM,Chimenti C,Rebecchi M,Drago F,Miraldi F,Natale A,Vizza CD,Lavalle C", + "auth_pos": 12, + "meshterms": "Adult, Child, Humans, Arrhythmias, Cardiac, Arrhythmias, Cardiac/epidemiology, Arrhythmias, Cardiac/genetics, Heart Diseases*, Heart, Long QT Syndrome*, Cardiomyopathy, Hypertrophic*, Cardiomyopathy, Dilated*, Cardiomyopathy, Dilated/epidemiology, Cardiomyopathy, Dilated/genetics", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2416, + "user_id": 1841382421, + "artical_title": "Fourth Time's a Charm: Complex Closure of Incomplete Left Atrial Appendage Exclusion.", + "pmid": 37632481, + "journal_name": "JACC. Cardiovascular interventions", + "date": "2024-01-26", + "author": "Pierucci N,Gianni C,Lawrence M,La Fazia VM,Natale A,Kanj M,Horton RP", + "auth_pos": 5, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Echocardiography, Transesophageal, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Septal Occluder Device*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Echocardiography, Transesophageal, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Septal Occluder Device*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Echocardiography, Transesophageal, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Septal Occluder Device*, Cardiac Catheterization, Cardiac Catheterization/adverse effects, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Treatment Outcome, Echocardiography, Transesophageal, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Septal Occluder Device*, Cardiac Catheterization, Cardiac Catheterization/adverse effects", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2417, + "user_id": 1841382421, + "artical_title": "Bilateral Cardiac Sympathetic Denervation for Refractory Multifocal Premature Ventricular Contractions in Patients With Nonischemic Cardiomyopathy.", + "pmid": 37943190, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-01-26", + "author": "Ahmed A,Charate R,Bawa D,Ghazal R,Garg J,Pothineni NVK,Kabra R,Della Rocca DG,Atkins D,Lakkireddy P,Bommana S,Al-Ahmad A,Shenthar J,Padmanabhan D,Narasimhan C,DiBiase L,Romeya A,Gopinathannair R,Natale A,Lakkireddy D", + "auth_pos": 19, + "meshterms": "Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods, Humans, Male, Adult, Middle Aged, Aged, Female, Ventricular Premature Complexes*, Stroke Volume, Ventricular Function, Left, Cardiomyopathies*, Anti-Arrhythmia Agents, Anti-Arrhythmia Agents/therapeutic use, Sympathectomy, Sympathectomy/adverse effects, Sympathectomy/methods", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2418, + "user_id": 1841382421, + "artical_title": "Pulsed Electric Field, Cryoballoon, and Radiofrequency for Paroxysmal Atrial Fibrillation Ablation: A Propensity Score-Matched Comparison.", + "pmid": 38245007, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-02-02", + "author": "Della Rocca DG,Marcon L,Magnocavallo M,Menè R,Pannone L,Mohanty S,Sousonis V,Sorgente A,Almorad A,Bisignani A,Głowniak A,Del Monte A,Bala G,Polselli M,Mouram S,La Fazia VM,Ströker E,Gianni C,Zeriouh S,Bianchi S,Sieira J,Combes S,Sarkozy A,Rossi P,Boveda S,Natale A,de Asmundis C,Cheirchia GB", + "auth_pos": 26, + "meshterms": "Female, Humans, Middle Aged, Aged, Male, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Cryosurgery*, Cryosurgery/adverse effects, Cryosurgery/methods, Propensity Score, Treatment Outcome, Heart Atria, Pulmonary Veins*, Pulmonary Veins/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Female, Humans, Middle Aged, Aged, Male, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Cryosurgery*, Cryosurgery/adverse effects, Cryosurgery/methods, Propensity Score, Treatment Outcome, Heart Atria, Pulmonary Veins*, Pulmonary Veins/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence, Female, Humans, Middle Aged, Aged, Male, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Cryosurgery*, Cryosurgery/adverse effects, Cryosurgery/methods, Propensity Score, Treatment Outcome, Heart Atria, Pulmonary Veins*, Pulmonary Veins/surgery, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2419, + "user_id": 1841382421, + "artical_title": "Three-dimensional intracardiac echocardiography for left atrial appendage sizing and percutaneous occlusion guidance.", + "pmid": 38225176, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-02-02", + "author": "Della Rocca DG,Magnocavallo M,Gianni C,Mohanty S,Al-Ahmad A,Bassiouny M,Denora M,La Fazia VM,Lavalle C,Gallinghouse GJ,Santangeli P,Polselli M,Sarkozy A,Vetta G,Ahmed A,Sanchez JE,Pannone L,Chierchia GB,Tschopp DR,de Asmundis C,Di Biase L,Lakkireddy D,Burkhardt DJ,Horton RP,Natale A", + "auth_pos": 25, + "meshterms": "Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Humans, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Cross-Sectional Studies, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Cardiac Catheterization, Echocardiography, Transesophageal, Echocardiography, Transesophageal/methods, Echocardiography, Echocardiography/methods, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2420, + "user_id": 1841382421, + "artical_title": "Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable?", + "pmid": 38310489, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-02-04", + "author": "Mohanty S,Casella M,Compagnucci P,Torlapati PG,Della Rocca DG,La Fazia VM,Gianni C,Chierchia GB,MacDonald B,Mayedo A,Khan UN,Allison J,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Al-Ahmad A,Di Biase L,de Asmundis C,Russo AD,Natale A", + "auth_pos": 21, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2421, + "user_id": 1841382421, + "artical_title": "Safety and feasibility of same-day discharge following uncomplicated transvenous lead extraction.", + "pmid": 38073051, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-02-07", + "author": "Gianni C,Elchouemi M,Helmy R,Spinetta L,La Fazia VM,Pierucci N,Asfour I,Della Rocca DG,Mohanty S,Bassiouny MA,Coffeen PC,Hranitzky PM,Neely RC,Natale A,Canby RC,Al-Ahmad A", + "auth_pos": 14, + "meshterms": "Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome, Humans, Device Removal, Feasibility Studies, Hospitalization*, Patient Discharge*, Retrospective Studies, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2422, + "user_id": 1841382421, + "artical_title": "A decrease in patient activity level: What is the cause?", + "pmid": 37735945, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-02-13", + "author": "Gianni C,Gilmore A,Natale A,Al-Ahmad A", + "auth_pos": 3, + "meshterms": "Humans, Pacemaker, Artificial*, Heart Rate, Humans, Pacemaker, Artificial*, Heart Rate", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2423, + "user_id": 1841382421, + "artical_title": "Pulmonary Vein Narrowing after Pulsed Field Versus Thermal Ablation.", + "pmid": 38305503, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-02-20", + "author": "Mansour M,Gerstenfeld EP,Patel C,Natale A,Whang W,Cuoco FA,Mountantonakis SE,Gibson DN,Harding JD,Holland SK,Achyutha AB,Schneider CW,Mugglin AS,Albrecht EM,Stein KM,Lehmann JW,Reddy VY", + "auth_pos": 4, + "meshterms": "Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Constriction, Pathologic, Constriction, Pathologic/complications, Constriction, Pathologic/surgery, Single-Blind Method, Treatment Outcome, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Atrial Fibrillation/complications, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Stenosis, Pulmonary Vein*, Stenosis, Pulmonary Vein/diagnostic imaging, Stenosis, Pulmonary Vein/etiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2424, + "user_id": 1841382421, + "artical_title": "Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes.", + "pmid": 38448258, + "journal_name": "Cardiovascular revascularization medicine : including molecular interventions", + "date": "2024-03-07", + "author": "Eppinger S,Piayda K,Galea R,Sandri M,Maarse M,Güner A,Karabay CY,Pershad A,Ding WY,Aminian A,Akin I,Davtyan KV,Chugunov IA,Marijon E,Rosseel L,Schmidt TR,Amabile N,Korsholm K,Lund J,Guerios E,Amat-Santos IJ,Boccuzzi G,Ellis CR,Sabbag A,Ebelt H,Clapp B,Assa HV,Levi A,Ledwoch J,Lehmann S,Lee OH,Mark G,Schell W,Della Rocca DG,Natale A,de Backer O,Kefer J,Esteban PP,Abelson M,Ram P,Moceri P,Galache Osuna JG,Alvarez XM,Cruz-Gonzalez I,de Potter T,Ghassan M,Osadchiy A,Chen W,Goyal SK,Giannini F,Rivero-Ayerza M,Afzal S,Jung C,Skurk C,Langel M,Spence M,Merkulov E,Lempereur M,Shin SY,Mesnier J,McKinney HL,Schuler BT,Armero S,Gheorghe L,Ancona MBM,Santos L,Mansourati J,Nombela-Franco L,Nappi F,Kühne M,Gaspardone A,van der Pals J,Montorfano M,Fernández-Armenta J,Harvey JE,Rodés-Cabau J,Klein N,Sabir SA,Kim JS,Cook S,Kornowski R,Saraste A,Nielsen-Kudsk JE,Gupta D,Boersma L,Räber L,Sievert K,Sievert H,Bertog S", + "auth_pos": 35, + "meshterms": "Retrieval Device*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2425, + "user_id": 1841382421, + "artical_title": "Stereotactic Radiotherapy in Refractory Ventricular Tachycardia: Is It Truly a Rising \"STAR\"?", + "pmid": 38456858, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-03-08", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2426, + "user_id": 1841382421, + "artical_title": "Bailout Deep Septal LV Pacing to Treat Inadvertent Complete AV Block During Complex Ablation Procedure.", + "pmid": 38464799, + "journal_name": "JACC. Case reports", + "date": "2024-03-11", + "author": "Volkov D,Lopin D,Skoriy D,Gianni C,La Fazia VM,Gallinghouse GJ,Horton R,Burkhardt JD,Mohanty S,Natale A", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2427, + "user_id": 1841382421, + "artical_title": "Characteristics and Clinical Value of Electroanatomical Voltage Mapping in Cardiac Amyloidosis.", + "pmid": 37923125, + "journal_name": "The Canadian journal of cardiology", + "date": "2024-03-18", + "author": "Casella M,Compagnucci P,Ciliberti G,Falanga U,Barbarossa A,Valeri Y,Cipolletta L,Volpato G,Stronati G,Rizzo S,De Gaspari M,Vagnarelli F,Lofiego C,Perna GP,Giovagnoni A,Natale A,Basso C,Guerra F,Russo AD", + "auth_pos": 16, + "meshterms": "Humans, Male, Aged, Female, Arrhythmogenic Right Ventricular Dysplasia*, Arrhythmogenic Right Ventricular Dysplasia/complications, Prospective Studies, Electrophysiologic Techniques, Cardiac, Heart Ventricles, Amyloidosis*, Amyloidosis/complications, Humans, Male, Aged, Female, Arrhythmogenic Right Ventricular Dysplasia*, Arrhythmogenic Right Ventricular Dysplasia/complications, Prospective Studies, Electrophysiologic Techniques, Cardiac, Heart Ventricles, Amyloidosis*, Amyloidosis/complications", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2428, + "user_id": 1841382421, + "artical_title": "Pulsed-Field Ablation Does Not Worsen Baseline Pulmonary Hypertension Following Prior Radiofrequency Ablations.", + "pmid": 38069973, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-03-29", + "author": "Mohanty S,Della Rocca DG,Torlapati PG,Chierchia GB,Dello Russo A,Casella M,Gianni C,MacDonald B,Mayedo A,La Fazia VM,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Al-Ahmad A,Di Biase L,Pannone L,de Asmundis C,Natale A", + "auth_pos": 19, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Hypertension, Pulmonary*, Hypertension, Pulmonary/etiology, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Radiofrequency Ablation*, Radiofrequency Ablation/adverse effects, Cardiac Catheterization", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2429, + "user_id": 1841382421, + "artical_title": "2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.", + "pmid": 38587017, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-04-09", + "author": "Tzeis S,Gerstenfeld EP,Kalman J,Saad EB,Sepehri Shamloo A,Andrade JG,Barbhaiya CR,Baykaner T,Boveda S,Calkins H,Chan NY,Chen M,Chen SA,Dagres N,Damiano RJ,De Potter T,Deisenhofer I,Derval N,Di Biase L,Duytschaever M,Dyrda K,Hindricks G,Hocini M,Kim YH,la Meir M,Merino JL,Michaud GF,Natale A,Nault I,Nava S,Nitta T,O'Neill M,Pak HN,Piccini JP,Pürerfellner H,Reichlin T,Saenz LC,Sanders P,Schilling R,Schmidt B,Supple GE,Thomas KL,Tondo C,Verma A,Wan EY,Steven D,Agbayani MJ,Jared Bunch T,Chugh A,Díaz JC,Freeman JV,Hardy CA,Heidbuchel H,Johar S,Linz D,Maesen B,Noseworthy PA,Oh S,Porta-Sanchez A,Potpara T,Rodriguez-Diez G,Sacher F,Suwalski P,Trines SA", + "auth_pos": 28, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/surgery, Latin America, Treatment Outcome, Catheters, Asia, Catheter Ablation*, Catheter Ablation/adverse effects, Catheter Ablation/methods, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2430, + "user_id": 1841382421, + "artical_title": "Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment.", + "pmid": 38592178, + "journal_name": "Journal of clinical medicine", + "date": "2024-04-09", + "author": "Compagnucci P,Selimi A,Cipolletta L,Volpato G,Gasperetti A,Valeri Y,Parisi Q,Curcio A,Natale A,Dello Russo A,Casella M", + "auth_pos": 9, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2431, + "user_id": 1841382421, + "artical_title": "European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on catheter and surgical ablation of atrial fibrillation.", + "pmid": 38597857, + "journal_name": "Heart rhythm", + "date": "2024-04-10", + "author": "Tzeis S,Gerstenfeld EP,Kalman J,Saad E,Shamloo AS,Andrade JG,Barbhaiya CR,Baykaner T,Boveda S,Calkins H,Chan NY,Chen M,Chen SA,Dagres N,Damiano RJ,De Potter T,Deisenhofer I,Derval N,Di Biase L,Duytschaever M,Dyrda K,Hindricks G,Hocini M,Kim YH,la Meir M,Merino JL,Michaud GF,Natale A,Nault I,Nava S,Nitta T,O'Neill M,Pak HN,Piccini JP,Pürerfellner H,Reichlin T,Saenz LC,Sanders P,Schilling R,Schmidt B,Supple GE,Thomas KL,Tondo C,Verma A,Wan EY", + "auth_pos": 28, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2432, + "user_id": 1841382421, + "artical_title": "2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.", + "pmid": 38609733, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2024-04-13", + "author": "Tzeis S,Gerstenfeld EP,Kalman J,Saad E,Shamloo AS,Andrade JG,Barbhaiya CR,Baykaner T,Boveda S,Calkins H,Chan NY,Chen M,Chen SA,Dagres N,Damiano RJ,De Potter T,Deisenhofer I,Derval N,Di Biase L,Duytschaever M,Dyrda K,Hindricks G,Hocini M,Kim YH,la Meir M,Merino JL,Michaud GF,Natale A,Nault I,Nava S,Nitta T,O'Neill M,Pak HN,Piccini JP,Pürerfellner H,Reichlin T,Saenz LC,Sanders P,Schilling R,Schmidt B,Supple GE,Thomas KL,Tondo C,Verma A,Wan EY", + "auth_pos": 28, + "meshterms": "Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2433, + "user_id": 1841382421, + "artical_title": "High-power short-duration catheter ablation of atrial fibrillation: is it really a new era? Comparison between new and old radiofrequency contact force-sensing catheters.", + "pmid": 37584862, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2024-04-15", + "author": "Dello Russo A,D'Angelo L,Compagnucci P,Cipolletta L,Parisi Q,Valeri Y,Campanelli F,Volpato G,Carboni L,Ciliberti G,Stronati GE,Barbarossa A,La Piscopia V,Bondavalli B,Guerra F,Natale A,Casella M", + "auth_pos": 16, + "meshterms": "Humans, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheters, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Treatment Outcome, Humans, Atrial Fibrillation*, Catheter Ablation*, Catheter Ablation/adverse effects, Catheters, Prospective Studies, Pulmonary Veins*, Pulmonary Veins/surgery, Recurrence, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2434, + "user_id": 1841382421, + "artical_title": "Pulsed Field Ablation Index-Guided Ablation for Lesion Formation: Impact of Contact Force and Number of Applications in the Ventricular Model.", + "pmid": 38390748, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2024-04-18", + "author": "Di Biase L,Marazzato J,Govari A,Altman A,Beeckler C,Keyes J,Sharma T,Grupposo V,Zou F,Sugawara M,Ikeda A,Raissi F,Bhardwaj R,Hsu JC,Lee M,Banker R,Mohanty S,Natale A,Chen Q,Parikh P,Zhang XD,Nakagawa H", + "auth_pos": 18, + "meshterms": "Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Swine, Animals, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Ventricles, Heart Ventricles/surgery, Catheters, Equipment Design, Guide Catheters*", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2435, + "user_id": 1841382421, + "artical_title": "First-in-Human Clinical Series of a Novel Conformable Large-Lattice Pulsed Field Ablation Catheter for Pulmonary Vein Isolation.", + "pmid": 38584468, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-04-29", + "author": "Reddy VY,Anter E,Peichl P,Rackauskas G,Petru J,Funasako M,Koruth JS,Marinskis G,Turagam M,Aidietis A,Kautzner J,Natale A,Neuzil P", + "auth_pos": 12, + "meshterms": "Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Fibrillation/diagnosis, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Male, Female, Middle Aged, Aged, Treatment Outcome, Recurrence*, Cardiac Catheters*, Equipment Design, Electrophysiologic Techniques, Cardiac, Time Factors, Heart Rate, Action Potentials, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Fibrillation/diagnosis, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Male, Female, Middle Aged, Aged, Treatment Outcome, Recurrence*, Cardiac Catheters*, Equipment Design, Electrophysiologic Techniques, Cardiac, Time Factors, Heart Rate, Action Potentials, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Fibrillation/diagnosis, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Male, Female, Middle Aged, Aged, Treatment Outcome, Recurrence*, Cardiac Catheters*, Equipment Design, Electrophysiologic Techniques, Cardiac, Time Factors, Heart Rate, Action Potentials, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Fibrillation/diagnosis, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Male, Female, Middle Aged, Aged, Treatment Outcome, Recurrence*, Cardiac Catheters*, Equipment Design, Electrophysiologic Techniques, Cardiac, Time Factors, Heart Rate, Action Potentials, Humans, Pulmonary Veins*, Pulmonary Veins/surgery, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Fibrillation/diagnosis, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Male, Female, Middle Aged, Aged, Treatment Outcome, Recurrence*, Cardiac Catheters*, Equipment Design, Electrophysiologic Techniques, Cardiac, Time Factors, Heart Rate, Action Potentials", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2436, + "user_id": 1841382421, + "artical_title": "Ask Not If, But Which Ablations May Be Performed In the ASC!", + "pmid": 38718941, + "journal_name": "Heart rhythm", + "date": "2024-05-09", + "author": "Aryana A,Kenigsberg D,Greenberg S,d'Avila A,Natale A", + "auth_pos": 5, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2437, + "user_id": 1841382421, + "artical_title": "Percutaneous Epicardial Access for Mapping and Ablation of Cardiac Arrhythmias: A Procedure in Need of Innovation.", + "pmid": 38590179, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-05-10", + "author": "Santangeli P,Di Biase L,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Catheter Ablation*, Catheter Ablation/methods, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/surgery, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Epicardial Mapping*, Pericardium, Pericardium/surgery, Electrophysiologic Techniques, Cardiac, Treatment Outcome, Humans, Catheter Ablation*, Catheter Ablation/methods, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/surgery, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Epicardial Mapping*, Pericardium, Pericardium/surgery, Electrophysiologic Techniques, Cardiac, Treatment Outcome, Humans, Catheter Ablation*, Catheter Ablation/methods, Arrhythmias, Cardiac*, Arrhythmias, Cardiac/surgery, Arrhythmias, Cardiac/diagnosis, Arrhythmias, Cardiac/physiopathology, Epicardial Mapping*, Pericardium, Pericardium/surgery, Electrophysiologic Techniques, Cardiac, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2438, + "user_id": 1841382421, + "artical_title": "Bipolar Ablation for an Intramural Septal Atrial Tachycardia.", + "pmid": 38749639, + "journal_name": "Cardiac electrophysiology clinics", + "date": "2024-05-16", + "author": "Barbati T,La Fazia VM,Gianni C,Mohanty S,Natale A", + "auth_pos": 5, + "meshterms": "Humans, Catheter Ablation*, Male, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Septum, Atrial Septum/surgery, Atrial Septum/diagnostic imaging, Humans, Catheter Ablation*, Male, Aged, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Atrial Septum, Atrial Septum/surgery, Atrial Septum/diagnostic imaging", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2439, + "user_id": 1841382421, + "artical_title": "Ischemic Stroke Severity and Mortality After Left Atrial Appendage Closure vs Non-warfarin Oral Anticoagulants in Patients with Prior Stroke.", + "pmid": 38762136, + "journal_name": "Heart rhythm", + "date": "2024-05-19", + "author": "Turagam MK,Kawamura I,Neuzil P,Nair D,Doshi S,Valderrabano M,Hala P,Della Rocca D,Gibson D,Funasako M,Ha G,Lee B,Musikantow D,Yoo D,Flautt T,Dukkipati S,Natale A,Gurol ME,Halperin J,Mansour M,Reddy VY", + "auth_pos": 17, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2440, + "user_id": 1841382421, + "artical_title": "Cardiac Perforation During High-Power Radiofrequency Ablation of the Left Lateral Ridge Using QDOT MICRO.", + "pmid": 38629294, + "journal_name": "Circulation. Arrhythmia and electrophysiology", + "date": "2024-05-21", + "author": "Gianni C,Dare M,Sanchez JE,Al-Ahmad A,Zagrodzky JD,Gallinghouse GJ,Burkhardt JD,Neely RC,Natale A", + "auth_pos": 9, + "meshterms": "Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female, Humans, Catheter Ablation*, Catheter Ablation/adverse effects, Heart Injuries*, Heart Injuries/etiology, Heart Injuries/diagnostic imaging, Heart Injuries/surgery, Male, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Treatment Outcome, Middle Aged, Female", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2441, + "user_id": 1841382421, + "artical_title": "Comparison of cerebral safety following atrial fibrillation using pulsed field and thermal ablation: Results of the Neurological Assessment Subgroup in the ADVENT Trial.", + "pmid": 38823667, + "journal_name": "Heart rhythm", + "date": "2024-06-02", + "author": "Patel C,Gerstenfeld EP,Gupta SK,Winterfield J,Woods C,Natale A,Schneider CW,Achyutha AB,Holland SK,Richards E,Albrecht EM,Lehmann JW,Mansour M,Reddy VY", + "auth_pos": 6, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2442, + "user_id": 1841382421, + "artical_title": "Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems.", + "pmid": 38087147, + "journal_name": "Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing", + "date": "2024-06-11", + "author": "Compagnucci P,Valeri Y,Conti S,Volpato G,Cipolletta L,Parisi Q,D'Angelo L,Campanelli F,Carboni L,Sgarito G,Natale A,Casella M,Dello Russo A", + "auth_pos": 11, + "meshterms": "Female, Humans, Male, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Catheter Ablation/instrumentation, Equipment Design*, Tachycardia, Ventricular*, Tachycardia, Ventricular/surgery, Treatment Outcome, Aged", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2443, + "user_id": 1841382421, + "artical_title": "Fascicular Substrate Modification to Treat Human Ventricular Fibrillation.", + "pmid": 38878012, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-06-15", + "author": "Bode WD,Mohanty S,Burkhardt JD,Torlapati PG,Gianni C,La Fazia VM,Della Rocca DG,Bassiouny M,Gallinghouse GJ,Horton R,Al-Ahmad A,Zhang XD,Zou F,Di Biase L,Santangeli P,Natale A", + "auth_pos": 16, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2444, + "user_id": 1841382421, + "artical_title": "Direct Epicardial Validation of Posterior Wall Electroporation in Persistent Atrial Fibrillation.", + "pmid": 38678453, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-06-27", + "author": "Solimene F,Compagnucci P,Tondo C,La Fazia VM,Schillaci V,Mohanty S,Cipolletta L,Fassini GM,Chiariello P,Mottola G,Schiavone M,Casella M,Dello Russo A,Natale A", + "auth_pos": 14, + "meshterms": "Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Humans, Electroporation*, Electroporation/methods, Catheter Ablation*, Catheter Ablation/methods, Pericardium, Pericardium/surgery, Pericardium/diagnostic imaging, Pericardium/physiopathology, Male, Middle Aged, Female, Aged, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/physiopathology, Humans, Electroporation*, Electroporation/methods, Catheter Ablation*, Catheter Ablation/methods, Pericardium, Pericardium/surgery, Pericardium/diagnostic imaging, Pericardium/physiopathology, Male, Middle Aged, Female, Aged", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2445, + "user_id": 1841382421, + "artical_title": "Low prevalence of new-onset severe tricuspid regurgitation following leadless pacemaker implantation in a large series of consecutive patients.", + "pmid": 38925334, + "journal_name": "Heart rhythm", + "date": "2024-06-27", + "author": "La Fazia VM,Lepone A,Pierucci N,Gianni C,Barletta V,Mohanty S,Della Rocca DG,La Valle C,Torlapati PG,Al-Ahmad M,Wadhwa M,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Al-Ahmad A,Di Biase L,Lakkireddy D,Zucchelli G,Natale A", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2446, + "user_id": 1841382421, + "artical_title": "Prevalence, Timing, and Impact of Early Recurrence of Atrial Tachyarrhythmias after Pulsed Field Ablation: A Secondary Analysis of the PULSED AF Trial.", + "pmid": 38925335, + "journal_name": "Heart rhythm", + "date": "2024-06-27", + "author": "Boersma LVA,Natale A,Haines D,DeLurgio D,Sood N,Marchlinski F,Calkins H,Hoyt RH,Sanders P,Irwin J,Packer D,Mittal S,Durrani S,DiBiase L,Sangrigoli R,Tada H,Sasano T,Tomita H,Yamane T,Kuck KH,Wazni O,Tarakji K,Cerkvenik J,van Bragt KA,Abeln BGS,Verma A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2447, + "user_id": 1841382421, + "artical_title": "Catheter Ablation as First-Line Therapy in Persistent Atrial Fibrillation: Patient Characteristics and Clinical Outcomes.", + "pmid": 38703164, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-06-27", + "author": "Barkagan M,Milman A,Zahavi G,Younis A,Dhakal B,Dixit S,Wong CX,Gerstenfeld EP,Narayan SM,Bunch JT,Cerbin L,Tzou WS,Metzl M,Khanani A,Siddiqui UR,Mohanty S,Natale A,Medina A,Anter E", + "auth_pos": 17, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Atrial Fibrillation/therapy, Male, Catheter Ablation*, Catheter Ablation/statistics & numerical data, Female, Middle Aged, Aged, Anti-Arrhythmia Agents*, Anti-Arrhythmia Agents/therapeutic use, Treatment Outcome, United States, United States/epidemiology", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2448, + "user_id": 1841382421, + "artical_title": "Impact of an Organized Treatment Pathway on Management of Atrial Fibrillation: The ER2EP Study.", + "pmid": 38939629, + "journal_name": "JACC. Advances", + "date": "2024-06-28", + "author": "Lakkireddy D,Ahmed A,Bawa D,Garg J,Atkins D,Kabra R,Pham N,Bernholtz J,Darden D,Bommana S,Gopinathannair R,Pothineni NVK,Park P,Vasamreddy C,Tummala R,Koerber S,Della Rocca D,DiBiase L,Al-Ahmad A,Natale A", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2449, + "user_id": 1841382421, + "artical_title": "Posterior wall ablation for persistent atrial fibrillation: Very-high-power short-duration versus standard-power radiofrequency ablation.", + "pmid": 38984361, + "journal_name": "Heart rhythm O2", + "date": "2024-07-10", + "author": "Compagnucci P,Volpato G,Cipolletta L,Parisi Q,Valeri Y,Campanelli F,D'Angelo L,Ciliberti G,Stronati G,Carboni L,Giovagnoni A,Guerra F,Natale A,Casella M,Dello Russo A", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2450, + "user_id": 1841382421, + "artical_title": "Best anticoagulation strategy with and without appendage occlusion for stroke-prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis.", + "pmid": 38751010, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-07-11", + "author": "Mohanty S,Torlapati PG,La Fazia VM,Kurt M,Gianni C,MacDonald B,Mayedo A,Allison J,Bassiouny M,Gallinghouse GJ,Burkhardt JD,Horton R,Di Biase L,Al-Ahmad A,Natale A", + "auth_pos": 15, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis, Humans, Atrial Fibrillation*, Atrial Fibrillation/diagnosis, Atrial Fibrillation/complications, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/surgery, Male, Female, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/physiopathology, Atrial Appendage/surgery, Aged, Middle Aged, Treatment Outcome, Stroke*, Stroke/prevention & control, Stroke/etiology, Stroke/diagnosis, Catheter Ablation*, Catheter Ablation/adverse effects, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Risk Factors, Time Factors, Amyloidosis*, Amyloidosis/complications, Amyloidosis/diagnosis, Amyloidosis/diagnostic imaging, Hemorrhage, Hemorrhage/chemically induced, Administration, Oral, Retrospective Studies, Risk Assessment, Aspirin, Aspirin/administration & dosage, Aspirin/adverse effects, Drug Administration Schedule, Cardiomyopathies, Cardiomyopathies/diagnostic imaging, Cardiomyopathies/complications, Cardiomyopathies/diagnosis", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2451, + "user_id": 1841382421, + "artical_title": "The association of hematological markers with occurrence of thrombotic and bleeding events following left atrial appendage occlusion.", + "pmid": 38986462, + "journal_name": "Cardiology", + "date": "2024-07-11", + "author": "Aarnink E,Della Rocca D,Cepas-Guillen P,Benito-González T,Polzin A,Branca L,Spoon D,Adamo M,Freixa X,Natale A,Boersma LVA", + "auth_pos": 10, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2452, + "user_id": 1841382421, + "artical_title": "Reply to the letter from Kataoka et al.", + "pmid": 39004812, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-07-15", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2453, + "user_id": 1841382421, + "artical_title": "Quest for safe and feasible isolation of superior vena cava by pulsed-field ablation: Are we there yet?", + "pmid": 38874397, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-07-17", + "author": "Mansour M,Mohanty S,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2454, + "user_id": 1841382421, + "artical_title": "Quest for safe and feasible isolation of superior vena cava by pulsed-field ablation: are we there yet?", + "pmid": 39082733, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-07-31", + "author": "Mansour M,Mohanty S,Natale A", + "auth_pos": 3, + "meshterms": "Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome, Humans, Vena Cava, Superior*, Vena Cava, Superior/surgery, Catheter Ablation*, Catheter Ablation/methods, Atrial Fibrillation*, Atrial Fibrillation/surgery, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2455, + "user_id": 1841382421, + "artical_title": "Benefits of Pulsed-Field Ablation in Patients With Atrial Fibrillation and Heart Failure.", + "pmid": 39084742, + "journal_name": "JACC. Clinical electrophysiology", + "date": "2024-08-01", + "author": "Mohanty S,Natale A", + "auth_pos": 2, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Heart Failure*, Heart Failure/therapy, Catheter Ablation*, Catheter Ablation/methods, Male, Female, Aged, Middle Aged, Treatment Outcome, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Heart Failure*, Heart Failure/therapy, Catheter Ablation*, Catheter Ablation/methods, Male, Female, Aged, Middle Aged, Treatment Outcome", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2456, + "user_id": 1841382421, + "artical_title": "Lower Rate of Major Bleeding in Very High-Risk Patients Undergoing Left Atrial Appendage Occlusion: A Propensity-Matched Comparison with Direct Oral Anticoagulation.", + "pmid": 38246567, + "journal_name": "Heart rhythm", + "date": "2024-08-01", + "author": "Magnocavallo M,Della Rocca DG,Vetta G,Mohanty S,Gianni C,Polselli M,Rossi P,Parlavecchio A,La Fazia MV,Guarracini F,De Vuono F,Bisignani A,Pannone L,Raposeiras-Roubín S,Lochy S,Cauti FM,Burkhardt JD,Boveda S,Sarkozy A,Sorgente A,Bianchi S,Chierchia GB,de Asmundis C,Al-Ahmad A,Di Biase L,Horton RP,Natale A", + "auth_pos": 27, + "meshterms": "Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over, Humans, Male, Female, Atrial Fibrillation*, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Appendage*, Atrial Appendage/surgery, Aged, Propensity Score*, Anticoagulants*, Anticoagulants/administration & dosage, Anticoagulants/therapeutic use, Administration, Oral, Risk Assessment, Risk Assessment/methods, Hemorrhage, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Stroke, Stroke/prevention & control, Stroke/etiology, Stroke/epidemiology, Risk Factors, Follow-Up Studies, Prospective Studies, Incidence, Treatment Outcome, Thromboembolism, Thromboembolism/prevention & control, Thromboembolism/etiology, Thromboembolism/epidemiology, Aged, 80 and over", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2457, + "user_id": 1841382421, + "artical_title": "Step-by-step recommendations utilizing four-dimensional intracardiac echocardiography in left atrial appendage procedures.", + "pmid": 38887842, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-08-02", + "author": "Gidney B,Della Rocca DG,Horton R,Hoffman J,Valderrábano M,Natale A,Garg J,Bhardwaj R,Doshi S", + "auth_pos": 6, + "meshterms": "Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male, Atrial Appendage*, Atrial Appendage/diagnostic imaging, Atrial Appendage/surgery, Humans, Workflow*, Echocardiography, Transesophageal*, Echocardiography, Four-Dimensional*, Atrial Fibrillation, Atrial Fibrillation/surgery, Atrial Fibrillation/diagnostic imaging, Atrial Fibrillation/physiopathology, Predictive Value of Tests, Cardiac Catheterization, Cardiac Catheterization/instrumentation, Ultrasonography, Interventional, Male", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2458, + "user_id": 1841382421, + "artical_title": "Feasibility, safety, and efficacy of a novel external compression vascular closure device: The LockeT® study.", + "pmid": 39099135, + "journal_name": "Journal of cardiovascular electrophysiology", + "date": "2024-08-05", + "author": "Katapadi A,Pham N,Chelikam N,Ghazal R,Mansabdar A,Ehteshamuddin F,Darden D,Gopinathannair R,Kabra R,Pothineni NV,Bommana S,Atkins D,DiBiase L,Al-Ahmad A,Natale A,Lakkireddy D", + "auth_pos": 15, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2459, + "user_id": 1841382421, + "artical_title": "Safety and Feasibility of Cardiac Electrophysiology Procedures In Ambulatory Surgery Centers.", + "pmid": 39111610, + "journal_name": "Heart rhythm", + "date": "2024-08-08", + "author": "Aryana A,Thihalolipavan S,Willcox ME,Swarup S,Zagrodzky J,Wang HJ,Lupercio FA,Kenigsberg DN,Kenigsberg S,Mahapatra RA,O'Neill PG,Compton SJ,Natale A,Ellenbogen KA,Swarup V", + "auth_pos": 13, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2460, + "user_id": 1841382421, + "artical_title": "Redefining the blanking period following pulsed-field ablation in patients with atrial fibrillation.", + "pmid": 39117003, + "journal_name": "Heart rhythm", + "date": "2024-08-09", + "author": "Mohanty S,Torlapati PG,Casella M,Della Rocca DG,Schiavone M,Doty B,La Fazia VM,Pahi S,Pierucci N,Valeri Y,Gianni C,Al-Ahmad A,Burkhardt JD,Gallinghouse JG,Di Biase L,Chierchia GB,Nair DG,Dello Russo A,Tondo C,Natale A", + "auth_pos": 20, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2461, + "user_id": 1841382421, + "artical_title": "Application Repetition and Electrode-Tissue-Contact Results in Deeper Lesions Using a Pulsed-Field Ablation Circular Variable Loop Catheter.", + "pmid": 39150065, + "journal_name": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology", + "date": "2024-08-16", + "author": "Di Biase L,Marazzato J,Gomez T,Byun E,Zou F,Grupposo V,Mohanty S,La Fazia VM,Ammirati G,Lin A,Garcia DY,Della Rocca D,Al Ahamad A,Schiavone M,Gasperetti A,Freilich M,Serna JC,Forleo G,Liu X,Lakkireddy D,Tondo C,Natale A,Zhang XD", + "auth_pos": 22, + "meshterms": "", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + }, + { + "id": 2462, + "user_id": 1841382421, + "artical_title": "Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial.", + "pmid": 38760584, + "journal_name": "Nature medicine", + "date": "2024-08-20", + "author": "Anter E,Mansour M,Nair DG,Sharma D,Taigen TL,Neuzil P,Kiehl EL,Kautzner J,Osorio J,Mountantonakis S,Natale A,Hummel JD,Amin AK,Siddiqui UR,Harlev D,Hultz P,Liu S,Onal B,Tarakji KG,Reddy VY", + "auth_pos": 11, + "meshterms": "Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence, Humans, Atrial Fibrillation*, Atrial Fibrillation/surgery, Atrial Fibrillation/therapy, Male, Female, Middle Aged, Catheter Ablation*, Catheter Ablation/methods, Aged, Treatment Outcome, Single-Blind Method, Recurrence", + "Authorship Type": "", + "Kol_Name": "Andrea Natale" + } + ], + "Affiliations": [ + { + "id": "", + "user_id": 1447203401, + "org_name": "Abbott", + "dept": "", + "role": "Research", + "time_frame": "2021", + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Abbott Medical Devices", + "dept": "", + "role": "XIENCE 28 Global Study", + "time_frame": "2018 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Abbott Medical Devices", + "dept": "", + "role": "XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.", + "time_frame": "2017 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Abiomed", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Abiomed", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Alleviant Medical", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Alleviant Medical", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Alleviant Medical, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "AM-Pharma B.V.", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "AM-Pharma B.V.", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College Of Cardiology", + "dept": "2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Repor", + "role": "Member", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College Of Cardiology", + "dept": "Board of Trustee", + "role": "Trustee", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology / American Association for Thoracic Surgery / American Heart Association / American Society of Echocardiography / Ameri", + "dept": "Appropriate Use Criteria For Multimodality Imaging In The Assessment Of Cardiac Structure And Function In Nonvalvular Heart Disease; Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2019, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology / American Association for Thoracic Surgery / American Heart Association / American Society of Echocardiography / Ameri", + "dept": "Appropriate Use Criteria For Multimodality Imaging In Valvular Heart Disease; Writing Group", + "role": "Author", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology Foundation", + "dept": "North Carolina Chapter, Board of Trustees", + "role": "Member", + "time_frame": 2023, + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology Foundation", + "dept": "ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of", + "role": "Member", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology Foundation", + "dept": "Board of Trustees", + "role": "Trustee", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology Foundation", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology Foundation", + "dept": "Scientific Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American", + "dept": "Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease : A Report, Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2019, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American", + "dept": "Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease, American College of Cardiology Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European", + "dept": "Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report, American College of Cardiology Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2019, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European", + "dept": "Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease, American College of Cardiology Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2018, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Heart Association", + "dept": "Guideline for Coronary Artery Revascularization: A Report, American College of Cardiology/American Heart Association Joint Committee", + "role": "Author", + "time_frame": 2022, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Heart Association", + "dept": "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines; Task Force", + "role": "Member", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology, American Heart Association", + "dept": "Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease, American Heart Association Task Force", + "role": "Author", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology/American Heart Association", + "dept": "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Writing Com", + "role": "Member", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology/American Heart Association", + "dept": "2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardio", + "role": "Member", + "time_frame": 2014, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions", + "dept": "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Writing Committee", + "role": "Member", + "time_frame": 2021, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions", + "dept": "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline", + "role": "Member", + "time_frame": 2015, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College Of Chest Physicians", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American College of Physicians", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American Heart Association, Inc.", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American Heart Association, Inc.", + "dept": "Go Red for Women Scientific Advisory Group", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "American Heart Journal", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Amgen Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Applied Therapeutics", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Applied Therapeutics", + "dept": "", + "role": "Member: Scientific Advisory Board", + "time_frame": 2020, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Arena Pharmaceuticals Ltd", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Arena Pharmaceuticals Ltd", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Arena Pharmaceuticals, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "AstraZeneca", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "AstraZeneca", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Atricure, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Bayer AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Bayer AG", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Biosensors International Group, Ltd.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Biosensors International Group, Ltd.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Biotronik", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Biotronik", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Bristol-Myers Squibb Company", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Bristol-Myers Squibb Company", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cardiac Interventions Today", + "dept": "Editorial Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CardiaWave", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CardiaWave", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cardiology Now News & Views", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cardiovascular Diseases & Diagnosis", + "dept": "Editorial Board", + "role": "Editor-in-Chief", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cardiovascular Research Foundation", + "dept": "", + "role": "Faculty", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cardiovascular Research Foundation", + "dept": "Clinical Trials Center", + "role": "Chief Scientific Officer", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Catheterization and Cardiovascular Interventions", + "dept": "Editorial Board", + "role": "Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cellaegis Devices Inc", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CellAegis Devices Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CeloNova Biosciences", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CeloNova Biosciences", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Chiesi Farmaceutici S.p.A.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Chiesi Farmaceutici S.p.A.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CineMed", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Circulation", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Circulation Research", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Circulation: Cardiovascular Interventions", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Clinical Research in Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Columbia University Irving Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Concept Medical", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Concept Medical", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Concept Medical Inc.", + "dept": "", + "role": "ABILITY Diabetes Global", + "time_frame": "2020 - 2024", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "ControlRad", + "dept": "", + "role": "Ownership Interest/Partnership/Principal", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Coronary Artery Disease", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Csl Behring", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Csl Behring", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Cytokinetics", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "CytoSorbents Europe GmbH", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Daiichi Sankyo Company, Limited", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Daiichi Sankyo Company, Limited", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "EClinicalMedicine", + "dept": "Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Element Science, Inc.", + "dept": "", + "role": "The Jewel IDE Study", + "time_frame": "2022 - 2023", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Element Science, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Elemental Science", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Elil Lilly and Company", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Elixir Medical", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "European Society Of Cardiology", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Faraday Pharmaceuticals", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Harboring Hearts", + "dept": "Board of Directors", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Board of Director", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Healio Cardiac/Vascular Intervention", + "dept": "Editorial Board", + "role": "Associate Medical Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Humacyte, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Humacyte, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Icahn School of Medicine at Mount Sinai", + "dept": "Department of Medicine, Division of Cardiology", + "role": "Professor", + "time_frame": 2021, + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Icahn School of Medicine at Mount Sinai", + "dept": "The Zena and Michael A. Wiener Cardiovascular Institute, Interventional Cardiovascular Research", + "role": "Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Icahn School of Medicine at Mount Sinai", + "dept": "Center for Interventional Cardiovascular Research and Clinical Trials", + "role": "Medical Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Icahn School of Medicine at Mount Sinai", + "dept": "", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Idorsia Pharmaceuticals Ltd", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Idorsia Pharmaceuticals Ltd", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Idorsia Pharmaceuticals Ltd", + "dept": "", + "role": "Member: Advisory Board", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Insel Gruppe AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Insel Gruppe AG", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Interventional Cardiology", + "dept": "Editorial Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Interventional Cardiology: Reviews, Research, Resources", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Interventional Cardiology: Reviews, Research, Resources", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "JAMA Cardiology", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Janssen Global Services, Llc", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Janssen Pharmaceuticals, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Janssen Pharmaceuticals, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Journal of Cardiology", + "dept": "Editorial Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Journal of Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Journal of Cardiology Cases", + "dept": "Editorial Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board, Clinical Trials and Registries Section", + "role": "Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Koninklijke Philips N.V.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Koninklijke Philips N.V.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Magenta Medical", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Magenta Therapeutics", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Medstar Washington Hospital Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Medtronic", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Medtronic", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Mount Sinai Hospital", + "dept": ".", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Nature Cardiovascular Research", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Novartis AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Novartis AG", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "NYU Langone Health", + "dept": "Renal Committee", + "role": "Member", + "time_frame": "", + "org_type": "University", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "OrbusNeich Medical Company Limited", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "OrbusNeich Medical Company Limited", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Pediatric Interventional Cardiology Early Career Society", + "dept": "Development/Industry Relations Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Penumbra, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "PhaseBio Pharmaceuticals, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Pi-Cardia", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "PLx Pharma Inc.", + "dept": "", + "role": "Member: Scientific Advisory Board", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Protembis GmbH", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "REC: Interventional Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Regeneron Pharmaceuticals Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "RenalPro Medical", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "RenalPro Medical, Inc.", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "RM Global Partners", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Roivant Sciences Ltd.", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Sanofi", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Shockwave Medical Inc.", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Siemens Healthcare GmbH", + "dept": "", + "role": "Consultant", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society for Cardiovascular Angiography & Interventions", + "dept": "Diversity, Equity and Inclusion Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society for Cardiovascular Angiography & Interventions", + "dept": "Scientific Oversight Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "SCAI expert consensus statement on out of hospital cardiac arrest, Writing Committee", + "role": "Member", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document, Writing Committee", + "role": "Author", + "time_frame": 2014, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "Development/Industry Relations Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "Board of Trustees", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "Scientific Oversight Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society For Cardiovascular Angiography And Interventions", + "dept": "Diversity, Equity & Inclusion (DEI) Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Society for Cardiovascular Angiography and Interventions / American Association for Thoracic Surgery / American Heart Association / American Society o", + "dept": "Appropriate Use Criteria for Diagnostic Catheterization; Appropriate Use Criteria Task Force", + "role": "Author", + "time_frame": 2012, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Steel Therapeutics", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "The Society For Cardiovascular Angiography And Interventions", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Transverse Medical", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Universal Scientific Education and Research Network", + "dept": "Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Vivasure", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Vivasure Medical", + "dept": "", + "role": "Research", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Vivasure Medical", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Watermark Research Partners", + "dept": "Data Safety Monitoring Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Women As One", + "dept": "", + "role": "Founding Director/Board Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Zoll Medical Corporation", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1447203401, + "org_name": "Zoll Medical Corporation", + "dept": "", + "role": "Research", + "time_frame": 2021, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 256884 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "National Heart, Lung, And Blood Institute", + "dept": "", + "role": "Heart Failure Clinical Trials Network: $713000", + "time_frame": 2018, + "org_type": "Association", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": "" + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "National Heart, Lung, And Blood Institute", + "dept": "", + "role": "Developmental/Pilot Research Component", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": "" + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Abbott", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Adrenomed AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "American Heart Journal", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "American Regent, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Amgen Inc.", + "dept": "", + "role": "Member: Data Safety Monitoring Board", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Applied Therapeutics", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "AstraZeneca", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Bayer AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Baylor Scott & White Health", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Boehringer Ingelheim International Gmbh", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Bristol-Myers Squibb Company", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Cardiac failure review", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Circulation", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Corvia Medical, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Cvrx, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Eli Lilly and Company", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "European Heart Journal", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "European Journal of Heart Failure", + "dept": "Editorial board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "F. Hoffmann-La Roche Ltd.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Fire 1", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Heart Failure Reviews", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Heart Failure Society Of America", + "dept": "Indications for Cardiac Resynchronization Therapy: 2011 Update, Writing Committee", + "role": "Author", + "time_frame": 2011, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Heart Failure Society Of America", + "dept": "Scientific Statements Committee", + "role": "Co-Liaison", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Impulse Dynamics", + "dept": "", + "role": "Assessment of CCM in HF With Higher Ejection Fraction", + "time_frame": "2022 - 2026", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Impulse Dynamics", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "International Journal of Heart Failure", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Janssen Global Services, Llc", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board", + "role": "Guest Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Journal of the American College of Cardiology", + "dept": "Heart Failure Section, Heart Failure", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "LivaNova PLC", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Luitpold Pharmaceuticals", + "dept": "", + "role": "Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency", + "time_frame": "2017 - 2022", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Medtronic", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Merck & Co., Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "National Forum For Heart Disease And Stroke Prevention", + "dept": "", + "role": "Director", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Novartis AG", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Novo Nordisk A/S", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Occlutech", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Pfizer Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Stony Brook University Hospital", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "The Heart Failure Society Of America, Inc.", + "dept": "Annual Scientific Meeting Program Committee", + "role": "Chair", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "University of Mississippi Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1639100928, + "org_name": "Vifor Pharma", + "dept": "", + "role": "Consultant", + "time_frame": 2022, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 23726 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "National Heart, Lung, And Blood Institute", + "dept": "", + "role": "SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READING", + "time_frame": 2008, + "org_type": "Association", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": "" + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "American Journal of Preventive Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Boehringer Ingelheim", + "dept": "", + "role": "EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)", + "time_frame": "2017 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Coronary Artery Disease", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Crossing Rivers Health Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Frontiers in Cardiovascular Medicine", + "dept": "Editorial Board", + "role": "Guest Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Harbor-UCLA Faculty Practice Plan A Medical Group Inc.", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "IJC Heart & Vasculature", + "dept": "Editorial Board", + "role": "Consulting Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Innolife Co., Ltd.", + "dept": "", + "role": "Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction", + "time_frame": "2019 - 2021", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "International Journal of Cardiology. Heart & Vasculature", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "JACC: Cardiovascular Imaging", + "dept": "Editorial Board", + "role": "Editorial Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Journal of Geriatric Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Journal Of Invasive Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board", + "role": "Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Lac/Harbor-Ucla Med Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "National Lipid Association", + "dept": "Scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction, Writing Committee", + "role": "Author", + "time_frame": 2021, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Prairie Du Chien Memorial Hospital Association, Inc.", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Prohealth Partners, A Medical Group", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Ronald Reagan UCLA Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society for Atherosclerosis Imaging and Prevention, Society of Cardiovascular Computed Tomography", + "dept": "Guideline for minimizing radiation exposure during acquisition of coronary artery calcium scans with the use of multidetector computed tomography: A report, Writing Committee", + "role": "Author", + "time_frame": 2011, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society For Heart Attack Prevention And Eradication", + "dept": "Scientific Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "The role of cardiovascular CT in occupational health assessment for coronary heart disease: An expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT), Writing Committee", + "role": "Member", + "time_frame": 2021, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "The role of cardiovascular CT in occupational health assessment for coronary heart disease: An expert consensus document, Writing Committee", + "role": "Author", + "time_frame": 2021, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging – Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque, Writing Committee", + "role": "Member", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "Advocacy Committee", + "role": "Senior Advisor", + "time_frame": "2019 - 2023", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "CAC-DRS: Coronary Artery Calcium Data and Reporting System. An expert consensus document, Writing Committee", + "role": "Author", + "time_frame": 2018, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement, US Preventive Services Task Force", + "role": "Author", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "Guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans, Writing Committee", + "role": "Author", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society Of Cardiovascular Computed Tomography", + "dept": "Advocacy Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography / American College of Radiology / North American Society for Cardiovascular Imaging", + "dept": "CAD-RADS(TM) Coronary Artery Disease - Reporting And Data System. An Expert Consensus Document Of The Society Of Cardiovascular Computed Tomography, The American College Of Radiology And The North American Society For Cardiovascular Imaging; Writing", + "role": "Author", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging", + "dept": "Expert Consensus Document On Coronary CT Imaging Of Atherosclerotic Plaque; Writing Committee", + "role": "Author", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography / Society of Thoracic Radiology", + "dept": "Guidelines For Coronary Artery Calcium Scoring Of Noncontrast Noncardiac Chest CT Scans; Writing Committee", + "role": "Author", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography, American College of Cardiology, American College of Radiology, North America Society of Cardiovascular", + "dept": "CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System.: An expert consensus document, Writing Committee", + "role": "Author", + "time_frame": 2022, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography, American College of Radiology, North America Society of Cardiovascular Imaging", + "dept": "CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert Consensus Document, Writing Committee", + "role": "Author", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography, American College of Radiology, North America Society of Cardiovascular Imaging", + "dept": "Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document, Writing Committee", + "role": "Author", + "time_frame": 2016, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "Society of Cardiovascular Computed Tomography, North American Society of Cardiovascular Imaging", + "dept": "Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque, Writing Committee", + "role": "Author", + "time_frame": 2021, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "The American Society for Preventive Cardiology", + "dept": "Board of Directors", + "role": "Member", + "time_frame": 2023, + "org_type": "Association", + "emg_type": "Board of Director", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1811967433, + "org_name": "UCLA Santa Monica Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 20514 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Abbott", + "dept": "", + "role": "Consultant", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American College of Cardiology Foundation", + "dept": "Competency Management Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Interventional Echocardiography Council", + "role": "Member", + "time_frame": "2023 - 2024", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Industry Relations Committee", + "role": "Member at Large", + "time_frame": "2023 - 2024", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "PR Committee", + "role": "Member", + "time_frame": "2023 - 2024", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Scientific Sessions Program Committee", + "role": "Member", + "time_frame": "2022 - 2024", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography, Writing Committee", + "role": "Member", + "time_frame": 2022, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Industry Relations Committee", + "role": "Member", + "time_frame": "2022 - 2023", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease; Writing Committee", + "role": "Member", + "time_frame": 2011, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society Of Echocardiography", + "dept": "Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination, Writing Committee", + "role": "Author", + "time_frame": "", + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, Society for Card", + "dept": "Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement, Writing Committee", + "role": "Author", + "time_frame": 2019, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society of Echocardiography, Society for Cardiovascular Magnetic Resonance, Society of Cardiovascular Computed Tomography", + "dept": "Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report, Writing Committee", + "role": "Author", + "time_frame": 2024, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "American Society of Echocardiography, Society of Cardiovascular Anesthesiologists, Society of Thoracic Surgeons", + "dept": "Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination in Children and All Patients with Congenital Heart Disease: Recommendations from the American Society of Echocardiography; Writing Committee", + "role": "Member", + "time_frame": 2018, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Baylis Medical Company, Inc", + "dept": "", + "role": "Speaker", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Baylis Medical Company, Inc", + "dept": "", + "role": "Consultant", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Speaker", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Cardiovascular Research Foundation", + "dept": "CRF Clinical Trials : Echocardiography Core Laboratory", + "role": "Director", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Cardiovascular Research Foundation", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Cardiovascular Research Foundation", + "dept": "Management Team", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Columbia University Irving Medical Center", + "dept": ".", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Columbia University Irving Medical Center", + "dept": "Structural Heart and Valve Center", + "role": "Director of Interventional Echocardiography", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Columbia University Vagelos College of Physicians and Surgeons", + "dept": "Department of Medicine", + "role": "Professor", + "time_frame": "", + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Edwards Lifesciences", + "dept": "", + "role": "Edwards CLASP TR EFS", + "time_frame": "2019 - 2025", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Edwards Lifesciences", + "dept": "", + "role": "Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study", + "time_frame": "2018 - 2024", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Edwards Lifesciences Corporation", + "dept": "", + "role": "Speaker", + "time_frame": 2020, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "GE HealthCare", + "dept": "", + "role": "Speaker", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "JACC: Cardiovascular Imaging", + "dept": "Editorial Board", + "role": "Senior Editorial Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Journal Of Structural Heart Disease", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Koninklijke Philips N.V.", + "dept": "", + "role": "Speaker", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Koninklijke Philips N.V.", + "dept": "", + "role": "Consultant", + "time_frame": 2018, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Medtronic", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Medtronic", + "dept": "", + "role": "Research", + "time_frame": 2019, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Mitralign, Inc.", + "dept": "", + "role": "Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.", + "time_frame": "2015 - 2019", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "NewYork-Presbyterian Queens Hospital", + "dept": "Cardiology Service", + "role": "Cardiologist", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Siemens Healthcare GmbH", + "dept": "", + "role": "Speaker", + "time_frame": 2018, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Society For Vascular Surgery", + "dept": "Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication; Writing Committee", + "role": "Member", + "time_frame": 2015, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "Structural Heart", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1497893077, + "org_name": "W. L. Gore & Associates, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 22909 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Abbott", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Abbott", + "dept": "", + "role": "Co-Principal Investigator: VT Ablation vs Amiodarone in ICD", + "time_frame": 2008, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Abbott Medical Devices", + "dept": "", + "role": "Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation", + "time_frame": "2018 - 2021", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Advanced Cooling Therapy, Inc., d/b/a Attune Medical", + "dept": "", + "role": "Oesophageal Protection Study: A Multicentre Study.", + "time_frame": "2022 - 2025", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Advances in Arrhythmias", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2007, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American College of Cardiology Foundation", + "dept": "", + "role": "Fellow", + "time_frame": 2006, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American College of Cardiology Foundation", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American Heart Association, Inc.", + "dept": "", + "role": "Member", + "time_frame": 2003, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American Heart Journal", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American Journal of Cardiovascular Disease", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2011, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "American Medical Association", + "dept": "", + "role": "Member", + "time_frame": 2005, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Arrhythmia and Electrophysiology Review", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "AtriCure, Inc", + "dept": "", + "role": "Consultant", + "time_frame": 2015, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Baylis Medical Company, Inc", + "dept": "", + "role": "Consultant", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biosense Webster, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biosense Webster, Inc.", + "dept": "", + "role": "Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation", + "time_frame": "2019 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biosense Webster, Inc.", + "dept": "", + "role": "Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)", + "time_frame": "2018 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biosense Webster, Inc.", + "dept": "", + "role": "Oral Anticoagulation Therapy Pilot Study", + "time_frame": "2013 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biosense Webster, Inc.", + "dept": "", + "role": "Principal Investigator: RAAFTS 2", + "time_frame": 2006, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "BioSig Technologies, Inc", + "dept": "", + "role": "Chairman: Scientific Advisory Board", + "time_frame": 2011, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "BioTelemetry, Inc.", + "dept": "", + "role": "Member: Medical Advisory Board", + "time_frame": 2009, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biotronik", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Biotronik", + "dept": "", + "role": "Speaker", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation", + "time_frame": "2023 - 2024", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Boston Scientific Corporation", + "dept": "", + "role": "Speaker", + "time_frame": 2016, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "California Pacific Medical Center", + "dept": "Electrophysiology and Arrhythmia Services Atrial Fibrillation", + "role": "Senior Medical Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "California Pacific Medical Ctr-Pacific Campus Hosp", + "dept": ".", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Cardiac Electrophysiology Clinics", + "dept": "Editorial Board", + "role": "Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Cardialen, Inc.", + "dept": "", + "role": "Termination Therapy for Ventricular Tachyarrhythmias", + "time_frame": "2019 - 2021", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "CardioFocus", + "dept": "", + "role": "Consultant", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "CardioVisual", + "dept": "", + "role": "Member: Board of Advisor", + "time_frame": 2019, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Case Western Reserve University School of Medicine", + "dept": "", + "role": "Associate Professor", + "time_frame": 2008, + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Circulation", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Clinical Electrophysiology", + "dept": "Editorial Board", + "role": "Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Corvia Medical", + "dept": "", + "role": "REDUCE LAP-HF TRIAL II", + "time_frame": "2017 - 2024", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Cvrx, Inc.", + "dept": "", + "role": "Barostim Therapy for Heart Failure", + "time_frame": "2016 - 2021", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Electrophysiology", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "EP Lab Digest", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "EP Lab Digest", + "dept": "Editorial Board", + "role": "Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "EPIX Therapeutics", + "dept": "", + "role": "DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation", + "time_frame": "2018 - 2020", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Europace", + "dept": "Editorial Board", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Sociedad Latinoamericana de Estimulación Cardíaca y Electrofi", + "dept": "Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Executive Summary, Writing Committee", + "role": "Author", + "time_frame": 2018, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "European Society Of Cardiology", + "dept": "", + "role": "Fellow", + "time_frame": 2010, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "George F. and Ann Harris Bellows Foundation", + "dept": "", + "role": "Research", + "time_frame": "", + "org_type": "Association", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Global Atrial Fibrillation Alliance", + "dept": "Executive Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Golden State Providers, A Medical Corporation", + "dept": ".", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "HCA Healthcare", + "dept": "", + "role": "Medical Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "HCA Healthcare Austin Diagnostic Clinic", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society", + "dept": "Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: a Survey Analysis of Stakeholder Practices, Needs, and Barriers, Writing Committee", + "role": "Author", + "time_frame": 2022, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society", + "dept": "Rationale, Considerations, and Goals for Atrial Fibrillation Centers of Excellence: a Heart Rhythm Society Perspective, Writing Committee", + "role": "Author", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society", + "dept": "Board of Trustees", + "role": "Member", + "time_frame": 2011, + "org_type": "Association", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society", + "dept": "", + "role": "Member", + "time_frame": 2006, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society", + "dept": "", + "role": "Fellow", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society/American Heart Association", + "dept": "Guidance for Rebooting Electrophysiology Through the Covid-19 Pandemic, Writing Committee", + "role": "Author", + "time_frame": 2020, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society/Asia Pacific Heart Rhythm Society/ Sociedad Latinoamericana", + "dept": "2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, Writing Committee", + "role": "Member", + "time_frame": 2017, + "org_type": "Association", + "emg_type": "Guideline", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Tronics Inc", + "dept": "", + "role": "Consultant", + "time_frame": 2018, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Tronics Inc", + "dept": "", + "role": "Member: Medical Advisory Board", + "time_frame": 2004, + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Heart Valve Disease", + "dept": "Editorial Board", + "role": "Editor-In-Chief", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "International Academy Of Cardiology", + "dept": "Scientific Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "International Journal of Arrhythmia", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "International Magazine of Health Emergencies", + "dept": "Scientific Committee", + "role": "Member", + "time_frame": "", + "org_type": "Others", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Italian College of Physicians", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Italian Scientists and Scholars of North America Foundation", + "dept": "Steering Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "JACC: Clinical Electrophysiology", + "dept": "Editorial board", + "role": "Editorial Consultant", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Janssen Global Services, Llc", + "dept": "", + "role": "Consultant", + "time_frame": 2015, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Janssen Pharmaceuticals, Inc", + "dept": "", + "role": "Consultant", + "time_frame": 2015, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Japanese Journal of Cardiac Arrhythmia", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Japanese Journal of Cardiac Arrhythmia", + "dept": "Advisory Committee", + "role": "Member", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Johnson & Johnson Services, Inc.", + "dept": "", + "role": "Consultant", + "time_frame": 2014, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Arrhythmia", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Atrial Fibrillation", + "dept": "Editorial Board", + "role": "Founding Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Cardiovascular Electrophysiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2002, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Cardiovascular Medicine", + "dept": "Editorial Board", + "role": "International Associate Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Electrocardiology", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Geriatric Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2011, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Interventional Cardiac Electrophysiology", + "dept": "Editorial Board", + "role": "Associate Editor", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of Interventional Cardiac Electrophysiology", + "dept": "Editorial Board", + "role": "Editor-in-Chief", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Journal of the American College of Cardiology", + "dept": "Editorial Board, Electrophysiology Section", + "role": "Consultant Editor", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Kalila Medical", + "dept": "", + "role": "Owner", + "time_frame": 2017, + "org_type": "Industry", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "LifeWatch", + "dept": "", + "role": "Speaker", + "time_frame": 2016, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Los Robles Hospital & Medical Center", + "dept": ".", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "LuxCath LLC", + "dept": "", + "role": "Scientific Advisor", + "time_frame": "", + "org_type": "Industry", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Medtronic", + "dept": "", + "role": "Consultant", + "time_frame": 2023, + "org_type": "Industry", + "emg_type": "Speaker / Consultant", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Medtronic", + "dept": "", + "role": "Research", + "time_frame": 2012, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Montefiore Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "North American Society Of Pacing And Electrophysiology", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Pacing and Clinical Electrophysiology", + "dept": "Editorial Board", + "role": "Guest Editor", + "time_frame": 2003, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Pacing and Clinical Electrophysiology", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Physician Advisory Board", + "dept": "", + "role": "Member", + "time_frame": 2005, + "org_type": "Others", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Scripps Green Hospital", + "dept": "Interventional Electrophysiology", + "role": "Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Scripps Memorial Hospital La Jolla", + "dept": ".", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Socità Italiana di Cardiologia", + "dept": "", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St David'S Medical Center", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St Davids Heart And Vascular Pllc", + "dept": ".", + "role": "Faculty", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St Davids North Austin Medical Center", + "dept": "Cardiology Services", + "role": "Cardiologist", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St. Jude Medical, Inc.", + "dept": "", + "role": "TactiSense IDE Trial Of TactiCath SE For Paroxysmal Atrial Fibrillation", + "time_frame": "2017 - 2019", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St. Jude Medical, Inc.", + "dept": "", + "role": "Principal Investigator: IRASE Irrigated Ablation System Evaluation for AF", + "time_frame": 2010, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St. Jude Medical, Inc.", + "dept": "", + "role": "Principal Investigator: Implantable Loop Recorder", + "time_frame": 2009, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St. Jude Medical, Inc.", + "dept": "", + "role": "Co-Principal Investigator: VT Ablation vs Amiodarone in ICD", + "time_frame": 2008, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "St.David's HealthCare", + "dept": "", + "role": "Executive Medical Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Leadership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Stanford Health Care", + "dept": "Division of Cardiology", + "role": "Consulting Professor", + "time_frame": 2005, + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Stereotaxis, Inc", + "dept": "", + "role": "Comparison Of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach In A Low LVEF Population", + "time_frame": "2016 - 2019", + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "StopAfib.org", + "dept": "Medical Advisory Board", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Sutter Medical Center, Sacramento", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Sutter West Bay Hospitals", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Texas Cardiac Arrhythmia Institute", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Texas Cardiac Arrhythmia Institute", + "dept": "", + "role": "Executive Medical Director", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Texas Medical Association", + "dept": "", + "role": "Member", + "time_frame": 2008, + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "The American Journal of Cardiology", + "dept": "Editorial Board", + "role": "Reviewer", + "time_frame": "", + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "The Journal of Innovations in Cardiac Rhythm Management", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2010, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "The MetroHealth System", + "dept": "", + "role": "Physician", + "time_frame": "", + "org_type": "University", + "emg_type": "Clinical Practice", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "The Ohio State University College of Medicine", + "dept": "", + "role": "Senior Advisor", + "time_frame": 2004, + "org_type": "University", + "emg_type": "Advisory Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Toray Industries (America), Inc.", + "dept": "", + "role": "Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation", + "time_frame": 2013, + "org_type": "Industry", + "emg_type": "Clinical Study", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "Transoma Medical, Inc.", + "dept": "", + "role": "Principal Investigator: Implantable Monitoring for AF ablation Generating Insight & New Evidence", + "time_frame": 2009, + "org_type": "Industry", + "emg_type": "Grants / Funding", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "U.S. Food And Drug Administration", + "dept": "Task Force Committee", + "role": "Member", + "time_frame": "", + "org_type": "Association", + "emg_type": "Membership", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "University of Texas at Austin Dell Medical School", + "dept": "", + "role": "Professor", + "time_frame": "", + "org_type": "University", + "emg_type": "Teaching", + "Url1": "", + "Url2": "", + "Org ID": 24328 + }, + { + "id": "", + "user_id": 1841382421, + "org_name": "World Journal of Cardiology", + "dept": "Editorial Board", + "role": "Member", + "time_frame": 2009, + "org_type": "Others", + "emg_type": "Editorial Board", + "Url1": "", + "Url2": "", + "Org ID": 24328 + } + ], + "Events": [ + { + "id": 1, + "user_id": 1447203401, + "event_name": "Women's Health and Roe v. Wade 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Women's Health and Roe v. Wade", + "role": "Speaker", + "topic": "Education And Research", + "Start": "07/13/2022", + "End": "07/13/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 2, + "user_id": 1447203401, + "event_name": "What’s Ahead for Cardiology in 2022? 2021", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "What’s Ahead for Cardiology in 2022?", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "12/16/2021", + "End": "12/16/2021", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 3, + "user_id": 1447203401, + "event_name": "What's Ahead at ESC 2022 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "What's Ahead at ESC 2022", + "role": "Speaker", + "topic": "Education And Research", + "Start": "08/17/2022", + "End": "08/17/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 4, + "user_id": 1447203401, + "event_name": "What Makes a Workplace Hostile? 2021", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "What Makes a Workplace Hostile?", + "role": "Speaker", + "topic": "Education And Research", + "Start": "05/12/2021", + "End": "05/12/2021", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 5, + "user_id": 1447203401, + "event_name": "Toward Equity in Women’s Health Research 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Toward Equity in Women’s Health Research", + "role": "Speaker", + "topic": "Education And Research", + "Start": "11/17/2021", + "End": "11/17/2021", + "Organizer": "Swissnex", + "Organizer_Type": "Other", + "Sponsor": "Swissnex", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 6, + "user_id": 1447203401, + "event_name": "Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention", + "role": "Speaker", + "topic": "Aspirin | Ticagrelor", + "Start": "01/01/2022", + "End": "01/01/2022", + "Organizer": "CardiologyTalk", + "Organizer_Type": "Other", + "Sponsor": "CardiologyTalk", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 7, + "user_id": 1447203401, + "event_name": "The Next Generation 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "The Next Generation", + "role": "Speaker", + "topic": "Education And Research", + "Start": "06/15/2022", + "End": "06/15/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 8, + "user_id": 1447203401, + "event_name": "The Approach to the High-Risk of Bleeding Patient 2019", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "The Approach to the High-Risk of Bleeding Patient", + "role": "Speaker", + "topic": "Hemorrhage", + "Start": "06/18/2019", + "End": "06/18/2019", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 9, + "user_id": 1447203401, + "event_name": "TAVR in women. SMART trial 2020", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "TAVR in women. SMART trial", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "12/02/2020", + "End": "12/02/2020", + "Organizer": "Otamendi Sanatorium", + "Organizer_Type": "Other", + "Sponsor": "Otamendi Sanatorium", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 10, + "user_id": 1447203401, + "event_name": "TAVI Turns 20 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "TAVI Turns 20", + "role": "Speaker", + "topic": "Aortic Valve Disease", + "Start": "04/13/2022", + "End": "04/13/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 11, + "user_id": 1447203401, + "event_name": "Optimal DAPT Therapies 2020", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Optimal DAPT Therapies", + "role": "Speaker", + "topic": "Dual Anti-Platelet Therapy", + "Start": "02/21/2020", + "End": "02/21/2020", + "Organizer": "HMP Global", + "Organizer_Type": "Other", + "Sponsor": "HMP Global", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 12, + "user_id": 1447203401, + "event_name": "Lower the risk of bleeding in patients undregoing PCI: A clinical imperative? 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Lower the risk of bleeding in patients undregoing PCI: A clinical imperative?", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "04/09/2021", + "End": "04/09/2021", + "Organizer": "Sanofi", + "Organizer_Type": "Industry", + "Sponsor": "Sanofi", + "Sponsor_Type": "Industry", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 13, + "user_id": 1447203401, + "event_name": "International Women's Day 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "International Women's Day", + "role": "Speaker", + "topic": "Education And Research", + "Start": "03/09/2022", + "End": "03/09/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 14, + "user_id": 1447203401, + "event_name": "Innovation in Cardiology 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Innovation in Cardiology", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "01/21/2022", + "End": "01/21/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 15, + "user_id": 1447203401, + "event_name": "Hypertension in Women 2021", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Hypertension in Women", + "role": "Speaker", + "topic": "Hypertension", + "Start": "08/11/2021", + "End": "08/11/2021", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 16, + "user_id": 1447203401, + "event_name": "Heart Tank for the Cardiovascular Investigator 2020", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Heart Tank for the Cardiovascular Investigator", + "role": "Speaker", + "topic": "Heart | Heart Diseases", + "Start": "12/01/2020", + "End": "12/01/2020", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 17, + "user_id": 1447203401, + "event_name": "Heart Disease In Women: Global Burden Of Disease And The Main Recommendations Of The Lancet Commission 2022", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Heart Disease In Women: Global Burden Of Disease And The Main Recommendations Of The Lancet Commission", + "role": "Speaker", + "topic": "Heart | Heart Diseases", + "Start": "03/08/2022", + "End": "03/08/2022", + "Organizer": "Fundación Cardiológica Argentina", + "Organizer_Type": "Association", + "Sponsor": "Fundación Cardiológica Argentina", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 18, + "user_id": 1447203401, + "event_name": "Discussion on Quality Improvement Tools 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Discussion on Cardiovascular Angiography and Interventions", + "role": "Moderator", + "topic": "Angiography", + "Start": "09/10/2021", + "End": "09/10/2021", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 19, + "user_id": 1447203401, + "event_name": "Clinical Trials in the Time of Pandemic 2021", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Clinical Trials in the Time of Pandemic", + "role": "Speaker", + "topic": "Clinical Trials As Topic", + "Start": "11/18/2021", + "End": "11/18/2021", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 20, + "user_id": 1447203401, + "event_name": "Challenging Scenarios in the Cath Lab Webinar 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Challenging Scenarios in the Cath Lab", + "role": "Moderator", + "topic": "Catheterization", + "Start": "07/15/2021", + "End": "07/15/2021", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 21, + "user_id": 1447203401, + "event_name": "cardiology meetings during Covid-19 2020", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "cardiology meetings during Covid-19", + "role": "Speaker", + "topic": "Covid-19", + "Start": "09/10/2020", + "End": "09/10/2020", + "Organizer": "Rox Heart Radio", + "Organizer_Type": "Other", + "Sponsor": "Rox Heart Radio", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 22, + "user_id": 1447203401, + "event_name": "Cardio-Obstetrics at Mount Sinai 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Cardio-Obstetrics at Mount Sinai", + "role": "Speaker", + "topic": "Heart | Heart Diseases", + "Start": "04/18/2021", + "End": "04/18/2021", + "Organizer": "The Mount Sinai Hospital", + "Organizer_Type": "University/Hospital", + "Sponsor": "The Mount Sinai Hospital", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 23, + "user_id": 1447203401, + "event_name": "Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease 2020", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease", + "role": "Speaker", + "topic": "Atrial Fibrillation", + "Start": "07/23/2020", + "End": "07/23/2020", + "Organizer": "Anticoagulation Forum", + "Organizer_Type": "Other", + "Sponsor": "Anticoagulation Forum", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 24, + "user_id": 1447203401, + "event_name": "AI in Medicine 2022", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "AI in Medicine", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "05/11/2022", + "End": "05/11/2022", + "Organizer": "Apple Inc", + "Organizer_Type": "Other", + "Sponsor": "Apple Inc", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 25, + "user_id": 1447203401, + "event_name": "2024 Society for Cardiovascular Angiography and Interventions Scientific Sessions", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "History of WaO and SCAI WIN: How far we’ve Come, and how far we Must Go", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "Long Beach Convention Center", + "Address": "300 E Ocean Blvd", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://scai.confex.com/scai/2024/meetingapp.cgi/Day/2024-05-02", + "Url2": "" + }, + { + "id": 26, + "user_id": 1447203401, + "event_name": "2024 Society for Cardiovascular Angiography & Interventions Scientific Sessions (SCAI)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "Round Table Discussion Leader", + "role": "Speaker", + "topic": "Angiography", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "ZOLL Medical Corporation", + "Sponsor_Type": "Industry", + "Location": "Long Beach Convention & Entertainment Center", + "Address": "300 East Ocean Boulevard", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://scai.confex.com/scai/2024/meetingapp.cgi/Day/2024-05-02", + "Url2": "" + }, + { + "id": 27, + "user_id": 1447203401, + "event_name": "2024 Society for Cardiovascular Angiography & Interventions Scientific Sessions (SCAI)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "History of WaO and SCAI WIN: How far we’ve Come, and how far we Must Go!", + "role": "Speaker", + "topic": "Angiography", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "Long Beach Convention & Entertainment Center", + "Address": "300 East Ocean Boulevard", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://scai.confex.com/scai/2024/meetingapp.cgi/Day/2024-05-02", + "Url2": "" + }, + { + "id": 28, + "user_id": 1447203401, + "event_name": "2024 Society for Cardiovascular Angiography & Interventions Scientific Sessions (SCAI)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "Prehospital Therapy for STEMI: Current Challenges and Unmet Needs", + "role": "Speaker", + "topic": "ST Elevation Myocardial Infarction", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "CeleCor Therapeutics", + "Sponsor_Type": "Industry", + "Location": "Long Beach Convention & Entertainment Center", + "Address": "300 East Ocean Boulevard", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://scai.confex.com/scai/2024/meetingapp.cgi/Day/2024-05-02", + "Url2": "" + }, + { + "id": 29, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Director", + "topic": "Admin. & Management", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 30, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Left Main, Bifurcation Lesions and LV Support", + "role": "Moderator", + "topic": "Bifurcation Lesions | Coronary Artery Disease | Heart-Assist Devices", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 31, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Inflammation", + "role": "Speaker", + "topic": "Inflammation", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 32, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Discussion on the Latest in Managing Co-Morbidities in Complex PCI", + "role": "Moderator", + "topic": "Comorbidity | Percutaneous Coronary Intervention", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 33, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Diffuse Calcified Bifurcation Lesions", + "role": "Moderator", + "topic": "Bifurcation Lesions | Coronary Artery Disease | Vascular Calcification", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 34, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Calcified Bifurcation Undilatable Lesions", + "role": "Moderator", + "topic": "Bifurcation Lesions | Coronary Artery Disease | Vascular Calcification", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 35, + "user_id": 1447203401, + "event_name": "2024 Icahn School of Medicine at Mount Sinai Complex Coronary Case Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Contrast-Induced Nephropathy", + "role": "Speaker", + "topic": "Kidney Diseases", + "Start": "06/13/2024", + "End": "06/14/2024", + "Organizer": "Icahn School of Medicine at Mount Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Icahn School of Medicine at Mount Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://cccsymposium.org/", + "Url2": "" + }, + { + "id": 36, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Great Debate: mechanical circulatory support in cardiogenic shock - 'the course of true love never did run smooth'", + "role": "Chair", + "topic": "Mechanical Circulatory Support | Shock, Cardiogenic", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 37, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Transforming TAVI practice: evidence, equity, and durability", + "role": "Chair", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 38, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "ChatGPT, Copilot, and other large language models (LLMs): transforming cardiovascular education, care, and science", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 39, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Update from The Lancet Women and Cardiovascular Disease Commission", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 40, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "SMART Trial results - a landmark head-to-head randomised controlled TAVI trial", + "role": "Speaker", + "topic": "Randomized Controlled Trials As Topic | SMART Trial | Transcatheter Aortic Valve Replacement", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 41, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Durability in TAVI valves: data, predictors, and real-world insights", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 42, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Ischaemia reperfusion injury", + "role": "Speaker", + "topic": "Ischemia | Reperfusion Injury", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Faraday Pharmaceuticals", + "Sponsor_Type": "Industry", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 43, + "user_id": 1447203401, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Inflammation in acute myocardial infarction (AMI): where do we stand?", + "role": "Speaker", + "topic": "Inflammation | Myocardial Infarction", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 44, + "user_id": 1447203401, + "event_name": "2024 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "05/14/2024", + "End": "05/17/2024", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "The Palais des Congrès in Paris", + "Address": "2 Place de la Pte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://www.pcronline.com/Courses/EuroPCR", + "Url2": "" + }, + { + "id": 45, + "user_id": 1447203401, + "event_name": "2024 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Targeting inflammation in AMI: a debate", + "role": "Faculty", + "topic": "Acute Myocardial Infarction | Inflammation", + "Start": "05/14/2024", + "End": "05/17/2024", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "The Palais des Congrès in Paris", + "Address": "2 Place de la Pte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://www.pcronline.com/Courses/EuroPCR", + "Url2": "" + }, + { + "id": 46, + "user_id": 1447203401, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Women In Cardiology – Beyond Awareness: Taking Action To Improve Outcomes In Women With Aortic Stenosis", + "role": "Moderator", + "topic": "Aortic Valve Stenosis | Heart Diseases | Women's Health", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 47, + "user_id": 1447203401, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Women And Tavr: Undiagnosed And Untreated", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 48, + "user_id": 1447203401, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "How To Minimize Disparity In Clinical Trials", + "role": "Speaker", + "topic": "Clinical Trials As Topic", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 49, + "user_id": 1447203401, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Leveraging Real-World Evidence: Where Are We Now And What Lies Ahead?", + "role": "Faculty", + "topic": "Evidence-Based Practice", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 89, + "user_id": 1447203401, + "event_name": "2023 Society of Thoracic Surgeons Coronary Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Challenges to Revascularization in Women", + "role": "Speaker", + "topic": "Myocardial Revascularization", + "Start": "06/03/2023", + "End": "06/04/2023", + "Organizer": "The Society of Thoracic Surgeons", + "Organizer_Type": "Association", + "Sponsor": "The Society of Thoracic Surgeons", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Miami", + "Postal_Code": "", + "Url1": "https://www.sts.org/meetings/2023-sts-coronary-conference-agenda", + "Url2": "" + }, + { + "id": 90, + "user_id": 1447203401, + "event_name": "2023 Society of Thoracic Surgeons Coronary Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Who Are the Best Candidates for Hybrid Coronary Revascularization?", + "role": "Speaker", + "topic": "Coronary Artery Disease", + "Start": "06/03/2023", + "End": "06/04/2023", + "Organizer": "The Society of Thoracic Surgeons", + "Organizer_Type": "Association", + "Sponsor": "The Society of Thoracic Surgeons", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Miami", + "Postal_Code": "", + "Url1": "https://www.sts.org/meetings/2023-sts-coronary-conference-agenda", + "Url2": "" + }, + { + "id": 91, + "user_id": 1447203401, + "event_name": "2023 Scripps Health Arrhythmias and Cardiomyopathy in Women Annual Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Sex and Gender Related Differences ACS – Reducing the Global Burden of CVD in Women", + "role": "Speaker", + "topic": "Acute Coronary Syndrome | COVID-19", + "Start": "02/11/2023", + "End": "02/11/2023", + "Organizer": "Scripps Health", + "Organizer_Type": "University/Hospital", + "Sponsor": "Scripps Health", + "Sponsor_Type": "University/Hospital", + "Location": "San Diego Marriott La Jolla", + "Address": "", + "Country": "United States", + "State": "California", + "City": "La Jolla", + "Postal_Code": "", + "Url1": "https://www.scripps.org/event_schedules/3645-third-annual-scripps-arrhythmias-and-cardiomyopathy-in-women-symposium/agenda-arrhythmias-and-cardiomyopathy-in-women-2023", + "Url2": "" + }, + { + "id": 92, + "user_id": 1447203401, + "event_name": "2023 PCR London Valves Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?", + "role": "Speaker", + "topic": "Anticoagulation | Transcatheter Aortic Valve Replacement", + "Start": "11/19/2023", + "End": "11/21/2023", + "Organizer": "Europa Group, European association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Organizer_Type": "Other", + "Sponsor": "Europa Group, European association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Sponsor_Type": "Other", + "Location": "ExCel London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://www.pcronline.com/Courses/PCR-London-Valves/Programme/2023/Course-Programme", + "Url2": "" + }, + { + "id": 93, + "user_id": 1447203401, + "event_name": "2023 PCR London Valves Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "New devices for tricuspid valve intervention", + "role": "Faculty", + "topic": "Transcatheter Tricuspid Valve Intervention", + "Start": "11/19/2023", + "End": "11/21/2023", + "Organizer": "Europa Group, European association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Organizer_Type": "Other", + "Sponsor": "Europa Group, European association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Sponsor_Type": "Other", + "Location": "ExCel London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://www.pcronline.com/Courses/PCR-London-Valves/Programme/2023/Course-Programme", + "Url2": "" + }, + { + "id": 94, + "user_id": 1447203401, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Non-Invasive Non-Liver Evaluations in MASLD/MASH TRIALS. 'Must Have' Vs. 'Good To Have'?", + "role": "Chair", + "topic": "Non-alcoholic Fatty Liver Disease", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 95, + "user_id": 1447203401, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Atherosclerosis endpoints: Imaging", + "role": "Speaker", + "topic": "Atherosclerosis | Diagnostic Imaging", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 96, + "user_id": 1447203401, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "The MOSAIC Multistakeholder Panel Debate SHORTLISTING NON-INVASIVE NON-LIVER EVALUATIONS FOR MASLD/MASH TRIALS", + "role": "Chair", + "topic": "Non-alcoholic Fatty Liver Disease", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 97, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Discussion on Interventional Cardiology", + "role": "Director", + "topic": "Catheters | Heart Diseases", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 98, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "DCB", + "role": "Chair", + "topic": "Angioplasty, Balloon", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 99, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Live Cases From Milan", + "role": "Chair", + "topic": "Heart Diseases", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "Alvimedica", + "Sponsor_Type": "Industry", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 100, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Antithrombotic after PCI: dealing with DAPT dilemmas; balancing ischemic and bleeding risks", + "role": "Chair", + "topic": "Dual Anti-Platelet Therapy | Fibrinolytic Agents | Hemorrhage | Ischemia | Percutaneous Coronary Intervention", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 101, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "State of the art: Antithrombotic choices in AF pts undergoing PCI: state of the art - US and European perspectives", + "role": "Speaker", + "topic": "Atrial Fibrillation | Fibrinolytic Agents | Percutaneous Coronary Intervention", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 102, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Beyond PCI: secondary prevention. What every Interventionalists needs to Know - Lipids; inflammation and more", + "role": "Chair", + "topic": "Inflammation | Percutaneous Coronary Intervention", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 103, + "user_id": 1447203401, + "event_name": "2023 Italian Society of Interventional Cardiology Joint Interventional Meeting (GISE)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Lp(a): the new kid on the block", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "02/09/2023", + "End": "02/11/2023", + "Organizer": "OIC S.r.l", + "Organizer_Type": "Other", + "Sponsor": "OIC S.r.l", + "Sponsor_Type": "Other", + "Location": "Rosa Grand", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "http://jimgise2023.it/wp-content/uploads/2023/02/GiseJim_2023_PROGRAMMA_9-2-2023.pdf", + "Url2": "" + }, + { + "id": 104, + "user_id": 1447203401, + "event_name": "2023 Global Heart Conference - Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Heart Disease & Failure", + "role": "Speaker", + "topic": "Heart | Heart Diseases | Heart Failure", + "Start": "01/23/2023", + "End": "01/24/2023", + "Organizer": "Conference Mind PVT. LTD", + "Organizer_Type": "Other", + "Sponsor": "Conference Mind PVT. LTD", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://www.conferencemind.com/conference/globalheartconference#Scientific_Sessions", + "Url2": "" + }, + { + "id": 105, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Innovations in cardiovascular medicine that impact clinical practice", + "role": "Chair", + "topic": "Cardiovascular Diseases", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 106, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Exploring the role of novel CETP inhibitors in lipid management", + "role": "Speaker", + "topic": "Cholesterol Ester Transfer Proteins | Lipids", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 107, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Drivers of cardiovascular risk: systemic inflammation and LDL-C", + "role": "Speaker", + "topic": "Cholesterol, LDL | Heart Disease Risk Factors | Inflammation", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 108, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Targeting inflammation in atherosclerotic cardiovascular disease: what do we know?", + "role": "Speaker", + "topic": "Atherosclerosis | Cardiovascular Diseases", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 109, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Inflammation, chronic kidney disease and cardiovascular outcomes: what is the current status?", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Inflammation | Renal Insufficiency, Chronic", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 110, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Looking beyond the atherosclerotic cardiovascular disease / chronic kidney disease clinical care pathway: what is on the horizon?", + "role": "Speaker", + "topic": "Atherosclerosis | Cardiovascular Diseases | Critical Pathways | Renal Insufficiency, Chronic", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 111, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "EuroHeart on the road to international quality registries and registry-based trials", + "role": "Chair", + "topic": "Heart Diseases", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 112, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Aortic stenosis and TAVI: new trials, devices and data", + "role": "Chair", + "topic": "Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 113, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Overcoming echo acquisition challenges in aortic stenosis", + "role": "Speaker", + "topic": "Aortic Valve Stenosis | Echocardiography", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 114, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "TAVI Evolut-ion - data, and new devices", + "role": "Speaker", + "topic": "Heart-Assist Devices | Transcatheter Aortic Valve Replacement", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtronic", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 115, + "user_id": 1447203401, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Defining essential principles for Medical device trials", + "role": "Speaker", + "topic": "Medical Device Trials", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 116, + "user_id": 1447203401, + "event_name": "2023 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Late-Breaking Clinical Data: Tavi", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "05/16/2023", + "End": "05/19/2023", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "Palais des Congrès in Paris", + "Address": "2 Place de la Porte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2023.pdf", + "Url2": "" + }, + { + "id": 117, + "user_id": 1447203401, + "event_name": "2023 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Bifurcation: Live Case From Policlinico Universitario Fondazione Agostino Gemelli, Rome - Italy", + "role": "Speaker", + "topic": "Coronary Vessels | Myocardial Ischemia", + "Start": "05/16/2023", + "End": "05/19/2023", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "Palais des Congrès in Paris", + "Address": "2 Place de la Porte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2023.pdf", + "Url2": "" + }, + { + "id": 118, + "user_id": 1447203401, + "event_name": "2023 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Multivessel Disease - Which Patients For Pci, Cabg Or Medical Treatment?", + "role": "Speaker", + "topic": "Coronary Artery Bypass | Percutaneous Coronary Intervention", + "Start": "05/16/2023", + "End": "05/19/2023", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "Palais des Congrès in Paris", + "Address": "2 Place de la Porte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2023.pdf", + "Url2": "" + }, + { + "id": 119, + "user_id": 1447203401, + "event_name": "2023 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "A Patient With Multivessel Disease", + "role": "Speaker", + "topic": "Cerebral Small Vessel Diseases", + "Start": "05/16/2023", + "End": "05/19/2023", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "Palais des Congrès in Paris", + "Address": "2 Place de la Porte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2023.pdf", + "Url2": "" + }, + { + "id": 120, + "user_id": 1447203401, + "event_name": "2023 European Association of Percutaneous Cardiovascular Interventions Annual Meeting (EuroPCR)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Treatment Strategy", + "role": "Speaker", + "topic": "Coronary Artery Disease", + "Start": "05/16/2023", + "End": "05/19/2023", + "Organizer": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Organizer_Type": "Other", + "Sponsor": "European Association of Percutaneous Cardiovascular Interventions (EuroPCR), Europa Group", + "Sponsor_Type": "Other", + "Location": "Palais des Congrès in Paris", + "Address": "2 Place de la Porte Maillot", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": 75017, + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2023.pdf", + "Url2": "" + }, + { + "id": 121, + "user_id": 1447203401, + "event_name": "2023 Cleveland Clinic Veith Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "What Is New In Coronary Artery Stenting: What Is The Role For Bare Metal Stents", + "role": "Speaker", + "topic": "Bare Metal Stents | Coronary Artery Stenting", + "Start": "11/14/2023", + "End": "11/18/2023", + "Organizer": "Cleveland Clinic", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cleveland Clinic", + "Sponsor_Type": "University/Hospital", + "Location": "New York Hilton Midtown", + "Address": "1335 6th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10019, + "Url1": "https://www.veithsymposium.org/index.php?pg=program-2023", + "Url2": "" + }, + { + "id": 122, + "user_id": 1447203401, + "event_name": "2023 Cleveland Clinic Veith Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Progress In Coronary Artery Stenting, Transcatheter Valve Replacement, And Treatment Of Ascending Aortic Disease", + "role": "Moderator", + "topic": "Aortic Diseases | Coronary Artery Stenting | Transcatheter Aortic Valve Replacement", + "Start": "11/14/2023", + "End": "11/18/2023", + "Organizer": "Cleveland Clinic", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cleveland Clinic", + "Sponsor_Type": "University/Hospital", + "Location": "New York Hilton Midtown", + "Address": "1335 6th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10019, + "Url1": "https://www.veithsymposium.org/index.php?pg=program-2023", + "Url2": "" + }, + { + "id": 123, + "user_id": 1447203401, + "event_name": "2023 Cleveland Clinic Veith Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work)", + "role": "Speaker", + "topic": "PCSK9 Inhibitors | Vascular Diseases", + "Start": "11/14/2023", + "End": "11/18/2023", + "Organizer": "Cleveland Clinic", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cleveland Clinic", + "Sponsor_Type": "University/Hospital", + "Location": "New York Hilton Midtown", + "Address": "1335 6th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10019, + "Url1": "https://www.veithsymposium.org/index.php?pg=program-2023", + "Url2": "" + }, + { + "id": 124, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Sex-Based Outcomes After Pci In Complex High Bleeding Risk Patients: 2-Year Results From The Onyx One Clear Study", + "role": "Speaker", + "topic": "Hemorrhage | Percutaneous Coronary Intervention", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 125, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Optimization Of Anticoagulation Therapy For Acs Patients", + "role": "Moderator", + "topic": "Acute Coronary Syndrome | Anticoagulation Bridge", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 126, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Balancing Ischemic And Bleeding Risk With Antiplatelet Therapy – Personalizing Treatment To Optimize Outcomes", + "role": "Moderator", + "topic": "Dual Anti-Platelet Therapy | Hemorrhage | Ischemia", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 127, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Women Leaders In Interventional Cardiology", + "role": "Speaker", + "topic": "Cardiac Catheters | Catheter-Related Infections", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 128, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Monotherapy For Every Patient - Drop Aspirin", + "role": "Speaker", + "topic": "Aspirin | Therapeutics", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 129, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Optimal Duration Of Dapt - How To Optimize Future Study Designs", + "role": "Speaker", + "topic": "Dual Anti-Platelet Therapy", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 130, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Defining Peri-Procedural Mi In Clinical Trials", + "role": "Faculty", + "topic": "Myocardial Infarction", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 131, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Featured Clinical Science Session", + "role": "Moderator", + "topic": "Medical Laboratory Science", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 132, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Monotherapy For All Ready For Prime Time", + "role": "Speaker", + "topic": "Therapeutics", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 133, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Are Risk Scoring Systems Still Useful In Selecting Acs Patients For Angiography", + "role": "Speaker", + "topic": "Acute Coronary Syndrome | Angiography", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 134, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Contemporary Topics In Stemi And Acs", + "role": "Speaker", + "topic": "Acute Coronary Syndrome | ST Elevation Myocardial Infarction", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 135, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Stemi 2022 Contemporary Topics Thrombus Management And Anticoagulation", + "role": "Speaker", + "topic": "Anticoagulation Bridge | ST Elevation Myocardial Infarction | Thrombosis", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "CRTonline.org", + "Organizer_Type": "Other", + "Sponsor": "CRTonline.org", + "Sponsor_Type": "Other", + "Location": "Omni Shoreham Hotel", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 136, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Tavr Complex Anatomies And New Procedural Techniques", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "06/07/2023", + "End": "06/10/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Phoenix Convention Center", + "Address": "100 North 3rd Street", + "Country": "United States", + "State": "Arizona", + "City": "Phoenix", + "Postal_Code": 85004, + "Url1": "https://tvt2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 137, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Low Gradient As, Valve Hemodynamics, And The Small Annulus Patient: Plenty Of Room For Debate", + "role": "Moderator", + "topic": "Aortic Valve Stenosis | Cardiac Valve Annuloplasty | Hemodynamics", + "Start": "06/07/2023", + "End": "06/10/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Phoenix Convention Center", + "Address": "100 North 3rd Street", + "Country": "United States", + "State": "Arizona", + "City": "Phoenix", + "Postal_Code": 85004, + "Url1": "https://tvt2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 138, + "user_id": 1447203401, + "event_name": "2023 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Important New Fda Regulatory Pathways", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "06/07/2023", + "End": "06/10/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Phoenix Convention Center", + "Address": "100 North 3rd Street", + "Country": "United States", + "State": "Arizona", + "City": "Phoenix", + "Postal_Code": 85004, + "Url1": "https://tvt2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 139, + "user_id": 1447203401, + "event_name": "2023 Annual Cardiovascular Research Technologies Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Are Risk Scoring Systems Still Useful in Selecting ACS Patients for Angiography?", + "role": "Speaker", + "topic": "Acute Coronary Syndrome | Angiography", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 140, + "user_id": 1447203401, + "event_name": "2023 American Heart Association Scientific Sessions (AHA)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "TCT at AHA: Emerging Data from Key Trials in the Interventional Space", + "role": "Moderator", + "topic": "Cardiovascular Diseases | Transcatheter Aortic Valve Replacement", + "Start": "11/11/2023", + "End": "11/13/2023", + "Organizer": "American Heart Association, Inc.", + "Organizer_Type": "Association", + "Sponsor": "American Heart Association, Inc.", + "Sponsor_Type": "Association", + "Location": "Pennsylvania Convention Center", + "Address": "1101 Arch Street", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19107, + "Url1": "https://www.abstractsonline.com/pp8/?_ga=2.62588588.1409085307.1693826434-41755426.1693826431#!/10871", + "Url2": "" + }, + { + "id": 141, + "user_id": 1447203401, + "event_name": "2023 American Heart Association Scientific Sessions (AHA)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care", + "role": "Chair", + "topic": "Anticoagulants | Thrombosis", + "Start": "11/11/2023", + "End": "11/13/2023", + "Organizer": "American Heart Association, Inc.", + "Organizer_Type": "Association", + "Sponsor": "PeerView, Bristol-Myers Squibb Company", + "Sponsor_Type": "Other", + "Location": "Pennsylvania Convention Center", + "Address": "1101 Arch Street", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19107, + "Url1": "https://www.abstractsonline.com/pp8/?_ga=2.62588588.1409085307.1693826434-41755426.1693826431#!/10871", + "Url2": "" + }, + { + "id": 142, + "user_id": 1447203401, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Dead, Alive Or Somewhere In Between: Viability/Ischemia Testing Still Useful", + "role": "Faculty", + "topic": "Ischemia", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 143, + "user_id": 1447203401, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Interventional Cardiology", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 179, + "user_id": 1447203401, + "event_name": "2022 Olympiad in Cardiovascular Medicine International Symposium on Experimental & Clinical Cardiology", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Current Trends in Cardiology Clinical Practice and Research", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "04/27/2022", + "End": "04/30/2022", + "Organizer": "Masonic Medical Research Institute", + "Organizer_Type": "Other", + "Sponsor": "Masonic Medical Research Institute", + "Sponsor_Type": "Other", + "Location": "Galaxy Hotel Heraklion", + "Address": "75 Dimokratias Avenue", + "Country": "Greece", + "State": "", + "City": "", + "Postal_Code": 71306, + "Url1": "", + "Url2": "" + }, + { + "id": 180, + "user_id": 1447203401, + "event_name": "2022 Mount Sinai Hospital Top Ten Topics in Clinical Cardiology Course", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Long-Term Antiplatelet /Antithrombotic Therapies in Stable CAD (Post PCI/MI)", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "10/21/2022", + "End": "10/21/2022", + "Organizer": "The Mount Sinai Hospital", + "Organizer_Type": "University/Hospital", + "Sponsor": "The Mount Sinai Hospital", + "Sponsor_Type": "University/Hospital", + "Location": "Hatch Auditorium (2nd Floor)", + "Address": "", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": "", + "Url1": "https://mssm.cloud-cme.com/assets/MSSM/data/TopTen2022_Bro8a.pdf", + "Url2": "" + }, + { + "id": 181, + "user_id": 1447203401, + "event_name": "2022 Leipzig Interventional Course", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "How should you approach patients with a vasculogenic erectile dysfunction?", + "role": "Moderator", + "topic": "Erectile Dysfunction", + "Start": "06/06/2022", + "End": "06/09/2022", + "Organizer": "Leipzig Interventional Course", + "Organizer_Type": "Other", + "Sponsor": "Leipzig Interventional Course", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Germany", + "State": "Sachsen", + "City": "Leipzig", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 182, + "user_id": 1447203401, + "event_name": "2022 Joint Interventional Meeting", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Organizing Committee", + "role": "Director", + "topic": "Admin. & Management", + "Start": "02/10/2022", + "End": "02/12/2022", + "Organizer": "Victory Project Congressi", + "Organizer_Type": "Other", + "Sponsor": "Victory Project Congressi", + "Sponsor_Type": "Other", + "Location": "Grand Visconti Palace Hotel", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 183, + "user_id": 1447203401, + "event_name": "2022 Joint Interventional Meeting", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Drug-Coated Balloons And Innovation In Pci", + "role": "Chair", + "topic": "Percutaneous Coronary Intervention", + "Start": "02/10/2022", + "End": "02/12/2022", + "Organizer": "Victory Project Congressi", + "Organizer_Type": "Other", + "Sponsor": "Victory Project Congressi", + "Sponsor_Type": "Other", + "Location": "Grand Visconti Palace Hotel", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 184, + "user_id": 1447203401, + "event_name": "2022 Joint Interventional Meeting", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Discussion On Pci Complication", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "02/10/2022", + "End": "02/12/2022", + "Organizer": "Victory Project Congressi", + "Organizer_Type": "Other", + "Sponsor": "Victory Project Congressi", + "Sponsor_Type": "Other", + "Location": "Grand Visconti Palace Hotel", + "Address": "", + "Country": "Italy", + "State": "Lombardia", + "City": "Milano", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 185, + "user_id": 1447203401, + "event_name": "2022 International Society for Cardiovascular Translational Research Course Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Guideline Requirements for Diagnostic Devices", + "role": "Speaker", + "topic": "Heart-Assist Devices", + "Start": "01/01/2022", + "End": "01/01/2022", + "Organizer": "International Society for Cardiovascular Translational Research", + "Organizer_Type": "Association", + "Sponsor": "International Society For Cardiovascular Translational Research", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 186, + "user_id": 1447203401, + "event_name": "2022 Heart Valve Society Annual Meting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Shared Decision Making In Treatment Aortic Stenosis: From The Mechanical Surgical Prosthesis To Tavr", + "role": "Speaker", + "topic": "Aortic Valve Stenosis | Therapeutic And Diagnostic Procedure", + "Start": "03/02/2022", + "End": "03/05/2022", + "Organizer": "The Heart Valve Society", + "Organizer_Type": "Association", + "Sponsor": "The Heart Valve Society", + "Sponsor_Type": "Association", + "Location": "Eden Roc Miami Beach", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Miami Beach", + "Postal_Code": "", + "Url1": "https://heartvalvesociety.org/meeting/program/2022/", + "Url2": "" + }, + { + "id": 187, + "user_id": 1447203401, + "event_name": "2022 Harvard Medical School Advancing Cardiovascular Care for Women Conference - Virtual", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Global Burden Of Cardiovascular Disease In Women", + "role": "Speaker", + "topic": "Heart Diseases | Women'S Health", + "Start": "05/20/2022", + "End": "05/20/2022", + "Organizer": "Harvard Medical School", + "Organizer_Type": "University/Hospital", + "Sponsor": "Harvard Medical School", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://cmeregistration.hms.harvard.edu/events/advancing-cardiovascular-care-for-women/event-summary-ed5fa9c40b3141ba9f5a5d0a627321cc.aspx", + "Url2": "" + }, + { + "id": 188, + "user_id": 1447203401, + "event_name": "2022 Global Cardiovascular Clinical Trialists Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Early Feasibility Studies: Efforts To Increase The Clinical Evaluation Of Innovative Technologies", + "role": "Chair", + "topic": "Cardiac Surgical Procedures", + "Start": "12/01/2022", + "End": "12/03/2022", + "Organizer": "CVCT Forum", + "Organizer_Type": "Other", + "Sponsor": "CVCT Forum", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.globalcvctforum.com/_files/ugd/d5bd15_bb9a879bfa47470592e4e2d1ebb039a5.pdf", + "Url2": "" + }, + { + "id": 189, + "user_id": 1447203401, + "event_name": "2022 Global Cardiovascular Clinical Trialists Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "How To Promote Innovative Technologies Through Early Feasibility Studies", + "role": "Chair", + "topic": "Cardiac Surgical Procedures", + "Start": "12/01/2022", + "End": "12/03/2022", + "Organizer": "CVCT Forum", + "Organizer_Type": "Other", + "Sponsor": "CVCT Forum", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.globalcvctforum.com/_files/ugd/d5bd15_bb9a879bfa47470592e4e2d1ebb039a5.pdf", + "Url2": "" + }, + { + "id": 195, + "user_id": 1447203401, + "event_name": "2022 German Society for Cardiology Annual Meeting", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "My Top 3 Publications In Coronary Artery Disease In The Last 12 Months", + "role": "Speaker", + "topic": "Coronary Artery Disease | Coronary Vessels | Disease", + "Start": "04/20/2022", + "End": "04/26/2022", + "Organizer": "German Society for Cardiology", + "Organizer_Type": "Association", + "Sponsor": "German Society for Cardiology", + "Sponsor_Type": "Association", + "Location": "Congress Center Rosengarten", + "Address": "", + "Country": "Germany", + "State": "Baden-Wurttemberg", + "City": "Mannheim", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 196, + "user_id": 1447203401, + "event_name": "2022 European Society of Cardiology Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Post-ACS: the patient, and the Guidelines", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "08/26/2022", + "End": "08/29/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medscape", + "Sponsor_Type": "Other", + "Location": "Fira Barcelona Gran Via", + "Address": "", + "Country": "Spain", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/esc-congress/schedule", + "Url2": "" + }, + { + "id": 197, + "user_id": 1447203401, + "event_name": "2022 European Society of Cardiology Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Lipid lowering and antiplatelet strategies post-ACS", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "08/26/2022", + "End": "08/29/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medscape", + "Sponsor_Type": "Other", + "Location": "Fira Barcelona Gran Via", + "Address": "", + "Country": "Spain", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/esc-congress/schedule", + "Url2": "" + }, + { + "id": 198, + "user_id": 1447203401, + "event_name": "2022 EuroPCR Course", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Left Main Bifurcation Stenting", + "role": "Speaker", + "topic": "Coronary Disease | Stents", + "Start": "05/17/2022", + "End": "05/20/2022", + "Organizer": "European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Sponsor_Type": "Association", + "Location": "Paris Convention Centre", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2022.pdf", + "Url2": "" + }, + { + "id": 199, + "user_id": 1447203401, + "event_name": "2022 EuroPCR Course", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "What'S Next In Des Technology? Innovative Des Platforms Combining Des With Dcb", + "role": "Speaker", + "topic": "Heart Diseases | Percutaneous Coronary Intervention", + "Start": "05/17/2022", + "End": "05/20/2022", + "Organizer": "European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Organizer_Type": "Association", + "Sponsor": "Concept Medical Inc", + "Sponsor_Type": "Industry", + "Location": "Paris Convention Centre", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2022.pdf", + "Url2": "" + }, + { + "id": 200, + "user_id": 1447203401, + "event_name": "2022 EuroPCR Course", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "A View To The Future: Indications And Rationale For Approach", + "role": "Speaker", + "topic": "Heart Diseases | Percutaneous Coronary Intervention", + "Start": "05/17/2022", + "End": "05/20/2022", + "Organizer": "European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI)", + "Organizer_Type": "Association", + "Sponsor": "Concept Medical Inc", + "Sponsor_Type": "Industry", + "Location": "Paris Convention Centre", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "https://programme.europa-organisation.com/administrator/components/com_program/states/programme_europcr-2022.pdf", + "Url2": "" + }, + { + "id": 201, + "user_id": 1447203401, + "event_name": "2022 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Catalysing a more equitable workforce in medicine – Women as One", + "role": "Speaker", + "topic": "Education And Research", + "Start": "05/17/2022", + "End": "05/20/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 202, + "user_id": 1447203401, + "event_name": "2022 Dallas Cardiovascular Updates Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Revascularization Guideline updates", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "02/19/2022", + "End": "02/19/2022", + "Organizer": "Foundation for Advanced Cardiovascular Education and Training", + "Organizer_Type": "Association", + "Sponsor": "Foundation For Advanced Cardiovascular Education And Training", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 345, + "user_id": 1447203401, + "event_name": "2019 European Society of Cardiology Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results?", + "role": "Speaker", + "topic": "Acute Coronary Syndrome | Coronary Artery Disease | Platelet Aggregation Inhibitors", + "Start": "08/31/2019", + "End": "09/05/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 346, + "user_id": 1447203401, + "event_name": "2019 European Society of Cardiology Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Innovative strategies in percutaneous coronary intervention", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "08/31/2019", + "End": "09/05/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 347, + "user_id": 1447203401, + "event_name": "2019 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "High-bleeding risk PCI patients enrolled in ongoing clinical trials", + "role": "Chair", + "topic": "Percutaneous Coronary Intervention", + "Start": "05/21/2019", + "End": "05/24/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 348, + "user_id": 1447203401, + "event_name": "2019 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Ability to treat diabetic patients: DES + DCB strategy", + "role": "Chair", + "topic": "Diabetes Mellitus", + "Start": "05/21/2019", + "End": "05/24/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 349, + "user_id": 1447203401, + "event_name": "2019 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "All you need to know about high-bleeding risk (HBR) patients", + "role": "Speaker", + "topic": "Hemorrhage", + "Start": "05/21/2019", + "End": "05/24/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 350, + "user_id": 1447203401, + "event_name": "2019 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Why you should treat your PCI patients with the COMBO Plus stent – Insight from clinical-based evidence", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "05/21/2019", + "End": "05/24/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 351, + "user_id": 1447203401, + "event_name": "2019 EuroPCR Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Obstructive and non-obstructive coronary disease in women", + "role": "Chair", + "topic": "Coronary Artery Disease", + "Start": "05/21/2019", + "End": "05/24/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "France", + "State": "Ile-De-France", + "City": "Paris", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 368, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Drop ASA/ REDUCE Duration", + "role": "Speaker", + "topic": "Anesthesia", + "Start": "09/25/2019", + "End": "09/29/2019", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 369, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Final Words", + "role": "Speaker", + "topic": "Education And Research", + "Start": "09/25/2019", + "End": "09/29/2019", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 370, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Guideline Requirement for Diagnostic Devices", + "role": "Speaker", + "topic": "Reagent Kits, Diagnostic", + "Start": "09/25/2019", + "End": "09/29/2019", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 371, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Discussion on Cardiovascular", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Cardiovascular System", + "Start": "09/25/2019", + "End": "09/29/2019", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 372, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Innovations Foundations Digital Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "How to select patients for PCI: from COURAGE to ISCHEMIA", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention", + "Start": "07/18/2019", + "End": "07/20/2019", + "Organizer": "Cardiovascular Innovations Foundations", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Innovations Foundations", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 373, + "user_id": 1447203401, + "event_name": "2019 Cardiovascular Innovations Foundations Digital Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "PCI How-to Part 4: Complex Lesions and Patients", + "role": "Moderator", + "topic": "Percutaneous Coronary Intervention", + "Start": "07/18/2019", + "End": "07/20/2019", + "Organizer": "Cardiovascular Innovations Foundations", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Innovations Foundations", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 374, + "user_id": 1447203401, + "event_name": "2019 American College Of Cardiology Scientific Sessions", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Dual antiplatelet therapy (dapt) cessation and cardiovascular risk in relation to age: analysis from the paris (patterns of nonadherence to anti-platelet regimens in stented patients) registry", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Dual Anti-Platelet Therapy", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 394, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Medical Management Post AVR", + "role": "Faculty", + "topic": "Aortic Valve Replacement", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 395, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Incorporation of PROs in Composite Endpoints: Is the Win Ratio the Optimal Approach?", + "role": "Faculty", + "topic": "Patient Reported Outcome Measures", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 396, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?", + "role": "Faculty", + "topic": "Guideline-Directed Medical Therapy | Mitral Transcatheter Edge-to-Edge Repair | Mitral Valve Insufficiency", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 397, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Secondary MR: Still a Management Conundrum", + "role": "Moderator", + "topic": "Mitral Valve Insufficiency", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 398, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Structural Interventions to Treat HFrEF", + "role": "Speaker", + "topic": "Heart Failure, Systolic | Structural Interventions", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 399, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Heart Failure Therapeutics and Trials: Looking Towards the Future", + "role": "Moderator", + "topic": "Clinical Trials As Topic | Heart Failure | Therapeutics", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 400, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Featured Late-Breaking Clinical Science Abstracts", + "role": "Speaker", + "topic": "Clinical Trials As Topic", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 401, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "CCM® Therapy in Addition to GDMT: Optimizing Strategy for Heart Failure Management", + "role": "Moderator", + "topic": "Calcium Citrate Malate | Guideline-Directed Medical Therapy | Heart Failure", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Impulse Dynamics", + "Sponsor_Type": "Industry", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 402, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Topic 2: Devices for Chronic Heart Failure", + "role": "Speaker", + "topic": "Chronic Heart Failure | Heart-Assist Devices", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 403, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "CCM Applied to Patients With HFpEF", + "role": "Speaker", + "topic": "Cardiac Contractility Modulation | Heart Failure With Preserved Ejection Fraction", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 404, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System", + "role": "Speaker", + "topic": "Coronary Sinus | Heart Shunt", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 405, + "user_id": 1639100928, + "event_name": "2024 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Heart Failure Management Today – GDMT, CRT, and CCM Therapy", + "role": "Speaker", + "topic": "Cardiac Contractility Modulation | Cardiac Resynchronization Therapy | Guideline-Directed Medical Therapy | Heart Failure", + "Start": "03/04/2024", + "End": "03/06/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Impulse Dynamics", + "Sponsor_Type": "Industry", + "Location": "The Westin Boston Seaport District", + "Address": "425 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://tht2024.crfconnect.com/", + "Url2": "" + }, + { + "id": 406, + "user_id": 1639100928, + "event_name": "2024 Annual Heart in Diabetes CME Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Scientific Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn's Landing", + "Address": "201 South Christopher Columbus Boulevard", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/agenda", + "Url2": "" + }, + { + "id": 407, + "user_id": 1639100928, + "event_name": "2024 Annual Heart in Diabetes CME Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "DCRM 2.0- Multi-Specialty Practice Recommendations for DM, Cardiorenal & Metabolic Discases", + "role": "Chair", + "topic": "Cardio-Renal Syndrome | Diabetes Mellitus | Metabolic Diseases", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn's Landing", + "Address": "201 South Christopher Columbus Boulevard", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/agenda", + "Url2": "" + }, + { + "id": 408, + "user_id": 1639100928, + "event_name": "2024 Annual Heart in Diabetes CME Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Harnessing SGLT Inhibition in the Treatment and Prevention of HF", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "Lexicon Pharmaceuticals, Inc", + "Sponsor_Type": "Industry", + "Location": "Hilton Philadelphia at Penn's Landing", + "Address": "201 South Christopher Columbus Boulevard", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/agenda", + "Url2": "" + }, + { + "id": 409, + "user_id": 1639100928, + "event_name": "2024 Annual Heart in Diabetes CME Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Valvular Disease & HF Post MI Outcome in the DCRM Patient", + "role": "Speaker", + "topic": "Heart Failure | Heart Valve Diseases | Myocardial Infarction", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn's Landing", + "Address": "201 South Christopher Columbus Boulevard", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/agenda", + "Url2": "" + }, + { + "id": 410, + "user_id": 1639100928, + "event_name": "2024 American Diabetes Association Scientific Sessions (ADA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Does Weight Reduction Modulate Heart Failure Benefit? Insights from STEP-HFpEF", + "role": "Speaker", + "topic": "Heart Failure, Diastolic | Weight Loss", + "Start": "06/21/2024", + "End": "06/24/2024", + "Organizer": "American Diabetes Association (ADA)", + "Organizer_Type": "Association", + "Sponsor": "American Diabetes Association (ADA)", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center", + "Address": "9800 International Drive", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": 32819, + "Url1": "https://professional.diabetes.org/sites/dpro/files/2024-06/2024-Program-Information_6-10.pdf", + "Url2": "" + }, + { + "id": 411, + "user_id": 1639100928, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "The Sweet Science of SGLT2 inhibitors in Heart Failure", + "role": "Moderator", + "topic": "Heart Failure | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 412, + "user_id": 1639100928, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review", + "role": "Chair", + "topic": "Cardiomyopathies | Heart Failure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 413, + "user_id": 1639100928, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Empagliflozin After Acute Myocardial Infarction: Results Of The Empact Mi Trial", + "role": "Speaker", + "topic": "Empagliflozin | Myocardial Infarction", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 414, + "user_id": 1639100928, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "Addressing Risk of HF Rehospitalization With an Additional Guideline-Recommended Medication", + "role": "Speaker", + "topic": "Guideline-Recommended Medication | Heart Failure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Merck & Co Inc", + "Sponsor_Type": "Industry", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard Northwest", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 415, + "user_id": 1639100928, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Program Committee", + "role": "Chair", + "topic": "Admin. & Management", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 416, + "user_id": 1639100928, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Patients with Heart Failure and preserved ejection fraction, often have liver and renal related issues associated with poor outcome", + "role": "Speaker", + "topic": "Heart Failure, Diastolic | Liver Diseases | Renal Insufficiency", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 417, + "user_id": 1639100928, + "event_name": "2023 MOSAIC - Global NASH Trialist Forum", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Heart Failure endpoints", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "10/19/2023", + "End": "10/20/2023", + "Organizer": "Translational Medicine Academy: TMA", + "Organizer_Type": "Other", + "Sponsor": "Translational Medicine Academy: TMA", + "Sponsor_Type": "Other", + "Location": "Embassy of France", + "Address": "4101 Reservoir Road North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20007, + "Url1": "https://mosaic-nash.tmacademy.org/wp-content/uploads/2023/08/MOSAIC-NASH-program.docx.pdf", + "Url2": "" + }, + { + "id": 418, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Soluble Guanylate Cyclase Modulators: Role in Existing HF Treatment Paradigms", + "role": "Speaker", + "topic": "Heart Failure | Soluble Guanylyl Cyclase Modulators", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Vindico Medical Education, Merck & Co Inc", + "Sponsor_Type": "Other", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://hfsa.org/asm/satellite-symposia-ce", + "Url2": "" + }, + { + "id": 419, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The New Standard Of Care: Leveraging The Benefits Of SGLT2 Inhibitors Across The Heart Failure Spectrum", + "role": "Speaker", + "topic": "Heart Failure | Sodium-Glucose Transporter 2 Inhibitors | Standard Of Care", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Clinical Care Options LLC, Heart Failure Society of America (HFSA), Boehringer Ingelheim International GmbH, Eli Lilly and Company", + "Sponsor_Type": "Other", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://hfsa.org/asm/satellite-symposia-ce", + "Url2": "" + }, + { + "id": 420, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "A Phase 3, Multicenter, Randomized, Double-blind Trial To Evaluate The Efficacy And Safety Of Aficamten Compared To Placebo In Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy", + "role": "Speaker", + "topic": "Aficamten | Cardiomyopathy, Hypertrophic | Randomized Controlled Trials As Topic", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Heart Failure Society Of America", + "Sponsor_Type": "Association", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=HFSA23", + "Url2": "" + }, + { + "id": 421, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results", + "role": "Speaker", + "topic": "Autonomic Regulation Therapy | Heart Failure, Systolic", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Heart Failure Society Of America", + "Sponsor_Type": "Association", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=HFSA23", + "Url2": "" + }, + { + "id": 422, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Patiromer Enables The Initiation Of Mineralocorticoid Receptor Antagonists (MRAs) For Heart Failure With Reduced Ejection Fraction (HFrEF) In Patients With Hyperkalemia (HK) Or Previous HK: Post HocAnalysis Of The DIAMOND Trial", + "role": "Speaker", + "topic": "Heart Failure, Systolic | Hyperkalemia | Mineralocorticoid Receptor Antagonists | Patiromer | Post HocAnalysis Of The DIAMOND Trial", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Heart Failure Society Of America", + "Sponsor_Type": "Association", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=HFSA23", + "Url2": "" + }, + { + "id": 423, + "user_id": 1639100928, + "event_name": "2023 Heart Failure Society of America Annual Scientific Meeting (HFSA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Effects Of Semaglutide Across The Range Of Left Ventricular Ejection Fraction In Obesity Phenotype Of Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Trial", + "role": "Speaker", + "topic": "Heart Failure, Diastolic | Semaglutide | STEP-HFpEF Trial | Stroke Volume", + "Start": "10/06/2023", + "End": "10/09/2023", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Heart Failure Society Of America", + "Sponsor_Type": "Association", + "Location": "Huntington Convention Center of Cleveland", + "Address": "300 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44113, + "Url1": "https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=HFSA23", + "Url2": "" + }, + { + "id": 424, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Therapies For Decompensated Heart Failure: From Clinical Trials To Clinical Practice", + "role": "Chair", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 425, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Are Mechanisms Of Action Still Important For Treatment Of Heart Failure?", + "role": "Chair", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 426, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Vericiguat", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 427, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Worsening Heart Failure: A Critical Event", + "role": "Chair", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 428, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "When Bp Is Low", + "role": "Speaker", + "topic": "Hypotension", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 429, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Optimizing Hfref Treatment: A Panel Discussion", + "role": "Speaker", + "topic": "Heart Failure, Systolic", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medscap LLC", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 430, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Ccm: What Do We Know And What Are We Learning?", + "role": "Speaker", + "topic": "Myocardial Contraction", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Charité Friends & Sponsors Trust, Impulse Dynamics", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 431, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Sglt2 Inhibition Across The Spectrum Of Ejection Fraction - The Time For Implementation Is Now", + "role": "Speaker", + "topic": "Stroke Volume", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Boehringer Ingelheim International GmbH, Lilly", + "Sponsor_Type": "Industry", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 432, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Guideline-Recommended Therapy: Overcoming Challenges In Clinical Practice", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Bayer AG", + "Sponsor_Type": "Industry", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 433, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Optimizing Hfpef Treatment - A Panel Discussion: Meet William", + "role": "Speaker", + "topic": "Heart Failure, Diastolic", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medscap LLC", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 434, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "1St Case Presentation: Chronic Or Recurrent Hyperkalemia", + "role": "Speaker", + "topic": "Hyperkalemia", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtelligence, CSL Vifor", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 435, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Discussion Of Chronic Hyperkalemia Case", + "role": "Speaker", + "topic": "Hyperkalemia", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtelligence, CSL Vifor", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 436, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Heart Failure Congress (ESC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Panel Discussion, Take-Home Messages, Question & Answer", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/20/2023", + "End": "05/23/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Medtelligence, CSL Vifor", + "Sponsor_Type": "Other", + "Location": "O2 Universum", + "Address": "Českomoravská 2345/17", + "Country": "Czech Republic", + "State": "Hlavni Mesto Praha", + "City": "Prague", + "Postal_Code": "190 00", + "Url1": "https://esc365.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 437, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Poster Session", + "Session_Name": "Baseline characteristics of patients enrolled in the EMPACT-MI trial", + "role": "Speaker", + "topic": "EMPACT-MI Trial | Empagliflozin | Myocardial Infarction", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 438, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Poster Session", + "Session_Name": "Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Diabetes Mellitus | Heart Failure | Vericiguat | VICTORIA Trial", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 439, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Going beyond foundational therapy in HFrEF: what is the role of sGC stimulators?", + "role": "Chair", + "topic": "Heart Failure, Systolic | Soluble Guanylyl Cyclase", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Bayer AG", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 440, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Initiating SGLT2 inhibitors in patients with HFrEF: where in the sequence do they fit?", + "role": "Speaker", + "topic": "Heart Failure, Systolic | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Boehringer Ingelheim International GmbH, Lilly", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 441, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Recognising the challenge of worsening heart failure", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Bayer AG", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 442, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Key takeaways and close", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Bayer AG", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 443, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "RECORD MI: Heart Failure Complicating Acute Myocardial Infarction", + "role": "Speaker", + "topic": "Heart Failure | Myocardial Infarction", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 444, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Meet the expert: how to implement SGLT2 inhibitors in the management of patients with heart failure", + "role": "Speaker", + "topic": "Heart Failure | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Boehringer Ingelheim International GmbH, Lilly", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 445, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "The heart failure challenge: a practical approach to heart failure treatment with SGLT2 inhibitors", + "role": "Speaker", + "topic": "Heart Failure | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Boehringer Ingelheim International GmbH, Lilly", + "Sponsor_Type": "Industry", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 446, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "Poster Session", + "Session_Name": "Prognostic implications of angiopoietin-2 in heart failure and the influence of empagliflozin: the EMPEROR program", + "role": "Speaker", + "topic": "Angiopoietin-2 | Empagliflozin | Heart Failure", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 447, + "user_id": 1639100928, + "event_name": "2023 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "De novo heart failure: when to start treatment with an ARNI and SGLT2i", + "role": "Speaker", + "topic": "Heart Failure | Neprilysin | Receptors, Angiotensin | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "08/25/2023", + "End": "08/28/2023", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Amsterdam RAI", + "Address": "Europaplein 24", + "Country": "Netherlands", + "State": "Noord-Holland", + "City": "Amsterdam", + "Postal_Code": "1078 GZ", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme", + "Url2": "" + }, + { + "id": 448, + "user_id": 1639100928, + "event_name": "2023 Congress of the Portuguese Society of Cardiology (CPC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "The patient journey from the chronic HF to the episode of acute decompensation - is there a gap in trials in the high-risk HF population?", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "04/14/2023", + "End": "04/16/2023", + "Organizer": "Portuguese Society of Cardiology (CPC)", + "Organizer_Type": "Association", + "Sponsor": "Portuguese Society of Cardiology (CPC)", + "Sponsor_Type": "Association", + "Location": "Algarve Congress Center", + "Address": "Marina de Vilamoura", + "Country": "Portugal", + "State": "Faro", + "City": "Quarteira", + "Postal_Code": "8125-901", + "Url1": "https://cpc2023.appdoevento.pt/", + "Url2": "" + }, + { + "id": 449, + "user_id": 1639100928, + "event_name": "2023 Congress of the Portuguese Society of Cardiology (CPC)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Are HFrEF patients optimally treated with the fantastic four?", + "role": "Speaker", + "topic": "Heart Failure, Systolic", + "Start": "04/14/2023", + "End": "04/16/2023", + "Organizer": "Portuguese Society of Cardiology (CPC)", + "Organizer_Type": "Association", + "Sponsor": "Eli Lilly and Company, Novartis AG", + "Sponsor_Type": "Industry", + "Location": "Algarve Congress Center", + "Address": "Marina de Vilamoura", + "Country": "Portugal", + "State": "Faro", + "City": "Quarteira", + "Postal_Code": "8125-901", + "Url1": "https://cpc2023.appdoevento.pt/", + "Url2": "" + }, + { + "id": 450, + "user_id": 1639100928, + "event_name": "2023 Cleveland Clinic Global EP Summit", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Medical Management of HFrEF and AF", + "role": "Speaker", + "topic": "Atrial Fibrillation | Heart Failure, Systolic", + "Start": "09/29/2023", + "End": "09/30/2023", + "Organizer": "Cleveland Clinic", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cleveland Clinic", + "Sponsor_Type": "University/Hospital", + "Location": "Hilton Cleveland Downtown", + "Address": "100 Lakeside Avenue East", + "Country": "United States", + "State": "Ohio", + "City": "Cleveland", + "Postal_Code": 44114, + "Url1": "https://www.clevelandclinicmeded.com/live/courses/globalep23/agenda.asp", + "Url2": "" + }, + { + "id": 451, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Chronic Heart Failure (E.G., Lv Reshaping, Neuromodulation)", + "role": "Speaker", + "topic": "Heart Failure | Transcutaneous Electric Nerve Stimulation", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 452, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Ccm Therapy In Addition To Gdmt: A Contemporary Strategy For Heart Failure Management", + "role": "Faculty", + "topic": "Heart Failure | Myocardial Contraction | Opiate Substitution Treatment", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Impulse Dynamics", + "Sponsor_Type": "Industry", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 453, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Ccm® - Body Of Evidence – What We Know And What We’Re Learning", + "role": "Speaker", + "topic": "Myocardial Contraction", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Impulse Dynamics", + "Sponsor_Type": "Industry", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 454, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Neuromodulation And Electrical Therapies For Heart Failure", + "role": "Speaker", + "topic": "Heart Failure | Transcutaneous Electric Nerve Stimulation", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 455, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Cardiac Contractility Modulation For Hfref And Hfpef: Impulse Dynamics", + "role": "Speaker", + "topic": "Heart Failure, Systolic | Myocardial Contraction", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 456, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "The Role of Technology and Innovation in the Current Era of Medical Therapy in Heart Failure", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 457, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Assessing the Residual Risk: What Gaps Should New Technologies Fill", + "role": "Speaker", + "topic": "Heart Disease Risk Factors", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 458, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Medical Therapies for Heart Failure: An Eye Towards the Future", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 459, + "user_id": 1639100928, + "event_name": "2023 Cardiovascular Research Foundation Technology & Heart Failure Therapeutics Conference (THT)", + "event_type": "Conference", + "session_type": "Abstract Presentation", + "Session_Name": "General Heart Failure", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "03/20/2023", + "End": "03/22/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "The Westin Boston Seaport District", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://tht2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 460, + "user_id": 1639100928, + "event_name": "2023 American Heart Association Scientific Sessions (AHA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Navigating Cardiorenal Health: From Swift Diagnosis to Personalized Treatment Pathways", + "role": "Speaker", + "topic": "Cardio-Renal Syndrome | Diagnosis", + "Start": "11/11/2023", + "End": "11/13/2023", + "Organizer": "American Heart Association, Inc.", + "Organizer_Type": "Association", + "Sponsor": "PRIME Education, LLC, Boehringer Ingelheim International GmbH, Eli Lilly and Company", + "Sponsor_Type": "Other", + "Location": "Pennsylvania Convention Center", + "Address": "1101 Arch Street", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19107, + "Url1": "https://www.abstractsonline.com/pp8/?_ga=2.62588588.1409085307.1693826434-41755426.1693826431#!/10871", + "Url2": "" + }, + { + "id": 461, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Jardiance (Empagliflozin) Tablets: A Review Of The Latest Data", + "role": "Speaker", + "topic": "Empagliflozin", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "Boehringer Ingelheim International GmbH, Eli Lilly and Company", + "Sponsor_Type": "Industry", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 462, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Biomarkers And Strain Echocardiography For The Detection Of Subclinical Cardiotoxicity In Breast Cancer Patients Receiving Anthracyclines", + "role": "Author", + "topic": "Anthracyclines | Biomarkers | Breast Neoplasms | Cardiotoxicity | Echocardiography", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 463, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Nt-Probnp During Screening In The Study Of Vericiguat In Participants With Heart Failure With Reduced Ejection Fraction (Victoria) Trial: Insights Into Outcomes And Vericiguat", + "role": "Author", + "topic": "Heart Failure", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 464, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Effect Of Sglt2 Inhibitors On Health-Related Quality Of Life In Patients With Heart Failure: A Systematic Review And Meta-Analysis", + "role": "Author", + "topic": "Heart Failure | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 465, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Characterizing The Digital Divide & Access To Mobile Health Interventions In Heart Failure: Insights From The Connect-Hf Mhealth Substudy", + "role": "Author", + "topic": "Heart Failure", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 466, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Why Measure Nt - Probnp Serially In Chronic Heart Failure? Mechanistic Associations Of Natriuretic Peptide Slope Following Initiation Of Sacubitril/Valsartan", + "role": "Author", + "topic": "Heart Failure", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 467, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Trends In Prevalence Of Heart Failure In Cancer: Insights From The National Health And Nutrition Examination Survey", + "role": "Author", + "topic": "Heart Failure | Neoplasms", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 468, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Adjustment Of Guideline-Directed Medical Therapy One Year Post-Heart Failure Hospitalization Falls Short: Insights From The Connect-Hf Trial", + "role": "Author", + "topic": "Heart Failure", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 469, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Angiotensin Receptor Neprilysin Inhibition In Acute Myocardial Infarction: A Systematic Review And Meta-Analysis", + "role": "Author", + "topic": "Myocardial Infarction", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 470, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Electrocardiographic T Wave Inversion Is Associated With Incident Heart Failure In Black Americans: The Jackson Heart Study", + "role": "Author", + "topic": "Electrocardiographic | Heart Failure | Longitudinal Studies", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 471, + "user_id": 1639100928, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Utilization Rates Of Sglt2 Inhibitors And Their Facility-Level Variation Among Patients With Type 2 Diabetes (T2Dm), Heart Failure (Hf) And Atherosclerotic Cardiovascular Disease (Ascvd): Insights From The Department Of Veterans Affairs (Va)", + "role": "Author", + "topic": "Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Heart Failure | Sodium-Glucose Transporter 2 Inhibitors", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 472, + "user_id": 1639100928, + "event_name": "2023 American Association of Heart Failure Nurses Annual Meeting (AAHFN)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure Supported Through an Independent Educational Grant from American Regent", + "role": "Speaker", + "topic": "Diagnosis | Heart Failure | Iron Deficiencies", + "Start": "06/29/2023", + "End": "07/01/2023", + "Organizer": "American Association of Heart Failure Nurses", + "Organizer_Type": "Association", + "Sponsor": "American Association of Heart Failure Nurses", + "Sponsor_Type": "Association", + "Location": "Boston Marriott Copley Place", + "Address": "110 Huntington Avenue", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02116", + "Url1": "https://2023aahfn.eventscribe.net/agenda.asp?BCFO=&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 473, + "user_id": 1639100928, + "event_name": "2022 Portuguese Society of Cardiology Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Rethinking Heart Failure: Vericiguat A New Option", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "04/22/2022", + "End": "04/24/2022", + "Organizer": "Portuguese Society of Cardiology (CPC)", + "Organizer_Type": "Association", + "Sponsor": "Portuguese Society of Cardiology (CPC)", + "Sponsor_Type": "Association", + "Location": "Algarve Congress Palace", + "Address": "", + "Country": "Portugal", + "State": "Faro", + "City": "Albufeira", + "Postal_Code": "", + "Url1": "https://cpc2022.appdoevento.pt/", + "Url2": "" + }, + { + "id": 474, + "user_id": 1639100928, + "event_name": "2022 Heart Failure Society of America Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Management of HFrEF: Will Novel Therapies Fit into Existing Treatment Paradigms", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "09/30/2022", + "End": "10/03/2022", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Merck & Co., Inc", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "", + "Postal_Code": "", + "Url1": "https://hfsa.org/sites/default/files/2022-09/ASM2022_FINAL_PROGRAM_V4_0.pdf", + "Url2": "" + }, + { + "id": 475, + "user_id": 1639100928, + "event_name": "2022 Heart Failure Society of America Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure", + "role": "Chair", + "topic": "Heart Failure", + "Start": "09/30/2022", + "End": "10/03/2022", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "AstraZeneca Pharmaceuticals", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "", + "Postal_Code": "", + "Url1": "https://hfsa.org/sites/default/files/2022-09/ASM2022_FINAL_PROGRAM_V4_0.pdf", + "Url2": "" + }, + { + "id": 476, + "user_id": 1639100928, + "event_name": "2022 Heart Failure Society of America Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Optimizing Heart Failure Outcomes with Intravenous Iron: Adaptive Approaches for Effective Diagnosis and Treatment of Iron Deficiency in HFrEF", + "role": "Chair", + "topic": "Diagnostic Techniques And Procedures | Heart Failure", + "Start": "09/30/2022", + "End": "10/03/2022", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "American Regent, Inc.", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "", + "Postal_Code": "", + "Url1": "https://hfsa.org/sites/default/files/2022-09/ASM2022_FINAL_PROGRAM_V4_0.pdf", + "Url2": "" + }, + { + "id": 477, + "user_id": 1639100928, + "event_name": "2022 Heart Failure Society of America Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Hope is Here – A Modern Approach to Heart Failure Treatment", + "role": "Faculty", + "topic": "Heart Failure", + "Start": "09/30/2022", + "End": "10/03/2022", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Impulse Dynamics", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "", + "Postal_Code": "", + "Url1": "https://hfsa.org/sites/default/files/2022-09/ASM2022_FINAL_PROGRAM_V4_0.pdf", + "Url2": "" + }, + { + "id": 478, + "user_id": 1639100928, + "event_name": "2022 Heart Failure Society of America Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Treatment Considerations for Patients with HFrEF and Select Updates From the 2022 HF Guideline", + "role": "Faculty", + "topic": "Heart Failure", + "Start": "09/30/2022", + "End": "10/03/2022", + "Organizer": "Heart Failure Society Of America", + "Organizer_Type": "Association", + "Sponsor": "Merck & Co., Inc", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "", + "Postal_Code": "", + "Url1": "https://hfsa.org/sites/default/files/2022-09/ASM2022_FINAL_PROGRAM_V4_0.pdf", + "Url2": "" + }, + { + "id": 479, + "user_id": 1639100928, + "event_name": "2022 Going Back to the Heart of Cardiology Annual Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "The Present and Future of Device-Based Care in HF", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "12/03/2022", + "End": "12/05/2022", + "Organizer": "WebMD LLC", + "Organizer_Type": "Other", + "Sponsor": "WebMD LLC", + "Sponsor_Type": "Other", + "Location": "Hilton La Jolla Torrey Pines", + "Address": "", + "Country": "United States", + "State": "California", + "City": "La Jolla", + "Postal_Code": "", + "Url1": "https://na.eventscloud.com/website/36345/agenda/", + "Url2": "" + }, + { + "id": 480, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Quality Of Life As A Major Endpoint", + "role": "Speaker", + "topic": "Heart Diseases | Heart-Assist Devices", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 481, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "In-Hospital Trajectories", + "role": "Speaker", + "topic": "Body-Weight Trajectory", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 482, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Dyskalaemia In Heart Failure", + "role": "Speaker", + "topic": "Cardiac Surgical Procedures | Heart Diseases | Heart Failure", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 483, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Emperor-Preserved: Outcomes Using Alternate Endpoint Definitions", + "role": "Speaker", + "topic": "Heart Diseases | Heart-Assist Devices", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 484, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Cardiac Contractility Modulation In The Future: Looking Ahead To Drive Heart Failure Device Treatment", + "role": "Speaker", + "topic": "Cardiac Surgical Procedures | Heart Diseases | Heart Failure", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 485, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Management Of Patients With Worsening Hf: The Latest Data", + "role": "Speaker", + "topic": "Cardiac Surgical Procedures | Heart Diseases | Heart Failure", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 486, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Early Diagnosis Of Heart Failure - Insights From Real World Data", + "role": "Speaker", + "topic": "Cardiac Surgical Procedures | Heart Diseases | Heart Failure", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 487, + "user_id": 1639100928, + "event_name": "2022 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "A Time To Optimize Hf Therapy At Hospital Discharge", + "role": "Speaker", + "topic": "Cardiac Surgical Procedures | Heart Diseases | Heart Failure", + "Start": "05/21/2022", + "End": "05/24/2022", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "IFEMA Madrid congress centre", + "Address": "", + "Country": "Spain", + "State": "Madrid", + "City": "Madrid", + "Postal_Code": "", + "Url1": "https://digital-congress.escardio.org/Heart-Failure/programme", + "Url2": "" + }, + { + "id": 542, + "user_id": 1639100928, + "event_name": "2020 American Association of Heart Failure Nurses Annual Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Keynote: Spotlight on Cardiometabolic Disease and the HF Patient", + "role": "Speaker", + "topic": "Heart Failure | Kidney Diseases", + "Start": "06/24/2020", + "End": "06/26/2020", + "Organizer": "American Association of Heart Failure Nurses", + "Organizer_Type": "Association", + "Sponsor": "American Association of Heart Failure Nurses", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 543, + "user_id": 1639100928, + "event_name": "2019 Inova Heart And Vascular Institute Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "The Risk Of Living In A Food Desert", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "04/26/2019", + "End": "04/27/2019", + "Organizer": "INOVA Heart and Vascular Institiute", + "Organizer_Type": "Other", + "Sponsor": "INOVA Heart and Vascular Institiute", + "Sponsor_Type": "Other", + "Location": "Falls Church Marriott Fairview Park", + "Address": "", + "Country": "United States", + "State": "Virginia", + "City": "Falls Church", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 544, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology World Congress on Heart Failure", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Treatment of type 2 diabetes with/without heart failure: pending results from ongoing trials", + "role": "Speaker", + "topic": "Heart", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 545, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Obesity and diabetes: impact on heart failure outcomes", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 546, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Ongoing clinical trials in HFPEF", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 547, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "The evolving role of cardiologists: can we help decrease the cardiovascular event burden in patients with type 2 diabetes?", + "role": "Speaker", + "topic": "Diabetes Mellitus, Type 2", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 548, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Optimising treatment for patients in the vulnerable phase", + "role": "Speaker", + "topic": "Patient Care Management", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 549, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Making critical choices for patients at the right time", + "role": "Speaker", + "topic": "Patient Care Management", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 550, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Treatment choices to optimise benefits for heart failure patients", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 551, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Management of hyperkalaemia in patients with heart failure - Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 552, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "sGC-cGMP: currently an untapped pathway in HFrEF", + "role": "Speaker", + "topic": "Heart Failure, Systolic", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 553, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "SGLT2 inhibitors: what is the evidence so far?", + "role": "Speaker", + "topic": "Sodium-Glucose Transporter 2", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 554, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Treatment of type 2 diabetes with/without heart failure: pending results from ongoing trials", + "role": "Speaker", + "topic": "Diabetes Mellitus, Type 2 | Heart Failure", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 555, + "user_id": 1639100928, + "event_name": "2019 European Society of Cardiology Heart Failure Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "New therapeutic options in the treatment of mitral regurgitation: practical considerations", + "role": "Speaker", + "topic": "Mitral Valve Insufficiency", + "Start": "05/25/2019", + "End": "05/28/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "Megaron Athens International Conference Centre", + "Address": "Leoforos Vasilissis Sofias and Kokkali 1", + "Country": "Greece", + "State": "Attiki", + "City": "Athens", + "Postal_Code": "115 21", + "Url1": "", + "Url2": "" + }, + { + "id": 556, + "user_id": 1639100928, + "event_name": "2019 Cardiometabolic Health Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Updates in HF and T2DM", + "role": "Speaker", + "topic": "Heart Failure | Diabetes Mellitus", + "Start": "10/13/2019", + "End": "10/13/2019", + "Organizer": "Cardiometabolic Health Congress", + "Organizer_Type": "Association", + "Sponsor": "Cardiometabolic Health Congress", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 557, + "user_id": 1639100928, + "event_name": "2019 Association of Black Cardiologists / Heart Institute Caribbean Joint Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Current and Future of Heart Failure and Diabetes", + "role": "Speaker", + "topic": "Heart | Heart Failure", + "Start": "01/18/2019", + "End": "01/20/2019", + "Organizer": "Heart Institute of the Caribbean, Association Of Black Cardiologists, Inc.", + "Organizer_Type": "Other", + "Sponsor": "Heart Institute of the Caribbean, Association Of Black Cardiologists, Inc.", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Jamaica", + "State": "Kingston", + "City": "Kingston", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 558, + "user_id": 1639100928, + "event_name": "2019 Association of Black Cardiologists / Heart Institute Caribbean Joint Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Driving Quality and Standard of Care-Insights From Umiss", + "role": "Speaker", + "topic": "Patient Care", + "Start": "01/18/2019", + "End": "01/20/2019", + "Organizer": "Heart Institute of the Caribbean, Association Of Black Cardiologists, Inc.", + "Organizer_Type": "Other", + "Sponsor": "Heart Institute of the Caribbean, Association Of Black Cardiologists, Inc.", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Jamaica", + "State": "Kingston", + "City": "Kingston", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 559, + "user_id": 1811967433, + "event_name": "How Heart Disease Evolves with Treatment: A Personalized Approach to Cardiovascular Disease Prevention 2022", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "How Heart Disease Evolves with Treatment: A Personalized Approach to Cardiovascular Disease Prevention", + "role": "Faculty", + "topic": "Cardiovascular Diseases | Heart Diseases", + "Start": "07/21/2022", + "End": "07/21/2022", + "Organizer": "Cleerly, Inc", + "Organizer_Type": "Industry", + "Sponsor": "Cleerly, Inc.", + "Sponsor_Type": "Industry", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://cleerlyhealth.com/transforming-cardiac-care/", + "Url2": "" + }, + { + "id": 560, + "user_id": 1811967433, + "event_name": "CAD Tracking 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "CAD Tracking", + "role": "Speaker", + "topic": "Coronary Artery Disease", + "Start": "10/07/2021", + "End": "10/07/2021", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://www.youtube.com/watch?v=e1tPWcZpEIU", + "Url2": "" + }, + { + "id": 561, + "user_id": 1811967433, + "event_name": "Association of Coronary Artery Calcification With Subsequent Cardiovascular Disease in Dcct (Diabetes Control and Complications Trial) and The Edic (Epidemiology of Diabetes Interventions and Complications) Study 2019", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Association of Coronary Artery Calcification With Subsequent Cardiovascular Disease in Dcct (Diabetes Control and Complications Trial) and The Edic (Epidemiology of Diabetes Interventions and Complications) Study", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Coronary Vessels", + "Start": "01/01/2019", + "End": "01/01/2019", + "Organizer": "", + "Organizer_Type": "", + "Sponsor": "", + "Sponsor_Type": "", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 562, + "user_id": 1811967433, + "event_name": "2024 Society of Cardiovascular Computed Tomography Annual Scientific Meeting (SCCT)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Advancing Precision Cardiovascular Pathways with Histology-based Plaque Quantitation: See What You Can Treat", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "07/18/2024", + "End": "07/21/2024", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Elucid", + "Sponsor_Type": "Other", + "Location": "Marriott Marquis Washington, DC", + "Address": "901 Massachusetts Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20001, + "Url1": "https://scct.org/page/SCCT2024", + "Url2": "" + }, + { + "id": 563, + "user_id": 1811967433, + "event_name": "2024 Society of Cardiovascular Computed Tomography Annual Scientific Meeting (SCCT)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Cardiac Ct In Clinical Trials", + "role": "Chair", + "topic": "Clinical Trial | Tomography, X-Ray Computed", + "Start": "07/18/2024", + "End": "07/21/2024", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "Marriott Marquis Washington, DC", + "Address": "901 Massachusetts Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20001, + "Url1": "https://scct.org/page/SCCT2024", + "Url2": "" + }, + { + "id": 564, + "user_id": 1811967433, + "event_name": "2024 Pri-Med West-Primary Care Conference & Expo", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "New Tools and Opportunities for Managing Patients with or at High Risk of CVD", + "role": "Speaker", + "topic": "Cardiovascular Diseases", + "Start": "07/18/2024", + "End": "07/20/2024", + "Organizer": "Pri-Med LLC", + "Organizer_Type": "Other", + "Sponsor": "HealthSpanRX, Amarin Pharma Inc", + "Sponsor_Type": "Industry", + "Location": "Anaheim Convention Center", + "Address": "800 West Katella Avenue", + "Country": "United States", + "State": "California", + "City": "Anaheim", + "Postal_Code": 92802, + "Url1": "https://www.pri-med.com/cme-conferences/west/agenda?refurl=www.google.com", + "Url2": "" + }, + { + "id": 565, + "user_id": 1811967433, + "event_name": "2024 Medical University of South Carolina Frontiers in Preventive Cardiology and Cardiometabolic Health Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pictures are Worth 1,000 Words: The Role of Imaging in CV Risk Assessment and Risk Management", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques | Heart Diseases", + "Start": "02/16/2024", + "End": "02/17/2024", + "Organizer": "Medical University of South Carolina", + "Organizer_Type": "University/Hospital", + "Sponsor": "Medical University of South Carolina", + "Sponsor_Type": "University/Hospital", + "Location": "Hyatt Place Charleston/Historic District", + "Address": "560 King St", + "Country": "United States", + "State": "South Carolina", + "City": "Charleston", + "Postal_Code": 29403, + "Url1": "https://medicine.musc.edu/-/sm/medicine/education/cme/current/f/2024-frontiers-in-preventive-cardiology.pdf", + "Url2": "" + }, + { + "id": 566, + "user_id": 1811967433, + "event_name": "2024 Medical University of South Carolina Frontiers in Preventive Cardiology and Cardiometabolic Health Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Changing the Paradigm: The Top Recent Trials in Preventive Cardiology and Cardiometabolic Health", + "role": "Speaker", + "topic": "Cardiometabolic Risk Factors", + "Start": "02/16/2024", + "End": "02/17/2024", + "Organizer": "Medical University of South Carolina", + "Organizer_Type": "University/Hospital", + "Sponsor": "Medical University of South Carolina", + "Sponsor_Type": "University/Hospital", + "Location": "Hyatt Place Charleston/Historic District", + "Address": "560 King St", + "Country": "United States", + "State": "South Carolina", + "City": "Charleston", + "Postal_Code": 29403, + "Url1": "https://medicine.musc.edu/-/sm/medicine/education/cme/current/f/2024-frontiers-in-preventive-cardiology.pdf", + "Url2": "" + }, + { + "id": 567, + "user_id": 1811967433, + "event_name": "2024 International Garlic Symposium", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Discussion on Cardiovascular System", + "role": "Chair", + "topic": "Cardiovascular System", + "Start": "04/26/2024", + "End": "04/28/2024", + "Organizer": "Garlic Symposium", + "Organizer_Type": "Other", + "Sponsor": "Garlic Symposium", + "Sponsor_Type": "Other", + "Location": "The Westin Grand Munich", + "Address": "Arabellastrasse 6", + "Country": "Germany", + "State": "Bayern", + "City": "Munich", + "Postal_Code": 81925, + "Url1": "https://garlicsymposium2024.com/", + "Url2": "" + }, + { + "id": 568, + "user_id": 1811967433, + "event_name": "2024 Heart in Diabetes Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "A Multidisciplinary Approach: A GLP-1 RA for Patients With T2D and ASCVD", + "role": "Speaker", + "topic": "Atherosclerosis | Diabetes Mellitus, Type 2 | Glucagon-Like Peptide-1 Receptor Agonists", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "Novo Nordisk", + "Sponsor_Type": "Industry", + "Location": "Hilton Philadelphia at Penn’s Landing", + "Address": "201 S Christopher Columbus Blvd", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/_files/ugd/a72e45_482af96f316f463cbd3e199555a4b142.pdf", + "Url2": "" + }, + { + "id": 569, + "user_id": 1811967433, + "event_name": "2024 Heart in Diabetes Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Diagnosing ASCVD In 2023", + "role": "Chair", + "topic": "Atherosclerosis | Heart Disease", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn’s Landing", + "Address": "201 S Christopher Columbus Blvd", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/_files/ugd/a72e45_482af96f316f463cbd3e199555a4b142.pdf", + "Url2": "" + }, + { + "id": 570, + "user_id": 1811967433, + "event_name": "2024 Heart in Diabetes Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Anatomical vs Functional Assessment of CAD", + "role": "Speaker", + "topic": "Coronary Artery Disease", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn’s Landing", + "Address": "201 S Christopher Columbus Blvd", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/_files/ugd/a72e45_482af96f316f463cbd3e199555a4b142.pdf", + "Url2": "" + }, + { + "id": 571, + "user_id": 1811967433, + "event_name": "2024 Heart in Diabetes Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "COVID-19 In The Cardiometabolic Patient", + "role": "Chair", + "topic": "Cardiometabolic Risk Factors | COVID-19", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn’s Landing", + "Address": "201 S Christopher Columbus Blvd", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/_files/ugd/a72e45_482af96f316f463cbd3e199555a4b142.pdf", + "Url2": "" + }, + { + "id": 572, + "user_id": 1811967433, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Imaging to personalise lipid-lowering", + "role": "Speaker", + "topic": "Diagnostic Imaging | Lipid-Lowering Therapies", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 573, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Application of CAC in Symptomatic Patients", + "role": "Speaker", + "topic": "Coronary Disease", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099&IsExhibitor=false", + "Url2": "" + }, + { + "id": 574, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Chest Pain in the ED and Observation Units: CTA/CAC", + "role": "Speaker", + "topic": "Chest Pain | Computed Tomography Angiography", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099&IsExhibitor=false", + "Url2": "" + }, + { + "id": 575, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Debates: Stress Imaging vs Coronary CTA in Suspected and Known CAD", + "role": "Speaker", + "topic": "Coronary Artery Disease | Diagnostic Imaging", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099&IsExhibitor=false", + "Url2": "" + }, + { + "id": 576, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "BATTLE OF THE EXPERTS Challenging Unknown CCTA Cases from Clinical Practice", + "role": "Speaker", + "topic": "Computed Tomography Angiography | Heart Diseases", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099&IsExhibitor=false", + "Url2": "" + }, + { + "id": 577, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Coronary Artery Calcium (CAC) Scanning: Central Role in Preventive Cardiology", + "role": "Speaker", + "topic": "Coronary Vessels | Vascular Calcification", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099&IsExhibitor=false", + "Url2": "" + }, + { + "id": 578, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Debates: Stress Imaging Vs Coronary CTA In Suspected And Known CAD", + "role": "Speaker", + "topic": "Coronary Artery Disease | Coronary Computed Tomography Angiography | Echocardiography, Stress", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "Cedars Sinai Medical Center Harvey Morse Conference Center South Tower", + "Address": "8701 Gracie Allen Drive", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": 90048, + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099", + "Url2": "" + }, + { + "id": 579, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "CT And MPI In Acute Chest Pain Syndromes - Chest Pain In The Ed And Observation Units: CTA/CAC", + "role": "Speaker", + "topic": "Cardiac Computed Tomography Angiography | Chest Pain | Coronary Artery Calcium | Myocardial Perfusion Imaging | Tomography, X-Ray Computed", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "Cedars Sinai Medical Center Harvey Morse Conference Center South Tower", + "Address": "8701 Gracie Allen Drive", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": 90048, + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099", + "Url2": "" + }, + { + "id": 580, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Coronary CTA And Coronary Calcium: Current Status And Future Applications - Coronary Artery Calcium (CAC) Scanning: Central Role In Preventive Cardiology", + "role": "Speaker", + "topic": "Coronary Artery Calcium | Coronary Computed Tomography Angiography", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "Cedars Sinai Medical Center Harvey Morse Conference Center South Tower", + "Address": "8701 Gracie Allen Drive", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": 90048, + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099", + "Url2": "" + }, + { + "id": 581, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Battle Of The Experts Challenging Unknown CCTA Cases From Clinical Practice", + "role": "Speaker", + "topic": "Coronary Computed Tomography Angiography | Magnetic Resonance Imaging", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "Cedars Sinai Medical Center Harvey Morse Conference Center South Tower", + "Address": "8701 Gracie Allen Drive", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": 90048, + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099", + "Url2": "" + }, + { + "id": 582, + "user_id": 1811967433, + "event_name": "2024 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Application Of Cac In Symptomatic Patients", + "role": "Speaker", + "topic": "Coronary Artery Calcium", + "Start": "01/19/2024", + "End": "01/21/2024", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "Cedars Sinai Medical Center Harvey Morse Conference Center South Tower", + "Address": "8701 Gracie Allen Drive", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": 90048, + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?P=5&EID=22099", + "Url2": "" + }, + { + "id": 583, + "user_id": 1811967433, + "event_name": "2024 Annual Heart in Diabetes CME Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Scientific Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "06/07/2024", + "End": "06/09/2024", + "Organizer": "The Metabolic Institute of America (TMIOA)", + "Organizer_Type": "Other", + "Sponsor": "The Metabolic Institute of America (TMIOA)", + "Sponsor_Type": "Other", + "Location": "Hilton Philadelphia at Penn's Landing", + "Address": "201 South Christopher Columbus Boulevard", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19106, + "Url1": "https://www.heartindiabetes.com/agenda", + "Url2": "" + }, + { + "id": 584, + "user_id": 1811967433, + "event_name": "2024 American Society for Preventive Cardiology Congress on CVD Prevention (ASPC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "CAC/CCTA is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention", + "role": "Speaker", + "topic": "Atherosclerosis | Computed Tomography Angiography", + "Start": "08/02/2024", + "End": "08/04/2024", + "Organizer": "American Society For Preventive Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American Society For Preventive Cardiology", + "Sponsor_Type": "Association", + "Location": "Hyatt Regency Salt Lake City", + "Address": "170 South West Temple", + "Country": "United States", + "State": "Utah", + "City": "Salt Lake City", + "Postal_Code": 84101, + "Url1": "https://assets.noviams.com/novi-file-uploads/aspc/ASPC_2024_Congress_on_CVD_Prevention_Program_Agenda_v12_20240613.pdf", + "Url2": "" + }, + { + "id": 585, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "More Than Just Weight Loss: Discover The Power Of A Glp 1 Ra", + "role": "Speaker", + "topic": "Glucagon-Like Peptide-1 Receptor Agonists | Weight Loss", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 586, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Use Of Cardiac Computed Tomography (Ct) And Cardiac Magnetic Resonance Imaging (Cmri) Biomarker Variables For Incident Heart Failure: Multi-Ethnic Study Of Atherosclerosis", + "role": "Speaker", + "topic": "Atherosclerosis | Cardiac Magnetic Resonance Imaging | Heart Failure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 587, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Association Of Thoracic Aortic Calcification And Stroke In Multi-Ethnic Study Of Atherosclerosis (Mesa)", + "role": "Speaker", + "topic": "Atherosclerosis | Stroke | Thoracic Aortic Calcification", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 588, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Automated Detection Of Adverse Low-Density Non-Calcified Plaque Morphology", + "role": "Speaker", + "topic": "Plaque Morphology", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 589, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Genetic Risk And Coronary Artery Calcium In Personalizing Antihypertensive Treatment: A Pooled Cohort Analysis", + "role": "Speaker", + "topic": "Antihypertensive Agents | Coronary Artery Calcium", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 590, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Hypertension In Pregnancy And Coronary Artery Calcium Among Women In Rural Alabama: Initial Findings From The Rural Cohort Study", + "role": "Speaker", + "topic": "Coronary Artery Calcium | Hypertension | Pregnancy", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 591, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Effect Of Semaglutide On Epicardial Adipose Tissue Volume And Density In Type 2 Diabetes: Insights From The Stop Randomized Trial", + "role": "Speaker", + "topic": "Diabetes Mellitus, Type 2 | Semaglutide", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 592, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Thoracic Aortic Arch Calcification In Relation To Diabetes: Multi-Ethnic Study Of Atherosclerosis (Mesa)", + "role": "Speaker", + "topic": "Aorta, Thoracic | Atherosclerosis | Diabetes Mellitus", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 593, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Effects Of Purified Eicosapentaenoic Acid Versus Mixed Eicosapentaenoic/Docosahexaenoic Acid On Cardiovascular Mortality: Meta-Analysis Of Randomized Clinical Endpoint Trials", + "role": "Speaker", + "topic": "Docosahexaenoic Acids | Eicosapentaenoic Acid | Randomized Controlled Trials As Topic", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 594, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The Association Of Low Attenuation Plaque With Zero Coronary Artery Calcium In A Cohort Of South Asians And Non-Hispanic Whites", + "role": "Speaker", + "topic": "Coronary Artery Calcium | Low Attenuation Plaque", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 595, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Association Of Aortic Valve Calcium With Risk Of Stroke And Risk Of Dementia In The Multi-Ethnic Study Of Atherosclerosis", + "role": "Speaker", + "topic": "Aortic Valve Calcium | Atherosclerosis | Dementia | Stroke", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 596, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Cac Progression In Men And Women: Is There An Inflection At Menopause?", + "role": "Speaker", + "topic": "Coronary Artery Calcium | Menopause", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 597, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Automated Plaque Analysis In Patients Without Coronary Artery Calcium On Coronary Ct Angiography", + "role": "Speaker", + "topic": "Coronary Artery Calcium | Coronary Computed Tomography Angiography | Plaque Analysis", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 598, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Relationship Between Differential Quantitative Coronary Plaque As Assessed On Ccta Across Various Measures Of Obesity: Miami Heart Study At Baptist Health South Florida", + "role": "Speaker", + "topic": "Coronary Computed Tomography Angiography | Coronary Plaque | Obesity", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 599, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The Effects Of Alcohol Consumption On Coronary Artery Calcification", + "role": "Speaker", + "topic": "Alcohol Drinking | Coronary Artery Calcification", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 600, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Association Of Cardiovascular Risk Factors To Quantitative Coronary Plaque Characteristics: Miami Heart Study At Baptist Health South Florida", + "role": "Speaker", + "topic": "Coronary Plaque | Heart Disease Risk Factors", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 601, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Variation Of Coronary Atherosclerosis Across Spectrum Of Increasing Lp(A) Using Quantitative Ccta Plaque Analysis: Miami Heart Study At Baptist Health South Florida", + "role": "Speaker", + "topic": "Atherosclerosis | Coronary Computed Tomography Angiography", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 602, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Left Ventricular Volume Index Determined By Noncontrast Cardiac Ct As A Long-Term Predictor Of Heart Failure: Multiethnic Study Of Atherosclerosis (Mesa)", + "role": "Speaker", + "topic": "Atherosclerosis | Cardiac Computed Tomography | Heart Failure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 603, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Variation In The Serum Biomarker Levels Across Worsening Obesity Categories: Miami Heart Study At Baptist Health South Florida", + "role": "Speaker", + "topic": "Obesity | Serum Biomarkers", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 604, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Effects Of Evolocumab On Coronary Atherosclerotic Plaque Composition And Microcalcification Activity By Coronary Pet-Ct Angiography: Results Of The Prospective Evolve Study", + "role": "Speaker", + "topic": "Coronary Artery Disease | Coronary Computed Tomography Angiography | Evolocumab", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 605, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Exploring The Association Between Diabetes And Coronary Atherosclerosis Using Automated Ct Plaque Analysis", + "role": "Speaker", + "topic": "Atherosclerosis | Diabetes Mellitus | Tomography, X-Ray Computed", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 606, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Distribution Of Coronary Atherosclerosis Between Genders Using Automated Ct Plaque Analysis", + "role": "Speaker", + "topic": "Atherosclerosis | Tomography, X-Ray Computed", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 607, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Aspirin Use For Primary Prevention Among U.S. Adults With And Without Elevated Lipoprotein(A)", + "role": "Speaker", + "topic": "Lipoprotein(a)", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 608, + "user_id": 1811967433, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "More Than Just Weight Loss: Discover the Power of a GLP-1 RA", + "role": "Speaker", + "topic": "Glucagon-Like Peptide-1 Receptor Agonists | Weight Loss", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "Novo Nordisk A/S", + "Sponsor_Type": "Industry", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard Northwest", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 609, + "user_id": 1811967433, + "event_name": "2023 Transcatheter Cardiovascular Therapeutics Conference (TCT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Aha @ Tct - Beyond The Pci: Optimizing Outcomes In Secondary Prevention", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention | Secondary Prevention", + "Start": "10/23/2023", + "End": "10/26/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Moscone Center", + "Address": "747 Howard Street", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": 94103, + "Url1": "https://tct2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 610, + "user_id": 1811967433, + "event_name": "2023 Transcatheter Cardiovascular Therapeutics Conference (TCT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Imaging Guidance Of Cto Decision Making", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques | Chronic Total Occlusion | Decision Making", + "Start": "10/23/2023", + "End": "10/26/2023", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Moscone Center", + "Address": "747 Howard Street", + "Country": "United States", + "State": "California", + "City": "San Francisco", + "Postal_Code": 94103, + "Url1": "https://tct2023.crfconnect.com/program-guide", + "Url2": "" + }, + { + "id": 611, + "user_id": 1811967433, + "event_name": "2023 Society of Cardiovascular Computed Tomography Cardiovascular Disease Prevention Symposium - Virtual", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Bempedoic Acid", + "role": "Speaker", + "topic": "Bempedoic Acid", + "Start": "08/12/2023", + "End": "08/12/2023", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://scct.org/page/2023PrevSymp", + "Url2": "" + }, + { + "id": 612, + "user_id": 1811967433, + "event_name": "2023 Society of Cardiovascular Computed Tomography Cardiovascular Disease Prevention Symposium - Virtual", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Role of CCTA in prevention", + "role": "Speaker", + "topic": "Computed Tomography Angiography | Coronary Disease", + "Start": "08/12/2023", + "End": "08/12/2023", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://scct.org/page/2023PrevSymp", + "Url2": "" + }, + { + "id": 613, + "user_id": 1811967433, + "event_name": "2023 Society For Cardiovascular Magnetic Resonance Annual Scientific Sessions", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Non-Alcoholic Fatty Liver Disease And Cmr-Measures Of Interstitial Myocardial Fibrosis: The Multi-Ethnic Study Of Atherosclerosis", + "role": "Author", + "topic": "Atherosclerosis | Cardiovascular Diseases | Magnetic Resonance Imaging | Non-alcoholic Fatty Liver Disease", + "Start": "01/25/2023", + "End": "01/28/2023", + "Organizer": "Society for Cardiovascular Magnetic Resonance (SCMR)", + "Organizer_Type": "Association", + "Sponsor": "Society for Cardiovascular Magnetic Resonance (SCMR)", + "Sponsor_Type": "Association", + "Location": "Sheraton San Diego Hotel & Marina", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Diego", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/SCMR/agenda.asp?BCFO=&pfp=&fa=&fb=&fc=&fd=&all=1&mode", + "Url2": "" + }, + { + "id": 614, + "user_id": 1811967433, + "event_name": "2023 San Diego Cardiac Center Maui Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Cardiac CT and CT Flow", + "role": "Speaker", + "topic": "Tomography, X-Ray Computed", + "Start": "10/18/2023", + "End": "10/21/2023", + "Organizer": "San Diego Cardiac Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "San Diego Cardiac Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Hawaii", + "City": "Hawi", + "Postal_Code": "", + "Url1": "https://www.mauicardiovascularsymposium.com/agenda/", + "Url2": "" + }, + { + "id": 615, + "user_id": 1811967433, + "event_name": "2023 San Diego Cardiac Center Maui Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Discussion on Cardiovascular Diseases", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "10/18/2023", + "End": "10/21/2023", + "Organizer": "San Diego Cardiac Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "San Diego Cardiac Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Hawaii", + "City": "Hawi", + "Postal_Code": "", + "Url1": "https://www.mauicardiovascularsymposium.com/agenda/", + "Url2": "" + }, + { + "id": 616, + "user_id": 1811967433, + "event_name": "2023 National Sarasota Congress on Cardiovascular Disease Prevention", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "New Lipid Therapy to Reduce Atherosclerotic Cardiovascular Disease Risk", + "role": "Speaker", + "topic": "Atherosclerosis | Cardiovascular Diseases", + "Start": "02/03/2023", + "End": "02/04/2023", + "Organizer": "International Society for Cardiovascular Disease Prevention, Cardiovascular Center of Sarasota", + "Organizer_Type": "Other", + "Sponsor": "International Society for Cardiovascular Disease Prevention, Cardiovascular Center of Sarasota", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Sarasota", + "Postal_Code": "", + "Url1": "http://www.iscvdp.org/storage/app/media/iscdvp-brochure2023-ours.pdf", + "Url2": "" + }, + { + "id": 617, + "user_id": 1811967433, + "event_name": "2023 International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions (ISHLT)", + "event_type": "Annual Meeting", + "session_type": "Symposium", + "Session_Name": "Addressing Risk Of Hf Rehospitalization With An Additional Guideline-Recommended Medication", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "04/19/2023", + "End": "04/22/2023", + "Organizer": "International Society for Heart & Lung Transplantation (ISHLT)", + "Organizer_Type": "Association", + "Sponsor": "Merck KGaA", + "Sponsor_Type": "Industry", + "Location": "Colorado Convention Center", + "Address": "", + "Country": "United States", + "State": "Colorado", + "City": "Denver", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10757", + "Url2": "" + }, + { + "id": 618, + "user_id": 1811967433, + "event_name": "2023 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "CAC in Assessment of Symptomatic Patients", + "role": "Speaker", + "topic": "Coronary Occlusion", + "Start": "01/20/2023", + "End": "01/22/2023", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?EID=11604", + "Url2": "" + }, + { + "id": 619, + "user_id": 1811967433, + "event_name": "2023 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Acute Chest Pain Syndromes: Right Test for the Right Patient", + "role": "Speaker", + "topic": "Chest Pain", + "Start": "01/20/2023", + "End": "01/22/2023", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?EID=11604", + "Url2": "" + }, + { + "id": 620, + "user_id": 1811967433, + "event_name": "2023 Cedars-Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI Annual Case Review with the Experts", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Coronary Artery Calcium (CAC) Scanning: Central Role in Preventive Cardiology", + "role": "Speaker", + "topic": "Coronary Vessels | Vascular Calcification", + "Start": "01/20/2023", + "End": "01/22/2023", + "Organizer": "Cedars-Sinai", + "Organizer_Type": "University/Hospital", + "Sponsor": "Cedars-Sinai", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "https://cedars.cloud-cme.com/course/courseoverview?EID=11604", + "Url2": "" + }, + { + "id": 621, + "user_id": 1811967433, + "event_name": "2023 Cardiometabolic Health Congress", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Explore This GLP-1 RA For Your Patients With T2D and Established ASCVD", + "role": "Speaker", + "topic": "Atherosclerosis | Diabetes Mellitus, Type 2 | Glucagon-Like Peptide-1 Receptor Agonists", + "Start": "10/18/2023", + "End": "10/21/2023", + "Organizer": "Cardiometabolic Health Congress", + "Organizer_Type": "Other", + "Sponsor": "Novo Nordisk", + "Sponsor_Type": "Industry", + "Location": "Hilton Boston Park Plaza", + "Address": "50 Park Plaza", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02116", + "Url1": "https://www.cardiometabolichealth.org/wp-content/uploads/2023/10/CMHC_2023_Annual_Agenda_101023_FINAL.pdf", + "Url2": "" + }, + { + "id": 622, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "The Density Adjusted Volume Score: A Novel Coronary Artery Calcium Score", + "role": "Speaker", + "topic": "Coronary Artery Disease", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 623, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Distribution Of Coronary Atherosclerosis In Patients With Diabetes Mellitus, Using Quantitative Ct Plaque Analysis: Results From The Miami Heart Study", + "role": "Author", + "topic": "Atherosclerosis | Coronary Artery Disease | Plaque Analysis | Tomography, X-Ray Computed", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 624, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Firefighters Coronary Plaque Prevalence And Characteristics In Comparison To Non-Firefighters", + "role": "Author", + "topic": "Plaque, Atherosclerotic", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 625, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Progression Of Coronary Artery Calcium And Long-Term Risk For Atherosclerotic Cardiovascular Disease Events: The Multi-Ethnic Study Of Atherosclerosis", + "role": "Author", + "topic": "Atherosclerosis | Cardiovascular Diseases | Coronary Artery Disease", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 626, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Coronary Artery Calcium For Allocation Of Aspirin In Trial Eligible Participants: Results From The Multi-Ethnic Study Of Atherosclerosis (Mesa)", + "role": "Author", + "topic": "Atherosclerosis | Coronary Artery Disease", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 627, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Sex Difference In Thoracic Aortic Arch Calcification Prevalence In Relation To Zero Coronary Artery Calcium: Multiethnic Study Of Atherosclerosis (Mesa)", + "role": "Author", + "topic": "Atherosclerosis | Coronary Artery Disease", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 628, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Cardiac Computed Tomography Core Lab Investigation Of Prevalence Ofobstructivecoronary Artery Disease Inasymptomatic Individuals Withcalciumscore Zero Receivingcoronarycomputedtomographyangiography:Cocacs-Cctastudy", + "role": "Author", + "topic": "Computed Tomography Angiography | Coronary Artery Disease", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 629, + "user_id": 1811967433, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "The Prevalence Of Normal Coronary Arteries As Determined By A Coronary Artery Calcium Score Of Zero Amongst Subjects With Diabetes Mellitus", + "role": "Author", + "topic": "Coronary Artery Disease | Diabetes Mellitus", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 695, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Winter Meeting", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pushing beyond today's frontiers in CT analysis", + "role": "Speaker", + "topic": "Tomography, X-Ray Computed", + "Start": "01/20/2019", + "End": "01/25/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Ireland", + "State": "Dublin", + "City": "Dublin", + "Postal_Code": "", + "Url1": "https://scct.org/page/SCCT2022Program", + "Url2": "" + }, + { + "id": 696, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting / Annual SCCT Comprehensive Board Review and Update of Cardiovascular CT", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "How to increase reimbursement and advocate locally?", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 697, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting / Annual SCCT Comprehensive Board Review and Update of Cardiovascular CT", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "History of CAC: What led to the 2017 SCCT guidelines?", + "role": "Speaker", + "topic": "Coronary Artery Disease | Heart Diseases", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 698, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting / Annual SCCT Comprehensive Board Review and Update of Cardiovascular CT", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Risk Assesment And Therapy Guidance By Cta And Cac", + "role": "Chair", + "topic": "Computed Tomography Angiography | Risk | Therapeutics", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 699, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting / Annual SCCT Comprehensive Board Review and Update of Cardiovascular CT", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Novel therapies for treating diabetes and improving CVD outcomes", + "role": "Speaker", + "topic": "Diabetes Mellitus | Heart Diseases", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 700, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "How to increase reimbursement and advocate locally?", + "role": "Speaker", + "topic": "Patient Advocacy | Reimbursement Mechanisms", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://indd.adobe.com/view/publication/13967cf7-35cb-4c19-bd5e-7c32b3df0efb/vf64/publication-web-resources/pdf/scct_2019_printed_program_FINAL.pdf", + "Url2": "" + }, + { + "id": 701, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "History of CAC: What led to the 2017 SCCT guidelines", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques | Computed Tomography Angiography", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://indd.adobe.com/view/publication/13967cf7-35cb-4c19-bd5e-7c32b3df0efb/vf64/publication-web-resources/pdf/scct_2019_printed_program_FINAL.pdf", + "Url2": "" + }, + { + "id": 702, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Diabetes: Risk Assesment And Therapy Guidance By Cta And Cac", + "role": "Chair", + "topic": "Computed Tomography Angiography | Diabetes Mellitus | Vascular Calcification", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://indd.adobe.com/view/publication/13967cf7-35cb-4c19-bd5e-7c32b3df0efb/vf64/publication-web-resources/pdf/scct_2019_printed_program_FINAL.pdf", + "Url2": "" + }, + { + "id": 703, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Novel therapies for treating diabetes and improving CVD outcomes", + "role": "Speaker", + "topic": "Diabetes Mellitus", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://indd.adobe.com/view/publication/13967cf7-35cb-4c19-bd5e-7c32b3df0efb/vf64/publication-web-resources/pdf/scct_2019_printed_program_FINAL.pdf", + "Url2": "" + }, + { + "id": 704, + "user_id": 1811967433, + "event_name": "2019 Society of Cardiovascular Computed Tomography Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Relationship between CardioAnkle Vascular Index (CAVI) & Obstructive Coronary Artery Disease (CAD)", + "role": "Speaker", + "topic": "Coronary Artery Disease | Coronary Vessels", + "Start": "07/11/2019", + "End": "07/14/2019", + "Organizer": "Society of Cardiovascular Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://indd.adobe.com/view/publication/13967cf7-35cb-4c19-bd5e-7c32b3df0efb/vf64/publication-web-resources/pdf/scct_2019_printed_program_FINAL.pdf", + "Url2": "" + }, + { + "id": 705, + "user_id": 1811967433, + "event_name": "2019 International Association of Computed Tomography Annual International Symposium on CT", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "CT for Atherosclerosis: CACS & Plaques", + "role": "Speaker", + "topic": "Atherosclerosis | Coronary Vessels | Plaque, Atherosclerotic", + "Start": "09/19/2019", + "End": "09/21/2019", + "Organizer": "International Society for Computed Tomography", + "Organizer_Type": "Association", + "Sponsor": "International Association of Computed Tomography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "California", + "City": "San Diego", + "Postal_Code": "", + "Url1": "https://static1.squarespace.com/static/57d6f79fe3df285bca9ab421/t/5d81606768243a15977aa618/1568759917762/ISCT+2019+9-17.pdf", + "Url2": "" + }, + { + "id": 706, + "user_id": 1811967433, + "event_name": "2019 Cardiovascular Interventions Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pcsk9 Inhibitors For The Interventionalist: Which Patients Do We Choose And How Do We Use?", + "role": "Speaker", + "topic": "PCSK9 Inhibitors", + "Start": "10/29/2019", + "End": "11/01/2019", + "Organizer": "The Society for Cardiovascular Angiography and Interventions", + "Organizer_Type": "Association", + "Sponsor": "The Society for Cardiovascular Angiography and Interventions", + "Sponsor_Type": "Association", + "Location": "Hilton La Jolla Torrey Pines", + "Address": "", + "Country": "United States", + "State": "California", + "City": "La Jolla", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 707, + "user_id": 1811967433, + "event_name": "2019 Annual World Congress Insulin Resistance Diabetes & Cardiovascular Disease", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Atherosclerosis Burden In T1Dm, T2Dm And The General Population", + "role": "Speaker", + "topic": "Atherosclerosis", + "Start": "12/04/2019", + "End": "12/04/2019", + "Organizer": "CMI Education Institute, Inc, Metabolic Endocrine Education Foundation", + "Organizer_Type": "Other", + "Sponsor": "CMI Education Institute, Inc, Metabolic Endocrine Education Foundation", + "Sponsor_Type": "Other", + "Location": "Hilton Los Angeles/Universal City", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Universal City", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 708, + "user_id": 1811967433, + "event_name": "2019 Annual World Congress Insulin Resistance Diabetes & Cardiovascular Disease", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Esc/Easd 2019 Guidelines: The Prevention And Management Of Cardiovascular Disease In Diabetes", + "role": "Speaker", + "topic": "Diabetes Mellitus | Heart Diseases", + "Start": "12/04/2019", + "End": "12/07/2019", + "Organizer": "The Metabolic Institute of America", + "Organizer_Type": "University/Hospital", + "Sponsor": "Boehringer Ingelheim / Eli Lilly and Company", + "Sponsor_Type": "Industry", + "Location": "Hilton Los Angeles/Universal City", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Universal City", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 709, + "user_id": 1811967433, + "event_name": "2019 Annual World Congress Insulin Resistance Diabetes & Cardiovascular Disease", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Expert Insights: Managing Cardiovascular Risk Based On A Landmark Cv Outcomes Study", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "12/04/2019", + "End": "12/07/2019", + "Organizer": "The Metabolic Institute of America", + "Organizer_Type": "University/Hospital", + "Sponsor": "Boehringer Ingelheim / Eli Lilly and Company", + "Sponsor_Type": "Industry", + "Location": "Hilton Los Angeles/Universal City", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Universal City", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 710, + "user_id": 1811967433, + "event_name": "2019 Annual Maui Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Lipid Therapy Beyond Statins: How Can I Lower Events?", + "role": "Speaker", + "topic": "Cardiovascular Surgical Procedures | Heart Diseases", + "Start": "10/24/2019", + "End": "10/26/2019", + "Organizer": "American College of Cardiology Foundation, Hawaii and California Chapters", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology Foundation, Hawaii and California Chapters", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Hawaii", + "City": "Wailuku", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 711, + "user_id": 1811967433, + "event_name": "2019 Annual Maui Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Cardiovascular Benefits Of New Diabetes Agents", + "role": "Speaker", + "topic": "Diabetes Mellitus", + "Start": "10/24/2019", + "End": "10/26/2019", + "Organizer": "American College of Cardiology Foundation, Hawaii and California Chapters", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology Foundation, Hawaii and California Chapters", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Hawaii", + "City": "Wailuku", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 712, + "user_id": 1811967433, + "event_name": "2019 American Association of Clinical Endocrinologists Annual Scientific & Clinical Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Impact of Hyperglycemia and Hyperlipidemia on Atherosclerosis", + "role": "Speaker", + "topic": "Atherosclerosis | Hyperglycemia | Hyperlipidemias", + "Start": "04/24/2019", + "End": "04/28/2019", + "Organizer": "American Association of Clinical Endocrinologists", + "Organizer_Type": "Association", + "Sponsor": "American Association of Clinical Endocrinologists", + "Sponsor_Type": "Association", + "Location": "Los Angeles Convention Center", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 713, + "user_id": 1811967433, + "event_name": "2019 American Association of Clinical Endocrinologists Annual Scientific & Clinical Congress", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Practical Use of Calcium Scores and CVD Risk", + "role": "Speaker", + "topic": "Calcium | Cardiovascular Diseases | Risk", + "Start": "04/24/2019", + "End": "04/28/2019", + "Organizer": "American Association of Clinical Endocrinologists", + "Organizer_Type": "Association", + "Sponsor": "American Association of Clinical Endocrinologists", + "Sponsor_Type": "Association", + "Location": "Los Angeles Convention Center", + "Address": "", + "Country": "United States", + "State": "California", + "City": "Los Angeles", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 714, + "user_id": 1497893077, + "event_name": "Tricuspid Valve Therapy & Innovative Clinical Trials: A Comprehensive Discussion 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Tricuspid Valve Therapy & Innovative Clinical Trials: A Comprehensive Discussion", + "role": "Speaker", + "topic": "Tricuspid Valve", + "Start": "01/01/2021", + "End": "01/01/2021", + "Organizer": "NewYork-Presbyterian Hospital", + "Organizer_Type": "University/Hospital", + "Sponsor": "NewYork-Presbyterian Hospital", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 715, + "user_id": 1497893077, + "event_name": "Tricuspid Valve Interventions 2020", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Tricuspid Valve Interventions", + "role": "Moderator", + "topic": "Heart Diseases | Tricuspid Valve Insufficiency", + "Start": "11/20/2020", + "End": "11/20/2020", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 716, + "user_id": 1497893077, + "event_name": "Tricuspid Valve Interventions 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Tricuspid Valve Interventions", + "role": "Faculty", + "topic": "Heart Diseases | Tricuspid Valve Insufficiency", + "Start": "09/03/2021", + "End": "09/03/2021", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 717, + "user_id": 1497893077, + "event_name": "Tricuspid Valve Disease—Surgical or Transcatheter? 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Tricuspid Valve Disease—Surgical or Transcatheter?", + "role": "Speaker", + "topic": "Catheters | Tricuspid Valve", + "Start": "11/19/2021", + "End": "11/19/2021", + "Organizer": "The Society of Thoracic Surgeons", + "Organizer_Type": "Association", + "Sponsor": "The Society of Thoracic Surgeons", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 718, + "user_id": 1497893077, + "event_name": "Tips and Tricks in Imaging Your Patients With Valvular Heart Disease – Aortic Stenosis, Mitral Regurgitation and Tricuspid Regurgitation 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Tips and Tricks for Imaging your Patients with Aortic Stenosis", + "role": "Speaker", + "topic": "Aortic Valve Stenosis", + "Start": "06/24/2021", + "End": "06/24/2021", + "Organizer": "Radcliffe Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Radcliffe Cardiology", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 719, + "user_id": 1497893077, + "event_name": "The TRILUMINATE pivotal trial: impact on practice and perspectives 2023", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "The Triluminate Pivotal Trial: Impact On Practice And Perspectives", + "role": "Speaker", + "topic": "Therapeutic And Diagnostic Procedure", + "Start": "04/05/2023", + "End": "04/05/2023", + "Organizer": "PCRonline", + "Organizer_Type": "Other", + "Sponsor": "PCRonline", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 720, + "user_id": 1497893077, + "event_name": "The role of imaging in transcatheter treatment for tricuspid valve disease 2022", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "The role of imaging in transcatheter treatment for tricuspid valve disease", + "role": "Speaker", + "topic": "Catheters | Tricuspid Valve", + "Start": "01/01/2022", + "End": "01/01/2022", + "Organizer": "PCRonline", + "Organizer_Type": "Other", + "Sponsor": "PCRonline", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 721, + "user_id": 1497893077, + "event_name": "Severe Aortic Stenosis: Stratifying Patients for Lifetime Management 2022", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Severe Aortic Stenosis: Stratifying Patients For Lifetime Management", + "role": "Speaker", + "topic": "Aortic Valve Stenosis | Prealbumin", + "Start": "03/09/2022", + "End": "03/09/2022", + "Organizer": "Radcliffe Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Radcliffe Cardiology", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 722, + "user_id": 1497893077, + "event_name": "Severe Aortic Stenosis: Stratifying Patients for Lifetime Management 2022", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Severe Aortic Stenosis: Stratifying Patients for Lifetime Management", + "role": "Speaker", + "topic": "Aortic Valve Stenosis", + "Start": "04/12/2022", + "End": "04/12/2022", + "Organizer": "Radcliffe Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Radcliffe Cardiology", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 723, + "user_id": 1497893077, + "event_name": "Severe Aortic Stenosis: Stratifying Patients for Lifetime Management 2022", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "04/12/2022", + "End": "04/12/2022", + "Organizer": "Radcliffe Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Radcliffe Cardiology", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 724, + "user_id": 1497893077, + "event_name": "Severe Aortic Stenosis: Stratifying Patients for Lifetime Management 2022", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us?", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "04/12/2022", + "End": "04/12/2022", + "Organizer": "Radcliffe Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Radcliffe Cardiology", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 725, + "user_id": 1497893077, + "event_name": "PPM for TAVR: A Review of Current Evidence 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "PPM for TAVR: A Review of Current Evidence", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "08/31/2021", + "End": "08/31/2021", + "Organizer": "Evolve Medical Education, LLC", + "Organizer_Type": "Other", + "Sponsor": "Evolve Medical Education, LLC", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 726, + "user_id": 1497893077, + "event_name": "Oakstone Echocardiography – A Comprehensive Review Videos Course 2020", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Discussion on Mitral Stenosis", + "role": "Speaker", + "topic": "Mitral Valve Stenosis", + "Start": "01/31/2020", + "End": "01/31/2020", + "Organizer": "Medical CME Center", + "Organizer_Type": "Other", + "Sponsor": "Medical CME Center", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 727, + "user_id": 1497893077, + "event_name": "Novel Concepts of Tricuspid Regurgitation: Anatomy, Pathophysiology and Management 2024", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Novel Concepts of Tricuspid Regurgitation: Anatomy, Pathophysiology and Management", + "role": "Speaker", + "topic": "Anatomy | Tricuspid Valve Insufficiency", + "Start": "04/22/2024", + "End": "04/22/2024", + "Organizer": "Emory University School of Medicine", + "Organizer_Type": "University/Hospital", + "Sponsor": "Emory University School of Medicine", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://med.emory.edu/departments/medicine/divisions/cardiology/cme/cme-archives.html", + "Url2": "" + }, + { + "id": 728, + "user_id": 1497893077, + "event_name": "Natural history and prognosis of tricuspid valve disease", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Natural history and prognosis of tricuspid valve disease", + "role": "Speaker", + "topic": "Tricuspid Valve", + "Start": "09/23/2021", + "End": "09/23/2021", + "Organizer": "PCRonline", + "Organizer_Type": "Other", + "Sponsor": "PCRonline", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 729, + "user_id": 1497893077, + "event_name": "Management of Concomitant Mitral and Tricuspid Valve Regurgitation: Procedural and Imaging Considerations 2020", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Management of Concomitant Mitral and Tricuspid Valve Regurgitation: Procedural and Imaging Considerations", + "role": "Speaker", + "topic": "Tricuspid Valve Insufficiency", + "Start": "12/01/2020", + "End": "12/01/2020", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 730, + "user_id": 1497893077, + "event_name": "Introduction to the Guidelines and Review of Aortic and Mitral Imaging 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Introduction to the Guidelines and Review of Aortic and Mitral Imaging", + "role": "Speaker", + "topic": "Mitral Valve Insufficiency", + "Start": "12/15/2021", + "End": "12/15/2021", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 731, + "user_id": 1497893077, + "event_name": "How should we use Transcatheter Tricuspid Valve Repair to treat patients with Tricuspid Regurgitation? 2020", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "How should we use Transcatheter Tricuspid Valve Repair to treat patients with Tricuspid Regurgitation?", + "role": "Speaker", + "topic": "Catheters | Tricuspid Valve Insufficiency", + "Start": "11/02/2020", + "End": "11/02/2020", + "Organizer": "PCRonline", + "Organizer_Type": "Other", + "Sponsor": "PCRonline", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 732, + "user_id": 1497893077, + "event_name": "Guidelines and Review of Tricuspid and Interatrial Septum/LAA Imaging Protocols 2021", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Guidelines and Review of Tricuspid and Interatrial Septum/LAA Imaging Protocols", + "role": "Speaker", + "topic": "Atrial Appendage | Tricuspid Valve Insufficiency", + "Start": "12/17/2021", + "End": "12/17/2021", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 733, + "user_id": 1497893077, + "event_name": "Five Key Elements of a Comprehensive MR Echocardiogram 2020", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Five Key Elements of a Comprehensive MR Echocardiogram", + "role": "Speaker", + "topic": "Echocardiography", + "Start": "12/21/2020", + "End": "12/21/2020", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 734, + "user_id": 1497893077, + "event_name": "Expert Consensus Decision Pathway for MR: Focus on Patient Evaluation and Management 2021", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "Expert Consensus Decision Pathway for MR: Focus on Patient Evaluation and Management", + "role": "Speaker", + "topic": "Mitral Valve Insufficiency", + "Start": "01/22/2021", + "End": "01/22/2021", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 735, + "user_id": 1497893077, + "event_name": "Discussion on Advanced Cardiac Imaging 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Discussion on CT-fluoroscopy, CT-Echocardiography, and Multi-Modality Fusion", + "role": "Speaker", + "topic": "Echocardiography | Fluoroscopy", + "Start": "07/01/2021", + "End": "07/01/2021", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 736, + "user_id": 1497893077, + "event_name": "Demystifying the Tricuspid Valve: Anatomy, Pathophysiology and Treatment 2021", + "event_type": "Grand Round", + "session_type": "Grand Round", + "Session_Name": "Demystifying the Tricuspid Valve: Anatomy, Pathophysiology and Treatment", + "role": "Speaker", + "topic": "Tricuspid Valve", + "Start": "02/09/2021", + "End": "02/09/2021", + "Organizer": "UC San Diego School of Medicine", + "Organizer_Type": "University/Hospital", + "Sponsor": "UC San Diego School of Medicine", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 737, + "user_id": 1497893077, + "event_name": "Defining the Heart Team in 2021: New Roles for the Interventional Imager 2021", + "event_type": "Online", + "session_type": "CME", + "Session_Name": "Defining the Heart Team in 2021: New Roles for the Interventional Imager", + "role": "Speaker", + "topic": "Education And Research | Heart | Methods", + "Start": "04/01/2021", + "End": "04/01/2021", + "Organizer": "Houston Methodist", + "Organizer_Type": "University/Hospital", + "Sponsor": "Houston Methodist", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 738, + "user_id": 1497893077, + "event_name": "Advances in Imaging for Tricuspid Valve Intervention: Lessons Learned 2024", + "event_type": "Online", + "session_type": "Webinar", + "Session_Name": "Advances in Imaging for Tricuspid Valve Intervention: Lessons Learned", + "role": "Speaker", + "topic": "Diagnostic Imaging | Tricuspid Valve", + "Start": "01/05/2024", + "End": "01/05/2024", + "Organizer": "New York Transcatheter Valves", + "Organizer_Type": "Other", + "Sponsor": "New York Transcatheter Valves", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "https://www.youtube.com/watch?v=6jLBTSzTT3s", + "Url2": "" + }, + { + "id": 739, + "user_id": 1497893077, + "event_name": "ACC/AHA Guideline Update: What's New for Secondary MR 2020", + "event_type": "Online", + "session_type": "Podcast", + "Session_Name": "ACC/AHA Guideline Update: What's New for Secondary MR", + "role": "Speaker", + "topic": "Mitral Valve Insufficiency", + "Start": "12/21/2020", + "End": "12/21/2020", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 740, + "user_id": 1497893077, + "event_name": "2024 University of Michigan Cardiovascular Medicine Grand Rounds", + "event_type": "Grand Round", + "session_type": "CME", + "Session_Name": "Tricuspid Regurgitation: Current Understanding of Anatomy, Pathophysiology and Management", + "role": "Speaker", + "topic": "Anatomy | Tricuspid Valve Insufficiency", + "Start": "05/02/2024", + "End": "05/02/2024", + "Organizer": "University of Michigan", + "Organizer_Type": "University/Hospital", + "Sponsor": "University of Michigan", + "Sponsor_Type": "University/Hospital", + "Location": "University of Michigan", + "Address": "500 S State St", + "Country": "United States", + "State": "Michigan", + "City": "Ann Arbor", + "Postal_Code": 48109, + "Url1": "https://sites.google.com/umich.edu/cvmgrandrounds/home", + "Url2": "" + }, + { + "id": 741, + "user_id": 1497893077, + "event_name": "2024 Society of Cardiovascular Anesthesiologists Annual Meeting and Workshops (SCA)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Tricuspid Valve Anatomy - Old Valve, New Insight, Procedural Imaging Clarified", + "role": "Speaker", + "topic": "Procedural Imaging | Tricuspid Valve Insufficiency", + "Start": "04/27/2024", + "End": "04/30/2024", + "Organizer": "Society of Cardiovascular Anesthesiologists (SCA), American Association for Thoracic Surgeons (AATS)", + "Organizer_Type": "Association", + "Sponsor": "Society of Cardiovascular Anesthesiologists (SCA), American Association for Thoracic Surgeons (AATS)", + "Sponsor_Type": "Association", + "Location": "Metro Toronto Convention Centre (MTCC) South Building", + "Address": "222 Bremner Boulevard", + "Country": "Canada", + "State": "Ontario", + "City": "Toronto", + "Postal_Code": "M5V 3L9", + "Url1": "https://scahq.org/event/2024-annual-meetings-workshops/", + "Url2": "" + }, + { + "id": 742, + "user_id": 1497893077, + "event_name": "2024 Society for Cardiovascular Angiography and Interventions Scientific Sessions", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Update from the First-in-human Study with the Novel DurAVR Biomimetic Transcatheter Heart Valve", + "role": "Speaker", + "topic": "Biomimetics | Catheters | Heart Valves", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "Long Beach Convention Center", + "Address": "Atlantic Avenue 80", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://www.sciencedirect.com/journal/journal-of-the-society-for-cardiovascular-angiography-and-interventions/vol/3/issue/5/suppl/S", + "Url2": "" + }, + { + "id": 743, + "user_id": 1497893077, + "event_name": "2024 Society for Cardiovascular Angiography and Interventions Scientific Sessions", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "DurAVR biomimetic transcatheter heart valve: first-in-human study results update", + "role": "Speaker", + "topic": "Biomimetics | Catheters | Heart Valves", + "Start": "05/02/2024", + "End": "05/04/2024", + "Organizer": "Society For Cardiovascular Angiograpy and Inventions", + "Organizer_Type": "Association", + "Sponsor": "Society For Cardiovascular Angiograpy and Inventions", + "Sponsor_Type": "Association", + "Location": "Long Beach Convention Center", + "Address": "Atlantic Avenue 80", + "Country": "United States", + "State": "California", + "City": "Long Beach", + "Postal_Code": 90802, + "Url1": "https://www.sciencedirect.com/journal/journal-of-the-society-for-cardiovascular-angiography-and-interventions/vol/3/issue/5/suppl/S", + "Url2": "" + }, + { + "id": 744, + "user_id": 1497893077, + "event_name": "2024 Penn Medicine / American College of Cardiology Pennsylvania Chapter Advanced Multimodality Cardiac Imaging Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Imaging Considerations for Tricuspid Valve Interventions", + "role": "Speaker", + "topic": "Diagnostic Imaging | Tricuspid Valve Insufficiency", + "Start": "05/03/2024", + "End": "05/04/2024", + "Organizer": "Penn Medicine / American College of Cardiology", + "Organizer_Type": "Other", + "Sponsor": "Penn Medicine / American College of Cardiology", + "Sponsor_Type": "Other", + "Location": "Smilow Center for Translational Research", + "Address": "3400 Civic Center Blvd", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19104, + "Url1": "https://pcacc.org/resources/Pictures/AMCIS24_Brochure_v16.pdf", + "Url2": "" + }, + { + "id": 745, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Basic Echocardiography/Imaging Modalities", + "role": "Moderator", + "topic": "Diagnostic Imaging | Echocardiography", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 746, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Valvular Heart Disease I: Mitral And Tricuspid Valve", + "role": "Moderator", + "topic": "Heart Valve Diseases", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 747, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Tricuspid Regurgitation: Massive and Torrential Criteria Necessary?", + "role": "Speaker", + "topic": "Tricuspid Valve Insufficiency", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 748, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Contrast, Stress, And Strain Echocardiography", + "role": "Moderator", + "topic": "Strain Echocardiography | Stress Disorders", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 749, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Strain Imaging in VHD: When Does It Help? Who Needs Strain Imaging? Can Strain Determine the Timing of Intervention?", + "role": "Speaker", + "topic": "Heart Valve Diseases | Strain Imaging", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 750, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Imaging For Interventional And Intraoperative Procedures", + "role": "Moderator", + "topic": "Diagnostic Imaging | Intraoperative Complications", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 751, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Interventional Echocardiography IV: Transcatheter Tricuspid Valve Repair, Transcatheter Tricuspid Valve Replacement", + "role": "Speaker", + "topic": "Echocardiography | Transcatheter Tricuspid Valve Replacement", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 752, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "ICE and TEE", + "role": "Moderator", + "topic": "Echocardiography, Transesophageal | Intracardiac Echocardiography", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 753, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Imaging COVID 19", + "role": "Speaker", + "topic": "COVID-19 | Diagnostic Imaging", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 754, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "TEE 3-D: Techniques and Tricks", + "role": "Speaker", + "topic": "Echocardiography, Transesophageal | Imaging, Three-Dimensional", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 755, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Congenital Heart Disease", + "role": "Moderator", + "topic": "Heart Defects, Congenital", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 756, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Estimating Intracardiac Pressures Non-Invasively", + "role": "Speaker", + "topic": "Intracardiac Pressure", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 757, + "user_id": 1497893077, + "event_name": "2024 Mayo Clinic Annual State-of-the-Art Echo Course", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Director", + "topic": "Admin. & Management", + "Start": "08/12/2024", + "End": "08/14/2024", + "Organizer": "Mayo Clinic, Columbia Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Clinic, Columbia Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "New York Marriott Marquis", + "Address": "1535 Broadway", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10035, + "Url1": "https://cveducation.mayo.edu/store/echo-imaging-new-york-state-of-the-art-2024/program", + "Url2": "" + }, + { + "id": 758, + "user_id": 1497893077, + "event_name": "2024 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "How To Use 2D/3D/4D Tee Imaging For Effective Laa Exclusion", + "role": "Speaker", + "topic": "Echocardiography, Four-Dimensional | Echocardiography, Transesophageal | Imaging, Three-Dimensional | Left Atrial Appendage Closure", + "Start": "03/01/2024", + "End": "03/02/2024", + "Organizer": "Academy for Continued Healthcare Learning (ACHL), ISLAA Foundation", + "Organizer_Type": "Other", + "Sponsor": "Academy for Continued Healthcare Learning (ACHL), ISLAA Foundation", + "Sponsor_Type": "Other", + "Location": "InterContinental New York Times Square, an IHG Hotel", + "Address": "300 West 44th Street", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10036, + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 759, + "user_id": 1497893077, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "What is the evidence for TEER in tricuspid regurgitation?", + "role": "Speaker", + "topic": "Tricuspid Transcatheter Edge-to-edge Repair | Tricuspid Valve Insufficiency", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 760, + "user_id": 1497893077, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Imaging of tricuspid regurgitation", + "role": "Speaker", + "topic": "Diagnostic Imaging | Tricuspid Valve Insufficiency", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 761, + "user_id": 1497893077, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Repairing the tricuspid valve in heart failure: is it beneficial?", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 762, + "user_id": 1497893077, + "event_name": "2024 European Society of Cardiology Congress (ESC)", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Heart failure and valvular heart disease: imaging to the rescue", + "role": "Speaker", + "topic": "Diagnostic Imaging | Heart Failure | Heart Valve Diseases", + "Start": "08/30/2024", + "End": "09/02/2024", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "ExCeL London", + "Address": "Royal Victoria Dock, 1 Western Gateway", + "Country": "United Kingdom", + "State": "England", + "City": "London", + "Postal_Code": "E16 1XL", + "Url1": "https://esc365.escardio.org/ESC-Congress/programme?text=&docType=DigitalSession&page=1", + "Url2": "" + }, + { + "id": 763, + "user_id": 1497893077, + "event_name": "2024 CSI Foundation Frankfurt Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "06/19/2024", + "End": "06/22/2024", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "Congress Center Messe Frankfurt", + "Address": "Ludwig-Erhard-Anlage 1", + "Country": "Germany", + "State": "Hessen", + "City": "Frankfurt", + "Postal_Code": 60327, + "Url1": "https://www.csi-congress.org/conferences-courses/conferences/csi-frankfurt/scientific-program/csi-program-overview/pag", + "Url2": "" + }, + { + "id": 764, + "user_id": 1497893077, + "event_name": "2024 CSI Foundation Frankfurt Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Patho-anatomy and imaging of the tricuspid valve", + "role": "Speaker", + "topic": "Diagnostic Imaging | Tricuspid Valve Insufficiency", + "Start": "06/19/2024", + "End": "06/22/2024", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "Congress Center Messe Frankfurt", + "Address": "Ludwig-Erhard-Anlage 1", + "Country": "Germany", + "State": "Hessen", + "City": "Frankfurt", + "Postal_Code": 60327, + "Url1": "https://www.csi-congress.org/conferences-courses/conferences/csi-frankfurt/scientific-program/csi-program-overview/pag", + "Url2": "" + }, + { + "id": 765, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Imaging The Mitral & Tricuspid Valve", + "role": "Moderator", + "topic": "Cardiac Imaging Techniques | Mitral Valve Disease | Tricuspid Valve Disease", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 766, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Imaging The Mitral And Tricuspid", + "role": "Moderator", + "topic": "Mitral Valve Disease | Tomography, X-Ray Computed | Tricuspid Valve Disease", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 767, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Echocardiographic Diagnosis And Longitudinal Follow-Up Of Tavr Failure", + "role": "Speaker", + "topic": "Echocardiography | Transcatheter Aortic Valve Replacement", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 768, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Imaging The Aortic Valve", + "role": "Faculty", + "topic": "Aortic Valve Disease | Cardiac Imaging Techniques", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 769, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Which Patients For Repair Versus Replacement? The Imaging Call", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 770, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "When Repair And When Replacement", + "role": "Faculty", + "topic": "Cardiac Surgical Procedures", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 771, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Who Should Perform Tricuspid Repair/Replacement And What Will Be The Fate Of Surgery And Future Technologies For Tricuspid Disease", + "role": "Faculty", + "topic": "Tricuspid Valve Replacement And Repair", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 772, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Technologies Meeting (CRT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Quantifying Tricuspid Regurgitation: Not Just About The Valve", + "role": "Speaker", + "topic": "Tricuspid Valve Insufficiency", + "Start": "03/09/2024", + "End": "03/12/2024", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Other", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Other", + "Location": "Washington Hilton", + "Address": "1919 Connecticut Avenue North West", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20009, + "Url1": "https://www.crtmeeting.org/Default.aspx", + "Url2": "" + }, + { + "id": 773, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Director", + "topic": "Admin. & Management", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 774, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials", + "role": "Speaker", + "topic": "Balloon Expandable Valves | Small Annulus", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 775, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Echocardiographic Characterization", + "role": "Faculty", + "topic": "Echocardiography", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 776, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "TEE and ICE Simulation for Tricuspid Valve Interventions​", + "role": "Faculty", + "topic": "Echocardiography, Transesophageal | Intracardiac Echocardiography | Tricuspid Valve Diseases", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 777, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "5-year outcomes of randomized TAVI trials by gender", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Edwards Lifesciences Corporation", + "Sponsor_Type": "Industry", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 778, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Guiding Atrio-Ventricular Valve Procedures: Tips and Tricks", + "role": "Moderator", + "topic": "Atrioventricular Valve Procedures", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 779, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure", + "role": "Faculty", + "topic": "Bioprosthetic Valve Dysfunction | Echocardiography", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 780, + "user_id": 1497893077, + "event_name": "2024 Cardiovascular Research Foundation Transcatheter Valve Therapy Structural Heart Summit (TVT)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Transcatheter Tricuspid Therapies: Now FDA Approved, Off and Running!", + "role": "Moderator", + "topic": "Transcatheter Tricuspid Valve Intervention", + "Start": "06/05/2024", + "End": "06/07/2024", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Jacob Javits Convention Center", + "Address": "429 11th Avenue", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10001, + "Url1": "https://nyvalves2024.crfconferences.com/program-guide", + "Url2": "" + }, + { + "id": 875, + "user_id": 1497893077, + "event_name": "2023 Annual Cardiovascular Research Technologies Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Imaging the Mitral AND Tricuspid", + "role": "Moderator", + "topic": "Diagnostic Imaging | Mitral Valve | Tricuspid Valve", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 876, + "user_id": 1497893077, + "event_name": "2023 Annual Cardiovascular Research Technologies Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Imaging The Mitral & Tricuspid Valve", + "role": "Moderator", + "topic": "Diagnostic Imaging | Tricuspid Valve", + "Start": "02/25/2023", + "End": "02/28/2023", + "Organizer": "Cardiovascular Research Technologies", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Technologies", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/CRT2023/agenda.asp?BCFO=M|PL&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1&mode=", + "Url2": "" + }, + { + "id": 877, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Future of Cardiovascular Ultrasound Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Chair", + "topic": "Admin. & Management", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Maryland", + "City": "Baltimore", + "Postal_Code": "", + "Url1": "https://www.asescientificsessions.org/program-committee/", + "Url2": "" + }, + { + "id": 878, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Program Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 879, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Introduction to Interventional Imaging: Not Just About the Intervention", + "role": "Chair", + "topic": "Ultrasonography, Interventional", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 880, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Learning Lab: 3D Cropping for Valve Interventions", + "role": "Chair", + "topic": "Echocardiography, Three-Dimensional", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 881, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Transcatheter Tricuspid Valve Interventions: Lesson’s Learned from Tricuspid Valve Surgery", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement | Tricuspid Valve Insufficiency", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 882, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "ABC on Imaging for TAVI Valve Sizing", + "role": "Speaker", + "topic": "Transcatheter Aortic Valve Replacement", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 883, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Interventional Echocardiography: Building a New Subspecialty", + "role": "Faculty", + "topic": "Echocardiography", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 884, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Intracardiac Echocardiography: State of Field and the Role of the Echocardiographer", + "role": "Speaker", + "topic": "Echocardiography", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "American Society Of Echocardiography", + "Sponsor_Type": "Association", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 885, + "user_id": 1497893077, + "event_name": "2023 American Society of Echocardiography Annual Scientific Sessions (ASE)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Experts Sharing Insights: How Innovative Imaging Technologies are Transforming Patient Care", + "role": "Chair", + "topic": "Echocardiography", + "Start": "06/23/2023", + "End": "06/26/2023", + "Organizer": "American Society of Echocardiography", + "Organizer_Type": "Association", + "Sponsor": "Koninklijke Philips NV", + "Sponsor_Type": "Industry", + "Location": "Gaylord National Resort & Convention Center", + "Address": "201 Waterfront Street", + "Country": "United States", + "State": "Maryland", + "City": "Fort Washington", + "Postal_Code": 20745, + "Url1": "https://www.asescientificsessions.org/", + "Url2": "" + }, + { + "id": 886, + "user_id": 1497893077, + "event_name": "2023 American Heart Association Scientific Sessions (AHA)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Forgotten Valve No More: Update on Recent Data Presented on Tricuspid Interventions", + "role": "Speaker", + "topic": "Tricuspid Valve Insufficiency", + "Start": "11/11/2023", + "End": "11/13/2023", + "Organizer": "American Heart Association, Inc.", + "Organizer_Type": "Association", + "Sponsor": "American Heart Association, Inc.", + "Sponsor_Type": "Association", + "Location": "Pennsylvania Convention Center", + "Address": "1101 Arch Street", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19107, + "Url1": "https://www.abstractsonline.com/pp8/?_ga=2.62588588.1409085307.1693826434-41755426.1693826431#!/10871", + "Url2": "" + }, + { + "id": 887, + "user_id": 1497893077, + "event_name": "2023 American College of Physicians Internal Medicine Meeting", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "General Internal Medicine", + "role": "Speaker", + "topic": "Internal Medicine", + "Start": "04/03/2023", + "End": "04/05/2023", + "Organizer": "American College of Physicians", + "Organizer_Type": "Association", + "Sponsor": "American College of Physicians", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "", + "Postal_Code": "", + "Url1": "https://annualmeeting.acponline.org/sites/default/files/documents/educational-program/imm23-scientific-program-and-pre-course-faculty-disclosures.pdf", + "Url2": "" + }, + { + "id": 888, + "user_id": 1497893077, + "event_name": "2023 American College of Cardiology New York Cardiovascular Symposium", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Tricuspid Regurgitation: Four Diagnostic and Management Challenges", + "role": "Speaker", + "topic": "Tricuspid Valve Insufficiency", + "Start": "12/08/2023", + "End": "12/10/2023", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "New York Hilton Midtown", + "Address": "1335 6th Ave", + "Country": "United States", + "State": "New York", + "City": "New York", + "Postal_Code": 10019, + "Url1": "https://www.acc.org/-/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Meetings/2023/Agendas/2023-NYCVS-Agenda.pdf?la=en&hash=871B9CCF6ADD40D3758C94E2670A810C90946CA3", + "Url2": "" + }, + { + "id": 962, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session and Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The Other Side of Heart Failure - Right-Heart Interventions", + "role": "Speaker", + "topic": "Heart Failure", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 963, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session and Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Diagnosing Valvular Heart Disease: Throw Away Your Stethoscope!", + "role": "Chair", + "topic": "Heart Diseases", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 964, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session and Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Tricuspid Valve: the New Frontier", + "role": "Chair", + "topic": "Tricuspid Valve", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 965, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session and Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Tricuspid Regurgitation 2021: Where We'Ve Been and Where We'Re Going", + "role": "Speaker", + "topic": "Tricuspid Valve", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 966, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "MultiVessel Pci And Cabg Demonstrate Significant Improvements In PostProcedure Global Longitudinal Strain And Left Ventricular Ejection Fraction", + "role": "Speaker", + "topic": "Global Longitudinal Strain | Ventricular Function, Left", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "801 Mount Vernon Place Northwest", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20001, + "Url1": "", + "Url2": "" + }, + { + "id": 967, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Left Ventricular Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement In Patients With Pure Aortic Regurgitation", + "role": "Speaker", + "topic": "Aortic Valve Insufficiency | Transcatheter Aortic Valve Replacement | Ventricular Function, Left", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "801 Mount Vernon Place Northwest", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20001, + "Url1": "", + "Url2": "" + }, + { + "id": 968, + "user_id": 1497893077, + "event_name": "2022 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Effect Of Sex And Low Flow After Surgical Or Transcatheter Aortic Valve Replacement: An Analysis Of Partner 2 And 3 Trials", + "role": "Speaker", + "topic": "Sex | Surgical Procedures, Operative | Transcatheter Aortic Valve Replacement", + "Start": "04/02/2022", + "End": "04/04/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Walter E. Washington Convention Center", + "Address": "801 Mount Vernon Place Northwest", + "Country": "United States", + "State": "District of Columbia", + "City": "Washington", + "Postal_Code": 20001, + "Url1": "", + "Url2": "" + }, + { + "id": 969, + "user_id": 1497893077, + "event_name": "2022 Advances in Cardiovascular Imaging and Interventions Annual Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Advances in Cardiovascular Imaging and Intervention", + "role": "Speaker", + "topic": "Cardiovascular Diseases | Diagnostic Imaging", + "Start": "10/06/2022", + "End": "10/07/2022", + "Organizer": "Beaumont Health", + "Organizer_Type": "University/Hospital", + "Sponsor": "Beaumont Health", + "Sponsor_Type": "University/Hospital", + "Location": "Detroit Marriott Troy", + "Address": "200 W Big Beaver Rd", + "Country": "United States", + "State": "Michigan", + "City": "Troy", + "Postal_Code": 48084, + "Url1": "https://beaumont.cloud-cme.com/course/courseoverview?P=5&EID=59319", + "Url2": "" + }, + { + "id": 970, + "user_id": 1497893077, + "event_name": "2022 Adult Clinical Cardiology Self-Assessment Program", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Understanding And Managing Mr:Evolving Science And Policy", + "role": "Speaker", + "topic": "Education And Research", + "Start": "01/01/2022", + "End": "01/01/2022", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 971, + "user_id": 1497893077, + "event_name": "2021 Women As One CLIMB Skills Training Program", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Complex Structural Interventional Procedures", + "role": "Director", + "topic": "Cardiovascular Surgical Procedures", + "Start": "04/21/2021", + "End": "04/21/2021", + "Organizer": "Women As One", + "Organizer_Type": "Other", + "Sponsor": "Women As One", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 972, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Structural Heart Disease - Live Case", + "role": "Speaker", + "topic": "Heart Diseases", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 973, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Tricuspid Valve Interventions", + "role": "Moderator", + "topic": "Percutaneous Coronary Intervention | Transcatheter Aortic Valve Replacement | Tricuspid Valve", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 974, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "TAVR Hot Topic: Valve Hemodynamics and PPM Assessment", + "role": "Moderator", + "topic": "Hemodynamics | Transcatheter Aortic Valve Replacement", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center", + "Address": "", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 975, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Tee And FluoroscopyGuided Watchman Implantation Without Administration Of Iodinated Contrast Material", + "role": "Speaker", + "topic": "Fluoroscopy", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center - West Concourse", + "Address": "9800 International Dr", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": 32819, + "Url1": "", + "Url2": "" + }, + { + "id": 976, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Net Adverse Clinical Outcomes In Patients Undergoing Transcatheter Aortic Valve Replacement With A History Of Remote, Recent, Or Concurrent Percutaneous Coronary Intervention", + "role": "Speaker", + "topic": "Percutaneous Coronary Intervention | Transcatheter Aortic Valve Replacement", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center - West Concourse", + "Address": "9800 International Dr", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": 32819, + "Url1": "", + "Url2": "" + }, + { + "id": 977, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Accelerated Left Atrial Appendage Closure With The NewGeneration Watchman Flx By Ccta At 45 Days Postimplant Author Links Open Overlay Panel", + "role": "Speaker", + "topic": "Atrial Appendage", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center - West Concourse", + "Address": "9800 International Dr", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": 32819, + "Url1": "", + "Url2": "" + }, + { + "id": 978, + "user_id": 1497893077, + "event_name": "2021 Transcatheter Cardiovascular Therapeutics Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Impact Of Right VentriclePulmonary Artery Coupling On Clinical Outcomes After Transcatheter And Surgical Aortic Valve Replacement: An Analysis Of The Partner 3 Trial", + "role": "Speaker", + "topic": "Heart Ventricles | Pulmonary Artery | Transcatheter Aortic Valve Replacement", + "Start": "11/04/2021", + "End": "11/06/2021", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "Orange County Convention Center - West Concourse", + "Address": "9800 International Dr", + "Country": "United States", + "State": "Florida", + "City": "Orlando", + "Postal_Code": 32819, + "Url1": "", + "Url2": "" + }, + { + "id": 1041, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Valve Therapies Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Imaging Assessment of Technical Outcomes Post-Mitral Intervention", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques", + "Start": "06/18/2020", + "End": "06/28/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1042, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Valve Therapies Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Patient Selection for Tricuspid Intervention — Lessons From Surgery", + "role": "Moderator", + "topic": "Tricuspid Valve", + "Start": "06/18/2020", + "End": "06/28/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1043, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Valve Therapies Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Transcatheter Tricuspid Intervention — Imaging Essentials", + "role": "Moderator", + "topic": "Cardiac Imaging Techniques | Transcatheter Aortic Valve Replacement", + "Start": "06/18/2020", + "End": "06/28/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1044, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Valve Therapies Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Heart Team Roundtable — Imaging and Tricuspid Device Selection", + "role": "Moderator", + "topic": "Heart", + "Start": "06/18/2020", + "End": "06/28/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1045, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Valve Therapies Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Transcatheter Leaflet Grasping for Tricuspid Regurgitation", + "role": "Moderator", + "topic": "Catheters | Tricuspid Valve Insufficiency", + "Start": "06/18/2020", + "End": "06/28/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1046, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Initial SingleCenter Experience With Transfemoral Transcatheter Aortic Valve Replacement In Patients With Symptomatic Severe Aortic Regurgitation", + "role": "Speaker", + "topic": "Heart Diseases | Transcatheter Aortic Valve Replacement", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1047, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Impact Of Flow On The Incidence And Prognosis Of ProsthesisPatient Mismatch Following Aortic Valve Replacement In The Partner 2 Study And Registry", + "role": "Speaker", + "topic": "Heart Diseases | Transcatheter Aortic Valve Replacement", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1048, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Impact Of Right VentricularPulmonary Arterial Coupling In Heart Failure Patients With Functional Mitral Regurgitation: Analysis From The Coapt Trial", + "role": "Speaker", + "topic": "Mitral Valve Insufficiency | Pulmonary Arterial Hypertension", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1049, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Impact Of TimeOfDay Of Surgical Or Transcatheter Aortic Valve Replacement Procedure On Outcomes: A PropensityScore Matched Analysis From Partner Trials", + "role": "Speaker", + "topic": "Heart Diseases | Transcatheter Aortic Valve Replacement", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1050, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Real World Outcomes With Small (20Mm) Balloon Expandable Sapien 3 Valves Compared To Larger Valves (23, 26, And 29Mm)", + "role": "Speaker", + "topic": "Angioplasty, Balloon, LaserAssisted", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1051, + "user_id": 1497893077, + "event_name": "2020 Transcatheter Cardiovascular Therapeutics Annual Scientific Symposium Virtual", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "The Pascal Transcatheter Valve Repair System For The Treatment Of Tricuspid Regurgitation: 30Day Outcomes From The Clasp Tr Early Feasibility Study", + "role": "Speaker", + "topic": "Heart Diseases | Tricuspid Valve Insufficiency", + "Start": "10/14/2020", + "End": "10/18/2020", + "Organizer": "Cardiovascular Research Foundation", + "Organizer_Type": "Association", + "Sponsor": "Cardiovascular Research Foundation", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1100, + "user_id": 1497893077, + "event_name": "2020 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Impact Of Tricuspid Regurgitation On Outcomes After Mitraclip Treatment Of Secondary Mitral Regurgitation: Results From The Coapt Trial", + "role": "Speaker", + "topic": "Mitral Valve | Mitral Valve Insufficiency | Tricuspid Valve Insufficiency", + "Start": "03/28/2020", + "End": "03/30/2020", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Marriott Marquis Chicago", + "Address": "2121 S Prairie Avenue", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60611, + "Url1": "", + "Url2": "" + }, + { + "id": 1101, + "user_id": 1497893077, + "event_name": "2020 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The Alignment Of Transcatheter Aortic Valve NeoCommissures (Align Tavr) Study Author Links Open Overlay Panel", + "role": "Speaker", + "topic": "Heart Diseases | Transcatheter Aortic Valve Replacement", + "Start": "03/28/2020", + "End": "03/30/2020", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Marriott Marquis Chicago", + "Address": "2121 S Prairie Avenue", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60611, + "Url1": "", + "Url2": "" + }, + { + "id": 1148, + "user_id": 1497893077, + "event_name": "2019 European Society of Cardiology 3D Echo 360 Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "How to use 3DE to monitor interventional procedures on the tricuspid valve", + "role": "Speaker", + "topic": "Echocardiography, Three-Dimensional | Tricuspid Valve", + "Start": "09/13/2019", + "End": "09/15/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Padova", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1149, + "user_id": 1497893077, + "event_name": "2019 European Society of Cardiology 3D Echo 360 Conference", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Photorealistic imaging: a new vision of 3D / 4D imaging", + "role": "Speaker", + "topic": "Imaging, Three-Dimensional", + "Start": "09/13/2019", + "End": "09/15/2019", + "Organizer": "European Society of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Padova", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1150, + "user_id": 1497893077, + "event_name": "2019 European Association of Cardiovascular Imaging EuroEcho Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Scientific Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "12/04/2019", + "End": "12/07/2019", + "Organizer": "European Association of Cardiovascular Imaging", + "Organizer_Type": "Association", + "Sponsor": "European Association of Cardiovascular Imaging", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Austria", + "State": "Wien", + "City": "Vienna", + "Postal_Code": "", + "Url1": "https://www.escardio.org/static-file/Escardio/Congresses/EuroEcho/Documents/FP%20EuroEcho2019_300dpi_%20Interactiv-Update.pdf", + "Url2": "" + }, + { + "id": 1151, + "user_id": 1497893077, + "event_name": "2019 European Association of Cardiovascular Imaging EuroEcho Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Understanding the tricuspid valve - An imaging perspective", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques", + "Start": "12/04/2019", + "End": "12/07/2019", + "Organizer": "European Association of Cardiovascular Imaging", + "Organizer_Type": "Association", + "Sponsor": "European Association of Cardiovascular Imaging", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Austria", + "State": "Wien", + "City": "Vienna", + "Postal_Code": "", + "Url1": "https://www.escardio.org/static-file/Escardio/Congresses/EuroEcho/Documents/FP%20EuroEcho2019_300dpi_%20Interactiv-Update.pdf", + "Url2": "" + }, + { + "id": 1152, + "user_id": 1497893077, + "event_name": "2019 European Association of Cardiovascular Imaging Annual Scientific Meeting", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Focus on left atrial appendage closure", + "role": "Speaker", + "topic": "Atrial Appendage", + "Start": "12/04/2019", + "End": "12/07/2019", + "Organizer": "European Association of Cardiovascular Imaging", + "Organizer_Type": "Association", + "Sponsor": "European Association of Cardiovascular Imaging", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Austria", + "State": "Wien", + "City": "Vienna", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1153, + "user_id": 1497893077, + "event_name": "2019 EuroECHO Imaging Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Quantitative Imaging Of Tr", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques", + "Start": "12/04/2019", + "End": "04/07/2019", + "Organizer": "European Association of Cardiovascular Imaging", + "Organizer_Type": "Association", + "Sponsor": "European Association of Cardiovascular Imaging", + "Sponsor_Type": "Association", + "Location": "Messe Wien Congress Center", + "Address": "", + "Country": "Austria", + "State": "Wien", + "City": "Vienna", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1197, + "user_id": 1841382421, + "event_name": "2024 Heart Rhythm Society Heart Rhythm Conference (HRS)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "The Future of AI Implementation in AF Ablation Procedures", + "role": "Speaker", + "topic": "Artificial Intelligence | Atrial Fibrillation", + "Start": "05/16/2024", + "End": "05/19/2024", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Volta Medical", + "Sponsor_Type": "Industry", + "Location": "Boston Convention and Exhibition Center", + "Address": "415 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://heartrhythm.com/", + "Url2": "" + }, + { + "id": 1198, + "user_id": 1841382421, + "event_name": "2024 Heart Rhythm Society Heart Rhythm Conference (HRS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "EP Cases for the Real World", + "role": "Speaker", + "topic": "Cardiac Electrophysiology", + "Start": "05/16/2024", + "End": "05/19/2024", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Mediasphere Medical, CineMed, Abbott, Biosense Webster Inc, Boston Scientific Corporation, Medtronic, Texas Cardiac Arrhythmia Institute, HCA Healthcare Inc", + "Sponsor_Type": "Other", + "Location": "Boston Convention and Exhibition Center", + "Address": "415 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://heartrhythm.com/", + "Url2": "" + }, + { + "id": 1199, + "user_id": 1841382421, + "event_name": "2024 Heart Rhythm Society Heart Rhythm Conference (HRS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "AF Ablation Indications, Strategies and Controversies in Clinical Practice: Learn From the Experts", + "role": "Faculty", + "topic": "Atrial Fibrillation", + "Start": "05/16/2024", + "End": "05/19/2024", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Boston Convention and Exhibition Center", + "Address": "415 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://heartrhythm.com/", + "Url2": "" + }, + { + "id": 1200, + "user_id": 1841382421, + "event_name": "2024 European Society of Cardiology (ESC) / European Heart Rhythm Association (EHRA) Annual Congress", + "event_type": "Congress", + "session_type": "Abstract Presentation", + "Session_Name": "Atrial fibrillation: ablation", + "role": "Chair", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "04/07/2024", + "End": "04/09/2024", + "Organizer": "European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA)", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA)", + "Sponsor_Type": "Association", + "Location": "CityCube Berlin", + "Address": "Messedamm 26", + "Country": "Germany", + "State": "Berlin", + "City": "Berlin", + "Postal_Code": 14055, + "Url1": "https://esc365.escardio.org/EHRA-Congress", + "Url2": "" + }, + { + "id": 1201, + "user_id": 1841382421, + "event_name": "2024 European Society of Cardiology (ESC) / European Heart Rhythm Association (EHRA) Annual Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Live-in-the-Box: non-PV trigger mapping", + "role": "Speaker", + "topic": "Arrhythmias, Cardiac", + "Start": "04/07/2024", + "End": "04/09/2024", + "Organizer": "European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA)", + "Organizer_Type": "Association", + "Sponsor": "European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA)", + "Sponsor_Type": "Association", + "Location": "CityCube Berlin", + "Address": "Messedamm 26", + "Country": "Germany", + "State": "Berlin", + "City": "Berlin", + "Postal_Code": 14055, + "Url1": "https://esc365.escardio.org/EHRA-Congress", + "Url2": "" + }, + { + "id": 1202, + "user_id": 1841382421, + "event_name": "2024 CSI Foundation Frankfurt Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Left atrial appendage isolation: latest findings", + "role": "Speaker", + "topic": "Left Atrial Appendage Closure", + "Start": "06/19/2024", + "End": "06/22/2024", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "Congress Center Messe Frankfurt", + "Address": "Ludwig-Erhard-Anlage 1", + "Country": "Germany", + "State": "Hessen", + "City": "Frankfurt", + "Postal_Code": 60327, + "Url1": "https://www.csi-congress.org/conferences-courses/conferences/csi-frankfurt/scientific-program/csi-program-overview/pag", + "Url2": "" + }, + { + "id": 1203, + "user_id": 1841382421, + "event_name": "2024 CSI Foundation Frankfurt Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Rhythmology – Focus LAA", + "role": "Faculty", + "topic": "Left Atrial Appendage Closure", + "Start": "06/19/2024", + "End": "06/22/2024", + "Organizer": "CSI Foundation", + "Organizer_Type": "Association", + "Sponsor": "CSI Foundation", + "Sponsor_Type": "Association", + "Location": "Congress Center Messe Frankfurt", + "Address": "Ludwig-Erhard-Anlage 1", + "Country": "Germany", + "State": "Hessen", + "City": "Frankfurt", + "Postal_Code": 60327, + "Url1": "https://www.csi-congress.org/conferences-courses/conferences/csi-frankfurt/scientific-program/csi-program-overview/pag", + "Url2": "" + }, + { + "id": 1204, + "user_id": 1841382421, + "event_name": "2024 Annual Western Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pulsed Field Ablation Beyond the Pulmonary Veins: Impact on AF ablation outcomes", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Pulmonary Veins | Pulsed Field Ablation", + "Start": "02/23/2024", + "End": "02/24/2024", + "Organizer": "HMP Global", + "Organizer_Type": "Other", + "Sponsor": "HMP Global", + "Sponsor_Type": "Other", + "Location": "Sheraton Park City", + "Address": "1895 Sidewinder Drive", + "Country": "United States", + "State": "Utah", + "City": "Park City", + "Postal_Code": 84060, + "Url1": "https://www.hmpglobalevents.com/wafib", + "Url2": "" + }, + { + "id": 1205, + "user_id": 1841382421, + "event_name": "2024 Annual Western Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Roundtable and Live Case Review: Recent Advances in Stroke Prevention", + "role": "Speaker", + "topic": "Stroke", + "Start": "02/23/2024", + "End": "02/24/2024", + "Organizer": "HMP Global", + "Organizer_Type": "Other", + "Sponsor": "Boston Scientific Corporation", + "Sponsor_Type": "Industry", + "Location": "Sheraton Park City", + "Address": "1895 Sidewinder Drive", + "Country": "United States", + "State": "Utah", + "City": "Park City", + "Postal_Code": 84060, + "Url1": "https://www.hmpglobalevents.com/wafib", + "Url2": "" + }, + { + "id": 1206, + "user_id": 1841382421, + "event_name": "2024 Annual Western Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Implementing Volta AI Based Dispersion EGM Guided Strategies for the Complex Substrate Patient Population", + "role": "Moderator", + "topic": "Artificial Intelligence | Electromyography", + "Start": "02/23/2024", + "End": "02/24/2024", + "Organizer": "HMP Global", + "Organizer_Type": "Other", + "Sponsor": "Volta Medical", + "Sponsor_Type": "Industry", + "Location": "Sheraton Park City", + "Address": "1895 Sidewinder Drive", + "Country": "United States", + "State": "Utah", + "City": "Park City", + "Postal_Code": 84060, + "Url1": "https://www.hmpglobalevents.com/wafib", + "Url2": "" + }, + { + "id": 1207, + "user_id": 1841382421, + "event_name": "2024 Annual International Atrial Fibrillation Symposium (AFS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Improving Technologies and Workflows for Efficiency and Outcomes", + "role": "Speaker", + "topic": "Clinical Studies As Topic", + "Start": "02/01/2024", + "End": "02/03/2024", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Abbott", + "Sponsor_Type": "Industry", + "Location": "Omni Boston at the Seaport", + "Address": "450 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://www.afsymposium.com/2024-program", + "Url2": "" + }, + { + "id": 1208, + "user_id": 1841382421, + "event_name": "2024 Annual International Atrial Fibrillation Symposium (AFS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Role of Posterior Wall Isolation in AF Ablation - Impact of Pulsed Field Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Posterior Wall Isolation | Pulsed Field Ablation", + "Start": "02/01/2024", + "End": "02/03/2024", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston at the Seaport", + "Address": "450 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://www.afsymposium.com/2024-program", + "Url2": "" + }, + { + "id": 1209, + "user_id": 1841382421, + "event_name": "2024 Annual International Atrial Fibrillation Symposium (AFS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "First in Human Experience with Novel Pulsed Field Ablation Technologies", + "role": "Speaker", + "topic": "Ablation Techniques | First-In-Human Clinical Trial | Pulsed Field Ablation", + "Start": "02/01/2024", + "End": "02/03/2024", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston at the Seaport", + "Address": "450 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://www.afsymposium.com/2024-program", + "Url2": "" + }, + { + "id": 1210, + "user_id": 1841382421, + "event_name": "2024 Annual International Atrial Fibrillation Symposium (AFS)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Practical Considerations for Optimizing the Efficacy of AF Ablation in the Era of Pulsed Field Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Pulsed Field Ablation", + "Start": "02/01/2024", + "End": "02/03/2024", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston at the Seaport", + "Address": "450 Summer Street", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "https://www.afsymposium.com/2024-program", + "Url2": "" + }, + { + "id": 1211, + "user_id": 1841382421, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Debate: My Patient With Laa Closure Has A Leak, Should It Be Closed? Yes, Close The Leak", + "role": "Speaker", + "topic": "Left Atrial Appendage Closure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 1212, + "user_id": 1841382421, + "event_name": "2024 American College of Cardiology Annual Scientific Session & Expo (ACC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Real World Management Problems in the Patient With Left Atrial Appendage Closure", + "role": "Faculty", + "topic": "Left Atrial Appendage Closure", + "Start": "04/06/2024", + "End": "04/08/2024", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "Georgia World Congress Center", + "Address": "285 Andrew Young International Boulevard North West", + "Country": "United States", + "State": "Georgia", + "City": "Atlanta", + "Postal_Code": 30313, + "Url1": "https://www.abstractsonline.com/pp8/#!/10973", + "Url2": "" + }, + { + "id": 1213, + "user_id": 1841382421, + "event_name": "2023 University of Pennsylvania Annual International Symposium on Ventricular Arrhythmias", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Endocardial and Epicardial Ablation in All Post-MI VT Patients?", + "role": "Speaker", + "topic": "Ablation Techniques | Endocardial Ablation | Epicardial Ablation | Myocardial Infarction | Tachycardia, Ventricular", + "Start": "10/13/2023", + "End": "10/14/2023", + "Organizer": "University of Pennsylvania", + "Organizer_Type": "University/Hospital", + "Sponsor": "University of Pennsylvania", + "Sponsor_Type": "University/Hospital", + "Location": "Bellevue Hotel Philadelphia", + "Address": "200 South Broad Street", + "Country": "United States", + "State": "Pennsylvania", + "City": "Philadelphia", + "Postal_Code": 19102, + "Url1": "https://www.vtsymposium.com/program/agenda", + "Url2": "" + }, + { + "id": 1214, + "user_id": 1841382421, + "event_name": "2023 Kansas City Heart Rhythm Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "EP Pioneer Award Celebration", + "role": "Speaker", + "topic": "Cardiac Electrophysiology", + "Start": "08/19/2023", + "End": "08/20/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "6100 College Boulevard", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": 66211, + "Url1": "https://www.kchrs.com/agenda/", + "Url2": "" + }, + { + "id": 1215, + "user_id": 1841382421, + "event_name": "2023 Kansas City Heart Rhythm Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Current Data on PFA for AF Therapy", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "08/19/2023", + "End": "08/20/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "6100 College Boulevard", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": 66211, + "Url1": "https://www.kchrs.com/agenda/", + "Url2": "" + }, + { + "id": 1216, + "user_id": 1841382421, + "event_name": "2023 Kansas City Heart Rhythm Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Improving the Efficiency of Ablation", + "role": "Speaker", + "topic": "Ablation Techniques", + "Start": "08/19/2023", + "End": "08/20/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "6100 College Boulevard", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": 66211, + "Url1": "https://www.kchrs.com/agenda/", + "Url2": "" + }, + { + "id": 1217, + "user_id": 1841382421, + "event_name": "2023 Kansas City Heart Rhythm Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Electrophysiology Practice Concepts", + "role": "Speaker", + "topic": "Cardiac Electrophysiology", + "Start": "08/19/2023", + "End": "08/20/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "6100 College Boulevard", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": 66211, + "Url1": "https://www.kchrs.com/agenda/", + "Url2": "" + }, + { + "id": 1218, + "user_id": 1841382421, + "event_name": "2023 Kansas City Heart Rhythm Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "What Is the Most Practical Approach to Performing VT Ablation?", + "role": "Speaker", + "topic": "Ablation Techniques", + "Start": "08/19/2023", + "End": "08/20/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "6100 College Boulevard", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": 66211, + "Url1": "https://www.kchrs.com/agenda/", + "Url2": "" + }, + { + "id": 1219, + "user_id": 1841382421, + "event_name": "2023 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Endocardial LAA Isolation with RFA Followed by an Occluder Placement is a Better Strategy for Persistent AF Patients", + "role": "Speaker", + "topic": "Atrial Appendage | Atrial Fibrillation | Radiofrequency Ablation", + "Start": "03/31/2023", + "End": "04/01/2023", + "Organizer": "International Symposium on Left Atrial Appendage (ISLAA)", + "Organizer_Type": "Association", + "Sponsor": "International Symposium on Left Atrial Appendage (ISLAA)", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": "", + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 1220, + "user_id": 1841382421, + "event_name": "2023 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Innovations, Tools and Techniques", + "role": "Speaker", + "topic": "Cardiac Imaging Techniques", + "Start": "03/31/2023", + "End": "04/01/2023", + "Organizer": "International Symposium on Left Atrial Appendage (ISLAA)", + "Organizer_Type": "Association", + "Sponsor": "International Symposium on Left Atrial Appendage (ISLAA)", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": "", + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 1221, + "user_id": 1841382421, + "event_name": "2023 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Half Dose NOAC’s After LAAO - The TCAI Approach", + "role": "Speaker", + "topic": "Anticoagulants | Coronary Occlusion", + "Start": "03/31/2023", + "End": "04/01/2023", + "Organizer": "International Symposium on Left Atrial Appendage (ISLAA)", + "Organizer_Type": "Association", + "Sponsor": "International Symposium on Left Atrial Appendage (ISLAA)", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": "", + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 1222, + "user_id": 1841382421, + "event_name": "2023 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Planning Committee", + "role": "Faculty", + "topic": "Admin. & Management", + "Start": "03/31/2023", + "End": "04/01/2023", + "Organizer": "International Symposium on Left Atrial Appendage (ISLAA)", + "Organizer_Type": "Association", + "Sponsor": "International Symposium on Left Atrial Appendage (ISLAA)", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": "", + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 1223, + "user_id": 1841382421, + "event_name": "2023 International Symposium on Left Atrial Appendage (ISLAA)", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Novel LAAO Technologies", + "role": "Speaker", + "topic": "Coronary Occlusion", + "Start": "03/31/2023", + "End": "04/01/2023", + "Organizer": "International Symposium on Left Atrial Appendage (ISLAA)", + "Organizer_Type": "Association", + "Sponsor": "International Symposium on Left Atrial Appendage (ISLAA)", + "Sponsor_Type": "Association", + "Location": "Sheraton Overland Park Hotel at the Convention Center", + "Address": "", + "Country": "United States", + "State": "Kansas", + "City": "Overland Park", + "Postal_Code": "", + "Url1": "https://islaasymposium.com/agenda/", + "Url2": "" + }, + { + "id": 1224, + "user_id": 1841382421, + "event_name": "2023 International Congress on Electrocardiology", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Nonpharmacological Treatment To Ventricular Tachyarrhythmias", + "role": "Chair", + "topic": "Arrhythmias, Cardiac | Tachycardia, Ventricular", + "Start": "07/06/2023", + "End": "07/08/2023", + "Organizer": "International Society for Holter and Noninvasive Electrocardiology, International Society of Electrocardiology", + "Organizer_Type": "Association", + "Sponsor": "International Society for Holter and Noninvasive Electrocardiology, International Society of Electrocardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Japan", + "State": "Hokkaido", + "City": "Sapporo", + "Postal_Code": "", + "Url1": "https://electrocardiology.org/meetings/ice2023/program-ice-2023.pdf", + "Url2": "" + }, + { + "id": 1225, + "user_id": 1841382421, + "event_name": "2023 International Congress on Electrocardiology", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Alternate Ablation Strategy In Patients With Persistent Af (Tentative)", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "07/06/2023", + "End": "07/08/2023", + "Organizer": "International Society for Holter and Noninvasive Electrocardiology, International Society of Electrocardiology", + "Organizer_Type": "Association", + "Sponsor": "International Society for Holter and Noninvasive Electrocardiology, International Society of Electrocardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "Japan", + "State": "Hokkaido", + "City": "Sapporo", + "Postal_Code": "", + "Url1": "https://electrocardiology.org/meetings/ice2023/program-ice-2023.pdf", + "Url2": "" + }, + { + "id": 1226, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society International Lasi Arrhythmia Forum", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "LAA isolation", + "role": "Speaker", + "topic": "Atrial Appendage", + "Start": "04/19/2023", + "End": "04/23/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://iasi-arrhythmia.com/event-program/", + "Url2": "" + }, + { + "id": 1227, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society Annual Scientific Sessions (HRS)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Improving Workflow and Patient Satisfaction Post-EP Procedure Using VASCADE MVP System", + "role": "Author", + "topic": "Electrophysiologic Techniques, Cardiac", + "Start": "05/19/2023", + "End": "05/21/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Haemonetics Corporation", + "Sponsor_Type": "Industry", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23", + "Url2": "" + }, + { + "id": 1228, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society Annual Scientific Sessions (HRS)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "The Symposium on Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure", + "role": "Faculty", + "topic": "Anticoagulation Bridge | Atrial Appendage | Atrial Fibrillation | Stroke", + "Start": "05/19/2023", + "End": "05/21/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "CineMed, MediaSphere Medical LLC, ATRICURE, Boston Scientific Corporation, Abbott, Biosense Webster Inc, East End Medical I LLC, Siemens Healthcare Private Limited", + "Sponsor_Type": "Industry", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23", + "Url2": "" + }, + { + "id": 1229, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society Annual Scientific Sessions (HRS)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Optimal Strategies to Improve Care of the Undiagnosed and Untreated Arrhythmia Patient Population", + "role": "Director", + "topic": "Arrhythmias, Cardiac", + "Start": "05/19/2023", + "End": "05/21/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "CineMed, MediaSphere Medical LLC, ATRICURE", + "Sponsor_Type": "Industry", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23", + "Url2": "" + }, + { + "id": 1230, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society Annual Scientific Sessions (HRS)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "EP Cases for the Real World", + "role": "Director", + "topic": "Electrophysiologic Techniques, Cardiac", + "Start": "05/19/2023", + "End": "05/21/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "CineMed, MediaSphere Medical LLC, Medtronic, Boston Scientific Corporation, Abbott, Biosense Webster Inc, Texas Cardiac Arrhythmia, HCA Healthcare", + "Sponsor_Type": "Other", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23", + "Url2": "" + }, + { + "id": 1231, + "user_id": 1841382421, + "event_name": "2023 Heart Rhythm Society Annual Scientific Sessions (HRS)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Left Atrial Appendage Isolation", + "role": "Author", + "topic": "Atrial Appendage | Atrial Fibrillation", + "Start": "05/19/2023", + "End": "05/21/2023", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23", + "Url2": "" + }, + { + "id": 1232, + "user_id": 1841382421, + "event_name": "2023 European Heart Rhythm Association Annual Congress (EHRA)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Atrial fibrillation ablation: past, present, and future", + "role": "Speaker", + "topic": "Atrial Fibrillation", + "Start": "04/16/2023", + "End": "04/18/2023", + "Organizer": "European Heart Rhythm Association (EHRA)", + "Organizer_Type": "Association", + "Sponsor": "European Heart Rhythm Association (EHRA)", + "Sponsor_Type": "Association", + "Location": "Hall 8, Fira Gran Via", + "Address": "Carrer de l'Alumini, s/n", + "Country": "Spain", + "State": "", + "City": "", + "Postal_Code": "08908", + "Url1": "https://esc365.escardio.org/EHRA-Congress/programme?q=XQAAAAJXAAAAAAAAAABEKQqGU_0GVjz0KqTTm431-wycxAZq-t_JgZi5l1NQJ9d4h2WcuV0ZfcAIBur1Bz5x_0Zcf6CJIDeJllRjEVCjZciMVV6U6foefqAHdeDU76Siv_-2-EAA", + "Url2": "" + }, + { + "id": 1233, + "user_id": 1841382421, + "event_name": "2023 European Heart Rhythm Association Annual Congress (EHRA)", + "event_type": "Congress", + "session_type": "Symposium", + "Session_Name": "Discussion: Disaster management", + "role": "Speaker", + "topic": "Arrhythmias, Cardiac", + "Start": "04/16/2023", + "End": "04/18/2023", + "Organizer": "European Heart Rhythm Association (EHRA)", + "Organizer_Type": "Association", + "Sponsor": "European Heart Rhythm Association (EHRA)", + "Sponsor_Type": "Association", + "Location": "Hall 8, Fira Gran Via", + "Address": "Carrer de l'Alumini, s/n", + "Country": "Spain", + "State": "", + "City": "", + "Postal_Code": "08908", + "Url1": "https://esc365.escardio.org/EHRA-Congress/programme?q=XQAAAAJXAAAAAAAAAABEKQqGU_0GVjz0KqTTm431-wycxAZq-t_JgZi5l1NQJ9d4h2WcuV0ZfcAIBur1Bz5x_0Zcf6CJIDeJllRjEVCjZciMVV6U6foefqAHdeDU76Siv_-2-EAA", + "Url2": "" + }, + { + "id": 1241, + "user_id": 1841382421, + "event_name": "2023 Annual Western Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "How is my AF ablation procedure different in year 2023 compared to 20 years ago?", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "02/24/2023", + "End": "02/25/2023", + "Organizer": "HMP Global", + "Organizer_Type": "Other", + "Sponsor": "HMP Global", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Utah", + "City": "Park City", + "Postal_Code": "", + "Url1": "https://www.eventscribe.net/2023/WAFIB/agenda.asp?startdate=2/25/2023&enddate=2/25/2023&BCFO=&pfp=FullSchedule&mode=&fa=&fb=&fc=&fd=", + "Url2": "" + }, + { + "id": 1242, + "user_id": 1841382421, + "event_name": "2023 Annual International Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Half Dose Doac And Aspirin For Patients With Laa Closure Devices", + "role": "Speaker", + "topic": "Atrial Appendage | Atrial Fibrillation", + "Start": "02/02/2023", + "End": "02/04/2023", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston Hotel at the Seaport", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://www.afsymposium.com/2023-program", + "Url2": "" + }, + { + "id": 1243, + "user_id": 1841382421, + "event_name": "2023 Annual International Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pvi Is Sufficient For Catheter Ablation Of Persistent Af: Implications Of Capla Vs Erase Af", + "role": "Speaker", + "topic": "Atrial Fibrillation | Catheter Ablation | Pulmonary Veins", + "Start": "02/02/2023", + "End": "02/04/2023", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston Hotel at the Seaport", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://www.afsymposium.com/2023-program", + "Url2": "" + }, + { + "id": 1244, + "user_id": 1841382421, + "event_name": "2023 Annual International Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Clinical Outcomes With Focal Pulsed Field Ablation Systems", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "02/02/2023", + "End": "02/04/2023", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "Omni Boston Hotel at the Seaport", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://www.afsymposium.com/2023-program", + "Url2": "" + }, + { + "id": 1245, + "user_id": 1841382421, + "event_name": "2023 Annual International Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Clinical Value and Safety of Early Ambulation and Same Day Discharge in AF Ablation using VASCADE MVP", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "02/02/2023", + "End": "02/04/2023", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Haemonetics", + "Sponsor_Type": "Industry", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://www.afsymposium.com/2023-program", + "Url2": "" + }, + { + "id": 1246, + "user_id": 1841382421, + "event_name": "2023 Annual International Atrial Fibrillation Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Real-Time and Prerecorded Case Transmissions", + "role": "Speaker", + "topic": "Education And Research", + "Start": "02/02/2023", + "End": "02/04/2023", + "Organizer": "Atrial Fibrillation Symposium", + "Organizer_Type": "Other", + "Sponsor": "Atrial Fibrillation Symposium", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "", + "Url1": "https://www.afsymposium.com/2023-program", + "Url2": "" + }, + { + "id": 1247, + "user_id": 1841382421, + "event_name": "2023 American Heart Association International Stroke Conference (ISC)", + "event_type": "Conference", + "session_type": "Symposium", + "Session_Name": "Atrial Fibrillation Ablation Should Be Used to Prevent Stroke", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Stroke", + "Start": "02/08/2023", + "End": "02/10/2023", + "Organizer": "American Heart Association, Inc.", + "Organizer_Type": "Association", + "Sponsor": "American Heart Association, Inc.", + "Sponsor_Type": "Association", + "Location": "Kay Bailey Hutchison Convention Center", + "Address": "", + "Country": "United States", + "State": "Texas", + "City": "Dallas", + "Postal_Code": "", + "Url1": "https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=ISC23&proof=false", + "Url2": "" + }, + { + "id": 1248, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Pulsed Field Ablation Treatment In Paroxysmal And Persistent Atrial Fibrillation Patients: Acute And Long-Term Outcomes From The Pulsed Af Pivotal Trial", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 1249, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Impact Of Remote Cardiac Device Monitoring On Green House Emissions: Data From The Global Cardiovascular Carbon Footprint (Gccf) Project", + "role": "Speaker", + "topic": "Cardiac Resynchronization Therapy Devices | Cardiovascular Diseases", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 1250, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Can Laac Be Considered A True Alternative To Oac", + "role": "Speaker", + "topic": "Atrial Premature Complexes", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 1251, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Meeting", + "Session_Name": "Laao: Cardioversion, Anticoagulation, Leaks, Clots, And Other Tribulations", + "role": "Faculty", + "topic": "Clot Retraction | Electric Countershock", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://www.abstractsonline.com/pp8/#!/10674/sessions/@timeSlot=Mar04/1", + "Url2": "" + }, + { + "id": 1252, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Outcomes Of Catheter Ablation Of Atrial Tachyarrhythmia Guided Exclusively By Activation Mapping", + "role": "Author", + "topic": "Catheter Ablation | Tachycardia", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1253, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Efficacy Of Venous Closure Methods After Electrophysiological Procedures", + "role": "Author", + "topic": "Electrophysiological Phenomena | Patent Ductus Venosus", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1254, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Role Of High Frequency Algorithm Of Pure Ep For Low Amplitude Signal Detection During Cardiac Ablation", + "role": "Author", + "topic": "Ablation Techniques", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1255, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Is Transesophageal Echocardiography Necessary In Patients Undergoing Atrial Fibrillation Ablation Using Intracardiac Echocardiography? A Survey Of High Volume Centers In The Us From The Real-Af Registry", + "role": "Author", + "topic": "Atrial Fibrillation | Echocardiography", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1256, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Impact Of Colchicine Monotherapy On The Risk Of Acute Pericarditis Following Catheter Ablation In Patients With Atrial Fibrillation", + "role": "Author", + "topic": "Atrial Fibrillation | Catheter Ablation | Pericarditis", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1257, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "Catheter Ablation Approach And Outcome In Hiv-Positive Patients With Recurrent Atrial Fibrillation", + "role": "Author", + "topic": "Atrial Fibrillation | Catheter Ablation", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1258, + "user_id": 1841382421, + "event_name": "2023 American College of Cardiology Annual Scientific Session & Expo (ACC) / World Congress of Cardiology (WCC)", + "event_type": "Annual Meeting", + "session_type": "Poster Session", + "Session_Name": "First Experience With A Novel 3D Ice Probe To Guide Cardiac Interventional Procedures", + "role": "Author", + "topic": "Magnetic Resonance Imaging", + "Start": "03/04/2023", + "End": "03/06/2023", + "Organizer": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology (ACC), World Heart Federation (WHF)", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest North Morial Convention Center", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "https://accscientificsession.acc.org/Plan-Your-Program", + "Url2": "" + }, + { + "id": 1259, + "user_id": 1841382421, + "event_name": "2022 VeniceArrhythmias Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Ablation Of Iatrogenic Atipical Atrial Flutter", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Flutter", + "Start": "10/13/2022", + "End": "10/15/2022", + "Organizer": "Adria Congrex Srl", + "Organizer_Type": "Other", + "Sponsor": "Adria Congrex Srl", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Venice", + "Postal_Code": "", + "Url1": "https://www.venicearrhythmias.org/wp-content/uploads/2022/10/VA2022-Final-PRG-141022.pdf", + "Url2": "" + }, + { + "id": 1260, + "user_id": 1841382421, + "event_name": "2022 VeniceArrhythmias Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Af Ablation With Pfa", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "10/13/2022", + "End": "10/15/2022", + "Organizer": "Adria Congrex Srl", + "Organizer_Type": "Other", + "Sponsor": "Adria Congrex Srl", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Venice", + "Postal_Code": "", + "Url1": "https://www.venicearrhythmias.org/wp-content/uploads/2022/10/VA2022-Final-PRG-141022.pdf", + "Url2": "" + }, + { + "id": 1261, + "user_id": 1841382421, + "event_name": "2022 VeniceArrhythmias Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Approaching Complex Ablations", + "role": "Speaker", + "topic": "Ablation Techniques", + "Start": "10/13/2022", + "End": "10/15/2022", + "Organizer": "Adria Congrex Srl", + "Organizer_Type": "Other", + "Sponsor": "Adria Congrex Srl", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Venice", + "Postal_Code": "", + "Url1": "https://www.venicearrhythmias.org/wp-content/uploads/2022/10/VA2022-Final-PRG-141022.pdf", + "Url2": "" + }, + { + "id": 1262, + "user_id": 1841382421, + "event_name": "2022 VeniceArrhythmias Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Emerging & Innovative Approaches In AF Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "10/13/2022", + "End": "10/15/2022", + "Organizer": "Adria Congrex Srl", + "Organizer_Type": "Other", + "Sponsor": "Adria Congrex Srl", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Venice", + "Postal_Code": "", + "Url1": "https://www.venicearrhythmias.org/wp-content/uploads/2022/10/VA2022-Final-PRG-141022.pdf", + "Url2": "" + }, + { + "id": 1263, + "user_id": 1841382421, + "event_name": "2022 VeniceArrhythmias Congress", + "event_type": "Congress", + "session_type": "CME", + "Session_Name": "Ep Live Session On Ventricular Tachycardia", + "role": "Chair", + "topic": "Tachycardia, Ventricular", + "Start": "10/13/2022", + "End": "10/15/2022", + "Organizer": "Adria Congrex Srl", + "Organizer_Type": "Other", + "Sponsor": "Adria Congrex Srl", + "Sponsor_Type": "Other", + "Location": "", + "Address": "", + "Country": "Italy", + "State": "Veneto", + "City": "Venice", + "Postal_Code": "", + "Url1": "https://www.venicearrhythmias.org/wp-content/uploads/2022/10/VA2022-Final-PRG-141022.pdf", + "Url2": "" + }, + { + "id": 1346, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Early Intervention Significantly Improves Ablation Success In Patients With Atrial Fibrillation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1347, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Extended Pulmonary Vein Isolation: Is It Sufficient To Achieve Long-term Sinus Rhythm In Octogenarian Women With Atrial Fibrillation?", + "role": "Speaker", + "topic": "Atrial Fibrillation | Pulmonary Veins | Sick Sinus Syndrome", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1348, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Electrophysiological Findings In Patients Undergoing Left Atrial Appendage Occlusion Following Previous Electrical Isolation", + "role": "Speaker", + "topic": "Cardiac Electrophysiology | Left Atrial Appendage Occlusion", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1349, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Short And Long-term Clinical Outcomes Of Left Atrial Appendage Electrical Isolation In Patients With Non-paroxysmal Atrial Fibrillation: A Systematic Review And Meta-analysis", + "role": "Speaker", + "topic": "Atrial Fibrillation | Left Atrial Appendage", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1350, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Best Ablation Strategy In Patients Presenting With Atrial Flutter Following Successful Isolation Of Pulmonary Veins For Atrial Fibrillation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Atrial Flutter | Pulmonary Veins", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1351, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Direct Thrombin Inhibitors As An Alternative To Heparin During Catheter Ablation: A Multi-Center Experience", + "role": "Speaker", + "topic": "Antithrombins | Catheter Ablation | Heparin", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1352, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Warfarin Versus Non-vitamin K Oral Anticoagulants For Left Atrial Appendage Thrombus: A Meta-analysis", + "role": "Speaker", + "topic": "Anticoagulants | Heart Atria | Thrombosis | Warfarin", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1353, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Inotrope Use To Distinguish Between Dense Spontaneous Echo Contrast Versus Thrombus In The Left Atrial Appendage", + "role": "Speaker", + "topic": "Atrial Appendage | Left Atrial Appendage | Magnetic Resonance Imaging | Thrombosis", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1354, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Adverse Events After Watchman Left Atrial Appendage Closure: 5-year Post-approval Report From The Manufacturer And User Facility Device Experience (MAUDE) Database", + "role": "Speaker", + "topic": "Atrial Appendage | Left Atrial Appendage Closure", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1355, + "user_id": 1841382421, + "event_name": "2020 Heart Rhythm Society Science Online", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Safety And Effectiveness Of Left Atrial Appendage Occlusion In Patients With Chronic Kidney Disease", + "role": "Speaker", + "topic": "Left Atrial Appendage Occlusion | Renal Insufficiency, Chronic", + "Start": "06/12/2020", + "End": "06/12/2020", + "Organizer": "Heart Rhythm Society", + "Organizer_Type": "Association", + "Sponsor": "Heart Rhythm Society", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "", + "State": "", + "City": "", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1421, + "user_id": 1841382421, + "event_name": "2019 Annual International AF Symposium:Mechanisms and New Directions in Therapy", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "High Power Short Duration Ablation For Af: Unmet Needs And Potential Solutions", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "01/24/2019", + "End": "01/26/2019", + "Organizer": "AF Symposium", + "Organizer_Type": "Other", + "Sponsor": "AF Symposium", + "Sponsor_Type": "Other", + "Location": "Seaport World Trade Center", + "Address": "1 Seaport Lane", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "", + "Url2": "" + }, + { + "id": 1422, + "user_id": 1841382421, + "event_name": "2019 Annual International AF Symposium:Mechanisms and New Directions in Therapy", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Laa Closure Combined With Af Ablation - Indications, Timing And Outcomes", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Appendage | Atrial Fibrillation", + "Start": "01/24/2019", + "End": "01/26/2019", + "Organizer": "AF Symposium", + "Organizer_Type": "Other", + "Sponsor": "AF Symposium", + "Sponsor_Type": "Other", + "Location": "Seaport World Trade Center", + "Address": "1 Seaport Lane", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "", + "Url2": "" + }, + { + "id": 1423, + "user_id": 1841382421, + "event_name": "2019 Annual International AF Symposium:Mechanisms and New Directions in Therapy", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Pulmonary Vein Isolation With A Multi-Electrode Radiofrequency Balloon Catheter", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Pulmonary Veins", + "Start": "01/24/2019", + "End": "01/26/2019", + "Organizer": "AF Symposium", + "Organizer_Type": "Other", + "Sponsor": "AF Symposium", + "Sponsor_Type": "Other", + "Location": "Seaport World Trade Center", + "Address": "1 Seaport Lane", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "", + "Url2": "" + }, + { + "id": 1424, + "user_id": 1841382421, + "event_name": "2019 Annual International AF Symposium:Mechanisms and New Directions in Therapy", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Real-Time Case Transmissions: New Imaging, Mapping And Ablation Technologies", + "role": "Speaker", + "topic": "Ablation Techniques", + "Start": "01/24/2019", + "End": "01/26/2019", + "Organizer": "AF Symposium", + "Organizer_Type": "Other", + "Sponsor": "AF Symposium", + "Sponsor_Type": "Other", + "Location": "Seaport World Trade Center", + "Address": "1 Seaport Lane", + "Country": "United States", + "State": "Massachusetts", + "City": "Boston", + "Postal_Code": "02210", + "Url1": "", + "Url2": "" + }, + { + "id": 1425, + "user_id": 1841382421, + "event_name": "2019 American College Of Cardiology Scientific Sessions", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Is it safe to discontinue oral anticoagulation after catheter ablation of atrial fibrillation? a systematic review and meta-analysis", + "role": "Speaker", + "topic": "Anticoagulants | Atrial Fibrillation", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1426, + "user_id": 1841382421, + "event_name": "2019 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "A New, Simple Ecg Algorithm For The Rapid Identification Of Ventricular Tachycardia Based On Opposing Qrs Complexes On Limb Leads", + "role": "Speaker", + "topic": "Ablation Techniques | Tachycardia, Ventricular", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "", + "Url2": "" + }, + { + "id": 1427, + "user_id": 1841382421, + "event_name": "2019 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Association Of Subclinical Atrial Fibrillation With Risk Of Stroke: Results From A Meta-Analysis", + "role": "Speaker", + "topic": "Atrial Fibrillation | Stroke", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "", + "Url2": "" + }, + { + "id": 1428, + "user_id": 1841382421, + "event_name": "2019 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "First Experience Of Left Atrial Appendage Occlusion With Cardioform Septal Occluder In Patients With Left Atrial Appendage Residual Patency Or Complex Anatomy", + "role": "Speaker", + "topic": "Atrial Appendage", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "", + "Url2": "" + }, + { + "id": 1429, + "user_id": 1841382421, + "event_name": "2019 American College of Cardiology Annual Scientific Session & Expo", + "event_type": "Annual Meeting", + "session_type": "CME", + "Session_Name": "Prevalence Of Triggers From Non-Pulmonary Vein Sites In Patients With Prior Coronary Artery Bypass Grafting Or Maze Procedure Undergoing Catheter Ablation For Atrial Fibrillation", + "role": "Speaker", + "topic": "Atrial Fibrillation | Coronary Artery Disease", + "Start": "03/16/2019", + "End": "03/18/2019", + "Organizer": "American College of Cardiology", + "Organizer_Type": "Association", + "Sponsor": "American College of Cardiology", + "Sponsor_Type": "Association", + "Location": "New Orleans Ernest N. Morial Convention Center", + "Address": "900 Convention Center Boulevard", + "Country": "United States", + "State": "Louisiana", + "City": "New Orleans", + "Postal_Code": 70130, + "Url1": "", + "Url2": "" + }, + { + "id": 1430, + "user_id": 1841382421, + "event_name": "2019 Albert Einstein College of Medicine / Montefiore Medical Center Annual BronxHeart Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Ablation In Af", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Atrial Flutter", + "Start": "05/18/2019", + "End": "05/19/2019", + "Organizer": "Albert Einstein College of Medicine, Montefiore Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Albert Einstein College of Medicine, Montefiore Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "New York", + "City": "Bronx", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1431, + "user_id": 1841382421, + "event_name": "2019 Albert Einstein College of Medicine / Montefiore Medical Center Annual BronxHeart Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Atrial Fibrillation In Hf - The Case For Rhythm Control With Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation | Heart Failure", + "Start": "05/18/2019", + "End": "05/19/2019", + "Organizer": "Albert Einstein College of Medicine, Montefiore Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Albert Einstein College of Medicine, Montefiore Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "New York", + "City": "Bronx", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1432, + "user_id": 1841382421, + "event_name": "2019 AF, VT, VF Summit", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "AF Mapping and Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "12/05/2019", + "End": "12/07/2019", + "Organizer": "Aurora Sinai Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Aurora Sinai Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": "", + "Url1": "https://cme.advocateaurorahealth.org/sites/default/files/FINAL%20BROCHURE%20AF%2C%20VT%2C%20VF%20Summit%202019.pdf", + "Url2": "" + }, + { + "id": 1433, + "user_id": 1841382421, + "event_name": "2019 AF, VT, VF Summit", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Discussion on AF, VT, VF", + "role": "Director", + "topic": "Atrial Fibrillation | Tachycardia, Ventricular | Ventricular Fibrillation", + "Start": "12/05/2019", + "End": "12/07/2019", + "Organizer": "Aurora Sinai Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Aurora Sinai Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": "", + "Url1": "https://cme.advocateaurorahealth.org/sites/default/files/FINAL%20BROCHURE%20AF%2C%20VT%2C%20VF%20Summit%202019.pdf", + "Url2": "" + }, + { + "id": 1434, + "user_id": 1841382421, + "event_name": "2019 AF, VT, VF Summit", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "ECG's and Intracardiac Recordings in Complex Arrhythmias", + "role": "Speaker", + "topic": "Arrhythmias, Cardiac", + "Start": "12/05/2019", + "End": "12/07/2019", + "Organizer": "Aurora Sinai Medical Center", + "Organizer_Type": "University/Hospital", + "Sponsor": "Aurora Sinai Medical Center", + "Sponsor_Type": "University/Hospital", + "Location": "", + "Address": "", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": "", + "Url1": "https://cme.advocateaurorahealth.org/sites/default/files/FINAL%20BROCHURE%20AF%2C%20VT%2C%20VF%20Summit%202019.pdf", + "Url2": "" + }, + { + "id": 1435, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Approaches To Ablating Atrial Fibrillation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Advanced Revascularization Chapter XI", + "Organizer_Type": "Other", + "Sponsor": "Advanced Revascularization Chapter XI", + "Sponsor_Type": "Other", + "Location": "Four Seasons Hotel", + "Address": "999 North 2nd Street", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": 63102, + "Url1": "", + "Url2": "" + }, + { + "id": 1436, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "How To Perform Scar Homogenization For Vt", + "role": "Speaker", + "topic": "Tachycardia, Ventricular", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Advanced Revascularization Chapter XI", + "Organizer_Type": "Other", + "Sponsor": "Advanced Revascularization Chapter XI", + "Sponsor_Type": "Other", + "Location": "Four Seasons Hotel", + "Address": "999 North 2nd Street", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": 63102, + "Url1": "", + "Url2": "" + }, + { + "id": 1437, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Innovation In Af Ablation: Better Methods / Techniques For Successful Ablation", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Advanced Revascularization Chapter XI", + "Organizer_Type": "Other", + "Sponsor": "Advanced Revascularization Chapter XI", + "Sponsor_Type": "Other", + "Location": "Four Seasons Hotel", + "Address": "999 North 2nd Street", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": 63102, + "Url1": "", + "Url2": "" + }, + { + "id": 1438, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Today'S Ideas That Will Shape The Way We Practice Ep Tomorrow", + "role": "Speaker", + "topic": "Electrophysiology", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Advanced Revascularization Chapter XI", + "Organizer_Type": "Other", + "Sponsor": "Advanced Revascularization Chapter XI", + "Sponsor_Type": "Other", + "Location": "Four Seasons Hotel", + "Address": "999 North 2nd Street", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": 63102, + "Url1": "", + "Url2": "" + }, + { + "id": 1439, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Organization Committee", + "role": "Director", + "topic": "Admin. & Management", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Gaffney Events", + "Organizer_Type": "Other", + "Sponsor": "Gaffney Events", + "Sponsor_Type": "Other", + "Location": "The Four Seasons Hotel", + "Address": "", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1440, + "user_id": 1841382421, + "event_name": "2019 Advanced Revascularization-Chapter XII Symposium", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "TodayS Ideas That Will Shape The Way\nWe Practice Ep Tomorrow", + "role": "Speaker", + "topic": "Volition", + "Start": "04/09/2019", + "End": "04/13/2019", + "Organizer": "Gaffney Events", + "Organizer_Type": "Other", + "Sponsor": "Gaffney Events", + "Sponsor_Type": "Other", + "Location": "The Four Seasons Hotel", + "Address": "", + "Country": "United States", + "State": "Missouri", + "City": "St. Louis", + "Postal_Code": "", + "Url1": "", + "Url2": "" + }, + { + "id": 1441, + "user_id": 1841382421, + "event_name": "2019 Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Identifying And Ablating Non Pv Triggers: A Case Based Approach", + "role": "Speaker", + "topic": "Catheter Ablation", + "Start": "09/07/2019", + "End": "09/10/2019", + "Organizer": "Mayo Foundation for Medical Education and Research", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Foundation For Medical Education And Research", + "Sponsor_Type": "University/Hospital", + "Location": "Swissotel Chicago", + "Address": "323 East Upper Wacker Drive", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60601, + "Url1": "", + "Url2": "" + }, + { + "id": 1442, + "user_id": 1841382421, + "event_name": "2019 Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Interactive Case Based Discussions Of Persistent Af: What Is The Best Approach In 2019?", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "09/07/2019", + "End": "09/10/2019", + "Organizer": "Mayo Foundation for Medical Education and Research", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Foundation For Medical Education And Research", + "Sponsor_Type": "University/Hospital", + "Location": "Swissotel Chicago", + "Address": "323 East Upper Wacker Drive", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60601, + "Url1": "", + "Url2": "" + }, + { + "id": 1443, + "user_id": 1841382421, + "event_name": "2019 Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Putting It All Together: Complex Atrial Arrhythmias - Post AF Ablation and Otherwise", + "role": "Speaker", + "topic": "Ablation Techniques | Atrial Fibrillation", + "Start": "09/07/2019", + "End": "09/10/2019", + "Organizer": "Mayo Foundation for Medical Education and Research", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Foundation For Medical Education And Research", + "Sponsor_Type": "University/Hospital", + "Location": "Swissotel Chicago", + "Address": "323 East Upper Wacker Drive", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60601, + "Url1": "", + "Url2": "" + }, + { + "id": 1444, + "user_id": 1841382421, + "event_name": "2019 Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Discussion on Advanced Catheter Ablation", + "role": "Moderator", + "topic": "Catheter Ablation", + "Start": "09/07/2019", + "End": "09/10/2019", + "Organizer": "Mayo Foundation for Medical Education and Research", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Foundation For Medical Education And Research", + "Sponsor_Type": "University/Hospital", + "Location": "Swissotel Chicago", + "Address": "323 East Upper Wacker Drive", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60601, + "Url1": "", + "Url2": "" + }, + { + "id": 1445, + "user_id": 1841382421, + "event_name": "2019 Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias Conference", + "event_type": "Conference", + "session_type": "CME", + "Session_Name": "Scar Homogenization For Vts: Who And How", + "role": "Speaker", + "topic": "Ablation Techniques | Tachycardia, Ventricular", + "Start": "09/07/2019", + "End": "09/10/2019", + "Organizer": "Mayo Foundation for Medical Education and Research", + "Organizer_Type": "University/Hospital", + "Sponsor": "Mayo Foundation For Medical Education And Research", + "Sponsor_Type": "University/Hospital", + "Location": "Swissotel Chicago", + "Address": "323 East Upper Wacker Drive", + "Country": "United States", + "State": "Illinois", + "City": "Chicago", + "Postal_Code": 60601, + "Url1": "", + "Url2": "" + } + ], + "Trials": [ + { + "id": 1, + "user_id": 1447203401, + "ct_id": "NCT05201495", + "Study_Type": "Interventional", + "trial_name": "The Jewel IDE Study", + "condition": "", + "intervention": "D;J;A;T", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 290, + "trial sites": "", + "sponsors": "Element Science, Inc.", + "status": "Active, not recruiting", + "Start_Date": "2022-01-12", + "End_Date": "2023-06-01", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Javed Butler, M.D.;John Hummel, M.D.;Roxana Mehran, M.D.;Mehran Roxana", + "Collaborator": "", + "Purpose": "The Jewel IDE Study: A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for\n Sudden Cardiac Arrest. (\"JEWEL\")", + "Official_Title": "A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest", + "Keywords": "", + "MeSH_Terms": "Heart Arrest,Death, Sudden, Cardiac", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05201495" + }, + { + "id": 2, + "user_id": 1447203401, + "ct_id": "NCT04722250", + "Study_Type": "Interventional", + "trial_name": "SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial", + "condition": "Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement", + "intervention": "Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems;Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems", + "phase": "Others", + "Role": "", + "enrollees": 716, + "trial sites": 92, + "sponsors": "Medtronic Cardiovascular", + "status": "Active, not recruiting", + "Start_Date": "2021-04-02", + "End_Date": "2027-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Howard Herrmann, MD;Roxana Mehran, MD;Didier Tchétché, MD;", + "Collaborator": "", + "Purpose": "The purpose of this trial is to generate clinical evidence on valve safety and performance of\n self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement\n (TAVR) in subjects with a small aortic annulus and symptomatic severe native aortic stenosis.\n\n Additionally, a stress echocardiography sub-study will be conducted as part of the SMART\n Trial at select sites. The purpose of the sub-study is to evaluate performance of SE versus\n BE TAVR in subjects with a small aortic annulus and symptomatic severe native aortic stenosis\n after undergoing exercise stress echocardiographic testing.", + "Official_Title": "SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial", + "Keywords": "", + "MeSH_Terms": "Aortic Valve Stenosis,Constriction, Pathologic", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04722250" + }, + { + "id": 3, + "user_id": 1447203401, + "ct_id": "NCT04236609", + "Study_Type": "Interventional", + "trial_name": "Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global", + "condition": "Diabetes, Coronary Artery Disease, Acute Coronary Syndrome", + "intervention": "Abluminus DES+ Sirolimus Eluting Stent System (SES);XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)", + "phase": "Others", + "Role": "", + "enrollees": 3050, + "trial sites": 90, + "sponsors": "Concept Medical Inc.", + "status": "Active, not recruiting", + "Start_Date": "2020-06-15", + "End_Date": "2024-09-30", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Roxana Mehran;", + "Collaborator": "", + "Purpose": "To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with\n minimal exclusion criteria, the efficacy and safety of Abluminus DES+ sirolimus- eluting\n stents (SES) versus XIENCE Everolimus-Eluting Stents (EES). At least 40% of patients are\n expected to be affected by multivessel coronary artery disease and 30% with acute coronary\n syndrome", + "Official_Title": "ABILITY Diabetes Global", + "Keywords": "", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Acute Coronary Syndrome,Diabetes Mellitus,Sirolimus,Everolimus", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04236609" + }, + { + "id": 4, + "user_id": 1447203401, + "ct_id": "NCT03815175", + "Study_Type": "Interventional", + "trial_name": "XIENCE 28 USA Study", + "condition": "Bleeding Disorder, Ischemic Stroke, Hemorrhagic Stroke, Hematological Diseases, Thrombocytopenia, Coagulation Disorder, Anemia, Renal Insufficiency, Coronary Artery Disease", + "intervention": "XIENCE;DAPT (aspirin and/or P2Y12 receptor inhibitor)", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 1605, + "trial sites": 58, + "sponsors": "Abbott Medical Devices", + "status": "Completed", + "Start_Date": "2019-02-25", + "End_Date": "2021-12-01", + "Min_Age": "18 Years", + "Max_Age": "100 Years", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Henry Chen, MD;Akil Loli, MD;Bimal Padaliya, MD;Anthony White, MD;Andre Paixao, MD;Ashit Jain, MD;Jeffrey Cavendish, MD;Nikhil Daga, MD;Joseph Aragon, MD;Edward Portnay, MD;Ron Waksman, MD;Lang Lin, MD;Bernardo Stein, MD;John Katopodis, MD;Nima Ghasemzadeh, MD;Hector Picon, MD, FAAC;Bassem Chehab, MD;Aziz Maksoud, MD;Peter VerLee, MD;John Wang, MD;Rahul Sakhuja, MD;Robert Yeh, MD;Daniel Lee;Kevin Clayton;Nicholas Burke, MD;Brett Bennett, MD;Anthony Spaedy, MD;Matt Bach, MD;Michael Kim, MD;Ronald Caputo, MD;Robert Iwaoka, MD;Christopher McAlhany, MD;William Newman, MD;Robert Applegate, MD;Niranjan Reddy, MD;Ameer Kabour, MD;Gurjaipal Kang, MD;Gene Chang, MD;David Lasorda, MD;Guy Piegari, MD;William Bachinsky, MD;Brent McLaurin, MD;Tomasz Stys, MD;Basil Paulus;Malcolm Foster, MD;Jeffrey Webber;Frank Zidar, MD;James Choi, MD;Osvaldo Gigliotti, MD;Nhan Nguyen, MD;Robert Carney, MD;Harish Chandra, MD;Aravinda Nanjundappa, MD;Bryan Har, MD;Simon Robinson, MD;Robert Teskey, MD;Richard Gallo, MD;Eric Schampaert, MD;Bach Matt", + "Collaborator": "", + "Purpose": "", + "Official_Title": "XIENCE 28 USA Study", + "Keywords": "High Bleeding Risk (HBR),dual antiplatelet therapy (DAPT),Drug eluting stent (DES),XIENCE,Percutaneous Coronary Intervention (PCI),coronary artery disease,P2Y12 Inhibitor,thrombolysis,BARC bleeding,Coronary Stent", + "MeSH_Terms": "Stroke,Renal Insufficiency,Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Hemostatic Disorders,Thrombocytopenia,Blood Coagulation Disorders,Hematologic Diseases,Disease,Aspirin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03815175" + }, + { + "id": 5, + "user_id": 1447203401, + "ct_id": "NCT03355742", + "Study_Type": "Interventional", + "trial_name": "XIENCE 28 Global Study", + "condition": "Bleeding Disorder, Stroke, Ischemic, Stroke Hemorrhagic, Hematological Disease, Thrombocytopenia, Coagulation Disorder, Anemia, Renal Insufficiency, Coronary Artery Disease", + "intervention": "XIENCE;DAPT", + "phase": "Others", + "Role": "", + "enrollees": 963, + "trial sites": 52, + "sponsors": "Abbott Medical Devices", + "status": "Completed", + "Start_Date": "2018-02-09", + "End_Date": "2020-04-30", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Marco Valgimigli, MD;Mehran Roxana", + "Collaborator": "", + "Purpose": "XIENCE 28 Global Study is a prospective, single arm, multi-center, open label, non-randomized\n trial to further evaluate the safety of 1-month (as short as 28 days) dual antiplatelet\n therapy (DAPT) in subjects at high risk of bleeding (HBR) undergoing percutaneous coronary\n intervention (PCI) with the approved XIENCE family (XIENCE Xpedition Everolimus Eluting\n Coronary Stent System [EECSS], XIENCE Alpine EECSS, XIENCE PROX EECSS, XIENCE ProA EECSS or\n XIENCE Sierra EECSS of coronary drug-eluting stents", + "Official_Title": "XIENCE 28 Global Study", + "Keywords": "XIENCE,High Bleeding Risk (HBR),dual antiplatelet therapy (DAPT),coronary artery disease,Drug eluting stent (DES),P2Y12 Inhibitor,thrombolysis,BARC bleeding,Coronary Stent", + "MeSH_Terms": "Stroke,Renal Insufficiency,Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Hemostatic Disorders,Thrombocytopenia,Blood Coagulation Disorders,Hematologic Diseases,Disease", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03355742" + }, + { + "id": 6, + "user_id": 1447203401, + "ct_id": "NCT03318575", + "Study_Type": "Interventional", + "trial_name": "Remote Ischemic Conditioning Using the autoRIC", + "condition": "Ischemia-Reperfusion Injury", + "intervention": "autoRIC;autoRIC Sham", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 500, + "trial sites": 16, + "sponsors": "CellAegis US, Inc.", + "status": "Unknown status", + "Start_Date": "2018-01-30", + "End_Date": "2019-04-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Massoud Leesar, MD;Hal Wasserman, MD;Andres Pineda Maldonado, MD;Magdi Ghali, MD;Gerald Koenig, MD, PhD;John Saxon, MD;Cindy Grines, MD;Joseph Sweeney, MD;Amjad Almahameed, MD;Mohit Pasi, MD;Shy Amlani, MD;Akshay Bagai, MD;Magdi G Ghali", + "Collaborator": "", + "Purpose": "The purpose of the study is to evaluate the hypothesis that patients receiving remote\n ischemic conditioning using the autoRIC device show statistically significant reduction in\n the prevalence of ischemia-reperfusion injury to the myocardium as compared to patients in\n the autoRIC Sham device arm (within 12-24 hours post non-emergent PCI with stent\n implantation).", + "Official_Title": "Safety and Effectiveness of Remote Ischemic Conditioning With the autoRIC Prior to Elective Percutaneous Coronary Intervention (PCI) Study", + "Keywords": "remote ischemic conditioning (RIC),Percutaneous Coronary Intervention,PCI,cardiac troponin I,Cardiac Catheterization,Myocardial injury,myocardial necrosis,autoRIC,Ischemia-Reperfusion Injury (IRI),Automated Remote Ischemic Conditioning,Coronary Stent", + "MeSH_Terms": "Ischemia,Reperfusion Injury", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03318575" + }, + { + "id": 7, + "user_id": 1447203401, + "ct_id": "NCT03218787", + "Study_Type": "Interventional", + "trial_name": "XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.", + "condition": "Coronary Artery Lesions", + "intervention": "XIENCE;DAPT", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 2047, + "trial sites": 103, + "sponsors": "Abbott Medical Devices", + "status": "Completed", + "Start_Date": "2017-06-15", + "End_Date": "2020-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran", + "Collaborator": "", + "Purpose": "XIENCE 90 study is a prospective, single arm, multi-center, open label trial to evaluate the\n safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding (HBR)\n undergoing percutaneous coronary intervention (PCI) with the approved XIENCE family of\n coronary drug-eluting stents.\n\n The XIENCE family stent systems include commercially approved XIENCE Xpedition Everolimus\n Eluting Coronary Stent System (EECSS), XIENCE Alpine EECSS, XIENCE PRO^X EECSS [rebrand of\n the XIENCE Xpedition Stent System and is only available outside of the United States (OUS)],\n XIENCE PRO^A EECSS (rebrand of the XIENCE Alpine Stent System and is only available OUS) and\n XIENCE Sierra EECSS of coronary drug-eluting stents.", + "Official_Title": "A Safety Evaluation of 3-month Dual Antiplatelet Therapy in Subjects at High Risk of Bleeding Undergoing Percutaneous Coronary Intervention With XIENCE.", + "Keywords": "Coronary Artery Lesions,XIENCE,dual antiplatelet therapy (DAPT),Reduced DAPT,Risk of bleeding,Drug-eluting stents,P2Y12 Inhibitor,thrombolysis,BARC bleeding,Coronary Stent", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03218787" + }, + { + "id": 8, + "user_id": 1447203401, + "ct_id": "NCT02270242", + "Study_Type": "Interventional", + "trial_name": "Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention", + "condition": "Cardiovascular Disease, Interventional Cardiology", + "intervention": "Aspirin;Placebo;Ticagrelor", + "phase": "Phase 4", + "Role": "Study Chair", + "enrollees": 9006, + "trial sites": 1, + "sponsors": "Icahn School of Medicine at Mount Sinai", + "status": "Completed", + "Start_Date": "2015-07-01", + "End_Date": "2019-08-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Usman Baber, MD;Baber Usman", + "Collaborator": "AstraZeneca", + "Purpose": "The purpose of this study is to compare the use of ticagrelor alone versus ticagrelor and\n aspirin together. Both ticagrelor and aspirin stop platelets from sticking together and\n forming a blood clot that could block blood flow to the heart. This study will look to\n determine the effectiveness and safety of ticagrelor alone, compared to ticagrelor plus\n aspirin in reducing clinically relevant bleeding and in reducing ischemic adverse events\n among high-risk patients who have had a percutaneous intervention with at least one\n drug-eluting stent. A patient is considered high-risk if they meet certain clinical and/or\n anatomic criteria.\n\n Up to 9000 subjects will be enrolled at the time of their index PCI. Subjects meeting\n randomization eligibility criteria at 3 months post enrollment will be randomized to either\n ticagrelor plus aspirin or ticagrelor plus placebo for an additional 12 months. Follow-up\n clinic visits will be performed at 3 months, 9 months and 15 months post enrollment.", + "Official_Title": "Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention", + "Keywords": "PCI,DAPT,Ticagrelor,aspirin,BARC bleeding,Coronary Stent", + "MeSH_Terms": "Cardiovascular Diseases,Aspirin,Ticagrelor", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02270242" + }, + { + "id": 9, + "user_id": 1447203401, + "ct_id": "NCT02362659", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry", + "condition": "Non-valvular Atrial Fibrillation", + "intervention": "", + "phase": "", + "Role": "Study Director", + "enrollees": 514, + "trial sites": 1, + "sponsors": "Icahn School of Medicine at Mount Sinai", + "status": "Completed", + "Start_Date": "2015-04-01", + "End_Date": "2018-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Usman Baber, MD;Baber Usman", + "Collaborator": "Bristol-Myers Squibb", + "Purpose": "The purpose of this observational registry is to compare the safety and efficacy of an\n antithrombotic regimen comprising one single antiplatelet agent plus an oral anti-thrombotic\n versus those consisting of DAPT alone or DAPT plus oral antithrombotic therapy. This registry\n will assess whether the antithrombotic therapy intensity will vary positively with physician\n perceived ischemic risk at the time of percutaneous coronary intervention (PCI), and whether\n an inverse association will be observed with perceived bleeding risk.\n\n This study will also evaluate the physician use of objective benefit-risk assessment scores\n and their influence on prescription of antithrombotic therapy in atrial fibrillation (AF)\n patients undergoing PCI. Additionally the study will investigate whether patient perceived\n relevance and accessibility of anti-platelet and anticoagulant treatment regiments will\n predict treatment adherence and whether non-adherence will independently influence outcome.\n\n Approximately 2500 subjects with non-valvular AF undergoing all-comer PCI with stenting will\n be enrolled in North America and Europe, sites to be determined. Follow-up will be done via\n telephone by trained research coordinators at each participating site at 30 days, 6 months\n and 12 months.", + "Official_Title": "Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI", + "Keywords": "non-valvular,Atrial Fibrillation,Percutaneous Coronary Intervention,BARC bleeding,Coronary Stent", + "MeSH_Terms": "Atrial Fibrillation,Coronary Disease,Coronary Artery Disease,Anticoagulants,Platelet Aggregation Inhibitors", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02362659" + }, + { + "id": 10, + "user_id": 1447203401, + "ct_id": "NCT02240810", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "PLATINUM Diversity", + "condition": "Atherosclerosis, Coronary Artery Disease", + "intervention": "Percutaneous coronary intervention (Promus PREMIER)", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 1501, + "trial sites": 52, + "sponsors": "Boston Scientific Corporation", + "status": "Completed", + "Start_Date": "2014-10-01", + "End_Date": "2016-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Wayne Batchelor, MD;Wayne B Batchelor", + "Collaborator": "", + "Purpose": "To compile acute procedural performance and clinical outcomes data for the Promus PREMIER\n everolimus-eluting coronary stent system in understudied/underserved patient populations\n including women and minorities.", + "Official_Title": "PLATINUM Diversity: Outcomes With the Promus PREMIER™ Stent in Women and Minorities (S2326)", + "Keywords": "Coronary Stent", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Atherosclerosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02240810" + }, + { + "id": 11, + "user_id": 1447203401, + "ct_id": "NCT02132611", + "Study_Type": "Interventional", + "trial_name": "Coronary Orbital Atherectomy System Study", + "condition": "CAD", + "intervention": "Diamondback 360® Micro Crown OAS", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 100, + "trial sites": 12, + "sponsors": "Abbott Medical Devices", + "status": "Completed", + "Start_Date": "2014-06-01", + "End_Date": "2018-08-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "Both", + "Investigators": "Gregg Stone, MD;Gregg W Stone", + "Collaborator": "", + "Purpose": "The purpose of the COAST clinical study data will be to utilize and to gain approval in\n commercializing the micro crown as part of the Coronary Orbital Atherectomy system (OAS).", + "Official_Title": "Coronary Orbital Atherectomy System Study", + "Keywords": "Coronary Stent", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02132611" + }, + { + "id": 12, + "user_id": 1447203401, + "ct_id": "NCT02097290", + "Study_Type": "Interventional", + "trial_name": "Evaluation Of Automatic Threshold Algorithms", + "condition": "Heart Failure", + "intervention": "CRT-D", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 216, + "trial sites": 36, + "sponsors": "Boston Scientific Corporation", + "status": "Completed", + "Start_Date": "2014-04-01", + "End_Date": "2017-05-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Kenneth Ellenbogen, MD;Mark Fayez Sedrak", + "Collaborator": "", + "Purpose": "This Study Will Evaluate The PaceSafe Right Ventricular Autothreshold (RVAT) And Left\n Ventricular Autothreshold (LVAT) Features For AUTOGEN Cardiac Resynchronization Therapy\n Defibrillator (CRT-D) Devices.", + "Official_Title": "CAPTure Information Via Automatic Threshold Evaluation", + "Keywords": "Threshold algorithms,CRT-D", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02097290" + }, + { + "id": 13, + "user_id": 1447203401, + "ct_id": "NCT01976299", + "Study_Type": "Interventional", + "trial_name": "AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN", + "condition": "Contrast Induced Nephropathy (CIN)", + "intervention": "AVERT", + "phase": "Others", + "Role": "", + "enrollees": 578, + "trial sites": 39, + "sponsors": "Osprey Medical, Inc", + "status": "Completed", + "Start_Date": "2013-12-01", + "End_Date": "2015-09-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD, FACC;Guilherme V Silva", + "Collaborator": "", + "Purpose": "The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the\n kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced\n nephropathy (CIN).", + "Official_Title": "AVERT™ Clinical Trial", + "Keywords": "", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01976299" + }, + { + "id": 14, + "user_id": 1447203401, + "ct_id": "NCT01930214", + "Study_Type": "Observational", + "trial_name": "Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)", + "condition": "Coronary Artery Disease", + "intervention": "percutaneous coronary intervention", + "phase": "", + "Role": "", + "enrollees": 350, + "trial sites": 34, + "sponsors": "Abbott Medical Devices", + "status": "Completed", + "Start_Date": "2013-09-26", + "End_Date": "2017-06-30", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Samin K Sharma, MD;Sharma Samin", + "Collaborator": "", + "Purpose": "The objective of this study is to assess the current standard of care treatment outcome in\n none/mild, moderate and severely calcified coronary lesions using:\n\n - A composite of MACE at 30-day and one (1) year post procedure, and\n\n - Procedural and lesion success", + "Official_Title": "Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)", + "Keywords": "Coronary Stent", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01930214" + }, + { + "id": 15, + "user_id": 1447203401, + "ct_id": "NCT01848106", + "Study_Type": "Interventional", + "trial_name": "A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI", + "condition": "Coronary Artery Disease", + "intervention": "pegnivacogin/anivamersen;Bivalirudin", + "phase": "Phase 3", + "Role": "", + "enrollees": 3232, + "trial sites": 0, + "sponsors": "Regado Biosciences, Inc.", + "status": "Terminated", + "Start_Date": "2013-09-01", + "End_Date": "2015-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "Both", + "Investigators": "Steven L Zelenkofske, DO, FACC;A. Michael Lincoff, MD;Roxana Mehran, MD;John H Alexander, MD, MHS;", + "Collaborator": "The Cleveland Clinic,Duke Clinical Research Institute,Canadian VIGOUR Centre,Icahn School of Medicine at Mount Sinai,Parexel", + "Purpose": "This study is designed to determine the efficacy of REG1 compared to bivalirudin in\n preventing periprocedural ischemic complications and major bleeding in patients undergoing\n PCI as a treatment for CAD. Bivalirudin has been studied in patients undergoing PCI in both\n ACS (NSTEMI and unstable angina [UA]) and elective PCI. In comparison to UFH, bivalirudin\n has shown similar rates of ischemic events while demonstrating a significant reduction in\n bleeding and an improved net clinical benefit.\n\n Evidence from previous studies indicates that pegnivacogin represents an extremely potent,\n chemically unique anticoagulant that can be reversed by anivamersen across multiple\n populations (refer to Section 1.2.2). The question that still remains is whether Factor IX\n (FIX) inhibition by pegnivacogin can result in fewer ischemic events than a previously\n studied agent while active control with anivamersen can preserve the benefit of reduced\n bleeding. The purpose of this study is to evaluate REG1 in an adequately powered definitive\n study with an open-label, multi-center, active-controlled, randomized design to answer that\n question.", + "Official_Title": "A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention", + "Keywords": "Percutaneous Coronary Intervention,coronary artery disease,Acute Coronary Syndrome,Regado,Reg 1,bivalirudin", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Bivalirudin,Hirudins", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01848106" + }, + { + "id": 16, + "user_id": 1447203401, + "ct_id": "NCT01732341", + "Study_Type": "Interventional", + "trial_name": "Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction", + "condition": "Acute Myocardial Infarction", + "intervention": "STENTYS self-apposing stent;VISION balloon-expandable stent", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 318, + "trial sites": 3, + "sponsors": "Stentys", + "status": "Terminated", + "Start_Date": "2013-05-01", + "End_Date": "2017-03-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Maurice Buchbinder, MD;Buchbinder Maurice", + "Collaborator": "", + "Purpose": "This study will test compare the Stentys Stent with the Multi-Link Vision™ stent system\n (Abbott Vascular Inc.)in patients with a heart attack. It is expected that the Stentys stent\n is not worse than the Vision stent.", + "Official_Title": "APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction", + "Keywords": "STEMI,BMS,Self-expanding stent,Coronary Stent", + "MeSH_Terms": "Infarction,Myocardial Infarction", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01732341" + }, + { + "id": 17, + "user_id": 1447203401, + "ct_id": "NCT01819181", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "Women's INternational Transcatheter Aortic Valve Implantation Registry", + "condition": "Symptomatic Aortic Stenosis", + "intervention": "", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 1019, + "trial sites": 10, + "sponsors": "Icahn School of Medicine at Mount Sinai", + "status": "Completed", + "Start_Date": "2013-03-01", + "End_Date": "2018-04-26", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "Female", + "Investigators": "Alaide Chieffo, MD;Roxana Mehran, MD;Mehran Roxana", + "Collaborator": "Society for Cardiovascular Angiography and Interventions", + "Purpose": "The study will evaluate all female patients with severe aortic stenosis undergoing\n transcatheter valve implantation with commercially available valves and delivery systems.", + "Official_Title": "Women's INternational Transcatheter Aortic Valve Implantation Registry", + "Keywords": "TAVI,Women,Aortic Stenosis,VARC2,BARC bleeding", + "MeSH_Terms": "Aortic Valve Stenosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01819181" + }, + { + "id": 18, + "user_id": 1447203401, + "ct_id": "NCT01584622", + "Study_Type": "Interventional", + "trial_name": "Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases", + "condition": "Coronary Artery Disease", + "intervention": "CADence System", + "phase": "Others", + "Role": "Study Chair", + "enrollees": 0, + "trial sites": 7, + "sponsors": "AUM Cardiovascular, Inc.", + "status": "Withdrawn", + "Start_Date": "2012-07-01", + "End_Date": "2013-02-01", + "Min_Age": "18 Years", + "Max_Age": "N/A", + "Gender": "Both", + "Investigators": "Robert Wilson, MD;Roxana Mehran, MD;James Chapman, MD;Mark Tannenbaum, PhD;Robert Schwartz, MD;Jeff Chambers, MD;Giora Weisz, MD;Wilson Robert", + "Collaborator": "", + "Purpose": "The purpose of the study is to evaluate the effectiveness of the CADence system, a\n non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in\n the coronary tree.", + "Official_Title": "Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases", + "Keywords": "", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01584622" + }, + { + "id": 19, + "user_id": 1447203401, + "ct_id": "NCT01456013", + "Study_Type": "Interventional", + "trial_name": "Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients", + "condition": "Contrast Induced Nephropathy", + "intervention": "RenalGuard Therapy;Standard Therapy", + "phase": "Phase 3", + "Role": "", + "enrollees": 326, + "trial sites": 18, + "sponsors": "CardioRenal Systems, Inc.", + "status": "Active, not recruiting", + "Start_Date": "2012-01-01", + "End_Date": "2018-06-01", + "Min_Age": "18 Years", + "Max_Age": "N/A", + "Gender": "Both", + "Investigators": "Charles Davidson, MD;Richard Solomon, MD;Roxana Mehran, MD;Paul H Gordon", + "Collaborator": "", + "Purpose": "Contrast-Induced Nephropathy (CIN) can occur when patients with pre-existing kidney problems\n undergo procedures that use iodinated contrast media, such as cardiac catheterizations.\n RenalGuard Therapy was developed to enable the patient to clear the contrast out of their\n kidney before it can do significant damage. This study aims to enroll patients with\n increased risk of developing CIN who are scheduled for a cardiovascular catheterization.\n Patients will be randomized to either RenalGuard therapy or standard therapy.", + "Official_Title": "A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory", + "Keywords": "", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01456013" + }, + { + "id": 20, + "user_id": 1447203401, + "ct_id": "NCT05132062", + "Study_Type": "Observational", + "trial_name": "Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI", + "condition": "Contrast-induced Nephropathy", + "intervention": "percutaneous coronary intervention", + "phase": "", + "Role": "Study Chair", + "enrollees": 14616, + "trial sites": 1, + "sponsors": "Icahn School of Medicine at Mount Sinai", + "status": "Completed", + "Start_Date": "2012-01-01", + "End_Date": "2021-09-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Mehran Roxana", + "Collaborator": "", + "Purpose": "Consecutive patients having percutaneous coronary intervention (PCI) over a period of 9 years\n at a large tertiary care center with available creatinine measurements both before and within\n 48 hours after the procedure were included; patients on chronic dialysis were excluded.\n Patients treated between 2012 and 2017 comprised the derivation cohort (n=14,616) and those\n treated from 2018 to 2020 formed the validation cohort (n=5,606). The primary endpoint is\n contrast-associated acute kidney injury (CA-AKI, defined per Acute Kidney Injury Network\n [AKIN]). In addition, independent predictors of CA-AKI will be derived from multivariate\n logistic regression analysis. Model 1 will include only preprocedural variables, while Model\n 2 will also include procedural variables. A weighted integer score based on the effect\n estimate of each independent variable will be used to calculate the final risk score for each\n patient. Impact on 1-year mortality will be also evaluated.", + "Official_Title": "A Contemporary Simple Risk Score for Prediction of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention Development and Initial Validation", + "Keywords": "", + "MeSH_Terms": "Kidney Diseases", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05132062" + }, + { + "id": 21, + "user_id": 1447203401, + "ct_id": "NCT00967902", + "Study_Type": "Interventional", + "trial_name": "Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent", + "condition": "Coronary Artery Lesions", + "intervention": "Coronary stenting", + "phase": "Phase 2", + "Role": "Study Director", + "enrollees": 180, + "trial sites": 1, + "sponsors": "OrbusNeich", + "status": "Completed", + "Start_Date": "2009-11-01", + "End_Date": "2015-09-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Ian T Meredith, MBBS, PhD;Stephan Windecker, MD;Alexandre Abizaid, MD;Roxana Mehran, MD;Alexandra Lansky, MD;Alexandra J Lansky", + "Collaborator": "", + "Purpose": "To demonstrate the safety and effectiveness of the Combo Bio-engineered Sirolimus Eluting\n Stent (Combo Stent) compared to the Taxus® Liberté® Stent in the treatment of coronary artery\n lesions.", + "Official_Title": "The REMEDEE Study: A Prospective, Randomized Study to Evaluate the Safety and Efficacy of an Abluminal Sirolimus Coated Bio-engineered Stent (Combo Bio-engineered Sirolimus Eluting Stent)", + "Keywords": "intracoronary stent,drug eluting stent,Sirolimus,Endothelial progenitor cells,Coronary Stent", + "MeSH_Terms": "Sirolimus,Everolimus", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00967902" + }, + { + "id": 22, + "user_id": 1447203401, + "ct_id": "NCT00998127", + "Study_Type": "Observational", + "trial_name": "Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients", + "condition": "Medication Non-adherence, Stent Thrombosis", + "intervention": "", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 5031, + "trial sites": 15, + "sponsors": "Icahn School of Medicine at Mount Sinai", + "status": "Completed", + "Start_Date": "2009-06-01", + "End_Date": "2013-03-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roxana Mehran, MD;Antonio Colombo, MD;Mehran Roxana", + "Collaborator": "Bristol-Myers Squibb,Sanofi", + "Purpose": "The purpose of this observational research study is to determine when and why patients\n discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed\n following stent implantation, and to examine the relationship between specific patterns of\n non-adherence and patient outcomes.", + "Official_Title": "Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients: An Observational Single-Arm Study (The PARIS Registry)", + "Keywords": "Dual Anti-Platelet Therapy,non-adherence,MACE,NACE,Ischemia-driven revascularization,TIMI bleeding", + "MeSH_Terms": "Thrombosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00998127" + }, + { + "id": 23, + "user_id": 1447203401, + "ct_id": "NCT00433966", + "Study_Type": "Interventional", + "trial_name": "Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction", + "condition": "Myocardial Infarction", + "intervention": "Bivalirudin;Unfractionated Heparin;Bare Metal Stent;Paclitaxel-eluting stent", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 3602, + "trial sites": 1, + "sponsors": "Cardiovascular Research Foundation, New York", + "status": "Completed", + "Start_Date": "2005-03-01", + "End_Date": "2010-11-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "Both", + "Investigators": "Gregg W Stone, MD;Roxana Mehran, MD", + "Collaborator": "Boston Scientific Corporation,The Medicines Company", + "Purpose": "The Primary Objectives Of The Trial Are:\n\n 1. To Establish The Safety And Efficacy Of The Use Of Bivalirudin (+ Bail-out GP IIb/IIIa\n Inhibitors) Compared To The Use Of Unfractionated Heparin + GP IIb/IIIa Inhibitors In\n Patients With Acute Myocardial Infarction Undergoing A Primary Angioplasty Strategy.\n\n 2. To Establish The Safety And Efficacy Of The Slow Rate Release Paclitaxel-eluting TAXUS™\n Stent Compared To An Otherwise Identical Uncoated Bare Metal EXPRESS2™ Stent.", + "Official_Title": "Dual Arm Factorial Randomized Trial In Patients W/ST Segment Elevation AMI To Compare The Results Of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition Or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; And Primary Angioplasty With Stent Implantation With Either A Slow Rate-release Paclitaxel-eluting Stent (TAXUS™) Or Uncoated Bare Metal Stent (EXPRESS2™)", + "Keywords": "myocardial infarction,Angioplasty,myocardial ischemia,Myocardial Reperfusion,stents,Heart Disease,Coronary Stent", + "MeSH_Terms": "Infarction,Myocardial Infarction,Calcium heparin,Bivalirudin,Heparin,Paclitaxel", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00433966" + }, + { + "id": 24, + "user_id": 1639100928, + "ct_id": "NCT05201495", + "Study_Type": "Interventional", + "trial_name": "The Jewel IDE Study", + "condition": "", + "intervention": "D;J;A;T", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 290, + "trial sites": "", + "sponsors": "Element Science, Inc.", + "status": "Active, not recruiting", + "Start_Date": "2022-01-12", + "End_Date": "2023-06-01", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Javed Butler, M.D.;John Hummel, M.D.;Roxana Mehran, M.D.;Mehran Roxana", + "Collaborator": "", + "Purpose": "The Jewel IDE Study: A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for\n Sudden Cardiac Arrest. (\"JEWEL\")", + "Official_Title": "A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest", + "Keywords": "", + "MeSH_Terms": "Heart Arrest,Death, Sudden, Cardiac", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05201495" + }, + { + "id": 25, + "user_id": 1639100928, + "ct_id": "NCT05064709", + "Study_Type": "Interventional", + "trial_name": "Assessment of CCM in HF With Higher Ejection Fraction", + "condition": "Heart Failure, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction", + "intervention": "Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System;Sham Therapy", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 1500, + "trial sites": 0, + "sponsors": "Impulse Dynamics", + "status": "Recruiting", + "Start_Date": "2022-01-01", + "End_Date": "2026-02-01", + "Min_Age": "21 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Javed Butler, MD, MPH, MBA;Oussama Wazni, MD, MBA;Butler Javed", + "Collaborator": "", + "Purpose": "The AIM HIGHer Clinical Trial will evaluate the efficacy and safety of Cardiac Contractility\n Modulation (CCM) therapy in patients with heart failure with LVEF ?40% and ?60%.", + "Official_Title": "Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction", + "Keywords": "HFpEF,Heart failure,CCM,CCM Therapy,Cardiac contractility modulation,Symptomatic Heart Failure,Left ventricular ejection fraction,LVEF,Optimizer,Optimizer Smart Mini,Quality of life", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05064709" + }, + { + "id": 26, + "user_id": 1639100928, + "ct_id": "NCT04452149", + "Study_Type": "Interventional", + "trial_name": "Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure", + "condition": "Heart Failure NYHA Class II, Heart Failure NYHA Class III", + "intervention": "Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download;Medication intervention", + "phase": "Others", + "Role": "", + "enrollees": 900, + "trial sites": 58, + "sponsors": "Medtronic Cardiac Rhythm and Heart Failure", + "status": "Recruiting", + "Start_Date": "2020-09-03", + "End_Date": "2025-04-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Javed Butler, MD;", + "Collaborator": "", + "Purpose": "The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site,\n interventional, investigational device exemption (IDE) pivotal study. The purpose of the\n study is to demonstrate the safety and efficacy of a patient management pathway that utilizes\n an integrated device diagnostic-based risk stratification algorithm to guide patient care in\n subjects with NYHA class II and III heart failure, and to demonstrate the safety of the\n Reveal LINQ™ system and procedure in the study population.", + "Official_Title": "Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure", + "Keywords": "Heart failure,insertable cardiac monitor", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04452149" + }, + { + "id": 27, + "user_id": 1639100928, + "ct_id": "NCT03037931", + "Study_Type": "Interventional", + "trial_name": "Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency", + "condition": "Heart Failure, Iron-deficiency", + "intervention": "Ferric carboxymaltose;Placebos", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 3065, + "trial sites": 197, + "sponsors": "American Regent, Inc.", + "status": "Completed", + "Start_Date": "2017-03-15", + "End_Date": "2022-06-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Adrian F Hernandez, MD;William R Davis, MD;Brian Foley, MD;Frank M Lester, MD;Christopher Malozzi, DO;Ankie Amos, MD;Bonifasiyo Ssennyamantono, MD;Samuel M Butman, MD;Jalal Abbas, MD;Brenda C Peart, MD;Abdul-Nasser Adjei, MD;Dharmendra V Patel, MD;Michael Huber, MD;Norman E Lepor, MD;William J French, MD;Suhail H Zavaro, MD;Majed Chane, MD;Kanagaratnam Sivalingam, MD;Maleah Grover, MD;Lydie Hazan, MD;Michael Miyamoto, MD;Michael M Radin, MD;Masoud M Azizad, MD;Christopher G Chow, MD;Eugene Soroka, MD;William F Penny Jr, MD;Arash Vahdat, MD;Afshine Emrani, MD;Ira Dauber, MD;Carol Gemayel-Barra, MD;David Hsi, MD;Ashish Parikh, MD;Sourin Banerji, MD;Anthony Alfieri, DO;Lawrence Weinstein, MD;Eulogio J Sanchez, MD;Miguel E Trevino, MD;Bruce Rankin, DO;Surya Rao, MD;Ioana Dumitru, MD;Raguveer Murthy, MD;Francesco Franchi, MD;Ambar M Patel, MD;Shahyar Gharacholou, MD;Sandor Romero, MD;Jesus Rodriguez de la Torre, MD;Ramon E Alegret, MD;Felix Chion-Fong, MD;Jonathan Fialkow, MD;Gregory Alfred, MD;Antonio Blanco, MD;Siva S Gummadi, MD;Nirav Ravel, MD;Duccio Baldari, MD;Misal Khan, MD;Gladys Andrade, MD;Brent D Videau, MD;Rohit Amin, MD;Fadi E Saba, MD;Seth Baker, DO;Neerav Shah, MD;Arthur B Chandler, MD;Neal Weintraub, MD;Felix O Sogade, MD;Hemant Goyal, MD;Michael T Morris, MD;Omar Almousalli, MD;Roy W Robertson, MD;Michael Barron, MD;Ashwin Ravichandran, MD;Wayne L Gray, MD;John McGinty, MD;John F Kobayashi, MD;Naseem Jaffrani, MD;Ghiath Mikdadi, MD;Peter S Fail, MD;Anand Irimpen, MD;Hamang Patel, MD;Bruce J Iteld, MD;Samuel T Coffin, MD;James Welker, DO;Mauro Moscucci, MD;Gregory Kumkumian, MD;Erin Coglianese, MD;Marwa Sabe, MD;Ehab Sorial, MD;David Dobies, MD;Christopher Rogers, DO;Naveed Akhtar, MD;Peter Eckman, MD;Margaret Redfield, MD;Barry Bertolet, MD;David M Hahn, MD;Gil Vardi, MD;Gina Mentzer, MD;Venkata Alla, MD;Lawrence Madoff, MD;Lance Berger, MD;Andrey Espinoza, MD;Ranzan Zakir, MD;Abbas Shehadeh, MD;Mark Quadrel, MD;Vineshkumar Patel, MD;Kariann Abbate, MD;Dinesh K Singal, MD;Angel J Mulkay, MD;John Heitner, MD;Michael J Hong, MD;Anuradha Lala-Trindade, MD;Richard Grodman, MD;Hal A Skopicki, MD;Muzamil I Rana, MD;Benjamin Trichon, MD;Paul Rosenberg, MD;Jagadeesh Ganji, MD;David Smith, MD;Elmer H Stout, MD;Patrick Simpson, MD;Christopher Chien, MD;Stuart D Russell, MD;Matthew J Janik, MD;Samir Turk, MD;Rizwan Sardar, MD;Khalil Murad, MD;Mazen Hanna, MD;Sitaramesh Emani, MD;Ademola K Abiose, MD;Chander M Arora, MD;William P McGuinn, MD;Sayed MT Rizvi, MD;Naeem Khan Tahirkheli, MD;Donald C Haas, MD;Rejesh Dave, MD;Lindsay Castle, DO;Syed F Hasni, MD;Alaa Shalaby, MD;Priya Kumar, MD;Vipul Shah, MD;Alexander Schabauer, MD;Malcolm T Foster, MD;Milan Sheth, DO;Alan Chu, MD;Sammy L Cox, MD;Martin R Berk, MD;Chrisette Dharma, MD;Shelley Hall, MD;Theodore Takata, MD;Nitin Mahajan, MD;Raymond Little, MD;Terry L Wells, MD;Venkata Chilakapati, MD;Faizan Iftikhar, MD;Jamil A Malik, MD;Lazaros Nikolaidis, MD;Thomas Buzbee, MD;Samantapudi Daya, MD;Vedampattu Ganeshram, MD;Charles Dahl, MD;Stephen Miller, MD;Johannes Steiner, MD;Brian Schietinger, MD;Wayne Old, MD;Mary Ann Peberdy, MD;David Sane, MD;Vivek Bhatia, MD;Bryan E Fuhs, MD;Eric M Ball, MD;Guatum S Nayak, MD;Kelley P Anderson, MD;Jagdeep Sabharwal, MD;Brian Clarke, MD;Justin Ezekowitz, MBBCh;Mikael Hanninen, MD;Richard Vandegriend, MD;Amit Khosla, MD;Mustafa Toma, MD;Elizabeth Swiggum, MD;Gordon Hoag, MD;Bruce Sussex, MD;Miroslaw Rajda, MD;Sudip Datta, MD;Shekhar Pandey, MD;Saul Vizel, MD;Ryan Davey, MD;Gordon Moe, MD;Denis Saulnier, MD;Eileen O'Meara, MD;Nadia S Giannetti, MD;Sébastien Bergeron, MD;Danielle Dion, MD;Yves Pesant, MD;Ying Tung Sia, MD;Alexander Zhai, MD;Jocelyne Benatar, MD;Richard Troughton, MD;David W Smith", + "Collaborator": "Duke Clinical Research Institute", + "Purpose": "The primary objective of this study is to determine the efficacy and safety of iron therapy\n using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of\n participants in heart failure with iron deficiency and with a reduced ejection fraction.", + "Official_Title": "A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Anemia, Iron-Deficiency,Ferric Compounds", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03037931" + }, + { + "id": 28, + "user_id": 1639100928, + "ct_id": "NCT02519283", + "Study_Type": "Interventional", + "trial_name": "Get With the Guidelines in ED Patients With Heart Failure", + "condition": "Heart Failure", + "intervention": "GUIDED-HF;Standard of Care", + "phase": "Others", + "Role": "", + "enrollees": 529, + "trial sites": 6, + "sponsors": "Vanderbilt University", + "status": "Completed", + "Start_Date": "2015-10-01", + "End_Date": "2018-09-01", + "Min_Age": "21 Years", + "Max_Age": "N/A", + "Gender": "Both", + "Investigators": "Sean Collins, MD;Javed Butler, MD;Miller Karen", + "Collaborator": "Patient-Centered Outcomes Research Institute,Stony Brook University,Indiana University,Wayne State University,VA Office of Research and Development,University of Cincinnati,Washington University School of Medicine,Baylor College of Medicine,MetroHealth Medical Center,University of Mississippi Medical Center,Emory University,University of Iowa,Thomas Jefferson University,University of Texas,Virginia Commonwealth University", + "Purpose": "Approximately 20-30% of patients presenting with acute heart failure are discharged from the\n ED. Compared to patients discharged from the hospital, they more frequently return to the ED\n and hospital for further management. While inpatient discharges are often enrolled in\n transitions programs and have their care tailored to evidence-based recommendations, ED\n discharges do not. The investigators propose to evaluate current standard ED discharge to an\n ED-based intervention which will transition patients to outpatient follow-up on\n guideline-recommended therapy.", + "Official_Title": "Get With the Guidelines in ED Patients With Heart Failure", + "Keywords": "AHF,HF,ED,ER,Emergency department,Emergency Room", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02519283" + }, + { + "id": 29, + "user_id": 1639100928, + "ct_id": "NCT02467296", + "Study_Type": "Interventional", + "trial_name": "Dietary Sodium Intake and Outcomes in Heart Failure", + "condition": "Heart Failure", + "intervention": "Dietary plan with controlled amount of Sodium", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 27, + "trial sites": 1, + "sponsors": "Stony Brook University", + "status": "Completed", + "Start_Date": "2015-02-01", + "End_Date": "2017-09-01", + "Min_Age": "21 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Javed Butler, MD, MPH, MBA;Butler Javed", + "Collaborator": "National Heart, Lung, and Blood Institute (NHLBI)", + "Purpose": "Currently, the recommendations for sodium intake restriction for patients with heart failure\n are mostly based on expert consensus and observational evidence, whereas smaller randomized\n studies have actually suggested that strict dietary sodium reduction may be harmful in heart\n failure. In the present clinical trial pilot study, the investigators plan to collect data\n on enrollment rates, compliance, outcomes, and safety of a 12-week dietary intervention in\n heart failure patients, with prepared food containing two different levels of sodium (1,500\n mg and 3,000 mg) daily, followed by a 12-week surveillance for safety and effectiveness. The\n goal is to inform the design of a fullscale clinical trial that will provide more definitive\n evidence for dietary sodium recommendations in heart failure.", + "Official_Title": "Rationale and Design of the PRevent Adverse Outcomes in Heart faIlure By limITing Sodium Study", + "Keywords": "Sodium,Outcomes", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02467296" + }, + { + "id": 30, + "user_id": 1639100928, + "ct_id": "NCT01606085", + "Study_Type": "Interventional", + "trial_name": "Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes", + "condition": "Diabetes Mellitus, Heart Failure", + "intervention": "HF DM self care;Usual care", + "phase": "Others", + "Role": "Study Director", + "enrollees": 141, + "trial sites": 1, + "sponsors": "Emory University", + "status": "Completed", + "Start_Date": "2009-09-01", + "End_Date": "2014-04-01", + "Min_Age": "21 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Sandra B Dunbar, PhD;Javed Butler, MD;Stephen Culler, MD;Rebecca A. Gary, PhD;Carolyn M. Reilly, PhD;Butler Javed", + "Collaborator": "Atlanta VA Medical Center,Atlanta Clinical and Translational Science Institute,National Institute of Nursing Research (NINR)", + "Purpose": "The purposes of this study are:\n\n 1. to develop and test an integrated self care intervention for Heart Failure (HF)patients\n with Diabetes (DM) for its effects on patient outcomes including health related quality\n of life (HRQOL), physical function and health resource utilization.\n\n 2. to assess the costs and cost effectiveness of the intervention.\n\n The intervention is designed to go beyond usual care of providing separate Heart Failure\n (HF) and Diabetes (DM) patient education by educating HF-DM patients on integrated self care\n and self management related to a HF-DM diet, HF-DM medication-taking behaviors, physical\n activity, and HF-DM symptom monitoring and management. An integrated self care intervention\n will compare HF-DM patients who receive the intervention with those who receive usual\n care-attention control for effects on patient outcomes,self care process measures, and\n health care utilization. If effective, the intervention will lead to improved self care,\n improved quality of life, and reduced health care resource use and costs. This study will\n facilitate greater understanding of self care within the context of two chronic illnesses\n and will lead directly to improved clinical practice and future research on comorbid self\n care in Heart Failure.", + "Official_Title": "Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes", + "Keywords": "diabetes,Heart failure,Quality of life,Self care", + "MeSH_Terms": "Diabetes Mellitus,Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01606085" + }, + { + "id": 31, + "user_id": 1639100928, + "ct_id": "NCT00599014", + "Study_Type": "Observational", + "trial_name": "Heart Failure Study: The Atlanta Cardiomyopathy Consortium", + "condition": "Heart Failure", + "intervention": "", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 335, + "trial sites": 2, + "sponsors": "Emory University", + "status": "Completed", + "Start_Date": "2007-11-01", + "End_Date": "2013-06-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Javed Butler, MD, MPH;Butler Javed", + "Collaborator": "", + "Purpose": "Heart failure is a very common cause of hospital admission and there are half a million new\n cases diagnosed each year in the United States. While some important progress has been made\n over the last two decades for the treatment of heart failure, there still remains a critical\n need for further advances in our understanding of this disease in order to significantly\n improve patient outcomes. Large numbers of heart failure patients need to be studied over\n time to allow scientists to investigate those factors that influence the responses to\n therapy.", + "Official_Title": "The Atlanta Cardiomyopathy Consortium", + "Keywords": "Cardiomyopathy, heart failure, DNA,,echocardiography, messenger RNA, natural history", + "MeSH_Terms": "Heart Failure,Cardiomyopathies", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00599014" + }, + { + "id": 32, + "user_id": 1639100928, + "ct_id": "NCT02693509", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "Get With The Guidelines-Heart Failure Registry", + "condition": "Heart Failure", + "intervention": "GWTG Heart Failure program", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 128026, + "trial sites": 1, + "sponsors": "American Heart Association", + "status": "Recruiting", + "Start_Date": "2005-01-01", + "End_Date": "2020-01-01", + "Min_Age": "18 Years", + "Max_Age": "125 Years", + "Gender": "All", + "Investigators": "Javed Butler, MD;Gayle Whitman, PHD, RN;Butler Javed", + "Collaborator": "", + "Purpose": "Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients\n hospitalized with heart failure. The program aims to help ensure that eligible patients are\n initiated on guideline recommended therapies and receive appropriate counseling prior to\n hospital discharge.", + "Official_Title": "Get With The Guidelines-Heart Failure Registry", + "Keywords": "", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02693509" + }, + { + "id": 33, + "user_id": 1639100928, + "ct_id": "NCT02693223", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "Get With the Guidelines-Stroke Registry", + "condition": "Stroke", + "intervention": "GWTG Stroke program", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 3892063, + "trial sites": 1, + "sponsors": "American Heart Association", + "status": "Recruiting", + "Start_Date": "2003-01-01", + "End_Date": "2020-01-01", + "Min_Age": "18 Years", + "Max_Age": "125 Years", + "Gender": "All", + "Investigators": "Javed Butler, MD;Gayle Whitman, PhD, RN;Butler Javed", + "Collaborator": "", + "Purpose": "Get With The Guidelines-Stroke is a program for improving the quality of care for patients\n hospitalized with stroke by promoting consistent adherence to the latest evidence-based\n clinical practice guidelines.", + "Official_Title": "Get With the Guidelines-Stroke Registry", + "Keywords": "stroke,Modified Rankin scale (mRS)", + "MeSH_Terms": "Stroke", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02693223" + }, + { + "id": 34, + "user_id": 1811967433, + "ct_id": "NCT05708859", + "Study_Type": "Interventional", + "trial_name": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT", + "condition": "Type II Diabetes, Atherosclerosis", + "intervention": "Tirzepatide;Placebo", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 120, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Recruiting", + "Start_Date": "2024-01-02", + "End_Date": "2026-05-01", + "Min_Age": "40 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Matthew A Budoff, MD;Matthew J Budoff, MD;Matthew J Budoff", + "Collaborator": "Eli Lilly and Company", + "Purpose": "", + "Official_Title": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT", + "Keywords": "", + "MeSH_Terms": "Atherosclerosis,Coronary Artery Disease,Myocardial Ischemia,Diabetes Mellitus, Type 2,Tirzepatide", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05708859" + }, + { + "id": 35, + "user_id": 1811967433, + "ct_id": "NCT06342609", + "Study_Type": "Interventional", + "trial_name": "Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease", + "condition": "", + "intervention": "D;C;0;", + "phase": "Phase 4", + "Role": "", + "enrollees": 84, + "trial sites": "", + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Active, not recruiting", + "Start_Date": "2023-03-15", + "End_Date": "2024-09-07", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "This is a randomized double-blind, placebo-controlled, investigator-initiated trial that\n compares Colchicine 0.5mg/day with placebo, among patients with stable CAD. Subjects will be\n educated to maintain medication compliance with other prescribed medications.", + "Official_Title": "Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With STable CoROnary Artery Disease CoMpared to Placebo - EKSTROM Trial", + "Keywords": "", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Atherosclerosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT06342609" + }, + { + "id": 36, + "user_id": 1811967433, + "ct_id": "NCT05030428", + "Study_Type": "Interventional", + "trial_name": "Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease", + "condition": "Atherosclerotic Cardiovascular Disease", + "intervention": "Inclisiran sodium 300 mg;Placebo", + "phase": "Phase 3", + "Role": "", + "enrollees": 17006, + "trial sites": 997, + "sponsors": "Novartis Pharmaceuticals", + "status": "Active, not recruiting", + "Start_Date": "2021-11-23", + "End_Date": "2027-10-13", + "Min_Age": "40 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Novartis Pharmaceuticals;", + "Collaborator": "", + "Purpose": "Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on\n major adverse cardiovascular (MACE) events in participants with established cardiovascular\n disease (CVD).", + "Official_Title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)", + "Keywords": "atherosclerotic cardiovascular disease,hypercholesterolemia,Dyslipidemia,High Cholesterol,hyperlipidemia,Inclisiran,siRNA,KJX839", + "MeSH_Terms": "Cardiovascular Diseases,Atherosclerosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05030428" + }, + { + "id": 37, + "user_id": 1811967433, + "ct_id": "NCT05733325", + "Study_Type": "Observational", + "trial_name": "Diet-induced Elevations in LDL-C and Progression of Atherosclerosis", + "condition": "", + "intervention": "", + "phase": "", + "Role": "", + "enrollees": 100, + "trial sites": "", + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Active, not recruiting", + "Start_Date": "2021-10-18", + "End_Date": "2024-05-01", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Matthew A Budoff, MD;Matthew J Budoff", + "Collaborator": "Citizen Science Foundation", + "Purpose": "This is an observational study examining the progression of subclinical coronary\n atherosclerosis in healthy participants who have an elevated LDL-C (above 190mg/dl) secondary\n to diet not associated with genetic familial hypercholesterolemia (FH). This study\n participants are classified to be Lean-Mass-Hyper-Responder (LMHR).", + "Official_Title": "Diet-induced Elevations in LDL-C and Progression of Atherosclerosis", + "Keywords": "", + "MeSH_Terms": "Atherosclerosis,Hypercholesterolemia", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05733325" + }, + { + "id": 38, + "user_id": 1811967433, + "ct_id": "NCT03875183", + "Study_Type": "Interventional", + "trial_name": "Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction", + "condition": "Heart Failure, Reduced Ejection Fraction", + "intervention": "INL1;Placebo", + "phase": "Phase 2", + "Role": "", + "enrollees": 200, + "trial sites": 9, + "sponsors": "Innolife Co., Ltd.", + "status": "Recruiting", + "Start_Date": "2019-12-01", + "End_Date": "2021-01-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Michael Chen, MD;Amin H Karim", + "Collaborator": "", + "Purpose": "", + "Official_Title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction", + "Keywords": "Heart failure", + "MeSH_Terms": "Heart Failure", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03875183" + }, + { + "id": 39, + "user_id": 1811967433, + "ct_id": "NCT03985384", + "Study_Type": "Interventional", + "trial_name": "Semaglutide Treatment On Coronary Progression", + "condition": "Type 2 Diabetes, Coronary Artery Disease", + "intervention": "Semaglutide 2 MG/1.5 ML Subcutaneous Solution;Placebo", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 140, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2019-04-30", + "End_Date": "2020-09-01", + "Min_Age": "40 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Effect of Semaglutide on Coronary Atherosclerosis Plaque Progression in Type 2 Diabetics", + "Keywords": "", + "MeSH_Terms": "Coronary Artery Disease", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03985384" + }, + { + "id": 40, + "user_id": 1811967433, + "ct_id": "NCT03906825", + "Study_Type": "Interventional", + "trial_name": "Effect of CEAG on Inflammation and Endothelial Function", + "condition": "Inflammation, Endothelial Dysfunction", + "intervention": "CEAG;Placebo", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 80, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2018-05-17", + "End_Date": "2018-08-13", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Acute Effects of Curcuminoids, EPA (Omega-3), Astaxanthin and GLA (CEAG) on Inflammation and Endothelial Function", + "Keywords": "endothelium", + "MeSH_Terms": "Inflammation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03906825" + }, + { + "id": 41, + "user_id": 1811967433, + "ct_id": "NCT03448406", + "Study_Type": "Interventional", + "trial_name": "This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.", + "condition": "Heart Failure", + "intervention": "Empagliflozin;Placebo", + "phase": "Phase 3", + "Role": "", + "enrollees": 315, + "trial sites": 69, + "sponsors": "Boehringer Ingelheim", + "status": "Completed", + "Start_Date": "2018-03-20", + "End_Date": "2019-06-07", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Eaves William", + "Collaborator": "Eli Lilly and Company", + "Purpose": "The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus\n placebo on exercise ability using the 6 minute walk test (6MWT) in patients with chronic\n heart failure (CHF) with preserved ejection fraction (LVEF > 40%).\n\n Secondary objectives are to assess Patient-Reported Outcome (PRO)", + "Official_Title": "A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Preserved Ejection Fraction (HFpEF) (EMPERIAL - Preserved)", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Empagliflozin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03448406" + }, + { + "id": 42, + "user_id": 1811967433, + "ct_id": "NCT03448419", + "Study_Type": "Interventional", + "trial_name": "This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms", + "condition": "Heart Failure", + "intervention": "Empagliflozin;Placebo", + "phase": "Phase 3", + "Role": "", + "enrollees": 312, + "trial sites": 70, + "sponsors": "Boehringer Ingelheim", + "status": "Completed", + "Start_Date": "2018-03-20", + "End_Date": "2019-06-07", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Eaves William", + "Collaborator": "Eli Lilly and Company", + "Purpose": "The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus\n placebo on exercise ability using the 6 minute walk test in patients with chronic HF with\n reduced ejection fraction (LVEF ? 40%) Secondary objectives are to assess Patient-Reported\n Outcome (PRO)", + "Official_Title": "A Phase III Randomised, Double-blind Trial to Evaluate the Effect of 12 Weeks Treatment of Once Daily EMPagliflozin 10 mg Compared With Placebo on ExeRcise Ability and Heart Failure Symptoms, In Patients With Chronic HeArt FaiLure With Reduced Ejection Fraction (HFrEF) (EMPERIAL-reduced)", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Empagliflozin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03448419" + }, + { + "id": 43, + "user_id": 1811967433, + "ct_id": "NCT03417388", + "Study_Type": "Interventional", + "trial_name": "Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD", + "condition": "Coronary Artery Disease", + "intervention": "High dose potent statin;PCSK9 Inhibitor;ACE-I (lisinopril) or ARB (losartan);Aspirin;lifestyle counseling;Quality of Life Questionnaires", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 4422, + "trial sites": 20, + "sponsors": "University of Florida", + "status": "Recruiting", + "Start_Date": "2018-02-09", + "End_Date": "2022-12-30", + "Min_Age": "18 Years", + "Max_Age": "100 Years", + "Gender": "Female", + "Investigators": "Carl Pepine, MD;Carl J Pepine", + "Collaborator": "United States Department of Defense", + "Purpose": "The Ischemia-IMT (Ischemia-Intensive Medical Treatment Reduces Events in Women with\n Non-Obstructive CAD), subtitle: Women's Ischemia Trial to Reduce Events in Non-Obstructive\n CAD (WARRIOR) trial is a multicenter, prospective, randomized, blinded outcome evaluation\n (PROBE design) evaluating intensive statin/ACE-I (or ARB)/aspirin treatment (IMT) vs. usual\n care (UC) in 4,422 symptomatic women patients with symptoms and/or signs of ischemia but no\n obstructive CAD. The hypothesis is that IMT will reduce major adverse coronary events (MACE)\n 20% vs. UC. The primary outcome is first occurrence of MACE as death, nonfatal MI, nonfatal\n stroke/transient ischemic attack (TIA) or hospitalization for heart failure or angina.\n Secondary outcomes include quality of life, time to \"return to duty\"/work, health resource\n consumption, angina, cardiovascular (CV) death and primary outcome components. Events will be\n adjudicated by an experienced Clinical Events Committee (CEC). Follow-up will be 3-years\n using 50 sites: primarily VA and Active Duty Military Hospitals/Clinics and a National\n Patient-Centered Clinical Research Network (PCORnet) clinical data research network\n (CDRN)(OneFlorida Consortium).\n\n This study is being conducted to determine whether intensive medication treatment to modify\n risk factors and vascular function in women patients with coronary arteries showing no flow\n limit obstruction but with cardiac symptoms (i.e., chest pain, shortness of breath) will\n reduce the patient's likelihood of dying, having a heart attack, stroke/TIA or being\n hospitalized for cardiac reasons. The results will provide evidence data necessary to inform\n future guidelines regarding how best to treat this growing population of patients, and\n ultimately improve the patient's cardiac health and quality of life and reduce health-care\n costs.", + "Official_Title": "Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD", + "Keywords": "Coronary angiography,Coronary CT angiogram,ischemia,Non-obstructive CAD", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Ischemia,Aspirin,Atorvastatin Calcium,Rosuvastatin Calcium,Lisinopril,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Losartan", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03417388" + }, + { + "id": 44, + "user_id": 1811967433, + "ct_id": "NCT03909789", + "Study_Type": "Interventional", + "trial_name": "Effect of Inorganic Nitrate Supplement on Blood Pressure", + "condition": "Blood Pressure, Endothelial Dysfunction", + "intervention": "Plant based bioequivalent Nitrate supplementation;Placebo", + "phase": "Others", + "Role": "", + "enrollees": 67, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2017-11-17", + "End_Date": "2018-06-22", + "Min_Age": "40 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Matthew J Budoff", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Acute and Sustained Effects of Plant- Based Bio-Equivalent Nitrate Supplement Tablets on Blood Pressure Reduction, Nitric Oxide Mediated Endothelial Function and Saliva Bioconversion of Dietary Nitrate in Hypertensive Men and Women", + "Keywords": "endothelium", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03909789" + }, + { + "id": 45, + "user_id": 1811967433, + "ct_id": "NCT03253692", + "Study_Type": "Observational", + "trial_name": "Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)", + "condition": "Coronary Artery Disease, Coronary Disease, Myocardial Ischemia, Arterial Occlusive Diseases, Arteriosclerosis", + "intervention": "", + "phase": "", + "Role": "", + "enrollees": 36, + "trial sites": 1, + "sponsors": "National Heart, Lung, and Blood Institute (NHLBI)", + "status": "Completed", + "Start_Date": "2017-10-03", + "End_Date": "2018-10-11", + "Min_Age": "18 Years", + "Max_Age": "100 Years", + "Gender": "All", + "Investigators": "Marcus Y Chen, M.D.;", + "Collaborator": "", + "Purpose": "Background:\n\n CCTA is a common way to evaluate coronary artery disease. It stands for coronary computed\n tomography angiography. It uses scanning to look at the arteries that supply blood to the\n heart. It is noninvasive, widely available, and generally accurate. But it does expose people\n to radiation. Exposure to high amounts of radiation can increase a person s risk of getting\n cancer. Researchers want to learn more about the relationship between CCTA and radiation\n exposure.\n\n Objective:\n\n To see how much radiation is used to take pictures of the heart and how measures to reduce\n radiation are used around the world.\n\n Eligibility:\n\n People ages 18 years and older who need a computed tomography (CT) scan of the heart\n\n Design:\n\n Participants will be screened with a review of their medical records.\n\n Participants may have a pregnancy test.\n\n Participants will have the scheduled scan. Small, sticky discs will be placed on the chest. A\n small tube will be placed into a vein in the arm. A contrast material (dye) will be given\n through it. Participants will lie on the CT scanning table.\n\n A CCTA scan usually takes about 15 minutes if the heart rate is slow and steady.", + "Official_Title": "Prospective Multicenter Registry On Radiation Dose Estimates of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)", + "Keywords": "Cardiac computed tomography,Radiation,Iterative Reconstruction,Natural history", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Arteriosclerosis,Arterial Occlusive Diseases,Ischemia", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03253692" + }, + { + "id": 46, + "user_id": 1811967433, + "ct_id": "NCT03057977", + "Study_Type": "Interventional", + "trial_name": "EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)", + "condition": "Heart Failure", + "intervention": "Empagliflozin;Placebo", + "phase": "Phase 3", + "Role": "", + "enrollees": 3730, + "trial sites": 171, + "sponsors": "Boehringer Ingelheim", + "status": "Completed", + "Start_Date": "2017-03-06", + "End_Date": "2020-06-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Boehringer Ingelheim;Dy Johnny", + "Collaborator": "Eli Lilly and Company", + "Purpose": "The aim of the study is to investigate the safety and efficacy of empagliflozin versus\n placebo on top of guideline-directed medical therapy in patients with heart failure with\n reduced ejection fraction.", + "Official_Title": "Efficacy and Safety of Empagliflozin Compared to Placebo in Patients With Heart Failure With Reduced Ejection Fraction", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Empagliflozin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03057977" + }, + { + "id": 47, + "user_id": 1811967433, + "ct_id": "NCT03057951", + "Study_Type": "Interventional", + "trial_name": "EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)", + "condition": "Heart Failure", + "intervention": "Empagliflozin;Placebo", + "phase": "Phase 3", + "Role": "", + "enrollees": 5988, + "trial sites": 277, + "sponsors": "Boehringer Ingelheim", + "status": "Completed", + "Start_Date": "2017-03-02", + "End_Date": "2020-06-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Boehringer Ingelheim;Rajesh M Patel", + "Collaborator": "Eli Lilly and Company", + "Purpose": "The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on\n top of guideline-directed medical therapy in patients with heart failure with preserved\n ejection fraction", + "Official_Title": "A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Empagliflozin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03057951" + }, + { + "id": 48, + "user_id": 1811967433, + "ct_id": "NCT02926027", + "Study_Type": "Interventional", + "trial_name": "Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy", + "condition": "Hypertriglyceridemia", + "intervention": "Vascepa;Placebo", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 80, + "trial sites": 2, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2016-09-01", + "End_Date": "2019-09-01", + "Min_Age": "30 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff, MD;J B Muhlestein, MD;J B Muhlestein", + "Collaborator": "Intermountain Research and Medical Foundation", + "Purpose": "Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons with Elevated\n Triglycerides (200-499) on Statin Therapy. The study is to determine progression rates of low\n attenuation plaque under influence of Vascepa as compared to placebo.", + "Official_Title": "Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons With Elevated Triglycerides (200-499) on Statin Therapy", + "Keywords": "", + "MeSH_Terms": "Atherosclerosis,Hypertriglyceridemia,Coronary Artery Disease,Myocardial Ischemia,Eicosapentaenoic acid ethyl ester", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02926027" + }, + { + "id": 49, + "user_id": 1811967433, + "ct_id": "NCT03931434", + "Study_Type": "Interventional", + "trial_name": "Effect of Aged Garlic Extract (AGE) on Improving Coronary Atherosclerosis in People With Type 2 Diabetes Mellitus", + "condition": "Coronary Arteriosclerosis, Endothelial Dysfunction, Type 2 Diabetes Mellitus", + "intervention": "Aged Garlic Extract (AGE);Placebo", + "phase": "Others", + "Role": "", + "enrollees": 88, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2016-02-23", + "End_Date": "2018-05-07", + "Min_Age": "30 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Matthew J Budoff", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Effect of Aged Garlic Extract (AGE) on Progression of Coronary Atherosclerosis in Persons With Type 2 Diabetes Mellitus", + "Keywords": "coronary artery disease,endothelium", + "MeSH_Terms": "Atherosclerosis,Arteriosclerosis,Coronary Artery Disease,Myocardial Ischemia,Diabetes Mellitus,Diabetes Mellitus, Type 2", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03931434" + }, + { + "id": 50, + "user_id": 1811967433, + "ct_id": "NCT02376010", + "Study_Type": "Interventional", + "trial_name": "Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium", + "condition": "Atherosclerosis", + "intervention": "Rivaroxaban;Warfarin", + "phase": "Phase 4", + "Role": "", + "enrollees": 110, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2015-04-02", + "End_Date": "2018-04-01", + "Min_Age": "18 Years", + "Max_Age": "84 Years", + "Gender": "All", + "Investigators": "Matthew J Budoff", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium", + "Keywords": "Atherosclerosis,coronary artery disease,Cardiac CT,computed tomographic angiography", + "MeSH_Terms": "Atherosclerosis,Warfarin,Rivaroxaban,Calcium", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02376010" + }, + { + "id": 51, + "user_id": 1811967433, + "ct_id": "NCT02121288", + "Study_Type": "Interventional", + "trial_name": "Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients", + "condition": "Peripheral Artery Disease, Vascular Disease, Arterial Occlusion Disease, Intermittent Claudication, Ankle Brachial Index (0.9 or Less)", + "intervention": "Ticagrelor;Clopidogrel", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 0, + "trial sites": 0, + "sponsors": "AstraZeneca", + "status": "Withdrawn", + "Start_Date": "2014-12-01", + "End_Date": "2016-02-01", + "Min_Age": "18 Years", + "Max_Age": "59 Years", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Gabriel Vorobiof, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "The purpose of the study is to assess the effect of blood flow to the heart when subjects are\n treated with ticagrelor (Brilinta) or clopidogrel (antiplatelet drugs that stop the blood\n from clumping together) in patients with Peripheral Artery Disease (PAD).", + "Official_Title": "A Randomized, Open-Label, Parallel, Multi-Center, Phase IV Study to Assess the Effect of Ticagrelor vs Clopidogrel on Adenosine-Induced Myocardial Blood Flow in Peripheral Artery Disease (PAD)Patients", + "Keywords": "Peripheral Artery Disease,myocardial blood flow,Cardiac Blood Flow", + "MeSH_Terms": "Vascular Diseases,Intermittent Claudication,Peripheral Arterial Disease,Clopidogrel,Ticlopidine,Ticagrelor,Adenosine", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02121288" + }, + { + "id": 52, + "user_id": 1811967433, + "ct_id": "NCT02090075", + "Study_Type": "Interventional", + "trial_name": "Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque", + "condition": "Atrial Fibrillation", + "intervention": "Apixaban;Warfarin", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 66, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2014-09-01", + "End_Date": "2017-04-05", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "Vitamin K-antagonists (VKA) such as warfarin are the most widely used blood thinners for\n irregular heart beats like atrial fibrillation. Several lines of evidence indicate, however,\n that these agents also cause calcification of vessels (hardening of the vessels). Vascular\n calcification is one of the recently revealed side-effects of warfarin therapy. We will be\n randomizing 66 patients to either take warfarin or a new blood thinner that works without\n affecting vitamin k (apixaban). Patients will undergo blood testing and a CT angiogram\n (non-invasive angiogram) at the beginning of the study, and then be followed for one year\n with quarterly visits including blood tests and given either warfarin or vitamin K. After one\n year, they will undergo another CT angiogram and examination and blood tests and the effect\n of apixaban and warfarin are tested to look at plaque and changes over time. Patients will be\n consented in a private room and the risks and benefits will be explained. The risks include\n the CT angiogram and the possibility of either remaining on warfarin therapy for another year\n (standard of care) or taking a medicine that doesn't require monitoring (apixaban) for one\n year. The CT angiograms will require some contrast and some radiation dose, which will be\n minimized as much as possible. A cardiologist will be present during each CT angiogram to\n minimize risk and ensure patient safety.", + "Official_Title": "Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque", + "Keywords": "Cardiac computed tomography,coronary calcification,Intervention,Warfarin,Apixaban", + "MeSH_Terms": "Atrial Fibrillation,Calcinosis,Apixaban,Warfarin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02090075" + }, + { + "id": 53, + "user_id": 1811967433, + "ct_id": "NCT01534910", + "Study_Type": "Interventional", + "trial_name": "Effect of Aged Garlic Extract on Atherosclerosis", + "condition": "Metabolic Syndrome", + "intervention": "aged garlic extract;Placebo", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 65, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2012-05-01", + "End_Date": "2014-12-01", + "Min_Age": "40 Years", + "Max_Age": "65 Years", + "Gender": "All", + "Investigators": "Matthew Budoff, MD;Matthew J Budoff", + "Collaborator": "Wakunaga Pharmaceutical Co., Ltd.", + "Purpose": "The investigators will be assessing the effect of Aged Garlic Extract on the coronary\n arteries. The investigators will enroll patients in a double blind study, where half the\n patients will receive placebo, and have the patients undergo a series of tests of plaque (CT\n scan of the heart, carotid ultrasound) and follow the patients on the drug or placebo and\n then repeat the tests and blood work at the end of one year. The investigators will assess if\n being on aged garlic extract adds any benefit to plaque in the coronary or neck arteries. The\n investigators will also assess the effect of aged garlic extract on markers of inflammation.\n Patients will receive free drug, free testing and be compensated, and learn more about their\n heart and neck arteries. if successful, more patients can use this drug to benefit their\n health. The harms include the radiation from the CT scan and the medication, which has mild\n side effects.", + "Official_Title": "Effect of Aged Garlic Extract on Atherosclerosis", + "Keywords": "garlic,CT Angiography,Atherosclerosis,carotid IMT", + "MeSH_Terms": "Metabolic Syndrome X,Atherosclerosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01534910" + }, + { + "id": 54, + "user_id": 1811967433, + "ct_id": "NCT00860847", + "Study_Type": "Interventional", + "trial_name": "Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)", + "condition": "Coronary Atherosclerosis, Coronary Artery Calcification, Coronary Stenosis", + "intervention": "Aged garlic extract and Coenzyme Q10", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 65, + "trial sites": 1, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2009-05-01", + "End_Date": "2010-09-01", + "Min_Age": "35 Years", + "Max_Age": "84 Years", + "Gender": "Male", + "Investigators": "Matthew J Budoff, MD;Matthew J Budoff", + "Collaborator": "", + "Purpose": "1. Statement of Problem\n\n According to the National Fire Protection Association (NFPA), 43.7% of all firefighters\n that died on the job experienced sudden cardiac death. The job also affords an\n incredible amount of stress. Cholesterol therapy has been well demonstrated to reduce\n coronary plaque progression. However is certainly not the only factor in evaluating for\n progression of coronary artery disease (CAD), and other factors must play a role. Garlic\n therapy has been shown to retard atherosclerosis independently.\n\n 2. Hypothesis and Specific Aims The hypothesis of this proposal is: In comparison to the\n placebo group, Aged Garlic Extract (AGE) therapy + Coenzyme Q10 (CoQ10) will be\n effective in slowing progression of coronary artery calcification (CAC) in firefighters\n with established atherosclerosis, independent of baseline blood pressure, statin use or\n other cardiovascular risk factors.\n\n Specific Aims:\n\n 1. Compare the effects of cholesterol lowering effects in a firefighter population of\n patients under the influence of Aged Garlic Extract + CoQ10 or placebo.\n\n 2. Compare whether degree of change in atherosclerotic coronary artery plaque burden will\n change at a different rate under the influence of Aged Garlic Extract + CoQ10 compared\n to placebo treatment.\n\n 3. Compare whether Aged Garlic Extract + CoQ10 therapy induces changes in baseline values\n including biological and biochemical parameters, such as LDL cholesterol, homocysteine,\n C-reactive protein (CRP), and endothelial function.", + "Official_Title": "Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)", + "Keywords": "Progression of Atherosclerosis,Aged garlic extract,Biomarkers of inflammation,Coronary Plaque Volume and coronary Stenosis,Vascular Function", + "MeSH_Terms": "Heart Diseases,Atherosclerosis,Calcinosis,Coronary Stenosis,Coronary Artery Disease,Myocardial Ischemia,Coenzyme Q10,Ubiquinone", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00860847" + }, + { + "id": 55, + "user_id": 1811967433, + "ct_id": "NCT00486447", + "Study_Type": "Interventional", + "trial_name": "Perfusion Imaging and CT -Understanding Relative Efficacy", + "condition": "Coronary Artery Disease", + "intervention": "64 Channel VCT", + "phase": "Others", + "Role": "Study Chair", + "enrollees": 249, + "trial sites": 1, + "sponsors": "GE Healthcare", + "status": "Terminated", + "Start_Date": "2007-06-01", + "End_Date": "2009-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Matthew Budoff", + "Collaborator": "", + "Purpose": "To determine the relative efficacy of Cardiac Computed Tomography Angiography (CCTA) and\n Single Positron Emission Computed Tomography (SPECT) in patients with an intermediate risk of\n CAD.", + "Official_Title": "A Prospective Multi-center Study Comparing Cardiac Computed Tomography (CT) Using a 64-detector Row Volumetric Computed Tomography (VCT) Scanner for the Detection of Coronary Artery Disease With Cardiac Radionuclide Imaging.", + "Keywords": "", + "MeSH_Terms": "Coronary Artery Disease,Myocardial Ischemia,Coronary Disease", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00486447" + }, + { + "id": 56, + "user_id": 1811967433, + "ct_id": "NCT00154180", + "Study_Type": "Interventional", + "trial_name": "Kronos Early Estrogen Prevention Study (KEEPS)", + "condition": "Menopause, Arteriosclerosis", + "intervention": "Conjugated equine estrogens 0.45 mg/day;Transdermal estradiol, 50 mcg/day;Micronized progesterone, 200 mg/day x 12 d/month;CEE , progesterone, estradiol patch or placebo for each;CEE, progesterone, transdermal patch or the placebo", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 728, + "trial sites": 9, + "sponsors": "Kronos Longevity Research Institute", + "status": "Unknown status", + "Start_Date": "2005-09-01", + "End_Date": "2012-07-01", + "Min_Age": "42 Years", + "Max_Age": "58 Years", + "Gender": "Female", + "Investigators": "S Mitchell Harman, MD, PhD;Frederick Naftolin, MD, PhD;Michael Mendelsohn, MD;Howard Hodis, MD;Matthew Budoff, MD;Sanjay Asthana, MD;Dennis M Black, PhD;Matthew J Budoff", + "Collaborator": "Albert Einstein College of Medicine,Brigham and Women's Hospital,Columbia University,Mayo Clinic,University of California, San Francisco,University of Utah,University of Washington,Yale University", + "Purpose": "The study will examine the effects of estrogen and progesterone on the development of\n atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the\n menopausal transition.", + "Official_Title": "Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women", + "Keywords": "Perimenopause,Coronary disease,Estrogen Replacement Therapy,hormone replacement therapy", + "MeSH_Terms": "Arteriosclerosis,Estradiol,Polyestradiol phosphate,Estrogens,Estrogens, Conjugated (USP),Progesterone,Estradiol 3-benzoate,Estradiol 17 beta-cypionate,Estradiol valerate", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00154180" + }, + { + "id": 57, + "user_id": 1811967433, + "ct_id": "NCT00065780", + "Study_Type": "Observational", + "trial_name": "Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA", + "condition": "Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Arteriosclerosis", + "intervention": "", + "phase": "", + "Role": "", + "enrollees": 6814, + "trial sites": 0, + "sponsors": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", + "status": "Completed", + "Start_Date": "2003-08-01", + "End_Date": "2008-07-01", + "Min_Age": "45 Years", + "Max_Age": "84 Years", + "Gender": "All", + "Investigators": "Matthew J Budoff", + "Collaborator": "National Heart, Lung, and Blood Institute (NHLBI)", + "Purpose": "", + "Official_Title": "", + "Keywords": "", + "MeSH_Terms": "Cardiovascular Diseases,Heart Diseases,Atherosclerosis,Arteriosclerosis,Coronary Artery Disease,Myocardial Ischemia", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00065780" + }, + { + "id": 58, + "user_id": 1811967433, + "ct_id": "NCT00005487", + "Study_Type": "Observational", + "trial_name": "Multi-Ethnic Study of Atherosclerosis (MESA)", + "condition": "Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Artery Disease, Coronary Disease, Stroke, Myocardial Infarction, Heart Failure, Diabetes Mellitus, Type 2, Hypertension, Diabetes Mellitus", + "intervention": "", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 6418, + "trial sites": 0, + "sponsors": "National Heart, Lung, and Blood Institute (NHLBI)", + "status": "Active, not recruiting", + "Start_Date": "1999-01-01", + "End_Date": "2009-06-01", + "Min_Age": "45 Years", + "Max_Age": "84 Years", + "Gender": "All", + "Investigators": "David Bluemke;Gregory Burke;Aaron Folsom;Richard Kronmal;Kiang Liu;Daniel O'Leary;Steven Shea;Moyses Szklo;Russell Tracy;Matthew Budoff;Karol Watson", + "Collaborator": "", + "Purpose": "To conduct a prospective observational study of the characteristics of subclinical\n cardiovascular disease (disease detected non-invasively before it has produced signs and\n symptoms) that predict progression to clinically overt cardiovascular disease in a diverse\n and representative population-based sample of men and women aged 35-84. Specifically the\n study shall: determine characteristics related to progression of subclinical to clinical\n cardiovascular disease; identify factors related to newer measures of subclinical disease and\n examine relationship of new to established measures; and develop population-based methods,\n suitable for application in future screening and intervention studies, for identifying\n asymptomatic persons at highest risk of clinical events.", + "Official_Title": "Multi-Ethnic Study of Atherosclerosis (MESA)", + "Keywords": "coronary arteriosclerosis,Cerebrovascular Accident,Heart Failure, Congestive,Diabetes Mellitus, Non-Insulin Dependent", + "MeSH_Terms": "Diabetes Mellitus,Heart Failure,Infarction,Cardiovascular Diseases,Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Heart Diseases,Myocardial Infarction,Diabetes Mellitus, Type 2,Atherosclerosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00005487" + }, + { + "id": 59, + "user_id": 1497893077, + "ct_id": "NCT04482062", + "Study_Type": "Interventional", + "trial_name": "TRISCEND II Pivotal Trial", + "condition": "Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure", + "intervention": "Edwards EVOQUE System;optimal medical therapy", + "phase": "Others", + "Role": "", + "enrollees": 1070, + "trial sites": 65, + "sponsors": "Edwards Lifesciences", + "status": "Recruiting", + "Start_Date": "2021-04-09", + "End_Date": "2029-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Rebecca Hahn, MD;Susheel Kodali, MD;Philipp Lurz, MD;Vinod Thourani, MD;Hursh Naik, MD;Thomas Waggoner, DO;Curtiss Stinis, MD;Raj Makkar, MD;Gagan Singh, MD;Andrew Rassi, MD;Sammy Elmariah, MD;Rahul P Sharma, MBBS;Marcos Nores, MD;Charles Klodell, MD;Robert Cubeddu, MD;Vasilis Babaliaros, MD;Pradeep Yadav, MD;Charles Davidson, MD;James Hermiller, MD;Peter Tadros, MD;Bassem Chehab;Bradley Taylor, MD;Ignacio Inglessis, MD;Pinak B Shah, MD;Roger Laham, MD;Gorav Ailawadi, MD;Stanley Chetcuti, MD;Brian P. O'Neill, MD;Mackram Eleid, MD;Adnan Chhatriwalla, MD;Robert Kipperman, MD;Mark Russo, MD;M. Azeem Latib, MD;Vijay Iyer, MD;Bruce Rutkin, MD;Mathew Williams, MD;Cezar S. Staniloae, MD;Mark Reisman, MD;George A Petrossian, MD;John Paul Vavalle, MD;Mike Rinaldi, MD;Joseph Choo, MD;Samir Kapadia, MD;Kamran Muhammad, MD;Firas Zahr, MD;Scott Chadderdon, MD;Howard Hermann, MD;William Gray, MD;Michael Morse, MD;Colin Barker, MD;Brian Lindman, MD;Pranav Loyalka, MD;Abhijeet Dhoble, MD;Robert Smith, MD;Molly Szerlip, MD;Brian Whisenant, MD;Scott Lim, MD;Paul Mahoney, MD;Ming Zhang, MD;Sameer Gafoor, MD;James McCabe, MD;", + "Collaborator": "", + "Purpose": "Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve\n replacement system", + "Official_Title": "Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device", + "Keywords": "", + "MeSH_Terms": "Cardiovascular Diseases,Heart Valve Diseases,Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04482062" + }, + { + "id": 60, + "user_id": 1497893077, + "ct_id": "NCT04221490", + "Study_Type": "Interventional", + "trial_name": "2019-06 TRISCEND Study", + "condition": "Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases", + "intervention": "Transcatheter Tricuspid Valve Replacement", + "phase": "Others", + "Role": "", + "enrollees": 200, + "trial sites": 25, + "sponsors": "Edwards Lifesciences", + "status": "Recruiting", + "Start_Date": "2020-05-06", + "End_Date": "2025-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Susheel Kodali, MD;Josep Rodés-Cabau, MD;", + "Collaborator": "", + "Purpose": "Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE\n Tricuspid Valve Replacement System", + "Official_Title": "Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device", + "Keywords": "Tricuspid regurgitation,Transcatheter,replacement,Functional,Degenerative,Regurgitation,valve replacement,cardiovascular disease", + "MeSH_Terms": "Cardiovascular Diseases,Heart Valve Diseases,Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04221490" + }, + { + "id": 61, + "user_id": 1497893077, + "ct_id": "NCT04097145", + "Study_Type": "Interventional", + "trial_name": "Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial", + "condition": "Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease", + "intervention": "Edwards PASCAL System;optimal medical therapy", + "phase": "Others", + "Role": "", + "enrollees": 870, + "trial sites": 44, + "sponsors": "Edwards Lifesciences", + "status": "Recruiting", + "Start_Date": "2019-12-11", + "End_Date": "2027-03-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Marcella Press, MD;Olcay Aksoy, MD;Jeannette Lin, MD;Eric Yang, MD;Gabriel Vorobiof, MD;Parntip Lai, NP;Richard Shemin, MD;Peyman Benharash, MD;Gentian Lluri, MD;Ali Nsair, MD;Jamil Aboulhosn, MD;Andrew Rassi, MD;Jacob Mishell, MD;Ahmad Sheikh, MD;David Lange, MD;Gordon Leung, MD;Ivy Ku, MD;Jana Svetlichnaya, MD;Jonathan Zaroff, MD;Van Selby, MD;Timothy Lee, MD;Rahul Sharma, MD;David P. Lee, MD;Jack Boyd, MD;Christiane Haeffele, MD;Shirin Jimenez, MD;David H. Liang, MD;Mirela Tuzovic, MD;John W. MacArthur, MD;Mohamad Lazkani, MD;Brad Oldemeyer, MD;Stephen Treat, MD;Justin Strote, MD;Tristan Dow, MD;Lance Richards, MD;Hao Pan, MD;Mark Guadagnoli, MD;Charles Klodell, MD;Ilie Barb, MD;Ann Tong, MD;Catherine Wong, PA;Thomas Zeyl, MD;William Smith, MD;Kimberly Frye, PA-C;Aubrey Hall, ARNP;Heather Reed, MD;Jessica Perry, PA;Nirat Beohar, MD;Steve Xydas, MD;Jorge Fuentes, MD;Angelo LaPietra, MD;Christos Mihos, DO;Esteban Escolar, MD;Steven Debeer, MD;Ivan Arenas, MD;Mark Larralde, MD;Robert Cubeddu, MD;Brian Solomon, MD;David Axline, MD;Randolph Panetta, MD;Adam Greenbaum, MD;Chandan Devireddy, MD;Divya Gupta, MD;Gaetano Paone, MD;George Hanzel, MD;Isida Byku, MD;Jeffrey Miller, MD;Kendra Grubb, MD;Lucia Alvarez, MD;Patrick Gleason, MD;Robert Guyton, MD;Steven Macheers, MD;Vasilis Babaliaros, MD;Charles Davidson, MD;S. Chris Malaisrie, MD;James Hermiller, MD;David Heimansohn, MD;Sina Moainie, MD;Ashwin Ravichandran, MD;Andrew Sampson, MD;Emily Wandel;Lucas Mitchel, MD;Douglas Segar, MD;Frank Green, MD;Rafael Garcia-Cortes, MD;Benjamin Havens, MD;Sidakpal Panaich, MD;Mohammad Bashir, MD;Linda Cadaret, MD;Phillip A. Horwitz, MD;Sharon B. Larson, DO;Anthony Panos, MD;James D. Rossen, MD;Ernesto Ruiz Duque, MD;Arun Singhal, MD;Kimberly Staffey, MD;Ramzi El Accaoui, MD;J. Stephen Jenkins, MD;Clement Eiswirth, MD;Homeyar Dinshaw, MD;Joseph Englert, MD;Merrill Stewart, MD;Michael Cash, MD;Patrick Parrino, MD;Salima Qamruddin, MD;Sapna Desai, MD;Selim Krim, MD;Stephen Ramee, MD;Stephen Spindel, MD;Yvonne Gililland, MD;Isabelle Hatfield, PA;Jose T. Soto, MD;Sammy Elmariah, MD, MPH;Ignacio Inglessis, MD;Rahul Sakhuja, MD;Arminder Jassar, MBBS;Nathaniel Langer, MD;Jacob Dal-Bianco, MD;Evin Yucel, MD;Erin Coglianese, MD;Dhaval Kolte, MBBS, PhD;Jonathan Passeri, MD;Stanley Chetcuti, MD;Steven Bolling, MD;Daniel Menees, MD;Matthew Romano, MD;Neal Duggal, MD;Abbas Bitar, MD;Andrew Harris, MD;Gorav Ailawadi, MD;Megan Joseph, MD;William O' Neill, MD;Tiberio Frisoli, MD;Dee Dee Wang, MD;James Lee, MD;Pedro Villablanca, MD;Brian O' Neill, MD;Mudassar Ahmed, MD;Marat Yanavitski, MD;Stephen Huddleston, MD;Mitchell Timmons, DO;Justin Halbe, MD;Terrie-Ann Benjamin, MD;Mackram Eleid, MD;Mayra Guerrero, MD;Mohamad Aikhouli, MD;Sorin Pislaru, MD;Sunil Mankad, MD;Jeremy Thaden, MD;Charanjit Rihal, MD;John Stulak, MD;Grace Lin, MD;Ratnasari \"Sari\" Padang, MD;Vuyisile Nkomo, MD;Hector Michelena, MD;Lawrence Sinak, MD;Adnan Chhatriwalla, MD;Anthony Magalski, MD;Bethany Austin, MD;Chetan Huded, MD;David Skolnick, MD;J. Russell Davis, MD;John Saxon, MD;Keith Allen, MD;Michael Main, MD;Taiyeb Khumri, MD;James Maddux, MD;Daniel Spoon, MD;Michael Young, MD;Alexander Iribarne, MD;Gregory Dadekian, MD;Lauren Gilstrap, MD;Shawn Ahmad, MD;Susan P. D'Anna, APRN;James DeVries, MD;Kerrilynn Hennessey, MD;Robert Kipperman, MD;Philippe Genereux, MD;Konstantinos Koulogiannis, MD;Leo Marcoff, MD;James Slater, MD;Chris Magovern, MD;Bledi Zaku, MD;Abhishek Singh, MD;John Brown, MD;Mark Russo, MD;Abdul Hakeem, MD;Ankur Sethi, MD;Antonio Chiricolo, MD;Bruce Haik, MD;Chunguang Chen, MD;Deepa Iyer, MD;Ashok Chaudhary, MD;Mohamed A. Latib, MD;Edwin Ho, MD;Mei Chau, MD;Ulrich Jorde, MD;Ythan Goldberg, MD;Sandhya Murthy, MD;James Doolittle, PA;Vijay Iyer, MD, PhD;Thomas Cimato, MD;Stanley Fernandez, MD;Eileen Daetsch, RN, MS, ANP;Hashmat M. Ashraf, MD;Susan Graham, MD;Susheel Kodali, MD;Rebecca Hahn, MD;Isaac George, MD;Melana Yuzefpolskaya, MD;Shing Chiu Wong, MD;Geoffrey Bergman, MBBS;Irina Sobol, MD;Stephanie Mick, MD;Evelyn Horn, MD;Jennifer Jantz, MD;Jennifer Chen, MD;Mark Reisman, MD;David Majure, MD;Erin Iannacone, MD;Richard Devereux, MD;Maria Karas, MD;Udhay Krishnan, MD;Jiwon Kim, MD;Robert Minutello, MD;Chad Kliger, MD;Nirav C. Patel, MD;Luigi Pirelli, MD;Priti Mehla, MD;Gerin Stevens, MD;Biana Trost, MD;Craig Basman, MD;Sirish Vullaganti, MD;Jeremiah Depta, MD;Bipul Baibhav, MD;David Corteville, MD;Deyanira Prastine, MD;Konstantine Tzimas, MD;George A. Petrossian, MD;Newell B. Robinson, MD;William Chung, MD;Rita Jermyn, MD;Lin Wang, MD;Aman M. Shah, MD;Thomas Haldis, DO;Cornelius Dyke, MD;Carlos Miranda, MD;Ismail Bekdash, MD;Heeraimangalore Manjunath, MD;Jill Hankey, PA;Konstantinos Boudoulas, MD;Scott Lilly, MD;Ajay Vallakati, MD;Asvin Ganapathi, MD;Bryan Whitson, MD;David Orsinelli, MD;Jovan Bozinovski, MD;Nahush Mokadam, MD;Sitaramesh Emani, MD;Susan O'Neil, NP;Thura Harfi, MD;Mohammad Ghani, MD;Jeffrey Garrett, MD;John M. Williams, MD;Nicole Tran, MD;Pamela Craven, MD;R. Mark Bodenhamer, MD;Varun Khanna, MD;Kamran Muhammad, MD;Ajit Tharakan, MD;Georgianne Tokarchik, APRN-CNS;John Tulloch, MD;Mathew Good, DO;Michael Phillips, MD;Wayne Leimbach, MD;Firas Zahr, MD;Scott Chadderdon, MD;Howard Song, MD;Johannes Steiner, MD;Harsh Golwala, MD;Katherine Rajotte, MPAS, PA-C;Stephanie Khouw, NP;Mubashir Mumtaz, MD;Hemal Gada, MD;Atizazul Mansoor, MD;Roberto Hodara, MD;Brian Corbally, DO;Amit Vora, MD;David Loran, MD;William Gray, MD;Basel Ramlawi, MD;Christopher Droogan, DO;Eric Gnall, DO;Katie Hawthorne, MD;Paul Coady, MD;Sandra Abramson, MD;Scott Goldman, MD;Roberto Rodriguez, MD;Steven Domsky, MD;Colin Barker, MD;Brian R. Lindman, MD;Kashish Goel, MD;Holly Gonzales, MD;Kelly Schlendorf, MD;Melissa Levack, MD;Michael Baker, MD;Jordan Hoffman, MD;Tarek Absi, MD;Mias Pretorius, MD;Ashish Shah, MD;Pranav Loyalka, MD;Eyal Porat, MD;Abdul H. Chaugle, MD;Stephanie Coulter, MD;Joggy George, MD;Guilherme Silva, MD;Leo Simpson, MD;Srikanth Koneru, MD;Kenneth Liao, MD;Joseph Coselli, MD;Vicente Orozco-Sevilla, MD;Alexis Shafii, MD;Abhijeet Dhoble, MD;Richard Smalling, MD;Enrique Garcia-Sayan, MD;Anthony Estrera, MD;Konstantinos Charitakis, MD;Deepa Raghunathan, MD;Biswajit Kar, MD;Igor Gregoric, MD;Manish Patel, MD;Marwan Jumean, MD;Sachin Kumar, MD;Sriram Nathan, MD;Sukhdeep Basra, MD;Angelo Nascimbene, MD;Robert L. Smith, MD;Molly Szerlip, MD;Paul Grayburn, MD;Karim Al-Azizi, MD;Sameh Sayfo, MD;Timothy George, MD;Kelley Hutcheson, MD;Zuyue Wang, MD;Aasim Afzal, MD;Scott Lim, MD;Sula Mazimba, MD;Nishtha Sodhi, MD;Josep Rodés-Cabau, MD;Kim O'Connor, MD;Élisabeth Bédard, MD;Jonathan Beaudoin, MD;Francois Dagenais, MD;Mathieu Bernier, MD;Erwan Salaun, MD;Puthumana Jyothy", + "Collaborator": "", + "Purpose": "To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System\n in patients with symptomatic severe tricuspid regurgitation who have been determined to be at\n an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the\n cardiac surgeon with concurrence by the local Heart Team", + "Official_Title": "A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation", + "Keywords": "", + "MeSH_Terms": "Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04097145" + }, + { + "id": 62, + "user_id": 1497893077, + "ct_id": "NCT03745313", + "Study_Type": "Interventional", + "trial_name": "Edwards CLASP TR EFS", + "condition": "Tricuspid Regurgitation", + "intervention": "Transcatheter Tricuspid Valve Repair", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 65, + "trial sites": 9, + "sponsors": "Edwards Lifesciences", + "status": "Active, not recruiting", + "Start_Date": "2019-02-05", + "End_Date": "2025-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Susheel K. Kodali, MD;Adam Greenbaum, MD;Vasilis Babaliaros, MD;Kendra Grubb, MD;Patrick Gleason, MD;Chandan Deveriddy, MD;Charles Davidson, MD;Mark Ricciardi, MD;Akhil Narang, MD;Allen Anderson, MD;Chris Malaisrie, MD;Mackram Eleid, MD;Mayra Guerrero, MD;Grace Lin, MD;Sorin Pislaru, MD;Sunil Mankad, MD;John Stulak, MD;Chet Rihal, MD;Robert Kipperman, MD;Philippe Genereux, MD;John Brown, MD;Chris Magovern, MD;James Slater, MD;Leo Marcoff, MD;Konstantinos Koulogiannis, MD;Marc Goldschmidt, MD;Susheel K Kodali, MD;Maritn B Leon, MD;Rebecca Hahn, MD;Omar Khalique, MD;Firas Zahr, MD;Scott Chadderdon, MD;Howard Song, MD;Johannes Steiner, MD;Katherine Rajotte;Stephanie Khouw;William Gray, MD;Scott Goldman, MD;Katie Hawthorne, MD;Sandra Abramson, MD;Steven Domsky, MD;Paul Coady, MD;Roberto Rodriguez, MD;Eric Gnall, MD;Christopher Droogan, MD;Robert Smith, MD;Molly Szerlip, MD;Timothy George, MD;Paul Grayburn, MD;Kelley Hutcheson, MD;Sameh Sayfo, MD;Scott Lim, MD;Gorav Ailawadi, MD;Sula Mazimba, MD;Sayfo Sameh", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study", + "Keywords": "Functional,TR,FTR,Transcatheter,repair,Regurgitation,Degenerative", + "MeSH_Terms": "Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03745313" + }, + { + "id": 63, + "user_id": 1497893077, + "ct_id": "NCT03706833", + "Study_Type": "Interventional", + "trial_name": "Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial", + "condition": "Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation", + "intervention": "Edwards PASCAL System;Abbott Mitraclip System", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 1247, + "trial sites": 43, + "sponsors": "Edwards Lifesciences", + "status": "Recruiting", + "Start_Date": "2018-11-30", + "End_Date": "2028-01-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Scott Lim, MD;Robert Smith, MD;Linda Gillam, MD;Jeff Popma, MD;Vinod Thourani, MD;Paul Grayburn, MD;Raj Makkar, MD;Alfredo Trento, MD;Mamoo Nakamura, MD;Danny Ramzy, MD;Tarun Chakravarty, MD;Wen Cheng, MD;Moody Makar, MD;Siddharth Singh, MD;Christian Spies, MD;Devin Kehl, MD;David Daniels, MD;Mitul Kadakia, MD;James Lai, MD;Brett Sheridan, MD;Conrad Vial, MD;Tomomi Oka, MD;Russel Stanten, MD;Andrew Rassi, MD;Jacob Mishell, MD;Vic Melikian, MD;Gordon Leung, MD;Ivy Ku, MD;David Lange, MD;Jonathan Zaroff, MD;Ahmad Sheikh, MD;William Hiesinger, MD;David Lee, MD;Jack Boyd, MD;Rahul Sharma, MD;David Liang, MD;William Fearon, MD;Albert Cheung, MD;John Carroll, MD;Joseph Cleveland, MD;Andreas Brieke, MD;Edward Gill, MD;Robert Quaife, MD;Mohamad Lazkani, MD;Justin Strote, MD;Mark Douthit, MD;Tristan Dow, MD;C. Patrick Green, MD;Mark Guadagnoli, MD;Satish Chacko, MD;J. Bradley Oldemeyer, MD;Stephen Treat, MD;Lowell Satler, MD;Ron Waksman, MD;Istik Ben-dor, MD;Toby Rogers, MD;Christian Shults, MD;Kevin Accola, MD;Jose Arias, MD;Phillip Anderson, MD;Nipun Arora, MD;Adam Greenbaum, MD;Vasilis Babaliaros, MD;Kendra Grubb, MD;Patrick Gleason, MD;Chandan Deveriddy, MD;Mark Ricciardi, MD;Charles Davidson, MD;S. Chris Malaisrie, MD;Duc Thinh Pham, MD;Andrei Churyla, MD;James Thomas, MD;Jyothy Puthumana, MD;Anhil Narang, MD;James B Hermiller, MD;Andrew Sampson, MD;Sina Moainie, MD;David Heimansohn, MD;Bassem M Chehab, MD;Brett E Grizzell, MD;Pinak Shah, MD;Tsuyoshi Kaneko, MD;Roger Laham, MD;Kamal Khabbaz, MD;David C Lui, MD;Senthil Nathan, MD;Louis Chu, MD;Eli Gelfand, MD;Duane Pinto, MD;Jeffrey Popma, MD;James Chang, MD;Marie France Poulin, MD;Feroze Mahmood, MD;William O'Neill, MD;Marvin Eng, MD;Tiberio Frisoli, MD;Dee Dee Wang, MD;James Lee, MD;Hassan Nemeh, MD;Raed Alnajjar, MD;Mayra Guerrero, MD;Guy Reeder, MD;Charanjit Rihal, MD;Ratnasari Padang, MD;Juan Crestanello, MD;Adnan Chhatriwalla, MD;Keith Allen, MD;David Skolnick, MD;V. Erick Thompson, MD;Bethany Austin, MD;John Saxon, MD;Kenneth Huber, MD;Anthony Magalski, MD;Michael Main, MD;A. Michael Borkon, MD;J. Russell Davis, MD;Robert Kipperman, MD;Philippe Genereux, MD;John Brown, MD;Mathew Williams, MD;Cezar Staniloae, MD;Homam Ibrahim, MD;Susheel Kodali;Tamim Nazif;Isaac George;Vinayak Bapat;Torsten Vahl;Vivian Ng;Rebecca Hahn;Amisha Patel;Omar Khalique;Chad A Kliger, MD;S. Jacob Scheinerman, MD;Nirav C Patel, MD;Luigi Pirelli, MD;Itzhak Kronzon, MD;Prihi Mehla, MD;George A Petrossian, MD;Newell B Robinson, MD;Andrew D Berke, MD;William Chung, MD;Lin Wang, MD;Michael Rinaldi, MD;Jonathan Schwartz, MD;Troy Leo, MD;Eric Skipper, MD;Sanjeev Gulati, MD;Joseph Mishkin, MD;Geoffrey Rose, MD;Theodore Frank, MD;Markus Scherer, MD;Ian Sarembock, MD;Mario Castillo-Sang, MD;Joseph Choo, MD;Sayta Shreenivas, MD;Terri Stewart-Dehner, MD;Samir Kapadia, MD;Leonard Rodriguez, MD;James Yun, MD;Rhonda Miyasaka, MD;Serge Harb, MD;Amar Krishnaswamy, MD;Konstantinos Boudoulas, MD;Scott Lily, MD;Gregory Rushing, MD;David Orsinelli, MD;Thura Harfi, MD;Susan O'Neil, MD;Robert W Hodson, MD;Eric Kirker, MD;Ethan Korngold, MD;Brandon Jones, MD;Geoff Wilson, MD;Craig Walsh, MD;Firas Zahr, MD;Howard Song, MD, PhD;Scott Chadderdon, MD;Kate Rajotte, PA-C;Kellie Graham, NP;Howard Herrmann, MD;Wilson Szeto, MD;Mubashir Mumtaz, MD;Hemal Gada, MD;Amit Vora, MD;David Loran, MD;Nikhil Jaik, MD;Atizazul Mansoor, MD;Roberto Hodara, MD;Scott Goldman, MD;William Gray, MD;Roberto Rodriguez, MD;Paul Coady, MD;Sandra Abramson, MD;Katie Hawthorne, MD;John Riddick, MD;Sreekumar Subramanian, MD;Thomas McRae, MD;Thomas Johnston, MD;David Huneycutt, MD;Samuel Horr, MD;Andrew Goodman, MD;Parag Patel, MD;Michael A Morse, MD;Evelio Rodriguez, MD;Wilson E Kemp, MD;John B Biglane, MD;Andrew Zurick, MD;Sasan Raissi, MD;Bruce Bowers, MD;Todd Dewey, MD;Pranav Loyalka, MD;Abdul Hannan-Chaugle, MD;Carlos Encarnacion, MD;Eyal Porat, MD;Stephanie Coulter, MD;Neal Kleiman, MD;Michael Reardon, MD;Nadeen Faza, MD;Apurva Patel, MD;Manuel Reyes, MD;Marvin Atkins, MD;Abhijeet Dhoble, MD;Richard W Smalling, MD, PhD;Enrique Garcia-Sayan, MD;Tom C Nguyen, MD;Anthony Estrera, MD;Robert L Smith, MD;Molly Szerlip, MD;Timothy George, MD;Sameh Sayfo, MD;Brian K Whisenant, MD;James Harkness, MD;Kent Jones, MD;Stephen Clayson, MD;David Scott Lim, MD;Gorav Ailawadi, MD;Paul Mahoney, MD;David Adler, MD;Joseph Newton, MD;Mark Reisman, MD;Gabriel Aldea, MD;Todd Zwink, MD;Georg Mackensen, MD;Robert Boone, MD;John Webb, MD;Mustafa Toma, MD;Jian Ye, MD;Abdullah Alkhadair, MD;Mark Hensey, MD;Robert Moss, MD;Arora Nipun;Scott Lim, MD;Robert Smith, MD;Linda Gillam, MD;Vinod Thourani, MD;Paul Grayburn, MD;Brian K Whisenant, MD;Jörg Hausleiter, MD;Ralph Stephan von Bardeleben, MD;Mustafa Ahmed, MD;Andrew Lenneman, MD;Panayotis Vardas, MD;Marvin Eng, MD;Prakash Balan, MD;Philip Gideon, MD;Nickalaus Gramze, MD;Timothy Byrne, MD;Akil Loli, MD;Merick Kirshner, MD;Robert Shull, MD;Thomas Waggoner, DO;Neil Gheewala, MD;Nader Makki, MD;Gregory Franklin, MD;Kushagra Katariya, MD;Steven Burstein, MD;Bruce Macrum, MD;Joe Rahman, MD;Raj Makkar, MD;Alfredo Trento, MD;Mamoo Nakamura, MD;Danny Ramzy, MD;Tarun Chakravarty, MD;Wen Cheng, MD;Moody Makar, MD;Siddharth Singh, MD;Aidan Raney, MD;Thomas Kim, MD;Taylor Tang, MD;Erum Bajwa, MD;Brian Kolski, MD;Pei-Hsiu Huang, MD;Michael Ingram, MD;David Roberts, MD;Zi-Jian Xu, MD;Gurpreet Sodhi, MD;Richard Ericson, MD;Matthew Price, MD;Stephen Romero, MD;Scot Brewster, MD;Sam Baradarian, MD;Ashish Rastogi, MD;Federico De Puy, MD;John Tyner, MD;Ajay Srivastava, MD;Rajeev Mohan, MD;Thomas Heywood, MD;Jessica Funk, MD;Christian Spies, MD;Devin Kehl, MD;David Daniels, MD;Mitul Kadakia, MD;James Lai, MD;Brett Sheridan, MD;Conrad Vial, MD;Tomomi Oka, MD;Russel Stanten, MD;Andrew Rassi, MD;Jacob Mishell, MD;Vic Melikian, MD;Gordon Leung, MD;Ivy Ku, MD;David Lange, MD;Jonathan Zaroff, MD;Ahmad Sheikh, MD;William Hiesinger, MD;David Lee, MD;Jack Boyd, MD;Rahul Sharma, MD;David Liang, MD;William Fearon, MD;Albert Cheung, MD;Saibal Kar, MD;David Aliabadi, MD;Philip Faraci, MD;Gregory Fontana, MD;Dustin Lloyd, MD;Andrew Gohbrial, MD;Vishva Dev, MD;Steven Voskanian, MD;John Carroll, MD;Joseph Cleveland, MD;Andreas Brieke, MD;Edward Gill, MD;Robert Quaife, MD;David Fullerton, MD;Aken Desai, MD;Mohamad Lazkani, MD;Justin Strote, MD;Mark Douthit, MD;Tristan Dow, MD;C. Patrick Green, MD;Mark Guadagnoli, MD;Satish Chacko, MD;J. Bradley Oldemeyer, MD;Stephen Treat, MD;Lowell Satler, MD;Ron Waksman, MD;Istik Ben-dor, MD;Toby Rogers, MD;Preetham Kumar, MD;Brian Forrestal, MD;Patrick Bering, MD;Michael Slack, MD;Charles Klodell, MD;Ilie Barb, MD;Ann Tong, MD;Heather Reed, MD;William Brit-Smith, MD;Aubrey Hall, APRN;Jessica Perry, PA;Angela Rivera, PA;Thomas Zeyl, MD;Kelly Chewning, APRN;Nirat Beohar, MD;Steve Xydas, MD;Ivan Arenas, MD;Mark Larralde, MD;Christos Mihos, MD;Esteban Escolar, MD;Pradeep Yadavs, MD;James Kauten, MD;W. Morris Brown, MD;Vivek Rajagopal, MD;Christopher Meduri, MD;Benjamin DeMoss, MD;Peter Flueckiger, MD;Sara Mobasseri, MD;Venkateshwar Polsani, MD;Hassan Sayegh, MD;Mani Vannan, MD;Vibhav Rangarajan, MD;Roshin Mathew, MD;Ramona Davis, PA;Amy Simone, PA;Adam Greenbaum, MD;Vasilis Babaliaros, MD;Kendra Grubb, MD;Patrick Gleason, MD;Chandan Deveriddy, MD;Charles Davidson, MD;S. Chris Malaisrie, MD;Duc Thinh Pham, MD;Andrei Churyla, MD;James Thomas, MD;Jyothy Puthumana, MD;Akhil Narang, MD;James B Hermiller, MD;Andrew Sampson, MD;Sina Moainie, MD;David Heimansohn, MD;Sidakpal Panaich, MD;Phillip A Horwitz, MD;James D Rossen, MD;Linda Cadaret, MD;Ernesto Ruiz Duque, MD;Ramzi El Accaoui, MD;Mohammad Bashir, MD;Anthony Panos, MD;Kimberly Staffey, MD;Stephen Jenkins, MD;Stephen Ramee, MD;Clement Eiswirth, MD;Stephen Spindel, MD;Selim Krim, MD;Hamang Patel, MD;Hector Ventura, MD;Patrick Parrino, MD;Stacy Mandras, MD;Ignacio Inglessis-Azuaje, MD;Sammy Elmariah, MD;Rahul Sakhuja, MD;Igor Palacios, MD;Arminder Jassar, MD;Nathaniel Langer, MD;Jonathan Passeri, MD;Jacob Dal-Bianco, MD;Evin Yucel, MD;Gregory Lewis, MD;William Carlson, MD;Erin Coglianese, MD;Sunu Thomas, MD;Nasrien Ibrahim, MD;Pinak Shah, MD;Tsuyoshi Kaneko, MD;Roger Laham, MD;Kamal Khabbaz, MD;David C Lui, MD;Senthil Nathan, MD;Louis Chu, MD;Eli Gelfand, MD;Duane Pinto, MD;James Chang, MD;Marie France Poulin, MD;Feroze Mahmood, MD;Stanley Chetcuti, MD;Steven Bolling, MD;Daniel Menees, MD;Matthew Romano, MD;Neal Duggal, MD;Abbas Bitar, MD;Troy LaBounty, MD;William O'Neill, MD;Tiberio Frisoli, MD;Dee Dee Wang, MD;James Lee, MD;Hassan Nemeh, MD;Raed Alnajjar, MD;Mudassar Ahmed, MD;Marat Yanavitski, MD;Stephen Huddleston, MD;Mitchell Timmons, MD;Terrie-Ann Benjamin, MD;Mayra Guerrero, MD;Guy Reeder, MD;Charanjit Rihal, MD;Ratnasari Padang, MD;Juan Crestanello, MD;Mackram Eleid, MD;Adnan Chhatriwalla, MD;Keith Allen, MD;David Skolnick, MD;V. Erick Thompson, MD;Bethany Austin, MD;John Saxon, MD;Kenneth Huber, MD;Anthony Magalski, MD;Michael Main, MD;A. Michael Borkon, MD;J. Russell Davis, MD;Robert Kipperman, MD;Philippe Genereux, MD;John Brown, MD;Mark Russo, MD;Leonard Lee, MD;Abdul Hakeem, MD;Bruce Haik, MD;Deepa Iyer, MD;Sabha Bhatti, MD;Chanderdeep Singh, MD;Augustin Delago, MD;Mohammad El-Hajjar, MD;Eugene Pashkovetsky, MD;Lance Sullenberger, MD;Mohammed Latib, MD;Mei Chau, MD;Courtney Lucyk, RN;Mary Meneses, RN;Sandhya Murthy, MD;Patricia Chevez, MD;Vijay Iyer, MD;Stanley Fernandez, MD;Richard Schwartz, DO;Khaled Salhab, MD;Nicholas Raio, MD;Daniel Donohue, MD;George Gubernikoff, MD;Richard Jacaruso, MD;Mathew Williams, MD;Cezar Staniloae, MD;Homam Ibrahim, MD;Susheel Kodali;Tamim Nazif;Isaac George;Vinayak Bapat;Torsten Vahl;Vivian Ng;Rebecca Hahn;Amisha Patel;Omar Khalique;Chad A Kliger, MD;S. Jacob Scheinerman, MD;Nirav C Patel, MD;Luigi Pirelli, MD;Prihi Mehla, MD;Bruce Rutkin, MD;Elana Koss, MD;Jeremiah Depta, MD;Bipul Baibhav, MD;Konstantine Tzimas, MD;Vishal Parikh, MD;Deyanira Prastein, MD;David Corteville, MD;George A Petrossian, MD;Newell B Robinson, MD;Andrew D Berke, MD;William Chung, MD;Lin Wang, MD;Joseph Choo, MD;Mario Castillo-Sang, MD;Sayta Shreenivas, MD;Terri Stewart-Dehner, MD;Samir Kapadia, MD;Leonard Rodriguez, MD;James Yun, MD;Rhonda Miyasaka, MD;Serge Harb, MD;Amar Krishnaswamy, MD;Konstantinos Boudoulas, MD;Scott Lily, MD;Gregory Rushing, MD;David Orsinelli, MD;Thura Harfi, MD;Susan O'Neil, MD;Carlos Sanchez, MD;Nathan Howard Kander, MD;Arash Arshi, MD;Steven Yakubov, MD;Steven Duff, MD;Naveen Saha, MD;David Richards, MD;Jeffrey Sparling, MD;Jon Blaschke, MD;George Chrysant, MD;Douglas Horstmanshof, MD;David Vanhooser, MD;Mohammad Ghani, MD;John Williams, MD;Mark Bodenhamer, MD;Pamela Craven, MD;Jeffery Garrett, MD;Varun Khanna, MD;Nicole Tran, MD;Kamran Muhammad, MD;Wayne Leimbach, MD;Hoda Butrous, MD;John Tulloch, MD;Michael Phillips, MD;Georgianne Tokarchik, APRN-CNS;Brandon Jones, MD;Eric Kirker, MD;Ethan Korngold, MD;Geoff Wilson, MD;Craig Walsh, MD;Firas Zahr, MD;Howard Song, MD, PhD;Scott Chadderdon, MD;Harsh Golwala, MD;Howard Herrmann, MD;Wilson Szeto, MD;Gene Chang, MD;Hansie Methelier, MD;Walter McGregor, MD;Mithun Chakravarthy, MD;David Lasorda, MD;Stephen Bailey, MD;Victor Farah, MD;Matthew Lander, MD;Rachel Hughes-Doichev, MD;Mubashir Mumtaz, MD;Hemal Gada, MD;Amit Vora, MD;David Loran, MD;Nikhil Jaik, MD;Atizazul Mansoor, MD;Roberto Hodara, MD;Scott Goldman, MD;William Gray, MD;Roberto Rodriguez, MD;Paul Coady, MD;Sandra Abramson, MD;Katie Hawthorne, MD;John Riddick, MD;Sreekumar Subramanian, MD;Thomas McRae, MD;Thomas Johnston, MD;David Huneycutt, MD;Samuel Horr, MD;Andrew Goodman, MD;Parag Patel, MD;Michael A Morse, MD;Evelio Rodriguez, MD;Wilson E Kemp, MD;John B Biglane, MD;Andrew Zurick, MD;Sasan Raissi, MD;Colin Barker, MD;Brian Lindman, MD;Kashish Goel, MD;Holly Gonzales, MD;Michael Baker, MD;Kelly Schlendorf, MD;Mias Pretorius, MD;Bruce Bowers, MD;Todd Dewey, MD;Pranav Loyalka, MD;Abdul Hannan-Chaugle, MD;Carlos Encarnacion, MD;Eyal Porat, MD;Stephanie Coulter, MD;Amir Gahremanpour, MD;Srikanth Koneru, MD;Kenneth Liao, MD;Guilherme Silva, MD;Leo Simpson, MD;Neal Kleiman, MD;Michael Reardon, MD;Nadeen Faza, MD;Apurva Patel, MD;Manuel Reyes, MD;Marvin Atkins, MD;Abhijeet Dhoble, MD;Richard W Smalling, MD, PhD;Enrique Garcia-Sayan, MD;Anthony Estrera, MD;Robert L Smith, MD;Molly Szerlip, MD;Timothy George, MD;Sameh Sayfo, MD;James Harkness, MD;Kent Jones, MD;Stephen Clayson, MD;David Scott Lim, MD;Gorav Ailawadi, MD;Paul Mahoney, MD;David Adler, MD;Joseph Newton, MD;Sameer Gafoor, MD;John Petersen, MD;Oana Petrescu, MD;Patrick Ryan, MD;Eric Lehr, MD;Gabriel Aldea, MD;Georg Mackensen, MD;James McCabe, MD;Suhail Allaqaband, MD;Eric Weiss, MD;Renuka Jain, MD;Nasir Sulemanjee, MD;Daniel Harland, MD;Tanvir Bajwa, MD;Robert Boone, MD;John Webb, MD;Mustafa Toma, MD;Jian Ye, MD;Robert Moss, MD;Neil Fam, MD;Gordon Moe, MD;Geraldine Ong, MD;Kim Connelly, MD;Jeremy Edwards, MD;Askhay Bagai, MD;Mark Peterson, MD;Josep Rodés-Cabau, MD;Kim O'Connor, MD;Jonathan Beaudoin, MD;Mathieu Bernier, MD;Francois Dagenais, MD;Eric Dumont, MD;Jean-Michel Paradis, MD;Alberto Alperi-Garcia, MD;Erwan Salaun, MD;Volker Rudolph, MD;Kai Friedrichs, MD;Werner Scholtz, MD;Tanja Rudolph, MD;Fabian Roder, MD;Sabine Bleiziffer, MD;Rene Schramm, MD;Kavous Hakim-Meibodi, MD;Tomasz Gilis-Januszewski, MD;Nobuyuki Furukawa, MD;Muhammed Gercek, MD;Arseniy Goncharov, MD;Max Potratz, MD;Hazem Omran, MD;Stephan Baldus, MD;Roman Pfister, MD;Marcel Halbach, MD;Elmar Kuhn, MD;Christos Iliadis, MD;Henrik ten Freyhaus, MD;Axel Linke, MD;Stephen Haussig, MD;Christian Pflücke, MD;Norman Mangner, MD;Felix Heidrich, MD;Krunoslav M Sveric, MD;Goerg Ende, MD;Ephraim Winzer, MD;Utz Kappert, MD;Konstantinos Alexiou, MD;Nora Rochor, MD;Peter Ludike, MD;Tienush Rassaf, MD;Alexander Weymann, MD;Alexander Lind, MD;Bastian Schmack, MD;Matthias Riebisch, MD;Stefanie Hendricks, MD;Lars Michel, MD;Amir-Abbas Mahabadi, MD;Holger Nef, MD;Niklas Boeder, MD;Matthias Bayer, MD;Birgit Assmus, MD;Peter Roth, MD;Annika Klär, MD;Stanislav Keranov, MD;Korinna Feldmann, MD;Edith Lubos, MD;Niklas Schofer, MD;Daniel Kalbacher, MD;Dorit Knappe, MD;Lenard Conradi, MD;Johannes Schirmer, MD;Fabian J Brunner, MD;Christoph Sinning, MD;Peter Moritz-Becher, MD;Peter Clemmensen, MD;Philip Raake, MD;Mathias Konstandin, MD;Matthias Aurich, MD;Gregor Warnecke, MD;Michael Kreußer, MD;Philipp Schlegel, MD;Martin Volz, MD;Nicolas Geis, MD;Philipp Lurz, MD;Thilo Noack, MD;Philipp Kiefer, MD;Christian Besler, MD;Steffen Desch, MD;Holger Thiele, MD;Maximilian von Roeder, MD;Marcus Sandri, MD;Marion Zimmer, MD;Silke John, MD;Ricardo Spampinato, MD;Danilo Obradovic, MD;Jörg Ender, MD;Anna Flo Forner, MD;Carmine Bevilacqua, MD;Georg Stachel, MD;Florian Fahr, MD;Massimiliano Meineri, MD;Johannes Rotta detto Loria, MD;Ralph von Bardeleben, MD;Felix Kreidel, MD;Alexander Tamm, MD;Tobias Ruf, MD;Martin Geyer, MD;Philip Wenzel, MD;Markus Vosseler, MD;Simon Distelmeier, MD;Jaqueline Grace da Rocha e Silva, MD;Martin Oberhoffer, MD;Daniel-Sebastian Dohle, MD;Hendrik Treede, MD;Michael Näbauer, MD;Daniel Braun, MD;Thomas Johannes Stocker, MD;Sebastian Sadoni, MD;Sven Peterss, MD;Peter Boekstegers, MD;Harald Beucher, MD;Abdel Karim Al-Ghaddioui, MD;Rolf Hampel-Landsberg, MD;Bakary Camara, MD;Mirjam Keßler, MD;Sinisa Markovic, MD;Wolfgang Rottbauer, MD;Leonhard Moritz-Schneider, MD;Christine Reichart, MD;Christian Liewald, MD;Matthias Gröger, MD;Maria-Theresa Harris, MD;Jinny Scheffler, MD;Nicoletta Nita, MD;Hagen Gorki, MD;Natalia Wojtkowski, MD;Fabien Praz, MD;Stephan Windecker, MD;Nicolas Brugger, MD;David Reineke, MD;Lukas Hunziker Munsch, MD;Joanna Bartkowiak, MD;Gercek Muhammed", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation", + "Keywords": "", + "MeSH_Terms": "Mitral Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03706833" + }, + { + "id": 64, + "user_id": 1497893077, + "ct_id": "NCT03382457", + "Study_Type": "Interventional", + "trial_name": "Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study", + "condition": "Tricuspid Regurgitation", + "intervention": "Transcatheter Tricuspid Valve Reconstruction", + "phase": "Others", + "Role": "Sub-Investigator", + "enrollees": 55, + "trial sites": 5, + "sponsors": "Edwards Lifesciences", + "status": "Active, not recruiting", + "Start_Date": "2018-07-01", + "End_Date": "2024-06-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "William Gray, MD;Charles Davidson, MD;Mark Ricciardi, MD;James Thomas, MD;Robert Kipperman, MD;Philippe Genereux,, MD;Marc Goldschmidt, MD;John Brown, MD;Seth Uretsky, MD;Konstantinos Koulogiannis, MD;Leo Marcoff, MD;Lillian Aldaia, MD;Martin Leon, MD;Tamim Nazif, MD;Rebecca Hahn, MD;Susheel Kodali, MD;Robert Smith, MD;Molly Szerlip, MD;Paul Grayburn, MD;Scott Lim, MD;Gorav Ailawadi, MD;Dale Fowler;Susheel K Kodali", + "Collaborator": "", + "Purpose": "Early feasibility study to assess the safety and performance of the Edwards Cardioband\n Tricuspid Valve Reconstruction System", + "Official_Title": "Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study", + "Keywords": "Functional,TR,FTR,Transcatheter,Reconstruction", + "MeSH_Terms": "Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03382457" + }, + { + "id": 65, + "user_id": 1497893077, + "ct_id": "NCT02574650", + "Study_Type": "Interventional", + "trial_name": "Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.", + "condition": "Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Heart Valve Disease", + "intervention": "Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 30, + "trial sites": 11, + "sponsors": "Mitralign, Inc.", + "status": "Unknown status", + "Start_Date": "2015-11-01", + "End_Date": "2019-05-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Rebecca Hahn, MD;Christopher Meduri, MD, MPH;Saibal Kar, MD;Andrew Rassi, MD;Lowell Satler, MD;Brijeshwar Maini, MD;Christopher Meduri, MD;Stuart Rich, MD;Mario Goessl, MD, PhD;Colin Baker, MD;Scott Lim, MD;Sameer Gafoor, MD;Gafoor Sameer", + "Collaborator": "", + "Purpose": "The purpose of this study is to assess the early safety and performance of the Mitralign\n Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for the treatment of symptomatic\n chronic functional tricuspid regurgitation (FTR).\n\n The procedure will be performed with the PTVAS device using a non-surgical percutaneous\n approach to tricuspid valve repair in patients who have FTR with a minimum of moderate\n tricuspid regurgitation.", + "Official_Title": "Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for Symptomatic Chronic Functional Tricuspid Regurgitation", + "Keywords": "", + "MeSH_Terms": "Heart Valve Diseases,Tricuspid Valve Insufficiency", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02574650" + }, + { + "id": 66, + "user_id": 1841382421, + "ct_id": "NCT05464940", + "Study_Type": "Interventional", + "trial_name": "Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction", + "condition": "Atrial Fibrillation", + "intervention": "Intravenous caffeine;Masked Placebo", + "phase": "Others", + "Role": "", + "enrollees": 100, + "trial sites": 9, + "sponsors": "Kansas City Heart Rhythm Research Foundation", + "status": "Not yet recruiting", + "Start_Date": "2023-06-01", + "End_Date": "2023-12-01", + "Min_Age": "21 Years", + "Max_Age": "90 Years", + "Gender": "All", + "Investigators": "Dhanunjaya Lakkireddy;", + "Collaborator": "Kansas City Heart Rhythm Institute, Overland Park, KS,Texas Cardiac Arrhythmia Institute, Austin, TX, USA,Loma Linda University, Loma Linda, California, USA", + "Purpose": "This \"How caffeine Induces Atrial Tachyarrhythmias\" trial will be a multi-center, randomized,\n double-blinded trial of intravenous caffeine versus placebo among patients undergoing\n pulmonary vein isolation procedures for Atrial Fibrillation(AF).", + "Official_Title": "Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation: The COFFEE-AF Trial", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation,Caffeine", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05464940" + }, + { + "id": 67, + "user_id": 1841382421, + "ct_id": "NCT05510167", + "Study_Type": "Interventional", + "trial_name": "Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF", + "condition": "", + "intervention": "B;S;P;", + "phase": "Others", + "Role": "", + "enrollees": 130, + "trial sites": "", + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Not yet recruiting", + "Start_Date": "2022-08-22", + "End_Date": "2025-08-01", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Andrea Natale", + "Collaborator": "", + "Purpose": "Earlier studies have shown a dose-dependent relationship between alcohol intake and incident\n atrial fibrillation (AF) as well as a causal link with several risk factors for AF such as\n hypertension, obesity and sleep apnea. However, the effect of drinking (alcohol) on\n post-ablation outcome such as arrhythmia recurrence, quality of life (QoL) and cognitive\n function in AF patients is unclear. Therefore, we aim to find the answer for a very\n frequently asked question, \"is it safe to continue drinking alcohol (at the pre-ablation\n level) following catheter ablation OR should the intake be reduced for better outcome?\", in\n this randomized trial.", + "Official_Title": "Impact of Post-ablation Alcohol Intake on Arrhythmia Recurrence, Quality of Life and Cognition in Patients With Atrial Fibrillation", + "Keywords": "Alcohol,AF,Catheter ablation,Recurrence", + "MeSH_Terms": "Atrial Fibrillation,Recurrence", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05510167" + }, + { + "id": 68, + "user_id": 1841382421, + "ct_id": "NCT04577859", + "Study_Type": "Interventional", + "trial_name": "Oesophageal Protection Study: A Multicentre Study.", + "condition": "AF - Atrial Fibrillation, Complication, Atrio-Esophageal Fistula", + "intervention": "ensoETM. Esophageal cooling during AF ablation;Esophageal temperature monitoring probe", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 500, + "trial sites": 6, + "sponsors": "Advanced Cooling Therapy, Inc., d/b/a Attune Medical", + "status": "Recruiting", + "Start_Date": "2022-03-10", + "End_Date": "2025-03-10", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Mark M Gallagher, MD;David Callans, MD;Wendy Tzou, MD;Andrew Locke, MD;Timothy Maher, MD;Cory Tscahbrunn, PhD;Andrea Natale, MD;Kenneth Ellenbogen, MD;Manav Sohal, PhD;Abhay Bajpai, MD;Zia Zuberi, PhD;Anthony Li, MD;Mark Norman, PhD;Riyaz Kaba, MD;Natale Andrea", + "Collaborator": "St. George's Hospital, London,University of Pennsylvania,National Health Service, United Kingdom,Berry Consultants,Virginia Commonwealth University,University of Colorado, Denver,Texas Cardiac Arrhythmia Research Foundation,Beth Israel Deaconess Medical Center,Royal Brompton & Harefield NHS Foundation Trust,The Queen Elizabeth Hospital,Guy's and St Thomas' NHS Foundation Trust", + "Purpose": "", + "Official_Title": "Improving Oesophageal Protection During AF Ablation: a Multicentre Double-blind Randomized Clinical Trial.", + "Keywords": "AF ablation,radiofrequency,Esophageal thermal injury,atrio-esophageal fistula,Esophageal protection,Esophageal cooling,Esophageal temperature monitoring probe", + "MeSH_Terms": "Esophageal Fistula,Atrial Fibrillation,Fistula", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04577859" + }, + { + "id": 69, + "user_id": 1841382421, + "ct_id": "NCT05139329", + "Study_Type": "Observational", + "trial_name": "The ORCHESTRATE-Myocarditis Registry", + "condition": "Myocarditis, Ischemia, Chest Pain", + "intervention": "Imaging", + "phase": "", + "Role": "", + "enrollees": 382, + "trial sites": 4, + "sponsors": "Kansas City Heart Rhythm Research Foundation", + "status": "Not yet recruiting", + "Start_Date": "2022-01-01", + "End_Date": "2022-05-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Dhanunjaya Lakkireddy, MD;Garg Jalaj", + "Collaborator": "Kansas City Heart Rhythm Institute,Texas Cardiac Arrhythmia Research Foundation,Montefiore Medical Center,Loma Linda University International Heart Institute", + "Purpose": "A retrospective, observational study consisting of patients who presents with\n typical/atypical chest pain and have an ensuing negative ischemic evaluation", + "Official_Title": "Observational Registry of Ischemia Negative Chest Pain as the Presentation of Underlying Myocarditis: the ORCHESTRATE-Myocarditis Registry", + "Keywords": "", + "MeSH_Terms": "Myocarditis,Ischemia,Chest Pain", + "Url": "http://clinicaltrials.gov/ct2/show/NCT05139329" + }, + { + "id": 70, + "user_id": 1841382421, + "ct_id": "NCT04505163", + "Study_Type": "Interventional", + "trial_name": "Left Atrial Posterior Wall and PV Isolation Using Cryoballoon for Treatment of Persistent AF", + "condition": "Persistent Atrial Fibrillation", + "intervention": "", + "phase": "Others", + "Role": "", + "enrollees": 153, + "trial sites": 14, + "sponsors": "Dignity Health Medical Foundation", + "status": "Active, not recruiting", + "Start_Date": "2021-04-30", + "End_Date": "2023-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "", + "Collaborator": "Mercy General Hospital and Dignity Health Medical Foundation,Beth Israel Deaconess Medical Center,UC Health Medical Center,MedStar Georgetown University Hospital and Medical Center,Tampa Cardiac Specialists,Bethesda North Hospital,Brigham and Women's Hospital,Texas Cardiac Arrhythmia Institute At St. Davids Medical Center,St. Luke's Hospital and Health Network, Pennsylvania,Sarasota Memorial Health Care System,Nebraska Methodist Hospital-Methodist Physicians Clinic", + "Purpose": "The purpose of this study it to learn whether pulmonary vein isolation (PVI) along with\n isolation of the posterior left atrial wall (PWI) in the region of the pulmonary venous\n component will reduce the likelihood of atrial fibrillation (AF) recurrence in patients with\n persistent atrial fibrillation at 12 months, after a single ablation procedure, in comparison\n to PVI alone.\n\n The investigator hypothesizes that the combination of PVI + PWI will result in a significant\n reduction in recurrence of atrial fibrillation at 12 months after ablation.", + "Official_Title": "Left Atrial Posterior Wall Isolation in Conjunction With Pulmonary Vein Isolation Using the Cryoballoon for Treatment of Persistent Atrial Fibrillation (PIVoTAL) - IDE Trial", + "Keywords": "", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04505163" + }, + { + "id": 71, + "user_id": 1841382421, + "ct_id": "NCT04830774", + "Study_Type": "Interventional", + "trial_name": "Natural History of COVID-19-Related Atrial Fibrillation", + "condition": "COVID-19, Atrial Fibrillation New Onset", + "intervention": "ILR, PMK, ICD", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 200, + "trial sites": 12, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Recruiting", + "Start_Date": "2021-04-15", + "End_Date": "2023-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Domenico G Della Rocca, MD;Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "The unCOVer-AF prospective, multicenter registry aims at determining the natural history of\n atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first\n arrhythmic episode during COVID-19 hospitalization.", + "Official_Title": "Natural History and Recurrence Rate of Atrial Fibrillation After the First, COVID-19-Related Atrial Arrhythmic Episode: A Prospective Evaluation Using Continuous Cardiac Rhythm Monitoring", + "Keywords": "Atrial Fibrillation,COVID-19,Natural history,stroke,loop recorder,cardiac implantable electronic device,remote monitoring", + "MeSH_Terms": "COVID-19,Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04830774" + }, + { + "id": 72, + "user_id": 1841382421, + "ct_id": "NCT04726943", + "Study_Type": "Interventional", + "trial_name": "RF Applications for Residual LAA Leaks", + "condition": "Left Atrial Appendage Thrombosis, Stroke, Ischemic, Atrial Fibrillation", + "intervention": "Radiofrequency Energy Applications", + "phase": "Others", + "Role": "", + "enrollees": 100, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2021-02-01", + "End_Date": "2022-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Natale Andrea", + "Collaborator": "", + "Purpose": "Although the clinical impact of residual left atrial appendage (LAA) leaks still requires\n confirmation, its patency resulting from incomplete LAA closure may promote blood stagnation\n and thrombus formation, and increase the risk of thromboembolic events. The main purpose of\n this trial is to evaluate the safety and efficacy of percutaneous leak closure with\n radiofrequency energy applications.", + "Official_Title": "Radiofrequency Energy Applications Targeting Significant Residual Leaks After Left Atrial Appendage Occlusion", + "Keywords": "stroke,Atrial Fibrillation,Left atrial appendage,prevention,leak,radiofrequency", + "MeSH_Terms": "Ischemic Stroke,Atrial Fibrillation,Thrombosis", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04726943" + }, + { + "id": 73, + "user_id": 1841382421, + "ct_id": "NCT04736524", + "Study_Type": "Observational", + "trial_name": "Immune Response Following COVID-19 Vaccination", + "condition": "IgM and IgG in Blood", + "intervention": "Rapid antibody test", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 500, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2021-01-15", + "End_Date": "2022-03-01", + "Min_Age": "16 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Andrea Natale;Sanghamitra Mohanty;Andrea Natale, MD;Mitra Mohanty, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "Few trials have reported the safety and efficacy of the COVID-19 vaccines. However, these\n trials were mostly focused on post-vaccination adverse events and short-term antibody\n detection with none monitoring the presence of immunoglobulin G (IgG) in blood at long-term\n follow-up after the vaccination. This study aims to evaluate the immune response in\n post-vaccinated individuals across a follow-up period of one year.", + "Official_Title": "Immune Response Following COVID-19 Vaccination (IFVAC)", + "Keywords": "", + "MeSH_Terms": "Antibodies", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04736524" + }, + { + "id": 74, + "user_id": 1841382421, + "ct_id": "NCT04657705", + "Study_Type": "Interventional", + "trial_name": "Application of High Power Radio Frequency Energy in the Ventricular Tachycardia Treatment", + "condition": "Ventricular Tachycardia, Heart Diseases", + "intervention": "High power ablation;Standard ablation power", + "phase": "Others", + "Role": "", + "enrollees": 119, + "trial sites": 7, + "sponsors": "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia", + "status": "Completed", + "Start_Date": "2020-12-05", + "End_Date": "2022-09-20", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Sergey V. Korolev, MD;Natale Andrea", + "Collaborator": "Meshalkin National Medical Research Center, Ministry of Health of Russian Federation,Heart and Vascular Center Bad Bevensen, Germany,National Medical Research Center for Cardiology, Ministry of Health of Russian Federation,National Research Center of Surgery, Russia,I.M. Sechenov First Moscow State Medical University,Texas Cardiac Arrhythmia Institute, Austin, Texas", + "Purpose": "Background: Patient's freedom from VT after RFA remains non-optimal and it depends on many\n factors. One of them is the effective reduction of the myocardium with RF energy during the\n operation. The standardization of the parameters of RF will help to increase the success of\n the procedure.\n\n Hypothesis: Radiofrequency ablation of ventricular tachycardias with high power parameters\n has comparable safety and leads to greater efficacy (absence of ventricular tachycardias and\n all types of cardioverter-defibrillator therapies) in the long-term compared with ablation\n with standard parameters in patients with structural heart disease.\n\n Purpose: to evaluate the safety and the efficiency of ablation of ventricular tachycardia in\n patients with structural heart disease using high power RF energy.", + "Official_Title": "Application of High Power Radio Frequency Energy in the Interventional Treatment of Patients With Ventricular Tachycardia and Structural Heart Disease", + "Keywords": "High Power Radio Frequency Energy,ventricular tachycardia,Structural Heart Disease", + "MeSH_Terms": "Heart Diseases,Tachycardia,Tachycardia, Ventricular", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04657705" + }, + { + "id": 75, + "user_id": 1841382421, + "ct_id": "NCT04506229", + "Study_Type": "Observational", + "trial_name": "Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function", + "condition": "Covid19", + "intervention": "Whole exome sequencing", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 60, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2020-08-20", + "End_Date": "2021-09-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale", + "Collaborator": "", + "Purpose": "There is a considerable variation in the disease behavior in terms of contracting the\n infection, manifesting none to a range of symptoms and severity of the infection among\n individuals exposed to or infected with SARS-CoV-2 virus, the causative organism of COVID-19.\n Although the respiratory system appears to be the primary target of this virus infection,\n emerging evidences suggests involvement of extra-pulmonary organs including central nervous\n system. We aim to compare the genetic profile of individuals with vs without COVID-19 after\n being exposed to infected cases. Additionally, we will assess the cognitive function in\n covid-19 positive cases with vs. without neurological symptoms at the time of infection and\n 1-month follow-up using the Montreal Cognitive Assessment (MoCA) questionnaire.", + "Official_Title": "Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function", + "Keywords": "", + "MeSH_Terms": "COVID-19", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04506229" + }, + { + "id": 76, + "user_id": 1841382421, + "ct_id": "NCT04502017", + "Study_Type": "Interventional", + "trial_name": "Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion", + "condition": "Device-Related Thrombosis, Atrial Fibrillation, Left Atrial Appendage Occlusion", + "intervention": "ASA plus Clopidogrel;Genetic-Tailored AntiThrombotic Strategy;Half-Dose of novel OAC", + "phase": "Phase 4", + "Role": "", + "enrollees": 360, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Recruiting", + "Start_Date": "2020-08-05", + "End_Date": "2023-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Natale Andrea", + "Collaborator": "", + "Purpose": "Comparison among three different antithrombotic strategies after percutaneous LAA occlusion\n with a Watchman FLX LAAC device.", + "Official_Title": "Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion", + "Keywords": "Left atrial appendage,WATCHMAN,Antithrombotic Therapy,device-related thrombosis", + "MeSH_Terms": "Atrial Fibrillation,Thrombosis,Clopidogrel", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04502017" + }, + { + "id": 77, + "user_id": 1841382421, + "ct_id": "NCT04356040", + "Study_Type": "Interventional", + "trial_name": "TactiFlex AF IDE Trial", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 355, + "trial sites": 45, + "sponsors": "Abbott Medical Devices", + "status": "Active, not recruiting", + "Start_Date": "2020-06-29", + "End_Date": "2022-12-01", + "Min_Age": "18 Years", + "Max_Age": "130 Years", + "Gender": "All", + "Investigators": "", + "Collaborator": "", + "Purpose": "Prospective, non-randomized multi-center clinical investigation. Design includes a main study\n and a separate substudy. Subjects in the main study are to be treated using the full range of\n ablation power settings in the IFU. Subjects in the substudy are to be treated in the upper\n end of the recommended ablation power settings (40-50 Watts).", + "Official_Title": "Safety and Effectiveness of TactiFlex™ Ablation Catheter, Sensor Enabled™ (TactiFlex SE) for the Treatment of Drug Refractory, Symptomatic, Atrial Fibrillation", + "Keywords": "", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04356040" + }, + { + "id": 78, + "user_id": 1841382421, + "ct_id": "NCT04371926", + "Study_Type": "Interventional", + "trial_name": "Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk", + "condition": "COVID-19", + "intervention": "Hydroxychloroquine Sulfate", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 0, + "trial sites": 0, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Withdrawn", + "Start_Date": "2020-06-01", + "End_Date": "2021-07-01", + "Min_Age": "18 Months", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)", + "Keywords": "", + "MeSH_Terms": "Hydroxychloroquine", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04371926" + }, + { + "id": 79, + "user_id": 1841382421, + "ct_id": "NCT04372004", + "Study_Type": "Interventional", + "trial_name": "Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)", + "condition": "COVID-19", + "intervention": "diagnostic tests for COVID-19 infection", + "phase": "Phase 1", + "Role": "", + "enrollees": 100, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2020-05-08", + "End_Date": "2021-06-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Natale Andrea", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)", + "Keywords": "", + "MeSH_Terms": "COVID-19", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04372004" + }, + { + "id": 80, + "user_id": 1841382421, + "ct_id": "NCT04352764", + "Study_Type": "Observational [Patient Registry]", + "trial_name": "ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings", + "condition": "Covid19", + "intervention": "CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 5000, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2020-03-27", + "End_Date": "2021-01-31", + "Min_Age": "", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD FACC FHRS;Natale Andrea", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings", + "Keywords": "", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04352764" + }, + { + "id": 81, + "user_id": 1841382421, + "ct_id": "NCT04160000", + "Study_Type": "Interventional", + "trial_name": "Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure", + "condition": "Atrial Fibrillation, Heart Failure, Diastolic Heart Failure", + "intervention": "Catheter Ablation;Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation", + "phase": "Phase 4", + "Role": "Study Chair", + "enrollees": 360, + "trial sites": 2, + "sponsors": "Electrophysiology Research Foundation", + "status": "Recruiting", + "Start_Date": "2020-03-01", + "End_Date": "2024-10-31", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Sanjeev Saksena, MD;Andrea Natale, MD;Saksena Sanjeev", + "Collaborator": "", + "Purpose": "", + "Official_Title": "A Phase 4, Randomized, Open Label, Multicenter Prospective Comparative Study To Evaluate The Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure", + "Keywords": "Atrial Fibrillation,Heart failure,Diastolic Heart Failure,Catheter ablation,Antiarrhythmic drugs", + "MeSH_Terms": "Heart Failure,Atrial Fibrillation,Heart Failure, Diastolic,Anti-Arrhythmia Agents", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04160000" + }, + { + "id": 82, + "user_id": 1841382421, + "ct_id": "NCT04216667", + "Study_Type": "Interventional", + "trial_name": "Systematic Evaluation of Ablation Techniques for Non-Paroxysmal Atrial Fibrillation.", + "condition": "Atrial Fibrillation", + "intervention": "Catheter Ablation", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 124, + "trial sites": 4, + "sponsors": "Montefiore Medical Center", + "status": "Terminated", + "Start_Date": "2020-01-16", + "End_Date": "2027-06-01", + "Min_Age": "18 Years", + "Max_Age": "99 Years", + "Gender": "All", + "Investigators": "Jorge E Romero, MD;Luigi Di Biase, MD, PhD;Andrea Natale, MD;Natale Andrea", + "Collaborator": "Biosense Webster, Inc.", + "Purpose": "", + "Official_Title": "Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation (The PLEA Trial)", + "Keywords": "Catheter ablation,Arrhythmia Recurrence,Embolic Stroke,Mortality", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04216667" + }, + { + "id": 83, + "user_id": 1841382421, + "ct_id": "NCT04182620", + "Study_Type": "Interventional", + "trial_name": "Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation", + "condition": "Atrial Fibrillation", + "intervention": "Renal Denervation;Catheter Ablation", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 160, + "trial sites": 11, + "sponsors": "Vivek Reddy", + "status": "Recruiting", + "Start_Date": "2020-01-01", + "End_Date": "2021-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Vivek Reddy, MD;Vijendra Swarup, MD;Douglas Gibson, MD;Roderick Tung, MD;Moussa Mansour, MD;Marc Lahiri, MD;Mohamed Kanj, MD;Andrea Natale, MD;Christian Ukena, MD;Swarup Vijendra", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: A Pilot Study", + "Keywords": "renal denervation,Atrial Fibrillation,Cardiology,Electrophysiology", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04182620" + }, + { + "id": 84, + "user_id": 1841382421, + "ct_id": "NCT04198701", + "Study_Type": "Interventional", + "trial_name": "Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF", + "condition": "Atrial Fibrillation", + "intervention": "Medtronic PulseSelect Pulsed Field Ablation (PFA) System", + "phase": "Others", + "Role": "", + "enrollees": 421, + "trial sites": 41, + "sponsors": "Medtronic Cardiac Rhythm and Heart Failure", + "status": "Completed", + "Start_Date": "2019-12-10", + "End_Date": "2022-11-28", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Atul Verma, MD;", + "Collaborator": "", + "Purpose": "The study is a prospective, multi-center, non-randomized, unblinded worldwide pre-market\n clinical study. The purpose of the study is to provide data demonstrating the safety and\n effectiveness of the PulseSelect™ PFA System for the treatment of atrial fibrillation (AF).\n The study will also provide first in human insights into clinical safety and device function\n of the PulseSelect PFA System for pulmonary vein isolation (PVI) as a treatment for AF. To\n this end, the clinical study has been designed into phases (Pilot and Pivotal), with each\n phase comprising a separate data set that will be analyzed and reported on per the below\n objectives.", + "Official_Title": "Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04198701" + }, + { + "id": 85, + "user_id": 1841382421, + "ct_id": "NCT04115436", + "Study_Type": "Observational", + "trial_name": "Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation", + "condition": "", + "intervention": "", + "phase": "", + "Role": "", + "enrollees": 40, + "trial sites": "", + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2019-10-01", + "End_Date": "2020-10-01", + "Min_Age": "", + "Max_Age": "", + "Gender": "", + "Investigators": "Natale Andrea", + "Collaborator": "", + "Purpose": "Life-long therapy with oral anticoagulants (OAC) is strongly recommended in AF patients\n receiving left atrial appendage isolation (LAAI) to prevent thromboembolic (TE) events.\n However, some patients are observed to remain stroke-free while off OACs for years whereas\n others experience TE events if OAC is discontinued even for a short period of time.\n Therefore, we aim to evaluate the association of genetic variants (single nucleotide\n polymorphisms - SNPs) with off-anticoagulation stroke-risk in AF patients.", + "Official_Title": "Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation,Thromboembolism", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04115436" + }, + { + "id": 86, + "user_id": 1841382421, + "ct_id": "NCT04037397", + "Study_Type": "Interventional", + "trial_name": "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)", + "condition": "Atrial Fibrillation", + "intervention": "Anti Arrhythmics;Pulmonary Vein Isolation performed by Radio Frequency Catheter Ablation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 120, + "trial sites": 6, + "sponsors": "University of Pennsylvania", + "status": "Recruiting", + "Start_Date": "2019-09-24", + "End_Date": "2024-03-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Jose Osorio, MD;Anshul Patel, MD;Sanghamitra Mohanty, MD;Philip Gentlesk, MD;Philip J Gentlesk", + "Collaborator": "Biosense Webster, Inc.,Texas Cardiac Arrhythmia Research Foundation", + "Purpose": "", + "Official_Title": "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment", + "Keywords": "pulmonary vein isolation", + "MeSH_Terms": "Atrial Fibrillation,Anti-Arrhythmia Agents", + "Url": "http://clinicaltrials.gov/ct2/show/NCT04037397" + }, + { + "id": 87, + "user_id": 1841382421, + "ct_id": "NCT03946072", + "Study_Type": "Interventional", + "trial_name": "Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli", + "condition": "Neurocognitive Dysfunction", + "intervention": "Transseptal Aortic Approach Catheter Ablation Procedure;Retrograde Aortic Approach Catheter Ablation Procedure", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 153, + "trial sites": 1, + "sponsors": "University of California, San Francisco", + "status": "Active, not recruiting", + "Start_Date": "2019-07-02", + "End_Date": "2021-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Gregory Marcus, MD;Gregory M Marcus", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Multi-center Comparative Effectiveness RCT to Assess a Transseptal Approach to Left Ventricular Ablation Compared to a Retrograde Aortic Approach to Prevent Cerebral Emboli & Neurocognitive Decline in Adults With VT and/or PVCs", + "Keywords": "", + "MeSH_Terms": "Cognitive Dysfunction", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03946072" + }, + { + "id": 88, + "user_id": 1841382421, + "ct_id": "NCT03093051", + "Study_Type": "Observational", + "trial_name": "Termination Therapy for Ventricular Tachyarrhythmias", + "condition": "Ventricular Fibrillation, Ventricular Tachycardia", + "intervention": "Unpinning Termination therapy", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 6, + "trial sites": 9, + "sponsors": "Cardialen, Inc.", + "status": "Terminated", + "Start_Date": "2019-03-12", + "End_Date": "2021-02-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Daniel H Cooper, MD;Christopher Woods, MD;P. Gearoid O'Neill, MD;Venkatakrishna N Tholakanahalli, MD;Brett Atwater, MD;John D Hummel, MD;Anish Amin, MD;Andrea Natale, MD;Daniel H Cooper", + "Collaborator": "National Heart, Lung, and Blood Institute (NHLBI),Washington University School of Medicine", + "Purpose": "", + "Official_Title": "Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias", + "Keywords": "Termination,Unpinning,Therapy", + "MeSH_Terms": "Tachycardia,Tachycardia, Ventricular,Ventricular Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03093051" + }, + { + "id": 89, + "user_id": 1841382421, + "ct_id": "NCT03775512", + "Study_Type": "Interventional", + "trial_name": "Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "RF Ablation with QDOT Micro", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 283, + "trial sites": 1, + "sponsors": "Biosense Webster, Inc.", + "status": "Completed", + "Start_Date": "2019-01-30", + "End_Date": "2020-10-30", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Emile Daoud;Jose Osorio;Francis Marchlinksi;Michael Cutler;Andrea Natale;Daniel Melby;Miguel Valderabanno;George Monir;Craig Delaughter;Christopher Liu;Saumil Oza;Ayman Hussein;Robert Fishel;Kenneth Ellenbogen;Gery Tomassoni;Tristram Bahnson;Chris Ellis;Emerson Liu;David Wilber;Moussa Mansour;Srinivas Dukkipati;Hugh McElderry;Patrick Hranitzky;Monir George", + "Collaborator": "", + "Purpose": "", + "Official_Title": "Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation (PVI) in Subjects With PAF", + "Keywords": "Microcatheters", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT03775512" + }, + { + "id": 112, + "user_id": 1841382421, + "ct_id": "NCT02533843", + "Study_Type": "Interventional", + "trial_name": "Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation", + "condition": "Atrial Fibrillation", + "intervention": "Radiofrequency catheter ablation", + "phase": "Phase 3", + "Role": "Study Director", + "enrollees": 120, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2014-04-01", + "End_Date": "2017-07-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "Specific Aim: This prospective randomized study aims to compare the impact of three different\n catheter ablation approaches on long-term procedure outcome in terms of arrhythmia recurrence\n in persistent (PeAF) and long-standing persistent atrial fibrillation (LSPAF) patients. The\n three strategies to be evaluated are 1) ablation at sources guided by FIRMap (using\n RhythmView™ Workstation from TOPERA), 2) ablation at sources guided by FIRMap + conventional\n pulmonary vein antrum isolation (PVAI) and 3) Extended PVAI plus ablation of non-PV triggers\n and complex fractionated atrial electrograms (CFAE).", + "Official_Title": "Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02533843" + }, + { + "id": 113, + "user_id": 1841382421, + "ct_id": "NCT02209064", + "Study_Type": "Interventional", + "trial_name": "EASE\" Epicardial Access With the EpiAccess System", + "condition": "Arrhythmias, Cardiac", + "intervention": "Pericardial access", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 25, + "trial sites": 1, + "sponsors": "EpiEP, Inc.", + "status": "Completed", + "Start_Date": "2013-12-01", + "End_Date": "2015-11-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "Prospective non-randomized, single arm trial to further evaluate the safety and performance\n of EpiAccess, the study device, for gaining access to the normal, non-distended pericardial\n space during epicardial diagnostic or therapeutic (ablation) procedures.", + "Official_Title": "EASe 2- an Epicardial Access Study With the EpiAccess System- A Post-market Follow up Study.", + "Keywords": "Subxiphoid,Access,Guidewires", + "MeSH_Terms": "Arrhythmias, Cardiac", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02209064" + }, + { + "id": 114, + "user_id": 1841382421, + "ct_id": "NCT01997736", + "Study_Type": "Interventional", + "trial_name": "Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "Ablation", + "phase": "Others", + "Role": "", + "enrollees": 41, + "trial sites": 4, + "sponsors": "Toray Industries (America), Inc.", + "status": "Completed", + "Start_Date": "2013-11-01", + "End_Date": "", + "Min_Age": "18 Years", + "Max_Age": "N/A", + "Gender": "Both", + "Investigators": "David Haines, MD;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The purpose of this study is to collect preliminary safety and effectiveness data evaluating\n the Toray Satake Balloon Thermal Ablation System (TSB)to treat subjects with symptomatic\n paroxysmal atrial fibrillation that is resistant to antiarrhythmic drug therapy.", + "Official_Title": "A Pilot Study Evaluating the Safety and Effectiveness of the Toray Satake Balloon Thermal Ablation System for the Treatment of Paroxysmal Atrial Fibrillation", + "Keywords": "Paroxysmal Atrial Fibrillation,Catheter ablation,Ablation Techniques", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01997736" + }, + { + "id": 115, + "user_id": 1841382421, + "ct_id": "NCT01898221", + "Study_Type": "Interventional", + "trial_name": "Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation", + "condition": "Ventricular Tachycardia, Atrial Fibrillation", + "intervention": "Ethanol;Ablation", + "phase": "Phase 2/Phase 3", + "Role": "", + "enrollees": 423, + "trial sites": 12, + "sponsors": "Miguel X. Valderrabano, MD", + "status": "Completed", + "Start_Date": "2013-10-01", + "End_Date": "2020-12-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Miguel Valderrabano, MD;Natale Andrea", + "Collaborator": "National Institutes of Health (NIH),National Heart, Lung, and Blood Institute (NHLBI),The Methodist Hospital Research Institute", + "Purpose": "The broad, long-term objective of this project is to evaluate the therapeutic value of vein\n of Marshall (VOM) ethanol infusion when added to catheter ablation of atrial fibrillation\n (AF). AF is the most common sustained arrhythmia in adults, and it is a leading cause of\n stroke, disability and increased mortality. Catheter ablation - pulmonary vein (PV) antral\n isolation (PVAI)- can lead to cure, but is best suited for paroxysmal AF, in which ectopic\n beats arising from the pulmonary veins were shown to initiate AF. PVAI success is lower in\n persistent AF, in which the role of the cardiac autonomic system, particularly the intrinsic\n cardiac ganglia, is being increasingly recognized. Expanding the ablation lesions to include\n greater areas the left atrial (LA) anatomy marginally improves outcomes, but also leads to\n increases in procedural complexity and duration, need of repeat procedures, and complications\n such as atrial flutters, particularly perimitral flutter (PMF). The investigators have\n developed a technique to perform rapid ablation of atrial tissues in AF using ethanol\n infusion in the vein of Marshall (VOM), and have shown: 1) Effective, rapid and safe tissue\n ablation of LA tissue neighboring the LA ridge and left inferior PV; 2) Regional LA vagal\n denervation by reaching the intrinsic cardiac ganglia; and 3) Facilitation of cure of PMF by\n ablating most of the mitral isthmus.\n\n The investigators propose to evaluate outcomes differences yielded by VOM ethanol when added\n to conventional PVAI. The specific aims are: #1.To assesses the impact of VOM ethanol\n infusion in procedure success when added to de novo catheter ablation of persistent AF. The\n investigators will randomize patients with persistent AF undergoing a first AF ablation to\n standard PVAI vs. a combined VOM ethanol infusion plus PVAI (VOM-PV) #2. To assess the impact\n of VOM ethanol infusion added to repeat catheter ablation of recurrent AF after a failed\n ablation. Patients undergoing a repeat procedure for persistent AF after a failed PVAI will\n be randomized to either PVAI or VOM-PV as their repeat procedure. End points will include\n freedom from symptomatic or electrocardiographic AF after 12-15 months.", + "Official_Title": "Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation", + "Keywords": "Balloon Catheters,Guide Catheters", + "MeSH_Terms": "Atrial Fibrillation,Tachycardia,Tachycardia, Ventricular,Ethanol", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01898221" + }, + { + "id": 116, + "user_id": 1841382421, + "ct_id": "NCT01959425", + "Study_Type": "Interventional", + "trial_name": "Oral Anticoagulation Therapy Pilot Study", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "Off OAT Group (Test);On OAT Group (Control)", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 80, + "trial sites": 7, + "sponsors": "Biosense Webster, Inc.", + "status": "Terminated", + "Start_Date": "2013-08-01", + "End_Date": "2020-03-31", + "Min_Age": "18 Years", + "Max_Age": "90 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Antonio Raviele, MD;Michael Riley, MD;Karl Heinz Kuck, MD;Michel Haissaguerre, MD;Pierre Jais, MD;Sakis Themistoclakis, MD;Dhanunjaya Lakkireddy, MD;Ohad Ziv, MD;Karl-Heinz Kuck, MD;Ziv Ohad", + "Collaborator": "", + "Purpose": "The objective of this study is to determine the safety of discontinuing oral anticoagulation\n therapy in high risk patients who have had a successful cardiac ablation and remain AF\n recurrence free for 3 months post ablation.", + "Official_Title": "Safety of Oral Anticoagulation Therapy Withdrawal After Successful Cardiac Ablation in Patients With Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT Pilot Study)", + "Keywords": "Anticoagulation,oral,Paroxysmal Atrial Fibrillation,Patients post successful cardiac ablation,Symptomatic high-burden paroxysmal AF,3 months post procedure,Remain free from AF recurrence", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01959425" + }, + { + "id": 117, + "user_id": 1841382421, + "ct_id": "NCT01122173", + "Study_Type": "Interventional", + "trial_name": "Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "Ablation", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 150, + "trial sites": 13, + "sponsors": "Hansen Medical", + "status": "Terminated", + "Start_Date": "2013-07-01", + "End_Date": "2017-04-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Joseph Gallinghouse, M.D.;Andrea Natale, M.D.;Brenda Cayme, RN., BSN;Natale Andrea", + "Collaborator": "", + "Purpose": "The purpose of this study is to assess the safety and performance of the Hansen Medical\n Sensei Robotic System and Artisan Catheter when used to robotically manipulate RF ablation\n catheters for the treatment of paroxysmal atrial fibrillation (irregular heartbeats\n originating in the upper chambers of the heart).", + "Official_Title": "A Prospective, Single Arm Study of the Hansen System for Introducing and Positioning RF Ablation Catheters in Subjects With Paroxysmal Atrial Fibrillation", + "Keywords": "Atrial Fibrillation,Robotic Control,Remote Control,Guide Catheters", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01122173" + }, + { + "id": 118, + "user_id": 1841382421, + "ct_id": "NCT01672346", + "Study_Type": "Interventional", + "trial_name": "PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "PVAI followed by adenosine provocation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 188, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2013-05-01", + "End_Date": "2018-12-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "California Pacific Medical Center", + "Purpose": "In this prospective randomized study, we aim to compare the rate of PV reconnection following\n PVAI performed at different energy settings (30 Watts vs 40 Watts) where dormant PV\n conduction will be unmasked by adenosine-provocation.", + "Official_Title": "Pulmonary Vein (PV) Reconnection After Pulmonary Vein Antrm Isolation (PVAI) at Different Power Settings and Adenosine Provocation", + "Keywords": "PAF", + "MeSH_Terms": "Atrial Fibrillation,Adenosine", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01672346" + }, + { + "id": 119, + "user_id": 1841382421, + "ct_id": "NCT01672138", + "Study_Type": "Interventional", + "trial_name": "Pulmonary Vein Antrum Isolation (PVAI) Plus Isolation of Complex Fractionated Atrial Electrograms (CAFE) and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation", + "condition": "Persistent Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation", + "intervention": "Pulmonary Vein Antrum Isolation;CFAE ablation;Isolation of non-PV triggers", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 186, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2013-02-01", + "End_Date": "2018-12-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "RCCS Monzino Hospital, Milan, Italy,Ospedale dell'Angelo, Venezia-Mestre", + "Purpose": "This study aims to examine the long-term success rate of catheter ablation in non-paroxysmal\n atrial fibrillation patients using different ablation strategies such as 1) PVAI alone, 2)\n PVAI+ CFAE, 3) PVAI+ CFAE+ non-PV trigger ablation.\n\n [ PVAI: Pulmonary Vein Antrum Isolation CFAE: Complex Fractionated Atrial Electrograms Non-PV\n triggers: Triggers arising from sites other than pulmonary veins]", + "Official_Title": "PVAI Plus Isolation of CAFEs and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation", + "Keywords": "PVAI,CFAE,NPAF", + "MeSH_Terms": "Atrial Fibrillation,Recurrence", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01672138" + }, + { + "id": 120, + "user_id": 1841382421, + "ct_id": "NCT02076594", + "Study_Type": "Interventional", + "trial_name": "Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer", + "condition": "Locally Advanced Unresectable Gastric Cancer, Metastatic Gastric Cancer", + "intervention": "Docetaxel;Epirubicin;Oxaliplatin;Capecitabine", + "phase": "Phase 3", + "Role": "", + "enrollees": 171, + "trial sites": 25, + "sponsors": "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente", + "status": "Terminated", + "Start_Date": "2013-01-01", + "End_Date": "2018-12-31", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Roberto Labianca, MD;Enrico Cortesi, MD;Domenico Cristiano Corsi, MD;Pietro Sozzi, MD;Luigi Cavanna, MD;Domenico Bilancia, MD;Rosa Rita Silva, MD;Nicola Fazio, MD;Monica Giordano, MD;Alessandro Bertolini, MD;Giovanni Ucci, MD;Donato Natale, MD;Daris Ferrari, MD;Graziella Pinotti, MD;Ermanno Rondini, MD;Massimo Cirillo, MD;Rosario Vincenzo Iaffaioli, MD;Andrea Ciarlo, MD;Elena Piazza, MD;Libero Ciuffreda, MD;Stefania Dell'Oro, MD;Fabrizio Artioli, MD;Claudio Verusio, MD;Vincenzo Catalano, MD;Claudio Graiff, MD;Domenico Amoroso, MD;Maria Di Bartolomeo, MD;Nicola Silvestris, MD;Maria C. Zavettieri, MD;Enzo Veltri, MD;Francesco Ferraù, MD;Giampaolo Tortora, MD;Sandro Barni, MD;Mario Scartozzi, MD;Natale Andrea", + "Collaborator": "Regione Lombardia", + "Purpose": "", + "Official_Title": "A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer", + "Keywords": "", + "MeSH_Terms": "Stomach Neoplasms,Docetaxel,Capecitabine,Oxaliplatin,Epirubicin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT02076594" + }, + { + "id": 121, + "user_id": 1841382421, + "ct_id": "NCT01751607", + "Study_Type": "Observational", + "trial_name": "Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)", + "condition": "Atrial Fibrillation", + "intervention": "", + "phase": "", + "Role": "Study Director", + "enrollees": 400, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2012-12-01", + "End_Date": "2014-08-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Mitra Mohanty, MD;Natale Andrea", + "Collaborator": "University of Texas at Austin", + "Purpose": "This prospective study aims to examine the association of specific genetic variants (single\n nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary\n vein triggers (NPVT) as well as ablation-outcome in AF patients", + "Official_Title": "Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)", + "Keywords": "AF, catheter ablation, non-PV triggers, SNP", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01751607" + }, + { + "id": 122, + "user_id": 1841382421, + "ct_id": "NCT01747837", + "Study_Type": "Interventional", + "trial_name": "REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients", + "condition": "Ventricular Tachycardia", + "intervention": "", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 48, + "trial sites": 8, + "sponsors": "Vivek Reddy", + "status": "Completed", + "Start_Date": "2012-10-01", + "End_Date": "2021-10-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "Both", + "Investigators": "Vivek Reddy, MD;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The objective of this trial is to determine the efficacy and safety of adjunctive\n catheter-based renal sympathetic denervation (RSDN) in the primary prevention of ICD therapy\n in patients with ischemic or non-ischemic ventricular dysfunction, who are to receive an ICD\n for either i) secondary prevention, or ii) primary prevention + inducible VT by programmed\n ventricular stimulation at the time of ICD implantation. These patients will be randomized\n to ICD alone or ICD + RSDN.", + "Official_Title": "REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients", + "Keywords": "renal sympathetic denervation,renal catheter ablation,ventricular tachycardia", + "MeSH_Terms": "Tachycardia,Tachycardia, Ventricular", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01747837" + }, + { + "id": 123, + "user_id": 1841382421, + "ct_id": "NCT01687166", + "Study_Type": "Interventional", + "trial_name": "Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation", + "condition": "Paroxysmal Atrial Fibrillation (PAF)", + "intervention": "Blazer Open-Irrigated Ablation Catheter (Boston Scientific);FDA Approved Open-Irrigated Ablation Catheter", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 398, + "trial sites": 38, + "sponsors": "Boston Scientific Corporation", + "status": "Completed", + "Start_Date": "2012-10-01", + "End_Date": "2016-10-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, M.D.;Natale Andrea", + "Collaborator": "", + "Purpose": "The purpose of this study is to establish the safety and effectiveness of the Blazer\n Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory,\n recurrent, symptomatic, paroxysmal atrial fibrillation.", + "Official_Title": "Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation", + "Keywords": "Paroxysmal Atrial Fibrillation,Cardiac arrhythmias,Heart Disease,cardiovascular disease,radiofrequency ablation", + "MeSH_Terms": "Atrial Fibrillation,Acifluorfen", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01687166" + }, + { + "id": 124, + "user_id": 1841382421, + "ct_id": "NCT01635998", + "Study_Type": "Interventional", + "trial_name": "Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation", + "condition": "Uncontrolled Hypertension, Atrial Fibrillation", + "intervention": "", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 50, + "trial sites": 9, + "sponsors": "Vivek Reddy", + "status": "Completed", + "Start_Date": "2012-09-01", + "End_Date": "2021-09-01", + "Min_Age": "18 Years", + "Max_Age": "85 Years", + "Gender": "Both", + "Investigators": "Vivek Reddy, MD;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The objective of the H-FIB trial is to determine the role of renal sympathetic denervation\n in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension for\n whom a catheter-based AF ablation procedure is planned. Patients will be randomized to\n either AF catheter ablation (usual therapy) or AF catheter ablation plus renal sympathetic\n denervation.", + "Official_Title": "Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation", + "Keywords": "renal sympathetic denervation,renal catheter ablation,hypertension", + "MeSH_Terms": "Hypertension,Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01635998" + }, + { + "id": 125, + "user_id": 1841382421, + "ct_id": "NCT01660100", + "Study_Type": "Interventional", + "trial_name": "Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation", + "condition": "Atrial Fibrillation", + "intervention": "Pulmonary vein antrum isolation (PVAI);PVAI plus left atrial posterior wall (LAPW) isolation", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 400, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2012-07-01", + "End_Date": "2016-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Luigi Di Biase, MD, PhD;Claudio Tondo, MD;Rong Bai, MD;Natale Andrea", + "Collaborator": "Centro Cardiologico Monzino,Catholic University of the Sacred Heart,Capital Medical University", + "Purpose": "Objective: This prospective study aims to examine the outcome of atrial fibrillation (AF)\n ablation after permanent pulmonary vein antrum isolation or pulmonary vein antrum isolation\n plus left atrial posterior wall isolation is proven by a repeat procedure. The study will be\n conducted in patients with different types of AF: paroxysmal AF (PAF) and non-PAF (Persistent\n AF and Long Standing Persistent AF).\n\n Hypothesis: In addition to permanent pulmonary vein antrum isolation, proven isolation of\n left atrial posterior wall is associated with more freedom from atrial arrhythmia at\n long-term follow-up after atrial fibrillation ablation, especially in non-PAF patients.", + "Official_Title": "Freedom From Atrial Arrhythmia in Atrial Fibrillation Patients After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation", + "Keywords": "Atrial Fibrillation ablation", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01660100" + }, + { + "id": 126, + "user_id": 1841382421, + "ct_id": "NCT01557842", + "Study_Type": "Interventional", + "trial_name": "Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators", + "condition": "Ventricular Tachycardia, Ischemic", + "intervention": "Drug Treatment;Catheter Ablation", + "phase": "Phase 4", + "Role": "Study Chair", + "enrollees": 15, + "trial sites": 23, + "sponsors": "Biosense Webster, Inc.", + "status": "Terminated", + "Start_Date": "2012-06-01", + "End_Date": "2017-09-01", + "Min_Age": "18 Years", + "Max_Age": "N/A", + "Gender": "Both", + "Investigators": "David Callans, MD;Francis Marchlinski, MD;Andrea Natale, MD;Vivek Reddy, MD;David Wilber, MD;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The purpose of this study is to determine if early ablation (i.e., ablation of ventricular\n tachycardia in patients with infrequent VT episodes) is more effective than medical therapy\n alone for the treatment of ischemic ventricular tachycardia in patients with Implantable\n Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia\n despite drug therapy.", + "Official_Title": "Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators", + "Keywords": "Ischemic,ventricular tachycardia,Implantable Cardioverter Defibrillators,Antiarrhythmic Drug Therapy,Ablation,Electrophysiology", + "MeSH_Terms": "Ischemia,Tachycardia,Tachycardia, Ventricular", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01557842" + }, + { + "id": 127, + "user_id": 1841382421, + "ct_id": "NCT01696344", + "Study_Type": "Observational", + "trial_name": "Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?", + "condition": "Atrial Fibrillation", + "intervention": "PVAI;PVAI + ablation of extraPV triggers", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 60, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2012-05-01", + "End_Date": "2019-12-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "California Pacific Medical Center", + "Purpose": "This prospective study aims to investigate if termination of atrial fibrillation (AF) after\n pulmonary vein antrum isolation (PVAI) without additional ablation of non-PV triggers, in\n long-standing persistent (LSP) AF, is enough to ensure long-term success.", + "Official_Title": "Does AF Termination Without Additional Ablation Influence Outcome?", + "Keywords": "LSPAF,AF termination,PVAI,nonPV triggers,Long-standing persistent", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01696344" + }, + { + "id": 128, + "user_id": 1841382421, + "ct_id": "NCT01456000", + "Study_Type": "Interventional", + "trial_name": "Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)", + "condition": "Paroxysmal Atrial Fibrillation", + "intervention": "EAS-AC (HeartLight);Control Arm Ablation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 405, + "trial sites": 21, + "sponsors": "CardioFocus", + "status": "Completed", + "Start_Date": "2012-01-01", + "End_Date": "2016-06-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "Both", + "Investigators": "Burke Barrett;Vivek Reddy, MD;Andrea Natale, MD;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus\n Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial\n fibrillation by creating electrical isolation of the pulmonary veins.", + "Official_Title": "Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation", + "Keywords": "Atrial Fibrillation,AF,PAF,PVI,Ablation,Paroxysmal Atrial Fibrillation,pulmonary vein isolation", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01456000" + }, + { + "id": 129, + "user_id": 1841382421, + "ct_id": "NCT01439386", + "Study_Type": "Interventional", + "trial_name": "Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter", + "condition": "Atrial Arrhythmia, Quality of Life", + "intervention": "Catheter Ablation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 86, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2011-09-01", + "End_Date": "2016-07-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "Monzino Hospital, Milan, Italy,Ospedale dell'Angelo, Venezia-Mestre,Catholic University, Italy,University of Rome Tor Vergata", + "Purpose": "This prospective, multi-center, single blinded study aims to compare the influence of two\n different catheter ablation strategies, on long-term ablation outcome in terms of AF\n recurrence and quality of life (QoL) in patients presenting with coexistent AF and AFL. The\n two strategies to be evaluated are 1) the ablation of paroxysmal atrial fibrillation (PAF)\n with or without flutter (AFL) ablation (AF ± AFL) versus 2) AFL ablation alone.", + "Official_Title": "Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation,Atrial Flutter", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01439386" + }, + { + "id": 130, + "user_id": 1841382421, + "ct_id": "NCT01385202", + "Study_Type": "Interventional", + "trial_name": "THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation", + "condition": "Heart Diseases, Arrhythmia, Atrial Fibrillation", + "intervention": "THERMOCOOL® SMARTTOUCH™ Catheter", + "phase": "Phase 3", + "Role": "Study Chair", + "enrollees": 172, + "trial sites": 23, + "sponsors": "Biosense Webster, Inc.", + "status": "Completed", + "Start_Date": "2011-06-01", + "End_Date": "2013-05-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD;David J Wilber, MD;Francis E Marchlinski, MD;Douglas L Packer, MD;Hiroshi Nakagawa, MD, Ph.D.;Hans Kottkamp, MD;Douglas L Packer", + "Collaborator": "", + "Purpose": "The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL®\n SMARTTOUCH™ Catheters with Contact Force Sensing Capability in the treatment of drug\n refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology\n mapping and RF procedures.", + "Official_Title": "THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation", + "Keywords": "Atrial Fibrillation,Paroxysmal Atrial Fibrillation", + "MeSH_Terms": "Atrial Fibrillation,Heart Diseases", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01385202" + }, + { + "id": 131, + "user_id": 1841382421, + "ct_id": "NCT01391091", + "Study_Type": "Interventional", + "trial_name": "Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine", + "condition": "Migraine, Atrial Fibrillation", + "intervention": "Radiofrequency catheter ablation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 173, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-12-01", + "End_Date": "2014-04-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Luigi Di Biase, MD, Phd;Natale Andrea", + "Collaborator": "", + "Purpose": "The purpose of this prospective study is to evaluate the effect of catheter ablation on\n incidence, prevalence and disease-severity of migraine in AF patients undergoing ablation,\n with or without a history of migraine.", + "Official_Title": "Effect of Catheter Ablation on the Prevalence, Clinical Manifestation and MRI Findings of Migraine in AF Patients With or Without a Previous History of Migraine", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation,Migraine Disorders", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01391091" + }, + { + "id": 132, + "user_id": 1841382421, + "ct_id": "NCT01362738", + "Study_Type": "Interventional", + "trial_name": "Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation", + "condition": "Persistent Atrial Fibrillation", + "intervention": "RFCA of PV and extra-PV triggers;LAA isolation along with the conventional ablation strategy", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 156, + "trial sites": 2, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-11-01", + "End_Date": "2016-11-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "The purpose of this prospective randomized study is to assess whether empirical Left Atrial\n Appendage (LAA) isolation along with the standard approach of pulmonary vein isolation (PVI)\n and ablation of extra-pulmonary triggers is superior to the standard approach alone in\n enhancing the long-term success rate of catheter ablation in persistent or long-standing\n persistent atrial fibrillation (AF) patients.", + "Official_Title": "Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation", + "Keywords": "Long-standing persistent atrial fibrillation", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01362738" + }, + { + "id": 133, + "user_id": 1841382421, + "ct_id": "NCT01173809", + "Study_Type": "Interventional", + "trial_name": "Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation", + "condition": "Atrial Fibrillation", + "intervention": "Amiodarone", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 176, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-10-01", + "End_Date": "2014-07-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Luigi Di Biase, Md, PhD;Natale Andrea", + "Collaborator": "University of Kansas,California Pacific Medical Center,Stanford University,Case Western Reserve University,Southlake Regional Health Centre,Catholic University, Italy", + "Purpose": "This prospective randomized study aims to investigate the effect of continuous versus\n interrupted use of Amiodarone on the procedure outcome in long-standing persistent (LSP)\n atrial fibrillation patients undergoing pulmonary vein antral isolation (PVAI).", + "Official_Title": "Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation", + "Keywords": "AF,Catheter ablation,Recurrence of AF,Amiodarone", + "MeSH_Terms": "Atrial Fibrillation,Amiodarone", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01173809" + }, + { + "id": 134, + "user_id": 1841382421, + "ct_id": "NCT01097330", + "Study_Type": "Interventional", + "trial_name": "Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia", + "condition": "Defibrillators, Implantable, Tachycardia, Ventricular", + "intervention": "Ablation;Amiodarone", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 12, + "trial sites": 11, + "sponsors": "Population Health Research Institute", + "status": "Terminated", + "Start_Date": "2010-08-01", + "End_Date": "2014-12-01", + "Min_Age": "19 Years", + "Max_Age": "84 Years", + "Gender": "All", + "Investigators": "Andrea Natale, M.D.;David J Callans, M.D.;Carlos A. Morillo, M.D.;Girish M. Nair, M.D.;David J Callans", + "Collaborator": "Abbott Medical Devices,Hamilton Health Sciences Corporation", + "Purpose": "Implantable Cardioverter Defibrillators (ICDs) provide a shock or pacing therapy to bring\n back a normal heart beat when a patient experiences a dangerous abnormal heart rhythm such as\n ventricular tachycardia (VT). ICDs are very successful in bringing back a normal heart beat\n when VT occurs, but they do not prevent further dangerous heart rhythms from occurring. This\n study is designed to determine the best way to manage patients who have an ICD and who\n continue to have episodes of VT. There are two methods for treatment the VT: 1) Ablation, and\n 2) Medication.\n\n An ablation procedure involves placing a flexible catheter (insulated wire) in the groin area\n and threading it into the heart. After the doctor has located the affected area responsible\n for the VT, radiofrequency energy is delivered by the power generator through the catheter to\n the inside of the heart. The radiofrequency energy ablates (burns) a small area of the heart\n tissue thought to cause the VT.\n\n A medication called Amiodarone is an \"anti-arrhythmic\" prescribed to prevent abnormal heart\n rhythms from recurring.\n\n The purpose of this study is to compare these two different methods for treating VT.\n Treatment with ablation and amiodarone are both considered the standard of care for patients\n with VT but they have not been compared directly in a study like this before.", + "Official_Title": "Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial", + "Keywords": "Defibrillators, Implantable,Tachycardia, Ventricular,Catheter ablation,Amiodarone", + "MeSH_Terms": "Tachycardia,Tachycardia, Ventricular,Amiodarone", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01097330" + }, + { + "id": 135, + "user_id": 1841382421, + "ct_id": "NCT01148914", + "Study_Type": "Observational", + "trial_name": "The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation", + "condition": "Atrial Fibrillation", + "intervention": "Inflammatory biomarkers", + "phase": "", + "Role": "", + "enrollees": 48, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-06-01", + "End_Date": "2012-04-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Natale Andrea", + "Collaborator": "", + "Purpose": "", + "Official_Title": "The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation", + "Keywords": "inflammatory biomarkers,Atrial Fibrillation,Catheter ablation,To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of proce,To evaluate the inflammatory activation following catheter ablation and examine its predictive role ,To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlati,To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent o", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01148914" + }, + { + "id": 136, + "user_id": 1841382421, + "ct_id": "NCT01173796", + "Study_Type": "Interventional", + "trial_name": "Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes", + "condition": "Atrial Fibrillation, Perimitral Flutter", + "intervention": "Catheter Ablation", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 44, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-03-01", + "End_Date": "2011-09-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "", + "Purpose": "This prospective, randomized study aims to compare the impact of ablation of perimitral\n flutter only versus cardioversion and repeat isolation of pulmonary veins with ablation of\n additional triggers, on procedure outcome.", + "Official_Title": "Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes", + "Keywords": "", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01173796" + }, + { + "id": 137, + "user_id": 1841382421, + "ct_id": "NCT01006876", + "Study_Type": "Interventional", + "trial_name": "Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation", + "condition": "Thromboembolism", + "intervention": "Coumadin", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 1584, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-01-01", + "End_Date": "2014-04-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "University of Kansas,California Pacific Medical Center,Stanford University,Case Western Reserve University,Southlake Regional Health Centre,Catholic University, Italy", + "Purpose": "This study aims to explore the risk of periprocedural thromboembolic events in continuous\n versus interrupted Coumadin therapy in a large, randomized high-risk patient population\n undergoing radio-frequency catheter ablation for atrial fibrillation.", + "Official_Title": "Role of Coumadin in Preventing Periprocedural Thrombo-Embolism as a Complication of Radio Frequency Catheter Ablation in High-risk Atrial Fibrillation Patients", + "Keywords": "Coumadin,peri-procedural thromboembolism,RFCA,high risk atrial fibrillation", + "MeSH_Terms": "Atrial Fibrillation,Thromboembolism,Warfarin,Heparin, Low-Molecular-Weight,Dalteparin", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01006876" + }, + { + "id": 138, + "user_id": 1841382421, + "ct_id": "NCT01045668", + "Study_Type": "Interventional", + "trial_name": "Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation", + "condition": "Ventricular Tachycardia", + "intervention": "Radiofrequency Catheter Ablation (RFCA)", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 120, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2010-01-01", + "End_Date": "2014-07-01", + "Min_Age": "18 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD FACC FHRS;Natale Andrea", + "Collaborator": "University of Kansas,California Pacific Medical Center,Stanford University,Case Western Reserve University,Southlake Regional Health Centre,Catholic University, Italy,Ospedale dell'Angelo, Venezia-Mestre,RCCS Monzino Hospital, Milan, Italy,University of Rome Tor Vergata", + "Purpose": "This study aims to assess whether a combined technique of substrate ablation and ablation of\n the clinically presenting VT at the site of early activation is superior to ablation of the\n clinically presenting VT alone, in enhancing long-term success of VT ablation.", + "Official_Title": "Comparison of the Effect of Ablation of the Clinically Presenting Ventricular Tachycardia (VT) Only Versus the Addition of Substrate Ablation Based on Scar Mapping; on the Long Term Success Rate of VT Ablation", + "Keywords": "", + "MeSH_Terms": "Tachycardia,Tachycardia, Ventricular", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01045668" + }, + { + "id": 139, + "user_id": 1841382421, + "ct_id": "NCT01892774", + "Study_Type": "Observational", + "trial_name": "Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation", + "condition": "Chronic Atrial Fibrillation", + "intervention": "Radiofrequency catheter ablation", + "phase": "", + "Role": "Principal Investigator", + "enrollees": 150, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Unknown status", + "Start_Date": "2010-01-01", + "End_Date": "2019-12-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Natale Andrea", + "Collaborator": "University of Texas at Austin", + "Purpose": "This study would assess the impact of radio-frequency catheter ablation on exercise capacity\n and quality of life in long-standing persistent atrial fibrillation (LSP-AF) patients", + "Official_Title": "Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation", + "Keywords": "LSPAF,asymptomatic,exercise tolerance", + "MeSH_Terms": "Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01892774" + }, + { + "id": 140, + "user_id": 1841382421, + "ct_id": "NCT00911508", + "Study_Type": "Interventional", + "trial_name": "Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial", + "condition": "Atrial Fibrillation, Arrhythmia", + "intervention": "Left atrial ablation;Rate or Rhythm Control Therapy", + "phase": "Others", + "Role": "Principal Investigator", + "enrollees": 2204, + "trial sites": 118, + "sponsors": "Mayo Clinic", + "status": "Completed", + "Start_Date": "2009-11-13", + "End_Date": "2017-12-31", + "Min_Age": "18 Years", + "Max_Age": "90 Years", + "Gender": "All", + "Investigators": "Douglas L. Packer, M.D.;Kerry L. Lee, Ph.D.;Daniel B. Mark, M.D., MPH;Rich A. Robb, Ph.D. Phy;Yves D. Rosenberg, M.D., MPH;Daniel B Mark", + "Collaborator": "National Heart, Lung, and Blood Institute (NHLBI),Abbott Medical Devices,Biosense Webster, Inc.", + "Purpose": "The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial)\n CABANA Trial has the overall goal of establishing the appropriate roles for medical and\n ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the\n hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of\n eliminating atrial fibrillation (AF) will be superior to current state-of-the-art therapy\n with either rate control or rhythm control drugs for decreasing the incidence of the\n composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest\n in patients with untreated or incompletely treated AF.", + "Official_Title": "Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial", + "Keywords": "Atrial Fibrillation,Left Atrial Ablation,pulmonary vein isolation,Catheter ablation,Antiarrhythmic Drug Therapy", + "MeSH_Terms": "Atrial Fibrillation,Anti-Arrhythmia Agents", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00911508" + }, + { + "id": 141, + "user_id": 1841382421, + "ct_id": "NCT01378572", + "Study_Type": "Observational", + "trial_name": "Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy", + "condition": "Dilated Cardiomyopathy, Primary Prevention of Sudden Cardiac Death, Implantable Cardioverter Defibrillator", + "intervention": "", + "phase": "", + "Role": "", + "enrollees": 200, + "trial sites": 3, + "sponsors": "Catholic University of the Sacred Heart", + "status": "Unknown status", + "Start_Date": "2009-11-01", + "End_Date": "", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Santangeli Pasquale", + "Collaborator": "Texas Cardiac Arrhythmia Research Foundation,Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, Milan, Italy,Policlinico Casilino ASL RMB, Rome, Italy,Dell'Angelo Hospital, Mestre-Venice, Italy", + "Purpose": "With the present study the investigators intend to identify the morphologic and\n electrophysiologic substrate markers of increased arrhythmic risk in patients with dilated\n cardiomyopathy undergoing implantation of a defibrillator for the primary prevention of\n sudden cardiac death. Moreover, the investigators also aim to identify if there is any\n electrophysiological substrate modification at the time of the first arrhythmic event in\n these patients. To this aim, the investigators will prospectively correlate electroanatomic\n mapping and cardiac magnetic resonance findings with arrhythmic events, in order to identify\n substrate markers of increased arrhythmic risk in patients with dilated cardiomyopathy, who\n are therefore more likely to benefit from a defibrillator implantation. Furthermore,\n electroanatomic mapping will be repeated at the time of the first arrhythmic event and\n compared with that at baseline, in order to evaluate any electrophysiological substrate\n changes.", + "Official_Title": "", + "Keywords": "ICD,Sudden Cardiac Death,Mapping", + "MeSH_Terms": "Cardiomyopathies,Death,Cardiomyopathy, Dilated,Death, Sudden, Cardiac", + "Url": "http://clinicaltrials.gov/ct2/show/NCT01378572" + }, + { + "id": 142, + "user_id": 1841382421, + "ct_id": "NCT00729911", + "Study_Type": "Interventional", + "trial_name": "Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD", + "condition": "Heart Failure", + "intervention": "Atrial Fibrillation ablation;Amiodarone", + "phase": "Phase 4", + "Role": "Principal Investigator", + "enrollees": 203, + "trial sites": 1, + "sponsors": "Texas Cardiac Arrhythmia Research Foundation", + "status": "Completed", + "Start_Date": "2008-10-01", + "End_Date": "2018-12-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Andrea Natale, MD;Luigi Di Biase, MD, PhD;Natale Andrea", + "Collaborator": "Casa Sollievo della Sofferenza IRCCS,Catholic University, Italy,Southlake Regional Health Centre,Stanford University,University of Kansas,The University of Texas Medical Branch, Galveston,University of Foggia,Sutter Health", + "Purpose": "1. To determine if catheter-based atrial fibrillation (AF) ablation is superior to\n Amiodarone treatment for symptomatic persistent/permanent AF in ICD/CRTD patients with\n an impaired left ventricular function.\n\n 2. Hypothesis: AF ablation is better than Amiodarone for subjects with symptomatic\n persistent or permanent AF and impaired LV function in terms of recurrence of AF,\n quality of life, 6-minute walk distance, EF and total number of hospitalizations.", + "Official_Title": "Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD", + "Keywords": "Atrial Fibrillation ablation", + "MeSH_Terms": "Heart Failure,Atrial Fibrillation,Amiodarone", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00729911" + }, + { + "id": 143, + "user_id": 1841382421, + "ct_id": "NCT00477230", + "Study_Type": "Interventional", + "trial_name": "Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs", + "condition": "Atrial Fibrillation", + "intervention": "Endoscopic Ablation System;Standard Anti-arrhythmic Drug (AAD) Therapy", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 64, + "trial sites": 18, + "sponsors": "CardioFocus", + "status": "Terminated", + "Start_Date": "2007-03-01", + "End_Date": "2009-05-01", + "Min_Age": "18 Years", + "Max_Age": "80 Years", + "Gender": "Both", + "Investigators": "Vivek Reddy, MD;Andrea Natale, MD;Burke Barrett;Vivek K Reddy", + "Collaborator": "", + "Purpose": "The purpose of the study is to compare two types of treatment for atrial fibrillation (AF)\n that are designed to treat the symptoms of atrial fibrillation. The treatments being\n compared are:\n\n - A single catheter ablation procedure with the investigational EAS, a visually-guided,\n light-energy catheter\n\n - Standard drug therapy (antiarrhythmic drugs)\n\n To learn more about the CardioFocus ENABLE investigational clinical study, please contact\n the study site closest to you.\n\n Eligibility Criteria\n\n Persons with paroxysmal atrial fibrillation may be eligible for this study. Other study\n eligibility criteria include:\n\n - 18 to 80 years of age\n\n - Frequent episodes of AF\n\n - Failed at least 1 drug treatment for AF (beta-blockers or standard AADs)\n\n - Other criteria", + "Official_Title": "Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation (AF)", + "Keywords": "AF,PAF,Paroxysmal Atrial Fibrillation,Ablation,failed drugs", + "MeSH_Terms": "", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00477230" + }, + { + "id": 144, + "user_id": 1841382421, + "ct_id": "NCT00392054", + "Study_Type": "Interventional", + "trial_name": "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)", + "condition": "Atrial Fibrillation", + "intervention": "Pulmonary Vein Isolation performed by Catheter Ablation;Conventional Antiarrhythmic Drug Therapy", + "phase": "Phase 3", + "Role": "Principal Investigator", + "enrollees": 127, + "trial sites": 16, + "sponsors": "Population Health Research Institute", + "status": "Completed", + "Start_Date": "2006-08-01", + "End_Date": "2012-01-01", + "Min_Age": "19 Years", + "Max_Age": "75 Years", + "Gender": "All", + "Investigators": "Carlos A Morillo, MD;Natale Andrea, MD;Natale Andrea", + "Collaborator": "Johnson & Johnson", + "Purpose": "", + "Official_Title": "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment: A Multi-center Randomized Trial", + "Keywords": "Atrial Fibrillation,Paroxysmal,pulmonary vein isolation,ablation catheter,Anti-arrhythmic Drug Therapy,First Line Therapy", + "MeSH_Terms": "Atrial Fibrillation,Anti-Arrhythmia Agents", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00392054" + }, + { + "id": 145, + "user_id": 1841382421, + "ct_id": "NCT00599976", + "Study_Type": "Interventional", + "trial_name": "Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF)", + "condition": "Atrial Fibrillation, Congestive Heart Failure", + "intervention": "Pulmonary Vein Isolation", + "phase": "Others", + "Role": "", + "enrollees": 81, + "trial sites": 0, + "sponsors": "Azienda Policlinico Umberto I", + "status": "Completed", + "Start_Date": "2002-11-01", + "End_Date": "2006-11-01", + "Min_Age": "18 Years", + "Max_Age": "", + "Gender": "All", + "Investigators": "Natale Andrea", + "Collaborator": "The Cleveland Clinic", + "Purpose": "", + "Official_Title": "Randomized Controlled Trial of Pulmonary Vein Antrum Isolation vs. AV Node Ablation With Bi-Ventricular Pacing for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure (PABA CHF)", + "Keywords": "", + "MeSH_Terms": "Heart Failure,Atrial Fibrillation", + "Url": "http://clinicaltrials.gov/ct2/show/NCT00599976" + } + ], + "Speaker": [ + { + "id": 1, + "programtopic": "Topic", + "speakername": "Abbas11", + "role": "Member", + "evaluatorname": "Javed", + "programdate": "12/01/2024", + "created_at": "2024-07-29T14:18:29.000000Z", + "updated_at": "2024-07-29T14:18:29.000000Z" + }, + { + "id": 2, + "programtopic": "cardiology", + "speakername": "Abbas", + "role": "morderator", + "evaluatorname": "dd", + "programdate": "21-05-2002", + "created_at": "2024-07-29T14:19:36.000000Z", + "updated_at": "2024-07-29T14:19:36.000000Z" + } + ], + "Engagement": [ + { + "id": 1, + "hcpname": "Abraham", + "main thereutic area": "Main Ther 2 Eng", + "relationship with chiesi": "Acromegaly Team", + "level of engagement": "Easy to reach and open to collaboration", + "date": "07-06-2024", + "plan of action": "Far far away, behind the word mountains,", + "recorded by": "pooja", + "created_at": "2024-07-29T17:21:28.000000Z", + "updated_at": "2024-07-09T17:21:28.000000Z" + }, + { + "id": 2, + "hcpname": "Abraham11", + "main thereutic area": "Main Ther 1", + "relationship with chiesi": "Acromegaly Team11", + "level of engagement": "Easy to reach and open to collaboration", + "date": "05-08-2024", + "plan of action": "Far far away, behind the word mountains,", + "recorded by": "pooja", + "created_at": "2024-07-29T17:21:28.000000Z", + "updated_at": "2024-07-09T17:21:28.000000Z" + }, + { + "id": 3, + "hcpname": "pooja", + "main thereutic area": "pooja", + "relationship with chiesi": "pooja", + "level of engagement": "pooja", + "date": "07-08-2024", + "plan of action": "pooja", + "recorded by": "pooja", + "created_at": null, + "updated_at": null + }, + { + "id": 4, + "hcpname": "Abraham", + "main thereutic area": "Main Ther 2", + "relationship with chiesi": "Acromegaly Team", + "level of engagement": "Easy to reach and open to collaboration", + "date": "11-08-2024", + "plan of action": "Far far away, behind the word mountains,", + "recorded by": "pooja", + "created_at": "2024-07-29T17:21:28.000000Z", + "updated_at": "2024-07-09T17:21:28.000000Z" + } + ], + "Location": [ + { + "id": 1, + "user_id": 1447203401, + "Institution": "Icahn School of Medicine at Mount Sinai", + "Address": "1 Gustave L Levy Pl", + "City": "New York", + "State": "New York", + "Postal_code": 10029, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 2, + "user_id": 1639100928, + "Institution": "Baylor Scott & White Health", + "Address": "3434 Live Oak St", + "City": "Dallas", + "State": "Texas", + "Postal_code": 75204, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 3, + "user_id": 1639100928, + "Institution": "University of Mississippi Medical Center", + "Address": "2500 North State Street", + "City": "Jackson", + "State": "Mississippi", + "Postal_code": 39216, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 4, + "user_id": 1811967433, + "Institution": "UCLA Santa Monica Medical Center", + "Address": "10833 Le Conte Ave", + "City": "Los Angeles", + "State": "California", + "Postal_code": 90095, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 5, + "user_id": 1811967433, + "Institution": "Harbor-UCLA Faculty Practice Plan A Medical Group Inc.", + "Address": "21840 S Normandie Avenue, Suite 100", + "City": "Torrance", + "State": "California", + "Postal_code": 90502, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 6, + "user_id": 1811967433, + "Institution": "Prohealth Partners, A Medical Group", + "Address": "1124 W Carson St", + "City": "Torrance", + "State": "California", + "Postal_code": 90502, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 7, + "user_id": 1811967433, + "Institution": "Prohealth Partners, A Medical Group", + "Address": "21840 Normandie Ave", + "City": "Torrance", + "State": "California", + "Postal_code": 90502, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 8, + "user_id": 1811967433, + "Institution": "Prohealth Partners, A Medical Group", + "Address": "3816 Woodruff Ave", + "City": "Long Beach", + "State": "California", + "Postal_code": 90808, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 9, + "user_id": 1497893077, + "Institution": "Columbia University Irving Medical Center", + "Address": "161 Fort Washington Avenue, 6th Floor", + "City": "New York", + "State": "New York", + "Postal_code": 10032, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 10, + "user_id": 1841382421, + "Institution": "Texas Cardiac Arrhythmia Institute", + "Address": "3000 N. IH-35, Suite 720", + "City": "Austin", + "State": "Texas", + "Postal_code": 78705, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 11, + "user_id": 1841382421, + "Institution": "Texas Cardiac Arrhythmia", + "Address": "12221 N Mopac Expy", + "City": "Austin", + "State": "Texas", + "Postal_code": 78758, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 12, + "user_id": 1841382421, + "Institution": "Scripps Green Hospital", + "Address": "9896 Genesee Ave", + "City": "La Jolla", + "State": "California", + "Postal_code": 92037, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 13, + "user_id": 1841382421, + "Institution": "St Davids Heart And Vascular Pllc", + "Address": "3000 N Ih, 35 Suite 700", + "City": "Austin", + "State": "Texas", + "Postal_code": 78705, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 14, + "user_id": 1841382421, + "Institution": "St Davids Heart And Vascular Pllc", + "Address": "4316 James Casey St, Suite C201", + "City": "Austin", + "State": "Texas", + "Postal_code": 78745, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + }, + { + "id": 15, + "user_id": 1841382421, + "Institution": "Golden State Providers, A Medical Corporation", + "Address": "215 W Janss Rd", + "City": "Thousand Oaks", + "State": "California", + "Postal_code": 91360, + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "" + } + ], + "PhoneNo": [ + { + "id": 1, + "user_id": 1447203401, + "Phone type": "Office Phone", + "Locations": "Icahn School of Medicine at Mount Sinai", + "phone Number": "+12127317822", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 2, + "user_id": 1447203401, + "Phone type": "Office Phone", + "Locations": "Icahn School of Medicine at Mount Sinai", + "phone Number": "+12122417784", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 3, + "user_id": 1447203401, + "Phone type": "fax", + "Locations": "Icahn School of Medicine at Mount Sinai", + "phone Number": "+16465378547", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 4, + "user_id": 1447203401, + "Phone type": "Office Phone", + "Locations": "Icahn School of Medicine at Mount Sinai", + "phone Number": "+12126599691", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 5, + "user_id": 1639100928, + "Phone type": "Office Phone", + "Locations": "Baylor Scott & White Health", + "phone Number": "+12148202687", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 6, + "user_id": 1639100928, + "Phone type": "Office Phone", + "Locations": "Baylor Scott & White Health", + "phone Number": "+12148652700", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 7, + "user_id": 1639100928, + "Phone type": "Office Phone", + "Locations": "Baylor Scott & White Health", + "phone Number": "+16019841000", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 8, + "user_id": 1639100928, + "Phone type": "fax", + "Locations": "University of Mississippi Medical Center", + "phone Number": "+16316384170", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 9, + "user_id": 1639100928, + "Phone type": "Office Phone", + "Locations": "University of Mississippi Medical Center", + "phone Number": "+16314440650", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 10, + "user_id": 1811967433, + "Phone type": "Office Phone", + "Locations": "Prohealth Partners, A Medical Group", + "phone Number": "+13102225189", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 11, + "user_id": 1811967433, + "Phone type": "Office Phone", + "Locations": "Prohealth Partners, A Medical Group", + "phone Number": "+13102222773", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 12, + "user_id": 1811967433, + "Phone type": "fax", + "Locations": "Harbor-UCLA Faculty Practice Plan A Medical Group Inc.", + "phone Number": "+13107829652", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 13, + "user_id": 1811967433, + "Phone type": "Office Phone", + "Locations": "Harbor-UCLA Faculty Practice Plan A Medical Group Inc.", + "phone Number": "+13102225101", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 14, + "user_id": 1497893077, + "Phone type": "Office Phone", + "Locations": "Columbia University Irving Medical Center", + "phone Number": "+12123420444", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 15, + "user_id": 1497893077, + "Phone type": "Office Phone", + "Locations": "Columbia University Irving Medical Center", + "phone Number": "+12123054931", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 16, + "user_id": 1841382421, + "Phone type": "Answering Service", + "Locations": "Texas Cardiac Arrhythmia Institute", + "phone Number": "+15125442342", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 17, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Golden State Providers, A Medical Corporation", + "phone Number": "+18058529100", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 18, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Texas Cardiac Arrhythmia", + "phone Number": "+15125447111", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 19, + "user_id": 1841382421, + "Phone type": "fax", + "Locations": "Texas Cardiac Arrhythmia", + "phone Number": "+15124587879", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 20, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Texas Cardiac Arrhythmia", + "phone Number": "+15129011111", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 21, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Texas Cardiac Arrhythmia", + "phone Number": "+16153449551", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 22, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Scripps Green Hospital", + "phone Number": "+18584559100", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 23, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Texas Cardiac Arrhythmia", + "phone Number": "+18586264123", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + }, + { + "id": 24, + "user_id": 1841382421, + "Phone type": "Office Phone", + "Locations": "Texas Cardiac Arrhythmia Institute", + "phone Number": "+15125442342", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "" + } + ], + "Email": [ + { + "id": 1, + "user_id": 1447203401, + "Email Type": "Work", + "Email": "roxana.mehran@mountsinai.org", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 2, + "user_id": 1639100928, + "Email Type": "Work", + "Email": "javed.butler@bswhealth.org", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 3, + "user_id": 1639100928, + "Email Type": "Work", + "Email": "javed.butler@stonybrookmedicine.edu", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 4, + "user_id": 1639100928, + "Email Type": "Work", + "Email": "jbutler4@umc.edu", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 5, + "user_id": 1811967433, + "Email Type": "Work", + "Email": "Budoff@ucla.edu", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 6, + "user_id": 1497893077, + "Email Type": "Work", + "Email": "rth2@cumc.columbia.edu", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 7, + "user_id": 1497893077, + "Email Type": "Work", + "Email": "rth2@columbia.edu", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 8, + "user_id": 1841382421, + "Email Type": "Work", + "Email": "andrea.natale@hcahealthcare.com", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 9, + "user_id": 1841382421, + "Email Type": "Work", + "Email": "dr.natale@gmail.com", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + }, + { + "id": 10, + "user_id": 1841382421, + "Email Type": "Work", + "Email": "andrea.natale@stdavids.com", + "": "", + "__1": "", + "__2": "", + "__3": "", + "__4": "", + "__5": "", + "__6": "", + "__7": "" + } + ], + "Patent": [ + { + "id": 1, + "user_id": 1639100928, + "Patent Title": "cell therapy for the treatment of non-ischemic heart failure", + "Status": "RO PROCESSING COMPLETED-PLACED IN STORAGE" + }, + { + "id": 2, + "user_id": 1811967433, + "Patent Title": "method and apparatus for cardiac imaging with minimized cardiac motion artifact", + "Status": "Patented Case" + }, + { + "id": 3, + "user_id": 1841382421, + "Patent Title": "ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart", + "Status": "Patented Case" + } + ], + "Training": [ + { + "id": 32, + "user_id": 1639100928, + "Education Type": "Training", + "Institution Name": "Yale School of Medicine", + "Degree": "Residency", + "Specialty": "Internal Medicine", + "Time Frame": "1992 - 1994", + "Url1": "", + "Url2": "" + }, + { + "id": 33, + "user_id": 1639100928, + "Education Type": "Training", + "Institution Name": "Yale School of Medicine", + "Degree": "Chief Residency", + "Specialty": "Internal Medicine", + "Time Frame": "1994 - 1995", + "Url1": "", + "Url2": "" + }, + { + "id": 34, + "user_id": 1639100928, + "Education Type": "Training", + "Institution Name": "Vanderbilt University Medical Center", + "Degree": "Fellowship", + "Specialty": "Cardiovascular Disease", + "Time Frame": "1995 - 1997", + "Url1": "", + "Url2": "" + }, + { + "id": 35, + "user_id": 1639100928, + "Education Type": "Training", + "Institution Name": "Vanderbilt University Medical Center", + "Degree": "Fellowship", + "Specialty": "Heart Failure and Transplant", + "Time Frame": "1997 - 1998", + "Url1": "", + "Url2": "" + }, + { + "id": 36, + "user_id": 1639100928, + "Education Type": "Training", + "Institution Name": "Massachusetts General Hospital", + "Degree": "Fellowship", + "Specialty": "Cardiac Imaging", + "Time Frame": "2005 - 2006", + "Url1": "", + "Url2": "" + }, + { + "id": 44, + "user_id": 1811967433, + "Education Type": "Training", + "Institution Name": "Harbor UCLA Medical Center", + "Degree": "Internship", + "Specialty": "Internal Medicine", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 45, + "user_id": 1811967433, + "Education Type": "Training", + "Institution Name": "Harbor UCLA Medical Center", + "Degree": "Residency", + "Specialty": "Internal Medicine", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 46, + "user_id": 1811967433, + "Education Type": "Training", + "Institution Name": "Harbor UCLA Medical Center", + "Degree": "Fellowship", + "Specialty": "Cardiology", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 51, + "user_id": 1497893077, + "Education Type": "Training", + "Institution Name": "Columbia University Irving Medical Center", + "Degree": "Residency", + "Specialty": "Internal Medicine", + "Time Frame": "1984 - 1985", + "Url1": "", + "Url2": "" + }, + { + "id": 52, + "user_id": 1497893077, + "Education Type": "Training", + "Institution Name": "Columbia University Irving Medical Center", + "Degree": "Fellowship", + "Specialty": "Internal Medicine", + "Time Frame": "1985 - 1987", + "Url1": "", + "Url2": "" + }, + { + "id": 53, + "user_id": 1497893077, + "Education Type": "Training", + "Institution Name": "Columbia University Irving Medical Center", + "Degree": "Fellowship", + "Specialty": "Cardiovascular Disease", + "Time Frame": "1987 - 1990", + "Url1": "", + "Url2": "" + }, + { + "id": 69, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "Western University Schulich School of Medicine & Dentistry", + "Degree": "Fellowship", + "Specialty": "Cardiology and Cardiac Electrophysiology", + "Time Frame": 1992, + "Url1": "", + "Url2": "" + }, + { + "id": 70, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "University of Wisconsin, Sinai Samaritan Medical Center", + "Degree": "Fellowship", + "Specialty": "Electrophysiology", + "Time Frame": 1993, + "Url1": "", + "Url2": "" + }, + { + "id": 71, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "Università Cattolica del Sacro Cuore", + "Degree": "Residency", + "Specialty": "Cardiology", + "Time Frame": "1985 - 1989", + "Url1": "", + "Url2": "" + }, + { + "id": 89, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "CHI St. Luke's Health Baylor St. Luke's Medical Center", + "Degree": "Fellowship", + "Specialty": "Cardiology", + "Time Frame": 1989, + "Url1": "", + "Url2": "" + }, + { + "id": 90, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "Catholic University of Sacred Heart", + "Degree": "Residency", + "Specialty": "Cardiology", + "Time Frame": "1985 - 1989", + "Url1": "", + "Url2": "" + }, + { + "id": 91, + "user_id": 1841382421, + "Education Type": "Training", + "Institution Name": "University of Florence Faculty of Medicine and Surgery", + "Degree": "Internship", + "Specialty": "Medicine", + "Time Frame": "1979 - 1985", + "Url1": "", + "Url2": "" + } + ], + "Education": [ + { + "id": 4, + "user_id": 1447203401, + "Education Type": "Education", + "Institution Name": "St. George's University Medical School", + "Degree": "MD", + "Specialty": "", + "Time Frame": 1987, + "Url1": "", + "Url2": "" + }, + { + "id": 5, + "user_id": 1447203401, + "Education Type": "Education", + "Institution Name": "New York University", + "Degree": "BA", + "Specialty": "Chemistry", + "Time Frame": "1979 - 1983", + "Url1": "", + "Url2": "" + }, + { + "id": 29, + "user_id": 1639100928, + "Education Type": "Education", + "Institution Name": "The Aga Khan University", + "Degree": "MBBS", + "Specialty": "", + "Time Frame": "1985 - 1990", + "Url1": "", + "Url2": "" + }, + { + "id": 30, + "user_id": 1639100928, + "Education Type": "Education", + "Institution Name": "Harvard T.H. Chan School of Public Health", + "Degree": "MPH", + "Specialty": "", + "Time Frame": "1996 - 1998", + "Url1": "", + "Url2": "" + }, + { + "id": 31, + "user_id": 1639100928, + "Education Type": "Education", + "Institution Name": "Emory University Goizueta Business School", + "Degree": "MBA", + "Specialty": "", + "Time Frame": "2013 - 2015", + "Url1": "", + "Url2": "" + }, + { + "id": 40, + "user_id": 1811967433, + "Education Type": "Education", + "Institution Name": "George Washington University School of Medicine and Health Sciences", + "Degree": "MD", + "Specialty": "", + "Time Frame": 1990, + "Url1": "", + "Url2": "" + }, + { + "id": 43, + "user_id": 1811967433, + "Education Type": "Education", + "Institution Name": "University Of California, Riverside", + "Degree": "Undergradute Degree (Cum Luade)", + "Specialty": "Biochemistry", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 50, + "user_id": 1497893077, + "Education Type": "Education", + "Institution Name": "Washington University School of Medicine in St. Louis", + "Degree": "MD", + "Specialty": "", + "Time Frame": "1980 - 1984", + "Url1": "", + "Url2": "" + }, + { + "id": 56, + "user_id": 1497893077, + "Education Type": "Education", + "Institution Name": "Harvard University", + "Degree": "BS", + "Specialty": "Biological Sciences", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 63, + "user_id": 1841382421, + "Education Type": "Education", + "Institution Name": "Università degli Studi di Firenze Facoltà di Medicina e Chirurgia", + "Degree": "MD(Summa Cum Laude)", + "Specialty": "", + "Time Frame": "1979 - 1985", + "Url1": "", + "Url2": "" + } + ], + "Awards": [ + { + "id": 6, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FACC", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 7, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FACP", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 8, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FCCP", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 9, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FESC", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 10, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FAHA", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 11, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "FSCAI", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 12, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "MSCAI", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 16, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Ellis Island Medal of Honor", + "Degree": "", + "Specialty": "", + "Time Frame": 2019, + "Url1": "", + "Url2": "" + }, + { + "id": 17, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Andreas Gruntzig Award and Silver Medal, European Society of Cardiology", + "Degree": "", + "Specialty": "", + "Time Frame": 2019, + "Url1": "", + "Url2": "" + }, + { + "id": 18, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Nanette Wenger Award for Excellence in Medical Leadership", + "Degree": "", + "Specialty": "", + "Time Frame": 2018, + "Url1": "", + "Url2": "" + }, + { + "id": 19, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Bernadine Healy Leadership in Women's CV Disease Distinguished Award, American College of Cardiology Foundation", + "Degree": "", + "Specialty": "", + "Time Frame": 2017, + "Url1": "", + "Url2": "" + }, + { + "id": 20, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Most Cited Researchers – Top 1%, Clarivate Analytics", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 21, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "The World’s Most Influential Scientific Minds, Thomson Reuters list", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 22, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Terry Ann Krulwich Physician-Scientist Alumni Award, Icahn School of Medicine at Mount Sinai", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 23, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Linda Joy Pollin Heart Health Leadership Award", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 24, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Doctor Honoris Causa, Università della Svizzera Italiana", + "Degree": "", + "Specialty": "", + "Time Frame": 2022, + "Url1": "", + "Url2": "" + }, + { + "id": 25, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "America's Top Doctors, Castle Connolly", + "Degree": "", + "Specialty": "", + "Time Frame": "2016 - 2021", + "Url1": "", + "Url2": "" + }, + { + "id": 26, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Top Doctors: New York Metro Area, Castle Connolly", + "Degree": "", + "Specialty": "", + "Time Frame": "2016 - 2022", + "Url1": "", + "Url2": "" + }, + { + "id": 27, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Exceptional Women In Medicine", + "Degree": "", + "Specialty": "", + "Time Frame": "2019 - 2021", + "Url1": "", + "Url2": "" + }, + { + "id": 28, + "user_id": 1447203401, + "Education Type": "Honors and Awards", + "Institution Name": "Top Doctors, New York Magazine", + "Degree": "", + "Specialty": "", + "Time Frame": "2014 - 2022", + "Url1": "", + "Url2": "" + }, + { + "id": 49, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "FACC", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 54, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "FESC", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 55, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "FASE", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 57, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "Fellow of the Glenda Garvey Teaching Academy, Columbia University Vagelos College of Physicians and Surgeons", + "Degree": "", + "Specialty": "", + "Time Frame": 2010, + "Url1": "", + "Url2": "" + }, + { + "id": 58, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "Richard Popp Excellence in Teaching Award, American Society of Echocardiography", + "Degree": "", + "Specialty": "", + "Time Frame": 2009, + "Url1": "", + "Url2": "" + }, + { + "id": 59, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "Scholarship Achievement Citation, American Medical Women’s Association, Inc.", + "Degree": "", + "Specialty": "", + "Time Frame": 1984, + "Url1": "", + "Url2": "" + }, + { + "id": 60, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "Award, Alpha Omega Alpha Honor Medical Society", + "Degree": "", + "Specialty": "", + "Time Frame": 1984, + "Url1": "", + "Url2": "" + }, + { + "id": 61, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "Irwin Levy Prize in Neurology and Neurologic Surgery Award", + "Degree": "", + "Specialty": "", + "Time Frame": 1983, + "Url1": "", + "Url2": "" + }, + { + "id": 62, + "user_id": 1497893077, + "Education Type": "Honors and Awards", + "Institution Name": "All-American: Women’s Squash", + "Degree": "", + "Specialty": "", + "Time Frame": 1980, + "Url1": "", + "Url2": "" + }, + { + "id": 72, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Eric N. Prystowsky, MD Advocate for Patients award, StopAfib.org", + "Degree": "", + "Specialty": "", + "Time Frame": 2017, + "Url1": "", + "Url2": "" + }, + { + "id": 73, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "PTV Star of Texas Healthcare Award, PTV Healthcare Capital", + "Degree": "", + "Specialty": "", + "Time Frame": 2018, + "Url1": "", + "Url2": "" + }, + { + "id": 74, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Fundación Cardioinfantil Instituto De Cardiologia Award, Fundación Cardio Infantil - Instituto de Cardiología", + "Degree": "", + "Specialty": "", + "Time Frame": 2011, + "Url1": "", + "Url2": "" + }, + { + "id": 75, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "The Best Doctors in America", + "Degree": "", + "Specialty": "", + "Time Frame": "2011 - 2012", + "Url1": "", + "Url2": "" + }, + { + "id": 76, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "The Bury + Partners Innovation Award, St. Davids Medical Center", + "Degree": "", + "Specialty": "", + "Time Frame": 2009, + "Url1": "", + "Url2": "" + }, + { + "id": 77, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Best Doctors, Austin Monthly Magazine", + "Degree": "", + "Specialty": "", + "Time Frame": 2009, + "Url1": "", + "Url2": "" + }, + { + "id": 78, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Best Doctors", + "Degree": "", + "Specialty": "", + "Time Frame": "2003 - 2008", + "Url1": "", + "Url2": "" + }, + { + "id": 79, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Cleveland Top Doctor, Northern Ohio Live", + "Degree": "", + "Specialty": "", + "Time Frame": "2004 - 2007", + "Url1": "", + "Url2": "" + }, + { + "id": 80, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Best Doctors in America, Cleveland Magazine", + "Degree": "", + "Specialty": "", + "Time Frame": "2004 - 2006", + "Url1": "", + "Url2": "" + }, + { + "id": 81, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Innovator Award, The Cleveland Clinic Foundation", + "Degree": "", + "Specialty": "", + "Time Frame": "2004 - 2006", + "Url1": "", + "Url2": "" + }, + { + "id": 82, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Cleveland Clinic Bakken Heart-Brain Institute Research Award", + "Degree": "", + "Specialty": "", + "Time Frame": 2005, + "Url1": "", + "Url2": "" + }, + { + "id": 83, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "American College of Cardiology Travel Award, American College of Cardiology Foundation", + "Degree": "", + "Specialty": "", + "Time Frame": 1994, + "Url1": "", + "Url2": "" + }, + { + "id": 84, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Travel Award, North American Society of Pacing and Electrophysiology", + "Degree": "", + "Specialty": "", + "Time Frame": 1993, + "Url1": "", + "Url2": "" + }, + { + "id": 85, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "FESC", + "Degree": "", + "Specialty": "", + "Time Frame": 2010, + "Url1": "", + "Url2": "" + }, + { + "id": 86, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "FACC", + "Degree": "", + "Specialty": "", + "Time Frame": 2006, + "Url1": "", + "Url2": "" + }, + { + "id": 87, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "FHRS", + "Degree": "", + "Specialty": "", + "Time Frame": "", + "Url1": "", + "Url2": "" + }, + { + "id": 88, + "user_id": 1841382421, + "Education Type": "Honors and Awards", + "Institution Name": "Frist Humanitarian Award, HCA Foundation", + "Degree": "", + "Specialty": "", + "Time Frame": 2012, + "Url1": "", + "Url2": "" + } + ], + "Certificate": [ + { + "id": 1, + "user_id": 1447203401, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Internal Medicine", + "Time Frame": 1990, + "Url1": "", + "Url2": "" + }, + { + "id": 2, + "user_id": 1447203401, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Cardiovascular Disease", + "Time Frame": 1997, + "Url1": "", + "Url2": "" + }, + { + "id": 3, + "user_id": 1447203401, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Interventional Cardiology", + "Time Frame": 1999, + "Url1": "", + "Url2": "" + }, + { + "id": 37, + "user_id": 1639100928, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Internal Medicine", + "Time Frame": 1994, + "Url1": "", + "Url2": "" + }, + { + "id": 38, + "user_id": 1639100928, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Cardiovascular Disease", + "Time Frame": 1998, + "Url1": "", + "Url2": "" + }, + { + "id": 39, + "user_id": 1639100928, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Advanced Heart Failure and Transplant Cardiology", + "Time Frame": 2010, + "Url1": "", + "Url2": "" + }, + { + "id": 41, + "user_id": 1811967433, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Internal Medicine", + "Time Frame": 1993, + "Url1": "", + "Url2": "" + }, + { + "id": 42, + "user_id": 1811967433, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Cardiovascular Disease", + "Time Frame": 1997, + "Url1": "", + "Url2": "" + }, + { + "id": 47, + "user_id": 1497893077, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Internal Medicine", + "Time Frame": 1987, + "Url1": "", + "Url2": "" + }, + { + "id": 48, + "user_id": 1497893077, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Cardiovascular Disease", + "Time Frame": 1989, + "Url1": "", + "Url2": "" + }, + { + "id": 64, + "user_id": 1841382421, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Cardiovascular Disease", + "Time Frame": 2000, + "Url1": "", + "Url2": "" + }, + { + "id": 65, + "user_id": 1841382421, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Clinical Cardiac Electrophysiology", + "Time Frame": 2001, + "Url1": "", + "Url2": "" + }, + { + "id": 66, + "user_id": 1841382421, + "Education Type": "Board Certification", + "Institution Name": "American Board of Internal Medicine", + "Degree": "", + "Specialty": "Internal Medicine", + "Time Frame": 1999, + "Url1": "", + "Url2": "" + }, + { + "id": 67, + "user_id": 1841382421, + "Education Type": "Board Certification", + "Institution Name": "Italian Board of Medicine", + "Degree": "", + "Specialty": "Medicine", + "Time Frame": 1985, + "Url1": "", + "Url2": "" + }, + { + "id": 68, + "user_id": 1841382421, + "Education Type": "Board Certification", + "Institution Name": "Italian Board of Cardiology", + "Degree": "", + "Specialty": "Cardiology", + "Time Frame": 1989, + "Url1": "", + "Url2": "" + } + ], + "NIHGrants": [ + { + "user_id": 1811967433, + "pi_id": 6197477, + "pi_names": "BUDOFF, MATTHEW J;", + "first_name": "MATTHEW", + "middle_name": "J", + "last_name": "BUDOFF", + "Organization Name": "LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER", + "Department Name": "", + "org_city": "TORRANCE", + "org_state": "CA", + "Study/Purpose": "Coronary Artery Calcium, Aortic Calcification and Density in MESA", + "NIH Center/Institute": "NATIONAL HEART, LUNG, AND BLOOD INSTITUTE", + "total_cost": "7,73,354", + "project_start": "04-01-2020", + "project_end": "03/31/2024", + "budget_start": "03/27/2020", + "budget_end": "04-01-2020", + "created_on": "40:50.0" + }, + { + "user_id": 1811967433, + "pi_id": 6197477, + "pi_names": "BUDOFF, MATTHEW J;", + "first_name": "MATTHEW", + "middle_name": "J", + "last_name": "BUDOFF", + "Organization Name": "UNIVERSITY OF ILLINOIS AT CHICAGO", + "Department Name": "INTERNAL MEDICINE/MEDICINE", + "org_city": "Chicago", + "org_state": "IL", + "Study/Purpose": "Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults", + "NIH Center/Institute": "NATIONAL HEART, LUNG, AND BLOOD INSTITUTE", + "total_cost": "43,76,445", + "project_start": "01-01-2021", + "project_end": "12-31-2025", + "budget_start": "01-01-2021", + "budget_end": "12-31-2025", + "created_on": "40:50.0" + }, + { + "user_id": 1811967433, + "pi_id": 6197477, + "pi_names": "BUDOFF, MATTHEW J;", + "first_name": "MATTHEW", + "middle_name": "J", + "last_name": "BUDOFF", + "Organization Name": "GENERAL ELECTRIC GLOBAL RESEARCH CTR", + "Department Name": "", + "org_city": "", + "org_state": "", + "Study/Purpose": "Cardiac CT Deblooming", + "NIH Center/Institute": "NATIONAL HEART, LUNG, AND BLOOD INSTITUTE", + "total_cost": "9,45,933", + "project_start": "01-01-2020", + "project_end": "12-31-2024", + "budget_start": "01-01-2020", + "budget_end": "12-31-2024", + "created_on": "40:50.0" + } + ], + "Procedure": [ + { + "user_id": 1447203401, + "Procedure code": 93000, + "Procedure": "Routine ekg using at least 12 leads including interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 19, + "Total_bene_day_services": 18, + "Program year": 2021 + }, + { + "user_id": 1447203401, + "Procedure code": 93000, + "Procedure": "Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 13, + "Total Services": 28, + "Total_bene_day_services": 27, + "Program year": 2022 + }, + { + "user_id": 1447203401, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, 20-29 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 22, + "Total_bene_day_services": 22, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 76377, + "Procedure": "3d radiographic procedure with computerized image postprocessing", + "Place of Service": "Facility", + "Total Beneficiaries": 17, + "Total Services": 17, + "Total_bene_day_services": 17, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 97, + "Total Services": 116, + "Total_bene_day_services": 116, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 143, + "Total Services": 159, + "Total_bene_day_services": 159, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93312, + "Procedure": "Insertion of probe in esophagus for heart ultrasound examination including interpretation and report", + "Place of Service": "Facility", + "Total Beneficiaries": 57, + "Total Services": 58, + "Total_bene_day_services": 58, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93320, + "Procedure": "Doppler ultrasound study of heart blood flow, valves, and chambers", + "Place of Service": "Facility", + "Total Beneficiaries": 55, + "Total Services": 56, + "Total_bene_day_services": 56, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93325, + "Procedure": "Doppler ultrasound study of color-directed heart blood flow, rate, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 55, + "Total Services": 56, + "Total_bene_day_services": 56, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 93355, + "Procedure": "Insertion of probe in esophagus for heart ultrasound examination during procedure on heart or great blood vessel via catheter", + "Place of Service": "Facility", + "Total Beneficiaries": 87, + "Total Services": 88, + "Total_bene_day_services": 88, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 99152, + "Procedure": "Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2020 + }, + { + "user_id": 1497893077, + "Procedure code": 76377, + "Procedure": "3d radiographic procedure with computerized image postprocessing", + "Place of Service": "Facility", + "Total Beneficiaries": 21, + "Total Services": 21, + "Total_bene_day_services": 21, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 105, + "Total Services": 117, + "Total_bene_day_services": 117, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 189, + "Total Services": 204, + "Total_bene_day_services": 204, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93312, + "Procedure": "Insertion of probe in esophagus for heart ultrasound examination including interpretation and report", + "Place of Service": "Facility", + "Total Beneficiaries": 48, + "Total Services": 49, + "Total_bene_day_services": 49, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93320, + "Procedure": "Doppler ultrasound study of heart blood flow, valves, and chambers", + "Place of Service": "Facility", + "Total Beneficiaries": 49, + "Total Services": 50, + "Total_bene_day_services": 50, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93320, + "Procedure": "Doppler ultrasound study of heart blood flow, valves, and chambers", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93325, + "Procedure": "Doppler ultrasound study of color-directed heart blood flow, rate, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 49, + "Total Services": 50, + "Total_bene_day_services": 50, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93325, + "Procedure": "Doppler ultrasound study of color-directed heart blood flow, rate, and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 12, + "Total_bene_day_services": 12, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 93355, + "Procedure": "Insertion of probe in esophagus for heart ultrasound examination during procedure on heart or great blood vessel via catheter", + "Place of Service": "Facility", + "Total Beneficiaries": 109, + "Total Services": 109, + "Total_bene_day_services": 109, + "Program year": 2021 + }, + { + "user_id": 1497893077, + "Procedure code": 76377, + "Procedure": "3d radiographic procedure with computerized image postprocessing", + "Place of Service": "Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound of heart with color-depicted blood flow, rate, direction and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 62, + "Total Services": 75, + "Total_bene_day_services": 75, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93306, + "Procedure": "Ultrasound of heart with color-depicted blood flow, rate, direction and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 94, + "Total Services": 101, + "Total_bene_day_services": 101, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93312, + "Procedure": "Ultrasound of heart with probe in esophagus, with report", + "Place of Service": "Facility", + "Total Beneficiaries": 43, + "Total Services": 43, + "Total_bene_day_services": 43, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93320, + "Procedure": "Ultrasound of heart blood flow, valves and chambers", + "Place of Service": "Facility", + "Total Beneficiaries": 43, + "Total Services": 43, + "Total_bene_day_services": 43, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93325, + "Procedure": "Ultrasound of heart with color-depicted blood flow, rate and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 36, + "Total Services": 36, + "Total_bene_day_services": 36, + "Program year": 2022 + }, + { + "user_id": 1497893077, + "Procedure code": 93355, + "Procedure": "Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report", + "Place of Service": "Facility", + "Total Beneficiaries": 104, + "Total Services": 105, + "Total_bene_day_services": 105, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": "0504T", + "Procedure": "Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 70498, + "Procedure": "Ct scan of neck blood vessels with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 129, + "Total Services": 129, + "Total_bene_day_services": 129, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 71250, + "Procedure": "Ct scan chest", + "Place of Service": "Non Facility", + "Total Beneficiaries": 55, + "Total Services": 57, + "Total_bene_day_services": 57, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 71270, + "Procedure": "Ct scan chest before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 16, + "Total Services": 16, + "Total_bene_day_services": 16, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 71275, + "Procedure": "Ct scan of blood vessels in chest with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 32, + "Total Services": 33, + "Total_bene_day_services": 33, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 74176, + "Procedure": "Ct scan of abdomen and pelvis", + "Place of Service": "Non Facility", + "Total Beneficiaries": 28, + "Total Services": 28, + "Total_bene_day_services": 28, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 74177, + "Procedure": "Ct scan of abdomen and pelvis with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 15, + "Total Services": 24, + "Total_bene_day_services": 24, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 74178, + "Procedure": "Ct scan of abdomen and pelvis before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 75571, + "Procedure": "Ct scan of heart with evaluation of blood vessel calcium", + "Place of Service": "Non Facility", + "Total Beneficiaries": 309, + "Total Services": 309, + "Total_bene_day_services": 309, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 75574, + "Procedure": "Ct scan of heart blood vessels and grafts with contrast dye", + "Place of Service": "Non Facility", + "Total Beneficiaries": 462, + "Total Services": 467, + "Total_bene_day_services": 467, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 76377, + "Procedure": "3d radiographic procedure with computerized image postprocessing", + "Place of Service": "Non Facility", + "Total Beneficiaries": 177, + "Total Services": 191, + "Total_bene_day_services": 177, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 77078, + "Procedure": "Ct scan bone mineral density study 1 or more sites", + "Place of Service": "Non Facility", + "Total Beneficiaries": 120, + "Total Services": 120, + "Total_bene_day_services": 120, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 86328, + "Procedure": "Ia nfct ab sarscov2 covid19", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 43, + "Total Services": 44, + "Total_bene_day_services": 44, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 34, + "Total Services": 39, + "Total_bene_day_services": 39, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 96374, + "Procedure": "Injection of drug or substance into a vein for therapy, diagnosis, or prevention", + "Place of Service": "Non Facility", + "Total Beneficiaries": 66, + "Total Services": 67, + "Total_bene_day_services": 67, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 99204, + "Procedure": "New patient office or other outpatient visit, typically 45 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 33, + "Total Services": 33, + "Total_bene_day_services": 33, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 99211, + "Procedure": "Established patient office or other outpatient visit, typically 5 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, typically 15 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 17, + "Total Services": 21, + "Total_bene_day_services": 21, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": 99214, + "Procedure": "Established patient office or other outpatient, visit typically 25 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 43, + "Total Services": 61, + "Total_bene_day_services": 61, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": "J3490", + "Procedure": "Unclassified drugs", + "Place of Service": "Non Facility", + "Total Beneficiaries": 58, + "Total Services": 402, + "Total_bene_day_services": 59, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": "Q9967", + "Procedure": "Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml", + "Place of Service": "Non Facility", + "Total Beneficiaries": 507, + "Total Services": 53641, + "Total_bene_day_services": 523, + "Program year": 2020 + }, + { + "user_id": 1811967433, + "Procedure code": "0504T", + "Procedure": "Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review", + "Place of Service": "Non Facility", + "Total Beneficiaries": 22, + "Total Services": 22, + "Total_bene_day_services": 22, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 70498, + "Procedure": "Ct scan of neck blood vessels with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 54, + "Total Services": 54, + "Total_bene_day_services": 54, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 71250, + "Procedure": "Diagnostic ct scan of chest", + "Place of Service": "Non Facility", + "Total Beneficiaries": 44, + "Total Services": 44, + "Total_bene_day_services": 44, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 71270, + "Procedure": "Diagnostic ct scan of chest before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 27, + "Total Services": 28, + "Total_bene_day_services": 28, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 71275, + "Procedure": "Ct scan of blood vessels in chest with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 14, + "Total Services": 14, + "Total_bene_day_services": 14, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 74176, + "Procedure": "Ct scan of abdomen and pelvis", + "Place of Service": "Non Facility", + "Total Beneficiaries": 17, + "Total Services": 17, + "Total_bene_day_services": 17, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 74177, + "Procedure": "Ct scan of abdomen and pelvis with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 15, + "Total_bene_day_services": 15, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 74178, + "Procedure": "Ct scan of abdomen and pelvis before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 37, + "Total Services": 37, + "Total_bene_day_services": 37, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 75571, + "Procedure": "Ct scan of heart with evaluation of blood vessel calcium", + "Place of Service": "Non Facility", + "Total Beneficiaries": 585, + "Total Services": 587, + "Total_bene_day_services": 587, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 75574, + "Procedure": "Ct scan of heart blood vessels and grafts with contrast dye", + "Place of Service": "Non Facility", + "Total Beneficiaries": 721, + "Total Services": 722, + "Total_bene_day_services": 722, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 77078, + "Procedure": "Ct scan bone mineral density study 1 or more sites", + "Place of Service": "Non Facility", + "Total Beneficiaries": 161, + "Total Services": 161, + "Total_bene_day_services": 161, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 58, + "Total Services": 59, + "Total_bene_day_services": 59, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 31, + "Total Services": 32, + "Total_bene_day_services": 32, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 96374, + "Procedure": "Injection of drug or substance into a vein for therapy, diagnosis, or prevention", + "Place of Service": "Non Facility", + "Total Beneficiaries": 120, + "Total Services": 120, + "Total_bene_day_services": 120, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 96375, + "Procedure": "Injection of different drug or substance into a vein for therapy, diagnosis, or prevention", + "Place of Service": "Non Facility", + "Total Beneficiaries": 32, + "Total Services": 32, + "Total_bene_day_services": 32, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 99204, + "Procedure": "New patient outpatient visit, total time 45-59 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 17, + "Total Services": 17, + "Total_bene_day_services": 17, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 99211, + "Procedure": "Established patient outpatient visit, minimal presenting problem", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": 99214, + "Procedure": "Established patient outpatient visit, total time 30-39 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 39, + "Total Services": 55, + "Total_bene_day_services": 55, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": "J3490", + "Procedure": "Unclassified drugs", + "Place of Service": "Non Facility", + "Total Beneficiaries": 57, + "Total Services": 108, + "Total_bene_day_services": 57, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": "Q9967", + "Procedure": "Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml", + "Place of Service": "Non Facility", + "Total Beneficiaries": 766, + "Total Services": 61975, + "Total_bene_day_services": 775, + "Program year": 2021 + }, + { + "user_id": 1811967433, + "Procedure code": "0501T", + "Procedure": "Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 62, + "Total Services": 63, + "Total_bene_day_services": 63, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": "0503T", + "Procedure": "Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, analysis of fluid dynamics", + "Place of Service": "Non Facility", + "Total Beneficiaries": 19, + "Total Services": 19, + "Total_bene_day_services": 19, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": "0504T", + "Procedure": "Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 18, + "Total_bene_day_services": 18, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 70460, + "Procedure": "Ct scan head or brain with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 14, + "Total Services": 14, + "Total_bene_day_services": 14, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 70498, + "Procedure": "Ct scan of blood vessels of neck with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 32, + "Total Services": 33, + "Total_bene_day_services": 33, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 71250, + "Procedure": "Ct scan of chest without contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 66, + "Total Services": 66, + "Total_bene_day_services": 66, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 71270, + "Procedure": "Ct scan of chest before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 26, + "Total Services": 26, + "Total_bene_day_services": 26, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 71275, + "Procedure": "Ct scan of blood vessels of chest with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 12, + "Total_bene_day_services": 12, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 74176, + "Procedure": "Ct scan of abdomen and pelvis without contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 23, + "Total Services": 23, + "Total_bene_day_services": 23, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 74178, + "Procedure": "Ct scan of abdomen and pelvis before and after contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 44, + "Total Services": 44, + "Total_bene_day_services": 44, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 75571, + "Procedure": "Ct scan of heart with evaluation of blood vessel calcium", + "Place of Service": "Non Facility", + "Total Beneficiaries": 548, + "Total Services": 550, + "Total_bene_day_services": 550, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 75574, + "Procedure": "Ct scan of blood vessels and grafts of heart with contrast", + "Place of Service": "Non Facility", + "Total Beneficiaries": 820, + "Total Services": 824, + "Total_bene_day_services": 824, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 77078, + "Procedure": "Ct scan for measuring calcium and other minerals in bone", + "Place of Service": "Non Facility", + "Total Beneficiaries": 126, + "Total Services": 126, + "Total_bene_day_services": 126, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound of heart with color-depicted blood flow, rate, direction and valve function", + "Place of Service": "Facility", + "Total Beneficiaries": 55, + "Total Services": 57, + "Total_bene_day_services": 57, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 93306, + "Procedure": "Ultrasound of heart with color-depicted blood flow, rate, direction and valve function", + "Place of Service": "Non Facility", + "Total Beneficiaries": 39, + "Total Services": 41, + "Total_bene_day_services": 41, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 96374, + "Procedure": "Injection of drug or substance into vein", + "Place of Service": "Non Facility", + "Total Beneficiaries": 85, + "Total Services": 85, + "Total_bene_day_services": 85, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 96375, + "Procedure": "Injection of additional new drug or substance into vein", + "Place of Service": "Non Facility", + "Total Beneficiaries": 24, + "Total Services": 24, + "Total_bene_day_services": 24, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 99204, + "Procedure": "New patient office or other outpatient visit, 45-59 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 25, + "Total Services": 25, + "Total_bene_day_services": 25, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, 20-29 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 14, + "Total Services": 21, + "Total_bene_day_services": 21, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 99214, + "Procedure": "Established patient office or other outpatient visit, 30-39 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 49, + "Total Services": 72, + "Total_bene_day_services": 72, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": 99215, + "Procedure": "Established patient office or other outpatient visit, 40-54 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 12, + "Total_bene_day_services": 12, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": "J3490", + "Procedure": "Unclassified drugs", + "Place of Service": "Non Facility", + "Total Beneficiaries": 30, + "Total Services": 42, + "Total_bene_day_services": 30, + "Program year": 2022 + }, + { + "user_id": 1811967433, + "Procedure code": "Q9967", + "Procedure": "Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml", + "Place of Service": "Non Facility", + "Total Beneficiaries": 861, + "Total Services": 61356, + "Total_bene_day_services": 872, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": "0296T", + "Procedure": "External ekg recording for more than 48 hours up to 21 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 19, + "Total_bene_day_services": 19, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": "0298T", + "Procedure": "Review and interpretation of external ekg recording for more than 48 hours up to 21 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 143, + "Total Services": 175, + "Total_bene_day_services": 175, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 33340, + "Procedure": "Repair of left upper heart", + "Place of Service": "Facility", + "Total Beneficiaries": 64, + "Total Services": 64, + "Total_bene_day_services": 64, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 92960, + "Procedure": "External shock to heart to regulate heart beat", + "Place of Service": "Facility", + "Total Beneficiaries": 13, + "Total Services": 13, + "Total_bene_day_services": 13, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93000, + "Procedure": "Routine ekg using at least 12 leads including interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 174, + "Total Services": 222, + "Total_bene_day_services": 222, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93228, + "Procedure": "Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 20, + "Total Services": 20, + "Total_bene_day_services": 20, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93280, + "Procedure": "Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 18, + "Total Services": 24, + "Total_bene_day_services": 24, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93291, + "Procedure": "Evaluation of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 13, + "Total_bene_day_services": 13, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93462, + "Procedure": "Insertion of catheter into left heart for diagnosis", + "Place of Service": "Facility", + "Total Beneficiaries": 53, + "Total Services": 61, + "Total_bene_day_services": 61, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93613, + "Procedure": "Insertion of catheters for 3d mapping of electrical impulses to heart muscles", + "Place of Service": "Facility", + "Total Beneficiaries": 181, + "Total Services": 217, + "Total_bene_day_services": 217, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93621, + "Procedure": "Insertion of catheters for recording, pacing, and attempted induction of abnormal rhythm in left upper heart", + "Place of Service": "Facility", + "Total Beneficiaries": 65, + "Total Services": 75, + "Total_bene_day_services": 75, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93622, + "Procedure": "Insertion of catheters for recording, pacing, and attempted induction of abnormal rhythm in left lower heart", + "Place of Service": "Facility", + "Total Beneficiaries": 25, + "Total Services": 30, + "Total_bene_day_services": 30, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93623, + "Procedure": "Programmed heart rhythm stimulation after drug infusion into a vein", + "Place of Service": "Facility", + "Total Beneficiaries": 116, + "Total Services": 131, + "Total_bene_day_services": 131, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93653, + "Procedure": "Evaluation and insertion of catheters for creation of complete heart block", + "Place of Service": "Facility", + "Total Beneficiaries": 74, + "Total Services": 88, + "Total_bene_day_services": 88, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93655, + "Procedure": "Insertion of catheters for treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 95, + "Total Services": 143, + "Total_bene_day_services": 110, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93656, + "Procedure": "Evaluation and insertion of catheters for recording, pacing, and treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 116, + "Total Services": 129, + "Total_bene_day_services": 129, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93657, + "Procedure": "Destruction of tissue of right or left upper heart chamber via catheter for treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 97, + "Total Services": 117, + "Total_bene_day_services": 105, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 93662, + "Procedure": "Ultrasound evaluation of heart blood vessel", + "Place of Service": "Facility", + "Total Beneficiaries": 180, + "Total Services": 216, + "Total_bene_day_services": 216, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99202, + "Procedure": "New patient office or other outpatient visit, typically 20 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 15, + "Total Services": 15, + "Total_bene_day_services": 15, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99203, + "Procedure": "New patient office or other outpatient visit, typically 30 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 19, + "Total Services": 19, + "Total_bene_day_services": 19, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99204, + "Procedure": "New patient office or other outpatient visit, typically 45 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 38, + "Total Services": 38, + "Total_bene_day_services": 38, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99212, + "Procedure": "Established patient office or other outpatient visit, typically 10 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 32, + "Total Services": 33, + "Total_bene_day_services": 33, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, typically 15 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 28, + "Total Services": 33, + "Total_bene_day_services": 33, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, typically 15 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 188, + "Total Services": 266, + "Total_bene_day_services": 265, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99214, + "Procedure": "Established patient office or other outpatient, visit typically 25 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 11, + "Total Services": 12, + "Total_bene_day_services": 12, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99214, + "Procedure": "Established patient office or other outpatient, visit typically 25 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 68, + "Total Services": 72, + "Total_bene_day_services": 72, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99441, + "Procedure": "Physician telephone patient service, 5-10 minutes of medical discussion", + "Place of Service": "Non Facility", + "Total Beneficiaries": 13, + "Total Services": 13, + "Total_bene_day_services": 13, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99442, + "Procedure": "Physician telephone patient service, 11-20 minutes of medical discussion", + "Place of Service": "Non Facility", + "Total Beneficiaries": 48, + "Total Services": 55, + "Total_bene_day_services": 55, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 99443, + "Procedure": "Physician telephone patient service, 21-30 minutes of medical discussion", + "Place of Service": "Non Facility", + "Total Beneficiaries": 13, + "Total Services": 13, + "Total_bene_day_services": 13, + "Program year": 2020 + }, + { + "user_id": 1841382421, + "Procedure code": 33285, + "Procedure": "Insertion of heart rhythm monitor under skin", + "Place of Service": "Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 33340, + "Procedure": "Repair of left upper heart", + "Place of Service": "Facility", + "Total Beneficiaries": 120, + "Total Services": 120, + "Total_bene_day_services": 120, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93000, + "Procedure": "Routine ekg using at least 12 leads including interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 134, + "Total Services": 164, + "Total_bene_day_services": 164, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93228, + "Procedure": "Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 13, + "Total Services": 13, + "Total_bene_day_services": 13, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93244, + "Procedure": "Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 73, + "Total Services": 77, + "Total_bene_day_services": 77, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93248, + "Procedure": "Heart rhythm review and interpretation of continous external ekg over 8-15 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 64, + "Total Services": 67, + "Total_bene_day_services": 67, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93280, + "Procedure": "Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 16, + "Total Services": 21, + "Total_bene_day_services": 21, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93291, + "Procedure": "Evaluation of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 12, + "Total_bene_day_services": 12, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93462, + "Procedure": "Insertion of catheter into left heart through the septum or apical area of the heart", + "Place of Service": "Facility", + "Total Beneficiaries": 55, + "Total Services": 55, + "Total_bene_day_services": 55, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93613, + "Procedure": "Insertion of catheters for 3d mapping of electrical impulses to heart muscles", + "Place of Service": "Facility", + "Total Beneficiaries": 206, + "Total Services": 237, + "Total_bene_day_services": 237, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93621, + "Procedure": "Insertion of catheters for recording, pacing, and attempted induction of abnormal rhythm in left upper heart", + "Place of Service": "Facility", + "Total Beneficiaries": 85, + "Total Services": 90, + "Total_bene_day_services": 90, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93622, + "Procedure": "Insertion of catheters for recording, pacing, and attempted induction of abnormal rhythm in left lower heart", + "Place of Service": "Facility", + "Total Beneficiaries": 37, + "Total Services": 41, + "Total_bene_day_services": 41, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93623, + "Procedure": "Programmed heart rhythm stimulation after drug infusion into a vein", + "Place of Service": "Facility", + "Total Beneficiaries": 82, + "Total Services": 87, + "Total_bene_day_services": 87, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93653, + "Procedure": "Evaluation and insertion of catheters for creation of complete heart block", + "Place of Service": "Facility", + "Total Beneficiaries": 109, + "Total Services": 117, + "Total_bene_day_services": 117, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93655, + "Procedure": "Insertion of catheters for treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 80, + "Total Services": 110, + "Total_bene_day_services": 86, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93656, + "Procedure": "Evaluation and insertion of catheters for recording, pacing, and treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 113, + "Total Services": 121, + "Total_bene_day_services": 121, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93657, + "Procedure": "Destruction of tissue of right or left upper heart chamber via catheter for treatment of abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 93, + "Total Services": 121, + "Total_bene_day_services": 96, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 93662, + "Procedure": "Ultrasound evaluation of heart blood vessel", + "Place of Service": "Facility", + "Total Beneficiaries": 204, + "Total Services": 236, + "Total_bene_day_services": 236, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99203, + "Procedure": "New patient outpatient visit, total time 30-44 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 49, + "Total Services": 49, + "Total_bene_day_services": 49, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99204, + "Procedure": "New patient outpatient visit, total time 45-59 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99212, + "Procedure": "Established patient outpatient visit, total time 10-19 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 22, + "Total Services": 24, + "Total_bene_day_services": 24, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient outpatient visit, total time 20-29 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 27, + "Total Services": 37, + "Total_bene_day_services": 37, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient outpatient visit, total time 20-29 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 226, + "Total Services": 324, + "Total_bene_day_services": 324, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99214, + "Procedure": "Established patient outpatient visit, total time 30-39 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 14, + "Total Services": 15, + "Total_bene_day_services": 15, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99214, + "Procedure": "Established patient outpatient visit, total time 30-39 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 92, + "Total Services": 105, + "Total_bene_day_services": 105, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99217, + "Procedure": "Hospital observation care on day of discharge", + "Place of Service": "Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99442, + "Procedure": "Physician telephone patient service, 11-20 minutes of medical discussion", + "Place of Service": "Non Facility", + "Total Beneficiaries": 40, + "Total Services": 44, + "Total_bene_day_services": 44, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 99443, + "Procedure": "Physician telephone patient service, 21-30 minutes of medical discussion", + "Place of Service": "Non Facility", + "Total Beneficiaries": 49, + "Total Services": 53, + "Total_bene_day_services": 53, + "Program year": 2021 + }, + { + "user_id": 1841382421, + "Procedure code": 33285, + "Procedure": "Insertion of heart rhythm monitor under skin", + "Place of Service": "Facility", + "Total Beneficiaries": 11, + "Total Services": 11, + "Total_bene_day_services": 11, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 33340, + "Procedure": "Repair of left upper heart chamber with implant with review by radiologist", + "Place of Service": "Facility", + "Total Beneficiaries": 88, + "Total Services": 88, + "Total_bene_day_services": 88, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 92960, + "Procedure": "External shock to heart to regulate heart beat", + "Place of Service": "Facility", + "Total Beneficiaries": 16, + "Total Services": 16, + "Total_bene_day_services": 16, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93000, + "Procedure": "Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report", + "Place of Service": "Non Facility", + "Total Beneficiaries": 124, + "Total Services": 153, + "Total_bene_day_services": 153, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93244, + "Procedure": "Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 87, + "Total Services": 93, + "Total_bene_day_services": 93, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93248, + "Procedure": "Heart rhythm review and interpretation of continous external ekg over 8-15 days", + "Place of Service": "Non Facility", + "Total Beneficiaries": 36, + "Total Services": 36, + "Total_bene_day_services": 36, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93291, + "Procedure": "Evaluation of cardiac rhythm monitor system", + "Place of Service": "Non Facility", + "Total Beneficiaries": 12, + "Total Services": 14, + "Total_bene_day_services": 14, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93462, + "Procedure": "Insertion of tube in left heart chamber through heart septum", + "Place of Service": "Facility", + "Total Beneficiaries": 66, + "Total Services": 69, + "Total_bene_day_services": 69, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93622, + "Procedure": "Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 20, + "Total Services": 21, + "Total_bene_day_services": 21, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93623, + "Procedure": "Programming of heart rhythm stimulation after drug infusion", + "Place of Service": "Facility", + "Total Beneficiaries": 65, + "Total Services": 68, + "Total_bene_day_services": 68, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93653, + "Procedure": "Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate)", + "Place of Service": "Facility", + "Total Beneficiaries": 98, + "Total Services": 110, + "Total_bene_day_services": 110, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93655, + "Procedure": "Insertion of catheters and destruction of tissue to treat abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 77, + "Total Services": 105, + "Total_bene_day_services": 83, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93656, + "Procedure": "Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation", + "Place of Service": "Facility", + "Total Beneficiaries": 100, + "Total Services": 103, + "Total_bene_day_services": 103, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93657, + "Procedure": "Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm", + "Place of Service": "Facility", + "Total Beneficiaries": 79, + "Total Services": 110, + "Total_bene_day_services": 80, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 93662, + "Procedure": "Ultrasound evaluation of heart blood vessel with review by radiologist", + "Place of Service": "Facility", + "Total Beneficiaries": 118, + "Total Services": 133, + "Total_bene_day_services": 133, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99203, + "Procedure": "New patient office or other outpatient visit, 30-44 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 51, + "Total Services": 51, + "Total_bene_day_services": 51, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99204, + "Procedure": "New patient office or other outpatient visit, 45-59 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 26, + "Total Services": 26, + "Total_bene_day_services": 26, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99212, + "Procedure": "Established patient office or other outpatient visit, 10-19 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 30, + "Total Services": 30, + "Total_bene_day_services": 30, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, 20-29 minutes", + "Place of Service": "Facility", + "Total Beneficiaries": 35, + "Total Services": 43, + "Total_bene_day_services": 43, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99213, + "Procedure": "Established patient office or other outpatient visit, 20-29 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 208, + "Total Services": 270, + "Total_bene_day_services": 270, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99214, + "Procedure": "Established patient office or other outpatient visit, 30-39 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 106, + "Total Services": 116, + "Total_bene_day_services": 116, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99215, + "Procedure": "Established patient office or other outpatient visit, 40-54 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 22, + "Total Services": 23, + "Total_bene_day_services": 23, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99442, + "Procedure": "Telephone medical discussion with physician, 11-20 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 22, + "Total Services": 22, + "Total_bene_day_services": 22, + "Program year": 2022 + }, + { + "user_id": 1841382421, + "Procedure code": 99443, + "Procedure": "Telephone medical discussion with physician, 21-30 minutes", + "Place of Service": "Non Facility", + "Total Beneficiaries": 36, + "Total Services": 40, + "Total_bene_day_services": 40, + "Program year": 2022 + } + ] +} \ No newline at end of file diff --git a/lib/contacts_module/check.dart b/lib/contacts_module/check.dart new file mode 100644 index 0000000..a4dd67c --- /dev/null +++ b/lib/contacts_module/check.dart @@ -0,0 +1,230 @@ +// import 'package:flutter/material.dart'; + +// class ModalBottomSheetDemo extends StatelessWidget { +// const ModalBottomSheetDemo({Key? key}) : super(key: key); + +// @override +// Widget build(BuildContext context) { +// return Center( +// child: ElevatedButton( +// child: const Text('showModalBottomSheet'), +// onPressed: () { +// // when raised button is pressed +// // we display showModalBottomSheet +// showModalBottomSheet( +// isScrollControlled: true, +// // context and builder are +// // required properties in this widget +// context: context, +// builder: (BuildContext context) { +// // we set up a container inside which +// // we create center column and display text + +// // Returning SizedBox instead of a Container +// return Container( +// width: double.infinity, +// child: Wrap( +// // mainAxisSize: MainAxisSize.max, +// children: [ +// Expanded( +// child: SingleChildScrollView( +// child: Column( +// //mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), +// Text('GeeksforGeeks'), + +// // ListView( +// // children: [ +// // ...List.generate( +// // 10, +// // (index) => Text('GeeksforGeeks'), +// // ) +// // ], +// // ) +// ], +// ), +// ), +// ), +// ], +// ), +// ); +// }, +// ); +// }, +// ), +// ); +// } +// } +// import 'package:flutter/material.dart'; + +// // Define your number of items +// const int numberOfItems = 5; // Replace with the desired number + +// class MyCarousel extends StatelessWidget { +// @override +// Widget build(BuildContext context) { +// return Scaffold( +// body: ExpandableCarousel( +// options: CarouselOptions( +// showIndicator: false, +// slideIndicator: CircularWaveSlideIndicator( +// alignment: Alignment.bottomCenter, +// currentIndicatorColor: Colors.blue, // Replace with your color +// indicatorBackgroundColor: Colors.grey, +// ), +// autoPlay: true, +// autoPlayInterval: const Duration(seconds: 2), +// ), +// items: List.generate(numberOfItems, (index) { +// return Builder( +// builder: (BuildContext context) { +// return Center( +// child: Padding( +// padding: const EdgeInsets.all(8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(10), +// ), +// child: Container( +// decoration: BoxDecoration( +// color: Colors.blueAccent, // Replace with your gradient or color +// borderRadius: BorderRadius.circular(10), +// ), +// child: Padding( +// padding: EdgeInsets.all(10.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Text( +// index == 0 +// ? "Top Event Topics" +// : index == 1 +// ? "Top Publication Topics" +// : index == 2 +// ? "Top Products Discussed" +// : index == 3 +// ? "Drugs Prescribed" +// : "Condition Treated", +// style: TextStyle( +// fontSize: 16.0, +// fontWeight: FontWeight.bold, +// color: Colors.white, +// ), +// ), +// const SizedBox(height: 10.0), +// // Example content, you can replace this with your dynamic data +// Row( +// children: [ +// Container( +// decoration: BoxDecoration( +// color: Colors.grey[800], // Replace with your color +// borderRadius: BorderRadius.circular(10), +// ), +// child: Padding( +// padding: const EdgeInsets.all(5.0), +// child: Row( +// children: [ +// Icon( +// Icons.circle, +// color: Colors.white, +// size: 13.0, +// ), +// SizedBox(width: 5.0), +// Text( +// "Item $index", +// style: TextStyle( +// fontSize: 14.0, +// color: Colors.white, +// ), +// ), +// SizedBox(width: 5.0), +// Container( +// decoration: BoxDecoration( +// color: Colors.black, // Replace with your color +// borderRadius: BorderRadius.circular(5), +// ), +// child: Padding( +// padding: const EdgeInsets.all(1.0), +// child: Text( +// "(378)", +// style: TextStyle( +// fontSize: 14.0, +// color: Colors.white, +// ), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ], +// ), +// ], +// ), +// ), +// ), +// ), +// ), +// ); +// }, +// ); +// }).toList(), +// ), +// ); +// } +// } + diff --git a/lib/contacts_module/connectivity.dart b/lib/contacts_module/connectivity.dart new file mode 100644 index 0000000..2afb59b --- /dev/null +++ b/lib/contacts_module/connectivity.dart @@ -0,0 +1,33 @@ +import 'dart:async'; +import 'dart:io'; + +import 'package:connectivity_plus/connectivity_plus.dart'; +import 'package:dio/dio.dart'; + +class NetworkConnectivity { + // Future isInternetAvailable() async { + // var connectivityResult = await (Connectivity().checkConnectivity()); + // return connectivityResult != ConnectivityResult.none; + // } + Future isInternetAvailable() async { + var connectivityResult = await Connectivity().checkConnectivity(); + if (connectivityResult == ConnectivityResult.none) { + return false; + } else { + try { + // final result = await InternetAddress.lookup('google.com'); + // return true; + final result = await Dio().get('www.google.com'); + + if (result.statusCode == 200) { + // if (result.isNotEmpty && result[0].rawAddress.isNotEmpty) { + return true; + //} + } + return false; + } on SocketException catch (_) { + return false; + } + } + } +} diff --git a/lib/contacts_module/constants.dart b/lib/contacts_module/constants.dart new file mode 100644 index 0000000..e4d24b4 --- /dev/null +++ b/lib/contacts_module/constants.dart @@ -0,0 +1,30 @@ +import 'dart:ui'; + +import 'package:flutter/material.dart'; +import 'package:flutter/services.dart'; + +class Constants { + static Color k2color = Color.fromARGB(255, 0, 71, 132); + static Color k2color1 = Color.fromARGB(255, 0, 71, 132); + + static Color cardtext = Colors.transparent; + static Color cardtextdark = Colors.transparent; + + static const Color bgcolor = Color(0xFFF2F3F8); + static Color bgcolor2 = const Color.fromARGB(255, 0, 112, 184); + + static Color k2color11 = Colors.white; + + static final Future response = + rootBundle.loadString('assets/section.json'); + static const Color tabbgColor = Color.fromARGB(255, 0, 112, 184); + + static const url = "http://192.168.2.143:8000/api"; + + // static const url = "http://192.168.21.50:8000/api"; + + //static const url = 'http://192.168.2.143:8085/api';http://127.0.0.1:8001 + //static const url = 'http://192.168.153.50:8082/api';192.168.21.50:8000 + + static const k2url = "http://192.168.2.130:8888/api"; +} diff --git a/lib/contacts_module/custom_widget/custom_expansiontile.dart b/lib/contacts_module/custom_widget/custom_expansiontile.dart new file mode 100644 index 0000000..ab34c18 --- /dev/null +++ b/lib/contacts_module/custom_widget/custom_expansiontile.dart @@ -0,0 +1,212 @@ +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_aff_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_awards_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_education_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_email_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_event_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_location_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_pno_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_training_k2.dart'; +import 'package:flutter/material.dart'; + +class CustomExpansionTile extends StatefulWidget { + final String title; + final List itemList; + final String buttonText; + final String field1; + final String field2; + + final Function(T) onItemSelected; + + const CustomExpansionTile({ + Key? key, + required this.title, + required this.itemList, + required this.buttonText, + required this.onItemSelected, + required this.field1, + required this.field2, + }) : super(key: key); + + @override + _CustomExpansionTileState createState() => _CustomExpansionTileState(); +} + +class _CustomExpansionTileState extends State> { + bool _isExpanded = false; + + @override + Widget build(BuildContext context) { + print("Chekingg_Field_one: ${widget.field1}"); + + return ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.symmetric(horizontal: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black, + ), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + children: [ + Text1( + title: widget.title, + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0, + ), + const SizedBox(width: 8.0), + Text1( + title: "(${widget.itemList.length})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0, + ), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: MediaQuery.of(context).size.width, + ), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: [ + DataColumn( + label: Expanded( + child: Text( + widget.field1 ?? 'Item', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true, + ), + ), + ), + DataColumn( + label: Expanded( + child: Text( + widget.field2 ?? 'Details', + style: TextStyle(fontWeight: FontWeight.w600), + ), + ), + ), + ], + rows: List.generate(widget.itemList.take(2).length, + (index) { + final item = widget.itemList[index]; + + return DataRow( + onSelectChanged: (value) { + widget.onItemSelected(widget.itemList[index]); + }, + cells: [ + DataCell(getdatacel1(item)), + DataCell( + getdatacel2(item), + ), + ], + ); + }), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + // Handle the button action here + }, + child: Text( + widget.buttonText, + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ), + ], + ), + ), + ), + ), + ); + } + + getdatacel1(T location) { + if (location is Data) { + return Text1(title: "${location.address1}"); + } else if (location is DataPhno) { + return Text1(title: "${location.phoneTypeName}"); + } else if (location is EmailData) { + return Text1(title: "${location.emailTypeName}"); + } else if (location is TrainingList) { + return Text1(title: "${location.organizationId}"); + } else if (location is EducationList) { + return Text1(title: "${location.organizationId}"); + } else if (location is AwardsList) { + return Text1(title: "${location.name}"); + } else if (location is CertificateList) { + return Text1(title: "${location.organizationId}"); + } else if (location is AffList) { + return Text1(title: "${location.title}"); + } else if (location is EventList) { + return Text1(title: "${location.name}"); + } + } + + getdatacel2(T location) { + if (location is Data) { + return Text1(title: "${location.postalCode}"); + } else if (location is DataPhno) { + return Text1(title: "${location.number}"); + } else if (location is EmailData) { + return Text1(title: "${location.email}"); + } else if (location is TrainingList) { + return Text1(title: "${location.degree}"); + } else if (location is EducationList) { + return Text1(title: "${location.degree}"); + } else if (location is AwardsList) { + return Text1(title: "${location.startDate} ${location.endDate}"); + } else if (location is CertificateList) { + return Text1(title: "${location.specialty}"); + } else if (location is AffList) { + return Text1(title: "${location.role}"); + } else if (location is EventList) { + return Text1(title: "${location.notes}"); + } + } +} diff --git a/lib/contacts_module/custom_widget/elevation_btn.dart b/lib/contacts_module/custom_widget/elevation_btn.dart new file mode 100644 index 0000000..f81508f --- /dev/null +++ b/lib/contacts_module/custom_widget/elevation_btn.dart @@ -0,0 +1,31 @@ +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; + +// ignore: must_be_immutable +class ElevationBtn extends StatefulWidget { + ElevationBtn( + {this.text, this.color, required this.onPressed, this.textcolor}); + String? text; + Color? color; + final VoidCallback onPressed; + Color? textcolor; + + @override + State createState() => _ElevationBtnState(); +} + +class _ElevationBtnState extends State { + @override + Widget build(BuildContext context) { + return ElevatedButton( + onPressed: widget.onPressed, + style: ElevatedButton.styleFrom( + backgroundColor: widget.color?.withOpacity(0.9), + ), + child: Text( + widget.text!, + style: TextStyle(color: widget.textcolor), + ), + ); + } +} diff --git a/lib/contacts_module/custom_widget/floating_btn.dart b/lib/contacts_module/custom_widget/floating_btn.dart new file mode 100644 index 0000000..d0f5a4a --- /dev/null +++ b/lib/contacts_module/custom_widget/floating_btn.dart @@ -0,0 +1,33 @@ +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; + +// ignore: must_be_immutable +class FloatingBtn extends StatefulWidget { + FloatingBtn({ + this.height, + this.width, + required this.title, + this.onTap, + required this.icon, + }); + + double? height; + double? width; + String title; + VoidCallback? onTap; + IconData? icon; + + @override + State createState() => _FloatingBtnState(); +} + +class _FloatingBtnState extends State { + @override + Widget build(BuildContext context) { + return FloatingActionButton( + onPressed: widget.onTap, + child: Icon(Icons.add), + ); + } +} diff --git a/lib/contacts_module/custom_widget/show_alert.dart b/lib/contacts_module/custom_widget/show_alert.dart new file mode 100644 index 0000000..1058a1f --- /dev/null +++ b/lib/contacts_module/custom_widget/show_alert.dart @@ -0,0 +1,25 @@ +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:flutter/material.dart'; +import 'package:http_mock_adapter/http_mock_adapter.dart'; + +class Alert extends StatelessWidget { + Alert({super.key, required this.data, required this.onPressed}); + String? data; + VoidCallbackAction? oidCallbackAction; + final void Function() onPressed; + + @override + Widget build(BuildContext context) { + return AlertDialog( + title: Text1( + title: "Alert", + txtfont: 22.0, + ), + content: Text1( + title: data!, + txtfont: 18.0, + ), + actions: [TextButton(onPressed: onPressed, child: Text("Ok"))], + ); + } +} diff --git a/lib/contacts_module/custom_widget/text.dart b/lib/contacts_module/custom_widget/text.dart new file mode 100644 index 0000000..e74ef75 --- /dev/null +++ b/lib/contacts_module/custom_widget/text.dart @@ -0,0 +1,33 @@ +import 'package:flutter/material.dart'; + +// ignore: must_be_immutable +class Text1 extends StatefulWidget { + Text1({ + super.key, + required this.title, + this.txtcolor, + this.txtfont, + this.fontweight, + }); + final String title; + Color? txtcolor; + double? txtfont; + FontWeight? fontweight; + + @override + State createState() => _Text1State(); +} + +class _Text1State extends State { + @override + Widget build(BuildContext context) { + return Text( + widget.title, + softWrap: true, + style: TextStyle( + color: widget.txtcolor, + fontSize: widget.txtfont, + fontWeight: widget.fontweight), + ); + } +} diff --git a/lib/contacts_module/custom_widget/textfield.dart b/lib/contacts_module/custom_widget/textfield.dart new file mode 100644 index 0000000..88b489c --- /dev/null +++ b/lib/contacts_module/custom_widget/textfield.dart @@ -0,0 +1,31 @@ +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; + +// ignore: must_be_immutable +class TxtField extends StatefulWidget { + TxtField( + {super.key, + required this.text, + this.voidCallback, + this.contentPadding, + this.icon, + this.border, + this.decoration}); + + final String? text; + final VoidCallback? voidCallback; + final Padding? contentPadding; + Icon? icon; + Border? border; + Decoration? decoration; + + @override + State createState() => _TxtFieldState(); +} + +class _TxtFieldState extends State { + @override + Widget build(BuildContext context) { + return TextField(); + } +} diff --git a/lib/contacts_module/hive_fun.dart b/lib/contacts_module/hive_fun.dart new file mode 100644 index 0000000..53a22ff --- /dev/null +++ b/lib/contacts_module/hive_fun.dart @@ -0,0 +1,390 @@ +// import 'package:discover_module/storage_hive/kol_info/kol_info_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +class HiveFunctions { + // String userHiveBox="User Box"; + // Box which will use to store the things + static final _contactbox = Hive.box("mycontact"); + static var box1 = Hive.box('checkvalue'); + + static final apihcpdata = Hive.box("hcpdata"); + + static final apihcpdata123 = Hive.box('kolshive'); + + static createUser(Map data) { + _contactbox.add(data); + } + + static List getAllUsers11() { + final data = _contactbox.keys.map((key) { + final value = _contactbox.get(key); + print("Checking_Name : $value"); + return { + "inid": value["inid"], + "id": value["id"], + "name": value["name"], + "org": value["org"], + "addr": value["addr"], + "phone": value["phone"], + "phone_no": value["phone_no"], + "email": value["email"], + "summarry": value["summarry"], + "speciality": value["speciality"], + "sub_speciality": value["sub_speciality"], + "img_path": value["img_path"] + }; + }).toList(); + + return data.reversed.toList(); + } + + static List getAllUsers() { + final data = _contactbox.keys.map((key) { + final value = _contactbox.get(key); + print("Checking_Name : $value"); + return { + "id": value["id"], + "name": value["name"], + "org": value["org"], + "addr": value["addr"], + "phone": value["phone"], + "phone_no": value["phone_no"], + "email": value["email"], + "affiliations_count": value["affiliations_count"], + "events_count": value["events_count"], + "publications_count": value["publications_count"], + "trail_count": value["trail_count"], + "summarry": value["summarry"], + "license_no": value["license_no"], + "p_suffix": value["p_suffix"], + "speciality": value["speciality"], + "sub_speciality": value["sub_speciality"], + "img_path": value["img_path"] + }; + }).toList(); + + return data; + } + + static List getindexUsers() { + final data = _contactbox.keys.map((key) { + final value = _contactbox.get(key); + print("Checking_Name : $value"); + return { + "name": value["name"], + "org": value["org"], + "adrr": value["adrr"], + "phone": value["phone"], + "Pphone": value["Pphone"], + "email": value["email"], + "affno": value["affno"], + "eveno": value["eveno"], + "pubno": value["pubno"], + "trailno": value["trailno"] + }; + }).toList(); + + return data.reversed.toList(); + } + //static deleteUser112(row) {} + + static deleteUser11(id) async { + print("Hive_id: $id"); + + for (var entry in _contactbox.toMap().entries) { + var contactData = entry.value; + + print("Selected_del_value: $contactData"); + + if (contactData['id'] == id) { + print("entry.keyentry.key: ${entry.key}."); + + // Found the contact with the matching id + await _contactbox.delete(entry.key); // Delete by key + print("Record with id $id has been deleted."); + return; // Exit the function after deletion + } + } + } + + static Future deleteUser(int selectedremoveIndic) async { + print("storeddelData_id: ${selectedremoveIndic}"); + + // final userId = "some_user_id"; // Replace with the actual ID you want to query + final value = _contactbox.get(selectedremoveIndic - 1); + print("ValueeeGet: $value"); + if (value == null) { + final value1 = _contactbox.get(selectedremoveIndic); + print("Valueee11Get: $value1"); + print("UniqueId11 : ${value["inid"]}"); + } else { + final value1 = _contactbox.get(2); + print("Valueee11Get: $value1"); + print("UniqueId111 : ${value["inid"]}"); + } + + // print(await _contactbox.getAt(selectedremoveIndic)); + + // int data = selectedremoveIndic; + + // final storeddelData = _contactbox.get(data); + // print("storeddelData_iss: $storeddelData"); + + // if (storeddelData != null) { + // print("I_amNotnull ${storeddelData["id"]}"); + // _contactbox.deleteAt(storeddelData["id"]); + //} + // _hiveBox.delete(dataDel.id); + // _contactbox.deleteAt(selectedremoveIndic); + // final data = _contactbox.keys.map((_contactbox) { + // final value = _contactbox.get(selectedremoveIndic); + + // print("Del_valuee_is: ${value}"); + + // }); + } + + // void deleteUser(String userId) { + // var _contactbox = Hive.box('contactBox'); + + // // Find the key corresponding to the userId + // for (var key in _contactbox.keys) { + // final value = _contactbox.get(key); + // if (value["id"] == userId) { + // _contactbox.delete(key); + // print("Deleted user with id: $userId"); + // break; // Exit the loop once the item is deleted + // } + // } + // } + + // static void deleteUser(int selectedremoveIndic) { + // print("I_Am: selectedremoveIndic: ${selectedremoveIndic}"); + // // final data = _contactbox.keys.map((key) { + // final value = _contactbox.get(selectedremoveIndic); + + // _contactbox.deleteAt(selectedremoveIndic); + + // // if (value["id"] == selectedremoveIndic) { + // // print("I_Am: selectedremoveIndicnew: ${value["name"]}"); + // // } + // // }); + // } + + // static addno(int selectedRowId) { + // // final box1 = Hive.box("mycontact"); + + // print("SelectedStoredvaluessss: $selectedRowId"); + + // box1.add(selectedRowId); + // } + + // static removeno(int selectedRowId) { + // // final box1 = Hive.box("mycontact"); + + // print("SelectedStoredvaluessss: $selectedRowId"); + + // box1.deleteAt(selectedRowId); + // } + + // static getno() { + // // final box1 = Hive.box("mycontact"); + + // return box1.values; + // } + + static storehcpdata(Map data) { + apihcpdata.add(data); + } + + static gethcpdata() { + return apihcpdata.values.toList(); + } + + static List getindexUser(String query) { + //static getindexUser(String text) async { + print("Text_issssssS: $query"); + + final value = _contactbox.values.toList(); + print("Checking_Name_Offline_Searchh : ${value}"); + + // final offlinesearch1 = value.map((e) => e["name"].toString()).toList(); + + // print("Checking_offlinesearch1 : ${offlinesearch1}"); + + List data = value + .where((hcp) => + hcp['name'].toLowerCase().contains(query.toLowerCase()) || + hcp['speciality'].toLowerCase().contains(query.toLowerCase()) || + hcp['addr'].toLowerCase().contains(query.toLowerCase())) + .toList(); + + print("Checking_Name_data : ${data}"); + + // print("Checking_Name : ${value.contains(text)}"); + // final dataa = value.get(text); + + // return { + // "name": value["name"], + // "org": value["org"], + // "adrr": value["adrr"], + // "phone": value["phone"], + // "Pphone": value["Pphone"], + // "email": value["email"], + // "affno": value["affno"], + // "eveno": value["eveno"], + // "pubno": value["pubno"], + // "trailno": value["trailno"] + // }; + // }).toList(); + + // print("Check_data_is: $data"); + return data.toList(); + } + + static getuser(int selectedremoveIndic) { + final data = _contactbox.keys.map((selectedremoveIndic) { + final value = _contactbox.get(selectedremoveIndic); + print("Checking_Name111 : $value"); + return { + "inid": value["inid"], + "id": value["id"], + "name": value["name"], + "org": value["org"], + "addr": value["addr"], + "phone": value["phone"], + "phone_no": value["phone_no"], + "email": value["email"], + "summarry": value["summarry"], + "speciality": value["speciality"], + "sub_speciality": value["sub_speciality"], + "img_path": value["img_path"] + }; + }).toList(); + + return data; + } + + static getAllhcpdata(String? option) { + List myhcpname = _contactbox.values.toList(); + + if (option == "HCP Name") { + return myhcpname.map((e) => e["name"].toString()).toList(); + } else { + return myhcpname.map((e) => e["speciality"].toString()).toList(); + } + } + + static List OfflineStored_getindexUser(String query) { + //static getindexUser(String text) async { + + print("Text_issssssS: $query"); + + final value = apihcpdata123.values.toList(); + print("Checking_Name_Offline_Searchh : ${value}"); + + // final offlinesearch1 = value.map((e) => e["name"].toString()).toList(); + + // print("Checking_offlinesearch1 : ${offlinesearch1}"); + + List data = value + .where((hcp) => + hcp['name'].toLowerCase().contains(query.toLowerCase()) || + // (hcp['speciality'].toLowerCase().contains(query.toLowerCase()) ?? + // hcp['spl'].toLowerCase().contains(query.toLowerCase())) || + + hcp['speciality'].toLowerCase().contains(query.toLowerCase()) || + hcp['addr'].toLowerCase().contains(query.toLowerCase())) + .toList(); + + print("Checking_Name_data : ${data}"); + + // print("Checking_Name : ${value.contains(text)}"); + // final dataa = value.get(text); + + // return { + // "name": value["name"], + // "org": value["org"], + // "adrr": value["adrr"], + // "phone": value["phone"], + // "Pphone": value["Pphone"], + // "email": value["email"], + // "affno": value["affno"], + // "eveno": value["eveno"], + // "pubno": value["pubno"], + // "trailno": value["trailno"] + // }; + // }).toList(); + + // print("Check_data_is: $data"); + return data.toList(); + } + + // static void savemyContact(List selectedIndices, [List displayedHCPList]) async { + // print("Iam selectedd $selectedIndices"); + + // for (int i = 0; i < selectedIndices.length; i++) { + // Map? row = await findRecordById1(selectedIndices[i]); + + // print("StoringgggMyContactneww_isss_isss:Row $row"); + // } + // } + + // Map findRecordById(String selectedIndic) { + // final list = _contactbox.values.toList(); + // } + + static Map? findRecordById1(String selectedIndic) { + final list = _contactbox.values.toList(); + return list + .firstWhere((element) => element['id'] == int.parse(selectedIndic)); + } + + static savemyContact(Map row) async { + print("CheckingRowww ${row!["email"]}"); + + final value1 = await _contactbox.values.toList(); + + List value11 = await value1 + .where((element) => element["email"] == row["email"]) + .toList(); + + print("Getted_valueee: ${value11}"); + if (value11.isEmpty) { + print("Getted_valueee_imaEmpty"); + + Map data = await { + "id": row["id"], + "name": row["name"], + "org": row["org"], + "addr": row["addr"], + "phone": row["phone"], + "phone_no": row["phone_no"], + "email": row["email"], + "summarry": row["summarry"], + "speciality": row["speciality"], + "sub_speciality": row["sub_speciality"], + "img_path": row["img_path"] + }; + print("Inserting_data_is: $data"); + + await _contactbox.put(await getNextAutoIncrementValue(), data); + + // await _contactbox.add(row); + } + } + + static Future getNextAutoIncrementValue() async { + var counterBox = await Hive.openBox('counterBox'); + if (!counterBox.containsKey('counter')) { + counterBox.put('counter', 0); + } + + int? counter = counterBox.get('counter'); + counterBox.put('counter', counter! + 1); + + await counterBox.close(); + + return counter; + } +} diff --git a/lib/contacts_module/model_class/affiliations.dart b/lib/contacts_module/model_class/affiliations.dart new file mode 100644 index 0000000..73ed0ea --- /dev/null +++ b/lib/contacts_module/model_class/affiliations.dart @@ -0,0 +1,63 @@ +// To parse this JSON data, do +// +// final affiliations = affiliationsFromJson(jsonString); + +import 'dart:convert'; + +List affiliationsFromJson(String str) => List.from( + json.decode(str).map((x) => Affiliations.fromJson(x))); + +String affiliationsToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Affiliations { + int id; + int userId; + String orgName; + String dept; + String role; + String timeFrame; + String orgType; + String emgType; + dynamic createdAt; + dynamic updatedAt; + + Affiliations({ + required this.id, + required this.userId, + required this.orgName, + required this.dept, + required this.role, + required this.timeFrame, + required this.orgType, + required this.emgType, + required this.createdAt, + required this.updatedAt, + }); + + factory Affiliations.fromJson(Map json) => Affiliations( + id: json["id"], + userId: json["user_id"], + orgName: json["org_name"], + dept: json["dept"], + role: json["role"], + timeFrame: json["time_frame"], + orgType: json["org_type"], + emgType: json["emg_type"], + createdAt: json["created_at"], + updatedAt: json["updated_at"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "org_name": orgName, + "dept": dept, + "role": role, + "time_frame": timeFrame, + "org_type": orgType, + "emg_type": emgType, + "created_at": createdAt, + "updated_at": updatedAt, + }; +} diff --git a/lib/contacts_module/model_class/awards_model.dart b/lib/contacts_module/model_class/awards_model.dart new file mode 100644 index 0000000..11f4eee --- /dev/null +++ b/lib/contacts_module/model_class/awards_model.dart @@ -0,0 +1,59 @@ +// To parse this JSON data, do +// +// final awa = awaFromJson(jsonString); + +import 'dart:convert'; + +List awaFromJson(String str) => + List.from(json.decode(str).map((x) => Awa.fromJson(x))); + +String awaToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Awa { + int id; + int userId; + String educationType; + String institutionName; + String degree; + String specialty; + String timeFrame; + String url1; + String url2; + + Awa({ + required this.id, + required this.userId, + required this.educationType, + required this.institutionName, + required this.degree, + required this.specialty, + required this.timeFrame, + required this.url1, + required this.url2, + }); + + factory Awa.fromJson(Map json) => Awa( + id: json["id"], + userId: json["user_id"], + educationType: json["Education Type"], + institutionName: json["Institution Name"], + degree: json["Degree"], + specialty: json["Specialty"], + timeFrame: json["Time Frame"], + url1: json["Url1"], + url2: json["Url2"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Education Type": educationType, + "Institution Name": institutionName, + "Degree": degree, + "Specialty": specialty, + "Time Frame": timeFrame, + "Url1": url1, + "Url2": url2, + }; +} diff --git a/lib/contacts_module/model_class/certificate_model.dart b/lib/contacts_module/model_class/certificate_model.dart new file mode 100644 index 0000000..c190c37 --- /dev/null +++ b/lib/contacts_module/model_class/certificate_model.dart @@ -0,0 +1,59 @@ +// To parse this JSON data, do +// +// final cer = cerFromJson(jsonString); + +import 'dart:convert'; + +List cerFromJson(String str) => + List.from(json.decode(str).map((x) => Cer.fromJson(x))); + +String cerToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Cer { + int id; + int userId; + String educationType; + String institutionName; + String degree; + String specialty; + int timeFrame; + String url1; + String url2; + + Cer({ + required this.id, + required this.userId, + required this.educationType, + required this.institutionName, + required this.degree, + required this.specialty, + required this.timeFrame, + required this.url1, + required this.url2, + }); + + factory Cer.fromJson(Map json) => Cer( + id: json["id"], + userId: json["user_id"], + educationType: json["Education Type"], + institutionName: json["Institution Name"], + degree: json["Degree"], + specialty: json["Specialty"], + timeFrame: json["Time Frame"], + url1: json["Url1"], + url2: json["Url2"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Education Type": educationType, + "Institution Name": institutionName, + "Degree": degree, + "Specialty": specialty, + "Time Frame": timeFrame, + "Url1": url1, + "Url2": url2, + }; +} diff --git a/lib/contacts_module/model_class/education_model.dart b/lib/contacts_module/model_class/education_model.dart new file mode 100644 index 0000000..7bcc9bb --- /dev/null +++ b/lib/contacts_module/model_class/education_model.dart @@ -0,0 +1,51 @@ +// To parse this JSON data, do +// +// final edu = eduFromJson(jsonString); + +import 'dart:convert'; + +List eduFromJson(String str) => + List.from(json.decode(str).map((x) => Edu.fromJson(x))); + +String eduToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Edu { + int id; + int userId; + String educationType; + String institutionName; + String degree; + String specialty; + int timeFrame; + + Edu({ + required this.id, + required this.userId, + required this.educationType, + required this.institutionName, + required this.degree, + required this.specialty, + required this.timeFrame, + }); + + factory Edu.fromJson(Map json) => Edu( + id: json["id"], + userId: json["user_id"], + educationType: json["Education Type"], + institutionName: json["Institution Name"], + degree: json["Degree"], + specialty: json["Specialty"], + timeFrame: json["Time Frame"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Education Type": educationType, + "Institution Name": institutionName, + "Degree": degree, + "Specialty": specialty, + "Time Frame": timeFrame, + }; +} diff --git a/lib/contacts_module/model_class/email_model.dart b/lib/contacts_module/model_class/email_model.dart new file mode 100644 index 0000000..5e3b096 --- /dev/null +++ b/lib/contacts_module/model_class/email_model.dart @@ -0,0 +1,39 @@ +// To parse this JSON data, do +// +// final email = emailFromJson(jsonString); + +import 'dart:convert'; + +List emailFromJson(String str) => + List.from(json.decode(str).map((x) => Email.fromJson(x))); + +String emailToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Email { + int id; + int userId; + String emailType; + String email; + + Email({ + required this.id, + required this.userId, + required this.emailType, + required this.email, + }); + + factory Email.fromJson(Map json) => Email( + id: json["id"], + userId: json["user_id"], + emailType: json["Email Type"], + email: json["Email"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Email Type": emailType, + "Email": email, + }; +} diff --git a/lib/contacts_module/model_class/event_model.dart b/lib/contacts_module/model_class/event_model.dart new file mode 100644 index 0000000..b32fa3f --- /dev/null +++ b/lib/contacts_module/model_class/event_model.dart @@ -0,0 +1,59 @@ +// To parse this JSON data, do +// +// final events = eventsFromJson(jsonString); + +import 'dart:convert'; + +List eventsFromJson(String str) => + List.from(json.decode(str).map((x) => Events.fromJson(x))); + +String eventsToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Events { + int id; + int userId; + String eventName; + String sessionType; + String topic; + String role; + DateTime? createdAt; + DateTime? updatedAt; + + Events({ + required this.id, + required this.userId, + required this.eventName, + required this.sessionType, + required this.topic, + required this.role, + required this.createdAt, + required this.updatedAt, + }); + + factory Events.fromJson(Map json) => Events( + id: json["id"], + userId: json["user_id"], + eventName: json["event_name"], + sessionType: json["session_type"], + topic: json["topic"], + role: json["role"], + createdAt: json["created_at"] == null + ? null + : DateTime.parse(json["created_at"]), + updatedAt: json["updated_at"] == null + ? null + : DateTime.parse(json["updated_at"]), + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "event_name": eventName, + "session_type": sessionType, + "topic": topic, + "role": role, + "created_at": createdAt?.toIso8601String(), + "updated_at": updatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/hcp_details.dart b/lib/contacts_module/model_class/hcp_details.dart new file mode 100644 index 0000000..7cbd807 --- /dev/null +++ b/lib/contacts_module/model_class/hcp_details.dart @@ -0,0 +1,99 @@ +// To parse this JSON data, do +// +// final table = tableFromJson(jsonString); + +import 'dart:convert'; + +List tableFromJson(String str) => + List
.from(json.decode(str).map((x) => Table.fromJson(x))); + +String tableToJson(List
data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Table { + int id; + String name; + String email; + DateTime emailVerifiedAt; + String summarry; + String addr; + int licenseNo; + String pSuffix; + String speciality; + String subSpeciality; + int phoneNo; + int rank; + int score; + DateTime? createdAt; + DateTime? updatedAt; + int eventsCount; + int affiliationsCount; + int publicationsCount; + + Table({ + required this.id, + required this.name, + required this.email, + required this.emailVerifiedAt, + required this.summarry, + required this.addr, + required this.licenseNo, + required this.pSuffix, + required this.speciality, + required this.subSpeciality, + required this.phoneNo, + required this.rank, + required this.score, + required this.createdAt, + required this.updatedAt, + required this.eventsCount, + required this.affiliationsCount, + required this.publicationsCount, + }); + + factory Table.fromJson(Map json) => Table( + id: json["id"], + name: json["name"], + email: json["email"], + emailVerifiedAt: DateTime.parse(json["email_verified_at"]), + summarry: json["summarry"], + addr: json["addr"], + licenseNo: json["license_no"], + pSuffix: json["p_suffix"], + speciality: json["speciality"], + subSpeciality: json["sub_speciality"], + phoneNo: json["phone_no"], + rank: json["rank"], + score: json["score"], + createdAt: json["created_at"] == null + ? null + : DateTime.parse(json["created_at"]), + updatedAt: json["updated_at"] == null + ? null + : DateTime.parse(json["updated_at"]), + eventsCount: json["events_count"], + affiliationsCount: json["affiliations_count"], + publicationsCount: json["publications_count"], + ); + + Map toJson() => { + "id": id, + "name": name, + "email": email, + "email_verified_at": emailVerifiedAt.toIso8601String(), + "summarry": summarry, + "addr": addr, + "license_no": licenseNo, + "p_suffix": pSuffix, + "speciality": speciality, + "sub_speciality": subSpeciality, + "phone_no": phoneNo, + "rank": rank, + "score": score, + "created_at": createdAt?.toIso8601String(), + "updated_at": updatedAt?.toIso8601String(), + "events_count": eventsCount, + "affiliations_count": affiliationsCount, + "publications_count": publicationsCount, + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart new file mode 100644 index 0000000..4f1458f --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart @@ -0,0 +1,122 @@ +// To parse this JSON data, do +// +// final dataCertificate = dataCertificateFromJson(jsonString); + +import 'dart:convert'; + +DataCertificate dataCertificateFromJson(String str) => + DataCertificate.fromJson(json.decode(str)); + +String dataCertificateToJson(DataCertificate data) => + json.encode(data.toJson()); + +class DataCertificate { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataCertificate({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataCertificate.fromJson(Map json) => + DataCertificate( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => CertificateList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class CertificateList { + String? uniqueId; + int? kolId; + int? clientId; + int? organizationId; + dynamic specialty; + String? startDate; + String? endDate; + String? url; + dynamic switchedUserId; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + CertificateList({ + this.uniqueId, + this.kolId, + this.clientId, + this.organizationId, + this.specialty, + this.startDate, + this.endDate, + this.url, + this.switchedUserId, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory CertificateList.fromJson(Map json) => + CertificateList( + uniqueId: json["unique_id"], + kolId: json["kol_id"], + clientId: json["client_id"], + organizationId: json["organization_id"], + specialty: json["specialty"], + startDate: json["start_date"], + endDate: json["end_date"], + url: json["url"], + switchedUserId: json["switched_user_id"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "kol_id": kolId, + "client_id": clientId, + "organization_id": organizationId, + "specialty": specialty, + "start_date": startDate, + "end_date": endDate, + "url": url, + "switched_user_id": switchedUserId, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_aff_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_aff_k2.dart new file mode 100644 index 0000000..9384967 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_aff_k2.dart @@ -0,0 +1,144 @@ +// To parse this JSON data, do +// +// final dataAffiliations = dataAffiliationsFromJson(jsonString); + +import 'dart:convert'; + +DataAffiliations dataAffiliationsFromJson(String str) => + DataAffiliations.fromJson(json.decode(str)); + +String dataAffiliationsToJson(DataAffiliations data) => + json.encode(data.toJson()); + +class DataAffiliations { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataAffiliations({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataAffiliations.fromJson(Map json) => + DataAffiliations( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from(json["data"]!.map((x) => AffList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class AffList { + String? uniqueId; + String? department; + String? title; + String? startYear; + String? endYear; + String? role; + dynamic switchedUserId; + dynamic kolOrganizationUniqueId; + dynamic kolOrganizationName; + String? kolOrganizationType; + String? kolEngagementType; + String? kolEngagementTypeUniqueId; + String? startAndEndYear; + String? createdByUser; + String? updatedByUser; + dynamic deletedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + dynamic formattedDeletedAt; + + AffList({ + this.uniqueId, + this.department, + this.title, + this.startYear, + this.endYear, + this.role, + this.switchedUserId, + this.kolOrganizationUniqueId, + this.kolOrganizationName, + this.kolOrganizationType, + this.kolEngagementType, + this.kolEngagementTypeUniqueId, + this.startAndEndYear, + this.createdByUser, + this.updatedByUser, + this.deletedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + this.formattedDeletedAt, + }); + + factory AffList.fromJson(Map json) => AffList( + uniqueId: json["unique_id"], + department: json["department"], + title: json["title"], + startYear: json["start_year"], + endYear: json["end_year"], + role: json["role"], + switchedUserId: json["switched_user_id"], + kolOrganizationUniqueId: json["kol_organization_unique_id"], + kolOrganizationName: json["kol_organization_name"], + kolOrganizationType: json["kol_organization_type"], + kolEngagementType: json["kol_engagement_type"], + kolEngagementTypeUniqueId: json["kol_engagement_type_unique_id"], + startAndEndYear: json["start_and_end_year"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + deletedByUser: json["deleted_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + formattedDeletedAt: json["formatted_deleted_at"], + ); + + Map toJson() => { + "unique_id": uniqueId, + "department": department, + "title": title, + "start_year": startYear, + "end_year": endYear, + "role": role, + "switched_user_id": switchedUserId, + "kol_organization_unique_id": kolOrganizationUniqueId, + "kol_organization_name": kolOrganizationName, + "kol_organization_type": kolOrganizationType, + "kol_engagement_type": kolEngagementType, + "kol_engagement_type_unique_id": kolEngagementTypeUniqueId, + "start_and_end_year": startAndEndYear, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "deleted_by_user": deletedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + "formatted_deleted_at": formattedDeletedAt, + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_awards_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_awards_k2.dart new file mode 100644 index 0000000..4158ca7 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_awards_k2.dart @@ -0,0 +1,115 @@ +// To parse this JSON data, do +// +// final dataAwards = dataAwardsFromJson(jsonString); + +import 'dart:convert'; + +DataAwards dataAwardsFromJson(String str) => + DataAwards.fromJson(json.decode(str)); + +String dataAwardsToJson(DataAwards data) => json.encode(data.toJson()); + +class DataAwards { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataAwards({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataAwards.fromJson(Map json) => DataAwards( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => AwardsList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class AwardsList { + String? uniqueId; + int? kolId; + int? clientId; + String? name; + String? startDate; + String? endDate; + String? url; + dynamic switchedUserId; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + AwardsList({ + this.uniqueId, + this.kolId, + this.clientId, + this.name, + this.startDate, + this.endDate, + this.url, + this.switchedUserId, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory AwardsList.fromJson(Map json) => AwardsList( + uniqueId: json["unique_id"], + kolId: json["kol_id"], + clientId: json["client_id"], + name: json["name"], + startDate: json["start_date"], + endDate: json["end_date"], + url: json["url"], + switchedUserId: json["switched_user_id"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "kol_id": kolId, + "client_id": clientId, + "name": name, + "start_date": startDate, + "end_date": endDate, + "url": url, + "switched_user_id": switchedUserId, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_education_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_education_k2.dart new file mode 100644 index 0000000..41b5424 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_education_k2.dart @@ -0,0 +1,123 @@ +// To parse this JSON data, do +// +// final dataEducation = dataEducationFromJson(jsonString); + +import 'dart:convert'; + +DataEducation dataEducationFromJson(String str) => + DataEducation.fromJson(json.decode(str)); + +String dataEducationToJson(DataEducation data) => json.encode(data.toJson()); + +class DataEducation { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataEducation({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataEducation.fromJson(Map json) => DataEducation( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => EducationList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class EducationList { + String? uniqueId; + int? kolId; + int? clientId; + dynamic organizationId; + dynamic degree; + dynamic specialty; + String? startDate; + String? endDate; + String? url; + dynamic switchedUserId; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + EducationList({ + this.uniqueId, + this.kolId, + this.clientId, + this.organizationId, + this.degree, + this.specialty, + this.startDate, + this.endDate, + this.url, + this.switchedUserId, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory EducationList.fromJson(Map json) => EducationList( + uniqueId: json["unique_id"], + kolId: json["kol_id"], + clientId: json["client_id"], + organizationId: json["organization_id"], + degree: json["degree"], + specialty: json["specialty"], + startDate: json["start_date"], + endDate: json["end_date"], + url: json["url"], + switchedUserId: json["switched_user_id"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "kol_id": kolId, + "client_id": clientId, + "organization_id": organizationId, + "degree": degree, + "specialty": specialty, + "start_date": startDate, + "end_date": endDate, + "url": url, + "switched_user_id": switchedUserId, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_email_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_email_k2.dart new file mode 100644 index 0000000..19f36f1 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_email_k2.dart @@ -0,0 +1,102 @@ +// To parse this JSON data, do +// +// final dataEmail = dataEmailFromJson(jsonString); + +import 'dart:convert'; + +DataEmail dataEmailFromJson(String str) => DataEmail.fromJson(json.decode(str)); + +String dataEmailToJson(DataEmail data) => json.encode(data.toJson()); + +class DataEmail { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataEmail({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataEmail.fromJson(Map json) => DataEmail( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => EmailData.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class EmailData { + String? uniqueId; + String? email; + String? kolUniqueId; + String? emailTypeName; + String? formattedIsPrimary; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + EmailData({ + this.uniqueId, + this.email, + this.kolUniqueId, + this.emailTypeName, + this.formattedIsPrimary, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory EmailData.fromJson(Map json) => EmailData( + uniqueId: json["unique_id"], + email: json["email"], + kolUniqueId: json["kol_unique_id"], + emailTypeName: json["email_type_name"], + formattedIsPrimary: json["formatted_is_primary"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "email": email, + "kol_unique_id": kolUniqueId, + "email_type_name": emailTypeName, + "formatted_is_primary": formattedIsPrimary, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_event_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_event_k2.dart new file mode 100644 index 0000000..9a67a7e --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_event_k2.dart @@ -0,0 +1,98 @@ +// To parse this JSON data, do +// +// final dataEvent = dataEventFromJson(jsonString); + +import 'dart:convert'; + +DataEvent dataEventFromJson(String str) => DataEvent.fromJson(json.decode(str)); + +String dataEventToJson(DataEvent data) => json.encode(data.toJson()); + +class DataEvent { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataEvent({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataEvent.fromJson(Map json) => DataEvent( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => EventList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class EventList { + String? uniqueId; + String? name; + dynamic notes; + int? partiallyReleasedEvent; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + EventList({ + this.uniqueId, + this.name, + this.notes, + this.partiallyReleasedEvent, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory EventList.fromJson(Map json) => EventList( + uniqueId: json["unique_id"], + name: json["name"], + notes: json["notes"], + partiallyReleasedEvent: json["partially_released_event"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "name": name, + "notes": notes, + "partially_released_event": partiallyReleasedEvent, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_location_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_location_k2.dart new file mode 100644 index 0000000..845c5ee --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_location_k2.dart @@ -0,0 +1,128 @@ +class KolLocation { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + KolLocation( + {this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count}); + + KolLocation.fromJson(Map json) { + code = json['code']; + message = json['message']; + if (json['data'] != null) { + data = []; + json['data'].forEach((v) { + data!.add(new Data.fromJson(v)); + }); + } + lastPage = json['last_page']; + lastRow = json['last_row']; + count = json['count']; + } + + Map toJson() { + final Map data = new Map(); + data['code'] = this.code; + data['message'] = this.message; + if (this.data != null) { + data['data'] = this.data!.map((v) => v.toJson()).toList(); + } + data['last_page'] = this.lastPage; + data['last_row'] = this.lastRow; + data['count'] = this.count; + return data; + } +} + +class Data { + String? uniqueId; + Null? orgInstitutionId; + String? address1; + String? postalCode; + String? kolUniqueId; + String? formattedIsPrimary; + Null? organizationUniqueId; + Null? organizationName; + String? countryUniqueId; + String? countryName; + String? stateUniqueId; + String? stateName; + String? cityUniqueId; + String? cityName; + String? createdByUser; + String? updatedByUser; + String? formattedCreatedAt; + String? formattedUpdatedAt; + + Data( + {this.uniqueId, + this.orgInstitutionId, + this.address1, + this.postalCode, + this.kolUniqueId, + this.formattedIsPrimary, + this.organizationUniqueId, + this.organizationName, + this.countryUniqueId, + this.countryName, + this.stateUniqueId, + this.stateName, + this.cityUniqueId, + this.cityName, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt}); + + Data.fromJson(Map json) { + uniqueId = json['unique_id']; + orgInstitutionId = json['org_institution_id']; + address1 = json['address1']; + postalCode = json['postal_code']; + kolUniqueId = json['kol_unique_id']; + formattedIsPrimary = json['formatted_is_primary']; + organizationUniqueId = json['organization_unique_id']; + organizationName = json['organization_name']; + countryUniqueId = json['country_unique_id']; + countryName = json['country_name']; + stateUniqueId = json['state_unique_id']; + stateName = json['state_name']; + cityUniqueId = json['city_unique_id']; + cityName = json['city_name']; + createdByUser = json['created_by_user']; + updatedByUser = json['updated_by_user']; + formattedCreatedAt = json['formatted_created_at']; + formattedUpdatedAt = json['formatted_updated_at']; + } + + Map toJson() { + final Map data = new Map(); + data['unique_id'] = this.uniqueId; + data['org_institution_id'] = this.orgInstitutionId; + data['address1'] = this.address1; + data['postal_code'] = this.postalCode; + data['kol_unique_id'] = this.kolUniqueId; + data['formatted_is_primary'] = this.formattedIsPrimary; + data['organization_unique_id'] = this.organizationUniqueId; + data['organization_name'] = this.organizationName; + data['country_unique_id'] = this.countryUniqueId; + data['country_name'] = this.countryName; + data['state_unique_id'] = this.stateUniqueId; + data['state_name'] = this.stateName; + data['city_unique_id'] = this.cityUniqueId; + data['city_name'] = this.cityName; + data['created_by_user'] = this.createdByUser; + data['updated_by_user'] = this.updatedByUser; + data['formatted_created_at'] = this.formattedCreatedAt; + data['formatted_updated_at'] = this.formattedUpdatedAt; + return data; + } +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_pno_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_pno_k2.dart new file mode 100644 index 0000000..bdc5290 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_pno_k2.dart @@ -0,0 +1,116 @@ +// To parse this JSON data, do +// +// final dataPno = dataPnoFromJson(jsonString); + +import 'dart:convert'; + +DataaPnoresponse dataPnoFromJson(String str) => + DataaPnoresponse.fromJson(json.decode(str)); + +String dataPnoToJson(DataaPnoresponse data) => json.encode(data.toJson()); + +class DataaPnoresponse { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataaPnoresponse({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataaPnoresponse.fromJson(Map json) => + DataaPnoresponse( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => DataPhno.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class DataPhno { + String? uniqueId; + int? number; + String? kolUniqueId; + String? phoneTypeName; + String? phoneTypeUniqueId; + String? formattedIsPrimary; + dynamic organizationUniqueId; + dynamic organizationName; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + DataPhno({ + this.uniqueId, + this.number, + this.kolUniqueId, + this.phoneTypeName, + this.phoneTypeUniqueId, + this.formattedIsPrimary, + this.organizationUniqueId, + this.organizationName, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory DataPhno.fromJson(Map json) => DataPhno( + uniqueId: json["unique_id"], + number: json["number"], + kolUniqueId: json["kol_unique_id"], + phoneTypeName: json["phone_type_name"], + phoneTypeUniqueId: json["phone_type_unique_id"], + formattedIsPrimary: json["formatted_is_primary"], + organizationUniqueId: json["organization_unique_id"], + organizationName: json["organization_name"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "number": number, + "kol_unique_id": kolUniqueId, + "phone_type_name": phoneTypeName, + "phone_type_unique_id": phoneTypeUniqueId, + "formatted_is_primary": formattedIsPrimary, + "organization_unique_id": organizationUniqueId, + "organization_name": organizationName, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kol_training_k2.dart b/lib/contacts_module/model_class/k2_api_model/kol_training_k2.dart new file mode 100644 index 0000000..2ef2a63 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kol_training_k2.dart @@ -0,0 +1,127 @@ +// To parse this JSON data, do +// +// final dataTraining = dataTrainingFromJson(jsonString); + +import 'dart:convert'; + +DataTraining dataTrainingFromJson(String str) => + DataTraining.fromJson(json.decode(str)); + +String dataTrainingToJson(DataTraining data) => json.encode(data.toJson()); + +class DataTraining { + int? code; + String? message; + List? data; + int? lastPage; + int? lastRow; + int? count; + + DataTraining({ + this.code, + this.message, + this.data, + this.lastPage, + this.lastRow, + this.count, + }); + + factory DataTraining.fromJson(Map json) => DataTraining( + code: json["code"], + message: json["message"], + data: json["data"] == null + ? [] + : List.from( + json["data"]!.map((x) => TrainingList.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": data == null + ? [] + : List.from(data!.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class TrainingList { + String? uniqueId; + int? kolId; + int? orgId; + int? clientId; + dynamic organizationId; + dynamic degree; + dynamic specialty; + String? startDate; + String? endDate; + String? url; + dynamic switchedUserId; + String? createdByUser; + String? updatedByUser; + DateTime? formattedCreatedAt; + DateTime? formattedUpdatedAt; + + TrainingList({ + this.uniqueId, + this.kolId, + this.orgId, + this.clientId, + this.organizationId, + this.degree, + this.specialty, + this.startDate, + this.endDate, + this.url, + this.switchedUserId, + this.createdByUser, + this.updatedByUser, + this.formattedCreatedAt, + this.formattedUpdatedAt, + }); + + factory TrainingList.fromJson(Map json) => TrainingList( + uniqueId: json["unique_id"], + kolId: json["kol_id"], + orgId: json["org_id"], + clientId: json["client_id"], + organizationId: json["organization_id"], + degree: json["degree"], + specialty: json["specialty"], + startDate: json["start_date"], + endDate: json["end_date"], + url: json["url"], + switchedUserId: json["switched_user_id"], + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + formattedCreatedAt: json["formatted_created_at"] == null + ? null + : DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: json["formatted_updated_at"] == null + ? null + : DateTime.parse(json["formatted_updated_at"]), + ); + + Map toJson() => { + "unique_id": uniqueId, + "kol_id": kolId, + "org_id": orgId, + "client_id": clientId, + "organization_id": organizationId, + "degree": degree, + "specialty": specialty, + "start_date": startDate, + "end_date": endDate, + "url": url, + "switched_user_id": switchedUserId, + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "formatted_created_at": formattedCreatedAt?.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt?.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/k2_api_model/kolcontact_list_k2.dart b/lib/contacts_module/model_class/k2_api_model/kolcontact_list_k2.dart new file mode 100644 index 0000000..d8b2fb3 --- /dev/null +++ b/lib/contacts_module/model_class/k2_api_model/kolcontact_list_k2.dart @@ -0,0 +1,272 @@ +// To parse this JSON data, do +// +// final kolcontact = kolcontactFromJson(jsonString); + +import 'dart:convert'; + +Kolcontact kolcontactFromJson(String str) => + Kolcontact.fromJson(json.decode(str)); + +String kolcontactToJson(Kolcontact data) => json.encode(data.toJson()); + +class Kolcontact { + int code; + String message; + List data; + int lastPage; + int lastRow; + int count; + + Kolcontact({ + required this.code, + required this.message, + required this.data, + required this.lastPage, + required this.lastRow, + required this.count, + }); + + factory Kolcontact.fromJson(Map json) => Kolcontact( + code: json["code"], + message: json["message"], + data: List.from(json["data"].map((x) => Datum.fromJson(x))), + lastPage: json["last_page"], + lastRow: json["last_row"], + count: json["count"], + ); + + Map toJson() => { + "code": code, + "message": message, + "data": List.from(data.map((x) => x.toJson())), + "last_page": lastPage, + "last_row": lastRow, + "count": count, + }; +} + +class Datum { + String uniqueId; + dynamic profileImage; + String? npiNum; + String fullName; + String? specialityName; + List subSpecialities; + dynamic primaryOrganization; + String? primaryEmail; + int? primaryPhoneNumber; + dynamic primaryFax; + dynamic primaryCountry; + dynamic primaryState; + dynamic primaryCity; + dynamic primaryPostalCode; + dynamic profileDocumentUniqueId; + dynamic profileDocumentImage; + dynamic latitude; + dynamic longitude; + List organizations; + List emails; + List
address; + List stateLicense; + String createdByUser; + String updatedByUser; + dynamic deletedByUser; + DateTime formattedCreatedAt; + DateTime formattedUpdatedAt; + dynamic formattedDeletedAt; + dynamic profile; + + Datum({ + required this.uniqueId, + required this.profileImage, + required this.npiNum, + required this.fullName, + required this.specialityName, + required this.subSpecialities, + required this.primaryOrganization, + required this.primaryEmail, + required this.primaryPhoneNumber, + required this.primaryFax, + required this.primaryCountry, + required this.primaryState, + required this.primaryCity, + required this.primaryPostalCode, + required this.profileDocumentUniqueId, + required this.profileDocumentImage, + required this.latitude, + required this.longitude, + required this.organizations, + required this.emails, + required this.address, + required this.stateLicense, + required this.createdByUser, + required this.updatedByUser, + required this.deletedByUser, + required this.formattedCreatedAt, + required this.formattedUpdatedAt, + required this.formattedDeletedAt, + required this.profile, + }); + + factory Datum.fromJson(Map json) => Datum( + uniqueId: json["unique_id"], + profileImage: json["profile_image"], + npiNum: json["npi_num"], + fullName: json["full_name"], + specialityName: json["speciality_name"], + subSpecialities: + List.from(json["sub_specialities"].map((x) => x)), + primaryOrganization: json["primary_organization"], + primaryEmail: json["primary_email"], + primaryPhoneNumber: json["primary_phone_number"], + primaryFax: json["primary_fax"], + primaryCountry: json["primary_country"], + primaryState: json["primary_state"], + primaryCity: json["primary_city"], + primaryPostalCode: json["primary_postal_code"], + profileDocumentUniqueId: json["profile_document_unique_id"], + profileDocumentImage: json["profile_document_image"], + latitude: json["latitude"], + longitude: json["longitude"], + organizations: List.from(json["organizations"].map((x) => x)), + emails: List.from(json["emails"].map((x) => Email.fromJson(x))), + address: + List
.from(json["address"].map((x) => Address.fromJson(x))), + stateLicense: List.from( + json["state_license"].map((x) => StateLicense.fromJson(x))), + createdByUser: json["created_by_user"], + updatedByUser: json["updated_by_user"], + deletedByUser: json["deleted_by_user"], + formattedCreatedAt: DateTime.parse(json["formatted_created_at"]), + formattedUpdatedAt: DateTime.parse(json["formatted_updated_at"]), + formattedDeletedAt: json["formatted_deleted_at"], + profile: json["profile"], + ); + + Map toJson() => { + "unique_id": uniqueId, + "profile_image": profileImage, + "npi_num": npiNum, + "full_name": fullName, + "speciality_name": specialityName, + "sub_specialities": List.from(subSpecialities.map((x) => x)), + "primary_organization": primaryOrganization, + "primary_email": primaryEmail, + "primary_phone_number": primaryPhoneNumber, + "primary_fax": primaryFax, + "primary_country": primaryCountry, + "primary_state": primaryState, + "primary_city": primaryCity, + "primary_postal_code": primaryPostalCode, + "profile_document_unique_id": profileDocumentUniqueId, + "profile_document_image": profileDocumentImage, + "latitude": latitude, + "longitude": longitude, + "organizations": List.from(organizations.map((x) => x)), + "emails": List.from(emails.map((x) => x.toJson())), + "address": List.from(address.map((x) => x.toJson())), + "state_license": + List.from(stateLicense.map((x) => x.toJson())), + "created_by_user": createdByUser, + "updated_by_user": updatedByUser, + "deleted_by_user": deletedByUser, + "formatted_created_at": formattedCreatedAt.toIso8601String(), + "formatted_updated_at": formattedUpdatedAt.toIso8601String(), + "formatted_deleted_at": formattedDeletedAt, + "profile": profile, + }; + + // @override + // String toString() { + // // TODO: implement toString + // return profileImage.toString(); + // } +} + +class Address { + String address1; + String? address2; + String country; + String? state; + City city; + + Address({ + required this.address1, + required this.address2, + required this.country, + required this.state, + required this.city, + }); + + factory Address.fromJson(Map json) => Address( + address1: json["address1"], + address2: json["address2"], + country: json["country"], + state: json["state"], + city: cityValues.map[json["city"]]!, + ); + + Map toJson() => { + "address1": address1, + "address2": address2, + "country": country, + "state": state, + "city": cityValues.reverse[city], + }; +} + +enum City { ONTARIO } + +final cityValues = EnumValues({"Ontario": City.ONTARIO}); + +class Email { + dynamic type; + String phoneNo; + + Email({ + required this.type, + required this.phoneNo, + }); + + factory Email.fromJson(Map json) => Email( + type: json["type"], + phoneNo: json["phone_no"], + ); + + Map toJson() => { + "type": type, + "phone_no": phoneNo, + }; +} + +class StateLicense { + String licenseNumber; + dynamic stateCode; + + StateLicense({ + required this.licenseNumber, + required this.stateCode, + }); + + factory StateLicense.fromJson(Map json) => StateLicense( + licenseNumber: json["license_number"], + stateCode: json["state_code"], + ); + + Map toJson() => { + "license_number": licenseNumber, + "state_code": stateCode, + }; +} + +class EnumValues { + Map map; + late Map reverseMap; + + EnumValues(this.map); + + Map get reverse { + reverseMap = map.map((k, v) => MapEntry(v, k)); + return reverseMap; + } +} diff --git a/lib/contacts_module/model_class/location_model.dart b/lib/contacts_module/model_class/location_model.dart new file mode 100644 index 0000000..d2370a4 --- /dev/null +++ b/lib/contacts_module/model_class/location_model.dart @@ -0,0 +1,51 @@ +// To parse this JSON data, do +// +// final loc = locFromJson(jsonString); + +import 'dart:convert'; + +List locFromJson(String str) => + List.from(json.decode(str).map((x) => Loc.fromJson(x))); + +String locToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Loc { + int id; + int userId; + String institution; + String address; + String city; + String state; + int postalCode; + + Loc({ + required this.id, + required this.userId, + required this.institution, + required this.address, + required this.city, + required this.state, + required this.postalCode, + }); + + factory Loc.fromJson(Map json) => Loc( + id: json["id"], + userId: json["user_id"], + institution: json["Institution"], + address: json["Address"], + city: json["City"], + state: json["State"], + postalCode: json["Postal_code"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Institution": institution, + "Address": address, + "City": city, + "State": state, + "Postal_code": postalCode, + }; +} diff --git a/lib/contacts_module/model_class/nih_model.dart b/lib/contacts_module/model_class/nih_model.dart new file mode 100644 index 0000000..2f4f6d7 --- /dev/null +++ b/lib/contacts_module/model_class/nih_model.dart @@ -0,0 +1,100 @@ +// To parse this JSON data, do +// +// final nih = nihFromJson(jsonString); + +import 'dart:convert'; + +List nihFromJson(String str) => + List.from(json.decode(str).map((x) => Nih.fromJson(x))); + +String nihToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Nih { + int id; + int userId; + + String piNames; + String firstName; + String middleName; + String lastName; + String organizationName; + String departmentName; + String orgCity; + String orgState; + String purpose; + String institute; + String totalCost; + String projectStart; + String projectEnd; + String budgetStart; + String budgetEnd; + String createdOn; + int piId; + + Nih({ + required this.id, + required this.userId, + required this.piNames, + required this.firstName, + required this.middleName, + required this.lastName, + required this.organizationName, + required this.departmentName, + required this.orgCity, + required this.orgState, + required this.purpose, + required this.institute, + required this.totalCost, + required this.projectStart, + required this.projectEnd, + required this.budgetStart, + required this.budgetEnd, + required this.createdOn, + required this.piId, + }); + + factory Nih.fromJson(Map json) => Nih( + id: json["id"], + userId: json["user_id"], + piNames: json["pi_names"], + firstName: json["first_name"], + middleName: json["middle_name"], + lastName: json["last_name"], + organizationName: json["organizationName"], + departmentName: json["departmentName"], + orgCity: json["org_city"], + orgState: json["org_state"], + purpose: json["purpose"], + institute: json["institute"], + totalCost: json["total_cost"], + projectStart: json["project_start"], + projectEnd: json["project_end"], + budgetStart: json["budget_start"], + budgetEnd: json["budget_end"], + createdOn: json["created_on"], + piId: json["pi_id"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "pi_names": piNames, + "first_name": firstName, + "middle_name": middleName, + "last_name": lastName, + "organizationName": organizationName, + "departmentName": departmentName, + "org_city": orgCity, + "org_state": orgState, + "purpose": purpose, + "institute": institute, + "total_cost": totalCost, + "project_start": projectStart, + "project_end": projectEnd, + "budget_start": budgetStart, + "budget_end": budgetEnd, + "created_on": createdOn, + "pi_id": piId, + }; +} diff --git a/lib/contacts_module/model_class/patent_model.dart b/lib/contacts_module/model_class/patent_model.dart new file mode 100644 index 0000000..a6c920c --- /dev/null +++ b/lib/contacts_module/model_class/patent_model.dart @@ -0,0 +1,39 @@ +// To parse this JSON data, do +// +// final patent = patentFromJson(jsonString); + +import 'dart:convert'; + +List patentFromJson(String str) => + List.from(json.decode(str).map((x) => Patent.fromJson(x))); + +String patentToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Patent { + int id; + int userId; + String patentTitle; + String status; + + Patent({ + required this.id, + required this.userId, + required this.patentTitle, + required this.status, + }); + + factory Patent.fromJson(Map json) => Patent( + id: json["id"], + userId: json["user_id"], + patentTitle: json["Patent Title"], + status: json["Status"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Patent Title": patentTitle, + "Status": status, + }; +} diff --git a/lib/contacts_module/model_class/pno_model.dart b/lib/contacts_module/model_class/pno_model.dart new file mode 100644 index 0000000..334af4e --- /dev/null +++ b/lib/contacts_module/model_class/pno_model.dart @@ -0,0 +1,43 @@ +// To parse this JSON data, do +// +// final phoneno = phonenoFromJson(jsonString); + +import 'dart:convert'; + +List phonenoFromJson(String str) => + List.from(json.decode(str).map((x) => Phoneno.fromJson(x))); + +String phonenoToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Phoneno { + int id; + int userId; + String phoneType; + String locations; + String phoneNumber; + + Phoneno({ + required this.id, + required this.userId, + required this.phoneType, + required this.locations, + required this.phoneNumber, + }); + + factory Phoneno.fromJson(Map json) => Phoneno( + id: json["id"], + userId: json["user_id"], + phoneType: json["Phone type"], + locations: json["Locations"], + phoneNumber: json["phone Number"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Phone type": phoneType, + "Locations": locations, + "phone Number": phoneNumber, + }; +} diff --git a/lib/contacts_module/model_class/procedure_model.dart b/lib/contacts_module/model_class/procedure_model.dart new file mode 100644 index 0000000..3bed015 --- /dev/null +++ b/lib/contacts_module/model_class/procedure_model.dart @@ -0,0 +1,59 @@ +// To parse this JSON data, do +// +// final pro = proFromJson(jsonString); + +import 'dart:convert'; + +List proFromJson(String str) => + List.from(json.decode(str).map((x) => Pro.fromJson(x))); + +String proToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Pro { + int id; + int userId; + int procedureCode; + String procedure; + String placeOfService; + int totalBeneficiaries; + int totalServices; + int totalBeneDayServices; + int programYear; + + Pro({ + required this.id, + required this.userId, + required this.procedureCode, + required this.procedure, + required this.placeOfService, + required this.totalBeneficiaries, + required this.totalServices, + required this.totalBeneDayServices, + required this.programYear, + }); + + factory Pro.fromJson(Map json) => Pro( + id: json["id"], + userId: json["user_id"], + procedureCode: json["Procedure code"], + procedure: json["Procedure"], + placeOfService: json["Place of Service"], + totalBeneficiaries: json["Total Beneficiaries"], + totalServices: json["Total Services"], + totalBeneDayServices: json["Total_bene_day_services"], + programYear: json["Program year"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Procedure code": procedureCode, + "Procedure": procedure, + "Place of Service": placeOfService, + "Total Beneficiaries": totalBeneficiaries, + "Total Services": totalServices, + "Total_bene_day_services": totalBeneDayServices, + "Program year": programYear, + }; +} diff --git a/lib/contacts_module/model_class/publication_model.dart b/lib/contacts_module/model_class/publication_model.dart new file mode 100644 index 0000000..75aa74b --- /dev/null +++ b/lib/contacts_module/model_class/publication_model.dart @@ -0,0 +1,55 @@ +// To parse this JSON data, do +// +// final publications = publicationsFromJson(jsonString); + +import 'dart:convert'; + +List publicationsFromJson(String str) => List.from( + json.decode(str).map((x) => Publications.fromJson(x))); + +String publicationsToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Publications { + int id; + int userId; + String articalTitle; + String journalName; + DateTime date; + String author; + dynamic createdAt; + dynamic updatedAt; + + Publications({ + required this.id, + required this.userId, + required this.articalTitle, + required this.journalName, + required this.date, + required this.author, + required this.createdAt, + required this.updatedAt, + }); + + factory Publications.fromJson(Map json) => Publications( + id: json["id"], + userId: json["user_id"], + articalTitle: json["artical_title"], + journalName: json["journal_name"], + date: DateTime.parse(json["date"]), + author: json["author"], + createdAt: json["created_at"], + updatedAt: json["updated_at"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "artical_title": articalTitle, + "journal_name": journalName, + "date": date.toIso8601String(), + "author": author, + "created_at": createdAt, + "updated_at": updatedAt, + }; +} diff --git a/lib/contacts_module/model_class/section.dart b/lib/contacts_module/model_class/section.dart new file mode 100644 index 0000000..19f060b --- /dev/null +++ b/lib/contacts_module/model_class/section.dart @@ -0,0 +1,103 @@ +class Publication { + int id; + int userId; + String articleTitle; + String journalName; + DateTime date; + String author; + DateTime? createdAt; + DateTime? updatedAt; + + Publication({ + required this.id, + required this.userId, + required this.articleTitle, + required this.journalName, + required this.date, + required this.author, + this.createdAt, + this.updatedAt, + }); + + // Convert a Publication to a Map + Map toMap() { + return { + 'id': id, + 'user_id': userId, + 'article_title': articleTitle, + 'journal_name': journalName, + 'date': date.toIso8601String(), + 'author': author, + 'created_at': createdAt?.toIso8601String(), + 'updated_at': updatedAt?.toIso8601String(), + }; + } + + // Create a Publication from a Map + factory Publication.fromMap(Map map) { + return Publication( + id: map['id'], + userId: map['user_id'], + articleTitle: map['article_title'], + journalName: map['journal_name'], + date: DateTime.parse(map['date']), + author: map['author'], + createdAt: + map['created_at'] != null ? DateTime.parse(map['created_at']) : null, + updatedAt: + map['updated_at'] != null ? DateTime.parse(map['updated_at']) : null, + ); + } +} + +class Affiliation { + int id; + int userId; + String articleTitle; + String journalName; + DateTime date; + String author; + DateTime? createdAt; + DateTime? updatedAt; + + Affiliation({ + required this.id, + required this.userId, + required this.articleTitle, + required this.journalName, + required this.date, + required this.author, + this.createdAt, + this.updatedAt, + }); + + // Convert an Affiliation to a Map + Map toMap() { + return { + 'id': id, + 'user_id': userId, + 'article_title': articleTitle, + 'journal_name': journalName, + 'date': date.toIso8601String(), + 'author': author, + 'created_at': createdAt?.toIso8601String(), + 'updated_at': updatedAt?.toIso8601String(), + }; + } + + // Create an Affiliation from a Map + factory Affiliation.fromMap(Map map) { + return Affiliation( + id: map['id'], + userId: map['user_id'], + articleTitle: map['article_title'], + journalName: map['journal_name'], + date: DateTime.parse(map['date']), + author: map['author'], + createdAt: + map['created_at'] != null ? DateTime.parse(map['created_at']) : null, + updatedAt: + map['updated_at'] != null ? DateTime.parse(map['updated_at']) : null, + ); + } +} diff --git a/lib/contacts_module/model_class/single_hcpinfo.dart b/lib/contacts_module/model_class/single_hcpinfo.dart new file mode 100644 index 0000000..fff4a88 --- /dev/null +++ b/lib/contacts_module/model_class/single_hcpinfo.dart @@ -0,0 +1,82 @@ +// To parse this JSON data, do +// +// final userdetails = userdetailsFromJson(jsonString); + +import 'dart:convert'; + +Userdetails userdetailsFromJson(String str) => + Userdetails.fromJson(json.decode(str)); + +String userdetailsToJson(Userdetails data) => json.encode(data.toJson()); + +class Userdetails { + int id; + String name; + String email; + DateTime emailVerifiedAt; + String summarry; + String addr; + int licenseNo; + String pSuffix; + String speciality; + String subSpeciality; + int phoneNo; + int rank; + int score; + dynamic createdAt; + dynamic updatedAt; + + Userdetails({ + required this.id, + required this.name, + required this.email, + required this.emailVerifiedAt, + required this.summarry, + required this.addr, + required this.licenseNo, + required this.pSuffix, + required this.speciality, + required this.subSpeciality, + required this.phoneNo, + required this.rank, + required this.score, + required this.createdAt, + required this.updatedAt, + }); + + factory Userdetails.fromJson(Map json) => Userdetails( + id: json["id"], + name: json["name"], + email: json["email"], + emailVerifiedAt: DateTime.parse(json["email_verified_at"]), + summarry: json["summarry"], + addr: json["addr"], + licenseNo: json["license_no"], + pSuffix: json["p_suffix"], + speciality: json["speciality"], + subSpeciality: json["sub_speciality"], + phoneNo: json["phone_no"], + rank: json["rank"], + score: json["score"], + createdAt: json["created_at"], + updatedAt: json["updated_at"], + ); + + Map toJson() => { + "id": id, + "name": name, + "email": email, + "email_verified_at": emailVerifiedAt.toIso8601String(), + "summarry": summarry, + "addr": addr, + "license_no": licenseNo, + "p_suffix": pSuffix, + "speciality": speciality, + "sub_speciality": subSpeciality, + "phone_no": phoneNo, + "rank": rank, + "score": score, + "created_at": createdAt, + "updated_at": updatedAt, + }; +} diff --git a/lib/contacts_module/model_class/speaker.dart b/lib/contacts_module/model_class/speaker.dart new file mode 100644 index 0000000..753d690 --- /dev/null +++ b/lib/contacts_module/model_class/speaker.dart @@ -0,0 +1,55 @@ +// To parse this JSON data, do +// +// final speaker = speakerFromJson(jsonString); + +import 'dart:convert'; + +List speakerFromJson(String str) => + List.from(json.decode(str).map((x) => Speaker.fromJson(x))); + +String speakerToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Speaker { + int id; + String programtopic; + String speakername; + String role; + String evaluatorname; + String programdate; + DateTime createdAt; + DateTime updatedAt; + + Speaker({ + required this.id, + required this.programtopic, + required this.speakername, + required this.role, + required this.evaluatorname, + required this.programdate, + required this.createdAt, + required this.updatedAt, + }); + + factory Speaker.fromJson(Map json) => Speaker( + id: json["id"], + programtopic: json["programtopic"], + speakername: json["speakername"], + role: json["role"], + evaluatorname: json["evaluatorname"], + programdate: json["programdate"], + createdAt: DateTime.parse(json["created_at"]), + updatedAt: DateTime.parse(json["updated_at"]), + ); + + Map toJson() => { + "id": id, + "programtopic": programtopic, + "speakername": speakername, + "role": role, + "evaluatorname": evaluatorname, + "programdate": programdate, + "created_at": createdAt.toIso8601String(), + "updated_at": updatedAt.toIso8601String(), + }; +} diff --git a/lib/contacts_module/model_class/trainig_model.dart b/lib/contacts_module/model_class/trainig_model.dart new file mode 100644 index 0000000..b2a4230 --- /dev/null +++ b/lib/contacts_module/model_class/trainig_model.dart @@ -0,0 +1,51 @@ +// To parse this JSON data, do +// +// final traning = traningFromJson(jsonString); + +import 'dart:convert'; + +List traningFromJson(String str) => + List.from(json.decode(str).map((x) => Traning.fromJson(x))); + +String traningToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Traning { + int id; + int userId; + String educationType; + String institutionName; + String degree; + String specialty; + String timeFrame; + + Traning({ + required this.id, + required this.userId, + required this.educationType, + required this.institutionName, + required this.degree, + required this.specialty, + required this.timeFrame, + }); + + factory Traning.fromJson(Map json) => Traning( + id: json["id"], + userId: json["user_id"], + educationType: json["Education Type"], + institutionName: json["Institution Name"], + degree: json["Degree"], + specialty: json["Specialty"], + timeFrame: json["Time Frame"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "Education Type": educationType, + "Institution Name": institutionName, + "Degree": degree, + "Specialty": specialty, + "Time Frame": timeFrame, + }; +} diff --git a/lib/contacts_module/model_class/trials.dart b/lib/contacts_module/model_class/trials.dart new file mode 100644 index 0000000..a4fb391 --- /dev/null +++ b/lib/contacts_module/model_class/trials.dart @@ -0,0 +1,67 @@ +// To parse this JSON data, do +// +// final trials = trialsFromJson(jsonString); + +import 'dart:convert'; + +List trialsFromJson(String str) => + List.from(json.decode(str).map((x) => Trials.fromJson(x))); + +String trialsToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class Trials { + int id; + int userId; + String ctId; + String trialName; + String status; + String sponsors; + String condition; + String intervention; + String phase; + dynamic createdAt; + dynamic updatedAt; + + Trials({ + required this.id, + required this.userId, + required this.ctId, + required this.trialName, + required this.status, + required this.sponsors, + required this.condition, + required this.intervention, + required this.phase, + required this.createdAt, + required this.updatedAt, + }); + + factory Trials.fromJson(Map json) => Trials( + id: json["id"], + userId: json["user_id"], + ctId: json["ct_id"], + trialName: json["trial_name"], + status: json["status"], + sponsors: json["sponsors"], + condition: json["condition"], + intervention: json["intervention"], + phase: json["phase"], + createdAt: json["created_at"], + updatedAt: json["updated_at"], + ); + + Map toJson() => { + "id": id, + "user_id": userId, + "ct_id": ctId, + "trial_name": trialName, + "status": status, + "sponsors": sponsors, + "condition": condition, + "intervention": intervention, + "phase": phase, + "created_at": createdAt, + "updated_at": updatedAt, + }; +} diff --git a/lib/contacts_module/network_connection/network_check.dart b/lib/contacts_module/network_connection/network_check.dart new file mode 100644 index 0000000..33ed9e4 --- /dev/null +++ b/lib/contacts_module/network_connection/network_check.dart @@ -0,0 +1,10 @@ +import 'dart:async'; + +import 'package:connectivity_plus/connectivity_plus.dart'; + +class NetworkConnectivity { + Future isInternetAvailable() async { + var connectivityResult = await (Connectivity().checkConnectivity()); + return connectivityResult != ConnectivityResult.none; + } +} diff --git a/lib/contacts_module/provider_class/affiliationsprovider.dart b/lib/contacts_module/provider_class/affiliationsprovider.dart new file mode 100644 index 0000000..f1622d3 --- /dev/null +++ b/lib/contacts_module/provider_class/affiliationsprovider.dart @@ -0,0 +1,46 @@ +import 'dart:convert'; + +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/aff_data/insert_aff.dart'; +import 'package:flutter/cupertino.dart'; + +class AffiliationsProvider extends ChangeNotifier { + final affapi = Callapi(); + + List affiliations1 = []; + List allaffiliations1 = []; + + List get adddta => affiliations1; + List get affiliationsAll => allaffiliations1; + + getAffiliationsdata(text) async { + print("Affiliations_is: ${text}"); + final affdata = await affapi.getaffiliationsdata(text); + print("Affiliations_is after:$affdata "); + + // final Map jsonData = json.decode(affdata); + // // final List affiliations = jsonData['Affiliations']; + // print("Affiliations_is return:$jsonData "); + + affiliations1 = affdata; + + notifyListeners(); + } + + getAllAffiliationsdata() async { + print("Affiliations_is: "); + final affdata = await affapi.getallaffiliationsdata(); + print("Affiliations_is after:$affdata "); + + allaffiliations1 = affdata; + notifyListeners(); + } + + storeAff(row) async { + final affdata = await affapi.getaffiliationsdata(row); + + print("Affiliations_MyStoringData:$affdata "); + + await addAffiliation(affdata); + } +} diff --git a/lib/contacts_module/provider_class/award_provider.dart b/lib/contacts_module/provider_class/award_provider.dart new file mode 100644 index 0000000..72a823d --- /dev/null +++ b/lib/contacts_module/provider_class/award_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/awa_data/crud_awa.dart'; +import 'package:flutter/cupertino.dart'; + +class AwardProvider extends ChangeNotifier { + final apicall = Callapi(); + List awalist = []; + + List get awardlist => awalist; + + awainfo(text) async { + print("Location_Text"); + final email_result = await apicall.getawarddata(text); + awalist = email_result; + notifyListeners(); + } + + storeAwa(row) async { + final awaresult = await apicall.getawarddata(row); + await addAwa(awaresult); + } +} diff --git a/lib/contacts_module/provider_class/certificate_provider.dart b/lib/contacts_module/provider_class/certificate_provider.dart new file mode 100644 index 0000000..6981a17 --- /dev/null +++ b/lib/contacts_module/provider_class/certificate_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/cer_hive/crud_cer.dart'; +import 'package:flutter/cupertino.dart'; + +class CertificateProvider extends ChangeNotifier { + final apicall = Callapi(); + List cerlist = []; + + List get certificatelist => cerlist; + + certificateinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getcerlistdata(text); + cerlist = email_result; + notifyListeners(); + } + + storeCer(row) async { + final cerResult = await apicall.getcerlistdata(row); + await addCer(cerResult); + } +} diff --git a/lib/contacts_module/provider_class/educationprovider.dart b/lib/contacts_module/provider_class/educationprovider.dart new file mode 100644 index 0000000..4285d7e --- /dev/null +++ b/lib/contacts_module/provider_class/educationprovider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/edu_data/crud_edu.dart'; +import 'package:flutter/cupertino.dart'; + +class EducationProvider extends ChangeNotifier { + final apicall = Callapi(); + List edulist = []; + + List get educationlist => edulist; + + eduinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getedulistdata(text); + edulist = email_result; + notifyListeners(); + } + + storeEdu(row) async { + final emailresult = await apicall.getedulistdata(row); + await addEdu(emailresult); + } +} diff --git a/lib/contacts_module/provider_class/email_provider.dart b/lib/contacts_module/provider_class/email_provider.dart new file mode 100644 index 0000000..1db87b3 --- /dev/null +++ b/lib/contacts_module/provider_class/email_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/crud_email.dart'; +import 'package:flutter/cupertino.dart'; + +class EmailProvider extends ChangeNotifier { + final apicall = Callapi(); + List emaillist = []; + + List get emailkollist => emaillist; + + emailinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getemaildata(text); + emaillist = email_result; + notifyListeners(); + } + + storeEmail(row) async { + final emailresult = await apicall.getemaildata(row); + await addEmail(emailresult); + } +} diff --git a/lib/contacts_module/provider_class/engagement_provider.dart b/lib/contacts_module/provider_class/engagement_provider.dart new file mode 100644 index 0000000..318d065 --- /dev/null +++ b/lib/contacts_module/provider_class/engagement_provider.dart @@ -0,0 +1,79 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:flutter/cupertino.dart'; + +class EnagagementProvider extends ChangeNotifier { + final callapi = Callapi(); + + List enagement = []; + List get engagementdata => enagement; + + List enagementhcpname = []; + List get engagementhcppname => enagementhcpname; + + List enagementhcpmain = []; + List get enagementhcppmain => enagementhcpmain; + + List enagementhcprel = []; + List get enagementhcpprel => enagementhcprel; + + List enagementhcplevel = []; + List get enagementhcpplevel => enagementhcplevel; + + getengagementdata() async { + final engdata = await callapi.getEngdata(); + enagement = engdata; + notifyListeners(); + } + + gethcpname() async { + if (enagementhcpname.isNotEmpty) { + enagementhcpname.clear(); + } + + for (var hname in engagementdata) { + enagementhcpname.add(hname['hcpname']); + + //print("checkin_eng: ${hname['hcpname']}"); + notifyListeners(); + } + } + + getmaintherepeutic() async { + if (enagementhcpmain.isNotEmpty) { + enagementhcpmain.clear(); + } + + for (var hname in engagementdata) { + enagementhcpmain.add(hname['main thereutic area']); + + //print("checkin_eng: ${hname['hcpname']}"); + notifyListeners(); + } + } + + getrelationship() async { + if (enagementhcprel.isNotEmpty) { + enagementhcprel.clear(); + } + + for (var hname in engagementdata) { + enagementhcprel.add(hname['relationship with chiesi']); + + //print("checkin_eng: ${hname['hcpname']}"); + notifyListeners(); + } + } + + getrelationlevel() async { + if (enagementhcplevel.isNotEmpty) { + enagementhcplevel.clear(); + } + + for (var hname in engagementdata) { + enagementhcplevel.add(hname['level of engagement']); + + //print("checkin_eng: ${hname['hcpname']}"); + notifyListeners(); + } + } +} diff --git a/lib/contacts_module/provider_class/events_provider.dart b/lib/contacts_module/provider_class/events_provider.dart new file mode 100644 index 0000000..6e9c81d --- /dev/null +++ b/lib/contacts_module/provider_class/events_provider.dart @@ -0,0 +1,34 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/crud_event.dart'; +import 'package:flutter/cupertino.dart'; + +class EventProvider extends ChangeNotifier { + final apicall = Callapi(); + + List eventlist = []; + + List get EventsList => eventlist; + + List alleventlist = []; + + List get allEventsList => alleventlist; + + geteventdata(text) async { + final events = await apicall.geteventsdata(text); + + eventlist = events; + notifyListeners(); + } + + allgeteventdata() async { + final events = await apicall.allgeteventsdata(); + + alleventlist = events; + notifyListeners(); + } + + storeEvent(row) async { + final events = await apicall.geteventsdata(row); + await addEvent(events); + } +} diff --git a/lib/contacts_module/provider_class/hcp _provider.dart b/lib/contacts_module/provider_class/hcp _provider.dart new file mode 100644 index 0000000..9943d95 --- /dev/null +++ b/lib/contacts_module/provider_class/hcp _provider.dart @@ -0,0 +1,123 @@ +// import 'package:konectar_events/hive_fun.dart'; +// import 'package:konectar_events/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:flutter/foundation.dart'; + +class hcpProvider extends ChangeNotifier { + final apicall = Callapi(); + + List _list = []; + + List get list => _list; + + getHCPProvider() async { + final jsondata = await apicall.getallhcpdata(); + + print("kkoollll_dataaaa: ${jsondata}"); + + _list = jsondata; + + notifyListeners(); + } + + // getHCPHive() async { + // final jsondata = await apicall.getallhcpdata(); + + // _list = jsondata; + + // notifyListeners(); + // } + + List searchHCP(String query) { + if (query.isEmpty) { + return List.from(_list); // Return full list if query is empty + } else { + // return _list + // .where( + // (hcp) => hcp['name'].toLowerCase().contains(query.toLowerCase())) + // .toList(); + print("JsonIssList: $_list"); + print("queryIssList: $query"); + + return _list + .where((hcp) => + hcp['name'].toLowerCase().contains(query.toLowerCase()) || + // (hcp['speciality'].toLowerCase().contains(query.toLowerCase()) ?? + // hcp['spl'].toLowerCase().contains(query.toLowerCase())) || + + hcp['speciality'].toLowerCase().contains(query.toLowerCase()) || + hcp['addr'].toLowerCase().contains(query.toLowerCase())) + .toList(); + + // return _list.where((hcp) { + // // Perform multiple checks using logical AND (&&) + // return hcp['name'].toLowerCase().contains(query.toLowerCase()) && + // hcp['speciality'].toLowerCase().contains(query.toLowerCase()) && + // hcp['addr'].toLowerCase().contains(query.toLowerCase()); + // // Add more conditions as needed + // }).toList(); + } + } + + getHCPProviderHive() async { + final jsondata = await HiveFunctions.gethcpdata(); + print("JsonDtaa: ${jsondata}"); + + _list = jsondata; + print("JsonDtaaList: $_list"); + + notifyListeners(); + //print("Get_hcp_dataaaL ${HiveFunctions.gethcpdata()}"); + } + + gethcpNamefilter(String? option) { + if (option == "HCP Name") { + return _list.map((e) => e["name"].toString()).toList(); + } else { + return _list.map((e) => e["speciality"].toString()).toList(); + } + } + + getHCPProviderFilters(String? _selectedValue1, List value) { + print("I_am Provider_filterr"); + if (_selectedValue1 == "Profile Type") { + print("PPPP11"); + return value = [ + "All Profile", + 'Full Profile', + 'Basic Profile', + ]; + } + // else if (_selectedValue1 == "HCP Name") { + // print("FilterHcpNameee"); + // fecthhcpbyname(); + // } else if (_selectedValue1 == "Speciality") { + // print("kkk"); + // fecthhcpbyspl(); + // } + + else if (_selectedValue1 == "Country") { + print("kkk"); + return value = [ + "United States", + "United States", + "United States", + ]; + } else if (_selectedValue1 == "State") { + print("kkk"); + return value = [ + "Karnataka", + 'Karnataka', + 'Karnataka', + ]; + } else if (_selectedValue1 == "City") { + print("kkk"); + return value = [ + "Hubli", + 'Hubli', + 'Hubli', + ]; + } + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_aff_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_aff_provider.dart new file mode 100644 index 0000000..7bdc8cf --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_aff_provider.dart @@ -0,0 +1,37 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_aff_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class AffiliationsProviderk2 extends ChangeNotifier { + final affapi = CallK2api(); + + List affiliations1 = []; + List allaffiliations1 = []; + + List get adddta => affiliations1; + List get affiliationsAll => allaffiliations1; + + getAffiliationsdata(text) async { + print("Affiliations_is: ${text}"); + final affdata = await affapi.getaffiliationsdata(text); + print("Affiliations_is after:$affdata "); + + // final Map jsonData = json.decode(affdata); + // // final List affiliations = jsonData['Affiliations']; + // print("Affiliations_is return:$jsonData "); + + affiliations1 = affdata!; + // print("Affiliations_is return:$affiliations1 "); + + notifyListeners(); + } + + getAllAffiliationsdata() async { + print("Affiliations_is: "); + final affdata = await affapi.getallaffiliationsdata(); + print("Affiliations_is after:$affdata "); + + allaffiliations1 = affdata; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_awards_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_awards_provider.dart new file mode 100644 index 0000000..479bc58 --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_awards_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_awards_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class AwardProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List awalist = []; + + List get awardlist => awalist; + + awainfo(text) async { + print("Location_Text"); + final email_result = await apicall.getawarddata(text); + awalist = email_result!; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_certificate_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_certificate_provider.dart new file mode 100644 index 0000000..b9f2dbc --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_certificate_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class CertificateProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List cerlist = []; + + List get certificatelist => cerlist; + + certificateinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getcerlistdata(text); + cerlist = email_result!; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_education_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_education_provider.dart new file mode 100644 index 0000000..db55e3e --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_education_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_education_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class EducationProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List edulist = []; + + List get educationlist => edulist; + + eduinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getedulistdata(text); + edulist = email_result!; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_email_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_email_provider.dart new file mode 100644 index 0000000..df78686 --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_email_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_email_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class EmailProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List emaillist = []; + + List get emailkollist => emaillist; + + emailinfo(text) async { + print("Location_Text"); + final email_result = await apicall.getemaildata(text); + emaillist = email_result!; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_event_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_event_provider.dart new file mode 100644 index 0000000..1557424 --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_event_provider.dart @@ -0,0 +1,29 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_event_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class EventProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + + List eventlist = []; + + List get EventsList => eventlist; + + List alleventlist = []; + + List get allEventsList => alleventlist; + + geteventdata(text) async { + final events = await apicall.geteventsdata(text); + + eventlist = events!; + notifyListeners(); + } + + allgeteventdata() async { + final events = await apicall.allgeteventsdata(); + + alleventlist = events; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_list_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_list_provider.dart new file mode 100644 index 0000000..392448b --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_list_provider.dart @@ -0,0 +1,61 @@ +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/foundation.dart'; + +class KolListProvider extends ChangeNotifier { + final apicall = CallK2api(); + + List _list = []; + + List get list => _list; + + getHCPProvider() async { + final jsondata = await apicall.getallhcpdata(); + + print("kkoollll_dataaaa: ${jsondata}"); + + _list = jsondata; + + notifyListeners(); + } + + List searchHCP(String query) { + if (query.isEmpty) { + return List.from(_list); // Return full list if query is empty + } else { + // return _list + // .where( + // (hcp) => hcp['name'].toLowerCase().contains(query.toLowerCase())) + // .toList(); + print("JsonIssList: $_list"); + print("queryIssList: $query"); + + return _list + .where((hcp) => + hcp['full_name'] + .toLowerCase() + .contains(query.toLowerCase()) || + // (hcp['speciality'].toLowerCase().contains(query.toLowerCase()) ?? + // hcp['spl'].toLowerCase().contains(query.toLowerCase())) || + + hcp['speciality_name'] + .toLowerCase() + .contains(query.toLowerCase()) + // || + // hcp['addr'].toLowerCase().contains(query.toLowerCase()) + ) + .toList(); + } + } + + getHCPProviderHive() async { + final jsondata = await HiveFunctions.gethcpdata(); + print("JsonDtaa: ${jsondata}"); + + _list = jsondata; + print("JsonDtaaList: $_list"); + + notifyListeners(); + //print("Get_hcp_dataaaL ${HiveFunctions.gethcpdata()}"); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_locationprovider.dart b/lib/contacts_module/provider_class/k2_provider/kol_locationprovider.dart new file mode 100644 index 0000000..583cded --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_locationprovider.dart @@ -0,0 +1,16 @@ +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class LocationKolProvider extends ChangeNotifier { + final apicall = CallK2api(); + List loclist = []; + + List get locationlist => loclist; + + locationinfo(text) async { + print("Location_Text"); + final publication_result = await apicall.getlocationsdata(text); + loclist = publication_result; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_pno_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_pno_provider.dart new file mode 100644 index 0000000..05ead08 --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_pno_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_pno_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class PhonenoProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List? phonelist = []; + + List get phonenolist => phonelist!; + + phonek2info(text) async { + print("Location_Text"); + final phone_result = await apicall.getphonedata(text); + phonelist = phone_result; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/k2_provider/kol_training_provider.dart b/lib/contacts_module/provider_class/k2_provider/kol_training_provider.dart new file mode 100644 index 0000000..3077bfa --- /dev/null +++ b/lib/contacts_module/provider_class/k2_provider/kol_training_provider.dart @@ -0,0 +1,17 @@ +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_training_k2.dart'; +import 'package:konectar_events/contacts_module/service.dart/k2_service/Apicall_k2.dart'; +import 'package:flutter/cupertino.dart'; + +class TrainigProviderK2 extends ChangeNotifier { + final apicall = CallK2api(); + List tralist = []; + + List get traininglist => tralist; + + traininginfo(text) async { + print("Location_Text"); + final email_result = await apicall.gettrainingdata(text); + tralist = email_result!; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/location_provider.dart b/lib/contacts_module/provider_class/location_provider.dart new file mode 100644 index 0000000..e7127ab --- /dev/null +++ b/lib/contacts_module/provider_class/location_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/crud_loc.dart'; +import 'package:flutter/cupertino.dart'; + +class LocationProvider extends ChangeNotifier { + final apicall = Callapi(); + List loclist = []; + + List get locationlist => loclist; + + locationinfo(text) async { + print("Location_Text"); + final publication_result = await apicall.getlocationsdata(text); + loclist = publication_result; + notifyListeners(); + } + + storeLoc(row) async { + final publicationResult = await apicall.getlocationsdata(row); + await addLoc(publicationResult); + } +} diff --git a/lib/contacts_module/provider_class/medicalinsightprovider.dart b/lib/contacts_module/provider_class/medicalinsightprovider.dart new file mode 100644 index 0000000..0b3733c --- /dev/null +++ b/lib/contacts_module/provider_class/medicalinsightprovider.dart @@ -0,0 +1,16 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:flutter/cupertino.dart'; + +class MediacalInsightProvider extends ChangeNotifier { + final callapi = Callapi(); + + List med = []; + + List get trialsinfo => med; + + medicalinsightdata() async { + final jsonres = await callapi.getallMedicalInsightdata(); + med = jsonres; + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/nih_provider.dart b/lib/contacts_module/provider_class/nih_provider.dart new file mode 100644 index 0000000..201e870 --- /dev/null +++ b/lib/contacts_module/provider_class/nih_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/nih_grant_data/crud_nih.dart'; +import 'package:flutter/cupertino.dart'; + +class NIHGrantsProvider extends ChangeNotifier { + final apicall = Callapi(); + List nihlist = []; + + List get nihgrantslist => nihlist; + + nihinfo(text) async { + print("Location_Text"); + final nih_result = await apicall.getnihdata(text); + nihlist = nih_result; + notifyListeners(); + } + + storeNih(row) async { + final nihresult = await apicall.getnihdata(row); + await addNih(nihresult); + } +} diff --git a/lib/contacts_module/provider_class/patent_provider.dart b/lib/contacts_module/provider_class/patent_provider.dart new file mode 100644 index 0000000..4f549a9 --- /dev/null +++ b/lib/contacts_module/provider_class/patent_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/patent_data/crud_patent.dart'; +import 'package:flutter/cupertino.dart'; + +class PatentProvider extends ChangeNotifier { + final apicall = Callapi(); + List palist = []; + + List get patentlist => palist; + + patentinfo(text) async { + print("Location_Text"); + final patent_result = await apicall.getpatentdata(text); + palist = patent_result; + notifyListeners(); + } + + storePet(row) async { + final patentresult = await apicall.getpatentdata(row); + await addPatent(patentresult); + } +} diff --git a/lib/contacts_module/provider_class/phoneno_provider.dart b/lib/contacts_module/provider_class/phoneno_provider.dart new file mode 100644 index 0000000..79093f8 --- /dev/null +++ b/lib/contacts_module/provider_class/phoneno_provider.dart @@ -0,0 +1,23 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/crud_pno.dart'; +import 'package:flutter/cupertino.dart'; + +class PhonenoProvider extends ChangeNotifier { + final apicall = Callapi(); + List phonelist = []; + + List get phonenolist => phonelist; + + phoneinfo(text) async { + print("Location_Text"); + final phone_result = await apicall.getphonedata(text); + phonelist = phone_result; + notifyListeners(); + } + + storePno(row) async { + print("Location_Text"); + final phoneresult = await apicall.getphonedata(row); + await addPno(phoneresult); + } +} diff --git a/lib/contacts_module/provider_class/procedureprovider.dart b/lib/contacts_module/provider_class/procedureprovider.dart new file mode 100644 index 0000000..6bb5338 --- /dev/null +++ b/lib/contacts_module/provider_class/procedureprovider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/procedure_data/crud_pro.dart'; +import 'package:flutter/cupertino.dart'; + +class ProcedureProvider extends ChangeNotifier { + final apicall = Callapi(); + List procedurelist = []; + + List get prolist => procedurelist; + + proinfo(text) async { + print("Location_Text"); + final nih_result = await apicall.getprodata(text); + procedurelist = nih_result; + notifyListeners(); + } + + storePro(row) async { + final proData = await apicall.getprodata(row); + await addPro(proData); + } +} diff --git a/lib/contacts_module/provider_class/publications_provider.dart b/lib/contacts_module/provider_class/publications_provider.dart new file mode 100644 index 0000000..cfc27f0 --- /dev/null +++ b/lib/contacts_module/provider_class/publications_provider.dart @@ -0,0 +1,35 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pub_data/curd_pub.dart'; + +import 'package:flutter/cupertino.dart'; + +class PublicatioProvider extends ChangeNotifier { + final apicall = Callapi(); + List publist = []; + + List get publicationlist => publist; + + List allpublist = []; + + List get allpublicationlist => allpublist; + + publicatininfo(text) async { + final publication_result = await apicall.getpublicationsdata(text); + publist = publication_result; + notifyListeners(); + } + + allpublicatininfo() async { + final publication_result = await apicall.getallpublicationsdata(); + allpublist = publication_result; + notifyListeners(); + } + + storePub(row) async { + final publication_result = await apicall.getpublicationsdata(row); + + print("Affiliations_MyStoringData:$publication_result "); + + await addPublication(publication_result); + } +} diff --git a/lib/contacts_module/provider_class/single_hcpprovider.dart b/lib/contacts_module/provider_class/single_hcpprovider.dart new file mode 100644 index 0000000..e2372a9 --- /dev/null +++ b/lib/contacts_module/provider_class/single_hcpprovider.dart @@ -0,0 +1,23 @@ +import 'package:konectar_events/contacts_module/model_class/single_hcpinfo.dart'; +import 'package:konectar_events/contacts_module/service.dart/service.dart'; + +import 'package:flutter/foundation.dart'; + +class Singlehcpdetails extends ChangeNotifier { + final apicall = Callapi(); + + List _singlehcplist = []; + + List get singlehcpinfo => _singlehcplist; + + Future hcpinfo() async { + final getdata = await apicall.getsinglehcpdata(); + + print("Provider_data: $getdata"); + + // _singlehcplist = getdata; + _singlehcplist.add(Userdetails.fromJson(getdata)); + + notifyListeners(); + } +} diff --git a/lib/contacts_module/provider_class/speaker_provider.dart b/lib/contacts_module/provider_class/speaker_provider.dart new file mode 100644 index 0000000..7750be3 --- /dev/null +++ b/lib/contacts_module/provider_class/speaker_provider.dart @@ -0,0 +1,24 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/speaker_data/crud.speaker.dart'; + +import 'package:flutter/cupertino.dart'; + +class SpekerEvalutionProvider extends ChangeNotifier { + final callapi = Callapi(); + + List speaker_data = []; + + List get speakerlist => speaker_data; + + getspeakerdata() async { + final data = await callapi.getSpeakerdata(); + + speaker_data = data; + notifyListeners(); + } + + storeSpeaker(row) async { + final dataSpe = await callapi.getSpeakerdata(); + await addSpeaker(dataSpe); + } +} diff --git a/lib/contacts_module/provider_class/training_provider.dart b/lib/contacts_module/provider_class/training_provider.dart new file mode 100644 index 0000000..59f5ad3 --- /dev/null +++ b/lib/contacts_module/provider_class/training_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/crud_training.dart'; +import 'package:flutter/cupertino.dart'; + +class TrainigProvider extends ChangeNotifier { + final apicall = Callapi(); + List tralist = []; + + List get traininglist => tralist; + + traininginfo(text) async { + print("Location_Text"); + final email_result = await apicall.gettrainingdata(text); + tralist = email_result; + notifyListeners(); + } + + storeTraining(row) async { + final trainingresult = await apicall.gettrainingdata(row); + await addtraining(trainingresult); + } +} diff --git a/lib/contacts_module/provider_class/trials_provider.dart b/lib/contacts_module/provider_class/trials_provider.dart new file mode 100644 index 0000000..0dfc10c --- /dev/null +++ b/lib/contacts_module/provider_class/trials_provider.dart @@ -0,0 +1,22 @@ +import 'package:konectar_events/contacts_module/service.dart/service.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/crud_trials.dart'; +import 'package:flutter/cupertino.dart'; + +class TrialsProvider extends ChangeNotifier { + final callapi = Callapi(); + + List trials = []; + + List get trialsinfo => trials; + + trialsdata(text) async { + final jsonres = await callapi.getalltrials(text); + trials = jsonres; + notifyListeners(); + } + + storeTrials(row) async { + final jsonres = await callapi.getalltrials(row); + await addTrials(jsonres); + } +} diff --git a/lib/contacts_module/row_class.dart b/lib/contacts_module/row_class.dart new file mode 100644 index 0000000..4e69813 --- /dev/null +++ b/lib/contacts_module/row_class.dart @@ -0,0 +1,26 @@ +class _Row { + _Row( + this.identifier, + this.valueA, + this.valueC, + this.valueD, + this.valueE, + this.valueF, + this.valueG, + this.valueH, + this.valueI, + this.selected, // Add selected parameter + ); + + final int identifier; + final String valueA; + final String valueC; + final String valueD; + final String valueE; + final String valueF; + final String valueG; + final String valueH; + final String valueI; + + bool selected = false; +} diff --git a/lib/contacts_module/service.dart/k2_service/Apicall_k2.dart b/lib/contacts_module/service.dart/k2_service/Apicall_k2.dart new file mode 100644 index 0000000..bce7c67 --- /dev/null +++ b/lib/contacts_module/service.dart/k2_service/Apicall_k2.dart @@ -0,0 +1,496 @@ +import 'dart:convert'; + +import 'package:dio/dio.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_aff_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_awards_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_education_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_email_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_event_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_location_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_pno_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_training_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kolcontact_list_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/nih_model.dart'; +import 'package:konectar_events/contacts_module/model_class/patent_model.dart'; +import 'package:konectar_events/contacts_module/model_class/procedure_model.dart'; +import 'package:konectar_events/contacts_module/model_class/publication_model.dart'; +import 'package:konectar_events/contacts_module/model_class/speaker.dart'; +import 'package:konectar_events/contacts_module/model_class/trials.dart'; + +const String curl = Constants.k2url; + +class CallK2api { + getallhcpdata() async { + const url = '$curl/contacts/v2/en/fetch_kols'; + + print("K2_Urll: $url"); + + // final response = await Dio().get(url); + + final response = await Dio().post(url, + data: {"page": 1, "limit": 100}, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("ResponseeeeK2: ${response.statusCode}"); + + if (response.statusCode == 200) { + List users = (response.data['data'] as List) + .map((userJson) => Datum.fromJson(userJson)) + .toList(); + return users; + } + + // final jsonresponse = response.data; + + // final jsonresponse211 = response.data["data"]; + + // print("jsonresponse211: ${jsonresponse211}"); + + // final kolresponse = + // jsonresponse211.map((kollist) => Datum.fromJson(kollist)).toList(); + + // print("kolresponse_isss: ${kolresponse}"); + + // return kolresponse; + } + + getsinglehcpdata() async { + const url = '$curl/users/1'; + + final responsehcp = await Dio().post(url); + final jsonresponse1 = responsehcp.data; + + // final List Json = json.decode(responsehcp.data); + + print("Singlejsondata : ${jsonresponse1}"); + return jsonresponse1; + } + + Future?> getaffiliationsdata(id) async { + print("Affiliation_iddd: ${id}"); + var url = '$curl/affiliations/v1/en/fetch'; + + final affiliationres = await Dio().post(url, + data: {"page": 1, "limit": 100}, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + if (affiliationres.statusCode == 200) { + DataAffiliations dataaff = DataAffiliations.fromJson(affiliationres.data); + + List afflist = dataaff.data!; + + return afflist; + } + + // print("Gettingdata_isss: ${'''[$affiliationres]'''}"); + + // String arrayText = '''[$affiliationres]'''; + + // final jsonresponse2 = json.decode(arrayText); + + // return jsonresponse2 + // .map((doctor) => Affiliations.fromJson(doctor)) + // .toList(); + } + + getpublicationsdata(id) async { + print("getpublicationsdata_iddd: ${id}"); + + var url = '$curl/publications/$id'; + final publicationres = await Dio().get(url); + String arrayText = '''[$publicationres]'''; + + final jsonresponse2 = json.decode(arrayText); + + return jsonresponse2 + .map((doctor) => Publications.fromJson(doctor)) + .toList(); + } + + Future?> geteventsdata(id) async { + var url = '$curl/events/v1/en/fetch'; + + final events = await Dio().post(url, + data: {"page": 1, "limit": 100}, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + if (events.statusCode == 200) { + DataEvent dataeve = DataEvent.fromJson(events.data); + List evelist = dataeve.data!; + return evelist; + } + + // String evn = '''[$events]'''; + // final jsonEvent = json.decode(evn); + // print("All_event: $jsonEvent"); + // return jsonEvent.map((doctor) => Events.fromJson(doctor)).toList(); + } + + getallaffiliationsdata() async { + const url = '$curl/affiliations/'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + getallpublicationsdata() async { + const url = '$curl/publications'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + allgeteventsdata() async { + const url = '$curl/events'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + getalltrials(id) async { + print("TrialsssssAPIIIIIIIIII: $id"); + // var url = '$curl/trails/$id'; + var url = '$curl/trails/1'; + + final trials = await Dio().get(url); + String dataa = "[${trials}]"; + final jsontrials = jsonDecode(dataa); + print("All_trialsss: $jsontrials"); + // return jsontrials; + if (jsontrials.isEmpty) { + print("notnulllllll: $jsontrials"); + //return jsontrials.map((doctor) => Trials.fromJson(doctor)).toList(); + } else { + return jsontrials.map((doctor) => Trials.fromJson(doctor)).toList(); + } + } + + getallMedicalInsightdata() async { + const url = '$curl/medicalinsight'; + + final response = await Dio().get(url); + + final jsonresponse = response.data; + return jsonresponse; + } + + getSpeakerdata() async { + // print("TrialsssssAPIIIIIIIIII: $id"); + // var url = '$curl/trails/$id'; + var url = '$curl/speaker/1'; + + final speaker = await Dio().get(url); + + print("Checkkkkk: Speakerrr: $speaker"); + + final List jsonspe = speaker.data; // Directly use the data + + return jsonspe.map((location) => Speaker.fromJson(location)).toList(); + } + + getEngdata() async { + final String response = await Constants.response; + + final Engagement = await json.decode(response); + final List eng = Engagement['Engagement']; + + print("engData_isss: $eng"); + return eng; + } + + getlocationsdata($id) async { + const url = '$curl/contacts/v2/en/kol_location_fetch'; + + // var url = '$curl/location/1'; + + // final location = await Dio().get(url); + + final location = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + // print("All_locDataaK22: ${location.data}"); + + final List jsonEvent = location.data["data"]; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + // return jsonEvent.map((location) => Loc.fromJson(location)).toList(); + + if (location.statusCode == 200) { + List kolLocation = jsonEvent.map((e) => Data.fromJson(e)).toList(); + + print("All_locDataaK22: ${kolLocation}"); + + return kolLocation; + } + } + + Future?> getphonedata($id) async { + var url = '$curl/contacts/v2/en/kol_phoneno_fetch'; + + // final phoneno = await Dio().get(url); + final phoneno = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + if (phoneno.statusCode == 200) { + final List jsonpno = phoneno.data["data"]; // Directly use the data + print("All_locDataaphone_pnos: ${jsonpno}"); + DataaPnoresponse dataPno = DataaPnoresponse.fromJson(phoneno.data); + List? datalist = dataPno.data; + + // List kol_pno = jsonpno.map((e) => pno.PhnoData.fromJson(e)).toList(); + + print("All_kol_pnoDataa123: ${datalist}"); + + // List users = (response.data['data'] as List) + // .map((userJson) => Datum.fromJson(userJson)) + // .toList(); + // return users; + + return datalist; + } + // return datalist; + + // return jsonEvent.map((pno) => Phoneno.fromJson(pno)).toList(); + } + + Future?> getemaildata($id) async { + var url = '$curl/contacts/v2/en/kol_email_fetch'; + + final email = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("All_locDataaEmaillK22: ${email.data}"); + + if (email.statusCode == 200) { + DataEmail email1 = DataEmail.fromJson(email.data); + + List? emailinfo = email1.data; + + return emailinfo; + } + + // final List jsonEvent = email.data; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + //return jsonEvent.map((email) => Email.fromJson(email)).toList(); + } + + getpatentdata(id) async { + var url = '$curl/patent/1'; + + final patent = await Dio().get(url); + + print("All_locDataa: ${patent.data}"); + + final List jsonEvent = patent.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((email) => Patent.fromJson(email)).toList(); + } + + Future?> getcerlistdata(id) async { + var url = '$curl/contacts/v2/en/kol_certification_fetch'; + + final cer = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("All_locDataa: ${cer.data}"); + + if (cer.statusCode == 200) { + DataCertificate datacer = DataCertificate.fromJson(cer.data); + List? cerlist = datacer.data; + + return cerlist; + } + + // final List jsonEvent = cer.data; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + // return jsonEvent.map((certificate) => Cer.fromJson(certificate)).toList(); + } + + Future?> getedulistdata($id) async { + var url = '$curl/contacts/v2/en/kol_education_fetch'; + + final edu = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("All_locDataa: ${edu.data}"); + + if (edu.statusCode == 200) { + DataEducation dataedu = DataEducation.fromJson(edu.data); + + List? edulist = dataedu.data; + + return edulist; + } + + // final List jsonEvent = edu.data; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + // return jsonEvent.map((edu) => Edu.fromJson(edu)).toList(); + } + + Future?> getawarddata(id) async { + var url = '$curl/contacts/v2/en/kol_awards_fetch'; + + final awa = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("All_locDataa: ${awa.data}"); + + if (awa.statusCode == 200) { + DataAwards awardss = DataAwards.fromJson(awa.data); + List awalist = awardss.data!; + return awalist; + } + + // // String loc = "{$location}"; + // // final jsonEvent = json.decode(loc); + // // print("All_loc: $jsonEvent"); + + // final List jsonEvent = awa.data; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + // return jsonEvent.map((awards) => Awa.fromJson(awards)).toList(); + } + + Future?> gettrainingdata(id) async { + var url = '$curl/contacts/v2/en/kol_training_fetch'; + + final training = await Dio().post(url, + data: { + "page": 1, + "limit": 100, + "kol_id": "b470ae0ac9ff5cf81e2d44b8fbfe32b1" + }, + options: Options(headers: { + "Authorization": + "Bearer 245|J1GeqJKw33m4YhCOfiMNyQm2U8jbx8rf1JkC567ffcb2f9bd" + })); + + print("All_locDataa:Training: ${training.data}"); + + if (training.statusCode == 200) { + DataTraining trainingdata = DataTraining.fromJson(training.data); + List? traininglist = trainingdata.data; + + return traininglist; + } + + // // String loc = "{$location}"; + // // final jsonEvent = json.decode(loc); + // // print("All_loc: $jsonEvent"); + + // final List jsonEvent = training.data; // Directly use the data + + // print("All_locDataa123: ${jsonEvent}"); + + // return jsonEvent.map((awards) => Traning.fromJson(awards)).toList(); + } + + getnihdata(id) async { + var url = '$curl/nih/1'; + + final nih = await Dio().get(url); + + print("All_locDataa: ${nih.data}"); + + final List jsonEvent = nih.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Nih.fromJson(awards)).toList(); + } + + getprodata(id) async { + var url = '$curl/pro/1'; + + final pro = await Dio().get(url); + + print("All_locDataa: ${pro.data}"); + + final List jsonEvent = pro.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Pro.fromJson(awards)).toList(); + } +} diff --git a/lib/contacts_module/service.dart/service.dart b/lib/contacts_module/service.dart/service.dart new file mode 100644 index 0000000..d16d6e8 --- /dev/null +++ b/lib/contacts_module/service.dart/service.dart @@ -0,0 +1,730 @@ +import 'dart:convert'; + +import 'package:dio/dio.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/model_class/affiliations.dart'; +import 'package:konectar_events/contacts_module/model_class/awards_model.dart'; +import 'package:konectar_events/contacts_module/model_class/certificate_model.dart'; +import 'package:konectar_events/contacts_module/model_class/education_model.dart'; +import 'package:konectar_events/contacts_module/model_class/email_model.dart'; +import 'package:konectar_events/contacts_module/model_class/event_model.dart'; +import 'package:konectar_events/contacts_module/model_class/location_model.dart'; +import 'package:konectar_events/contacts_module/model_class/nih_model.dart'; +import 'package:konectar_events/contacts_module/model_class/patent_model.dart'; +import 'package:konectar_events/contacts_module/model_class/pno_model.dart'; +import 'package:konectar_events/contacts_module/model_class/procedure_model.dart'; +import 'package:konectar_events/contacts_module/model_class/publication_model.dart'; +import 'package:konectar_events/contacts_module/model_class/speaker.dart'; +import 'package:konectar_events/contacts_module/model_class/trainig_model.dart'; +import 'package:konectar_events/contacts_module/model_class/trials.dart'; + +const String curl = Constants.url; + +class Callapi { + getallhcpdata() async { + const url = '$curl/users'; + + final response = await Dio().get(url); + + print("Responseeee: ${response.statusCode}"); + + final jsonresponse = response.data; + + // final apihcpdata = Hive.box("hcpdata"); +// if (apihcpdata.isEmpty) { + // print("alldata_is: , ${jsonresponse} ${jsonresponse.length}"); + // for (int i = 0; i < jsonresponse.length; i++) { + // print("hcp:data_is: , ${jsonresponse[i]['email']}"); + + // // HiveFunctions.storehcpdata({ + // // "id": jsonresponse[i]['id'], + // // "name": jsonresponse[i]['name'], + // // "email": jsonresponse[i]['email'], + // // "summarry": jsonresponse[i]['summarry'], + // // "addr": jsonresponse[i]['addr'], + // // "license_no": jsonresponse[i]['license_no'], + // // "p_suffix": jsonresponse[i]['p_suffix'], + // // "speciality": jsonresponse[i]['speciality'], + // // "sub_speciality": jsonresponse[i]['sub_speciality'], + // // "phone_no": jsonresponse[i]['phone_no'], + // // "rank": jsonresponse[i]['rank'], + // // "score": jsonresponse[i]['score'], + // // "events_count": jsonresponse[i]['events_count'], + // // "affiliations_count": jsonresponse[i]['affiliations_count'], + // // "publications_count": jsonresponse[i]['publications_count'], + // // "img_path": jsonresponse[i]["img_path"], + // // }); + // } + // } + + return jsonresponse; + + // print("OfflineJsonnnn"); + // final String response = await rootBundle.loadString('assets/contact.json'); + // final data = await json.decode(response); + // print("Data_isss: $data"); + // return data; + } + + getsinglehcpdata() async { + // const url = 'http://127.0.0.1:8000/api/users/1'; + // const url = 'http://192.168.2.143:8082/api/users/1'; + // const url = 'http://192.168.172.50:8081/api/users/1'; + const url = '$curl/users/1'; + + final responsehcp = await Dio().post(url); + final jsonresponse1 = responsehcp.data; + + // final List Json = json.decode(responsehcp.data); + + print("Singlejsondata : ${jsonresponse1}"); + return jsonresponse1; + } + +// getaffiliationsdata(id) async { +// print("Affiliation_iddd: ${id}"); +// var url = '$curl/affiliations/$id'; + +// // final affiliationres = await Dio().get(url); +// // final jsonresponse2 = affiliationres.data.take(2).toList(); + +// final affiliationres = await Dio().get(url); + +// print("Gettingdata_isss: ${'''[$affiliationres]'''}"); + +// String arrayText = '''[$affiliationres]'''; + +// final jsonresponse2 = json.decode(arrayText); + +// print("Gettingdata_jsonresponse2isss: ${jsonresponse2}"); + +// return jsonresponse2; +// ////////////////////////////////offline////////////////////////// +// // final String response = await Constants.response; + +// // final Affiliation = await json.decode(response); +// // ///////////////////////////////////////////////////// +// // final List> filteredData = Affiliation['Affiliations'] +// // .where((item) => item['user_id'] == id) +// // .cast>() +// // .toList(); +// // print("filteredDatafilteredDatafilteredData: ${filteredData}"); + +// // // Print filtered data + +// // final List affiliations = Affiliation['Affiliations']; + +// // print("Data_isss: $affiliations"); +// // return filteredData; +// } + + getaffiliationsdata(id) async { + print("Affiliation_iddd: ${id}"); + var url = '$curl/affiliations/$id'; + + // final affiliationres = await Dio().get(url); + // final jsonresponse2 = affiliationres.data.take(2).toList(); + + final affiliationres = await Dio().get(url); + + print("Gettingdata_isss: ${'''[$affiliationres]'''}"); + + String arrayText = '''[$affiliationres]'''; + + final jsonresponse2 = json.decode(arrayText); + + return jsonresponse2 + .map((doctor) => Affiliations.fromJson(doctor)) + .toList(); + + // print("Gettingdata_jsonresponse2isss: ${jsonresponse2}"); + + // return jsonresponse2; + } + + getpublicationsdata(id) async { + print("getpublicationsdata_iddd: ${id}"); + + // const url = '$curl/publications'; + + // final affiliationres = await Dio().get(url); + // final jsonresponse2 = affiliationres.data.take(2).toList(); + + // return jsonresponse2; + var url = '$curl/publications/$id'; + final publicationres = await Dio().get(url); + String arrayText = '''[$publicationres]'''; + + //print("Gettingdata_isss: ${affiliationres}"); + + // final jsonresponse2 = affiliationres.data; + final jsonresponse2 = json.decode(arrayText); + + return jsonresponse2 + .map((doctor) => Publications.fromJson(doctor)) + .toList(); + //return jsonresponse2; + ////////////////////////////////offline////////////////////////// + + // final String response = await Constants.response; + + // final Publications = await json.decode(response); + // final List publication = Publications['Publications']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Publications['Publications'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("filteredDatafilteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + + // print("publicationData_isss: $publication"); + // return filteredData; + } + + geteventsdata(id) async { + var url = '$curl/events/$id'; + + final events = await Dio().get(url); + // // final jsonEvent = events.data; + // final jsonEvent = events.data; + // print("All_event: $jsonEvent"); + // final jsonEvent1 = events.data.take(2).toList(); + + // print("only few : $jsonEvent1"); + + // return jsonEvent1; + + // final jsonEvent = events.data; + + String evn = '''[$events]'''; + final jsonEvent = json.decode(evn); + print("All_event: $jsonEvent"); + return jsonEvent.map((doctor) => Events.fromJson(doctor)).toList(); + //return jsonEvent; + + ////////////////////////////////offline////////////////////////// + + // final String response = await Constants.response; + + // final Events = await json.decode(response); + // final List event = Events['Events']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Events['Events'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("filteredDatafilteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("eventData_isss: $event"); + // return filteredData; + } + + getallaffiliationsdata() async { + // const url = 'http://192.168.2.143:8082/api/affiliations'; + //const url = 'http://192.168.172.50:8081/api/affiliations'; + const url = '$curl/affiliations/'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + getallpublicationsdata() async { + // const url = 'http://192.168.2.143:8082/api/publications'; + //const url = 'http://192.168.172.50:8081/api/publications'; + const url = '$curl/publications'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + allgeteventsdata() async { + //const url = 'http://192.168.2.143:8082/api/events'; + //const url = 'http://192.168.172.50:8081/api/events'; + const url = '$curl/events'; + + final events = await Dio().get(url); + // final jsonEvent = events.data; + final jsonEvent = events.data; + print("All_event: $jsonEvent"); + + return jsonEvent; + } + + getalltrials(id) async { + // print("TrialsssssAPIIIIIIIIII: $id"); + // const url = '$curl/trails'; + + // final trials = await Dio().get(url); + // final jsontrials = trials.data; + // print("All_trialsss: $jsontrials"); + // return jsontrials; + + print("TrialsssssAPIIIIIIIIII: $id"); + // var url = '$curl/trails/$id'; + var url = '$curl/trails/1'; + + final trials = await Dio().get(url); + String dataa = "[${trials}]"; + final jsontrials = jsonDecode(dataa); + print("All_trialsss: $jsontrials"); + // return jsontrials; + if (jsontrials.isEmpty) { + print("notnulllllll: $jsontrials"); + //return jsontrials.map((doctor) => Trials.fromJson(doctor)).toList(); + } else { + return jsontrials.map((doctor) => Trials.fromJson(doctor)).toList(); + } + ////////////////////////////////offline////////////////////////// + + // final String response = await Constants.response; + + // final Trials = await json.decode(response); + // final List trials = Trials['Trials']; + // ///////////////////////////////////////////////////// + // final List> filteredData = Trials['Trials'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("TrialsssssAPIIIIIIIIIIilteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + + // print("trialsData_isss: $trials"); + // return filteredData; + } + + getallMedicalInsightdata() async { + // const url = 'http://127.0.0.1:8000/api/users'; + // const url = 'http://192.168.2.143:8082/api/users'; + // const url = 'http://192.168.172.50:8082/api/users'; + // const url = 'http://192.168.172.50:8081/api/users'; + + const url = '$curl/medicalinsight'; + + final response = await Dio().get(url); + + final jsonresponse = response.data; + return jsonresponse; + } + + // getSpeakerdata() async { + // // const url = '$curl/speaker'; + + // // final response = await Dio().get(url); + + // // final jsonresponse = response.data; + + // // return jsonresponse; + + // final String response = await Constants.response; + + // final Speaker = await json.decode(response); + // final List speaker = Speaker['Speaker']; + + // print("speakerData_isss: $speaker"); + // return speaker; + // } + + getSpeakerdata() async { + // print("TrialsssssAPIIIIIIIIII: $id"); + // var url = '$curl/trails/$id'; + var url = '$curl/speaker/1'; + + final speaker = await Dio().get(url); + + print("Checkkkkk: Speakerrr: $speaker"); + + // final jsonspe = jsonDecode(speaker.data); + // print("All_trialsss: $jsonspe"); + + final List jsonspe = speaker.data; // Directly use the data + + return jsonspe.map((location) => Speaker.fromJson(location)).toList(); + } + + getEngdata() async { + // const url = '$curl/engagement'; + + // final response = await Dio().get(url); + + // final jsonresponse = response.data; + + // return jsonresponse; + // } + final String response = await Constants.response; + + final Engagement = await json.decode(response); + final List eng = Engagement['Engagement']; + + print("engData_isss: $eng"); + return eng; + } + + // getlocationsdata(id) async { + // final String response = await Constants.response; + + // final Location = await json.decode(response); + // final List event = Location['Location']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Location['Location'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("LocationfilteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("LocationeventData_isss: $event"); + // return filteredData; + // } + getlocationsdata($id) async { + var url = '$curl/location/1'; + + final location = await Dio().get(url); + + print("All_locDataa: ${location.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = location.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((location) => Loc.fromJson(location)).toList(); + } + + // getphonedata(id) async { + // final String response = await Constants.response; + + // final PhoneNo = await json.decode(response); + // final List event = PhoneNo['Location']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = PhoneNo['PhoneNo'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PhoneNofilteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PhoneNoeventData_isss: $event"); + // return filteredData; + // } + getphonedata($id) async { + var url = '$curl/pno/1'; + + final phoneno = await Dio().get(url); + + print("All_locDataa: ${phoneno.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = phoneno.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((pno) => Phoneno.fromJson(pno)).toList(); + } + + // getemaildata(id) async { + // final String response = await Constants.response; + + // final Email = await json.decode(response); + // final List event = Email['Email']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Email['Email'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("EmaililteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("EmaileventData_isss: $event"); + // return filteredData; + // } + + getemaildata($id) async { + var url = '$curl/email/1'; + + final email = await Dio().get(url); + + print("All_locDataa: ${email.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = email.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((email) => Email.fromJson(email)).toList(); + } + + // getpatentdata(id) async { + // final String response = await Constants.response; + + // final Patent = await json.decode(response); + // final List event = Patent['Patent']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Patent['Patent'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + getpatentdata(id) async { + var url = '$curl/patent/1'; + + final patent = await Dio().get(url); + + print("All_locDataa: ${patent.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = patent.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((email) => Patent.fromJson(email)).toList(); + } + + // getcerlistdata(id) async { + // final String response = await Constants.response; + + // final Certificate = await json.decode(response); + // final List event = Certificate['Certificate']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Certificate['Certificate'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + getcerlistdata(id) async { + var url = '$curl/cer/1'; + + final cer = await Dio().get(url); + + print("All_locDataa: ${cer.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = cer.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((certificate) => Cer.fromJson(certificate)).toList(); + } + // getedulistdata(id) async { + // final String response = await Constants.response; + + // final Education = await json.decode(response); + // final List event = Education['Education']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Education['Education'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + getedulistdata($id) async { + var url = '$curl/edu/1'; + + final edu = await Dio().get(url); + + print("All_locDataa: ${edu.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = edu.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((edu) => Edu.fromJson(edu)).toList(); + } + + // getawarddata(id) async { + // final String response = await Constants.response; + + // final Awards = await json.decode(response); + // final List event = Awards['Awards']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Awards['Awards'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + getawarddata(id) async { + var url = '$curl/awa/1'; + + final awa = await Dio().get(url); + + print("All_locDataa: ${awa.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = awa.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Awa.fromJson(awards)).toList(); + } + + // gettrainingdata(id) async { + // final String response = await Constants.response; + + // final Training = await json.decode(response); + // final List event = Training['Training']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Training['Training'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + gettrainingdata(id) async { + var url = '$curl/training/1'; + + final training = await Dio().get(url); + + print("All_locDataa: ${training.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = training.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Traning.fromJson(awards)).toList(); + } + // getnihdata(id) async { + // final String response = await Constants.response; + + // final Nih = await json.decode(response); + // final List event = Nih['NIHGrants']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Nih['NIHGrants'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + getnihdata(id) async { + var url = '$curl/nih/1'; + + final nih = await Dio().get(url); + + print("All_locDataa: ${nih.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = nih.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Nih.fromJson(awards)).toList(); + } + + // getprodata(id) async { + // final String response = await Constants.response; + + // final Pro = await json.decode(response); + // final List event = Pro['Procedure']; + + // ///////////////////////////////////////////////////// + // final List> filteredData = Pro['Procedure'] + // .where((item) => item['user_id'] == id) + // .cast>() + // .toList(); + // print("PatenteredDatafilteredData111: ${filteredData}"); + + // // Print filtered data + // print("PatenttData_isss: $event"); + // return filteredData; + // } + + getprodata(id) async { + var url = '$curl/pro/1'; + + final pro = await Dio().get(url); + + print("All_locDataa: ${pro.data}"); + + // String loc = "{$location}"; + // final jsonEvent = json.decode(loc); + // print("All_loc: $jsonEvent"); + + final List jsonEvent = pro.data; // Directly use the data + + print("All_locDataa123: ${jsonEvent}"); + + return jsonEvent.map((awards) => Pro.fromJson(awards)).toList(); + } +} diff --git a/lib/contacts_module/storage_hive/aff_data/aff_model_hive.dart b/lib/contacts_module/storage_hive/aff_data/aff_model_hive.dart new file mode 100644 index 0000000..baf6f40 --- /dev/null +++ b/lib/contacts_module/storage_hive/aff_data/aff_model_hive.dart @@ -0,0 +1,49 @@ +import 'package:hive/hive.dart'; + +part 'aff_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 30) // Use a unique typeId for this class +class Affiliation extends HiveObject { + @HiveField(0) + final int? id; + + @HiveField(1) + final int? userId; + + @HiveField(2) + final String? orgName; + + @HiveField(3) + final String? dept; + + @HiveField(4) + final String? role; + + @HiveField(5) + final String? timeFrame; + + @HiveField(6) + final String? orgType; + + @HiveField(7) + final String? emgType; + + @HiveField(8) + final DateTime? createdAt; + + @HiveField(9) + final DateTime? updatedAt; // Nullable + + Affiliation({ + this.id, + this.userId, + this.orgName, + this.dept, + this.role, + this.timeFrame, + this.orgType, + this.emgType, + this.createdAt, + this.updatedAt, + }); +} diff --git a/lib/contacts_module/storage_hive/aff_data/aff_model_hive.g.dart b/lib/contacts_module/storage_hive/aff_data/aff_model_hive.g.dart new file mode 100644 index 0000000..c3b8f3e --- /dev/null +++ b/lib/contacts_module/storage_hive/aff_data/aff_model_hive.g.dart @@ -0,0 +1,68 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'aff_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class AffiliationAdapter extends TypeAdapter { + @override + final int typeId = 30; + + @override + Affiliation read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Affiliation( + id: fields[0] as int?, + userId: fields[1] as int?, + orgName: fields[2] as String?, + dept: fields[3] as String?, + role: fields[4] as String?, + timeFrame: fields[5] as String?, + orgType: fields[6] as String?, + emgType: fields[7] as String?, + createdAt: fields[8] as DateTime?, + updatedAt: fields[9] as DateTime?, + ); + } + + @override + void write(BinaryWriter writer, Affiliation obj) { + writer + ..writeByte(10) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.orgName) + ..writeByte(3) + ..write(obj.dept) + ..writeByte(4) + ..write(obj.role) + ..writeByte(5) + ..write(obj.timeFrame) + ..writeByte(6) + ..write(obj.orgType) + ..writeByte(7) + ..write(obj.emgType) + ..writeByte(8) + ..write(obj.createdAt) + ..writeByte(9) + ..write(obj.updatedAt); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is AffiliationAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/aff_data/insert_aff.dart b/lib/contacts_module/storage_hive/aff_data/insert_aff.dart new file mode 100644 index 0000000..cb24b27 --- /dev/null +++ b/lib/contacts_module/storage_hive/aff_data/insert_aff.dart @@ -0,0 +1,70 @@ +import 'package:hive_flutter/hive_flutter.dart'; + +import 'aff_model_hive.dart'; + +addAffiliation(List affilist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + //final box = Hive.box('affiliationshive'); + + var box = await Hive.openBox('affiliationshive'); + + print("IamAffiliation_dataaa: ${affilist}"); + + // Convert JSON list to List + List affiliations = affilist.map((json) { + print("CheckinggJsonnnn: ${json.id}, ${json.userId}"); + return Affiliation( + id: json.id, + userId: json.userId, + orgName: json.orgName, + dept: json.dept, + role: json.role, + timeFrame: json.timeFrame, + orgType: json.orgType, + emgType: json.emgType, + createdAt: DateTime.parse(json.createdAt), + updatedAt: json.updatedAt != null ? DateTime.parse(json.updatedAt) : null, + ); + }).toList(); + + for (var affiliation in affiliations) { + print("Storing_Affff: ${affiliation.orgName}"); + await box.put(affiliation.id, affiliation); // Use `put` with id as key + } +} + +retrieveAffiliations() async { + var box = await Hive.openBox('affiliationshive'); + print('Retrive Doctor}'); + + List affiliations = box.values.toList(); + print('Retrive Doctor affiliations ${affiliations}}'); + + for (var affiliation in affiliations) { + print('Retrive Organization Name: ${affiliation.orgName}'); + print('Department: ${affiliation.dept}'); + // Access other fields as needed + } + return affiliations; +} + +retrieveidAffiliations(int text) async { + var box = await Hive.openBox('affiliationshive'); + print('Retrive Doctor123 ${text}}'); + + var affiliations = box.get(text); + + List affiliations1 = []; + if (affiliations != null) { + affiliations1.add(affiliations); // Add to the list if not null + } + print('Retrive Doctor affiliations ${affiliations}'); + + // for (var affiliation in affiliations) { + // print('Retrive Organization Name: ${affiliation.orgName}'); + // print('Department: ${affiliation.dept}'); + // // Access other fields as needed + // } + return affiliations1; +} diff --git a/lib/contacts_module/storage_hive/awa_data/awa_model_hive.dart b/lib/contacts_module/storage_hive/awa_data/awa_model_hive.dart new file mode 100644 index 0000000..6cf95ad --- /dev/null +++ b/lib/contacts_module/storage_hive/awa_data/awa_model_hive.dart @@ -0,0 +1,36 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'awa_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 40) +class Awa extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? educationType; + + @HiveField(3) + final String? institutionName; + + @HiveField(4) + final String? degree; + + @HiveField(5) + final String? specialty; + + @HiveField(6) + final String? timeFrame; + + Awa({ + required this.id, + required this.userId, + this.educationType, + this.institutionName, + this.degree, + this.specialty, + this.timeFrame, + }); +} diff --git a/lib/contacts_module/storage_hive/awa_data/awa_model_hive.g.dart b/lib/contacts_module/storage_hive/awa_data/awa_model_hive.g.dart new file mode 100644 index 0000000..9437f2d --- /dev/null +++ b/lib/contacts_module/storage_hive/awa_data/awa_model_hive.g.dart @@ -0,0 +1,59 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'awa_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class AwaAdapter extends TypeAdapter { + @override + final int typeId = 40; + + @override + Awa read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Awa( + id: fields[0] as int, + userId: fields[1] as int, + educationType: fields[2] as String?, + institutionName: fields[3] as String?, + degree: fields[4] as String?, + specialty: fields[5] as String?, + timeFrame: fields[6] as String?, + ); + } + + @override + void write(BinaryWriter writer, Awa obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.educationType) + ..writeByte(3) + ..write(obj.institutionName) + ..writeByte(4) + ..write(obj.degree) + ..writeByte(5) + ..write(obj.specialty) + ..writeByte(6) + ..write(obj.timeFrame); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is AwaAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/awa_data/crud_awa.dart b/lib/contacts_module/storage_hive/awa_data/crud_awa.dart new file mode 100644 index 0000000..d8dce3c --- /dev/null +++ b/lib/contacts_module/storage_hive/awa_data/crud_awa.dart @@ -0,0 +1,61 @@ +import 'package:konectar_events/contacts_module/storage_hive/awa_data/awa_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addAwa(List awalist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('awahive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List edus = awalist.map((json) { + return Awa( + id: json.id, + userId: json.userId, + educationType: json.educationType ?? '', + institutionName: json.institutionName ?? '', + degree: json.degree ?? '', + specialty: json.specialty ?? '', + timeFrame: json.timeFrame.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${edus}"); + + for (var edu in edus) { + print("Storing_Eduactionnsss: ${edu.specialty}"); + await box.put(edu.id, edu); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidawa(int id) async { + var box = await Hive.openBox('awahive'); + + print('Retrive Doctor}'); + + var edus = box.get(id); + print('Retrive Doctor Eduuu ${edus}}'); + + List dataedu = []; + if (edus != null) { + dataedu.add(edus); // Add to the list if not null + } + return dataedu; +} diff --git a/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.dart b/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.dart new file mode 100644 index 0000000..ed1a9e0 --- /dev/null +++ b/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.dart @@ -0,0 +1,36 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'cer_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 41) +class Cer extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? educationType; + + @HiveField(3) + final String? institutionName; + + @HiveField(4) + final String? degree; + + @HiveField(5) + final String? specialty; + + @HiveField(6) + final String? timeFrame; + + Cer({ + required this.id, + required this.userId, + this.educationType, + this.institutionName, + this.degree, + this.specialty, + this.timeFrame, + }); +} diff --git a/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.g.dart b/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.g.dart new file mode 100644 index 0000000..c8938b8 --- /dev/null +++ b/lib/contacts_module/storage_hive/cer_hive/cer_model_hive.g.dart @@ -0,0 +1,59 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'cer_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class CerAdapter extends TypeAdapter { + @override + final int typeId = 41; + + @override + Cer read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Cer( + id: fields[0] as int, + userId: fields[1] as int, + educationType: fields[2] as String?, + institutionName: fields[3] as String?, + degree: fields[4] as String?, + specialty: fields[5] as String?, + timeFrame: fields[6] as String?, + ); + } + + @override + void write(BinaryWriter writer, Cer obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.educationType) + ..writeByte(3) + ..write(obj.institutionName) + ..writeByte(4) + ..write(obj.degree) + ..writeByte(5) + ..write(obj.specialty) + ..writeByte(6) + ..write(obj.timeFrame); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is CerAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/cer_hive/crud_cer.dart b/lib/contacts_module/storage_hive/cer_hive/crud_cer.dart new file mode 100644 index 0000000..de67488 --- /dev/null +++ b/lib/contacts_module/storage_hive/cer_hive/crud_cer.dart @@ -0,0 +1,63 @@ +// import 'package:konectar_events/storage_hive/awa_data/awa_model_hive.dart'; + +import 'package:konectar_events/contacts_module/storage_hive/awa_data/awa_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addCer(List cerlist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('cerhive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List cers = cerlist.map((json) { + return Awa( + id: json.id, + userId: json.userId, + educationType: json.educationType ?? '', + institutionName: json.institutionName ?? '', + degree: json.degree ?? '', + specialty: json.specialty ?? '', + timeFrame: json.timeFrame.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${cers}"); + + for (var cer in cers) { + print("Storing_Eduactionnsss: ${cer.specialty}"); + await box.put(cer.id, cer); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidcer(int id) async { + var box = await Hive.openBox('cerhive'); + + print('Retrive Doctor}'); + + var cers = box.get(id); + print('Retrive Doctor Eduuu ${cers}}'); + + List datacer = []; + if (cers != null) { + datacer.add(cers); // Add to the list if not null + } + return datacer; +} diff --git a/lib/contacts_module/storage_hive/edu_data/crud_edu.dart b/lib/contacts_module/storage_hive/edu_data/crud_edu.dart new file mode 100644 index 0000000..4875946 --- /dev/null +++ b/lib/contacts_module/storage_hive/edu_data/crud_edu.dart @@ -0,0 +1,64 @@ +import 'package:konectar_events/contacts_module/storage_hive/edu_data/edu_model_hive.dart'; +// import 'package:konectar_events/storage_hive/edu_data/edu_model_hive.dart'; +// import 'package:konectar_events/storage_hive/loc_data/location_model_hive.dart'; +// import 'package:konectar_events/storage_hive/pno_data/pno_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addEdu(List edulist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('edulhive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List edus = edulist.map((json) { + return Edu( + id: json.id, + userId: json.userId, + educationType: json.educationType ?? '', + institutionName: json.institutionName ?? '', + degree: json.degree ?? '', + specialty: json.specialty ?? '', + timeFrame: json.timeFrame.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${edus}"); + + for (var edu in edus) { + print("Storing_Eduactionnsss: ${edu.specialty}"); + await box.put(edu.id, edu); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidedus(int id) async { + var box = await Hive.openBox('edulhive'); + + print('Retrive Doctor}'); + + var edus = box.get(4); + print('Retrive Doctor Eduuu ${edus}}'); + + List dataedu = []; + if (edus != null) { + dataedu.add(edus); // Add to the list if not null + } + return dataedu; +} diff --git a/lib/contacts_module/storage_hive/edu_data/edu_model_hive.dart b/lib/contacts_module/storage_hive/edu_data/edu_model_hive.dart new file mode 100644 index 0000000..00371ef --- /dev/null +++ b/lib/contacts_module/storage_hive/edu_data/edu_model_hive.dart @@ -0,0 +1,36 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'edu_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 39) +class Edu extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? educationType; + + @HiveField(3) + final String? institutionName; + + @HiveField(4) + final String? degree; + + @HiveField(5) + final String? specialty; + + @HiveField(6) + final String? timeFrame; + + Edu({ + required this.id, + required this.userId, + this.educationType, + this.institutionName, + this.degree, + this.specialty, + this.timeFrame, + }); +} diff --git a/lib/contacts_module/storage_hive/edu_data/edu_model_hive.g.dart b/lib/contacts_module/storage_hive/edu_data/edu_model_hive.g.dart new file mode 100644 index 0000000..c357644 --- /dev/null +++ b/lib/contacts_module/storage_hive/edu_data/edu_model_hive.g.dart @@ -0,0 +1,59 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'edu_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class EduAdapter extends TypeAdapter { + @override + final int typeId = 39; + + @override + Edu read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Edu( + id: fields[0] as int, + userId: fields[1] as int, + educationType: fields[2] as String?, + institutionName: fields[3] as String?, + degree: fields[4] as String?, + specialty: fields[5] as String?, + timeFrame: fields[6] as String?, + ); + } + + @override + void write(BinaryWriter writer, Edu obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.educationType) + ..writeByte(3) + ..write(obj.institutionName) + ..writeByte(4) + ..write(obj.degree) + ..writeByte(5) + ..write(obj.specialty) + ..writeByte(6) + ..write(obj.timeFrame); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is EduAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/email_data/crud_email.dart b/lib/contacts_module/storage_hive/email_data/crud_email.dart new file mode 100644 index 0000000..337b86a --- /dev/null +++ b/lib/contacts_module/storage_hive/email_data/crud_email.dart @@ -0,0 +1,60 @@ +// import 'package:konectar_events/storage_hive/email_data/email_model_hive.dart'; +// import 'package:konectar_events/storage_hive/loc_data/location_model_hive.dart'; +// import 'package:konectar_events/storage_hive/pno_data/pno_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/email_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addEmail(List emaillist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('emailhive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List emails = emaillist.map((json) { + return Email( + id: json.id, + userId: json.userId, + emailType: json.emailType ?? '', + email: json.email ?? '', + ); + }).toList(); + + print("Publicattionnsss_isss: ${emails}"); + + for (var email in emails) { + print("Storing_Affff: ${email.emailType}"); + await box.put(email.id, email); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidemails(int id) async { + var box = await Hive.openBox('emailhive'); + print('Retrive Doctor}'); + + var pnos = box.get(id); + print('Retrive Doctor locations ${pnos}}'); + + List dataemail = []; + if (pnos != null) { + dataemail.add(pnos); // Add to the list if not null + } + return dataemail; +} diff --git a/lib/contacts_module/storage_hive/email_data/email_model_hive.dart b/lib/contacts_module/storage_hive/email_data/email_model_hive.dart new file mode 100644 index 0000000..bb51363 --- /dev/null +++ b/lib/contacts_module/storage_hive/email_data/email_model_hive.dart @@ -0,0 +1,25 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'email_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 38) +class Email extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? emailType; + + @HiveField(3) + final String? email; + + Email({ + required this.id, + required this.userId, + this.emailType, + this.email, + e, + }); +} diff --git a/lib/contacts_module/storage_hive/email_data/email_model_hive.g.dart b/lib/contacts_module/storage_hive/email_data/email_model_hive.g.dart new file mode 100644 index 0000000..1e697d2 --- /dev/null +++ b/lib/contacts_module/storage_hive/email_data/email_model_hive.g.dart @@ -0,0 +1,50 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'email_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class EmailAdapter extends TypeAdapter { + @override + final int typeId = 38; + + @override + Email read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Email( + id: fields[0] as int, + userId: fields[1] as int, + emailType: fields[2] as String?, + email: fields[3] as String?, + ); + } + + @override + void write(BinaryWriter writer, Email obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.emailType) + ..writeByte(3) + ..write(obj.email); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is EmailAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/events_data/crud_event.dart b/lib/contacts_module/storage_hive/events_data/crud_event.dart new file mode 100644 index 0000000..3809be9 --- /dev/null +++ b/lib/contacts_module/storage_hive/events_data/crud_event.dart @@ -0,0 +1,76 @@ +// import 'package:konectar_events/storage_hive/events_data/event_model_hive.dart'; +// import 'package:konectar_events/storage_hive/pub_data/pub_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/event_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addEvent(List publist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('eventhive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List events = publist.map((json) { + return Events( + id: json.id, + userId: json.userId, + event_name: json.eventName ?? '', + event_type: '', + session_type: json.sessionType ?? '', + session_Name: '', + role: json.role ?? '', + topic: json.topic ?? '', + start: '', + end: '', + organizer: '', + organizer_Type: '', + sponsor: '', + sponsor_Type: '', + location: '', + address: '', + country: '', + state: '', + city: '', + postal_Code: '', + url1: '', + url2: ''); + }).toList(); + + print("Events_isss: ${events}"); + + for (var events in events) { + print("Storing_Affff: ${events.event_name}"); + await box.put(events.id, events); // Use `put` with id as key + } +} + +Future retrieveEventss() async { + var box = await Hive.openBox('eventhive'); + print('Retrive Doctor}'); + + List events1 = box.values.toList(); + print('Retrive Doctor Events ${events1}}'); + + for (var Events in events1) { + print('Retrive Events Name: ${Events.event_name}'); + print('Events: ${Events.event_type}'); + // Access other fields as needed + } +} + +retrieveidEvent(int id) async { + var box = await Hive.openBox('eventhive'); + print('Retrive Doctor}'); + + var events = box.get(id); + print('Retrive Doctor publications ${events}}'); + + List datapub = []; + if (events != null) { + datapub.add(events); // Add to the list if not null + } + return datapub; +} diff --git a/lib/contacts_module/storage_hive/events_data/event_model_hive.dart b/lib/contacts_module/storage_hive/events_data/event_model_hive.dart new file mode 100644 index 0000000..2338455 --- /dev/null +++ b/lib/contacts_module/storage_hive/events_data/event_model_hive.dart @@ -0,0 +1,96 @@ +import 'package:hive/hive.dart'; + +part 'event_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 33) // Use a unique typeId for this class +class Events extends HiveObject { + @HiveField(0) + final int? id; + + @HiveField(1) + final int? userId; + + @HiveField(2) + final String? event_name; + + @HiveField(3) + final String? event_type; + + @HiveField(4) + final String? session_type; + + @HiveField(5) + final String? session_Name; + + @HiveField(6) + final String? role; + + @HiveField(7) + final String? topic; + + @HiveField(8) + final String? start; + + @HiveField(9) + final String? end; + + @HiveField(10) + final String? organizer; + + @HiveField(11) + final String? organizer_Type; + + @HiveField(12) + final String? sponsor; + + @HiveField(13) + final String? sponsor_Type; + + @HiveField(14) + final String? location; + + @HiveField(15) + final String? address; + + @HiveField(16) + final String? country; + + @HiveField(17) + final String? state; + + @HiveField(18) + final String? city; + + @HiveField(19) + final String? postal_Code; + + @HiveField(20) + final String? url1; // Nullable + @HiveField(21) + final String? url2; // Nullable + + Events({ + this.id, + this.userId, + this.event_name, + this.event_type, + this.session_type, + this.session_Name, + this.role, + this.topic, + this.start, + this.end, + this.organizer, + this.organizer_Type, + this.sponsor, + this.sponsor_Type, + this.location, + this.address, + this.country, + this.state, + this.city, + this.postal_Code, + this.url1, + this.url2, + }); +} diff --git a/lib/contacts_module/storage_hive/events_data/event_model_hive.g.dart b/lib/contacts_module/storage_hive/events_data/event_model_hive.g.dart new file mode 100644 index 0000000..35b138c --- /dev/null +++ b/lib/contacts_module/storage_hive/events_data/event_model_hive.g.dart @@ -0,0 +1,104 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'event_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class EventsAdapter extends TypeAdapter { + @override + final int typeId = 33; + + @override + Events read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Events( + id: fields[0] as int?, + userId: fields[1] as int?, + event_name: fields[2] as String?, + event_type: fields[3] as String?, + session_type: fields[4] as String?, + session_Name: fields[5] as String?, + role: fields[6] as String?, + topic: fields[7] as String?, + start: fields[8] as String?, + end: fields[9] as String?, + organizer: fields[10] as String?, + organizer_Type: fields[11] as String?, + sponsor: fields[12] as String?, + sponsor_Type: fields[13] as String?, + location: fields[14] as String?, + address: fields[15] as String?, + country: fields[16] as String?, + state: fields[17] as String?, + city: fields[18] as String?, + postal_Code: fields[19] as String?, + url1: fields[20] as String?, + url2: fields[21] as String?, + ); + } + + @override + void write(BinaryWriter writer, Events obj) { + writer + ..writeByte(22) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.event_name) + ..writeByte(3) + ..write(obj.event_type) + ..writeByte(4) + ..write(obj.session_type) + ..writeByte(5) + ..write(obj.session_Name) + ..writeByte(6) + ..write(obj.role) + ..writeByte(7) + ..write(obj.topic) + ..writeByte(8) + ..write(obj.start) + ..writeByte(9) + ..write(obj.end) + ..writeByte(10) + ..write(obj.organizer) + ..writeByte(11) + ..write(obj.organizer_Type) + ..writeByte(12) + ..write(obj.sponsor) + ..writeByte(13) + ..write(obj.sponsor_Type) + ..writeByte(14) + ..write(obj.location) + ..writeByte(15) + ..write(obj.address) + ..writeByte(16) + ..write(obj.country) + ..writeByte(17) + ..write(obj.state) + ..writeByte(18) + ..write(obj.city) + ..writeByte(19) + ..write(obj.postal_Code) + ..writeByte(20) + ..write(obj.url1) + ..writeByte(21) + ..write(obj.url2); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is EventsAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/kol_info/curd_kol.dart b/lib/contacts_module/storage_hive/kol_info/curd_kol.dart new file mode 100644 index 0000000..8e631e9 --- /dev/null +++ b/lib/contacts_module/storage_hive/kol_info/curd_kol.dart @@ -0,0 +1,86 @@ +import 'dart:convert'; + +// import 'package:konectar_events/storage_hive/kol_info/kol_info_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/kol_info/kol_info_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addKolInfo(Map kollist) async { + var box = await Hive.openBox('kolshive'); + print("IamKolInfo_dataaa: ${kollist}"); + + var doctor = KolInfo( + id: kollist['id'], + name: kollist['name'], + email: kollist['email'], + summarry: kollist['summarry'], + addr: kollist['addr'], + license_no: kollist['license_no'].toString(), + p_suffix: kollist['p_suffix'], + speciality: kollist['speciality'], + sub_speciality: kollist['sub_speciality'], + phone_no: kollist['phone_no'].toString(), + // created_at: DateTime.parse('2023-11-28T15:58:08.000000Z'), + // updated_at: DateTime.parse('2024-01-16T11:26:10.000000Z'), + img_path: kollist['img_path'].toString(), + country: kollist['country'].toString(), + ); + + print("Checkinggg_thatt : ${doctor}, ${doctor.id}"); + + await box.put(doctor.id, doctor); + + // await box.put(affiliation.id, affiliation); // Use `put` with id as key + +// return KolInfo(id : json['id'], name : json['id'], email :json['email'], summarry, addr, license_no, p_suffix, speciality, sub_speciality, phone_no, created_at, updated_at, img_path, country) +// }); +} + +retrievekol() async { + var box = await Hive.openBox('kolshive'); + print('Retrive Kol Namehii}'); + + List doctordata = box.values.toList(); + print('Retrive Kol123 ${doctordata}, ${doctordata.length}'); + + for (var affiliation in doctordata) { + print(' Name: ${affiliation.name}'); + print('email: ${affiliation.email}'); + // Access other fields as needed + } + return doctordata; +} + +deletekol(id) async { + var box = await Hive.openBox('kolshive'); + + print("DeletingKolll"); + + await box.delete(id); +} + +searchkol(String query) async { + var box = await Hive.openBox('kolshive'); + print('Retrive Kol Namehii}'); + + List doctordata = box.values.toList(); + print('Searchh Kol123 ${doctordata}, ${doctordata.length}'); + + List data = doctordata + .where((hcp) => + hcp.name.toLowerCase().contains(query.toLowerCase()) || + // (hcp['speciality'].toLowerCase().contains(query.toLowerCase()) ?? + // hcp['spl'].toLowerCase().contains(query.toLowerCase())) || + + hcp.speciality.toLowerCase().contains(query.toLowerCase()) || + hcp.addr.toLowerCase().contains(query.toLowerCase())) + .toList(); + + print("Checking_Name_data : ${data}"); + + // for (var affiliation in doctordata) { + // print(' Name: ${affiliation.name}'); + // print('email: ${affiliation.email}'); + // // Access other fields as needed + // } + return data.toList(); +} diff --git a/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.dart b/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.dart new file mode 100644 index 0000000..1751520 --- /dev/null +++ b/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.dart @@ -0,0 +1,63 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'kol_info_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 31) +class KolInfo extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final String name; + + @HiveField(2) + final String? email; + + @HiveField(3) + final String? summarry; + + @HiveField(4) + final String? addr; + + @HiveField(5) + final String? license_no; + + @HiveField(6) + final String? p_suffix; + + @HiveField(7) + final String? speciality; + + @HiveField(8) + final String? sub_speciality; + + @HiveField(9) + final String? phone_no; + + @HiveField(10) + final String? created_at; + + @HiveField(11) + final String? updated_at; + + @HiveField(12) + final String? img_path; + + @HiveField(13) + final String? country; + + KolInfo( + {required this.id, + required this.name, + this.email, + this.summarry, + this.addr, + this.license_no, + this.p_suffix, + this.speciality, + this.sub_speciality, + this.phone_no, + this.created_at, + this.updated_at, + required this.img_path, + this.country}); +} diff --git a/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.g.dart b/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.g.dart new file mode 100644 index 0000000..baf20a5 --- /dev/null +++ b/lib/contacts_module/storage_hive/kol_info/kol_info_model_hive.g.dart @@ -0,0 +1,80 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'kol_info_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class KolInfoAdapter extends TypeAdapter { + @override + final int typeId = 31; + + @override + KolInfo read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return KolInfo( + id: fields[0] as int, + name: fields[1] as String, + email: fields[2] as String?, + summarry: fields[3] as String?, + addr: fields[4] as String?, + license_no: fields[5] as String?, + p_suffix: fields[6] as String?, + speciality: fields[7] as String?, + sub_speciality: fields[8] as String?, + phone_no: fields[9] as String?, + created_at: fields[10] as String?, + updated_at: fields[11] as String?, + img_path: fields[12] as String?, + country: fields[13] as String?, + ); + } + + @override + void write(BinaryWriter writer, KolInfo obj) { + writer + ..writeByte(14) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.name) + ..writeByte(2) + ..write(obj.email) + ..writeByte(3) + ..write(obj.summarry) + ..writeByte(4) + ..write(obj.addr) + ..writeByte(5) + ..write(obj.license_no) + ..writeByte(6) + ..write(obj.p_suffix) + ..writeByte(7) + ..write(obj.speciality) + ..writeByte(8) + ..write(obj.sub_speciality) + ..writeByte(9) + ..write(obj.phone_no) + ..writeByte(10) + ..write(obj.created_at) + ..writeByte(11) + ..write(obj.updated_at) + ..writeByte(12) + ..write(obj.img_path) + ..writeByte(13) + ..write(obj.country); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is KolInfoAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/loc_data/crud_loc.dart b/lib/contacts_module/storage_hive/loc_data/crud_loc.dart new file mode 100644 index 0000000..f702bc8 --- /dev/null +++ b/lib/contacts_module/storage_hive/loc_data/crud_loc.dart @@ -0,0 +1,61 @@ +// import 'package:konectar_events/storage_hive/loc_data/location_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/location_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addLoc(List loclist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('lochive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List locations = loclist.map((json) { + return Location( + id: json.id, + userId: json.userId, + institution: json.institution ?? '', + address: json.address ?? '', + city: json.city ?? '', + state: json.state ?? '', + postalCode: json.postalCode.toString() ?? '', + ); + }).toList(); + + print("Publicattionnsss_isss: ${locations}"); + + for (var loc in locations) { + print("Storing_Affff: ${loc.institution}"); + await box.put(loc.id, loc); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidlocations(int id) async { + var box = await Hive.openBox('lochive'); + print('Retrive Doctor}'); + + var locations = box.get(id); + print('Retrive Doctor locations ${locations}}'); + + List dataloc = []; + if (locations != null) { + dataloc.add(locations); // Add to the list if not null + } + return dataloc; +} diff --git a/lib/contacts_module/storage_hive/loc_data/location_model_hive.dart b/lib/contacts_module/storage_hive/loc_data/location_model_hive.dart new file mode 100644 index 0000000..666b0cd --- /dev/null +++ b/lib/contacts_module/storage_hive/loc_data/location_model_hive.dart @@ -0,0 +1,36 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'location_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 36) +class Location extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? institution; + + @HiveField(3) + final String? address; + + @HiveField(4) + final String? city; + + @HiveField(5) + final String? state; + + @HiveField(6) + final String? postalCode; + + Location({ + required this.id, + required this.userId, + this.institution, + this.address, + this.city, + this.state, + this.postalCode, + }); +} diff --git a/lib/contacts_module/storage_hive/loc_data/location_model_hive.g.dart b/lib/contacts_module/storage_hive/loc_data/location_model_hive.g.dart new file mode 100644 index 0000000..9904d8c --- /dev/null +++ b/lib/contacts_module/storage_hive/loc_data/location_model_hive.g.dart @@ -0,0 +1,59 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'location_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class LocationAdapter extends TypeAdapter { + @override + final int typeId = 36; + + @override + Location read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Location( + id: fields[0] as int, + userId: fields[1] as int, + institution: fields[2] as String?, + address: fields[3] as String?, + city: fields[4] as String?, + state: fields[5] as String?, + postalCode: fields[6] as String?, + ); + } + + @override + void write(BinaryWriter writer, Location obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.institution) + ..writeByte(3) + ..write(obj.address) + ..writeByte(4) + ..write(obj.city) + ..writeByte(5) + ..write(obj.state) + ..writeByte(6) + ..write(obj.postalCode); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is LocationAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/nih_grant_data/crud_nih.dart b/lib/contacts_module/storage_hive/nih_grant_data/crud_nih.dart new file mode 100644 index 0000000..643d54e --- /dev/null +++ b/lib/contacts_module/storage_hive/nih_grant_data/crud_nih.dart @@ -0,0 +1,55 @@ +// import 'package:konectar_events/storage_hive/nih_grant_data/nih_model_hive.dart'; + +import 'package:konectar_events/contacts_module/storage_hive/nih_grant_data/nih_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addNih(List nihlist) async { + var box = await Hive.openBox('nihhive'); + + List nihs = nihlist.map((json) { + print("Checkingggg: ${json.piNames}"); + return Nih( + id: json.id, + userId: json.userId, + piNames: json.piNames ?? '', + firstName: json.firstName ?? '', + middleName: json.middleName ?? '', + lastName: json.lastName ?? '', + organizationName: json.organizationName ?? '', + departmentName: json.departmentName ?? '', + orgCity: json.orgCity ?? '', + orgState: json.orgState ?? '', + purpose: json.purpose ?? '', + institute: json.institute ?? '', + totalCost: json.totalCost ?? '', + projectStart: json.projectStart ?? '', + projectEnd: json.projectEnd ?? '', + budgetStart: json.budgetStart ?? '', + budgetEnd: json.budgetEnd ?? '', + createdOn: json.createdOn ?? '', + piId: json.piId ?? '', + ); + }).toList(); + + print("Eduactionnsss ${nihs}"); + + for (var nih in nihs) { + print("Storing_Eduactionnsss: ${nih.piNames}"); + await box.put(nih.id, nih); // Use `put` with id as key + } +} + +retrieveidnih(int id) async { + var box = await Hive.openBox('nihhive'); + + print('Retrive Doctor}'); + + var nihs = box.get(id); + print('Retrive Doctor Eduuu ${nihs}}'); + + List datanih = []; + if (nihs != null) { + datanih.add(nihs); // Add to the list if not null + } + return datanih; +} diff --git a/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.dart b/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.dart new file mode 100644 index 0000000..019770b --- /dev/null +++ b/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.dart @@ -0,0 +1,84 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'nih_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 43) +class Nih extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? piNames; + + @HiveField(3) + final String? firstName; + + @HiveField(4) + final String? middleName; + + @HiveField(5) + final String? lastName; + + @HiveField(6) + final String? organizationName; + + @HiveField(7) + final String? departmentName; + + @HiveField(8) + final String? orgCity; + + @HiveField(9) + final String? orgState; + + @HiveField(10) + final String? purpose; + + @HiveField(11) + final String? institute; + + @HiveField(12) + final String? totalCost; + + @HiveField(13) + final String? projectStart; + + @HiveField(14) + final String? projectEnd; + + @HiveField(15) + final String? budgetStart; + + @HiveField(16) + final String? budgetEnd; + + @HiveField(17) + final String? createdOn; + + @HiveField(18) + final int? piId; + + Nih({ + required this.id, + required this.userId, + this.piNames, + this.firstName, + this.middleName, + this.lastName, + this.organizationName, + this.departmentName, + this.orgCity, + this.orgState, + this.purpose, + this.institute, + this.totalCost, + this.projectStart, + this.projectEnd, + this.budgetStart, + this.budgetEnd, + this.createdOn, + this.piId, + }); +} diff --git a/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.g.dart b/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.g.dart new file mode 100644 index 0000000..513a9e4 --- /dev/null +++ b/lib/contacts_module/storage_hive/nih_grant_data/nih_model_hive.g.dart @@ -0,0 +1,95 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'nih_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class NihAdapter extends TypeAdapter { + @override + final int typeId = 43; + + @override + Nih read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Nih( + id: fields[0] as int, + userId: fields[1] as int, + piNames: fields[2] as String?, + firstName: fields[3] as String?, + middleName: fields[4] as String?, + lastName: fields[5] as String?, + organizationName: fields[6] as String?, + departmentName: fields[7] as String?, + orgCity: fields[8] as String?, + orgState: fields[9] as String?, + purpose: fields[10] as String?, + institute: fields[11] as String?, + totalCost: fields[12] as String?, + projectStart: fields[13] as String?, + projectEnd: fields[14] as String?, + budgetStart: fields[15] as String?, + budgetEnd: fields[16] as String?, + createdOn: fields[17] as String?, + piId: fields[18] as int?, + ); + } + + @override + void write(BinaryWriter writer, Nih obj) { + writer + ..writeByte(19) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.piNames) + ..writeByte(3) + ..write(obj.firstName) + ..writeByte(4) + ..write(obj.middleName) + ..writeByte(5) + ..write(obj.lastName) + ..writeByte(6) + ..write(obj.organizationName) + ..writeByte(7) + ..write(obj.departmentName) + ..writeByte(8) + ..write(obj.orgCity) + ..writeByte(9) + ..write(obj.orgState) + ..writeByte(10) + ..write(obj.purpose) + ..writeByte(11) + ..write(obj.institute) + ..writeByte(12) + ..write(obj.totalCost) + ..writeByte(13) + ..write(obj.projectStart) + ..writeByte(14) + ..write(obj.projectEnd) + ..writeByte(15) + ..write(obj.budgetStart) + ..writeByte(16) + ..write(obj.budgetEnd) + ..writeByte(17) + ..write(obj.createdOn) + ..writeByte(18) + ..write(obj.piId); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is NihAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/note_data/crud_note.dart b/lib/contacts_module/storage_hive/note_data/crud_note.dart new file mode 100644 index 0000000..7d961d9 --- /dev/null +++ b/lib/contacts_module/storage_hive/note_data/crud_note.dart @@ -0,0 +1,20 @@ +// import 'package:discover_module/storage_hive/note_data/note_model_hive.dart'; +// import 'package:discover_module/storage_hive/patent_data/patent_model_hive.dart'; + +import 'package:hive_flutter/hive_flutter.dart'; + +final Box box = Hive.box('notehive'); + +addNote(String text) async { + // var box = await Hive.openBox('notehive'); + + print("Text_issss: $text"); + + box.add(text); // Save text with a key +} + +List getText() { + //var box = await Hive.openBox('notehive'); + print("SavedNotesssL : ${box.values.toList()}"); + return box.values.toList(); +} diff --git a/lib/contacts_module/storage_hive/note_data/note_model_hive.dart b/lib/contacts_module/storage_hive/note_data/note_model_hive.dart new file mode 100644 index 0000000..d842c22 --- /dev/null +++ b/lib/contacts_module/storage_hive/note_data/note_model_hive.dart @@ -0,0 +1,16 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'note_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 47) +class Note extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final String? note; + + Note({ + required this.id, + this.note, + }); +} diff --git a/lib/contacts_module/storage_hive/note_data/note_model_hive.g.dart b/lib/contacts_module/storage_hive/note_data/note_model_hive.g.dart new file mode 100644 index 0000000..612832d --- /dev/null +++ b/lib/contacts_module/storage_hive/note_data/note_model_hive.g.dart @@ -0,0 +1,44 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'note_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class NoteAdapter extends TypeAdapter { + @override + final int typeId = 47; + + @override + Note read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Note( + id: fields[0] as int, + note: fields[1] as String?, + ); + } + + @override + void write(BinaryWriter writer, Note obj) { + writer + ..writeByte(2) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.note); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is NoteAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/patent_data/crud_patent.dart b/lib/contacts_module/storage_hive/patent_data/crud_patent.dart new file mode 100644 index 0000000..15ea3bf --- /dev/null +++ b/lib/contacts_module/storage_hive/patent_data/crud_patent.dart @@ -0,0 +1,40 @@ +// import 'package:konectar_events/storage_hive/awa_data/awa_model_hive.dart'; +// import 'package:konectar_events/storage_hive/patent_data/patent_model_hive.dart'; + +import 'package:konectar_events/contacts_module/storage_hive/patent_data/patent_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addPatent(List cerpat) async { + var box = await Hive.openBox('pethive'); + + List pets = cerpat.map((json) { + return Patent( + id: json.id, + userId: json.userId, + patentTitle: json.patentTitle ?? '', + status: json.status ?? '', + ); + }).toList(); + + print("Eduactionnsss ${pets}"); + + for (var pet in pets) { + print("Storing_Eduactionnsss: ${pet.patentTitle}"); + await box.put(pet.id, pet); // Use `put` with id as key + } +} + +retrieveidpatent(int id) async { + var box = await Hive.openBox('pethive'); + + print('Retrive Doctor}'); + + var cers = box.get(id); + print('Retrive Doctor Eduuu ${cers}}'); + + List datapet = []; + if (cers != null) { + datapet.add(cers); // Add to the list if not null + } + return datapet; +} diff --git a/lib/contacts_module/storage_hive/patent_data/patent_model_hive.dart b/lib/contacts_module/storage_hive/patent_data/patent_model_hive.dart new file mode 100644 index 0000000..3bbc7a9 --- /dev/null +++ b/lib/contacts_module/storage_hive/patent_data/patent_model_hive.dart @@ -0,0 +1,24 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'patent_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 42) +class Patent extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? patentTitle; + + @HiveField(3) + final String? status; + + Patent({ + required this.id, + required this.userId, + this.patentTitle, + this.status, + }); +} diff --git a/lib/contacts_module/storage_hive/patent_data/patent_model_hive.g.dart b/lib/contacts_module/storage_hive/patent_data/patent_model_hive.g.dart new file mode 100644 index 0000000..c57cbf8 --- /dev/null +++ b/lib/contacts_module/storage_hive/patent_data/patent_model_hive.g.dart @@ -0,0 +1,50 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'patent_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class PatentAdapter extends TypeAdapter { + @override + final int typeId = 42; + + @override + Patent read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Patent( + id: fields[0] as int, + userId: fields[1] as int, + patentTitle: fields[2] as String?, + status: fields[3] as String?, + ); + } + + @override + void write(BinaryWriter writer, Patent obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.patentTitle) + ..writeByte(3) + ..write(obj.status); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is PatentAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/pno_data/crud_pno.dart b/lib/contacts_module/storage_hive/pno_data/crud_pno.dart new file mode 100644 index 0000000..7242d29 --- /dev/null +++ b/lib/contacts_module/storage_hive/pno_data/crud_pno.dart @@ -0,0 +1,60 @@ +// import 'package:konectar_events/storage_hive/loc_data/location_model_hive.dart'; +// import 'package:konectar_events/storage_hive/pno_data/pno_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/pno_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addPno(List pnolist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('pnohive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List pnonos = pnolist.map((json) { + return PhoneNo( + id: json.id, + userId: json.userId, + phoneType: json.phoneType ?? '', + locations: json.locations ?? '', + phoneNumber: json.phoneNumber ?? '', + ); + }).toList(); + + print("Publicattionnsss_isss: ${pnonos}"); + + for (var pno in pnonos) { + print("Storing_Affff: ${pno.phoneNumber}"); + await box.put(pno.id, pno); // Use `put` with id as key + } +} + +// Future retrievePublications() async { +// var box = await Hive.openBox('pubhive'); +// print('Retrive Doctor}'); + +// List publications = box.values.toList(); +// print('Retrive Doctor publications ${publications}}'); + +// for (var publications in publications) { +// print('Retrive artical_title Name: ${publications.artical_title}'); +// print('journal_name: ${publications.journal_name}'); +// // Access other fields as needed +// } +// } + +retrieveidpnos(int id) async { + var box = await Hive.openBox('pnohive'); + print('Retrive Doctor}'); + + var pnos = box.get(id); + print('Retrive Doctor locations ${pnos}}'); + + List datapno = []; + if (pnos != null) { + datapno.add(pnos); // Add to the list if not null + } + return datapno; +} diff --git a/lib/contacts_module/storage_hive/pno_data/pno_model_hive.dart b/lib/contacts_module/storage_hive/pno_data/pno_model_hive.dart new file mode 100644 index 0000000..008cd44 --- /dev/null +++ b/lib/contacts_module/storage_hive/pno_data/pno_model_hive.dart @@ -0,0 +1,29 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'pno_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 37) +class PhoneNo extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? phoneType; + + @HiveField(3) + final String? locations; + + @HiveField(4) + final String? phoneNumber; + + PhoneNo({ + required this.id, + required this.userId, + this.phoneType, + this.locations, + this.phoneNumber, + e, + }); +} diff --git a/lib/contacts_module/storage_hive/pno_data/pno_model_hive.g.dart b/lib/contacts_module/storage_hive/pno_data/pno_model_hive.g.dart new file mode 100644 index 0000000..05b4c27 --- /dev/null +++ b/lib/contacts_module/storage_hive/pno_data/pno_model_hive.g.dart @@ -0,0 +1,53 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'pno_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class PhoneNoAdapter extends TypeAdapter { + @override + final int typeId = 37; + + @override + PhoneNo read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return PhoneNo( + id: fields[0] as int, + userId: fields[1] as int, + phoneType: fields[2] as String?, + locations: fields[3] as String?, + phoneNumber: fields[4] as String?, + ); + } + + @override + void write(BinaryWriter writer, PhoneNo obj) { + writer + ..writeByte(5) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.phoneType) + ..writeByte(3) + ..write(obj.locations) + ..writeByte(4) + ..write(obj.phoneNumber); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is PhoneNoAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/procedure_data/crud_pro.dart b/lib/contacts_module/storage_hive/procedure_data/crud_pro.dart new file mode 100644 index 0000000..e1c92d6 --- /dev/null +++ b/lib/contacts_module/storage_hive/procedure_data/crud_pro.dart @@ -0,0 +1,44 @@ +// import 'package:konectar_events/storage_hive/procedure_data/pro_model_hive.dart'; + +import 'package:konectar_events/contacts_module/storage_hive/procedure_data/pro_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addPro(List nihlist) async { + var box = await Hive.openBox('prohive'); + + List pros = nihlist.map((json) { + return Pro( + id: json.id, + userId: json.userId, + procedureCode: json.procedureCode.toString() ?? '', + placeOfService: json.placeOfService ?? '', + totalBeneficiaries: json.totalBeneficiaries.toString() ?? '', + totalServices: json.totalServices.toString() ?? '', + totalBeneDayServices: json.totalBeneDayServices.toString() ?? '', + programYear: json.programYear.toString() ?? '', + procedure: json.procedure.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${pros}"); + + for (var pro in pros) { + print("Storing_Eduactionnsss: ${pro.placeOfService}"); + await box.put(pro.id, pro); // Use `put` with id as key + } +} + +retrieveidpro(int id) async { + var box = await Hive.openBox('prohive'); + + print('Retrive Doctor}'); + + var pros = box.get(id); + print('Retrive Doctor Procedure123 ${pros}'); + + List datapro = []; + if (pros != null) { + datapro.add(pros); // Add to the list if not null + } + return datapro; +} diff --git a/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.dart b/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.dart new file mode 100644 index 0000000..1dbec67 --- /dev/null +++ b/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.dart @@ -0,0 +1,43 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'pro_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 44) +class Pro extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? procedureCode; + + @HiveField(3) + final String? placeOfService; + + @HiveField(4) + final String? totalBeneficiaries; + + @HiveField(5) + final String? totalServices; + + @HiveField(6) + final String? totalBeneDayServices; + + @HiveField(7) + final String? programYear; + + @HiveField(8) + final String? procedure; + + Pro( + {required this.id, + required this.userId, + this.procedureCode, + this.placeOfService, + this.totalBeneficiaries, + this.totalServices, + this.totalBeneDayServices, + this.programYear, + this.procedure}); +} diff --git a/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.g.dart b/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.g.dart new file mode 100644 index 0000000..86443f3 --- /dev/null +++ b/lib/contacts_module/storage_hive/procedure_data/pro_model_hive.g.dart @@ -0,0 +1,65 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'pro_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class ProAdapter extends TypeAdapter { + @override + final int typeId = 44; + + @override + Pro read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Pro( + id: fields[0] as int, + userId: fields[1] as int, + procedureCode: fields[2] as String?, + placeOfService: fields[3] as String?, + totalBeneficiaries: fields[4] as String?, + totalServices: fields[5] as String?, + totalBeneDayServices: fields[6] as String?, + programYear: fields[7] as String?, + procedure: fields[8] as String?, + ); + } + + @override + void write(BinaryWriter writer, Pro obj) { + writer + ..writeByte(9) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.procedureCode) + ..writeByte(3) + ..write(obj.placeOfService) + ..writeByte(4) + ..write(obj.totalBeneficiaries) + ..writeByte(5) + ..write(obj.totalServices) + ..writeByte(6) + ..write(obj.totalBeneDayServices) + ..writeByte(7) + ..write(obj.programYear) + ..writeByte(8) + ..write(obj.procedure); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is ProAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/pub_data/curd_pub.dart b/lib/contacts_module/storage_hive/pub_data/curd_pub.dart new file mode 100644 index 0000000..3c1b6aa --- /dev/null +++ b/lib/contacts_module/storage_hive/pub_data/curd_pub.dart @@ -0,0 +1,64 @@ +import 'package:konectar_events/contacts_module/storage_hive/pub_data/pub_model_hive.dart'; +// import 'package:discover_module/storage_hive/pub_data/pub_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addPublication(List publist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('pubhive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List publications = publist.map((json) { + return Publication( + id: json.id, + user_id: json.userId, + artical_title: json.articalTitle ?? '', + pmid: '', + journal_name: json.journalName ?? '', + date: json.date.toString() ?? '', + author: json.author ?? '', + auth_pos: '', + meshterms: '', + authorshipType: '', + kol_name: ''); + }).toList(); + + print("Publicattionnsss_isss: ${publications}"); + + for (var pub in publications) { + print("Storing_Affff: ${pub.artical_title}"); + await box.put(pub.id, pub); // Use `put` with id as key + } +} + +Future retrievePublications() async { + var box = await Hive.openBox('pubhive'); + print('Retrive Doctor}'); + + List publications = box.values.toList(); + print('Retrive Doctor publications ${publications}}'); + + for (var publications in publications) { + print('Retrive artical_title Name: ${publications.artical_title}'); + print('journal_name: ${publications.journal_name}'); + // Access other fields as needed + } +} + +retrieveidPublications(int id) async { + var box = await Hive.openBox('pubhive'); + print('Retrive Doctor}'); + + var publications = box.get(id); + print('Retrive Doctor publications ${publications}}'); + + List datapub = []; + if (publications != null) { + datapub.add(publications); // Add to the list if not null + } + return datapub; +} diff --git a/lib/contacts_module/storage_hive/pub_data/pub_model_hive.dart b/lib/contacts_module/storage_hive/pub_data/pub_model_hive.dart new file mode 100644 index 0000000..fffe64f --- /dev/null +++ b/lib/contacts_module/storage_hive/pub_data/pub_model_hive.dart @@ -0,0 +1,52 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'pub_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 32) +class Publication extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int user_id; + + @HiveField(2) + final String? artical_title; + + @HiveField(3) + final String? pmid; + + @HiveField(4) + final String? journal_name; + + @HiveField(5) + final String? date; + + @HiveField(6) + final String? author; + + @HiveField(7) + final String? auth_pos; + + @HiveField(8) + final String? meshterms; + + @HiveField(9) + final String? authorshipType; + + @HiveField(10) + final String? kol_name; + + Publication({ + required this.id, + required this.user_id, + this.artical_title, + this.pmid, + this.journal_name, + this.date, + this.author, + this.auth_pos, + this.meshterms, + this.authorshipType, + this.kol_name, + }); +} diff --git a/lib/contacts_module/storage_hive/pub_data/pub_model_hive.g.dart b/lib/contacts_module/storage_hive/pub_data/pub_model_hive.g.dart new file mode 100644 index 0000000..54c4af6 --- /dev/null +++ b/lib/contacts_module/storage_hive/pub_data/pub_model_hive.g.dart @@ -0,0 +1,71 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'pub_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class PublicationAdapter extends TypeAdapter { + @override + final int typeId = 32; + + @override + Publication read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Publication( + id: fields[0] as int, + user_id: fields[1] as int, + artical_title: fields[2] as String?, + pmid: fields[3] as String?, + journal_name: fields[4] as String?, + date: fields[5] as String?, + author: fields[6] as String?, + auth_pos: fields[7] as String?, + meshterms: fields[8] as String?, + authorshipType: fields[9] as String?, + kol_name: fields[10] as String?, + ); + } + + @override + void write(BinaryWriter writer, Publication obj) { + writer + ..writeByte(11) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.user_id) + ..writeByte(2) + ..write(obj.artical_title) + ..writeByte(3) + ..write(obj.pmid) + ..writeByte(4) + ..write(obj.journal_name) + ..writeByte(5) + ..write(obj.date) + ..writeByte(6) + ..write(obj.author) + ..writeByte(7) + ..write(obj.auth_pos) + ..writeByte(8) + ..write(obj.meshterms) + ..writeByte(9) + ..write(obj.authorshipType) + ..writeByte(10) + ..write(obj.kol_name); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is PublicationAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/speaker_data/crud.speaker.dart b/lib/contacts_module/storage_hive/speaker_data/crud.speaker.dart new file mode 100644 index 0000000..a88e166 --- /dev/null +++ b/lib/contacts_module/storage_hive/speaker_data/crud.speaker.dart @@ -0,0 +1,42 @@ +// import 'package:konectar_events/storage_hive/speaker_data/speaker_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/speaker_data/speaker_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addSpeaker(List nihlist) async { + var box = await Hive.openBox('speahive'); + + List pros = nihlist.map((json) { + return Spe( + id: json.id, + programtopic: json.programtopic, + speakername: json.speakername.toString() ?? '', + role: json.role ?? '', + evaluatorname: json.evaluatorname.toString() ?? '', + programdate: json.programdate.toString() ?? '', + createdAt: json.createdAt.toString() ?? '', + updatedAt: json.updatedAt.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${pros}"); + + for (var pro in pros) { + print("Storing_Eduactionnsss: ${pro.evaluatorname}"); + await box.put(pro.id, pro); // Use `put` with id as key + } +} + +retrieveidspeaker(int id) async { + var box = await Hive.openBox('speahive'); + + print('Retrive Doctor}'); + + var pros = box.get(id); + print('Retrive Doctor Procedure123 ${pros}'); + + List datapro = []; + if (pros != null) { + datapro.add(pros); // Add to the list if not null + } + return datapro; +} diff --git a/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.dart b/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.dart new file mode 100644 index 0000000..4b47076 --- /dev/null +++ b/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.dart @@ -0,0 +1,39 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'speaker_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 46) +class Spe extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final String? programtopic; + + @HiveField(2) + final String? role; + + @HiveField(3) + final String? evaluatorname; + + @HiveField(4) + final String? programdate; + + @HiveField(5) + final String? createdAt; + + @HiveField(6) + final String? updatedAt; + + @HiveField(7) + final String? speakername; + + Spe( + {required this.id, + this.programtopic, + this.role, + this.evaluatorname, + this.programdate, + this.createdAt, + this.updatedAt, + this.speakername}); +} diff --git a/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.g.dart b/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.g.dart new file mode 100644 index 0000000..42626a8 --- /dev/null +++ b/lib/contacts_module/storage_hive/speaker_data/speaker_model_hive.g.dart @@ -0,0 +1,62 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'speaker_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class SpeAdapter extends TypeAdapter { + @override + final int typeId = 46; + + @override + Spe read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Spe( + id: fields[0] as int, + programtopic: fields[1] as String?, + role: fields[2] as String?, + evaluatorname: fields[3] as String?, + programdate: fields[4] as String?, + createdAt: fields[5] as String?, + updatedAt: fields[6] as String?, + speakername: fields[7] as String?, + ); + } + + @override + void write(BinaryWriter writer, Spe obj) { + writer + ..writeByte(8) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.programtopic) + ..writeByte(2) + ..write(obj.role) + ..writeByte(3) + ..write(obj.evaluatorname) + ..writeByte(4) + ..write(obj.programdate) + ..writeByte(5) + ..write(obj.createdAt) + ..writeByte(6) + ..write(obj.updatedAt) + ..writeByte(7) + ..write(obj.speakername); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SpeAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/traning_data/crud_training.dart b/lib/contacts_module/storage_hive/traning_data/crud_training.dart new file mode 100644 index 0000000..7cea703 --- /dev/null +++ b/lib/contacts_module/storage_hive/traning_data/crud_training.dart @@ -0,0 +1,41 @@ +// import 'package:konectar_events/storage_hive/traning_data/traning_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/traning_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addtraining(List nihlist) async { + var box = await Hive.openBox('traininghive'); + + List trai = nihlist.map((json) { + return Training1( + id: json.id, + userId: json.userId, + educationType: json.educationType ?? '', + institutionName: json.institutionName ?? '', + degree: json.degree.toString() ?? '', + specialty: json.specialty.toString() ?? '', + timeFrame: json.timeFrame.toString() ?? '', + ); + }).toList(); + + print("Eduactionnsss ${trai}"); + + for (var pro in trai) { + print("Storing_Eduactionnsss: ${pro.institutionName}"); + await box.put(pro.id, pro); // Use `put` with id as key + } +} + +retrieveidtri(int id) async { + var box = await Hive.openBox('traininghive'); + + print('Retrive Doctor}'); + + var tris = box.get(id); + print('Retrive Doctor Procedure123 ${tris}'); + + List datatri = []; + if (tris != null) { + datatri.add(tris); // Add to the list if not null + } + return datatri; +} diff --git a/lib/contacts_module/storage_hive/traning_data/traning_model_hive.dart b/lib/contacts_module/storage_hive/traning_data/traning_model_hive.dart new file mode 100644 index 0000000..f495a7a --- /dev/null +++ b/lib/contacts_module/storage_hive/traning_data/traning_model_hive.dart @@ -0,0 +1,36 @@ +import 'package:hive_flutter/hive_flutter.dart'; +part 'traning_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 45) +class Training1 extends HiveObject { + @HiveField(0) + final int id; + + @HiveField(1) + final int userId; + + @HiveField(2) + final String? educationType; + + @HiveField(3) + final String? institutionName; + + @HiveField(4) + final String? degree; + + @HiveField(5) + final String? specialty; + + @HiveField(6) + final String? timeFrame; + + Training1({ + required this.id, + required this.userId, + this.educationType, + this.institutionName, + this.degree, + this.specialty, + this.timeFrame, + }); +} diff --git a/lib/contacts_module/storage_hive/traning_data/traning_model_hive.g.dart b/lib/contacts_module/storage_hive/traning_data/traning_model_hive.g.dart new file mode 100644 index 0000000..a022b9b --- /dev/null +++ b/lib/contacts_module/storage_hive/traning_data/traning_model_hive.g.dart @@ -0,0 +1,59 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'traning_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class Training1Adapter extends TypeAdapter { + @override + final int typeId = 45; + + @override + Training1 read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Training1( + id: fields[0] as int, + userId: fields[1] as int, + educationType: fields[2] as String?, + institutionName: fields[3] as String?, + degree: fields[4] as String?, + specialty: fields[5] as String?, + timeFrame: fields[6] as String?, + ); + } + + @override + void write(BinaryWriter writer, Training1 obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.educationType) + ..writeByte(3) + ..write(obj.institutionName) + ..writeByte(4) + ..write(obj.degree) + ..writeByte(5) + ..write(obj.specialty) + ..writeByte(6) + ..write(obj.timeFrame); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is Training1Adapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/storage_hive/trials_data/crud_trials.dart b/lib/contacts_module/storage_hive/trials_data/crud_trials.dart new file mode 100644 index 0000000..2fcebca --- /dev/null +++ b/lib/contacts_module/storage_hive/trials_data/crud_trials.dart @@ -0,0 +1,80 @@ +// import 'package:konectar_events/storage_hive/events_data/event_model_hive.dart'; +// import 'package:konectar_events/storage_hive/trials_data/trial_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/trial_model_hive.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +addTrials(List publist) async { + // static final apihcpdata = Hive.box("hcpdata"); + + var box = await Hive.openBox('trialshive'); +// + //var box = await Hive.openBox('affiliationshive'); + + // print("IamPublication_dataaa: ${publist},${publist.}"); + + // Convert JSON list to List + List trials = publist.map((json) { + return Trials( + id: json.id, + userId: json.userId, + ct_id: json.ctId ?? '', + study_Type: '', + trial_name: json.trialName ?? '', + condition: json.condition ?? '', + intervention: json.intervention ?? '', + phase: json.phase ?? '', + role: '', + enrollees: '', + trial_sites: '', + sponsors: '', + status: '', + start_Date: '', + end_Date: '', + min_Age: '', + max_Age: '', + gender: '', + investigators: '', + collaborator: '', + purpose: '', + official_Title: '', + keywords: '', + meSH_Terms: '', + url: '', + ); + }).toList(); + + print("Events_isss: ${trials}"); + + for (var trials in trials) { + print("Storing_Affff: ${trials.trial_name}"); + await box.put(trials.id, trials); // Use `put` with id as key + } +} + +Future retrieveTrials() async { + var box = await Hive.openBox('trialshive'); + print('Retrive Doctor}'); + + List events1 = box.values.toList(); + print('Retrive Doctor Trials ${events1}}'); + + for (var Events in events1) { + print('Retrive Trials Name: ${Events.trial_name}'); + print('Trials: ${Events.status}'); + // Access other fields as needed + } +} + +retrieveidTrials(int id) async { + var box = await Hive.openBox('trialshive'); + print('Retrive Doctor}'); + + var trials = box.get(id); + print('Retrive Doctor publications ${trials}}'); + + List datatrials = []; + if (trials != null) { + datatrials.add(trials); // Add to the list if not null + } + return datatrials; +} diff --git a/lib/contacts_module/storage_hive/trials_data/trial_model_hive.dart b/lib/contacts_module/storage_hive/trials_data/trial_model_hive.dart new file mode 100644 index 0000000..a917c01 --- /dev/null +++ b/lib/contacts_module/storage_hive/trials_data/trial_model_hive.dart @@ -0,0 +1,107 @@ +import 'package:hive/hive.dart'; + +part 'trial_model_hive.g.dart'; // This part file will be generated + +@HiveType(typeId: 34) // Use a unique typeId for this class +class Trials extends HiveObject { + @HiveField(0) + final int? id; + + @HiveField(1) + final int? userId; + + @HiveField(2) + final String? ct_id; + + @HiveField(3) + final String? study_Type; + + @HiveField(4) + final String? trial_name; + + @HiveField(5) + final String? condition; + + @HiveField(6) + final String? intervention; + + @HiveField(7) + final String? phase; + + @HiveField(8) + final String? role; + + @HiveField(9) + final String? enrollees; + + @HiveField(10) + final String? trial_sites; + + @HiveField(11) + final String? sponsors; + + @HiveField(12) + final String? status; + + @HiveField(13) + final String? start_Date; + + @HiveField(14) + final String? end_Date; + + @HiveField(15) + final String? min_Age; + + @HiveField(16) + final String? max_Age; + + @HiveField(17) + final String? gender; + + @HiveField(18) + final String? investigators; + + @HiveField(19) + final String? collaborator; + + @HiveField(20) + final String? purpose; // Nullable + @HiveField(21) + final String? official_Title; // Nullable + + @HiveField(22) + final String? keywords; + + @HiveField(23) + final String? meSH_Terms; // Nullable + @HiveField(24) + final String? url; + + Trials({ + this.id, + this.userId, + this.ct_id, + this.study_Type, + this.trial_name, + this.condition, + this.intervention, + this.phase, + this.role, + this.enrollees, + this.trial_sites, + this.sponsors, + this.status, + this.start_Date, + this.end_Date, + this.min_Age, + this.max_Age, + this.gender, + this.investigators, + this.collaborator, + this.purpose, + this.official_Title, + this.keywords, + this.meSH_Terms, + this.url, + }); +} diff --git a/lib/contacts_module/storage_hive/trials_data/trial_model_hive.g.dart b/lib/contacts_module/storage_hive/trials_data/trial_model_hive.g.dart new file mode 100644 index 0000000..1310ad2 --- /dev/null +++ b/lib/contacts_module/storage_hive/trials_data/trial_model_hive.g.dart @@ -0,0 +1,113 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'trial_model_hive.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class TrialsAdapter extends TypeAdapter { + @override + final int typeId = 34; + + @override + Trials read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Trials( + id: fields[0] as int?, + userId: fields[1] as int?, + ct_id: fields[2] as String?, + study_Type: fields[3] as String?, + trial_name: fields[4] as String?, + condition: fields[5] as String?, + intervention: fields[6] as String?, + phase: fields[7] as String?, + role: fields[8] as String?, + enrollees: fields[9] as String?, + trial_sites: fields[10] as String?, + sponsors: fields[11] as String?, + status: fields[12] as String?, + start_Date: fields[13] as String?, + end_Date: fields[14] as String?, + min_Age: fields[15] as String?, + max_Age: fields[16] as String?, + gender: fields[17] as String?, + investigators: fields[18] as String?, + collaborator: fields[19] as String?, + purpose: fields[20] as String?, + official_Title: fields[21] as String?, + keywords: fields[22] as String?, + meSH_Terms: fields[23] as String?, + url: fields[24] as String?, + ); + } + + @override + void write(BinaryWriter writer, Trials obj) { + writer + ..writeByte(25) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.userId) + ..writeByte(2) + ..write(obj.ct_id) + ..writeByte(3) + ..write(obj.study_Type) + ..writeByte(4) + ..write(obj.trial_name) + ..writeByte(5) + ..write(obj.condition) + ..writeByte(6) + ..write(obj.intervention) + ..writeByte(7) + ..write(obj.phase) + ..writeByte(8) + ..write(obj.role) + ..writeByte(9) + ..write(obj.enrollees) + ..writeByte(10) + ..write(obj.trial_sites) + ..writeByte(11) + ..write(obj.sponsors) + ..writeByte(12) + ..write(obj.status) + ..writeByte(13) + ..write(obj.start_Date) + ..writeByte(14) + ..write(obj.end_Date) + ..writeByte(15) + ..write(obj.min_Age) + ..writeByte(16) + ..write(obj.max_Age) + ..writeByte(17) + ..write(obj.gender) + ..writeByte(18) + ..write(obj.investigators) + ..writeByte(19) + ..write(obj.collaborator) + ..writeByte(20) + ..write(obj.purpose) + ..writeByte(21) + ..write(obj.official_Title) + ..writeByte(22) + ..write(obj.keywords) + ..writeByte(23) + ..write(obj.meSH_Terms) + ..writeByte(24) + ..write(obj.url); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is TrialsAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/textScalar.dart b/lib/contacts_module/textScalar.dart new file mode 100644 index 0000000..85bbf9f --- /dev/null +++ b/lib/contacts_module/textScalar.dart @@ -0,0 +1,11 @@ +import 'dart:math'; +import 'package:flutter/material.dart'; + +class ScaleSize { + static double textScaleFactor(BuildContext context, + {double maxTextScaleFactor = 2}) { + final width = MediaQuery.of(context).size.width; + double val = (width / 1400) * maxTextScaleFactor; + return max(1, min(val, maxTextScaleFactor)); + } +} diff --git a/lib/contacts_module/ui_screen/activity_tab.dart b/lib/contacts_module/ui_screen/activity_tab.dart new file mode 100644 index 0000000..487378d --- /dev/null +++ b/lib/contacts_module/ui_screen/activity_tab.dart @@ -0,0 +1,982 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +// import 'package:konectar_events/provider_class/events_provider.dart'; +// import 'package:konectar_events/provider_class/publications_provider.dart'; +// import 'package:konectar_events/provider_class/trials_provider.dart'; +// import 'package:konectar_events/ui_screen/affiliation_data.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:konectar_events/ui_screen/events_data.dart'; +// import 'package:konectar_events/ui_screen/publication_data.dart'; +// import 'package:konectar_events/ui_screen/trials_show_more.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/provider_class/affiliationsprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/events_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/affiliation_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/events_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/publication_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/trials_show_more.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class Activities extends StatefulWidget { + //Activities({super.key, required text}); + Activities({required this.text, Key? key}) : super(key: key); + + final int text; + + @override + State createState() => _ActivitiesState(); +} + +class _ActivitiesState extends State { + bool _isExpanded = false; + + List affiliation_data = []; + List publication_data = []; + List event_data = []; + List trial_data = []; + List medinsightData = []; + List speaker = []; + List eng = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + getaffiliations(); + } + + getaffiliations() async { + var affiliations = + Provider.of(context, listen: false); + + await affiliations.getAffiliationsdata(widget.text); + final affilist = affiliations.adddta; + + print("CheckingAfflist: $affilist"); + + var publication = Provider.of(context, listen: false); + + await publication.publicatininfo(widget.text); + final publist = publication.publicationlist; + + var events = Provider.of(context, listen: false); + await events.geteventdata(widget.text); + final eventlist = events.EventsList; + + //var form = Provider.of(context, listen: false); + // form.savedList; + + var trials = Provider.of(context, listen: false); + await trials.trialsdata(widget.text); + + final trialslist = trials.trialsinfo; + + // var med = Provider.of(context, listen: false); + // await med.medicalinsightdata(); + // final medlist = med.trialsinfo; + + // var speaker11 = + // Provider.of(context, listen: false); + + // await speaker11.getspeakerdata(); + + // final speakerlist = speaker11.speaker; + + // var engtype = Provider.of(context, listen: false); + // await engtype.getengagementdata(); + // final engtypelist = engtype.engagementdata; + + setState(() { + affiliation_data = affilist; + publication_data = publist; + event_data = eventlist; + // viewformData = form.savedList; + trial_data = trialslist; + // medinsightData = medlist; + // speaker = speakerlist; + // eng = engtypelist; + }); + + print("Affiliations_data_isNewOff123: ${affiliation_data}"); + print("Publication_data_isNewOff: $publication_data"); + + // print("trialslist_data_is: $trialslist"); + //final affiliationsss = affiliation_data['Affiliations'] as List>; + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView(children: [ + affiliation_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) async { + print("HeyyyPooja"); + + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Affiliations", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: + "(${affiliation_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + // width: + // MediaQuery.of(context) + // .size + // .width, + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text( + 'Organization Name', + style: TextStyle( + fontWeight: FontWeight.w600), + ), + )), + DataColumn( + label: Expanded( + child: Text('Time Frame', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + affiliation_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message11 ${affiliation_data[index]}"); + + bottomshet(affiliation_data[index]); + }, + color: MaterialStateProperty.resolveWith< + Color?>((Set states) { + if (index.isEven) { + return Colors.grey.withOpacity(0.1); + } + return null; + }), + cells: [ + DataCell(Text( + affiliation_data[index] + .orgName + .toString(), + softWrap: true)), + + DataCell(Text( + affiliation_data[index] + .timeFrame + .toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + print("Passing_Id_isss: ${widget.text}"); + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => AffiliationsData( + text: widget.text))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + publication_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Publications", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: + "(${publication_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + //isAlwaysShown: true, + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Article Title', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + + DataColumn( + label: Expanded( + child: Text('Authors', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + publication_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message ${publication_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet( + publication_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + publication_data[index] + .articalTitle + .toString(), + softWrap: true)), + + DataCell(Text( + publication_data[index] + .author + .toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => PublicationsData( + text: widget.text))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + event_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Events", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${event_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: MediaQuery.of(context).size.width, + ), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Event Name', + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600)), + )), + + DataColumn( + label: Expanded( + child: Text('Role', + softWrap: true, + style: TextStyle( + fontWeight: + FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + event_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${event_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(event_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + event_data[index] + .eventName + .toString(), + softWrap: true)), + + DataCell(Text( + event_data[index].role.toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => EventsData( + text: widget.text, + ))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + trial_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Trials", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${trial_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Trial Name', + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600)), + )), + DataColumn( + label: Expanded( + child: Text('Status', + softWrap: true, + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + trial_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${trial_data[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(trial_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + trial_data[index] + .trialName + .toString(), + softWrap: true)), + DataCell(Text( + trial_data[index].status.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => TrialsShowmore( + text: widget.text))); + }, + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + ]), + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // Row( + // children: [ + // Text( + // "Affiliation", + // style: TextStyle(fontSize: 20.0), + // ) + // ], + // ), + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data.org_name, + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 16.0, color: Colors.black), + ), + ), + ), + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + + affiliation_data['dept'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['role'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['time_frame'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame".toString(), + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'] + .toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['org_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + + affiliation_data['emg_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/add_event/add_event.dart b/lib/contacts_module/ui_screen/add_event/add_event.dart new file mode 100644 index 0000000..480b062 --- /dev/null +++ b/lib/contacts_module/ui_screen/add_event/add_event.dart @@ -0,0 +1,22 @@ +import 'package:flutter/material.dart'; + +class AddEventScreen extends StatefulWidget { + const AddEventScreen({super.key}); + + @override + State createState() => _AddEventScreenState(); +} + +class _AddEventScreenState extends State { + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: const Text("Event Form"), + ), + body: Column( + children: [], + ), + ); + } +} diff --git a/lib/contacts_module/ui_screen/add_event/add_hcp.dart b/lib/contacts_module/ui_screen/add_event/add_hcp.dart new file mode 100644 index 0000000..f9f3b2a --- /dev/null +++ b/lib/contacts_module/ui_screen/add_event/add_hcp.dart @@ -0,0 +1,199 @@ +import 'package:flutter/material.dart'; + +class Addhcp extends StatefulWidget { + const Addhcp({super.key}); + + @override + State createState() => _AddhcpState(); +} + +class _AddhcpState extends State { + late _DataSource _dataSource; // Instance variable for _DataSource + + @override + void initState() { + super.initState(); + print("hii_initState"); + _dataSource = _DataSource(context); // Initialize _DataSource + } + + @override + Widget build(BuildContext context) { + return Scaffold( + body: ListView( + padding: const EdgeInsets.all(3), + children: [ + PaginatedDataTable( + header: const Text( + 'HCP RANKING', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 18.0, + fontStyle: FontStyle.normal), + ), + showFirstLastButtons: true, + showEmptyRows: false, + showCheckboxColumn: true, + rowsPerPage: 5, + columns: const [ + DataColumn( + label: Text('Name', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Tier', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Rank', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Score', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Event', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Affliations', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Publications', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Trails', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + ], + source: _dataSource, + ), + ], + ), + floatingActionButton: Visibility( + visible: true, + child: FloatingActionButton( + onPressed: () { + Navigator.pop(context); + }, + child: Icon(Icons.add), + ), + ), + ); + } +} + +class _Row { + _Row(this.identifier, this.valueA, this.valueC, this.valueD, this.valueE, + this.valueF, this.valueG, this.valueH, this.valueI); + + final int identifier; + final String valueA; + final String valueC; + final String valueD; + final String valueE; + final String valueF; + final String valueG; + final String valueH; + final String valueI; + + bool selected = false; +} + +class _DataSource extends DataTableSource { + final BuildContext context; + late List<_Row> _rows; + // late List _selectedRowsIndexes = []; // List to track selected rows + final List _selectedRowIds = []; + + _DataSource(this.context) { + _rows = <_Row>[ + for (int i = 0; i < 20; i++) + _Row(i, 'pooja', 'Tier1', '1', '0', '0', '0', '0', '0'), + ]; + //} + } + + List getSelectedRowIds() { + return _selectedRowIds; // Return a copy to prevent direct modification + } + + int _selectedCount = 0; + + @override + DataRow? getRow(int index) { + assert(index >= 0); + if (index >= _rows.length) return null; + final row = _rows[index]; + return DataRow.byIndex( + index: index, + selected: row.selected, + onSelectChanged: (value) { + if (row.selected != value) { + // _selectedCount += value! ? 1 : -1; + // assert(_selectedCount >= 0); + row.selected = value!; + + if (value) { + print("Selected"); + _selectedRowIds.add(row.valueA); // Add the row ID to the list + print("Selected_selectedRowIds :$_selectedRowIds"); + } else { + _selectedRowIds + .remove(row.valueA); // Remove the row ID from the list + } + notifyListeners(); + + print("Selectedddd_is $value"); + print("Selectedddd_value ${row.valueA}"); + } + }, + cells: [ + DataCell( + Text(row.valueA), + onTap: () { + print("hiii Data cell tap ${row.valueA}"); + + // Navigator.push( + // context, MaterialPageRoute(builder: (context) => Profile())); + }, + ), + DataCell(Text(row.valueC)), + DataCell(Text(row.valueD.toString())), + DataCell(Text(row.valueE)), + DataCell(Text(row.valueF)), + DataCell(Text(row.valueG)), + DataCell(Text(row.valueH)), + DataCell(Text(row.valueI)), + ], + ); + } + + @override + int get rowCount => _rows.length; + + @override + bool get isRowCountApproximate => false; + + @override + int get selectedRowCount => _selectedCount; +} diff --git a/lib/contacts_module/ui_screen/add_event/model/event_model.dart b/lib/contacts_module/ui_screen/add_event/model/event_model.dart new file mode 100644 index 0000000..0dbb7a2 --- /dev/null +++ b/lib/contacts_module/ui_screen/add_event/model/event_model.dart @@ -0,0 +1,57 @@ +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:pwa_ios/model/interaction_data.dart'; + +part 'event_model.g.dart'; + +class UIDataEventResponse { + bool success; + String message; + + List formFields; + + UIDataEventResponse({ + required this.success, + required this.message, + required this.formFields, + }); + + factory UIDataEventResponse.fromJson(Map json) => + UIDataEventResponse( + success: json["success"], + message: json["message"], + formFields: List.from( + json["data"].map((x) => FormFieldData.fromJson(x))), + ); + + Map toJson() => { + "success": success, + "message": message, + "form-fields": List.from(formFields.map((x) => x.toJson())), + }; + + @override + String toString() { + // TODO: implement toString + return List.from(formFields.map((x) => x.toJson())).toString(); + } +} + +@HiveType(typeId: 20) +class EventConfigData { + @HiveField(1) + InteractionResultData widgets; + @HiveField(2) + String id; + @HiveField(3) + String name; + + EventConfigData({ + required this.widgets, + required this.id, + required this.name, + }); + + Map toJson() => {"widgets": widgets}; +} diff --git a/lib/contacts_module/ui_screen/add_event/model/event_model.g.dart b/lib/contacts_module/ui_screen/add_event/model/event_model.g.dart new file mode 100644 index 0000000..08b0dc1 --- /dev/null +++ b/lib/contacts_module/ui_screen/add_event/model/event_model.g.dart @@ -0,0 +1,47 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'event_model.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class EventConfigDataAdapter extends TypeAdapter { + @override + final int typeId = 20; + + @override + EventConfigData read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return EventConfigData( + widgets: fields[1] as InteractionResultData, + id: fields[2] as String, + name: fields[3] as String, + ); + } + + @override + void write(BinaryWriter writer, EventConfigData obj) { + writer + ..writeByte(3) + ..writeByte(1) + ..write(obj.widgets) + ..writeByte(2) + ..write(obj.id) + ..writeByte(3) + ..write(obj.name); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is EventConfigDataAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/affiliation_data.dart b/lib/contacts_module/ui_screen/affiliation_data.dart new file mode 100644 index 0000000..3164aa8 --- /dev/null +++ b/lib/contacts_module/ui_screen/affiliation_data.dart @@ -0,0 +1,455 @@ +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/affiliationsprovider.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; +// import 'package:konectar_events/ui_screen/new_new_profile.dart'; + +class AffiliationsData extends StatefulWidget { + final int text; + //PublicationsData(text, {super.key}); + + // AffiliationsData({required this.text}) : super(key: key); + AffiliationsData({required this.text, Key? key}) : super(key: key); + + @override + State createState() => _AffiliationsDataState(); +} + +class _AffiliationsDataState extends State { + List hcpaffiliations = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + print("Checkingg_passing_is: ${widget.text}"); + affdata(); + } + + affdata() async { + final affprovider = + Provider.of(context, listen: false); + await affprovider.getAffiliationsdata(widget.text); + + // await affprovider.getAffiliationsdata(1447203401); + + final affdata = affprovider.adddta; + setState(() { + hcpaffiliations = affdata; + }); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Affiliations'), + ), + body: ListView.builder( + itemCount: hcpaffiliations.length, + itemBuilder: (context, index) { + return Column( + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Column( + mainAxisAlignment: MainAxisAlignment.start, + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Text("Organization Name"), + Text( + hcpaffiliations[index]['org_name'], + style: TextStyle(fontSize: 15.0, color: Colors.black), + ), + SizedBox( + height: 10.0, + ), + Text("Department"), + Text(hcpaffiliations[index]['dept'], + style: + TextStyle(fontSize: 15.0, color: Colors.black)), + SizedBox( + height: 10.0, + ), + Text("Role"), + Text(hcpaffiliations[index]['role'], + style: + TextStyle(fontSize: 15.0, color: Colors.black)), + SizedBox( + height: 10.0, + ), + Text("Time Frame"), + Text(hcpaffiliations[index]['time_frame'], + style: + TextStyle(fontSize: 15.0, color: Colors.black)), + SizedBox( + height: 10.0, + ), + Text("Organization Type"), + Text(hcpaffiliations[index]['org_type'], + style: + TextStyle(fontSize: 15.0, color: Colors.black)), + SizedBox( + height: 10.0, + ), + Text("Engagement Type"), + Text(hcpaffiliations[index]['emg_type'], + style: + TextStyle(fontSize: 15.0, color: Colors.black)), + Divider() + ], + ), + ), + ], + ); + + // ListTile( + // title: Text(hcpaffiliations[index]['org_name'].toString())); + }) + + // Scrollbar(, + // child: SingleChildScrollView( + // scrollDirection: Axis.horizontal, + // child: SingleChildScrollView( + // scrollDirection: Axis.vertical, + // child: Container( + // constraints: + // BoxConstraints(minWidth: MediaQuery.of(context).size.width), + // color: Colors.white, + // child: DataTable( + // showCheckboxColumn: false, + // columns: const [ + // //DataColumn(label: Expanded(child: Text('sl no'))), + // DataColumn( + // label: Expanded( + // child: Text('Organization Name'), + // )), + // DataColumn( + // label: Expanded( + // child: Text('Department', softWrap: true))), + // DataColumn( + // label: Expanded(child: Text('Role', softWrap: true))), + // DataColumn( + // label: Expanded( + // child: Text('Time Frame', softWrap: true))), + // DataColumn( + // label: + // Expanded(child: Text('Org Type', softWrap: true))), + // DataColumn( + // label: + // Expanded(child: Text('Eng Type', softWrap: true))), + // // Add more columns as needed + // ], + // rows: List.generate( + // hcpaffiliations.length, + // (index) => DataRow( + // onSelectChanged: (value) { + // // =======> Use onSelectChanged for tab + // print("message11 ${hcpaffiliations[index]}"); + + // bottomshet(hcpaffiliations[index]); + // }, + // cells: [ + // // DataCell(Text(hcpaffiliations[index]['id'].toString(), + // // softWrap: true)), + // DataCell(Text( + // hcpaffiliations[index]['org_name'].toString(), + // softWrap: true)), + // DataCell(Text(hcpaffiliations[index]['dept'].toString(), + // softWrap: true)), + // DataCell(Text(hcpaffiliations[index]['role'].toString(), + // softWrap: true)), + // DataCell(Text( + // hcpaffiliations[index]['time_frame'].toString(), + // softWrap: true)), + // DataCell(Text( + // hcpaffiliations[index]['org_type'].toString(), + // softWrap: true)), + // DataCell(Text( + // hcpaffiliations[index]['emg_type'].toString(), + // softWrap: true)), + // // Add more DataCells as needed + // ], + // ), + // ), + // ), + // ), + // ), + // ), + // ) + + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // Row( + // children: [ + // Text( + // "Affiliation", + // style: TextStyle(fontSize: 20.0), + // ) + // ], + // ), + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data['org_name'], + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 16.0, color: Colors.black), + ), + ), + ), + // Padding( + // padding: const EdgeInsets.only(left: 18.0), + // child: + // GestureDetector( + // onTap: () async { + // final ConfigDataProvider + // configDataProvider = + // ConfigDataProvider(); + // await configDataProvider + // .initConfigUIDataEng(); + + // final provider = + // Provider.of( + // context, + // listen: false); + + // if (getCount( + // provider.intConfigDataList[index] + // .name, + // provider) != + // 0) { + // provider.savedList + // .where((element) => + // element.form == + // provider + // .intConfigDataList[index] + // .name) + // .toList(); + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: + // (BuildContext context) => + // SavedFormListScreen( + // formname: provider + // .intConfigDataList[ + // index] + // .name, + // ))); + // } + // // Navigator.push( + // // context, + // // MaterialPageRoute( + // // builder: (context) => + // // const InteractionListScreen())); + // }, + // child: Text( + // affiliation_data['org_name'], + // softWrap: true, + // maxLines: 4, + // style: TextStyle( + // fontSize: 18.0, + // color: Colors.grey[700]), + // ), + // ), + // ) + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'].toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'].toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/awardshowmore.dart b/lib/contacts_module/ui_screen/awardshowmore.dart new file mode 100644 index 0000000..5c5ecd6 --- /dev/null +++ b/lib/contacts_module/ui_screen/awardshowmore.dart @@ -0,0 +1,110 @@ +// import 'package:konectar_events/provider_class/award_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/award_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class AwardShowMore extends StatefulWidget { + AwardShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _AwardShowMoreState(); +} + +class _AwardShowMoreState extends State { + List award = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var awa = Provider.of(context, listen: false); + + await awa.awainfo(widget.text); + final awa1 = awa.awardlist; + setState(() { + award = awa1; + }); + + print("locationList: ${award}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Awards'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + award.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${award[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(award[index]); + }, + ); + }, + cells: [ + DataCell(Text(award[index]['Education Type'].toString(), + softWrap: true)), + DataCell(Text( + award[index]['Institution Name'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/bottom_sheet.dart b/lib/contacts_module/ui_screen/bottom_sheet.dart new file mode 100644 index 0000000..b3d402c --- /dev/null +++ b/lib/contacts_module/ui_screen/bottom_sheet.dart @@ -0,0 +1,1399 @@ +// import 'package:konectar_events/ui_screen/interactionform/configprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/view_forms_list.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/configprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/view_forms_list.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:provider/provider.dart'; + +class bsheet extends StatefulWidget { + const bsheet(this.publicationdata, {super.key}); + final publicationdata; + + @override + State createState() => _MyWidgetState(); +} + +class _MyWidgetState extends State { + String? field1, + field2, + field3, + field4, + field5, + field6, + field7, + field8, + field9, + field10; + String? subfield2, + subfield3, + subfield4, + subfield5, + subfield6, + subfield7, + subfield8, + subfield9, + subfield10; + bool? f2, f3, f4, f5, f6, f7, f8, f9, f10; + bool engbtn = false; + @override + void initState() { + // TODO: implement initState + super.initState(); + print("data-isssbottomshett: ${widget.publicationdata}"); + if (widget.publicationdata['artical_title'] != null) { + setState(() { + field1 = widget.publicationdata['artical_title']; + + subfield2 = "Journal Name"; + field2 = widget.publicationdata['journal_name']; + f2 = true; + + subfield3 = "Date"; + field3 = widget.publicationdata['date']; + f3 = true; + + subfield4 = "Author"; + field4 = widget.publicationdata['author']; + f4 = true; + + subfield5 = "PMID"; + field5 = widget.publicationdata['pmid'].toString(); + f5 = true; + + subfield6 = "Auth Position"; + field6 = widget.publicationdata['auth_pos'].toString(); + f6 = true; + + subfield7 = "Meshterms"; + field7 = widget.publicationdata['meshterms']; + f7 = true; + + subfield8 = ""; + field8 = " "; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + subfield10 = ""; + field10 = " "; + f10 = false; + }); + + //print("isssbottomshett123: ${widget.publicationdata['event_name']}"); + } else if (widget.publicationdata['event_name'] != null) { + setState(() { + field1 = widget.publicationdata['event_name']; + + subfield4 = "Session Type"; + field4 = widget.publicationdata['session_type']; + f2 = true; + + subfield3 = "Topic"; + field3 = widget.publicationdata['topic']; + f3 = true; + + subfield2 = "Role"; + field2 = widget.publicationdata['role']; + f4 = true; + + subfield5 = "Session_Name"; + field5 = widget.publicationdata['Session_Name']; + f5 = true; + + subfield6 = "Organizer"; + field6 = widget.publicationdata['Organizer']; + f6 = true; + + subfield7 = "Sponsor"; + field7 = widget.publicationdata['Sponsor']; + f7 = true; + + subfield8 = "Start Date"; + field8 = widget.publicationdata['Start']; + f8 = true; + + subfield9 = "End Date"; + field9 = widget.publicationdata['End']; + f9 = true; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['trial_name'] != null) { + setState(() { + field1 = widget.publicationdata['trial_name']; + + subfield2 = "Status"; + field2 = widget.publicationdata['status']; + f2 = true; + + subfield3 = "Sponsors"; + field3 = widget.publicationdata['sponsors']; + f3 = true; + + subfield4 = "Condtion"; + field4 = widget.publicationdata['condition']; + f4 = true; + + subfield5 = "Intervention"; + field5 = widget.publicationdata['intervention']; + f5 = true; + + subfield6 = "Phase"; + field6 = widget.publicationdata['phase']; + f6 = true; + + subfield7 = "Study_Type"; + field7 = widget.publicationdata['Study_Type']; + f7 = true; + + subfield8 = "intervention"; + field8 = widget.publicationdata['intervention']; + f8 = true; + + subfield9 = "Start Date"; + field9 = widget.publicationdata['Start_Date']; + f9 = true; + + subfield10 = "End Date"; + field10 = widget.publicationdata['End_Date']; + f10 = true; + }); + } else if (widget.publicationdata['programtopic'] != null) { + setState(() { + field1 = widget.publicationdata['programtopic']; + + subfield2 = "Speaker Name"; + field2 = widget.publicationdata['speakername']; + f2 = true; + + subfield3 = "Role"; + field3 = widget.publicationdata['role']; + f3 = true; + + subfield4 = "Evalutor Name"; + field4 = widget.publicationdata['evaluatorname']; + f4 = true; + + subfield5 = "Date"; + field5 = widget.publicationdata['programdate']; + f5 = true; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = " "; + f7 = false; + }); + } else if (widget.publicationdata['hcpname'] != null) { + setState(() { + field1 = widget.publicationdata['hcpname']; + + subfield2 = "Main Therapeutic Area"; + field2 = widget.publicationdata['main thereutic area']; + f2 = true; + + subfield3 = "Relationship with Chiesi"; + field3 = widget.publicationdata['relationship with chiesi']; + f3 = true; + + subfield4 = "Level of Engagement"; + field4 = widget.publicationdata['level of engagement']; + f4 = true; + + subfield5 = "Date"; + field5 = widget.publicationdata['date']; + f5 = true; + + subfield6 = "Plan of Action"; + field6 = widget.publicationdata['plan of action']; + f6 = true; + + subfield7 = "Recorded By"; + field7 = widget.publicationdata['recorded by']; + f7 = true; + + engbtn = true; + }); + } else if (widget.publicationdata['Institution'] != null) { + setState(() { + field1 = widget.publicationdata['Institution']; + + subfield2 = "Address"; + field2 = widget.publicationdata['Address']; + f2 = true; + + subfield3 = "City"; + field3 = widget.publicationdata['City']; + f3 = true; + + subfield4 = "State"; + field4 = widget.publicationdata['State']; + f4 = true; + + subfield5 = "Postalcode"; + field5 = widget.publicationdata['Postalcode'] ?? ""; + f5 = true; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['Phone type'] != null) { + setState(() { + field1 = widget.publicationdata['Phone type']; + + subfield2 = "Locations"; + field2 = widget.publicationdata['Locations']; + f2 = true; + + subfield3 = "phone Number"; + field3 = widget.publicationdata['phone Number']; + f3 = true; + + subfield4 = ""; + field4 = ""; + f4 = false; + + subfield5 = ""; + field5 = ""; + f5 = false; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['Email Type'] != null) { + setState(() { + field1 = widget.publicationdata['Email Type']; + + subfield2 = "Email"; + field2 = widget.publicationdata['Email']; + f2 = true; + + subfield3 = " "; + field3 = ""; + f3 = false; + + subfield4 = ""; + field4 = ""; + f4 = false; + + subfield5 = ""; + field5 = ""; + f5 = false; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['Education Type'] != null) { + setState(() { + field1 = widget.publicationdata['Education Type']; + + subfield2 = "Institution Name"; + field2 = widget.publicationdata['Institution Name']; + f2 = true; + + subfield3 = " Degree"; + field3 = widget.publicationdata['Degree']; + + f3 = true; + + subfield4 = ""; + field4 = ""; + f4 = false; + + subfield5 = ""; + field5 = ""; + f5 = false; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['Patent Title'] != null) { + setState(() { + field1 = widget.publicationdata['Patent Title']; + + subfield2 = "Status"; + field2 = widget.publicationdata['Status']; + f2 = true; + + subfield3 = " "; + field3 = ""; + + f3 = false; + + subfield4 = ""; + field4 = ""; + f4 = false; + + subfield5 = ""; + field5 = ""; + f5 = false; + + subfield6 = ""; + field6 = ""; + f6 = false; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['pi_names'] != null) { + setState(() { + field1 = widget.publicationdata['pi_names']; + + subfield2 = "Name"; + field2 = widget.publicationdata['first_name'] ?? + "" + " " + widget.publicationdata['middle_name'] ?? + "" + "" + widget.publicationdata['last_name'] ?? + ""; + f2 = true; + + subfield3 = "Organization Name"; + field3 = widget.publicationdata['Organization Name']; + + f3 = true; + + subfield4 = "Org City"; + field4 = widget.publicationdata['org_city']; + f4 = true; + + subfield5 = "Org State"; + field5 = widget.publicationdata['org_state']; + f5 = true; + + subfield6 = "Study/Purpose"; + field6 = widget.publicationdata['Study/Purpose']; + f6 = true; + + subfield7 = "NIH Center/Institute"; + field7 = widget.publicationdata['Study/NIH Center/Institute'] ?? ""; + f7 = true; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } else if (widget.publicationdata['Procedure'] != null) { + setState(() { + field1 = widget.publicationdata['Procedure']; + + subfield2 = "Place of Service"; + field2 = widget.publicationdata['Place of Service'] ?? ""; + + f2 = true; + + subfield3 = "Total Beneficiaries"; + field3 = widget.publicationdata['Total Beneficiaries'].toString(); + + f3 = true; + + subfield4 = "Total Services"; + field4 = widget.publicationdata['Total Services'].toString(); + f4 = true; + + subfield5 = "Total_bene_day_services"; + field5 = widget.publicationdata['Total_bene_day_services'].toString(); + f5 = true; + + subfield6 = "Program year"; + field6 = widget.publicationdata['Program year'].toString(); + f6 = true; + + subfield7 = ""; + field7 = ""; + f7 = false; + + //engbtn = true; + + subfield8 = ""; + field8 = ""; + f8 = false; + + subfield9 = ""; + field9 = " "; + f9 = false; + + subfield10 = ""; + field10 = " "; + f10 = false; + }); + } + + // print("data-isssbottomshett: ${widget.publicationdata['artical_title']}"); + } + + @override + Widget build(BuildContext context) { + return DraggableScrollableSheet( + expand: false, + // initialChildSize: + // 0.7, + // maxChildSize: + // 1, + // minChildSize: + // 0.5, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Color.fromARGB(255, 246, 248, 252), + decoration: BoxDecoration(borderRadius: BorderRadius.circular(0)), + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field1!, + softWrap: true, + style: TextStyle( + fontSize: 16.0, + color: Colors.grey[700]), + ), + ), + ) + ], + ), + SizedBox( + height: 0.0, + ), + Visibility( + visible: engbtn, + child: Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: FittedBox( + fit: BoxFit.fill, + child: GestureDetector( + onTap: () async { + final ConfigDataProvider + configDataProvider = + ConfigDataProvider(); + await configDataProvider + .initConfigUIDataEng(); + + final provider = + Provider.of( + context, + listen: false); + + if (getCount( + provider + .intConfigDataList[index] + .name, + provider) != + 0) { + provider.savedList + .where((element) => + element.form == + provider + .intConfigDataList[index] + .name) + .toList(); + Navigator.push( + context, + MaterialPageRoute( + builder: + (BuildContext context) => + SavedFormListScreen( + formname: provider + .intConfigDataList[ + index] + .name, + ))); + } + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (context) => + // const InteractionListScreen())); + }, + child: Text( + "View Engagement Form", + style: TextStyle( + fontSize: 14.0, + color: Colors.black), + ), + ), + ), + ) + ], + ), + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + Visibility( + visible: f2!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + subfield2!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field2!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f3!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield3!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field3!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f4!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield4!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field4!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f5!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield5!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field5!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f6!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield6!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field6!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f7!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield7!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field7!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f8!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield8!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field8!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f9!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield9!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field9!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + Visibility( + visible: f10!, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + subfield10!, + style: TextStyle( + fontSize: 13.0, + color: Colors.grey[700]), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + field10!, + style: TextStyle( + fontSize: 15.0, color: Colors.black), + ), + ) + ], + ), + ), + ], + ); + }), + ), + ], + ), + ); + }, + ); + } + + Future getCount(String form, InteractionProvider provider) async { + await provider.getRecords(); + + return provider.savedList.where((element) => element.form == form).length; + } +} + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +// import 'package:discover_module/ui_screen/interactionform/configprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/view_forms_list.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/widgets.dart'; +// import 'package:provider/provider.dart'; + +// class bsheet extends StatefulWidget { +// const bsheet(this.publicationdata, {super.key}); +// final publicationdata; + +// @override +// State createState() => _MyWidgetState(); +// } + +// class _MyWidgetState extends State { +// String? field1, field2, field3, field4, field5, field6, field7; +// String? subfield2, subfield3, subfield4, subfield5, subfield6, subfield7; +// bool? f2, f3, f4, f5, f6, f7; +// bool engbtn = false; +// @override +// void initState() { +// // TODO: implement initState +// super.initState(); +// print("data-isssbottomshett: ${widget.publicationdata}"); +// if (widget.publicationdata['artical_title'] != null) { +// setState(() { +// field1 = widget.publicationdata['artical_title']; + +// subfield2 = "Journal Name"; +// field2 = widget.publicationdata['journal_name']; +// f2 = true; + +// subfield3 = "Date"; +// field3 = widget.publicationdata['date']; +// f3 = true; + +// subfield4 = "Author"; +// field4 = widget.publicationdata['author']; +// f4 = true; + +// subfield5 = ""; +// field5 = " "; +// f5 = false; + +// subfield6 = ""; +// field6 = " "; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); + +// //print("isssbottomshett123: ${widget.publicationdata['event_name']}"); +// } else if (widget.publicationdata['event_name'] != null) { +// setState(() { +// field1 = widget.publicationdata['event_name']; + +// subfield2 = "Session Type"; +// field2 = widget.publicationdata['session_type']; +// f2 = true; + +// subfield3 = "Topic"; +// field3 = widget.publicationdata['topic']; +// f3 = true; + +// subfield4 = "Role"; +// field4 = widget.publicationdata['role']; +// f4 = true; + +// subfield5 = ""; +// field5 = " "; +// f5 = false; + +// subfield6 = ""; +// field6 = " "; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['trial_name'] != null) { +// setState(() { +// field1 = widget.publicationdata['trial_name']; + +// subfield2 = "Status"; +// field2 = widget.publicationdata['status']; +// f2 = true; + +// subfield3 = "Sponsors"; +// field3 = widget.publicationdata['sponsors']; +// f3 = true; + +// subfield4 = "Condtion"; +// field4 = widget.publicationdata['condition']; +// f4 = true; + +// subfield5 = "Intervention"; +// field5 = widget.publicationdata['intervention']; +// f5 = true; + +// subfield6 = "Phase"; +// field6 = widget.publicationdata['phase']; +// f6 = true; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['programtopic'] != null) { +// setState(() { +// field1 = widget.publicationdata['programtopic']; + +// subfield2 = "Speaker Name"; +// field2 = widget.publicationdata['speakername']; +// f2 = true; + +// subfield3 = "Role"; +// field3 = widget.publicationdata['role']; +// f3 = true; + +// subfield4 = "Evalutor Name"; +// field4 = widget.publicationdata['evaluatorname']; +// f4 = true; + +// subfield5 = "Date"; +// field5 = widget.publicationdata['programdate']; +// f5 = true; + +// subfield6 = ""; +// field6 = ""; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['hcpname'] != null) { +// setState(() { +// field1 = widget.publicationdata['hcpname']; + +// subfield2 = "Main Therapeutic Area"; +// field2 = widget.publicationdata['main thereutic area']; +// f2 = true; + +// subfield3 = "Relationship with Chiesi"; +// field3 = widget.publicationdata['relationship with chiesi']; +// f3 = true; + +// subfield4 = "Level of Engagement"; +// field4 = widget.publicationdata['level of engagement']; +// f4 = true; + +// subfield5 = "Date"; +// field5 = widget.publicationdata['date']; +// f5 = true; + +// subfield6 = "Plan of Action"; +// field6 = widget.publicationdata['plan of action']; +// f6 = true; + +// subfield7 = "Recorded By"; +// field7 = widget.publicationdata['recorded by']; +// f7 = true; + +// engbtn = true; +// }); +// } +// // print("data-isssbottomshett: ${widget.publicationdata['artical_title']}"); +// } + +// @override +// Widget build(BuildContext context) { +// return DraggableScrollableSheet( +// expand: false, +// // initialChildSize: +// // 0.7, +// // maxChildSize: +// // 1, +// // minChildSize: +// // 0.5, +// builder: (BuildContext context, ScrollController scrollController) { +// return Container( +// width: MediaQuery.of(context).size.width, +// //color: Color.fromARGB(255, 246, 248, 252), +// decoration: BoxDecoration(borderRadius: BorderRadius.circular(0)), +// child: Column( +// children: [ +// Expanded( +// child: ListView.builder( +// controller: scrollController, +// itemCount: 1, +// itemBuilder: (BuildContext context, int index) { +// return Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// mainAxisSize: MainAxisSize.min, +// mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// SizedBox( +// height: 18.0, +// ), +// Row( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field1!, +// softWrap: true, +// style: TextStyle( +// fontSize: 16.0, color: Colors.black), +// ), +// ), +// ) +// ], +// ), +// SizedBox( +// height: 0.0, +// ), +// Visibility( +// visible: engbtn, +// child: Row( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: FittedBox( +// fit: BoxFit.fill, +// child: GestureDetector( +// onTap: () async { +// final ConfigDataProvider +// configDataProvider = +// ConfigDataProvider(); +// await configDataProvider +// .initConfigUIDataEng(); + +// final provider = +// Provider.of( +// context, +// listen: false); + +// if (getCount( +// provider +// .intConfigDataList[index] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[index] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: +// (BuildContext context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// index] +// .name, +// ))); +// } +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (context) => +// // const InteractionListScreen())); +// }, +// child: Text( +// "View Engagement Form", +// style: TextStyle( +// fontSize: 14.0, +// color: Colors.grey[700]), +// ), +// ), +// ), +// ) +// ], +// ), +// ), +// SizedBox( +// height: 18.0, +// ), +// Divider(), +// SizedBox( +// height: 8.0, +// ), +// Visibility( +// visible: f2!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// subfield2!, +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field2!, +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// Visibility( +// visible: f3!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// subfield3!, +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field3!, +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// Visibility( +// visible: f4!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// subfield4!, +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field4!, +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// Visibility( +// visible: f5!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// "Oraganization Type", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// "fff", +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// Visibility( +// visible: f6!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// subfield6!, +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field6!, +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// Visibility( +// visible: f7!, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// subfield7!, +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// field7!, +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ), +// ], +// ); +// }), +// ), +// ], +// ), +// ); +// }, +// ); +// } + +// Future getCount(String form, InteractionProvider provider) async { +// await provider.getRecords(); + +// return provider.savedList.where((element) => element.form == form).length; +// } +// } diff --git a/lib/contacts_module/ui_screen/bottommmsheet.dart b/lib/contacts_module/ui_screen/bottommmsheet.dart new file mode 100644 index 0000000..37d08b9 --- /dev/null +++ b/lib/contacts_module/ui_screen/bottommmsheet.dart @@ -0,0 +1,194 @@ +import 'package:flutter/material.dart'; + +class BottomSheetHelper { + static void showBottomSheet(BuildContext context, dynamic affiliation_data) { + showModalBottomSheet( + context: context, + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + builder: (BuildContext context) { + // Replace this with your desired bottom sheet content + return DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data['org_name'], + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 18.0, + color: Colors.grey[700]), + ), + ), + ), + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'].toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'].toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/bottomsheet_dynamicheight.dart b/lib/contacts_module/ui_screen/bottomsheet_dynamicheight.dart new file mode 100644 index 0000000..ee48bd9 --- /dev/null +++ b/lib/contacts_module/ui_screen/bottomsheet_dynamicheight.dart @@ -0,0 +1,215 @@ +// import 'package:flutter/cupertino.dart'; + +// class bsheetDynamicheight extends StatefulWidget { +// const bsheetDynamicheight(this.publicationdata, {super.key}); +// final publicationdata; +// @override +// State createState() => _bsheetDynamicheightState(); +// } + +// class _bsheetDynamicheightState extends State { +// String? field1, field2, field3, field4, field5, field6, field7; +// String? subfield2, subfield3, subfield4, subfield5, subfield6, subfield7; +// bool? f2, f3, f4, f5, f6, f7; +// bool engbtn = false; +// @override +// void initState() { +// // TODO: implement initState +// super.initState(); +// print("data-isssbottomshett: ${widget.publicationdata}"); +// if (widget.publicationdata['artical_title'] != null) { +// setState(() { +// field1 = widget.publicationdata['artical_title']; + +// subfield2 = "Journal Name"; +// field2 = widget.publicationdata['journal_name']; +// f2 = true; + +// subfield3 = "Date"; +// field3 = widget.publicationdata['date']; +// f3 = true; + +// subfield4 = "Author"; +// field4 = widget.publicationdata['author']; +// f4 = true; + +// subfield5 = ""; +// field5 = " "; +// f5 = false; + +// subfield6 = ""; +// field6 = " "; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); + +// //print("isssbottomshett123: ${widget.publicationdata['event_name']}"); +// } else if (widget.publicationdata['event_name'] != null) { +// setState(() { +// field1 = widget.publicationdata['event_name']; + +// subfield2 = "Session Type"; +// field2 = widget.publicationdata['session_type']; +// f2 = true; + +// subfield3 = "Topic"; +// field3 = widget.publicationdata['topic']; +// f3 = true; + +// subfield4 = "Role"; +// field4 = widget.publicationdata['role']; +// f4 = true; + +// subfield5 = ""; +// field5 = " "; +// f5 = false; + +// subfield6 = ""; +// field6 = " "; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['trial_name'] != null) { +// setState(() { +// field1 = widget.publicationdata['trial_name']; + +// subfield2 = "Status"; +// field2 = widget.publicationdata['status']; +// f2 = true; + +// subfield3 = "Sponsors"; +// field3 = widget.publicationdata['sponsors']; +// f3 = true; + +// subfield4 = "Condtion"; +// field4 = widget.publicationdata['condition']; +// f4 = true; + +// subfield5 = "Intervention"; +// field5 = widget.publicationdata['intervention']; +// f5 = true; + +// subfield6 = "Phase"; +// field6 = widget.publicationdata['phase']; +// f6 = true; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['programtopic'] != null) { +// setState(() { +// field1 = widget.publicationdata['programtopic']; + +// subfield2 = "Speaker Name"; +// field2 = widget.publicationdata['speakername']; +// f2 = true; + +// subfield3 = "Role"; +// field3 = widget.publicationdata['role']; +// f3 = true; + +// subfield4 = "Evalutor Name"; +// field4 = widget.publicationdata['evaluatorname']; +// f4 = true; + +// subfield5 = "Date"; +// field5 = widget.publicationdata['programdate']; +// f5 = true; + +// subfield6 = ""; +// field6 = ""; +// f6 = false; + +// subfield7 = ""; +// field7 = " "; +// f7 = false; +// }); +// } else if (widget.publicationdata['hcpname'] != null) { +// setState(() { +// field1 = widget.publicationdata['hcpname']; + +// subfield2 = "Main Therapeutic Area"; +// field2 = widget.publicationdata['main thereutic area']; +// f2 = true; + +// subfield3 = "Relationship with Chiesi"; +// field3 = widget.publicationdata['relationship with chiesi']; +// f3 = true; + +// subfield4 = "Level of Engagement"; +// field4 = widget.publicationdata['level of engagement']; +// f4 = true; + +// subfield5 = "Date"; +// field5 = widget.publicationdata['date']; +// f5 = true; + +// subfield6 = "Plan of Action"; +// field6 = widget.publicationdata['plan of action']; +// f6 = true; + +// subfield7 = "Recorded By"; +// field7 = widget.publicationdata['recorded by']; +// f7 = true; + +// engbtn = true; +// }); +// } +// // print("data-isssbottomshett: ${widget.publicationdata['artical_title']}"); +// } + +// @override +// Widget build(BuildContext context) { +// return Container( +// child: showModalBottomSheet( +// isScrollControlled: true, +// // context and builder are +// // required properties in this widget +// context: context, +// builder: (BuildContext context) { +// // we set up a container inside which +// // we create center column and display text + +// // Returning SizedBox instead of a Container +// return Container( +// width: double.infinity, +// child: Wrap( +// // mainAxisSize: MainAxisSize.max, +// children: [ +// Expanded( +// child: SingleChildScrollView( +// child: Column( +// //mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// // Text( +// // 'GeeksforGeeks'), +// // Text( +// // 'GeeksforGeeks'), + +// // ListView( +// // children: [ +// ...List.generate( +// 20, +// (index) => Text('GeeksforGeeks $index'), +// ) +// ], +// // ) +// // ], +// ), +// ), +// ), +// ], +// ), +// ); +// }, +// ), +// ); +// } +// } diff --git a/lib/contacts_module/ui_screen/cer_show_more.dart b/lib/contacts_module/ui_screen/cer_show_more.dart new file mode 100644 index 0000000..e9b40d8 --- /dev/null +++ b/lib/contacts_module/ui_screen/cer_show_more.dart @@ -0,0 +1,111 @@ +// import 'package:konectar_events/provider_class/certificate_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/certificate_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class CerShowMore extends StatefulWidget { + CerShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _CerShowMoreState(); +} + +class _CerShowMoreState extends State { + List certificate = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var cer = Provider.of(context, listen: false); + + await cer.certificateinfo(widget.text); + final cer1 = cer.certificatelist; + setState(() { + certificate = cer1; + }); + + print("locationList: ${certificate}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Certificates'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + certificate.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${certificate[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(certificate[index]); + }, + ); + }, + cells: [ + DataCell(Text( + certificate[index]['Education Type'].toString(), + softWrap: true)), + DataCell(Text( + certificate[index]['Institution Name'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/chart.dart b/lib/contacts_module/ui_screen/chart.dart new file mode 100644 index 0000000..b5cdd35 --- /dev/null +++ b/lib/contacts_module/ui_screen/chart.dart @@ -0,0 +1,251 @@ +// import 'package:flutter/material.dart'; +// import 'package:charts_flutter/flutter.dart' as charts; + +// class Chart extends StatefulWidget { +// const Chart({super.key}); + +// @override +// State createState() => _ChartState(); +// } + +// class _ChartState extends State { +// @override +// Widget build(BuildContext context) { +// return Center( +// child: Container( +// height: 200, +// child: _buildChart(), +// ), +// ); +// } +// } + +// Widget _buildChart() { +// final data = [ +// LinearSales("Jan", [50, 100]), +// LinearSales("Feb", [75, 25]), +// LinearSales("Mar", [50, 0]), +// LinearSales("Apr", [25, 85]), +// LinearSales("May", [10, 20]), +// ]; +// final chart = charts.BarChart( +// [ +// charts.Series( +// id: 'Sales', +// colorFn: (_, __) => charts.MaterialPalette.blue.shadeDefault, +// domainFn: (LinearSales sales, _) => sales.month, +// // measureFn: (LinearSales sales, _) => sales.sales, +// measureFn: (LinearSales sales, _) => +// sales.sales.reduce((value, element) => value + element), + +// // measureFn: (LinearSales sales, _) { +// // sales.month; +// // sales.affliations; +// // }, +// data: data, +// ), +// ], +// animate: true, +// ); +// return chart; +// } + +// class LinearSales { +// final String month; +// final List sales; // List of values for the y-axis + +// // final int sales; +// // final int affliations; +// // LinearSales(this.month, this.sales, this.affliations); +// LinearSales(this.month, this.sales); +// } + +import 'package:flutter/material.dart'; +import 'package:charts_flutter/flutter.dart' as charts; + +class Chart extends StatefulWidget { + const Chart({super.key}); + + @override + State createState() => _ChartState(); +} + +class _ChartState extends State { + @override + Widget build(BuildContext context) { + return Center( + child: Container( + height: 200, + child: _buildChart(), + ), + ); + } +} + +Widget _buildChart() { + final data = [ + LinearSales("Jan12weas", [50, 100]), + LinearSales("Febghfctgfc", [75, 35]), + LinearSales("Mardfdxfdx", [50, 20]), + LinearSales("Apr", [25, 85]), + LinearSales("May", [10, 50]), + LinearSales("May1", [10, 50]), + ]; + + final chart = charts.BarChart( + [ + charts.Series( + id: 'Sales', + colorFn: (_, __) => charts.MaterialPalette.blue.shadeDefault, + domainFn: (LinearSales sales, _) => sales.month, + measureFn: (LinearSales sales, _) => + sales.sales.reduce((value, element) => value + element), + data: data, + fillColorFn: (LinearSales sales, _) { + print("Salesss"); + print(sales.sales.length); + if (sales.sales.length == 2) { + print("hii"); + + print(sales.sales.indexOf( + sales.sales.reduce((value, element) => value + element)) == + 1); + print(sales.sales.indexOf( + sales.sales.reduce((value, element) => value + element))); + //print(sales.sales.indexOf(2)); + + // final maxIndex = sales.sales.indexOf(sales.sales + // .reduce((value, element) => value > element ? value : element)); + // return sales.sales[0] == 50 + // ? charts.MaterialPalette.red.shadeDefault.lighter + // : charts.MaterialPalette.green.shadeDefault.lighter; + + final totalSales = + sales.sales.reduce((value, element) => value + element); + + print("totalSales $totalSales"); + print(sales.sales[0]); + + int index = data.indexOf(sales); + print("totalSales $index"); + + return totalSales == sales.sales[0] + ? charts.MaterialPalette.red.shadeDefault + : charts.MaterialPalette.green.shadeDefault; + } else { + // If there are more than two values, assign color based on the total sales + final totalSales = + sales.sales.reduce((value, element) => value + element); + return totalSales == sales.sales[0] + ? charts.MaterialPalette.red.shadeDefault.lighter + : charts.MaterialPalette.green.shadeDefault.lighter; + } + }, + ), + ], + animate: true, + ); + + return SizedBox( + height: 300, // Adjust the height as needed + child: chart, + ); +} + +class LinearSales { + final String month; + final List sales; + + LinearSales(this.month, this.sales); +} + +// Widget _buildChart() { +// final data = [ +// LinearSales("Jan", [50, 100]), +// LinearSales("Feb", [75, 35]), +// LinearSales("Mar", [50, 20]), +// LinearSales("Apr", [25, 85]), +// LinearSales("May", [10, 50]), +// ]; + +// final chart = charts.BarChart( +// [ +// charts.Series( +// id: 'Sales', +// colorFn: (_, __) => charts.MaterialPalette.blue.shadeDefault, +// domainFn: (LinearSales sales, _) => sales.month, +// measureFn: (LinearSales sales, _) => +// sales.sales.reduce((value, element) => value + element), +// data: data, +// fillColorFn: (LinearSales sales, _) { +// final totalSales = +// sales.sales.reduce((value, element) => value + element); +// print("Salessss: "); +// print(sales.sales[0]); +// if (sales.sales.length > 1) { +// return totalSales == sales.sales[0] +// ? charts.MaterialPalette.red.shadeDefault.lighter +// : charts.MaterialPalette.red.shadeDefault.lighter; +// } else { +// return totalSales == sales.sales[0] +// ? charts.MaterialPalette.red.shadeDefault.lighter +// : charts.MaterialPalette.green.shadeDefault.lighter; +// } +// }, +// ), +// ], +// animate: true, +// ); + +// return SizedBox( +// height: 300, // Adjust the height as needed +// child: chart, +// ); +// } + +// class LinearSales { +// final String month; +// final List sales; + +// LinearSales(this.month, this.sales); +// } + +// Widget _buildChart() { +// final data = [ +// LinearSales("Jan", [50, 100]), +// LinearSales("Feb", [75, 35]), +// LinearSales("Mar", [50, 20]), +// LinearSales("Apr", [25, 85]), +// LinearSales("May", [10, 50]), +// ]; +// final chart = charts.BarChart( +// [ +// charts.Series( +// id: 'Sales', +// colorFn: (_, __) => charts.MaterialPalette.blue.shadeDefault, +// domainFn: (LinearSales sales, _) => sales.month, +// // measureFn: (LinearSales sales, _) => sales.sales, +// measureFn: (LinearSales sales, _) => +// sales.sales.reduce((value, element) => value + element), + +// // measureFn: (LinearSales sales, _) { +// // sales.month; +// // sales.affliations; +// // }, +// data: data, +// ), +// ], +// animate: true, +// ); +// return chart; +// } + +// class LinearSales { +// final String month; +// final List sales; // List of values for the y-axis + +// // final int sales; +// // final int affliations; +// // LinearSales(this.month, this.sales, this.affliations); +// LinearSales(this.month, this.sales); +// } diff --git a/lib/contacts_module/ui_screen/contact_filters.dart b/lib/contacts_module/ui_screen/contact_filters.dart new file mode 100644 index 0000000..c0830f9 --- /dev/null +++ b/lib/contacts_module/ui_screen/contact_filters.dart @@ -0,0 +1,314 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/hive_fun.dart'; +// import 'package:konectar_events/provider_class/hcp%20_provider.dart'; +// import 'package:konectar_events/ui_screen/new_contacts.dart'; +// import 'package:konectar_events/ui_screen/saved_profiles/saved_contact.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/provider_class/hcp%20_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_contacts.dart'; +import 'package:konectar_events/contacts_module/ui_screen/saved_profiles/saved_contact.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; +import 'package:dropdownfield2/dropdownfield2.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class FilterDrawer extends StatefulWidget { + FilterDrawer(this.switchValue, this.searchController); + bool switchValue; + TextEditingController searchController = TextEditingController(); + @override + State createState() => _FilterDrawerState(); +} + +class _FilterDrawerState extends State { + var items = [ + 'Profile Type', + 'HCP Name', + 'Speciality', + 'Country', + 'Region', + 'State', + 'City', + 'List', + 'Organization', + 'Event', + ]; + + @override + Widget build(BuildContext context) { + final dropdownProvider = + Provider.of(context); // Adjust to your provider + + return Drawer( + child: ValueListenableBuilder>( + valueListenable: ddlist, + builder: (context, value, child) { + return ListView( + children: [ + // DrawerHeader removed + ListTile( + title: Padding( + padding: const EdgeInsets.all(8.0), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + const Icon( + Icons.sort, + size: 30.0, + ), + const Text( + "Filters", + style: TextStyle( + fontSize: 18.0, fontWeight: FontWeight.bold), + ), + GestureDetector( + onTap: () { + Navigator.pop(context); + // print("hiii"); + }, + child: const Icon(Icons.cancel)) + ], + ), + ), + ), + + ListTile( + title: Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + OutlinedButton( + onPressed: () { + setState(() {}); + }, + child: Text( + 'Reset Filter', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ], + ), + ), + + ListTile( + title: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + hint: Text("Select the Type"), + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: + const EdgeInsets.symmetric(vertical: 9), + + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + isExpanded: true, + value: selectedType, + items: items.map((String item) { + return DropdownMenuItem( + value: item, + child: Text(item), + ); + }).toList(), + onChanged: (String? newValue) { + setState(() { + selectedType = newValue; + optionsData(); + }); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 50, + width: 200, + ), + dropdownStyleData: DropdownStyleData( + maxHeight: 200, + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(14), + ), + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + // padding: const EdgeInsets.only( + // top: 8, + // bottom: 4, + // right: 8, + // left: 8, + // ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + final itemString = + item.value.toString().toLowerCase(); + final searchString = searchValue.toLowerCase(); + return itemString.contains(searchString); + }, + ), + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + iconStyleData: IconStyleData( + icon: Icon(Icons.arrow_drop_down), + iconSize: 20, + ), + ), + ), + ), + ListTile( + title: Container( + decoration: BoxDecoration( + border: Border.all(color: Colors.black), + borderRadius: BorderRadius.circular(10)), + child: Padding( + padding: const EdgeInsets.all(3.5), + child: DropDownField( + hintText: 'Select an option', + items: value, + onValueChanged: (newValue) { + // setState(() { + selectedValue = newValue; + + searchController.text = selectedValue; + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => Contacts1()), + ).then((value) => setState(() {})); + // }); + }, + value: selectedValue, + ), + ), + ), + ), + + ListTile( + title: Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const SavedContacts1())); + print("refresh done 111"); + // }) + }, + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + child: Text1( + title: 'Saved Profiles123', + txtcolor: Constants.k2color, + ), + ), + ], + ), + ), + ], + ); + })); + } + + optionsData() async { + print("hiiiiiiiii"); + if (selectedType == "Profile Type") { + print("PPPP11"); + setState(() { + ddlist.value = [ + "All Profile", + 'Full Profile', + 'Basic Profile', + ]; + }); + } else if (selectedType == "HCP Name") { + print("FilterHcpNameeeNeww"); + fetchhcpname(selectedType); + } else if (selectedType == "Speciality") { + fetchhcpname(selectedType); + } else if (selectedType == "Country") { + print("kkk"); + setState(() { + ddlist.value = [ + "United States", + "United States", + "United States", + ]; + }); + } else if (selectedType == "State") { + print("kkk"); + setState(() { + ddlist.value = [ + "Karnataka", + 'Karnataka', + 'Karnataka', + ]; + }); + } else if (selectedType == "City") { + print("kkk"); + setState(() { + ddlist.value = [ + "Hubli", + 'Hubli', + 'Hubli', + ]; + }); + } + } + + Future fetchhcpname([String? selectedType]) async { + print("selectedTypeselectedType: ${selectedType}, ${widget.switchValue}"); + var hcpDataProvider1 = Provider.of(context, listen: false); + + if (widget.switchValue == false) { + List namelist = + await hcpDataProvider1.gethcpNamefilter(selectedType); + ddlist.value = namelist; + setState(() {}); + } else { + List offlinenamelist = + await HiveFunctions.getAllhcpdata(selectedType); + ddlist.value = offlinenamelist; + } + } +} diff --git a/lib/contacts_module/ui_screen/contacts.dart b/lib/contacts_module/ui_screen/contacts.dart new file mode 100644 index 0000000..6152596 --- /dev/null +++ b/lib/contacts_module/ui_screen/contacts.dart @@ -0,0 +1,518 @@ +// // import 'package:discover_module/hive_fun.dart'; +// // import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; + +// // import 'package:discover_module/provider_class/hcp%20_provider.dart'; +// // import 'package:discover_module/ui_screen/profile.dart'; +// // import 'package:discover_module/ui_screen/ranking.dart'; +// // import 'package:flutter/cupertino.dart'; +// // import 'package:flutter/material.dart'; +// // import 'package:flutter/services.dart'; +// // import 'package:flutter/widgets.dart'; +// // import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +// // import 'package:hive_flutter/hive_flutter.dart'; +// // import 'package:provider/provider.dart'; + +// // class Contacts extends StatefulWidget { +// // const Contacts({super.key}); + +// // @override +// // State createState() => _ContactsState(); +// // } + +// // class _ContactsState extends State { +// // // final _contactbox = Hive.box('mycontact'); +// // static final _contactbox = Hive.box("mycontact"); + +// // bool _switchValue = false; + +// // bool isOnline2 = false; + +// // // List alldata = _contactbox.values.toList(); +// // @override +// // void initState() { +// // // TODO: implement initState +// // super.initState(); +// // setupConnectivityListener(); + +// // getcall(); +// // } + +// // NetworkConnectivity networkConnectivity = NetworkConnectivity(); + +// // Future setupConnectivityListener() async { +// // while (true) { +// // bool isOnline = await networkConnectivity.isInternetAvailable(); +// // print('Internetcontact available: $isOnline'); +// // // Perform actions based on connectivity status +// // await Future.delayed(Duration(seconds: 10)); + +// // setState(() { +// // isOnline2 = isOnline; +// // }); // Example: Check every 10 seconds +// // } +// // } + +// // void getcall() async { +// // await Provider.of(context, listen: false).getHCPProvider(); +// // } + +// // @override +// // Widget build(BuildContext context) { +// // SystemChrome.setSystemUIOverlayStyle( +// // SystemUiOverlayStyle(statusBarColor: Color.fromARGB(255, 0, 71, 132))); +// // print( +// // "newdata_is: ${_contactbox.values.toList()},${_contactbox.values.toList().length}"); + +// // print( +// // "Data_newww: ${HiveFunctions.getAllUsers()} ,${HiveFunctions.getAllUsers().length} "); + +// // return SafeArea( +// // child: Scaffold( +// // // appBar: AppBar( +// // // title: const Text('Contacts'), +// // // ), +// // body: Consumer(builder: (context, value, child) { +// // print("todoss: ${value},${value.list.length}"); +// // return Column( +// // children: [ +// // Row( +// // mainAxisAlignment: MainAxisAlignment +// // .center, // Align children to start and end of the row + +// // children: [ +// // Expanded( +// // child: Padding( +// // padding: const EdgeInsets.only(left: 45.0), +// // child: Text( +// // _switchValue ? "My Contacts" : "All Contacts", +// // textAlign: TextAlign.center, +// // style: TextStyle( +// // fontSize: 20.0, +// // fontWeight: FontWeight.w500, +// // fontStyle: FontStyle.normal, +// // color: +// // _switchValue ? Colors.black : Colors.black), +// // ), +// // ), +// // ), +// // // Expanded( +// // Row( +// // // Adjust alignment as needed +// // mainAxisSize: MainAxisSize.min, +// // children: [ +// // _switchValue +// // ? const Text( +// // 'All', +// // style: TextStyle( +// // fontSize: 12, +// // decoration: TextDecoration.lineThrough, +// // decorationThickness: 0.85, +// // ), +// // // TODO: implement dispose +// // ) +// // : const Text('All', +// // style: TextStyle( +// // fontSize: 12, +// // )), +// // CupertinoSwitch( +// // activeColor: Color.fromARGB(255, 0, 71, 132), +// // value: _switchValue, +// // onChanged: (value) { +// // setState(() { +// // print("Switch_value_is : $value"); +// // _switchValue = value; +// // }); +// // }, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(right: 8.0), +// // child: !_switchValue +// // ? const Text( +// // 'My', +// // style: TextStyle( +// // fontSize: 12, +// // decoration: TextDecoration.lineThrough, +// // decorationThickness: 0.85, +// // ), +// // ) +// // : const Text('My', +// // style: TextStyle( +// // fontSize: 12, +// // )), +// // ) +// // ], +// // ), +// // // ), +// // ]), +// // isOnline2 +// // ? Expanded( +// // child: ListView.builder( +// // itemCount: value.list.length, +// // itemBuilder: (BuildContext context, int index) { +// // // var data = HiveFunctions.getAllUsers()[index]; +// // var data = value.list[index]; + +// // print("dataaaa_isss:$data"); + +// // return Column( +// // children: [ +// // ListTile( +// // onTap: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (context) => Profile( +// // text: data, +// // ))); +// // }, +// // // title: Text(_contactbox.values.toString()), +// // leading: ProfilePicture( +// // name: data["name"], +// // radius: 20, +// // fontsize: 12, +// // ), +// // title: Text( +// // data["name"], +// // style: const TextStyle( +// // fontSize: 18.0, +// // fontWeight: FontWeight.bold), +// // ), +// // subtitle: const Text( +// // "Added by Pooja.K", +// // style: TextStyle( +// // fontSize: 14.0, +// // fontWeight: FontWeight.normal), +// // ), +// // ), +// // ], +// // ); +// // }, +// // ), +// // ) +// // : Expanded( +// // child: ListView.builder( +// // itemCount: HiveFunctions.getAllUsers().length, +// // itemBuilder: (BuildContext context, int index) { +// // var data = HiveFunctions.getAllUsers()[index]; + +// // print("dataaaa_isss:$data"); + +// // return Column( +// // children: [ +// // ListTile( +// // onTap: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (context) => Profile( +// // text: data, +// // ))); +// // }, +// // // title: Text(_contactbox.values.toString()), +// // leading: ProfilePicture( +// // name: data["name"], +// // radius: 20, +// // fontsize: 12, +// // ), +// // title: Text( +// // data["name"], +// // style: const TextStyle( +// // fontSize: 18.0, +// // fontWeight: FontWeight.bold), +// // ), +// // subtitle: const Text( +// // "Added by Pooja.K", +// // style: TextStyle( +// // fontSize: 14.0, +// // fontWeight: FontWeight.normal), +// // ), +// // ), +// // ], +// // ); +// // }, +// // ), +// // ), + +// // /////////////////////////////////////////////// +// // // Expanded( +// // // child: ListView.builder( +// // // itemCount: HiveFunctions.getAllUsers().length, +// // // itemBuilder: (BuildContext context, int index) { +// // // var data = HiveFunctions.getAllUsers()[index]; + +// // // print("dataaaa_isss:$data"); + +// // // return Column( +// // // children: [ +// // // ListTile( +// // // onTap: () { +// // // Navigator.push( +// // // context, +// // // MaterialPageRoute( +// // // builder: (context) => Profile( +// // // text: data, +// // // ))); +// // // }, +// // // // title: Text(_contactbox.values.toString()), +// // // leading: ProfilePicture( +// // // name: data["name"], +// // // radius: 20, +// // // fontsize: 12, +// // // ), +// // // title: Text( +// // // data["name"], +// // // style: const TextStyle( +// // // fontSize: 18.0, fontWeight: FontWeight.bold), +// // // ), +// // // subtitle: const Text( +// // // "Added by Pooja.K", +// // // style: TextStyle( +// // // fontSize: 14.0, fontWeight: FontWeight.normal), +// // // ), +// // // ), +// // // ], +// // // ); +// // // }, +// // // ), +// // // ), +// // ], +// // ); +// // }), +// // ), +// // ); +// // } +// // } + +// import 'package:discover_module/provider_class/hcp%20_provider.dart'; +// import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; +// import 'package:discover_module/ui_screen/new_profile.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:provider/provider.dart'; +// import 'package:flutter/services.dart'; +// import 'package:discover_module/ui_screen/profile.dart'; + +// class Contacts extends StatefulWidget { +// const Contacts({Key? key}) : super(key: key); + +// @override +// State createState() => _ContactsState(); +// } + +// class _ContactsState extends State { +// final _contactBox = Hive.box("mycontact"); +// bool _switchValue = false; +// bool? isOnline2; + +// @override +// void initState() { +// super.initState(); +// setupConnectivityListener(); +// // getCall(); +// } + +// Future setupConnectivityListener() async { +// while (true) { +// bool isOnline = await NetworkConnectivity().isInternetAvailable(); +// print('Internet contact available: $isOnline'); +// await Future.delayed(Duration(seconds: 2)); +// if (mounted) { +// setState(() { +// isOnline2 = isOnline; +// }); +// } +// if (isOnline2 == true) { +// getCall(); +// } +// } +// } + +// // @override +// // void dispose() { +// // // TODO: implement dispose +// // } +// void getCall() async { +// await Provider.of(context, listen: false).getHCPProvider(); +// } + +// @override +// Widget build(BuildContext context) { +// SystemChrome.setSystemUIOverlayStyle( +// SystemUiOverlayStyle(statusBarColor: Color.fromARGB(255, 0, 71, 132))); + +// print("internet data_is: $isOnline2"); +// return SafeArea( +// child: Scaffold( +// body: Consumer( +// builder: (context, value, child) { +// return Column( +// children: [ +// Row( +// mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 45.0), +// child: Text( +// _switchValue ? "My Contacts" : "All Contacts", +// textAlign: TextAlign.center, +// style: TextStyle( +// fontSize: 20.0, +// fontWeight: FontWeight.w500, +// ), +// ), +// ), +// ), +// Row( +// mainAxisSize: MainAxisSize.min, +// children: [ +// _switchValue +// ? const Text( +// 'All', +// style: TextStyle( +// fontSize: 12, +// decoration: TextDecoration.lineThrough, +// decorationThickness: 0.85, +// ), +// ) +// : const Text( +// 'All', +// style: TextStyle( +// fontSize: 12, +// ), +// ), +// CupertinoSwitch( +// activeColor: Color.fromARGB(255, 0, 71, 132), +// value: _switchValue, +// onChanged: (value) { +// setState(() { +// _switchValue = value; +// }); +// }, +// ), +// Padding( +// padding: const EdgeInsets.only(right: 8.0), +// child: !_switchValue +// ? const Text( +// 'My', +// style: TextStyle( +// fontSize: 12, +// decoration: TextDecoration.lineThrough, +// decorationThickness: 0.85, +// ), +// ) +// : const Text( +// 'My', +// style: TextStyle( +// fontSize: 12, +// ), +// ), +// ) +// ], +// ), +// ], +// ), +// if (isOnline2 == true) +// Expanded( +// child: ListView.builder( +// itemCount: value.list.length, +// itemBuilder: (BuildContext context, int index) { +// var data = value.list[index]; +// return ListTile( +// onTap: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (context) => Profile( +// // text: data, +// // ), +// // ), +// // ); + +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => NewProfile(text: data))); +// }, +// leading: data["img_path"] == null +// ? ProfilePicture( +// name: data["name"], +// radius: 20, +// fontsize: 12, +// ) +// : ClipOval( +// child: SizedBox.fromSize( +// size: Size.fromRadius(20), +// child: Image.network(data["img_path"], +// fit: BoxFit.cover), +// ), +// ), +// title: Text( +// data["name"], +// style: TextStyle( +// fontSize: 18.0, +// fontWeight: FontWeight.bold, +// ), +// ), +// subtitle: Text( +// "Added by Pooja.K", +// style: TextStyle( +// fontSize: 14.0, +// fontWeight: FontWeight.normal, +// ), +// ), +// ); +// }, +// ), +// ) +// else +// Expanded( +// child: ListView.builder( +// itemCount: _contactBox.values.length, +// itemBuilder: (BuildContext context, int index) { +// var data = _contactBox.get(index); +// print(":data_is: $data"); +// return ListTile( +// onTap: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (context) => Profile( +// text: data!, +// ), +// ), +// ); +// }, +// leading: ProfilePicture( +// name: data["name"], +// radius: 20, +// fontsize: 12, +// ), +// title: Text( +// data["name"], +// style: TextStyle( +// fontSize: 18.0, +// fontWeight: FontWeight.bold, +// ), +// ), +// subtitle: Text( +// "Added by Pooja.K", +// style: TextStyle( +// fontSize: 14.0, +// fontWeight: FontWeight.normal, +// ), +// ), +// ); +// }, +// ), +// ), +// ], +// ); +// }, +// ), +// ), +// ); +// } +// } diff --git a/lib/contacts_module/ui_screen/discover.dart b/lib/contacts_module/ui_screen/discover.dart new file mode 100644 index 0000000..1b3fd0e --- /dev/null +++ b/lib/contacts_module/ui_screen/discover.dart @@ -0,0 +1,64 @@ +// import 'package:discover_module/ui_screen/ranking.dart'; +// import 'package:discover_module/ui_screen/rising_stars.dart'; +// import 'package:discover_module/ui_screen/trends.dart'; +// import 'package:flutter/material.dart'; + +// class Discover extends StatefulWidget { +// const Discover(this.outerTab, {super.key}); + +// final String outerTab; + +// @override +// State createState() => _DiscoverState(); +// } + +// class _DiscoverState extends State with TickerProviderStateMixin { +// late final TabController _tabController; + +// @override +// void initState() { +// super.initState(); +// _tabController = TabController(length: 3, vsync: this); +// } + +// @override +// void dispose() { +// _tabController.dispose(); +// super.dispose(); +// } + +// @override +// Widget build(BuildContext context) { +// return Column( +// children: [ +// TabBar.secondary( +// controller: _tabController, +// labelStyle: +// const TextStyle(fontSize: 12.0, fontWeight: FontWeight.bold), +// indicatorWeight: 1.0, +// indicatorColor: const Color.fromARGB(255, 0, 71, 135), +// labelPadding: EdgeInsets.all(0.0), +// tabs: const [ +// Tab(text: 'Ranking'), +// // Tab(text: 'Chart'), +// Tab(text: 'Trends'), +// //Tab(text: 'Referral'), +// Tab(text: 'Rising Stars '), +// ], +// ), +// Expanded( +// child: TabBarView( +// controller: _tabController, +// children: [ +// Ranking(), +// // const Chart1(), +// const Trends(), +// //const Referral(), +// const RisingStar(), +// ], +// ), +// ), +// ], +// ); +// } +// } diff --git a/lib/contacts_module/ui_screen/edu_show_more.dart b/lib/contacts_module/ui_screen/edu_show_more.dart new file mode 100644 index 0000000..f146d10 --- /dev/null +++ b/lib/contacts_module/ui_screen/edu_show_more.dart @@ -0,0 +1,112 @@ +// import 'package:konectar_events/provider_class/educationprovider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/educationprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class EducationShowMore extends StatefulWidget { + EducationShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _EducationShowMoreState(); +} + +class _EducationShowMoreState extends State { + @override + List education = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var edu = Provider.of(context, listen: false); + + await edu.eduinfo(widget.text); + final edu1 = edu.educationlist; + setState(() { + education = edu1; + }); + + print("locationList: ${education}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Education'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + education.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${education[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(education[index]); + }, + ); + }, + cells: [ + DataCell(Text( + education[index]['Education Type'].toString(), + softWrap: true)), + DataCell(Text( + education[index]['Institution Name'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/email_show_more.dart b/lib/contacts_module/ui_screen/email_show_more.dart new file mode 100644 index 0000000..1ae1b99 --- /dev/null +++ b/lib/contacts_module/ui_screen/email_show_more.dart @@ -0,0 +1,109 @@ +// import 'package:konectar_events/provider_class/email_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/email_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class EmailShowMore extends StatefulWidget { + EmailShowMore({required this.text, Key? key}) : super(key: key); + final int text; + @override + State createState() => _EmailShowMoreState(); +} + +class _EmailShowMoreState extends State { + @override + List emailid = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var email = Provider.of(context, listen: false); + + await email.emailinfo(widget.text); + final emailno1 = email.emailkollist; + setState(() { + emailid = emailno1; + }); + + print("locationList: ${emailid}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Emails'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Email Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Email', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + emailid.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${emailid[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(emailid[index]); + }, + ); + }, + cells: [ + DataCell(Text(emailid[index]['Email Type'].toString(), + softWrap: true)), + DataCell(Text(emailid[index]['Email'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/engagementlist.dart b/lib/contacts_module/ui_screen/engagementlist.dart new file mode 100644 index 0000000..0314030 --- /dev/null +++ b/lib/contacts_module/ui_screen/engagementlist.dart @@ -0,0 +1,733 @@ +import 'dart:collection'; +import 'dart:convert'; + +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/provider_class/engagement_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:flutter/cupertino.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/provider_class/engagement_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:intl/intl.dart'; +import 'package:provider/provider.dart'; +import 'package:multi_dropdown/multiselect_dropdown.dart'; + +class EngagementList extends StatefulWidget { + const EngagementList({super.key}); + + @override + State createState() => _EngagementListState(); +} + +class _EngagementListState extends State { + List eng = []; + + List filteredList = []; + List hcpname = []; + List main = []; + List rel = []; + List level = []; + + DateTime? selectedDate; + final TextEditingController textController = TextEditingController(); + + bool calview = false; + String start = '', end = ''; + + TextEditingController _searchController = TextEditingController(); + + final TextEditingController startController = TextEditingController(); + final TextEditingController endController = TextEditingController(); + + String searchQuery = ''; + + List _dropDownValue1 = [], + _dropDownValue2 = [], + _dropDownValue3 = [], + _dropDownValue4 = [], + _dropDownValue5 = []; + + final TextEditingController textController1 = TextEditingController(); + + @override + void initState() { + // TODO: implement initState + super.initState(); + init(); + } + + Future init() async { + var engagement = + await Provider.of(context, listen: false); + final data = engagement.getengagementdata(); + + final data1 = engagement.engagementdata; + + engagement.gethcpname(); + hcpname = engagement.engagementhcppname; + + print("getnewData: ${hcpname}"); + + engagement.getmaintherepeutic(); + + engagement.getrelationship(); + + engagement.getrelationlevel(); + + setState(() { + eng = data1; + + filteredList = eng; + + main = engagement.enagementhcppmain; + + rel = engagement.enagementhcpprel; + level = engagement.enagementhcplevel; + }); + } + + void _filterList(String query) { + print('filteredList_is: $filteredList'); + setState(() { + searchQuery = query; + filteredList = eng + .where((item) => item['main thereutic area'] + .toLowerCase() + .contains(query.toLowerCase())) + .toList(); + }); + } + + void filtermulti(List query, List query2, List query3, + List query4, String startt, String endd) { + print("query: $query"); + print("query2: $query2"); + print("query3: $query3"); + print("query4: $query4"); + print("startt: $startt"); + print("endd: $endd"); + + // Apply Filters to Each List + // List filteredQuery1 = filterList(query); + // List filteredQuery2 = filterList(query2); + // List filteredQuery3 = filterList(query3); + // List filteredQuery4 = filterList(query4); + + // // Print Results + // print('Filtered Query 1: $filteredQuery1'); + // print('Filtered Query 2: $filteredQuery2'); + // print('Filtered Query 3: $filteredQuery3'); + // print('Filtered Query 4: $filteredQuery4'); + +// Function to filter a list based on each element being used as a keyword + +// filteredList = eng.where((map) { +// String value = map['main thereutic area']?.toLowerCase() ?? ''; +// return query.any((keyword) => value.contains(keyword.toLowerCase())); +// }).toList(); + + final DateFormat formatter = DateFormat('dd-MM-yyyy'); + + //DateTime itemDate = formatter.parse(map['date']); + + setState(() { + filteredList = eng + .where((map) => + // String value = map['main thereutic area'].toLowerCase(); + + //print("Vlaueee_isss: ${value} ${query2}"); + query2.any((keyword) => map['main thereutic area'] + .toLowerCase() + .contains(keyword.toLowerCase())) || + query.any((keyword) => map['hcpname'] + .toLowerCase() + .contains(keyword.toLowerCase())) || + query3.any((keyword) => map['relationship with chiesi'] + .toLowerCase() + .contains(keyword.toLowerCase())) || + query4.any((keyword) => map['level of engagement'] + .toLowerCase() + .contains(keyword.toLowerCase())) + //|| + // formatter + // .parse(map['date']) + // .isAfter(formatter.parse(startt)) && + // formatter + // .parse(map['date']) + // .isBefore(formatter.parse(endd)) + // || + // (DateTime.parse(map['date']).isAfter(DateTime.parse(startt)) && + // DateTime.parse(map['date']) + // .isBefore(DateTime.parse(endd).add(Duration(days: 1)))) + ) + .toList(); + }); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text("Enagagement"), + ), + endDrawer: Drawer( + child: ListView( + children: [ + Row( + children: [ + Expanded( + flex: 1, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: TextFormField( + controller: startController, + readOnly: true, // Make the TextFormField read-only + decoration: InputDecoration( + isDense: true, + labelText: 'Start Date', + // suffixIcon: Icon(Icons.calendar_today), + enabledBorder: OutlineInputBorder( + borderSide: BorderSide(color: Colors.black), + borderRadius: BorderRadius.circular(10))), + onTap: () => + _selectDate(context), // Show date picker on tap + ), + ), + ), + Expanded( + flex: 1, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: TextFormField( + controller: endController, + readOnly: true, // Make the TextFormField read-only + decoration: InputDecoration( + isDense: true, + labelText: 'End Date', + // suffixIcon: Icon(Icons.calendar_today), + enabledBorder: OutlineInputBorder( + borderSide: BorderSide(color: Colors.black), + borderRadius: BorderRadius.circular(10))), + onTap: () => + _selectDate1(context), // Show date picker on tap + ), + ), + ), + ], + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: MultiSelectDropDown.network( + borderColor: Colors.black, + fieldBackgroundColor: Colors.transparent, + hint: "Select Employee Name", + dropdownHeight: 300, + onOptionSelected: (options) { + debugPrint("checkking" + options.toString()); + + // String label = options[0].label; + List label1 = []; + + // var label; + // debugPrint("checkking " + label); + + // for (var option in options) { + // label1.add(option.label); + // debugPrint("Selected label: $label"); + // } + + for (var option in options) { + print("Options_isssssss: ${option}"); + if (option.label.isNotEmpty) { + label1.add(option.label); + } else { + label1.clear(); + } + debugPrint("Selected label: $label1, ${option.label}"); + } + setState(() { + _dropDownValue1 = label1; + }); + }, + searchEnabled: true, + networkConfig: NetworkConfig( + url: '${Constants.url}/engagement', + method: RequestMethod.get, + headers: { + 'Content-Type': 'application/json', + }, + ), + chipConfig: const ChipConfig(wrapType: WrapType.wrap), + responseParser: (response) { + final list = (response as List).map((e) { + final item = e as Map; + return ValueItem( + label: item['hcpname'], + value: item['id'].toString(), + ); + }).toList(); + + return Future.value(list); + }, + responseErrorBuilder: ((context, body) { + return const Padding( + padding: EdgeInsets.all(16.0), + child: Text('Error fetching the data'), + ); + }), + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: MultiSelectDropDown.network( + borderColor: Colors.black, + fieldBackgroundColor: Colors.transparent, + hint: "Select Main Therapeutic Area", + dropdownHeight: 300, + onOptionSelected: (options) { + debugPrint(options.toString()); + + // String label = options[0].label; + List label1 = []; + + // var label; + // debugPrint("checkking " + label); + + // for (var option in options) { + // label1.add(option.label); + // debugPrint("Selected label: $label"); + // } + + for (var option in options) { + print("Options_isssssss: ${option}"); + if (option.label.isNotEmpty) { + label1.add(option.label); + } else { + label1.clear(); + } + debugPrint("Selected label: $label1, ${option.label}"); + } + setState(() { + _dropDownValue2 = label1; + }); + }, + searchEnabled: true, + networkConfig: NetworkConfig( + url: '${Constants.url}/engagement', + method: RequestMethod.get, + headers: { + 'Content-Type': 'application/json', + }, + ), + chipConfig: const ChipConfig(wrapType: WrapType.wrap), + responseParser: (response) { + final list = (response as List).map((e) { + final item = e as Map; + return ValueItem( + label: item['main thereutic area'], + value: item['id'].toString(), + ); + }).toList(); + + return Future.value(list); + }, + responseErrorBuilder: ((context, body) { + return const Padding( + padding: EdgeInsets.all(16.0), + child: Text('Error fetching the data'), + ); + }), + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: MultiSelectDropDown.network( + borderColor: Colors.black, + fieldBackgroundColor: Colors.transparent, + hint: "Select Relationship with Chiesi", + dropdownHeight: 300, + onOptionSelected: (options) { + debugPrint(options.toString()); + + // String label = options[0].label; + List label1 = []; + + // var label; + // debugPrint("checkking " + label); + + // for (var option in options) { + // label1.add(option.label); + // debugPrint("Selected label: $label"); + // } + for (var option in options) { + print("Options_isssssss: ${option}"); + if (option.label.isNotEmpty) { + label1.add(option.label); + } else { + label1.clear(); + } + debugPrint("Selected label: $label1, ${option.label}"); + } + + setState(() { + _dropDownValue3 = label1; + }); + }, + searchEnabled: true, + networkConfig: NetworkConfig( + url: '${Constants.url}/engagement', + method: RequestMethod.get, + headers: { + 'Content-Type': 'application/json', + }, + ), + chipConfig: const ChipConfig(wrapType: WrapType.wrap), + responseParser: (response) { + final list = (response as List).map((e) { + final item = e as Map; + return ValueItem( + label: item['relationship with chiesi'], + value: item['id'].toString(), + ); + }).toList(); + + return Future.value(list); + }, + responseErrorBuilder: ((context, body) { + return const Padding( + padding: EdgeInsets.all(16.0), + child: Text('Error fetching the data'), + ); + }), + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: MultiSelectDropDown.network( + borderColor: Colors.black, + fieldBackgroundColor: Colors.transparent, + hint: "Select Level of Engagement", + dropdownHeight: 300, + onOptionSelected: (options) { + debugPrint(options.toString()); + + // String label = options[0].label.toString(); + List label1 = []; + + // var label; + // debugPrint("checkking " + label); + //debugPrint("checkking " + label.isNotEmpty); + + // if (label.isNotEmpty) { + for (var option in options) { + print("Options_isssssss: ${option}"); + if (option.label.isNotEmpty) { + label1.add(option.label); + } else { + label1.clear(); + } + debugPrint("Selected label: $label1, ${option.label}"); + } + // } else { + // debugPrint("DESelected label: $label"); + + // label1.clear(); + // } + + setState(() { + _dropDownValue4 = label1; + }); + }, + searchEnabled: true, + networkConfig: NetworkConfig( + url: '${Constants.url}/engagement', + method: RequestMethod.get, + headers: { + 'Content-Type': 'application/json', + }, + ), + chipConfig: const ChipConfig(wrapType: WrapType.wrap), + responseParser: (response) { + final list = (response as List).map((e) { + final item = e as Map; + return ValueItem( + label: item['level of engagement'], + value: item['id'].toString(), + ); + }).toList(); + + return Future.value(list); + }, + responseErrorBuilder: ((context, body) { + return const Padding( + padding: EdgeInsets.all(16.0), + child: Text('Error fetching the data'), + ); + }), + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + print( + "$_dropDownValue1 , $_dropDownValue2, $_dropDownValue3, $_dropDownValue4"); + + filtermulti(_dropDownValue1, _dropDownValue2, _dropDownValue3, + _dropDownValue4, start, end); + // filtermulti(_dropDownValue1 ?? null, _dropDownValue2 ?? null, + // _dropDownValue3 ?? null, _dropDownValue4 ?? null); + + // setState(() { + // // searchQuery = query; + + // filteredList = eng + // .where((item) => item['level of engagement'] + // .toLowerCase() + // .contains(_dropDownValue4!.toLowerCase())|| + // item['relationship with chiesi'].toLowerCase().contains(_dropDownValue3!.toLowerCase()) || + // item['main thereutic area'].toLowerCase().contains(_dropDownValue2!.toLowerCase())|| + // item['recorded by'].toLowerCase().contains(_dropDownValue1!.toLowerCase()) ) + // .toList(); + // }); + }, + child: Text( + 'Apply Filters', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ], + ), + //child: // Populate the Drawer in the next step. + ), + body: Column(children: [ + Padding( + padding: const EdgeInsets.only( + top: 15.0, bottom: 0.0, left: 20.0, right: 20.0), + child: Center( + child: TextField( + controller: _searchController, + onChanged: _filterList, + decoration: InputDecoration( + fillColor: Constants.k2color, + contentPadding: EdgeInsets.symmetric(vertical: 9.0), + border: OutlineInputBorder(), + labelText: ' Search', + prefixIcon: Icon( + Icons.search, + ), + ), + ), + ), + ), + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + // width: + // MediaQuery.of(context) + // .size + // .width, + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + // DataColumn( + // label: Expanded( + // child: Text( + // '', + // softWrap: + // true))), + DataColumn( + label: Expanded( + child: Text( + 'Main Therapeutic Area', + style: TextStyle(fontWeight: FontWeight.w600), + ), + )), + // DataColumn( + // label: Expanded( + // child: Text( + // 'Department'))), + // DataColumn( + // label: Expanded( + // child: Text( + // 'Role'))), + DataColumn( + label: Expanded( + child: Text('Date', + style: TextStyle(fontWeight: FontWeight.w600)))), + // DataColumn( + // label: Expanded( + // child: Text( + // 'Org Type'))), + // DataColumn( + // label: Expanded( + // child: Text( + // 'Eng Type'))), + + // Add more columns as needed + ], + rows: List.generate( + filteredList.length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + // print("message ${eng[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(filteredList[index]); + }, + ); + // showBottomSheet( + // context: + // context, + // builder: + // (BuildContext + // context) { + // return bsheet( + // publication_data[ + // index]); // returns your BottomSheet widget + // }); + }, + color: MaterialStateProperty.resolveWith( + (Set states) { + if (index.isEven) { + return Colors.grey.withOpacity(0.1); + } + return null; + }), + cells: [ + DataCell(Text( + filteredList[index]['main thereutic area'].toString(), + softWrap: true)), + // DataCell(Text( + // affiliation_data[ + // index] + // [ + // 'dept'] + // .toString(), + // softWrap: + // true)), + // DataCell(Text( + // affiliation_data[ + // index] + // [ + // 'role'] + // .toString(), + // softWrap: + // true)), + DataCell(Text(filteredList[index]['date'].toString(), + softWrap: true)), + // DataCell(Text( + // affiliation_data[ + // index] + // [ + // 'org_type'] + // .toString(), + // softWrap: + // true)), + // DataCell(Text( + // affiliation_data[ + // index] + // [ + // 'emg_type'] + // .toString(), + // softWrap: + // true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + ]), + ); + } + + Future _selectDate(BuildContext context) async { + final DateTime? picked = await showDatePicker( + context: context, + initialDate: selectedDate, + firstDate: DateTime(1901, 1), + lastDate: DateTime(2100)); + if (picked != null && picked != selectedDate) { + setState(() { + selectedDate = picked; + String convertedDateTime = + "${picked.day.toString().padLeft(2, '0')}-${picked.month.toString().padLeft(2, '0')}-${picked.year.toString()}"; + // widget.textController.value = TextEditingValue(text: picked.toString()); + startController.value = TextEditingValue(text: convertedDateTime); + // textController1.value = TextEditingValue(text: convertedDateTime); + + start = convertedDateTime; + + print("Iam__Start: $start"); + }); + } + } + + Future _selectDate1(BuildContext context) async { + final DateTime? picked = await showDatePicker( + context: context, + initialDate: selectedDate, + firstDate: DateTime(1901, 1), + lastDate: DateTime(2100)); + if (picked != null && picked != selectedDate) { + setState(() { + selectedDate = picked; + String convertedDateTime = + "${picked.day.toString().padLeft(2, '0')}-${picked.month.toString().padLeft(2, '0')}-${picked.year.toString()}"; + // widget.textController.value = TextEditingValue(text: picked.toString()); + endController.value = TextEditingValue(text: convertedDateTime); + + end = convertedDateTime; + }); + } + } + + String _convertDateStringToISO(String dateString) { + DateTime dateTime = DateTime.parse(DateTime.tryParse( + dateString.split('/').reversed.join('-') + 'T00:00:00Z')! + .toIso8601String()); + + print("dateTimedateTime: $dateTime"); + return dateTime.toIso8601String(); + } + // List filterList(List list) { + // return list + // .where((item) => list.any((keyword) => item.contains(keyword))) + // .toList(); + // } +} diff --git a/lib/contacts_module/ui_screen/engagementtab.dart b/lib/contacts_module/ui_screen/engagementtab.dart new file mode 100644 index 0000000..80ea7e6 --- /dev/null +++ b/lib/contacts_module/ui_screen/engagementtab.dart @@ -0,0 +1,1271 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/model_class/speaker.dart'; +// import 'package:konectar_events/provider_class/medicalinsightprovider.dart'; +// import 'package:konectar_events/provider_class/nih_provider.dart'; +// import 'package:konectar_events/provider_class/patent_provider.dart'; +// import 'package:konectar_events/provider_class/procedureprovider.dart'; +// import 'package:konectar_events/provider_class/speaker_provider.dart'; +// import 'package:konectar_events/provider_class/training_provider.dart'; +// import 'package:konectar_events/storage_hive/nih_grant_data/crud_nih.dart'; +// import 'package:konectar_events/storage_hive/patent_data/crud_patent.dart'; +// import 'package:konectar_events/storage_hive/procedure_data/crud_pro.dart'; +// import 'package:konectar_events/storage_hive/speaker_data/crud.speaker.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/view_forms_list.dart'; +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:konectar_events/ui_screen/medical_insight.dart'; +// import 'package:konectar_events/ui_screen/new_editinteraction.dart'; +// import 'package:konectar_events/ui_screen/new_viewinteraction.dart'; +// import 'package:konectar_events/ui_screen/nih_show_more.dart'; +// import 'package:konectar_events/ui_screen/patent_show_more.dart'; +// import 'package:konectar_events/ui_screen/pro_show_more.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/provider_class/nih_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/patent_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/procedureprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/speaker_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/nih_grant_data/crud_nih.dart'; +import 'package:konectar_events/contacts_module/storage_hive/patent_data/crud_patent.dart'; +import 'package:konectar_events/contacts_module/storage_hive/procedure_data/crud_pro.dart'; +import 'package:konectar_events/contacts_module/storage_hive/speaker_data/crud.speaker.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/view_forms_list.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_editinteraction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_viewinteraction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/nih_show_more.dart'; +import 'package:konectar_events/contacts_module/ui_screen/patent_show_more.dart'; +import 'package:konectar_events/contacts_module/ui_screen/pro_show_more.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class EngagementTab extends StatefulWidget { + EngagementTab({required this.text, this.offline, Key? key}) : super(key: key); + + final int text; + int? offline; + @override + State createState() => _EngagementTabState(); +} + +class _EngagementTabState extends State { + bool _isExpanded = false; + List medinsightData = []; + List patent = []; + List nihgrants = []; + List procedure = []; + List speakerlistt = []; + + // List training = []; + + // List eng = []; + + var item; + @override + void initState() { + // TODO: implement initState + super.initState(); + getdata(); + } + + getdata() async { + var form = Provider.of(context, listen: false); + form.savedList; + final patentt1, nih1, pro1, tri1, speakerlist; + //var med = Provider.of(context, listen: false); + //await med.medicalinsightdata(); + // final medlist = med.trialsinfo; + + if (widget.offline == 1) { + patentt1 = await retrieveidpatent(widget.text); + print("Savedd_CheckingloclistEdu123: $patentt1"); + } else { + var patentt = Provider.of(context, listen: false); + await patentt.patentinfo(widget.text); + patentt1 = patentt.patentlist; + } + + if (widget.offline == 1) { + nih1 = await retrieveidnih(widget.text); + print("Savedd_CheckingloclistEdu123: $nih1"); + } else { + var nih = Provider.of(context, listen: false); + await nih.nihinfo(widget.text); + nih1 = nih.nihgrantslist; + } + + if (widget.offline == 1) { + pro1 = await retrieveidpro(widget.text); + print("Savedd_CheckingloclistEdupro1123: $pro1"); + } else { + var pro = Provider.of(context, listen: false); + await pro.proinfo(widget.text); + pro1 = pro.prolist; + } + + if (widget.offline == 1) { + speakerlist = await retrieveidspeaker(widget.text); + print("Savedd_CheckingloclistEdupro1123: $pro1"); + } else { + var speaker1 = + Provider.of(context, listen: false); + await speaker1.getspeakerdata(); + speakerlist = speaker1.speakerlist; + } + + setState(() { + // medinsightData = medlist; + patent = patentt1; + nihgrants = nih1; + procedure = pro1; + // training = tri1; + speakerlistt = speakerlist; + // eng = engtypelist; + }); + + // print("CheckingPro: ${pro1.procedure}"); + // print("Checkingnihgrants: $nihgrants"); + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView( + children: [ + // ListTileTheme( + // dense: true, + // child: Padding( + // padding: const EdgeInsets.only(left: 8.0, right: 8.0), + // child: Card( + // margin: EdgeInsets.all(1.0), + // //elevation: 5, + // shape: RoundedRectangleBorder( + // borderRadius: BorderRadius.circular(0.0), + // ), + // color: Constants.k2color11, + // child: ExpansionTile( + // initiallyExpanded: false, + // maintainState: true, + // onExpansionChanged: (bool expanded) { + // setState(() { + // _isExpanded = expanded; + // }); + // }, + // backgroundColor: Constants.k2color11, + // trailing: Icon( + // _isExpanded + // ? Icons.keyboard_arrow_up + // : Icons.keyboard_arrow_down, + // color: Colors.black), + // // collapsedBackgroundColor: Color(0xFF2b9af3), + // // initiallyExpanded: true, + // title: Row( + // mainAxisAlignment: MainAxisAlignment.start, + // // mainAxisSize: MainAxisSize.min, + // children: [ + // Text1( + // title: "Medical Insights", + // txtcolor: Colors.black, + // fontweight: FontWeight.normal, + // txtfont: 17.0), + // const SizedBox( + // width: 8.0, + // ), + // Text1( + // title: "(3)", + // txtcolor: Colors.black, + // fontweight: FontWeight.normal, + // txtfont: 17.0), + // ], + // ), + // children: [ + // Container( + // width: MediaQuery.of(context).size.width, + + // /// 5, + // color: Colors.white, + // child: Consumer(builder: + // (BuildContext context, value, Widget? child) { + // print("med1 : ${value.med.length}"); + + // if (value.med.length != 0) { + // return ListView.builder( + // physics: const ScrollPhysics(), + // // scrollDirection: Axis.vertical, + // shrinkWrap: true, + // itemCount: value.med.take(2).length, + // itemBuilder: (context, index) { + // item = value.med[index]; + + // print( + // "Item_Medical_insight ${item['Therapeutic Area']}"); + // return Padding( + // padding: const EdgeInsets.all(8.0), + // child: Card( + // margin: EdgeInsets.zero, + + // elevation: 4, + // surfaceTintColor: Colors.white, + // shape: RoundedRectangleBorder( + // borderRadius: BorderRadius.zero, + // ), + + // child: SizedBox( + // width: MediaQuery.sizeOf(context).width, + // child: ListTile( + // dense: true, + // title: Column( + // // crossAxisAlignment: CrossAxisAlignment.center, + // children: [ + // // Text( + // // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + + // RichText( + // text: TextSpan( + // text: '', + // style: DefaultTextStyle.of( + // context) + // .style, + // children: const [ + // TextSpan( + // text: + // 'Acute neurology ', + // style: TextStyle( + // fontWeight: + // FontWeight + // .bold)), + // // TextSpan( + // // text: ' therapeutic area ', + // // style: TextStyle( + // // fontWeight: + // // FontWeight.bold)), + // TextSpan( + // text: + // 'is the therapeutic area of the medical insight for '), + // TextSpan( + // text: + // 'Product A. The age of treatment', + // style: TextStyle( + // fontWeight: + // FontWeight + // .bold)), + // TextSpan( + // text: + // ' is the topic of interest for this source type'), + // TextSpan( + // text: ' publication.', + // style: TextStyle( + // fontWeight: + // FontWeight + // .bold)), + // ], + // ), + // ), + + // const Padding( + // padding: EdgeInsets.all(8.0), + // child: Row( + // mainAxisAlignment: + // MainAxisAlignment + // .spaceBetween, + // children: [ + // Row( + // children: [ + // Icon( + // Icons.person, + // size: 20, + // ), + // Text( + // "pooja", + // style: TextStyle( + // fontSize: 14.0), + // ) + // ], + // ), + // Row( + // children: [ + // Icon( + // Icons.calendar_today, + // size: 20, + // ), + // Text( + // "11/11/2022 ", + // style: TextStyle( + // fontSize: 14.0), + // ) + // ], + // ) + // ], + // ), + // ), + // ], + // ), + // ), + // ), + // // shape: BorderRadius.only(bottomRight: Radius.circular(50)), + // ), + // ); + // }); + // } else { + // return Container( + // color: Colors.white, + // width: MediaQuery.of(context).size.width, + // child: Column( + // children: [ + // Text("No records"), + // ], + // ), + // ); + // } + // }), + // ), + // Container( + // color: Colors.white, + // child: Align( + // alignment: Alignment.center, + // child: Padding( + // padding: const EdgeInsets.all(8.0), + // child: OutlinedButton( + // onPressed: () { + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (_) => + // const MedicalInsight1())); + // }, + // child: Text( + // 'Show More', + // style: TextStyle(color: Constants.k2color), + // ), + // style: OutlinedButton.styleFrom( + // shape: RoundedRectangleBorder( + // borderRadius: BorderRadius.circular(12), + // ), + // ), + // ), + // ), + // ), + // ) + // ]), + // ), + // ), + // ), + + ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + //mainAxisSize: MainAxisSize.min, + children: [ + GestureDetector( + onTap: () async { + final provider = Provider.of( + context, + listen: false); + if (getCount(provider.intConfigDataList[0].name, + provider) != + 0) { + provider.savedList + .where((element) => + element.form == + provider.intConfigDataList[0].name) + .toList(); + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + SavedFormListScreen( + formname: provider + .intConfigDataList[0].name, + ))); + } + }, + child: Text1( + title: "Interactions", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ), + const SizedBox( + width: 8.0, + ), + ], + ), + children: [ + Container( + height: MediaQuery.of(context).size.height / 5, + color: Colors.white, + child: Consumer(builder: + (BuildContext context, provider, Widget? child) { + print("P_leangth : ${provider.savedList.length}"); + + if (provider.savedList.length != 0) { + return ListView.builder( + shrinkWrap: true, + physics: NeverScrollableScrollPhysics(), + itemCount: provider.savedList.take(2).length, + itemBuilder: (context, index) { + print("Indexxxxxx $index"); + return Column( + children: [ + ListTile( + subtitle: Text( + 'Updated on ${provider.savedList[index].updatedTime}', + //style: TextStyle(fontStyle: FontStyle.italic), + ), + title: Text( + provider.savedList[index].id, + ), + trailing: SizedBox( + width: 150, + child: Row(children: [ + IconButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext + context) => + ViewInteractionScreen1( + saveInteraction: + provider.savedList[ + index], + ))); + }, + icon: const Icon( + Icons.info_outline, + size: 24, + color: Color.fromARGB( + 255, 8, 39, 92), + ), + ), + IconButton( + onPressed: () async { + await provider + .initConfigData() + .then({ + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext + context) => + EditInteractionScreen1( + saveInteraction: + provider.savedList[ + index], + ))) + }); + }, + icon: const Icon( + Icons.edit, + size: 24, + color: Color.fromARGB( + 255, 8, 39, 92), + ), + ), + IconButton( + onPressed: () { + showDeleteRecordAlertDialog( + context, + provider + .savedList[index].id, + provider.savedList[index]); + }, + icon: const Icon( + Icons.delete, + size: 24, + color: Color.fromARGB( + 255, 8, 39, 92), + ), + ), + ]), + ), + onTap: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext + context) => + ViewInteractionScreen1( + saveInteraction: + provider.savedList[ + index], + ))); + }, + ), + const Divider(), + ], + ); + }); + } else { + return Container( + color: Colors.white, + width: MediaQuery.of(context).size.width, + child: Column( + children: [ + Text("No records"), + ], + ), + ); + } + }), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + final provider = + Provider.of(context, + listen: false); + if (getCount(provider.intConfigDataList[0].name, + provider) != + 0) { + provider.savedList + .where((element) => + element.form == + provider.intConfigDataList[0].name) + .toList(); + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + SavedFormListScreen( + formname: provider + .intConfigDataList[0].name, + ))); + } + }, + child: Text('Show More'), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + + speakerlistt.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Speaker Evalution", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${speakerlistt.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text( + 'Program Topic', + style: TextStyle( + fontWeight: FontWeight.w600), + ), + )), + DataColumn( + label: Expanded( + child: Text('Speaker Name', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + speakerlistt.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message ${speakerlistt[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet( + speakerlistt[index]); + }, + ); + }, + color: MaterialStateProperty + .resolveWith( + (Set states) { + if (index.isEven) { + return Colors.grey.withOpacity(0.1); + } + return null; + }), + cells: [ + DataCell(Text( + speakerlistt[index] + .programtopic + .toString(), + softWrap: true)), + DataCell(Text( + speakerlistt[index] + .speakername + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (_) => + // AffiliationsData())); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + nihgrants.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "NIH Grants", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${nihgrants.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('NIH Center', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Organization Name', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + nihgrants.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${nihgrants[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(nihgrants[index]); + }, + ); + }, + cells: [ + DataCell(Text( + nihgrants[index] + .piNames + .toString(), + softWrap: true)), + DataCell(Text( + nihgrants[index] + .institute + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => NIHShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + procedure.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Procedures", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${procedure.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Program Year', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Procedure', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + procedure.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${procedure[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(procedure[index]); + }, + ); + }, + cells: [ + DataCell(Text( + procedure[index] + .procedure + .toString(), + softWrap: true)), + DataCell(Text( + procedure[index] + .placeOfService + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => ProShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + patent.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Patents", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${patent.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Patent Title', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Status', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + patent.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${patent[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(patent[index]); + }, + ); + }, + cells: [ + DataCell(Text( + patent[index] + .patentTitle + .toString(), + softWrap: true)), + DataCell(Text( + patent[index].status.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => PatentShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), + ], + ), + ); + } + + Future getCount(String form, InteractionProvider provider) async { + await provider.getRecords(); + + return provider.savedList.where((element) => element.form == form).length; + } + + showDeleteRecordAlertDialog( + BuildContext context, String record, SaveInteraction saveInteraction) { + // set up the buttons + ViewInteractionProvider provider = + Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("YES"), + onPressed: () async { + await provider.deleteRecord(saveInteraction).then((value) { + _displaySnackBar("Deleted sucessfully!"); + Navigator.of(context).pop(); + }); + }, + ); + Widget continueButton = TextButton( + child: const Text("NO"), + onPressed: () { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text("Are you sure you want to delete the record $record ?"), + actions: [ + cancelButton, + continueButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } +} diff --git a/lib/contacts_module/ui_screen/events_data.dart b/lib/contacts_module/ui_screen/events_data.dart new file mode 100644 index 0000000..1a23d2d --- /dev/null +++ b/lib/contacts_module/ui_screen/events_data.dart @@ -0,0 +1,117 @@ +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +// import 'package:konectar_events/provider_class/events_provider.dart'; +// import 'package:konectar_events/provider_class/publications_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/events_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class EventsData extends StatefulWidget { +// const EventsData({super.key}); + EventsData({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _EventsDataState(); +} + +class _EventsDataState extends State { + List event_data = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var events = Provider.of(context, listen: false); + await events.geteventdata(widget.text); + final eventlist = events.EventsList; + setState(() { + event_data = eventlist; + }); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Events'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Event Name', + softWrap: true, + style: TextStyle(fontWeight: FontWeight.w600)), + )), + + DataColumn( + label: Expanded( + child: Text('Role', + softWrap: true, + style: + TextStyle(fontWeight: FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + event_data.length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${event_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(event_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + event_data[index]['event_name'].toString(), + softWrap: true)), + + DataCell(Text(event_data[index]['role'].toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/filters_menu.dart b/lib/contacts_module/ui_screen/filters_menu.dart new file mode 100644 index 0000000..cc8fa35 --- /dev/null +++ b/lib/contacts_module/ui_screen/filters_menu.dart @@ -0,0 +1,324 @@ +// import 'package:konectar_events/custom_widget/elevation_btn.dart'; +// import 'package:konectar_events/custom_widget/show_alert.dart'; +import 'package:konectar_events/contacts_module/custom_widget/elevation_btn.dart'; +import 'package:konectar_events/contacts_module/custom_widget/show_alert.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +class Filters extends StatefulWidget { + const Filters({super.key}); + + @override + State createState() => _FiltersState(); +} + +class _FiltersState extends State { + late bool value = true; + + var _selectedItem; + var _selectedItem1; + + Label? selectedColor; + bool shouldDisplay = false; + + double? checkwidth; + + TextEditingController txt1 = TextEditingController(); + TextEditingController txt2 = TextEditingController(); + @override + Widget build(BuildContext context) { + if (MediaQuery.of(context).orientation == Orientation.portrait) { + print("it is Portrait"); + checkwidth = MediaQuery.of(context).size.width * 0.90; + } else { +// is landscape + print("it is landscape"); + checkwidth = MediaQuery.of(context).size.width * 0.95; + } + + return ListView( + children: [ + // DrawerHeader removed + ListTile( + title: Padding( + padding: const EdgeInsets.all(8.0), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + const Icon( + Icons.filter_alt, + size: 30.0, + ), + const Text( + "Filters", + style: TextStyle(fontSize: 18.0, fontWeight: FontWeight.bold), + ), + GestureDetector( + onTap: () { + Navigator.pop(context); + // print("hiii"); + }, + child: const Icon(Icons.cancel)) + ], + ), + ), + ), + + ListTile( + title: Container( + padding: const EdgeInsets.all(10), + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(10), + border: Border.all(color: Colors.grey), + ), + child: DropdownButtonFormField( + decoration: const InputDecoration.collapsed(hintText: ''), + value: _selectedItem, + onChanged: (String? value) { + setState(() { + _selectedItem = value; + }); + }, + items: [ + 'Ivoclar EU Staging', + 'Cardiology', + 'CYTK_EU', + 'Otolaryngology' + ].map>((String value) { + return DropdownMenuItem( + value: value, + child: Text(value), + ); + }).toList(), + hint: const Text('Select an Project Scope'), + isExpanded: true, + ), + ), + ), + ListTile( + title: TextField( + controller: txt1, + decoration: InputDecoration( + prefixIcon: const Icon(Icons.search), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelText: 'Keyword', + isDense: false, + contentPadding: const EdgeInsets.all(3), + ), + ), + ), + ListTile( + title: TextField( + controller: txt2, + decoration: InputDecoration( + prefixIcon: const Icon(Icons.search), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelText: 'Drugs', + isDense: false, + contentPadding: const EdgeInsets.all(3), // Added this + ), + ), + ), + ListTile( + title: Padding( + padding: const EdgeInsets.all(0.0), + child: Container( + padding: const EdgeInsets.all(9.0), + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(10), + border: Border.all(color: Colors.grey), + ), + child: DropdownButtonFormField( + decoration: const InputDecoration.collapsed(hintText: ''), + value: _selectedItem1, + onChanged: (String? value) { + setState(() { + _selectedItem1 = value; + }); + }, + items: ['Tag', 'Specialities', 'Country', 'Region'] + .map>((String value) { + return DropdownMenuItem( + value: value, + child: Text(value), + ); + }).toList(), + hint: const Text('Select an Filter'), + isExpanded: true, + ), + ), + ), + ), + ListTile( + title: SizedBox( + width: checkwidth, + child: DropdownMenu( + // width: MediaQuery.of(context).size.width * 0.95, + // width: MediaQuery.of(context).size.width * 0.90, + width: checkwidth, + + // width: 340.0, + requestFocusOnTap: true, + hintText: "Select text", + enableFilter: true, + onSelected: (color) { + if (color != null) { + setState(() { + // _themeColor =color; + }); + } + }, + inputDecorationTheme: InputDecorationTheme( + isDense: false, + contentPadding: const EdgeInsets.symmetric(horizontal: 10), + constraints: BoxConstraints.tight(const Size.fromHeight(45)), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + ), + // ignore: prefer_const_literals_to_create_immutables + dropdownMenuEntries: >[ + const DropdownMenuEntry( + value: Colors.white, label: 'Cardiovascular Disease'), + const DropdownMenuEntry( + value: Colors.red, label: 'Interventional Cardiology'), + const DropdownMenuEntry( + value: Colors.pinkAccent, label: 'Oncology'), + ], + ), + ), + ), + + ListTile( + title: Padding( + padding: const EdgeInsets.only(left: 40.0, right: 40.0), + child: ElevationBtn( + onPressed: () { + print(_selectedItem); + + print(_selectedItem1); + print(selectedColor); + print("Txt1 : ${txt1.text}"); + print("Txt2 ${txt2.text}"); + // Respond to button press + + if (_selectedItem != null || + selectedColor != null || + txt1.text.isNotEmpty || + txt2.text.isNotEmpty) { + HiveFunctions1.createUser({ + "name": _selectedItem, + "name1": _selectedItem1, + "name2": txt1.text, + "name3": txt2.text + }); + + print("StoredHive datais: ${HiveFunctions1.getAllUsers()}"); + setState(() { + shouldDisplay = !shouldDisplay; + }); + } else { + print("Iam else"); + + showDialog( + context: context, + builder: (_) { + return Alert( + data: "Please select the Filter", + onPressed: () { + Navigator.of(context).pop(); + }, + ); + }); + } + }, + text: "ADD", + color: const Color.fromARGB(255, 0, 71, 132), + textcolor: Colors.white, + ), + ), + ), + + ListView.builder( + shrinkWrap: true, + itemCount: HiveFunctions1.getAllUsers().length, + itemBuilder: (BuildContext context, int index) { + var data = HiveFunctions1.getAllUsers()[index]; + + // return Text("Data_isssss: ${data["name"]}"); + + return ListTile( + title: Center( + child: Padding( + padding: const EdgeInsets.all(8.0), + child: Text(data["name"], + style: const TextStyle( + fontSize: 21.0, fontWeight: FontWeight.bold)), + ), + ), + subtitle: Column( + children: [ + Text(data["name1"], + style: const TextStyle( + fontSize: 18.0, fontWeight: FontWeight.bold)), + Text(data["name2"], + style: const TextStyle( + fontSize: 18.0, fontWeight: FontWeight.bold)), + Text(data["name3"], + style: const TextStyle( + fontSize: 18.0, fontWeight: FontWeight.bold)), + ], + ), + ); + }), + ], + ); + } +} + +String selectCity = ""; +final cityselected = TextEditingController(); +List city = ["hubli", "dvg"]; + +enum Label { + Cardiology('Cardiology'), + Cardiac('Cardiac Surgery'), + Interventional('Interventional Cardiology'), + Cardiovascular('Cardiovascular Disease'); + //grey('Grey'); + + const Label( + this.label, + ); + final String label; +} + +class HiveFunctions1 { + // String userHiveBox="User Box"; + // Box which will use to store the things + static final _contactbox = Hive.box("myfilter"); + + static createUser(Map data) { + print("Dataa_isssss: $data"); + _contactbox.add(data); + } + + static List getAllUsers() { + final data = _contactbox.keys.map((key) { + final value = _contactbox.get(key); + return { + "name": value["name"], + "name1": value["name1"], + "name2": value["name2"], + "name3": value["name3"] + }; + }).toList(); + + return data.reversed.toList(); + } +} diff --git a/lib/contacts_module/ui_screen/horizontal_listview.dart b/lib/contacts_module/ui_screen/horizontal_listview.dart new file mode 100644 index 0000000..7645958 --- /dev/null +++ b/lib/contacts_module/ui_screen/horizontal_listview.dart @@ -0,0 +1,58 @@ +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; + +class HorizontalScrollView extends StatefulWidget { + @override + State createState() => _HorizontalScrollViewState(); +} + +class _HorizontalScrollViewState extends State { + @override + Widget build(BuildContext context) { + return Center( + child: Padding( + padding: const EdgeInsets.all(03.0), + child: Card( + surfaceTintColor: Colors.white, + elevation: 10.0, + child: Column( + children: [ + const Padding( + padding: EdgeInsets.all(10.0), + child: SearchBar( + leading: Icon(Icons.search), + hintText: "Search here", + ), + ), + Expanded( + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: DataTable( + columns: List.generate( + 10, // Number of columns + (index) => DataColumn(label: Text('Column $index')), + ), + rows: List.generate( + 5, // Number of rows + (rowIndex) => DataRow( + cells: List.generate( + 10, // Number of cells in each row + (cellIndex) => DataCell( + Text('Data 21223wewds $rowIndex'), + ), + ), + ), + ), + ), + ), + ), + ), + ], + ), + ), + ), + ); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/NewtworkConnectivity.dart b/lib/contacts_module/ui_screen/interactionform/NewtworkConnectivity.dart new file mode 100644 index 0000000..ba8a199 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/NewtworkConnectivity.dart @@ -0,0 +1,44 @@ +import 'dart:async'; +import 'dart:io'; + +import 'package:connectivity_plus/connectivity_plus.dart'; +import 'package:dio/dio.dart'; +import 'package:flutter/foundation.dart'; + +class NetworkConnectivity { + // Future isInternetAvailable() async { + // var connectivityResult = await (Connectivity().checkConnectivity()); + // return connectivityResult != ConnectivityResult.none; + // } + Future isInternetAvailable() async { + var connectivityResult = await Connectivity().checkConnectivity(); + if (connectivityResult == ConnectivityResult.none) { + return false; + } else { + try { + if (!kIsWeb) { + final result = await InternetAddress.lookup('google.com'); + return true; + } else { + final result = await Dio().get('www.google.com'); + + if (result.statusCode == 200) { + // if (result.isNotEmpty && result[0].rawAddress.isNotEmpty) { + return true; + //} + } + } + // final result = await Dio().get('www.google.com'); + + // if (result.statusCode == 200) { + // // if (result.isNotEmpty && result[0].rawAddress.isNotEmpty) { + // return true; + // //} + // } + return false; + } on SocketException catch (_) { + return false; + } + } + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/configprovider.dart b/lib/contacts_module/ui_screen/interactionform/configprovider.dart new file mode 100644 index 0000000..b6e79d2 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/configprovider.dart @@ -0,0 +1,226 @@ +// import 'package:konectar_events/ui_screen/interactionform/NewtworkConnectivity.dart'; +// import 'package:konectar_events/ui_screen/interactionform/mockapi.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/NewtworkConnectivity.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/mockapi.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:flutter/foundation.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +class ConfigDataProvider extends ChangeNotifier { + Future initConfigUIData() async { + List interactionConfigData = []; + // interactionConfigData = await fetchInteactionConfigData(); + //interactionConfigData = fetchInteactionUIConfigData(jsonResult); + NetworkConnectivity networkConnectivity = NetworkConnectivity(); + bool isOnline = await networkConnectivity.isInternetAvailable(); + + print("Checkonline: $isOnline"); + if (isOnline) { + interactionConfigData = await fetchLocalInteactionConfigData(); + print("interactionConfigData_is $interactionConfigData"); + var box = Hive.box('InteractionConfigDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox( + 'InteractionConfigDataBox'); + } + + if (box.isEmpty) { + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } else { + box.clear(); + print("IamELse"); + + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } + } + notifyListeners(); + } + + Future> fetchLocalInteactionConfigData() async { + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + dynamic jsonResult = await MockApiCall().getConfigData(); + + List interactionConfigData = []; + + ResponseData responseData = ResponseDataFromJson(jsonResult); + print('Response_data_is: $responseData'); + print('Response_data_dta_is: ${responseData.data}'); + + for (InteractionResultData obj in responseData.data) { + interactionConfigData + .add(InteractionConfigData(widgets: obj, id: obj.id, name: obj.name)); + } + print("interactionConfigData_issss: ${interactionConfigData.length}"); + return interactionConfigData; + } + + //pooja + + Future initConfigUIData123() async { + List interactionConfigData = []; + // interactionConfigData = await fetchInteactionConfigData(); + //interactionConfigData = fetchInteactionUIConfigData(jsonResult); + NetworkConnectivity networkConnectivity = NetworkConnectivity(); + bool isOnline = await networkConnectivity.isInternetAvailable(); + if (isOnline) { + interactionConfigData = await fetchLocalInteactionConfigData123(); + var box = Hive.box('InteractionConfigDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox( + 'InteractionConfigDataBox'); + } + + if (box.isEmpty) { + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } else { + box.clear(); + print("IamELse"); + + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } + } + notifyListeners(); + } + + Future> + fetchLocalInteactionConfigData123() async { + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + dynamic jsonResult = await MockApiCall().getConfigData123(); + + List interactionConfigData = []; + + ResponseData responseData = ResponseDataFromJson(jsonResult); + print('Response_data_is: $responseData'); + print('Response_data_dta_is: ${responseData.data}'); + + for (InteractionResultData obj in responseData.data) { + interactionConfigData + .add(InteractionConfigData(widgets: obj, id: obj.id, name: obj.name)); + } + print("interactionConfigData_issss: ${interactionConfigData.length}"); + return interactionConfigData; + } + + Future initConfigUIDataMedical() async { + List interactionConfigData = []; + // interactionConfigData = await fetchInteactionConfigData(); + //interactionConfigData = fetchInteactionUIConfigData(jsonResult); + + NetworkConnectivity networkConnectivity = NetworkConnectivity(); + bool isOnline = await networkConnectivity.isInternetAvailable(); + if (isOnline) { + // if (await InternetConnectionChecker().hasConnection) { + interactionConfigData = await fetchLocalInteactionConfigDataMedical(); + var box = Hive.box('InteractionConfigDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox( + 'InteractionConfigDataBox'); + } + + if (box.isEmpty) { + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } else { + box.clear(); + print("IamELse"); + + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } + } + notifyListeners(); + } + + Future> + fetchLocalInteactionConfigDataMedical() async { + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + dynamic jsonResult = await MockApiCall().getConfigDataMedical(); + + List interactionConfigData = []; + + ResponseData responseData = ResponseDataFromJson(jsonResult); + print('Response_data_is: $responseData'); + print('Response_data_dta_is: ${responseData.data}'); + + for (InteractionResultData obj in responseData.data) { + interactionConfigData + .add(InteractionConfigData(widgets: obj, id: obj.id, name: obj.name)); + } + print("interactionConfigData_issss: ${interactionConfigData.length}"); + return interactionConfigData; + } + + Future initConfigUIDataEng() async { + List interactionConfigData = []; + // interactionConfigData = await fetchInteactionConfigData(); + //interactionConfigData = fetchInteactionUIConfigData(jsonResult); + // if (await InternetConnectionChecker().hasConnection) { + + NetworkConnectivity networkConnectivity = NetworkConnectivity(); + bool isOnline = await networkConnectivity.isInternetAvailable(); + if (isOnline) { + interactionConfigData = await fetchLocalInteactionConfigDataEng(); + var box = Hive.box('InteractionConfigDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox( + 'InteractionConfigDataBox'); + } + + if (box.isEmpty) { + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } else { + box.clear(); + print("IamELse"); + + for (InteractionConfigData data in interactionConfigData) { + box.put(await getNextAutoIncrementValue(), data); + } + } + } + notifyListeners(); + } + + Future> + fetchLocalInteactionConfigDataEng() async { + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + dynamic jsonResult = await MockApiCall().getConfigDataEng(); + + List interactionConfigData = []; + + ResponseData responseData = ResponseDataFromJson(jsonResult); + print('Response_data_is: $responseData'); + print('Response_data_dta_is: ${responseData.data}'); + + for (InteractionResultData obj in responseData.data) { + interactionConfigData + .add(InteractionConfigData(widgets: obj, id: obj.id, name: obj.name)); + } + print("interactionConfigData_issss: ${interactionConfigData.length}"); + return interactionConfigData; + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/edit_interaction_screen.dart b/lib/contacts_module/ui_screen/interactionform/edit_interaction_screen.dart new file mode 100644 index 0000000..fa91180 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/edit_interaction_screen.dart @@ -0,0 +1,3287 @@ +import 'dart:convert'; +import 'dart:io'; + +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/textScalar.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/services.dart'; +import 'package:intl/intl.dart'; +import 'package:path_provider/path_provider.dart'; +import 'package:provider/provider.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; +// import 'package:pwa_ios/main.dart'; +// import 'package:pwa_ios/model/interaction_data.dart'; +// import 'package:pwa_ios/model/save_interaction.dart'; +// import 'package:pwa_ios/utils/util.dart'; +// import 'package:pwa_ios/viewmodel/viewinteractionprovider.dart'; +import 'package:permission_handler/permission_handler.dart'; +// import 'package:pwa_ios/widgets/custombutton.dart'; +// import 'package:pwa_ios/widgets/customrangeslider.dart'; +// import 'package:pwa_ios/widgets/interatciontextfield.dart'; +import 'package:file_picker/file_picker.dart'; +// import 'package:pwa_ios/widgets/responsive_ext.dart'; +import 'package:path/path.dart' as p; + +class EditInteractionScreen extends StatefulWidget { + // int index; + // String form; + SaveInteraction saveInteraction; + EditInteractionScreen( + {super.key, + // required this.index, + // required this.form, + required this.saveInteraction}); + + @override + State createState() => _EditInteractionScreenState(); +} + +class _EditInteractionScreenState extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + + @override + void dispose() { + super.dispose(); + + // WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // Provider.of(context, listen: false).dispose(); + // }); + } + + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // initConfig(); + // if (mytimer!.isActive) { + // cancelTimer(); + // } + init(); + }); + + super.initState(); + } + + initConfig() async { + // await Provider.of(context, listen: false) + // .init(widget.index); + await Provider.of(context, listen: false) + .initConfigData(); + + // setState(() {}); + } + + init() async { + // await Provider.of(context, listen: false) + // .init(widget.index); + + await Provider.of(context, listen: false) + .initSavedForm(widget.saveInteraction); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + // print("build context"); + // print("Providerr_is: ${provider.multipletextEditingControllerList}"); + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + backgroundColor: Colors.white, + appBar: AppBar( + title: Text( + widget.saveInteraction.id, + style: TextStyle( + fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + // backgroundColor: const Color(0xFF2b9af3), + automaticallyImplyLeading: false, + actions: [saveActions(provider)], + leading: InkWell( + onTap: () async { + await provider.disposeValues().then((value) { + Navigator.pop(context); + }); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + mainAxisSize: MainAxisSize.min, + children: [ + Expanded( + child: ListView.builder( + itemCount: provider.interactionReponseList.length, + padding: EdgeInsets.zero, + cacheExtent: double.parse( + provider.interactionReponseList.length.toString()), + itemBuilder: (context, index) { + var item = provider.interactionReponseList[index]; + sectionList = item.sectionList; + return Container( + //elevation: 4, + // shape: RoundedRectangleBorder( + // borderRadius: BorderRadius.circular(0.0), + // ), + color: Constants.k2color, + child: ExpansionTile( + maintainState: true, + // backgroundColor: Colors.white, + backgroundColor: Constants.k2color, + + // collapsedBackgroundColor: Color(0xFF2b9af3), + initiallyExpanded: true, + title: Stack( + alignment: AlignmentDirectional.center, + children: [ + Container( + // height: double.infinity, + width: double.infinity, + padding: const EdgeInsets.all(0.0), + decoration: BoxDecoration( + // color: Color(0xFF2b9af3), + color: Constants.k2color), + child: Text( + item.sectionName, + style: const TextStyle( + color: Colors.white, + fontWeight: FontWeight.bold, + fontSize: 18.0), + )), + item.multiple + ? Align( + alignment: Alignment.centerRight, + child: IconButton( + onPressed: () { + provider.getSectionItem( + item.sectionName); + // print("index is $listIndex"); + setState(() { + // for (var item + }); + }, + icon: const Icon( + Icons.add_circle_outline, + size: 30, + color: Colors.white, + ), + ), + ) + : const SizedBox.shrink() + ]), + children: [ + Container( + color: Colors.white, + child: Padding( + padding: const EdgeInsets.only(top: 8.0), + child: Column( + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + GridView.count( + physics: + const NeverScrollableScrollPhysics(), + // crossAxisCount: + // context.responsive( + // 1, + // sm: 1, // small + // md: 1, // medium + // lg: sectionList.length == 1 + // ? 1 + // : 4, // large + // xl: 3, // extra large screen + // ), + crossAxisCount: + context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || + !isTablet + ? 1 + : 3.5, + shrinkWrap: true, + padding: EdgeInsets.zero, + + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation + .landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.5, + children: List.generate( + sectionList.length, + (i) { + // print(sectionList); + SectionList sectionItem = + sectionList[i]; + dropdownvalue = + sectionItem.widget == + InteractionWidget + .DROPDOWN + ? sectionItem.value ?? + "Select" + : ' '; + List< + InputClass> list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem.widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget + .MULTISELECT + ? provider + .getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == + InteractionWidget + .CHECKBOX + ? provider.getData2( + sectionItem) + : []; + + return Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem.input == + 'add' + ? const SizedBox + .shrink() + : Padding( + padding: + const EdgeInsets + .only( + left: 8.0, + right: 8.0), + // child: Text( + // '${sectionItem.name}:*', + // style: TextStyle( + // color: Colors + // .orange + // .shade800, + // fontSize: + // isTablet + // ? 18 + // : 12, + // ), + // ), + child: Text( + sectionItem + .isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: TextStyle( + color: Colors + .orange + .shade800, + fontSize: 18.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + ), + ), + // SizedBox( + // height: + // isTablet ? 15 : 5, + // ), + returnWidget( + sectionItem: + sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: index, + widgetData: + sectionItem.widget!, + multiple: false), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + ], + ); + }, + ), + ), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + index) + : const SizedBox.shrink(), + provider.interactionReponseList + .length == + index - 1 + ? saveActions(provider) + : const SizedBox.shrink() + //const Spacer(), + ], + ), + ), + ), + ]), + ); + }, + ), + ), + // const Spacer(), + // saveActions(provider), + ], + )), + ); + }), + ); + }); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required ViewInteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + required bool multiple, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? customMultiselectDropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + + case InteractionWidget.AUTOCOMPLETE: + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + + case InteractionWidget.MULTISELECT: + return customMultiselectDropdown(sectionItem, provider, list, multiple); + + case InteractionWidget.RADIO: + print("Radiiooooo"); + return (sectionItem.inputList!.length >= 5) + ? customdropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildRadio(sectionItem, provider); + + case InteractionWidget.LABEL: + return Text(sectionItem.input!); + + case InteractionWidget.RANGESLIDER: + return CustomRangeSlider( + sliderPos: sectionItem.selectedValue!.isNotEmpty + ? double.parse(sectionItem.selectedValue!.last.toString()) + : 10.0, + onChanged: (val) { + setState(() { + sectionItem.selectedValue = []; + sectionItem.selectedId = val.toString(); + sectionItem.selectedValue!.add(val.toInt()); + }); + }, + ); + + case InteractionWidget.BUTTON: + return sectionItem.input == 'add' + ? const Offstage( + offstage: true, + child: Text("Visible"), + ) + : Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB(255, 233, 229, 229), + onPressed: () async { + if (sectionItem.selectedValue!.isNotEmpty) { + showFilesAlertDialog(context, + sectionItem.fileName!.join(','), sectionItem); + } else { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + } + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? 'File Uploaded' + : 'No file uploaded', + style: TextStyle( + color: sectionItem.selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ); + + case InteractionWidget.TEXT: + return sectionItem.input == 'Date' + ? buildDateWidget(sectionItem) + : sectionItem.input == "textArea" + ? Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: InteractionTextField( + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + // maxlines: 4, + // minlines: 3, + onChanged: (val) { + sectionItem.selectedValue = []; + setState(() {}); + + sectionItem.selectedValue!.add(val); + }, + ), + ), + ) + : Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + height: isTablet ? 50 : 40, + child: InteractionTextField( + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + inputType: sectionItem.input == "number" + ? TextInputType.number + : TextInputType.name, + labelText: sectionItem.name, + onChanged: (val) { + sectionItem.selectedValue = []; + provider.setTextValue(val, sectionItem, multiple); + }, + ), + ), + ), + ); + case InteractionWidget.DROPDOWN: + // return customdropdown(sectionItem, provider, list, multiple); + + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + } + } + + Widget buildDateWidget(SectionList sectionItem) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + // height: isTablet ? 50 : 40, + child: TextField( + controller: + sectionItem.controller, //editing controller of this TextField + decoration: InputDecoration( + // border: OutlineInputBorder(), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelStyle: const TextStyle(fontSize: 16), + suffixIcon: const Icon(Icons.calendar_today), //icon of text field + labelText: "Enter Date" //label text of field + ), + readOnly: true, //set it true, so that user will not able to edit text + onTap: () async { + DateTime? pickedDate = await showDatePicker( + context: context, + initialDate: DateTime.now(), + firstDate: DateTime( + 2000), //DateTime.now() - not to allow to choose before today. + lastDate: DateTime(2101)); + + if (pickedDate != null) { + print( + pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 + String formattedDate = + DateFormat('yyyy-MM-dd').format(pickedDate); + print( + formattedDate); //formatted date output using intl package => 2021-03-16 + //you can implement different kind of Date Format here according to your requirement + + setState(() { + sectionItem.controller!.text = formattedDate; + sectionItem.selectedValue = []; + sectionItem.selectedValue! + .add(formattedDate); //set output date to TextField value. + }); + } else { + print("Date is not selected"); + } + }, + ), + ), + ); + } + + Widget saveActions(ViewInteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + Padding( + //padding: const EdgeInsets.all(4.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + child: CustomButton( + backgroundColor: Colors.green.shade500, + onPressed: () async { + // if (textFieldsValidation(provider).isEmpty) { + await provider.saveJsonObject(context, + widget.saveInteraction.intId, widget.saveInteraction); + + // showAlertDialog(context, widget.saveInteraction.id); + + print("Validation_isss: ${provider.isLoading}"); + + if (provider.isLoading == false) { + print("Validation_false"); + showAlertDialog1(context, "Please fill all the fields"); + } else { + showAlertDialog(context, widget.saveInteraction.id); + print("Validation_True"); + } + // } else { + // _displaySnackBar(textFieldsValidation(provider)); + // } + }, + textColor: Colors.white, + title: "Update", + // height: 40, + // width: isTablet ? 120 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget buildRadio(SectionList sectionItem, ViewInteractionProvider provider) { + List list = provider.getData2(sectionItem); + // .map((itemWord) => InputClass.fromJson(itemWord)) + // .toList(); + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 250 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (InputClass value in list) + Row( + children: [ + Radio( + value: value.name, + activeColor: Colors.black, + groupValue: provider.radioValue, + onChanged: (String? value) { + setState(() { + // print(value); + provider.radioValue = value!; + int index = + list.indexWhere((element) => element.name == value); + sectionItem.selectedValue!.add(list[index].id); + }); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget buildCheckbox(SectionList sectionItem, String sectionName, + ViewInteractionProvider provider, bool multiple) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: 250, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (var value in provider.checkboxlist) + Row( + children: [ + CheckboxListTile( + dense: true, + value: value.ischecked ?? false, + activeColor: Colors.black, + checkColor: Colors.white, + onChanged: (bool? newvalue) { + value.ischecked = newvalue!; + provider.setcheckBoxValue(sectionItem, sectionName, + newvalue, value.id, multiple); + //setState(() {}); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget customdropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + // sectionItem.value = ''; + // print("%%%%${sectionItem.selectedValue!.last}"); + print("ItemList_is: $list"); + if (list.isEmpty) { + print("###list empty###"); + list = []; + InputClass inputClass = + InputClass(id: "no value", name: "Select ${sectionItem.name}"); + list.add(inputClass); + sectionItem.selectedObject = list[0]; + } + // InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + isDense: true, + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select ${sectionItem.name}', + style: const TextStyle(fontSize: 14), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedValue!.isNotEmpty + ? list[list.indexWhere( + (element) => element.id == sectionItem.selectedValue!.last, + )] + : list[0], + // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) + // sectionItem.value ?? list[0].name, + validator: (value) { + if (value == null) { + return 'Please select ${sectionItem.name}'; + } + return null; + }, + onChanged: (value) { + //Do something when selected item is changed. + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple, value); + print("selected ${sectionItem.value}"); + // setState(() {}); + }, + onSaved: (value) { + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple, value); + // setState(() {}); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(right: 8), + ), + iconStyleData: const IconStyleData( + icon: Icon( + Icons.arrow_drop_down, + color: Colors.black45, + ), + iconSize: 24, + ), + dropdownStyleData: DropdownStyleData( + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(15), + ), + ), + menuItemStyleData: const MenuItemStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + ), + ), + ), + ); + } + + Widget customAutoCompletedropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + // sectionItem.value = list[0].name; + if (list.isEmpty) { + list = sectionItem.inputList!; + } + //InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Item', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject, + onSaved: (value) { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onChanged: (value) { + // setState(() { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + // setState(() {}); + //}); + }, + + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 40, + width: 200, + ), + dropdownStyleData: const DropdownStyleData( + maxHeight: 200, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + padding: const EdgeInsets.only( + top: 8, + bottom: 4, + right: 8, + left: 8, + ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + return item.value!.name.toString().contains(searchValue); + }, + ), + //This to clear the search value when you close the menu + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + ), + ), + ), + ); + } + + Widget customMultiselectDropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + if (list.isEmpty) { + list = sectionItem.inputList!; + } + InputClass selectedObj = list[0]; + + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + isDense: true, + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Items', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list.map((item) { + return DropdownMenuItem( + value: item, + //disable default onTap to avoid closing menu when selecting an item + enabled: false, + child: StatefulBuilder( + builder: (context, menuSetState) { + final isSelected = + sectionItem.selectedValue!.contains(item.name); + return InkWell( + onTap: () { + isSelected + ? sectionItem.selectedValue!.remove(item.name) + : sectionItem.selectedValue!.add(item.name); + //This rebuilds the StatefulWidget to update the button's text + setState(() {}); + //This rebuilds the dropdownMenu Widget to update the check mark + menuSetState(() {}); + }, + child: Container( + height: double.infinity, + padding: const EdgeInsets.symmetric(horizontal: 16.0), + child: Row( + children: [ + if (isSelected) + const Icon(Icons.check_box_outlined) + else + const Icon(Icons.check_box_outline_blank), + const SizedBox(width: 16), + Expanded( + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + ), + ], + ), + ), + ); + }, + ), + ); + }).toList(), + //Use last selected item as the current value so if we've limited menu height, it scroll to last item. + value: selectedObj, + // ? null + // : provider.selectedItems.last, + onChanged: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onSaved: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + selectedItemBuilder: (context) { + return list.map( + (item) { + return Container( + alignment: AlignmentDirectional.center, + child: Text( + sectionItem.selectedValue!.join(', '), + style: const TextStyle( + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + maxLines: 1, + ), + ); + }, + ).toList(); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(left: 16, right: 8), + height: 40, + width: 140, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + padding: EdgeInsets.zero, + ), + ), + ), + ), + ); + } + + // Widget gridViewWidget( + // ViewInteractionProvider provider, + // String sectionName, + // List sectionList, + // Orientation orientation, + // FormFieldData item, + // int listIndex) { + // print("SectionListtt:isss: $sectionList"); + // return Padding( + // padding: isTablet + // ? const EdgeInsets.only(left: 8.0) + // : const EdgeInsets.only(left: 12.0, right: 12.0), + // child: GridView.count( + // physics: const NeverScrollableScrollPhysics(), + // crossAxisCount: context.responsive( + // 1, // default + // sm: 1, // small + // md: 1, // medium + // lg: sectionList.length == 1 ? 1 : 4, // large + // xl: 5, // extra large screen + // ), + // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, + // shrinkWrap: true, + // padding: EdgeInsets.zero, + // childAspectRatio: sectionList.length == 1 || !isTablet + // ? orientation == Orientation.landscape + // ? 10 + // : 4.2 + // : 1.8, + // children: List.generate( + // sectionList.length, + // (i) { + // // print(sectionList); + // SectionList sectionItem = sectionList[i]; + // dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN + // ? sectionItem.value ?? "Select" + // : ' '; + // List list = + // sectionItem.widget == InteractionWidget.DROPDOWN || + // sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + // sectionItem.widget == InteractionWidget.MULTISELECT + // ? provider.getData2(sectionItem) + // : []; + // provider.checkboxlist = + // sectionItem.widget == InteractionWidget.CHECKBOX + // ? provider.getData2(sectionItem) + // : []; + + // return Wrap(children: [ + // Column( + // crossAxisAlignment: CrossAxisAlignment.start, + // children: [ + // sectionItem.widget == InteractionWidget.BUTTON && + // sectionItem.param == 'add' || + // sectionItem.param == 'deletebtn' + // ? const SizedBox.shrink() + // : Text( + // '${sectionItem.name}:*', + // style: TextStyle( + // color: Colors.orange.shade800, + // fontSize: isTablet ? 18 : 14, + // ), + // ), + // const SizedBox( + // height: 15, + // ), + // sectionItem.widget == InteractionWidget.BUTTON + // ? sectionItem.input == 'chooseFile' + // ? Row( + // children: [ + // CustomButton( + // backgroundColor: const Color.fromARGB( + // 255, 233, 229, 229), + // onPressed: () async { + // if (sectionItem + // .selectedValue!.isNotEmpty) { + // showFilesAlertDialog( + // context, + // sectionItem.fileName!.join(','), + // sectionItem); + // } else { + // sectionItem.selectedValue = []; + // sectionItem.extension = []; + // sectionItem.fileName = []; + // await getEncodedFile(sectionItem); + // } + // setState(() {}); + // }, + // width: 120, + // height: 40, + // fontsize: 12, + // textColor: Colors.black, + // title: sectionItem.name), + // const SizedBox( + // width: 5, + // ), + // Text( + // sectionItem.selectedValue!.isNotEmpty + // ? 'File uploaded' + // : 'No file uploaded', + // style: TextStyle( + // color: + // sectionItem.selectedValue!.isNotEmpty + // ? Colors.green + // : Colors.red), + // ), + // ], + // ) + // : isTablet + // ? IconButton( + // onPressed: () { + // provider.deleteMultipleRows( + // sectionItem.gid!, + // sectionList[i], + // sectionName); + + // setState(() {}); + // }, + // icon: const Icon( + // Icons.cancel, + // size: 30, + // color: Color.fromARGB(255, 8, 39, 92), + // ), + // ) + // : Padding( + // padding: + // const EdgeInsets.only(left: 3.0, top: 5), + // child: CustomButton( + // backgroundColor: const Color.fromARGB( + // 255, 233, 75, 75), + // onPressed: () { + // provider.deleteMultipleRows( + // sectionItem.gid!, + // sectionList[i], + // sectionName); + + // setState(() {}); + // }, + // width: 80, + // height: 30, + // fontsize: 12, + // textColor: Colors.white, + // title: "Delete"), + // ) + // : returnWidget( + // sectionItem: sectionItem, + // item: item, + // provider: provider, + // list: list, + // gridIndex: i, + // listIndex: listIndex, + // widgetData: sectionItem.widget!, + // multiple: true), + // ], + // ), + // ]); + // }, + // ), + // ), + // ); + // } + + Widget gridViewWidget( + ViewInteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + print("SectionListtt:isss: $sectionList"); + + List pooja = sectionList; + + print("Pooja: $pooja"); + + List> convertedArray = []; + print("Provider Length: ${item.sectionList.length}"); + + for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { + print("Section List11111: $sectionList"); + print("item.sectionList.length List11111: ${item.sectionList.length}"); + + convertedArray + .add(sectionList.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArrayEditMulti.leangth: $convertedArray"); + print("ConvertedArray.leangth: ${convertedArray.length}"); + return Column( + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: Wrap( + children: [ + //GestureDetector(child: Text("data")), + GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : (sectionList.length >= 1 ? 3 : 3), // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || !isTablet ? 1 : 2, + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.0, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = + sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = + sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == + InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + + return SizedBox( + height: MediaQuery.of(context).size.height, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + sectionItem.widget == InteractionWidget.BUTTON && + sectionItem.param == 'add' || + sectionItem.param == 'deletebtn' + ? const SizedBox.shrink() + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: Text( + sectionItem.isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: TextStyle( + color: Colors.orange.shade800, + fontSize: 18.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + )), + const SizedBox( + height: 15, + ), + sectionItem.widget == InteractionWidget.BUTTON + ? sectionItem.input == 'chooseFile' + ? Row( + children: [ + CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 229, 229), + onPressed: () async { + if (sectionItem.selectedValue! + .isNotEmpty) { + showFilesAlertDialog( + context, + sectionItem.fileName! + .join(','), + sectionItem); + } else { + sectionItem.selectedValue = + []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile( + sectionItem); + } + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem + .selectedValue!.isNotEmpty + ? 'File uploaded' + : 'No file uploaded', + style: TextStyle( + color: sectionItem + .selectedValue! + .isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ) + : isTablet + ? IconButton( + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + icon: const Icon( + Icons.cancel, + size: 30, + color: Color.fromARGB( + 255, 8, 39, 92), + ), + ) + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 75, 75), + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + // width: 80, + // height: 30, + height: 40, + fontsize: 12, + textColor: Colors.white, + title: "Delete"), + ) + : returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!, + multiple: true), + ], + ), + ); + }), + ], + ), + ), + ], + ); + } + + // String textFieldsValidation(ViewInteractionProvider provider) { + // if (provider.sectionList + // .any((element) => element.controller!.text.isEmpty)) { + // return 'Fields cannot be empty'; + // } + // if (provider.textEditingControllerList.isNotEmpty) { + // if (provider.validateTextFields()) { + // return 'Fields cannot be empty'; + // } + // } + // if (provider.multipletextEditingControllerList.isNotEmpty) { + // if (provider.validateMultipleRows()) { + // return 'Fields cannot be empty'; + // } + // } + + // return ''; + // } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } + + Future getEncodedFile(SectionList sectionItem) async { + String base64Image = ''; + var status = Platform.isAndroid + ? await Permission.manageExternalStorage.status + : await Permission.storage.status; + if (status.isGranted) { + FilePickerResult? result = + await FilePicker.platform.pickFiles(allowMultiple: true); + + if (result != null) { + print(result.files.first.path); + print(result.files.last.path); + for (var files in result.files) { + File file = File(files.path!); + print("check file path : ${file.path}"); + fileName = file.path.split('/').last; + // Get the application folder directory + Directory? directory = Platform.isAndroid + ? await getExternalStorageDirectory() //FOR ANDROID + : await getApplicationDocumentsDirectory(); + String newPath = ""; //FOR ios + String convertedDirectoryPath = (directory?.path).toString(); + + print("see the converted directory path $convertedDirectoryPath"); + + newPath = "$convertedDirectoryPath/konectar/files"; + print("new path :$newPath"); + directory = Directory(newPath); + if (!await directory.exists()) { + await directory.create(recursive: true); + } + File newFile = await file.copy('${directory.path}/$fileName'); + print("new path is ${newFile.path}"); + final extension = p.extension(newFile.path); + List imageBytes = await newFile.readAsBytes(); + Uint8List imageUint8List = Uint8List.fromList(imageBytes); + base64Image = base64Encode(imageUint8List); + sectionItem.selectedValue!.add(base64Image); + sectionItem.extension!.add(extension); + sectionItem.fileName!.add(fileName); + } + } + } else { + print("not permitted"); + await requestPermission(Platform.isAndroid + ? Permission.manageExternalStorage + : Permission.storage); + } + } + + Future requestPermission(Permission permission) async { + final status = await permission.request(); + + setState(() { + print(status); + }); + } + + showAlertDialog(BuildContext context, String record) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text("Form $record Updated Successfully!"), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showAlertDialog1(BuildContext context, String record) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showFilesAlertDialog( + BuildContext context, String files, SectionList sectionItem) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Upload"), + onPressed: () async { + Navigator.of(context).pop(); + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + }, + ); + Widget okButton = TextButton( + child: const Text("Cancel"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text( + "Following File(s) $files uploaded .Do you still want to upload files ?", + style: const TextStyle(fontSize: 15), + ), + actions: [cancelButton, okButton], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } +} + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +//import 'dart:convert'; +// import 'dart:io'; + +// import 'package:discover_module/constants.dart'; +// import 'package:discover_module/textScalar.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/responsive_ext.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/services.dart'; +// import 'package:intl/intl.dart'; +// import 'package:path_provider/path_provider.dart'; +// import 'package:provider/provider.dart'; +// import 'package:dropdown_button2/dropdown_button2.dart'; +// // import 'package:pwa_ios/main.dart'; +// // import 'package:pwa_ios/model/interaction_data.dart'; +// // import 'package:pwa_ios/model/save_interaction.dart'; +// // import 'package:pwa_ios/utils/util.dart'; +// // import 'package:pwa_ios/viewmodel/viewinteractionprovider.dart'; +// import 'package:permission_handler/permission_handler.dart'; +// // import 'package:pwa_ios/widgets/custombutton.dart'; +// // import 'package:pwa_ios/widgets/customrangeslider.dart'; +// // import 'package:pwa_ios/widgets/interatciontextfield.dart'; +// import 'package:file_picker/file_picker.dart'; +// // import 'package:pwa_ios/widgets/responsive_ext.dart'; +// import 'package:path/path.dart' as p; + +// class EditInteractionScreen extends StatefulWidget { +// // int index; +// // String form; +// SaveInteraction saveInteraction; +// EditInteractionScreen( +// {super.key, +// // required this.index, +// // required this.form, +// required this.saveInteraction}); + +// @override +// State createState() => _EditInteractionScreenState(); +// } + +// class _EditInteractionScreenState extends State { +// List interactionReponseList = []; +// List sectionList = []; +// List textEditingControllerList = []; +// int textfieldIndex = 0; +// String dropdownvalue = 'Select value'; +// String? fileName; +// final TextEditingController textEditingController = TextEditingController(); + +// @override +// void dispose() { +// super.dispose(); + +// // WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// // Provider.of(context, listen: false).dispose(); +// // }); +// } + +// @override +// void initState() { +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// // initConfig(); +// // if (mytimer!.isActive) { +// // cancelTimer(); +// // } +// init(); +// }); + +// super.initState(); +// } + +// initConfig() async { +// // await Provider.of(context, listen: false) +// // .init(widget.index); +// await Provider.of(context, listen: false) +// .initConfigData(); + +// // setState(() {}); +// } + +// init() async { +// // await Provider.of(context, listen: false) +// // .init(widget.index); + +// await Provider.of(context, listen: false) +// .initSavedForm(widget.saveInteraction); +// setState(() {}); +// } + +// @override +// Widget build(BuildContext context) { +// return Consumer( +// builder: (BuildContext context, provider, Widget? child) { +// // print("build context"); +// // print("Providerr_is: ${provider.multipletextEditingControllerList}"); +// return GestureDetector( +// onTap: () { +// FocusScope.of(context).requestFocus(FocusNode()); +// }, +// child: OrientationBuilder(builder: (context, orientation) { +// return SafeArea( +// child: Scaffold( +// //resizeToAvoidBottomInset: false, +// appBar: AppBar( +// title: Text( +// widget.saveInteraction.id, +// style: TextStyle( +// fontSize: isTablet ? 22 : 14, color: Colors.white), +// ), +// // backgroundColor: const Color(0xFF2b9af3), +// automaticallyImplyLeading: false, +// actions: [saveActions(provider)], +// leading: InkWell( +// onTap: () async { +// await provider.disposeValues().then((value) { +// Navigator.pop(context); +// }); +// }, +// child: const Icon( +// Icons.arrow_back_ios, +// color: Colors.white, +// ), +// ), +// ), +// body: Column( +// children: [ +// Expanded( +// child: ListView.builder( +// itemCount: provider.interactionReponseList.length, +// padding: EdgeInsets.zero, +// cacheExtent: double.parse( +// provider.interactionReponseList.length.toString()), +// itemBuilder: (context, index) { +// var item = provider.interactionReponseList[index]; +// sectionList = item.sectionList; +// return Card( +// child: ExpansionTile( +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// initiallyExpanded: true, +// title: Stack( +// alignment: AlignmentDirectional.center, +// children: [ +// Container( +// // height: double.infinity, +// width: double.infinity, +// padding: const EdgeInsets.all(8.0), +// decoration: BoxDecoration( +// // color: Color(0xFF2b9af3), +// color: Constants.k2color), +// child: Text( +// item.sectionName, +// style: const TextStyle( +// color: Colors.white, +// fontWeight: FontWeight.bold, +// fontSize: 18.0), +// )), +// item.multiple +// ? Align( +// alignment: Alignment.centerRight, +// child: IconButton( +// onPressed: () { +// provider.getSectionItem( +// item.sectionName); +// // print("index is $listIndex"); +// setState(() { +// // for (var item +// }); +// }, +// icon: const Icon( +// Icons.add_circle_outline, +// size: 30, +// color: Colors.white, +// ), +// ), +// ) +// : const SizedBox.shrink() +// ]), +// children: [ +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: Column( +// crossAxisAlignment: +// CrossAxisAlignment.center, +// children: [ +// const SizedBox( +// height: 20, +// ), + +// Padding( +// padding: isTablet +// ? const EdgeInsets.only( +// left: 14.0) +// : const EdgeInsets.only( +// left: 12.0, right: 12.0), +// child: GridView.count( +// physics: +// const NeverScrollableScrollPhysics(), +// // crossAxisCount: +// // context.responsive( +// // 1, +// // sm: 1, // small +// // md: 1, // medium +// // lg: sectionList.length == 1 +// // ? 1 +// // : 4, // large +// // xl: 3, // extra large screen +// // ), +// crossAxisCount: +// context.responsive( +// 1, +// sm: 1, // small +// md: 2, // medium +// lg: sectionList.length == 1 +// ? 1 +// : 3, // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: +// sectionList.length == 1 || +// !isTablet +// ? 1 +// : 3.5, +// shrinkWrap: true, +// padding: EdgeInsets.zero, + +// childAspectRatio: +// sectionList.length == 1 +// ? orientation == +// Orientation +// .landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.5, +// children: List.generate( +// sectionList.length, +// (i) { +// // print(sectionList); +// SectionList sectionItem = +// sectionList[i]; +// dropdownvalue = +// sectionItem.widget == +// InteractionWidget +// .DROPDOWN +// ? sectionItem.value ?? +// "Select" +// : ' '; +// List< +// InputClass> list = sectionItem +// .widget == +// InteractionWidget +// .DROPDOWN || +// sectionItem.widget == +// InteractionWidget +// .AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget +// .MULTISELECT +// ? provider +// .getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == +// InteractionWidget +// .CHECKBOX +// ? provider.getData2( +// sectionItem) +// : []; + +// return Column( +// crossAxisAlignment: +// CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == +// InteractionWidget +// .BUTTON && +// sectionItem.input == +// 'add' +// ? const SizedBox +// .shrink() +// : Padding( +// padding: +// const EdgeInsets +// .only( +// left: 8.0, +// right: 8.0), +// // child: Text( +// // '${sectionItem.name}:*', +// // style: TextStyle( +// // color: Colors +// // .orange +// // .shade800, +// // fontSize: +// // isTablet +// // ? 18 +// // : 12, +// // ), +// // ), +// child: Text( +// sectionItem +// .isRequired +// ? '${sectionItem.name}:*' +// : '${sectionItem.name}:', +// style: TextStyle( +// color: Colors +// .orange +// .shade800, +// fontSize: 18.0, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// ), +// ), +// ), +// SizedBox( +// height: isTablet ? 15 : 5, +// ), +// returnWidget( +// sectionItem: +// sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: index, +// widgetData: +// sectionItem.widget!, +// multiple: false), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), +// ], +// ); +// }, +// ), +// ), +// ), +// SizedBox( +// height: isTablet ? 15 : 5, +// ), +// item.multiple +// ? gridViewWidget( +// provider, +// item.sectionName, +// item.multipleList ?? [], +// orientation, +// item, +// index) +// : const SizedBox.shrink(), +// provider.interactionReponseList +// .length == +// index - 1 +// ? saveActions(provider) +// : const SizedBox.shrink() +// //const Spacer(), +// ], +// ), +// ), +// ]), +// ); +// }, +// ), +// ), +// // const Spacer(), +// // saveActions(provider), +// ], +// )), +// ); +// }), +// ); +// }); +// } + +// Widget returnWidget({ +// required SectionList sectionItem, +// required FormFieldData item, +// required ViewInteractionProvider provider, +// required List list, +// required int gridIndex, +// required int listIndex, +// required InteractionWidget widgetData, +// required bool multiple, +// }) { +// switch (widgetData) { +// case InteractionWidget.CHECKBOX: +// return (sectionItem.inputList!.length >= 5) +// ? customMultiselectDropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + +// case InteractionWidget.AUTOCOMPLETE: +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); + +// case InteractionWidget.MULTISELECT: +// return customMultiselectDropdown(sectionItem, provider, list, multiple); + +// case InteractionWidget.RADIO: +// print("Radiiooooo"); +// return (sectionItem.inputList!.length >= 5) +// ? customdropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildRadio(sectionItem, provider); + +// case InteractionWidget.LABEL: +// return Text(sectionItem.input!); + +// case InteractionWidget.RANGESLIDER: +// return CustomRangeSlider( +// sliderPos: sectionItem.selectedValue!.isNotEmpty +// ? double.parse(sectionItem.selectedValue!.last.toString()) +// : 10.0, +// onChanged: (val) { +// setState(() { +// sectionItem.selectedValue = []; +// sectionItem.selectedId = val.toString(); +// sectionItem.selectedValue!.add(val.toInt()); +// }); +// }, +// ); + +// case InteractionWidget.BUTTON: +// return sectionItem.input == 'add' +// ? const Offstage( +// offstage: true, +// child: Text("Visible"), +// ) +// : Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB(255, 233, 229, 229), +// onPressed: () async { +// if (sectionItem.selectedValue!.isNotEmpty) { +// showFilesAlertDialog(context, +// sectionItem.fileName!.join(','), sectionItem); +// } else { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); +// } + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? 'File Uploaded' +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem.selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ); + +// case InteractionWidget.TEXT: +// return sectionItem.input == 'Date' +// ? buildDateWidget(sectionItem) +// : sectionItem.input == "textArea" +// ? Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: InteractionTextField( +// maxchars: int.parse(sectionItem.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// // maxlines: 4, +// // minlines: 3, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// setState(() {}); + +// sectionItem.selectedValue!.add(val); +// }, +// ), +// ), +// ) +// : Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// height: isTablet ? 50 : 40, +// child: InteractionTextField( +// maxchars: int.parse(sectionItem.chars ?? "0"), +// controller: sectionItem.controller!, +// inputType: sectionItem.input == "number" +// ? TextInputType.number +// : TextInputType.name, +// labelText: sectionItem.name, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// provider.setTextValue(val, sectionItem, multiple); +// }, +// ), +// ), +// ), +// ); +// case InteractionWidget.DROPDOWN: +// // return customdropdown(sectionItem, provider, list, multiple); + +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); +// } +// } + +// Widget buildDateWidget(SectionList sectionItem) { +// return SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// height: isTablet ? 50 : 40, +// child: TextField( +// controller: +// sectionItem.controller, //editing controller of this TextField +// decoration: InputDecoration( +// // border: OutlineInputBorder(), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// labelStyle: const TextStyle(fontSize: 16), +// suffixIcon: const Icon(Icons.calendar_today), //icon of text field +// labelText: "Enter Date" //label text of field +// ), +// readOnly: true, //set it true, so that user will not able to edit text +// onTap: () async { +// DateTime? pickedDate = await showDatePicker( +// context: context, +// initialDate: DateTime.now(), +// firstDate: DateTime( +// 2000), //DateTime.now() - not to allow to choose before today. +// lastDate: DateTime(2101)); + +// if (pickedDate != null) { +// print( +// pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 +// String formattedDate = DateFormat('yyyy-MM-dd').format(pickedDate); +// print( +// formattedDate); //formatted date output using intl package => 2021-03-16 +// //you can implement different kind of Date Format here according to your requirement + +// setState(() { +// sectionItem.controller!.text = formattedDate; +// sectionItem.selectedValue = []; +// sectionItem.selectedValue! +// .add(formattedDate); //set output date to TextField value. +// }); +// } else { +// print("Date is not selected"); +// } +// }, +// ), +// ); +// } + +// Widget saveActions(ViewInteractionProvider provider) { +// return Align( +// alignment: Alignment.centerRight, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceEvenly, +// children: [ +// Padding( +// padding: const EdgeInsets.all(4.0), +// child: CustomButton( +// backgroundColor: Colors.green.shade500, +// onPressed: () async { +// // if (textFieldsValidation(provider).isEmpty) { +// await provider.saveJsonObject(context, +// widget.saveInteraction.intId, widget.saveInteraction); + +// // showAlertDialog(context, widget.saveInteraction.id); + +// print("Validation_isss: ${provider.isLoading}"); + +// if (provider.isLoading == false) { +// print("Validation_false"); +// showAlertDialog1(context, "Please fill all the fields"); +// } else { +// showAlertDialog(context, widget.saveInteraction.id); +// print("Validation_True"); +// } +// // } else { +// // _displaySnackBar(textFieldsValidation(provider)); +// // } +// }, +// textColor: Colors.white, +// title: "Update", +// // height: 40, +// // width: isTablet ? 120 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// width: isTablet ? 20 : 2, +// ), +// ], +// ), +// ); +// } + +// Widget buildRadio(SectionList sectionItem, ViewInteractionProvider provider) { +// List list = provider.getData2(sectionItem); +// // .map((itemWord) => InputClass.fromJson(itemWord)) +// // .toList(); +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 250 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (InputClass value in list) +// Row( +// children: [ +// Radio( +// value: value.name, +// activeColor: Colors.black, +// groupValue: provider.radioValue, +// onChanged: (String? value) { +// setState(() { +// // print(value); +// provider.radioValue = value!; +// int index = +// list.indexWhere((element) => element.name == value); +// sectionItem.selectedValue!.add(list[index].id); +// }); +// }, +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget buildCheckbox(SectionList sectionItem, String sectionName, +// ViewInteractionProvider provider, bool multiple) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: 250, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (var value in provider.checkboxlist) +// Row( +// children: [ +// Checkbox( +// value: value.ischecked ?? false, +// activeColor: Colors.black, +// checkColor: Colors.white, +// onChanged: (bool? newvalue) { +// value.ischecked = newvalue!; +// provider.setcheckBoxValue(sectionItem, sectionName, +// newvalue, value.id, multiple); +// //setState(() {}); +// }, +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget customdropdown(SectionList sectionItem, +// ViewInteractionProvider provider, List list, bool multiple) { +// // sectionItem.value = ''; +// // print("%%%%${sectionItem.selectedValue!.last}"); +// print("ItemList_is: $list"); +// if (list.isEmpty) { +// print("###list empty###"); +// list = []; +// InputClass inputClass = +// InputClass(id: "no value", name: "Select ${sectionItem.name}"); +// list.add(inputClass); +// sectionItem.selectedObject = list[0]; +// } +// // InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select ${sectionItem.name}', +// style: const TextStyle(fontSize: 14), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedValue!.isNotEmpty +// ? list[list.indexWhere( +// (element) => element.id == sectionItem.selectedValue!.last, +// )] +// : list[0], +// // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) +// // sectionItem.value ?? list[0].name, +// validator: (value) { +// if (value == null) { +// return 'Please select ${sectionItem.name}'; +// } +// return null; +// }, +// onChanged: (value) { +// //Do something when selected item is changed. +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple, value); +// print("selected ${sectionItem.value}"); +// // setState(() {}); +// }, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple, value); +// // setState(() {}); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(right: 8), +// ), +// iconStyleData: const IconStyleData( +// icon: Icon( +// Icons.arrow_drop_down, +// color: Colors.black45, +// ), +// iconSize: 24, +// ), +// dropdownStyleData: DropdownStyleData( +// decoration: BoxDecoration( +// borderRadius: BorderRadius.circular(15), +// ), +// ), +// menuItemStyleData: const MenuItemStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// ), +// ), +// ), +// ); +// } + +// Widget customAutoCompletedropdown(SectionList sectionItem, +// ViewInteractionProvider provider, List list, bool multiple) { +// // sectionItem.value = list[0].name; +// if (list.isEmpty) { +// list = sectionItem.inputList!; +// } +// //InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Item', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onChanged: (value) { +// // setState(() { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// // setState(() {}); +// //}); +// }, + +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// height: 40, +// width: 200, +// ), +// dropdownStyleData: const DropdownStyleData( +// maxHeight: 200, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// ), +// dropdownSearchData: DropdownSearchData( +// searchController: textEditingController, +// searchInnerWidgetHeight: 50, +// searchInnerWidget: Container( +// height: 50, +// padding: const EdgeInsets.only( +// top: 8, +// bottom: 4, +// right: 8, +// left: 8, +// ), +// child: TextFormField( +// expands: true, +// maxLines: null, +// controller: textEditingController, +// decoration: InputDecoration( +// isDense: true, +// contentPadding: const EdgeInsets.symmetric( +// horizontal: 10, +// vertical: 8, +// ), +// hintText: 'Search for an item...', +// hintStyle: const TextStyle(fontSize: 12), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(8), +// ), +// ), +// ), +// ), +// searchMatchFn: (item, searchValue) { +// return item.value!.name.toString().contains(searchValue); +// }, +// ), +// //This to clear the search value when you close the menu +// onMenuStateChange: (isOpen) { +// if (!isOpen) { +// textEditingController.clear(); +// } +// }, +// ), +// ), +// ), +// ); +// } + +// Widget customMultiselectDropdown(SectionList sectionItem, +// ViewInteractionProvider provider, List list, bool multiple) { +// if (list.isEmpty) { +// list = sectionItem.inputList!; +// } +// InputClass selectedObj = list[0]; + +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Items', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list.map((item) { +// return DropdownMenuItem( +// value: item, +// //disable default onTap to avoid closing menu when selecting an item +// enabled: false, +// child: StatefulBuilder( +// builder: (context, menuSetState) { +// final isSelected = +// sectionItem.selectedValue!.contains(item.name); +// return InkWell( +// onTap: () { +// isSelected +// ? sectionItem.selectedValue!.remove(item.name) +// : sectionItem.selectedValue!.add(item.name); +// //This rebuilds the StatefulWidget to update the button's text +// setState(() {}); +// //This rebuilds the dropdownMenu Widget to update the check mark +// menuSetState(() {}); +// }, +// child: Container( +// height: double.infinity, +// padding: const EdgeInsets.symmetric(horizontal: 16.0), +// child: Row( +// children: [ +// if (isSelected) +// const Icon(Icons.check_box_outlined) +// else +// const Icon(Icons.check_box_outline_blank), +// const SizedBox(width: 16), +// Expanded( +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// }, +// ), +// ); +// }).toList(), +// //Use last selected item as the current value so if we've limited menu height, it scroll to last item. +// value: selectedObj, +// // ? null +// // : provider.selectedItems.last, +// onChanged: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onSaved: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// selectedItemBuilder: (context) { +// return list.map( +// (item) { +// return Container( +// alignment: AlignmentDirectional.center, +// child: Text( +// sectionItem.selectedValue!.join(', '), +// style: const TextStyle( +// fontSize: 14, +// overflow: TextOverflow.ellipsis, +// ), +// maxLines: 1, +// ), +// ); +// }, +// ).toList(); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(left: 16, right: 8), +// height: 40, +// width: 140, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// padding: EdgeInsets.zero, +// ), +// ), +// ), +// ), +// ); +// } + +// // Widget gridViewWidget( +// // ViewInteractionProvider provider, +// // String sectionName, +// // List sectionList, +// // Orientation orientation, +// // FormFieldData item, +// // int listIndex) { +// // print("SectionListtt:isss: $sectionList"); +// // return Padding( +// // padding: isTablet +// // ? const EdgeInsets.only(left: 8.0) +// // : const EdgeInsets.only(left: 12.0, right: 12.0), +// // child: GridView.count( +// // physics: const NeverScrollableScrollPhysics(), +// // crossAxisCount: context.responsive( +// // 1, // default +// // sm: 1, // small +// // md: 1, // medium +// // lg: sectionList.length == 1 ? 1 : 4, // large +// // xl: 5, // extra large screen +// // ), +// // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, +// // shrinkWrap: true, +// // padding: EdgeInsets.zero, +// // childAspectRatio: sectionList.length == 1 || !isTablet +// // ? orientation == Orientation.landscape +// // ? 10 +// // : 4.2 +// // : 1.8, +// // children: List.generate( +// // sectionList.length, +// // (i) { +// // // print(sectionList); +// // SectionList sectionItem = sectionList[i]; +// // dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN +// // ? sectionItem.value ?? "Select" +// // : ' '; +// // List list = +// // sectionItem.widget == InteractionWidget.DROPDOWN || +// // sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// // sectionItem.widget == InteractionWidget.MULTISELECT +// // ? provider.getData2(sectionItem) +// // : []; +// // provider.checkboxlist = +// // sectionItem.widget == InteractionWidget.CHECKBOX +// // ? provider.getData2(sectionItem) +// // : []; + +// // return Wrap(children: [ +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // sectionItem.widget == InteractionWidget.BUTTON && +// // sectionItem.param == 'add' || +// // sectionItem.param == 'deletebtn' +// // ? const SizedBox.shrink() +// // : Text( +// // '${sectionItem.name}:*', +// // style: TextStyle( +// // color: Colors.orange.shade800, +// // fontSize: isTablet ? 18 : 14, +// // ), +// // ), +// // const SizedBox( +// // height: 15, +// // ), +// // sectionItem.widget == InteractionWidget.BUTTON +// // ? sectionItem.input == 'chooseFile' +// // ? Row( +// // children: [ +// // CustomButton( +// // backgroundColor: const Color.fromARGB( +// // 255, 233, 229, 229), +// // onPressed: () async { +// // if (sectionItem +// // .selectedValue!.isNotEmpty) { +// // showFilesAlertDialog( +// // context, +// // sectionItem.fileName!.join(','), +// // sectionItem); +// // } else { +// // sectionItem.selectedValue = []; +// // sectionItem.extension = []; +// // sectionItem.fileName = []; +// // await getEncodedFile(sectionItem); +// // } +// // setState(() {}); +// // }, +// // width: 120, +// // height: 40, +// // fontsize: 12, +// // textColor: Colors.black, +// // title: sectionItem.name), +// // const SizedBox( +// // width: 5, +// // ), +// // Text( +// // sectionItem.selectedValue!.isNotEmpty +// // ? 'File uploaded' +// // : 'No file uploaded', +// // style: TextStyle( +// // color: +// // sectionItem.selectedValue!.isNotEmpty +// // ? Colors.green +// // : Colors.red), +// // ), +// // ], +// // ) +// // : isTablet +// // ? IconButton( +// // onPressed: () { +// // provider.deleteMultipleRows( +// // sectionItem.gid!, +// // sectionList[i], +// // sectionName); + +// // setState(() {}); +// // }, +// // icon: const Icon( +// // Icons.cancel, +// // size: 30, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ) +// // : Padding( +// // padding: +// // const EdgeInsets.only(left: 3.0, top: 5), +// // child: CustomButton( +// // backgroundColor: const Color.fromARGB( +// // 255, 233, 75, 75), +// // onPressed: () { +// // provider.deleteMultipleRows( +// // sectionItem.gid!, +// // sectionList[i], +// // sectionName); + +// // setState(() {}); +// // }, +// // width: 80, +// // height: 30, +// // fontsize: 12, +// // textColor: Colors.white, +// // title: "Delete"), +// // ) +// // : returnWidget( +// // sectionItem: sectionItem, +// // item: item, +// // provider: provider, +// // list: list, +// // gridIndex: i, +// // listIndex: listIndex, +// // widgetData: sectionItem.widget!, +// // multiple: true), +// // ], +// // ), +// // ]); +// // }, +// // ), +// // ), +// // ); +// // } + +// Widget gridViewWidget( +// ViewInteractionProvider provider, +// String sectionName, +// List sectionList, +// Orientation orientation, +// FormFieldData item, +// int listIndex) { +// print("SectionListtt:isss: $sectionList"); + +// List pooja = sectionList; + +// print("Pooja: $pooja"); + +// List> convertedArray = []; +// print("Provider Length: ${item.sectionList.length}"); + +// for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { +// print("Section List11111: $sectionList"); +// print("item.sectionList.length List11111: ${item.sectionList.length}"); + +// convertedArray +// .add(sectionList.sublist(i, i + item.sectionList.length + 1)); +// } +// print("ConvertedArrayEditMulti.leangth: $convertedArray"); +// print("ConvertedArray.leangth: ${convertedArray.length}"); +// return Padding( +// padding: isTablet +// ? const EdgeInsets.only(left: 0.0) +// : const EdgeInsets.only(left: 12.0, right: 12.0), +// child: Column( +// children: [ +// for (var i = 0; i < convertedArray.length; i++) +// DecoratedBox( +// decoration: BoxDecoration( +// color: i % 2 == 0 +// ? Color.fromARGB(133, 213, 241, 254) +// : Colors.white, +// ), +// child: Wrap( +// children: [ +// //GestureDetector(child: Text("data")), +// GridView.builder( +// physics: const NeverScrollableScrollPhysics(), +// gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( +// crossAxisCount: context.responsive( +// 1, +// sm: 1, // small +// md: 2, // medium +// lg: sectionList.length == 1 +// ? 1 +// : (sectionList.length >= 1 ? 3 : 3), // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: +// sectionList.length == 1 || !isTablet ? 1 : 2, +// childAspectRatio: sectionList.length == 1 +// ? orientation == Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.0, +// ), +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// itemCount: convertedArray[i].length, +// itemBuilder: (context, index) { +// SectionList sectionItem = convertedArray[i][index]; +// dropdownvalue = +// sectionItem.widget == InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = +// sectionItem.widget == InteractionWidget.DROPDOWN || +// sectionItem.widget == +// InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget.MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; + +// return SizedBox( +// height: MediaQuery.of(context).size.height, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == InteractionWidget.BUTTON && +// sectionItem.param == 'add' || +// sectionItem.param == 'deletebtn' +// ? const SizedBox.shrink() +// : Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Text( +// sectionItem.isRequired +// ? '${sectionItem.name}:*' +// : '${sectionItem.name}:', +// style: TextStyle( +// color: Colors.orange.shade800, +// fontSize: 18.0, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// ), +// )), +// const SizedBox( +// height: 15, +// ), +// sectionItem.widget == InteractionWidget.BUTTON +// ? sectionItem.input == 'chooseFile' +// ? Row( +// children: [ +// CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 229, 229), +// onPressed: () async { +// if (sectionItem.selectedValue! +// .isNotEmpty) { +// showFilesAlertDialog( +// context, +// sectionItem.fileName! +// .join(','), +// sectionItem); +// } else { +// sectionItem.selectedValue = +// []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile( +// sectionItem); +// } +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem +// .selectedValue!.isNotEmpty +// ? 'File uploaded' +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem +// .selectedValue! +// .isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ) +// : isTablet +// ? IconButton( +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// icon: const Icon( +// Icons.cancel, +// size: 30, +// color: Color.fromARGB( +// 255, 8, 39, 92), +// ), +// ) +// : Padding( +// padding: const EdgeInsets.only( +// left: 3.0, top: 5), +// child: CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 75, 75), +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// // width: 80, +// // height: 30, +// height: 40, +// fontsize: 12, +// textColor: Colors.white, +// title: "Delete"), +// ) +// : returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: listIndex, +// widgetData: sectionItem.widget!, +// multiple: true), +// ], +// ), +// ); +// }), +// ], +// ), +// ), +// ], +// ), +// ); +// } + +// String textFieldsValidation(ViewInteractionProvider provider) { +// if (provider.sectionList +// .any((element) => element.controller!.text.isEmpty)) { +// return 'Fields cannot be empty'; +// } +// if (provider.textEditingControllerList.isNotEmpty) { +// if (provider.validateTextFields()) { +// return 'Fields cannot be empty'; +// } +// } +// if (provider.multipletextEditingControllerList.isNotEmpty) { +// if (provider.validateMultipleRows()) { +// return 'Fields cannot be empty'; +// } +// } + +// return ''; +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } + +// Future getEncodedFile(SectionList sectionItem) async { +// String base64Image = ''; +// var status = Platform.isAndroid +// ? await Permission.manageExternalStorage.status +// : await Permission.storage.status; +// if (status.isGranted) { +// FilePickerResult? result = +// await FilePicker.platform.pickFiles(allowMultiple: true); + +// if (result != null) { +// print(result.files.first.path); +// print(result.files.last.path); +// for (var files in result.files) { +// File file = File(files.path!); +// print("check file path : ${file.path}"); +// fileName = file.path.split('/').last; +// // Get the application folder directory +// Directory? directory = Platform.isAndroid +// ? await getExternalStorageDirectory() //FOR ANDROID +// : await getApplicationDocumentsDirectory(); +// String newPath = ""; //FOR ios +// String convertedDirectoryPath = (directory?.path).toString(); + +// print("see the converted directory path $convertedDirectoryPath"); + +// newPath = "$convertedDirectoryPath/konectar/files"; +// print("new path :$newPath"); +// directory = Directory(newPath); +// if (!await directory.exists()) { +// await directory.create(recursive: true); +// } +// File newFile = await file.copy('${directory.path}/$fileName'); +// print("new path is ${newFile.path}"); +// final extension = p.extension(newFile.path); +// List imageBytes = await newFile.readAsBytes(); +// Uint8List imageUint8List = Uint8List.fromList(imageBytes); +// base64Image = base64Encode(imageUint8List); +// sectionItem.selectedValue!.add(base64Image); +// sectionItem.extension!.add(extension); +// sectionItem.fileName!.add(fileName); +// } +// } +// } else { +// print("not permitted"); +// await requestPermission(Platform.isAndroid +// ? Permission.manageExternalStorage +// : Permission.storage); +// } +// } + +// Future requestPermission(Permission permission) async { +// final status = await permission.request(); + +// setState(() { +// print(status); +// }); +// } + +// showAlertDialog(BuildContext context, String record) { +// // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text("Form $record Updated Successfully!"), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// showAlertDialog1(BuildContext context, String record) { +// // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// showFilesAlertDialog( +// BuildContext context, String files, SectionList sectionItem) { +// // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("Upload"), +// onPressed: () async { +// Navigator.of(context).pop(); +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); +// }, +// ); +// Widget okButton = TextButton( +// child: const Text("Cancel"), +// onPressed: () async { +// Navigator.of(context).pop(); +// }, +// ); +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text( +// "Following File(s) $files uploaded .Do you still want to upload files ?", +// style: const TextStyle(fontSize: 15), +// ), +// actions: [cancelButton, okButton], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } +// } + + + + + + + + + + + + + + + + + + + + + + + + + + + + diff --git a/lib/contacts_module/ui_screen/interactionform/interaction_screen.dart b/lib/contacts_module/ui_screen/interactionform/interaction_screen.dart new file mode 100644 index 0000000..a7f47e5 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/interaction_screen.dart @@ -0,0 +1,4668 @@ +import 'dart:convert'; +import 'dart:io'; + +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/ui_screen/add_event/add_hcp.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/add_event/add_hcp.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/rendering.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter/widgets.dart'; +import 'package:intl/intl.dart'; +import 'package:path_provider/path_provider.dart'; +import 'package:popover/popover.dart'; +import 'package:provider/provider.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; + +import 'package:file_picker/file_picker.dart'; +// import 'package:pwa_ios/widgets/responsive_ext.dart'; +import 'package:permission_handler/permission_handler.dart'; +import 'package:path/path.dart' as p; + +// import 'package:popover/popover.dart'; + +class InteractionScreen extends StatefulWidget { + int index; + String form; + InteractionScreen({super.key, required this.index, required this.form}); + + @override + State createState() => _InteractionScreenState(); +} + +class _InteractionScreenState extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + + bool _isExpanded = false; + + late int _value; + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // if (mytimer!.isActive) { + // cancelTimer(); + // } + init(); + }); + + super.initState(); + } + + init() async { + await Provider.of(context, listen: false) + .init(widget.index); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + //resizeToAvoidBottomInset: false, + appBar: AppBar( + title: const FittedBox( + fit: BoxFit.scaleDown, + child: Text( + 'Record New Interaction', + style: TextStyle( + // fontSize: isTablet ? 22 : 14, color: Colors.white + // fontSize: 20, + color: Colors.white), + ), + ), + // backgroundColor: const Color(0xFF2b9af3), + automaticallyImplyLeading: false, + actions: [saveActions(provider)], + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + mainAxisSize: MainAxisSize.min, + children: [ + Expanded( + child: ListView.builder( + itemCount: provider.interactionReponseList.length, + cacheExtent: double.parse( + provider.interactionReponseList.length.toString()), + itemBuilder: (context, index) { + var item = provider.interactionReponseList[index]; + sectionList = item.sectionList; + + return Column( + children: [ + Card( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + elevation: 5, + color: Constants.k2color, + child: ExpansionTile( + maintainState: true, + backgroundColor: Constants.k2color, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.white), + // collapsedBackgroundColor: Color(0xFF2b9af3), + initiallyExpanded: true, + title: Stack( + alignment: AlignmentDirectional.center, + children: [ + Container( + // height: double.infinity, + width: double.infinity, + padding: const EdgeInsets.all(0.0), + decoration: BoxDecoration( + // color: Color(0xFF2b9af3), + color: Constants.k2color, + ), + child: Text( + item.sectionName, + style: const TextStyle( + color: Colors.white, + fontWeight: FontWeight.normal, + // fontSize: isTablet ? 18 : 14 + ), + )), + item.multiple + ? Align( + alignment: + Alignment.centerRight, + child: IconButton( + onPressed: () { + if (item.sectionName == + "HCP") { + Navigator.push( + context, + MaterialPageRoute( + builder: + (context) => + Addhcp())); + + provider.getSectionItem( + item.sectionName, + ); + // print("index is $listIndex"); + setState(() { + // for (var item + }); + } else { + provider.getSectionItem( + item.sectionName, + ); + // print("index is $listIndex"); + setState(() {}); + } + }, + icon: const Icon( + Icons.add_circle_outline, + size: 24, + color: Colors.white, + ), + ), + ) + : const SizedBox.shrink() + ]), + children: [ + Container( + color: Colors.white, + child: Padding( + padding: + const EdgeInsets.only(top: 8.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + GridView.count( + physics: + const NeverScrollableScrollPhysics(), + + crossAxisCount: + context.responsive( + 1, + sm: 1, // small + md: isTablet + ? 2 + : orientation == + Orientation + .landscape + ? 2 + : 1, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + + mainAxisSpacing: + sectionList.length == 1 || + !isTablet + ? 1 + : 3.5, + // mainAxisSpacing: + // orientation == Orientation.portrait + // ? 1 + // : 3, + shrinkWrap: true, + padding: EdgeInsets.zero, + + // childAspectRatio: + // sectionList.length == 1 + // ? orientation == + // Orientation.landscape + // ? 10 + // : 4.8 + // : isTablet + // ? 2.8 + // : 3.0, + + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation + .landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.5, + + children: List.generate( + sectionList.length, + (i) { + SectionList sectionItem = + sectionList[i]; + dropdownvalue = + sectionItem.widget == + InteractionWidget + .DROPDOWN + ? sectionItem.value ?? + "Select" + : ' '; + List< + InputClass> list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem.widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget + .MULTISELECT + ? provider + .getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == + InteractionWidget + .CHECKBOX + ? provider.getData2( + sectionItem) + : []; + + return Column( + //mainAxisSize: MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment + .start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem + .input == + 'add' + ? const SizedBox + .shrink() + : Padding( + padding: + const EdgeInsets + .only( + left: 8.0, + right: + 8.0), + child: FittedBox( + fit: BoxFit + .scaleDown, + child: Text( + sectionItem + .validation! + .isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: + TextStyle( + color: Colors + .orange + .shade800, + fontSize: + 18.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + ), + ), + ), + returnWidget( + sectionItem: + sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: index, + widgetData: + sectionItem + .widget!, + multiple: false), + ], + ); + }, + ), + ), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + index) + : const SizedBox.shrink(), + provider.interactionReponseList + .length == + index - 1 + ? saveActions(provider) + : const SizedBox.shrink() + //const Spacer(), + ], + ), + ), + ), + ]), + ), + ], + ); + }, + ), + ), + // const Spacer(), + //saveActions(provider), + Align( + alignment: Alignment.bottomRight, + child: Container( + height: 80.0, + width: 80.0, + + //child: + // Text(provider.interactionReponseList.toString()))) + child: _offsetPopup(provider.interactionReponseList))) + ], + ), + ), + ); + }), + ); + }); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required InteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + required bool multiple, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? customMultiselectDropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + + case InteractionWidget.AUTOCOMPLETE: + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + + case InteractionWidget.MULTISELECT: + return customMultiselectDropdown(sectionItem, provider, list, multiple); + + case InteractionWidget.RADIO: + return (sectionItem.inputList!.length >= 5) + ? customdropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildRadio(sectionItem, provider); + + case InteractionWidget.LABEL: + return Text(sectionItem.input!); + + case InteractionWidget.RANGESLIDER: + return CustomRangeSlider( + max: double.parse(sectionItem.max!), + min: double.parse(sectionItem.min!), + sliderPos: sectionItem.selectedValue!.isNotEmpty + ? double.parse(sectionItem.selectedValue!.last.toString()) + : double.parse(sectionItem.min!), + onChanged: (val) { + setState(() { + sectionItem.selectedValue = []; + sectionItem.selectedId = val.toString(); + sectionItem.selectedValue!.add(val.toInt()); + }); + }, + ); + + case InteractionWidget.BUTTON: + return sectionItem.input == 'add' + ? const Offstage( + offstage: true, + child: Text("Visible"), + ) + : Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB(255, 233, 229, 229), + onPressed: () async { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.length > 1 + ? 'Files uploaded' + : "File Uploaded" + : 'No file uploaded', + style: TextStyle( + color: sectionItem.selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ); + + case InteractionWidget.TEXT: + return sectionItem.input == 'Date' + ? buildDateWidget(sectionItem) + : sectionItem.input == "textArea" + ? Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: InteractionTextField( + // maxchars: int.parse(sectionItem.validation!.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + // maxlines: 8, + //minlines: 4, + onChanged: (val) { + sectionItem.selectedValue = []; + setState(() {}); + + sectionItem.selectedValue!.add(val); + }, + ), + ), + ) + ////Poojaaaaa + : sectionItem.input == "text1" + ? Text( + sectionItem.depid!, + style: TextStyle( + fontSize: 18.0, fontWeight: FontWeight.normal), + ) + : Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: + // isTablet ? 200 : MediaQuery.of(context).size.width, + //height: isTablet ? 50 : 40, + width: MediaQuery.of(context).size.width, + height: isTablet ? 50 : 40, + + child: InteractionTextField( + inputType: sectionItem.input == "number" + ? TextInputType.number + : TextInputType.name, + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + onChanged: (val) { + sectionItem.selectedValue = []; + // sectionItem.selectedValue!.clear(); + + provider.setTextValue( + val, sectionItem, multiple); + }, + ), + ), + ), + ); + case InteractionWidget.DROPDOWN: + // return customdropdown(sectionItem, provider, list, multiple); + + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + } + } + + Future requestPermission(Permission permission) async { + final status = await permission.request(); + + setState(() { + print(status); + // _permissionStatus = status; + // print(_permissionStatus); + }); + } + + Widget buildDateWidget(SectionList sectionItem) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 50 : 40, + width: MediaQuery.of(context).size.width, + child: TextField( + controller: + sectionItem.controller, //editing controller of this TextField + decoration: InputDecoration( + // border: OutlineInputBorder(), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelStyle: const TextStyle(fontSize: 16), + suffixIcon: const Icon(Icons.calendar_today), //icon of text field + labelText: "Enter Date" //label text of field + ), + readOnly: true, //set it true, so that user will not able to edit text + onTap: () async { + DateTime? pickedDate = await showDatePicker( + context: context, + initialDate: DateTime.now(), + firstDate: DateTime( + 2000), //DateTime.now() - not to allow to choose before today. + lastDate: DateTime(2101)); + + if (pickedDate != null) { + print( + pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 + String formattedDate = + DateFormat('yyyy-MM-dd').format(pickedDate); + print( + formattedDate); //formatted date output using intl package => 2021-03-16 + //you can implement different kind of Date Format here according to your requirement + + setState(() { + sectionItem.controller!.text = formattedDate; + sectionItem.selectedValue = []; + sectionItem.selectedValue! + .add(formattedDate); //set output date to TextField value. + }); + } else { + print("Date is not selected"); + } + }, + ), + ), + ); + } + + Widget saveActions(InteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + Padding( + // padding: const EdgeInsets.all(4.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + + child: CustomButton( + backgroundColor: Colors.red.shade800, + onPressed: () { + //showDeleteProfileAlertDialog(context); + for (var textcontrollers + in provider.textEditingControllerList) { + textcontrollers.text = ''; + } + }, + textColor: Colors.white, + title: "Reset", + // height: 40, + // width: isTablet ? 100 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + // fontsize: isTablet ? 15 : 10.2, + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + //width: isTablet ? 20 : 4, + width: isTablet ? 20 : 2, + ), + Padding( + // padding: const EdgeInsets.all(8.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0), + + child: CustomButton( + backgroundColor: Colors.green.shade500, + onPressed: () async { + String record = + await provider.saveJsonObject(context, widget.form); + + print("Validation_isss: ${provider.isLoading}"); + + if (provider.isLoading == false) { + print("Validation_false"); + showAlertDialog1(context, "Please fill all the fields"); + } else { + showAlertDialog(context, "Form $record Saved Successfully!"); + print("Validation_True"); + } + }, + textColor: Colors.white, + title: "Save", + // height: 40, + // width: isTablet ? 100 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + // width: MediaQuery.of(context).size.width * 0.1, + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget buildRadio(SectionList sectionItem, InteractionProvider provider) { + List list = provider.getData2(sectionItem); + // .map((itemWord) => InputClass.fromJson(itemWord)) + // .toList(); + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 250 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (InputClass value in list) + Row( + children: [ + Radio( + value: value.name, + activeColor: Colors.black, + groupValue: provider.radioValue, + onChanged: (String? value) { + setState(() { + print(value); + provider.radioValue = value!; + int index = + list.indexWhere((element) => element.name == value); + sectionItem.selectedValue!.add(list[index].id); + }); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget buildCheckbox(SectionList sectionItem, String sectionName, + InteractionProvider provider, bool multiple) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: 250, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (var value in provider.checkboxlist) + Row( + children: [ + FittedBox( + fit: BoxFit.scaleDown, + child: CheckboxListTile( + dense: true, + //contentPadding: const EdgeInsets.symmetric(vertical: 5), + value: value.ischecked ?? false, + activeColor: Colors.black, + checkColor: Colors.white, + onChanged: (bool? newvalue) { + value.ischecked = newvalue!; + provider.setcheckBoxValue(sectionItem, sectionName, + newvalue, value.id, multiple); + //setState(() {}); + }, + ), + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget customdropdown(SectionList sectionItem, InteractionProvider provider, + List list, bool multiple) { + // sectionItem.value = ''; + + if (list.isEmpty) { + list = []; + InputClass inputClass = + InputClass(id: "no value", name: "Select ${sectionItem.name}"); + list.add(inputClass); + sectionItem.selectedObject = list[0]; + } + // InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + width: MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select ${sectionItem.name}', + style: const TextStyle(fontSize: 14), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject ?? list[0], + // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) + // sectionItem.value ?? list[0].name, + validator: (value) { + if (value == null) { + return 'Please select ${sectionItem.name}'; + } + return null; + }, + onChanged: (value) { + //Do something when selected item is changed. + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple); + print("selected ${sectionItem.value}"); + // setState(() {}); + }, + onSaved: (value) { + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple); + // setState(() {}); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(right: 8), + ), + iconStyleData: const IconStyleData( + icon: Icon( + Icons.arrow_drop_down, + color: Colors.black45, + ), + iconSize: 24, + ), + dropdownStyleData: DropdownStyleData( + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(10.0), + ), + ), + menuItemStyleData: const MenuItemStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + ), + ), + ), + ); + } + + Widget customAutoCompletedropdown(SectionList sectionItem, + InteractionProvider provider, List list, bool multiple) { + list = sectionItem.inputList!; + print("***Autocomplete list ${list[0].name}"); + //} + //InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Item', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject, + onSaved: (value) { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onChanged: (value) { + // setState(() { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + // setState(() {}); + //}); + }, + + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 40, + width: 200, + ), + dropdownStyleData: const DropdownStyleData( + maxHeight: 200, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + padding: const EdgeInsets.only( + top: 8, + bottom: 4, + right: 8, + left: 8, + ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + return item.value!.name.toString().contains(searchValue); + }, + ), + //This to clear the search value when you close the menu + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + ), + ), + ), + ); + } + + Widget customMultiselectDropdown(SectionList sectionItem, + InteractionProvider provider, List list, bool multiple) { + if (list.isEmpty) { + list = sectionItem.inputList!; + } + InputClass selectedObj = list[0]; + + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + // height: MediaQuery.of(context).size.height, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Items', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list.map((item) { + return DropdownMenuItem( + value: item, + //disable default onTap to avoid closing menu when selecting an item + enabled: false, + child: StatefulBuilder( + builder: (context, menuSetState) { + final isSelected = + sectionItem.selectedValue!.contains(item.name); + return InkWell( + onTap: () { + isSelected + ? sectionItem.selectedValue!.remove(item.name) + : sectionItem.selectedValue!.add(item.name); + //This rebuilds the StatefulWidget to update the button's text + setState(() {}); + //This rebuilds the dropdownMenu Widget to update the check mark + menuSetState(() {}); + }, + child: Container( + height: double.infinity, + padding: const EdgeInsets.symmetric(horizontal: 16.0), + child: Row( + children: [ + if (isSelected) + const Icon(Icons.check_box_outlined) + else + const Icon(Icons.check_box_outline_blank), + const SizedBox(width: 16), + Expanded( + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + ), + ], + ), + ), + ); + }, + ), + ); + }).toList(), + //Use last selected item as the current value so if we've limited menu height, it scroll to last item. + value: selectedObj, + // ? null + // : provider.selectedItems.last, + onChanged: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onSaved: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + selectedItemBuilder: (context) { + return list.map( + (item) { + return Container( + alignment: AlignmentDirectional.center, + child: Text( + sectionItem.selectedValue!.join(', '), + style: const TextStyle( + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + maxLines: 1, + ), + ); + }, + ).toList(); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(left: 16, right: 8), + height: 40, + width: 140, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + padding: EdgeInsets.zero, + ), + ), + ), + ), + ); + } + + Widget gridViewWidget( + InteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + print("ListInex: $listIndex"); + print("sectionName: $sectionName"); + print("sectionName: $sectionName"); + + print("gridsectionlost_is: $sectionList"); + print("gridsectionlostleangth_is: ${sectionList.length}"); + + List pooja = sectionList; + + print("Pooja_isss: $pooja"); + print("Pooja_leangth_isss: ${pooja.length}"); + + ////////////////////////////////////mycode/////////////////////////// + + List> convertedArray = []; + print("Provider_leangth: ${item.sectionList.length}"); + + for (int i = 0; i < pooja.length; i += item.sectionList.length + 1) { + print("poojaleangth: $pooja"); + + convertedArray.add(pooja.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArray.leangth: $convertedArray"); + print("ConvertedArray.leangth: ${convertedArray.length}"); + + return Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10.0), + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, + sm: 1, // small + md: isTablet + ? 2 + : orientation == Orientation.landscape + ? 2 + : 1, // medium + lg: sectionList.length == 1 ? 1 : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 1, + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.7, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = + sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = sectionItem.widget == + InteractionWidget.DROPDOWN || + sectionItem.widget == + InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + return Padding( + padding: const EdgeInsets.only(top: 12.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + // sectionItem.widget == InteractionWidget.BUTTON && + // sectionItem.input == 'add' || + // sectionItem.input == 'deletebtn' + // ? const SizedBox.shrink() + // : + Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: FittedBox( + fit: BoxFit.scaleDown, + child: Text( + sectionItem.validation!.isRequired + ? "${sectionItem.name}*" + : sectionItem.name, + style: TextStyle( + color: Colors.orange.shade800, fontSize: 18), + ), + ), + ), + // const SizedBox( + // height: 15, + // ), + sectionItem.widget == InteractionWidget.BUTTON + ? sectionItem.input == 'chooseFile' + ? Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB( + 255, 233, 229, 229), + onPressed: () async { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? sectionItem + .selectedValue!.isNotEmpty + ? 'File uploaded' + : "Files Uploaded" + : 'No file uploaded', + style: TextStyle( + color: sectionItem + .selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ) + : isTablet + ? IconButton( + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + icon: const Icon( + Icons.cancel, + size: 30, + color: Color.fromARGB(255, 8, 39, 92), + ), + ) + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 75, 75), + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + height: 40, + + // height: + // MediaQuery.of(context).size.height * + // 0.2, + fontsize: 12, + textColor: Colors.white, + title: "Delete"), + ) + : returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!, + multiple: true), + ], + ), + ); + }), + ) + ], + ); + //); + } + + // String fieldsValidation(InteractionProvider provider) { + // List secList = provider.sectionList + // .where((element) => element.validation!.isRequired = true) + // .toList(); + // if (secList.any((element) => element.selectedValue!.isEmpty)) { + // return 'Fields cannot be empty'; + // } + // return ''; + // } + + String textFieldsValidation(InteractionProvider provider) { + return ''; + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } + + Future getEncodedFile(SectionList sectionItem) async { + String base64Image = ''; + var status = Platform.isAndroid + ? await Permission.manageExternalStorage.status + : await Permission.storage.status; + if (status.isGranted) { + FilePickerResult? result = + await FilePicker.platform.pickFiles(allowMultiple: true); + + if (result != null) { + print(result.files.first.path); + print(result.files.last.path); + for (var files in result.files) { + File file = File(files.path!); + print("check file path : ${file.path}"); + fileName = file.path.split('/').last; + // Get the application folder directory + Directory? directory = Platform.isAndroid + ? await getExternalStorageDirectory() //FOR ANDROID + : await getApplicationDocumentsDirectory(); + String newPath = ""; //FOR ios + String convertedDirectoryPath = (directory?.path).toString(); + + print("see the converted directory path $convertedDirectoryPath"); + + newPath = "$convertedDirectoryPath/konectar/files"; + print("new path :$newPath"); + directory = Directory(newPath); + if (!await directory.exists()) { + await directory.create(recursive: true); + } + File newFile = await file.copy('${directory.path}/$fileName'); + print("new path is ${newFile.path}"); + final extension = p.extension(newFile.path); + List imageBytes = await newFile.readAsBytes(); + Uint8List imageUint8List = Uint8List.fromList(imageBytes); + base64Image = base64Encode(imageUint8List); + sectionItem.selectedValue!.add(base64Image); + sectionItem.extension!.add(extension); + sectionItem.fileName!.add(fileName); + } + } + } else { + print("not permitted"); + await requestPermission(Platform.isAndroid + ? Permission.manageExternalStorage + : Permission.storage); + } + } + + showAlertDialog(BuildContext context, String record) { + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showAlertDialog1(BuildContext context, String record) { + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + Widget _offsetPopup(List interactionReponseList) { + List trueElements = + interactionReponseList.where((element) => element.multiple).toList(); + print("trueElements_iss: $trueElements"); + + return PopupMenuButton( + onSelected: (newValue) { + var provider = + Provider.of(context, listen: false); + setState(() { + _value = newValue; // it gives the value which is selected + + var item = trueElements[_value]; + + provider.getSectionItem( + item.sectionName, + ); + }); + print("Clicked Section111 $_value "); // add this property + print( + "interactionReponseList1 ${interactionReponseList} "); // add this property + }, + itemBuilder: (context) { + return List.generate(trueElements.length, (index) { + var provider = + Provider.of(context, listen: false); + + var item = trueElements[index]; + + print("itemitemitemitem_isss: ${item.multiple}"); + + return PopupMenuItem( + value: index, + child: item.multiple == true + ? GestureDetector( + onTap: () { + print("Clicked Section ${item.sectionName}"); + // provider.getSectionItem( + // item.sectionName, + // ); + //print("Clicked Section : ${sectionList}") + setState(() { + provider.getSectionItem( + item.sectionName, + ); + }); + + const DecoratedBox( + decoration: BoxDecoration( + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10.0), + border: Border( + bottom: + BorderSide(width: 1.5, color: Colors.black), + //top: BorderSide(width: 1.5, color: Colors.black), + ), + ), + ); + }, + child: item.multiple == true + ? Text(' ${item.sectionName}') + : const SizedBox.shrink()) + : SizedBox.shrink(), + ); + }); + }, + icon: Container( + height: double.infinity, + width: double.infinity, + decoration: const ShapeDecoration( + color: Color.fromARGB(255, 8, 39, 92), + shape: StadiumBorder( + side: BorderSide(color: Colors.white, width: 2), + ), + ), + child: Icon(Icons.add, color: Colors.white), + )); + } +} + + + + + + +// import 'dart:convert'; +// import 'dart:io'; + +// import 'package:discover_module/constants.dart'; +// import 'package:discover_module/ui_screen/add_event/add_hcp.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/responsive_ext.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/rendering.dart'; +// import 'package:flutter/services.dart'; +// import 'package:flutter/widgets.dart'; +// import 'package:intl/intl.dart'; +// import 'package:path_provider/path_provider.dart'; +// import 'package:popover/popover.dart'; +// import 'package:provider/provider.dart'; +// import 'package:dropdown_button2/dropdown_button2.dart'; + +// import 'package:file_picker/file_picker.dart'; +// // import 'package:pwa_ios/widgets/responsive_ext.dart'; +// import 'package:permission_handler/permission_handler.dart'; +// import 'package:path/path.dart' as p; + +// // import 'package:popover/popover.dart'; + +// class InteractionScreen extends StatefulWidget { +// int index; +// String form; +// InteractionScreen({super.key, required this.index, required this.form}); + +// @override +// State createState() => _InteractionScreenState(); +// } + +// class _InteractionScreenState extends State { +// List interactionReponseList = []; +// List sectionList = []; +// List textEditingControllerList = []; +// int textfieldIndex = 0; +// String dropdownvalue = 'Select value'; +// String? fileName; +// final TextEditingController textEditingController = TextEditingController(); +// @override +// void initState() { +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// // if (mytimer!.isActive) { +// // cancelTimer(); +// // } +// init(); +// }); + +// super.initState(); +// } + +// init() async { +// await Provider.of(context, listen: false) +// .init(widget.index); +// setState(() {}); +// } + +// @override +// Widget build(BuildContext context) { +// return Consumer( +// builder: (BuildContext context, provider, Widget? child) { +// return GestureDetector( +// onTap: () { +// FocusScope.of(context).requestFocus(FocusNode()); +// }, +// child: OrientationBuilder(builder: (context, orientation) { +// return SafeArea( +// child: Scaffold( +// //resizeToAvoidBottomInset: false, +// appBar: AppBar( +// title: const FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// 'Record New Interaction', +// style: TextStyle( +// // fontSize: isTablet ? 22 : 14, color: Colors.white +// // fontSize: 20, +// color: Colors.white), +// ), +// ), +// // backgroundColor: const Color(0xFF2b9af3), +// automaticallyImplyLeading: false, +// actions: [saveActions(provider)], +// leading: InkWell( +// onTap: () { +// Navigator.pop(context); +// }, +// child: const Icon( +// Icons.arrow_back_ios, +// color: Colors.white, +// ), +// ), +// ), +// body: Column( +// mainAxisSize: MainAxisSize.min, +// children: [ +// Expanded( +// child: ListView.builder( +// itemCount: provider.interactionReponseList.length, +// padding: EdgeInsets.zero, +// cacheExtent: double.parse( +// provider.interactionReponseList.length.toString()), +// itemBuilder: (context, index) { +// var item = provider.interactionReponseList[index]; +// sectionList = item.sectionList; +// return Column( +// children: [ +// Card( +// color: Constants.k2color, +// child: ExpansionTile( +// maintainState: true, +// backgroundColor: Constants.k2color, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// initiallyExpanded: true, +// title: Stack( +// alignment: AlignmentDirectional.center, +// children: [ +// Container( +// // height: double.infinity, +// width: double.infinity, +// padding: const EdgeInsets.all(0.0), +// decoration: BoxDecoration( +// // color: Color(0xFF2b9af3), +// color: Constants.k2color, +// ), +// child: Text( +// item.sectionName, +// style: const TextStyle( +// color: Colors.white, +// fontWeight: FontWeight.bold, +// // fontSize: isTablet ? 18 : 14 +// ), +// )), +// item.multiple +// ? Align( +// alignment: +// Alignment.centerRight, +// child: IconButton( +// onPressed: () { +// if (item.sectionName == +// "HCP") { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: +// (context) => +// Addhcp())); + +// provider.getSectionItem( +// item.sectionName, +// ); +// // print("index is $listIndex"); +// setState(() { +// // for (var item +// }); +// } else { +// provider.getSectionItem( +// item.sectionName, +// ); +// // print("index is $listIndex"); +// setState(() {}); +// } +// }, +// icon: const Icon( +// Icons.add_circle_outline, +// size: 30, +// color: Colors.white, +// ), +// ), +// ) +// : const SizedBox.shrink() +// ]), +// children: [ +// Container( +// color: Colors.white, +// child: Padding( +// padding: +// const EdgeInsets.only(top: 8.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: +// CrossAxisAlignment.center, +// children: [ +// GridView.count( +// physics: +// const NeverScrollableScrollPhysics(), + +// crossAxisCount: +// context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == +// Orientation +// .landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 +// ? 1 +// : 3, // large +// xl: 3, // extra large screen +// ), + +// mainAxisSpacing: +// sectionList.length == 1 || +// !isTablet +// ? 1 +// : 3.5, +// // mainAxisSpacing: +// // orientation == Orientation.portrait +// // ? 1 +// // : 3, +// shrinkWrap: true, +// padding: EdgeInsets.zero, + +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.0, + +// childAspectRatio: +// sectionList.length == 1 +// ? orientation == +// Orientation +// .landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.5, + +// children: List.generate( +// sectionList.length, +// (i) { +// SectionList sectionItem = +// sectionList[i]; +// dropdownvalue = +// sectionItem.widget == +// InteractionWidget +// .DROPDOWN +// ? sectionItem.value ?? +// "Select" +// : ' '; +// List< +// InputClass> list = sectionItem +// .widget == +// InteractionWidget +// .DROPDOWN || +// sectionItem.widget == +// InteractionWidget +// .AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget +// .MULTISELECT +// ? provider +// .getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == +// InteractionWidget +// .CHECKBOX +// ? provider.getData2( +// sectionItem) +// : []; + +// return Column( +// //mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: +// CrossAxisAlignment +// .start, +// children: [ +// sectionItem.widget == +// InteractionWidget +// .BUTTON && +// sectionItem +// .input == +// 'add' +// ? const SizedBox +// .shrink() +// : Padding( +// padding: +// const EdgeInsets +// .only( +// left: 8.0, +// right: +// 8.0), +// child: FittedBox( +// fit: BoxFit +// .scaleDown, +// child: Text( +// sectionItem +// .validation! +// .isRequired +// ? '${sectionItem.name}:*' +// : '${sectionItem.name}:', +// style: +// TextStyle( +// color: Colors +// .orange +// .shade800, +// fontSize: +// 18.0, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// ), +// ), +// ), +// ), +// returnWidget( +// sectionItem: +// sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: index, +// widgetData: +// sectionItem +// .widget!, +// multiple: false), +// ], +// ); +// }, +// ), +// ), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), +// item.multiple +// ? gridViewWidget( +// provider, +// item.sectionName, +// item.multipleList ?? [], +// orientation, +// item, +// index) +// : const SizedBox.shrink(), +// provider.interactionReponseList +// .length == +// index - 1 +// ? saveActions(provider) +// : const SizedBox.shrink() +// //const Spacer(), +// ], +// ), +// ), +// ), +// ]), +// ), +// ], +// ); +// }, +// ), +// ), +// // const Spacer(), +// // saveActions(provider), +// // Align( +// // alignment: Alignment.bottomRight, +// // child: Container( +// // height: 80.0, +// // width: 80.0, +// // child: _offsetPopup(provider.interactionReponseList))) +// ], +// ), +// ), +// ); +// }), +// ); +// }); +// } + +// Widget returnWidget({ +// required SectionList sectionItem, +// required FormFieldData item, +// required InteractionProvider provider, +// required List list, +// required int gridIndex, +// required int listIndex, +// required InteractionWidget widgetData, +// required bool multiple, +// }) { +// switch (widgetData) { +// case InteractionWidget.CHECKBOX: +// return (sectionItem.inputList!.length >= 5) +// ? customMultiselectDropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + +// case InteractionWidget.AUTOCOMPLETE: +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); + +// case InteractionWidget.MULTISELECT: +// return customMultiselectDropdown(sectionItem, provider, list, multiple); + +// case InteractionWidget.RADIO: +// return (sectionItem.inputList!.length >= 5) +// ? customdropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildRadio(sectionItem, provider); + +// case InteractionWidget.LABEL: +// return Text(sectionItem.input!); + +// case InteractionWidget.RANGESLIDER: +// return CustomRangeSlider( +// max: double.parse(sectionItem.max!), +// min: double.parse(sectionItem.min!), +// sliderPos: sectionItem.selectedValue!.isNotEmpty +// ? double.parse(sectionItem.selectedValue!.last.toString()) +// : double.parse(sectionItem.min!), +// onChanged: (val) { +// setState(() { +// sectionItem.selectedValue = []; +// sectionItem.selectedId = val.toString(); +// sectionItem.selectedValue!.add(val.toInt()); +// }); +// }, +// ); + +// case InteractionWidget.BUTTON: +// return sectionItem.input == 'add' +// ? const Offstage( +// offstage: true, +// child: Text("Visible"), +// ) +// : Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB(255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.length > 1 +// ? 'Files uploaded' +// : "File Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem.selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ); + +// case InteractionWidget.TEXT: +// return sectionItem.input == 'Date' +// ? buildDateWidget(sectionItem) +// : sectionItem.input == "textArea" +// ? Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: InteractionTextField( +// // maxchars: int.parse(sectionItem.validation!.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// // maxlines: 8, +// //minlines: 4, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// setState(() {}); + +// sectionItem.selectedValue!.add(val); +// }, +// ), +// ), +// ) +// ////Poojaaaaa +// : sectionItem.input == "text1" +// ? Text( +// sectionItem.depid!, +// style: TextStyle( +// fontSize: 18.0, fontWeight: FontWeight.normal), +// ) +// : Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: +// // isTablet ? 200 : MediaQuery.of(context).size.width, +// //height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// height: isTablet ? 50 : 40, + +// child: InteractionTextField( +// inputType: sectionItem.input == "number" +// ? TextInputType.number +// : TextInputType.name, +// maxchars: int.parse(sectionItem.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// // sectionItem.selectedValue!.clear(); + +// provider.setTextValue( +// val, sectionItem, multiple); +// }, +// ), +// ), +// ), +// ); +// case InteractionWidget.DROPDOWN: +// // return customdropdown(sectionItem, provider, list, multiple); + +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); +// } +// } + +// Future requestPermission(Permission permission) async { +// final status = await permission.request(); + +// setState(() { +// print(status); +// // _permissionStatus = status; +// // print(_permissionStatus); +// }); +// } + +// Widget buildDateWidget(SectionList sectionItem) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// child: TextField( +// controller: +// sectionItem.controller, //editing controller of this TextField +// decoration: InputDecoration( +// // border: OutlineInputBorder(), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// labelStyle: const TextStyle(fontSize: 16), +// suffixIcon: const Icon(Icons.calendar_today), //icon of text field +// labelText: "Enter Date" //label text of field +// ), +// readOnly: true, //set it true, so that user will not able to edit text +// onTap: () async { +// DateTime? pickedDate = await showDatePicker( +// context: context, +// initialDate: DateTime.now(), +// firstDate: DateTime( +// 2000), //DateTime.now() - not to allow to choose before today. +// lastDate: DateTime(2101)); + +// if (pickedDate != null) { +// print( +// pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 +// String formattedDate = +// DateFormat('yyyy-MM-dd').format(pickedDate); +// print( +// formattedDate); //formatted date output using intl package => 2021-03-16 +// //you can implement different kind of Date Format here according to your requirement + +// setState(() { +// sectionItem.controller!.text = formattedDate; +// sectionItem.selectedValue = []; +// sectionItem.selectedValue! +// .add(formattedDate); //set output date to TextField value. +// }); +// } else { +// print("Date is not selected"); +// } +// }, +// ), +// ), +// ); +// } + +// Widget saveActions(InteractionProvider provider) { +// return Align( +// alignment: Alignment.centerRight, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceEvenly, +// children: [ +// Padding( +// // padding: const EdgeInsets.all(4.0), +// padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + +// child: CustomButton( +// backgroundColor: Colors.red.shade800, +// onPressed: () { +// //showDeleteProfileAlertDialog(context); +// for (var textcontrollers +// in provider.textEditingControllerList) { +// textcontrollers.text = ''; +// } +// }, +// textColor: Colors.white, +// title: "Reset", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// // fontsize: isTablet ? 15 : 10.2, +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// //width: isTablet ? 20 : 4, +// width: isTablet ? 20 : 2, +// ), +// Padding( +// // padding: const EdgeInsets.all(8.0), +// padding: const EdgeInsets.only(top: 8.0, bottom: 8.0), + +// child: CustomButton( +// backgroundColor: Colors.green.shade500, +// onPressed: () async { +// String record = +// await provider.saveJsonObject(context, widget.form); + +// print("Validation_isss: ${provider.isLoading}"); + +// if (provider.isLoading == false) { +// print("Validation_false"); +// showAlertDialog1(context, "Please fill all the fields"); +// } else { +// showAlertDialog(context, "Form $record Saved Successfully!"); +// print("Validation_True"); +// } +// }, +// textColor: Colors.white, +// title: "Save", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// // width: MediaQuery.of(context).size.width * 0.1, +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// width: isTablet ? 20 : 2, +// ), +// ], +// ), +// ); +// } + +// Widget buildRadio(SectionList sectionItem, InteractionProvider provider) { +// List list = provider.getData2(sectionItem); +// // .map((itemWord) => InputClass.fromJson(itemWord)) +// // .toList(); +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 250 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (InputClass value in list) +// Row( +// children: [ +// Radio( +// value: value.name, +// activeColor: Colors.black, +// groupValue: provider.radioValue, +// onChanged: (String? value) { +// setState(() { +// print(value); +// provider.radioValue = value!; +// int index = +// list.indexWhere((element) => element.name == value); +// sectionItem.selectedValue!.add(list[index].id); +// }); +// }, +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget buildCheckbox(SectionList sectionItem, String sectionName, +// InteractionProvider provider, bool multiple) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: 250, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (var value in provider.checkboxlist) +// Row( +// children: [ +// FittedBox( +// fit: BoxFit.scaleDown, +// child: CheckboxListTile( +// dense: true, +// //contentPadding: const EdgeInsets.symmetric(vertical: 5), +// value: value.ischecked ?? false, +// activeColor: Colors.black, +// checkColor: Colors.white, +// onChanged: (bool? newvalue) { +// value.ischecked = newvalue!; +// provider.setcheckBoxValue(sectionItem, sectionName, +// newvalue, value.id, multiple); +// //setState(() {}); +// }, +// ), +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget customdropdown(SectionList sectionItem, InteractionProvider provider, +// List list, bool multiple) { +// // sectionItem.value = ''; + +// if (list.isEmpty) { +// list = []; +// InputClass inputClass = +// InputClass(id: "no value", name: "Select ${sectionItem.name}"); +// list.add(inputClass); +// sectionItem.selectedObject = list[0]; +// } +// // InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// width: MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select ${sectionItem.name}', +// style: const TextStyle(fontSize: 14), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject ?? list[0], +// // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) +// // sectionItem.value ?? list[0].name, +// validator: (value) { +// if (value == null) { +// return 'Please select ${sectionItem.name}'; +// } +// return null; +// }, +// onChanged: (value) { +// //Do something when selected item is changed. +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// print("selected ${sectionItem.value}"); +// // setState(() {}); +// }, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// // setState(() {}); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(right: 8), +// ), +// iconStyleData: const IconStyleData( +// icon: Icon( +// Icons.arrow_drop_down, +// color: Colors.black45, +// ), +// iconSize: 24, +// ), +// dropdownStyleData: DropdownStyleData( +// decoration: BoxDecoration( +// borderRadius: BorderRadius.circular(10.0), +// ), +// ), +// menuItemStyleData: const MenuItemStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// ), +// ), +// ), +// ); +// } + +// Widget customAutoCompletedropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// list = sectionItem.inputList!; +// print("***Autocomplete list ${list[0].name}"); +// //} +// //InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Item', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onChanged: (value) { +// // setState(() { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// // setState(() {}); +// //}); +// }, + +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// height: 40, +// width: 200, +// ), +// dropdownStyleData: const DropdownStyleData( +// maxHeight: 200, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// ), +// dropdownSearchData: DropdownSearchData( +// searchController: textEditingController, +// searchInnerWidgetHeight: 50, +// searchInnerWidget: Container( +// height: 50, +// padding: const EdgeInsets.only( +// top: 8, +// bottom: 4, +// right: 8, +// left: 8, +// ), +// child: TextFormField( +// expands: true, +// maxLines: null, +// controller: textEditingController, +// decoration: InputDecoration( +// isDense: true, +// contentPadding: const EdgeInsets.symmetric( +// horizontal: 10, +// vertical: 18, +// ), +// hintText: 'Search for an item...', +// hintStyle: const TextStyle(fontSize: 12), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// ), +// ), +// ), +// searchMatchFn: (item, searchValue) { +// return item.value!.name.toString().contains(searchValue); +// }, +// ), +// //This to clear the search value when you close the menu +// onMenuStateChange: (isOpen) { +// if (!isOpen) { +// textEditingController.clear(); +// } +// }, +// ), +// ), +// ), +// ); +// } + +// Widget customMultiselectDropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// if (list.isEmpty) { +// list = sectionItem.inputList!; +// } +// InputClass selectedObj = list[0]; + +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, +// // height: MediaQuery.of(context).size.height, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Items', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list.map((item) { +// return DropdownMenuItem( +// value: item, +// //disable default onTap to avoid closing menu when selecting an item +// enabled: false, +// child: StatefulBuilder( +// builder: (context, menuSetState) { +// final isSelected = +// sectionItem.selectedValue!.contains(item.name); +// return InkWell( +// onTap: () { +// isSelected +// ? sectionItem.selectedValue!.remove(item.name) +// : sectionItem.selectedValue!.add(item.name); +// //This rebuilds the StatefulWidget to update the button's text +// setState(() {}); +// //This rebuilds the dropdownMenu Widget to update the check mark +// menuSetState(() {}); +// }, +// child: Container( +// height: double.infinity, +// padding: const EdgeInsets.symmetric(horizontal: 16.0), +// child: Row( +// children: [ +// if (isSelected) +// const Icon(Icons.check_box_outlined) +// else +// const Icon(Icons.check_box_outline_blank), +// const SizedBox(width: 16), +// Expanded( +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// }, +// ), +// ); +// }).toList(), +// //Use last selected item as the current value so if we've limited menu height, it scroll to last item. +// value: selectedObj, +// // ? null +// // : provider.selectedItems.last, +// onChanged: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onSaved: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// selectedItemBuilder: (context) { +// return list.map( +// (item) { +// return Container( +// alignment: AlignmentDirectional.center, +// child: Text( +// sectionItem.selectedValue!.join(', '), +// style: const TextStyle( +// fontSize: 14, +// overflow: TextOverflow.ellipsis, +// ), +// maxLines: 1, +// ), +// ); +// }, +// ).toList(); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(left: 16, right: 8), +// height: 40, +// width: 140, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// padding: EdgeInsets.zero, +// ), +// ), +// ), +// ), +// ); +// } + +// Widget gridViewWidget( +// InteractionProvider provider, +// String sectionName, +// List sectionList, +// Orientation orientation, +// FormFieldData item, +// int listIndex) { +// print("ListInex: $listIndex"); +// print("sectionName: $sectionName"); +// print("sectionName: $sectionName"); + +// print("gridsectionlost_is: $sectionList"); +// print("gridsectionlostleangth_is: ${sectionList.length}"); + +// List pooja = sectionList; + +// print("Pooja_isss: $pooja"); +// print("Pooja_leangth_isss: ${pooja.length}"); + +// ////////////////////////////////////mycode/////////////////////////// + +// List> convertedArray = []; +// print("Provider_leangth: ${item.sectionList.length}"); + +// for (int i = 0; i < pooja.length; i += item.sectionList.length + 1) { +// print("poojaleangth: $pooja"); + +// convertedArray.add(pooja.sublist(i, i + item.sectionList.length + 1)); +// } +// print("ConvertedArray.leangth: $convertedArray"); +// print("ConvertedArray.leangth: ${convertedArray.length}"); + +// return Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// for (var i = 0; i < convertedArray.length; i++) +// DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// color: i % 2 == 0 +// ? Color.fromARGB(133, 213, 241, 254) +// : Colors.white, +// ), +// child: GridView.builder( +// physics: const NeverScrollableScrollPhysics(), +// gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( +// crossAxisCount: context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == Orientation.landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 ? 1 : 3, // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 1, +// childAspectRatio: sectionList.length == 1 +// ? orientation == Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.7, +// ), +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// itemCount: convertedArray[i].length, +// itemBuilder: (context, index) { +// SectionList sectionItem = convertedArray[i][index]; +// dropdownvalue = +// sectionItem.widget == InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = sectionItem.widget == +// InteractionWidget.DROPDOWN || +// sectionItem.widget == +// InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; +// return Padding( +// padding: const EdgeInsets.only(top: 12.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// // sectionItem.widget == InteractionWidget.BUTTON && +// // sectionItem.input == 'add' || +// // sectionItem.input == 'deletebtn' +// // ? const SizedBox.shrink() +// // : +// Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// sectionItem.validation!.isRequired +// ? "${sectionItem.name}*" +// : sectionItem.name, +// style: TextStyle( +// color: Colors.orange.shade800, fontSize: 18), +// ), +// ), +// ), +// // const SizedBox( +// // height: 15, +// // ), +// sectionItem.widget == InteractionWidget.BUTTON +// ? sectionItem.input == 'chooseFile' +// ? Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB( +// 255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem +// .selectedValue!.isNotEmpty +// ? 'File uploaded' +// : "Files Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem +// .selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ) +// : isTablet +// ? IconButton( +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// icon: const Icon( +// Icons.cancel, +// size: 30, +// color: Color.fromARGB(255, 8, 39, 92), +// ), +// ) +// : Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 75, 75), +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// height: 40, + +// // height: +// // MediaQuery.of(context).size.height * +// // 0.2, +// fontsize: 12, +// textColor: Colors.white, +// title: "Delete"), +// ) +// : returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: listIndex, +// widgetData: sectionItem.widget!, +// multiple: true), +// ], +// ), +// ); +// }), +// ) +// ], +// ); +// //); +// } + +// String fieldsValidation(InteractionProvider provider) { +// List secList = provider.sectionList +// .where((element) => element.validation!.isRequired = true) +// .toList(); +// if (secList.any((element) => element.selectedValue!.isEmpty)) { +// return 'Fields cannot be empty'; +// } +// return ''; +// } + +// String textFieldsValidation(InteractionProvider provider) { +// return ''; +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } + +// Future getEncodedFile(SectionList sectionItem) async { +// String base64Image = ''; +// var status = Platform.isAndroid +// ? await Permission.manageExternalStorage.status +// : await Permission.storage.status; +// if (status.isGranted) { +// FilePickerResult? result = +// await FilePicker.platform.pickFiles(allowMultiple: true); + +// if (result != null) { +// print(result.files.first.path); +// print(result.files.last.path); +// for (var files in result.files) { +// File file = File(files.path!); +// print("check file path : ${file.path}"); +// fileName = file.path.split('/').last; +// // Get the application folder directory +// Directory? directory = Platform.isAndroid +// ? await getExternalStorageDirectory() //FOR ANDROID +// : await getApplicationDocumentsDirectory(); +// String newPath = ""; //FOR ios +// String convertedDirectoryPath = (directory?.path).toString(); + +// print("see the converted directory path $convertedDirectoryPath"); + +// newPath = "$convertedDirectoryPath/konectar/files"; +// print("new path :$newPath"); +// directory = Directory(newPath); +// if (!await directory.exists()) { +// await directory.create(recursive: true); +// } +// File newFile = await file.copy('${directory.path}/$fileName'); +// print("new path is ${newFile.path}"); +// final extension = p.extension(newFile.path); +// List imageBytes = await newFile.readAsBytes(); +// Uint8List imageUint8List = Uint8List.fromList(imageBytes); +// base64Image = base64Encode(imageUint8List); +// sectionItem.selectedValue!.add(base64Image); +// sectionItem.extension!.add(extension); +// sectionItem.fileName!.add(fileName); +// } +// } +// } else { +// print("not permitted"); +// await requestPermission(Platform.isAndroid +// ? Permission.manageExternalStorage +// : Permission.storage); +// } +// } + +// showAlertDialog(BuildContext context, String record) { +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// showAlertDialog1(BuildContext context, String record) { +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// Widget _offsetPopup(List interactionReponseList) => +// PopupMenuButton( +// itemBuilder: (context) { +// return List.generate(interactionReponseList.length, (index) { +// var provider = +// Provider.of(context, listen: false); + +// var item = provider.interactionReponseList[index]; + +// return PopupMenuItem( +// value: index, +// child: item.multiple +// ? GestureDetector( +// onTap: () { +// print("Clicked Section ${item.sectionName}"); +// // provider.getSectionItem( +// // item.sectionName, +// // ); +// setState(() { +// provider.getSectionItem( +// item.sectionName, +// ); +// }); + +// const DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// border: Border( +// bottom: +// BorderSide(width: 1.5, color: Colors.black), +// //top: BorderSide(width: 1.5, color: Colors.black), +// ), +// ), +// ); +// }, +// child: Text(' ${item.sectionName}')) +// : Container(), +// ); +// }); +// }, +// icon: Container( +// height: double.infinity, +// width: double.infinity, +// decoration: const ShapeDecoration( +// color: Color.fromARGB(255, 8, 39, 92), +// shape: StadiumBorder( +// side: BorderSide(color: Colors.white, width: 2), +// ), +// ), +// child: Icon(Icons.add, color: Colors.white), +// )); +// } + +////////////////////////////////////////////////////////////////////////////////////////// +// import 'dart:convert'; +// import 'dart:io'; +// // import 'dart:js_interop'; +// // import 'dart:js_util'; + +// import 'package:discover_module/constants.dart'; +// import 'package:discover_module/custom_widget/floating_btn.dart'; +// import 'package:discover_module/ui_screen/add_event/add_hcp.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/responsive_ext.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/rendering.dart'; +// import 'package:flutter/services.dart'; +// import 'package:flutter/widgets.dart'; +// import 'package:intl/intl.dart'; +// import 'package:path_provider/path_provider.dart'; +// import 'package:popover/popover.dart'; +// import 'package:provider/provider.dart'; +// import 'package:dropdown_button2/dropdown_button2.dart'; + +// import 'package:file_picker/file_picker.dart'; +// // import 'package:pwa_ios/widgets/responsive_ext.dart'; +// import 'package:permission_handler/permission_handler.dart'; +// import 'package:path/path.dart' as p; + +// // import 'package:popover/popover.dart'; + +// class InteractionScreen extends StatefulWidget { +// int index; +// String form; +// InteractionScreen({super.key, required this.index, required this.form}); + +// @override +// State createState() => _InteractionScreenState(); +// } + +// class _InteractionScreenState extends State { +// List interactionReponseList = []; +// List sectionList = []; +// List textEditingControllerList = []; +// int textfieldIndex = 0; +// String dropdownvalue = 'Select value'; +// String? fileName; +// final TextEditingController textEditingController = TextEditingController(); +// @override +// void initState() { +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// // if (mytimer!.isActive) { +// // cancelTimer(); +// // } +// init(); +// }); + +// super.initState(); +// } + +// init() async { +// await Provider.of(context, listen: false) +// .init(widget.index); +// setState(() {}); +// } + +// @override +// Widget build(BuildContext context) { +// return Consumer( +// builder: (BuildContext context, provider, Widget? child) { +// return GestureDetector( +// onTap: () { +// FocusScope.of(context).requestFocus(FocusNode()); +// }, +// child: OrientationBuilder(builder: (context, orientation) { +// return SafeArea( +// child: Scaffold( +// //resizeToAvoidBottomInset: false, +// appBar: AppBar( +// title: const FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// 'Record New Interaction', +// style: TextStyle( +// // fontSize: isTablet ? 22 : 14, color: Colors.white +// // fontSize: 20, +// color: Colors.white), +// ), +// ), +// // backgroundColor: const Color(0xFF2b9af3), +// automaticallyImplyLeading: false, +// actions: [saveActions(provider)], +// leading: InkWell( +// onTap: () { +// Navigator.pop(context); +// }, +// child: const Icon( +// Icons.arrow_back_ios, +// color: Colors.white, +// ), +// ), +// ), +// body: Column( +// children: [ +// Expanded( +// child: ListView.builder( +// itemCount: provider.interactionReponseList.length, +// padding: EdgeInsets.zero, +// cacheExtent: double.parse( +// provider.interactionReponseList.length.toString()), +// itemBuilder: (context, index) { +// var item = provider.interactionReponseList[index]; +// sectionList = item.sectionList; +// return ExpansionTile( +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// initiallyExpanded: true, +// title: Stack( +// alignment: AlignmentDirectional.center, +// children: [ +// Container( +// // height: double.infinity, +// width: double.infinity, +// padding: const EdgeInsets.all(8.0), +// decoration: BoxDecoration( +// // color: Color(0xFF2b9af3), +// color: Constants.k2color, +// ), +// child: Text( +// item.sectionName, +// style: const TextStyle( +// color: Colors.white, +// fontWeight: FontWeight.bold, +// // fontSize: isTablet ? 18 : 14 +// ), +// )), +// item.multiple +// ? Align( +// alignment: Alignment.centerRight, +// child: IconButton( +// onPressed: () { +// if (item.sectionName == "HCP") { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (context) => +// Addhcp())); + +// provider.getSectionItem( +// item.sectionName, +// ); +// // print("index is $listIndex"); +// setState(() { +// // for (var item +// }); +// } else { +// provider.getSectionItem( +// item.sectionName, +// ); +// // print("index is $listIndex"); +// setState(() {}); +// } +// }, +// icon: const Icon( +// Icons.add_circle_outline, +// size: 30, +// color: Colors.white, +// ), +// ), +// ) +// : const SizedBox.shrink() +// ]), +// children: [ +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.center, +// children: [ +// Padding( +// padding: isTablet +// ? const EdgeInsets.only(left: 14.0) +// : const EdgeInsets.only( +// left: 12.0, right: 12.0), +// child: GridView.count( +// physics: +// const NeverScrollableScrollPhysics(), +// // crossAxisCount: +// // context.responsive( +// // 1, +// // sm: 1, // small +// // md: 1, // medium +// // lg: sectionList.length == 1 +// // ? 1 +// // : 3, // large +// // xl: 3, // extra large screen +// // ), + +// crossAxisCount: context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == +// Orientation.landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 +// ? 1 +// : 3, // large +// xl: 3, // extra large screen +// ), + +// // crossAxisCount: +// // orientation == Orientation.portrait +// // ? 1 +// // : 3, +// // crossAxisCount: (MediaQuery.of(context) +// // .orientation == +// // Orientation.landscape) +// // ? 3 +// // : 1, + +// mainAxisSpacing: +// sectionList.length == 1 || !isTablet +// ? 1 +// : 3.5, +// // mainAxisSpacing: +// // orientation == Orientation.portrait +// // ? 1 +// // : 3, +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// // childAspectRatio: MediaQuery.of(context) +// // .size +// // .aspectRatio * +// // 0.10, +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 3.8 +// // : 2.4, +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 3.8 +// // : isTablet +// // ? 2.8 +// // : 3.8, + +// childAspectRatio: +// sectionList.length == 1 +// ? orientation == +// Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.0, +// // /:2.4, +// // childAspectRatio: 3.8, + +// children: List.generate( +// sectionList.length, +// (i) { +// SectionList sectionItem = +// sectionList[i]; +// dropdownvalue = sectionItem +// .widget == +// InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = sectionItem +// .widget == +// InteractionWidget +// .DROPDOWN || +// sectionItem.widget == +// InteractionWidget +// .AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget +// .MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = sectionItem +// .widget == +// InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; + +// return Column( +// crossAxisAlignment: +// CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == +// InteractionWidget +// .BUTTON && +// sectionItem.input == +// 'add' +// ? const SizedBox.shrink() +// : Padding( +// padding: +// const EdgeInsets +// .only( +// left: 8.0, +// right: 8.0), +// child: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// sectionItem +// .validation! +// .isRequired +// ? '${sectionItem.name}:*' +// : '${sectionItem.name}:', +// style: TextStyle( +// color: Colors +// .orange +// .shade800, +// fontSize: 18.0, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// ), +// ), +// ), +// ), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), +// returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: index, +// widgetData: +// sectionItem.widget!, +// multiple: false), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), + +// // sectionItem.depid == 'pooja' +// // ? Text( +// // sectionItem.validation! +// // .isRequired +// // ? '${sectionItem.depid}:*' +// // : '${sectionItem.depid}:', +// // style: TextStyle( +// // color: Colors +// // .orange.shade800, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// // ), +// // ) +// // : const SizedBox.shrink(), +// ], +// ); +// }, +// ), +// ), +// ), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), +// item.multiple +// ? gridViewWidget( +// provider, +// item.sectionName, +// item.multipleList ?? [], +// orientation, +// item, +// index) +// : const SizedBox.shrink(), +// provider.interactionReponseList.length == +// index - 1 +// ? saveActions(provider) +// : const SizedBox.shrink() +// //const Spacer(), +// ], +// ), +// ), +// ]); +// }, +// ), +// ), +// // const Spacer(), +// // saveActions(provider), +// Align( +// alignment: Alignment.bottomRight, +// child: Container( +// height: 80.0, +// width: 80.0, +// child: _offsetPopup(provider.interactionReponseList))) +// ], +// ), +// // floatingActionButton: FloatingBtn( +// // title: "data", +// // icon: Icons.add, +// // onTap: () { +// // showPopover( +// // context: context, +// // bodyBuilder: (context) { +// // return Padding( +// // padding: const EdgeInsets.symmetric(vertical: 8), +// // child: ListView( +// // padding: const EdgeInsets.all(8), +// // children: [ +// // InkWell( +// // onTap: () { + +// // }, +// // child: Container( +// // height: 50, +// // color: Colors.amber[100], +// // child: const Center(child: Text('Entry A')), +// // ), +// // ), +// // const Divider(), +// // Container( +// // height: 50, +// // color: Colors.amber[200], +// // child: const Center(child: Text('Entry B')), +// // ), +// // const Divider(), +// // Container( +// // height: 50, +// // color: Colors.amber[300], +// // child: const Center(child: Text('Entry C')), +// // ), +// // const Divider(), +// // Container( +// // height: 50, +// // color: Colors.amber[400], +// // child: const Center(child: Text('Entry D')), +// // ), +// // const Divider(), +// // Container( +// // height: 50, +// // color: Colors.amber[500], +// // child: const Center(child: Text('Entry E')), +// // ), +// // const Divider(), +// // Container( +// // height: 50, +// // color: Colors.amber[600], +// // child: const Center(child: Text('Entry F')), +// // ), +// // ], +// // ), +// // ); +// // }, +// // ); + +// // var itemsectionname = +// // provider.interactionReponseList.length; + +// // print("ItemSectionname: $itemsectionname"); + +// // for (int i = 0; i < itemsectionname; i++) { +// // var item = provider.interactionReponseList[i]; + +// // print( +// // "Check_ProviderNameL ${item.sectionName}, ${item.multiple}"); +// // } + +// // // provider.getSectionItem( +// // // item.sectionName, +// // // ); +// // }, +// // ) +// ), +// ); +// }), +// ); +// }); +// } + +// Widget returnWidget({ +// required SectionList sectionItem, +// required FormFieldData item, +// required InteractionProvider provider, +// required List list, +// required int gridIndex, +// required int listIndex, +// required InteractionWidget widgetData, +// required bool multiple, +// }) { +// switch (widgetData) { +// case InteractionWidget.CHECKBOX: +// return (sectionItem.inputList!.length >= 5) +// ? customMultiselectDropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + +// case InteractionWidget.AUTOCOMPLETE: +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); + +// case InteractionWidget.MULTISELECT: +// return customMultiselectDropdown(sectionItem, provider, list, multiple); + +// case InteractionWidget.RADIO: +// return (sectionItem.inputList!.length >= 5) +// ? customdropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildRadio(sectionItem, provider); + +// case InteractionWidget.LABEL: +// return Text(sectionItem.input!); + +// case InteractionWidget.RANGESLIDER: +// return CustomRangeSlider( +// max: double.parse(sectionItem.max!), +// min: double.parse(sectionItem.min!), +// sliderPos: sectionItem.selectedValue!.isNotEmpty +// ? double.parse(sectionItem.selectedValue!.last.toString()) +// : double.parse(sectionItem.min!), +// onChanged: (val) { +// setState(() { +// sectionItem.selectedValue = []; +// sectionItem.selectedId = val.toString(); +// sectionItem.selectedValue!.add(val.toInt()); +// }); +// }, +// ); + +// case InteractionWidget.BUTTON: +// return sectionItem.input == 'add' +// ? const Offstage( +// offstage: true, +// child: Text("Visible"), +// ) +// : Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB(255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.length > 1 +// ? 'Files uploaded' +// : "File Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem.selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ); + +// case InteractionWidget.TEXT: +// return sectionItem.input == 'Date' +// ? buildDateWidget(sectionItem) +// : sectionItem.input == "textArea" +// ? Expanded( +// child: InteractionTextField( +// // maxchars: int.parse(sectionItem.validation!.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// // maxlines: 8, +// //minlines: 4, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// setState(() {}); + +// sectionItem.selectedValue!.add(val); +// }, +// ), +// ) +// ////Poojaaaaa +// : sectionItem.input == "text1" +// ? Text( +// sectionItem.depid!, +// style: TextStyle( +// fontSize: 18.0, fontWeight: FontWeight.normal), +// ) +// : Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: +// // isTablet ? 200 : MediaQuery.of(context).size.width, +// //height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// height: isTablet ? 50 : 40, + +// child: InteractionTextField( +// inputType: sectionItem.input == "number" +// ? TextInputType.number +// : TextInputType.name, +// maxchars: int.parse(sectionItem.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// // sectionItem.selectedValue!.clear(); + +// provider.setTextValue( +// val, sectionItem, multiple); +// }, +// ), +// ), +// ), +// ); +// case InteractionWidget.DROPDOWN: +// // return customdropdown(sectionItem, provider, list, multiple); + +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); +// } +// } + +// Future requestPermission(Permission permission) async { +// final status = await permission.request(); + +// setState(() { +// print(status); +// // _permissionStatus = status; +// // print(_permissionStatus); +// }); +// } + +// Widget buildDateWidget(SectionList sectionItem) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// child: TextField( +// controller: +// sectionItem.controller, //editing controller of this TextField +// decoration: InputDecoration( +// // border: OutlineInputBorder(), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// labelStyle: const TextStyle(fontSize: 16), +// suffixIcon: const Icon(Icons.calendar_today), //icon of text field +// labelText: "Enter Date" //label text of field +// ), +// readOnly: true, //set it true, so that user will not able to edit text +// onTap: () async { +// DateTime? pickedDate = await showDatePicker( +// context: context, +// initialDate: DateTime.now(), +// firstDate: DateTime( +// 2000), //DateTime.now() - not to allow to choose before today. +// lastDate: DateTime(2101)); + +// if (pickedDate != null) { +// print( +// pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 +// String formattedDate = +// DateFormat('yyyy-MM-dd').format(pickedDate); +// print( +// formattedDate); //formatted date output using intl package => 2021-03-16 +// //you can implement different kind of Date Format here according to your requirement + +// setState(() { +// sectionItem.controller!.text = formattedDate; +// sectionItem.selectedValue = []; +// sectionItem.selectedValue! +// .add(formattedDate); //set output date to TextField value. +// }); +// } else { +// print("Date is not selected"); +// } +// }, +// ), +// ), +// ); +// } + +// Widget saveActions(InteractionProvider provider) { +// return Align( +// alignment: Alignment.centerRight, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceEvenly, +// children: [ +// Padding( +// padding: const EdgeInsets.all(4.0), +// child: CustomButton( +// backgroundColor: Colors.red.shade800, +// onPressed: () { +// //showDeleteProfileAlertDialog(context); +// for (var textcontrollers +// in provider.textEditingControllerList) { +// textcontrollers.text = ''; +// } + +// // setState(() { +// // provider.resetAllWidgetsData(); +// // }); +// }, +// textColor: Colors.white, +// title: "Reset", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// fontsize: isTablet ? 15 : 10.2, +// ), +// ), +// SizedBox( +// width: isTablet ? 20 : 4, +// ), +// Padding( +// padding: const EdgeInsets.all(4.0), +// child: CustomButton( +// backgroundColor: Colors.green.shade500, +// onPressed: () async { +// // if (textFieldsValidation(provider).isEmpty) { +// // print("Form_issss: ${widget.form}"); +// // String record = +// // await provider.saveJsonObject(context, widget.form); +// // showAlertDialog(context, record); +// // } else { +// // _displaySnackBar(textFieldsValidation(provider)); +// // } + +// ////////////////////////////////////////////////actual code/////////////////// +// /// +// // String record = +// // await provider.saveJsonObject(context, widget.form); +// // showAlertDialog(context, record); + +// ///Cnahging Code////////////// +// /// +// /// +// ///validateTextFields + +// // if (provider.validateTextFields()) { +// // print("Form_issss: ${widget.form}"); +// String record = +// await provider.saveJsonObject(context, widget.form); +// // showAlertDialog(context, record); + +// // for (int i = 0; i < sectionList.length; i++) { +// // SectionList sectionItem = sectionList[i]; + +// // print( +// // "ValidationMandotary_isss: ${sectionItem.validation!.isRequired}"); +// // } + +// print("Validation_isss: ${provider.isLoading}"); + +// if (provider.isLoading == false) { +// print("Validation_false"); +// showAlertDialog1(context, "Please fill all the fields"); +// } else { +// showAlertDialog(context, "Form $record Saved Successfully!"); +// print("Validation_True"); +// } + +// // print("Interaction_Type:"); +// // } else { +// // _displaySnackBar(textFieldsValidation(provider)); +// // } +// }, +// textColor: Colors.white, +// title: "Save", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// // width: MediaQuery.of(context).size.width * 0.1, +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// width: isTablet ? 20 : 2, +// ), +// ], +// ), +// ); +// } + +// Widget buildRadio(SectionList sectionItem, InteractionProvider provider) { +// List list = provider.getData2(sectionItem); +// // .map((itemWord) => InputClass.fromJson(itemWord)) +// // .toList(); +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 250 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (InputClass value in list) +// Row( +// children: [ +// Radio( +// value: value.name, +// activeColor: Colors.black, +// groupValue: provider.radioValue, +// onChanged: (String? value) { +// setState(() { +// print(value); +// provider.radioValue = value!; +// int index = +// list.indexWhere((element) => element.name == value); +// sectionItem.selectedValue!.add(list[index].id); +// }); +// }, +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget buildCheckbox(SectionList sectionItem, String sectionName, +// InteractionProvider provider, bool multiple) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: 250, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (var value in provider.checkboxlist) +// Row( +// children: [ +// FittedBox( +// fit: BoxFit.scaleDown, +// child: Checkbox( +// value: value.ischecked ?? false, +// activeColor: Colors.black, +// checkColor: Colors.white, +// onChanged: (bool? newvalue) { +// value.ischecked = newvalue!; +// provider.setcheckBoxValue(sectionItem, sectionName, +// newvalue, value.id, multiple); +// //setState(() {}); +// }, +// ), +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget customdropdown(SectionList sectionItem, InteractionProvider provider, +// List list, bool multiple) { +// // sectionItem.value = ''; + +// if (list.isEmpty) { +// list = []; +// InputClass inputClass = +// InputClass(id: "no value", name: "Select ${sectionItem.name}"); +// list.add(inputClass); +// sectionItem.selectedObject = list[0]; +// } +// // InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// width: MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select ${sectionItem.name}', +// style: const TextStyle(fontSize: 14), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject ?? list[0], +// // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) +// // sectionItem.value ?? list[0].name, +// validator: (value) { +// if (value == null) { +// return 'Please select ${sectionItem.name}'; +// } +// return null; +// }, +// onChanged: (value) { +// //Do something when selected item is changed. +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// print("selected ${sectionItem.value}"); +// // setState(() {}); +// }, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// // setState(() {}); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(right: 8), +// ), +// iconStyleData: const IconStyleData( +// icon: Icon( +// Icons.arrow_drop_down, +// color: Colors.black45, +// ), +// iconSize: 24, +// ), +// dropdownStyleData: DropdownStyleData( +// decoration: BoxDecoration( +// borderRadius: BorderRadius.circular(15), +// ), +// ), +// menuItemStyleData: const MenuItemStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// ), +// ), +// ), +// ); +// } + +// Widget customAutoCompletedropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// // sectionItem.value = list[0].name; + +// // if (list.isEmpty) { +// // print("list is empty"); +// list = sectionItem.inputList!; +// print("***Autocomplete list ${list[0].name}"); +// //} +// //InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Item', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onChanged: (value) { +// // setState(() { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// // setState(() {}); +// //}); +// }, + +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// height: 40, +// width: 200, +// ), +// dropdownStyleData: const DropdownStyleData( +// maxHeight: 200, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// ), +// dropdownSearchData: DropdownSearchData( +// searchController: textEditingController, +// searchInnerWidgetHeight: 50, +// searchInnerWidget: Container( +// height: 50, +// padding: const EdgeInsets.only( +// top: 8, +// bottom: 4, +// right: 8, +// left: 8, +// ), +// child: TextFormField( +// expands: true, +// maxLines: null, +// controller: textEditingController, +// decoration: InputDecoration( +// isDense: true, +// contentPadding: const EdgeInsets.symmetric( +// horizontal: 10, +// vertical: 8, +// ), +// hintText: 'Search for an item...', +// hintStyle: const TextStyle(fontSize: 12), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(8), +// ), +// ), +// ), +// ), +// searchMatchFn: (item, searchValue) { +// return item.value!.name.toString().contains(searchValue); +// }, +// ), +// //This to clear the search value when you close the menu +// onMenuStateChange: (isOpen) { +// if (!isOpen) { +// textEditingController.clear(); +// } +// }, +// ), +// ), +// ), +// ); +// } + +// Widget customMultiselectDropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// if (list.isEmpty) { +// list = sectionItem.inputList!; +// } +// InputClass selectedObj = list[0]; + +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, +// // height: MediaQuery.of(context).size.height, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(15), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Items', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list.map((item) { +// return DropdownMenuItem( +// value: item, +// //disable default onTap to avoid closing menu when selecting an item +// enabled: false, +// child: StatefulBuilder( +// builder: (context, menuSetState) { +// final isSelected = +// sectionItem.selectedValue!.contains(item.name); +// return InkWell( +// onTap: () { +// isSelected +// ? sectionItem.selectedValue!.remove(item.name) +// : sectionItem.selectedValue!.add(item.name); +// //This rebuilds the StatefulWidget to update the button's text +// setState(() {}); +// //This rebuilds the dropdownMenu Widget to update the check mark +// menuSetState(() {}); +// }, +// child: Container( +// height: double.infinity, +// padding: const EdgeInsets.symmetric(horizontal: 16.0), +// child: Row( +// children: [ +// if (isSelected) +// const Icon(Icons.check_box_outlined) +// else +// const Icon(Icons.check_box_outline_blank), +// const SizedBox(width: 16), +// Expanded( +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// }, +// ), +// ); +// }).toList(), +// //Use last selected item as the current value so if we've limited menu height, it scroll to last item. +// value: selectedObj, +// // ? null +// // : provider.selectedItems.last, +// onChanged: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onSaved: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// selectedItemBuilder: (context) { +// return list.map( +// (item) { +// return Container( +// alignment: AlignmentDirectional.center, +// child: Text( +// sectionItem.selectedValue!.join(', '), +// style: const TextStyle( +// fontSize: 14, +// overflow: TextOverflow.ellipsis, +// ), +// maxLines: 1, +// ), +// ); +// }, +// ).toList(); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(left: 16, right: 8), +// height: 40, +// width: 140, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// padding: EdgeInsets.zero, +// ), +// ), +// ), +// ), +// ); +// } + +// Widget gridViewWidget( +// InteractionProvider provider, +// String sectionName, +// List sectionList, +// Orientation orientation, +// FormFieldData item, +// int listIndex) { +// print("ListInex: $listIndex"); +// print("sectionName: $sectionName"); +// print("sectionName: $sectionName"); + +// print("gridsectionlost_is: $sectionList"); +// print("gridsectionlostleangth_is: ${sectionList.length}"); + +// List pooja = sectionList; + +// print("Pooja_isss: $pooja"); +// print("Pooja_leangth_isss: ${pooja.length}"); + +// ////////////////////////////////////mycode/////////////////////////// +// /// +// /// +// // final provider = context.read(); +// // var yourVariable = provider.ge; +// // print("ProviderLength: $yourVariable"); +// // print("ProviderLength: ${yourVariable.length}"); + +// List> convertedArray = []; +// print("Provider_leangth: ${item.sectionList.length}"); + +// for (int i = 0; i < pooja.length; i += item.sectionList.length + 1) { +// print("poojaleangth: $pooja"); + +// convertedArray.add(pooja.sublist(i, i + item.sectionList.length + 1)); +// } +// print("ConvertedArray.leangth: $convertedArray"); +// print("ConvertedArray.leangth: ${convertedArray.length}"); + +// return Padding( +// padding: isTablet +// ? const EdgeInsets.only(left: 0.0) +// : const EdgeInsets.only(left: 12.0, right: 12.0), +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// for (var i = 0; i < convertedArray.length; i++) +// DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// color: i % 2 == 0 +// ? Color.fromARGB(133, 213, 241, 254) +// : Colors.white, +// ), +// child: GridView.builder( +// physics: const NeverScrollableScrollPhysics(), +// gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( +// crossAxisCount: context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == Orientation.landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 ? 1 : 3, // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: +// sectionList.length == 1 || !isTablet ? 1 : 1, +// childAspectRatio: sectionList.length == 1 +// ? orientation == Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.0, +// ), +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// itemCount: convertedArray[i].length, +// itemBuilder: (context, index) { +// SectionList sectionItem = convertedArray[i][index]; +// dropdownvalue = +// sectionItem.widget == InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = sectionItem.widget == +// InteractionWidget.DROPDOWN || +// sectionItem.widget == +// InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; +// return SizedBox( +// height: MediaQuery.of(context).size.height, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == InteractionWidget.BUTTON && +// sectionItem.input == 'add' || +// sectionItem.input == 'deletebtn' +// ? const SizedBox.shrink() +// : Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// sectionItem.validation!.isRequired +// ? "${sectionItem.name}*" +// : sectionItem.name, +// style: TextStyle( +// color: Colors.orange.shade800, +// fontSize: 18), +// ), +// ), +// ), +// // const SizedBox( +// // height: 15, +// // ), +// sectionItem.widget == InteractionWidget.BUTTON +// ? sectionItem.input == 'chooseFile' +// ? Row( +// children: [ +// CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem +// .selectedValue!.isNotEmpty +// ? 'File uploaded' +// : "Files Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem +// .selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ) +// : isTablet +// ? IconButton( +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// icon: const Icon( +// Icons.cancel, +// size: 30, +// color: +// Color.fromARGB(255, 8, 39, 92), +// ), +// ) +// : Padding( +// padding: const EdgeInsets.only( +// left: 3.0, top: 5), +// child: CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 75, 75), +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// // width: 80, +// // height: 30, + +// height: 40, + +// // height: +// // MediaQuery.of(context).size.height * +// // 0.2, +// fontsize: 12, +// textColor: Colors.white, +// title: "Delete"), +// ) +// : returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: listIndex, +// widgetData: sectionItem.widget!, +// multiple: true), +// ], +// ), +// ); +// }), +// ) +// ], +// ), +// ); +// //); +// } + +// String fieldsValidation(InteractionProvider provider) { +// List secList = provider.sectionList +// .where((element) => element.validation!.isRequired = true) +// .toList(); +// if (secList.any((element) => element.selectedValue!.isEmpty)) { +// return 'Fields cannot be empty'; +// } +// return ''; +// } + +// String textFieldsValidation(InteractionProvider provider) { +// // if (provider.sectionList +// // .any((element) => element.widget == InteractionWidget.TEXT)) { +// // if (provider.sectionList +// // .any((element) => element.controller!.text.isEmpty)) { +// // return 'Fields cannot be empty'; +// // } +// // if (provider.textEditingControllerList.isNotEmpty) { +// // if (provider.validateTextFields()) { +// // return 'Fields cannot be empty'; +// // } +// // } + +// // if (provider.multipletextEditingControllerList.isNotEmpty) { +// // if (provider.validateMultipleRows()) { +// // return 'Fields cannot be empty'; +// // } +// // } +// // } + +// return ''; +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } + +// Future getEncodedFile(SectionList sectionItem) async { +// String base64Image = ''; +// var status = Platform.isAndroid +// ? await Permission.manageExternalStorage.status +// : await Permission.storage.status; +// if (status.isGranted) { +// FilePickerResult? result = +// await FilePicker.platform.pickFiles(allowMultiple: true); + +// if (result != null) { +// print(result.files.first.path); +// print(result.files.last.path); +// for (var files in result.files) { +// File file = File(files.path!); +// print("check file path : ${file.path}"); +// fileName = file.path.split('/').last; +// // Get the application folder directory +// Directory? directory = Platform.isAndroid +// ? await getExternalStorageDirectory() //FOR ANDROID +// : await getApplicationDocumentsDirectory(); +// String newPath = ""; //FOR ios +// String convertedDirectoryPath = (directory?.path).toString(); + +// print("see the converted directory path $convertedDirectoryPath"); + +// newPath = "$convertedDirectoryPath/konectar/files"; +// print("new path :$newPath"); +// directory = Directory(newPath); +// if (!await directory.exists()) { +// await directory.create(recursive: true); +// } +// File newFile = await file.copy('${directory.path}/$fileName'); +// print("new path is ${newFile.path}"); +// final extension = p.extension(newFile.path); +// List imageBytes = await newFile.readAsBytes(); +// Uint8List imageUint8List = Uint8List.fromList(imageBytes); +// base64Image = base64Encode(imageUint8List); +// sectionItem.selectedValue!.add(base64Image); +// sectionItem.extension!.add(extension); +// sectionItem.fileName!.add(fileName); +// } +// } +// } else { +// print("not permitted"); +// await requestPermission(Platform.isAndroid +// ? Permission.manageExternalStorage +// : Permission.storage); +// } +// } + +// showAlertDialog(BuildContext context, String record) { +// // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// showAlertDialog1(BuildContext context, String record) { +// // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// Widget _offsetPopup(List interactionReponseList) => PopupMenuButton< +// int>( +// itemBuilder: (context) { +// return List.generate(interactionReponseList.length, (index) { +// var provider = +// Provider.of(context, listen: false); + +// var item = provider.interactionReponseList[index]; + +// return PopupMenuItem( +// value: index, +// child: item.multiple +// ? GestureDetector( +// onTap: () { +// print("Clicked Section ${item.sectionName}"); +// // provider.getSectionItem( +// // item.sectionName, +// // ); +// setState(() { +// provider.getSectionItem( +// item.sectionName, +// ); +// }); + +// const DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// border: Border( +// bottom: BorderSide(width: 1.5, color: Colors.black), +// //top: BorderSide(width: 1.5, color: Colors.black), +// ), +// ), +// ); +// }, +// child: Text(' ${item.sectionName}')) +// : Container(), +// ); +// }); +// }, +// // itemBuilder: (context) => [ + +// // const PopupMenuItem( +// // value: 1, +// // child: Text( +// // "Flutter Open", +// // style: +// // TextStyle(color: Colors.black, fontWeight: FontWeight.w700), +// // ), +// // ), +// // const PopupMenuItem( +// // value: 2, +// // child: Text( +// // "Flutter Tutorial", +// // style: +// // TextStyle(color: Colors.black, fontWeight: FontWeight.w700), +// // ), +// // ), +// // ], +// icon: Container( +// height: double.infinity, +// width: double.infinity, +// decoration: const ShapeDecoration( +// color: Color.fromARGB(255, 8, 39, 92), +// shape: StadiumBorder( +// side: BorderSide(color: Colors.white, width: 2), +// ), +// ), +// child: Icon(Icons.add, color: Colors.white), +// )); +// } diff --git a/lib/contacts_module/ui_screen/interactionform/interactionlistscreen.dart b/lib/contacts_module/ui_screen/interactionform/interactionlistscreen.dart new file mode 100644 index 0000000..6320f6f --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/interactionlistscreen.dart @@ -0,0 +1,181 @@ +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/new_dynamicform.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/view_forms_list.dart'; +// import 'package:discover_module/ui_screen/interactionform/interaction_screen.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:discover_module/ui_screen/interactionform/new_dynamicform.dart'; +// import 'package:discover_module/ui_screen/interactionform/view_forms_list.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class InteractionListScreen extends StatefulWidget { + const InteractionListScreen({super.key}); + + @override + State createState() => _InteractionListScreenState(); +} + +class _InteractionListScreenState extends State { + List savedList = []; + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // if (!mytimer!.isActive) { + // activateTimer(); + // } + print("interactionListt"); + init(); + }); + + super.initState(); + } + + init() async { + print("init"); + + await Provider.of(context, listen: false) + .initConfigData(); + + await Provider.of(context, listen: false).getRecords(); + setState(() {}); + } + + Future getCount(String form, InteractionProvider provider) async { + await provider.getRecords(); + + return provider.savedList.where((element) => element.form == form).length; + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + return SafeArea( + child: Scaffold( + appBar: AppBar( + title: Text( + 'Interaction Forms', + //style: TextStyle(fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + automaticallyImplyLeading: false, + // backgroundColor: const Color(0xFF2b9af3), + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Container( + child: Center( + child: ListView.builder( + itemCount: provider.intConfigDataList.length, + cacheExtent: double.parse( + provider.intConfigDataList.length.toString()), + itemBuilder: (context, index) { + print("ism Screenindex $index"); + return Column( + children: [ + ListTile( + title: Row( + children: [ + Text( + provider.intConfigDataList[index].name, + ), + const SizedBox( + width: 20, + ), + IconButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + InteractionScreen1( + index: index, + form: provider + .intConfigDataList[index] + .name, + ))); + }, + icon: const Icon( + Icons.arrow_circle_right_outlined, + size: 30, + color: Color.fromARGB(255, 8, 39, 92), + ), + ), + ], + ), + trailing: provider.savedList.indexWhere((element) => + element.form == + provider + .intConfigDataList[index].name) != + -1 + ? InkWell( + onTap: () { + print("inwesm Screenindex $index"); + + if (getCount( + provider.intConfigDataList[index] + .name, + provider) != + 0) { + provider.savedList + .where((element) => + element.form == + provider + .intConfigDataList[index] + .name) + .toList(); + Navigator.push( + context, + MaterialPageRoute( + builder: + (BuildContext context) => + SavedFormListScreen( + formname: provider + .intConfigDataList[ + index] + .name, + ))); + } + }, + child: FittedBox( + fit: BoxFit.scaleDown, + child: Text( + "${provider.savedList.where((element) => element.form == provider.intConfigDataList[index].name).length} record(s) saved", + style: TextStyle( + // fontSize: isTablet ? 18.0 : 14, + fontSize: 18.0, + color: Colors.blue.shade900), + ), + ), + ) + : const SizedBox.shrink(), + onTap: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + InteractionScreen1( + index: index, + form: provider + .intConfigDataList[index].name, + ))); + }, + ), + const Divider(), + ], + ); + })), + ), + ), + ); + }); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/interactionprovider.dart b/lib/contacts_module/ui_screen/interactionform/interactionprovider.dart new file mode 100644 index 0000000..51ffe72 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/interactionprovider.dart @@ -0,0 +1,1773 @@ +// import 'dart:convert'; +// // import 'dart:html'; + +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/repository/hive_repository.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; + +// import 'package:konectar_events/ui_screen/interactionform/model/json_form_data.dart'; + +// import 'package:konectar_events/ui_screen/interactionform/model/location_model.dart'; + +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; + +// class InteractionProvider extends ChangeNotifier { +// List interactionReponseList = []; +// // List sectionList = []; +// List sectionList = []; +// late Location locationList; +// List textEditingControllerList = []; +// List multipletextEditingControllerList = []; +// int textfieldIndex = 0; + +// List checkboxlist = []; + +// String radioValue = ''; +// bool checkboxValue = false; + +// //List data = []; +// List newList = []; +// String sectionName = ''; +// late String selectedCity = 'Selected City', selectedState = 'Selected State'; + +// String? selectedValue; +// List selectedItems = []; +// InputClass? selectedObj; +// List savedList = []; +// List intConfigDataList = []; +// String? intId, intName; +// final HiveDataRepository _hiveprovider = HiveDataRepository( +// Hive.box('InteractionConfigDataBox')); + +// late bool _isLoading; + +// get isLoading => _isLoading; + +// initConfigData() async { +// _hiveprovider.openHiveBox(); +// intConfigDataList = _hiveprovider.getAllDataFromHive(); +// notifyListeners(); +// } + +// Future getRecords() async { +// var box = Hive.box('InteractionDataBox'); + +// if (!box.isOpen) { +// box = await Hive.openBox('InteractionDataBox'); +// } + +// savedList = box.values.toList(); +// print("savedListt: $savedList"); +// notifyListeners(); +// } + +// init(int index) async { +// await initConfigData(); +// InteractionConfigData interactionConfigData = intConfigDataList[index]; +// intId = intConfigDataList[index].id; +// intName = intConfigDataList[index].name; + +// radioValue = ''; +// print("data $intConfigDataList"); + +// await fetchData(interactionConfigData.widgets); +// notifyListeners(); +// } + +// initSavedForm(SaveInteraction saveInteractiondata) { +// interactionReponseList = saveInteractiondata.save +// .map((e) => FormFieldData( +// multipleList: e.multipleList == null +// ? [] +// : e.multipleList! +// .map((mobj) => SectionList( +// depid: mobj.depid, +// id: mobj.id, +// inputList: mobj.inputList, +// isRequired: mobj.isRequired, +// name: mobj.name, +// param: mobj.param, +// selectedValue: mobj.selectedValue, +// fileName: mobj.fileName, +// extension: mobj.extension, +// widget: mobj.widget, +// controller: mobj.controller, +// gid: mobj.gid, +// input: mobj.input, +// selectedId: mobj.selectedId, +// value: mobj.value)) +// .toList(), +// sectionList: e.sectionList +// .map((obj) => SectionList( +// depid: obj.depid, +// id: obj.id, +// inputList: obj.inputList, +// isRequired: obj.isRequired, +// name: obj.name, +// param: obj.param, +// fileName: obj.fileName, +// extension: obj.extension, +// selectedValue: obj.selectedValue, +// widget: obj.widget, +// controller: obj.controller, +// gid: obj.gid, +// input: obj.input, +// selectedId: obj.selectedId, +// value: obj.value, +// )) +// .toList(), +// sectionName: e.sectionName, +// multiple: e.multiple)) +// .toList(); + +// textEditingControllerList.clear(); + +// for (var item in interactionReponseList) { +// sectionList = item.sectionList; +// for (var sectionItem in item.sectionList) { +// if (sectionItem.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// textEditingControllerList.add(textEditingController); +// sectionItem.controller = textEditingControllerList.last; +// } +// if (sectionItem.widget == InteractionWidget.DROPDOWN || +// sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT) { +// List list = sectionItem.inputList!; +// sectionItem.value = list[0].id; +// print("value : ${list.first} "); +// } +// } +// } +// print(interactionReponseList); +// print("check textcontrollers ${textEditingControllerList.length}"); +// } + +// String getDataValue(String widgetId, String id) { +// print("issue *************"); +// if (id != "") { +// List list = []; +// String value = ' '; + +// for (FormFieldData obj1 in interactionReponseList) { +// // List list = +// for (SectionList obj in obj1.sectionList) { +// if (obj.id == widgetId) { +// list = obj.inputList!; +// } +// } +// } + +// if (list.isNotEmpty) { +// int index = list.indexWhere((element) => element.id.toString() == id); + +// if (index != -1) { +// value = list[index].name; +// } +// } + +// return value; +// } else { +// return " "; +// } +// } + +// // TODO: Search for widget with depid and check if selected is not null and by selected id get the data of current widget + +// List getData2(SectionList sectionItem) { +// print("SEctionItemmmmm: $selectedValue"); +// List list = []; +// // if (sectionItem.inputList != null) { +// list = sectionItem.inputList!; +// if (sectionItem.depid != "") { +// // print("check depid : ${sectionItem.depid}"); +// int i = 0; +// for (var obj in interactionReponseList) { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.depid); +// // print("check depid index: $i"); +// if (i != -1) { +// //print("check depid value: ${obj.sectionList[i].value}"); +// if (obj.sectionList[i].value != null) { +// if (list +// .where((element) => element.pid == obj.sectionList[i].value) +// .isNotEmpty) { +// list = list +// .where((element) => element.pid == obj.sectionList[i].value) +// .toList(); + +// sectionItem.selectedObject = list[0]; +// } else { +// // InputClass obj = InputClass( +// // id: "obj.sectionList[i].value", +// // name: "Select ${sectionItem.name}"); +// list = []; +// // list.add(obj); +// sectionItem.selectedObject = null; +// } +// } else { +// // int index = obj.sectionList +// // .indexWhere((element) => element.id == sectionItem.id); + +// // list = obj.sectionList[index].inputList; +// } +// } +// } + +// // int index = data[i].data.indexWhere((element) => element.) +// } +// // } +// return list; +// } + +// setDropDownValue(String value, SectionList sectionItem, bool multiple) { +// int i = 0; +// print("selected $value"); +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList! +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].selectedValue!.add(value); +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].selectedValue!.add(value); +// } +// } +// } +// notifyListeners(); +// } + +// // setTextValue(String value, SectionList sectionItem, bool multiple) { +// // print("Text_val = $value, $sectionItem, $multiple"); +// // int i = 0; +// // for (var obj in interactionReponseList) { +// // if (multiple && obj.multipleList != null) { +// // i = obj.multipleList! +// // .indexWhere((element) => element.id == sectionItem.id); +// // if (i != -1) { +// // obj.multipleList![i].value = value; +// // obj.multipleList![i].selectedValue!.add(value); +// // } +// // } else { +// // i = obj.sectionList +// // .indexWhere((element) => element.id == sectionItem.id); +// // if (i != -1) { +// // obj.sectionList[i].value = value; +// // obj.sectionList[i].selectedValue!.add(value); +// // } +// // } +// // } +// // notifyListeners(); +// // } + +// setTextValue(String value, SectionList sectionItem, bool multiple) { +// int i = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList!.indexWhere((element) => +// element.id == sectionItem.id && element.gid == sectionItem.gid); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].selectedValue!.add(value); +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].selectedValue!.add(value); +// } +// } +// } +// notifyListeners(); +// } + +// setAutoCompleteValue(String value, SectionList sectionItem, bool multiple) { +// int i = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList! +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].selectedValue!.add(value); +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].selectedValue!.add(value); +// } +// } +// } +// notifyListeners(); +// } + +// Future fetchData(InteractionResultData interactionResultData) async { +// InteractionResultData interactionConfig = interactionResultData; + +// print("itemCategoryModel Item = + ${interactionConfig.result}"); +// // } +// interactionReponseList = interactionConfig.result; +// print("check stored: $interactionReponseList"); + +// textEditingControllerList.clear(); + +// for (var item in interactionReponseList) { +// sectionList = item.sectionList; +// for (var sectionItem in item.sectionList) { +// sectionItem.selectedValue = []; +// if (sectionItem.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// textEditingControllerList.add(textEditingController); +// sectionItem.controller = textEditingControllerList.last; +// } +// if (sectionItem.widget == InteractionWidget.DROPDOWN || +// sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT) { +// // int index = data +// // .indexWhere((element) => element.widgetId == sectionItem.id); +// // List list = data[index].data; +// List list = sectionItem.inputList!; +// sectionItem.value = list[0].id; +// if (sectionItem.widget == InteractionWidget.MULTISELECT) { +// sectionItem.selectedValue!.add(list[0].name); +// } else { +// sectionItem.selectedValue!.add(list[0].id); +// } + +// sectionItem.selectedObject = list[0]; +// print("value : ${list.first} "); +// } else if (sectionItem.widget == InteractionWidget.CHECKBOX) { +// List list = sectionItem.inputList!; +// if (list.isNotEmpty) { +// for (var element in sectionItem.inputList!) { +// element.ischecked = false; +// } +// } +// // sectionItem.value = list[0].id; +// // sectionItem.selectedValue!.add(list[0].id); +// } +// } +// } +// print(interactionReponseList); +// print("check textcontrollers ${textEditingControllerList.length}"); +// notifyListeners(); + +// return "success"; +// } + +// resetAllWidgetsData() { +// textEditingControllerList.clear(); + +// for (var item in interactionReponseList) { +// item.multipleList = []; +// sectionList = item.sectionList; +// for (var sectionItem in item.sectionList) { +// sectionItem.selectedValue = []; +// // sectionItem.value = ''; +// // sectionItem.selectedObject = InputClass(id: '', name: ''); +// if (sectionItem.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// textEditingControllerList.add(textEditingController); +// sectionItem.controller = textEditingControllerList.last; +// } +// if (item.sectionName != "Other") { +// if (sectionItem.widget == InteractionWidget.DROPDOWN || +// sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT) { +// // int index = data +// // .indexWhere((element) => element.widgetId == sectionItem.id); +// print("Selected widget : ${sectionItem.id}"); +// List list = sectionItem.inputList!; +// sectionItem.value = list[0].id; +// sectionItem.selectedObject = list[0]; +// print("value : ${list.first.name} "); +// } +// } +// } +// } +// print(interactionReponseList); +// print("check textcontrollers ${textEditingControllerList.length}"); +// notifyListeners(); +// } + +// setRadioValue(SectionList sectionItem) { +// List list = (sectionItem.input as List) +// .map((itemWord) => InputClass.fromJson(itemWord)) +// .toList(); +// radioValue = list[0].name; + +// notifyListeners(); +// } + +// setcheckBoxValue(SectionList sectionItem, String sectionName, bool newValue, +// String id, bool multiple) { +// int index = +// sectionItem.inputList!.indexWhere((element) => element.id == id); +// sectionItem.inputList![index].ischecked = newValue; +// // sectionItem.selectedValue.add(data[i].data[index].id); +// int index2 = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// index2 = obj.multipleList! +// .indexWhere((element) => element.id == sectionItem.id); +// if (index2 != -1) { +// obj.multipleList![index2].value = sectionItem.inputList![index].id; +// obj.multipleList![index2].selectedValue! +// .add(sectionItem.inputList![index].id); +// } +// } else { +// index2 = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (index2 != -1) { +// obj.sectionList[index2].value = sectionItem.inputList![index].id; +// obj.sectionList[index2].selectedValue! +// .add(sectionItem.inputList![index].id); +// } +// } +// } +// notifyListeners(); +// } + +// // getSectionItem(String sectionName) { +// // print("sectionName_issss : $sectionName"); +// // newList = []; +// // List addList = []; +// // int index = interactionReponseList +// // .indexWhere((element) => element.sectionName == sectionName); + +// // print("addList_isss: $addList"); + +// // addList = interactionReponseList[index] +// // .sectionList +// // .map((e) => SectionList( +// // depid: e.depid, +// // id: e.id, +// // inputList: e.inputList, +// // isRequired: e.isRequired, +// // name: e.name, +// // param: e.param, +// // selectedValue: [], +// // widget: e.widget, +// // controller: e.controller, +// // gid: e.gid, +// // input: e.input, +// // selectedId: e.selectedId, +// // value: e.value)) +// // .toList(); +// // SectionList delItem = SectionList( +// // name: "delete", +// // param: "deletebtn", +// // id: "deletebtn", +// // selectedValue: [], +// // depid: "", +// // widget: InteractionWidget.BUTTON, +// // inputList: [], +// // isRequired: true); + +// // addList.add(delItem); + +// // // if (interactionReponseList[index].multipleList!.isEmpty) { +// // // newList = addList; +// // // } else { +// // if (interactionReponseList[index].multipleList == null) { +// // interactionReponseList[index].multipleList = addList; +// // print("iff: $addList"); +// // } else { +// // // interactionReponseList[index].multipleList = +// // // // interactionReponseList[index].multipleList! + addList; +// // // interactionReponseList[index].multipleList! + addList; + +// // interactionReponseList[index].multipleList = +// // interactionReponseList[index].multipleList! + addList; + +// // print("iffelse: $addList"); +// // } + +// // newList = interactionReponseList[index].multipleList!; + +// // print("newList_iss: $newList"); + +// // // newList = newList + addList; +// // // } +// // if (interactionReponseList[index].multipleList != null) { +// // for (SectionList obj in interactionReponseList[index].multipleList!) { +// // obj.gid = obj.gid ?? interactionReponseList[index].multipleList!.length; +// // if (obj.widget == InteractionWidget.TEXT) { +// // print("objectt"); +// // var textEditingController = TextEditingController(); + +// // multipletextEditingControllerList.add(textEditingController); +// // obj.controller = multipletextEditingControllerList.last; +// // } +// // // newList.add(obj); +// // } +// // } + +// // print( +// // "check length : ${interactionReponseList[index].multipleList!.length}"); +// // notifyListeners(); +// // } + +// getSectionItem(String sectionName) { +// newList = []; +// List addList = []; +// int index = interactionReponseList +// .indexWhere((element) => element.sectionName == sectionName); +// var textEditingController = TextEditingController(); +// addList = interactionReponseList[index] +// .sectionList +// .map((e) => SectionList( +// depid: e.depid, +// id: e.id, +// inputList: e.inputList, +// isRequired: e.isRequired, +// name: e.name, +// param: e.param, +// selectedValue: [], +// widget: e.widget, +// controller: e.controller, +// gid: e.gid, +// input: e.input, +// selectedId: e.selectedId, +// value: e.value)) +// .toList(); +// SectionList delItem = SectionList( +// name: "delete", +// param: "deletebtn", +// id: "deletebtn", +// selectedValue: [], +// depid: "", +// widget: InteractionWidget.BUTTON, +// inputList: [], +// isRequired: true); + +// addList.add(delItem); + +// for (SectionList obj in addList) { +// //obj.gid = obj.gid ?? addList.length; +// if (obj.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// multipletextEditingControllerList.add(textEditingController); +// obj.controller = multipletextEditingControllerList.last; +// } +// // newList.add(obj); +// } + +// // if (interactionReponseList[index].multipleList!.isEmpty) { +// // newList = addList; +// // } else { +// if (interactionReponseList[index].multipleList == null) { +// interactionReponseList[index].multipleList = addList; +// } else { +// interactionReponseList[index].multipleList = +// interactionReponseList[index].multipleList! + addList; +// } + +// newList = interactionReponseList[index].multipleList!; +// // newList = newList + addList; +// // } +// if (interactionReponseList[index].multipleList != null) { +// for (SectionList obj in interactionReponseList[index].multipleList!) { +// obj.gid = obj.gid ?? interactionReponseList[index].multipleList!.length; +// // if (obj.widget == InteractionWidget.TEXT) { +// // var textEditingController = TextEditingController(); + +// // multipletextEditingControllerList.add(textEditingController); +// // obj.controller = multipletextEditingControllerList.last; +// // } +// //newList.add(obj); +// } +// } + +// print( +// "check length : ${interactionReponseList[index].multipleList!.length}"); +// notifyListeners(); +// } + +// deleteMultipleRows( +// int gid, SectionList sectionItem, String selectedSectionName) { +// int index = interactionReponseList +// .indexWhere((element) => element.sectionName == selectedSectionName); + +// print("controllerssssss : ${multipletextEditingControllerList.length}"); +// interactionReponseList[index] +// .multipleList! +// .removeWhere((item) => item.gid == gid); + +// notifyListeners(); +// } + +// bool validateMultipleRows() { +// for (var obj in interactionReponseList) { +// if (obj.multipleList != null) { +// for (var mulobj in obj.multipleList!) { +// if (mulobj.widget == InteractionWidget.TEXT) { +// if (mulobj.controller!.text.isEmpty) { +// return true; +// } +// } +// } +// } +// } +// return false; +// } + +// // bool validateTextFields() { +// // for (var obj in interactionReponseList) { +// // print("validateForm_is: ${obj.sectionList}"); +// // for (var mulobj in obj.sectionList) { +// // print("mulobj_is: ${mulobj}"); +// // print("mulobj_is: ${mulobj.widget}"); +// // print("mulobj_is: ${mulobj.isRequired}"); + +// // if (mulobj.widget == InteractionWidget.TEXT) { +// // if (mulobj.controller!.text.isEmpty) { +// // return true; +// // } +// // } +// // } +// // } +// // return false; +// // } + +// bool validateTextFields() { +// print("Validation_is : ${interactionReponseList.isEmpty}"); +// for (var obj in interactionReponseList) { +// print("validateForm_is: ${obj.sectionList}"); +// for (var mulobj in obj.sectionList) { +// print("mulobj_is: ${mulobj}"); +// print("mulobj_is: ${mulobj.widget}"); +// print("mulobj_is: ${mulobj.validation!.isRequired}"); + +// // if (mulobj.widget == InteractionWidget.TEXT) { +// // if (mulobj.controller!.text.isEmpty) { +// // print("I_amTextWidget"); +// // return false; +// // } +// // } + +// if (mulobj.validation!.isRequired == true) { +// if (mulobj.widget == InteractionWidget.TEXT) { +// if (mulobj.controller!.text.isEmpty) { +// print("Text_isEmpty"); +// //return false; +// } +// } else if (mulobj.widget == InteractionWidget.AUTOCOMPLETE) { +// if (mulobj.selectedId == null) { +// print("Auto_isEmpty"); +// //return false; +// } +// } else if (mulobj.widget == InteractionWidget.DROPDOWN) { +// if (mulobj.selectedId == null) { +// print("Dropdown_isEmpty"); +// //return false; +// } +// } else if (mulobj.widget == InteractionWidget.values) { +// if (mulobj.selectedId == null) { +// print("Dropdown_isEmpty"); +// //return false; +// } +// } +// // showDialog(context: context, builder: (_){ + +// // return AboutDialog() +// // }); +// } +// } +// return false; +// } +// return false; +// } + +// Future saveJsonObject(BuildContext context, String form, +// {bool isEdit = false}) async { +// print("form_data: $form"); +// List resultData = interactionReponseList +// .map((e) => FormFieldData( +// multipleList: e.multipleList == null +// ? [] +// : e.multipleList! +// .map((mobj) => SectionList( +// depid: mobj.depid, +// id: mobj.id, +// inputList: mobj.inputList, +// isRequired: mobj.isRequired, +// name: mobj.name, +// param: mobj.param, +// selectedValue: mobj.selectedValue, +// extension: mobj.extension, +// fileName: mobj.fileName, +// widget: mobj.widget, +// // controller: mobj.controller, +// gid: mobj.gid, +// input: mobj.input, +// selectedId: mobj.selectedId, +// value: mobj.value)) +// .toList(), +// sectionList: e.sectionList +// .map((obj) => SectionList( +// depid: obj.depid, +// id: obj.id, +// inputList: obj.inputList, +// isRequired: obj.isRequired, +// name: obj.name, +// param: obj.param, +// selectedValue: obj.selectedValue, +// widget: obj.widget, +// controller: obj.controller, +// gid: obj.gid, +// input: obj.input, +// extension: obj.extension, +// fileName: obj.fileName, +// selectedId: obj.selectedId, +// value: obj.value)) +// .toList(), +// sectionName: e.sectionName, +// multiple: e.multiple)) +// .toList(); + +// String generateId = '${intId}R${await getNextAutoIncrementValue()}'; + +// print("Result_data_is: ${FormFieldData}"); + +// if (validateSectionList(resultData)) { +// _isLoading = true; +// notifyListeners(); +// final data = SaveInteraction( +// save: resultData, +// id: generateId, +// updatedTime: DateTime.now().toString(), +// form: form, +// intId: intId ?? "id", +// intName: intName ?? "name"); +// var box = Hive.box('InteractionDataBox'); + +// if (!box.isOpen) { +// box = await Hive.openBox('InteractionDataBox'); +// } + +// print("Data_Result_is: ${data}"); + +// // // if (validateJson1(data.save.first)) { +// await box.put(await getNextAutoIncrementValue(), data); +// } else { +// _isLoading = false; +// notifyListeners(); + +// // Handle validation error +// print("JSON data is not valid according to the schema."); +// } +// // box.close(); +// await getRecords(); +// return generateId; +// } + +// List getModifiedList(List sectionList) { +// List newSectionList = []; +// for (var obj in sectionList) { +// if (obj.id != 'deletebtn') { +// if (obj.input == 'chooseFile') { +// MultipleSectionList newobj = MultipleSectionList( +// id: obj.id, +// selectedValue: obj.selectedValue!, +// extension: obj.extension!, +// fileName: obj.fileName!, +// ); + +// newSectionList.add(newobj); +// } else { +// MultipleSectionList newobj = MultipleSectionList( +// id: obj.id, +// selectedValue: obj.selectedValue!, +// ); +// newSectionList.add(newobj); +// } +// } +// } +// return newSectionList; +// } + +// List> getMultipleSectionList( +// List sectionList, List multipleList) { +// List> list = []; +// List> listing = []; +// List secList = getModifiedList(sectionList); +// List multipleList0 = getModifiedList(multipleList); +// list.add(secList); +// listing.add(secList); +// // List listing = []; +// if (multipleList.isNotEmpty) { +// final releaseDateMap = multipleList.groupBy((m) => m.gid); +// print("see map : $releaseDateMap"); + +// if (releaseDateMap.isNotEmpty) { +// listing = []; +// List> mulList = +// releaseDateMap.values.toList(growable: true); +// for (var item in mulList) { +// listing.add(getModifiedList(item)); +// } +// listing.add(secList); +// list = [...listing]; + +// //}); +// } +// } +// return list; +// } + +// SaveInteractionFormJson formJson(SaveInteraction saveInteraction) { +// List saveList = []; +// for (var obj in saveInteraction.save) { +// Save saveobj = Save( +// sectionName: obj.sectionName, +// multipleSectionList: +// getMultipleSectionList(obj.sectionList, obj.multipleList!)); +// saveList.add(saveobj); +// } + +// SaveInteractionFormJson saveInteractionFormJson = SaveInteractionFormJson( +// interactionForm1: saveInteraction.form!, +// intId: saveInteraction.id, +// intName: saveInteraction.intName, +// save: saveList); +// return saveInteractionFormJson; +// } + +// bool validateJson1(FormFieldData data) { +// print("Checking_data1 ${data.sectionName}"); + +// print("Checking_data1 ${data.sectionList}"); +// return false; +// } + +// bool validateSectionList(List resultData) { +// for (var formData in resultData) { +// for (var section in formData.sectionList) { +// print("Section_isssss: $section"); +// print("Section_isssss: ${section.isRequired}"); +// print("Section_isssss: ${section.widget}"); + +// if (section.widget == InteractionWidget.TEXT) { +// if (section.controller!.text.isEmpty) { +// debugPrint("Iam text and empty"); +// notifyListeners(); + +// return false; +// } +// } else if (section.widget == InteractionWidget.AUTOCOMPLETE) { +// if (section.selectedValue!.isEmpty) { +// debugPrint("Iam AUTOCOMPLETE and empty"); +// notifyListeners(); + +// return false; +// } +// } else if (section.widget == InteractionWidget.DROPDOWN) { +// if (section.selectedValue!.isEmpty) { +// debugPrint("Iam dropdown and empty"); +// notifyListeners(); + +// return false; +// } +// } else if (section.widget == InteractionWidget.CHECKBOX) { +// if (section.selectedValue!.isEmpty) { +// debugPrint("Iam CHECKBOX and empty"); +// notifyListeners(); + +// return false; +// } +// } +// } +// // print("Multilist"); +// // for (var msection in formData.multipleList!) { +// // print("Multilist Enter"); + +// // print("Multilist Enterwidget: ${msection.widget}"); + +// // if (msection.widget == InteractionWidget.TEXT) { +// // if (msection.controller!.text.isEmpty) { +// // debugPrint("Iam text and empty"); +// // notifyListeners(); + +// // return false; +// // } +// // } else if (msection.widget == InteractionWidget.AUTOCOMPLETE) { +// // if (msection.selectedValue!.isEmpty) { +// // debugPrint("Iam AUTOCOMPLETE and empty"); +// // notifyListeners(); + +// // return false; +// // } +// // } else if (msection.widget == InteractionWidget.DROPDOWN) { +// // if (msection.selectedValue!.isEmpty) { +// // debugPrint("Iam dropdown and empty"); +// // notifyListeners(); + +// // return false; +// // } +// // } else if (msection.widget == InteractionWidget.CHECKBOX) { +// // if (msection.selectedValue!.isEmpty) { +// // debugPrint("Iam CHECKBOX and empty"); +// // notifyListeners(); + +// // return false; +// // } +// // } +// // } +// } +// notifyListeners(); + +// return true; +// } + +// String? validateId(String? value) { +// if (value == null || value.isEmpty) { +// print("D is required"); +// return 'ID is required'; +// } +// // Add more validation rules if needed +// return null; +// } +// } + +import 'dart:convert'; +// import 'dart:html'; + +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/json_form_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/location_model.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/repository/hive_repository.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/repository/hive_repository.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +// import 'package:discover_module/ui_screen/interactionform/model/json_form_data.dart'; + +// import 'package:discover_module/ui_screen/interactionform/model/location_model.dart'; + +// import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; + +class InteractionProvider extends ChangeNotifier { + List interactionReponseList = []; + // List sectionList = []; + List sectionList = []; + late Location locationList; + List textEditingControllerList = []; + List multipletextEditingControllerList = []; + int textfieldIndex = 0; + + List checkboxlist = []; + + String radioValue = ''; + bool checkboxValue = false; + + //List data = []; + List newList = []; + String sectionName = ''; + late String selectedCity = 'Selected City', selectedState = 'Selected State'; + + String? selectedValue; + List selectedItems = []; + InputClass? selectedObj; + List savedList = []; + List intConfigDataList = []; + String? intId, intName; + final HiveDataRepository _hiveprovider = HiveDataRepository( + Hive.box('InteractionConfigDataBox')); + + late bool _isLoading; + + get isLoading => _isLoading; + + initConfigData() async { + _hiveprovider.openHiveBox(); + intConfigDataList = _hiveprovider.getAllDataFromHive(); + notifyListeners(); + } + + Future getRecords() async { + var box = Hive.box('InteractionDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox('InteractionDataBox'); + } + + savedList = box.values.toList(); + print("savedListt: $savedList"); + notifyListeners(); + } + + init(int index) async { + await initConfigData(); + InteractionConfigData interactionConfigData = intConfigDataList[index]; + intId = intConfigDataList[index].id; + intName = intConfigDataList[index].name; + + radioValue = ''; + print("data $intConfigDataList"); + + await fetchData(interactionConfigData.widgets); + notifyListeners(); + } + + initSavedForm(SaveInteraction saveInteractiondata) { + interactionReponseList = saveInteractiondata.save + .map((e) => FormFieldData( + multipleList: e.multipleList == null + ? [] + : e.multipleList! + .map((mobj) => SectionList( + depid: mobj.depid, + id: mobj.id, + inputList: mobj.inputList, + isRequired: mobj.isRequired, + name: mobj.name, + param: mobj.param, + selectedValue: mobj.selectedValue, + fileName: mobj.fileName, + extension: mobj.extension, + widget: mobj.widget, + controller: mobj.controller, + gid: mobj.gid, + input: mobj.input, + selectedId: mobj.selectedId, + value: mobj.value)) + .toList(), + sectionList: e.sectionList + .map((obj) => SectionList( + depid: obj.depid, + id: obj.id, + inputList: obj.inputList, + isRequired: obj.isRequired, + name: obj.name, + param: obj.param, + fileName: obj.fileName, + extension: obj.extension, + selectedValue: obj.selectedValue, + widget: obj.widget, + controller: obj.controller, + gid: obj.gid, + input: obj.input, + selectedId: obj.selectedId, + value: obj.value, + )) + .toList(), + sectionName: e.sectionName, + multiple: e.multiple)) + .toList(); + + textEditingControllerList.clear(); + + for (var item in interactionReponseList) { + sectionList = item.sectionList; + for (var sectionItem in item.sectionList) { + if (sectionItem.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + + textEditingControllerList.add(textEditingController); + sectionItem.controller = textEditingControllerList.last; + } + if (sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT) { + List list = sectionItem.inputList!; + sectionItem.value = list[0].id; + print("value : ${list.first} "); + } + } + } + print(interactionReponseList); + print("check textcontrollers ${textEditingControllerList.length}"); + } + + String getDataValue(String widgetId, String id) { + print("issue *************"); + if (id != "") { + List list = []; + String value = ' '; + + for (FormFieldData obj1 in interactionReponseList) { + // List list = + for (SectionList obj in obj1.sectionList) { + if (obj.id == widgetId) { + list = obj.inputList!; + } + } + } + + if (list.isNotEmpty) { + int index = list.indexWhere((element) => element.id.toString() == id); + + if (index != -1) { + value = list[index].name; + } + } + + return value; + } else { + return " "; + } + } + +// TODO: Search for widget with depid and check if selected is not null and by selected id get the data of current widget + + List getData2(SectionList sectionItem) { + List list = []; + // if (sectionItem.inputList != null) { + list = sectionItem.inputList!; + if (sectionItem.depid != "") { + // print("check depid : ${sectionItem.depid}"); + int i = 0; + for (var obj in interactionReponseList) { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.depid); + // print("check depid index: $i"); + if (i != -1) { + //print("check depid value: ${obj.sectionList[i].value}"); + if (obj.sectionList[i].value != null) { + if (list + .where((element) => element.pid == obj.sectionList[i].value) + .isNotEmpty) { + list = list + .where((element) => element.pid == obj.sectionList[i].value) + .toList(); + + // sectionItem.selectedObject = list[0]; + sectionItem.selectedObject = list[0]; + } else { + // InputClass obj = InputClass( + // id: "obj.sectionList[i].value", + // name: "Select ${sectionItem.name}"); + list = []; + // list.add(obj); + sectionItem.selectedObject = null; + } + } else { + // int index = obj.sectionList + // .indexWhere((element) => element.id == sectionItem.id); + + // list = obj.sectionList[index].inputList; + } + } + } + + // int index = data[i].data.indexWhere((element) => element.) + } + // } + return list; + } + + setDropDownValue(String value, SectionList sectionItem, bool multiple) { + int i = 0; + print("selected $value"); + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList! + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].selectedValue!.add(value); + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].selectedValue!.add(value); + } + } + } + notifyListeners(); + } + + setTextValue(String value, SectionList sectionItem, bool multiple) { + int i = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList!.indexWhere((element) => + element.id == sectionItem.id && element.gid == sectionItem.gid); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].selectedValue!.add(value); + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].selectedValue!.add(value); + } + } + } + notifyListeners(); + } + + setAutoCompleteValue(String value, SectionList sectionItem, bool multiple) { + int i = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList! + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].selectedValue!.add(value); + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].selectedValue!.add(value); + } + } + } + notifyListeners(); + } + + Future fetchData(InteractionResultData interactionResultData) async { + InteractionResultData interactionConfig = interactionResultData; + + print("itemCategoryModel Item = + ${interactionConfig.result}"); + // } + interactionReponseList = interactionConfig.result; + print("check stored: $interactionReponseList"); + + textEditingControllerList.clear(); + + for (var item in interactionReponseList) { + sectionList = item.sectionList; + for (var sectionItem in item.sectionList) { + sectionItem.selectedValue = []; + if (sectionItem.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + + textEditingControllerList.add(textEditingController); + sectionItem.controller = textEditingControllerList.last; + } + if (sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT) { + // int index = data + // .indexWhere((element) => element.widgetId == sectionItem.id); + // List list = data[index].data; + List list = sectionItem.inputList!; + sectionItem.value = list[0].id; + if (sectionItem.widget == InteractionWidget.MULTISELECT) { + sectionItem.selectedValue!.add(list[0].name); + } else { + sectionItem.selectedValue!.add(list[0].id); + } + + sectionItem.selectedObject = list[0]; + print("value : ${list.first} "); + } else if (sectionItem.widget == InteractionWidget.CHECKBOX) { + List list = sectionItem.inputList!; + if (list.isNotEmpty) { + for (var element in sectionItem.inputList!) { + element.ischecked = false; + } + } + // sectionItem.value = list[0].id; + // sectionItem.selectedValue!.add(list[0].id); + } + } + } + print(interactionReponseList); + print("check textcontrollers ${textEditingControllerList.length}"); + notifyListeners(); + + return "success"; + } + + resetAllWidgetsData() { + textEditingControllerList.clear(); + + for (var item in interactionReponseList) { + item.multipleList = []; + sectionList = item.sectionList; + for (var sectionItem in item.sectionList) { + sectionItem.selectedValue = []; + // sectionItem.value = ''; + // sectionItem.selectedObject = InputClass(id: '', name: ''); + if (sectionItem.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + + textEditingControllerList.add(textEditingController); + sectionItem.controller = textEditingControllerList.last; + } + if (item.sectionName != "Other") { + if (sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT) { + // int index = data + // .indexWhere((element) => element.widgetId == sectionItem.id); + print("Selected widget : ${sectionItem.id}"); + List list = sectionItem.inputList!; + sectionItem.value = list[0].id; + sectionItem.selectedObject = list[0]; + print("value : ${list.first.name} "); + } + } + } + } + print(interactionReponseList); + print("check textcontrollers ${textEditingControllerList.length}"); + notifyListeners(); + } + + setRadioValue(SectionList sectionItem) { + List list = (sectionItem.input as List) + .map((itemWord) => InputClass.fromJson(itemWord)) + .toList(); + radioValue = list[0].name; + + notifyListeners(); + } + + setcheckBoxValue(SectionList sectionItem, String sectionName, bool newValue, + String id, bool multiple) { + int index = + sectionItem.inputList!.indexWhere((element) => element.id == id); + sectionItem.inputList![index].ischecked = newValue; + // sectionItem.selectedValue.add(data[i].data[index].id); + int index2 = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + index2 = obj.multipleList! + .indexWhere((element) => element.id == sectionItem.id); + if (index2 != -1) { + obj.multipleList![index2].value = sectionItem.inputList![index].id; + obj.multipleList![index2].selectedValue! + .add(sectionItem.inputList![index].id); + } + } else { + index2 = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (index2 != -1) { + obj.sectionList[index2].value = sectionItem.inputList![index].id; + obj.sectionList[index2].selectedValue! + .add(sectionItem.inputList![index].id); + } + } + } + notifyListeners(); + } + + getSectionItem(String sectionName) { + newList = []; + List addList = []; + int index = interactionReponseList + .indexWhere((element) => element.sectionName == sectionName); + var textEditingController = TextEditingController(); + addList = interactionReponseList[index] + .sectionList + .map((e) => SectionList( + depid: e.depid, + id: e.id, + inputList: e.inputList, + isRequired: e.isRequired, + name: e.name, + validation: e.validation, + param: e.param, + selectedValue: [], + widget: e.widget, + controller: e.controller, + gid: e.gid, + input: e.input, + selectedId: e.selectedId, + value: e.value)) + .toList(); + SectionList delItem = SectionList( + name: " ", + param: "deletebtn", + id: "deletebtn", + selectedValue: [], + depid: "", + widget: InteractionWidget.BUTTON, + inputList: [], + validation: Validation(isRequired: false), + isRequired: true); + + addList.add(delItem); + + for (SectionList obj in addList) { + //obj.gid = obj.gid ?? addList.length; + if (obj.widget == InteractionWidget.TEXT) { + // multipletextEditingControllerList.clear(); + var textEditingController = TextEditingController(); + obj.controller = textEditingController; + multipletextEditingControllerList.add(textEditingController); + } + // newList.add(obj); + } + + // if (interactionReponseList[index].multipleList!.isEmpty) { + // newList = addList; + // } else { + if (interactionReponseList[index].multipleList == null) { + interactionReponseList[index].multipleList = addList; + } else { + interactionReponseList[index].multipleList = + interactionReponseList[index].multipleList! + addList; + } + + newList = interactionReponseList[index].multipleList!; + // newList = newList + addList; + // } + if (interactionReponseList[index].multipleList != null) { + for (SectionList obj in interactionReponseList[index].multipleList!) { + obj.gid = obj.gid ?? interactionReponseList[index].multipleList!.length; + // if (obj.widget == InteractionWidget.TEXT) { + // var textEditingController = TextEditingController(); + + // multipletextEditingControllerList.add(textEditingController); + // obj.controller = multipletextEditingControllerList.last; + // } + //newList.add(obj); + } + } + + print( + "check length : ${interactionReponseList[index].multipleList!.length}"); + notifyListeners(); + } + + deleteMultipleRows( + int gid, SectionList sectionItem, String selectedSectionName) { + int index = interactionReponseList + .indexWhere((element) => element.sectionName == selectedSectionName); + + print("controllerssssss : ${multipletextEditingControllerList.length}"); + interactionReponseList[index] + .multipleList! + .removeWhere((item) => item.gid == gid); + + notifyListeners(); + } + + bool validateMultipleRows() { + for (var obj in interactionReponseList) { + if (obj.multipleList != null) { + for (var mulobj in obj.multipleList!) { + if (mulobj.widget == InteractionWidget.TEXT) { + if (mulobj.controller!.text.isEmpty) { + return true; + } + } + } + } + } + return false; + } + + bool validateTextFields() { + for (var obj in interactionReponseList) { + for (var mulobj in obj.sectionList) { + if (mulobj.widget == InteractionWidget.TEXT) { + if (mulobj.controller!.text.isEmpty) { + return true; + } + } + } + } + return false; + } + + Future saveJsonObject(BuildContext context, String form, + {bool isEdit = false}) async { + print("form_data: $form"); + // for (var ob in interactionReponseList) { + + // for (var ob2 in ob.multipleList!) { + // debugPrint("!!!!!!!!!!!!In multiple :${ob2.selectedValue}"); + // } + // } + List resultData = interactionReponseList + .map((e) => FormFieldData( + multipleList: e.multipleList == null + ? [] + : e.multipleList! + .map((mobj) => SectionList( + depid: mobj.depid, + validation: + Validation(isRequired: mobj.validation!.isRequired), + id: mobj.id, + inputList: mobj.inputList, + isRequired: mobj.validation!.isRequired, + name: mobj.name, + param: mobj.param, + selectedValue: mobj.selectedValue, + extension: mobj.extension, + fileName: mobj.fileName, + widget: mobj.widget, + // controller: mobj.controller, + gid: mobj.gid, + input: mobj.input, + selectedId: mobj.selectedId, + value: mobj.value)) + .toList(), + sectionList: e.sectionList + .map((obj) => SectionList( + depid: obj.depid, + id: obj.id, + validation: + Validation(isRequired: obj.validation!.isRequired), + inputList: obj.inputList, + isRequired: obj.validation!.isRequired, + name: obj.name, + param: obj.param, + selectedValue: obj.selectedValue, + widget: obj.widget, + controller: obj.controller, + gid: obj.gid, + input: obj.input, + extension: obj.extension, + fileName: obj.fileName, + selectedId: obj.selectedId, + value: obj.value)) + .toList(), + sectionName: e.sectionName, + multiple: e.multiple)) + .toList(); + + String generateId = '${intId}R${await getNextAutoIncrementValue()}'; + if (validateSectionList(resultData)) { + _isLoading = true; + notifyListeners(); + final data = SaveInteraction( + save: resultData, + id: generateId, + updatedTime: DateTime.now().toString(), + form: form, + intId: intId ?? "id", + intName: intName ?? "name"); + var box = Hive.box('InteractionDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox('InteractionDataBox'); + } + + print("Data_Result_is: ${data}"); + + // // if (validateJson1(data.save.first)) { + await box.put(await getNextAutoIncrementValue(), data); + } else { + _isLoading = false; + notifyListeners(); + + // Handle validation error + print("JSON data is not valid according to the schema."); + } + await getRecords(); + return generateId; + + // final data = SaveInteraction( + // save: resultData, + // id: generateId, + // updatedTime: DateTime.now().toString(), + // form: form, + // intId: intId ?? "id", + // intName: intName ?? "name"); + // var box = Hive.box('InteractionDataBox'); + + // if (!box.isOpen) { + // box = await Hive.openBox('InteractionDataBox'); + // } + + // await box.put(await getNextAutoIncrementValue(), data); + // // box.close(); + // await getRecords(); + // return generateId; + // await MockApiCall().postFormData(data); + // await prov.addOfflineData(data); + } + + List getModifiedList(List sectionList) { + List newSectionList = []; + for (var obj in sectionList) { + if (obj.id != 'deletebtn') { + if (obj.input == 'chooseFile') { + MultipleSectionList newobj = MultipleSectionList( + id: obj.id, + selectedValue: obj.selectedValue!, + extension: obj.extension!, + fileName: obj.fileName!, + ); + + newSectionList.add(newobj); + } else { + MultipleSectionList newobj = MultipleSectionList( + id: obj.id, + selectedValue: obj.selectedValue!, + ); + newSectionList.add(newobj); + } + } + } + return newSectionList; + } + + List> getMultipleSectionList( + List sectionList, List multipleList) { + List> list = []; + List> listing = []; + List secList = getModifiedList(sectionList); + List multipleList0 = getModifiedList(multipleList); + list.add(secList); + listing.add(secList); + // List listing = []; + if (multipleList.isNotEmpty) { + final releaseDateMap = multipleList.groupBy((m) => m.gid); + print("see map : $releaseDateMap"); + + if (releaseDateMap.isNotEmpty) { + listing = []; + List> mulList = + releaseDateMap.values.toList(growable: true); + for (var item in mulList) { + listing.add(getModifiedList(item)); + } + listing.add(secList); + list = [...listing]; + + //}); + } + } + return list; + } + + SaveInteractionFormJson formJson(SaveInteraction saveInteraction) { + List saveList = []; + for (var obj in saveInteraction.save) { + Save saveobj = Save( + sectionName: obj.sectionName, + multipleSectionList: + getMultipleSectionList(obj.sectionList, obj.multipleList!)); + saveList.add(saveobj); + } + + SaveInteractionFormJson saveInteractionFormJson = SaveInteractionFormJson( + interactionForm1: saveInteraction.form!, + intId: saveInteraction.id, + intName: saveInteraction.intName, + save: saveList); + return saveInteractionFormJson; + } + + bool validateSectionList(List resultData) { + for (var formData in resultData) { + for (var section in formData.sectionList) { + // print("Section.leangthiss: ${resultData.length}"); + // for (int i = 0; i <= resultData.length; i++) { + // SectionList sectionItem = formData.sectionList[i]; + // print("Section_isssss1111: ${sectionItem.validation!.isRequired}"); + // } + + print("Section_isssss: $section"); + print("Section_isssss: ${section.widget}"); + print("Section_isssss: ${section.selectedId}"); + print("Section_isssss1111: ${section.isRequired},${section.name}"); + + if (section.widget == InteractionWidget.TEXT) { + // if (section.controller!.text.isEmpty) { + if (section.isRequired == true && section.controller!.text.isEmpty) { + debugPrint("Iam text and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.AUTOCOMPLETE) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam AUTOCOMPLETE and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.DROPDOWN) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam dropdown and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.CHECKBOX) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam CHECKBOX and empty"); + notifyListeners(); + + return false; + } + } + } + print("Multilist"); + for (var msection in formData.multipleList!) { + print("Multilist Enter"); + + print("Multilist Enterwidget: ${msection.widget}"); + + if (msection.isRequired == true && + msection.widget == InteractionWidget.TEXT) { + print("Checkinggg: ${msection.id}"); + print("Checkinggg: ${msection.depid}"); + print("Checkinggg: ${msection.chars}"); + print("Checkinggg: ${msection.selectedId}"); + print("Checkinggg: ${msection.selectedValue!}"); + + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam multi text and empty"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.AUTOCOMPLETE) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam AUTOCOMPLETE and empty"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.DROPDOWN) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam dropdown and empty ${msection.widget}"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.CHECKBOX) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam CHECKBOX and empty"); + notifyListeners(); + + return false; + } + } + } + } + notifyListeners(); + + return true; + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/mockapi.dart b/lib/contacts_module/ui_screen/interactionform/mockapi.dart new file mode 100644 index 0000000..f85ecec --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/mockapi.dart @@ -0,0 +1,878 @@ +import 'dart:convert'; +import 'dart:developer'; +import 'dart:io'; + +import 'package:dio/dio.dart'; +import 'package:dio/io.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:flutter/services.dart'; +import 'package:http_mock_adapter/http_mock_adapter.dart'; +// import 'package:pwa_ios/model/interaction_config_data.dart'; + +class MockApiCall { + Future getConfigData() async { + print("Iam_getConfig"); + // final dio = Dio(BaseOptions()); + final dio = Dio(); + // (dio.httpClientAdapter as IOHttpClientAdapter).onHttpClientCreate = + // (HttpClient client) { + // client.badCertificateCallback = + // (X509Certificate cert, String host, int port) => true; + // return client; + // }; + + //final response = await dio.get('https://passvault.konectar.io/forms'); + + // dynamic response = + // jsonDecode(await rootBundle.loadString("assets/interaction.json")); + + // print("response1_isssss"); + // // print(response.data.toString()); + // // log(jsonEncode(response.data)); + + // final parsedJson = json.encode(response.data); + // print(parsedJson); + //return response.data; + return { + "success": true, + "message": "New form generated", + "data": [ + { + "id": "Form1", + "name": "Interaction Form", + "form-fields": [ + { + "sectionName": "Discussion Topic", + "multiple": true, + "sectionList": [ + { + "name": "Product", + "id": "discproduct_41", + "depid": "", + "param": "product", + "widget": "dropdown", + "input": "dropdown", + "inputList": [ + {"id": "41", "name": "Product1"}, + {"id": "42", "name": "Product2"} + ], + "validation": {"isRequired": true} + }, + { + "name": "Discussion Type", + "id": "disctype_51", + "depid": "", + "widget": "autocomplete", + "input": "autocomplete", + "inputList": [ + {"id": "51", "name": "Face to Face"}, + {"id": "52", "name": "Lecture"}, + {"id": "53", "name": "Mailing"}, + {"id": "54", "name": "Other"}, + {"id": "55", "name": "Phone"} + ], + "validation": {"isRequired": true} + }, + { + "name": "Discussion Topic", + "id": "disctopic_61", + "depid": "", + "widget": "multiselect", + "input": "multiselect", + "inputList": [ + {"id": "61", "name": "Face to Face"}, + {"id": "62", "name": "Lecture"}, + {"id": "63", "name": "Mailing"}, + {"id": "64", "name": "Other"}, + {"id": "65", "name": "Phone"} + ], + "validation": {"isRequired": true} + } + ] + }, + { + "sectionName": "Attendees", + "multiple": true, + "sectionList": [ + // { + // "name": "HCP Name", + // "id": "attendeeshcpname_3", + // "depid": "", + // "widget": "text", + // "input": "text1", + // "validation": {"isRequired": true} + // }, + { + "name": "HCP Name", + "id": "attendeeshcpname_3", + "depid": "", + "widget": "dropdown", + "inputList": [ + {"name": "", "id": "1", "pid": "1"}, + {"name": "Abraham, William", "id": "1", "pid": "1"}, + {"name": "Abbas, Samer", "id": "2", "pid": "1"}, + {"name": "Bulter, Javed", "id": "3", "pid": "1"}, + ], + "validation": {"isRequired": true} + }, + { + "name": "Speciality", + "id": "attendeeshcpspeciality_4", + "depid": "", + "widget": "text", + "input": "text", + "validation": {"isRequired": true} + }, + { + "name": "Title", + "id": "attendeestitle_5", + "depid": "", + "widget": "text", + "input": "text", + "validation": {"isRequired": true} + } + ] + }, + { + "sectionName": "Other", + "multiple": false, + "sectionList": [ + { + "name": "Address1", + "id": "otheraddress1_12", + "depid": "", + "widget": "text", + "input": "primary", + "validation": {"isRequired": true} + }, + { + "name": "Address2", + "id": "otheraddress2_13", + "depid": "", + "widget": "text", + "input": "Hubli", + "validation": {"isRequired": true} + }, + { + "name": "Postal code", + "id": "otherpostal_14", + "depid": "", + "widget": "text", + "input": "number", + "validation": {"isRequired": true} + }, + { + "name": "Country", + "id": "othercountry_15", + "depid": "", + "widget": "dropdown", + "inputList": [ + {"name": "India", "id": "1"}, + {"name": "USA", "id": "2"}, + {"name": "Nepal", "id": "3"} + ], + "validation": {"isRequired": true} + }, + { + "name": "State", + "id": "otherstate_16", + "depid": "othercountry_15", + "widget": "dropdown", + "inputList": [ + {"name": "Karnataka", "id": "1", "pid": "1"}, + {"name": "Maharashtra", "id": "2", "pid": "1"}, + {"name": "Andhra Pradesh", "id": "3", "pid": "1"}, + {"name": "Karnataka", "id": "4", "pid": "1"} + ], + "validation": {"isRequired": true} + }, + { + "name": "City", + "widget": "dropdown", + "id": "othercity_17", + "depid": "otherstate_16", + "inputList": [ + {"name": "Hubli", "id": "1", "pid": "1"}, + {"name": "Bangalore", "id": "2", "pid": "1"}, + {"name": "Belgavi", "id": "3", "pid": "1"} + ], + "validation": {"isRequired": true} + } + ] + }, + { + "sectionName": "Other Attendees", + "multiple": false, + "sectionList": [ + { + "name": "Attendee Name", + "id": "otherattendeename_18", + "depid": "", + "widget": "text", + "input": "text", + "validation": {"isRequired": true} + }, + { + "name": "Speciality", + "id": "otherattendeespeciality_19", + "depid": "", + "widget": "text", + "input": "text", + "validation": {"isRequired": true} + }, + { + "name": "Comments", + "id": "otherattendeecom_20", + "depid": "", + "widget": "text", + "input": "text", + "validation": {"isRequired": true} + } + ] + }, + // { + // "sectionName": "Attach Document(s)", + // "multiple": true, + // "sectionList": [ + // { + // "name": "Document Name", + // "id": "documentName_21", + // "depid": "", + // "widget": "text", + // "input": "text", + // "inputList": [], + // "validation": {"isRequired": true} + // }, + // { + // "name": "Description", + // "id": "documentDescription_21", + // "depid": "", + // "widget": "text", + // "input": "text", + // "inputList": [], + // "validation": {"isRequired": true} + // }, + // { + // "name": "Choose file", + // "id": "chooseFile_22", + // "depid": "", + // "widget": "button", + // "input": "chooseFile", + // "inputList": [], + // "validation": {"isRequired": true, "multipleFiles": true} + // } + // ] + // }, + ] + } + ] + }; + } + + Future postConfigData(var jsonObj) async { + // final dio = Dio(BaseOptions()); + final dio = Dio(); + + dio.httpClientAdapter = IOHttpClientAdapter( + createHttpClient: () { + // Don't trust any certificate just because their root cert is trusted. + final HttpClient client = + HttpClient(context: SecurityContext(withTrustedRoots: false)); + // You can test the intermediate / root cert here. We just ignore it. + client.badCertificateCallback = + ((X509Certificate cert, String host, int port) => true); + return client; + }, + ); + //final dioAdapter = DioAdapter(dio: dio); + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + // Set up a mock response for GET requests to "https://example.com" + // dio.get('192.168.2.64/passvault/public/forms' + // (server) => server.reply( + // 200, + // jsonResult, + // // Delay the response by 1 second + // delay: const Duration(seconds: 1), + // ), + // ); + // Send a GET request to "https://example.com" using Dio + final response = await dio + .post('http://192.168.2.64/konectar-app/public/forms', data: jsonObj); + + UIDataResponse dataResponse = UIDataResponse.fromJson(response.data); + // The response should contain the mock data we registered + print("response2_iss"); + print(response.data); + + return dataResponse; + } + + // Future getConfigWidgetData() async { + // final dio = Dio(BaseOptions()); + // final dioAdapter = DioAdapter(dio: dio); + // dynamic jsonResult = jsonDecode( + // await rootBundle.loadString("assets/images/interactiondata.json")); + // // Set up a mock response for GET requests to "https://example.com" + // dioAdapter.onGet( + // 'https://example.com', + // (server) => server.reply( + // 200, + // jsonResult, + // // Delay the response by 1 second + // delay: const Duration(seconds: 1), + // ), + // ); + // // Send a GET request to "https://example.com" using Dio + // final response = await dio.get('https://example.com'); + // // The response should contain the mock data we registered + // print(response.data); // {messa + // } + + Future postFormData(var jsonObj) async { + final dio = Dio(BaseOptions()); + final dioAdapter = DioAdapter(dio: dio); + + dioAdapter.onPost( + 'https://example.com', + data: jsonObj, + (server) => server.reply( + 200, + {"message": "success"}, + // Delay the response by 1 second + delay: const Duration(seconds: 1), + ), + ); + // Send a GET request to "https://example.com" using Dio + final response = await dio.post( + 'http://192.168.2.64/konectar-app/public/push_data', + data: jsonObj); + // The response should contain the mock data we registered + print(response.data); // {messa + } + + Future postSavedData(var jsonObj) async { + // final dio = Dio(BaseOptions()); + final dio = Dio(); + // ignore: deprecated_member_use + (dio.httpClientAdapter as IOHttpClientAdapter).onHttpClientCreate = + (HttpClient client) { + client.badCertificateCallback = + (X509Certificate cert, String host, int port) => true; + return client; + }; + + final options = Options( + sendTimeout: const Duration(seconds: 15), + receiveTimeout: const Duration(seconds: 15), + ); + + final response = await dio.get('https://passvault.konectar.io/push_data', + options: options, data: jsonObj); + + //UIDataResponse dataResponse = UIDataResponse.fromJson(response.data); + // The response should contain the mock data we registered + print("response3"); + print(response.data); + return response.data; + } + + Future uploadFileAndJsonData(var jsonObj) async { + // {required File empFace, required String empCode} + const url = 'http://192.168.2.64/konectar-app/public/push_data'; + try { + var formData = FormData.fromMap({ + "files": [ + MultipartFile.fromFileSync( + "/Users/aissel/Library/Developer/CoreSimulator/Devices/1E435121-7E65-45C6-9E0B-411C8B9915F5/data/Containers/Data/Application/3CBC1CFF-79AD-49FA-A6E0-13D0AA2959D2/tmp/Flutter Questionaire.pdf", + filename: "upload.txt"), + MultipartFile.fromFileSync("./example/upload.txt", + filename: "upload.txt"), + ], + "data": jsonObj + }); + final response = await Dio().post( + url, + data: jsonObj, + ); + if (response.statusCode == 200) { + var map = response.data as Map; + print("result $map"); + print('success'); + if (map['status'] == 'Successfully registered') { + return true; + } else { + return false; + } + } else if (response.statusCode != 200) { + var map = response.data as Map; + print("result $map"); + //BotToast is a package for toasts available on pub.dev + // BotToast.showText(text: 'Validation Error Occurs'); + return false; + } + } on DioException catch (error) { + log(error.message!); + + throw 'Something Went Wrong'; + } catch (_) { + log(_.toString()); + throw 'Something Went Wrong'; + } + return false; + } + + Future getConfigData123() async { + // final dio = Dio(BaseOptions()); + final dio = Dio(); + + dio.httpClientAdapter = IOHttpClientAdapter( + createHttpClient: () { + // Don't trust any certificate just because their root cert is trusted. + final HttpClient client = + HttpClient(context: SecurityContext(withTrustedRoots: false)); + // You can test the intermediate / root cert here. We just ignore it. + client.badCertificateCallback = + ((X509Certificate cert, String host, int port) => true); + return client; + }, + ); + + // final response = await dio.get('https://passvault.konectar.io/forms'); + + print("response123456"); + // print(response.data.toString()); + //log('${jsonEncode()}'); + + return { + "success": true, + "message": "New form generated", + "data": [ + { + "id": "form-pooja", + "name": "form-pooja1 demo", + "formtype": "Event", + "form-fields": [ + { + "sectionName": "section0", + "multiple": false, + "sectionList": [ + { + "name": "field_0_0", + "id": "field_0_0", + "depid": "", + "widget": "checkbox", + "input": "radio", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_1", + "id": "field_0_1", + "depid": "", + "widget": "dropdown", + "input": "checkbox", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_2", + "id": "field_0_2", + "depid": "", + "widget": "text", + "input": "date", + "validation": {"isRequired": true} + } + ] + }, + { + "sectionName": "section1", + "multiple": true, + "sectionList": [ + { + "name": "field_1_0", + "id": "field_1_0", + "depid": "", + "widget": "multiselect", + "input": "number", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_1_1", + "id": "field_1_1", + "depid": "", + "widget": "autocomplete", + "input": "checkbox", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_1_2", + "id": "field_1_2", + "depid": "", + "widget": "checkbox", + "input": "dropdown", + "validation": {"isRequired": false}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_1_3", + "id": "field_1_3", + "depid": "", + "widget": "checkbox", + "input": "date", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_1_4", + "id": "field_1_4", + "depid": "", + "widget": "dropdown", + "input": "autocomplete", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + } + ] + } + ] + } + ] + }; + } + + Future getConfigDataMedical() async { + // final dio = Dio(BaseOptions()); + final dio = Dio(); + // (dio.httpClientAdapter as IOHttpClientAdapter).onHttpClientCreate = + // (HttpClient client) { + // client.badCertificateCallback = + // (X509Certificate cert, String host, int port) => true; + // return client; + // }; + dio.httpClientAdapter = IOHttpClientAdapter( + createHttpClient: () { + // Don't trust any certificate just because their root cert is trusted. + final HttpClient client = + HttpClient(context: SecurityContext(withTrustedRoots: false)); + // You can test the intermediate / root cert here. We just ignore it. + client.badCertificateCallback = + ((X509Certificate cert, String host, int port) => true); + return client; + }, + ); + + // final response = await dio.get('https://passvault.konectar.io/forms'); + + print("response123456"); + // print(response.data.toString()); + //log('${jsonEncode()}'); + + return { + "success": true, + "message": "New form generated", + "data": [ + { + "id": "form-med", + "name": "form-med demo", + "formtype": "Event", + "form-fields": [ + { + "sectionName": "section0", + "multiple": false, + "sectionList": [ + { + "name": "field_0_0", + "id": "field_0_0", + "depid": "", + "widget": "checkbox", + "input": "radio", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_1", + "id": "field_0_1", + "depid": "", + "widget": "dropdown", + "input": "checkbox", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_2", + "id": "field_0_2", + "depid": "", + "widget": "text", + "input": "date", + "validation": {"isRequired": true} + } + ] + }, + ] + } + ] + }; + } + + Future getConfigDataEng() async { + // final dio = Dio(BaseOptions()); + final dio = Dio(); + // (dio.httpClientAdapter as IOHttpClientAdapter).onHttpClientCreate = + // (HttpClient client) { + // client.badCertificateCallback = + // (X509Certificate cert, String host, int port) => true; + // return client; + // }; + + dio.httpClientAdapter = IOHttpClientAdapter( + createHttpClient: () { + // Don't trust any certificate just because their root cert is trusted. + final HttpClient client = + HttpClient(context: SecurityContext(withTrustedRoots: false)); + // You can test the intermediate / root cert here. We just ignore it. + client.badCertificateCallback = + ((X509Certificate cert, String host, int port) => true); + return client; + }, + ); + // final response = await dio.get('https://passvault.konectar.io/forms'); + + print("response123456"); + // print(response.data.toString()); + //log('${jsonEncode()}'); + + return { + "success": true, + "message": "New form generated", + "data": [ + { + "id": "form-eng", + "name": "form-eng demo", + "formtype": "Event", + "form-fields": [ + { + "sectionName": "section0", + "multiple": false, + "sectionList": [ + { + "name": "field_0_0", + "id": "field_0_0", + "depid": "", + "widget": "checkbox", + "input": "radio", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_1", + "id": "field_0_1", + "depid": "", + "widget": "dropdown", + "input": "checkbox", + "validation": {"isRequired": true}, + "inputList": [ + {"id": "1", "name": "Option 1"}, + {"id": "2", "name": "Option 2"}, + {"id": "3", "name": "Option 3"}, + {"id": "4", "name": "Option 4"}, + {"id": "5", "name": "Option 5"}, + {"id": "6", "name": "Option 6"}, + {"id": "7", "name": "Option 7"} + ] + }, + { + "name": "field_0_2", + "id": "field_0_2", + "depid": "", + "widget": "text", + "input": "date", + "validation": {"isRequired": true} + } + ], + }, + // { + // "sectionName": "HCP", + // "multiple": true, + // "sectionList": [ + // { + // "name": "name", + // "id": "field_0_2", + // "depid": "pooja", + // "widget": "text", + // "input": "text1", + // "validation": {"isRequired": true} + // }, + // { + // "name": "Role", + // "id": "field_0_1", + // "depid": "", + // "widget": "dropdown", + // "input": "checkbox", + // "validation": {"isRequired": true}, + // "inputList": [ + // {"id": "1", "name": "Option 1"}, + // {"id": "2", "name": "Option 2"}, + // {"id": "3", "name": "Option 3"}, + // {"id": "4", "name": "Option 4"}, + // {"id": "5", "name": "Option 5"}, + // {"id": "6", "name": "Option 6"}, + // {"id": "7", "name": "Option 7"} + // ] + // }, + // { + // "name": "Attended", + // "id": "field_0_1", + // "depid": "", + // "widget": "dropdown", + // "input": "checkbox", + // "validation": {"isRequired": true}, + // "inputList": [ + // {"id": "1", "name": "Option 1"}, + // {"id": "2", "name": "Option 2"}, + // {"id": "3", "name": "Option 3"}, + // {"id": "4", "name": "Option 4"}, + // {"id": "5", "name": "Option 5"}, + // {"id": "6", "name": "Option 6"}, + // {"id": "7", "name": "Option 7"} + // ] + // }, + // { + // "name": "Honorarium", + // "id": "field_0_2", + // "depid": "", + // "widget": "text", + // "input": "date", + // "validation": {"isRequired": true} + // }, + // { + // "name": "created by", + // "id": "field_0_2", + // "depid": "poojatk", + // "widget": "text", + // "input": "text1", + // "validation": {"isRequired": true} + // }, + // { + // "name": "created on", + // "id": "field_0_2", + // "depid": "13/05/2024", + // "widget": "text", + // "input": "text1", + // "validation": {"isRequired": true} + // }, + // // { + // // "name": "field_0_0", + // // "id": "field_0_0", + // // "depid": "", + // // "widget": "checkbox", + // // "input": "radio", + // // "validation": {"isRequired": true}, + // // "inputList": [ + // // {"id": "1", "name": "Option 1"}, + // // {"id": "2", "name": "Option 2"}, + // // {"id": "3", "name": "Option 3"}, + // // {"id": "4", "name": "Option 4"}, + // // {"id": "5", "name": "Option 5"}, + // // {"id": "6", "name": "Option 6"}, + // // {"id": "7", "name": "Option 7"} + // // ] + // // }, + // // { + // // "name": "field_0_2", + // // "id": "field_0_2", + // // "depid": "", + // // "widget": "text", + // // "input": "date", + // // "validation": {"isRequired": true} + // // } + // ], + // }, + ] + } + ] + }; + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.dart b/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.dart new file mode 100644 index 0000000..4e36ad4 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.dart @@ -0,0 +1,122 @@ +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; +// // import 'package:pwa_ios/model/interaction_data.dart'; + +// part 'interaction_config_data.g.dart'; + +// class UIDataResponse { +// bool success; +// String message; + +// List formFields; + +// UIDataResponse({ +// required this.success, +// required this.message, +// required this.formFields, +// }); + +// factory UIDataResponse.fromJson(Map json) => UIDataResponse( +// success: json["success"], +// message: json["message"], +// formFields: List.from( +// json["data"].map((x) => FormFieldData.fromJson(x))), +// ); + +// Map toJson() => { +// "success": success, +// "message": message, +// "form-fields": List.from(formFields.map((x) => x.toJson())), +// }; + +// @override +// String toString() { +// // TODO: implement toString +// return List.from(formFields.map((x) => x.toJson())).toString(); +// } +// } + +// @HiveType(typeId: 19) +// class InteractionConfigData { +// @HiveField(1) +// InteractionResultData widgets; +// @HiveField(2) +// String id; +// @HiveField(3) +// String name; + +// InteractionConfigData({ +// required this.widgets, +// required this.id, +// required this.name, +// }); + +// Map toJson() => {"widgets": widgets}; +// } + +//pooja + +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:pwa_ios/model/interaction_data.dart'; + +part 'engagement_interaction.g.dart'; + +class UIDataResponse { + bool success; + String message; + + List formFields; + + String? formtype; + + UIDataResponse({ + required this.success, + required this.message, + required this.formFields, + this.formtype, + }); + + factory UIDataResponse.fromJson(Map json) => UIDataResponse( + success: json["success"], + message: json["message"], + formtype: json["formtype"], + formFields: List.from( + json["data"].map((x) => FormFieldData.fromJson(x))), + ); + + Map toJson() => { + "success": success, + "message": message, + "formtype": formtype, + "form-fields": List.from(formFields.map((x) => x.toJson())), + }; + + @override + String toString() { + // TODO: implement toString + return List.from(formFields.map((x) => x.toJson())).toString(); + } +} + +@HiveType(typeId: 29) +class InteractionConfigDataEng { + @HiveField(1) + InteractionConfigDataEng widgets; + @HiveField(2) + String id; + @HiveField(3) + String name; + @HiveField(4) + String? formtype; + + InteractionConfigDataEng({ + required this.widgets, + required this.id, + required this.name, + this.formtype, + }); + + Map toJson() => {"widgets": widgets}; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.g.dart b/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.g.dart new file mode 100644 index 0000000..5b86662 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/engagement_interaction.g.dart @@ -0,0 +1,51 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'engagement_interaction.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class InteractionConfigDataEngAdapter + extends TypeAdapter { + @override + final int typeId = 29; + + @override + InteractionConfigDataEng read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return InteractionConfigDataEng( + widgets: fields[1] as InteractionConfigDataEng, + id: fields[2] as String, + name: fields[3] as String, + formtype: fields[4] as String?, + ); + } + + @override + void write(BinaryWriter writer, InteractionConfigDataEng obj) { + writer + ..writeByte(4) + ..writeByte(1) + ..write(obj.widgets) + ..writeByte(2) + ..write(obj.id) + ..writeByte(3) + ..write(obj.name) + ..writeByte(4) + ..write(obj.formtype); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is InteractionConfigDataEngAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart new file mode 100644 index 0000000..0314f85 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart @@ -0,0 +1,122 @@ +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; +// // import 'package:pwa_ios/model/interaction_data.dart'; + +// part 'interaction_config_data.g.dart'; + +// class UIDataResponse { +// bool success; +// String message; + +// List formFields; + +// UIDataResponse({ +// required this.success, +// required this.message, +// required this.formFields, +// }); + +// factory UIDataResponse.fromJson(Map json) => UIDataResponse( +// success: json["success"], +// message: json["message"], +// formFields: List.from( +// json["data"].map((x) => FormFieldData.fromJson(x))), +// ); + +// Map toJson() => { +// "success": success, +// "message": message, +// "form-fields": List.from(formFields.map((x) => x.toJson())), +// }; + +// @override +// String toString() { +// // TODO: implement toString +// return List.from(formFields.map((x) => x.toJson())).toString(); +// } +// } + +// @HiveType(typeId: 19) +// class InteractionConfigData { +// @HiveField(1) +// InteractionResultData widgets; +// @HiveField(2) +// String id; +// @HiveField(3) +// String name; + +// InteractionConfigData({ +// required this.widgets, +// required this.id, +// required this.name, +// }); + +// Map toJson() => {"widgets": widgets}; +// } + +//pooja + +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:pwa_ios/model/interaction_data.dart'; + +part 'interaction_config_data.g.dart'; + +class UIDataResponse { + bool success; + String message; + + List formFields; + + String? formtype; + + UIDataResponse({ + required this.success, + required this.message, + required this.formFields, + this.formtype, + }); + + factory UIDataResponse.fromJson(Map json) => UIDataResponse( + success: json["success"], + message: json["message"], + formtype: json["formtype"], + formFields: List.from( + json["data"].map((x) => FormFieldData.fromJson(x))), + ); + + Map toJson() => { + "success": success, + "message": message, + "formtype": formtype, + "form-fields": List.from(formFields.map((x) => x.toJson())), + }; + + @override + String toString() { + // TODO: implement toString + return List.from(formFields.map((x) => x.toJson())).toString(); + } +} + +@HiveType(typeId: 19) +class InteractionConfigData { + @HiveField(1) + InteractionResultData widgets; + @HiveField(2) + String id; + @HiveField(3) + String name; + @HiveField(4) + String? formtype; + + InteractionConfigData({ + required this.widgets, + required this.id, + required this.name, + this.formtype, + }); + + Map toJson() => {"widgets": widgets}; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g.dart b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g.dart new file mode 100644 index 0000000..9b51d37 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g.dart @@ -0,0 +1,50 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'interaction_config_data.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class InteractionConfigDataAdapter extends TypeAdapter { + @override + final int typeId = 19; + + @override + InteractionConfigData read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return InteractionConfigData( + widgets: fields[1] as InteractionResultData, + id: fields[2] as String, + name: fields[3] as String, + formtype: fields[4] as String?, + ); + } + + @override + void write(BinaryWriter writer, InteractionConfigData obj) { + writer + ..writeByte(4) + ..writeByte(1) + ..write(obj.widgets) + ..writeByte(2) + ..write(obj.id) + ..writeByte(3) + ..write(obj.name) + ..writeByte(4) + ..write(obj.formtype); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is InteractionConfigDataAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g1.dart b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g1.dart new file mode 100644 index 0000000..d2bcbf6 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/interaction_config_data.g1.dart @@ -0,0 +1,47 @@ +// // GENERATED CODE - DO NOT MODIFY BY HAND + +// part of 'interaction_config_data.dart'; + +// // ************************************************************************** +// // TypeAdapterGenerator +// // ************************************************************************** + +// class InteractionConfigDataAdapter extends TypeAdapter { +// @override +// final int typeId = 19; + +// @override +// InteractionConfigData read(BinaryReader reader) { +// final numOfFields = reader.readByte(); +// final fields = { +// for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), +// }; +// return InteractionConfigData( +// widgets: fields[1] as InteractionResultData, +// id: fields[2] as String, +// name: fields[3] as String, +// ); +// } + +// @override +// void write(BinaryWriter writer, InteractionConfigData obj) { +// writer +// ..writeByte(3) +// ..writeByte(1) +// ..write(obj.widgets) +// ..writeByte(2) +// ..write(obj.id) +// ..writeByte(3) +// ..write(obj.name); +// } + +// @override +// int get hashCode => typeId.hashCode; + +// @override +// bool operator ==(Object other) => +// identical(this, other) || +// other is InteractionConfigDataAdapter && +// runtimeType == other.runtimeType && +// typeId == other.typeId; +// } diff --git a/lib/contacts_module/ui_screen/interactionform/model/interaction_data.dart b/lib/contacts_module/ui_screen/interactionform/model/interaction_data.dart new file mode 100644 index 0000000..3e1140c --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/interaction_data.dart @@ -0,0 +1,339 @@ +// To parse this JSON data, do +// +// final welcome = welcomeFromJson(jsonString); + +import 'dart:convert'; + +import 'package:flutter/material.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +part 'interaction_data.g.dart'; + +// InteractionResultData welcomeFromJson(String str) => +// InteractionResultData.fromJson(json.decode(str)); + +// String welcomeToJson(InteractionResultData data) => json.encode(data.toJson()); + +ResponseData ResponseDataFromJson(Map str) => + ResponseData.fromJson(str); + +String ResponseDataToJson(ResponseData data) => json.encode(data.toJson()); + +class ResponseData { + List data; + + ResponseData({ + required this.data, + }); + + factory ResponseData.fromJson(Map json) => ResponseData( + data: List.from( + json["data"].map((x) => InteractionResultData.fromJson(x))), + ); + + Map toJson() => { + "data": List.from(data.map((x) => x.toJson())), + }; +} + +@HiveType(typeId: 11) +class InteractionResultData { + @HiveField(0) + List result; + @HiveField(1) + String id; + @HiveField(2) + String name; + InteractionResultData( + {required this.result, required this.id, required this.name}); + + factory InteractionResultData.fromJson(Map json) => + InteractionResultData( + result: List.from( + json["form-fields"].map((x) => FormFieldData.fromJson(x))), + id: json["id"], + name: json["name"], + ); + + Map toJson() => { + "id": id, + "name": name, + "result": List.from(result.map((x) => x.toJson())), + }; + + Map saveToJson() => { + "save": List.from(result.map((x) => x.saveToJson())), + }; +} + +@HiveType(typeId: 4) +class FormFieldData { + @HiveField(0) + String sectionName; + @HiveField(1) + bool multiple; + @HiveField(2) + List sectionList; + @HiveField(3) + List? multipleList; + + FormFieldData({ + required this.sectionName, + required this.multiple, + required this.sectionList, + this.multipleList, + }); + + factory FormFieldData.fromJson(Map json) => FormFieldData( + sectionName: json["sectionName"], + multiple: json["multiple"], + sectionList: List.from( + json["sectionList"].map((x) => SectionList.fromJson(x))), + ); + + Map toJson() => { + "sectionName": sectionName, + "multiple": multiple, + "sectionList": List.from(sectionList.map((x) => x.toJson())), + }; + Map saveToJson() => { + "sectionName": sectionName, + }; + @override + String toString() { + // TODO: implement toString + return multiple.toString(); + } +} + +@HiveType(typeId: 5) +class SectionList { + @HiveField(0) + String name; + @HiveField(1) + String? param; + @HiveField(2) + String id; + @HiveField(3) + int? gid; + @HiveField(4) + List? selectedValue; + @HiveField(5) + String? depid; + @HiveField(6) + InteractionWidget? widget; + @HiveField(7) + String? input; + @HiveField(8) + List? inputList; + @HiveField(9) + bool isRequired; + + TextEditingController? controller; + @HiveField(10) + String? value; + @HiveField(11) + String? selectedId; + @HiveField(12) + InputClass? selectedObject; + @HiveField(13) + Validation? validation; + @HiveField(14) + String? chars; + @HiveField(15) + List? extension; + @HiveField(16) + List? fileName; + @HiveField(17) + List? tempselectedValue; + @HiveField(18) + String? max; + @HiveField(19) + String? min; + + SectionList( + {required this.name, + this.param, + required this.id, + this.selectedValue, + this.depid, + this.widget, + this.input, + this.gid, + this.inputList, + this.isRequired = false, + this.controller, + this.selectedObject, + this.selectedId, + this.validation, + this.chars, + this.extension, + this.fileName, + this.tempselectedValue, + this.max, + this.min, + this.value}); + + factory SectionList.fromJson(Map json) => SectionList( + name: json["name"], + // param: json["param"], + id: json["id"], + // selectedValue: List.from(json["selectedValue"].map((x) => x)), + depid: json["depid"], + widget: widgetValues.map[json["widget"]]!, + input: json["input"], + inputList: json["inputList"] == null + ? [] + : List.from( + json["inputList"]!.map((x) => InputClass.fromJson(x))), + + validation: Validation.fromJson(json["validation"]), + + // chars: json["chars"], + max: json["max"], + min: json["min"], + ); + + Map toJson() => { + "name": name, + "param": param, + "id": id, + "selectedValue": List.from(selectedValue!.map((x) => x)), + "depid": depid, + "widget": widgetValues.reverse[widget], + "input": input, + "inputList": inputList == null + ? [] + : List.from(inputList!.map((x) => x.toJson())), + "isRequired": isRequired, + "chars": chars, + "fileName": List.from(fileName!.map((x) => x)), + "extension": List.from(extension!.map((x) => x)), + "max": max, + "min": min, + }; + Map saveToJson() => { + "name": name, + "param": param, + "id": id, + "selectedValue": List.from(selectedValue!.map((x) => x)), + }; + @override + String toString() { + // TODO: implement toString + return name.toString(); + } +} + +@HiveType(typeId: 6) +class InputClass { + @HiveField(0) + dynamic id; + @HiveField(1) + String name; + @HiveField(2) + bool? ischecked; + @HiveField(3) + String? selectedId; + @HiveField(4) + String? selectedName; + @HiveField(5) + List? selectedItems; + @HiveField(6) + String? pid; + InputClass( + {required this.id, + required this.name, + this.ischecked, + this.pid, + this.selectedId, + this.selectedItems, + this.selectedName}); + + factory InputClass.fromJson(Map json) => InputClass( + id: json["id"], + name: json["name"], + pid: json["pid"], + ); + + Map toJson() => {"id": id, "name": name, "pid": pid}; +} + +@HiveType(typeId: 18) +class Validation { + @HiveField(0) + bool isRequired; + @HiveField(1) + bool? multipleFiles; + @HiveField(2) + String? type; + @HiveField(3) + String? chars; + + Validation({ + required this.isRequired, + this.multipleFiles, + this.type, + this.chars, + }); + + factory Validation.fromJson(Map json) => Validation( + isRequired: json["isRequired"], + multipleFiles: json["multipleFiles"], + type: json["type"], + chars: json["chars"], + ); + + Map toJson() => { + "isRequired": isRequired, + "multipleFiles": multipleFiles, + "type": type, + "chars": chars, + }; +} + +@HiveType(typeId: 12) +enum InteractionWidget { + @HiveField(0) + CHECKBOX, + @HiveField(1) + DROPDOWN, + @HiveField(2) + LABEL, + @HiveField(3) + RADIO, + @HiveField(4) + TEXT, + @HiveField(5) + BUTTON, + @HiveField(6) + AUTOCOMPLETE, + @HiveField(7) + MULTISELECT, + @HiveField(8) + RANGESLIDER +} + +final widgetValues = EnumValues({ + "checkbox": InteractionWidget.CHECKBOX, + "dropdown": InteractionWidget.DROPDOWN, + "label": InteractionWidget.LABEL, + "radio": InteractionWidget.DROPDOWN, + "text": InteractionWidget.TEXT, + "button": InteractionWidget.BUTTON, + "autocomplete": InteractionWidget.AUTOCOMPLETE, + "multiselect": InteractionWidget.MULTISELECT, + "rangeslider": InteractionWidget.RANGESLIDER +}); + +class EnumValues { + Map map; + + late Map reverseMap; + + EnumValues(this.map); + + Map get reverse { + reverseMap = map.map((k, v) => MapEntry(v, k)); + return reverseMap; + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/interaction_data.g.dart b/lib/contacts_module/ui_screen/interactionform/model/interaction_data.g.dart new file mode 100644 index 0000000..ad5f62c --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/interaction_data.g.dart @@ -0,0 +1,350 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'interaction_data.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class InteractionResultDataAdapter extends TypeAdapter { + @override + final int typeId = 11; + + @override + InteractionResultData read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return InteractionResultData( + result: (fields[0] as List).cast(), + id: fields[1] as String, + name: fields[2] as String, + ); + } + + @override + void write(BinaryWriter writer, InteractionResultData obj) { + writer + ..writeByte(3) + ..writeByte(0) + ..write(obj.result) + ..writeByte(1) + ..write(obj.id) + ..writeByte(2) + ..write(obj.name); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is InteractionResultDataAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class FormFieldDataAdapter extends TypeAdapter { + @override + final int typeId = 4; + + @override + FormFieldData read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return FormFieldData( + sectionName: fields[0] as String, + multiple: fields[1] as bool, + sectionList: (fields[2] as List).cast(), + multipleList: (fields[3] as List?)?.cast(), + ); + } + + @override + void write(BinaryWriter writer, FormFieldData obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.sectionName) + ..writeByte(1) + ..write(obj.multiple) + ..writeByte(2) + ..write(obj.sectionList) + ..writeByte(3) + ..write(obj.multipleList); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is FormFieldDataAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class SectionListAdapter extends TypeAdapter { + @override + final int typeId = 5; + + @override + SectionList read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return SectionList( + name: fields[0] as String, + param: fields[1] as String?, + id: fields[2] as String, + selectedValue: (fields[4] as List?)?.cast(), + depid: fields[5] as String?, + widget: fields[6] as InteractionWidget?, + input: fields[7] as String?, + gid: fields[3] as int?, + inputList: (fields[8] as List?)?.cast(), + isRequired: fields[9] as bool, + selectedObject: fields[12] as InputClass?, + selectedId: fields[11] as String?, + validation: fields[13] as Validation?, + chars: fields[14] as String?, + extension: (fields[15] as List?)?.cast(), + fileName: (fields[16] as List?)?.cast(), + tempselectedValue: (fields[17] as List?)?.cast(), + max: fields[18] as String?, + min: fields[19] as String?, + value: fields[10] as String?, + ); + } + + @override + void write(BinaryWriter writer, SectionList obj) { + writer + ..writeByte(20) + ..writeByte(0) + ..write(obj.name) + ..writeByte(1) + ..write(obj.param) + ..writeByte(2) + ..write(obj.id) + ..writeByte(3) + ..write(obj.gid) + ..writeByte(4) + ..write(obj.selectedValue) + ..writeByte(5) + ..write(obj.depid) + ..writeByte(6) + ..write(obj.widget) + ..writeByte(7) + ..write(obj.input) + ..writeByte(8) + ..write(obj.inputList) + ..writeByte(9) + ..write(obj.isRequired) + ..writeByte(10) + ..write(obj.value) + ..writeByte(11) + ..write(obj.selectedId) + ..writeByte(12) + ..write(obj.selectedObject) + ..writeByte(13) + ..write(obj.validation) + ..writeByte(14) + ..write(obj.chars) + ..writeByte(15) + ..write(obj.extension) + ..writeByte(16) + ..write(obj.fileName) + ..writeByte(17) + ..write(obj.tempselectedValue) + ..writeByte(18) + ..write(obj.max) + ..writeByte(19) + ..write(obj.min); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SectionListAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class InputClassAdapter extends TypeAdapter { + @override + final int typeId = 6; + + @override + InputClass read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return InputClass( + id: fields[0] as dynamic, + name: fields[1] as String, + ischecked: fields[2] as bool?, + pid: fields[6] as String?, + selectedId: fields[3] as String?, + selectedItems: (fields[5] as List?)?.cast(), + selectedName: fields[4] as String?, + ); + } + + @override + void write(BinaryWriter writer, InputClass obj) { + writer + ..writeByte(7) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.name) + ..writeByte(2) + ..write(obj.ischecked) + ..writeByte(3) + ..write(obj.selectedId) + ..writeByte(4) + ..write(obj.selectedName) + ..writeByte(5) + ..write(obj.selectedItems) + ..writeByte(6) + ..write(obj.pid); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is InputClassAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class ValidationAdapter extends TypeAdapter { + @override + final int typeId = 18; + + @override + Validation read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Validation( + isRequired: fields[0] as bool, + multipleFiles: fields[1] as bool?, + type: fields[2] as String?, + chars: fields[3] as String?, + ); + } + + @override + void write(BinaryWriter writer, Validation obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.isRequired) + ..writeByte(1) + ..write(obj.multipleFiles) + ..writeByte(2) + ..write(obj.type) + ..writeByte(3) + ..write(obj.chars); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is ValidationAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class InteractionWidgetAdapter extends TypeAdapter { + @override + final int typeId = 12; + + @override + InteractionWidget read(BinaryReader reader) { + switch (reader.readByte()) { + case 0: + return InteractionWidget.CHECKBOX; + case 1: + return InteractionWidget.DROPDOWN; + case 2: + return InteractionWidget.LABEL; + case 3: + return InteractionWidget.RADIO; + case 4: + return InteractionWidget.TEXT; + case 5: + return InteractionWidget.BUTTON; + case 6: + return InteractionWidget.AUTOCOMPLETE; + case 7: + return InteractionWidget.MULTISELECT; + case 8: + return InteractionWidget.RANGESLIDER; + default: + return InteractionWidget.CHECKBOX; + } + } + + @override + void write(BinaryWriter writer, InteractionWidget obj) { + switch (obj) { + case InteractionWidget.CHECKBOX: + writer.writeByte(0); + break; + case InteractionWidget.DROPDOWN: + writer.writeByte(1); + break; + case InteractionWidget.LABEL: + writer.writeByte(2); + break; + case InteractionWidget.RADIO: + writer.writeByte(3); + break; + case InteractionWidget.TEXT: + writer.writeByte(4); + break; + case InteractionWidget.BUTTON: + writer.writeByte(5); + break; + case InteractionWidget.AUTOCOMPLETE: + writer.writeByte(6); + break; + case InteractionWidget.MULTISELECT: + writer.writeByte(7); + break; + case InteractionWidget.RANGESLIDER: + writer.writeByte(8); + break; + } + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is InteractionWidgetAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/json_form_data.dart b/lib/contacts_module/ui_screen/interactionform/model/json_form_data.dart new file mode 100644 index 0000000..386b8ff --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/json_form_data.dart @@ -0,0 +1,135 @@ +// To parse this JSON data, do +// +// final saveInteractionFormJson = saveInteractionFormJsonFromJson(jsonString); + +import 'dart:convert'; + +import 'package:hive_flutter/hive_flutter.dart'; +part 'json_form_data.g.dart'; + +SaveInteractionFormJson saveInteractionFormJsonFromJson(String str) => + SaveInteractionFormJson.fromJson(json.decode(str)); + +String saveInteractionFormJsonToJson(DataJson data) => + json.encode(data.toJson()); + +String saveFormJsonToJson(SendSaveJson data) => json.encode(data.toJson()); + +class DataJson { + SendSaveJson sendSaveJson; + DataJson({required this.sendSaveJson}); + factory DataJson.fromJson(Map json) => DataJson( + sendSaveJson: json["data"], + ); + Map toJson() => { + "data": sendSaveJson, + }; +} + +@HiveType(typeId: 14) +class SendSaveJson { + @HiveField(0) + List savedList; + SendSaveJson({required this.savedList}); + factory SendSaveJson.fromJson(Map json) => SendSaveJson( + savedList: List.from( + json["data"].map((x) => SaveInteractionFormJson.fromJson(x))), + ); + Map toJson() => { + "data": List.from(savedList.map((x) => x.toJson())), + }; +} + +@HiveType(typeId: 15) +class SaveInteractionFormJson { + @HiveField(0) + String interactionForm1; + @HiveField(1) + String intId; + @HiveField(2) + String intName; + @HiveField(3) + List save; + + SaveInteractionFormJson({ + required this.interactionForm1, + required this.intId, + required this.intName, + required this.save, + }); + + factory SaveInteractionFormJson.fromJson(Map json) => + SaveInteractionFormJson( + interactionForm1: json["Interaction-form1"], + intId: json["intId"], + intName: json["intName"], + save: List.from(json["data"].map((x) => Save.fromJson(x))), + ); + + Map toJson() => { + "id": intId, + "page": intName, + "data": List.from(save.map((x) => x.toJson())), + }; +} + +@HiveType(typeId: 16) +class Save { + @HiveField(0) + String sectionName; + @HiveField(1) + List> multipleSectionList; + + Save({ + required this.sectionName, + required this.multipleSectionList, + }); + + factory Save.fromJson(Map json) => Save( + sectionName: json["sectionName"], + multipleSectionList: List>.from( + json["multipleSectionList"].map((x) => + List.from( + x.map((x) => MultipleSectionList.fromJson(x))))), + ); + + Map toJson() => { + "sectionName": sectionName, + "multipleSectionList": List.from(multipleSectionList + .map((x) => List.from(x.map((x) => x.toJson())))), + }; +} + +@HiveType(typeId: 17) +class MultipleSectionList { + @HiveField(0) + String id; + @HiveField(1) + List selectedValue; + @HiveField(2) + List? fileName; + @HiveField(3) + List? extension; + + MultipleSectionList( + {required this.id, + required this.selectedValue, + this.extension, + this.fileName}); + + factory MultipleSectionList.fromJson(Map json) => + MultipleSectionList( + id: json["id"], + selectedValue: List.from(json["selectedValue"].map((x) => x)), + ); + + Map toJson() => { + "id": id, + "selectedValue": List.from(selectedValue.map((x) => x)), + "extension": extension != null + ? List.from(extension!.map((x) => x)) + : [], + "fileName": + fileName != null ? List.from(fileName!.map((x) => x)) : [], + }; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/json_form_data.g.dart b/lib/contacts_module/ui_screen/interactionform/model/json_form_data.g.dart new file mode 100644 index 0000000..7c55c41 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/json_form_data.g.dart @@ -0,0 +1,167 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'json_form_data.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class SendSaveJsonAdapter extends TypeAdapter { + @override + final int typeId = 14; + + @override + SendSaveJson read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return SendSaveJson( + savedList: (fields[0] as List).cast(), + ); + } + + @override + void write(BinaryWriter writer, SendSaveJson obj) { + writer + ..writeByte(1) + ..writeByte(0) + ..write(obj.savedList); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SendSaveJsonAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class SaveInteractionFormJsonAdapter + extends TypeAdapter { + @override + final int typeId = 15; + + @override + SaveInteractionFormJson read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return SaveInteractionFormJson( + interactionForm1: fields[0] as String, + intId: fields[1] as String, + intName: fields[2] as String, + save: (fields[3] as List).cast(), + ); + } + + @override + void write(BinaryWriter writer, SaveInteractionFormJson obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.interactionForm1) + ..writeByte(1) + ..write(obj.intId) + ..writeByte(2) + ..write(obj.intName) + ..writeByte(3) + ..write(obj.save); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SaveInteractionFormJsonAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class SaveAdapter extends TypeAdapter { + @override + final int typeId = 16; + + @override + Save read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return Save( + sectionName: fields[0] as String, + multipleSectionList: (fields[1] as List) + .map((dynamic e) => (e as List).cast()) + .toList(), + ); + } + + @override + void write(BinaryWriter writer, Save obj) { + writer + ..writeByte(2) + ..writeByte(0) + ..write(obj.sectionName) + ..writeByte(1) + ..write(obj.multipleSectionList); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SaveAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} + +class MultipleSectionListAdapter extends TypeAdapter { + @override + final int typeId = 17; + + @override + MultipleSectionList read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return MultipleSectionList( + id: fields[0] as String, + selectedValue: (fields[1] as List).cast(), + extension: (fields[3] as List?)?.cast(), + fileName: (fields[2] as List?)?.cast(), + ); + } + + @override + void write(BinaryWriter writer, MultipleSectionList obj) { + writer + ..writeByte(4) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.selectedValue) + ..writeByte(2) + ..write(obj.fileName) + ..writeByte(3) + ..write(obj.extension); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is MultipleSectionListAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/location_model.dart b/lib/contacts_module/ui_screen/interactionform/model/location_model.dart new file mode 100644 index 0000000..2b8964b --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/location_model.dart @@ -0,0 +1,122 @@ +// To parse this JSON data, do +// +// final welcome = welcomeFromJson(jsonString); + +import 'dart:convert'; + +Locations welcomeFromJson(String str) => Locations.fromJson(json.decode(str)); + +String welcomeToJson(Locations data) => json.encode(data.toJson()); + +class Locations { + Location location; + + Locations({ + required this.location, + }); + + factory Locations.fromJson(Map json) => Locations( + location: Location.fromJson(json["location"]), + ); + + Map toJson() => { + "location": location.toJson(), + }; +} + +class Location { + List country; + List state; + List city; + + Location({ + required this.country, + required this.state, + required this.city, + }); + + factory Location.fromJson(Map json) => Location( + country: + List.from(json["country"].map((x) => Country.fromJson(x))), + state: List.from(json["state"].map((x) => States.fromJson(x))), + city: List.from(json["city"].map((x) => City.fromJson(x))), + ); + + Map toJson() => { + "country": List.from(country.map((x) => x.toJson())), + "state": List.from(state.map((x) => x.toJson())), + "city": List.from(city.map((x) => x.toJson())), + }; +} + +class City { + String cityName; + String distId; + String stateId; + String countryId; + + City({ + required this.cityName, + required this.distId, + required this.stateId, + required this.countryId, + }); + + factory City.fromJson(Map json) => City( + cityName: json["cityName"], + distId: json["distId"], + stateId: json["stateId"], + countryId: json["countryId"], + ); + + Map toJson() => { + "cityName": cityName, + "distId": distId, + "stateId": stateId, + "countryId": countryId, + }; +} + +class Country { + String countryName; + String countryId; + + Country({ + required this.countryName, + required this.countryId, + }); + + factory Country.fromJson(Map json) => Country( + countryName: json["countryName"], + countryId: json["countryId"], + ); + + Map toJson() => { + "countryName": countryName, + "countryId": countryId, + }; +} + +class States { + String stateName; + String stateId; + String countryId; + + States({ + required this.stateName, + required this.stateId, + required this.countryId, + }); + + factory States.fromJson(Map json) => States( + stateName: json["stateName"], + stateId: json["stateId"], + countryId: json["countryId"], + ); + + Map toJson() => { + "stateName": stateName, + "stateId": stateId, + "countryId": countryId, + }; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/medical_insight.dart b/lib/contacts_module/ui_screen/interactionform/model/medical_insight.dart new file mode 100644 index 0000000..b151b91 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/medical_insight.dart @@ -0,0 +1,60 @@ +// To parse this JSON data, do +// +// final medicalInsight = medicalInsightFromJson(jsonString); + +import 'dart:convert'; + +List medicalInsightFromJson(String str) => + List.from( + json.decode(str).map((x) => MedicalInsight.fromJson(x))); + +String medicalInsightToJson(List data) => + json.encode(List.from(data.map((x) => x.toJson()))); + +class MedicalInsight { + int id; + int interactionId; + String therapeuticArea; + String product; + String sourceType; + String topics; + String hcpName; + DateTime createdAt; + DateTime updatedAt; + + MedicalInsight({ + required this.id, + required this.interactionId, + required this.therapeuticArea, + required this.product, + required this.sourceType, + required this.topics, + required this.hcpName, + required this.createdAt, + required this.updatedAt, + }); + + factory MedicalInsight.fromJson(Map json) => MedicalInsight( + id: json["id"], + interactionId: json["Interaction Id"], + therapeuticArea: json["Therapeutic Area"], + product: json["Product"], + sourceType: json["Source Type"], + topics: json["Topics"], + hcpName: json["HCP Name"], + createdAt: DateTime.parse(json["created_at"]), + updatedAt: DateTime.parse(json["updated_at"]), + ); + + Map toJson() => { + "id": id, + "Interaction Id": interactionId, + "Therapeutic Area": therapeuticArea, + "Product": product, + "Source Type": sourceType, + "Topics": topics, + "HCP Name": hcpName, + "created_at": createdAt.toIso8601String(), + "updated_at": updatedAt.toIso8601String(), + }; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/save_interaction.dart b/lib/contacts_module/ui_screen/interactionform/model/save_interaction.dart new file mode 100644 index 0000000..e34b857 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/save_interaction.dart @@ -0,0 +1,151 @@ +// To parse this JSON data, do +// +// final welcome = welcomeFromJson(jsonString); + +import 'dart:convert'; + +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:pwa_ios/model/interaction_data.dart'; +part 'save_interaction.g.dart'; + +SaveInteraction welcomeFromJson(String str) => + SaveInteraction.fromJson(json.decode(str)); + +String welcomeToJson(SaveInteraction data) => json.encode(data.toJson()); + +class SendSavedDataJson { + List data; + SendSavedDataJson({required this.data}); + Map toJson() => { + "data": List.from(data.map((x) => x.toJson())), + }; +} + +@HiveType(typeId: 3) +class SaveInteraction { + @HiveField(0) + String id; + + @HiveField(1) + List save; + @HiveField(2) + String? form; + @HiveField(3) + String? updatedTime; + @HiveField(4) + String intId; + @HiveField(5) + String intName; + + SaveInteraction( + {required this.save, + required this.id, + this.form, + this.updatedTime, + required this.intId, + required this.intName}); + + factory SaveInteraction.fromJson(Map json) => + SaveInteraction( + save: List.from( + json["save"].map((x) => SaveData.fromJson(x))), + intId: 'intId', + intName: 'intName', + id: 'id'); + + Map toJson() => { + "save": List.from(save.map((x) => x.toJson())), + }; + + Map savetoJson() => { + "form": form, + "intId": intId, + }; + + @override + String toString() { + // TODO: implement toString + return save.toString(); + } +} + +class JsonFormat {} + +class SaveInteractionJson { + @HiveField(0) + int? id; + @HiveField(1) + List save; + + SaveInteractionJson({ + required this.save, + }); + + factory SaveInteractionJson.fromJson(Map json) => + SaveInteractionJson( + save: + List.from(json["save"].map((x) => SaveData.fromJson(x))), + ); + + Map toJson() => { + "save": List.from(save.map((x) => x.toJson())), + }; +} + +class SaveData { + String sectionName; + List multiple; + List sectionList; + List>? multiplesectionList; + + SaveData({ + required this.sectionName, + required this.multiple, + required this.sectionList, + this.multiplesectionList, + }); + + factory SaveData.fromJson(Map json) => SaveData( + sectionName: json["sectionName"], + multiple: List.from(json["multiple"].map((x) => x)), + sectionList: List.from( + json["sectionList"].map((x) => SaveSectionList.fromJson(x))), + ); + + Map toJson() => { + "sectionName": sectionName, + "multiple": List.from(multiple.map((x) => x)), + "sectionList": List.from(sectionList.map((x) => x.toJson())), + }; +} + +class SaveSectionList { + String param; + String id; + List selectedValue; + String? widget; + + SaveSectionList({ + required this.param, + required this.id, + required this.selectedValue, + this.widget, + }); + + factory SaveSectionList.fromJson(Map json) => + SaveSectionList( + param: json["param"], + id: json["id"], + selectedValue: List.from(json["selectedValue"].map((x) => x)), + widget: json["widget"], + ); + + Map toJson() => { + "param": param, + "id": id, + "selectedValue": List.from(selectedValue.map((x) => x)), + "widget": widget, + }; +} diff --git a/lib/contacts_module/ui_screen/interactionform/model/save_interaction.g.dart b/lib/contacts_module/ui_screen/interactionform/model/save_interaction.g.dart new file mode 100644 index 0000000..fb41995 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/model/save_interaction.g.dart @@ -0,0 +1,56 @@ +// GENERATED CODE - DO NOT MODIFY BY HAND + +part of 'save_interaction.dart'; + +// ************************************************************************** +// TypeAdapterGenerator +// ************************************************************************** + +class SaveInteractionAdapter extends TypeAdapter { + @override + final int typeId = 3; + + @override + SaveInteraction read(BinaryReader reader) { + final numOfFields = reader.readByte(); + final fields = { + for (int i = 0; i < numOfFields; i++) reader.readByte(): reader.read(), + }; + return SaveInteraction( + save: (fields[1] as List).cast(), + id: fields[0] as String, + form: fields[2] as String?, + updatedTime: fields[3] as String?, + intId: fields[4] as String, + intName: fields[5] as String, + ); + } + + @override + void write(BinaryWriter writer, SaveInteraction obj) { + writer + ..writeByte(6) + ..writeByte(0) + ..write(obj.id) + ..writeByte(1) + ..write(obj.save) + ..writeByte(2) + ..write(obj.form) + ..writeByte(3) + ..write(obj.updatedTime) + ..writeByte(4) + ..write(obj.intId) + ..writeByte(5) + ..write(obj.intName); + } + + @override + int get hashCode => typeId.hashCode; + + @override + bool operator ==(Object other) => + identical(this, other) || + other is SaveInteractionAdapter && + runtimeType == other.runtimeType && + typeId == other.typeId; +} diff --git a/lib/contacts_module/ui_screen/interactionform/new_dynamicform.dart b/lib/contacts_module/ui_screen/interactionform/new_dynamicform.dart new file mode 100644 index 0000000..75ff031 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/new_dynamicform.dart @@ -0,0 +1,4139 @@ +import 'dart:convert'; +import 'dart:io'; + +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:dropdownfield2/dropdownfield2.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/rendering.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter/widgets.dart'; +import 'package:intl/intl.dart'; +import 'package:path_provider/path_provider.dart'; +import 'package:popover/popover.dart'; +import 'package:provider/provider.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; + +import 'package:file_picker/file_picker.dart'; +// import 'package:pwa_ios/widgets/responsive_ext.dart'; +import 'package:permission_handler/permission_handler.dart'; +import 'package:path/path.dart' as p; +//import 'package:carousel_slider/carousel_slider.dart'; +import 'package:flutter_carousel_widget/flutter_carousel_widget.dart'; + +import 'widget/interatciontextfield.dart'; + +// import 'package:popover/popover.dart'; + +class InteractionScreen1 extends StatefulWidget { + int index; + String form; + InteractionScreen1({super.key, required this.index, required this.form}); + + @override + State createState() => _InteractionScreen1State(); +} + +class _InteractionScreen1State extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + + bool _isExpanded = false; + + late int _value; + + var list; + + var item1; + + final GlobalKey _formKey = GlobalKey(); + + int _currentPage = 0; + late int _totalPages = + Provider.of(context, listen: false) + .interactionReponseList + .length; + + List ddlist = ["aaaa", 'bbb']; + + // List ddlist = ['Option 1', 'Option 2', 'Option 3']; + + String _selectedValue = ''; + final TextEditingController _controller11 = TextEditingController(); + List _suggestions = [ + 'Flutter', + 'Dart', + 'Widget', + 'Stateful', + 'Stateless' + ]; + bool _showSuggestions = false; // Track if suggestions should be shown + + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // if (mytimer!.isActive) { + // cancelTimer(); + // } + init(); + }); + + super.initState(); + } + + init() async { + await Provider.of(context, listen: false) + .init(widget.index); + setState(() {}); + } + + final CarouselController _controller = CarouselController(); + + @override + void dispose() { + // TODO: implement dispose + super.dispose(); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + backgroundColor: Colors.white, + appBar: AppBar( + title: const FittedBox( + fit: BoxFit.scaleDown, + child: Text( + 'Record New Interaction', + style: TextStyle(color: Colors.white, fontSize: 18.0), + ), + ), + automaticallyImplyLeading: false, + //actions: [saveActions(provider)], + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + children: [ + Expanded( + child: + // ListView.builder( + // itemCount: provider.interactionReponseList.length, + // cacheExtent: double.parse(provider + // .interactionReponseList.length + // .toString()), + // itemBuilder: (context, index) { + // var item = provider.interactionReponseList[index]; + // sectionList = item.sectionList; + // print("Section_ListttPooja: $sectionList"); + FlutterCarousel( + options: CarouselOptions( + onPageChanged: (index, reason) { + setState(() { + _currentPage = index; + }); + // Example: Perform actions when reaching the last page + // if (_currentPage == _totalPages - 1) { + // print('Reached the last page!'); + // // Add your actions here + // } + }, + controller: _controller, + + height: MediaQuery.of(context) + .size + .height, // Adjust as needed + // aspectRatio: 16 / 9, // Optional aspect ratio adjustment + //viewportFraction: 0.9, + viewportFraction: 1.0, + + initialPage: 0, + enableInfiniteScroll: false, + reverse: false, + autoPlay: false, + autoPlayInterval: Duration(seconds: 3), + autoPlayAnimationDuration: Duration(milliseconds: 800), + autoPlayCurve: Curves.fastOutSlowIn, + enlargeCenterPage: false, + disableCenter: false, + showIndicator: true, + scrollDirection: Axis.horizontal, + + slideIndicator: CircularWaveSlideIndicator( + slideIndicatorOptions: SlideIndicatorOptions( + alignment: Alignment.bottomCenter, + currentIndicatorColor: Constants.k2color, + indicatorBackgroundColor: Colors.grey)), + ), + items: provider.interactionReponseList.map((item) { + sectionList = item.sectionList; + print("Item_sectionListt11: ${item.sectionName}"); + + print("Item_sectionListt: ${item.sectionList}"); + + // provider.interactionReponseList[index] + // .map((item) { + return ListView( + children: [ + ColoredBox( + color: Colors.white, + child: + // ExpansionTile( + // maintainState: true, + // // backgroundColor: Constants.k2color, + // onExpansionChanged: (bool expanded) { + // setState(() { + // _isExpanded = expanded; + // }); + // }, + // trailing: Icon( + // _isExpanded + // ? Icons.keyboard_arrow_up + // : Icons.keyboard_arrow_down, + // color: Colors.white), + // // collapsedBackgroundColor: Color(0xFF2b9af3), + // initiallyExpanded: true, + // title: + Padding( + padding: const EdgeInsets.all(8.0), + child: Text( + item.sectionName, + textAlign: TextAlign.center, + style: const TextStyle( + color: Colors.black, + fontSize: 18.0, + + fontWeight: FontWeight.bold, + // fontSize: isTablet ? 18 : 14 + ), + ), + ), + // children: [], + // ), + ), + Container( + color: Colors.white, + child: Column( + mainAxisSize: MainAxisSize.min, + children: [ + ColoredBox( + color: Colors.white, + child: Padding( + padding: const EdgeInsets.only(top: 5.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + GridView.count( + physics: + const NeverScrollableScrollPhysics(), + + crossAxisCount: + context.responsive( + 1, + sm: 1, // small + md: isTablet + ? 2 + : orientation == + Orientation.landscape + ? 2 + : 1, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + + // mainAxisSpacing: + // sectionList.length == 1 || + // !isTablet + // ? 1.8 + // : 3.5, + mainAxisSpacing: + sectionList.length == 1 || + !isTablet + ? 1.8 + : 3.5, + // mainAxisSpacing: + // orientation == Orientation.portrait + // ? 1 + // : 3, + shrinkWrap: true, + padding: EdgeInsets.zero, + + // childAspectRatio: + // sectionList.length == 1 + // ? orientation == + // Orientation.landscape + // ? 10 + // : 4.8 + // : isTablet + // ? 2.8 + // : 3.0, + + // childAspectRatio: + // sectionList.length == 1 + // ? orientation == + // Orientation + // .landscape + // ? 10 + // : 4.8 + // : isTablet + // ? 2.8 + // : 3.5, + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation + .landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 4.5, + + children: List.generate( + sectionList.length, + (i) { + SectionList sectionItem = + sectionList[i]; + dropdownvalue = + sectionItem.widget == + InteractionWidget + .DROPDOWN + ? sectionItem.value ?? + "Select" + : ' '; + List< + InputClass> list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem.widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget + .MULTISELECT + ? provider + .getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == + InteractionWidget + .CHECKBOX + ? provider.getData2( + sectionItem) + : []; + + return Column( + mainAxisSize: + MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem.input == + 'add' + ? const SizedBox + .shrink() + : Padding( + padding: + const EdgeInsets + .only( + left: 8.0, + right: 8.0), + child: FittedBox( + fit: BoxFit + .scaleDown, + child: Text( + sectionItem + .validation! + .isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: + TextStyle( + // color: Colors + // .orange + // .shade800, + color: Constants + .k2color, + + fontSize: + 14.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + ), + ), + ), + returnWidget( + sectionItem: + sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: 0, + widgetData: + sectionItem.widget!, + multiple: false), + ], + ); + }, + ), + ), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + 0) + : const SizedBox.shrink(), + provider.interactionReponseList + .length == + 0 - 1 + ? saveActions(provider) + : const SizedBox.shrink(), + + // Add your actions here + + //const Spacer(), + ], + ), + ), + ), + ], + ), + ), + item.multiple + ? Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: + const EdgeInsets.only(bottom: 18.0), + child: OutlinedButton( + onPressed: () { + provider.getSectionItem( + item.sectionName, + ); + }, + child: Text( + 'Add More', + style: TextStyle( + color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + : SizedBox.shrink(), + _currentPage == _totalPages - 1 + ? Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: + const EdgeInsets.only(bottom: 18.0), + child: OutlinedButton( + // onPressed: () {}, + onPressed: () async { + String record = + await provider.saveJsonObject( + context, widget.form); + + print( + "Validation_isss: ${provider.isLoading}"); + + if (provider.isLoading == false) { + print("Validation_false"); + showAlertDialog1(context, + "Please fill all the fields"); + } else { + showAlertDialog(context, + "Form $record Saved Successfully!"); + print("Validation_True"); + } + }, + child: Text( + 'Submit', + style: TextStyle( + color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + : SizedBox.shrink(), + ], + ); + }).toList(), + ) + //}), + ), + //const SizedBox(height: 16.0), + + Padding( + padding: const EdgeInsets.only(bottom: 8.0), + child: Align( + alignment: Alignment.bottomCenter, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Flexible( + child: OutlinedButton( + style: OutlinedButton.styleFrom( + shape: CircleBorder()), + onPressed: () { + //if (_currentPageIndex > _totalPages - 1) + _controller.previousPage(); + }, + child: Padding( + padding: EdgeInsets.all(8.0), + child: Icon( + Icons.arrow_back, + color: Constants.k2color, + ), + ), + ), + ), + Flexible( + child: OutlinedButton( + style: OutlinedButton.styleFrom( + shape: CircleBorder()), + // onPressed: () { + // _controller.nextPage( + // duration: Duration(milliseconds: 300), + // curve: Curves.ease, + // ); + // }, + onPressed: () { + // print("checkingggggg: ${sectionItem.name}") + _controller.nextPage( + duration: Duration(milliseconds: 300), + curve: Curves.ease, + ); + }, + child: Padding( + padding: EdgeInsets.all(8.0), + child: Icon( + Icons.arrow_forward, + color: Constants.k2color, + ), + ), + ), + ), + ], + ), + ), + ), + ], + ), + ), + ); + }), + ); + }, + ); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required InteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + required bool multiple, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? customMultiselectDropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + + case InteractionWidget.AUTOCOMPLETE: + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + + case InteractionWidget.MULTISELECT: + return customMultiselectDropdown(sectionItem, provider, list, multiple); + + case InteractionWidget.RADIO: + return (sectionItem.inputList!.length >= 5) + ? customdropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildRadio(sectionItem, provider); + + case InteractionWidget.LABEL: + return Text(sectionItem.input!); + + case InteractionWidget.RANGESLIDER: + return CustomRangeSlider( + max: double.parse(sectionItem.max!), + min: double.parse(sectionItem.min!), + sliderPos: sectionItem.selectedValue!.isNotEmpty + ? double.parse(sectionItem.selectedValue!.last.toString()) + : double.parse(sectionItem.min!), + onChanged: (val) { + setState(() { + sectionItem.selectedValue = []; + sectionItem.selectedId = val.toString(); + sectionItem.selectedValue!.add(val.toInt()); + }); + }, + ); + + case InteractionWidget.BUTTON: + return sectionItem.input == 'add' + ? const Offstage( + offstage: true, + child: Text("Visible"), + ) + : Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB(255, 233, 229, 229), + onPressed: () async { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.length > 1 + ? 'Files uploaded' + : "File Uploaded" + : 'No file uploaded', + style: TextStyle( + color: sectionItem.selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ); + + case InteractionWidget.TEXT: + return sectionItem.input == 'Date' + ? buildDateWidget(sectionItem) + : sectionItem.input == "textArea" + ? Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: InteractionTextField( + // maxchars: int.parse(sectionItem.validation!.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + // maxlines: 8, + //minlines: 4, + onChanged: (val) { + sectionItem.selectedValue = []; + setState(() {}); + + sectionItem.selectedValue!.add(val); + }, + ), + ), + ) + ////Poojaaaaa + : sectionItem.input == "text1" + ? + // Padding( + // padding: const EdgeInsets.only(left: 8.0, right: 8.0), + // child: SizedBox( + // width: MediaQuery.of(context).size.width, + // child: Container( + // decoration: BoxDecoration( + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10), + // ), + // child: DropdownButtonFormField( + // decoration: InputDecoration( + // hintText: 'Select an option', + // contentPadding: + // EdgeInsets.symmetric(horizontal: 12.0), + // border: InputBorder.none, + // ), + // value: _selectedValue, + // items: ddlist.map((String item) { + // return DropdownMenuItem( + // value: item, + // child: Text(item), + // ); + // }).toList(), + // onChanged: (String? newValue) { + // setState(() { + // _selectedValue = newValue!; + // }); + // }, + // ), + // ), + // ), + // ) + + // Expanded( + // child: Padding( + // padding: const EdgeInsets.only(left: 8.0, right: 8.0), + // child: Container( + // decoration: BoxDecoration( + // color: Colors.pink, + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10)), + // child: Column( + // children: [ + // Expanded( + // child: DropDownField( + // hintText: 'Select an option', + // items: ddlist, + // onValueChanged: (newValue) { + // setState(() { + // _selectedValue = newValue; + // }); + // }, + // value: _selectedValue, + // ), + // ), + // ], + // ), + // ), + // ), + // ) + + // Flexible( + // flex: 2, + // fit: FlexFit + // .tight, + // child: Padding( + // padding: const EdgeInsets.only(left: 8.0, right: 8.0), + // child: Container( + // decoration: BoxDecoration( + // color: Colors.pink, + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10), + // ), + // child: Column( + // children: [ + // DropDownField( + // hintText: 'Select an option', + // items: ddlist, + // onValueChanged: (newValue) { + // setState(() { + // _selectedValue = newValue; + // }); + // }, + // value: _selectedValue, + // ), + // ], + // ), + // ), + // ), + // ) + + // Expanded( + // child: Stack( + // children: [ + // Column( + // children: [ + // TextField( + // controller: _controller11, + // onChanged: (text) { + // setState(() { + // _showSuggestions = text + // .isNotEmpty; // Show suggestions if text is not empty + // }); + // }, + // decoration: InputDecoration( + // hintText: 'Start typing...', + // ), + // ), + // // Additional widgets can go here if needed + // ], + // ), + // if (_showSuggestions) + // Container( + // // height: 1200, + // color: Colors.white, + // child: SizedBox( + // height: MediaQuery.of(context).size.height, + // child: Expanded( + // child: ListView( + // shrinkWrap: true, + // padding: EdgeInsets.zero, + // children: _suggestions + // .where((suggestion) => suggestion + // .toLowerCase() + // .contains(_controller11.text + // .toLowerCase())) + // .map((suggestion) { + // final startIndex = suggestion + // .toLowerCase() + // .indexOf( + // _controller11.text.toLowerCase()); + // final endIndex = startIndex + + // _controller11.text.length; + + // return ListTile( + // title: RichText( + // text: TextSpan( + // children: [ + // TextSpan( + // text: suggestion.substring( + // 0, startIndex), + // style: TextStyle( + // color: Colors.black), + // ), + // TextSpan( + // text: suggestion.substring( + // startIndex, endIndex), + // style: TextStyle( + // color: Colors.blue, + // fontWeight: + // FontWeight.bold), + // ), + // TextSpan( + // text: suggestion + // .substring(endIndex), + // style: TextStyle( + // color: Colors.black), + // ), + // ], + // ), + // ), + // onTap: () { + // _controller11.text = suggestion; + // _controller11.selection = + // TextSelection.fromPosition( + // TextPosition( + // offset: + // _controller11.text.length), + // ); + // setState(() { + // _showSuggestions = + // false; // Hide suggestions after selection + // }); + // }, + // ); + // }).toList(), + // ), + // ), + // ), + // ), + // ], + // ) + // // child: Column( + // // children: [ + // // TextField( + // // controller: _controller11, + // // onChanged: (text) { + // // setState(() { + // // _showSuggestions = text + // // .isNotEmpty; // Show suggestions if text is not empty + // // }); + // // }, + // // decoration: InputDecoration( + // // hintText: 'Start typing...', + // // ), + // // ), + // // if (_showSuggestions) + // // Container( + // // height: 400, + // // child: Expanded( + // // child: ListView( + // // children: _suggestions + // // .where((suggestion) => suggestion + // // .toLowerCase() + // // .contains(_controller11.text + // // .toLowerCase())) + // // .map((suggestion) { + // // final startIndex = suggestion + // // .toLowerCase() + // // .indexOf( + // // _controller11.text.toLowerCase()); + // // final endIndex = startIndex + + // // _controller11.text.length; + + // // return ListTile( + // // title: RichText( + // // text: TextSpan( + // // children: [ + // // TextSpan( + // // text: suggestion.substring( + // // 0, startIndex), + // // style: TextStyle( + // // color: Colors.black), + // // ), + // // TextSpan( + // // text: suggestion.substring( + // // startIndex, endIndex), + // // style: TextStyle( + // // color: Colors.blue, + // // fontWeight: + // // FontWeight.bold), + // // ), + // // TextSpan( + // // text: suggestion + // // .substring(endIndex), + // // style: TextStyle( + // // color: Colors.black), + // // ), + // // ], + // // ), + // // ), + // // onTap: () { + // // _controller11.text = suggestion; + // // _controller11.selection = + // // TextSelection.fromPosition( + // // TextPosition( + // // offset: + // // _controller11.text.length), + // // ); + // // setState(() { + // // _showSuggestions = + // // false; // Hide suggestions after selection + // // }); + // // }, + // // ); + // // }).toList(), + // // ), + // // ), + // // ), + // // ], + // // ), + // ) + Text( + sectionItem.depid!, + style: TextStyle( + fontSize: 18.0, fontWeight: FontWeight.normal), + ) + : Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: + // isTablet ? 200 : MediaQuery.of(context).size.width, + //height: isTablet ? 50 : 40, + width: MediaQuery.of(context).size.width, + height: isTablet ? 50 : 40, + + child: InteractionTextField( + inputType: sectionItem.input == "number" + ? TextInputType.number + : TextInputType.name, + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + onChanged: (val) { + sectionItem.selectedValue = []; + // sectionItem.selectedValue!.clear(); + + provider.setTextValue( + val, sectionItem, multiple); + }, + ), + ), + ), + ); + case InteractionWidget.DROPDOWN: + // return customdropdown(sectionItem, provider, list, multiple); + + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + } + } + + Future requestPermission(Permission permission) async { + final status = await permission.request(); + + setState(() { + print(status); + // _permissionStatus = status; + // print(_permissionStatus); + }); + } + + Widget buildDateWidget(SectionList sectionItem) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 50 : 40, + width: MediaQuery.of(context).size.width, + child: TextField( + controller: + sectionItem.controller, //editing controller of this TextField + decoration: InputDecoration( + // border: OutlineInputBorder(), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelStyle: const TextStyle(fontSize: 16), + suffixIcon: const Icon(Icons.calendar_today), //icon of text field + labelText: "Enter Date" //label text of field + ), + readOnly: true, //set it true, so that user will not able to edit text + onTap: () async { + DateTime? pickedDate = await showDatePicker( + context: context, + initialDate: DateTime.now(), + firstDate: DateTime( + 2000), //DateTime.now() - not to allow to choose before today. + lastDate: DateTime(2101)); + + if (pickedDate != null) { + print( + pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 + String formattedDate = + DateFormat('yyyy-MM-dd').format(pickedDate); + print( + formattedDate); //formatted date output using intl package => 2021-03-16 + //you can implement different kind of Date Format here according to your requirement + + setState(() { + sectionItem.controller!.text = formattedDate; + sectionItem.selectedValue = []; + sectionItem.selectedValue! + .add(formattedDate); //set output date to TextField value. + }); + } else { + print("Date is not selected"); + } + }, + ), + ), + ); + } + + Widget saveActions(InteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + Padding( + // padding: const EdgeInsets.all(4.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + + child: CustomButton( + backgroundColor: Colors.red.shade800, + onPressed: () { + //showDeleteProfileAlertDialog(context); + for (var textcontrollers + in provider.textEditingControllerList) { + textcontrollers.text = ''; + } + }, + textColor: Colors.white, + title: "Reset", + // height: 40, + // width: isTablet ? 100 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + // fontsize: isTablet ? 15 : 10.2, + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + //width: isTablet ? 20 : 4, + width: isTablet ? 20 : 2, + ), + Padding( + // padding: const EdgeInsets.all(8.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0), + + child: CustomButton( + backgroundColor: Colors.green.shade500, + onPressed: () async { + String record = + await provider.saveJsonObject(context, widget.form); + + print("Validation_isss: ${provider.isLoading}"); + + if (provider.isLoading == false) { + print("Validation_false"); + showAlertDialog1(context, "Please fill all the fields"); + } else { + showAlertDialog(context, "Form $record Saved Successfully!"); + print("Validation_True"); + } + }, + textColor: Colors.white, + title: "Save", + // height: 40, + // width: isTablet ? 100 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + // width: MediaQuery.of(context).size.width * 0.1, + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget buildRadio(SectionList sectionItem, InteractionProvider provider) { + List list = provider.getData2(sectionItem); + // .map((itemWord) => InputClass.fromJson(itemWord)) + // .toList(); + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 250 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (InputClass value in list) + Row( + children: [ + Radio( + value: value.name, + activeColor: Colors.black, + groupValue: provider.radioValue, + onChanged: (String? value) { + setState(() { + print(value); + provider.radioValue = value!; + int index = + list.indexWhere((element) => element.name == value); + sectionItem.selectedValue!.add(list[index].id); + }); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget buildCheckbox(SectionList sectionItem, String sectionName, + InteractionProvider provider, bool multiple) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: 250, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (var value in provider.checkboxlist) + Row( + children: [ + FittedBox( + fit: BoxFit.scaleDown, + child: CheckboxListTile( + dense: true, + //contentPadding: const EdgeInsets.symmetric(vertical: 5), + value: value.ischecked ?? false, + activeColor: Colors.black, + checkColor: Colors.white, + onChanged: (bool? newvalue) { + value.ischecked = newvalue!; + provider.setcheckBoxValue(sectionItem, sectionName, + newvalue, value.id, multiple); + //setState(() {}); + }, + ), + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget customdropdown(SectionList sectionItem, InteractionProvider provider, + List list, bool multiple) { + // sectionItem.value = ''; + + if (list.isEmpty) { + list = []; + InputClass inputClass = + InputClass(id: "no value", name: "Select ${sectionItem.name}"); + list.add(inputClass); + sectionItem.selectedObject = list[0]; + } + // InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + width: MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select ${sectionItem.name}', + style: const TextStyle(fontSize: 14), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject ?? list[0], + // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) + // sectionItem.value ?? list[0].name, + validator: (value) { + if (value == null) { + return 'Please select ${sectionItem.name}'; + } + return null; + }, + onChanged: (value) { + //Do something when selected item is changed. + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple); + print("selected ${sectionItem.value}"); + // setState(() {}); + }, + onSaved: (value) { + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple); + // setState(() {}); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(right: 8), + ), + iconStyleData: const IconStyleData( + icon: Icon( + Icons.arrow_drop_down, + color: Colors.black45, + ), + iconSize: 24, + ), + dropdownStyleData: DropdownStyleData( + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(10.0), + ), + ), + menuItemStyleData: const MenuItemStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + ), + ), + ), + ); + } + + Widget customAutoCompletedropdown(SectionList sectionItem, + InteractionProvider provider, List list, bool multiple) { + list = sectionItem.inputList!; + print("***Autocomplete list ${list[0].name}"); + //} + //InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Item', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject, + onSaved: (value) { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onChanged: (value) { + // setState(() { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + // setState(() {}); + //}); + }, + + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 40, + width: 200, + ), + dropdownStyleData: const DropdownStyleData( + maxHeight: 200, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + padding: const EdgeInsets.only( + top: 8, + bottom: 4, + right: 8, + left: 8, + ), + child: TextFormField( + // expands: true, + // maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + return item.value!.name.toString().contains(searchValue); + }, + ), + //This to clear the search value when you close the menu + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + ), + ), + ), + ); + } + + Widget customMultiselectDropdown(SectionList sectionItem, + InteractionProvider provider, List list, bool multiple) { + if (list.isEmpty) { + list = sectionItem.inputList!; + } + InputClass selectedObj = list[0]; + + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + // height: MediaQuery.of(context).size.height, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Items', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list.map((item) { + return DropdownMenuItem( + value: item, + //disable default onTap to avoid closing menu when selecting an item + enabled: false, + child: StatefulBuilder( + builder: (context, menuSetState) { + final isSelected = + sectionItem.selectedValue!.contains(item.name); + return InkWell( + onTap: () { + isSelected + ? sectionItem.selectedValue!.remove(item.name) + : sectionItem.selectedValue!.add(item.name); + //This rebuilds the StatefulWidget to update the button's text + setState(() {}); + //This rebuilds the dropdownMenu Widget to update the check mark + menuSetState(() {}); + }, + child: Container( + height: double.infinity, + padding: const EdgeInsets.symmetric(horizontal: 16.0), + child: Row( + children: [ + if (isSelected) + const Icon(Icons.check_box_outlined) + else + const Icon(Icons.check_box_outline_blank), + const SizedBox(width: 16), + Expanded( + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + ), + ], + ), + ), + ); + }, + ), + ); + }).toList(), + //Use last selected item as the current value so if we've limited menu height, it scroll to last item. + value: selectedObj, + // ? null + // : provider.selectedItems.last, + onChanged: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onSaved: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + selectedItemBuilder: (context) { + return list.map( + (item) { + return Container( + alignment: AlignmentDirectional.center, + child: Text( + sectionItem.selectedValue!.join(', '), + style: const TextStyle( + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + maxLines: 1, + ), + ); + }, + ).toList(); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(left: 16, right: 8), + height: 40, + width: 140, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + padding: EdgeInsets.zero, + ), + ), + ), + ), + ); + } + + Widget gridViewWidget( + InteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + print("ListInex: $listIndex"); + print("sectionName: $sectionName"); + print("sectionName: $sectionName"); + + print("gridsectionlost_is: $sectionList"); + print("gridsectionlostleangth_is: ${sectionList.length}"); + + List pooja = sectionList; + + print("Pooja_isss: $pooja"); + print("Pooja_leangth_isss: ${pooja.length}"); + + ////////////////////////////////////mycode/////////////////////////// + + List> convertedArray = []; + print("Provider_leangth: ${item.sectionList.length}"); + + for (int i = 0; i < pooja.length; i += item.sectionList.length + 1) { + print("poojaleangth: $pooja"); + + convertedArray.add(pooja.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArray.leangth: $convertedArray"); + print("ConvertedArray.leangth: ${convertedArray.length}"); + + return Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10.0), + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, + sm: 1, // small + md: isTablet + ? 2 + : orientation == Orientation.landscape + ? 2 + : 1, // medium + lg: sectionList.length == 1 ? 1 : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 1, + // childAspectRatio: sectionList.length == 1 + // ? orientation == Orientation.landscape + // ? 10 + // : 4.8 + // : isTablet + // ? 2.8 + // : 3.7, + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 4.5, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = + sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = sectionItem.widget == + InteractionWidget.DROPDOWN || + sectionItem.widget == + InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + return Padding( + padding: const EdgeInsets.only(top: 12.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + // sectionItem.widget == InteractionWidget.BUTTON && + // sectionItem.input == 'add' || + // sectionItem.input == 'deletebtn' + // ? const SizedBox.shrink() + // : + Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: FittedBox( + fit: BoxFit.scaleDown, + child: Text( + sectionItem.validation!.isRequired + ? "${sectionItem.name}*" + : sectionItem.name, + style: TextStyle( + //color: Colors.orange.shade800, + color: Constants.k2color, + fontSize: 14), + ), + ), + ), + // const SizedBox( + // height: 15, + // ), + sectionItem.widget == InteractionWidget.BUTTON + ? sectionItem.input == 'chooseFile' + ? Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB( + 255, 233, 229, 229), + onPressed: () async { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? sectionItem + .selectedValue!.isNotEmpty + ? 'File uploaded' + : "Files Uploaded" + : 'No file uploaded', + style: TextStyle( + color: sectionItem + .selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ) + : isTablet + ? IconButton( + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + icon: const Icon( + Icons.cancel, + size: 30, + color: Color.fromARGB(255, 8, 39, 92), + ), + ) + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 75, 75), + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + height: 40, + + // height: + // MediaQuery.of(context).size.height * + // 0.2, + fontsize: 12, + textColor: Colors.white, + title: "Delete"), + ) + : returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!, + multiple: true), + ], + ), + ); + }), + ) + ], + ); + //); + } + + String fieldsValidation(InteractionProvider provider) { + List secList = provider.sectionList + .where((element) => element.validation!.isRequired = true) + .toList(); + if (secList.any((element) => element.selectedValue!.isEmpty)) { + return 'Fields cannot be empty'; + } + return ''; + } + + String textFieldsValidation(InteractionProvider provider) { + return ''; + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } + + Future getEncodedFile(SectionList sectionItem) async { + String base64Image = ''; + var status = Platform.isAndroid + ? await Permission.manageExternalStorage.status + : await Permission.storage.status; + if (status.isGranted) { + FilePickerResult? result = + await FilePicker.platform.pickFiles(allowMultiple: true); + + if (result != null) { + print(result.files.first.path); + print(result.files.last.path); + for (var files in result.files) { + File file = File(files.path!); + print("check file path : ${file.path}"); + fileName = file.path.split('/').last; + // Get the application folder directory + Directory? directory = Platform.isAndroid + ? await getExternalStorageDirectory() //FOR ANDROID + : await getApplicationDocumentsDirectory(); + String newPath = ""; //FOR ios + String convertedDirectoryPath = (directory?.path).toString(); + + print("see the converted directory path $convertedDirectoryPath"); + + newPath = "$convertedDirectoryPath/konectar/files"; + print("new path :$newPath"); + directory = Directory(newPath); + if (!await directory.exists()) { + await directory.create(recursive: true); + } + File newFile = await file.copy('${directory.path}/$fileName'); + print("new path is ${newFile.path}"); + final extension = p.extension(newFile.path); + List imageBytes = await newFile.readAsBytes(); + Uint8List imageUint8List = Uint8List.fromList(imageBytes); + base64Image = base64Encode(imageUint8List); + sectionItem.selectedValue!.add(base64Image); + sectionItem.extension!.add(extension); + sectionItem.fileName!.add(fileName); + } + } + } else { + print("not permitted"); + await requestPermission(Platform.isAndroid + ? Permission.manageExternalStorage + : Permission.storage); + } + } + + showAlertDialog(BuildContext context, String record) { + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showAlertDialog1(BuildContext context, String record) { + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + Widget _offsetPopup(List interactionReponseList) { + List trueElements = + interactionReponseList.where((element) => element.multiple).toList(); + print("trueElements_iss: $trueElements"); + + return PopupMenuButton( + onSelected: (newValue) { + var provider = + Provider.of(context, listen: false); + setState(() { + _value = newValue; // it gives the value which is selected + + var item = trueElements[_value]; + + provider.getSectionItem( + item.sectionName, + ); + }); + print("Clicked Section111 $_value "); // add this property + print( + "interactionReponseList1 ${interactionReponseList} "); // add this property + }, + itemBuilder: (context) { + return List.generate(trueElements.length, (index) { + var provider = + Provider.of(context, listen: false); + + var item = trueElements[index]; + + print("itemitemitemitem_isss: ${item.multiple}"); + + return PopupMenuItem( + value: index, + child: item.multiple == true + ? GestureDetector( + onTap: () { + print("Clicked Section ${item.sectionName}"); + // provider.getSectionItem( + // item.sectionName, + // ); + //print("Clicked Section : ${sectionList}") + setState(() { + provider.getSectionItem( + item.sectionName, + ); + }); + + const DecoratedBox( + decoration: BoxDecoration( + // border: Border.all(color: Colors.black), + // borderRadius: BorderRadius.circular(10.0), + border: Border( + bottom: + BorderSide(width: 1.5, color: Colors.black), + //top: BorderSide(width: 1.5, color: Colors.black), + ), + ), + ); + }, + child: item.multiple == true + ? Text(' ${item.sectionName}') + : const SizedBox.shrink()) + : SizedBox.shrink(), + ); + }); + }, + icon: Container( + height: double.infinity, + width: double.infinity, + decoration: const ShapeDecoration( + color: Color.fromARGB(255, 8, 39, 92), + shape: StadiumBorder( + side: BorderSide(color: Colors.white, width: 2), + ), + ), + child: Icon(Icons.add, color: Colors.white), + )); + } +} + + + + + + + + + + + + + + + + + + + + + +// import 'dart:convert'; +// import 'dart:io'; + +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/ui_screen/add_event/add_hcp.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/rendering.dart'; +// import 'package:flutter/services.dart'; +// import 'package:flutter/widgets.dart'; +// import 'package:intl/intl.dart'; +// import 'package:path_provider/path_provider.dart'; +// import 'package:popover/popover.dart'; +// import 'package:provider/provider.dart'; +// import 'package:dropdown_button2/dropdown_button2.dart'; + +// import 'package:file_picker/file_picker.dart'; +// // import 'package:pwa_ios/widgets/responsive_ext.dart'; +// import 'package:permission_handler/permission_handler.dart'; +// import 'package:path/path.dart' as p; +// //import 'package:carousel_slider/carousel_slider.dart'; +// import 'package:flutter_carousel_widget/flutter_carousel_widget.dart'; + +// // import 'package:popover/popover.dart'; + +// class InteractionScreen1 extends StatefulWidget { +// int index; +// String form; +// InteractionScreen1({super.key, required this.index, required this.form}); + +// @override +// State createState() => _InteractionScreen1State(); +// } + +// class _InteractionScreen1State extends State { +// List interactionReponseList = []; +// List sectionList = []; +// List textEditingControllerList = []; +// int textfieldIndex = 0; +// String dropdownvalue = 'Select value'; +// String? fileName; +// final TextEditingController textEditingController = TextEditingController(); + +// bool _isExpanded = false; + +// late int _value; + +// var list; + +// var item1; + +// final GlobalKey _formKey = GlobalKey(); + +// int _currentPage = 0; +// late int _totalPages = +// Provider.of(context, listen: false) +// .interactionReponseList +// .length; +// @override +// void initState() { +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// // if (mytimer!.isActive) { +// // cancelTimer(); +// // } +// init(); +// }); + +// super.initState(); +// } + +// init() async { +// await Provider.of(context, listen: false) +// .init(widget.index); +// setState(() {}); +// } + +// // @override +// // Widget build(BuildContext context) { +// // return Consumer( +// // builder: (BuildContext context, provider, Widget? child) { +// // return GestureDetector( +// // onTap: () { +// // FocusScope.of(context).requestFocus(FocusNode()); +// // }, +// // child: OrientationBuilder(builder: (context, orientation) { +// // return SafeArea( +// // child: Scaffold( +// // //resizeToAvoidBottomInset: false, +// // appBar: AppBar( +// // title: const FittedBox( +// // fit: BoxFit.scaleDown, +// // child: Text( +// // 'Record New Interaction', +// // style: TextStyle( +// // // fontSize: isTablet ? 22 : 14, color: Colors.white +// // // fontSize: 20, +// // color: Colors.white), +// // ), +// // ), +// // // backgroundColor: const Color(0xFF2b9af3), +// // automaticallyImplyLeading: false, +// // actions: [saveActions(provider)], +// // leading: InkWell( +// // onTap: () { +// // Navigator.pop(context); +// // }, +// // child: const Icon( +// // Icons.arrow_back_ios, +// // color: Colors.white, +// // ), +// // ), +// // ), +// // body: Column( +// // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Expanded( +// // child: ListView.builder( +// // itemCount: provider.interactionReponseList.length, +// // cacheExtent: double.parse( +// // provider.interactionReponseList.length.toString()), +// // itemBuilder: (context, index) { +// // var item = provider.interactionReponseList[index]; +// // sectionList = item.sectionList; + +// // return Column( +// // children: [ +// // Card( +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // elevation: 5, +// // color: Constants.k2color, +// // child: ExpansionTile( +// // maintainState: true, +// // backgroundColor: Constants.k2color, +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.white), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // initiallyExpanded: true, +// // title: +// // // Stack( +// // // alignment: AlignmentDirectional.center, +// // // children: [Contact Module Mobile app Filter section api issue Pooja p1 in-progress +// // Text( +// // item.sectionName, +// // style: const TextStyle( +// // color: Colors.white, +// // fontWeight: FontWeight.normal, +// // // fontSize: isTablet ? 18 : 14 +// // ), +// // ), +// // children: [ +// // Container( +// // color: Colors.white, +// // child: Padding( +// // padding: +// // const EdgeInsets.only(top: 8.0), +// // child: Column( +// // mainAxisSize: MainAxisSize.min, +// // crossAxisAlignment: +// // CrossAxisAlignment.center, +// // children: [ +// // GridView.count( +// // physics: +// // const NeverScrollableScrollPhysics(), + +// // crossAxisCount: +// // context.responsive( +// // 1, +// // sm: 1, // small +// // md: isTablet +// // ? 2 +// // : orientation == +// // Orientation +// // .landscape +// // ? 2 +// // : 1, // medium +// // lg: sectionList.length == 1 +// // ? 1 +// // : 3, // large +// // xl: 3, // extra large screen +// // ), + +// // mainAxisSpacing: +// // sectionList.length == 1 || +// // !isTablet +// // ? 1 +// // : 3.5, +// // // mainAxisSpacing: +// // // orientation == Orientation.portrait +// // // ? 1 +// // // : 3, +// // shrinkWrap: true, +// // padding: EdgeInsets.zero, + +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation +// // .landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.5, + +// // children: List.generate( +// // sectionList.length, +// // (i) { +// // SectionList sectionItem = +// // sectionList[i]; +// // dropdownvalue = +// // sectionItem.widget == +// // InteractionWidget +// // .DROPDOWN +// // ? sectionItem.value ?? +// // "Select" +// // : ' '; +// // List< +// // InputClass> list = sectionItem +// // .widget == +// // InteractionWidget +// // .DROPDOWN || +// // sectionItem.widget == +// // InteractionWidget +// // .AUTOCOMPLETE || +// // sectionItem.widget == +// // InteractionWidget +// // .MULTISELECT +// // ? provider +// // .getData2(sectionItem) +// // : []; +// // provider.checkboxlist = +// // sectionItem.widget == +// // InteractionWidget +// // .CHECKBOX +// // ? provider.getData2( +// // sectionItem) +// // : []; + +// // return Column( +// // //mainAxisSize: MainAxisSize.min, +// // crossAxisAlignment: +// // CrossAxisAlignment +// // .start, +// // children: [ +// // sectionItem.widget == +// // InteractionWidget +// // .BUTTON && +// // sectionItem +// // .input == +// // 'add' +// // ? const SizedBox +// // .shrink() +// // : Padding( +// // padding: +// // const EdgeInsets +// // .only( +// // left: 8.0, +// // right: +// // 8.0), +// // child: FittedBox( +// // fit: BoxFit +// // .scaleDown, +// // child: Text( +// // sectionItem +// // .validation! +// // .isRequired +// // ? '${sectionItem.name}:*' +// // : '${sectionItem.name}:', +// // style: +// // TextStyle( +// // color: Colors +// // .orange +// // .shade800, +// // fontSize: +// // 18.0, +// // // fontSize: isTablet +// // // ? 18 +// // // : 12, +// // ), +// // ), +// // ), +// // ), +// // returnWidget( +// // sectionItem: +// // sectionItem, +// // item: item, +// // provider: provider, +// // list: list, +// // gridIndex: i, +// // listIndex: index, +// // widgetData: +// // sectionItem +// // .widget!, +// // multiple: false), +// // ], +// // ); +// // }, +// // ), +// // ), +// // // SizedBox( +// // // height: isTablet ? 15 : 5, +// // // ), +// // item.multiple +// // ? gridViewWidget( +// // provider, +// // item.sectionName, +// // item.multipleList ?? [], +// // orientation, +// // item, +// // index) +// // : const SizedBox.shrink(), +// // provider.interactionReponseList +// // .length == +// // index - 1 +// // ? saveActions(provider) +// // : const SizedBox.shrink() +// // //const Spacer(), +// // ], +// // ), +// // ), +// // ), +// // ]), +// // ), +// // ], +// // ); +// // }, +// // ), +// // ), +// // // const Spacer(), +// // //saveActions(provider), +// // Align( +// // alignment: Alignment.bottomRight, +// // child: Container( +// // height: 80.0, +// // width: 80.0, + +// // //child: +// // // Text(provider.interactionReponseList.toString()))) +// // child: _offsetPopup(provider.interactionReponseList))) +// // ], +// // ), +// // ), +// // ); +// // }), +// // ); +// // }); +// // } +// final CarouselController _controller = CarouselController(); + +// @override +// Widget build(BuildContext context) { +// return Consumer( +// builder: (BuildContext context, provider, Widget? child) { +// return GestureDetector( +// onTap: () { +// FocusScope.of(context).requestFocus(FocusNode()); +// }, +// child: OrientationBuilder(builder: (context, orientation) { +// return SafeArea( +// child: Scaffold( +// backgroundColor: Colors.white, +// appBar: AppBar( +// title: const FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// 'Record New Interaction', +// style: TextStyle(color: Colors.white, fontSize: 18.0), +// ), +// ), +// automaticallyImplyLeading: false, +// //actions: [saveActions(provider)], +// leading: InkWell( +// onTap: () { +// Navigator.pop(context); +// }, +// child: const Icon( +// Icons.arrow_back_ios, +// color: Colors.white, +// ), +// ), +// ), +// body: Column( +// children: [ +// Expanded( +// child: +// // ListView.builder( +// // itemCount: provider.interactionReponseList.length, +// // cacheExtent: double.parse(provider +// // .interactionReponseList.length +// // .toString()), +// // itemBuilder: (context, index) { +// // var item = provider.interactionReponseList[index]; +// // sectionList = item.sectionList; +// // print("Section_ListttPooja: $sectionList"); +// FlutterCarousel( +// options: CarouselOptions( +// onPageChanged: (index, reason) { +// setState(() { +// _currentPage = index; +// }); +// // Example: Perform actions when reaching the last page +// // if (_currentPage == _totalPages - 1) { +// // print('Reached the last page!'); +// // // Add your actions here +// // } +// }, +// controller: _controller, + +// height: MediaQuery.of(context) +// .size +// .height, // Adjust as needed +// // aspectRatio: 16 / 9, // Optional aspect ratio adjustment +// //viewportFraction: 0.9, +// viewportFraction: 1.0, + +// initialPage: 0, +// enableInfiniteScroll: false, +// reverse: false, +// autoPlay: false, +// autoPlayInterval: Duration(seconds: 3), +// autoPlayAnimationDuration: Duration(milliseconds: 800), +// autoPlayCurve: Curves.fastOutSlowIn, +// enlargeCenterPage: false, +// disableCenter: false, +// showIndicator: true, +// scrollDirection: Axis.horizontal, + +// slideIndicator: CircularWaveSlideIndicator( +// alignment: Alignment.bottomCenter, +// currentIndicatorColor: Constants.k2color, +// indicatorBackgroundColor: Colors.grey), +// ), +// items: provider.interactionReponseList.map((item) { +// sectionList = item.sectionList; +// print("Item_sectionListt11: ${item.sectionName}"); + +// print("Item_sectionListt: ${item.sectionList}"); + +// // provider.interactionReponseList[index] +// // .map((item) { +// return ListView( +// children: [ +// ColoredBox( +// color: Colors.white, +// child: +// // ExpansionTile( +// // maintainState: true, +// // // backgroundColor: Constants.k2color, +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.white), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // initiallyExpanded: true, +// // title: +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: Text( +// item.sectionName, +// textAlign: TextAlign.center, +// style: const TextStyle( +// color: Colors.black, +// fontSize: 18.0, + +// fontWeight: FontWeight.bold, +// // fontSize: isTablet ? 18 : 14 +// ), +// ), +// ), +// // children: [], +// // ), +// ), +// Container( +// color: Colors.white, +// child: Column( +// mainAxisSize: MainAxisSize.min, +// children: [ +// ColoredBox( +// color: Colors.white, +// child: Padding( +// padding: const EdgeInsets.only(top: 5.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: +// CrossAxisAlignment.center, +// children: [ +// GridView.count( +// physics: +// const NeverScrollableScrollPhysics(), + +// crossAxisCount: +// context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == +// Orientation.landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 +// ? 1 +// : 3, // large +// xl: 3, // extra large screen +// ), + +// // mainAxisSpacing: +// // sectionList.length == 1 || +// // !isTablet +// // ? 1.8 +// // : 3.5, +// mainAxisSpacing: +// sectionList.length == 1 || +// !isTablet +// ? 1.8 +// : 3.5, +// // mainAxisSpacing: +// // orientation == Orientation.portrait +// // ? 1 +// // : 3, +// shrinkWrap: true, +// padding: EdgeInsets.zero, + +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.0, + +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation +// // .landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.5, +// childAspectRatio: +// sectionList.length == 1 +// ? orientation == +// Orientation +// .landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 4.5, + +// children: List.generate( +// sectionList.length, +// (i) { +// SectionList sectionItem = +// sectionList[i]; +// dropdownvalue = +// sectionItem.widget == +// InteractionWidget +// .DROPDOWN +// ? sectionItem.value ?? +// "Select" +// : ' '; +// List< +// InputClass> list = sectionItem +// .widget == +// InteractionWidget +// .DROPDOWN || +// sectionItem.widget == +// InteractionWidget +// .AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget +// .MULTISELECT +// ? provider +// .getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == +// InteractionWidget +// .CHECKBOX +// ? provider.getData2( +// sectionItem) +// : []; + +// return Column( +// mainAxisSize: +// MainAxisSize.min, +// crossAxisAlignment: +// CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == +// InteractionWidget +// .BUTTON && +// sectionItem.input == +// 'add' +// ? const SizedBox +// .shrink() +// : Padding( +// padding: +// const EdgeInsets +// .only( +// left: 8.0, +// right: 8.0), +// child: FittedBox( +// fit: BoxFit +// .scaleDown, +// child: Text( +// sectionItem +// .validation! +// .isRequired +// ? '${sectionItem.name}:*' +// : '${sectionItem.name}:', +// style: +// TextStyle( +// // color: Colors +// // .orange +// // .shade800, +// color: Constants +// .k2color, + +// fontSize: +// 14.0, +// // fontSize: isTablet +// // ? 18 +// // : 12, +// ), +// ), +// ), +// ), +// returnWidget( +// sectionItem: +// sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: 0, +// widgetData: +// sectionItem.widget!, +// multiple: false), +// ], +// ); +// }, +// ), +// ), +// // SizedBox( +// // height: isTablet ? 15 : 5, +// // ), +// item.multiple +// ? gridViewWidget( +// provider, +// item.sectionName, +// item.multipleList ?? [], +// orientation, +// item, +// 0) +// : const SizedBox.shrink(), +// provider.interactionReponseList +// .length == +// 0 - 1 +// ? saveActions(provider) +// : const SizedBox.shrink(), + +// // Add your actions here + +// //const Spacer(), +// ], +// ), +// ), +// ), +// ], +// ), +// ), +// item.multiple +// ? Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.only(bottom: 18.0), +// child: OutlinedButton( +// onPressed: () { +// provider.getSectionItem( +// item.sectionName, +// ); +// }, +// child: Text( +// 'Add More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// : SizedBox.shrink(), +// _currentPage == _totalPages - 1 +// ? Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.only(bottom: 18.0), +// child: OutlinedButton( +// // onPressed: () {}, +// onPressed: () async { +// String record = +// await provider.saveJsonObject( +// context, widget.form); + +// print( +// "Validation_isss: ${provider.isLoading}"); + +// if (provider.isLoading == false) { +// print("Validation_false"); +// showAlertDialog1(context, +// "Please fill all the fields"); +// } else { +// showAlertDialog(context, +// "Form $record Saved Successfully!"); +// print("Validation_True"); +// } +// }, +// child: Text( +// 'Submit', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// : SizedBox.shrink(), +// ], +// ); +// }).toList(), +// ) +// //}), +// ), +// //const SizedBox(height: 16.0), + +// Padding( +// padding: const EdgeInsets.only(bottom: 8.0), +// child: Align( +// alignment: Alignment.bottomCenter, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceBetween, +// children: [ +// Flexible( +// child: OutlinedButton( +// style: OutlinedButton.styleFrom( +// shape: CircleBorder()), +// onPressed: () { +// //if (_currentPageIndex > _totalPages - 1) +// _controller.previousPage(); +// }, +// child: Padding( +// padding: EdgeInsets.all(8.0), +// child: Icon( +// Icons.arrow_back, +// color: Constants.k2color, +// ), +// ), +// ), +// ), +// Flexible( +// child: OutlinedButton( +// style: OutlinedButton.styleFrom( +// shape: CircleBorder()), +// // onPressed: () { +// // _controller.nextPage( +// // duration: Duration(milliseconds: 300), +// // curve: Curves.ease, +// // ); +// // }, +// onPressed: () { +// _controller.nextPage( +// duration: Duration(milliseconds: 300), +// curve: Curves.ease, +// ); +// }, +// child: Padding( +// padding: EdgeInsets.all(8.0), +// child: Icon( +// Icons.arrow_forward, +// color: Constants.k2color, +// ), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// }), +// ); +// }, +// ); +// } + +// // @override +// // Widget build(BuildContext context) { +// // return Consumer( +// // builder: (BuildContext context, provider, Widget? child) { +// // return GestureDetector( +// // onTap: () { +// // FocusScope.of(context).requestFocus(FocusNode()); +// // }, +// // child: OrientationBuilder(builder: (context, orientation) { +// // return SafeArea( +// // child: Scaffold( +// // appBar: AppBar( +// // title: const FittedBox( +// // fit: BoxFit.scaleDown, +// // child: Text( +// // 'Record New Interaction', +// // style: TextStyle(color: Colors.white), +// // ), +// // ), +// // automaticallyImplyLeading: false, +// // actions: [saveActions(provider)], +// // leading: InkWell( +// // onTap: () { +// // Navigator.pop(context); +// // }, +// // child: const Icon( +// // Icons.arrow_back_ios, +// // color: Colors.white, +// // ), +// // ), +// // ), +// // body: Column( +// // children: [ +// // Expanded( +// // child: CarouselSlider.builder( +// // itemCount: provider.interactionReponseList.length, +// // options: CarouselOptions( +// // height: MediaQuery.of(context) +// // .size +// // .height, // Adjust as needed +// // aspectRatio: +// // 16 / 9, // Optional aspect ratio adjustment +// // viewportFraction: 0.9, +// // initialPage: 0, +// // enableInfiniteScroll: false, +// // reverse: false, +// // autoPlay: false, +// // autoPlayInterval: Duration(seconds: 3), +// // autoPlayAnimationDuration: +// // Duration(milliseconds: 800), +// // autoPlayCurve: Curves.fastOutSlowIn, +// // enlargeCenterPage: true, +// // scrollDirection: Axis.horizontal, +// // ), +// // itemBuilder: +// // (BuildContext context, int index, int realIndex) { +// // var item = provider.interactionReponseList[index]; +// // sectionList = item.sectionList; +// // return Card( +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // elevation: 5, +// // color: Constants.k2color, +// // child: Text("pooja ${index}"), +// // // ExpansionTile( +// // // maintainState: true, +// // // backgroundColor: Constants.k2color, +// // // onExpansionChanged: (bool expanded) { +// // // setState(() { +// // // _isExpanded = expanded; +// // // }); +// // // }, +// // // trailing: Icon( +// // // _isExpanded +// // // ? Icons.keyboard_arrow_up +// // // : Icons.keyboard_arrow_down, +// // // color: Colors.white, +// // // ), +// // // initiallyExpanded: true, +// // // title: Text( +// // // item.sectionName, +// // // style: const TextStyle( +// // // color: Colors.white, +// // // fontWeight: FontWeight.normal, +// // // ), +// // // ), +// // // children: [ +// // // Container( +// // // color: Colors.white, +// // // child: Padding( +// // // padding: const EdgeInsets.only(top: 8.0), +// // // child: Column( +// // // mainAxisSize: MainAxisSize.min, +// // // crossAxisAlignment: +// // // CrossAxisAlignment.center, +// // // children: [ +// // // GridView.count( +// // // physics: +// // // const NeverScrollableScrollPhysics(), +// // // crossAxisCount: +// // // context.responsive( +// // // 1, +// // // sm: 1, // small +// // // md: isTablet +// // // ? 2 +// // // : orientation == +// // // Orientation.landscape +// // // ? 2 +// // // : 1, // medium +// // // lg: sectionList.length == 1 +// // // ? 1 +// // // : 3, // large +// // // xl: 3, // extra large screen +// // // ), +// // // mainAxisSpacing: +// // // sectionList.length == 1 || +// // // !isTablet +// // // ? 1 +// // // : 3.5, +// // // childAspectRatio: +// // // sectionList.length == 1 +// // // ? orientation == +// // // Orientation.landscape +// // // ? 10 +// // // : 4.8 +// // // : isTablet +// // // ? 2.8 +// // // : 3.5, +// // // children: List.generate( +// // // sectionList.length, +// // // (i) { +// // // SectionList sectionItem = +// // // sectionList[i]; +// // // // Your existing code for building widgets inside the GridView +// // // return returnWidget( +// // // sectionItem: sectionItem, +// // // item: item, +// // // provider: provider, +// // // list: list, +// // // gridIndex: i, +// // // listIndex: index, +// // // widgetData: +// // // sectionItem.widget!, +// // // multiple: false); +// // // }, +// // // ), +// // // ), +// // // // Other widgets inside the ExpansionTile's children +// // // ], +// // // ), +// // // ), +// // // ), +// // // ], +// // // ), +// // // ); +// // ); +// // }, +// // ), +// // ), +// // Align( +// // alignment: Alignment.bottomRight, +// // child: Container( +// // height: 80.0, +// // width: 80.0, +// // child: _offsetPopup(provider.interactionReponseList), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ); +// // }), +// // ); +// // }, +// // ); +// // } + +// Widget returnWidget({ +// required SectionList sectionItem, +// required FormFieldData item, +// required InteractionProvider provider, +// required List list, +// required int gridIndex, +// required int listIndex, +// required InteractionWidget widgetData, +// required bool multiple, +// }) { +// switch (widgetData) { +// case InteractionWidget.CHECKBOX: +// return (sectionItem.inputList!.length >= 5) +// ? customMultiselectDropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + +// case InteractionWidget.AUTOCOMPLETE: +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); + +// case InteractionWidget.MULTISELECT: +// return customMultiselectDropdown(sectionItem, provider, list, multiple); + +// case InteractionWidget.RADIO: +// return (sectionItem.inputList!.length >= 5) +// ? customdropdown( +// sectionItem, provider, sectionItem.inputList!, multiple) +// : buildRadio(sectionItem, provider); + +// case InteractionWidget.LABEL: +// return Text(sectionItem.input!); + +// case InteractionWidget.RANGESLIDER: +// return CustomRangeSlider( +// max: double.parse(sectionItem.max!), +// min: double.parse(sectionItem.min!), +// sliderPos: sectionItem.selectedValue!.isNotEmpty +// ? double.parse(sectionItem.selectedValue!.last.toString()) +// : double.parse(sectionItem.min!), +// onChanged: (val) { +// setState(() { +// sectionItem.selectedValue = []; +// sectionItem.selectedId = val.toString(); +// sectionItem.selectedValue!.add(val.toInt()); +// }); +// }, +// ); + +// case InteractionWidget.BUTTON: +// return sectionItem.input == 'add' +// ? const Offstage( +// offstage: true, +// child: Text("Visible"), +// ) +// : Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB(255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.length > 1 +// ? 'Files uploaded' +// : "File Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem.selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ); + +// case InteractionWidget.TEXT: +// return sectionItem.input == 'Date' +// ? buildDateWidget(sectionItem) +// : sectionItem.input == "textArea" +// ? Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: InteractionTextField( +// // maxchars: int.parse(sectionItem.validation!.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// // maxlines: 8, +// //minlines: 4, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// setState(() {}); + +// sectionItem.selectedValue!.add(val); +// }, +// ), +// ), +// ) +// ////Poojaaaaa +// : sectionItem.input == "text1" +// ? Text( +// sectionItem.depid!, +// style: TextStyle( +// fontSize: 18.0, fontWeight: FontWeight.normal), +// ) +// : Expanded( +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: +// // isTablet ? 200 : MediaQuery.of(context).size.width, +// //height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// height: isTablet ? 50 : 40, + +// child: InteractionTextField( +// inputType: sectionItem.input == "number" +// ? TextInputType.number +// : TextInputType.name, +// maxchars: int.parse(sectionItem.chars ?? "0"), +// controller: sectionItem.controller!, +// labelText: sectionItem.name, +// onChanged: (val) { +// sectionItem.selectedValue = []; +// // sectionItem.selectedValue!.clear(); + +// provider.setTextValue( +// val, sectionItem, multiple); +// }, +// ), +// ), +// ), +// ); +// case InteractionWidget.DROPDOWN: +// // return customdropdown(sectionItem, provider, list, multiple); + +// return customAutoCompletedropdown( +// sectionItem, provider, list, multiple); +// } +// } + +// Future requestPermission(Permission permission) async { +// final status = await permission.request(); + +// setState(() { +// print(status); +// // _permissionStatus = status; +// // print(_permissionStatus); +// }); +// } + +// Widget buildDateWidget(SectionList sectionItem) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 50 : 40, +// width: MediaQuery.of(context).size.width, +// child: TextField( +// controller: +// sectionItem.controller, //editing controller of this TextField +// decoration: InputDecoration( +// // border: OutlineInputBorder(), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// labelStyle: const TextStyle(fontSize: 16), +// suffixIcon: const Icon(Icons.calendar_today), //icon of text field +// labelText: "Enter Date" //label text of field +// ), +// readOnly: true, //set it true, so that user will not able to edit text +// onTap: () async { +// DateTime? pickedDate = await showDatePicker( +// context: context, +// initialDate: DateTime.now(), +// firstDate: DateTime( +// 2000), //DateTime.now() - not to allow to choose before today. +// lastDate: DateTime(2101)); + +// if (pickedDate != null) { +// print( +// pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 +// String formattedDate = +// DateFormat('yyyy-MM-dd').format(pickedDate); +// print( +// formattedDate); //formatted date output using intl package => 2021-03-16 +// //you can implement different kind of Date Format here according to your requirement + +// setState(() { +// sectionItem.controller!.text = formattedDate; +// sectionItem.selectedValue = []; +// sectionItem.selectedValue! +// .add(formattedDate); //set output date to TextField value. +// }); +// } else { +// print("Date is not selected"); +// } +// }, +// ), +// ), +// ); +// } + +// Widget saveActions(InteractionProvider provider) { +// return Align( +// alignment: Alignment.centerRight, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceEvenly, +// children: [ +// Padding( +// // padding: const EdgeInsets.all(4.0), +// padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + +// child: CustomButton( +// backgroundColor: Colors.red.shade800, +// onPressed: () { +// //showDeleteProfileAlertDialog(context); +// for (var textcontrollers +// in provider.textEditingControllerList) { +// textcontrollers.text = ''; +// } +// }, +// textColor: Colors.white, +// title: "Reset", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// // fontsize: isTablet ? 15 : 10.2, +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// //width: isTablet ? 20 : 4, +// width: isTablet ? 20 : 2, +// ), +// Padding( +// // padding: const EdgeInsets.all(8.0), +// padding: const EdgeInsets.only(top: 8.0, bottom: 8.0), + +// child: CustomButton( +// backgroundColor: Colors.green.shade500, +// onPressed: () async { +// String record = +// await provider.saveJsonObject(context, widget.form); + +// print("Validation_isss: ${provider.isLoading}"); + +// if (provider.isLoading == false) { +// print("Validation_false"); +// showAlertDialog1(context, "Please fill all the fields"); +// } else { +// showAlertDialog(context, "Form $record Saved Successfully!"); +// print("Validation_True"); +// } +// }, +// textColor: Colors.white, +// title: "Save", +// // height: 40, +// // width: isTablet ? 100 : 80, +// height: MediaQuery.of(context).size.height * 0.2, + +// // width: MediaQuery.of(context).size.width * 0.1, +// fontsize: isTablet ? 16 : 12, +// ), +// ), +// SizedBox( +// width: isTablet ? 20 : 2, +// ), +// ], +// ), +// ); +// } + +// Widget buildRadio(SectionList sectionItem, InteractionProvider provider) { +// List list = provider.getData2(sectionItem); +// // .map((itemWord) => InputClass.fromJson(itemWord)) +// // .toList(); +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 250 : MediaQuery.of(context).size.width, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (InputClass value in list) +// Row( +// children: [ +// Radio( +// value: value.name, +// activeColor: Colors.black, +// groupValue: provider.radioValue, +// onChanged: (String? value) { +// setState(() { +// print(value); +// provider.radioValue = value!; +// int index = +// list.indexWhere((element) => element.name == value); +// sectionItem.selectedValue!.add(list[index].id); +// }); +// }, +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget buildCheckbox(SectionList sectionItem, String sectionName, +// InteractionProvider provider, bool multiple) { +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: 250, +// width: MediaQuery.of(context).size.width, + +// child: Row( +// children: [ +// for (var value in provider.checkboxlist) +// Row( +// children: [ +// FittedBox( +// fit: BoxFit.scaleDown, +// child: CheckboxListTile( +// dense: true, +// //contentPadding: const EdgeInsets.symmetric(vertical: 5), +// value: value.ischecked ?? false, +// activeColor: Colors.black, +// checkColor: Colors.white, +// onChanged: (bool? newvalue) { +// value.ischecked = newvalue!; +// provider.setcheckBoxValue(sectionItem, sectionName, +// newvalue, value.id, multiple); +// //setState(() {}); +// }, +// ), +// ), +// Text(value.name), +// ], +// ), +// ], +// ), +// ), +// ); +// } + +// Widget customdropdown(SectionList sectionItem, InteractionProvider provider, +// List list, bool multiple) { +// // sectionItem.value = ''; + +// if (list.isEmpty) { +// list = []; +// InputClass inputClass = +// InputClass(id: "no value", name: "Select ${sectionItem.name}"); +// list.add(inputClass); +// sectionItem.selectedObject = list[0]; +// } +// // InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// width: MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select ${sectionItem.name}', +// style: const TextStyle(fontSize: 14), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject ?? list[0], +// // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) +// // sectionItem.value ?? list[0].name, +// validator: (value) { +// if (value == null) { +// return 'Please select ${sectionItem.name}'; +// } +// return null; +// }, +// onChanged: (value) { +// //Do something when selected item is changed. +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// print("selected ${sectionItem.value}"); +// // setState(() {}); +// }, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// sectionItem.value = value.id; +// provider.setDropDownValue(value.id, sectionItem, multiple); +// // setState(() {}); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(right: 8), +// ), +// iconStyleData: const IconStyleData( +// icon: Icon( +// Icons.arrow_drop_down, +// color: Colors.black45, +// ), +// iconSize: 24, +// ), +// dropdownStyleData: DropdownStyleData( +// decoration: BoxDecoration( +// borderRadius: BorderRadius.circular(10.0), +// ), +// ), +// menuItemStyleData: const MenuItemStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// ), +// ), +// ), +// ); +// } + +// Widget customAutoCompletedropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// list = sectionItem.inputList!; +// print("***Autocomplete list ${list[0].name}"); +// //} +// //InputClass selectedObj = list[0]; +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Item', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list +// .map((item) => DropdownMenuItem( +// value: item, +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// )) +// .toList(), +// value: sectionItem.selectedObject, +// onSaved: (value) { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onChanged: (value) { +// // setState(() { +// sectionItem.selectedObject = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// // setState(() {}); +// //}); +// }, + +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.symmetric(horizontal: 16), +// height: 40, +// width: 200, +// ), +// dropdownStyleData: const DropdownStyleData( +// maxHeight: 200, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// ), +// dropdownSearchData: DropdownSearchData( +// searchController: textEditingController, +// searchInnerWidgetHeight: 50, +// searchInnerWidget: Container( +// height: 50, +// padding: const EdgeInsets.only( +// top: 8, +// bottom: 4, +// right: 8, +// left: 8, +// ), +// child: TextFormField( +// // expands: true, +// // maxLines: null, +// controller: textEditingController, +// decoration: InputDecoration( +// isDense: true, +// contentPadding: const EdgeInsets.symmetric( +// horizontal: 10, +// vertical: 18, +// ), +// hintText: 'Search for an item...', +// hintStyle: const TextStyle(fontSize: 12), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// ), +// ), +// ), +// searchMatchFn: (item, searchValue) { +// return item.value!.name.toString().contains(searchValue); +// }, +// ), +// //This to clear the search value when you close the menu +// onMenuStateChange: (isOpen) { +// if (!isOpen) { +// textEditingController.clear(); +// } +// }, +// ), +// ), +// ), +// ); +// } + +// Widget customMultiselectDropdown(SectionList sectionItem, +// InteractionProvider provider, List list, bool multiple) { +// if (list.isEmpty) { +// list = sectionItem.inputList!; +// } +// InputClass selectedObj = list[0]; + +// return Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: SizedBox( +// // width: isTablet ? 200 : MediaQuery.of(context).size.width, +// // height: isTablet ? 60 : 40, +// width: MediaQuery.of(context).size.width, +// // height: MediaQuery.of(context).size.height, + +// child: DropdownButtonHideUnderline( +// child: DropdownButtonFormField2( +// isExpanded: true, +// decoration: InputDecoration( +// // Add Horizontal padding using menuItemStyleData.padding so it matches +// // the menu padding when button's width is not specified. +// isDense: true, +// contentPadding: const EdgeInsets.symmetric(vertical: 5), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// // Add more decoration.. +// ), +// hint: Text( +// 'Select Items', +// style: TextStyle( +// fontSize: 14, +// color: Theme.of(context).hintColor, +// ), +// ), +// items: list.map((item) { +// return DropdownMenuItem( +// value: item, +// //disable default onTap to avoid closing menu when selecting an item +// enabled: false, +// child: StatefulBuilder( +// builder: (context, menuSetState) { +// final isSelected = +// sectionItem.selectedValue!.contains(item.name); +// return InkWell( +// onTap: () { +// isSelected +// ? sectionItem.selectedValue!.remove(item.name) +// : sectionItem.selectedValue!.add(item.name); +// //This rebuilds the StatefulWidget to update the button's text +// setState(() {}); +// //This rebuilds the dropdownMenu Widget to update the check mark +// menuSetState(() {}); +// }, +// child: Container( +// height: double.infinity, +// padding: const EdgeInsets.symmetric(horizontal: 16.0), +// child: Row( +// children: [ +// if (isSelected) +// const Icon(Icons.check_box_outlined) +// else +// const Icon(Icons.check_box_outline_blank), +// const SizedBox(width: 16), +// Expanded( +// child: Text( +// item.name, +// style: const TextStyle( +// fontSize: 14, +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// }, +// ), +// ); +// }).toList(), +// //Use last selected item as the current value so if we've limited menu height, it scroll to last item. +// value: selectedObj, +// // ? null +// // : provider.selectedItems.last, +// onChanged: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// onSaved: (value) { +// selectedObj = value!; +// provider.setAutoCompleteValue(value.id, sectionItem, multiple); +// sectionItem.value = value.name; +// }, +// selectedItemBuilder: (context) { +// return list.map( +// (item) { +// return Container( +// alignment: AlignmentDirectional.center, +// child: Text( +// sectionItem.selectedValue!.join(', '), +// style: const TextStyle( +// fontSize: 14, +// overflow: TextOverflow.ellipsis, +// ), +// maxLines: 1, +// ), +// ); +// }, +// ).toList(); +// }, +// buttonStyleData: const ButtonStyleData( +// padding: EdgeInsets.only(left: 16, right: 8), +// height: 40, +// width: 140, +// ), +// menuItemStyleData: const MenuItemStyleData( +// height: 40, +// padding: EdgeInsets.zero, +// ), +// ), +// ), +// ), +// ); +// } + +// Widget gridViewWidget( +// InteractionProvider provider, +// String sectionName, +// List sectionList, +// Orientation orientation, +// FormFieldData item, +// int listIndex) { +// print("ListInex: $listIndex"); +// print("sectionName: $sectionName"); +// print("sectionName: $sectionName"); + +// print("gridsectionlost_is: $sectionList"); +// print("gridsectionlostleangth_is: ${sectionList.length}"); + +// List pooja = sectionList; + +// print("Pooja_isss: $pooja"); +// print("Pooja_leangth_isss: ${pooja.length}"); + +// ////////////////////////////////////mycode/////////////////////////// + +// List> convertedArray = []; +// print("Provider_leangth: ${item.sectionList.length}"); + +// for (int i = 0; i < pooja.length; i += item.sectionList.length + 1) { +// print("poojaleangth: $pooja"); + +// convertedArray.add(pooja.sublist(i, i + item.sectionList.length + 1)); +// } +// print("ConvertedArray.leangth: $convertedArray"); +// print("ConvertedArray.leangth: ${convertedArray.length}"); + +// return Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// for (var i = 0; i < convertedArray.length; i++) +// DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// color: i % 2 == 0 +// ? Color.fromARGB(133, 213, 241, 254) +// : Colors.white, +// ), +// child: GridView.builder( +// physics: const NeverScrollableScrollPhysics(), +// gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( +// crossAxisCount: context.responsive( +// 1, +// sm: 1, // small +// md: isTablet +// ? 2 +// : orientation == Orientation.landscape +// ? 2 +// : 1, // medium +// lg: sectionList.length == 1 ? 1 : 3, // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 1, +// // childAspectRatio: sectionList.length == 1 +// // ? orientation == Orientation.landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.7, +// childAspectRatio: sectionList.length == 1 +// ? orientation == Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 4.5, +// ), +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// itemCount: convertedArray[i].length, +// itemBuilder: (context, index) { +// SectionList sectionItem = convertedArray[i][index]; +// dropdownvalue = +// sectionItem.widget == InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = sectionItem.widget == +// InteractionWidget.DROPDOWN || +// sectionItem.widget == +// InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; +// return Padding( +// padding: const EdgeInsets.only(top: 12.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// // sectionItem.widget == InteractionWidget.BUTTON && +// // sectionItem.input == 'add' || +// // sectionItem.input == 'deletebtn' +// // ? const SizedBox.shrink() +// // : +// Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text( +// sectionItem.validation!.isRequired +// ? "${sectionItem.name}*" +// : sectionItem.name, +// style: TextStyle( +// //color: Colors.orange.shade800, +// color: Constants.k2color, +// fontSize: 14), +// ), +// ), +// ), +// // const SizedBox( +// // height: 15, +// // ), +// sectionItem.widget == InteractionWidget.BUTTON +// ? sectionItem.input == 'chooseFile' +// ? Row( +// children: [ +// CustomButton( +// backgroundColor: const Color.fromARGB( +// 255, 233, 229, 229), +// onPressed: () async { +// sectionItem.selectedValue = []; +// sectionItem.extension = []; +// sectionItem.fileName = []; +// await getEncodedFile(sectionItem); + +// setState(() {}); +// }, +// width: 120, +// height: 40, +// fontsize: 12, +// textColor: Colors.black, +// title: sectionItem.name), +// const SizedBox( +// width: 5, +// ), +// Text( +// sectionItem.selectedValue!.isNotEmpty +// ? sectionItem +// .selectedValue!.isNotEmpty +// ? 'File uploaded' +// : "Files Uploaded" +// : 'No file uploaded', +// style: TextStyle( +// color: sectionItem +// .selectedValue!.isNotEmpty +// ? Colors.green +// : Colors.red), +// ), +// ], +// ) +// : isTablet +// ? IconButton( +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// icon: const Icon( +// Icons.cancel, +// size: 30, +// color: Color.fromARGB(255, 8, 39, 92), +// ), +// ) +// : Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: CustomButton( +// backgroundColor: +// const Color.fromARGB( +// 255, 233, 75, 75), +// onPressed: () { +// provider.deleteMultipleRows( +// sectionItem.gid!, +// sectionList[i], +// sectionName); + +// setState(() {}); +// }, +// height: 40, + +// // height: +// // MediaQuery.of(context).size.height * +// // 0.2, +// fontsize: 12, +// textColor: Colors.white, +// title: "Delete"), +// ) +// : returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: listIndex, +// widgetData: sectionItem.widget!, +// multiple: true), +// ], +// ), +// ); +// }), +// ) +// ], +// ); +// //); +// } + +// String fieldsValidation(InteractionProvider provider) { +// List secList = provider.sectionList +// .where((element) => element.validation!.isRequired = true) +// .toList(); +// if (secList.any((element) => element.selectedValue!.isEmpty)) { +// return 'Fields cannot be empty'; +// } +// return ''; +// } + +// String textFieldsValidation(InteractionProvider provider) { +// return ''; +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } + +// Future getEncodedFile(SectionList sectionItem) async { +// String base64Image = ''; +// var status = Platform.isAndroid +// ? await Permission.manageExternalStorage.status +// : await Permission.storage.status; +// if (status.isGranted) { +// FilePickerResult? result = +// await FilePicker.platform.pickFiles(allowMultiple: true); + +// if (result != null) { +// print(result.files.first.path); +// print(result.files.last.path); +// for (var files in result.files) { +// File file = File(files.path!); +// print("check file path : ${file.path}"); +// fileName = file.path.split('/').last; +// // Get the application folder directory +// Directory? directory = Platform.isAndroid +// ? await getExternalStorageDirectory() //FOR ANDROID +// : await getApplicationDocumentsDirectory(); +// String newPath = ""; //FOR ios +// String convertedDirectoryPath = (directory?.path).toString(); + +// print("see the converted directory path $convertedDirectoryPath"); + +// newPath = "$convertedDirectoryPath/konectar/files"; +// print("new path :$newPath"); +// directory = Directory(newPath); +// if (!await directory.exists()) { +// await directory.create(recursive: true); +// } +// File newFile = await file.copy('${directory.path}/$fileName'); +// print("new path is ${newFile.path}"); +// final extension = p.extension(newFile.path); +// List imageBytes = await newFile.readAsBytes(); +// Uint8List imageUint8List = Uint8List.fromList(imageBytes); +// base64Image = base64Encode(imageUint8List); +// sectionItem.selectedValue!.add(base64Image); +// sectionItem.extension!.add(extension); +// sectionItem.fileName!.add(fileName); +// } +// } +// } else { +// print("not permitted"); +// await requestPermission(Platform.isAndroid +// ? Permission.manageExternalStorage +// : Permission.storage); +// } +// } + +// showAlertDialog(BuildContext context, String record) { +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// showAlertDialog1(BuildContext context, String record) { +// Widget cancelButton = TextButton( +// child: const Text("Ok"), +// onPressed: () async { +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text(record), +// actions: [ +// cancelButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// Widget _offsetPopup(List interactionReponseList) { +// List trueElements = +// interactionReponseList.where((element) => element.multiple).toList(); +// print("trueElements_iss: $trueElements"); + +// return PopupMenuButton( +// onSelected: (newValue) { +// var provider = +// Provider.of(context, listen: false); +// setState(() { +// _value = newValue; // it gives the value which is selected + +// var item = trueElements[_value]; + +// provider.getSectionItem( +// item.sectionName, +// ); +// }); +// print("Clicked Section111 $_value "); // add this property +// print( +// "interactionReponseList1 ${interactionReponseList} "); // add this property +// }, +// itemBuilder: (context) { +// return List.generate(trueElements.length, (index) { +// var provider = +// Provider.of(context, listen: false); + +// var item = trueElements[index]; + +// print("itemitemitemitem_isss: ${item.multiple}"); + +// return PopupMenuItem( +// value: index, +// child: item.multiple == true +// ? GestureDetector( +// onTap: () { +// print("Clicked Section ${item.sectionName}"); +// // provider.getSectionItem( +// // item.sectionName, +// // ); +// //print("Clicked Section : ${sectionList}") +// setState(() { +// provider.getSectionItem( +// item.sectionName, +// ); +// }); + +// const DecoratedBox( +// decoration: BoxDecoration( +// // border: Border.all(color: Colors.black), +// // borderRadius: BorderRadius.circular(10.0), +// border: Border( +// bottom: +// BorderSide(width: 1.5, color: Colors.black), +// //top: BorderSide(width: 1.5, color: Colors.black), +// ), +// ), +// ); +// }, +// child: item.multiple == true +// ? Text(' ${item.sectionName}') +// : const SizedBox.shrink()) +// : SizedBox.shrink(), +// ); +// }); +// }, +// icon: Container( +// height: double.infinity, +// width: double.infinity, +// decoration: const ShapeDecoration( +// color: Color.fromARGB(255, 8, 39, 92), +// shape: StadiumBorder( +// side: BorderSide(color: Colors.white, width: 2), +// ), +// ), +// child: Icon(Icons.add, color: Colors.white), +// )); +// } +// } + diff --git a/lib/contacts_module/ui_screen/interactionform/repository/hive_repository.dart b/lib/contacts_module/ui_screen/interactionform/repository/hive_repository.dart new file mode 100644 index 0000000..a06b766 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/repository/hive_repository.dart @@ -0,0 +1,55 @@ +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:flutter/material.dart'; + +import 'package:hive/hive.dart'; +// import 'package:pwa_ios/model/interaction_config_data.dart'; + +class HiveDataRepository extends ChangeNotifier { + Box _hiveBox; // Use the correct type for your Hive box + + HiveDataRepository(this._hiveBox); + + List getAllDataFromHive() { + print("Stored_ALL_valuesssss : ${_hiveBox.values.toList().toString()}"); + print( + "Stored_ALL_valuesssss_leangthhh : ${_hiveBox.values.toList().length}"); + + return _hiveBox.values.toList(); + } + + Future openHiveBox() async { + _hiveBox = + await Hive.openBox('InteractionConfigDataBox'); + } + + Future closeHiveBox() async { + _hiveBox.close(); + } + + List getAllofflineData() { + return _hiveBox.values.toList(); + } + + Future addOfflineData(InteractionConfigData data, int id) async { + // _hiveBox = await Hive.openBox('InteractionDataBox'); + + await _hiveBox.put(id, data); + + notifyListeners(); + } + + Future getNextAutoIncrementValue() async { + var counterBox = await Hive.openBox('counterBox'); + if (!counterBox.containsKey('counter')) { + counterBox.put('counter', 0); + } + + int? counter = counterBox.get('counter'); + counterBox.put('counter', counter! + 1); + + await counterBox.close(); + + return counter; + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/util.dart b/lib/contacts_module/ui_screen/interactionform/util.dart new file mode 100644 index 0000000..759e15b --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/util.dart @@ -0,0 +1,116 @@ +import 'dart:io'; + +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/json_form_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/json_form_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:flutter/material.dart'; +import 'package:connectivity_plus/connectivity_plus.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +import 'package:shared_preferences/shared_preferences.dart'; + +Future isNetworkAvailable() async { + // check if there is a valid network connection + final connectivityResult = await Connectivity().checkConnectivity(); + if (connectivityResult != ConnectivityResult.mobile && + connectivityResult != ConnectivityResult.wifi) { + return false; + } + + // check if the network is really connected to Internet + try { + final result = await InternetAddress.lookup('example.com'); + if (result.isEmpty || result[0].rawAddress.isEmpty) { + return false; + } + } on SocketException catch (_) { + return false; + } + + return true; +} + +Future isPWAInstalled() async { + final prefs = await SharedPreferences.getInstance(); + return prefs.getBool('isInstalled') ?? false; +} + +void setPWAInstalled({bool installed = true}) async { + final prefs = await SharedPreferences.getInstance(); + await prefs.setBool('isInstalled', installed); +} + +bool get isTablet { + final firstView = WidgetsBinding.instance.platformDispatcher.views.first; + final logicalShortestSide = + firstView.physicalSize.shortestSide / firstView.devicePixelRatio; +// print("size:${logicalShortestSide > 600} tablet "); + return logicalShortestSide > 500; +} + +Future formJsonForSync() async { + final provider = ViewInteractionProvider(); + final prov = InteractionProvider(); + List senSavedList = []; + List savedList = await provider.getAllRecords(); + for (var obj in savedList) { + senSavedList.add(prov.formJson(obj)); + } + + SendSaveJson jsonData = SendSaveJson(savedList: senSavedList); + String jsonstr = saveFormJsonToJson(jsonData); + print(jsonstr); + return jsonstr; +} + +Future checkRecordsAvailable() async { + final provider = ViewInteractionProvider(); + List savedList = await provider.getAllRecords(); + return savedList.isNotEmpty; +} + +deleteRecords() async { + final provider = ViewInteractionProvider(); + List savedList = await provider.getAllRecords(); + for (var obj in savedList) { + provider.deleteRecord(obj); + } +} + +Future getNextAutoIncrementValue() async { + var counterBox = await Hive.openBox('counterBox'); + if (!counterBox.containsKey('counter')) { + counterBox.put('counter', 0); + } + + int? counter = counterBox.get('counter'); + counterBox.put('counter', counter! + 1); + + await counterBox.close(); + + return counter; +} + +class HexColor extends Color { + static int _getColorFromHex(String hexColor) { + hexColor = hexColor.toUpperCase().replaceAll("#", ""); + if (hexColor.length == 6) { + hexColor = "FF$hexColor"; + } + return int.parse(hexColor, radix: 16); + } + + HexColor(final String hexColor) : super(_getColorFromHex(hexColor)); +} + +extension Iterables on Iterable { + Map> groupBy(K Function(E) keyFunction) => fold( + >{}, + (Map> map, E element) => + map..putIfAbsent(keyFunction(element), () => []).add(element)); +} diff --git a/lib/contacts_module/ui_screen/interactionform/view_forms_list.dart b/lib/contacts_module/ui_screen/interactionform/view_forms_list.dart new file mode 100644 index 0000000..d73b7d7 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/view_forms_list.dart @@ -0,0 +1,255 @@ +// import 'package:konectar_events/ui_screen/interactionform/configprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/edit_interaction_screen.dart'; +// import 'package:konectar_events/ui_screen/interactionform/mockapi.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/view_interaction_screen.dart'; +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:konectar_events/ui_screen/new_editinteraction.dart'; +// import 'package:konectar_events/ui_screen/new_viewinteraction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/configprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/mockapi.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_editinteraction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_viewinteraction.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +// ignore: must_be_immutable +class SavedFormListScreen extends StatefulWidget { + // List savedList; + String formname; + SavedFormListScreen({super.key, required this.formname}); + + @override + State createState() => _SavedFormListScreenState(); +} + +class _SavedFormListScreenState extends State { + //List savedList = []; + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + init(); + }); + + super.initState(); + } + + init() async { + // await Provider.of(context, listen: false) + // .initConfigData(); + await Provider.of(context, listen: false) + .getRecords(widget.formname); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + return SafeArea( + child: Scaffold( + appBar: AppBar( + title: Text( + 'Records of ${widget.formname}', + style: + TextStyle(fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + automaticallyImplyLeading: false, + // backgroundColor: const Color(0xFF2b9af3), + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + actions: [ + IconButton( + onPressed: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + if (await checkRecordsAvailable()) { + String jsonstr = await formJsonForSync(); + + print("jsonrrrrr: $jsonstr"); + + var result = await MockApiCall().postSavedData(jsonstr); + + if (result != null) { + Navigator.pop(context); + + await deleteRecords(); + await configDataProvider + .initConfigUIData() + .then((value) {}); + + _displaySnackBar('Data synced sucessfully!'); + } else { + Navigator.pop(context); + _displaySnackBar('Something went wrong!'); + } + } else { + Navigator.pop(context); + _displaySnackBar('No records to sync!'); + } + }, + icon: Icon(Icons.upload)) + ], + ), + body: Container( + child: Center( + child: ListView.builder( + itemCount: provider.savedList.length, + cacheExtent: + double.parse(provider.savedList.length.toString()), + itemBuilder: (context, index) { + return Column( + children: [ + ListTile( + subtitle: Text( + 'Updated on ${provider.savedList[index].updatedTime}', + //style: TextStyle(fontStyle: FontStyle.italic), + ), + title: Text( + provider.savedList[index].id, + ), + trailing: SizedBox( + width: 150, + child: Row(children: [ + IconButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + ViewInteractionScreen1( + saveInteraction: + provider.savedList[index], + ))); + }, + icon: const Icon( + Icons.info_outline, + size: 24, + color: Color.fromARGB(255, 8, 39, 92), + ), + ), + IconButton( + onPressed: () async { + await provider.initConfigData().then({ + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (BuildContext context) => + // EditInteractionScreen( + // saveInteraction: provider + // .savedList[index], + // ))) + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + EditInteractionScreen1( + saveInteraction: provider + .savedList[index], + ))) + }); + }, + icon: const Icon( + Icons.edit, + size: 24, + color: Color.fromARGB(255, 8, 39, 92), + ), + ), + IconButton( + onPressed: () { + showDeleteRecordAlertDialog( + context, + provider.savedList[index].id, + provider.savedList[index]); + }, + icon: const Icon( + Icons.delete, + size: 24, + color: Color.fromARGB(255, 8, 39, 92), + ), + ), + ]), + ), + onTap: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + ViewInteractionScreen1( + saveInteraction: + provider.savedList[index], + ))); + }, + ), + const Divider(), + ], + ); + })), + ), + ), + ); + }); + } + + showDeleteRecordAlertDialog( + BuildContext context, String record, SaveInteraction saveInteraction) { + // set up the buttons + ViewInteractionProvider provider = + Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("YES"), + onPressed: () async { + await provider.deleteRecord(saveInteraction).then((value) { + _displaySnackBar("Deleted sucessfully!"); + Navigator.of(context).pop(); + }); + }, + ); + Widget continueButton = TextButton( + child: const Text("NO"), + onPressed: () { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text("Are you sure you want to delete the record $record ?"), + actions: [ + cancelButton, + continueButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/view_interaction_screen.dart b/lib/contacts_module/ui_screen/interactionform/view_interaction_screen.dart new file mode 100644 index 0000000..8e4afc2 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/view_interaction_screen.dart @@ -0,0 +1,1185 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +// ignore: must_be_immutable +class ViewInteractionScreen extends StatefulWidget { + SaveInteraction saveInteraction; + ViewInteractionScreen({super.key, required this.saveInteraction}); + + @override + State createState() => _ViewInteractionScreenState(); +} + +class _ViewInteractionScreenState extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + init(); + }); + + super.initState(); + } + + init() async { + await Provider.of(context, listen: false) + .initSavedForm(widget.saveInteraction); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + print("build context"); + print("${provider.interactionReponseList}"); + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + //resizeToAvoidBottomInset: false, + appBar: AppBar( + title: Text( + widget.saveInteraction.id, + style: TextStyle( + fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + // backgroundColor: const Color(0xFF2b9af3), + automaticallyImplyLeading: false, + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + mainAxisSize: MainAxisSize.min, + children: [ + Expanded( + child: ListView.builder( + itemCount: provider.interactionReponseList.length, + cacheExtent: double.parse( + provider.interactionReponseList.length.toString()), + itemBuilder: (context, index) { + var item = provider.interactionReponseList[index]; + sectionList = item.sectionList; + return Container( + color: Constants.k2color, + child: ExpansionTile( + initiallyExpanded: true, + title: Stack( + alignment: AlignmentDirectional.center, + children: [ + Container( + // height: double.infinity, + width: double.infinity, + padding: const EdgeInsets.all(0.0), + decoration: BoxDecoration( + // color: Color(0xFF2b9af3), + color: Constants.k2color, + ), + child: Text( + item.sectionName, + style: const TextStyle( + color: Colors.white, + fontWeight: FontWeight.bold, + fontSize: 18.0), + )), + ]), + children: [ + Container( + color: Colors.white, + child: Padding( + padding: const EdgeInsets.only(top: 8.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(18.0), + child: GridView.count( + physics: + const NeverScrollableScrollPhysics(), + crossAxisCount: + context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || + !isTablet + ? 1 + : 3.5, + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation + .landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.5, + shrinkWrap: true, + padding: EdgeInsets.zero, + children: List.generate( + sectionList.length, + (i) { + print(sectionList); + SectionList sectionItem = + sectionList[i]; + dropdownvalue = + sectionItem.widget == + InteractionWidget + .DROPDOWN + ? sectionItem.value ?? + "Select" + : ' '; + List< + InputClass> list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem.widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget + .MULTISELECT + ? provider + .getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == + InteractionWidget + .CHECKBOX + ? provider.getData2( + sectionItem) + : []; + + return Column( + crossAxisAlignment: + CrossAxisAlignment + .start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem + .param == + 'add' + ? const SizedBox + .shrink() + : Text( + '${sectionItem.name}:*', + style: TextStyle( + color: Colors + .orange + .shade800, + fontSize: + isTablet + ? 18 + : 12, + ), + ), + returnWidget( + sectionItem: + sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: index, + widgetData: + sectionItem + .widget!), + ], + ); + }, + ), + ), + ), + + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + index) + : const SizedBox.shrink(), + provider.interactionReponseList + .length == + index - 1 + ? saveActions(provider) + : const SizedBox.shrink() + //const Spacer(), + ], + ), + ), + ), + ]), + ); + }, + ), + ), + // const Spacer(), + // saveActions(provider), + ], + )), + ); + }), + ); + }); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required InteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? Text(sectionItem.selectedValue.toString()) + : Text(provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last)); + + case InteractionWidget.AUTOCOMPLETE: + return Text(provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last)); + + case InteractionWidget.MULTISELECT: + return Text(sectionItem.selectedValue.toString()); + + case InteractionWidget.RADIO: + return (sectionItem.inputList!.length >= 5) + ? Text(sectionItem.selectedValue!.isNotEmpty + ? provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last) + : " ") + : Text(provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last)); + + case InteractionWidget.LABEL: + return Text(sectionItem.input!); + + case InteractionWidget.RANGESLIDER: + return Text(sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.last.toString() + : " "); + + case InteractionWidget.TEXT: + return Text(sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.last.toString() + : " "); + + case InteractionWidget.BUTTON: + return sectionItem.input == "chooseFile" + ? sectionItem.selectedValue!.isNotEmpty + ? const Text("File Uploaded") + : const Text(" ") + : const Text(" "); + default: + return Text(sectionItem.selectedValue!.isNotEmpty + ? provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last) + : " "); + } + } + + Widget saveActions(InteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + CustomButton( + backgroundColor: Colors.red.shade800, + onPressed: () { + //showDeleteProfileAlertDialog(context); + for (var textcontrollers in provider.textEditingControllerList) { + textcontrollers.text = ''; + } + }, + textColor: Colors.white, + title: "Reset", + height: 40, + width: isTablet ? 100 : 60, + fontsize: isTablet ? 15 : 10.2, + ), + SizedBox( + width: isTablet ? 20 : 4, + ), + CustomButton( + backgroundColor: Colors.green.shade900, + onPressed: () async { + if (textFieldsValidation(provider).isEmpty) { + // await provider.saveJsonObject(context, widget.form); + _displaySnackBar('Form Saved Sucessfully!'); + } else { + _displaySnackBar(textFieldsValidation(provider)); + } + }, + textColor: Colors.white, + title: "Save", + height: 40, + width: isTablet ? 100 : 60, + fontsize: isTablet ? 16 : 12, + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget gridViewWidget( + InteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + List pooja = sectionList; + + print("Pooja: $pooja"); + + List> convertedArray = []; + print("Provider Length: ${item.sectionList.length}"); + + for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { + print("Section List11111: $sectionList"); + print("item.sectionList.length List11111: ${item.sectionList.length}"); + + convertedArray + .add(sectionList.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArrayEdit.leangth: $convertedArray"); + print("ConvertedArray.leangth2323: ${convertedArray.length}"); + + return Column( + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + // borderRadius: BorderRadius.circular(10.0), + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, // default + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : (sectionList.length >= 1 ? 3 : 3), + // lg: sectionList.length == 1 ? 1 : 3, // large + xl: 3, // extra large screen + ), + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.7, + + mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 3.5, + // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = sectionItem.widget == + InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + + return SizedBox( + height: MediaQuery.of(context).size.height, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + sectionItem.widget == InteractionWidget.BUTTON && + sectionItem.param == 'add' || + sectionItem.param == 'deletebtn' + ? const SizedBox.shrink() + + // ? const SizedBox.shrink() + : Text( + '${sectionItem.name}:*', + style: TextStyle( + color: Colors.orange.shade800, + fontSize: isTablet ? 18 : 14, + ), + ), + const SizedBox( + height: 15, + ), + returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!), + ], + ), + ); + }, + ), + ), + //), + ], + ); + } + + String textFieldsValidation(InteractionProvider provider) { + if (provider.sectionList + .any((element) => element.controller!.text.isEmpty)) { + return 'Fields cannot be empty'; + } + + return ''; + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } +} + + + + + + + + + + + + + + + + + + + + + + + + + + + +// import 'package:discover_module/constants.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:discover_module/ui_screen/interactionform/widget/responsive_ext.dart'; +// import 'package:flutter/material.dart'; +// import 'package:provider/provider.dart'; + +// // ignore: must_be_immutable +// class ViewInteractionScreen extends StatefulWidget { +// SaveInteraction saveInteraction; +// ViewInteractionScreen({super.key, required this.saveInteraction}); + +// @override +// State createState() => _ViewInteractionScreenState(); +// } + +// class _ViewInteractionScreenState extends State { +// List interactionReponseList = []; +// List sectionList = []; +// List textEditingControllerList = []; +// int textfieldIndex = 0; +// String dropdownvalue = 'Select value'; +// String? fileName; +// final TextEditingController textEditingController = TextEditingController(); +// @override +// void initState() { +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// init(); +// }); + +// super.initState(); +// } + +// init() async { +// await Provider.of(context, listen: false) +// .initSavedForm(widget.saveInteraction); +// setState(() {}); +// } + +// @override +// Widget build(BuildContext context) { +// return Consumer( +// builder: (BuildContext context, provider, Widget? child) { +// print("build context"); +// print("${provider.interactionReponseList}"); +// return GestureDetector( +// onTap: () { +// FocusScope.of(context).requestFocus(FocusNode()); +// }, +// child: OrientationBuilder(builder: (context, orientation) { +// return SafeArea( +// child: Scaffold( +// //resizeToAvoidBottomInset: false, +// appBar: AppBar( +// title: Text( +// widget.saveInteraction.id, +// style: TextStyle( +// fontSize: isTablet ? 22 : 14, color: Colors.white), +// ), +// // backgroundColor: const Color(0xFF2b9af3), +// automaticallyImplyLeading: false, +// leading: InkWell( +// onTap: () { +// Navigator.pop(context); +// }, +// child: const Icon( +// Icons.arrow_back_ios, +// color: Colors.white, +// ), +// ), +// ), +// body: Column( +// children: [ +// Expanded( +// child: ListView.builder( +// itemCount: provider.interactionReponseList.length, +// cacheExtent: double.parse( +// provider.interactionReponseList.length.toString()), +// itemBuilder: (context, index) { +// var item = provider.interactionReponseList[index]; +// sectionList = item.sectionList; +// return ExpansionTile( +// initiallyExpanded: true, +// title: Stack( +// alignment: AlignmentDirectional.center, +// children: [ +// Container( +// // height: double.infinity, +// width: double.infinity, +// padding: const EdgeInsets.all(8.0), +// decoration: BoxDecoration( +// // color: Color(0xFF2b9af3), +// color: Constants.k2color, +// ), +// child: Text( +// item.sectionName, +// style: const TextStyle( +// color: Colors.white, +// fontWeight: FontWeight.bold, +// fontSize: 18.0), +// )), +// ]), +// children: [ +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: Column( +// crossAxisAlignment: +// CrossAxisAlignment.center, +// children: [ +// const SizedBox( +// height: 20, +// ), + +// Padding( +// padding: isTablet +// ? const EdgeInsets.only(left: 18.0) +// : const EdgeInsets.only( +// left: 12.0, right: 12.0), +// child: GridView.count( +// physics: +// const NeverScrollableScrollPhysics(), +// // crossAxisCount: context.responsive( +// // 1, +// // sm: 1, // small +// // md: 1, // medium +// // lg: sectionList.length == 1 +// // ? 1 +// // : 4, // large +// // xl: 3, // extra large screen +// // ), +// // mainAxisSpacing: +// // sectionList.length == 1 || !isTablet +// // ? 1 +// // : 3.5, +// // shrinkWrap: true, +// // padding: EdgeInsets.zero, +// // childAspectRatio: +// // sectionList.length == 1 || !isTablet +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 3.8 +// // : 2.8, + +// crossAxisCount: +// context.responsive( +// 1, +// sm: 1, // small +// md: 2, // medium +// lg: sectionList.length == 1 +// ? 1 +// : 3, // large +// xl: 3, // extra large screen +// ), +// mainAxisSpacing: +// sectionList.length == 1 || +// !isTablet +// ? 1 +// : 3.5, +// childAspectRatio: +// sectionList.length == 1 +// ? orientation == +// Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.0, +// // childAspectRatio: +// // sectionList.length == 1 +// // ? orientation == +// // Orientation.landscape +// // ? 10 +// // : 4.8 +// // : isTablet +// // ? 2.8 +// // : 3.0, +// shrinkWrap: true, +// padding: EdgeInsets.zero, +// children: List.generate( +// sectionList.length, +// (i) { +// print(sectionList); +// SectionList sectionItem = +// sectionList[i]; +// dropdownvalue = sectionItem +// .widget == +// InteractionWidget.DROPDOWN +// ? sectionItem.value ?? +// "Select" +// : ' '; +// List< +// InputClass> list = sectionItem +// .widget == +// InteractionWidget +// .DROPDOWN || +// sectionItem.widget == +// InteractionWidget +// .AUTOCOMPLETE || +// sectionItem.widget == +// InteractionWidget +// .MULTISELECT +// ? provider +// .getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == +// InteractionWidget +// .CHECKBOX +// ? provider +// .getData2(sectionItem) +// : []; + +// return Column( +// crossAxisAlignment: +// CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == +// InteractionWidget +// .BUTTON && +// sectionItem.param == +// 'add' +// ? const SizedBox.shrink() +// : Text( +// '${sectionItem.name}:*', +// style: TextStyle( +// color: Colors.orange +// .shade800, +// fontSize: isTablet +// ? 18 +// : 12, +// ), +// ), +// SizedBox( +// height: isTablet ? 15 : 5, +// ), +// returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: index, +// widgetData: +// sectionItem.widget!), +// SizedBox( +// height: isTablet ? 15 : 5, +// ), +// ], +// ); +// }, +// ), +// ), +// ), +// SizedBox( +// height: isTablet ? 15 : 5, +// ), +// item.multiple +// ? gridViewWidget( +// provider, +// item.sectionName, +// item.multipleList ?? [], +// orientation, +// item, +// index) +// : const SizedBox.shrink(), +// provider.interactionReponseList.length == +// index - 1 +// ? saveActions(provider) +// : const SizedBox.shrink() +// //const Spacer(), +// ], +// ), +// ), +// ]); +// }, +// ), +// ), +// // const Spacer(), +// // saveActions(provider), +// ], +// )), +// ); +// }), +// ); +// }); +// } + +// Widget returnWidget({ +// required SectionList sectionItem, +// required FormFieldData item, +// required InteractionProvider provider, +// required List list, +// required int gridIndex, +// required int listIndex, +// required InteractionWidget widgetData, +// }) { +// switch (widgetData) { +// case InteractionWidget.CHECKBOX: +// return (sectionItem.inputList!.length >= 5) +// ? Text(sectionItem.selectedValue.toString()) +// : Text(provider.getDataValue( +// sectionItem.id, sectionItem.selectedValue!.last)); + +// case InteractionWidget.AUTOCOMPLETE: +// return Text(provider.getDataValue( +// sectionItem.id, sectionItem.selectedValue!.last)); + +// case InteractionWidget.MULTISELECT: +// return Text(sectionItem.selectedValue.toString()); + +// case InteractionWidget.RADIO: +// return (sectionItem.inputList!.length >= 5) +// ? Text(sectionItem.selectedValue!.isNotEmpty +// ? provider.getDataValue( +// sectionItem.id, sectionItem.selectedValue!.last) +// : " ") +// : Text(provider.getDataValue( +// sectionItem.id, sectionItem.selectedValue!.last)); + +// case InteractionWidget.LABEL: +// return Text(sectionItem.input!); + +// case InteractionWidget.RANGESLIDER: +// return Text(sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.last.toString() +// : " "); + +// case InteractionWidget.TEXT: +// return Text(sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.last.toString() +// : " "); + +// case InteractionWidget.BUTTON: +// return sectionItem.input == "chooseFile" +// ? sectionItem.selectedValue!.isNotEmpty +// ? const Text("File Uploaded") +// : const Text(" ") +// : const Text(" "); +// default: +// return Text(sectionItem.selectedValue!.isNotEmpty +// ? provider.getDataValue( +// sectionItem.id, sectionItem.selectedValue!.last) +// : " "); +// } +// } + +// Widget saveActions(InteractionProvider provider) { +// return Align( +// alignment: Alignment.centerRight, +// child: Row( +// mainAxisAlignment: MainAxisAlignment.spaceEvenly, +// children: [ +// CustomButton( +// backgroundColor: Colors.red.shade800, +// onPressed: () { +// //showDeleteProfileAlertDialog(context); +// for (var textcontrollers in provider.textEditingControllerList) { +// textcontrollers.text = ''; +// } +// }, +// textColor: Colors.white, +// title: "Reset", +// height: 40, +// width: isTablet ? 100 : 60, +// fontsize: isTablet ? 15 : 10.2, +// ), +// SizedBox( +// width: isTablet ? 20 : 4, +// ), +// CustomButton( +// backgroundColor: Colors.green.shade900, +// onPressed: () async { +// if (textFieldsValidation(provider).isEmpty) { +// // await provider.saveJsonObject(context, widget.form); +// _displaySnackBar('Form Saved Sucessfully!'); +// } else { +// _displaySnackBar(textFieldsValidation(provider)); +// } +// }, +// textColor: Colors.white, +// title: "Save", +// height: 40, +// width: isTablet ? 100 : 60, +// fontsize: isTablet ? 16 : 12, +// ), +// SizedBox( +// width: isTablet ? 20 : 2, +// ), +// ], +// ), +// ); +// } + +// // Widget gridViewWidget( +// // InteractionProvider provider, +// // String sectionName, +// // List sectionList, +// // Orientation orientation, +// // FormFieldData item, +// // int listIndex) { +// // return Padding( +// // padding: isTablet +// // ? const EdgeInsets.only(left: 22.0) +// // : const EdgeInsets.only(left: 12.0, right: 12.0), +// // child: GridView.count( +// // physics: const NeverScrollableScrollPhysics(), +// // crossAxisCount: context.responsive( +// // 1, // default +// // sm: 1, // small +// // md: 1, // medium +// // lg: sectionList.length == 1 ? 1 : 4, // large +// // xl: 5, // extra large screen +// // ), +// // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, +// // shrinkWrap: true, +// // padding: EdgeInsets.zero, +// // childAspectRatio: sectionList.length == 1 || !isTablet +// // ? orientation == Orientation.landscape +// // ? 10 +// // : 4.2 +// // : 1.8, +// // children: List.generate( +// // sectionList.length, +// // (i) { +// // print(sectionList); +// // SectionList sectionItem = sectionList[i]; +// // dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN +// // ? sectionItem.value ?? "Select" +// // : ' '; +// // List list = +// // sectionItem.widget == InteractionWidget.DROPDOWN || +// // sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// // sectionItem.widget == InteractionWidget.MULTISELECT +// // ? provider.getData2(sectionItem) +// // : []; +// // provider.checkboxlist = +// // sectionItem.widget == InteractionWidget.CHECKBOX +// // ? provider.getData2(sectionItem) +// // : []; + +// // return Wrap(children: [ +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // sectionItem.widget == InteractionWidget.BUTTON && +// // sectionItem.param == 'add' || +// // sectionItem.param == 'deletebtn' +// // ? const SizedBox.shrink() +// // : Text( +// // '${sectionItem.name}:*', +// // style: TextStyle( +// // color: Colors.orange.shade800, +// // fontSize: isTablet ? 18 : 14, +// // ), +// // ), +// // const SizedBox( +// // height: 15, +// // ), +// // returnWidget( +// // sectionItem: sectionItem, +// // item: item, +// // provider: provider, +// // list: list, +// // gridIndex: i, +// // listIndex: listIndex, +// // widgetData: sectionItem.widget!), +// // ], +// // ), +// // ]); +// // }, +// // ), +// // ), +// // ); +// // } + +// Widget gridViewWidget( +// InteractionProvider provider, +// String sectionName, +// List sectionList, +// Orientation orientation, +// FormFieldData item, +// int listIndex) { +// List pooja = sectionList; + +// print("Pooja: $pooja"); + +// List> convertedArray = []; +// print("Provider Length: ${item.sectionList.length}"); + +// for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { +// print("Section List11111: $sectionList"); +// print("item.sectionList.length List11111: ${item.sectionList.length}"); + +// convertedArray +// .add(sectionList.sublist(i, i + item.sectionList.length + 1)); +// } +// print("ConvertedArrayEdit.leangth: $convertedArray"); +// print("ConvertedArray.leangth2323: ${convertedArray.length}"); + +// return Padding( +// padding: isTablet +// ? const EdgeInsets.only(left: 0.0, right: 0.0) +// : const EdgeInsets.only(left: 12.0, right: 12.0), +// child: Column( +// children: [ +// for (var i = 0; i < convertedArray.length; i++) +// DecoratedBox( +// decoration: BoxDecoration( +// // borderRadius: BorderRadius.circular(10.0), +// color: i % 2 == 0 +// ? Color.fromARGB(133, 213, 241, 254) +// : Colors.white, +// ), +// child: GridView.builder( +// physics: const NeverScrollableScrollPhysics(), +// gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( +// crossAxisCount: context.responsive( +// 1, // default +// sm: 1, // small +// md: 2, // medium +// lg: sectionList.length == 1 +// ? 1 +// : (sectionList.length >= 1 ? 3 : 3), +// // lg: sectionList.length == 1 ? 1 : 3, // large +// xl: 3, // extra large screen +// ), +// childAspectRatio: sectionList.length == 1 +// ? orientation == Orientation.landscape +// ? 10 +// : 4.8 +// : isTablet +// ? 2.8 +// : 3.0, + +// mainAxisSpacing: +// sectionList.length == 1 || !isTablet ? 1 : 3.5, +// // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, +// ), +// shrinkWrap: true, +// padding: EdgeInsets.zero, + +// // childAspectRatio: sectionList.length == 1 || !isTablet +// // ? orientation == Orientation.landscape +// // ? 10 +// // : 4.2 +// // : 1.8, +// itemCount: convertedArray[i].length, +// itemBuilder: (context, index) { +// // children: List.generate( +// // sectionList.length, +// // (i) { +// // print(sectionList); +// // SectionList sectionItem = sectionList[i]; +// // dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN +// // ? sectionItem.value ?? "Select" +// // : ' '; +// // List list = +// // sectionItem.widget == InteractionWidget.DROPDOWN || +// // sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// // sectionItem.widget == InteractionWidget.MULTISELECT +// // ? provider.getData2(sectionItem) +// // : []; +// // provider.checkboxlist = +// // sectionItem.widget == InteractionWidget.CHECKBOX +// // ? provider.getData2(sectionItem) +// // : []; +// SectionList sectionItem = convertedArray[i][index]; +// dropdownvalue = +// sectionItem.widget == InteractionWidget.DROPDOWN +// ? sectionItem.value ?? "Select" +// : ' '; +// List list = sectionItem.widget == +// InteractionWidget.DROPDOWN || +// sectionItem.widget == +// InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT +// ? provider.getData2(sectionItem) +// : []; +// provider.checkboxlist = +// sectionItem.widget == InteractionWidget.CHECKBOX +// ? provider.getData2(sectionItem) +// : []; + +// return SizedBox( +// height: MediaQuery.of(context).size.height, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// sectionItem.widget == InteractionWidget.BUTTON && +// sectionItem.param == 'add' || +// sectionItem.param == 'deletebtn' +// ? const SizedBox.shrink() + +// // ? const SizedBox.shrink() +// : Text( +// '${sectionItem.name}:*', +// style: TextStyle( +// color: Colors.orange.shade800, +// fontSize: isTablet ? 18 : 14, +// ), +// ), +// const SizedBox( +// height: 15, +// ), +// returnWidget( +// sectionItem: sectionItem, +// item: item, +// provider: provider, +// list: list, +// gridIndex: i, +// listIndex: listIndex, +// widgetData: sectionItem.widget!), +// ], +// ), +// ); +// }, +// ), +// ), +// //), +// ], +// ), +// ); +// } + +// String textFieldsValidation(InteractionProvider provider) { +// if (provider.sectionList +// .any((element) => element.controller!.text.isEmpty)) { +// return 'Fields cannot be empty'; +// } + +// return ''; +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } +// } diff --git a/lib/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart b/lib/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart new file mode 100644 index 0000000..03b50ee --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart @@ -0,0 +1,1831 @@ +import 'dart:convert'; + +import 'package:dio/dio.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/json_form_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/location_model.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/repository/hive_repository.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/json_form_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/location_model.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/repository/hive_repository.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/services.dart'; +import 'package:hive_flutter/hive_flutter.dart'; + +class ViewInteractionProvider extends ChangeNotifier { + List interactionReponseList = []; + // List sectionList = []; + List sectionList = []; + late Location locationList; + List textEditingControllerList = []; + List multipletextEditingControllerList = []; + int textfieldIndex = 0; + List countryList = []; + List stateList = []; + List cityList = []; + List checkboxlist = []; + String selectedCountry = 'Selected Country'; + String radioValue = ''; + bool checkboxValue = false; + + late SaveInteraction saveInteraction; + List saveData = []; + + List newList = []; + String sectionName = ''; + late String selectedCity = 'Selected City', selectedState = 'Selected State'; + String customdropdownValue = ''; + String? selectedValue; + List selectedItems = []; + InputClass? selectedObj; + List savedList = []; + List intConfigDataList = []; + String? intId, intName; + final HiveDataRepository _hiveprovider = HiveDataRepository( + Hive.box('InteractionConfigDataBox')); + + late final InteractionProvider interactionProvider; + late bool _isLoadingView; + + get isLoading => _isLoadingView; + + initConfigData() async { + intConfigDataList = _hiveprovider.getAllDataFromHive(); + notifyListeners(); + } + + Future getRecords(String formname) async { + var box = await Hive.openBox('InteractionDataBox'); + savedList = box.values.toList(); + savedList = savedList + .where( + (element) => element.form == formname, + ) + .toList(); + notifyListeners(); + } + + Future> getAllRecords() async { + var box = await Hive.openBox('InteractionDataBox'); + List savedList = box.values.toList(); + + return savedList; + } + + init(int index) async { + // _hiveprovider = HiveDataRepository( + // Hive.box('InteractionConfigDataBox')); + // intConfigDataList = _hiveprovider.getAllDataFromHive(); + InteractionConfigData interactionConfigData = intConfigDataList[index]; + intId = intConfigDataList[index].id; + intName = intConfigDataList[index].name; + + print("data $intConfigDataList"); + // await fetchSaveDataJson(); + // await fetchDataSet(); + await fetchData(interactionConfigData.widgets); + await fetchLocationData(); + } + + initSavedForm(SaveInteraction saveInteractiondata) { + intConfigDataList + .indexWhere((element) => element.id == saveInteractiondata.intId); + + interactionReponseList = saveInteractiondata.save + .map((e) => FormFieldData( + multipleList: e.multipleList == null + ? [] + : e.multipleList! + .map((mobj) => SectionList( + depid: mobj.depid, + id: mobj.id, + inputList: mobj.inputList, + isRequired: mobj.isRequired, + extension: mobj.extension, + fileName: mobj.fileName, + selectedObject: mobj.selectedObject, + name: mobj.name, + param: mobj.param, + selectedValue: mobj.selectedValue, + widget: mobj.widget, + controller: mobj.controller, + gid: mobj.gid, + input: mobj.input, + selectedId: mobj.selectedId, + value: mobj.value)) + .toList(), + sectionList: e.sectionList + .map((obj) => SectionList( + depid: obj.depid, + id: obj.id, + inputList: obj.inputList, + isRequired: obj.isRequired, + extension: obj.extension, + fileName: obj.fileName, + name: obj.name, + param: obj.param, + selectedObject: obj.selectedObject, + selectedValue: obj.selectedValue, + widget: obj.widget, + controller: obj.controller, + gid: obj.gid, + input: obj.input, + selectedId: obj.selectedId, + value: obj.value)) + .toList(), + sectionName: e.sectionName, + multiple: e.multiple)) + .toList(); + + textEditingControllerList.clear(); + + for (var item in interactionReponseList) { + sectionList = item.sectionList; + + for (SectionList obj in item.multipleList!) { + obj.gid = obj.gid ?? item.multipleList!.length; + + if (obj.widget == InteractionWidget.TEXT) { + debugPrint("textcontr:${obj.gid}"); + debugPrint("textcontr:${obj.selectedValue}"); + // debugPrint("textcontr:${obj.controller!.value}"); + var textEditingController = TextEditingController(); + textEditingController.value = TextEditingValue( + text: obj.selectedValue!.isNotEmpty + ? obj.selectedValue!.last ?? "" + : ""); + textEditingController.text = obj.selectedValue!.isNotEmpty + ? obj.selectedValue!.last ?? "" + : ""; + multipletextEditingControllerList.add(textEditingController); + // obj.controller!.value = textEditingController.value; + obj.controller = textEditingController; + // obj.controller = obj.selectedValue.last ?? " "; + } + if (obj.widget == InteractionWidget.DROPDOWN || + obj.widget == InteractionWidget.AUTOCOMPLETE || + obj.widget == InteractionWidget.MULTISELECT) { + List list = obj.inputList!; + if (obj.selectedObject != null) { + } else { + obj.selectedObject = obj.selectedValue!.isNotEmpty + ? getDataObject(obj.id, obj.selectedValue!.last, list) + : list[0]; + } + + print("value : ${list.first.name} "); + } + if (obj.widget == InteractionWidget.CHECKBOX) { + List selectedvalues = []; + if (obj.selectedValue!.isNotEmpty) { + for (var id in obj.selectedValue!) { + int ind = + obj.inputList!.indexWhere((element) => element.id == id); + if (ind != -1) { + obj.inputList![ind].ischecked = true; + selectedvalues.add(obj.inputList![ind].name); + } + } + } + } + if (obj.widget == InteractionWidget.RADIO) { + List list = obj.inputList!; + + if (obj.selectedValue!.isNotEmpty) { + int ind = list + .indexWhere((element) => element.id == obj.selectedValue!.last); + if (ind != -1) { + obj.inputList![ind].ischecked = true; + radioValue = obj.inputList![ind].name; + } + } + } + // newList.add(obj); + } + for (var sectionItem in item.sectionList) { + if (sectionItem.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + textEditingController.text = sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.last ?? " " + : " "; + textEditingControllerList.add(textEditingController); + + sectionItem.controller = textEditingControllerList.last; + } + if (sectionItem.widget == InteractionWidget.DROPDOWN) { + List list = sectionItem.inputList!; + if (sectionItem.selectedObject != null) { + print("#######not null"); + } else { + print("#######is_null"); + if (sectionItem.selectedValue == null) { + print("#######is_null#####"); + } else { + print('###${sectionItem.selectedValue}'); + } + sectionItem.selectedObject = sectionItem.selectedValue!.isNotEmpty + ? getDataObject( + sectionItem.id, sectionItem.selectedValue!.last, list) + : list[0]; + } + + print("valuesssss : ${sectionItem.selectedObject!.name} "); + } + + if (sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT) { + List list = sectionItem.inputList!; + if (sectionItem.selectedObject != null) { + } else { + sectionItem.selectedObject = sectionItem.selectedValue!.isNotEmpty + ? getDataObject( + sectionItem.id, sectionItem.selectedValue!.last, list) + : list[0]; + } + + print("value : ${list.first.name} "); + } + if (sectionItem.widget == InteractionWidget.CHECKBOX) { + List selectedvalues = []; + if (sectionItem.selectedValue!.isNotEmpty) { + for (var id in sectionItem.selectedValue!) { + int ind = sectionItem.inputList! + .indexWhere((element) => element.id == id); + if (ind != -1) { + sectionItem.inputList![ind].ischecked = true; + selectedvalues.add(sectionItem.inputList![ind].name); + } + } + } + } + if (sectionItem.widget == InteractionWidget.RADIO) { + List list = sectionItem.inputList!; + + if (sectionItem.selectedValue!.isNotEmpty) { + int ind = list.indexWhere( + (element) => element.id == sectionItem.selectedValue!.last); + if (ind != -1) { + sectionItem.inputList![ind].ischecked = true; + radioValue = sectionItem.inputList![ind].name; + } + } + } + if (sectionItem.widget == InteractionWidget.BUTTON && + sectionItem.param == 'chooseFile' && + sectionItem.selectedValue!.isNotEmpty) { + print("choosed file"); + print(sectionItem.selectedValue!.last); + } + } + } + print(interactionReponseList); + print("check textcontrollers ${textEditingControllerList.length}"); + } + + Future fetchDataSet() async { + List list = getData("intlocation_1"); + print(list); + return "success"; + } + + List getData(String widgetId) { + List list = []; + + return list; + } + + InputClass getDataObject(String widgetId, String id, List list) { + // if (id != "") { + // List list = []; + InputClass value = InputClass(id: '', name: ''); + + if (list.isNotEmpty) { + int index = list.indexWhere((element) => element.id.toString() == id); + + if (index != -1) { + value = list[index]; + } + } + + return value; + } + +// TODO: Search for widget with depid and check if selected is not null and by selected id get the data of current widget + List getData2(SectionList sectionItem) { + List list = []; + // if (sectionItem.inputList != null) { + list = sectionItem.inputList!; + if (sectionItem.depid != "") { + // print("check depid : ${sectionItem.depid}"); + int i = 0; + for (var obj in interactionReponseList) { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.depid); + // print("check depid index: $i"); + if (i != -1) { + //print("check depid value: ${obj.sectionList[i].value}"); + if (obj.sectionList[i].value != null) { + if (list + .where((element) => element.pid == obj.sectionList[i].value) + .isNotEmpty) { + list = list + .where((element) => element.pid == obj.sectionList[i].value) + .toList(); + + sectionItem.selectedObject = list[0]; + } else { + // InputClass obj = InputClass( + // id: "obj.sectionList[i].value", + // name: "Select ${sectionItem.name}"); + list = []; + // list.add(obj); + sectionItem.selectedObject = null; + } + } else { + // int index = obj.sectionList + // .indexWhere((element) => element.id == sectionItem.id); + + // list = obj.sectionList[index].inputList; + } + } + } + + // int index = data[i].data.indexWhere((element) => element.) + } + // } + return list; + } + + setDropDownValue(String value, SectionList sectionItem, bool multiple, + InputClass selectedObject) { + int i = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList!.indexWhere((element) => + element.id == sectionItem.id && element.gid == sectionItem.gid); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].tempselectedValue = []; + obj.multipleList![i].tempselectedValue!.add(value); + // obj.multipleList![i].selectedObject = selectedObj; + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].tempselectedValue = []; + obj.sectionList[i].tempselectedValue!.add(value); + // obj.sectionList[i].selectedObject = selectedObj; + } + } + } + notifyListeners(); + } + + Future disposeValues() async { + print("dispose called"); + // await _hiveprovider.closeHiveBox(); + for (var obj in interactionReponseList) { + obj.multipleList!.clear(); + // for (var obj2 in obj.sectionList) { + // obj2.selectedObject = null; + // } + + obj.sectionList.clear(); + } + interactionReponseList.clear(); + } + + setTextValue(String value, SectionList sectionItem, bool multiple) { + int i = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList!.indexWhere((element) => + element.id == sectionItem.id && element.gid == sectionItem.gid); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].selectedValue!.add(value); + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].selectedValue!.add(value); + } + } + } + notifyListeners(); + } + + setAutoCompleteValue(String value, SectionList sectionItem, bool multiple) { + int i = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + i = obj.multipleList!.indexWhere((element) => + element.id == sectionItem.id && element.gid == sectionItem.gid); + if (i != -1) { + obj.multipleList![i].value = value; + obj.multipleList![i].tempselectedValue = []; + obj.multipleList![i].tempselectedValue!.add(value); + } + } else { + i = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (i != -1) { + obj.sectionList[i].value = value; + obj.sectionList[i].tempselectedValue = []; + obj.sectionList[i].tempselectedValue!.add(value); + } + } + } + notifyListeners(); + } + + String getDropDownValue( + String value, SectionList sectionItem, List list) { + int i = 0; + String svalue = ''; + + i = list.indexWhere((element) => element.id == value); + if (i != -1) { + svalue = list[i].name; + } else { + svalue = list[0].name; + } + + return svalue; + } + + Future fetchData(InteractionResultData interactionResultData) async { + InteractionResultData interactionConfig = interactionResultData; + + print("itemCategoryModel Item = + ${interactionConfig.result}"); + + interactionReponseList = interactionConfig.result; + print("check stored: $interactionReponseList"); + textEditingControllerList.clear(); + + for (var item in interactionReponseList) { + sectionList = item.sectionList; + for (var sectionItem in item.sectionList) { + if (sectionItem.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + + textEditingControllerList.add(textEditingController); + sectionItem.controller = textEditingControllerList.last; + } + if (sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT) { + List list = sectionItem.inputList!; + sectionItem.value = list[0].name; + print("value : ${list.first} "); + } + } + } + print(interactionReponseList); + print("check textcontrollers ${textEditingControllerList.length}"); + + return "success"; + } + + Future fetchLocationData() async { + var data = + await rootBundle.loadString("assets/images/locationdetailsform.json"); + + Locations loc = + Locations(location: Location.fromJson(json.decode(data)["location"])); + locationList = loc.location; + countryList = locationList.country; + stateList = locationList.state; + cityList = locationList.city; + + print(locationList); + notifyListeners(); + return "success"; + } + + List getState(String cid) { + List states = + stateList.where((element) => element.countryId == cid).toList(); + + return states; + } + + List getCity(String sid) { + List city = + cityList.where((element) => element.stateId == sid).toList(); + + return city; + } + + String getCountryId(String name) { + if (countryList.isNotEmpty) { + int i = countryList.indexWhere((element) => element.countryName == name); + return countryList[i].countryId; + } + return ''; + } + + String getStateId(String name) { + if (stateList.isNotEmpty) { + int i = stateList.indexWhere((element) => element.stateName == name); + return stateList[i].stateId; + } + return ''; + } + + String getCityId(String name) { + if (cityList.isNotEmpty) { + int i = cityList.indexWhere((element) => element.cityName == name); + return cityList[i].distId; + } + return ''; + } + + setRadioValue(SectionList sectionItem) { + List list = (sectionItem.input as List) + .map((itemWord) => InputClass.fromJson(itemWord)) + .toList(); + radioValue = list[0].name; + + notifyListeners(); + } + + setcheckBoxValue(SectionList sectionItem, String sectionName, bool newValue, + String id, bool multiple) { + int index = + sectionItem.inputList!.indexWhere((element) => element.id == id); + sectionItem.inputList![index].ischecked = newValue; + // sectionItem.selectedValue.add(data[i].data[index].id); + int index2 = 0; + for (var obj in interactionReponseList) { + if (multiple && obj.multipleList != null) { + index2 = obj.multipleList!.indexWhere((element) => + element.id == sectionItem.id && element.gid == sectionItem.gid); + if (index2 != -1) { + obj.multipleList![index2].value = sectionItem.inputList![index].id; + obj.multipleList![index2].selectedValue! + .add(sectionItem.inputList![index].id); + } + } else { + index2 = obj.sectionList + .indexWhere((element) => element.id == sectionItem.id); + if (index2 != -1) { + obj.sectionList[index2].value = sectionItem.inputList![index].id; + obj.sectionList[index2].selectedValue! + .add(sectionItem.inputList![index].id); + } + } + } + notifyListeners(); + } + + getSectionItem(String sectionName) { + newList = []; + List addList = []; + int index = interactionReponseList + .indexWhere((element) => element.sectionName == sectionName); + + addList = interactionReponseList[index] + .sectionList + .map((e) => SectionList( + depid: e.depid, + id: e.id, + inputList: e.inputList, + isRequired: e.isRequired, + name: e.name, + validation: e.validation, + param: e.param, + selectedValue: [], + widget: e.widget, + controller: e.controller, + gid: e.gid, + input: e.input, + selectedId: e.selectedId, + value: e.value)) + .toList(); + SectionList delItem = SectionList( + name: " ", + param: "deletebtn", + id: "deletebtn", + selectedValue: [], + depid: "", + widget: InteractionWidget.BUTTON, + inputList: [], + validation: Validation(isRequired: false), + isRequired: true); + + addList.add(delItem); + + // if (interactionReponseList[index].multipleList!.isEmpty) { + // newList = addList; + // } else { + + if (addList.isNotEmpty) { + for (SectionList obj in addList) { + // obj.gid = obj.gid ?? addList.length; + if (obj.widget == InteractionWidget.TEXT) { + var textEditingController = TextEditingController(); + + multipletextEditingControllerList.add(textEditingController); + obj.controller = multipletextEditingControllerList.last; + obj.controller!.text = + obj.selectedValue != null && obj.selectedValue!.isNotEmpty + ? obj.selectedValue!.last + : ''; + } + // newList.add(obj); + } + } + if (interactionReponseList[index].multipleList == null) { + interactionReponseList[index].multipleList = addList; + } else { + interactionReponseList[index].multipleList = + interactionReponseList[index].multipleList! + addList; + } + + newList = interactionReponseList[index].multipleList!; + // newList = newList + addList; + // } + if (interactionReponseList[index].multipleList != null) { + for (SectionList obj in interactionReponseList[index].multipleList!) { + obj.gid = obj.gid ?? interactionReponseList[index].multipleList!.length; + if (obj.widget == InteractionWidget.TEXT) { + obj.controller!.text = + obj.selectedValue != null && obj.selectedValue!.isNotEmpty + ? obj.selectedValue!.last + : ''; + } + // newList.add(obj); + } + } + + print( + "check length : ${interactionReponseList[index].multipleList!.length}"); + notifyListeners(); + } + + deleteMultipleRows( + int gid, SectionList sectionItem, String selectedSectionName) { + int index = interactionReponseList + .indexWhere((element) => element.sectionName == selectedSectionName); + interactionReponseList[index] + .multipleList! + .removeWhere((item) => item.gid == gid); + + notifyListeners(); + } + + // saveJsonObject(BuildContext context, String form, + // SaveInteraction saveInteraction) async { + // for (var res in interactionReponseList) { + // for (var sec in res.sectionList) { + // debugPrint("print ${sec.selectedValue}"); + // } + // for (var sec in res.multipleList!) { + // debugPrint("printmultiple ${sec.selectedValue}"); + // } + // } + // List resultData = interactionReponseList + // .map((e) => FormFieldData( + // multipleList: e.multipleList == null + // ? [] + // : e.multipleList! + // .map((mobj) => SectionList( + // depid: mobj.depid, + // id: mobj.id, + // inputList: mobj.inputList, + // isRequired: mobj.isRequired, + // extension: mobj.extension, + // fileName: mobj.fileName, + // name: mobj.name, + // param: mobj.param, + // selectedValue: + // mobj.tempselectedValue ?? mobj.selectedValue, + // widget: mobj.widget, + // gid: mobj.gid, + // input: mobj.input, + // selectedId: mobj.selectedId, + // value: mobj.value)) + // .toList(), + // sectionList: e.sectionList + // .map((obj) => SectionList( + // depid: obj.depid, + // id: obj.id, + // inputList: obj.inputList, + // extension: obj.extension, + // fileName: obj.fileName, + // isRequired: obj.isRequired, + // name: obj.name, + // param: obj.param, + // selectedValue: obj.tempselectedValue ?? obj.selectedValue, + // widget: obj.widget, + // controller: obj.controller, + // gid: obj.gid, + // input: obj.input, + // selectedId: obj.selectedId, + // value: obj.value)) + // .toList(), + // sectionName: e.sectionName, + // multiple: e.multiple, + // )) + // .toList(); + + // final data = SaveInteraction( + // save: resultData, + // id: saveInteraction.id, + // updatedTime: DateTime.now().toString(), + // form: saveInteraction.form, + // intId: saveInteraction.intId, + // intName: saveInteraction.intName, + // ); + // var box = Hive.box('InteractionDataBox'); + + // if (!box.isOpen) { + // box = await Hive.openBox('InteractionDataBox'); + // } + + // int index = + // box.values.toList().indexWhere((element) => element.id == data.id); + + // box.putAt(index, data); + // await getRecords(saveInteraction.form!); + // // box.close(); + + // // await MockApiCall().postFormData(data); + // } + + saveJsonObject(BuildContext context, String form, + SaveInteraction saveInteraction) async { + for (var res in interactionReponseList) { + for (var sec in res.sectionList) { + debugPrint("print ${sec.selectedValue}"); + } + for (var sec in res.multipleList!) { + debugPrint("printmultiple ${sec.selectedValue}"); + } + } + List resultData = interactionReponseList + .map((e) => FormFieldData( + multipleList: e.multipleList == null + ? [] + : e.multipleList! + .map((mobj) => SectionList( + depid: mobj.depid, + id: mobj.id, + inputList: mobj.inputList, + validation: mobj.validation, + isRequired: mobj.isRequired, + extension: mobj.extension, + fileName: mobj.fileName, + name: mobj.name, + param: mobj.param, + selectedValue: + mobj.tempselectedValue ?? mobj.selectedValue, + widget: mobj.widget, + gid: mobj.gid, + input: mobj.input, + selectedId: mobj.selectedId, + value: mobj.value)) + .toList(), + sectionList: e.sectionList + .map((obj) => SectionList( + depid: obj.depid, + id: obj.id, + inputList: obj.inputList, + validation: obj.validation, + isRequired: obj.isRequired, + extension: obj.extension, + fileName: obj.fileName, + name: obj.name, + param: obj.param, + selectedValue: obj.tempselectedValue ?? obj.selectedValue, + widget: obj.widget, + controller: obj.controller, + gid: obj.gid, + input: obj.input, + selectedId: obj.selectedId, + value: obj.value)) + .toList(), + sectionName: e.sectionName, + multiple: e.multiple, + )) + .toList(); + if (validateSectionList(resultData)) { + _isLoadingView = true; + notifyListeners(); + + final data = SaveInteraction( + save: resultData, + id: saveInteraction.id, + updatedTime: DateTime.now().toString(), + form: saveInteraction.form, + intId: saveInteraction.intId, + intName: saveInteraction.intName, + ); + var box = Hive.box('InteractionDataBox'); + + if (!box.isOpen) { + box = await Hive.openBox('InteractionDataBox'); + } + + int index = + box.values.toList().indexWhere((element) => element.id == data.id); + + box.putAt(index, data); + } else { + _isLoadingView = false; + notifyListeners(); + + // Handle validation error + print("JSON data is not valid according to the schema."); + } + await getRecords(saveInteraction.form!); + // box.close(); + + // await MockApiCall().postFormData(data); + } + + Future deleteRecord(SaveInteraction saveInteraction) async { + var box = await Hive.openBox('InteractionDataBox'); + final Map deliveriesmap = box.toMap(); + dynamic deleteKey; + deliveriesmap.forEach((key, value) { + if (value.id == saveInteraction.id) { + deleteKey = key; + } + }); + box.delete(deleteKey); + await getRecords(saveInteraction.form!); + //box.close(); + } + + List getModifiedList(List sectionList) { + List newSectionList = []; + for (var obj in sectionList) { + if (obj.id != 'deletebtn') { + if (obj.id == 'chooseFile') { + List files = []; + if (obj.selectedValue!.isNotEmpty && obj.selectedValue != null) { + for (var file in obj.selectedValue!) { + files.add(MultipartFile.fromFileSync(file)); + } + } + MultipleSectionList newobj = MultipleSectionList( + id: obj.id, + selectedValue: files, + ); + + newSectionList.add(newobj); + } else { + MultipleSectionList newobj = MultipleSectionList( + id: obj.id, + selectedValue: obj.selectedValue!, + ); + newSectionList.add(newobj); + } + } + } + return newSectionList; + } + + bool validateMultipleRows() { + for (var obj in interactionReponseList) { + if (obj.multipleList != null) { + for (var mulobj in obj.multipleList!) { + if (mulobj.widget == InteractionWidget.TEXT) { + if (mulobj.controller!.text.isEmpty) { + return true; + } + } + } + } + } + return false; + } + + bool validateTextFields() { + for (var obj in interactionReponseList) { + for (var mulobj in obj.sectionList) { + if (mulobj.widget == InteractionWidget.TEXT) { + if (mulobj.controller!.text.isEmpty) { + return true; + } + } + } + } + return false; + } + + bool validateSectionList(List resultData) { + for (var formData in resultData) { + for (var section in formData.sectionList) { + // print("Section.leangthiss: ${resultData.length}"); + // for (int i = 0; i <= resultData.length; i++) { + // SectionList sectionItem = formData.sectionList[i]; + // print("Section_isssss1111: ${sectionItem.validation!.isRequired}"); + // } + + print("Section_isssss: $section"); + print("Section_isssss: ${section.widget}"); + print("Section_isssss: ${section.selectedId}"); + + if (section.widget == InteractionWidget.TEXT) { + if (section.isRequired == true && section.controller!.text.isEmpty) { + debugPrint("Iam text and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.AUTOCOMPLETE) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam AUTOCOMPLETE and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.DROPDOWN) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam dropdown and empty"); + notifyListeners(); + + return false; + } + } else if (section.widget == InteractionWidget.CHECKBOX) { + if (section.isRequired == true && section.selectedValue!.isEmpty) { + debugPrint("Iam CHECKBOX and empty"); + notifyListeners(); + + return false; + } + } + } + print("Multilist"); + for (var msection in formData.multipleList!) { + print("Multilist Enter"); + + print("Multilist Enterwidget: ${msection.widget}"); + + if (msection.widget == InteractionWidget.TEXT) { + print("Checkinggg: ${msection.id}"); + print("Checkinggg: ${msection.depid}"); + print("Checkinggg: ${msection.chars}"); + print("Checkinggg: ${msection.selectedId}"); + print("Checkinggg: ${msection.selectedValue!}"); + + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam multi text and empty"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.AUTOCOMPLETE) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam AUTOCOMPLETE and empty"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.DROPDOWN) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam dropdown and empty"); + notifyListeners(); + + return false; + } + } else if (msection.widget == InteractionWidget.CHECKBOX) { + if (msection.isRequired == true && msection.selectedValue!.isEmpty) { + debugPrint("Iam CHECKBOX and empty"); + notifyListeners(); + + return false; + } + } + } + } + notifyListeners(); + + return true; + } +} + + + + + + + + + + +// import 'dart:convert'; + +// import 'package:dio/dio.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_config_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/json_form_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/location_model.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/repository/hive_repository.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/services.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; + +// class ViewInteractionProvider extends ChangeNotifier { +// List interactionReponseList = []; +// // List sectionList = []; +// List sectionList = []; +// late Location locationList; +// List textEditingControllerList = []; +// List multipletextEditingControllerList = []; +// int textfieldIndex = 0; +// List countryList = []; +// List stateList = []; +// List cityList = []; +// List checkboxlist = []; +// String selectedCountry = 'Selected Country'; +// String radioValue = ''; +// bool checkboxValue = false; + +// late SaveInteraction saveInteraction; +// List saveData = []; + +// List newList = []; +// String sectionName = ''; +// late String selectedCity = 'Selected City', selectedState = 'Selected State'; +// String customdropdownValue = ''; +// String? selectedValue; +// List selectedItems = []; +// InputClass? selectedObj; +// List savedList = []; +// List intConfigDataList = []; +// String? intId, intName; +// final HiveDataRepository _hiveprovider = HiveDataRepository( +// Hive.box('InteractionConfigDataBox')); + +// late final InteractionProvider interactionProvider; +// initConfigData() async { +// intConfigDataList = _hiveprovider.getAllDataFromHive(); +// notifyListeners(); +// } + +// Future getRecords(String formname) async { +// var box = await Hive.openBox('InteractionDataBox'); +// savedList = box.values.toList(); +// savedList = savedList +// .where( +// (element) => element.form == formname, +// ) +// .toList(); +// notifyListeners(); +// } + +// Future> getAllRecords() async { +// var box = await Hive.openBox('InteractionDataBox'); +// List savedList = box.values.toList(); + +// return savedList; +// } + +// init(int index) async { +// // _hiveprovider = HiveDataRepository( +// // Hive.box('InteractionConfigDataBox')); +// // intConfigDataList = _hiveprovider.getAllDataFromHive(); +// InteractionConfigData interactionConfigData = intConfigDataList[index]; +// intId = intConfigDataList[index].id; +// intName = intConfigDataList[index].name; + +// print("data $intConfigDataList"); +// // await fetchSaveDataJson(); +// // await fetchDataSet(); +// await fetchData(interactionConfigData.widgets); +// await fetchLocationData(); +// } + +// initSavedForm(SaveInteraction saveInteractiondata) { +// intConfigDataList +// .indexWhere((element) => element.id == saveInteractiondata.intId); + +// interactionReponseList = saveInteractiondata.save +// .map((e) => FormFieldData( +// multipleList: e.multipleList == null +// ? [] +// : e.multipleList! +// .map((mobj) => SectionList( +// depid: mobj.depid, +// id: mobj.id, +// inputList: mobj.inputList, +// isRequired: mobj.isRequired, +// extension: mobj.extension, +// fileName: mobj.fileName, +// selectedObject: mobj.selectedObject, +// name: mobj.name, +// param: mobj.param, +// selectedValue: mobj.selectedValue, +// widget: mobj.widget, +// controller: mobj.controller, +// gid: mobj.gid, +// input: mobj.input, +// selectedId: mobj.selectedId, +// value: mobj.value)) +// .toList(), +// sectionList: e.sectionList +// .map((obj) => SectionList( +// depid: obj.depid, +// id: obj.id, +// inputList: obj.inputList, +// isRequired: obj.isRequired, +// extension: obj.extension, +// fileName: obj.fileName, +// name: obj.name, +// param: obj.param, +// selectedObject: obj.selectedObject, +// selectedValue: obj.selectedValue, +// widget: obj.widget, +// controller: obj.controller, +// gid: obj.gid, +// input: obj.input, +// selectedId: obj.selectedId, +// value: obj.value)) +// .toList(), +// sectionName: e.sectionName, +// multiple: e.multiple)) +// .toList(); + +// textEditingControllerList.clear(); + +// for (var item in interactionReponseList) { +// sectionList = item.sectionList; + +// for (SectionList obj in item.multipleList!) { +// obj.gid = obj.gid ?? item.multipleList!.length; +// if (obj.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); +// textEditingController.value = TextEditingValue( +// text: obj.selectedValue!.isNotEmpty +// ? obj.selectedValue!.last ?? "" +// : ""); +// textEditingController.text = obj.selectedValue!.isNotEmpty +// ? obj.selectedValue!.last ?? "" +// : ""; +// multipletextEditingControllerList.add(textEditingController); +// // obj.controller = multipletextEditingControllerList.last; +// obj.controller = textEditingController; + +// } +// if (obj.widget == InteractionWidget.DROPDOWN || +// obj.widget == InteractionWidget.AUTOCOMPLETE || +// obj.widget == InteractionWidget.MULTISELECT) { +// List list = obj.inputList!; +// if (obj.selectedObject != null) { +// } else { +// obj.selectedObject = obj.selectedValue!.isNotEmpty +// ? getDataObject(obj.id, obj.selectedValue!.last, list) +// : list[0]; +// } + +// print("value : ${list.first.name} "); +// } +// if (obj.widget == InteractionWidget.CHECKBOX) { +// List selectedvalues = []; +// if (obj.selectedValue!.isNotEmpty) { +// for (var id in obj.selectedValue!) { +// int ind = +// obj.inputList!.indexWhere((element) => element.id == id); +// if (ind != -1) { +// obj.inputList![ind].ischecked = true; +// selectedvalues.add(obj.inputList![ind].name); +// } +// } +// } +// } +// if (obj.widget == InteractionWidget.RADIO) { +// List list = obj.inputList!; + +// if (obj.selectedValue!.isNotEmpty) { +// int ind = list +// .indexWhere((element) => element.id == obj.selectedValue!.last); +// if (ind != -1) { +// obj.inputList![ind].ischecked = true; +// radioValue = obj.inputList![ind].name; +// } +// } +// } +// // newList.add(obj); +// } +// for (var sectionItem in item.sectionList) { +// if (sectionItem.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); +// textEditingController.text = sectionItem.selectedValue!.isNotEmpty +// ? sectionItem.selectedValue!.last ?? " " +// : " "; +// textEditingControllerList.add(textEditingController); + +// sectionItem.controller = textEditingControllerList.last; +// } +// if (sectionItem.widget == InteractionWidget.DROPDOWN) { +// List list = sectionItem.inputList!; +// if (sectionItem.selectedObject != null) { +// print("#######not null"); +// } else { +// print("#######is_null"); +// if (sectionItem.selectedValue == null) { +// print("#######is_null#####"); +// } else { +// print('###${sectionItem.selectedValue}'); +// } +// sectionItem.selectedObject = sectionItem.selectedValue!.isNotEmpty +// ? getDataObject( +// sectionItem.id, sectionItem.selectedValue!.last, list) +// : list[0]; +// } + +// print("valuesssss : ${sectionItem.selectedObject!.name} "); +// } + +// if (sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT) { +// List list = sectionItem.inputList!; +// if (sectionItem.selectedObject != null) { +// } else { +// sectionItem.selectedObject = sectionItem.selectedValue!.isNotEmpty +// ? getDataObject( +// sectionItem.id, sectionItem.selectedValue!.last, list) +// : list[0]; +// } + +// print("value : ${list.first.name} "); +// } +// if (sectionItem.widget == InteractionWidget.CHECKBOX) { +// List selectedvalues = []; +// if (sectionItem.selectedValue!.isNotEmpty) { +// for (var id in sectionItem.selectedValue!) { +// int ind = sectionItem.inputList! +// .indexWhere((element) => element.id == id); +// if (ind != -1) { +// sectionItem.inputList![ind].ischecked = true; +// selectedvalues.add(sectionItem.inputList![ind].name); +// } +// } +// } +// } +// if (sectionItem.widget == InteractionWidget.RADIO) { +// List list = sectionItem.inputList!; + +// if (sectionItem.selectedValue!.isNotEmpty) { +// int ind = list.indexWhere( +// (element) => element.id == sectionItem.selectedValue!.last); +// if (ind != -1) { +// sectionItem.inputList![ind].ischecked = true; +// radioValue = sectionItem.inputList![ind].name; +// } +// } +// } +// if (sectionItem.widget == InteractionWidget.BUTTON && +// sectionItem.param == 'chooseFile' && +// sectionItem.selectedValue!.isNotEmpty) { +// print("choosed file"); +// print(sectionItem.selectedValue!.last); +// } +// } +// } +// print(interactionReponseList); +// print("check textcontrollers ${textEditingControllerList.length}"); +// } + +// Future fetchDataSet() async { +// List list = getData("intlocation_1"); +// print(list); +// return "success"; +// } + +// List getData(String widgetId) { +// List list = []; + +// return list; +// } + +// InputClass getDataObject(String widgetId, String id, List list) { +// // if (id != "") { +// // List list = []; +// InputClass value = InputClass(id: '', name: ''); + +// if (list.isNotEmpty) { +// int index = list.indexWhere((element) => element.id.toString() == id); + +// if (index != -1) { +// value = list[index]; +// } +// } + +// return value; +// } + +// // TODO: Search for widget with depid and check if selected is not null and by selected id get the data of current widget +// List getData2(SectionList sectionItem) { +// List list = []; +// // if (sectionItem.inputList != null) { +// list = sectionItem.inputList!; +// if (sectionItem.depid != "") { +// // print("check depid : ${sectionItem.depid}"); +// int i = 0; +// for (var obj in interactionReponseList) { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.depid); +// // print("check depid index: $i"); +// if (i != -1) { +// //print("check depid value: ${obj.sectionList[i].value}"); +// if (obj.sectionList[i].value != null) { +// if (list +// .where((element) => element.pid == obj.sectionList[i].value) +// .isNotEmpty) { +// list = list +// .where((element) => element.pid == obj.sectionList[i].value) +// .toList(); + +// sectionItem.selectedObject = list[0]; +// } else { +// // InputClass obj = InputClass( +// // id: "obj.sectionList[i].value", +// // name: "Select ${sectionItem.name}"); +// list = []; +// // list.add(obj); +// sectionItem.selectedObject = null; +// } +// } else { +// // int index = obj.sectionList +// // .indexWhere((element) => element.id == sectionItem.id); + +// // list = obj.sectionList[index].inputList; +// } +// } +// } + +// // int index = data[i].data.indexWhere((element) => element.) +// } +// // } + +// print("I_am_Returning_list: $list"); +// return list; +// } + +// setDropDownValue(String value, SectionList sectionItem, bool multiple, +// InputClass selectedObject) { +// int i = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList!.indexWhere((element) => +// element.id == sectionItem.id && element.gid == sectionItem.gid); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].tempselectedValue = []; +// obj.multipleList![i].tempselectedValue!.add(value); +// // obj.multipleList![i].selectedObject = selectedObj; +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].tempselectedValue = []; +// obj.sectionList[i].tempselectedValue!.add(value); +// // obj.sectionList[i].selectedObject = selectedObj; +// } +// } +// } +// notifyListeners(); +// } + +// Future disposeValues() async { +// print("dispose called"); +// // await _hiveprovider.closeHiveBox(); +// for (var obj in interactionReponseList) { +// obj.multipleList!.clear(); +// // for (var obj2 in obj.sectionList) { +// // obj2.selectedObject = null; +// // } + +// obj.sectionList.clear(); +// } +// interactionReponseList.clear(); +// } + +// setTextValue(String value, SectionList sectionItem, bool multiple) { +// int i = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList!.indexWhere((element) => +// element.id == sectionItem.id && element.gid == sectionItem.gid); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].selectedValue!.add(value); +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].selectedValue!.add(value); +// } +// } +// } +// notifyListeners(); +// } + +// setAutoCompleteValue(String value, SectionList sectionItem, bool multiple) { +// int i = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// i = obj.multipleList!.indexWhere((element) => +// element.id == sectionItem.id && element.gid == sectionItem.gid); +// if (i != -1) { +// obj.multipleList![i].value = value; +// obj.multipleList![i].tempselectedValue = []; +// obj.multipleList![i].tempselectedValue!.add(value); +// } +// } else { +// i = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (i != -1) { +// obj.sectionList[i].value = value; +// obj.sectionList[i].tempselectedValue = []; +// obj.sectionList[i].tempselectedValue!.add(value); +// } +// } +// } +// notifyListeners(); +// } +// String getDropDownValue( +// String value, SectionList sectionItem, List list) { +// int i = 0; +// String svalue = ''; + +// i = list.indexWhere((element) => element.id == value); +// if (i != -1) { +// svalue = list[i].name; +// } else { +// svalue = list[0].name; +// } + +// return svalue; +// } + +// Future fetchData(InteractionResultData interactionResultData) async { +// InteractionResultData interactionConfig = interactionResultData; + +// print("itemCategoryModel Item = + ${interactionConfig.result}"); + +// interactionReponseList = interactionConfig.result; +// print("check stored: $interactionReponseList"); +// textEditingControllerList.clear(); + +// for (var item in interactionReponseList) { +// sectionList = item.sectionList; +// for (var sectionItem in item.sectionList) { +// if (sectionItem.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// textEditingControllerList.add(textEditingController); +// sectionItem.controller = textEditingControllerList.last; +// } +// if (sectionItem.widget == InteractionWidget.DROPDOWN || +// sectionItem.widget == InteractionWidget.AUTOCOMPLETE || +// sectionItem.widget == InteractionWidget.MULTISELECT) { +// List list = sectionItem.inputList!; +// sectionItem.value = list[0].name; +// print("value : ${list.first} "); +// } +// } +// } +// print(interactionReponseList); +// print("check textcontrollers ${textEditingControllerList.length}"); + +// return "success"; +// } + +// Future fetchLocationData() async { +// var data = +// await rootBundle.loadString("assets/images/locationdetailsform.json"); + +// Locations loc = +// Locations(location: Location.fromJson(json.decode(data)["location"])); +// locationList = loc.location; +// countryList = locationList.country; +// stateList = locationList.state; +// cityList = locationList.city; + +// print(locationList); +// notifyListeners(); +// return "success"; +// } + +// List getState(String cid) { +// List states = +// stateList.where((element) => element.countryId == cid).toList(); + +// return states; +// } + +// List getCity(String sid) { +// List city = +// cityList.where((element) => element.stateId == sid).toList(); + +// return city; +// } + +// String getCountryId(String name) { +// if (countryList.isNotEmpty) { +// int i = countryList.indexWhere((element) => element.countryName == name); +// return countryList[i].countryId; +// } +// return ''; +// } + +// String getStateId(String name) { +// if (stateList.isNotEmpty) { +// int i = stateList.indexWhere((element) => element.stateName == name); +// return stateList[i].stateId; +// } +// return ''; +// } + +// String getCityId(String name) { +// if (cityList.isNotEmpty) { +// int i = cityList.indexWhere((element) => element.cityName == name); +// return cityList[i].distId; +// } +// return ''; +// } + +// setRadioValue(SectionList sectionItem) { +// List list = (sectionItem.input as List) +// .map((itemWord) => InputClass.fromJson(itemWord)) +// .toList(); +// radioValue = list[0].name; + +// notifyListeners(); +// } + +// setcheckBoxValue(SectionList sectionItem, String sectionName, bool newValue, +// String id, bool multiple) { +// int index = +// sectionItem.inputList!.indexWhere((element) => element.id == id); +// sectionItem.inputList![index].ischecked = newValue; +// // sectionItem.selectedValue.add(data[i].data[index].id); +// int index2 = 0; +// for (var obj in interactionReponseList) { +// if (multiple && obj.multipleList != null) { +// index2 = obj.multipleList!.indexWhere((element) => +// element.id == sectionItem.id && element.gid == sectionItem.gid); +// if (index2 != -1) { +// obj.multipleList![index2].value = sectionItem.inputList![index].id; +// obj.multipleList![index2].selectedValue! +// .add(sectionItem.inputList![index].id); +// } +// } else { +// index2 = obj.sectionList +// .indexWhere((element) => element.id == sectionItem.id); +// if (index2 != -1) { +// obj.sectionList[index2].value = sectionItem.inputList![index].id; +// obj.sectionList[index2].selectedValue! +// .add(sectionItem.inputList![index].id); +// } +// } +// } +// notifyListeners(); +// } + +// getSectionItem(String sectionName) { +// newList = []; +// List addList = []; +// int index = interactionReponseList +// .indexWhere((element) => element.sectionName == sectionName); + +// addList = interactionReponseList[index] +// .sectionList +// .map((e) => SectionList( +// depid: e.depid, +// id: e.id, +// inputList: e.inputList, +// isRequired: e.isRequired, +// name: e.name, +// param: e.param, +// selectedValue: [], +// widget: e.widget, +// controller: e.controller, +// gid: e.gid, +// input: e.input, +// selectedId: e.selectedId, +// value: e.value)) +// .toList(); +// SectionList delItem = SectionList( +// name: "delete", +// param: "deletebtn", +// id: "deletebtn", +// selectedValue: [], +// depid: "", +// widget: InteractionWidget.BUTTON, +// inputList: [], +// isRequired: true); + +// addList.add(delItem); + +// // if (interactionReponseList[index].multipleList!.isEmpty) { +// // newList = addList; +// // } else { +// if (interactionReponseList[index].multipleList == null) { +// interactionReponseList[index].multipleList = addList; +// } else { +// interactionReponseList[index].multipleList = +// interactionReponseList[index].multipleList! + addList; +// } + +// newList = interactionReponseList[index].multipleList!; +// // newList = newList + addList; +// // } +// if (interactionReponseList[index].multipleList != null) { +// for (SectionList obj in interactionReponseList[index].multipleList!) { +// obj.gid = obj.gid ?? interactionReponseList[index].multipleList!.length; +// if (obj.widget == InteractionWidget.TEXT) { +// var textEditingController = TextEditingController(); + +// multipletextEditingControllerList.add(textEditingController); +// obj.controller = multipletextEditingControllerList.last; +// obj.controller!.text = +// obj.selectedValue != null && obj.selectedValue!.isNotEmpty +// ? obj.selectedValue!.last +// : ''; +// } +// // newList.add(obj); +// } +// } + +// print( +// "check length : ${interactionReponseList[index].multipleList!.length}"); +// notifyListeners(); +// } + +// deleteMultipleRows( +// int gid, SectionList sectionItem, String selectedSectionName) { +// int index = interactionReponseList +// .indexWhere((element) => element.sectionName == selectedSectionName); +// interactionReponseList[index] +// .multipleList! +// .removeWhere((item) => item.gid == gid); + +// notifyListeners(); +// } + +// saveJsonObject(BuildContext context, String form, +// SaveInteraction saveInteraction) async { +// List resultData = interactionReponseList +// .map((e) => FormFieldData( +// multipleList: e.multipleList == null +// ? [] +// : e.multipleList! +// .map((mobj) => SectionList( +// depid: mobj.depid, +// id: mobj.id, +// inputList: mobj.inputList, +// isRequired: mobj.isRequired, +// extension: mobj.extension, +// fileName: mobj.fileName, +// name: mobj.name, +// param: mobj.param, +// selectedValue: +// mobj.tempselectedValue ?? mobj.selectedValue, +// widget: mobj.widget, +// gid: mobj.gid, +// input: mobj.input, +// selectedId: mobj.selectedId, +// value: mobj.value)) +// .toList(), +// sectionList: e.sectionList +// .map((obj) => SectionList( +// depid: obj.depid, +// id: obj.id, +// inputList: obj.inputList, +// extension: obj.extension, +// fileName: obj.fileName, +// isRequired: obj.isRequired, +// name: obj.name, +// param: obj.param, +// selectedValue: obj.tempselectedValue ?? obj.selectedValue, +// widget: obj.widget, +// controller: obj.controller, +// gid: obj.gid, +// input: obj.input, +// selectedId: obj.selectedId, +// value: obj.value)) +// .toList(), +// sectionName: e.sectionName, +// multiple: e.multiple, +// )) +// .toList(); + +// final data = SaveInteraction( +// save: resultData, +// id: saveInteraction.id, +// updatedTime: DateTime.now().toString(), +// form: saveInteraction.form, +// intId: saveInteraction.intId, +// intName: saveInteraction.intName, +// ); +// var box = Hive.box('InteractionDataBox'); + +// if (!box.isOpen) { +// box = await Hive.openBox('InteractionDataBox'); +// } + +// int index = +// box.values.toList().indexWhere((element) => element.id == data.id); + +// box.putAt(index, data); +// await getRecords(saveInteraction.form!); +// // box.close(); + +// // await MockApiCall().postFormData(data); +// } + +// Future deleteRecord(SaveInteraction saveInteraction) async { +// var box = await Hive.openBox('InteractionDataBox'); +// final Map deliveriesmap = box.toMap(); +// dynamic deleteKey; +// deliveriesmap.forEach((key, value) { +// if (value.id == saveInteraction.id) { +// deleteKey = key; +// } +// }); +// box.delete(deleteKey); +// await getRecords(saveInteraction.form!); +// //box.close(); +// } + +// List getModifiedList(List sectionList) { +// List newSectionList = []; +// for (var obj in sectionList) { +// if (obj.id != 'deletebtn') { +// if (obj.id == 'chooseFile') { +// List files = []; +// if (obj.selectedValue!.isNotEmpty && obj.selectedValue != null) { +// for (var file in obj.selectedValue!) { +// files.add(MultipartFile.fromFileSync(file)); +// } +// } +// MultipleSectionList newobj = MultipleSectionList( +// id: obj.id, +// selectedValue: files, +// ); + +// newSectionList.add(newobj); +// } else { +// MultipleSectionList newobj = MultipleSectionList( +// id: obj.id, +// selectedValue: obj.selectedValue!, +// ); +// newSectionList.add(newobj); +// } +// } +// } +// return newSectionList; +// } + +// bool validateMultipleRows() { +// for (var obj in interactionReponseList) { +// if (obj.multipleList != null) { +// for (var mulobj in obj.multipleList!) { +// if (mulobj.widget == InteractionWidget.TEXT) { +// if (mulobj.controller!.text.isEmpty) { +// return true; +// } +// } +// } +// } +// } +// return false; +// } + +// bool validateTextFields() { +// for (var obj in interactionReponseList) { +// for (var mulobj in obj.sectionList) { +// if (mulobj.widget == InteractionWidget.TEXT) { +// if (mulobj.controller!.text.isEmpty) { +// return true; +// } +// } +// } +// } +// return false; +// } +// } diff --git a/lib/contacts_module/ui_screen/interactionform/widget/custombutton.dart b/lib/contacts_module/ui_screen/interactionform/widget/custombutton.dart new file mode 100644 index 0000000..d072233 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/widget/custombutton.dart @@ -0,0 +1,48 @@ +import 'package:flutter/material.dart'; + +// ignore: must_be_immutable +class CustomButton extends StatelessWidget { + String title; + Color textColor; + Color backgroundColor; + VoidCallback onPressed; + double? width = 200; + double? height = 45.0; + double? fontsize = 45.0; + CustomButton( + {super.key, + required this.backgroundColor, + required this.onPressed, + required this.textColor, + required this.title, + this.fontsize, + this.height, + this.width}); + + @override + Widget build(BuildContext context) { + return SizedBox( + height: height, + width: width, + child: ElevatedButton( + onPressed: onPressed, + // style: ButtonStyle( + // backgroundColor: + // MaterialStateColor.resolveWith((states) => backgroundColor), + // ), + style: ElevatedButton.styleFrom( + backgroundColor: + MaterialStateColor.resolveWith((states) => backgroundColor), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(10), // <-- Radius + ), + ), + + child: Text( + title, + style: TextStyle(color: textColor, fontSize: fontsize ?? 24.0), + ), + ), + ); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart b/lib/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart new file mode 100644 index 0000000..9b33fa3 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart @@ -0,0 +1,47 @@ +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:flutter/material.dart'; + +// ignore: must_be_immutable +class CustomRangeSlider extends StatelessWidget { + final double sliderPos; + final void Function(double) onChanged; + double? min; + double? max; + + CustomRangeSlider( + {super.key, + required this.sliderPos, + required this.onChanged, + this.max, + this.min}); + + @override + Widget build(BuildContext context) { + return Column( + children: [ + SizedBox( + height: isTablet ? 40 : 40, + child: Slider( + activeColor: const Color(0xFF2b9af3), + onChanged: onChanged, + min: min ?? 10.0, + max: max ?? 80.0, + label: sliderPos.toInt().toString(), + divisions: 48, + value: sliderPos, + ), + ), + SizedBox( + height: isTablet ? 1 : 1, + ), + Text( + "Range: ${sliderPos.toInt()}", + style: TextStyle( + fontSize: isTablet ? 14.0 : 12, + ), + ), + ], + ); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart b/lib/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart new file mode 100644 index 0000000..1ed9984 --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart @@ -0,0 +1,141 @@ +// import 'package:flutter/material.dart'; +// import 'package:flutter/services.dart'; + +// // ignore: must_be_immutable +// class InteractionTextField extends StatelessWidget { +// String labelText; +// TextEditingController controller; +// String? hintText; +// IconButton? suffixIcon; +// bool? enabled = true; +// bool? obscure = false; +// Function onChanged; +// TextInputType? inputType; +// int? maxchars = 0; +// int? maxlines = 1; +// int? minlines = 0; +// InteractionTextField( +// {super.key, +// required this.controller, +// this.hintText, +// required this.labelText, +// this.suffixIcon, +// this.enabled, +// this.maxchars, +// this.maxlines, +// this.inputType, +// this.minlines, +// required this.onChanged, +// this.obscure}); + +// @override +// Widget build(BuildContext context) { +// return TextField( +// controller: controller, +// style: const TextStyle(fontSize: 16), +// enabled: enabled, +// obscureText: obscure ?? false, +// onTap: () {}, +// maxLines: maxlines ?? 1, +// minLines: minlines, +// keyboardType: inputType ?? TextInputType.name, +// onChanged: (value) { +// onChanged(value); +// }, +// onSubmitted: (value) { +// onChanged(value); +// }, +// inputFormatters: [ +// inputType == TextInputType.number +// ? FilteringTextInputFormatter.digitsOnly +// : maxchars == 0 +// ? LengthLimitingTextInputFormatter(100) +// : LengthLimitingTextInputFormatter(maxchars), +// ], +// decoration: InputDecoration( +// isDense: true, +// // contentPadding: const EdgeInsets.symmetric( +// // horizontal: 10, +// // vertical: 18, +// // ), +// contentPadding: EdgeInsets.all(13.0), +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(10.0), +// ), +// suffixIcon: suffixIcon, +// hintText: hintText, +// ), +// ); +// } +// } + +import 'package:flutter/material.dart'; +import 'package:flutter/services.dart'; + +// ignore: must_be_immutable +class InteractionTextField extends StatelessWidget { + String labelText; + TextEditingController controller; + String? hintText; + IconButton? suffixIcon; + bool? enabled = true; + bool? obscure = false; + Function onChanged; + TextInputType? inputType; + int? maxchars = 0; + int? maxlines = 1; + int? minlines = 0; + InteractionTextField( + {super.key, + required this.controller, + this.hintText, + required this.labelText, + this.suffixIcon, + this.enabled, + this.maxchars, + this.maxlines, + this.inputType, + this.minlines, + required this.onChanged, + this.obscure}); + + @override + Widget build(BuildContext context) { + return TextField( + controller: controller, + style: const TextStyle(fontSize: 16), + enabled: enabled, + obscureText: obscure ?? false, + onTap: () {}, + maxLines: maxlines ?? 1, + minLines: minlines, + keyboardType: inputType ?? TextInputType.name, + onChanged: (value) { + onChanged(value); + }, + onSubmitted: (value) { + onChanged(value); + }, + inputFormatters: [ + inputType == TextInputType.number + ? FilteringTextInputFormatter.digitsOnly + : maxchars == 0 + ? LengthLimitingTextInputFormatter(100) + : LengthLimitingTextInputFormatter(maxchars), + ], + decoration: InputDecoration( + isDense: true, + // contentPadding: const EdgeInsets.symmetric( + // horizontal: 10, + // vertical: 18, + // ), + contentPadding: EdgeInsets.all(13.0), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + suffixIcon: suffixIcon, + hintText: hintText, + ), + ); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/widget/location_showmore.dart b/lib/contacts_module/ui_screen/interactionform/widget/location_showmore.dart new file mode 100644 index 0000000..54654fa --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/widget/location_showmore.dart @@ -0,0 +1,111 @@ +// import 'package:konectar_events/provider_class/location_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/location_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class Locationfulldata extends StatefulWidget { + Locationfulldata({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _LocationfulldataState(); +} + +class _LocationfulldataState extends State { + List locationList = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + final location = Provider.of(context, listen: false); + + await location.locationinfo(widget.text); + final loclist = location.locationlist; + + setState(() { + locationList = loclist; + }); + + print("locationList: ${locationList}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Locations'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Institution', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Address', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + locationList.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${locationList[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(locationList[index]); + }, + ); + }, + cells: [ + DataCell(Text( + locationList[index]['Institution'].toString(), + softWrap: true)), + DataCell(Text(locationList[index]['Address'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart b/lib/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart new file mode 100644 index 0000000..52536ff --- /dev/null +++ b/lib/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart @@ -0,0 +1,22 @@ +import 'package:flutter/material.dart'; + +extension Responsive on BuildContext { + T responsive( + T defaultVal, { + T? sm, + T? md, + T? lg, + T? xl, + }) { + final wd = MediaQuery.of(this).size.width; + return wd >= 1280 + ? (xl ?? lg ?? md ?? sm ?? defaultVal) + : wd >= 1024 + ? (lg ?? md ?? sm ?? defaultVal) + : wd >= 768 + ? (md ?? sm ?? defaultVal) + : wd >= 640 + ? (sm ?? defaultVal) + : defaultVal; + } +} diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/activityk2_tab.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/activityk2_tab.dart new file mode 100644 index 0000000..b9fd34f --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/activityk2_tab.dart @@ -0,0 +1,737 @@ +// import 'package:konectar_events/constants.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/custom_expansiontile.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_aff_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_event_k2.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_aff_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_event_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/publication_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/trials_show_more.dart'; +// import 'package:discover_module/custom_widget/text.dart'; +// import 'package:discover_module/model_class/k2_api_model/kol_aff_k2.dart'; +// import 'package:discover_module/model_class/k2_api_model/kol_event_k2.dart'; +// import 'package:discover_module/provider_class/affiliationsprovider.dart'; +// import 'package:discover_module/provider_class/events_provider.dart'; +// import 'package:discover_module/provider_class/k2_provider/kol_aff_provider.dart'; +// import 'package:discover_module/provider_class/k2_provider/kol_event_provider.dart'; +// import 'package:discover_module/provider_class/publications_provider.dart'; +// import 'package:discover_module/provider_class/trials_provider.dart'; +// import 'package:discover_module/ui_screen/affiliation_data.dart'; +// import 'package:discover_module/ui_screen/bottom_sheet.dart'; +// import 'package:discover_module/ui_screen/events_data.dart'; +// import 'package:discover_module/ui_screen/k2api_integrated_ui/bottomsheetk2.dart'; +// import 'package:discover_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart'; +// import 'package:discover_module/ui_screen/publication_data.dart'; +// import 'package:discover_module/ui_screen/trials_show_more.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class ActivitiesK2 extends StatefulWidget { + //Activities({super.key, required text}); + ActivitiesK2({required this.text, Key? key}) : super(key: key); + + final int text; + + @override + State createState() => _ActivitiesState(); +} + +class _ActivitiesState extends State { + bool _isExpanded = false; + + List affiliation_data = []; + List publication_data = []; + List event_data = []; + List trial_data = []; + List medinsightData = []; + List speaker = []; + List eng = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + getaffiliations(); + } + + getaffiliations() async { + var publist; + var affiliations = + Provider.of(context, listen: false); + + await affiliations.getAffiliationsdata(widget.text); + final affilist = affiliations.adddta; + setState(() { + affiliation_data = affilist; + }); + + print("CheckingAfflist: $affilist"); + + if (mounted) { + var publication = Provider.of(context, listen: false); + + await publication.publicatininfo(widget.text); + publist = publication.publicationlist; + setState(() { + publication_data = publist; + }); + } + + if (mounted) { + var events = Provider.of(context, listen: false); + await events.geteventdata(widget.text); + final eventlist = events.EventsList; + + setState(() { + event_data = eventlist; + }); + } + + if (mounted) { + var trials = Provider.of(context, listen: false); + await trials.trialsdata(widget.text); + + final trialslist = trials.trialsinfo; + + setState(() { + trial_data = trialslist; + }); + } + + print("Affiliations_data_isNewOff123: ${affiliation_data}"); + print("Publication_data_isNewOff: $publication_data"); + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView(children: [ + affiliation_data.length != 0 + ? CustomExpansionTile( + title: "Affiliations", + itemList: affiliation_data.cast(), + buttonText: 'Show More', + field1: 'Organization Name', + field2: 'TimeFrame', + onItemSelected: (AffList selectedLocation) { + List> keyValue = [ + { + "Department": selectedLocation.department, + "Title": selectedLocation.title, + "Start Year": selectedLocation.startYear, + "End Year": selectedLocation.endYear, + "Role": selectedLocation.role, + "Organization Type": selectedLocation.kolOrganizationType, + "Engagement Type": selectedLocation.kolEngagementType, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + + publication_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Publications", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: + "(${publication_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + //isAlwaysShown: true, + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Article Title', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + + DataColumn( + label: Expanded( + child: Text('Authors', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + publication_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message ${publication_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet( + publication_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + publication_data[index] + .articalTitle + .toString(), + softWrap: true)), + + DataCell(Text( + publication_data[index] + .author + .toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => PublicationsData( + text: widget.text))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + event_data.length != 0 + ? CustomExpansionTile( + title: "Events", + itemList: event_data.cast(), + buttonText: 'Show More', + field1: 'Event Name', + field2: 'Role', + onItemSelected: (EventList selectedLocation) { + List> keyValue = [ + { + "Name": selectedLocation.name, + "Notes": selectedLocation.notes, + "Partially Released Event": + selectedLocation.partiallyReleasedEvent, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + + trial_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Trials", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${trial_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Trial Name', + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600)), + )), + DataColumn( + label: Expanded( + child: Text('Status', + softWrap: true, + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + trial_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${trial_data[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(trial_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + trial_data[index] + .trialName + .toString(), + softWrap: true)), + DataCell(Text( + trial_data[index].status.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => TrialsShowmore( + text: widget.text))); + }, + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + ]), + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // Row( + // children: [ + // Text( + // "Affiliation", + // style: TextStyle(fontSize: 20.0), + // ) + // ], + // ), + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data.org_name, + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 16.0, color: Colors.black), + ), + ), + ), + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + + affiliation_data['dept'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['role'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['time_frame'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame".toString(), + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'] + .toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['org_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + + affiliation_data['emg_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } + + void modelbsheet(List> keyValue) { + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: const RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheetk2new(keyValue); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/bottomsheetk2.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/bottomsheetk2.dart new file mode 100644 index 0000000..74d3b9c --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/bottomsheetk2.dart @@ -0,0 +1,292 @@ +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_Certificate_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_aff_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_awards_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_education_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_email_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_event_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_location_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_pno_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_training_k2.dart'; +// import 'package:konectar_events/storage_hive/email_data/email_model_hive.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_aff_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_awards_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_education_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_email_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_event_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_location_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_pno_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_training_k2.dart'; +import 'package:flutter/material.dart'; + +class bsheetk2 extends StatefulWidget { + bsheetk2(this.selectedLocation, {super.key}); + final selectedLocation; + + @override + State createState() => _bsheetk2State(); +} + +class _bsheetk2State extends State { + @override + Widget build(BuildContext context) { + return DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Color.fromARGB(255, 246, 248, 252), + decoration: BoxDecoration(borderRadius: BorderRadius.circular(0)), + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + getPostalCodeText(widget.selectedLocation), + // Padding( + // padding: const EdgeInsets.all(8.0), + // child: Text1( + // title: (widget.selectedLocation is Data) + // ? "PostalCode \n${widget.selectedLocation.postalCode}" + // : (widget.selectedLocation is DataPhno) + // ? "phoneTypeName \n${(widget.selectedLocation as DataPhno).phoneTypeName}" + // : (widget.selectedLocation is EmailData) + // ? "PhoneNo1 \n${(widget.selectedLocation as EmailData).emailTypeName}" + // : ""), + // ), + ], + ); + }), + ), + ], + ), + ); + }, + ); + } + + getPostalCodeText(location) { + if (location is Data) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Address \n${location.address1}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "PostalCode \n${location.postalCode}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1( + title: "Organization Name \n${location.organizationName}"), + ), + ], + ); + } else if (location is DataPhno) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Phone Type \n${location.phoneTypeName}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Phone Number \n${location.number}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1( + title: "Organization Name \n${location.organizationName}"), + ), + ], + ); + } else if (location is EmailData) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Email Type \n${location.emailTypeName}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Email \n${location.email}"), + ), + ], + ); + } else if (location is TrainingList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Institution \n${location.organizationId}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Degree \n${location.degree}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Specialty \n${location.specialty}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "StartDate \n${location.startDate}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "EndDate \n${location.endDate}"), + ), + ], + ); + } else if (location is EducationList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Institution \n${location.organizationId}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Degree \n${location.degree}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Specialty \n${location.specialty}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "StartDate \n${location.startDate}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "EndDate \n${location.endDate}"), + ), + ], + ); + } else if (location is AwardsList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Name \n${location.name}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Start Date \n${location.startDate}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "End Date \n${location.endDate}"), + ), + ], + ); + } else if (location is CertificateList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Name \n${location.organizationId}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Specialty \n${location.specialty}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Start Date \n${location.startDate}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "End Date \n${location.endDate}"), + ), + ], + ); + } else if (location is AffList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Title \n${location.title}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Role \n${location.role}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Start Year \n${location.startYear}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "End Year \n${location.endYear}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Start Year \n${location.startYear}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1( + title: "Organization Name \n${location.kolOrganizationName}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1( + title: "Organization Type \n${location.kolOrganizationType}"), + ), + ], + ); + } else if (location is EventList) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Name \n${location.name}"), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: Text1(title: "Notes \n${location.notes}"), + ), + ], + ); + } + } +} diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/callbottomsheet.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/callbottomsheet.dart new file mode 100644 index 0000000..712c995 --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/callbottomsheet.dart @@ -0,0 +1,34 @@ +// import 'package:flutter/material.dart'; + +// class callbsheet extends StatefulWidget { +// const callbsheet({super.key}); + +// @override +// State createState() => _callbsheetState(); +// } + +// class _callbsheetState extends State { +// @override +// Widget build(BuildContext context) { +// return const showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: false, +// enableDrag: true, +// useSafeArea: true, +// constraints: const BoxConstraints( +// maxWidth: double.infinity, +// ), +// shape: const RoundedRectangleBorder( +// borderRadius: BorderRadius.vertical( +// top: Radius.circular(0), +// ), +// ), +// clipBehavior: Clip.antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheetk2new(keyValue); +// }, +// ); +// ; +// } +// } diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart new file mode 100644 index 0000000..fbfebf3 --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart @@ -0,0 +1,72 @@ +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_Certificate_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_aff_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_awards_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_education_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_email_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_event_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_location_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_pno_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_training_k2.dart'; +// import 'package:konectar_events/storage_hive/email_data/email_model_hive.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:flutter/material.dart'; + +class bsheetk2new extends StatefulWidget { + bsheetk2new(this.selectedLocation, {super.key}); + final selectedLocation; + + @override + State createState() => _bsheetk2State(); +} + +class _bsheetk2State extends State { + @override + Widget build(BuildContext context) { + return DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Color.fromARGB(255, 246, 248, 252), + decoration: BoxDecoration(borderRadius: BorderRadius.circular(0)), + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: widget.selectedLocation.length, + itemBuilder: (BuildContext context, int index) { + var data = widget.selectedLocation[index]; + + List keys = data.keys.toList(); + + print("Checkingdata: $data"); + print("Checkingdata: $keys"); + + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // getPostalCodeText(widget.selectedLocation), + for (var key in keys) + Padding( + padding: + const EdgeInsets.symmetric(vertical: 4.0), + child: Text1( + title: + ' $key \n ${data[key]}', // Display key and corresponding value + ), + ) // Text1(title: data.keyValue) + ], + ); + }), + ), + ], + ), + ); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/kol_list.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/kol_list.dart new file mode 100644 index 0000000..da81493 --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/kol_list.dart @@ -0,0 +1,1372 @@ +import 'dart:io'; + +import 'package:cached_network_image/cached_network_image.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/provider_class/affiliationsprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/award_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/educationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/events_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_list_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/location_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/nih_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/patent_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/phoneno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/procedureprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/speaker_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/training_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/aff_data/insert_aff.dart'; +import 'package:konectar_events/contacts_module/storage_hive/awa_data/crud_awa.dart'; +import 'package:konectar_events/contacts_module/storage_hive/cer_hive/crud_cer.dart'; +import 'package:konectar_events/contacts_module/storage_hive/edu_data/crud_edu.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/crud_email.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/crud_event.dart'; +import 'package:konectar_events/contacts_module/storage_hive/kol_info/curd_kol.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/crud_loc.dart'; +import 'package:konectar_events/contacts_module/storage_hive/nih_grant_data/crud_nih.dart'; +import 'package:konectar_events/contacts_module/storage_hive/patent_data/crud_patent.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/crud_pno.dart'; +import 'package:konectar_events/contacts_module/storage_hive/procedure_data/crud_pro.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pub_data/curd_pub.dart'; +import 'package:konectar_events/contacts_module/storage_hive/speaker_data/crud.speaker.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/crud_training.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/crud_trials.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_new_profile.dart'; +import 'package:konectar_events/contacts_module/ui_screen/saved_profiles/saved_contact.dart'; +// import 'package:konectar_events/constants.dart'; +// import 'package:discover_module/custom_widget/text.dart'; +// import 'package:discover_module/hive_fun.dart'; +// import 'package:discover_module/provider_class/affiliationsprovider.dart'; +// import 'package:discover_module/provider_class/award_provider.dart'; +// import 'package:discover_module/provider_class/certificate_provider.dart'; +// import 'package:discover_module/provider_class/educationprovider.dart'; +// import 'package:discover_module/provider_class/email_provider.dart'; +// import 'package:discover_module/provider_class/events_provider.dart'; +// import 'package:discover_module/provider_class/k2_provider/kol_list_provider.dart'; +// import 'package:discover_module/provider_class/location_provider.dart'; +// import 'package:discover_module/provider_class/nih_provider.dart'; +// import 'package:discover_module/provider_class/patent_provider.dart'; +// import 'package:discover_module/provider_class/phoneno_provider.dart'; +// import 'package:discover_module/provider_class/procedureprovider.dart'; +// import 'package:discover_module/provider_class/publications_provider.dart'; +// import 'package:discover_module/provider_class/speaker_provider.dart'; +// import 'package:discover_module/provider_class/training_provider.dart'; +// import 'package:discover_module/provider_class/trials_provider.dart'; +// import 'package:discover_module/storage_hive/aff_data/insert_aff.dart'; +// import 'package:discover_module/storage_hive/awa_data/crud_awa.dart'; +// import 'package:discover_module/storage_hive/cer_hive/crud_cer.dart'; +// import 'package:discover_module/storage_hive/edu_data/crud_edu.dart'; +// import 'package:discover_module/storage_hive/email_data/crud_email.dart'; +// import 'package:discover_module/storage_hive/events_data/crud_event.dart'; +// import 'package:discover_module/storage_hive/kol_info/curd_kol.dart'; +// import 'package:discover_module/storage_hive/loc_data/crud_loc.dart'; +// import 'package:discover_module/storage_hive/nih_grant_data/crud_nih.dart'; +// import 'package:discover_module/storage_hive/patent_data/crud_patent.dart'; +// import 'package:discover_module/storage_hive/pno_data/crud_pno.dart'; +// import 'package:discover_module/storage_hive/procedure_data/crud_pro.dart'; +// import 'package:discover_module/storage_hive/pub_data/curd_pub.dart'; +// import 'package:discover_module/storage_hive/speaker_data/crud.speaker.dart'; +// import 'package:discover_module/storage_hive/traning_data/crud_training.dart'; +// import 'package:discover_module/storage_hive/trials_data/crud_trials.dart'; +// import 'package:discover_module/ui_screen/filters_menu.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/new_new_profile.dart'; +// import 'package:discover_module/ui_screen/new_new_profile_offline.dart'; +// import 'package:discover_module/ui_screen/saved_profiles/saved_contact.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; +import 'package:dropdownfield2/dropdownfield2.dart'; +import 'package:expandable/expandable.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:flutter_svg/svg.dart'; +import 'package:provider/provider.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; + +class Contactsk2 extends StatefulWidget { + const Contactsk2({Key? key}) : super(key: key); + + @override + State createState() => _Contactsk2State(); +} + +class _Contactsk2State extends State { + final GlobalKey _scaffoldKey = GlobalKey(); + + // final contactBox = Hive.box("mycontact"); + bool _switchValue = false; + bool isOnline2 = true; + + final TextEditingController _searchController = TextEditingController(); + + List ddlist = ["aaaa", 'bbb']; + + List ddlist1 = []; + + String _selectedValue = ''; + String? _selectedValue1; + + String dropdownvalue = 'Profile Type'; + + var items = [ + 'Profile Type', + 'HCP Name', + 'Speciality', + 'Country', + 'Region', + 'State', + 'City', + 'List', + 'Organization', + 'Event', + ]; + + bool isSearchClickd = false; + + final List _items = ['Option 1', 'Option 2', 'Option 3']; + + TextEditingController textEditingController = TextEditingController(); + + List displayedHCPList = []; + bool ActiveConnection = false; + String T = ""; + + bool isChecked = false; + //final Set _selectedIndices = Set(); + final List _selectedIndices = []; + final List _selectedremoveIndices = []; + + bool longpress = false; + bool longpressmy = false; + + @override + void initState() { + super.initState(); + // CheckUserConnection(); + Provider.of(context, listen: false).getHCPProvider(); + } + + @override + Widget build(BuildContext context) { + print("ProfileType $dropdownvalue, $_selectedValue1"); + + // print("all StoredUser: ${HiveFunctions.getAllUsers11()}"); + + if (_selectedValue1 == "Profile Type") { + print("PPPP11"); + setState(() { + ddlist = [ + "All Profile", + 'Full Profile', + 'Basic Profile', + ]; + }); + } else if (_selectedValue1 == "HCP Name") { + print("kkk_HcpNamess"); + fecthhcpbyname(); + } else if (_selectedValue1 == "Speciality") { + print("kkk"); + setState(() { + ddlist = [ + "Cardiovascular Disease", + 'Interventional Cardiology', + "Cardiovascular Disease", + ]; + }); + } else if (_selectedValue1 == "Country") { + print("kkk"); + setState(() { + ddlist = [ + "United States", + "United States", + "United States", + ]; + }); + } else if (_selectedValue1 == "State") { + print("kkk"); + setState(() { + ddlist = [ + "Karnataka", + 'Karnataka', + 'Karnataka', + ]; + }); + } else if (_selectedValue1 == "City") { + print("kkk"); + setState(() { + ddlist = [ + "Hubli", + 'Hubli', + 'Hubli', + ]; + }); + } + + SystemChrome.setSystemUIOverlayStyle( + SystemUiOverlayStyle(statusBarColor: Color.fromARGB(255, 0, 71, 132))); + + return SafeArea( + child: Scaffold( + key: _scaffoldKey, // Assign the key to the Scaffold + + appBar: AppBar( + automaticallyImplyLeading: false, + title: isSearchClickd + ? Container( + height: 40, + decoration: BoxDecoration( + color: Colors.white, + borderRadius: BorderRadius.circular(5.0)), + child: TextField( + controller: _searchController, + onChanged: (value) { + setState(() {}); + }, + decoration: InputDecoration( + fillColor: Constants.k2color, + contentPadding: EdgeInsets.symmetric(vertical: 9.0), + border: OutlineInputBorder(), + hintText: "Search", + // labelText: ' Search', + prefixIcon: Icon( + Icons.search, + ), + ), + ), + ) + : Text("Contacts"), + actions: [ + IconButton( + onPressed: () { + setState(() { + isSearchClickd = !isSearchClickd; + if (!isSearchClickd) { + _searchController.clear(); + } + }); + }, + icon: Icon(isSearchClickd ? Icons.close : Icons.search)) + ], + ), + endDrawer: Drawer( + // width: MediaQuery.of(context).size.width * 99.2, + child: listdata(), + ), + body: Consumer( + builder: (context, hcpProvider, child) { + print("_selectedValueConsumerConsumer_isss: $_selectedValue"); + + if (_selectedValue.isNotEmpty) { + _searchController.text = _selectedValue; + } + + displayedHCPList = hcpProvider.searchHCP(_searchController.text); + + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + //mainAxisSize: MainAxisSize.min, + children: [ + Container( + child: Wrap( + children: [ + Padding( + padding: + const EdgeInsets.only(left: 8.0, right: 2.0), + child: CupertinoSwitch( + activeColor: Color.fromARGB(255, 0, 71, 132), + value: _switchValue, + onChanged: (value) { + setState(() { + _switchValue = value; + }); + }, + ), + ), + Padding( + padding: + const EdgeInsets.only(right: 8.0, top: 9.0), + child: !_switchValue + ? Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + ) + : Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + )) + ], + ), + ), + Padding( + padding: const EdgeInsets.only(right: 8.0), + child: Row( + children: [ + Text1(title: 'My Filters'), + IconButton( + onPressed: () async { + List kol = await retrievekol(); + + print("IamKollll: ${kol}, ${kol.length}"); + + _scaffoldKey.currentState?.openEndDrawer(); + }, + icon: Icon( + Icons.sort, + size: 30, + )), + ], + ), + ) + ], + ), + SizedBox( + height: 5, + ), + !_switchValue + ? Expanded( + child: ListView.builder( + itemCount: displayedHCPList.length, + itemBuilder: (BuildContext context, int index) { + var data = displayedHCPList[index]; + + print("Checkinggggk2_data: ${data.profileImage}"); + + return Column( + children: [ + ListTile( + onLongPress: () { + print("LongPresss"); + setState(() { + longpress = true; + }); + }, + onTap: () async { + print("Check_data11 = ${data}"); + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + NewProfile1(text: data), + ), + ); + }, + leading: data.profileImage == null + ? ProfilePicture( + name: data.fullName, + radius: 30, + fontsize: 12, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(30), + child: CachedNetworkImage( + imageUrl: data.profileImage, + imageBuilder: + (context, imageProvider) => + Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + ), + ), + ), + trailing: Visibility( + visible: longpress, + child: Checkbox( + value: _selectedIndices + .contains(data.npiNum.toString()), + onChanged: (value) { + setState(() { + if (value!) { + print( + "Datata_issss_iddd: ${data["id"]}"); + _selectedIndices + .add(data["id"].toString()); + } else { + _selectedIndices.remove( + data["id"].toString()); + } + print( + "id_total123: ${_selectedIndices}"); + }); + }), + ), + title: Text1( + title: data.fullName, + fontweight: FontWeight.bold, + txtfont: isTablet ? 22 : 16, + ), + subtitle: Column( + children: [ + Row( + children: [ + Expanded( + child: Text1( + title: data.specialityName ?? "", + fontweight: FontWeight.normal, + txtfont: isTablet ? 20 : 14, + ), + ), + ], + ), + Row( + children: [ + Text1( + title: data.primaryState ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + SizedBox( + width: 3.0, + ), + Expanded( + child: Text1( + title: data.primaryCountry ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + ], + ), + ], + ), + ), + Row( + mainAxisAlignment: + MainAxisAlignment.spaceEvenly, + children: [ + Expanded( + //padding: EdgeInsets.only(left: 10.0), + child: Padding( + padding: + const EdgeInsets.only(left: 10.0), + child: Text1( + title: + "Added by ${data.createdByUser}", + // title: "Added by Pooja k", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + ), + Expanded( + //padding: EdgeInsets.only(right: 10.0), + child: Padding( + padding: + const EdgeInsets.only(right: 10.0), + child: Text1( + title: + "Added on ${data.formattedCreatedAt.toIso8601String().toString()}", + + // title: "Added on 01/07/2023", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + ) + ], + ), + Divider(), + ], + ); + }, + ), + ) + : Expanded( + child: ListView.builder( + itemCount: HiveFunctions.getAllUsers11().length, + itemBuilder: (BuildContext context, int index) { + var data = HiveFunctions.getAllUsers11()[index]; + + print("CheckinggggImage_path: ${data['img_path']}"); + print( + "CheckinggggImage_path: ${data['name']},${data['inid']}"); + + return Column( + children: [ + ListTile( + onLongPress: () { + print("LongPresss"); + setState(() { + longpressmy = true; + }); + }, + onTap: () async { + print("Check_data = $data"); + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + NewProfile1(text: data), + ), + ); + }, + leading: data["img_path"] == "" + ? ProfilePicture( + name: data["name"], + radius: 30, + fontsize: 12, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(30), + child: CachedNetworkImage( + imageUrl: data["img_path"], + imageBuilder: + (context, imageProvider) => + Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + // placeholder: (context, url) => + // CircularProgressIndicator(), + // errorWidget: (context, url, error) => + // Icon(Icons.error), + ), + ), + ), + trailing: Visibility( + visible: longpressmy, + child: Checkbox( + value: _selectedremoveIndices + .contains(data["id"]), + onChanged: (value) { + setState(() { + if (value!) { + _selectedremoveIndices + .add(data["id"]); + } else { + _selectedremoveIndices + .remove(data["id"]); + } + print( + "id_total: ${_selectedremoveIndices}"); + }); + }), + ), + title: Text( + "${data["name"]}", + style: TextStyle( + fontSize: isTablet ? 22 : 16, + fontWeight: FontWeight.bold, + ), + ), + subtitle: Column( + children: [ + Row( + children: [ + Expanded( + child: Text( + "${data["speciality"] ?? data['spl']},", + style: TextStyle( + fontSize: isTablet ? 20 : 14, + fontWeight: FontWeight.normal, + ), + ), + ), + ], + ), + Row( + children: [ + Text( + "${data["addr"]},", + style: const TextStyle( + fontSize: 14.0, + fontWeight: FontWeight.normal, + ), + ), + ], + ), + ], + ), + ), + const Row( + mainAxisAlignment: + MainAxisAlignment.spaceBetween, + children: [ + Padding( + padding: EdgeInsets.only(left: 10.0), + child: Text( + "Added by Pooja k", + style: TextStyle( + fontSize: 12.0, + fontWeight: FontWeight.normal, + ), + ), + ), + Padding( + padding: EdgeInsets.only(right: 10.0), + child: Text( + "Added on 01/07/2023", + style: TextStyle( + fontSize: 12.0, + fontWeight: FontWeight.normal, + ), + ), + ) + ], + ), + Divider(), + ], + ); + }, + ), + ), + !_switchValue + ? Align( + alignment: Alignment.bottomCenter, + child: longpress + ? Container( + color: const Color.fromARGB(255, 251, 242, 242), + width: MediaQuery.of(context).size.width, + height: 200.0, + child: Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + GestureDetector( + onTap: () async { + print("Selected: ${_selectedIndices}"); + print( + "Selected: ${_selectedIndices.length}"); + + for (int i = 0; + i < _selectedIndices.length; + i++) {} + _showMyDialog( + "Selected contact has been added to my contacts "); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.add, + color: Colors.green, + ), + ), + Text( + 'Add to My Contacts', + style: TextStyle( + color: Colors.black, + fontSize: 14.0), + ), + ], + ), + ), + Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.download, + color: Colors.blue, + ), + ), + GestureDetector( + onTap: () {}, + child: Text( + 'Download', + style: + TextStyle(color: Colors.black), + ), + ), + ], + ), + GestureDetector( + onTap: () { + setState(() { + longpress = false; + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + }); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.close, + color: Colors.red, + ), + ), + Text( + 'Cancel', + style: + TextStyle(color: Colors.black), + ), + ], + ), + ), + Expanded( + child: GestureDetector( + onTap: () async { + print( + "Selected: ${_selectedIndices}"); + for (int i = 0; + i < _selectedIndices.length; + i++) { + print( + 'The id id : ${_selectedIndices[i]}'); + + Map? row = + findRecordById(displayedHCPList, + _selectedIndices[i]); + + print("Storingggg_isss:Row $row"); + + print( + "checking_value_istrends: ${_selectedIndices[i]},${row!["license_no"]}, ${row["email"]}, ${row["img_path"]} "); + + await addKolInfo(row); + + var affiliations = Provider.of< + AffiliationsProvider>( + context, + listen: false); + + await affiliations + .getAffiliationsdata(row["id"]); + final affilist = + affiliations.adddta; + + print( + "CheckingAfflistInCon: $affilist"); + + await addAffiliation(affilist); + + var publication = + Provider.of( + context, + listen: false); + + await publication + .publicatininfo(row["id"]); + final publist = + publication.publicationlist; + print("Checkingpublist: $publist"); + + await addPublication(publist); + + var events = + Provider.of( + context, + listen: false); + await events + .geteventdata(row["id"]); + final eventlist = events.EventsList; + + print( + "Checkingeventlist: $eventlist"); + + await addEvent(eventlist); + + var trials = + Provider.of( + context, + listen: false); + await trials.trialsdata(row["id"]); + + final trialslist = + trials.trialsinfo; + print( + "Checkingtrialslist: $trialslist"); + + await addTrials(trialslist); + + var location = + Provider.of( + context, + listen: false); + await location + .locationinfo(row["id"]); + + final loclist = + location.locationlist; + print( + "Checkingloclist321: $loclist"); + + await addLoc(loclist); + + var phoneno = + Provider.of( + context, + listen: false); + await phoneno.phoneinfo(row["id"]); + + final pnolist = phoneno.phonenolist; + print( + "Checkingloclist321: $pnolist"); + + await addPno(pnolist); + + var emails = + Provider.of( + context, + listen: false); + await emails.emailinfo(row["id"]); + + final emailkollist = + emails.emailkollist; + print( + "Checkingloclist321: $emailkollist"); + + await addEmail(emailkollist); + + var edu = + Provider.of( + context, + listen: false); + await edu.eduinfo(row["id"]); + + final edukollist = + edu.educationlist; + print( + "Checkingloclist321: $edukollist"); + + await addEdu(edukollist); + + var awa = + Provider.of( + context, + listen: false); + await awa.awainfo(row["id"]); + + final awakollist = awa.awardlist; + print( + "Checkingloclist321: $awakollist"); + + await addAwa(awakollist); + + var cer = Provider.of< + CertificateProvider>( + context, + listen: false); + await cer + .certificateinfo(row["id"]); + + final cerlist = cer.certificatelist; + print( + "Checkingloclist321: $awakollist"); + + await addCer(cerlist); + + var pet = + Provider.of( + context, + listen: false); + await pet.patentinfo(row["id"]); + + final petlist = pet.patentlist; + print( + "Checkingloclist321: $petlist"); + + await addPatent(petlist); + + var nih = + Provider.of( + context, + listen: false); + await nih.nihinfo(row["id"]); + + final nihlist = nih.nihgrantslist; + print( + "Checkingloclist321: $nihlist"); + + await addNih(nihlist); + + var pro = + Provider.of( + context, + listen: false); + await pro.proinfo(row["id"]); + + final prolist = pro.procedurelist; + print( + "Checkingloclist321: $nihlist"); + + await addPro(prolist); + + var tri = + Provider.of( + context, + listen: false); + await tri.traininginfo(row["id"]); + + final trilist = tri.traininglist; + print( + "Checkingloclist321: $nihlist"); + + await addtraining(trilist); + + var spe = Provider.of< + SpekerEvalutionProvider>( + context, + listen: false); + await spe.getspeakerdata(); + + final spelist = spe.speakerlist; + print( + "Checkingloclist321: $spelist"); + + await addSpeaker(spelist); + + _showMyDialog( + "selected contact has been added to offline"); + } + + setState(() {}); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.save, + color: Colors.deepOrange, + ), + ), + Padding( + padding: + EdgeInsets.only(top: 15.0), + child: Text( + 'Save Offline', + style: TextStyle( + color: Colors.black), + ), + ), + ], + ), + ), + ), + ], + ), + ) + : Container(), + ) + : Align( + alignment: Alignment.bottomCenter, + child: longpressmy + ? Container( + color: const Color.fromARGB(255, 251, 242, 242), + width: MediaQuery.of(context).size.width, + height: 200.0, + child: Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + GestureDetector( + onTap: () async { + print( + "SelectedRemoveee: ${_selectedremoveIndices}"); + print( + "Selected: ${_selectedremoveIndices.length}"); + + for (int i = 0; + i < _selectedremoveIndices.length; + i++) { + print( + 'The id id : ${_selectedremoveIndices[i]}'); + + final row = + await HiveFunctions.getuser( + _selectedremoveIndices[i]); + // var data = HiveFunctions.getuser()[i]; + + print("Delete_Row ${row[i]}"); + print("Delete_Row ${row[i]["inid"]}"); + + final row1 = + await HiveFunctions.deleteUser11( + row[i]["inid"]); + setState(() {}); + } + _showMyDialog( + "selected contact has been removed"); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.remove, + color: Colors.green, + ), + ), + Text( + 'Remove from My Contacts', + style: + TextStyle(color: Colors.black), + ), + ], + ), + ), + Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.download, + color: Colors.blue, + ), + ), + GestureDetector( + onTap: () {}, + child: Text( + 'Download', + style: + TextStyle(color: Colors.black), + ), + ), + ], + ), + GestureDetector( + onTap: () { + setState(() { + longpressmy = false; + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + }); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.close, + color: Colors.red, + ), + ), + Text( + 'Cancel', + style: TextStyle( + color: Constants.k2color), + ), + ], + ), + ), + ], + ), + ) + : Container(), + ), + ], + ); + }, + ), + ), + ); + } + + listdata() { + return ListView( + children: [ + // DrawerHeader removed + ListTile( + title: Padding( + padding: const EdgeInsets.all(8.0), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + const Icon( + Icons.sort, + size: 30.0, + ), + const Text( + "Filters", + style: TextStyle(fontSize: 18.0, fontWeight: FontWeight.bold), + ), + GestureDetector( + onTap: () { + Navigator.pop(context); + // print("hiii"); + }, + child: const Icon(Icons.cancel)) + ], + ), + ), + ), + + ListTile( + title: Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + OutlinedButton( + onPressed: () { + //setState(() {}); + + Navigator.push( + context, + MaterialPageRoute(builder: (context) => Contactsk2()), + ).then((value) => setState(() {})); + print("refresh done "); + // }) + }, + child: Text( + 'Reset Filter', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ], + ), + ), + ListTile( + title: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + // decoration: InputDecoration( + // border: OutlineInputBorder(), + // labelText: 'Select an option', + // ), + hint: Text("Select the Type"), + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 9), + + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + isExpanded: true, + value: _selectedValue1, + items: items.map((String item) { + return DropdownMenuItem( + value: item, + child: Text(item), + ); + }).toList(), + onChanged: (String? newValue) { + setState(() { + _selectedValue1 = newValue; + }); + }, + // buttonStyleData: ButtonStyleData( + // height: 50, + // padding: EdgeInsets.symmetric(horizontal: 14), + // decoration: BoxDecoration( + // borderRadius: BorderRadius.circular(10), + // border: Border.all(color: Colors.grey), + // ), + // ), + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 50, + width: 200, + ), + dropdownStyleData: DropdownStyleData( + maxHeight: 200, + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(14), + ), + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + // padding: const EdgeInsets.only( + // top: 8, + // bottom: 4, + // right: 8, + // left: 8, + // ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + final itemString = item.value.toString().toLowerCase(); + final searchString = searchValue.toLowerCase(); + return itemString.contains(searchString); + }, + ), + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + iconStyleData: IconStyleData( + icon: Icon(Icons.arrow_drop_down), + iconSize: 20, + ), + ), + ), + ), + ListTile( + title: Container( + decoration: BoxDecoration( + border: Border.all(color: Colors.black), + borderRadius: BorderRadius.circular(10)), + child: Padding( + padding: const EdgeInsets.all(3.5), + child: DropDownField( + hintText: 'Select an option', + items: ddlist, + onValueChanged: (newValue) { + setState(() { + _selectedValue = newValue; + }); + }, + value: _selectedValue, + ), + ), + ), + ), + + ListTile( + title: Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + OutlinedButton( + onPressed: () { + ; + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => const SavedContacts1())); + print("refresh done 111"); + // }) + }, + child: Text( + 'Saved Profiles123', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ], + ), + ), + ], + ); + } + + filterss(String selectedValue) async { + setState(() { + print("_selectedValue_isss: $_selectedValue"); + }); + } + + Future _showMyDialog(String data) async { + return showDialog( + context: context, + barrierDismissible: false, // user must tap button! + builder: (BuildContext context) { + return AlertDialog( + title: const Text('Successfully'), + content: SingleChildScrollView( + child: ListBody( + children: [ + // Text('This is a demo alert dialog.'), + Text(data), + ], + ), + ), + actions: [ + TextButton( + child: const Text('Ok'), + onPressed: () { + Navigator.of(context).pop(); + setState(() { + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + longpress = false; + longpressmy = false; + }); + }, + ), + ], + ); + }, + ); + } + + Future getNextAutoIncrementValue() async { + var counterBox = await Hive.openBox('counterBox'); + if (!counterBox.containsKey('counter')) { + counterBox.put('counter', 0); + } + + int? counter = counterBox.get('counter'); + counterBox.put('counter', counter! + 1); + + await counterBox.close(); + + return counter; + } + + Map findRecordById( + List displayedHCPList, String selectedIndic) { + // print( + // "Gettt11111 ${displayedHCPList.firstWhere((element) => element['id'] == int.parse(selectedIndic))}"); + return displayedHCPList + .firstWhere((element) => element['id'] == int.parse(selectedIndic)); + } + + fecthhcpbyname() async { + var hcp = Provider.of(context, listen: false); + await hcp.getHCPProvider(); + + final hcplist = hcp.list; + // print("HCP_namessss: ${hcplist}"); + + final namelist = await hcplist.map((e) => e["name"] as String).toList(); + print("HCP_namessssListttt: ${namelist}"); + + setState(() { + ddlist = namelist; + }); + + //return namelist; + } +} diff --git a/lib/contacts_module/ui_screen/k2api_integrated_ui/locationk2_tab.dart b/lib/contacts_module/ui_screen/k2api_integrated_ui/locationk2_tab.dart new file mode 100644 index 0000000..76e89fc --- /dev/null +++ b/lib/contacts_module/ui_screen/k2api_integrated_ui/locationk2_tab.dart @@ -0,0 +1,362 @@ +// import 'package:konectar_events/custom_widget/custom_expansiontile.dart'; +import 'package:konectar_events/contacts_module/custom_widget/custom_expansiontile.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_Certificate_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_awards_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_education_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_email_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_location_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_pno_k2.dart'; +import 'package:konectar_events/contacts_module/model_class/k2_api_model/kol_training_k2.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_awards_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_education_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_locationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_pno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_training_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/awa_data/crud_awa.dart'; +import 'package:konectar_events/contacts_module/storage_hive/cer_hive/crud_cer.dart'; +import 'package:konectar_events/contacts_module/storage_hive/edu_data/crud_edu.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/crud_email.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/crud_loc.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/crud_pno.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/crud_training.dart'; +import 'package:konectar_events/contacts_module/ui_screen/k2api_integrated_ui/k2testbshhet.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_Certificate_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_awards_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_education_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_email_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_location_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_pno_k2.dart'; +// import 'package:konectar_events/model_class/k2_api_model/kol_training_k2.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_awards_provider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_certificate_provider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_education_provider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_email_provider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_locationprovider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_pno_provider.dart'; +// import 'package:konectar_events/provider_class/k2_provider/kol_training_provider.dart'; +// import 'package:konectar_events/storage_hive/awa_data/crud_awa.dart'; +// import 'package:konectar_events/storage_hive/cer_hive/crud_cer.dart'; +// import 'package:konectar_events/storage_hive/edu_data/crud_edu.dart'; +// import 'package:konectar_events/storage_hive/email_data/crud_email.dart'; +// import 'package:konectar_events/storage_hive/loc_data/crud_loc.dart'; +// import 'package:konectar_events/storage_hive/pno_data/crud_pno.dart'; +// import 'package:konectar_events/storage_hive/traning_data/crud_training.dart'; +// import 'package:konectar_events/ui_screen/k2api_integrated_ui/k2testbshhet.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class LocationK2Tab extends StatefulWidget { + // const LocationTab({super.key}); + LocationK2Tab({required this.text, this.offline, Key? key}) : super(key: key); + + final int text; + int? offline; + @override + State createState() => _LocationK2TabState(); +} + +class _LocationK2TabState extends State { + List locationList = []; + List pno = []; + List emailid = []; + + List training = []; + List education = []; + List award = []; + List certificate = []; + + @override + void initState() { + // TODO: implement initState + super.initState(); + + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + getAffiliations(); + }); + } + + Future getAffiliations() async { + // ignore: prefer_typing_uninitialized_variables + var loclist, phoneno, emailno1, edu1, awa1, cer1, training1; + + if (widget.offline == 1) { + loclist = await retrieveidlocations(widget.text); + print("Saved_Checkingloclist: $loclist"); + } else { + var location = Provider.of(context, listen: false); + await location.locationinfo(widget.text); + loclist = location.locationlist; + + setState(() { + locationList = loclist; + }); + } + + if (mounted) { + if (widget.offline == 1) { + phoneno = await retrieveidpnos(widget.text); + print("Saved_Checkingloclist: $loclist"); + } else { + var phone = Provider.of(context, listen: false); + await phone.phonek2info(widget.text); + phoneno = phone.phonenolist; + } + setState(() { + pno = phoneno; + }); + } + + if (mounted) { + if (widget.offline == 1) { + emailno1 = await retrieveidemails(widget.text); + print("Saved_CheckingloclistEmailll: $emailno1"); + } else { + var email = Provider.of(context, listen: false); + await email.emailinfo(widget.text); + emailno1 = email.emailkollist; + print("Saved_CheckingloclistEmailll123: $emailno1"); + } + + setState(() { + emailid = emailno1; + }); + } + + if (mounted) { + if (widget.offline == 1) { + training1 = await retrieveidtri(widget.text); + print("Saved_CheckingloclistEmailll: $emailno1"); + } else { + var trai = Provider.of(context, listen: false); + await trai.traininginfo(widget.text); + training1 = trai.traininglist; + } + + setState(() { + training = training1; + }); + } + + if (mounted) { + if (widget.offline == 1) { + edu1 = await retrieveidedus(widget.text); + print("Saved_CheckingloclistEdu: $edu1"); + } else { + var edu = Provider.of(context, listen: false); + await edu.eduinfo(widget.text); + edu1 = edu.educationlist; + print("Saved_CheckingloclistEdu123: $edu1"); + } + + setState(() { + education = edu1; + }); + } + + if (mounted) { + if (widget.offline == 1) { + awa1 = await retrieveidawa(widget.text); + print("Saved_CheckingloclistEdu: $edu1"); + } else { + var awa = Provider.of(context, listen: false); + await awa.awainfo(widget.text); + awa1 = awa.awardlist; + } + setState(() { + award = awa1; + }); + } + + if (mounted) { + if (widget.offline == 1) { + cer1 = await retrieveidcer(widget.text); + print("Saved_CheckingloclistEdu: $edu1"); + } else { + var cer = Provider.of(context, listen: false); + await cer.certificateinfo(widget.text); + cer1 = cer.certificatelist; + } + + setState(() { + certificate = cer1; + }); + } + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView(children: [ + locationList.length != 0 + ? CustomExpansionTile( + title: "Locations", + itemList: locationList.cast(), + buttonText: 'Show More', + field1: 'Institutation', + field2: 'Address', + onItemSelected: (Data selectedPhoneNumber) { + List> keyValue = [ + { + "Address": selectedPhoneNumber.address1, + "Postal Code": selectedPhoneNumber.postalCode, + "Primary": selectedPhoneNumber.formattedIsPrimary, + "organization Name": selectedPhoneNumber.organizationName, + "Country Name": selectedPhoneNumber.countryName, + "State Name": selectedPhoneNumber.stateName, + "City Name": selectedPhoneNumber.cityName, + } + ]; + + modelbsheet(keyValue); + }, + ) + : Container(), + pno.length != 0 + ? CustomExpansionTile( + title: "Phone Numbers", + itemList: pno.cast(), + buttonText: 'Show More', + field1: 'Phone Type', + field2: 'Phone No', + onItemSelected: (DataPhno selectedPhoneNumber) { + List> keyValue = [ + { + "Phone Number": selectedPhoneNumber.number, + "Phone Type": selectedPhoneNumber.phoneTypeName, + "Primary": selectedPhoneNumber.formattedIsPrimary, + "organization Name": selectedPhoneNumber.organizationName, + } + ]; + + modelbsheet(keyValue); + }, + ) + : Container(), + emailid.length != 0 + ? CustomExpansionTile( + title: "Emails", + itemList: emailid.cast(), + buttonText: 'Show More', + field1: 'Email Type', + field2: 'Email', + onItemSelected: (EmailData selectedPhoneNumber) { + List> keyValue = [ + { + "Email": selectedPhoneNumber.email, + "Email Type": selectedPhoneNumber.emailTypeName, + } + ]; + + modelbsheet(keyValue); + }, + ) + : Container(), + training.length != 0 + ? CustomExpansionTile( + title: "Trainings", + itemList: training.cast(), + buttonText: 'Show More', + field1: 'Education Type', + field2: 'Institution Name', + onItemSelected: (TrainingList selectedPhoneNumber) { + List> keyValue = [ + { + "organization Id": selectedPhoneNumber.organizationId, + "Degree": selectedPhoneNumber.degree, + "Specialty": selectedPhoneNumber.specialty, + "Start Date": selectedPhoneNumber.startDate, + "End Date": selectedPhoneNumber.endDate, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + education.length != 0 + ? CustomExpansionTile( + title: "Education", + itemList: education.cast(), + buttonText: 'Show More', + field1: 'Education Type', + field2: 'Institution Name', + onItemSelected: (EducationList selectedPhoneNumber) { + List> keyValue = [ + { + "organization Id": selectedPhoneNumber.organizationId, + "Degree": selectedPhoneNumber.degree, + "Specialty": selectedPhoneNumber.specialty, + "Start Date": selectedPhoneNumber.startDate, + "End Date": selectedPhoneNumber.endDate, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + award.length != 0 + ? CustomExpansionTile( + title: "Awards", + itemList: award.cast(), + buttonText: 'Show More', + field1: 'Education Type', + field2: 'Institution Name', + onItemSelected: (AwardsList selectedPhoneNumber) { + List> keyValue = [ + { + "Name": selectedPhoneNumber.name, + "Start Date": selectedPhoneNumber.startDate, + "End Date": selectedPhoneNumber.endDate, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + certificate.length != 0 + ? CustomExpansionTile( + title: "Certificates", + itemList: certificate.cast(), + buttonText: 'Show More', + field1: 'Education Type', + field2: 'Institution Name', + onItemSelected: (CertificateList selectedPhoneNumber) { + List> keyValue = [ + { + "Organization Id": selectedPhoneNumber.organizationId, + "specialty": selectedPhoneNumber.specialty, + "Start Date": selectedPhoneNumber.startDate, + "End Date": selectedPhoneNumber.endDate, + } + ]; + modelbsheet(keyValue); + }, + ) + : Container(), + ]), + ); + } + + void modelbsheet(List> keyValue) { + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: const RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheetk2new(keyValue); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/listview.dart b/lib/contacts_module/ui_screen/listview.dart new file mode 100644 index 0000000..340d893 --- /dev/null +++ b/lib/contacts_module/ui_screen/listview.dart @@ -0,0 +1,180 @@ +import 'package:flutter/material.dart'; + +class DataTableDemo extends StatefulWidget { + @override + State createState() => _DataTableDemoState(); +} + +class _DataTableDemoState extends State { + Widget build(BuildContext context) { + return SafeArea( + child: Scaffold( + body: ListView( + padding: const EdgeInsets.all(3), + children: [ + PaginatedDataTable( + header: const Text( + 'HCP RANKING', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 18.0, + fontStyle: FontStyle.normal), + ), + showFirstLastButtons: true, + showEmptyRows: false, + showCheckboxColumn: false, + // actions: const [Text("jii")], + rowsPerPage: 5, + columns: const [ + DataColumn( + label: Text('Name', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Opt-in Status', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Country', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Rank', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Score', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Event', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Affliations', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Publications', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Trails', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + ], + source: _DataSource(context), + ), + ], + ), + ), + ); + } +} + +class _Row { + _Row(this.identifier, this.valueA, this.valueB, this.valueC, this.valueD, + this.valueE, this.valueF, this.valueG, this.valueH, this.valueI); + final String identifier; + final String valueA; + final String valueB; + final String valueC; + final int valueD; + final String valueE; + final String valueF; + final String valueG; + final String valueH; + final String valueI; + + bool selected = false; +} + +class _DataSource extends DataTableSource { + final BuildContext context; + late List<_Row> _rows; + _DataSource(this.context) { + // _rows = <_Row>[ + // _Row('Cell A1', 'CellB1', 'CellC1', 1, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A2', 'CellB2', 'CellC2', 2, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A3', 'CellB3', 'CellC3', 3, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A4', 'CellB4', 'CellC4', 4, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A5', 'CellB1', 'CellC1', 1, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A6', 'CellB2', 'CellC2', 2, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A7', 'CellB3', 'CellC3', 3, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A8', 'CellB4', 'CellC4', 4, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // _Row('Cell A9', 'CellB1', 'CellC1', 1, 'CellE1', 'CellF1', 'CellG1', + // 'CellH1', 'CellI1'), + // ]; + + _rows = <_Row>[ + for (int i = 0; i < 20; i++) + _Row('$i', 'Gerosa, Gino', 'Active', 'Italy', 1, '0', '0', '0', '0', + '0'), + ]; + //} + } + + int _selectedCount = 0; + + @override + DataRow? getRow(int index) { + assert(index >= 0); + if (index >= _rows.length) return null; + final row = _rows[index]; + return DataRow.byIndex( + index: index, + selected: row.selected, + onSelectChanged: (value) { + // print("hii"); + // Navigator.push( + // context, MaterialPageRoute(builder: (context) => Profile())); + }, + cells: [ + DataCell(Text(row.valueA)), + DataCell(Text(row.valueB)), + DataCell(Text(row.valueC)), + DataCell(Text(row.valueD.toString())), + DataCell(Text(row.valueE)), + DataCell(Text(row.valueF)), + DataCell(Text(row.valueG)), + DataCell(Text(row.valueH)), + DataCell(Text(row.valueI)), + ], + ); + } + + @override + int get rowCount => _rows.length; + + @override + bool get isRowCountApproximate => false; + + @override + int get selectedRowCount => _selectedCount; +} diff --git a/lib/contacts_module/ui_screen/location_tab.dart b/lib/contacts_module/ui_screen/location_tab.dart new file mode 100644 index 0000000..45e16d1 --- /dev/null +++ b/lib/contacts_module/ui_screen/location_tab.dart @@ -0,0 +1,1251 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/provider_class/award_provider.dart'; +// import 'package:konectar_events/provider_class/certificate_provider.dart'; +// import 'package:konectar_events/provider_class/educationprovider.dart'; +// import 'package:konectar_events/provider_class/email_provider.dart'; +// import 'package:konectar_events/provider_class/location_provider.dart'; +// import 'package:konectar_events/provider_class/phoneno_provider.dart'; +// import 'package:konectar_events/provider_class/training_provider.dart'; +// import 'package:konectar_events/storage_hive/awa_data/crud_awa.dart'; +// import 'package:konectar_events/storage_hive/cer_hive/crud_cer.dart'; +// import 'package:konectar_events/storage_hive/edu_data/crud_edu.dart'; +// import 'package:konectar_events/storage_hive/email_data/crud_email.dart'; +// import 'package:konectar_events/storage_hive/loc_data/crud_loc.dart'; +// import 'package:konectar_events/storage_hive/pno_data/crud_pno.dart'; +// import 'package:konectar_events/storage_hive/traning_data/crud_training.dart'; +// import 'package:konectar_events/ui_screen/awardshowmore.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:konectar_events/ui_screen/cer_show_more.dart'; +// import 'package:konectar_events/ui_screen/edu_show_more.dart'; +// import 'package:konectar_events/ui_screen/email_show_more.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/location_showmore.dart'; +// import 'package:konectar_events/ui_screen/pno_showmore.dart'; +// import 'package:konectar_events/ui_screen/training_showmore.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/provider_class/award_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/educationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/location_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/phoneno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/training_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/awa_data/crud_awa.dart'; +import 'package:konectar_events/contacts_module/storage_hive/cer_hive/crud_cer.dart'; +import 'package:konectar_events/contacts_module/storage_hive/edu_data/crud_edu.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/crud_email.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/crud_loc.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/crud_pno.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/crud_training.dart'; +import 'package:konectar_events/contacts_module/ui_screen/awardshowmore.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/cer_show_more.dart'; +import 'package:konectar_events/contacts_module/ui_screen/edu_show_more.dart'; +import 'package:konectar_events/contacts_module/ui_screen/email_show_more.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/location_showmore.dart'; +import 'package:konectar_events/contacts_module/ui_screen/pno_showmore.dart'; +import 'package:konectar_events/contacts_module/ui_screen/training_showmore.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class LocationTab extends StatefulWidget { + // const LocationTab({super.key}); + LocationTab({required this.text, this.offline, Key? key}) : super(key: key); + + final int text; + int? offline; + @override + State createState() => _LocationTabState(); +} + +class _LocationTabState extends State { + bool _isExpanded = false; + List locationList = []; + List pno = []; + List emailid = []; + + List training = []; + List education = []; + List award = []; + List certificate = []; + + @override + void initState() { + // TODO: implement initState + super.initState(); + getaffiliations(); + + print("OfflineeStored_loccc: ${widget.offline}"); + } + + getaffiliations() async { + final loclist, phoneno, emailno1, edu1, awa1, cer1, training1; + if (widget.offline == 1) { + loclist = await retrieveidlocations(widget.text); + print("Savedd_Checkingloclist: $loclist"); + } else { + var location = Provider.of(context, listen: false); + + await location.locationinfo(widget.text); + loclist = location.locationlist; + print("Savedd_Checkingloclist123: $loclist"); + } + + if (widget.offline == 1) { + phoneno = await retrieveidpnos(widget.text); + print("Savedd_Checkingloclist: $loclist"); + } else { + var phone = Provider.of(context, listen: false); + + await phone.phoneinfo(widget.text); + phoneno = phone.phonenolist; + } + + if (widget.offline == 1) { + emailno1 = await retrieveidemails(widget.text); + print("Savedd_CheckingloclistEmailll: $emailno1"); + } else { + var email = Provider.of(context, listen: false); + + await email.emailinfo(widget.text); + emailno1 = email.emailkollist; + + print("Savedd_CheckingloclistEmailll123: $emailno1"); + } + + if (widget.offline == 1) { + training1 = await retrieveidtri(widget.text); + print("Savedd_CheckingloclistEmailll: $emailno1"); + } else { + var trai = Provider.of(context, listen: false); + + await trai.traininginfo(widget.text); + training1 = trai.traininglist; + } + + if (widget.offline == 1) { + edu1 = await retrieveidedus(widget.text); + print("Savedd_CheckingloclistEdu: $edu1"); + } else { + var edu = Provider.of(context, listen: false); + + await edu.eduinfo(widget.text); + edu1 = edu.educationlist; + + print("Savedd_CheckingloclistEdu123: $edu1"); + } + + if (widget.offline == 1) { + awa1 = await retrieveidawa(widget.text); + print("Savedd_CheckingloclistEdu: $edu1"); + } else { + var awa = Provider.of(context, listen: false); + + await awa.awainfo(widget.text); + awa1 = awa.awardlist; + } + + if (widget.offline == 1) { + cer1 = await retrieveidcer(widget.text); + print("Savedd_CheckingloclistEdu: $edu1"); + } else { + var cer = Provider.of(context, listen: false); + + await cer.certificateinfo(widget.text); + cer1 = cer.certificatelist; + } + setState(() { + locationList = loclist; + pno = phoneno; + emailid = emailno1; + + training = training1; + certificate = cer1; + education = edu1; + award = awa1; + }); + + print( + "locationListlocationList_isss: $locationList, ${locationList.length}"); + //final affiliationsss = affiliation_data['Affiliations'] as List>; + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView(children: [ + locationList.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Locations", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${locationList.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Institution', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Address', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + locationList.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print( + "message123 ${locationList[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet( + locationList[index]); + }, + ); + }, + cells: [ + DataCell(Text( + locationList[index].institution, + softWrap: true)), + DataCell(Text( + locationList[index].address, + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => Locationfulldata( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + + pno.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Phone Numbers", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${pno.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('phone Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Phone No', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + pno.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${pno[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(pno[index]); + }, + ); + }, + cells: [ + DataCell(Text( + pno[index].phoneType.toString(), + softWrap: true)), + DataCell(Text( + pno[index].phoneNumber.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => PhoneShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + + emailid.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Emails", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${emailid.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Email Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Email', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + emailid.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${emailid[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(emailid[index]); + }, + ); + }, + cells: [ + DataCell(Text( + emailid[index] + .emailType + .toString(), + softWrap: true)), + DataCell(Text( + emailid[index].email.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => EmailShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + + training.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Training ", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${training.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + training.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${training[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(training[index]); + }, + ); + }, + cells: [ + DataCell(Text( + training[index] + .educationType + .toString(), + softWrap: true)), + DataCell(Text( + training[index] + .institutionName + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => TrainingShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + + ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Education ", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${education.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: TextStyle( + fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + education.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${education[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(education[index]); + }, + ); + }, + cells: [ + DataCell(Text( + education[index] + .educationType + .toString(), + softWrap: true)), + DataCell(Text( + education[index] + .institutionName + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => EducationShowMore( + text: widget.text, + ))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ), // adds spacing between the text and image + award.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Awards ", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${award.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + award.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${award[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(award[index]); + }, + ); + }, + cells: [ + DataCell(Text( + award[index] + .educationType + .toString(), + softWrap: true)), + DataCell(Text( + award[index] + .institutionName + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => AwardShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + certificate.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Container( + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + backgroundColor: Constants.k2color11, + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Certificates ", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${certificate.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 16.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + certificate.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + print( + "message ${certificate[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: + BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(certificate[index]); + }, + ); + }, + cells: [ + DataCell(Text( + certificate[index] + .educationType + .toString(), + softWrap: true)), + DataCell(Text( + certificate[index] + .institutionName + .toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => CerShowMore( + text: widget.text))); + }, + child: Text( + 'Show More', + style: + TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ), + ) + : Container(), // adds spacing between the text and image + ]), + ); + } +} diff --git a/lib/contacts_module/ui_screen/medical_insight.dart b/lib/contacts_module/ui_screen/medical_insight.dart new file mode 100644 index 0000000..a04a5bf --- /dev/null +++ b/lib/contacts_module/ui_screen/medical_insight.dart @@ -0,0 +1,364 @@ +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/provider_class/medicalinsightprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/view_insight.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class MedicalInsight1 extends StatefulWidget { + const MedicalInsight1({super.key}); + + @override + State createState() => _MedicalInsightState(); +} + +class _MedicalInsightState extends State { + final List> cardData = [ + {'id': 'ID ', 'number': 'MI1688128025', 'id1': "jjj", 'number1': '265'}, + {'id': 'ID ', 'number': 20}, + {'id': 'ID ', 'number': 30}, + // Add more data entries as needed + ]; + + String selectedOption = 'None'; + late GlobalKey actionKey; + // DateTime? pickedDate; + + var item; + final TextEditingController textController = TextEditingController(); + + DateTime? selectedDate; + + bool calview = false; + String? start, end; + + final TextEditingController startController = TextEditingController(); + final TextEditingController endController = TextEditingController(); + + @override + void initState() { + actionKey = GlobalKey(); + super.initState(); + getapicall(); + } + + void getapicall() async { + await Provider.of(context, listen: false) + .medicalinsightdata(); + } + + // GlobalKey actionKey; + // final List> data = [ + // {'id': 'Data ID 1', 'number': 10}, + // {'id': 'Data ID 2', 'number': 20}, + // {'id': 'Data ID 3', 'number': 30}, + // // Add more data entries as needed + // ]; + @override + Widget build(BuildContext context) { + return Directionality( + textDirection: TextDirection.ltr, + child: SafeArea( + child: Scaffold( + // backgroundColor: const Color.fromARGB(255, 222, 237, 247), + backgroundColor: const Color.fromARGB(255, 246, 248, 252), + + appBar: AppBar( + title: const Text('Medical Insight'), + actions: [ + GestureDetector( + onTap: () { + setState(() { + calview = true; + }); + }, + child: Icon(Icons.calendar_month)) + ], + ), + body: Consumer( + builder: (context, value, child) { + return Column( + children: [ + // GestureDetector( + // onTap: () => _selectDate(context), + // child: AbsorbPointer( + // child: TextField( + // controller: textController, + // decoration: InputDecoration( + // focusedBorder: InputBorder.none, + // enabledBorder: InputBorder.none, + // contentPadding: EdgeInsets.all(10.0), + // labelText: "date", + // labelStyle: + // TextStyle(color: Colors.black, fontSize: 16), + // // pass the hint text parameter here + // hintStyle: TextStyle(color: Colors.black, fontSize: 16), + // suffixIcon: Icon(Icons.calendar_today), + // ), + // style: TextStyle(color: Colors.black, fontSize: 18), + // ), + // ), + // ), + Visibility( + visible: calview, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceAround, + children: [ + // OutlinedButton( + // onPressed: () { + // _selectDate(context); + // }, + // child: + // start == null ? Text('Start Date') : Text(start!), + // ), + Expanded( + flex: 1, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: TextFormField( + controller: startController, + decoration: InputDecoration( + isDense: true, + border: OutlineInputBorder(), + hintText: "ff", + labelText: + startController.text ?? 'Start Date'), + // focusNode: AlwaysDisabledFocusNode(), + onTap: () { + _selectDate(context); + }, + ), + ), + ), + Expanded( + flex: 1, + child: OutlinedButton( + onPressed: () { + _selectDate1(context); + }, + child: end == null ? Text('Start Date') : Text(end!), + ), + ), + ], + ), + ), + + Padding( + padding: const EdgeInsets.all(8.0), + child: TextField( + //controller: _searchController, + onChanged: (value) { + setState(() {}); + }, + decoration: InputDecoration( + fillColor: Constants.k2color, + contentPadding: const EdgeInsets.symmetric(vertical: 9.0), + border: const OutlineInputBorder( + borderRadius: BorderRadius.only( + bottomRight: Radius.circular(0))), + labelText: ' Search', + prefixIcon: const Icon( + Icons.search, + ), + ), + ), + ), + Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + // OutlinedButton( + // style: OutlinedButton.styleFrom( + // backgroundColor: Constants.k2color, + // foregroundColor: Colors.white), + // onPressed: () {}, + // child: Text("Create Medical Insight")) + ], + ), + Expanded( + child: ListView.builder( + physics: const ScrollPhysics(), + // scrollDirection: Axis.vertical, + shrinkWrap: true, + itemCount: value.med.length, + itemBuilder: (context, index) { + item = value.med[index]; + + print( + "Item_Medical_insight ${item['Therapeutic Area']}"); + return GestureDetector( + onTap: () { + _showAlertDialog(context); + }, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: Card( + margin: EdgeInsets.zero, + + elevation: 4, + surfaceTintColor: Colors.white, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.zero, + ), + + // shape: RoundedRectangleBorder( + // side: BorderSide(color: Colors.black, width: 1), + // borderRadius: BorderRadius.only( + // bottomRight: Radius.circular(30)), + // ), + child: SizedBox( + width: MediaQuery.sizeOf(context).width, + child: ListTile( + dense: true, + title: Column( + // crossAxisAlignment: CrossAxisAlignment.center, + children: [ + // Text( + // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + + RichText( + text: TextSpan( + text: '', + style: DefaultTextStyle.of(context) + .style, + children: const [ + TextSpan( + text: 'Acute neurology ', + style: TextStyle( + fontWeight: + FontWeight.bold)), + // TextSpan( + // text: ' therapeutic area ', + // style: TextStyle( + // fontWeight: + // FontWeight.bold)), + TextSpan( + text: + 'is the therapeutic area of the medical insight for '), + TextSpan( + text: + 'Product A. The age of treatment', + style: TextStyle( + fontWeight: + FontWeight.bold)), + TextSpan( + text: + ' is the topic of interest for this source type'), + TextSpan( + text: ' publication.', + style: TextStyle( + fontWeight: + FontWeight.bold)), + ], + ), + ), + + const Padding( + padding: EdgeInsets.all(8.0), + child: Row( + mainAxisAlignment: + MainAxisAlignment.spaceBetween, + children: [ + Row( + children: [ + Icon( + Icons.person, + size: 20, + ), + Text( + "pooja", + style: + TextStyle(fontSize: 14.0), + ) + ], + ), + Row( + children: [ + Icon( + Icons.calendar_today, + size: 20, + ), + Text( + "11/11/2022 ", + style: + TextStyle(fontSize: 14.0), + ) + ], + ) + ], + ), + ), + ], + ), + ), + ), + // shape: BorderRadius.only(bottomRight: Radius.circular(50)), + ), + ), + ); + }), + ) + ], + ); + }), + ), + ), + ); + } + + void _showAlertDialog(BuildContext context) { + showDialog( + context: context, + builder: (BuildContext context) { + return AlertDialog( + // title: Text('Alert'), + content: const MyWidget22(), + actions: [ + TextButton( + child: const Text('Close'), + onPressed: () { + Navigator.of(context).pop(); + }, + ), + ], + ); + }, + ); + } + + Future _selectDate(BuildContext context) async { + final DateTime? picked = await showDatePicker( + context: context, + initialDate: selectedDate, + firstDate: DateTime(1901, 1), + lastDate: DateTime(2100)); + if (picked != null && picked != selectedDate) + setState(() { + selectedDate = picked; + String convertedDateTime = + "${picked.year.toString()}-${picked.month.toString().padLeft(2, '0')}-${picked.day.toString().padLeft(2, '0')}"; + // widget.textController.value = TextEditingValue(text: picked.toString()); + startController.value = TextEditingValue(text: convertedDateTime); + + start = convertedDateTime; + ; + }); + } + + Future _selectDate1(BuildContext context) async { + final DateTime? picked = await showDatePicker( + context: context, + initialDate: selectedDate, + firstDate: DateTime(1901, 1), + lastDate: DateTime(2100)); + if (picked != null && picked != selectedDate) + setState(() { + selectedDate = picked; + String convertedDateTime = + "${picked.year.toString()}-${picked.month.toString().padLeft(2, '0')}-${picked.day.toString().padLeft(2, '0')}"; + // widget.textController.value = TextEditingValue(text: picked.toString()); + textController.value = TextEditingValue(text: convertedDateTime); + + end = convertedDateTime; + ; + }); + } +} diff --git a/lib/contacts_module/ui_screen/new_contacts.dart b/lib/contacts_module/ui_screen/new_contacts.dart new file mode 100644 index 0000000..a4d6c82 --- /dev/null +++ b/lib/contacts_module/ui_screen/new_contacts.dart @@ -0,0 +1,722 @@ +import 'dart:async'; + +import 'package:cached_network_image/cached_network_image.dart'; +import 'package:connectivity_plus/connectivity_plus.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/provider_class/affiliationsprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/award_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/educationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/events_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/hcp%20_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/location_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/nih_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/patent_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/phoneno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/procedureprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/speaker_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/training_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/kol_info/curd_kol.dart'; +import 'package:konectar_events/contacts_module/ui_screen/contact_filters.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_new_profile.dart'; +// import 'package:konectar_events/constants.dart'; +// import 'package:discover_module/custom_widget/text.dart'; +// import 'package:discover_module/hive_fun.dart'; +// import 'package:discover_module/provider_class/affiliationsprovider.dart'; +// import 'package:discover_module/provider_class/award_provider.dart'; +// import 'package:discover_module/provider_class/certificate_provider.dart'; +// import 'package:discover_module/provider_class/educationprovider.dart'; +// import 'package:discover_module/provider_class/email_provider.dart'; +// import 'package:discover_module/provider_class/events_provider.dart'; +// import 'package:discover_module/provider_class/hcp%20_provider.dart'; +// import 'package:discover_module/provider_class/location_provider.dart'; +// import 'package:discover_module/provider_class/nih_provider.dart'; +// import 'package:discover_module/provider_class/patent_provider.dart'; +// import 'package:discover_module/provider_class/phoneno_provider.dart'; +// import 'package:discover_module/provider_class/procedureprovider.dart'; +// import 'package:discover_module/provider_class/publications_provider.dart'; +// import 'package:discover_module/provider_class/speaker_provider.dart'; +// import 'package:discover_module/provider_class/training_provider.dart'; +// import 'package:discover_module/provider_class/trials_provider.dart'; +// import 'package:discover_module/storage_hive/kol_info/curd_kol.dart'; +// import 'package:discover_module/ui_screen/contact_filters.dart'; +// import 'package:discover_module/ui_screen/interactionform/util.dart'; +// import 'package:discover_module/ui_screen/new_new_profile.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:konectar_events/utils/constants.dart'; +import 'package:provider/provider.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter_profile_picture/flutter_profile_picture.dart'; + +final ValueNotifier> ddlist = ValueNotifier>([]); +String selectedValue = ''; +String? selectedType; +final TextEditingController searchController = TextEditingController(); + +TextEditingController textEditingController = TextEditingController(); + +class Contacts1 extends StatefulWidget { + const Contacts1({Key? key}) : super(key: key); + + @override + State createState() => _Contacts1State(); +} + +class _Contacts1State extends State { + final GlobalKey _scaffoldKey = GlobalKey(); + + bool _switchValue = false; + bool isOnline2 = true; + + bool isSearchClickd = false; + + List displayedHCPList = []; + List myContactHCPList = []; + + final List _selectedIndices = []; + final List _selectedremoveIndices = []; + + bool longpress = false; + bool longpressmy = false; + + late List hcpdataList; + // ignore: prefer_typing_uninitialized_variables + + var hcpDataProvider1; + + List _connectionStatus = [ConnectivityResult.none]; + final Connectivity _connectivity = Connectivity(); + late StreamSubscription> _connectivitySubscription; + + get developer => null; + + @override + void initState() { + super.initState(); + + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + initConnectivity(); + + _connectivitySubscription = + _connectivity.onConnectivityChanged.listen(_updateConnectionStatus); + hcpList(); + }); + } + + Future hcpList() async { + hcpDataProvider1 = Provider.of(context, listen: false); + + await hcpDataProvider1.getHCPProvider(); + final hcplist = hcpDataProvider1.list; + + hcpdataList = hcplist; + } + + @override + Widget build(BuildContext context) { + SystemChrome.setSystemUIOverlayStyle( + SystemUiOverlayStyle(statusBarColor: Color.fromARGB(255, 0, 71, 132))); + + return SafeArea( + child: Scaffold( + key: _scaffoldKey, // Assign the key to the Scaffold + + appBar: AppBar( + automaticallyImplyLeading: false, + centerTitle: true, + backgroundColor: EventsConstants.blueColor, + title: isSearchClickd + ? Container( + height: 40, + decoration: BoxDecoration( + color: Colors.white, + borderRadius: BorderRadius.circular(5.0)), + child: TextField( + controller: searchController, + onChanged: (value) { + setState(() {}); + }, + decoration: InputDecoration( + fillColor: Constants.k2color, + contentPadding: EdgeInsets.symmetric(vertical: 9.0), + border: OutlineInputBorder(), + hintText: "Search", + // labelText: ' Search', + prefixIcon: Icon( + Icons.search, + color: Colors.white, + ), + ), + ), + ) + : Text1( + title: "Contacts", + txtcolor: Colors.white, + ), + actions: [ + IconButton( + onPressed: () { + setState(() { + isSearchClickd = !isSearchClickd; + if (!isSearchClickd) { + searchController.clear(); + } + }); + }, + icon: Icon( + isSearchClickd ? Icons.close : Icons.search, + color: Colors.white, + )) + ], + ), + endDrawer: FilterDrawer(_switchValue, searchController), + + // Drawer( + // child: listdata(), + // ), + body: Consumer( + builder: (context, hcpProvider, child) { + print("_selectedValueConsumerConsumer_isss: $selectedValue"); + + if (selectedValue.isNotEmpty) { + searchController.text = selectedValue; + } else { + searchController.text = ""; + } + !_switchValue + ? displayedHCPList = + hcpProvider.searchHCP(searchController.text) + : myContactHCPList = + HiveFunctions.getindexUser(searchController.text); + + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Wrap( + children: [ + Padding( + padding: const EdgeInsets.only(left: 8.0, right: 2.0), + child: CupertinoSwitch( + activeColor: Color.fromARGB(255, 0, 71, 132), + value: _switchValue, + onChanged: (value) { + setState(() { + _switchValue = value; + }); + }, + ), + ), + Padding( + padding: + const EdgeInsets.only(right: 8.0, top: 9.0), + child: !_switchValue + ? Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + ) + : Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + )) + ], + ), + Padding( + padding: const EdgeInsets.only(right: 8.0), + child: Row( + children: [ + GestureDetector( + onTap: () { + print("SearchVon: ${searchController.text}"); + + setState(() { + selectedValue = ''; + }); + }, + child: Text1(title: 'My Filters'), + // child: Text1( + // title: _connectionStatus[0].toString(), + // ) + ), + IconButton( + onPressed: () async { + _scaffoldKey.currentState?.openEndDrawer(); + }, + icon: const Icon( + Icons.sort, + size: 30, + )), + ], + ), + ) + ], + ), + const SizedBox( + height: 5, + ), + // !_switchValue + // ? hcpContactlistview(displayedHCPList) + // : hcpContactlistview(myContactHCPList), + // contactsBottomdailog() + !_switchValue + ? _connectionStatus[0] + .toString() + .contains("ConnectivityResult.none") + ? hcpContactlistview(myContactHCPList) + : hcpContactlistview(displayedHCPList) + : hcpContactlistview(myContactHCPList), + contactsBottomdailog() + ], + ); + }, + ), + ), + ); + } + + Future _showMyDialog(String data) async { + return showDialog( + context: context, + barrierDismissible: false, // user must tap button! + builder: (BuildContext context) { + return AlertDialog( + title: const Text('Successfully'), + content: SingleChildScrollView( + child: ListBody( + children: [ + // Text('This is a demo alert dialog.'), + Text(data), + ], + ), + ), + actions: [ + TextButton( + child: const Text('Ok'), + onPressed: () { + Navigator.of(context).pop(); + setState(() { + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + longpress = false; + longpressmy = false; + }); + }, + ), + ], + ); + }, + ); + } + + Map findRecordById( + List displayedHCPList, String selectedIndic) { + // print( + // "Gettt11111 ${displayedHCPList.firstWhere((element) => element['id'] == int.parse(selectedIndic))}"); + return displayedHCPList + .firstWhere((element) => element['id'] == int.parse(selectedIndic)); + } + + hcpContactlistview(List HCPList) { + return Expanded( + child: ListView.builder( + itemCount: HCPList.length, + itemBuilder: (BuildContext context, int index) { + var data = HCPList[index]; + + print("CheckinggggImage_path: ${data['img_path']}"); + + return Column( + children: [ + ListTile( + onLongPress: () { + print("LongPresss"); + setState(() { + longpress = true; + }); + }, + onTap: () async { + print("Check_data11 = ${data}"); + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => NewProfile1(text: data), + ), + ); + }, + leading: data["img_path"] == "" + ? ProfilePicture( + name: data["First Name"], + radius: 30, + fontsize: 12, + ) + : ClipOval( + child: SizedBox.fromSize( + size: const Size.fromRadius(30), + child: CachedNetworkImage( + imageUrl: data["img_path"], + imageBuilder: (context, imageProvider) => Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + ), + ), + ), + trailing: Visibility( + visible: longpress, + child: !_switchValue + ? Checkbox( + value: + _selectedIndices.contains(data["id"].toString()), + onChanged: (value) { + setState(() { + if (value!) { + print("Datata_issss_iddd: ${data["id"]}"); + _selectedIndices.add(data["id"].toString()); + } else { + _selectedIndices.remove(data["id"].toString()); + } + print("id_total123: ${_selectedIndices}"); + }); + }) + : Checkbox( + value: _selectedremoveIndices.contains(data["id"]), + onChanged: (value) { + setState(() { + if (value!) { + _selectedremoveIndices.add(data["id"]); + } else { + _selectedremoveIndices.remove(data["id"]); + } + print("id_total: ${_selectedremoveIndices}"); + }); + }), + ), + title: Text1( + title: data['name'], + fontweight: FontWeight.bold, + txtfont: isTablet ? 22 : 16, + ), + subtitle: Column( + children: [ + Row( + children: [ + Expanded( + child: Text1( + title: data["speciality"] ?? data['spl'], + fontweight: FontWeight.normal, + txtfont: isTablet ? 20 : 14, + ), + ), + ], + ), + Row( + children: [ + Text1( + title: data["State"] ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + SizedBox( + width: 3.0, + ), + Expanded( + child: Text1( + title: data["Country"] ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + ], + ), + ], + ), + ), + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Padding( + padding: EdgeInsets.only(left: 10.0), + child: Text1( + title: "Added by Pooja k", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + Padding( + padding: EdgeInsets.only(right: 10.0), + child: Text1( + title: "Added on 01/07/2023", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ) + ], + ), + Divider(), + ], + ); + }, + ), + ); + } + + Future offlineProfileStore(List selectedIndices) async { + for (int i = 0; i < selectedIndices.length; i++) { + print('The id id : ${selectedIndices[i]}'); + + Map? row = + findRecordById(displayedHCPList, selectedIndices[i]); + + print("Storingggg_isss:Row $row"); + + await addKolInfo(row); + + await Provider.of(context, listen: false) + .storeAff(row["id"]); + + await Provider.of(context, listen: false) + .storePub(row["id"]); + + await Provider.of(context, listen: false) + .storeEvent(row["id"]); + + await Provider.of(context, listen: false) + .storeTrials(row["id"]); + + await Provider.of(context, listen: false) + .storeLoc(row["id"]); + + await Provider.of(context, listen: false) + .storePno(row["id"]); + + await Provider.of(context, listen: false) + .storeEmail(row["id"]); + + await Provider.of(context, listen: false) + .storeEdu(row["id"]); + + await Provider.of(context, listen: false) + .storeAwa(row["id"]); + + await Provider.of(context, listen: false) + .storeCer(row["id"]); + + await Provider.of(context, listen: false) + .storePet(row["id"]); + + await Provider.of(context, listen: false) + .storeNih(row["id"]); + + await Provider.of(context, listen: false) + .storePro(row["id"]); + + await Provider.of(context, listen: false) + .storeTraining(row["id"]); + + await Provider.of(context, listen: false) + .storeSpeaker(row["id"]); + } + } + + contactsBottomdailog() { + return Align( + alignment: Alignment.bottomCenter, + child: longpress + ? Container( + color: const Color.fromARGB(255, 251, 242, 242), + width: MediaQuery.of(context).size.width, + height: 200.0, + child: Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + !_switchValue + ? GestureDetector( + onTap: () async { + print("Selected: ${_selectedIndices}"); + print("Selected: ${_selectedIndices.length}"); + + for (int i = 0; i < _selectedIndices.length; i++) { + Map? row = findRecordById( + displayedHCPList, _selectedIndices[i]); + print("StoringgggMyContact_isss_isss:Row $row"); + + await HiveFunctions.savemyContact(row); + } + + _showMyDialog( + "Selected contact has been added to my contacts "); + }, + child: Row( + children: [ + const Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.add, + color: Colors.green, + ), + ), + Text1( + title: 'Add to My Contacts', + txtcolor: Colors.black, + txtfont: 14.0), + ], + ), + ) + : GestureDetector( + onTap: () async { + print( + "SelectedRemoveee: ${_selectedremoveIndices}"); + print("Selected: ${_selectedremoveIndices.length}"); + for (int i = 0; + i < _selectedremoveIndices.length; + i++) { + await HiveFunctions.deleteUser11( + _selectedremoveIndices[i]); + } + + setState(() {}); + + _showMyDialog("selected contact has been removed"); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.remove, + color: Colors.green, + ), + ), + Text( + 'Remove from My Contacts', + style: TextStyle(color: Colors.black), + ), + ], + ), + ), + Row( + children: [ + const Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.download, + color: Colors.blue, + ), + ), + GestureDetector( + onTap: () {}, + child: Text1( + title: 'Download', + txtcolor: Colors.black, + ), + ), + ], + ), + GestureDetector( + onTap: () { + setState(() { + longpress = false; + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + }); + }, + child: Row( + children: [ + const Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.close, + color: Colors.red, + ), + ), + Text1( + title: 'Cancel', + txtcolor: Colors.black, + ), + ], + ), + ), + Visibility( + visible: !_switchValue ? true : false, + child: Expanded( + child: GestureDetector( + onTap: () async { + print("Selected: ${_selectedIndices}"); + offlineProfileStore(_selectedIndices); + _showMyDialog( + "selected contact has been added to offline"); + + setState(() {}); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.save, + color: Colors.deepOrange, + ), + ), + Padding( + padding: EdgeInsets.only(top: 15.0), + child: Text( + 'Save Offline', + style: TextStyle(color: Colors.black), + ), + ), + ], + ), + ), + ), + ), + ], + ), + ) + : Container(), + ); + } + + Future initConnectivity() async { + late List result; + // Platform messages may fail, so we use a try/catch PlatformException. + try { + result = await _connectivity.checkConnectivity(); + } on PlatformException catch (e) { + developer.log('Couldn\'t check connectivity status', error: e); + return; + } + + // If the widget was removed from the tree while the asynchronous platform + // message was in flight, we want to discard the reply rather than calling + // setState to update our non-existent appearance. + if (!mounted) { + return Future.value(null); + } + + return _updateConnectionStatus(result); + } + + Future _updateConnectionStatus(List result) async { + setState(() { + _connectionStatus = result; + }); + // ignore: avoid_print + print('Connectivity changed: $_connectionStatus'); + } +} diff --git a/lib/contacts_module/ui_screen/new_editinteraction.dart b/lib/contacts_module/ui_screen/new_editinteraction.dart new file mode 100644 index 0000000..e4183b7 --- /dev/null +++ b/lib/contacts_module/ui_screen/new_editinteraction.dart @@ -0,0 +1,1500 @@ +import 'dart:convert'; +import 'dart:io'; + +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/textScalar.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/customrangeslider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/interatciontextfield.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/customrangeslider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/interatciontextfield.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter_carousel_widget/flutter_carousel_widget.dart'; +import 'package:intl/intl.dart'; +import 'package:path_provider/path_provider.dart'; +import 'package:provider/provider.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; + +import 'package:permission_handler/permission_handler.dart'; +// import 'package:pwa_ios/widgets/custombutton.dart'; +// import 'package:pwa_ios/widgets/customrangeslider.dart'; +// import 'package:pwa_ios/widgets/interatciontextfield.dart'; +import 'package:file_picker/file_picker.dart'; +// import 'package:pwa_ios/widgets/responsive_ext.dart'; +import 'package:path/path.dart' as p; + +class EditInteractionScreen1 extends StatefulWidget { + // int index; + // String form; + SaveInteraction saveInteraction; + EditInteractionScreen1( + {super.key, + // required this.index, + // required this.form, + required this.saveInteraction}); + + @override + State createState() => _EditInteractionScreenState(); +} + +class _EditInteractionScreenState extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + + final CarouselController _controller = CarouselController(); + + int _currentPage = 0; + late int _totalPages = + Provider.of(context, listen: false) + .interactionReponseList + .length; + + @override + void dispose() { + super.dispose(); + + // WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // Provider.of(context, listen: false).dispose(); + // }); + } + + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // initConfig(); + // if (mytimer!.isActive) { + // cancelTimer(); + // } + init(); + }); + + super.initState(); + } + + initConfig() async { + // await Provider.of(context, listen: false) + // .init(widget.index); + await Provider.of(context, listen: false) + .initConfigData(); + + // setState(() {}); + } + + init() async { + // await Provider.of(context, listen: false) + // .init(widget.index); + + await Provider.of(context, listen: false) + .initSavedForm(widget.saveInteraction); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + // print("build context"); + // print("Providerr_is: ${provider.multipletextEditingControllerList}"); + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + appBar: AppBar( + title: Text( + widget.saveInteraction.id, + style: TextStyle( + fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + // backgroundColor: const Color(0xFF2b9af3), + automaticallyImplyLeading: false, + actions: [saveActions(provider)], + leading: InkWell( + onTap: () async { + await provider.disposeValues().then((value) { + Navigator.pop(context); + }); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + mainAxisSize: MainAxisSize.min, + children: [ + Expanded( + // child: ListView.builder( + // itemCount: provider.interactionReponseList.length, + // padding: EdgeInsets.zero, + // cacheExtent: double.parse( + // provider.interactionReponseList.length.toString()), + // itemBuilder: (context, index) { + // var item = provider.interactionReponseList[index]; + // sectionList = item.sectionList; + child: FlutterCarousel( + options: CarouselOptions( + onPageChanged: (index, reason) { + setState(() { + _currentPage = index; + }); + // Example: Perform actions when reaching the last page + // if (_currentPage == _totalPages - 1) { + // print('Reached the last page!'); + // // Add your actions here + // } + }, + controller: _controller, + + height: MediaQuery.of(context) + .size + .height, // Adjust as needed + // aspectRatio: 16 / 9, // Optional aspect ratio adjustment + //viewportFraction: 0.9, + viewportFraction: 1.0, + + initialPage: 0, + enableInfiniteScroll: false, + reverse: false, + autoPlay: false, + autoPlayInterval: Duration(seconds: 3), + autoPlayAnimationDuration: + Duration(milliseconds: 800), + autoPlayCurve: Curves.fastOutSlowIn, + enlargeCenterPage: false, + disableCenter: false, + showIndicator: true, + scrollDirection: Axis.horizontal, + + slideIndicator: CircularWaveSlideIndicator( + slideIndicatorOptions: SlideIndicatorOptions( + alignment: Alignment.bottomCenter, + currentIndicatorColor: Constants.k2color, + indicatorBackgroundColor: Colors.grey), + ), + ), + items: provider.interactionReponseList.map((item) { + sectionList = item.sectionList; + print("Item_sectionListt11: ${item.sectionName}"); + + print("Item_sectionListt: ${item.sectionList}"); + return ListView( + children: [ + Padding( + padding: const EdgeInsets.all(10.0), + child: Text( + item.sectionName, + textAlign: TextAlign.center, + style: const TextStyle( + color: Colors.black, + fontWeight: FontWeight.normal, + fontSize: 18.0), + ), + ), + Container( + color: Colors.white, + child: Padding( + padding: const EdgeInsets.only(top: 0.0), + child: Column( + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + GridView.count( + physics: + const NeverScrollableScrollPhysics(), + // crossAxisCount: + // context.responsive( + // 1, + // sm: 1, // small + // md: 1, // medium + // lg: sectionList.length == 1 + // ? 1 + // : 4, // large + // xl: 3, // extra large screen + // ), + crossAxisCount: context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || !isTablet + ? 1 + : 3.5, + shrinkWrap: true, + padding: EdgeInsets.zero, + + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.5, + children: List.generate( + sectionList.length, + (i) { + // print(sectionList); + SectionList sectionItem = + sectionList[i]; + dropdownvalue = sectionItem + .widget == + InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem.widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget + .MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = sectionItem + .widget == + InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + + return Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem.input == + 'add' + ? const SizedBox.shrink() + : Padding( + padding: + const EdgeInsets + .only( + left: 8.0, + right: 8.0), + // child: Text( + // '${sectionItem.name}:*', + // style: TextStyle( + // color: Colors + // .orange + // .shade800, + // fontSize: + // isTablet + // ? 18 + // : 12, + // ), + // ), + child: Text( + sectionItem.isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: TextStyle( + color: Colors.orange + .shade800, + fontSize: 18.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + ), + ), + // SizedBox( + // height: + // isTablet ? 15 : 5, + // ), + returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: 0, + widgetData: + sectionItem.widget!, + multiple: false), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + ], + ); + }, + ), + ), + // SizedBox( + // height: isTablet ? 15 : 5, + // ), + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + 0) + : const SizedBox.shrink(), + provider.interactionReponseList.length == + 0 - 1 + ? saveActions(provider) + : const SizedBox.shrink() + //const Spacer(), + ], + ), + ), + ), + ], + ); + }).toList(), + ), + ), + // const Spacer(), + // saveActions(provider), + + Padding( + padding: const EdgeInsets.only(bottom: 8.0), + child: Align( + alignment: Alignment.bottomCenter, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Flexible( + child: OutlinedButton( + style: OutlinedButton.styleFrom( + shape: CircleBorder()), + onPressed: () { + //if (_currentPageIndex > _totalPages - 1) + _controller.previousPage(); + }, + child: Padding( + padding: EdgeInsets.all(8.0), + child: Icon( + Icons.arrow_back, + color: Constants.k2color, + ), + ), + ), + ), + Flexible( + child: OutlinedButton( + style: OutlinedButton.styleFrom( + shape: CircleBorder()), + // onPressed: () { + // _controller.nextPage( + // duration: Duration(milliseconds: 300), + // curve: Curves.ease, + // ); + // }, + onPressed: () { + _controller.nextPage( + duration: Duration(milliseconds: 300), + curve: Curves.ease, + ); + }, + child: Padding( + padding: EdgeInsets.all(8.0), + child: Icon( + Icons.arrow_forward, + color: Constants.k2color, + ), + ), + ), + ), + ], + ), + ), + ), + ], + )), + ); + }), + ); + }); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required ViewInteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + required bool multiple, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? customMultiselectDropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildCheckbox(sectionItem, item.sectionName, provider, multiple); + + case InteractionWidget.AUTOCOMPLETE: + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + + case InteractionWidget.MULTISELECT: + return customMultiselectDropdown(sectionItem, provider, list, multiple); + + case InteractionWidget.RADIO: + print("Radiiooooo"); + return (sectionItem.inputList!.length >= 5) + ? customdropdown( + sectionItem, provider, sectionItem.inputList!, multiple) + : buildRadio(sectionItem, provider); + + case InteractionWidget.LABEL: + return Text(sectionItem.input!); + + case InteractionWidget.RANGESLIDER: + return CustomRangeSlider( + sliderPos: sectionItem.selectedValue!.isNotEmpty + ? double.parse(sectionItem.selectedValue!.last.toString()) + : 10.0, + onChanged: (val) { + setState(() { + sectionItem.selectedValue = []; + sectionItem.selectedId = val.toString(); + sectionItem.selectedValue!.add(val.toInt()); + }); + }, + ); + + case InteractionWidget.BUTTON: + return sectionItem.input == 'add' + ? const Offstage( + offstage: true, + child: Text("Visible"), + ) + : Row( + children: [ + CustomButton( + backgroundColor: const Color.fromARGB(255, 233, 229, 229), + onPressed: () async { + if (sectionItem.selectedValue!.isNotEmpty) { + showFilesAlertDialog(context, + sectionItem.fileName!.join(','), sectionItem); + } else { + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + } + + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem.selectedValue!.isNotEmpty + ? 'File Uploaded' + : 'No file uploaded', + style: TextStyle( + color: sectionItem.selectedValue!.isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ); + + case InteractionWidget.TEXT: + return sectionItem.input == 'Date' + ? buildDateWidget(sectionItem) + : sectionItem.input == "textArea" + ? Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: InteractionTextField( + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + labelText: sectionItem.name, + // maxlines: 4, + // minlines: 3, + onChanged: (val) { + sectionItem.selectedValue = []; + setState(() {}); + + sectionItem.selectedValue!.add(val); + }, + ), + ), + ) + : Expanded( + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + height: isTablet ? 50 : 40, + child: InteractionTextField( + maxchars: int.parse(sectionItem.chars ?? "0"), + controller: sectionItem.controller!, + inputType: sectionItem.input == "number" + ? TextInputType.number + : TextInputType.name, + labelText: sectionItem.name, + onChanged: (val) { + sectionItem.selectedValue = []; + provider.setTextValue(val, sectionItem, multiple); + }, + ), + ), + ), + ); + case InteractionWidget.DROPDOWN: + // return customdropdown(sectionItem, provider, list, multiple); + + return customAutoCompletedropdown( + sectionItem, provider, list, multiple); + } + } + + Widget buildDateWidget(SectionList sectionItem) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + // height: isTablet ? 50 : 40, + child: TextField( + controller: + sectionItem.controller, //editing controller of this TextField + decoration: InputDecoration( + // border: OutlineInputBorder(), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + labelStyle: const TextStyle(fontSize: 16), + suffixIcon: const Icon(Icons.calendar_today), //icon of text field + labelText: "Enter Date" //label text of field + ), + readOnly: true, //set it true, so that user will not able to edit text + onTap: () async { + DateTime? pickedDate = await showDatePicker( + context: context, + initialDate: DateTime.now(), + firstDate: DateTime( + 2000), //DateTime.now() - not to allow to choose before today. + lastDate: DateTime(2101)); + + if (pickedDate != null) { + print( + pickedDate); //pickedDate output format => 2021-03-10 00:00:00.000 + String formattedDate = + DateFormat('yyyy-MM-dd').format(pickedDate); + print( + formattedDate); //formatted date output using intl package => 2021-03-16 + //you can implement different kind of Date Format here according to your requirement + + setState(() { + sectionItem.controller!.text = formattedDate; + sectionItem.selectedValue = []; + sectionItem.selectedValue! + .add(formattedDate); //set output date to TextField value. + }); + } else { + print("Date is not selected"); + } + }, + ), + ), + ); + } + + Widget saveActions(ViewInteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + Padding( + //padding: const EdgeInsets.all(4.0), + padding: const EdgeInsets.only(top: 8.0, bottom: 8.0, right: 5.0), + child: CustomButton( + backgroundColor: Colors.green.shade500, + onPressed: () async { + // if (textFieldsValidation(provider).isEmpty) { + await provider.saveJsonObject(context, + widget.saveInteraction.intId, widget.saveInteraction); + + // showAlertDialog(context, widget.saveInteraction.id); + + print("Validation_isss: ${provider.isLoading}"); + + if (provider.isLoading == false) { + print("Validation_false"); + showAlertDialog1(context, "Please fill all the fields"); + } else { + showAlertDialog(context, widget.saveInteraction.id); + print("Validation_True"); + } + // } else { + // _displaySnackBar(textFieldsValidation(provider)); + // } + }, + textColor: Colors.white, + title: "Update", + // height: 40, + // width: isTablet ? 120 : 80, + height: MediaQuery.of(context).size.height * 0.2, + + fontsize: isTablet ? 16 : 12, + ), + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget buildRadio(SectionList sectionItem, ViewInteractionProvider provider) { + List list = provider.getData2(sectionItem); + // .map((itemWord) => InputClass.fromJson(itemWord)) + // .toList(); + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 250 : MediaQuery.of(context).size.width, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (InputClass value in list) + Row( + children: [ + Radio( + value: value.name, + activeColor: Colors.black, + groupValue: provider.radioValue, + onChanged: (String? value) { + setState(() { + // print(value); + provider.radioValue = value!; + int index = + list.indexWhere((element) => element.name == value); + sectionItem.selectedValue!.add(list[index].id); + }); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget buildCheckbox(SectionList sectionItem, String sectionName, + ViewInteractionProvider provider, bool multiple) { + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: 250, + width: MediaQuery.of(context).size.width, + + child: Row( + children: [ + for (var value in provider.checkboxlist) + Row( + children: [ + CheckboxListTile( + dense: true, + value: value.ischecked ?? false, + activeColor: Colors.black, + checkColor: Colors.white, + onChanged: (bool? newvalue) { + value.ischecked = newvalue!; + provider.setcheckBoxValue(sectionItem, sectionName, + newvalue, value.id, multiple); + //setState(() {}); + }, + ), + Text(value.name), + ], + ), + ], + ), + ), + ); + } + + Widget customdropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + // sectionItem.value = ''; + // print("%%%%${sectionItem.selectedValue!.last}"); + print("ItemList_is: $list"); + if (list.isEmpty) { + print("###list empty###"); + list = []; + InputClass inputClass = + InputClass(id: "no value", name: "Select ${sectionItem.name}"); + list.add(inputClass); + sectionItem.selectedObject = list[0]; + } + // InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + isDense: true, + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + hint: Text( + 'Select ${sectionItem.name}', + style: const TextStyle(fontSize: 14), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedValue!.isNotEmpty + ? list[list.indexWhere( + (element) => element.id == sectionItem.selectedValue!.last, + )] + : list[0], + // // provider.getDropDownValue(sectionItem.value!, sectionItem, list) + // sectionItem.value ?? list[0].name, + validator: (value) { + if (value == null) { + return 'Please select ${sectionItem.name}'; + } + return null; + }, + onChanged: (value) { + //Do something when selected item is changed. + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple, value); + print("selected ${sectionItem.value}"); + // setState(() {}); + }, + onSaved: (value) { + sectionItem.selectedObject = value!; + sectionItem.value = value.id; + provider.setDropDownValue(value.id, sectionItem, multiple, value); + // setState(() {}); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(right: 8), + ), + iconStyleData: const IconStyleData( + icon: Icon( + Icons.arrow_drop_down, + color: Colors.black45, + ), + iconSize: 24, + ), + dropdownStyleData: DropdownStyleData( + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(15), + ), + ), + menuItemStyleData: const MenuItemStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + ), + ), + ), + ); + } + + Widget customAutoCompletedropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + // sectionItem.value = list[0].name; + if (list.isEmpty) { + list = sectionItem.inputList!; + } + //InputClass selectedObj = list[0]; + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Item', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list + .map((item) => DropdownMenuItem( + value: item, + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + )) + .toList(), + value: sectionItem.selectedObject, + onSaved: (value) { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onChanged: (value) { + // setState(() { + sectionItem.selectedObject = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + // setState(() {}); + //}); + }, + + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 40, + width: 200, + ), + dropdownStyleData: const DropdownStyleData( + maxHeight: 200, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + padding: const EdgeInsets.only( + top: 8, + bottom: 4, + right: 8, + left: 8, + ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + return item.value!.name.toString().contains(searchValue); + }, + ), + //This to clear the search value when you close the menu + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + ), + ), + ), + ); + } + + Widget customMultiselectDropdown(SectionList sectionItem, + ViewInteractionProvider provider, List list, bool multiple) { + if (list.isEmpty) { + list = sectionItem.inputList!; + } + InputClass selectedObj = list[0]; + + return Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: SizedBox( + // width: isTablet ? 200 : MediaQuery.of(context).size.width, + // height: isTablet ? 60 : 40, + width: MediaQuery.of(context).size.width, + + child: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + isExpanded: true, + decoration: InputDecoration( + isDense: true, + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + contentPadding: const EdgeInsets.symmetric(vertical: 5), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10), + ), + // Add more decoration.. + ), + hint: Text( + 'Select Items', + style: TextStyle( + fontSize: 14, + color: Theme.of(context).hintColor, + ), + ), + items: list.map((item) { + return DropdownMenuItem( + value: item, + //disable default onTap to avoid closing menu when selecting an item + enabled: false, + child: StatefulBuilder( + builder: (context, menuSetState) { + final isSelected = + sectionItem.selectedValue!.contains(item.name); + return InkWell( + onTap: () { + isSelected + ? sectionItem.selectedValue!.remove(item.name) + : sectionItem.selectedValue!.add(item.name); + //This rebuilds the StatefulWidget to update the button's text + setState(() {}); + //This rebuilds the dropdownMenu Widget to update the check mark + menuSetState(() {}); + }, + child: Container( + height: double.infinity, + padding: const EdgeInsets.symmetric(horizontal: 16.0), + child: Row( + children: [ + if (isSelected) + const Icon(Icons.check_box_outlined) + else + const Icon(Icons.check_box_outline_blank), + const SizedBox(width: 16), + Expanded( + child: Text( + item.name, + style: const TextStyle( + fontSize: 14, + ), + ), + ), + ], + ), + ), + ); + }, + ), + ); + }).toList(), + //Use last selected item as the current value so if we've limited menu height, it scroll to last item. + value: selectedObj, + // ? null + // : provider.selectedItems.last, + onChanged: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + onSaved: (value) { + selectedObj = value!; + provider.setAutoCompleteValue(value.id, sectionItem, multiple); + sectionItem.value = value.name; + }, + selectedItemBuilder: (context) { + return list.map( + (item) { + return Container( + alignment: AlignmentDirectional.center, + child: Text( + sectionItem.selectedValue!.join(', '), + style: const TextStyle( + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + maxLines: 1, + ), + ); + }, + ).toList(); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.only(left: 16, right: 8), + height: 40, + width: 140, + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + padding: EdgeInsets.zero, + ), + ), + ), + ), + ); + } + + Widget gridViewWidget( + ViewInteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + print("SectionListtt:isss: $sectionList"); + + List pooja = sectionList; + + print("Pooja: $pooja"); + + List> convertedArray = []; + print("Provider Length: ${item.sectionList.length}"); + + for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { + print("Section List11111: $sectionList"); + print("item.sectionList.length List11111: ${item.sectionList.length}"); + + convertedArray + .add(sectionList.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArrayEditMulti.leangth: $convertedArray"); + print("ConvertedArray.leangth: ${convertedArray.length}"); + return Column( + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: Wrap( + children: [ + //GestureDetector(child: Text("data")), + GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : (sectionList.length >= 1 ? 3 : 3), // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || !isTablet ? 1 : 2, + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 3.0, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = + sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = + sectionItem.widget == InteractionWidget.DROPDOWN || + sectionItem.widget == + InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == + InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + + return SizedBox( + height: MediaQuery.of(context).size.height, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + sectionItem.widget == InteractionWidget.BUTTON && + sectionItem.param == 'add' || + sectionItem.param == 'deletebtn' + ? const SizedBox.shrink() + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: Text( + sectionItem.isRequired + ? '${sectionItem.name}:*' + : '${sectionItem.name}:', + style: TextStyle( + color: Colors.orange.shade800, + fontSize: 18.0, + // fontSize: isTablet + // ? 18 + // : 12, + ), + )), + const SizedBox( + height: 15, + ), + sectionItem.widget == InteractionWidget.BUTTON + ? sectionItem.input == 'chooseFile' + ? Row( + children: [ + CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 229, 229), + onPressed: () async { + if (sectionItem.selectedValue! + .isNotEmpty) { + showFilesAlertDialog( + context, + sectionItem.fileName! + .join(','), + sectionItem); + } else { + sectionItem.selectedValue = + []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile( + sectionItem); + } + setState(() {}); + }, + width: 120, + height: 40, + fontsize: 12, + textColor: Colors.black, + title: sectionItem.name), + const SizedBox( + width: 5, + ), + Text( + sectionItem + .selectedValue!.isNotEmpty + ? 'File uploaded' + : 'No file uploaded', + style: TextStyle( + color: sectionItem + .selectedValue! + .isNotEmpty + ? Colors.green + : Colors.red), + ), + ], + ) + : isTablet + ? IconButton( + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + icon: const Icon( + Icons.cancel, + size: 30, + color: Color.fromARGB( + 255, 8, 39, 92), + ), + ) + : Padding( + padding: const EdgeInsets.only( + left: 8.0, right: 8.0), + child: CustomButton( + backgroundColor: + const Color.fromARGB( + 255, 233, 75, 75), + onPressed: () { + provider.deleteMultipleRows( + sectionItem.gid!, + sectionList[i], + sectionName); + + setState(() {}); + }, + // width: 80, + // height: 30, + height: 40, + fontsize: 12, + textColor: Colors.white, + title: "Delete"), + ) + : returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!, + multiple: true), + ], + ), + ); + }), + ], + ), + ), + ], + ); + } + + String textFieldsValidation(ViewInteractionProvider provider) { + if (provider.sectionList + .any((element) => element.controller!.text.isEmpty)) { + return 'Fields cannot be empty'; + } + if (provider.textEditingControllerList.isNotEmpty) { + if (provider.validateTextFields()) { + return 'Fields cannot be empty'; + } + } + if (provider.multipletextEditingControllerList.isNotEmpty) { + if (provider.validateMultipleRows()) { + return 'Fields cannot be empty'; + } + } + + return ''; + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } + + Future getEncodedFile(SectionList sectionItem) async { + String base64Image = ''; + var status = Platform.isAndroid + ? await Permission.manageExternalStorage.status + : await Permission.storage.status; + if (status.isGranted) { + FilePickerResult? result = + await FilePicker.platform.pickFiles(allowMultiple: true); + + if (result != null) { + print(result.files.first.path); + print(result.files.last.path); + for (var files in result.files) { + File file = File(files.path!); + print("check file path : ${file.path}"); + fileName = file.path.split('/').last; + // Get the application folder directory + Directory? directory = Platform.isAndroid + ? await getExternalStorageDirectory() //FOR ANDROID + : await getApplicationDocumentsDirectory(); + String newPath = ""; //FOR ios + String convertedDirectoryPath = (directory?.path).toString(); + + print("see the converted directory path $convertedDirectoryPath"); + + newPath = "$convertedDirectoryPath/konectar/files"; + print("new path :$newPath"); + directory = Directory(newPath); + if (!await directory.exists()) { + await directory.create(recursive: true); + } + File newFile = await file.copy('${directory.path}/$fileName'); + print("new path is ${newFile.path}"); + final extension = p.extension(newFile.path); + List imageBytes = await newFile.readAsBytes(); + Uint8List imageUint8List = Uint8List.fromList(imageBytes); + base64Image = base64Encode(imageUint8List); + sectionItem.selectedValue!.add(base64Image); + sectionItem.extension!.add(extension); + sectionItem.fileName!.add(fileName); + } + } + } else { + print("not permitted"); + await requestPermission(Platform.isAndroid + ? Permission.manageExternalStorage + : Permission.storage); + } + } + + Future requestPermission(Permission permission) async { + final status = await permission.request(); + + setState(() { + print(status); + }); + } + + showAlertDialog(BuildContext context, String record) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text("Form $record Updated Successfully!"), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showAlertDialog1(BuildContext context, String record) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Ok"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text(record), + actions: [ + cancelButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + showFilesAlertDialog( + BuildContext context, String files, SectionList sectionItem) { + // set up the buttons + // ViewInteractionProvider provider = + // Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("Upload"), + onPressed: () async { + Navigator.of(context).pop(); + sectionItem.selectedValue = []; + sectionItem.extension = []; + sectionItem.fileName = []; + await getEncodedFile(sectionItem); + }, + ); + Widget okButton = TextButton( + child: const Text("Cancel"), + onPressed: () async { + Navigator.of(context).pop(); + }, + ); + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text( + "Following File(s) $files uploaded .Do you still want to upload files ?", + style: const TextStyle(fontSize: 15), + ), + actions: [cancelButton, okButton], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/new_new_profile.dart b/lib/contacts_module/ui_screen/new_new_profile.dart new file mode 100644 index 0000000..aeaa4ef --- /dev/null +++ b/lib/contacts_module/ui_screen/new_new_profile.dart @@ -0,0 +1,858 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/ui_screen/engagementtab.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/k2api_integrated_ui/activityk2_tab.dart'; +// import 'package:konectar_events/ui_screen/k2api_integrated_ui/locationk2_tab.dart'; +// import 'package:konectar_events/ui_screen/newformlist.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/ui_screen/engagementtab.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/k2api_integrated_ui/activityk2_tab.dart'; +import 'package:konectar_events/contacts_module/ui_screen/k2api_integrated_ui/locationk2_tab.dart'; +import 'package:konectar_events/contacts_module/ui_screen/newformlist.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +import 'package:cached_network_image/cached_network_image.dart'; +import 'package:url_launcher/url_launcher.dart'; + +class NewProfile1 extends StatefulWidget { + const NewProfile1({Key? key, required this.text}) : super(key: key); + final Map text; + + @override + State createState() => _NewProfileState(); +} + +class _NewProfileState extends State + with TickerProviderStateMixin { + List viewformData = []; + + bool _isExpanded = false; + + var item; + + TextEditingController firstNameController = TextEditingController(); + + final ScrollController _scrollController = ScrollController(); + late final TabController _tabController; + + @override + void initState() { + super.initState(); + print("pooja123"); + + //init(); + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + _tabController = TabController(length: 3, vsync: this); + }); + } + + @override + void dispose() { + _tabController.dispose(); + super.dispose(); + } + + @override + Widget build(BuildContext context) { + return DefaultTabController( + length: 3, + child: SafeArea( + child: headerview(context), + ), + ); + // }); + } + + Widget headerview(BuildContext context) { + return SafeArea( + child: Scaffold( + backgroundColor: Constants.bgcolor, + body: Stack( + children: [ + Container( + // color: Colors.blue, + child: Column( + children: [ + getAppBarUI(), + Expanded( + child: NestedScrollView( + controller: _scrollController, + headerSliverBuilder: + (BuildContext context, bool innerBoxIsScrolled) { + return [ + SliverList( + delegate: SliverChildBuilderDelegate( + (BuildContext context, int index) { + return Column( + children: [ + buildCardView( + context, + ) + ], + ); + }, childCount: 1), + ), + SliverPersistentHeader( + pinned: true, + floating: true, + delegate: ContestTabHeader( + Container( + //color: Constants.bgcolor2, + decoration: BoxDecoration( + gradient: LinearGradient( + begin: Alignment.bottomCenter, + end: Alignment.topCenter, + colors: [ + Constants.tabbgColor, + Constants.k2color, + ]), + ), + child: TabBar( + indicatorColor: Colors.white, + labelColor: Colors + .white, // Color of the selected tab text + + unselectedLabelColor: Colors.black, + // unselectedLabelColor: + // Color.fromARGB(255, 163, 159, 159), + tabs: [ + // Tab(text: "Sentiment"), + Tab( + child: Text1( + title: "Details", + txtfont: 15.0, + ), + ), + Tab( + child: Text1( + title: "Activities", + txtfont: 15.0, + ), + ), + Tab( + child: Text1( + title: "Engagements", + txtfont: 15.0, + ), + ), + ], + ), + ), + ), + ) + ]; + }, + body: TabBarView( + //controller: _tabController, + children: [ + // LocationTab(text: widget.text["id"]), + + LocationK2Tab(text: widget.text["id"]), + + // Activities(text: widget.text["id"]), + ActivitiesK2(text: widget.text["id"]), + + EngagementTab(text: widget.text["id"]), + ], + ), + ), + ) + ], + ), + ), + ], + ), + floatingActionButton: Visibility( + visible: true, + child: FloatingActionButton( + onPressed: () async { + Navigator.push( + context, MaterialPageRoute(builder: (context) => FormList())); + }, + foregroundColor: Colors.white, + backgroundColor: const Color.fromARGB(255, 0, 71, 132), + child: new Icon(Icons.add), + ), + ), + ), + ); + } + + buildCardView(BuildContext context) { + MediaQuery.of(context).size.height * 0.35; + + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + children: [ + Stack( + clipBehavior: Clip.none, + alignment: Alignment.center, + children: [ + Container( + width: + MediaQuery.of(context).size.width, // Adjust width as needed + height: 110, // Adjust height as needed + decoration: BoxDecoration(color: Constants.k2color), + child: Column( + mainAxisAlignment: MainAxisAlignment.start, + children: [ + Text1( + title: widget.text!["name"], + txtcolor: Colors.white, + fontweight: FontWeight.normal, + txtfont: 20.0), + Text1( + title: widget.text!["speciality"], + txtcolor: Colors.white, + fontweight: FontWeight.normal, + txtfont: 14.0), + ], + ), + ), + Positioned( + bottom: -45, + child: Container( + child: widget.text["img_path"] == "" + ? ProfilePicture( + name: widget.text!["name"], + radius: 48, + fontsize: 21, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(48), + child: CachedNetworkImage( + imageUrl: widget.text!["img_path"], + imageBuilder: (context, imageProvider) => Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + ), + ), + ), + ), + ) + ], + ), + SizedBox( + height: 55.0, + ), + + _ProfileInfoRow(text: widget.text["id"]), + + locandpnoinfo(), + + const SizedBox( + height: 5.0, + ), + + Align( + alignment: Alignment.centerLeft, + child: Padding( + padding: const EdgeInsets.only(left: 8.0), + child: Text1( + title: "Profile Summary", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 18.0), + ), + ), + const SizedBox( + height: 5.0, + ), + Align( + alignment: Alignment.centerLeft, + child: Padding( + padding: const EdgeInsets.only(left: 15.0), + child: Text1( + title: widget.text!["summarry"], + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0), + ), + ), + + SizedBox( + height: 10.0, + ), + + ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Notes", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(0)", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: TextField( + decoration: InputDecoration( + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(8.0), + ), + hintText: 'Write your note here', + contentPadding: EdgeInsets.all(16.0), + ), + maxLines: + null, // Allows the TextField to expand vertically + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (_) => PublicationsData())); + }, + child: Text( + 'Save', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ]), + ), + ), + ), // adds spacing between the text and image + + SizedBox( + height: 10.0, + ), + ], + // ), + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data['org_name'], + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 18.0, + color: Colors.grey[700]), + ), + ), + ), + ], + ), + const SizedBox( + height: 18.0, + ), + Divider(), + const SizedBox( + height: 8.0, + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + const Padding( + padding: EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + const Padding( + padding: + EdgeInsets.only(left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame".toString(), + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + const Padding( + padding: + EdgeInsets.only(left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + const Padding( + padding: + EdgeInsets.only(left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } + + Widget getAppBarUI() { + return Container( + decoration: BoxDecoration( + color: Constants.k2color, + boxShadow: [ + BoxShadow( + color: Colors.grey.withOpacity(0.2), + offset: const Offset(0, 2), + blurRadius: 8.0), + ], + ), + child: Padding( + padding: EdgeInsets.only(top: 2, left: 8, right: 8), + child: Row( + children: [ + Container( + alignment: Alignment.topLeft, + // width: AppBar().preferredSize.height, + // height: AppBar().preferredSize.height, + child: Material( + color: Colors.transparent, + child: InkWell( + borderRadius: const BorderRadius.all( + Radius.circular(32.0), + ), + onTap: () { + Navigator.pop(context); + }, + child: const Padding( + padding: EdgeInsets.all(8.0), + child: Row( + children: [ + Icon( + Icons.arrow_back_ios_new, + size: 18, + color: Colors.white, + ), + SizedBox( + width: 8, + ), + Text( + "Contacts", + style: TextStyle(fontSize: 14.0, color: Colors.white), + ) + ], + ), + ), + ), + ), + ), + const Expanded( + child: Text( + "", + maxLines: 1, + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600, + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + ), + ), + ], + ), + ), + ); + } + + locandpnoinfo() { + return Column( + children: [ + const SizedBox( + height: 8.0, + ), + _buildClickableRow( + icon: Icons.location_city_sharp, + text: widget.text["addr"] ?? "Azienda Ospedaliera di Padova", + ), + const SizedBox( + height: 8.0, + ), + _buildClickableRow( + icon: Icons.location_pin, + text: widget.text?["Country"] ?? + "Via Giustiniani, 2, Padova, Veneto 35128, Italy", + onTap: _openMapsByAddress, + ), + const SizedBox( + height: 8.0, + ), + _buildClickableRow( + icon: Icons.email, + text: widget.text?["email"], + onTap: () async { + await emailSend(widget.text?["email"]); + }, + ), + SizedBox( + height: 8.0, + ), + _buildClickableRow( + icon: Icons.phone, + text: widget.text!["phone_no"].toString(), + onTap: () async { + await callinfo(widget.text?["phone_no"].toString()); + }, + ), + ], + ); + } + + Future _openMapsByAddress() async { + final address = 'Italy'; + final Uri mapsUri = Uri( + scheme: 'https', + host: 'www.google.com', + path: 'maps/search/', + query: address, + ); + + if (!await launchUrl(mapsUri)) { + throw 'Could not launch $mapsUri'; + } + } + + Future emailSend(email) async { + String? encodeQueryParameters(Map params) { + return params.entries + .map((MapEntry entry) => + Uri.encodeComponent(entry.key) + + '=' + + Uri.encodeComponent(entry.value)) + .join('&'); + } + + final Uri emailLaunchUri = Uri( + scheme: 'mailto', + path: email, + query: encodeQueryParameters({ + 'subject': 'Example Subject', + 'body': 'Hello, this is a sample body text.', + }), + ); + + if (await launchUrl(emailLaunchUri)) { + launchUrl(emailLaunchUri); + } else { + throw 'Could not launch $emailLaunchUri'; + } + } + + Future callinfo(pno) async { + final call = Uri.parse('tel:$pno'); + if (await canLaunchUrl(call)) { + launchUrl(call); + } else { + throw 'Could not launch $call'; + } + } +} + +dispalytext(dispalydata) { + return Text1( + title: dispalydata, + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0); +} + +getIcon(IconData icons) { + return Icon( + icons, + color: Color.fromARGB(255, 0, 71, 132), + ); +} + +Widget _buildClickableRow({ + required IconData icon, + required String text, + VoidCallback? onTap, +}) { + return Padding( + padding: const EdgeInsets.only(left: 8.0), + child: InkWell( + onTap: onTap, + child: Row( + children: [ + getIcon(icon), + const SizedBox(width: 3.0), + Expanded(child: dispalytext(text)), + ], + ), + ), + ); +} + +class _ProfileInfoRow extends StatelessWidget { +// _ProfileInfoRow({Key? key}) : super(key: key); + final int text; + + _ProfileInfoRow({required this.text, Key? key}) : super(key: key); + + final List _items = const [ + ProfileInfoItem("Publication(s)", 688), + ProfileInfoItem("Event(s)", 111), + ProfileInfoItem("Trial(s)", 10), + ]; + + @override + Widget build(BuildContext context) { + return Container( + height: 80, + constraints: const BoxConstraints(maxWidth: 400), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: _items + .map((item) => Expanded( + child: Row( + children: [ + if (_items.indexOf(item) != 0) const VerticalDivider(), + Expanded(child: _singleItem(context, item)), + ], + ))) + .toList(), + ), + ); + } + + Widget _singleItem(BuildContext context, item) => Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text( + item.value.toString(), + style: const TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14, + ), + ), + ), + Text( + item.title, + // style: const TextStyle( + // fontWeight: FontWeight.normal, + // fontSize: 18, + // ), + // style: Theme.of(context).textTheme.caption, + ) + ], + ); +} + +class ProfileInfoItem { + final String title; + final int value; + const ProfileInfoItem(this.title, this.value); +} + +class ContestTabHeader extends SliverPersistentHeaderDelegate { + ContestTabHeader( + this.searchUI, + ); + final Widget searchUI; + + @override + Widget build( + BuildContext context, double shrinkOffset, bool overlapsContent) { + return Container(color: Colors.white, child: searchUI); + } + + @override + double get maxExtent => 52.0; + + @override + double get minExtent => 52.0; + + @override + bool shouldRebuild(SliverPersistentHeaderDelegate oldDelegate) { + return true; + } +} diff --git a/lib/contacts_module/ui_screen/new_new_profile_offline.dart b/lib/contacts_module/ui_screen/new_new_profile_offline.dart new file mode 100644 index 0000000..b70fd6f --- /dev/null +++ b/lib/contacts_module/ui_screen/new_new_profile_offline.dart @@ -0,0 +1,18999 @@ +// import 'package:discover_module/check.dart'; +// import 'package:discover_module/constants.dart'; +// import 'package:discover_module/custom_widget/text.dart'; +// import 'package:discover_module/provider_class/affiliationsprovider.dart'; +// import 'package:discover_module/provider_class/engagement_provider.dart'; +// import 'package:discover_module/provider_class/events_provider.dart'; +// import 'package:discover_module/provider_class/medicalinsightprovider.dart'; +// import 'package:discover_module/provider_class/publications_provider.dart'; +// import 'package:discover_module/provider_class/speaker_provider.dart'; +// import 'package:discover_module/provider_class/trials_provider.dart'; +// import 'package:discover_module/ui_screen/affiliation_data.dart'; +// import 'package:discover_module/ui_screen/bottom_sheet.dart'; +// import 'package:discover_module/ui_screen/engagementlist.dart'; +// import 'package:discover_module/ui_screen/events_data.dart'; +// import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; +// import 'package:discover_module/ui_screen/interactionform/configprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/edit_interaction_screen.dart'; +// import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:discover_module/ui_screen/interactionform/view_forms_list.dart'; +// import 'package:discover_module/ui_screen/interactionform/view_interaction_screen.dart'; +// import 'package:discover_module/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:discover_module/ui_screen/medical_insight.dart'; +// import 'package:discover_module/ui_screen/newformlist.dart'; +// import 'package:discover_module/ui_screen/publication_data.dart'; +// import 'package:flutter/cupertino.dart'; +// import 'package:flutter/foundation.dart'; +// import 'package:flutter/material.dart'; +// import 'package:flutter/rendering.dart'; +// import 'package:flutter/widgets.dart'; +// import 'package:flutter_carousel_widget/flutter_carousel_widget.dart'; +// import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +// import 'package:provider/provider.dart'; +// import 'package:url_launcher/url_launcher.dart'; + +// class NewProfileoff extends StatefulWidget { +// const NewProfileoff({Key? key, required this.text}) : super(key: key); +// final Map text; + +// @override +// State createState() => _NewProfileState(); +// } + +// class _NewProfileState extends State +// with TickerProviderStateMixin { +// bool isonline = false; +// List affiliation_data = []; +// List publication_data = []; +// List event_data = []; +// List trial_data = []; +// List medinsightData = []; +// List speaker = []; +// List eng = []; + +// // final PageController _controller = PageController(viewportFraction: 0.8); + +// List viewformData = []; + +// bool _isExpanded = false; + +// var item; + +// TextEditingController firstNameController = TextEditingController(); + +// // final List gradients = [ +// // LinearGradient(colors: [ +// // Colors.red, +// // Colors.orange, +// // ]), +// // LinearGradient(colors: [Colors.green, Colors.yellow]), +// // LinearGradient(colors: [Colors.blue, Colors.purple]), +// // LinearGradient(colors: [Colors.pink, Colors.redAccent]), +// // LinearGradient(colors: [Colors.teal, Colors.blueAccent]), +// // ]; + +// final List gradients = [ +// const Color.fromARGB(255, 23, 162, 184), +// const Color.fromARGB(255, 40, 167, 69), +// const Color.fromARGB(255, 255, 193, 7), +// const Color.fromARGB(255, 220, 53, 69), +// const Color.fromARGB(255, 23, 162, 184), +// ]; +// final ScrollController _scrollController = ScrollController(); +// late final TabController _tabController; + +// static const _tabs = [ +// Tab(text: "Details"), +// Tab(text: "Speakers"), +// Tab(text: "Speakers"), +// ]; +// @override +// void initState() { +// // TODO: implement initState +// super.initState(); +// print("pooja123"); +// _tabController = TabController(length: 3, vsync: this); + +// //init(); +// WidgetsBinding.instance.addPostFrameCallback((timeStamp) { +// getaffiliations(); + +// getuserdetails(); + +// // print("Widget_isssIndex_iss ${widget.text}"); +// // print( +// // "Widget_isssIndex_iss ${widget.text!["id"]},${widget.text!["name"]},${widget.text!["img_path"]}"); +// }); +// } + +// init() async { +// await Provider.of(context, listen: false) +// .initConfigData(); +// final data = +// await Provider.of(context, listen: false); + +// // if(data.g) +// data.getRecords("form-3 demo"); +// // setState(() {}); +// } + +// getaffiliations() async { +// var affiliations = +// Provider.of(context, listen: false); + +// await affiliations.getAffiliationsdata(); +// final affilist = affiliations.adddta; + +// var publication = Provider.of(context, listen: false); + +// await publication.publicatininfo(); +// final publist = publication.publicationlist; + +// var events = Provider.of(context, listen: false); +// await events.geteventdata(); +// final eventlist = events.EventsList; + +// var form = Provider.of(context, listen: false); +// // form.savedList; + +// var trials = Provider.of(context, listen: false); +// await trials.trialsdata(); + +// final trialslist = trials.trialsinfo; + +// var med = Provider.of(context, listen: false); +// await med.medicalinsightdata(); +// final medlist = med.trialsinfo; + +// var speaker11 = +// Provider.of(context, listen: false); + +// await speaker11.getspeakerdata(); + +// final speakerlist = speaker11.speaker; + +// var engtype = Provider.of(context, listen: false); +// await engtype.getengagementdata(); +// final engtypelist = engtype.engagementdata; + +// setState(() { +// affiliation_data = affilist; +// publication_data = publist; +// event_data = eventlist; +// viewformData = form.savedList; +// trial_data = trialslist; +// medinsightData = medlist; +// speaker = speakerlist; +// eng = engtypelist; +// }); + +// print("Affiliations_data_is: $affilist"); +// print("trialslist_data_is: $trialslist"); +// } + +// getuserdetails() async { +// // HiveFunctions.getindexUser(widget.text); + +// NetworkConnectivity networkConnectivity = NetworkConnectivity(); +// bool isonline1 = await networkConnectivity.isInternetAvailable(); + +// setState(() { +// print("Profile_isOnline: $isonline1"); +// isonline = isonline1; +// }); +// } + +// @override +// void dispose() { +// _tabController.dispose(); +// super.dispose(); +// } + +// @override +// Widget build(BuildContext context) { +// // return Consumer( +// // builder: (BuildContext context, provider, Widget? child) { +// return DefaultTabController( +// length: 3, +// child: SafeArea( +// child: headerview(context), +// ), +// ); +// // }); +// } + +// Widget headerview(BuildContext context) { +// return SafeArea( +// child: Scaffold( +// backgroundColor: Constants.bgcolor, +// // appBar: AppBar(), +// body: Stack( +// children: [ +// Container( +// // color: Colors.blue, +// child: Column( +// children: [ +// getAppBarUI(), +// Expanded( +// child: NestedScrollView( +// controller: _scrollController, +// headerSliverBuilder: +// (BuildContext context, bool innerBoxIsScrolled) { +// return [ +// SliverList( +// delegate: SliverChildBuilderDelegate( +// (BuildContext context, int index) { +// return Container( +// //color: Constants.blueColor, +// child: Column( +// children: [ +// buildCardView( +// context, +// ) + +// // getTimeDateUI(), +// ], +// ), +// ); +// }, childCount: 1), +// ), +// SliverPersistentHeader( +// pinned: true, +// floating: true, +// delegate: ContestTabHeader( +// Container( +// color: Constants.bgcolor2, +// child: const TabBar( +// indicatorColor: Colors.white, +// labelColor: Colors +// .white, // Color of the selected tab text + +// unselectedLabelColor: +// Color.fromARGB(255, 163, 159, 159), +// tabs: [ +// // Tab(text: "Sentiment"), +// Tab( +// // text: "Related " +// child: Text( +// 'Activities', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 17.0), +// ), +// ), +// Tab( +// // text: "Activities " +// child: Text( +// 'Details', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 17.0), +// ), +// ), +// Tab( +// //text: "Engagement " + +// child: Text( +// 'Engagement', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 17.0), +// ), +// ), + +// // Tab(icon: Icon(Icons.email)), +// ], +// ), +// ), +// // const TabBar( +// // indicatorSize: TabBarIndicatorSize.label, +// // labelColor: Colors.black, +// // unselectedLabelColor: Colors.grey, +// // tabs: _tabs, +// // ), +// ), +// ) +// ]; +// }, +// body: TabBarView( +// //controller: _tabController, +// children: [ +// ListView(children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Affiliations", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// // width: +// // MediaQuery.of(context) +// // .size +// // .width, +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Organization Name', +// style: TextStyle( +// fontWeight: +// FontWeight.w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Time Frame', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// affiliation_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${affiliation_data[index]}"); + +// bottomshet( +// affiliation_data[ +// index]); +// }, +// color: MaterialStateProperty +// .resolveWith( +// (Set +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// affiliation_data[ +// index] +// ['org_name'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// affiliation_data[ +// index] +// ['time_frame'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// AffiliationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Publications", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// //isAlwaysShown: true, +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Artical Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), + +// DataColumn( +// label: Expanded( +// child: Text('Authors', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), + +// // Add more columns as needed +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Events", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: MediaQuery.of(context) +// .size +// .width, +// ), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Event Name', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)), +// )), + +// DataColumn( +// label: Expanded( +// child: Text('Role', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), + +// // Add more columns as needed +// ], +// rows: List.generate( +// event_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${event_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// event_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// event_data[index] +// ['event_name'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// event_data[index] +// ['role'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EventsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Trials", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Trial Name', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Status', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// trial_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${trial_data[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// trial_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// trial_data[index] +// ['trial_name'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// trial_data[index] +// ['status'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EventsData())); +// }, +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image +// ]), + +// ListView(children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Locations", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: true, +// // useSafeArea: true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: +// // double.infinity, +// // ), +// // shape: +// // const RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular(0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: context, +// // builder: (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); + +// showModalBottomSheet< +// dynamic>( +// isScrollControlled: +// true, +// // context and builder are +// // required properties in this widget +// context: context, +// builder: (BuildContext +// context) { +// // we set up a container inside which +// // we create center column and display text + +// // Returning SizedBox instead of a Container +// return Container( +// width: double +// .infinity, +// child: Wrap( +// // mainAxisSize: MainAxisSize.max, +// children: [ +// Expanded( +// child: +// SingleChildScrollView( +// child: +// Column( +// //mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// // Text( +// // 'GeeksforGeeks'), +// // Text( +// // 'GeeksforGeeks'), + +// // ListView( +// // children: [ +// ...List +// .generate( +// 15, +// (index) => +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: Column( +// children: [ +// Text('Heart Failure'), +// ], +// ), +// ), +// ) +// ], +// // ) +// // ], +// ), +// ), +// ), +// ], +// ), +// ); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Phone Numbers", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('phone Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Location', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Emails", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Email Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Email', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Staff/Assistant", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Location', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), + +// ///elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "State License", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('License No', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('State', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // ], +// ]), +// // +// ListView( +// children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// // initiallyExpanded: true, +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Medical Insight", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Container( +// width: MediaQuery.of(context) +// .size +// .width, + +// /// 5, +// color: Colors.white, +// child: Consumer< +// MediacalInsightProvider>( +// builder: (BuildContext context, +// value, Widget? child) { +// print( +// "med1 : ${value.med.length}"); + +// if (value.med.length != 0) { +// return ListView.builder( +// physics: +// const ScrollPhysics(), +// // scrollDirection: Axis.vertical, +// shrinkWrap: true, +// itemCount: value.med +// .take(2) +// .length, +// itemBuilder: +// (context, index) { +// item = value.med[index]; + +// print( +// "Item_Medical_insight ${item['Therapeutic Area']}"); +// return Padding( +// padding: +// const EdgeInsets +// .all(8.0), +// child: Card( +// margin: +// EdgeInsets.zero, + +// elevation: 4, +// surfaceTintColor: +// Colors.white, +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .zero, +// ), + +// child: SizedBox( +// width: MediaQuery +// .sizeOf( +// context) +// .width, +// child: ListTile( +// dense: true, +// title: Column( +// // crossAxisAlignment: CrossAxisAlignment.center, +// children: [ +// // Text( +// // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + +// RichText( +// text: +// TextSpan( +// text: '', +// style: DefaultTextStyle.of( +// context) +// .style, +// children: const [ +// TextSpan( +// text: +// 'Acute neurology ', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// // TextSpan( +// // text: ' therapeutic area ', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.bold)), +// TextSpan( +// text: +// 'is the therapeutic area of the medical insight for '), +// TextSpan( +// text: +// 'Product A. The age of treatment', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// TextSpan( +// text: +// ' is the topic of interest for this source type'), +// TextSpan( +// text: +// ' publication.', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// ], +// ), +// ), + +// const Padding( +// padding: +// EdgeInsets.all( +// 8.0), +// child: Row( +// mainAxisAlignment: +// MainAxisAlignment +// .spaceBetween, +// children: [ +// Row( +// children: [ +// Icon( +// Icons.person, +// size: 20, +// ), +// Text( +// "pooja", +// style: TextStyle(fontSize: 14.0), +// ) +// ], +// ), +// Row( +// children: [ +// Icon( +// Icons.calendar_today, +// size: 20, +// ), +// Text( +// "11/11/2022 ", +// style: TextStyle(fontSize: 14.0), +// ) +// ], +// ) +// ], +// ), +// ), +// ], +// ), +// ), +// ), +// // shape: BorderRadius.only(bottomRight: Radius.circular(50)), +// ), +// ); +// }); +// } else { +// return Container( +// color: Colors.white, +// width: MediaQuery.of(context) +// .size +// .width, +// child: Column( +// children: [ +// Text("No records"), +// ], +// ), +// ); +// } +// }), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// const MedicalInsight1())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// //mainAxisSize: MainAxisSize.min, +// children: [ +// GestureDetector( +// onTap: () async { +// final provider = Provider.of< +// InteractionProvider>( +// context, +// listen: false); +// if (getCount( +// provider +// .intConfigDataList[ +// 0] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[ +// 0] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// 0] +// .name, +// ))); +// } +// }, +// child: Text1( +// title: "Interactions", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ), +// const SizedBox( +// width: 8.0, +// ), +// ], +// ), +// children: [ +// Container( +// height: MediaQuery.of(context) +// .size +// .height / +// 5, +// color: Colors.white, +// child: Consumer< +// ViewInteractionProvider>( +// builder: (BuildContext context, +// provider, Widget? child) { +// print( +// "P_leangth : ${provider.savedList.length}"); + +// if (provider.savedList.length != +// 0) { +// return ListView.builder( +// shrinkWrap: true, +// physics: +// NeverScrollableScrollPhysics(), +// itemCount: provider +// .savedList +// .take(2) +// .length, +// itemBuilder: +// (context, index) { +// print( +// "Indexxxxxx $index"); +// return Column( +// children: [ +// ListTile( +// subtitle: Text( +// 'Updated on ${provider.savedList[index].updatedTime}', +// //style: TextStyle(fontStyle: FontStyle.italic), +// ), +// title: Text( +// provider +// .savedList[ +// index] +// .id, +// ), +// trailing: SizedBox( +// width: 150, +// child: Row( +// children: [ +// IconButton( +// onPressed: +// () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext context) => ViewInteractionScreen( +// saveInteraction: provider.savedList[index], +// ))); +// }, +// icon: +// const Icon( +// Icons +// .info_outline, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// IconButton( +// onPressed: +// () async { +// await provider +// .initConfigData() +// .then({ +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext context) => EditInteractionScreen( +// saveInteraction: provider.savedList[index], +// ))) +// }); +// }, +// icon: +// const Icon( +// Icons +// .edit, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// IconButton( +// onPressed: +// () { +// showDeleteRecordAlertDialog( +// context, +// provider.savedList[index].id, +// provider.savedList[index]); +// }, +// icon: +// const Icon( +// Icons +// .delete, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// ]), +// ), +// onTap: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// ViewInteractionScreen( +// saveInteraction: +// provider.savedList[index], +// ))); +// }, +// ), +// const Divider(), +// ], +// ); +// }); +// } else { +// return Container( +// color: Colors.white, +// width: MediaQuery.of(context) +// .size +// .width, +// child: Column( +// children: [ +// Text("No records"), +// ], +// ), +// ); +// } +// }), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// final provider = Provider +// .of( +// context, +// listen: false); +// if (getCount( +// provider +// .intConfigDataList[ +// 0] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[ +// 0] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// 0] +// .name, +// ))); +// } +// }, +// child: Text('Show More'), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Speaker Evalution", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Program Topic', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Speaker Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// speaker.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${speaker[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// speaker[index]); +// }, +// ); +// }, +// color: MaterialStateProperty +// .resolveWith< +// Color?>((Set< +// MaterialState> +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// speaker[index][ +// 'programtopic'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// speaker[index][ +// 'speakername'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // AffiliationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Engagement", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Main Therapeutic Area', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Date', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// eng.take(2).length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${eng[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// eng[index]); +// }, +// ); +// }, +// color: MaterialStateProperty +// .resolveWith< +// Color?>((Set< +// MaterialState> +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// eng[index][ +// 'main thereutic area'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// eng[index]['date'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EngagementList())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "NIH Grants", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('NIH Center', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Organization Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Procedures", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Program Year', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Procedure', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Patents", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Patent Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Status', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Patient Referrals", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: +// Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Referred By', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Type of Referrals', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: +// (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: double +// .infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index] +// [ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants +// .k2color), +// ), +// style: OutlinedButton +// .styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Training", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Institute Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Degree', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Case", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: +// Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: +// (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: double +// .infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index] +// [ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants +// .k2color), +// ), +// style: OutlinedButton +// .styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image +// ], +// ), + +// // /expandableDetails(), +// // speakersList(provider), +// ], +// ), +// ), +// ) +// ], +// ), +// ), +// ], +// ), +// floatingActionButton: Visibility( +// visible: true, +// child: FloatingActionButton( +// onPressed: () async { +// // final ConfigDataProvider configDataProvider = +// // ConfigDataProvider(); + +// // await configDataProvider.initConfigUIData(); +// Navigator.push( +// context, MaterialPageRoute(builder: (context) => FormList())); +// }, +// foregroundColor: Colors.white, +// backgroundColor: const Color.fromARGB(255, 0, 71, 132), +// child: new Icon(Icons.add), +// ), +// ), +// ), +// ); +// } + +// buildCardView(BuildContext context) { +// MediaQuery.of(context).size.height * 0.35; + +// return Container( +// //color: Colors.yellowAccent, +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// mainAxisSize: MainAxisSize.min, +// //mainAxisAlignment: MainAxisAlignment.spaceAround, +// children: [ +// Stack( +// clipBehavior: Clip.none, +// alignment: Alignment.center, +// children: [ +// Container( +// width: +// MediaQuery.of(context).size.width, // Adjust width as needed +// height: 60, // Adjust height as needed +// decoration: BoxDecoration(color: Constants.k2color), +// ), +// Positioned( +// bottom: -45, +// child: Container( +// child: widget.text["img_path"] == null +// ? ProfilePicture( +// name: widget.text!["name"], +// radius: 38, +// fontsize: 21, +// ) +// : ClipOval( +// child: SizedBox.fromSize( +// size: Size.fromRadius(48), // Image radius +// child: Image.network(widget.text!["img_path"], +// fit: BoxFit.fill), +// ), +// ), +// ), +// ) +// ], +// ), +// SizedBox( +// height: 55.0, +// ), +// // Profile photo +// Column( +// children: [ +// Text1( +// title: "Dr " + widget.text!["name"], +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 22.0), +// Text1( +// title: widget.text!["speciality"], +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), +// SizedBox( +// height: 8.0, +// ), +// Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: +// Row(mainAxisAlignment: MainAxisAlignment.center, children: [ +// const Icon( +// Icons.location_city_sharp, +// color: Color.fromARGB(255, 0, 71, 132), +// ), +// const SizedBox( +// width: 3.0, +// ), +// Expanded( +// child: Text1( +// title: +// //widget.text!["addr"] ?? +// "Florida Hospital Medical Group Inc", +// txtcolor: Colors.black, +// txtfont: 15.0, +// fontweight: FontWeight.normal, +// ), +// // child: RichText( +// // text: TextSpan( +// // text: widget.text!["addr"] ?? +// // "Azienda Ospedaliera di Padova", +// // style: TextStyle( +// // fontSize: 16.0, color: Colors.black), +// // ), +// // ), +// ), +// ]), +// ), +// const SizedBox( +// height: 8.0, +// ), +// Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: Row(children: [ +// const Icon( +// Icons.location_pin, +// color: Color.fromARGB(255, 0, 71, 132), +// ), +// const SizedBox( +// width: 3.0, +// ), +// Expanded( +// // child: Text( +// // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // style: TextStyle( +// // fontWeight: FontWeight.bold, fontSize: 14.0), +// // ), +// child: Text1( +// title: widget.text!["adrr"] ?? +// "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), + +// // child: RichText( +// // text: TextSpan( +// // text: widget.text!["adrr"] ?? +// // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // style: TextStyle( +// // fontSize: 16.0, color: Colors.black), +// // ), +// // ), +// ), +// ]), +// ), +// const SizedBox( +// height: 8.0, +// ), +// Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: GestureDetector( +// onTap: () async { +// print("Emailll"); +// String? encodeQueryParameters(Map params) { +// return params.entries +// .map((MapEntry entry) => +// Uri.encodeComponent(entry.key) + +// '=' + +// Uri.encodeComponent(entry.value)) +// .join('&'); +// } + +// final Uri emailLaunchUri = Uri( +// scheme: 'mailto', +// path: 'example@example.com', +// query: encodeQueryParameters({ +// 'subject': 'Example Subject', +// 'body': 'Hello, this is a sample body text.', +// }), +// ); + +// if (await launchUrl(emailLaunchUri)) { +// launchUrl(emailLaunchUri); +// } else { +// throw 'Could not launch $emailLaunchUri'; +// } +// }, +// child: Row(children: [ +// const Icon( +// Icons.email, +// color: Color.fromARGB(255, 0, 71, 132), +// ), +// const SizedBox( +// width: 3.0, +// ), +// Expanded( +// child: Text1( +// title: widget.text!["email"], +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), +// ), +// ]), +// ), +// ), +// SizedBox( +// height: 8.0, +// ), +// Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: Row(children: [ +// const Icon( +// Icons.phone, +// color: Color.fromARGB(255, 0, 71, 132), +// ), +// const SizedBox( +// width: 3.0, +// ), +// // Text( +// // "+390498212410 X 12", +// // style: TextStyle( +// // fontWeight: FontWeight.bold, fontSize: 14.0), +// // ), +// Text1( +// title: widget.text!["phone_no"].toString(), +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), +// ]), +// ), +// const SizedBox( +// height: 8.0, +// ), +// Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: Row(children: [ +// const Icon( +// Icons.call, +// color: Color.fromARGB(255, 0, 71, 132), +// ), +// const SizedBox( +// width: 3.0, +// ), +// Expanded( +// child: Text1( +// title: widget.text!["phone_no"].toString(), +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), +// ), +// ]), +// ), +// ], +// ), + +// const SizedBox( +// height: 12.0, +// ), +// Align( +// alignment: Alignment.centerLeft, +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: Text1( +// title: "Profile Summarry", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 18.0), +// ), +// ), +// const SizedBox( +// height: 5.0, +// ), +// Align( +// alignment: Alignment.centerLeft, +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0), +// child: Text1( +// title: widget.text!["summarry"] ?? "jhj", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 15.0), +// ), +// ), + +// ExpandableCarousel( +// options: CarouselOptions( +// showIndicator: false, +// slideIndicator: CircularWaveSlideIndicator( +// alignment: Alignment.bottomCenter, +// currentIndicatorColor: Constants.k2color1, +// indicatorBackgroundColor: Colors.grey, +// // padding: EdgeInsets.only(: 10), +// ), +// autoPlay: true, +// autoPlayInterval: const Duration(seconds: 2), +// ), +// // items: [1, 2, 3, 4, 5].map((i) { +// items: [1, 2, 3, 4, 5].asMap().entries.map((entry) { +// int index = entry.key; + +// return Builder( +// builder: (BuildContext context) { +// return Center( +// child: Padding( +// padding: const EdgeInsets.all(8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(10), +// ), +// child: Container( +// decoration: BoxDecoration( +// color: gradients[ +// index % gradients.length], // Apply gradient +// borderRadius: BorderRadius.circular(10), +// ), +// child: Padding( +// padding: EdgeInsets.all(10.0), +// child: Column( +// mainAxisSize: MainAxisSize.min, +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// const Text( +// "Top Event Topics", +// style: TextStyle( +// fontSize: 16.0, +// fontWeight: FontWeight.bold, +// color: Colors.white), +// ), +// const SizedBox( +// height: 10.0, +// ), +// Row( +// children: [ +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtext, +// borderRadius: BorderRadius.circular(10), +// ), +// child: Padding( +// padding: const EdgeInsets.all(5.0), +// child: Row( +// children: [ +// Text( +// "Angina Pectoris", +// style: TextStyle( +// color: Colors.white), +// ), +// SizedBox(width: 5.0), +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtextdark, +// borderRadius: +// BorderRadius.circular(5), +// ), +// child: Padding( +// padding: +// const EdgeInsets.all(1.0), +// child: Text( +// "(378)", +// style: TextStyle( +// color: Colors.white), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ], +// ), +// SizedBox(height: 5), +// Row( +// children: [ +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtext, +// borderRadius: BorderRadius.circular(5), +// ), +// child: Padding( +// padding: const EdgeInsets.all(5.0), +// child: Row( +// children: [ +// Text("Coronary Artery Disease", +// style: TextStyle( +// color: Colors.white), +// softWrap: true), +// SizedBox(width: 5.0), +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtextdark, +// borderRadius: +// BorderRadius.circular(5), +// ), +// child: Padding( +// padding: +// const EdgeInsets.all(1.0), +// child: Text( +// "(378)", +// style: TextStyle( +// color: Colors.white), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ], +// ), +// SizedBox(height: 5), +// Row( +// children: [ +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtext, +// borderRadius: BorderRadius.circular(5), +// ), +// child: Padding( +// padding: const EdgeInsets.all(5.0), +// child: Row( +// children: [ +// Text( +// "Hypertension", +// style: TextStyle( +// color: Colors.white), +// ), +// SizedBox(width: 5.0), +// Container( +// decoration: BoxDecoration( +// color: Constants.cardtextdark, +// borderRadius: +// BorderRadius.circular(5), +// ), +// child: Padding( +// padding: +// const EdgeInsets.all(1.0), +// child: Text( +// "(378)", +// style: TextStyle( +// color: Colors.white), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ], +// ), +// ], +// ), +// ), +// ), +// ), +// ), +// ); +// }, +// ); +// }).toList(), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.symmetric(horizontal: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, // Replace with Constants.k2color11 +// child: ExpansionTile( +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: +// Constants.k2color11, // Replace with Constants.k2color11 +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black, +// ), +// title: Row( +// children: [ +// Text( +// "Sentiment Score", +// style: TextStyle( +// color: Colors.black, +// fontWeight: FontWeight.normal, +// fontSize: 17.0, +// ), +// ), +// const SizedBox(width: 8.0), +// Text( +// "(3)", +// style: TextStyle( +// color: Colors.black, +// fontWeight: FontWeight.normal, +// fontSize: 17.0, +// ), +// ), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: MediaQuery.of(context).size.width, +// ), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Product', +// style: +// TextStyle(fontWeight: FontWeight.w600), +// ), +// ), +// ), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Aissel Engagement', +// style: +// TextStyle(fontWeight: FontWeight.w600), +// ), +// ), +// ), +// // Add more columns as needed +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: false, +// enableDrag: true, +// useSafeArea: true, +// constraints: const BoxConstraints( +// maxWidth: double.infinity, +// ), +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.vertical( +// top: Radius.circular(0), +// ), +// ), +// clipBehavior: Clip.antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet(publication_data[index]); +// }, +// ); +// }, +// cells: [ +// DataCell( +// Text( +// publication_data[index] +// ['artical_title'] ?? +// '', +// softWrap: true, +// ), +// ), +// DataCell( +// Text( +// publication_data[index]['author'] ?? '', +// softWrap: true, +// ), +// ), +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => PublicationsData(), +// ), +// ); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Colors +// .blue), // Replace with Constants.k2color +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(12), +// ), +// ), +// ), +// ), +// ), +// ), +// ], +// ), +// ), +// ), +// ), + +// SizedBox( +// height: 10.0, +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Note", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(0)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: TextField( +// decoration: InputDecoration( +// border: OutlineInputBorder( +// borderRadius: BorderRadius.circular(8.0), +// ), +// hintText: 'Write your note here', +// contentPadding: EdgeInsets.all(16.0), +// ), +// maxLines: +// null, // Allows the TextField to expand vertically +// ), +// ), +// Padding( +// padding: const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => PublicationsData())); +// }, +// child: Text( +// 'Save', +// style: TextStyle(color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(12), +// ), +// ), +// ), +// ), +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// SizedBox( +// height: 10.0, +// ), +// ], +// // ), +// ), +// ); +// } + +// Widget expandableDetails() { +// return Container( +// child: ListView( +// children: [ +// Column(children: [ +// SizedBox( +// height: 5, +// ), +// Container( +// // color: Colors.black, +// height: MediaQuery.sizeOf(context).height, +// width: MediaQuery.sizeOf(context).width, +// child: DefaultTabController( +// length: 3, + +// child: Column( +// children: [ +// Container( +// color: Constants.bgcolor2, +// child: const TabBar( +// indicatorColor: Colors.white, +// labelColor: +// Colors.white, // Color of the selected tab text + +// unselectedLabelColor: +// Color.fromARGB(255, 163, 159, 159), +// tabs: [ +// // Tab(text: "Sentiment"), +// Tab( +// // text: "Related " +// child: Text( +// 'Activities', +// style: TextStyle( +// fontWeight: FontWeight.bold, fontSize: 15.0), +// ), +// ), +// Tab( +// // text: "Activities " +// child: Text( +// 'Deatils', +// style: TextStyle( +// fontWeight: FontWeight.bold, fontSize: 15.0), +// ), +// ), +// Tab( +// //text: "Engagement " + +// child: Text( +// 'Engagement', +// softWrap: true, +// style: TextStyle( +// fontWeight: FontWeight.bold, fontSize: 15.0), +// ), +// ), + +// // Tab(icon: Icon(Icons.email)), +// ], +// ), +// ), +// // TabBarView +// Expanded( +// child: TabBarView( +// children: [ +// ListView(children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Locations", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// const RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Phone Numbers", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('phone Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Location', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Emails", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Email Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Email', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Staff/Assistant", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Location', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), + +// ///elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "State License", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('License No', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text('State', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'Institution'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['Address'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // ], +// ]), +// ListView(children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Affiliations", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// // width: +// // MediaQuery.of(context) +// // .size +// // .width, +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Organization Name', +// style: TextStyle( +// fontWeight: +// FontWeight.w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Time Frame', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// affiliation_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${affiliation_data[index]}"); + +// bottomshet( +// affiliation_data[ +// index]); +// }, +// color: MaterialStateProperty +// .resolveWith( +// (Set +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// affiliation_data[ +// index] +// ['org_name'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// affiliation_data[ +// index] +// ['time_frame'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// AffiliationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Publications", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// //isAlwaysShown: true, +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Artical Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), + +// DataColumn( +// label: Expanded( +// child: Text('Authors', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), + +// // Add more columns as needed +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Events", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: MediaQuery.of(context) +// .size +// .width, +// ), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Event Name', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)), +// )), + +// DataColumn( +// label: Expanded( +// child: Text('Role', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), + +// // Add more columns as needed +// ], +// rows: List.generate( +// event_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${event_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// event_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// event_data[index] +// ['event_name'] +// .toString(), +// softWrap: true)), + +// DataCell(Text( +// event_data[index] +// ['role'] +// .toString(), +// softWrap: true)), + +// // Add more DataCells as needed +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EventsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Trials", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Trial Name', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Status', +// softWrap: true, +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// trial_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${trial_data[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: +// Radius.circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// trial_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// trial_data[index] +// ['trial_name'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// trial_data[index] +// ['status'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EventsData())); +// }, +// style: OutlinedButton.styleFrom( +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants.k2color), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image +// ]), + +// // +// ListView( +// children: [ +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// // initiallyExpanded: true, +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Medical Insight", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Container( +// width: MediaQuery.of(context) +// .size +// .width, + +// /// 5, +// color: Colors.white, +// child: Consumer< +// MediacalInsightProvider>( +// builder: (BuildContext context, +// value, Widget? child) { +// print( +// "med1 : ${value.med.length}"); + +// if (value.med.length != 0) { +// return ListView.builder( +// physics: +// const ScrollPhysics(), +// // scrollDirection: Axis.vertical, +// shrinkWrap: true, +// itemCount: value.med +// .take(2) +// .length, +// itemBuilder: +// (context, index) { +// item = value.med[index]; + +// print( +// "Item_Medical_insight ${item['Therapeutic Area']}"); +// return Padding( +// padding: +// const EdgeInsets +// .all(8.0), +// child: Card( +// margin: +// EdgeInsets.zero, + +// elevation: 4, +// surfaceTintColor: +// Colors.white, +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .zero, +// ), + +// child: SizedBox( +// width: MediaQuery +// .sizeOf( +// context) +// .width, +// child: ListTile( +// dense: true, +// title: Column( +// // crossAxisAlignment: CrossAxisAlignment.center, +// children: [ +// // Text( +// // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + +// RichText( +// text: +// TextSpan( +// text: '', +// style: DefaultTextStyle.of( +// context) +// .style, +// children: const [ +// TextSpan( +// text: +// 'Acute neurology ', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// // TextSpan( +// // text: ' therapeutic area ', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.bold)), +// TextSpan( +// text: +// 'is the therapeutic area of the medical insight for '), +// TextSpan( +// text: +// 'Product A. The age of treatment', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// TextSpan( +// text: +// ' is the topic of interest for this source type'), +// TextSpan( +// text: +// ' publication.', +// style: +// TextStyle(fontWeight: FontWeight.bold)), +// ], +// ), +// ), + +// const Padding( +// padding: +// EdgeInsets.all( +// 8.0), +// child: Row( +// mainAxisAlignment: +// MainAxisAlignment +// .spaceBetween, +// children: [ +// Row( +// children: [ +// Icon( +// Icons.person, +// size: 20, +// ), +// Text( +// "pooja", +// style: TextStyle(fontSize: 14.0), +// ) +// ], +// ), +// Row( +// children: [ +// Icon( +// Icons.calendar_today, +// size: 20, +// ), +// Text( +// "11/11/2022 ", +// style: TextStyle(fontSize: 14.0), +// ) +// ], +// ) +// ], +// ), +// ), +// ], +// ), +// ), +// ), +// // shape: BorderRadius.only(bottomRight: Radius.circular(50)), +// ), +// ); +// }); +// } else { +// return Container( +// color: Colors.white, +// width: MediaQuery.of(context) +// .size +// .width, +// child: Column( +// children: [ +// Text("No records"), +// ], +// ), +// ); +// } +// }), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// const MedicalInsight1())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// //mainAxisSize: MainAxisSize.min, +// children: [ +// GestureDetector( +// onTap: () async { +// final provider = Provider.of< +// InteractionProvider>( +// context, +// listen: false); +// if (getCount( +// provider +// .intConfigDataList[ +// 0] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[ +// 0] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// 0] +// .name, +// ))); +// } +// }, +// child: Text1( +// title: "Interactions", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ), +// const SizedBox( +// width: 8.0, +// ), +// ], +// ), +// children: [ +// Container( +// height: MediaQuery.of(context) +// .size +// .height / +// 5, +// color: Colors.white, +// child: Consumer< +// ViewInteractionProvider>( +// builder: (BuildContext context, +// provider, Widget? child) { +// print( +// "P_leangth : ${provider.savedList.length}"); + +// if (provider.savedList.length != +// 0) { +// return ListView.builder( +// shrinkWrap: true, +// physics: +// NeverScrollableScrollPhysics(), +// itemCount: provider +// .savedList +// .take(2) +// .length, +// itemBuilder: +// (context, index) { +// print( +// "Indexxxxxx $index"); +// return Column( +// children: [ +// ListTile( +// subtitle: Text( +// 'Updated on ${provider.savedList[index].updatedTime}', +// //style: TextStyle(fontStyle: FontStyle.italic), +// ), +// title: Text( +// provider +// .savedList[ +// index] +// .id, +// ), +// trailing: SizedBox( +// width: 150, +// child: Row( +// children: [ +// IconButton( +// onPressed: +// () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext context) => ViewInteractionScreen( +// saveInteraction: provider.savedList[index], +// ))); +// }, +// icon: +// const Icon( +// Icons +// .info_outline, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// IconButton( +// onPressed: +// () async { +// await provider +// .initConfigData() +// .then({ +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext context) => EditInteractionScreen( +// saveInteraction: provider.savedList[index], +// ))) +// }); +// }, +// icon: +// const Icon( +// Icons +// .edit, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// IconButton( +// onPressed: +// () { +// showDeleteRecordAlertDialog( +// context, +// provider.savedList[index].id, +// provider.savedList[index]); +// }, +// icon: +// const Icon( +// Icons +// .delete, +// size: +// 24, +// color: Color.fromARGB( +// 255, +// 8, +// 39, +// 92), +// ), +// ), +// ]), +// ), +// onTap: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// ViewInteractionScreen( +// saveInteraction: +// provider.savedList[index], +// ))); +// }, +// ), +// const Divider(), +// ], +// ); +// }); +// } else { +// return Container( +// color: Colors.white, +// width: MediaQuery.of(context) +// .size +// .width, +// child: Column( +// children: [ +// Text("No records"), +// ], +// ), +// ); +// } +// }), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// final provider = Provider +// .of( +// context, +// listen: false); +// if (getCount( +// provider +// .intConfigDataList[ +// 0] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[ +// 0] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (BuildContext +// context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// 0] +// .name, +// ))); +// } +// }, +// child: Text('Show More'), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Speaker Evalution", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(4)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Program Topic', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Speaker Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// speaker.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${speaker[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// speaker[index]); +// }, +// ); +// }, +// color: MaterialStateProperty +// .resolveWith< +// Color?>((Set< +// MaterialState> +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// speaker[index][ +// 'programtopic'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// speaker[index][ +// 'speakername'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // AffiliationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Engagement", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Main Therapeutic Area', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// ), +// )), +// DataColumn( +// label: Expanded( +// child: Text('Date', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// eng.take(2).length, +// (index) => DataRow( +// onSelectChanged: (value) { +// // =======> Use onSelectChanged for tab +// print( +// "message ${eng[index]}"); + +// // bsheet( +// // publication_data[ +// // index]); +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// eng[index]); +// }, +// ); +// }, +// color: MaterialStateProperty +// .resolveWith< +// Color?>((Set< +// MaterialState> +// states) { +// if (index.isEven) { +// return Colors.grey +// .withOpacity(0.1); +// } +// return null; +// }), +// cells: [ +// DataCell(Text( +// eng[index][ +// 'main thereutic area'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// eng[index]['date'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// EngagementList())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "NIH Grants", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('NIH Center', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Organization Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Procedures", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Program Year', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Procedure', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Patents", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Patent Title', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Status', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// //elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Patient Referrals", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 17.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: +// Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Referred By', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Type of Referrals', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: +// (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: double +// .infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index] +// [ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants +// .k2color), +// ), +// style: OutlinedButton +// .styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// backgroundColor: Constants.k2color11, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Training", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text( +// 'Institute Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Degree', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: +// double.infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular(0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index][ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: +// Constants.k2color), +// ), +// style: +// OutlinedButton.styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular( +// 12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), // adds spacing between the text and image + +// ListTileTheme( +// dense: true, +// child: Padding( +// padding: const EdgeInsets.only( +// left: 8.0, right: 8.0), +// child: Container( +// child: Card( +// margin: EdgeInsets.all(1.0), +// // elevation: 5, +// shape: RoundedRectangleBorder( +// borderRadius: +// BorderRadius.circular(0.0), +// ), +// color: Constants.k2color11, +// child: ExpansionTile( +// backgroundColor: Constants.k2color11, +// initiallyExpanded: false, +// maintainState: true, +// // backgroundColor: Colors.white, +// // collapsedBackgroundColor: Color(0xFF2b9af3), +// onExpansionChanged: (bool expanded) { +// setState(() { +// _isExpanded = expanded; +// }); +// }, +// trailing: Icon( +// _isExpanded +// ? Icons.keyboard_arrow_up +// : Icons.keyboard_arrow_down, +// color: Colors.black), +// title: Row( +// mainAxisAlignment: +// MainAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// children: [ +// Text1( +// title: "Case", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// const SizedBox( +// width: 8.0, +// ), +// Text1( +// title: "(3)", +// txtcolor: Colors.black, +// fontweight: FontWeight.normal, +// txtfont: 16.0), +// ], +// ), +// children: [ +// Scrollbar( +// child: SingleChildScrollView( +// scrollDirection: +// Axis.horizontal, +// child: Container( +// constraints: BoxConstraints( +// minWidth: +// MediaQuery.of(context) +// .size +// .width), +// color: Colors.white, +// child: DataTable( +// showCheckboxColumn: false, +// columns: const [ +// DataColumn( +// label: Expanded( +// child: Text('Name', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600), +// softWrap: true), +// )), +// DataColumn( +// label: Expanded( +// child: Text( +// 'Type', +// style: TextStyle( +// fontWeight: +// FontWeight +// .w600)))), +// ], +// rows: List.generate( +// publication_data.length, +// (index) => DataRow( +// onSelectChanged: +// (value) { +// print( +// "message ${publication_data[index]}"); + +// showModalBottomSheet( +// useRootNavigator: +// true, +// isScrollControlled: +// false, +// enableDrag: true, +// useSafeArea: true, +// constraints: +// const BoxConstraints( +// maxWidth: double +// .infinity, +// ), +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .vertical( +// top: Radius +// .circular( +// 0), +// ), +// ), +// clipBehavior: Clip +// .antiAliasWithSaveLayer, +// context: context, +// builder: (context) { +// return bsheet( +// publication_data[ +// index]); +// }, +// ); +// }, +// cells: [ +// DataCell(Text( +// publication_data[ +// index] +// [ +// 'artical_title'] +// .toString(), +// softWrap: true)), +// DataCell(Text( +// publication_data[ +// index] +// ['author'] +// .toString(), +// softWrap: true)), +// ], +// ), +// ), +// ), +// ), +// ), +// ), +// Container( +// color: Colors.white, +// child: Align( +// alignment: Alignment.center, +// child: Padding( +// padding: +// const EdgeInsets.all(8.0), +// child: OutlinedButton( +// onPressed: () { +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: (_) => +// PublicationsData())); +// }, +// child: Text( +// 'Show More', +// style: TextStyle( +// color: Constants +// .k2color), +// ), +// style: OutlinedButton +// .styleFrom( +// shape: +// RoundedRectangleBorder( +// borderRadius: +// BorderRadius +// .circular(12), +// ), +// ), +// ), +// ), +// ), +// ) +// ]), +// ), +// ), +// ), +// ), // adds spacing between the text and image +// ], +// ), +// // Center(child: Icon(Icons.email)), +// ], +// ), +// ), +// // Other widgets below TabBarView +// ], +// ), +// // ), +// ), +// ), +// ]), +// ], +// ), +// ); +// } + +// // Widget build(BuildContext context) { +// // var size = MediaQuery.of(context).size; + +// // /*24 is for notification bar on Android*/ +// // final double itemHeight = (size.height - kToolbarHeight - 24) / 2; +// // final double itemWidth = size.width / 2; +// // return Scaffold( +// // body: SafeArea( +// // child: Container( +// // color: Constants.bgcolor, +// // child: Column( +// // children: [ +// // Expanded( +// // child: ListView( +// // children: [ +// // Column( +// // children: [ +// // Stack( +// // clipBehavior: Clip.none, +// // alignment: Alignment.center, +// // children: [ +// // Container( +// // width: MediaQuery.of(context) +// // .size +// // .width, // Adjust width as needed +// // height: 100, // Adjust height as needed +// // decoration: +// // BoxDecoration(color: Constants.k2color), +// // ), +// // Positioned( +// // bottom: -45, +// // child: Container( +// // child: widget.text["img_path"] == null +// // ? ProfilePicture( +// // name: widget.text!["name"], +// // radius: 38, +// // fontsize: 21, +// // ) +// // : ClipOval( +// // child: SizedBox.fromSize( +// // size: Size.fromRadius( +// // 48), // Image radius +// // child: Image.network( +// // widget.text!["img_path"], +// // fit: BoxFit.fill), +// // ), +// // ), +// // ), +// // ) +// // ], +// // ), +// // SizedBox( +// // height: 55.0, +// // ), +// // // Profile photo +// // Column( +// // children: [ +// // Text1( +// // title: "Dr " + widget.text!["name"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 22.0), +// // Text1( +// // title: widget.text!["speciality"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row( +// // mainAxisAlignment: MainAxisAlignment.center, +// // children: [ +// // const Icon( +// // Icons.location_city_sharp, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: +// // //widget.text!["addr"] ?? +// // "Florida Hospital Medical Group Inc", +// // txtcolor: Colors.black, +// // txtfont: 15.0, +// // fontweight: FontWeight.normal, +// // ), +// // // child: RichText( +// // // text: TextSpan( +// // // text: widget.text!["addr"] ?? +// // // "Azienda Ospedaliera di Padova", +// // // style: TextStyle( +// // // fontSize: 16.0, color: Colors.black), +// // // ), +// // // ), +// // ), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.location_pin, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // // child: Text( +// // // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // // style: TextStyle( +// // // fontWeight: FontWeight.bold, fontSize: 14.0), +// // // ), +// // child: Text1( +// // title: widget.text!["adrr"] ?? +// // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), + +// // // child: RichText( +// // // text: TextSpan( +// // // text: widget.text!["adrr"] ?? +// // // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // // style: TextStyle( +// // // fontSize: 16.0, color: Colors.black), +// // // ), +// // // ), +// // ), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.email, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: widget.text!["email"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ]), +// // ), +// // SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.phone, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // // Text( +// // // "+390498212410 X 12", +// // // style: TextStyle( +// // // fontWeight: FontWeight.bold, fontSize: 14.0), +// // // ), +// // Text1( +// // title: widget.text!["phone_no"].toString(), +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.call, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: +// // widget.text!["phone_no"].toString(), +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ]), +// // ), +// // ], +// // ), + +// // const SizedBox( +// // height: 12.0, +// // ), +// // Align( +// // alignment: Alignment.centerLeft, +// // child: Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Text1( +// // title: "Profile Summarry", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 18.0), +// // ), +// // ), +// // const SizedBox( +// // height: 5.0, +// // ), +// // Align( +// // alignment: Alignment.centerLeft, +// // child: Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Text1( +// // title: widget.text!["summarry"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ), + +// // ExpandableCarousel( +// // options: CarouselOptions( +// // slideIndicator: CircularWaveSlideIndicator( +// // alignment: Alignment.bottomCenter, +// // currentIndicatorColor: Constants.k2color1, +// // indicatorBackgroundColor: Colors.grey, +// // // padding: EdgeInsets.only(: 10), +// // ), +// // autoPlay: true, +// // autoPlayInterval: const Duration(seconds: 2), +// // ), +// // // items: [1, 2, 3, 4, 5].map((i) { +// // items: [1, 2, 3, 4, 5].asMap().entries.map((entry) { +// // int index = entry.key; + +// // return Builder( +// // builder: (BuildContext context) { +// // return Center( +// // child: Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(10), +// // ), +// // child: Container( +// // decoration: BoxDecoration( +// // gradient: gradients[index % +// // gradients +// // .length], // Apply gradient +// // borderRadius: +// // BorderRadius.circular(10), +// // ), +// // child: Padding( +// // padding: EdgeInsets.all(10.0), +// // child: Column( +// // mainAxisSize: MainAxisSize.min, +// // crossAxisAlignment: +// // CrossAxisAlignment.start, +// // children: [ +// // const Text( +// // "Top Event Topics", +// // style: TextStyle( +// // fontSize: 16.0, +// // fontWeight: FontWeight.bold, +// // color: Colors.white), +// // ), +// // const SizedBox( +// // height: 10.0, +// // ), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 10), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text( +// // "Angina Pectoris"), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // SizedBox(height: 5), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text( +// // "Coronary Artery Disease", +// // softWrap: true), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // SizedBox(height: 5), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text("Hypertension"), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ); +// // }, +// // ); +// // }).toList(), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: +// // const EdgeInsets.symmetric(horizontal: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // color: Constants +// // .k2color11, // Replace with Constants.k2color11 +// // child: ExpansionTile( +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: Constants +// // .k2color11, // Replace with Constants.k2color11 +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.black, +// // ), +// // title: Row( +// // children: [ +// // Text( +// // "Sentiment Score", +// // style: TextStyle( +// // color: Colors.black, +// // fontWeight: FontWeight.normal, +// // fontSize: 17.0, +// // ), +// // ), +// // const SizedBox(width: 8.0), +// // Text( +// // "(3)", +// // style: TextStyle( +// // color: Colors.black, +// // fontWeight: FontWeight.normal, +// // fontSize: 17.0, +// // ), +// // ), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of(context).size.width, +// // ), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Product', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600), +// // ), +// // ), +// // ), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Aissel Engagement', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600), +// // ), +// // ), +// // ), +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // publication_data.length, +// // (index) => DataRow( +// // onSelectChanged: (value) { +// // showModalBottomSheet( +// // useRootNavigator: true, +// // isScrollControlled: false, +// // enableDrag: true, +// // useSafeArea: true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double.infinity, +// // ), +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.vertical( +// // top: Radius.circular(0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: context, +// // builder: (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell( +// // Text( +// // publication_data[index] +// // ['artical_title'] ?? +// // '', +// // softWrap: true, +// // ), +// // ), +// // DataCell( +// // Text( +// // publication_data[index] +// // ['author'] ?? +// // '', +// // softWrap: true, +// // ), +// // ), +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData(), +// // ), +// // ); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Colors +// // .blue), // Replace with Constants.k2color +// // ), +// // style: OutlinedButton.styleFrom( +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ), + +// // SizedBox( +// // height: 10.0, +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: +// // const EdgeInsets.only(left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Note", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(0)", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: TextField( +// // decoration: InputDecoration( +// // border: OutlineInputBorder( +// // borderRadius: +// // BorderRadius.circular(8.0), +// // ), +// // hintText: 'Write your note here', +// // contentPadding: EdgeInsets.all(16.0), +// // ), +// // maxLines: +// // null, // Allows the TextField to expand vertically +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Save', +// // style: TextStyle( +// // color: Constants.k2color), +// // ), +// // style: OutlinedButton.styleFrom( +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(12), +// // ), +// // ), +// // ), +// // ), +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // SizedBox( +// // height: 10.0, +// // ), +// // ], +// // ), +// // Container( +// // // color: Colors.black, +// // height: MediaQuery.sizeOf(context).height * 0.7, +// // width: MediaQuery.sizeOf(context).width, +// // child: DefaultTabController( +// // length: 3, + +// // child: Column( +// // children: [ +// // Container( +// // color: Constants.bgcolor2, +// // child: const TabBar( +// // indicatorColor: Colors.white, +// // labelColor: Colors +// // .white, // Color of the selected tab text + +// // unselectedLabelColor: +// // Color.fromARGB(255, 163, 159, 159), +// // tabs: [ +// // // Tab(text: "Sentiment"), +// // Tab( +// // // text: "Related " +// // child: Text( +// // 'Related', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), +// // Tab( +// // // text: "Activities " +// // child: Text( +// // 'Activities', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), +// // Tab( +// // //text: "Engagement " + +// // child: Text( +// // 'Engagement', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), + +// // // Tab(icon: Icon(Icons.email)), +// // ], +// // ), +// // ), +// // // TabBarView +// // Expanded( +// // child: TabBarView( +// // children: [ +// // ListView(children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Locations", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // const RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Phone Numbers", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'phone Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Location', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Emails", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Email Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Email', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Staff/Assistant", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Location', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), + +// // ///elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "State License", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'License No', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'State', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // ], +// // ]), +// // ListView(children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Affiliations", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // // width: +// // // MediaQuery.of(context) +// // // .size +// // // .width, +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Organization Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Time Frame', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // affiliation_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${affiliation_data[index]}"); + +// // bottomshet( +// // affiliation_data[ +// // index]); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // affiliation_data[ +// // index] +// // [ +// // 'org_name'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // affiliation_data[ +// // index] +// // [ +// // 'time_frame'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // AffiliationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Publications", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // //isAlwaysShown: true, +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Artical Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: true), +// // )), + +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Authors', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), + +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[ +// // index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // publication_data[ +// // index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Events", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: +// // BoxConstraints( +// // minWidth: MediaQuery.of( +// // context) +// // .size +// // .width, +// // ), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Event Name', +// // softWrap: true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600)), +// // )), + +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Role', +// // softWrap: +// // true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), + +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // event_data.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${event_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // event_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // event_data[index] +// // [ +// // 'event_name'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // event_data[index] +// // [ +// // 'role'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EventsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Trials", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Trial Name', +// // softWrap: true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600)), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Status', +// // softWrap: +// // true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // trial_data.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${trial_data[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // trial_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // trial_data[index] +// // [ +// // 'trial_name'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // trial_data[index] +// // [ +// // 'status'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EventsData())); +// // }, +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image +// // ]), + +// // // +// // ListView( +// // children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // // initiallyExpanded: true, +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Medical Insight", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Container( +// // width: +// // MediaQuery.of(context) +// // .size +// // .width, + +// // /// 5, +// // color: Colors.white, +// // child: Consumer< +// // MediacalInsightProvider>( +// // builder: (BuildContext +// // context, +// // value, +// // Widget? child) { +// // print( +// // "med1 : ${value.med.length}"); + +// // if (value.med.length != +// // 0) { +// // return ListView.builder( +// // physics: +// // const ScrollPhysics(), +// // // scrollDirection: Axis.vertical, +// // shrinkWrap: true, +// // itemCount: value.med +// // .take(2) +// // .length, +// // itemBuilder: +// // (context, +// // index) { +// // item = value +// // .med[index]; + +// // print( +// // "Item_Medical_insight ${item['Therapeutic Area']}"); +// // return Padding( +// // padding: +// // const EdgeInsets +// // .all( +// // 8.0), +// // child: Card( +// // margin: +// // EdgeInsets +// // .zero, + +// // elevation: 4, +// // surfaceTintColor: +// // Colors +// // .white, +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .zero, +// // ), + +// // child: +// // SizedBox( +// // width: MediaQuery.sizeOf( +// // context) +// // .width, +// // child: +// // ListTile( +// // dense: +// // true, +// // title: +// // Column( +// // // crossAxisAlignment: CrossAxisAlignment.center, +// // children: [ +// // // Text( +// // // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + +// // RichText( +// // text: +// // TextSpan( +// // text: '', +// // style: DefaultTextStyle.of(context).style, +// // children: const [ +// // TextSpan(text: 'Acute neurology ', style: TextStyle(fontWeight: FontWeight.bold)), +// // // TextSpan( +// // // text: ' therapeutic area ', +// // // style: TextStyle( +// // // fontWeight: +// // // FontWeight.bold)), +// // TextSpan(text: 'is the therapeutic area of the medical insight for '), +// // TextSpan(text: 'Product A. The age of treatment', style: TextStyle(fontWeight: FontWeight.bold)), +// // TextSpan(text: ' is the topic of interest for this source type'), +// // TextSpan(text: ' publication.', style: TextStyle(fontWeight: FontWeight.bold)), +// // ], +// // ), +// // ), + +// // const Padding( +// // padding: +// // EdgeInsets.all(8.0), +// // child: +// // Row( +// // mainAxisAlignment: MainAxisAlignment.spaceBetween, +// // children: [ +// // Row( +// // children: [ +// // Icon( +// // Icons.person, +// // size: 20, +// // ), +// // Text( +// // "pooja", +// // style: TextStyle(fontSize: 14.0), +// // ) +// // ], +// // ), +// // Row( +// // children: [ +// // Icon( +// // Icons.calendar_today, +// // size: 20, +// // ), +// // Text( +// // "11/11/2022 ", +// // style: TextStyle(fontSize: 14.0), +// // ) +// // ], +// // ) +// // ], +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // // shape: BorderRadius.only(bottomRight: Radius.circular(50)), +// // ), +// // ); +// // }); +// // } else { +// // return Container( +// // color: Colors.white, +// // width: MediaQuery.of( +// // context) +// // .size +// // .width, +// // child: Column( +// // children: [ +// // Text( +// // "No records"), +// // ], +// // ), +// // ); +// // } +// // }), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // const MedicalInsight1())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // //mainAxisSize: MainAxisSize.min, +// // children: [ +// // GestureDetector( +// // onTap: () async { +// // final provider = Provider +// // .of( +// // context, +// // listen: false); +// // if (getCount( +// // provider +// // .intConfigDataList[ +// // 0] +// // .name, +// // provider) != +// // 0) { +// // provider.savedList +// // .where((element) => +// // element +// // .form == +// // provider +// // .intConfigDataList[ +// // 0] +// // .name) +// // .toList(); +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext +// // context) => +// // SavedFormListScreen( +// // formname: provider +// // .intConfigDataList[0] +// // .name, +// // ))); +// // } +// // }, +// // child: Text1( +// // title: "Interactions", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ), +// // const SizedBox( +// // width: 8.0, +// // ), +// // ], +// // ), +// // children: [ +// // Container( +// // height: +// // MediaQuery.of(context) +// // .size +// // .height / +// // 5, +// // color: Colors.white, +// // child: Consumer< +// // ViewInteractionProvider>( +// // builder: (BuildContext +// // context, +// // provider, +// // Widget? child) { +// // print( +// // "P_leangth : ${provider.savedList.length}"); + +// // if (provider.savedList +// // .length != +// // 0) { +// // return ListView.builder( +// // shrinkWrap: true, +// // physics: +// // NeverScrollableScrollPhysics(), +// // itemCount: provider +// // .savedList +// // .take(2) +// // .length, +// // itemBuilder: +// // (context, +// // index) { +// // print( +// // "Indexxxxxx $index"); +// // return Column( +// // children: [ +// // ListTile( +// // subtitle: +// // Text( +// // 'Updated on ${provider.savedList[index].updatedTime}', +// // //style: TextStyle(fontStyle: FontStyle.italic), +// // ), +// // title: Text( +// // provider +// // .savedList[ +// // index] +// // .id, +// // ), +// // trailing: +// // SizedBox( +// // width: +// // 150, +// // child: Row( +// // children: [ +// // IconButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => ViewInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))); +// // }, +// // icon: const Icon( +// // Icons.info_outline, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // IconButton( +// // onPressed: () async { +// // await provider.initConfigData().then({ +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => EditInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))) +// // }); +// // }, +// // icon: const Icon( +// // Icons.edit, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // IconButton( +// // onPressed: () { +// // showDeleteRecordAlertDialog(context, provider.savedList[index].id, provider.savedList[index]); +// // }, +// // icon: const Icon( +// // Icons.delete, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // ]), +// // ), +// // onTap: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => ViewInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))); +// // }, +// // ), +// // const Divider(), +// // ], +// // ); +// // }); +// // } else { +// // return Container( +// // color: Colors.white, +// // width: MediaQuery.of( +// // context) +// // .size +// // .width, +// // child: Column( +// // children: [ +// // Text( +// // "No records"), +// // ], +// // ), +// // ); +// // } +// // }), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // final provider = +// // Provider.of< +// // InteractionProvider>( +// // context, +// // listen: +// // false); +// // if (getCount( +// // provider +// // .intConfigDataList[ +// // 0] +// // .name, +// // provider) != +// // 0) { +// // provider.savedList +// // .where((element) => +// // element +// // .form == +// // provider +// // .intConfigDataList[ +// // 0] +// // .name) +// // .toList(); +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext +// // context) => +// // SavedFormListScreen( +// // formname: +// // provider.intConfigDataList[0].name, +// // ))); +// // } +// // }, +// // child: +// // Text('Show More'), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Speaker Evalution", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Program Topic', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Speaker Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // speaker.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${speaker[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // speaker[ +// // index]); +// // }, +// // ); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // speaker[index] +// // [ +// // 'programtopic'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // speaker[index] +// // [ +// // 'speakername'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // // Navigator.push( +// // // context, +// // // MaterialPageRoute( +// // // builder: (_) => +// // // AffiliationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Engagement", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Main Therapeutic Area', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Date', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // eng.take(2).length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${eng[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // eng[index]); +// // }, +// // ); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // eng[index][ +// // 'main thereutic area'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // eng[index][ +// // 'date'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EngagementList())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "NIH Grants", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'NIH Center', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Organization Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Procedures", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Program Year', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Procedure', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Patents", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Patent Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Status', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Patient Referrals", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: +// // Expanded( +// // child: Text( +// // 'Referred By', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type of Referrals', +// // style: +// // TextStyle(fontWeight: FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => +// // DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: +// // double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular(0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: +// // (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: +// // OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Training", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Institute Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Degree', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Case", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: +// // Expanded( +// // child: Text( +// // 'Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type', +// // style: +// // TextStyle(fontWeight: FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => +// // DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: +// // double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular(0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: +// // (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: +// // OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image +// // ], +// // ), +// // // Center(child: Icon(Icons.email)), +// // ], +// // ), +// // ), +// // // Other widgets below TabBarView +// // ], +// // ), +// // // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ], +// // ), +// // ), +// // // ), +// // ), +// // floatingActionButton: Visibility( +// // visible: true, +// // child: FloatingActionButton( +// // onPressed: () async { +// // // final ConfigDataProvider configDataProvider = +// // // ConfigDataProvider(); + +// // // await configDataProvider.initConfigUIData(); +// // Navigator.push( +// // context, MaterialPageRoute(builder: (context) => FormList())); +// // }, +// // foregroundColor: Colors.white, +// // backgroundColor: const Color.fromARGB(255, 0, 71, 132), +// // child: new Icon(Icons.add), +// // ), +// // ), +// // ); +// // } + +// Future getCount(String form, InteractionProvider provider) async { +// await provider.getRecords(); + +// return provider.savedList.where((element) => element.form == form).length; +// } + +// buidCard() { +// Text("Hiii"); +// } + +// showDeleteRecordAlertDialog( +// BuildContext context, String record, SaveInteraction saveInteraction) { +// // set up the buttons +// ViewInteractionProvider provider = +// Provider.of(context, listen: false); +// Widget cancelButton = TextButton( +// child: const Text("YES"), +// onPressed: () async { +// await provider.deleteRecord(saveInteraction).then((value) { +// _displaySnackBar("Deleted sucessfully!"); +// Navigator.of(context).pop(); +// }); +// }, +// ); +// Widget continueButton = TextButton( +// child: const Text("NO"), +// onPressed: () { +// Navigator.of(context).pop(); +// }, +// ); + +// // set up the AlertDialog +// AlertDialog alert = AlertDialog( +// title: const Text(""), +// content: Text("Are you sure you want to delete the record $record ?"), +// actions: [ +// cancelButton, +// continueButton, +// ], +// ); + +// // show the dialog +// showDialog( +// context: context, +// builder: (BuildContext context) { +// return alert; +// }, +// ); +// } + +// _displaySnackBar(String msg) { +// final snackBar = SnackBar( +// content: Text( +// msg, +// style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// )); +// ScaffoldMessenger.of(context).showSnackBar(snackBar); +// //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// } + +// Widget makeDismissible({required DraggableScrollableSheet child}) { +// return GestureDetector( +// behavior: HitTestBehavior.opaque, +// onTap: () => Navigator.of(context).pop(), +// child: GestureDetector( +// onTap: () {}, +// child: child, +// ), +// ); +// } + +// void bottomshet(affiliation_data) { +// // print("Aff_index_data: ${affiliation_data}"); +// showModalBottomSheet( +// // isScrollControlled: +// // true, + +// context: context, + +// useRootNavigator: true, +// isScrollControlled: false, +// enableDrag: true, +// useSafeArea: true, +// constraints: const BoxConstraints( +// maxWidth: double.infinity, +// ), + +// shape: RoundedRectangleBorder( +// borderRadius: BorderRadius.vertical( +// top: Radius.circular(0), +// ), +// ), +// clipBehavior: Clip.antiAliasWithSaveLayer, +// // sheetAnimationStyle: _animationStyle, +// builder: (BuildContext context) { +// return +// // makeDismissible( +// // child: +// DraggableScrollableSheet( +// expand: false, +// builder: (BuildContext context, ScrollController scrollController) { +// return Container( +// width: MediaQuery.of(context).size.width, +// //color: Colors.white, +// color: Color.fromARGB(255, 246, 248, 252), + +// // decoration: +// // BoxDecoration(borderRadius: BorderRadius.circular(10)), +// // child: ListView( +// // children: [ + +// // ], +// // ), + +// child: Column( +// children: [ +// Expanded( +// child: ListView.builder( +// controller: scrollController, +// itemCount: 1, +// itemBuilder: (BuildContext context, int index) { +// return Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// mainAxisSize: MainAxisSize.min, +// mainAxisAlignment: MainAxisAlignment.center, +// children: [ +// // Row( +// // children: [ +// // Text( +// // "Affiliation", +// // style: TextStyle(fontSize: 20.0), +// // ) +// // ], +// // ), +// SizedBox( +// height: 18.0, +// ), +// Row( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: GestureDetector( +// onTap: () async { +// final ConfigDataProvider +// configDataProvider = +// ConfigDataProvider(); +// await configDataProvider +// .initConfigUIDataEng(); + +// final provider = +// Provider.of( +// context, +// listen: false); + +// if (getCount( +// provider.intConfigDataList[index] +// .name, +// provider) != +// 0) { +// provider.savedList +// .where((element) => +// element.form == +// provider +// .intConfigDataList[index] +// .name) +// .toList(); +// Navigator.push( +// context, +// MaterialPageRoute( +// builder: +// (BuildContext context) => +// SavedFormListScreen( +// formname: provider +// .intConfigDataList[ +// index] +// .name, +// ))); +// } +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (context) => +// // const InteractionListScreen())); +// }, +// child: Text( +// affiliation_data['org_name'], +// style: TextStyle( +// fontSize: 18.0, +// color: Colors.grey[700]), +// ), +// ), +// ) +// ], +// ), +// SizedBox( +// height: 18.0, +// ), +// Divider(), +// SizedBox( +// height: 8.0, +// ), + +// Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// "Department", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// affiliation_data['dept'], +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// "Role", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// affiliation_data['role'], +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// "Time Frame", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// affiliation_data['time_frame'], +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// "Oraganization Type", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// affiliation_data['org_type'], +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Padding( +// padding: const EdgeInsets.only( +// left: 18.0, top: 18.0), +// child: Text( +// "Eng Type", +// style: TextStyle(fontSize: 13.0), +// ), +// ), +// Padding( +// padding: const EdgeInsets.only(left: 18.0), +// child: Text( +// affiliation_data['emg_type'], +// style: TextStyle( +// fontSize: 15.0, +// color: Colors.grey[700]), +// ), +// ) +// ], +// ), +// ], +// ); +// }, +// ), +// ), +// ], +// ), +// ); +// }, +// ); +// //); +// }, +// ); +// } + +// Widget _buildPaginationDots() { +// return Container( +// padding: EdgeInsets.symmetric(vertical: 8.0), +// child: Row( +// mainAxisAlignment: MainAxisAlignment.center, +// children: List.generate(10, (index) { +// return Container( +// margin: EdgeInsets.symmetric(horizontal: 4.0), +// width: 8.0, +// height: 8.0, +// decoration: BoxDecoration( +// shape: BoxShape.circle, +// color: 1 == index ? Colors.blue : Colors.grey, +// ), +// ); +// }), +// ), +// ); +// } + +// Widget getAppBarUI() { +// return Container( +// decoration: BoxDecoration( +// color: Constants.k2color, +// boxShadow: [ +// BoxShadow( +// color: Colors.grey.withOpacity(0.2), +// offset: const Offset(0, 2), +// blurRadius: 8.0), +// ], +// ), +// child: Padding( +// padding: EdgeInsets.only(top: 2, left: 8, right: 8), +// child: Row( +// children: [ +// Container( +// alignment: Alignment.topLeft, +// // width: AppBar().preferredSize.height, +// // height: AppBar().preferredSize.height, +// child: Material( +// color: Colors.transparent, +// child: InkWell( +// borderRadius: const BorderRadius.all( +// Radius.circular(32.0), +// ), +// onTap: () { +// Navigator.pop(context); +// }, +// child: Padding( +// padding: const EdgeInsets.all(8.0), +// child: Icon( +// Icons.arrow_back_ios_new, +// size: 18, +// color: Colors.white, +// ), +// ), +// ), +// ), +// ), +// Expanded( +// child: Text( +// "", +// maxLines: 1, +// softWrap: true, +// style: TextStyle( +// fontWeight: FontWeight.w600, +// fontSize: 14, +// overflow: TextOverflow.ellipsis, +// ), +// ), +// ), +// ], +// ), +// ), +// ); +// } + +// // Future _launchMailApp() async { +// // final Uri emailLaunchUri = Uri( +// // scheme: 'mailto', +// // path: 'example@example.com', +// // query: encodeQueryParameters({ +// // 'subject': 'Example Subject', +// // 'body': 'Hello, this is a sample body text.', +// // }), +// // ); + +// // if (!await launchUrl(emailLaunchUri)) { +// // throw 'Could not launch $emailLaunchUri'; +// // } +// // } + +// // String? encodeQueryParameters(Map params) { +// // return params.entries +// // .map((MapEntry entry) => +// // Uri.encodeComponent(entry.key) + +// // '=' + +// // Uri.encodeComponent(entry.value)) +// // .join('&'); +// // } + +// Widget listViewTopicCard(String title, String content, bool visible) { +// return Visibility( +// visible: visible, +// child: Card( +// child: Container( +// padding: EdgeInsets.all(8.0), +// width: double.maxFinite, +// decoration: BoxDecoration( +// // color: Color.fromARGB(179, 248, 238, 238), +// // color: Colors.white, +// ), +// child: Padding( +// padding: const EdgeInsets.only(left: 8.0, right: 14.0), +// child: Column( +// crossAxisAlignment: CrossAxisAlignment.start, +// children: [ +// Text( +// title, +// style: TextStyle( +// fontSize: 16, +// fontWeight: FontWeight.bold, +// ), +// ), +// Text( +// content, +// style: TextStyle( +// fontSize: 14, +// color: Colors.grey[700], +// ), +// ), +// ], +// ), +// ), +// ), +// ), +// ); +// } +// } + +// class ContestTabHeader extends SliverPersistentHeaderDelegate { +// ContestTabHeader( +// this.searchUI, +// ); +// final Widget searchUI; + +// @override +// Widget build( +// BuildContext context, double shrinkOffset, bool overlapsContent) { +// return Container(color: Colors.white, child: searchUI); +// } + +// @override +// double get maxExtent => 52.0; + +// @override +// double get minExtent => 52.0; + +// @override +// bool shouldRebuild(SliverPersistentHeaderDelegate oldDelegate) { +// return true; +// } +// } + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +// // import 'package:discover_module/constants.dart'; +// // import 'package:discover_module/custom_widget/text.dart'; +// // import 'package:discover_module/provider_class/affiliationsprovider.dart'; +// // import 'package:discover_module/provider_class/engagement_provider.dart'; +// // import 'package:discover_module/provider_class/events_provider.dart'; +// // import 'package:discover_module/provider_class/medicalinsightprovider.dart'; +// // import 'package:discover_module/provider_class/publications_provider.dart'; +// // import 'package:discover_module/provider_class/speaker_provider.dart'; +// // import 'package:discover_module/provider_class/trials_provider.dart'; +// // import 'package:discover_module/ui_screen/affiliation_data.dart'; +// // import 'package:discover_module/ui_screen/bottom_sheet.dart'; +// // import 'package:discover_module/ui_screen/engagementlist.dart'; +// // import 'package:discover_module/ui_screen/events_data.dart'; +// // import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; +// // import 'package:discover_module/ui_screen/interactionform/configprovider.dart'; +// // import 'package:discover_module/ui_screen/interactionform/edit_interaction_screen.dart'; +// // import 'package:discover_module/ui_screen/interactionform/interactionprovider.dart'; +// // import 'package:discover_module/ui_screen/interactionform/model/save_interaction.dart'; +// // import 'package:discover_module/ui_screen/interactionform/view_forms_list.dart'; +// // import 'package:discover_module/ui_screen/interactionform/view_interaction_screen.dart'; +// // import 'package:discover_module/ui_screen/interactionform/viewinteractionprovider.dart'; +// // import 'package:discover_module/ui_screen/medical_insight.dart'; +// // import 'package:discover_module/ui_screen/newformlist.dart'; +// // import 'package:discover_module/ui_screen/publication_data.dart'; +// // import 'package:flutter/cupertino.dart'; +// // import 'package:flutter/foundation.dart'; +// // import 'package:flutter/material.dart'; +// // import 'package:flutter/rendering.dart'; +// // import 'package:flutter/widgets.dart'; +// // import 'package:flutter_carousel_widget/flutter_carousel_widget.dart'; +// // import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +// // import 'package:provider/provider.dart'; + +// // class NewProfile1 extends StatefulWidget { +// // const NewProfile1({Key? key, required this.text}) : super(key: key); +// // final Map text; + +// // @override +// // State createState() => _NewProfileState(); +// // } + +// // class _NewProfileState extends State { +// // bool isonline = false; +// // List affiliation_data = []; +// // List publication_data = []; +// // List event_data = []; +// // List trial_data = []; +// // List medinsightData = []; +// // List speaker = []; +// // List eng = []; + +// // // final PageController _controller = PageController(viewportFraction: 0.8); +// // final ScrollController _scrollController = ScrollController(); + +// // List viewformData = []; + +// // bool _isExpanded = false; + +// // var item; + +// // List widgetList = ['Geeks', 'for', 'Geeks']; + +// // TextEditingController firstNameController = TextEditingController(); + +// // final List gradients = [ +// // LinearGradient(colors: [ +// // Colors.red, +// // Colors.orange, +// // ]), +// // LinearGradient(colors: [Colors.green, Colors.yellow]), +// // LinearGradient(colors: [Colors.blue, Colors.purple]), +// // LinearGradient(colors: [Colors.pink, Colors.redAccent]), +// // LinearGradient(colors: [Colors.teal, Colors.blueAccent]), +// // ]; + +// // @override +// // void initState() { +// // // TODO: implement initState +// // super.initState(); +// // print("pooja123"); +// // //init(); + +// // getaffiliations(); + +// // getuserdetails(); + +// // print("Widget_isssIndex_iss ${widget.text}"); +// // print( +// // "Widget_isssIndex_iss ${widget.text!["id"]},${widget.text!["name"]},${widget.text!["img_path"]}"); +// // } + +// // init() async { +// // await Provider.of(context, listen: false) +// // .initConfigData(); +// // final data = +// // await Provider.of(context, listen: false); + +// // // if(data.g) +// // data.getRecords("form-3 demo"); +// // // setState(() {}); +// // } + +// // getaffiliations() async { +// // var affiliations = +// // Provider.of(context, listen: false); + +// // await affiliations.getAffiliationsdata(); +// // final affilist = affiliations.adddta; + +// // var publication = Provider.of(context, listen: false); + +// // await publication.publicatininfo(); +// // final publist = publication.publicationlist; + +// // var events = Provider.of(context, listen: false); +// // await events.geteventdata(); +// // final eventlist = events.EventsList; + +// // var form = Provider.of(context, listen: false); +// // // form.savedList; + +// // var trials = Provider.of(context, listen: false); +// // await trials.trialsdata(); + +// // final trialslist = trials.trialsinfo; + +// // var med = Provider.of(context, listen: false); +// // await med.medicalinsightdata(); +// // final medlist = med.trialsinfo; + +// // var speaker11 = +// // Provider.of(context, listen: false); + +// // await speaker11.getspeakerdata(); + +// // final speakerlist = speaker11.speaker; + +// // var engtype = Provider.of(context, listen: false); +// // await engtype.getengagementdata(); +// // final engtypelist = engtype.engagementdata; + +// // setState(() { +// // affiliation_data = affilist; +// // publication_data = publist; +// // event_data = eventlist; +// // viewformData = form.savedList; +// // trial_data = trialslist; +// // medinsightData = medlist; +// // speaker = speakerlist; +// // eng = engtypelist; +// // }); + +// // print("Affiliations_data_is: $affilist"); +// // print("trialslist_data_is: $trialslist"); +// // } + +// // getuserdetails() async { +// // // HiveFunctions.getindexUser(widget.text); + +// // NetworkConnectivity networkConnectivity = NetworkConnectivity(); +// // bool isonline1 = await networkConnectivity.isInternetAvailable(); + +// // setState(() { +// // print("Profile_isOnline: $isonline1"); +// // isonline = isonline1; +// // }); +// // } + +// // @override +// // Widget build(BuildContext context) { +// // var size = MediaQuery.of(context).size; + +// // /*24 is for notification bar on Android*/ +// // final double itemHeight = (size.height - kToolbarHeight - 24) / 2; +// // final double itemWidth = size.width / 2; +// // return Scaffold( +// // body: SafeArea( +// // child: Container( +// // color: Constants.bgcolor, +// // child: Column( +// // children: [ +// // Expanded( +// // child: ListView( +// // children: [ +// // Column( +// // children: [ +// // Stack( +// // clipBehavior: Clip.none, +// // alignment: Alignment.center, +// // children: [ +// // Container( +// // width: MediaQuery.of(context) +// // .size +// // .width, // Adjust width as needed +// // height: 100, // Adjust height as needed +// // decoration: +// // BoxDecoration(color: Constants.k2color), +// // ), +// // Positioned( +// // bottom: -45, +// // child: Container( +// // child: widget.text["img_path"] == null +// // ? ProfilePicture( +// // name: widget.text!["name"], +// // radius: 38, +// // fontsize: 21, +// // ) +// // : ClipOval( +// // child: SizedBox.fromSize( +// // size: Size.fromRadius( +// // 48), // Image radius +// // child: Image.network( +// // widget.text!["img_path"], +// // fit: BoxFit.fill), +// // ), +// // ), +// // ), +// // ) +// // ], +// // ), +// // SizedBox( +// // height: 55.0, +// // ), +// // // Profile photo +// // Column( +// // children: [ +// // Text1( +// // title: "Dr " + widget.text!["name"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 22.0), +// // Text1( +// // title: widget.text!["speciality"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row( +// // mainAxisAlignment: MainAxisAlignment.center, +// // children: [ +// // const Icon( +// // Icons.location_city_sharp, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: +// // //widget.text!["addr"] ?? +// // "Florida Hospital Medical Group Inc", +// // txtcolor: Colors.black, +// // txtfont: 15.0, +// // fontweight: FontWeight.normal, +// // ), +// // // child: RichText( +// // // text: TextSpan( +// // // text: widget.text!["addr"] ?? +// // // "Azienda Ospedaliera di Padova", +// // // style: TextStyle( +// // // fontSize: 16.0, color: Colors.black), +// // // ), +// // // ), +// // ), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.location_pin, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // // child: Text( +// // // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // // style: TextStyle( +// // // fontWeight: FontWeight.bold, fontSize: 14.0), +// // // ), +// // child: Text1( +// // title: widget.text!["adrr"] ?? +// // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), + +// // // child: RichText( +// // // text: TextSpan( +// // // text: widget.text!["adrr"] ?? +// // // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", +// // // style: TextStyle( +// // // fontSize: 16.0, color: Colors.black), +// // // ), +// // // ), +// // ), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.email, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: widget.text!["email"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ]), +// // ), +// // SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.phone, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // // Text( +// // // "+390498212410 X 12", +// // // style: TextStyle( +// // // fontWeight: FontWeight.bold, fontSize: 14.0), +// // // ), +// // Text1( +// // title: widget.text!["phone_no"].toString(), +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ]), +// // ), +// // const SizedBox( +// // height: 8.0, +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Row(children: [ +// // const Icon( +// // Icons.call, +// // color: Color.fromARGB(255, 0, 71, 132), +// // ), +// // const SizedBox( +// // width: 3.0, +// // ), +// // Expanded( +// // child: Text1( +// // title: +// // widget.text!["phone_no"].toString(), +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ]), +// // ), +// // ], +// // ), + +// // const SizedBox( +// // height: 12.0, +// // ), +// // Align( +// // alignment: Alignment.centerLeft, +// // child: Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Text1( +// // title: "Profile Summarry", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 18.0), +// // ), +// // ), +// // const SizedBox( +// // height: 5.0, +// // ), +// // Align( +// // alignment: Alignment.centerLeft, +// // child: Padding( +// // padding: const EdgeInsets.only(left: 8.0), +// // child: Text1( +// // title: widget.text!["summarry"], +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 15.0), +// // ), +// // ), + +// // ExpandableCarousel( +// // options: CarouselOptions( +// // slideIndicator: CircularWaveSlideIndicator( +// // alignment: Alignment.bottomCenter, +// // currentIndicatorColor: Constants.k2color1, +// // indicatorBackgroundColor: Colors.grey, +// // // padding: EdgeInsets.only(: 10), +// // ), +// // autoPlay: true, +// // autoPlayInterval: const Duration(seconds: 2), +// // ), +// // // items: [1, 2, 3, 4, 5].map((i) { +// // items: [1, 2, 3, 4, 5].asMap().entries.map((entry) { +// // int index = entry.key; + +// // return Builder( +// // builder: (BuildContext context) { +// // return Center( +// // child: Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(10), +// // ), +// // child: Container( +// // decoration: BoxDecoration( +// // gradient: gradients[index % +// // gradients +// // .length], // Apply gradient +// // borderRadius: +// // BorderRadius.circular(10), +// // ), +// // child: Padding( +// // padding: EdgeInsets.all(10.0), +// // child: Column( +// // mainAxisSize: MainAxisSize.min, +// // crossAxisAlignment: +// // CrossAxisAlignment.start, +// // children: [ +// // const Text( +// // "Top Event Topics", +// // style: TextStyle( +// // fontSize: 16.0, +// // fontWeight: FontWeight.bold, +// // color: Colors.white), +// // ), +// // const SizedBox( +// // height: 10.0, +// // ), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 10), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text( +// // "Angina Pectoris"), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // SizedBox(height: 5), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text( +// // "Coronary Artery Disease", +// // softWrap: true), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // SizedBox(height: 5), +// // Row( +// // children: [ +// // Container( +// // decoration: BoxDecoration( +// // color: Constants.cardtext, +// // borderRadius: +// // BorderRadius.circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 5.0), +// // child: Row( +// // children: [ +// // Text("Hypertension"), +// // SizedBox(width: 5.0), +// // Container( +// // decoration: +// // BoxDecoration( +// // color: Constants +// // .cardtextdark, +// // borderRadius: +// // BorderRadius +// // .circular( +// // 5), +// // ), +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(1.0), +// // child: Text( +// // "(378)", +// // style: TextStyle( +// // color: Colors +// // .black), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ], +// // ), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ); +// // }, +// // ); +// // }).toList(), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: +// // const EdgeInsets.symmetric(horizontal: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // color: Constants +// // .k2color11, // Replace with Constants.k2color11 +// // child: ExpansionTile( +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: Constants +// // .k2color11, // Replace with Constants.k2color11 +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.black, +// // ), +// // title: Row( +// // children: [ +// // Text( +// // "Sentiment Score", +// // style: TextStyle( +// // color: Colors.black, +// // fontWeight: FontWeight.normal, +// // fontSize: 17.0, +// // ), +// // ), +// // const SizedBox(width: 8.0), +// // Text( +// // "(3)", +// // style: TextStyle( +// // color: Colors.black, +// // fontWeight: FontWeight.normal, +// // fontSize: 17.0, +// // ), +// // ), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of(context).size.width, +// // ), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Product', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600), +// // ), +// // ), +// // ), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Aissel Engagement', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600), +// // ), +// // ), +// // ), +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // publication_data.length, +// // (index) => DataRow( +// // onSelectChanged: (value) { +// // showModalBottomSheet( +// // useRootNavigator: true, +// // isScrollControlled: false, +// // enableDrag: true, +// // useSafeArea: true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double.infinity, +// // ), +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.vertical( +// // top: Radius.circular(0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: context, +// // builder: (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell( +// // Text( +// // publication_data[index] +// // ['artical_title'] ?? +// // '', +// // softWrap: true, +// // ), +// // ), +// // DataCell( +// // Text( +// // publication_data[index] +// // ['author'] ?? +// // '', +// // softWrap: true, +// // ), +// // ), +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData(), +// // ), +// // ); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Colors +// // .blue), // Replace with Constants.k2color +// // ), +// // style: OutlinedButton.styleFrom( +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // ), + +// // SizedBox( +// // height: 10.0, +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: +// // const EdgeInsets.only(left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons.keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Note", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(0)", +// // txtcolor: Colors.black, +// // fontweight: FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: TextField( +// // decoration: InputDecoration( +// // border: OutlineInputBorder( +// // borderRadius: +// // BorderRadius.circular(8.0), +// // ), +// // hintText: 'Write your note here', +// // contentPadding: EdgeInsets.all(16.0), +// // ), +// // maxLines: +// // null, // Allows the TextField to expand vertically +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Save', +// // style: TextStyle( +// // color: Constants.k2color), +// // ), +// // style: OutlinedButton.styleFrom( +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(12), +// // ), +// // ), +// // ), +// // ), +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // SizedBox( +// // height: 10.0, +// // ), +// // ], +// // ), +// // Container( +// // // color: Colors.black, +// // height: MediaQuery.sizeOf(context).height * 0.7, +// // width: MediaQuery.sizeOf(context).width, +// // child: DefaultTabController( +// // length: 3, + +// // child: Column( +// // children: [ +// // Container( +// // color: Constants.bgcolor2, +// // child: const TabBar( +// // indicatorColor: Colors.white, +// // labelColor: Colors +// // .white, // Color of the selected tab text + +// // unselectedLabelColor: +// // Color.fromARGB(255, 163, 159, 159), +// // tabs: [ +// // // Tab(text: "Sentiment"), +// // Tab( +// // // text: "Related " +// // child: Text( +// // 'Related', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), +// // Tab( +// // // text: "Activities " +// // child: Text( +// // 'Activities', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), +// // Tab( +// // //text: "Engagement " + +// // child: Text( +// // 'Engagement', +// // style: TextStyle( +// // fontWeight: FontWeight.bold, +// // fontSize: 17.0), +// // ), +// // ), + +// // // Tab(icon: Icon(Icons.email)), +// // ], +// // ), +// // ), +// // // TabBarView +// // Expanded( +// // child: TabBarView( +// // children: [ +// // ListView(children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Locations", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // const RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Phone Numbers", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'phone Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Location', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Emails", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Email Type', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Email', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Staff/Assistant", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Location', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), + +// // ///elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "State License", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'License No', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'State', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Institution'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'Address'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // ], +// // ]), +// // ListView(children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Affiliations", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // // width: +// // // MediaQuery.of(context) +// // // .size +// // // .width, +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Organization Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Time Frame', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // affiliation_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${affiliation_data[index]}"); + +// // bottomshet( +// // affiliation_data[ +// // index]); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // affiliation_data[ +// // index] +// // [ +// // 'org_name'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // affiliation_data[ +// // index] +// // [ +// // 'time_frame'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // AffiliationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Publications", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // //isAlwaysShown: true, +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Artical Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: true), +// // )), + +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Authors', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), + +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[ +// // index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // publication_data[ +// // index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Events", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: +// // BoxConstraints( +// // minWidth: MediaQuery.of( +// // context) +// // .size +// // .width, +// // ), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Event Name', +// // softWrap: true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600)), +// // )), + +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Role', +// // softWrap: +// // true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), + +// // // Add more columns as needed +// // ], +// // rows: List.generate( +// // event_data.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${event_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // event_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // event_data[index] +// // [ +// // 'event_name'] +// // .toString(), +// // softWrap: +// // true)), + +// // DataCell(Text( +// // event_data[index] +// // [ +// // 'role'] +// // .toString(), +// // softWrap: +// // true)), + +// // // Add more DataCells as needed +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EventsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons.keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Trials", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Trial Name', +// // softWrap: true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600)), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Status', +// // softWrap: +// // true, +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // trial_data.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${trial_data[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: Clip +// // .antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // trial_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // trial_data[index] +// // [ +// // 'trial_name'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // trial_data[index] +// // [ +// // 'status'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets.all( +// // 8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EventsData())); +// // }, +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image +// // ]), + +// // // +// // ListView( +// // children: [ +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // // initiallyExpanded: true, +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Medical Insight", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Container( +// // width: +// // MediaQuery.of(context) +// // .size +// // .width, + +// // /// 5, +// // color: Colors.white, +// // child: Consumer< +// // MediacalInsightProvider>( +// // builder: (BuildContext +// // context, +// // value, +// // Widget? child) { +// // print( +// // "med1 : ${value.med.length}"); + +// // if (value.med.length != +// // 0) { +// // return ListView.builder( +// // physics: +// // const ScrollPhysics(), +// // // scrollDirection: Axis.vertical, +// // shrinkWrap: true, +// // itemCount: value.med +// // .take(2) +// // .length, +// // itemBuilder: +// // (context, +// // index) { +// // item = value +// // .med[index]; + +// // print( +// // "Item_Medical_insight ${item['Therapeutic Area']}"); +// // return Padding( +// // padding: +// // const EdgeInsets +// // .all( +// // 8.0), +// // child: Card( +// // margin: +// // EdgeInsets +// // .zero, + +// // elevation: 4, +// // surfaceTintColor: +// // Colors +// // .white, +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .zero, +// // ), + +// // child: +// // SizedBox( +// // width: MediaQuery.sizeOf( +// // context) +// // .width, +// // child: +// // ListTile( +// // dense: +// // true, +// // title: +// // Column( +// // // crossAxisAlignment: CrossAxisAlignment.center, +// // children: [ +// // // Text( +// // // "Acute neurology is the therapeutic area of the medical insight for Product A. The age of treatment is the topic of interest for this source type publication."), + +// // RichText( +// // text: +// // TextSpan( +// // text: '', +// // style: DefaultTextStyle.of(context).style, +// // children: const [ +// // TextSpan(text: 'Acute neurology ', style: TextStyle(fontWeight: FontWeight.bold)), +// // // TextSpan( +// // // text: ' therapeutic area ', +// // // style: TextStyle( +// // // fontWeight: +// // // FontWeight.bold)), +// // TextSpan(text: 'is the therapeutic area of the medical insight for '), +// // TextSpan(text: 'Product A. The age of treatment', style: TextStyle(fontWeight: FontWeight.bold)), +// // TextSpan(text: ' is the topic of interest for this source type'), +// // TextSpan(text: ' publication.', style: TextStyle(fontWeight: FontWeight.bold)), +// // ], +// // ), +// // ), + +// // const Padding( +// // padding: +// // EdgeInsets.all(8.0), +// // child: +// // Row( +// // mainAxisAlignment: MainAxisAlignment.spaceBetween, +// // children: [ +// // Row( +// // children: [ +// // Icon( +// // Icons.person, +// // size: 20, +// // ), +// // Text( +// // "pooja", +// // style: TextStyle(fontSize: 14.0), +// // ) +// // ], +// // ), +// // Row( +// // children: [ +// // Icon( +// // Icons.calendar_today, +// // size: 20, +// // ), +// // Text( +// // "11/11/2022 ", +// // style: TextStyle(fontSize: 14.0), +// // ) +// // ], +// // ) +// // ], +// // ), +// // ), +// // ], +// // ), +// // ), +// // ), +// // // shape: BorderRadius.only(bottomRight: Radius.circular(50)), +// // ), +// // ); +// // }); +// // } else { +// // return Container( +// // color: Colors.white, +// // width: MediaQuery.of( +// // context) +// // .size +// // .width, +// // child: Column( +// // children: [ +// // Text( +// // "No records"), +// // ], +// // ), +// // ); +// // } +// // }), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // const MedicalInsight1())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // //mainAxisSize: MainAxisSize.min, +// // children: [ +// // GestureDetector( +// // onTap: () async { +// // final provider = Provider +// // .of( +// // context, +// // listen: false); +// // if (getCount( +// // provider +// // .intConfigDataList[ +// // 0] +// // .name, +// // provider) != +// // 0) { +// // provider.savedList +// // .where((element) => +// // element +// // .form == +// // provider +// // .intConfigDataList[ +// // 0] +// // .name) +// // .toList(); +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext +// // context) => +// // SavedFormListScreen( +// // formname: provider +// // .intConfigDataList[0] +// // .name, +// // ))); +// // } +// // }, +// // child: Text1( +// // title: "Interactions", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ), +// // const SizedBox( +// // width: 8.0, +// // ), +// // ], +// // ), +// // children: [ +// // Container( +// // height: +// // MediaQuery.of(context) +// // .size +// // .height / +// // 5, +// // color: Colors.white, +// // child: Consumer< +// // ViewInteractionProvider>( +// // builder: (BuildContext +// // context, +// // provider, +// // Widget? child) { +// // print( +// // "P_leangth : ${provider.savedList.length}"); + +// // if (provider.savedList +// // .length != +// // 0) { +// // return ListView.builder( +// // shrinkWrap: true, +// // physics: +// // NeverScrollableScrollPhysics(), +// // itemCount: provider +// // .savedList +// // .take(2) +// // .length, +// // itemBuilder: +// // (context, +// // index) { +// // print( +// // "Indexxxxxx $index"); +// // return Column( +// // children: [ +// // ListTile( +// // subtitle: +// // Text( +// // 'Updated on ${provider.savedList[index].updatedTime}', +// // //style: TextStyle(fontStyle: FontStyle.italic), +// // ), +// // title: Text( +// // provider +// // .savedList[ +// // index] +// // .id, +// // ), +// // trailing: +// // SizedBox( +// // width: +// // 150, +// // child: Row( +// // children: [ +// // IconButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => ViewInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))); +// // }, +// // icon: const Icon( +// // Icons.info_outline, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // IconButton( +// // onPressed: () async { +// // await provider.initConfigData().then({ +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => EditInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))) +// // }); +// // }, +// // icon: const Icon( +// // Icons.edit, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // IconButton( +// // onPressed: () { +// // showDeleteRecordAlertDialog(context, provider.savedList[index].id, provider.savedList[index]); +// // }, +// // icon: const Icon( +// // Icons.delete, +// // size: 24, +// // color: Color.fromARGB(255, 8, 39, 92), +// // ), +// // ), +// // ]), +// // ), +// // onTap: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext context) => ViewInteractionScreen( +// // saveInteraction: provider.savedList[index], +// // ))); +// // }, +// // ), +// // const Divider(), +// // ], +// // ); +// // }); +// // } else { +// // return Container( +// // color: Colors.white, +// // width: MediaQuery.of( +// // context) +// // .size +// // .width, +// // child: Column( +// // children: [ +// // Text( +// // "No records"), +// // ], +// // ), +// // ); +// // } +// // }), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // final provider = +// // Provider.of< +// // InteractionProvider>( +// // context, +// // listen: +// // false); +// // if (getCount( +// // provider +// // .intConfigDataList[ +// // 0] +// // .name, +// // provider) != +// // 0) { +// // provider.savedList +// // .where((element) => +// // element +// // .form == +// // provider +// // .intConfigDataList[ +// // 0] +// // .name) +// // .toList(); +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (BuildContext +// // context) => +// // SavedFormListScreen( +// // formname: +// // provider.intConfigDataList[0].name, +// // ))); +// // } +// // }, +// // child: +// // Text('Show More'), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Speaker Evalution", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(4)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Program Topic', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Speaker Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // speaker.length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${speaker[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // speaker[ +// // index]); +// // }, +// // ); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // speaker[index] +// // [ +// // 'programtopic'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // speaker[index] +// // [ +// // 'speakername'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // // Navigator.push( +// // // context, +// // // MaterialPageRoute( +// // // builder: (_) => +// // // AffiliationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Engagement", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Main Therapeutic Area', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // ), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Date', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // eng.take(2).length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // // =======> Use onSelectChanged for tab +// // print( +// // "message ${eng[index]}"); + +// // // bsheet( +// // // publication_data[ +// // // index]); +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // eng[index]); +// // }, +// // ); +// // }, +// // color: MaterialStateProperty +// // .resolveWith< +// // Color?>((Set< +// // MaterialState> +// // states) { +// // if (index +// // .isEven) { +// // return Colors +// // .grey +// // .withOpacity( +// // 0.1); +// // } +// // return null; +// // }), +// // cells: [ +// // DataCell(Text( +// // eng[index][ +// // 'main thereutic area'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // eng[index][ +// // 'date'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // EngagementList())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "NIH Grants", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'NIH Center', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Organization Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Procedures", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Program Year', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Procedure', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Patents", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Patent Title', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Status', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // //elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: +// // "Patient Referrals", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 17.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: +// // Expanded( +// // child: Text( +// // 'Referred By', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type of Referrals', +// // style: +// // TextStyle(fontWeight: FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => +// // DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: +// // double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular(0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: +// // (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: +// // OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // backgroundColor: +// // Constants.k2color11, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Training", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Institute Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Degree', +// // style: TextStyle( +// // fontWeight: +// // FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular( +// // 0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), // adds spacing between the text and image + +// // ListTileTheme( +// // dense: true, +// // child: Padding( +// // padding: const EdgeInsets.only( +// // left: 8.0, right: 8.0), +// // child: Container( +// // child: Card( +// // margin: EdgeInsets.all(1.0), +// // // elevation: 5, +// // shape: RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius.circular(0.0), +// // ), +// // color: Constants.k2color11, +// // child: ExpansionTile( +// // backgroundColor: +// // Constants.k2color11, +// // initiallyExpanded: false, +// // maintainState: true, +// // // backgroundColor: Colors.white, +// // // collapsedBackgroundColor: Color(0xFF2b9af3), +// // onExpansionChanged: +// // (bool expanded) { +// // setState(() { +// // _isExpanded = expanded; +// // }); +// // }, +// // trailing: Icon( +// // _isExpanded +// // ? Icons +// // .keyboard_arrow_up +// // : Icons +// // .keyboard_arrow_down, +// // color: Colors.black), +// // title: Row( +// // mainAxisAlignment: +// // MainAxisAlignment.start, +// // // mainAxisSize: MainAxisSize.min, +// // children: [ +// // Text1( +// // title: "Case", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // const SizedBox( +// // width: 8.0, +// // ), +// // Text1( +// // title: "(3)", +// // txtcolor: +// // Colors.black, +// // fontweight: +// // FontWeight.normal, +// // txtfont: 16.0), +// // ], +// // ), +// // children: [ +// // Scrollbar( +// // child: +// // SingleChildScrollView( +// // scrollDirection: +// // Axis.horizontal, +// // child: Container( +// // constraints: BoxConstraints( +// // minWidth: +// // MediaQuery.of( +// // context) +// // .size +// // .width), +// // color: Colors.white, +// // child: DataTable( +// // showCheckboxColumn: +// // false, +// // columns: const [ +// // DataColumn( +// // label: +// // Expanded( +// // child: Text( +// // 'Name', +// // style: TextStyle( +// // fontWeight: +// // FontWeight +// // .w600), +// // softWrap: +// // true), +// // )), +// // DataColumn( +// // label: Expanded( +// // child: Text( +// // 'Type', +// // style: +// // TextStyle(fontWeight: FontWeight.w600)))), +// // ], +// // rows: List.generate( +// // publication_data +// // .length, +// // (index) => +// // DataRow( +// // onSelectChanged: +// // (value) { +// // print( +// // "message ${publication_data[index]}"); + +// // showModalBottomSheet( +// // useRootNavigator: +// // true, +// // isScrollControlled: +// // false, +// // enableDrag: +// // true, +// // useSafeArea: +// // true, +// // constraints: +// // const BoxConstraints( +// // maxWidth: +// // double +// // .infinity, +// // ), +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .vertical( +// // top: Radius +// // .circular(0), +// // ), +// // ), +// // clipBehavior: +// // Clip.antiAliasWithSaveLayer, +// // context: +// // context, +// // builder: +// // (context) { +// // return bsheet( +// // publication_data[ +// // index]); +// // }, +// // ); +// // }, +// // cells: [ +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'artical_title'] +// // .toString(), +// // softWrap: +// // true)), +// // DataCell(Text( +// // publication_data[index] +// // [ +// // 'author'] +// // .toString(), +// // softWrap: +// // true)), +// // ], +// // ), +// // ), +// // ), +// // ), +// // ), +// // ), +// // Container( +// // color: Colors.white, +// // child: Align( +// // alignment: +// // Alignment.center, +// // child: Padding( +// // padding: +// // const EdgeInsets +// // .all(8.0), +// // child: OutlinedButton( +// // onPressed: () { +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: +// // (_) => +// // PublicationsData())); +// // }, +// // child: Text( +// // 'Show More', +// // style: TextStyle( +// // color: Constants +// // .k2color), +// // ), +// // style: +// // OutlinedButton +// // .styleFrom( +// // shape: +// // RoundedRectangleBorder( +// // borderRadius: +// // BorderRadius +// // .circular( +// // 12), +// // ), +// // ), +// // ), +// // ), +// // ), +// // ) +// // ]), +// // ), +// // ), +// // ), +// // ), // adds spacing between the text and image +// // ], +// // ), +// // // Center(child: Icon(Icons.email)), +// // ], +// // ), +// // ), +// // // Other widgets below TabBarView +// // ], +// // ), +// // // ), +// // ), +// // ), +// // ], +// // ), +// // ), +// // ], +// // ), +// // ), +// // // ), +// // ), +// // floatingActionButton: Visibility( +// // visible: true, +// // child: FloatingActionButton( +// // onPressed: () async { +// // // final ConfigDataProvider configDataProvider = +// // // ConfigDataProvider(); + +// // // await configDataProvider.initConfigUIData(); +// // Navigator.push( +// // context, MaterialPageRoute(builder: (context) => FormList())); +// // }, +// // foregroundColor: Colors.white, +// // backgroundColor: const Color.fromARGB(255, 0, 71, 132), +// // child: new Icon(Icons.add), +// // ), +// // ), +// // ); +// // } + +// // Future getCount(String form, InteractionProvider provider) async { +// // await provider.getRecords(); + +// // return provider.savedList.where((element) => element.form == form).length; +// // } + +// // buidCard() { +// // Text("Hiii"); +// // } + +// // showDeleteRecordAlertDialog( +// // BuildContext context, String record, SaveInteraction saveInteraction) { +// // // set up the buttons +// // ViewInteractionProvider provider = +// // Provider.of(context, listen: false); +// // Widget cancelButton = TextButton( +// // child: const Text("YES"), +// // onPressed: () async { +// // await provider.deleteRecord(saveInteraction).then((value) { +// // _displaySnackBar("Deleted sucessfully!"); +// // Navigator.of(context).pop(); +// // }); +// // }, +// // ); +// // Widget continueButton = TextButton( +// // child: const Text("NO"), +// // onPressed: () { +// // Navigator.of(context).pop(); +// // }, +// // ); + +// // // set up the AlertDialog +// // AlertDialog alert = AlertDialog( +// // title: const Text(""), +// // content: Text("Are you sure you want to delete the record $record ?"), +// // actions: [ +// // cancelButton, +// // continueButton, +// // ], +// // ); + +// // // show the dialog +// // showDialog( +// // context: context, +// // builder: (BuildContext context) { +// // return alert; +// // }, +// // ); +// // } + +// // _displaySnackBar(String msg) { +// // final snackBar = SnackBar( +// // content: Text( +// // msg, +// // style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), +// // )); +// // ScaffoldMessenger.of(context).showSnackBar(snackBar); +// // //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); +// // } + +// // Widget makeDismissible({required DraggableScrollableSheet child}) { +// // return GestureDetector( +// // behavior: HitTestBehavior.opaque, +// // onTap: () => Navigator.of(context).pop(), +// // child: GestureDetector( +// // onTap: () {}, +// // child: child, +// // ), +// // ); +// // } + +// // void bottomshet(affiliation_data) { +// // // print("Aff_index_data: ${affiliation_data}"); +// // showModalBottomSheet( +// // // isScrollControlled: +// // // true, + +// // context: context, + +// // useRootNavigator: true, +// // isScrollControlled: false, +// // enableDrag: true, +// // useSafeArea: true, +// // constraints: const BoxConstraints( +// // maxWidth: double.infinity, +// // ), + +// // shape: RoundedRectangleBorder( +// // borderRadius: BorderRadius.vertical( +// // top: Radius.circular(0), +// // ), +// // ), +// // clipBehavior: Clip.antiAliasWithSaveLayer, +// // // sheetAnimationStyle: _animationStyle, +// // builder: (BuildContext context) { +// // return +// // // makeDismissible( +// // // child: +// // DraggableScrollableSheet( +// // expand: false, +// // builder: (BuildContext context, ScrollController scrollController) { +// // return Container( +// // width: MediaQuery.of(context).size.width, +// // //color: Colors.white, +// // color: Color.fromARGB(255, 246, 248, 252), + +// // // decoration: +// // // BoxDecoration(borderRadius: BorderRadius.circular(10)), +// // // child: ListView( +// // // children: [ + +// // // ], +// // // ), + +// // child: Column( +// // children: [ +// // Expanded( +// // child: ListView.builder( +// // controller: scrollController, +// // itemCount: 1, +// // itemBuilder: (BuildContext context, int index) { +// // return Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // mainAxisSize: MainAxisSize.min, +// // mainAxisAlignment: MainAxisAlignment.center, +// // children: [ +// // // Row( +// // // children: [ +// // // Text( +// // // "Affiliation", +// // // style: TextStyle(fontSize: 20.0), +// // // ) +// // // ], +// // // ), +// // SizedBox( +// // height: 18.0, +// // ), +// // Row( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: GestureDetector( +// // onTap: () async { +// // final ConfigDataProvider +// // configDataProvider = +// // ConfigDataProvider(); +// // await configDataProvider +// // .initConfigUIDataEng(); + +// // final provider = +// // Provider.of( +// // context, +// // listen: false); + +// // if (getCount( +// // provider.intConfigDataList[index] +// // .name, +// // provider) != +// // 0) { +// // provider.savedList +// // .where((element) => +// // element.form == +// // provider +// // .intConfigDataList[index] +// // .name) +// // .toList(); +// // Navigator.push( +// // context, +// // MaterialPageRoute( +// // builder: +// // (BuildContext context) => +// // SavedFormListScreen( +// // formname: provider +// // .intConfigDataList[ +// // index] +// // .name, +// // ))); +// // } +// // // Navigator.push( +// // // context, +// // // MaterialPageRoute( +// // // builder: (context) => +// // // const InteractionListScreen())); +// // }, +// // child: Text( +// // affiliation_data['org_name'], +// // style: TextStyle( +// // fontSize: 18.0, +// // color: Colors.grey[700]), +// // ), +// // ), +// // ) +// // ], +// // ), +// // SizedBox( +// // height: 18.0, +// // ), +// // Divider(), +// // SizedBox( +// // height: 8.0, +// // ), + +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // "Department", +// // style: TextStyle(fontSize: 13.0), +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // affiliation_data['dept'], +// // style: TextStyle( +// // fontSize: 15.0, +// // color: Colors.grey[700]), +// // ), +// // ) +// // ], +// // ), +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only( +// // left: 18.0, top: 18.0), +// // child: Text( +// // "Role", +// // style: TextStyle(fontSize: 13.0), +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // affiliation_data['role'], +// // style: TextStyle( +// // fontSize: 15.0, +// // color: Colors.grey[700]), +// // ), +// // ) +// // ], +// // ), +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only( +// // left: 18.0, top: 18.0), +// // child: Text( +// // "Time Frame", +// // style: TextStyle(fontSize: 13.0), +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // affiliation_data['time_frame'], +// // style: TextStyle( +// // fontSize: 15.0, +// // color: Colors.grey[700]), +// // ), +// // ) +// // ], +// // ), +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only( +// // left: 18.0, top: 18.0), +// // child: Text( +// // "Oraganization Type", +// // style: TextStyle(fontSize: 13.0), +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // affiliation_data['org_type'], +// // style: TextStyle( +// // fontSize: 15.0, +// // color: Colors.grey[700]), +// // ), +// // ) +// // ], +// // ), +// // Column( +// // crossAxisAlignment: CrossAxisAlignment.start, +// // children: [ +// // Padding( +// // padding: const EdgeInsets.only( +// // left: 18.0, top: 18.0), +// // child: Text( +// // "Eng Type", +// // style: TextStyle(fontSize: 13.0), +// // ), +// // ), +// // Padding( +// // padding: const EdgeInsets.only(left: 18.0), +// // child: Text( +// // affiliation_data['emg_type'], +// // style: TextStyle( +// // fontSize: 15.0, +// // color: Colors.grey[700]), +// // ), +// // ) +// // ], +// // ), +// // ], +// // ); +// // }, +// // ), +// // ), +// // ], +// // ), +// // ); +// // }, +// // ); +// // //); +// // }, +// // ); +// // } + +// // Widget _buildPaginationDots() { +// // return Container( +// // padding: EdgeInsets.symmetric(vertical: 8.0), +// // child: Row( +// // mainAxisAlignment: MainAxisAlignment.center, +// // children: List.generate(10, (index) { +// // return Container( +// // margin: EdgeInsets.symmetric(horizontal: 4.0), +// // width: 8.0, +// // height: 8.0, +// // decoration: BoxDecoration( +// // shape: BoxShape.circle, +// // color: 1 == index ? Colors.blue : Colors.grey, +// // ), +// // ); +// // }), +// // ), +// // ); +// // } + +// // @override +// // void dispose() { +// // //_pageController.dispose(); +// // super.dispose(); +// // } +// // } diff --git a/lib/contacts_module/ui_screen/new_viewinteraction.dart b/lib/contacts_module/ui_screen/new_viewinteraction.dart new file mode 100644 index 0000000..1d63cc4 --- /dev/null +++ b/lib/contacts_module/ui_screen/new_viewinteraction.dart @@ -0,0 +1,539 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/interaction_data.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/custombutton.dart'; +// import 'package:konectar_events/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/custombutton.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/widget/responsive_ext.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +// ignore: must_be_immutable +class ViewInteractionScreen1 extends StatefulWidget { + SaveInteraction saveInteraction; + ViewInteractionScreen1({super.key, required this.saveInteraction}); + + @override + State createState() => _ViewInteractionScreenState(); +} + +class _ViewInteractionScreenState extends State { + List interactionReponseList = []; + List sectionList = []; + List textEditingControllerList = []; + int textfieldIndex = 0; + String dropdownvalue = 'Select value'; + String? fileName; + final TextEditingController textEditingController = TextEditingController(); + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + init(); + }); + + super.initState(); + } + + init() async { + await Provider.of(context, listen: false) + .initSavedForm(widget.saveInteraction); + setState(() {}); + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + print("build context"); + print("${provider.interactionReponseList}"); + return GestureDetector( + onTap: () { + FocusScope.of(context).requestFocus(FocusNode()); + }, + child: OrientationBuilder(builder: (context, orientation) { + return SafeArea( + child: Scaffold( + backgroundColor: Colors.white, + //resizeToAvoidBottomInset: false, + appBar: AppBar( + title: Text( + widget.saveInteraction.id, + style: TextStyle( + fontSize: isTablet ? 22 : 14, color: Colors.white), + ), + // backgroundColor: const Color(0xFF2b9af3), + automaticallyImplyLeading: false, + leading: InkWell( + onTap: () { + Navigator.pop(context); + }, + child: const Icon( + Icons.arrow_back_ios, + color: Colors.white, + ), + ), + ), + body: Column( + mainAxisSize: MainAxisSize.min, + children: [ + Expanded( + child: ListView.builder( + itemCount: provider.interactionReponseList.length, + cacheExtent: double.parse( + provider.interactionReponseList.length.toString()), + itemBuilder: (context, index) { + var item = provider.interactionReponseList[index]; + sectionList = item.sectionList; + return Card( + elevation: 4, + // color: Constants.k2color, + child: Container( + color: Color.fromARGB(255, 246, 248, 252), + child: ExpansionTile( + dense: true, + initiallyExpanded: true, + title: Stack( + alignment: AlignmentDirectional.center, + children: [ + Container( + // height: double.infinity, + width: double.infinity, + padding: const EdgeInsets.all(0.0), + decoration: BoxDecoration( + // color: Color(0xFF2b9af3), + // color: Constants.k2color, + ), + child: Text( + item.sectionName, + style: const TextStyle( + color: Colors.black, + fontWeight: FontWeight.normal, + fontSize: 18.0), + )), + ]), + children: [ + Container( + color: Colors.white, + child: Padding( + padding: + const EdgeInsets.only(top: 0.0), + child: Column( + mainAxisSize: MainAxisSize.min, + crossAxisAlignment: + CrossAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0), + child: GridView.count( + physics: + const NeverScrollableScrollPhysics(), + crossAxisCount: + context.responsive( + 1, + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : 3, // large + xl: 3, // extra large screen + ), + mainAxisSpacing: + sectionList.length == 1 || + !isTablet + ? 1 + : 3.5, + childAspectRatio: + sectionList.length == 1 + ? orientation == + Orientation + .landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 5.5, + shrinkWrap: true, + padding: EdgeInsets.zero, + children: List.generate( + sectionList.length, + (i) { + print(sectionList); + SectionList sectionItem = + sectionList[i]; + dropdownvalue = sectionItem + .widget == + InteractionWidget + .DROPDOWN + ? sectionItem.value ?? + "Select" + : ' '; + List< + InputClass> list = sectionItem + .widget == + InteractionWidget + .DROPDOWN || + sectionItem + .widget == + InteractionWidget + .AUTOCOMPLETE || + sectionItem + .widget == + InteractionWidget + .MULTISELECT + ? provider.getData2( + sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == + InteractionWidget + .CHECKBOX + ? provider.getData2( + sectionItem) + : []; + + return Column( + crossAxisAlignment: + CrossAxisAlignment + .start, + children: [ + sectionItem.widget == + InteractionWidget + .BUTTON && + sectionItem + .param == + 'add' + ? const SizedBox + .shrink() + : Text( + '${sectionItem.name}:*', + style: TextStyle( + color: Constants + .k2color, + fontSize: + isTablet + ? 18 + : 12, + fontWeight: + FontWeight + .normal), + ), + returnWidget( + sectionItem: + sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: index, + widgetData: + sectionItem + .widget!), + ], + ); + }, + ), + ), + ), + + item.multiple + ? gridViewWidget( + provider, + item.sectionName, + item.multipleList ?? [], + orientation, + item, + index) + : const SizedBox.shrink(), + provider.interactionReponseList + .length == + index - 1 + ? saveActions(provider) + : const SizedBox.shrink() + //const Spacer(), + ], + ), + ), + ), + ]), + ), + ); + }, + ), + ), + // const Spacer(), + // saveActions(provider), + ], + )), + ); + }), + ); + }); + } + + Widget returnWidget({ + required SectionList sectionItem, + required FormFieldData item, + required InteractionProvider provider, + required List list, + required int gridIndex, + required int listIndex, + required InteractionWidget widgetData, + }) { + switch (widgetData) { + case InteractionWidget.CHECKBOX: + return (sectionItem.inputList!.length >= 5) + ? Text(sectionItem.selectedValue.toString()) + : Text(provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last)); + + case InteractionWidget.AUTOCOMPLETE: + return Text(provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last)); + + case InteractionWidget.MULTISELECT: + return Text(sectionItem.selectedValue.toString()); + + case InteractionWidget.RADIO: + return (sectionItem.inputList!.length >= 5) + ? Text( + sectionItem.selectedValue!.isNotEmpty + ? provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last) + : " ", + style: TextStyle(fontSize: 18.0), + ) + : Text( + provider.getDataValue( + sectionItem.id, + sectionItem.selectedValue!.last, + ), + style: TextStyle(fontSize: 18.0), + ); + + case InteractionWidget.LABEL: + return Text( + sectionItem.input!, + style: TextStyle(fontSize: 18.0), + ); + + case InteractionWidget.RANGESLIDER: + return Text(sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.last.toString() + : " "); + + case InteractionWidget.TEXT: + return Text( + sectionItem.selectedValue!.isNotEmpty + ? sectionItem.selectedValue!.last.toString() + : " ", + style: TextStyle(fontSize: 18.0), + ); + + case InteractionWidget.BUTTON: + return sectionItem.input == "chooseFile" + ? sectionItem.selectedValue!.isNotEmpty + ? const Text("File Uploaded") + : const Text(" ") + : const Text(" "); + default: + return Text(sectionItem.selectedValue!.isNotEmpty + ? provider.getDataValue( + sectionItem.id, sectionItem.selectedValue!.last) + : " "); + } + } + + Widget saveActions(InteractionProvider provider) { + return Align( + alignment: Alignment.centerRight, + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: [ + CustomButton( + backgroundColor: Colors.red.shade800, + onPressed: () { + //showDeleteProfileAlertDialog(context); + for (var textcontrollers in provider.textEditingControllerList) { + textcontrollers.text = ''; + } + }, + textColor: Colors.white, + title: "Reset", + height: 40, + width: isTablet ? 100 : 60, + fontsize: isTablet ? 15 : 10.2, + ), + SizedBox( + width: isTablet ? 20 : 4, + ), + CustomButton( + backgroundColor: Colors.green.shade900, + onPressed: () async { + if (textFieldsValidation(provider).isEmpty) { + // await provider.saveJsonObject(context, widget.form); + _displaySnackBar('Form Saved Sucessfully!'); + } else { + _displaySnackBar(textFieldsValidation(provider)); + } + }, + textColor: Colors.white, + title: "Save", + height: 40, + width: isTablet ? 100 : 60, + fontsize: isTablet ? 16 : 12, + ), + SizedBox( + width: isTablet ? 20 : 2, + ), + ], + ), + ); + } + + Widget gridViewWidget( + InteractionProvider provider, + String sectionName, + List sectionList, + Orientation orientation, + FormFieldData item, + int listIndex) { + List pooja = sectionList; + + print("Pooja: $pooja"); + + List> convertedArray = []; + print("Provider Length: ${item.sectionList.length}"); + + for (int i = 0; i < sectionList.length; i += item.sectionList.length + 1) { + print("Section List11111: $sectionList"); + print("item.sectionList.length List11111: ${item.sectionList.length}"); + + convertedArray + .add(sectionList.sublist(i, i + item.sectionList.length + 1)); + } + print("ConvertedArrayEdit.leangth: $convertedArray"); + print("ConvertedArray.leangth2323: ${convertedArray.length}"); + + return Column( + children: [ + for (var i = 0; i < convertedArray.length; i++) + DecoratedBox( + decoration: BoxDecoration( + // borderRadius: BorderRadius.circular(10.0), + color: i % 2 == 0 + ? Color.fromARGB(133, 213, 241, 254) + : Colors.white, + ), + child: GridView.builder( + physics: const NeverScrollableScrollPhysics(), + gridDelegate: SliverGridDelegateWithFixedCrossAxisCount( + crossAxisCount: context.responsive( + 1, // default + sm: 1, // small + md: 2, // medium + lg: sectionList.length == 1 + ? 1 + : (sectionList.length >= 1 ? 3 : 3), + // lg: sectionList.length == 1 ? 1 : 3, // large + xl: 3, // extra large screen + ), + childAspectRatio: sectionList.length == 1 + ? orientation == Orientation.landscape + ? 10 + : 4.8 + : isTablet + ? 2.8 + : 5.5, + + mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 3.5, + // mainAxisSpacing: sectionList.length == 1 || !isTablet ? 1 : 2, + ), + shrinkWrap: true, + padding: EdgeInsets.zero, + itemCount: convertedArray[i].length, + itemBuilder: (context, index) { + SectionList sectionItem = convertedArray[i][index]; + dropdownvalue = sectionItem.widget == InteractionWidget.DROPDOWN + ? sectionItem.value ?? "Select" + : ' '; + List list = sectionItem.widget == + InteractionWidget.DROPDOWN || + sectionItem.widget == InteractionWidget.AUTOCOMPLETE || + sectionItem.widget == InteractionWidget.MULTISELECT + ? provider.getData2(sectionItem) + : []; + provider.checkboxlist = + sectionItem.widget == InteractionWidget.CHECKBOX + ? provider.getData2(sectionItem) + : []; + + return SizedBox( + height: MediaQuery.of(context).size.height, + child: Padding( + padding: const EdgeInsets.only(left: 18.0, top: 10.0), + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + sectionItem.widget == InteractionWidget.BUTTON && + sectionItem.param == 'add' || + sectionItem.param == 'deletebtn' + ? const SizedBox.shrink() + + // ? const SizedBox.shrink() + : Text( + '${sectionItem.name}:*', + style: TextStyle( + color: Constants.k2color, + fontSize: isTablet ? 18 : 12, + ), + ), + // const SizedBox( + // height: 15, + // ), + returnWidget( + sectionItem: sectionItem, + item: item, + provider: provider, + list: list, + gridIndex: i, + listIndex: listIndex, + widgetData: sectionItem.widget!), + ], + ), + ), + ); + }, + ), + ), + //), + ], + ); + } + + String textFieldsValidation(InteractionProvider provider) { + if (provider.sectionList + .any((element) => element.controller!.text.isEmpty)) { + return 'Fields cannot be empty'; + } + + return ''; + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } +} diff --git a/lib/contacts_module/ui_screen/newformlist.dart b/lib/contacts_module/ui_screen/newformlist.dart new file mode 100644 index 0000000..b335a3b --- /dev/null +++ b/lib/contacts_module/ui_screen/newformlist.dart @@ -0,0 +1,324 @@ +// import 'package:konectar_events/ui_screen/interactionform/configprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interaction_screen.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionlistscreen.dart'; +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; +// import 'package:konectar_events/ui_screen/interactionform/new_dynamicform.dart'; +// import 'package:konectar_events/ui_screen/interactionform/view_forms_list.dart'; +// import 'package:konectar_events/ui_screen/medical_insight.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/configprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionlistscreen.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/new_dynamicform.dart'; +import 'package:konectar_events/contacts_module/ui_screen/medical_insight.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:provider/provider.dart'; + +class FormList extends StatefulWidget { + const FormList({super.key}); + + @override + State createState() => _FormListState(); +} + +class _FormListState extends State { + List savedList = []; + @override + void initState() { + WidgetsBinding.instance.addPostFrameCallback((timeStamp) { + // if (!mytimer!.isActive) { + // activateTimer(); + // } + print("interactionListt"); + init(); + }); + + super.initState(); + } + + init() async { + print("init"); + + await Provider.of(context, listen: false) + .initConfigData(); + print("init1"); + + await Provider.of(context, listen: false).getRecords(); + print("init2"); + + //setState(() {}); + } + + Future getCount(String form, InteractionProvider provider) async { + await provider.getRecords(); + + return provider.savedList.where((element) => element.form == form).length; + } + + @override + Widget build(BuildContext context) { + return Consumer( + builder: (BuildContext context, provider, Widget? child) { + return SafeArea( + child: Scaffold( + appBar: AppBar( + title: Text("Form List"), + ), + body: provider.intConfigDataList.length == 1 + ? ListView.builder( + itemCount: provider.intConfigDataList.length, + cacheExtent: double.parse( + provider.intConfigDataList.length.toString()), + itemBuilder: (context, index) { + print("checkkkk"); + return Column( + children: [ + ListTile( + title: const Text( + "Add My Event", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIData123(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const InteractionListScreen())); + // Navigator.push(context, + // MaterialPageRoute(builder: (context) => AddEventScreen())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + Divider(), + // ListTile( + // title: const Text( + // "Interaction", + // style: TextStyle(fontSize: 18.0), + // ), + // onTap: () async { + // print("I am Interaction"); + // final ConfigDataProvider configDataProvider = + // ConfigDataProvider(); + + // await configDataProvider.initConfigUIData(); + // // Navigator.push(context, MaterialPageRoute(builder: (context)))=> InteractionScreen(); + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (context) => InteractionListScreen())); + // }, + // trailing: const Icon(Icons.arrow_forward_ios), + // ), + + ListTile( + title: const Text( + "Interaction", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + print( + "I am Interaction:${index}, ${provider.intConfigDataList[index].name}"); + + // final ConfigDataProvider configDataProvider = + // ConfigDataProvider(); + + // await configDataProvider.initConfigUIData(); + // // Navigator.push(context, MaterialPageRoute(builder: (context)))=> InteractionScreen(); + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (context) => InteractionListScreen())); + + if (provider.intConfigDataList.length == 1) { + setState(() {}); + + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIData(); + Navigator.push( + context, + MaterialPageRoute( + builder: (BuildContext context) => + InteractionScreen1( + index: index, + form: provider + .intConfigDataList[index].name, + ))); + } else { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIData(); + // Navigator.push(context, MaterialPageRoute(builder: (context)))=> InteractionScreen(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + InteractionListScreen())); + } + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + + Divider(), + ListTile( + title: const Text( + "Engagement", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + await configDataProvider.initConfigUIDataEng(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const InteractionListScreen())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + + const Divider(), + + ListTile( + title: const Text( + "Medical Insight", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIDataMedical(); + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (context) => + // const MedicalInsight1())); + }, + trailing: Icon(Icons.arrow_forward_ios), + ), + const Divider(), + ], + ); + }) + : ListView( + children: [ + ListTile( + title: const Text( + "Add My Event", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIData123(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const InteractionListScreen())); + // Navigator.push(context, + // MaterialPageRoute(builder: (context) => AddEventScreen())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + Divider(), + ListTile( + title: const Text( + "Interaction", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + print("I am Interaction"); + + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIData(); + // Navigator.push(context, MaterialPageRoute(builder: (context)))=> InteractionScreen(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => InteractionListScreen())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + const Divider(), + ListTile( + title: const Text( + "New Medical Insight", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + + await configDataProvider.initConfigUIDataMedical(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const InteractionListScreen())); + }, + trailing: Icon(Icons.arrow_forward_ios), + ), + Divider(), + ListTile( + title: const Text( + "Engagement", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + await configDataProvider.initConfigUIDataEng(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + const InteractionListScreen())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + Divider(), + ListTile( + title: const Text( + "Medical Insight", + style: TextStyle(fontSize: 18.0), + ), + onTap: () async { + final ConfigDataProvider configDataProvider = + ConfigDataProvider(); + await configDataProvider.initConfigUIDataEng(); + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => const MedicalInsight1())); + }, + trailing: const Icon(Icons.arrow_forward_ios), + ), + Divider(), + ], + ), + ), + ); + }); + } + + @override + void dispose() { + // TODO: implement dispose + super.dispose(); + } +} diff --git a/lib/contacts_module/ui_screen/nih_show_more.dart b/lib/contacts_module/ui_screen/nih_show_more.dart new file mode 100644 index 0000000..9a92d81 --- /dev/null +++ b/lib/contacts_module/ui_screen/nih_show_more.dart @@ -0,0 +1,109 @@ +// import 'package:konectar_events/provider_class/nih_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/nih_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class NIHShowMore extends StatefulWidget { + NIHShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _NIHShowMoreState(); +} + +class _NIHShowMoreState extends State { + List nihgrants = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var nih = Provider.of(context, listen: false); + await nih.nihinfo(widget.text); + final nih1 = nih.nihlist; + setState(() { + nihgrants = nih1; + }); + + print("locationList: ${nihgrants}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('NIH Grants'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('NIH Center', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Organization Name', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + nihgrants.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${nihgrants[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(nihgrants[index]); + }, + ); + }, + cells: [ + DataCell(Text(nihgrants[index]['pi_names'].toString(), + softWrap: true)), + DataCell(Text( + nihgrants[index]['NIH Center/Institute'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/patent_show_more.dart b/lib/contacts_module/ui_screen/patent_show_more.dart new file mode 100644 index 0000000..57a9045 --- /dev/null +++ b/lib/contacts_module/ui_screen/patent_show_more.dart @@ -0,0 +1,108 @@ +// import 'package:konectar_events/provider_class/patent_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/patent_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class PatentShowMore extends StatefulWidget { + PatentShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _PatentShowMoreState(); +} + +class _PatentShowMoreState extends State { + List patent = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var patentt = Provider.of(context, listen: false); + await patentt.patentinfo(widget.text); + final patentt1 = patentt.patentlist; + setState(() { + patent = patentt1; + }); + + print("locationList: ${patent}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Patents'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Patent Title', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Status', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + patent.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${patent[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(patent[index]); + }, + ); + }, + cells: [ + DataCell(Text(patent[index]['Patent Title'].toString(), + softWrap: true)), + DataCell(Text(patent[index]['Status'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/pno_showmore.dart b/lib/contacts_module/ui_screen/pno_showmore.dart new file mode 100644 index 0000000..a9e3a4a --- /dev/null +++ b/lib/contacts_module/ui_screen/pno_showmore.dart @@ -0,0 +1,109 @@ +// import 'package:konectar_events/provider_class/phoneno_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/phoneno_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class PhoneShowMore extends StatefulWidget { + PhoneShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _PhoneShowMoreState(); +} + +class _PhoneShowMoreState extends State { + List pno = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + final phone = Provider.of(context, listen: false); + + await phone.phoneinfo(widget.text); + final phoneno = phone.phonenolist; + setState(() { + pno = phoneno; + }); + + print("Phone Numbers: ${pno}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Phone Numbers'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('phone Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Phone No', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + pno.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${pno[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(pno[index]); + }, + ); + }, + cells: [ + DataCell(Text(pno[index]['Phone type'].toString(), + softWrap: true)), + DataCell(Text(pno[index]['phone Number'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/pro_show_more.dart b/lib/contacts_module/ui_screen/pro_show_more.dart new file mode 100644 index 0000000..30c88be --- /dev/null +++ b/lib/contacts_module/ui_screen/pro_show_more.dart @@ -0,0 +1,109 @@ +// import 'package:konectar_events/provider_class/procedureprovider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/procedureprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class ProShowMore extends StatefulWidget { + ProShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _ProShowMoreState(); +} + +class _ProShowMoreState extends State { + List procedure = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var pro = Provider.of(context, listen: false); + await pro.proinfo(widget.text); + final pro1 = pro.prolist; + setState(() { + procedure = pro1; + }); + + print("locationList: ${procedure}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Procedures'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Program Year', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Procedure', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + procedure.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${procedure[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(procedure[index]); + }, + ); + }, + cells: [ + DataCell(Text(procedure[index]['Procedure'].toString(), + softWrap: true)), + DataCell(Text( + procedure[index]['Place of Service'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/publication_data.dart b/lib/contacts_module/ui_screen/publication_data.dart new file mode 100644 index 0000000..b33b1da --- /dev/null +++ b/lib/contacts_module/ui_screen/publication_data.dart @@ -0,0 +1,124 @@ +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +// import 'package:konectar_events/provider_class/publications_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:konectar_events/ui_screen/bottommmsheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class PublicationsData extends StatefulWidget { + PublicationsData({required this.text, Key? key}) : super(key: key); + + final int text; + + @override + State createState() => _PublicationsDataState(); +} + +class _PublicationsDataState extends State { + List hcppublication = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + final affprovider = Provider.of(context, listen: false); + await affprovider.publicatininfo(widget.text); + + final affdata = affprovider.publicationlist; + setState(() { + hcppublication = affdata; + }); + + print("hcppppProfiledata: ${hcppublication}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Publications'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Article Title', softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Journal Name', softWrap: true))), + DataColumn( + label: Expanded(child: Text('Date', softWrap: true))), + DataColumn( + label: + Expanded(child: Text('Authors', softWrap: true))), + + // Add more columns as needed + ], + rows: List.generate( + hcppublication.length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message11 ${hcppublication[index]}"); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(hcppublication[index]); + }, + ); + }, + cells: [ + DataCell(Text( + hcppublication[index]['artical_title'].toString(), + softWrap: true)), + DataCell(Text( + hcppublication[index]['journal_name'].toString(), + softWrap: true)), + DataCell(Text(hcppublication[index]['date'].toString(), + softWrap: true)), + DataCell(Text( + hcppublication[index]['author'].toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/ranking.dart b/lib/contacts_module/ui_screen/ranking.dart new file mode 100644 index 0000000..40414b2 --- /dev/null +++ b/lib/contacts_module/ui_screen/ranking.dart @@ -0,0 +1,576 @@ +// import 'dart:convert'; +// import 'dart:io'; +// // import 'dart:js_interop'; + +// import 'package:discover_module/custom_widget/floating_btn.dart'; +// import 'package:discover_module/custom_widget/show_alert.dart'; +// import 'package:discover_module/hive_fun.dart'; +// import 'package:discover_module/provider_class/hcp%20_provider.dart'; +// import 'package:discover_module/ui_screen/contacts.dart'; +// import 'package:discover_module/ui_screen/filters_menu.dart'; +// import 'package:discover_module/ui_screen/interactionform/NewtworkConnectivity.dart'; +// import 'package:flutter/foundation.dart'; +// import 'package:flutter/foundation.dart' show kIsWeb; +// import 'package:flutter/material.dart'; +// import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:open_file/open_file.dart'; +// import 'package:path_provider/path_provider.dart'; +// import 'package:provider/provider.dart'; +// import 'package:syncfusion_flutter_xlsio/xlsio.dart'; +// import 'package:universal_html/html.dart' show AnchorElement; + +// List<_Row> _rows = []; +// bool isOnline1 = false; + +// class Ranking extends StatefulWidget { +// @override +// State createState() => _RankingState(); +// } + +// class _RankingState extends State { +// late _DataSource _dataSource; + +// List selectedno = []; +// @override +// void initState() { +// super.initState(); +// print("hii_initState"); +// setupConnectivityListener(); + +// gethcpdata(); +// _dataSource = _DataSource(context); // Initialize _DataSource +// } + +// NetworkConnectivity networkConnectivity = NetworkConnectivity(); + +// Future setupConnectivityListener() async { +// while (true) { +// bool isOnline = await networkConnectivity.isInternetAvailable(); +// print('Internet available: $isOnline'); +// // Perform actions based on connectivity status +// await Future.delayed(Duration(seconds: 10)); + + +// } +// } + +// @override +// Widget build(BuildContext context) { +// return SafeArea( +// child: Scaffold( +// body: ListView( +// padding: const EdgeInsets.all(3), +// children: [ +// PaginatedDataTable( +// header: const Text( +// 'HCP RANKING', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 18.0, +// fontStyle: FontStyle.normal), +// ), +// showFirstLastButtons: true, +// showEmptyRows: false, +// showCheckboxColumn: true, +// actions: [ +// IconButton( +// onPressed: () { +// _createExcel(); +// }, +// icon: const Icon(Icons.download, +// color: Color.fromARGB(255, 0, 71, 132))) +// ], +// rowsPerPage: 5, +// columns: const [ +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Name', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Tier', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Rank', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Score', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Event', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Affliations', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Publications', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// DataColumn( +// label: FittedBox( +// fit: BoxFit.scaleDown, +// child: Text('Trails', +// style: TextStyle( +// fontWeight: FontWeight.bold, +// fontSize: 14.0, +// fontStyle: FontStyle.normal)), +// )), +// ], +// source: _dataSource, +// ), +// ], +// ), +// floatingActionButton: Visibility( +// visible: true, +// child: FloatingBtn( +// icon: Icons.add, +// title: "add", +// onTap: () async { +// List selectedRowIds = _dataSource.getSelectedRowIds(); +// // Do something with selectedRowIds +// print('Selected Row IDstrndsss: $selectedRowIds'); + +// if (selectedRowIds.isEmpty) { +// showDialog( +// context: context, +// builder: (_) { +// return Alert( +// data: "Please Select the user", +// onPressed: () { +// Navigator.of(context).pop(); +// print('OK button pressed'); +// }, +// ); +// }); +// } else { +// for (int i = 0; i < selectedRowIds.length; i++) { +// print('The id id : ${selectedRowIds[i]}'); +// //List<_Row> _rows = []; + +// final row = _rows[selectedRowIds[i] - 1]; + +// print( +// "checking_value_istrends: ${selectedRowIds[i]},${row.valueA}"); + +// // selectedno.add(selectedRowIds[i]); + +// // HiveFunctions.addno(selectedRowIds[i]); + +// // _contactbox.put(i, selectedRowIds[i]); + +// HiveFunctions.createUser({ +// "id": selectedRowIds[i], +// "name": row.valueA, +// "org": row.org, +// "addr": row.addr, +// "phone": row.mno, +// "phone_no": row.mno, +// "email": row.valueC, +// "affiliations_count": row.valueG, +// "events_count": row.valueF, +// "publications_count": row.valueH, +// "trail_count": "1", +// "summarry": row.smry, +// "license_no": row.lin, +// "p_suffix": row.suffix, +// "speciality": row.spl, +// "sub_speciality": row.sub_spl, +// }); +// } +// showDialog( +// context: context, +// builder: (_) { +// return Alert( +// data: "User Added Successfully", +// onPressed: () { +// Navigator.of(context).pop(); +// // Navigator.push(context, +// // MaterialPageRoute(builder: (_) => Contacts())); +// }, +// ); +// }); +// } +// }, +// )), +// ), +// ); +// } + +// Future _createExcel() async { +// //Create an Excel document. + +// //Creating a workbook. +// final Workbook workbook = Workbook(); +// //Accessing via index +// final Worksheet sheet = workbook.worksheets[0]; + +// // sheet.getRangeByName('A1').setText('pooja'); +// ///////////////////////////////////////////////////////////////////////////// + +// sheet.getRangeByName('A1').setText('Name'); +// sheet.getRangeByName('A2').setText('Gerosa, Gino'); +// sheet.getRangeByName('A3').setText('Gerosa, Gino'); +// sheet.getRangeByName('A4').setText('Gerosa, Gino'); + +// final Style headingStyle = workbook.styles.add('HeadingStyle'); +// headingStyle.bold = true; +// headingStyle.hAlign = HAlignType.center; +// headingStyle.wrapText = true; +// sheet.getRangeByName('B1').setText('Tier'); +// sheet.getRangeByName('B2').setText("Tier1"); +// sheet.getRangeByName('B3').setText("Tier1"); +// sheet.getRangeByName('B4').setText("Tier1"); +// sheet.getRangeByName('C1').setText('Rank'); +// sheet.getRangeByName('C2').setNumber(1); +// sheet.getRangeByName('C3').setNumber(1); +// sheet.getRangeByName('C4').setNumber(1); +// sheet.getRangeByName('D1').setText('Score'); +// sheet.getRangeByName('D2').setNumber(0); +// sheet.getRangeByName('D3').setNumber(0); +// sheet.getRangeByName('D4').setNumber(0); + +// sheet.getRangeByName('E1').setText('Event'); +// sheet.getRangeByName('E2').setNumber(0); +// sheet.getRangeByName('E3').setNumber(0); +// sheet.getRangeByName('E4').setNumber(0); + +// sheet.getRangeByName('F1').setText('Affiliations'); +// sheet.getRangeByName('F2').setNumber(0); +// sheet.getRangeByName('F3').setNumber(0); +// sheet.getRangeByName('F4').setNumber(0); + +// sheet.getRangeByName('G1').setText('Publications'); +// sheet.getRangeByName('G2').setNumber(0); +// sheet.getRangeByName('G3').setNumber(0); +// sheet.getRangeByName('G4').setNumber(0); + +// sheet.getRangeByName('H1').setText('Trails'); +// sheet.getRangeByName('H2').setNumber(0); +// sheet.getRangeByName('H3').setNumber(0); +// sheet.getRangeByName('H4').setNumber(0); + +// //Defining a global style with properties. +// final Style globalStyle = workbook.styles.add('globalStyle'); +// //globalStyle.backColor = '#37D8E9'; +// globalStyle.fontName = 'Times New Roman'; +// globalStyle.fontSize = 12; +// // globalStyle.fontColor = '#C67878'; +// globalStyle.fontColor = '#C67878'; + +// globalStyle.italic = true; +// globalStyle.bold = true; +// globalStyle.underline = true; +// globalStyle.wrapText = true; +// globalStyle.hAlign = HAlignType.center; +// globalStyle.vAlign = VAlignType.center; +// globalStyle.borders.all.lineStyle = LineStyle.thick; +// // globalStyle.borders.all.color = '#9954CC'; + +// final Style globalStyle1 = workbook.styles.add('globalStyle1'); +// globalStyle1.fontSize = 14; +// // globalStyle1.fontColor = '#362191'; +// globalStyle1.hAlign = HAlignType.center; +// globalStyle1.vAlign = VAlignType.center; +// globalStyle1.borders.bottom.lineStyle = LineStyle.thin; +// //globalStyle1.borders.bottom.color = '#829193'; +// globalStyle1.numberFormat = '0.00'; + +// final List bytes = workbook.saveSync(); + +// print("hii"); + +// if (kIsWeb) { +// AnchorElement( +// href: +// 'data:application/octet-stream;charset=utf-16le;base64,${base64.encode(bytes)}') +// ..setAttribute('download', 'Output.xlsx') +// ..click(); +// } else { +// // final String path = (await getApplicationDocumentsDirectory()).path; +// //final directory = await getExternalStorageDirectory(); + +// Directory? directory = Platform.isAndroid +// ? await getExternalStorageDirectory() +// : await getApplicationDocumentsDirectory(); + +// final path = directory!.path; + +// final String filename = +// Platform.isWindows ? '$path\\Output.xlsx' : '$path/Output.xlsx'; +// // final String filename = '$path/Output.xlsx'; +// final File file = File(filename); +// await file.writeAsBytes(bytes, flush: true); +// OpenFile.open(filename); +// } +// } + +// void gethcpdata() { +// // final data = Provider.of(context, listen: false); +// } +// } + +// class _Row { +// _Row({ +// required this.identifier, +// required this.valueA, +// required this.valueC, +// required this.valueD, +// required this.valueE, +// required this.valueF, +// required this.valueG, +// required this.valueH, +// required this.valueI, +// required this.selected, +// this.org, +// this.mno, +// this.smry, +// this.lin, +// this.suffix, +// this.spl, +// this.sub_spl, +// this.addr, // Add selected parameter +// }); + +// final int identifier; +// final String valueA; +// final String valueC; +// final String valueD; +// final String valueE; +// final String valueF; +// final String valueG; +// final String valueH; +// final String valueI; +// bool selected = false; +// String? org; +// String? mno; +// String? smry; +// String? lin; +// String? suffix; +// String? spl; +// String? sub_spl; +// String? addr; +// } + +// class _DataSource extends DataTableSource { +// final BuildContext context; + +// // List<_Row> _rows = []; +// // late List _selectedRowsIndexes = []; // List to track selected rows +// final List _selectedRowIds = []; + +// List list = []; + +// _DataSource(this.context) { +// render_hcpdata(); +// // _rows = <_Row>[ +// // for (int i = 0; i < 20; i++) +// // _Row( +// // i, 'Gerosa, Gino', 'Tier1', '1', '0', '0', '0', '0', '0', check(i)), +// // ]; +// // } +// } + +// List getSelectedRowIds() { +// return _selectedRowIds; // Return a copy to prevent direct modification +// } + +// int _selectedCount = 0; + +// @override +// DataRow? getRow(int index) { +// assert(index >= 0); +// if (index >= _rows.length) return null; +// final row = _rows[index]; +// return DataRow.byIndex( +// index: index, +// selected: row.selected, +// onSelectChanged: (value) { +// if (row.selected != value) { +// // _selectedCount += value! ? 1 : -1; +// // assert(_selectedCount >= 0); +// row.selected = value!; + +// if (value) { +// print("Selected"); +// _selectedRowIds.add(row.identifier); // Add the row ID to the list +// print("Selected_selectedRowIds :$_selectedRowIds"); +// } else { +// _selectedRowIds +// .remove(row.identifier); // Remove the row ID from the list +// } +// notifyListeners(); + +// print("Selectedddd_is $value"); +// print("Selectedddd_value ${row.valueA}"); +// } +// }, +// cells: [ +// DataCell( +// Text(row.valueA), +// onTap: () { +// print("hiii Data cell tap ${row}"); + +// // Navigator.push( +// // context, MaterialPageRoute(builder: (context) => Profile())); +// }, +// ), +// DataCell(Text(row.valueC)), +// DataCell(Text(row.valueD.toString())), +// DataCell(Text(row.valueE)), +// DataCell(Text(row.valueF)), +// DataCell(Text(row.valueG)), +// DataCell(Text(row.valueH)), +// DataCell(Text(row.valueI)), +// ], +// ); +// } + +// @override +// int get rowCount => _rows.length; + +// @override +// bool get isRowCountApproximate => false; + +// @override +// int get selectedRowCount => _selectedCount; + +// bool check(int i) { +// // print("I_am_i: $i"); +// // print("_selectedRowIds_i: ${HiveFunctions.getno()}"); + +// // //HiveFunctions.getno(); +// // if (HiveFunctions.getno().contains(i)) { +// // print("Iam_in: $i"); +// // return true; +// // } + +// return false; +// } + +// Future render_hcpdata() async { +// NetworkConnectivity networkConnectivity = NetworkConnectivity(); +// // bool isOnline = await networkConnectivity.isInternetAvailable(); + +// bool isOnline = await networkConnectivity.isInternetAvailable(); +// print('Internet available: $isOnline'); +// print("RankingPage_isOnline: $isOnline"); + +// if (isOnline) { +// final hcpdata = Provider.of(context, listen: false); + +// // await hcpdata.getHCPProvider(); + +// final hcplist = hcpdata.list; + +// print("LookingHcpList: $hcplist"); + +// // _rows = <_Row>[ +// // for (int i = 0; i < 20; i++) +// // _Row( +// // i, 'Gerosa, Gino', 'Tier1', '1', '0', '0', '0', '0', '0', check(i)), +// // ]; + +// _rows = hcplist +// .map((e) => _Row( +// identifier: e['id'], +// valueA: e['name'], +// valueC: e['email'], +// valueD: e['rank'].toString(), +// valueE: e['score'].toString(), +// valueF: e['events_count'].toString(), +// valueG: e['affiliations_count'].toString(), +// valueH: e['publications_count'].toString(), +// valueI: '0', +// selected: check(e['id']), +// org: "Aissel", +// mno: e['phone_no'].toString(), +// smry: e['summarry'], +// lin: e['license_no'].toString(), +// suffix: e['p_suffix'], +// spl: e['speciality'], +// sub_spl: e['sub_speciality'], +// addr: e['addr'], +// )) +// .toList(); +// notifyListeners(); +// } else { +// print("get_Storeddata: ${HiveFunctions.gethcpdata()}"); + +// list = HiveFunctions.gethcpdata().toList(); +// // debugPrint(HiveFunctions.gethcpdata()); + +// // List offlinedata = HiveFunctions.gethcpdata(); +// print("offline_data_is: "); + +// print("offline_data_is: $list"); + +// _rows = list +// .map((e) => _Row( +// identifier: e['id'], +// valueA: e['name'], +// valueC: e['email'], +// valueD: e['rank'].toString(), +// valueE: e['score'].toString(), +// valueF: e['events_count'].toString(), +// valueG: e['affiliations_count'].toString(), +// valueH: e['publications_count'].toString(), +// valueI: '0', +// selected: check(e['id']), +// org: "Aissel", +// mno: e['phone_no'].toString(), +// smry: e['sumry'], +// lin: e['licno'].toString(), +// suffix: e['suffix'], +// spl: e['spl'], +// sub_spl: e['sub_sp'], +// )) +// .toList(); +// notifyListeners(); +// } +// } + +// @override +// void dispose() { +// // TODO: implement dispose +// super.dispose(); +// } +// } diff --git a/lib/contacts_module/ui_screen/rising_stars.dart b/lib/contacts_module/ui_screen/rising_stars.dart new file mode 100644 index 0000000..b979a4e --- /dev/null +++ b/lib/contacts_module/ui_screen/rising_stars.dart @@ -0,0 +1,235 @@ +// import 'package:konectar_events/custom_widget/floating_btn.dart'; +// import 'package:konectar_events/custom_widget/show_alert.dart'; +// import 'package:konectar_events/hive_fun.dart'; +// import 'package:konectar_events/ui_screen/ranking.dart'; +import 'package:konectar_events/contacts_module/custom_widget/floating_btn.dart'; +import 'package:konectar_events/contacts_module/custom_widget/show_alert.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:flutter/material.dart'; + +class RisingStar extends StatefulWidget { + const RisingStar({super.key}); + + @override + State createState() => RisingStarState(); +} + +class RisingStarState extends State { + late _DataSource _dataSource; + + @override + void initState() { + // TODO: implement initState + super.initState(); + + _dataSource = _DataSource(context); + } + + @override + Widget build(BuildContext context) { + return SafeArea( + child: Scaffold( + body: ListView( + padding: const EdgeInsets.all(3), + children: [ + PaginatedDataTable( + header: const Text( + 'HCP RANKING', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 18.0, + fontStyle: FontStyle.normal), + ), + showFirstLastButtons: true, + showEmptyRows: false, + showCheckboxColumn: true, + // actions: const [Text("jii")], + rowsPerPage: 5, + columns: const [ + DataColumn( + label: Text('Name', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Specialty', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Rank', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Discover Rank', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Indicator', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Previous year \n (2018-2022)', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Current year \n (2022-2024)', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Status', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + ], + source: _dataSource, + ), + ], + ), + floatingActionButton: Visibility( + visible: true, + child: FloatingBtn( + icon: Icons.add, + title: "add", + onTap: () { + List selectedRowIds = _dataSource.getSelectedRowIds(); + // Do something with selectedRowIds + print('Selected Row IDstrndsss: $selectedRowIds'); + + for (int i = 0; i < selectedRowIds.length; i++) { + print("checking_value_istrends: ${selectedRowIds[i]}"); + + // _contactbox.put(i, selectedRowIds[i]); + + HiveFunctions.createUser({ + "name": selectedRowIds[i], + "org": "Azienda Ospedaliera di Padova", + "adrr": "Via Giustiniani 2, Padova, Veneto 35128, Italy", + "phone": "+390498212410X12", + "Pphone": "+390498212410X12", + "email": "Gerosa,Gino@gmail.com", + "affno": "75", + "eveno": "8", + "pubno": "251", + "trailno": "1" + }); + } + showDialog( + context: context, + builder: (_) { + return Alert( + data: "User Added Successfully", + onPressed: () { + Navigator.of(context).pop(); + }, + ); + }); + }, + )), + ), + ); + } +} + +class _Row { + _Row(this.i, this.valueA, this.valueC, this.valueD, this.valueE, this.valueF, + this.valueG, this.valueH, this.valueI); + + final int i; + final String valueA; + final String valueC; + final String valueD; + final String valueE; + final String valueF; + final String valueG; + final String valueH; + final String valueI; + + bool selected = false; +} + +class _DataSource extends DataTableSource { + final BuildContext context; + late List<_Row> _rows; + final List _selectedRowIds = []; + _DataSource(this.context) { + _rows = <_Row>[ + for (int i = 0; i < 20; i++) + _Row(i, 'Gerosa, Gino', 'Cardiology', '1', '0', '0', 'Tier 1', 'Tier 1', + ''), + ]; + //} + } + List getSelectedRowIds() { + return _selectedRowIds; // Return a copy to prevent direct modification + } + + int _selectedCount = 0; + + @override + DataRow? getRow(int index) { + assert(index >= 0); + if (index >= _rows.length) return null; + final row = _rows[index]; + return DataRow.byIndex( + index: index, + selected: row.selected, + onSelectChanged: (value) { + // print("hii"); + // Navigator.push( + + if (row.selected != value) { + // _selectedCount += value! ? 1 : -1; + // assert(_selectedCount >= 0); + row.selected = value!; + + if (value) { + print("Selected"); + _selectedRowIds.add(row.valueA); // Add the row ID to the list + print("Selected_selectedRowIds :$_selectedRowIds"); + } else { + _selectedRowIds + .remove(row.valueA); // Remove the row ID from the list + } + notifyListeners(); + + print("Selectedddd_is $value"); + print("Selectedddd_value ${row.valueA}"); + } + // context, MaterialPageRoute(builder: (context) => Profile())); + }, + cells: [ + DataCell(Text(row.valueA)), + DataCell(Text(row.valueC)), + DataCell(Text(row.valueD.toString())), + DataCell(Text(row.valueE)), + DataCell(Text(row.valueF)), + DataCell(Text(row.valueG)), + DataCell(Text(row.valueH)), + DataCell(Text(row.valueI)), + ], + ); + } + + @override + int get rowCount => _rows.length; + + @override + bool get isRowCountApproximate => false; + + @override + int get selectedRowCount => _selectedCount; +} diff --git a/lib/contacts_module/ui_screen/saved_profiles/saved_activity.dart b/lib/contacts_module/ui_screen/saved_profiles/saved_activity.dart new file mode 100644 index 0000000..84e76b4 --- /dev/null +++ b/lib/contacts_module/ui_screen/saved_profiles/saved_activity.dart @@ -0,0 +1,978 @@ +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +// import 'package:konectar_events/provider_class/events_provider.dart'; +// import 'package:konectar_events/provider_class/publications_provider.dart'; +// import 'package:konectar_events/provider_class/trials_provider.dart'; +// import 'package:konectar_events/storage_hive/aff_data/insert_aff.dart'; +// import 'package:konectar_events/storage_hive/events_data/crud_event.dart'; +// import 'package:konectar_events/storage_hive/pub_data/curd_pub.dart'; +// import 'package:konectar_events/storage_hive/trials_data/crud_trials.dart'; +// import 'package:konectar_events/ui_screen/affiliation_data.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +// import 'package:konectar_events/ui_screen/events_data.dart'; +// import 'package:konectar_events/ui_screen/publication_data.dart'; +// import 'package:konectar_events/ui_screen/trials_show_more.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/storage_hive/aff_data/insert_aff.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/crud_event.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pub_data/curd_pub.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/crud_trials.dart'; +import 'package:konectar_events/contacts_module/ui_screen/affiliation_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/ui_screen/events_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/publication_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/trials_show_more.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class SavedActivities extends StatefulWidget { + //Activities({super.key, required text}); + SavedActivities({required this.text, Key? key}) : super(key: key); + + final int text; + + @override + State createState() => _SavedActivitiesState(); +} + +class _SavedActivitiesState extends State { + bool _isExpanded = false; + + List affiliation_data = []; + List publication_data = []; + List event_data = []; + List trial_data = []; + List medinsightData = []; + List speaker = []; + List eng = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + getaffiliations(); + } + + getaffiliations() async { + // var affiliations = + // Provider.of(context, listen: false); + + // await affiliations.getAffiliationsdata(widget.text); + // final affilist = affiliations.adddta; + + // print("CheckingAfflist: $affilist"); + + final affilist = await retrieveidAffiliations(widget.text); + print("Savedd_CheckingAfflist: $affilist"); + + // var publication = Provider.of(context, listen: false); + + // await publication.publicatininfo(widget.text); + // final publist = publication.publicationlist; + + final publist = await retrieveidPublications(widget.text); + print("Savedd_CheckingAfflist: $affilist"); + + // var events = Provider.of(context, listen: false); + // await events.geteventdata(widget.text); + // final eventlist = events.EventsList; + + final eventlist = await retrieveidEvent(widget.text); + print("Savedd_CheckingAfflist: $affilist"); + + // var trials = Provider.of(context, listen: false); + // await trials.trialsdata(widget.text); + + // final trialslist = trials.trialsinfo; + final trialslist = await retrieveidTrials(widget.text); + print("Savedd_CheckingAfflist: $affilist"); + + setState(() { + affiliation_data = affilist; + publication_data = publist; + event_data = eventlist; + trial_data = trialslist; + // medinsightData = medlist; + // speaker = speakerlist; + // eng = engtypelist; + }); + + print("Affiliations_data_isNewOff: $affiliation_data"); + print("Publication_data_isNewOff: $publication_data"); + + // print("trialslist_data_is: $trialslist"); + //final affiliationsss = affiliation_data['Affiliations'] as List>; + } + + @override + Widget build(BuildContext context) { + return Center( + child: ListView(children: [ + affiliation_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) async { + print("HeyyyPooja"); + + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Affiliations", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: + "(${affiliation_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + // width: + // MediaQuery.of(context) + // .size + // .width, + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text( + 'Organization Name', + style: TextStyle( + fontWeight: FontWeight.w600), + ), + )), + DataColumn( + label: Expanded( + child: Text('Time Frame', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + affiliation_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message11 ${affiliation_data[index]}"); + + bottomshet(affiliation_data[index]); + }, + color: MaterialStateProperty.resolveWith< + Color?>((Set states) { + if (index.isEven) { + return Colors.grey.withOpacity(0.1); + } + return null; + }), + cells: [ + DataCell(Text( + affiliation_data[index] + .orgName + .toString(), + softWrap: true)), + + DataCell(Text( + affiliation_data[index] + .timeFrame + .toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + print("Passing_Id_isss: ${widget.text}"); + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => AffiliationsData( + text: widget.text))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + publication_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Publications", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: + "(${publication_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + //isAlwaysShown: true, + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Article Title', + style: TextStyle( + fontWeight: FontWeight.w600), + softWrap: true), + )), + + DataColumn( + label: Expanded( + child: Text('Authors', + style: TextStyle( + fontWeight: + FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + publication_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print( + "message ${publication_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet( + publication_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + publication_data[index] + .artical_title + .toString(), + softWrap: true)), + + DataCell(Text( + publication_data[index] + .author + .toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => PublicationsData( + text: widget.text))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + event_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Events", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${event_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: MediaQuery.of(context).size.width, + ), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Event Name', + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600)), + )), + + DataColumn( + label: Expanded( + child: Text('Role', + softWrap: true, + style: TextStyle( + fontWeight: + FontWeight.w600)))), + + // Add more columns as needed + ], + rows: List.generate( + event_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${event_data[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(event_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + event_data[index] + .event_name + .toString(), + softWrap: true)), + + DataCell(Text( + event_data[index].role.toString(), + softWrap: true)), + + // Add more DataCells as needed + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => EventsData( + text: widget.text, + ))); + }, + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + + trial_data.length != 0 + ? ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + //elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + initiallyExpanded: false, + maintainState: true, + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + // backgroundColor: Colors.white, + // collapsedBackgroundColor: Color(0xFF2b9af3), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Trials", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(${trial_data.length.toString()})", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: Container( + constraints: BoxConstraints( + minWidth: + MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Trial Name', + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600)), + )), + DataColumn( + label: Expanded( + child: Text('Status', + softWrap: true, + style: TextStyle( + fontWeight: + FontWeight.w600)))), + ], + rows: List.generate( + trial_data.take(2).length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${trial_data[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: + Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(trial_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + trial_data[index] + .trial_name + .toString(), + softWrap: true)), + DataCell(Text( + trial_data[index].status.toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + Container( + color: Colors.white, + child: Align( + alignment: Alignment.center, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () { + Navigator.push( + context, + MaterialPageRoute( + builder: (_) => TrialsShowmore( + text: widget.text))); + }, + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + child: Text( + 'Show More', + style: TextStyle(color: Constants.k2color), + ), + ), + ), + ), + ) + ]), + ), + ), + ) + : Container(), // adds spacing between the text and image + ]), + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // Row( + // children: [ + // Text( + // "Affiliation", + // style: TextStyle(fontSize: 20.0), + // ) + // ], + // ), + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data['org_name'], + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 16.0, color: Colors.black), + ), + ), + ), + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + + affiliation_data['dept'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['role'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['time_frame'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame".toString(), + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'] + .toString(), + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + affiliation_data['org_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + + affiliation_data['emg_type'] != "" + ? Column( + crossAxisAlignment: + CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: + const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ) + : Container(), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } +} diff --git a/lib/contacts_module/ui_screen/saved_profiles/saved_contact.dart b/lib/contacts_module/ui_screen/saved_profiles/saved_contact.dart new file mode 100644 index 0000000..5f90337 --- /dev/null +++ b/lib/contacts_module/ui_screen/saved_profiles/saved_contact.dart @@ -0,0 +1,1308 @@ +import 'dart:io'; + +import 'package:cached_network_image/cached_network_image.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:konectar_events/contacts_module/provider_class/hcp%20_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/aff_data/insert_aff.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/crud_event.dart'; +import 'package:konectar_events/contacts_module/storage_hive/kol_info/curd_kol.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pub_data/curd_pub.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/crud_trials.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/util.dart'; +import 'package:konectar_events/contacts_module/ui_screen/saved_profiles/saved_profile_info.dart'; +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/hive_fun.dart'; +// import 'package:konectar_events/provider_class/affiliationsprovider.dart'; +// import 'package:konectar_events/provider_class/events_provider.dart'; +// import 'package:konectar_events/provider_class/hcp%20_provider.dart'; +// import 'package:konectar_events/provider_class/publications_provider.dart'; +// import 'package:konectar_events/provider_class/trials_provider.dart'; +// import 'package:konectar_events/storage_hive/aff_data/insert_aff.dart'; +// import 'package:konectar_events/storage_hive/events_data/crud_event.dart'; +// import 'package:konectar_events/storage_hive/kol_info/curd_kol.dart'; +// import 'package:konectar_events/storage_hive/kol_info/kol_info_model_hive.dart'; +// import 'package:konectar_events/storage_hive/pub_data/curd_pub.dart'; +// import 'package:konectar_events/storage_hive/trials_data/crud_trials.dart'; +// import 'package:konectar_events/ui_screen/filters_menu.dart'; +// import 'package:konectar_events/ui_screen/interactionform/util.dart'; +// import 'package:konectar_events/ui_screen/new_new_profile.dart'; +// import 'package:konectar_events/ui_screen/new_new_profile_offline.dart'; +// import 'package:konectar_events/ui_screen/saved_profiles/saved_profile_info.dart'; +import 'package:dropdown_button2/dropdown_button2.dart'; +import 'package:dropdownfield2/dropdownfield2.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/widgets.dart'; +import 'package:flutter_svg/svg.dart'; +import 'package:provider/provider.dart'; +import 'package:flutter/services.dart'; +import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +import 'package:hive_flutter/hive_flutter.dart'; +// import 'package:konectar_events/ui_screen/interactionform/NewtworkConnectivity.dart'; + +class SavedContacts1 extends StatefulWidget { + const SavedContacts1({Key? key}) : super(key: key); + + @override + State createState() => SavedContacts1State(); +} + +class SavedContacts1State extends State { + final GlobalKey _scaffoldKey = GlobalKey(); + + // final contactBox = Hive.box("mycontact"); + bool _switchValue = false; + bool isOnline2 = true; + + final TextEditingController _searchController = TextEditingController(); + + List ddlist = ["aaaa", 'bbb']; + + // List ddlist = ['Option 1', 'Option 2', 'Option 3']; + + String _selectedValue = ''; + String? _selectedValue1; + + String dropdownvalue = 'Profile Type'; + + // List of items in our dropdown menu + var items = [ + 'Profile Type', + 'HCP Name', + 'Speciality', + 'Country', + 'Region', + 'State', + 'City', + 'List', + 'Organization', + 'Event', + ]; + + bool isSearchClickd = false; + + final List _items = ['Option 1', 'Option 2', 'Option 3']; + + TextEditingController textEditingController = TextEditingController(); + + List displayedHCPList = []; + bool ActiveConnection = false; + String T = ""; + + bool isChecked = false; + //final Set _selectedIndices = Set(); + final List _selectedIndices = []; + final List _selectedremoveIndices = []; + + bool longpress = false; + bool longpressmy = false; + + List offlinekoldata = []; + + @override + void initState() { + super.initState(); + data(); + } + + data() async { + offlinekoldata = await retrievekol(); + setState(() {}); + + print("Lenghtttthhhh: ${offlinekoldata.length}"); + } + + @override + Widget build(BuildContext context) { + // print("ProfileType $dropdownvalue, $_selectedValue1"); + + // print("all StoredUser: ${HiveFunctions.getAllUsers11()}"); + + if (_selectedValue1 == "Profile Type") { + print("PPPP11"); + setState(() { + ddlist = [ + "All Profile", + 'Full Profile', + 'Basic Profile', + ]; + }); + } else if (_selectedValue1 == "HCP Name") { + print("kkkofflinekoldata ${offlinekoldata.map((e) => e.name)}"); + + List data = offlinekoldata.map((e) => e.name.toString()).toList(); + + print("Kol_name_data: $data"); + setState(() { + ddlist = data; + }); + } else if (_selectedValue1 == "Speciality") { + print("kkk"); + + List dataspl = + offlinekoldata.map((e) => e.speciality.toString()).toList(); + + setState(() { + ddlist = dataspl; + }); + + // setState(() { + // ddlist = [ + // "Cardiovascular Disease", + // 'Interventional Cardiology', + // "Cardiovascular Disease", + // ]; + // }); + } else if (_selectedValue1 == "Country") { + print("kkk"); + setState(() { + ddlist = [ + "United States", + "United States", + "United States", + ]; + }); + } else if (_selectedValue1 == "State") { + print("kkk"); + setState(() { + ddlist = [ + "Karnataka", + 'Karnataka', + 'Karnataka', + ]; + }); + } else if (_selectedValue1 == "City") { + print("kkk"); + setState(() { + ddlist = [ + "Hubli", + 'Hubli', + 'Hubli', + ]; + }); + } + + SystemChrome.setSystemUIOverlayStyle( + SystemUiOverlayStyle(statusBarColor: Color.fromARGB(255, 0, 71, 132))); + + return SafeArea( + child: Scaffold( + key: _scaffoldKey, // Assign the key to the Scaffold + + // backgroundColor: const Color.fromARGB(255, 246, 248, 252), + // backgroundColor: Color.fromARGB(255, 255, 242, 0.92), + appBar: AppBar( + automaticallyImplyLeading: false, + title: isSearchClickd + ? Container( + height: 40, + decoration: BoxDecoration( + color: Colors.white, + borderRadius: BorderRadius.circular(5.0)), + child: TextField( + controller: _searchController, + onChanged: (value) { + setState(() {}); + }, + decoration: InputDecoration( + fillColor: Constants.k2color, + contentPadding: EdgeInsets.symmetric(vertical: 9.0), + border: OutlineInputBorder(), + hintText: "Search", + // labelText: ' Search', + prefixIcon: Icon( + Icons.search, + ), + ), + ), + ) + : Text("Offline Contacts"), + actions: [ + IconButton( + onPressed: () { + setState(() { + isSearchClickd = !isSearchClickd; + if (!isSearchClickd) { + _searchController.clear(); + } + }); + }, + icon: Icon(isSearchClickd ? Icons.close : Icons.search)) + ], + ), + endDrawer: Drawer( + //width: MediaQuery.of(context).size.width * 99.2, + child: listdata(), + ), + body: + + // ListView.builder( + // itemCount: offlinekoldata.length, + // itemBuilder: (context, index) { + // var data11 = offlinekoldata[index]; + // print("Imammmm_data111: $data11"); + // return ListTile( + // title: Text("dd ${data11.name}"), + // ); + // }) + + Consumer( + builder: (context, hcpProvider, child) { + print("_selectedValueConsumerConsumer_isss: $_selectedValue"); + + if (_selectedValue.isNotEmpty) { + _searchController.text = _selectedValue; + } + + // displayedHCPList = hcpProvider.searchHCP(_searchController.text); + + // offlinekoldata = HiveFunctions.OfflineStored_getindexUser( + // _searchController.text); + + // where((hcp) => + // hcp['name'].toLowerCase().contains(query.toLowerCase()) + + offlinekoldata = offlinekoldata + .where((element) => + element.name + .toLowerCase() + .contains(_searchController.text.toLowerCase()) || + element.speciality + .toLowerCase() + .contains(_searchController.text.toLowerCase()) || + element.addr + .toLowerCase() + .contains(_searchController.text.toLowerCase())) + .toList(); + + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + //mainAxisSize: MainAxisSize.min, + children: [ + // _switchValue + // ? const Text( + // 'All', + // style: TextStyle( + // fontSize: 12, + // decoration: TextDecoration.lineThrough, + // decorationThickness: 0.85, + // ), + // ) + // : const Text( + // 'All', + // style: TextStyle( + // fontSize: 12, + // ), + // ), + Container( + child: Wrap( + children: [ + Padding( + padding: + const EdgeInsets.only(left: 8.0, right: 2.0), + child: CupertinoSwitch( + activeColor: Color.fromARGB(255, 0, 71, 132), + value: _switchValue, + onChanged: (value) { + setState(() { + _switchValue = value; + }); + }, + ), + ), + Padding( + padding: + const EdgeInsets.only(right: 8.0, top: 9.0), + child: !_switchValue + ? Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + ) + + // Text( + // 'My Contacts', + // style: TextStyle( + // fontSize: 15, color: Colors.grey), + // ) + : Text1( + title: 'My Contacts', + txtfont: 15, + txtcolor: Colors.grey, + ) + + // const Text( + // 'My Contacts', + // style: TextStyle( + // fontSize: 15, + // ), + // ), + ) + ], + ), + ), + + Padding( + padding: const EdgeInsets.only(right: 8.0), + child: Row( + children: [ + Text1(title: 'My Filters'), + IconButton( + onPressed: () { + retrievekol(); + + retrieveAffiliations(); + retrievePublications(); + retrieveEventss(); + retrieveTrials(); + _scaffoldKey.currentState?.openEndDrawer(); + }, + icon: Icon( + Icons.sort, + size: 30, + )), + ], + ), + ) + ], + ), + // Row( + // children: [ + // Expanded( + // child: Text( + // _switchValue ? "My Contacts" : "All Contacts", + // textAlign: TextAlign.center, + // style: TextStyle( + // fontSize: 20.0, + // fontWeight: FontWeight.w500, + // ), + // ), + // ), + // ], + // ), + // Padding( + // padding: const EdgeInsets.only( + // top: 8.0, bottom: 8.0, left: 20.0, right: 20.0), + // child: Center( + // child: TextField( + // controller: _searchController, + // onChanged: (value) { + // setState(() {}); + // }, + // decoration: InputDecoration( + // fillColor: Constants.k2color, + // contentPadding: EdgeInsets.symmetric(vertical: 9.0), + // border: OutlineInputBorder(), + // labelText: ' Search', + // prefixIcon: Icon( + // Icons.search, + // ), + // ), + // ), + // ), + // ), + + SizedBox( + height: 5, + ), + + !_switchValue + ? Expanded( + child: ListView.builder( + itemCount: offlinekoldata.length, + itemBuilder: (BuildContext context, int index) { + var data = offlinekoldata[index]; + + print( + "CheckinggggImage_pathOffline: ${data.img_path}"); + + return Column( + children: [ + ListTile( + onLongPress: () { + print("LongPresss"); + setState(() { + longpress = true; + }); + }, + onTap: () async { + print("Check_data11123 = ${data.name}"); + + Navigator.push( + context, + MaterialPageRoute( + builder: (context) => + SavedNewProfile1(text: data), + ), + ); + }, + leading: data.img_path == "" + ? ProfilePicture( + name: data.name, + radius: 30, + fontsize: 12, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(30), + child: CachedNetworkImage( + imageUrl: data.img_path, + imageBuilder: + (context, imageProvider) => + Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + // placeholder: (context, url) => + // CircularProgressIndicator(), + // errorWidget: (context, url, error) => + // Icon(Icons.error), + ), + ), + ), + trailing: Visibility( + visible: longpress, + child: Checkbox( + value: _selectedIndices + .contains(data.id.toString()), + onChanged: (value) { + // setState(() { + // _selectedIndices.add(data["id"]); + + // // isChecked = value!; + // }); + setState(() { + if (value!) { + _selectedIndices + .add(data.id.toString()); + } else { + _selectedIndices + .remove(data.id.toString()); + } + print( + "id_total123: ${_selectedIndices}"); + }); + }), + ), + title: Text1( + title: data.name, + fontweight: FontWeight.bold, + txtfont: isTablet ? 22 : 16, + ), + // Text( + // "${data["name"]}", + // style: TextStyle( + // fontSize: isTablet ? 22 : 16, + // fontWeight: FontWeight.bold, + // ), + // ), + subtitle: Column( + children: [ + Row( + children: [ + Expanded( + child: Text1( + title: data.speciality ?? + data['spl'], + fontweight: FontWeight.normal, + txtfont: isTablet ? 20 : 14, + ), + + // Text( + // "${data["speciality"] ?? data['spl']},", + // style: TextStyle( + // fontSize: isTablet ? 20 : 14, + // fontWeight: FontWeight.normal, + // ), + // ), + ), + ], + ), + Row( + children: [ + Text1( + title: data.name ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + // Text( + // "${data["State"] ?? ""},", + // style: const TextStyle( + // fontSize: 14.0, + // fontWeight: FontWeight.normal, + // ), + // ), + SizedBox( + width: 3.0, + ), + Expanded( + child: Text1( + title: data.name ?? '', + fontweight: FontWeight.normal, + txtfont: 14, + ), + // Text( + // "${data["Country"] ?? ""}", + // style: const TextStyle( + // fontSize: 14.0, + // fontWeight: FontWeight.normal, + // ), + // ), + ), + ], + ), + // Row( + // children: [ + // Text( + // "Added by Pooja k\nAdded on 01/07/2023", + // style: const TextStyle( + // fontSize: 12.0, + // fontWeight: FontWeight.normal, + // ), + // ) + // ], + // ) + ], + ), + ), + Row( + mainAxisAlignment: + MainAxisAlignment.spaceBetween, + children: [ + Padding( + padding: EdgeInsets.only(left: 10.0), + child: Text1( + title: "Added by Pooja k", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ), + Padding( + padding: EdgeInsets.only(right: 10.0), + child: Text1( + title: "Added on 01/07/2023", + fontweight: FontWeight.normal, + txtfont: 14, + ), + ) + ], + ), + Divider(), + ], + ); + }, + ), + ) + : Expanded( + child: ListView.builder( + itemCount: HiveFunctions.getAllUsers11().length, + itemBuilder: (BuildContext context, int index) { + var data = HiveFunctions.getAllUsers11()[index]; + + print("CheckinggggImage_path: ${data['img_path']}"); + print( + "CheckinggggImage_path: ${data['name']},${data['inid']}"); + + return Column( + children: [ + ListTile( + onLongPress: () { + print("LongPresss"); + setState(() { + longpressmy = true; + }); + }, + onTap: () async { + print("Check_data12345 = $data"); + + // Navigator.push( + // context, + // MaterialPageRoute( + // builder: (context) => + // NewProfile1(text: data), + // ), + // ); + }, + leading: data["img_path"] == "" + ? ProfilePicture( + name: data["name"], + radius: 30, + fontsize: 12, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(30), + child: CachedNetworkImage( + imageUrl: data["img_path"], + imageBuilder: + (context, imageProvider) => + Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + // placeholder: (context, url) => + // CircularProgressIndicator(), + // errorWidget: (context, url, error) => + // Icon(Icons.error), + ), + ), + ), + trailing: Visibility( + visible: longpressmy, + child: Checkbox( + value: _selectedremoveIndices + .contains(data["id"]), + onChanged: (value) { + setState(() { + if (value!) { + _selectedremoveIndices + .add(data["id"]); + } else { + _selectedremoveIndices + .remove(data["id"]); + } + print( + "id_total: ${_selectedremoveIndices}"); + }); + }), + ), + title: Text( + "${data["name"]}", + style: TextStyle( + fontSize: isTablet ? 22 : 16, + fontWeight: FontWeight.bold, + ), + ), + subtitle: Column( + children: [ + Row( + children: [ + Expanded( + child: Text( + "${data["speciality"] ?? data['spl']},", + style: TextStyle( + fontSize: isTablet ? 20 : 14, + fontWeight: FontWeight.normal, + ), + ), + ), + ], + ), + Row( + children: [ + Text( + "${data["addr"]},", + style: const TextStyle( + fontSize: 14.0, + fontWeight: FontWeight.normal, + ), + ), + ], + ), + ], + ), + ), + const Row( + mainAxisAlignment: + MainAxisAlignment.spaceBetween, + children: [ + Padding( + padding: EdgeInsets.only(left: 10.0), + child: Text( + "Added by Pooja k", + style: TextStyle( + fontSize: 12.0, + fontWeight: FontWeight.normal, + ), + ), + ), + Padding( + padding: EdgeInsets.only(right: 10.0), + child: Text( + "Added on 01/07/2023", + style: TextStyle( + fontSize: 12.0, + fontWeight: FontWeight.normal, + ), + ), + ) + ], + ), + Divider(), + ], + ); + }, + ), + ), + + !_switchValue + ? Align( + alignment: Alignment.bottomCenter, + child: longpress + ? Container( + color: const Color.fromARGB(255, 251, 242, 242), + width: MediaQuery.of(context).size.width, + height: 200.0, + child: Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + GestureDetector( + onTap: () async { + print("Selected: ${_selectedIndices}"); + print( + "Selected: ${_selectedIndices.length}"); + + for (int i = 0; + i < _selectedIndices.length; + i++) { + // print( + // 'The id id : ${_selectedIndices[i]}'); + // //List<_Row> _rows = []; + + // final row = displayedHCPList[ + // _selectedIndices[i] - 1]; + // var data = displayedHCPList[i]; + + // print( + // "checking_value_istrends: ${_selectedIndices[i]},${row["name"]}, ${row["id"]}"); + // int autoIncrementKey1 = + // await getNextAutoIncrementValue(); + // print(autoIncrementKey1); + + // HiveFunctions.createUser({ + // "inid": autoIncrementKey1, + // "id": autoIncrementKey1, + // "name": row["name"], + // "org": "med", + // "addr": row["addr"], + // "phone": row["phone_no"], + // "phone_no": row["phone_no"], + // "email": row["email"], + // "summarry": row["summarry"], + // "speciality": row["speciality"], + // "sub_speciality": + // row["sub_speciality"], + // "img_path": row["img_path"], + // }); + } + _showMyDialog( + "Selected contact has been added to my contacts "); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.add, + color: Colors.green, + ), + ), + Text( + 'Add to My Contacts', + style: TextStyle( + color: Colors.black, + fontSize: 14.0), + ), + ], + ), + ), + Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.download, + color: Colors.blue, + ), + ), + GestureDetector( + onTap: () {}, + child: Text( + 'Download', + style: + TextStyle(color: Colors.black), + ), + ), + ], + ), + GestureDetector( + onTap: () { + setState(() { + longpress = false; + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + }); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.close, + color: Colors.red, + ), + ), + Text( + 'Cancel', + style: + TextStyle(color: Colors.black), + ), + ], + ), + ), + Expanded( + child: GestureDetector( + onTap: () async { + print( + "Selected: ${_selectedIndices}"); + for (int i = 0; + i < _selectedIndices.length; + i++) { + print( + 'The id id : ${_selectedIndices[i]}'); + + // Map? row = + // findRecordById(offlinekoldata, + // _selectedIndices[i]); + + // print("Storingggg_isss:Row $row"); + + // print( + // "checking_Deleted_istrends: ${_selectedIndices[i]},${row!["license_no"]}, ${row["email"]}, ${row["img_path"]} "); + + await deletekol( + _selectedIndices[i]); + + _showMyDialog( + "selected contact has been removed"); + } + + // print( + // "CheckingAfflist: $affilist"); + setState(() {}); + }, + child: const Row( + children: [ + Padding( + padding: EdgeInsets.all(15.0), + child: Icon( + Icons.save, + color: Colors.deepOrange, + ), + ), + Padding( + padding: + EdgeInsets.only(top: 15.0), + child: Text( + 'Delete Offline', + style: TextStyle( + color: Colors.black), + ), + ), + ], + ), + ), + ), + ], + ), + ) + : Container(), + ) + : Align( + alignment: Alignment.bottomCenter, + child: longpressmy + ? Container( + color: const Color.fromARGB(255, 251, 242, 242), + width: MediaQuery.of(context).size.width, + height: 200.0, + child: Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + GestureDetector( + onTap: () async { + print( + "SelectedRemoveee: ${_selectedremoveIndices}"); + print( + "Selected: ${_selectedremoveIndices.length}"); + + for (int i = 0; + i < _selectedremoveIndices.length; + i++) { + print( + 'The id id : ${_selectedremoveIndices[i]}'); + //List<_Row> _rows = []; + + // final row = displayedHCPList[ + // _selectedremoveIndices[i] - 1]; + // var data = displayedHCPList[i]; + + final row = + await HiveFunctions.getuser( + _selectedremoveIndices[i]); + // var data = HiveFunctions.getuser()[i]; + + print("Delete_Row ${row[i]}"); + print("Delete_Row ${row[i]["inid"]}"); + + // print( + // "checking_valueRemove_istrends: ${_selectedremoveIndices[i]},${row["name"]}, ${row["id"]},${row["inid"]}"); + + //HiveFunctions.addno(_selectedIndices[i]); + // HiveFunctions.removeno(_selectedremoveIndices[i]); + + final row1 = + await HiveFunctions.deleteUser11( + row[i]["inid"]); + setState(() {}); + + // HiveFunctions.deleteUser(_selectedremoveIndices); + } + _showMyDialog( + "selected contact has been removed"); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.remove, + color: Colors.green, + ), + ), + Text( + 'Remove from My Contacts', + style: + TextStyle(color: Colors.black), + ), + ], + ), + ), + Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.download, + color: Colors.blue, + ), + ), + GestureDetector( + onTap: () {}, + child: Text( + 'Download', + style: + TextStyle(color: Colors.black), + ), + ), + ], + ), + GestureDetector( + onTap: () { + setState(() { + longpressmy = false; + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + }); + }, + child: Row( + children: [ + Padding( + padding: const EdgeInsets.all(15.0), + child: Icon( + Icons.close, + color: Colors.red, + ), + ), + Text( + 'Cancel', + style: TextStyle( + color: Constants.k2color), + ), + ], + ), + ), + ], + ), + ) + : Container(), + ), + ], + ); + }, + ), + ), + ); + } + + listdata() { + return ListView( + children: [ + // DrawerHeader removed + ListTile( + title: Padding( + padding: const EdgeInsets.all(8.0), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + const Icon( + Icons.sort, + size: 30.0, + ), + const Text( + "Filters", + style: TextStyle(fontSize: 18.0, fontWeight: FontWeight.bold), + ), + GestureDetector( + onTap: () { + Navigator.pop(context); + // print("hiii"); + }, + child: const Icon(Icons.cancel)) + ], + ), + ), + ), + + ListTile( + title: Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + OutlinedButton( + onPressed: () { + //setState(() {}); + + Navigator.push( + context, + MaterialPageRoute(builder: (context) => SavedContacts1()), + ).then((value) => setState(() {})); + print("refresh done "); + // }) + }, + child: Text( + 'Reset Filter', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ], + ), + ), + + ListTile( + title: DropdownButtonHideUnderline( + child: DropdownButtonFormField2( + hint: Text("Select the Type"), + decoration: InputDecoration( + // Add Horizontal padding using menuItemStyleData.padding so it matches + // the menu padding when button's width is not specified. + isDense: true, + contentPadding: const EdgeInsets.symmetric(vertical: 9), + + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + // Add more decoration.. + ), + isExpanded: true, + value: _selectedValue1, + items: items.map((String item) { + return DropdownMenuItem( + value: item, + child: Text(item), + ); + }).toList(), + onChanged: (String? newValue) { + setState(() { + _selectedValue1 = newValue; + }); + }, + buttonStyleData: const ButtonStyleData( + padding: EdgeInsets.symmetric(horizontal: 16), + height: 50, + width: 200, + ), + dropdownStyleData: DropdownStyleData( + maxHeight: 200, + decoration: BoxDecoration( + borderRadius: BorderRadius.circular(14), + ), + ), + menuItemStyleData: const MenuItemStyleData( + height: 40, + ), + dropdownSearchData: DropdownSearchData( + searchController: textEditingController, + searchInnerWidgetHeight: 50, + searchInnerWidget: Container( + height: 50, + // padding: const EdgeInsets.only( + // top: 8, + // bottom: 4, + // right: 8, + // left: 8, + // ), + child: TextFormField( + expands: true, + maxLines: null, + controller: textEditingController, + decoration: InputDecoration( + isDense: true, + contentPadding: const EdgeInsets.symmetric( + horizontal: 10, + vertical: 18, + ), + hintText: 'Search for an item...', + hintStyle: const TextStyle(fontSize: 12), + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(10.0), + ), + ), + ), + ), + searchMatchFn: (item, searchValue) { + final itemString = item.value.toString().toLowerCase(); + final searchString = searchValue.toLowerCase(); + return itemString.contains(searchString); + }, + ), + onMenuStateChange: (isOpen) { + if (!isOpen) { + textEditingController.clear(); + } + }, + iconStyleData: IconStyleData( + icon: Icon(Icons.arrow_drop_down), + iconSize: 20, + ), + ), + ), + ), + ListTile( + title: Container( + decoration: BoxDecoration( + border: Border.all(color: Colors.black), + borderRadius: BorderRadius.circular(10)), + child: Padding( + padding: const EdgeInsets.all(3.5), + child: DropDownField( + hintText: 'Select an option', + items: ddlist, + onValueChanged: (newValue) { + setState(() { + _selectedValue = newValue; + }); + }, + value: _selectedValue, + ), + ), + ), + ), + + // ListTile( + // title: Row( + // mainAxisAlignment: MainAxisAlignment.end, + // children: [ + // OutlinedButton( + // onPressed: () { + // setState(() {}); + + // print("refresh done 111"); + + // }, + // child: Text( + // 'Saved Profiles', + // style: TextStyle(color: Constants.k2color), + // ), + // style: OutlinedButton.styleFrom( + // shape: RoundedRectangleBorder( + // borderRadius: BorderRadius.circular(12), + // ), + // ), + // ), + // ], + // ), + // ), + ], + ); + } + + filterss(String selectedValue) async { + setState(() { + print("_selectedValue_isss: $_selectedValue"); + }); + } + + Future _showMyDialog(String data) async { + return showDialog( + context: context, + barrierDismissible: false, // user must tap button! + builder: (BuildContext context) { + return AlertDialog( + title: const Text('Successfully'), + content: SingleChildScrollView( + child: ListBody( + children: [ + // Text('This is a demo alert dialog.'), + Text(data), + ], + ), + ), + actions: [ + TextButton( + child: const Text('Ok'), + onPressed: () { + Navigator.of(context).pop(); + setState(() { + _selectedIndices.clear(); + _selectedremoveIndices.clear(); + longpress = false; + longpressmy = false; + }); + }, + ), + ], + ); + }, + ); + } + + Future getNextAutoIncrementValue() async { + var counterBox = await Hive.openBox('counterBox'); + if (!counterBox.containsKey('counter')) { + counterBox.put('counter', 0); + } + + int? counter = counterBox.get('counter'); + counterBox.put('counter', counter! + 1); + + await counterBox.close(); + + return counter; + } + + Map findRecordById( + List displayedHCPList, String selectedIndic) { + // print( + // "Gettt11111 ${displayedHCPList.firstWhere((element) => element['id'] == int.parse(selectedIndic))}"); + return displayedHCPList + .firstWhere((element) => element['id'] == int.parse(selectedIndic)); + } +} diff --git a/lib/contacts_module/ui_screen/saved_profiles/saved_profile_info.dart b/lib/contacts_module/ui_screen/saved_profiles/saved_profile_info.dart new file mode 100644 index 0000000..cabd1ee --- /dev/null +++ b/lib/contacts_module/ui_screen/saved_profiles/saved_profile_info.dart @@ -0,0 +1,1257 @@ +// import 'package:konectar_events/check.dart'; +// import 'package:konectar_events/constants.dart'; +// import 'package:konectar_events/custom_widget/text.dart'; +// import 'package:konectar_events/storage_hive/note_data/crud_note.dart'; + +// import 'package:konectar_events/ui_screen/activity_tab.dart'; + +// import 'package:konectar_events/ui_screen/engagementtab.dart'; + +// import 'package:konectar_events/ui_screen/interactionform/interactionprovider.dart'; +// import 'package:konectar_events/ui_screen/interactionform/model/save_interaction.dart'; + +// import 'package:konectar_events/ui_screen/interactionform/viewinteractionprovider.dart'; +// import 'package:konectar_events/ui_screen/location_tab.dart'; + +// import 'package:konectar_events/ui_screen/newformlist.dart'; +// import 'package:konectar_events/ui_screen/saved_profiles/saved_activity.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:konectar_events/contacts_module/custom_widget/text.dart'; +import 'package:konectar_events/contacts_module/storage_hive/note_data/crud_note.dart'; +import 'package:konectar_events/contacts_module/ui_screen/engagementtab.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/location_tab.dart'; +import 'package:konectar_events/contacts_module/ui_screen/newformlist.dart'; +import 'package:konectar_events/contacts_module/ui_screen/saved_profiles/saved_activity.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/foundation.dart'; +import 'package:flutter/material.dart'; +import 'package:flutter/painting.dart'; +import 'package:flutter/rendering.dart'; +import 'package:flutter/widgets.dart'; +import 'package:flutter_profile_picture/flutter_profile_picture.dart'; +import 'package:provider/provider.dart'; +import 'package:cached_network_image/cached_network_image.dart'; +import 'package:url_launcher/url_launcher.dart'; + +class SavedNewProfile1 extends StatefulWidget { + const SavedNewProfile1({Key? key, required this.text}) : super(key: key); + final dynamic text; + + @override + State createState() => SavedNewProfile1State(); +} + +class SavedNewProfile1State extends State + with TickerProviderStateMixin { + //bool isonline = false; + List affiliation_data = []; + List publication_data = []; + List event_data = []; + List trial_data = []; + List medinsightData = []; + List speaker = []; + List eng = []; + + // final PageController _controller = PageController(viewportFraction: 0.8); + + List viewformData = []; + + bool _isExpanded = false; + + var item; + + TextEditingController firstNameController = TextEditingController(); + + final List gradients = [ + const Color.fromARGB(255, 23, 162, 184), + const Color.fromARGB(255, 40, 167, 69), + Color.fromARGB(255, 187, 163, 7), + const Color.fromARGB(255, 220, 53, 69), + const Color.fromARGB(255, 23, 162, 184), + ]; + final ScrollController _scrollController = ScrollController(); + late final TabController _tabController; + + static const _tabs = [ + Tab(text: "Details"), + Tab(text: "Speakers"), + Tab(text: "Speakers"), + ]; + + final TextEditingController _controller = TextEditingController(); + + @override + void initState() { + // TODO: implement initState + super.initState(); + print("pooja123455667 ${widget.text}"); + _tabController = TabController(length: 3, vsync: this); + + //init(); + WidgetsBinding.instance.addPostFrameCallback((timeStamp) {}); + } + + init() async { + await Provider.of(context, listen: false) + .initConfigData(); + final data = + await Provider.of(context, listen: false); + + // if(data.g) + data.getRecords("form-3 demo"); + // setState(() {}); + } + + @override + void dispose() { + _tabController.dispose(); + super.dispose(); + } + + @override + Widget build(BuildContext context) { + // return Consumer( + // builder: (BuildContext context, provider, Widget? child) { + return DefaultTabController( + length: 3, + child: SafeArea( + child: headerview(context), + ), + ); + // }); + } + + Widget headerview(BuildContext context) { + return SafeArea( + child: Scaffold( + backgroundColor: Constants.bgcolor, + // appBar: AppBar(), + body: Stack( + children: [ + Container( + // color: Colors.blue, + child: Column( + children: [ + getAppBarUI(), + Expanded( + child: NestedScrollView( + controller: _scrollController, + headerSliverBuilder: + (BuildContext context, bool innerBoxIsScrolled) { + return [ + SliverList( + delegate: SliverChildBuilderDelegate( + (BuildContext context, int index) { + return Container( + //color: Constants.blueColor, + child: Column( + children: [ + buildCardView( + context, + ) + + // getTimeDateUI(), + ], + ), + ); + }, childCount: 1), + ), + SliverPersistentHeader( + pinned: true, + floating: true, + delegate: ContestTabHeader( + Container( + //color: Constants.bgcolor2, + decoration: BoxDecoration( + gradient: LinearGradient( + begin: Alignment.bottomCenter, + end: Alignment.topCenter, + colors: [ + // Constants.blueColor, + Constants.tabbgColor, + Constants.k2color, + // Constants.tabbgColor, + // const Color.fromARGB(255, 222, 237, 247), + // const Color.fromARGB(255, 222, 237, 247), + // Color(0xff006df1) + ]), + ), + child: const TabBar( + indicatorColor: Colors.white, + labelColor: Colors + .white, // Color of the selected tab text + + unselectedLabelColor: + Color.fromARGB(255, 241, 163, 163), + // unselectedLabelColor: + // Color.fromARGB(255, 163, 159, 159), + tabs: [ + // Tab(text: "Sentiment"), + Tab( + // text: "Related " + child: Text( + 'Details', + style: TextStyle( + fontWeight: FontWeight.normal, + fontSize: 15.0), + ), + ), + Tab( + // text: "Activities " + child: Text( + 'Activities', + style: TextStyle( + fontWeight: FontWeight.normal, + fontSize: 15.0), + ), + ), + Tab( + //text: "Engagement " + + child: Text( + 'Engagements', + style: TextStyle( + fontWeight: FontWeight.normal, + fontSize: 15.0), + ), + ), + + // Tab(icon: Icon(Icons.email)), + ], + ), + ), + // const TabBar( + // indicatorSize: TabBarIndicatorSize.label, + // labelColor: Colors.black, + // unselectedLabelColor: Colors.grey, + // tabs: _tabs, + // ), + ), + ) + ]; + }, + body: + + //Text("hiiii") + + TabBarView( + //controller: _tabController, + children: [ + //LocationTab(text: widget.text.id), + LocationTab(text: 1, offline: 1), + SavedActivities(text: widget.text.id), + // SavedActivities(text: widget.text.id), + EngagementTab(text: 1, offline: 1), + + //EngagementTab(text: widget.text.id), + ], + ), + ), + ) + ], + ), + ), + ], + ), + floatingActionButton: Visibility( + visible: true, + child: FloatingActionButton( + onPressed: () async { + // final ConfigDataProvider configDataProvider = + // ConfigDataProvider(); + + // await configDataProvider.initConfigUIData(); + Navigator.push( + context, MaterialPageRoute(builder: (context) => FormList())); + }, + foregroundColor: Colors.white, + backgroundColor: const Color.fromARGB(255, 0, 71, 132), + child: new Icon(Icons.add), + ), + ), + ), + ); + } + + buildCardView(BuildContext context) { + MediaQuery.of(context).size.height * 0.35; + + return Container( + //color: Colors.yellowAccent, + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + //mainAxisAlignment: MainAxisAlignment.spaceAround, + children: [ + Stack( + clipBehavior: Clip.none, + alignment: Alignment.center, + children: [ + Container( + width: + MediaQuery.of(context).size.width, // Adjust width as needed + height: 110, // Adjust height as needed + decoration: BoxDecoration(color: Constants.k2color), + child: Column( + mainAxisAlignment: MainAxisAlignment.start, + children: [ + Text1( + title: widget.text!.name, + txtcolor: Colors.white, + fontweight: FontWeight.normal, + txtfont: 20.0), + Text1( + title: widget.text!.speciality, + txtcolor: Colors.white, + fontweight: FontWeight.normal, + txtfont: 14.0), + ], + ), + ), + // Column( + // mainAxisAlignment: MainAxisAlignment.start, + // children: [ + // Text1( + // title: "Dr " + widget.text!["name"], + // txtcolor: Colors.white, + // fontweight: FontWeight.normal, + // txtfont: 22.0), + // Text1( + // title: widget.text!["speciality"], + // txtcolor: Colors.white, + // fontweight: FontWeight.normal, + // txtfont: 15.0), + // ], + // ), + Positioned( + bottom: -45, + child: Container( + child: widget.text.img_path == "" + ? ProfilePicture( + name: widget.text!.name, + radius: 48, + fontsize: 21, + ) + : ClipOval( + child: SizedBox.fromSize( + size: Size.fromRadius(48), + child: CachedNetworkImage( + imageUrl: widget.text!.img_path, + imageBuilder: (context, imageProvider) => + Container( + decoration: BoxDecoration( + image: DecorationImage( + image: imageProvider, + fit: BoxFit.fill, + ), + ), + ), + // placeholder: (context, url) => + // CircularProgressIndicator(), + // errorWidget: (context, url, error) => + // Icon(Icons.error), + ), + ), + ), + + // ClipOval( + // child: SizedBox.fromSize( + // size: Size.fromRadius(48), // Image radius + // child: Image.network(widget.text!["img_path"], + // fit: BoxFit.fill), + // ), + // ), + ), + ) + ], + ), + SizedBox( + height: 55.0, + ), + + _ProfileInfoRow(text: widget.text.id), + + // Profile photo + Column( + children: [ + // Text1( + // title: "Dr " + widget.text!["name"], + // txtcolor: Colors.black, + // fontweight: FontWeight.normal, + // txtfont: 22.0), + // Text1( + // title: widget.text!["speciality"], + // txtcolor: Colors.black, + // fontweight: FontWeight.normal, + // txtfont: 15.0), + SizedBox( + height: 8.0, + ), + Padding( + padding: const EdgeInsets.only(left: 8.0), + child: + Row(mainAxisAlignment: MainAxisAlignment.center, children: [ + const Icon( + Icons.location_city_sharp, + color: Color.fromARGB(255, 0, 71, 132), + ), + const SizedBox( + width: 3.0, + ), + Expanded( + child: Text1( + title: widget.text!.name ?? + "Florida Hospital Medical Group Inc", + txtcolor: Colors.black, + txtfont: 14.0, + fontweight: FontWeight.normal, + ), + // child: RichText( + // text: TextSpan( + // text: widget.text!["addr"] ?? + // "Azienda Ospedaliera di Padova", + // style: TextStyle( + // fontSize: 16.0, color: Colors.black), + // ), + // ), + ), + ]), + ), + const SizedBox( + height: 8.0, + ), + Padding( + padding: const EdgeInsets.only(left: 8.0), + child: InkWell( + onTap: () { + _openMapsByAddress(); + }, + child: Row(children: [ + const Icon( + Icons.location_pin, + color: Color.fromARGB(255, 0, 71, 132), + ), + const SizedBox( + width: 3.0, + ), + Expanded( + // child: Text( + // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", + // style: TextStyle( + // fontWeight: FontWeight.bold, fontSize: 14.0), + // ), + child: Text1( + title: + //widget.text!["Country"] ?? + "Via Giustiniani, 2, Padova, Veneto 35128, Italy", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0), + + // child: RichText( + // text: TextSpan( + // text: widget.text!["adrr"] ?? + // "Via Giustiniani, 2, Padova, Veneto 35128, Italy", + // style: TextStyle( + // fontSize: 16.0, color: Colors.black), + // ), + // ), + ), + ]), + ), + ), + const SizedBox( + height: 8.0, + ), + Padding( + padding: const EdgeInsets.only(left: 8.0), + child: InkWell( + onTap: () async { + print("Emailll"); + String? encodeQueryParameters(Map params) { + return params.entries + .map((MapEntry entry) => + Uri.encodeComponent(entry.key) + + '=' + + Uri.encodeComponent(entry.value)) + .join('&'); + } + + final Uri emailLaunchUri = Uri( + scheme: 'mailto', + path: 'example@example.com', + query: encodeQueryParameters({ + 'subject': 'Example Subject', + 'body': 'Hello, this is a sample body text.', + }), + ); + + if (await launchUrl(emailLaunchUri)) { + launchUrl(emailLaunchUri); + } else { + throw 'Could not launch $emailLaunchUri'; + } + }, + child: Row(children: [ + const Icon( + Icons.email, + color: Color.fromARGB(255, 0, 71, 132), + ), + const SizedBox( + width: 3.0, + ), + Expanded( + child: Text1( + title: widget.text!.email, + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0), + ), + ]), + ), + ), + SizedBox( + height: 8.0, + ), + Padding( + padding: const EdgeInsets.only(left: 8.0), + child: InkWell( + onTap: () async { + final call = Uri.parse('tel:${widget.text!.phone_no}'); + if (await canLaunchUrl(call)) { + launchUrl(call); + } else { + throw 'Could not launch $call'; + } + }, + child: Row(children: [ + const Icon( + Icons.phone, + color: Color.fromARGB(255, 0, 71, 132), + ), + const SizedBox( + width: 3.0, + ), + // Text( + // "+390498212410 X 12", + // style: TextStyle( + // fontWeight: FontWeight.bold, fontSize: 14.0), + // ), + Text1( + title: widget.text!.phone_no, + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0), + ]), + ), + ), + // const SizedBox( + // height: 8.0, + // ), + // Padding( + // padding: const EdgeInsets.only(left: 8.0), + // child: Row(children: [ + // const Icon( + // Icons.call, + // color: Color.fromARGB(255, 0, 71, 132), + // ), + // const SizedBox( + // width: 3.0, + // ), + // Expanded( + // child: Text1( + // title: widget.text!["phone_no"].toString(), + // txtcolor: Colors.black, + // fontweight: FontWeight.normal, + // txtfont: 15.0), + // ), + // ]), + // ), + ], + ), + + const SizedBox( + height: 5.0, + ), + + Align( + alignment: Alignment.centerLeft, + child: Padding( + padding: const EdgeInsets.only(left: 8.0), + child: Text1( + title: "Profile Summary", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 18.0), + ), + ), + const SizedBox( + height: 5.0, + ), + Align( + alignment: Alignment.centerLeft, + child: Padding( + padding: const EdgeInsets.only(left: 15.0), + child: Text1( + title: widget.text!.summarry, + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 14.0), + ), + ), + + SizedBox( + height: 10.0, + ), + + ListTileTheme( + dense: true, + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 8.0), + child: Card( + margin: EdgeInsets.all(1.0), + // elevation: 5, + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(0.0), + ), + color: Constants.k2color11, + child: ExpansionTile( + // collapsedBackgroundColor: Color(0xFF2b9af3), + onExpansionChanged: (bool expanded) { + setState(() { + _isExpanded = expanded; + }); + }, + backgroundColor: Constants.k2color11, + trailing: Icon( + _isExpanded + ? Icons.keyboard_arrow_up + : Icons.keyboard_arrow_down, + color: Colors.black), + title: Row( + mainAxisAlignment: MainAxisAlignment.start, + // mainAxisSize: MainAxisSize.min, + children: [ + Text1( + title: "Notes", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + const SizedBox( + width: 8.0, + ), + Text1( + title: "(0)", + txtcolor: Colors.black, + fontweight: FontWeight.normal, + txtfont: 17.0), + ], + ), + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: TextField( + controller: _controller, + decoration: InputDecoration( + border: OutlineInputBorder( + borderRadius: BorderRadius.circular(8.0), + ), + hintText: 'Write your note here', + contentPadding: EdgeInsets.all(16.0), + ), + maxLines: + null, // Allows the TextField to expand vertically + ), + ), + Padding( + padding: const EdgeInsets.all(8.0), + child: OutlinedButton( + onPressed: () async { + await addNote(_controller.text); + + _controller.clear(); + setState(() { + getText(); + }); + }, + child: Text( + 'Save', + style: TextStyle(color: Constants.k2color), + ), + style: OutlinedButton.styleFrom( + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.circular(12), + ), + ), + ), + ), + + Padding( + padding: EdgeInsets.all(10.0), + + // child: Text(getText().toString()), + + child: SizedBox( + height: 100, // Set a height for the list + child: ListView.builder( + itemCount: getText().length, // Number of notes + itemBuilder: (context, index) { + final note = + getText()[index]; // Get note at current index + return ListTile( + title: Text(note), // Display the note + ); + }, + ), + ), + // child: ListView.builder( + // itemCount: getText().length, + // itemBuilder: (context, index) { + // final data = getText()[index]; + + // return ListTile( + // title: Text(data), + // ); + // }), + ) + + // ListView.builder( + // itemCount: getText().length, + // itemBuilder: (context, index) { + // final text = getText()[index]; + // return ListTile( + // title: Text(text), + // ); + // }, + // ), + ]), + ), + ), + ), // adds spacing between the text and image + + SizedBox( + height: 10.0, + ), + ], + // ), + ), + ); + } + + Widget listViewTopicCard(String title, String content, bool visible) { + return Visibility( + visible: visible, + child: Card( + child: Container( + padding: EdgeInsets.all(8.0), + width: double.maxFinite, + decoration: BoxDecoration( + // color: Color.fromARGB(179, 248, 238, 238), + // color: Colors.white, + ), + child: Padding( + padding: const EdgeInsets.only(left: 8.0, right: 14.0), + child: Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Text( + title, + style: TextStyle( + fontSize: 16, + fontWeight: FontWeight.bold, + ), + ), + Text( + content, + style: TextStyle( + fontSize: 14, + color: Colors.grey[700], + ), + ), + ], + ), + ), + ), + ), + ); + } + + Future getCount(String form, InteractionProvider provider) async { + await provider.getRecords(); + + return provider.savedList.where((element) => element.form == form).length; + } + + buidCard() { + Text("Hiii"); + } + + showDeleteRecordAlertDialog( + BuildContext context, String record, SaveInteraction saveInteraction) { + // set up the buttons + ViewInteractionProvider provider = + Provider.of(context, listen: false); + Widget cancelButton = TextButton( + child: const Text("YES"), + onPressed: () async { + await provider.deleteRecord(saveInteraction).then((value) { + _displaySnackBar("Deleted sucessfully!"); + Navigator.of(context).pop(); + }); + }, + ); + Widget continueButton = TextButton( + child: const Text("NO"), + onPressed: () { + Navigator.of(context).pop(); + }, + ); + + // set up the AlertDialog + AlertDialog alert = AlertDialog( + title: const Text(""), + content: Text("Are you sure you want to delete the record $record ?"), + actions: [ + cancelButton, + continueButton, + ], + ); + + // show the dialog + showDialog( + context: context, + builder: (BuildContext context) { + return alert; + }, + ); + } + + _displaySnackBar(String msg) { + final snackBar = SnackBar( + content: Text( + msg, + style: const TextStyle(fontSize: 20.0, fontWeight: FontWeight.bold), + )); + ScaffoldMessenger.of(context).showSnackBar(snackBar); + //scaffoldKeyLogin.currentState!.showSnackBar(snackBar); + } + + Widget makeDismissible({required DraggableScrollableSheet child}) { + return GestureDetector( + behavior: HitTestBehavior.opaque, + onTap: () => Navigator.of(context).pop(), + child: GestureDetector( + onTap: () {}, + child: child, + ), + ); + } + + void bottomshet(affiliation_data) { + // print("Aff_index_data: ${affiliation_data}"); + showModalBottomSheet( + // isScrollControlled: + // true, + + context: context, + + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + // sheetAnimationStyle: _animationStyle, + builder: (BuildContext context) { + return + // makeDismissible( + // child: + DraggableScrollableSheet( + expand: false, + builder: (BuildContext context, ScrollController scrollController) { + return Container( + width: MediaQuery.of(context).size.width, + //color: Colors.white, + color: Color.fromARGB(255, 246, 248, 252), + + // decoration: + // BoxDecoration(borderRadius: BorderRadius.circular(10)), + // child: ListView( + // children: [ + + // ], + // ), + + child: Column( + children: [ + Expanded( + child: ListView.builder( + controller: scrollController, + itemCount: 1, + itemBuilder: (BuildContext context, int index) { + return Column( + crossAxisAlignment: CrossAxisAlignment.start, + mainAxisSize: MainAxisSize.min, + mainAxisAlignment: MainAxisAlignment.center, + children: [ + // Row( + // children: [ + // Text( + // "Affiliation", + // style: TextStyle(fontSize: 20.0), + // ) + // ], + // ), + SizedBox( + height: 18.0, + ), + Row( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Expanded( + child: Padding( + padding: const EdgeInsets.all(18.0), + child: Text( + affiliation_data['org_name'], + softWrap: true, + maxLines: 4, + style: TextStyle( + fontSize: 18.0, + color: Colors.grey[700]), + ), + ), + ), + ], + ), + SizedBox( + height: 18.0, + ), + Divider(), + SizedBox( + height: 8.0, + ), + + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + "Department", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['dept'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Role", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['role'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Time Frame".toString(), + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['time_frame'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Oraganization Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['org_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + Column( + crossAxisAlignment: CrossAxisAlignment.start, + children: [ + Padding( + padding: const EdgeInsets.only( + left: 18.0, top: 18.0), + child: Text( + "Eng Type", + style: TextStyle(fontSize: 13.0), + ), + ), + Padding( + padding: const EdgeInsets.only(left: 18.0), + child: Text( + affiliation_data['emg_type'], + style: TextStyle( + fontSize: 14.0, + color: Colors.grey[700]), + ), + ) + ], + ), + ], + ); + }, + ), + ), + ], + ), + ); + }, + ); + //); + }, + ); + } + + Widget _buildPaginationDots() { + return Container( + padding: EdgeInsets.symmetric(vertical: 8.0), + child: Row( + mainAxisAlignment: MainAxisAlignment.center, + children: List.generate(10, (index) { + return Container( + margin: EdgeInsets.symmetric(horizontal: 4.0), + width: 8.0, + height: 8.0, + decoration: BoxDecoration( + shape: BoxShape.circle, + color: 1 == index ? Colors.blue : Colors.grey, + ), + ); + }), + ), + ); + } + + Widget getAppBarUI() { + return Container( + decoration: BoxDecoration( + color: Constants.k2color, + boxShadow: [ + BoxShadow( + color: Colors.grey.withOpacity(0.2), + offset: const Offset(0, 2), + blurRadius: 8.0), + ], + ), + child: Padding( + padding: EdgeInsets.only(top: 2, left: 8, right: 8), + child: Row( + children: [ + Container( + alignment: Alignment.topLeft, + // width: AppBar().preferredSize.height, + // height: AppBar().preferredSize.height, + child: Material( + color: Colors.transparent, + child: InkWell( + borderRadius: const BorderRadius.all( + Radius.circular(32.0), + ), + onTap: () { + Navigator.pop(context); + }, + child: Padding( + padding: const EdgeInsets.all(8.0), + child: Row( + children: [ + Icon( + Icons.arrow_back_ios_new, + size: 18, + color: Colors.white, + ), + SizedBox( + width: 8, + ), + Text( + "Contacts", + style: TextStyle(fontSize: 14.0, color: Colors.white), + ) + ], + ), + ), + ), + ), + ), + Expanded( + child: Text( + "", + maxLines: 1, + softWrap: true, + style: TextStyle( + fontWeight: FontWeight.w600, + fontSize: 14, + overflow: TextOverflow.ellipsis, + ), + ), + ), + ], + ), + ), + ); + } + + Future _openMapsByAddress() async { + final address = 'Italy'; + final Uri mapsUri = Uri( + scheme: 'https', + host: 'www.google.com', + path: 'maps/search/', + query: address, + ); + + if (!await launchUrl(mapsUri)) { + throw 'Could not launch $mapsUri'; + } + } +} + +class _ProfileInfoRow extends StatelessWidget { +// _ProfileInfoRow({Key? key}) : super(key: key); + final int text; + + _ProfileInfoRow({required this.text, Key? key}) : super(key: key); + + final List _items = const [ + ProfileInfoItem("Publication(s)", 688), + ProfileInfoItem("Event(s)", 111), + ProfileInfoItem("Trial(s)", 10), + ]; + + @override + Widget build(BuildContext context) { + return Container( + height: 80, + constraints: const BoxConstraints(maxWidth: 400), + child: Row( + mainAxisAlignment: MainAxisAlignment.spaceEvenly, + children: _items + .map((item) => Expanded( + child: Row( + children: [ + if (_items.indexOf(item) != 0) const VerticalDivider(), + Expanded(child: _singleItem(context, item)), + ], + ))) + .toList(), + ), + ); + } + + Widget _singleItem(BuildContext context, item) => Column( + mainAxisAlignment: MainAxisAlignment.center, + children: [ + Padding( + padding: const EdgeInsets.all(8.0), + child: Text( + item.value.toString(), + style: const TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14, + ), + ), + ), + Text( + item.title, + // style: const TextStyle( + // fontWeight: FontWeight.normal, + // fontSize: 18, + // ), + // style: Theme.of(context).textTheme.caption, + ) + ], + ); +} + +class ProfileInfoItem { + final String title; + final int value; + const ProfileInfoItem(this.title, this.value); +} + +class ContestTabHeader extends SliverPersistentHeaderDelegate { + ContestTabHeader( + this.searchUI, + ); + final Widget searchUI; + + @override + Widget build( + BuildContext context, double shrinkOffset, bool overlapsContent) { + return Container(color: Colors.white, child: searchUI); + } + + @override + double get maxExtent => 52.0; + + @override + double get minExtent => 52.0; + + @override + bool shouldRebuild(SliverPersistentHeaderDelegate oldDelegate) { + return true; + } +} diff --git a/lib/contacts_module/ui_screen/training_showmore.dart b/lib/contacts_module/ui_screen/training_showmore.dart new file mode 100644 index 0000000..fa0ad5a --- /dev/null +++ b/lib/contacts_module/ui_screen/training_showmore.dart @@ -0,0 +1,110 @@ +import 'package:konectar_events/contacts_module/provider_class/training_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class TrainingShowMore extends StatefulWidget { + TrainingShowMore({required this.text, Key? key}) : super(key: key); + final int text; + + @override + State createState() => _TrainingShowMoreState(); +} + +class _TrainingShowMoreState extends State { + @override + List training = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var trai = Provider.of(context, listen: false); + + await trai.traininginfo(widget.text); + final training1 = trai.traininglist; + setState(() { + training = training1; + }); + + print("locationList: ${training}"); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Training'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + color: Colors.white, + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Education Type', + style: TextStyle(fontWeight: FontWeight.w600), + softWrap: true), + )), + DataColumn( + label: Expanded( + child: Text('Institution Name', + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + training.length, + (index) => DataRow( + onSelectChanged: (value) { + print("message ${training[index]}"); + + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(training[index]); + }, + ); + }, + cells: [ + DataCell(Text( + training[index]['Education Type'].toString(), + softWrap: true)), + DataCell(Text( + training[index]['Institution Name'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/trends.dart b/lib/contacts_module/ui_screen/trends.dart new file mode 100644 index 0000000..80dbdb8 --- /dev/null +++ b/lib/contacts_module/ui_screen/trends.dart @@ -0,0 +1,230 @@ +import 'package:konectar_events/contacts_module/custom_widget/floating_btn.dart'; +import 'package:konectar_events/contacts_module/custom_widget/show_alert.dart'; +import 'package:konectar_events/contacts_module/hive_fun.dart'; +import 'package:flutter/material.dart'; + +class Trends extends StatefulWidget { + const Trends({super.key}); + + @override + State createState() => _TrendsState(); +} + +class _TrendsState extends State { + late _DataSource _dataSource; // Instance variable for _DataSource + @override + void initState() { + super.initState(); + print("hii_initState"); + _dataSource = _DataSource(context); + } + + @override + Widget build(BuildContext context) { + return SafeArea( + child: Scaffold( + body: ListView( + padding: const EdgeInsets.all(3), + children: [ + PaginatedDataTable( + header: const Text( + 'HCP RANKING', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 18.0, + fontStyle: FontStyle.normal), + ), + showFirstLastButtons: true, + showEmptyRows: false, + showCheckboxColumn: true, + // actions: const [Text("jii")], + rowsPerPage: 5, + columns: const [ + DataColumn( + label: Text('Name', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Last 5 Years', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Last 3 Years', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + DataColumn( + label: Text('Last 1 Year', + style: TextStyle( + fontWeight: FontWeight.bold, + fontSize: 14.0, + fontStyle: FontStyle.normal))), + ], + source: _dataSource, + ), + ], + ), + floatingActionButton: Visibility( + visible: true, + child: FloatingBtn( + icon: Icons.add, + title: "add", + onTap: () { + List selectedRowIds = _dataSource.getSelectedRowIds(); + // Do something with selectedRowIds + print('Selected Row IDstrndsss: $selectedRowIds'); + + for (int i = 0; i < selectedRowIds.length; i++) { + print("checking_value_istrends: ${selectedRowIds[i]}"); + + // _contactbox.put(i, selectedRowIds[i]); + + HiveFunctions.createUser({ + "name": selectedRowIds[i], + "org": "Azienda Ospedaliera di Padova", + "adrr": "Via Giustiniani 2, Padova, Veneto 35128, Italy", + "phone": "+390498212410X12", + "Pphone": "+390498212410X12", + "email": "Gerosa,Gino@gmail.com", + "affno": "75", + "eveno": "8", + "pubno": "251", + "trailno": "1" + }); + } + showDialog( + context: context, + builder: (_) { + return Alert( + data: "User Added Successfully", + onPressed: () { + Navigator.of(context).pop(); + }, + ); + }); + }, + )), + ), + ); + } +} + +class _Row { + _Row(this.identifier, this.valueA, this.valueC, this.valueD, this.valueE); + + final int identifier; + final String valueA; + final String valueC; + final IconData valueD; + final IconData valueE; + + bool selected = false; +} + +class _DataSource extends DataTableSource { + // _DataSource(this.context) { + + // late BuildContext context; + // late List<_Row> _rows; + final BuildContext context; + late List<_Row> _rows; + + final List _selectedRowIds = []; + + _DataSource(this.context) { + _rows = <_Row>[ + for (int i = 0; i < 20; i++) + _Row( + i, + 'Gerosa, Gino', + '1', + Icons.arrow_upward_sharp, + Icons.arrow_downward_rounded, + ), + ]; + //} + } + List getSelectedRowIds() { + return _selectedRowIds; // Return a copy to prevent direct modification + } + + int _selectedCount = 0; + + @override + DataRow? getRow(int index) { + assert(index >= 0); + if (index >= _rows.length) return null; + final row = _rows[index]; + return DataRow.byIndex( + index: index, + selected: row.selected, + + // onSelectChanged: (value) { + // // print("hii"); + // Navigator.push( + // context, MaterialPageRoute(builder: (context) => Profile())); + // }, + + onSelectChanged: (value) { + if (row.selected != value) { + // _selectedCount += value! ? 1 : -1; + // assert(_selectedCount >= 0); + row.selected = value!; + if (value) { + print("Selected"); + _selectedRowIds.add(row.valueA); // Add the row ID to the list + print("Selected_selectedRowIds :$_selectedRowIds"); + } else { + _selectedRowIds + .remove(row.valueA); // Remove the row ID from the list + } + notifyListeners(); + } + }, + cells: [ + DataCell(Text(row.valueA)), + DataCell(Text(row.valueC)), + const DataCell( + Row( + children: [ + Icon( + Icons.arrow_drop_up, + color: Colors.green, + ), + SizedBox(width: 8), // Adding some space between icon and text + Text("1"), + ], + ), + + // Text + ), + const DataCell( + Row( + children: [ + Icon( + Icons.arrow_drop_down, + color: Colors.red, + ), + SizedBox(width: 8), // Adding some space between icon and text + Text("1"), + ], + ), + ), + ], + ); + } + + @override + int get rowCount => _rows.length; + + @override + bool get isRowCountApproximate => false; + + @override + int get selectedRowCount => _selectedCount; +} diff --git a/lib/contacts_module/ui_screen/trials_show_more.dart b/lib/contacts_module/ui_screen/trials_show_more.dart new file mode 100644 index 0000000..2c9488e --- /dev/null +++ b/lib/contacts_module/ui_screen/trials_show_more.dart @@ -0,0 +1,111 @@ +// import 'package:konectar_events/provider_class/trials_provider.dart'; +// import 'package:konectar_events/ui_screen/bottom_sheet.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/bottom_sheet.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; +import 'package:provider/provider.dart'; + +class TrialsShowmore extends StatefulWidget { + TrialsShowmore({required this.text, Key? key}) : super(key: key); + final int text; + @override + State createState() => _TrialsShowmoreState(); +} + +class _TrialsShowmoreState extends State { + List trial_data = []; + @override + void initState() { + // TODO: implement initState + super.initState(); + + affdata(); + } + + affdata() async { + var trials = Provider.of(context, listen: false); + await trials.trialsdata(widget.text); + + final trialslist = trials.trialsinfo; + setState(() { + trial_data = trialslist; + }); + } + + @override + Widget build(BuildContext context) { + return Scaffold( + appBar: AppBar( + title: Text('Trials'), + ), + body: Scrollbar( + child: SingleChildScrollView( + scrollDirection: Axis.horizontal, + child: SingleChildScrollView( + scrollDirection: Axis.vertical, + child: Container( + constraints: + BoxConstraints(minWidth: MediaQuery.of(context).size.width), + child: DataTable( + showCheckboxColumn: false, + columns: const [ + DataColumn( + label: Expanded( + child: Text('Trial Name', + softWrap: true, + style: TextStyle(fontWeight: FontWeight.w600)), + )), + DataColumn( + label: Expanded( + child: Text('Status', + softWrap: true, + style: + TextStyle(fontWeight: FontWeight.w600)))), + ], + rows: List.generate( + trial_data.length, + (index) => DataRow( + onSelectChanged: (value) { + // =======> Use onSelectChanged for tab + print("message ${trial_data[index]}"); + + // bsheet( + // publication_data[ + // index]); + showModalBottomSheet( + useRootNavigator: true, + isScrollControlled: false, + enableDrag: true, + useSafeArea: true, + constraints: const BoxConstraints( + maxWidth: double.infinity, + ), + shape: RoundedRectangleBorder( + borderRadius: BorderRadius.vertical( + top: Radius.circular(0), + ), + ), + clipBehavior: Clip.antiAliasWithSaveLayer, + context: context, + builder: (context) { + return bsheet(trial_data[index]); + }, + ); + }, + cells: [ + DataCell(Text( + trial_data[index]['trial_name'].toString(), + softWrap: true)), + DataCell(Text(trial_data[index]['status'].toString(), + softWrap: true)), + ], + ), + ), + ), + ), + ), + ), + )); + } +} diff --git a/lib/contacts_module/ui_screen/view_insight.dart b/lib/contacts_module/ui_screen/view_insight.dart new file mode 100644 index 0000000..2e1949e --- /dev/null +++ b/lib/contacts_module/ui_screen/view_insight.dart @@ -0,0 +1,95 @@ +// import 'package:konectar_events/constants.dart'; +import 'package:konectar_events/contacts_module/constants.dart'; +import 'package:flutter/cupertino.dart'; +import 'package:flutter/material.dart'; + +class MyWidget22 extends StatefulWidget { + const MyWidget22({super.key}); + + @override + State createState() => _MyWidget22State(); +} + +class _MyWidget22State extends State { + final List> cardData = [ + {'id': 'ID ', 'number': 10, 'id1': "jjj", 'number1': '265'}, + {'id': 'ID ', 'number': 20}, + {'id': 'ID ', 'number': 30}, + // Add more data entries as needed + ]; + @override + Widget build(BuildContext context) { + return Column( + mainAxisSize: MainAxisSize.min, + children: [ + ListTile( + title: Column( + children: [ + Row( + mainAxisAlignment: MainAxisAlignment.end, + children: [ + Icon( + Icons.edit, + color: Constants.k2color, + ) + ], + ), + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Text( + cardData[0]['id'], + style: TextStyle(fontSize: 16, fontWeight: FontWeight.bold), + ), + Text( + cardData[0]['number'].toString(), + style: TextStyle(fontSize: 16), + ), + ], + ), + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Text( + "Interaction Id", + style: TextStyle(fontSize: 16, fontWeight: FontWeight.bold), + ), + Text( + cardData[0]['number'].toString(), + style: TextStyle(fontSize: 16), + ), + ], + ), + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Text( + "Therapeutic Area", + style: TextStyle(fontSize: 16, fontWeight: FontWeight.bold), + ), + Text( + cardData[0]['number'].toString(), + style: TextStyle(fontSize: 16), + ), + ], + ), + Row( + mainAxisAlignment: MainAxisAlignment.spaceBetween, + children: [ + Text( + "Product", + style: TextStyle(fontSize: 16, fontWeight: FontWeight.bold), + ), + Text( + cardData[0]['number'].toString(), + style: TextStyle(fontSize: 16), + ), + ], + ), + ], + ), + ), + ], + ); + } +} diff --git a/lib/main.dart b/lib/main.dart index 2df32af..48f16fb 100644 --- a/lib/main.dart +++ b/lib/main.dart @@ -11,6 +11,57 @@ import 'package:flutter/services.dart'; import 'package:flutter/widgets.dart'; import 'package:hive_flutter/hive_flutter.dart'; +import 'package:konectar_events/contacts_module/provider_class/affiliationsprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/educationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/engagement_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/events_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/hcp%20_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_aff_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_awards_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_certificate_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_education_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_email_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_event_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_list_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_locationprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_pno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/k2_provider/kol_training_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/location_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/medicalinsightprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/nih_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/patent_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/phoneno_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/procedureprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/publications_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/single_hcpprovider.dart'; +import 'package:konectar_events/contacts_module/provider_class/speaker_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/training_provider.dart'; +import 'package:konectar_events/contacts_module/provider_class/trials_provider.dart'; +import 'package:konectar_events/contacts_module/storage_hive/aff_data/aff_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/awa_data/awa_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/cer_hive/cer_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/edu_data/edu_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/email_data/email_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/events_data/event_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/kol_info/kol_info_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/loc_data/location_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/nih_grant_data/nih_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/patent_data/patent_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pno_data/pno_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/procedure_data/pro_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/pub_data/pub_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/speaker_data/speaker_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/traning_data/traning_model_hive.dart'; +import 'package:konectar_events/contacts_module/storage_hive/trials_data/trial_model_hive.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/interactionprovider.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_config_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/interaction_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/json_form_data.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/model/save_interaction.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/repository/hive_repository.dart'; +import 'package:konectar_events/contacts_module/ui_screen/interactionform/viewinteractionprovider.dart'; import 'package:konectar_events/firebaseexample.dart'; import 'package:konectar_events/model/myeventsmodel.dart'; import 'package:konectar_events/model/neweventsmodel.dart'; @@ -31,6 +82,7 @@ import 'package:flutter_web_plugins/url_strategy.dart'; import 'package:shared_preferences/shared_preferences.dart'; //import 'openid/openid_io.dart' if (dart.library.html) 'openid_browser.dart'; +import 'contacts_module/provider_class/award_provider.dart'; import 'firebase_options.dart'; Future main() async { @@ -74,11 +126,58 @@ Future main() async { Hive.registerAdapter(EventsListAdapter()); Hive.registerAdapter(SessionNotesModelAdapter()); Hive.registerAdapter(MyEventsModelAdapter()); + Hive.registerAdapter(SaveInteractionAdapter()); + Hive.registerAdapter(InteractionConfigDataAdapter()); + + Hive.registerAdapter(InteractionResultDataAdapter()); + Hive.registerAdapter(FormFieldDataAdapter()); + Hive.registerAdapter(ValidationAdapter()); + Hive.registerAdapter(SectionListAdapter()); + Hive.registerAdapter(InputClassAdapter()); + Hive.registerAdapter(InteractionWidgetAdapter()); + + // Hive.registerAdapter(UserDataAdapter()); + Hive.registerAdapter(SendSaveJsonAdapter()); + Hive.registerAdapter(MultipleSectionListAdapter()); + Hive.registerAdapter(SaveAdapter()); + Hive.registerAdapter(SaveInteractionFormJsonAdapter()); + await Hive.openBox('InteractionDataBox'); + + await Hive.openBox('InteractionConfigDataBox'); + + var box = await Hive.openBox('mycontact'); + var box1 = await Hive.openBox('myfilter'); + + await Hive.openBox('checkvalue'); + + await Hive.openBox('hcpdata'); + + await Hive.openBox('notehive'); + + Hive.registerAdapter(AffiliationAdapter()); + // await Hive.openBox('affiliationshive'); + + Hive.registerAdapter(KolInfoAdapter()); + Hive.registerAdapter(PublicationAdapter()); + Hive.registerAdapter(EventsAdapter()); + Hive.registerAdapter(TrialsAdapter()); + Hive.registerAdapter(LocationAdapter()); + Hive.registerAdapter(PhoneNoAdapter()); + Hive.registerAdapter(EmailAdapter()); + Hive.registerAdapter(EduAdapter()); + Hive.registerAdapter(AwaAdapter()); + Hive.registerAdapter(CerAdapter()); + Hive.registerAdapter(PatentAdapter()); + Hive.registerAdapter(NihAdapter()); + Hive.registerAdapter(ProAdapter()); + Hive.registerAdapter(Training1Adapter()); + Hive.registerAdapter(SpeAdapter()); await Hive.openBox("UserDataBox"); await Hive.openBox("EventsListBox"); await Hive.openBox("SessionNotesModelBox"); await Hive.openBox("MyEventsBox"); + WidgetsFlutterBinding.ensureInitialized(); // FirebaseMessaging.instance.getToken().then((value) { // String? token = value; @@ -102,6 +201,44 @@ Future main() async { ChangeNotifierProvider(create: (_) => LoginProvider()), ChangeNotifierProvider(create: (_) => EventsProvider()), ChangeNotifierProvider(create: (_) => HcpProfileProvider()), + //Contacts + ChangeNotifierProvider(create: (_) => InteractionProvider()), + ChangeNotifierProvider(create: (_) => ViewInteractionProvider()), + ChangeNotifierProvider(create: (_) => hcpProvider()), + ChangeNotifierProvider(create: (_) => Singlehcpdetails()), + ChangeNotifierProvider(create: (_) => AffiliationsProvider()), + ChangeNotifierProvider(create: (_) => PublicatioProvider()), + ChangeNotifierProvider(create: (_) => EventProvider()), + ChangeNotifierProvider(create: (_) => TrialsProvider()), + ChangeNotifierProvider(create: (_) => MediacalInsightProvider()), + ChangeNotifierProvider(create: (_) => SpekerEvalutionProvider()), + ChangeNotifierProvider(create: (_) => EnagagementProvider()), + ChangeNotifierProvider(create: (_) => LocationProvider()), + ChangeNotifierProvider(create: (_) => PhonenoProvider()), + ChangeNotifierProvider(create: (_) => EmailProvider()), + ChangeNotifierProvider(create: (_) => PatentProvider()), + ChangeNotifierProvider(create: (_) => TrainigProvider()), + ChangeNotifierProvider(create: (_) => EducationProvider()), + ChangeNotifierProvider(create: (_) => AwardProvider()), + ChangeNotifierProvider(create: (_) => CertificateProvider()), + ChangeNotifierProvider(create: (_) => NIHGrantsProvider()), + ChangeNotifierProvider(create: (_) => ProcedureProvider()), + + //K2 Provider + + ChangeNotifierProvider(create: (_) => KolListProvider()), + ChangeNotifierProvider(create: (_) => LocationKolProvider()), + ChangeNotifierProvider(create: (_) => PhonenoProviderK2()), + ChangeNotifierProvider(create: (_) => EmailProviderK2()), + ChangeNotifierProvider(create: (_) => EducationProviderK2()), + ChangeNotifierProvider(create: (_) => TrainigProviderK2()), + ChangeNotifierProvider(create: (_) => AwardProviderK2()), + ChangeNotifierProvider(create: (_) => CertificateProviderK2()), + ChangeNotifierProvider(create: (_) => AffiliationsProviderk2()), + ChangeNotifierProvider(create: (_) => EventProviderK2()), + ChangeNotifierProvider( + create: (_) => HiveDataRepository( + Hive.box('InteractionConfigDataBox'))), ], child: SafeArea( top: true, diff --git a/lib/model/myeventsmodel.dart b/lib/model/myeventsmodel.dart index d71e36a..a52a4d6 100644 --- a/lib/model/myeventsmodel.dart +++ b/lib/model/myeventsmodel.dart @@ -1,7 +1,7 @@ import 'package:hive_flutter/hive_flutter.dart'; part 'myeventsmodel.g.dart'; -@HiveType(typeId: 3) +@HiveType(typeId: 23) class MyEventsModel { @HiveField(0) String? eventid; diff --git a/lib/model/myeventsmodel.g.dart b/lib/model/myeventsmodel.g.dart index ec61742..83fae2a 100644 --- a/lib/model/myeventsmodel.g.dart +++ b/lib/model/myeventsmodel.g.dart @@ -8,7 +8,7 @@ part of 'myeventsmodel.dart'; class MyEventsModelAdapter extends TypeAdapter { @override - final int typeId = 3; + final int typeId = 23; @override MyEventsModel read(BinaryReader reader) { diff --git a/lib/model/sessionnotesmodel.dart b/lib/model/sessionnotesmodel.dart index 4d5946f..7deb4b6 100644 --- a/lib/model/sessionnotesmodel.dart +++ b/lib/model/sessionnotesmodel.dart @@ -45,7 +45,7 @@ class NotesData { } } -@HiveType(typeId: 4) +@HiveType(typeId: 24) class SessionNotesModel { @HiveField(0) String? selectedSession; diff --git a/lib/model/sessionnotesmodel.g.dart b/lib/model/sessionnotesmodel.g.dart index 0b8fdab..9a2b280 100644 --- a/lib/model/sessionnotesmodel.g.dart +++ b/lib/model/sessionnotesmodel.g.dart @@ -8,7 +8,7 @@ part of 'sessionnotesmodel.dart'; class SessionNotesModelAdapter extends TypeAdapter { @override - final int typeId = 4; + final int typeId = 24; @override SessionNotesModel read(BinaryReader reader) { diff --git a/lib/utils/apicall.dart b/lib/utils/apicall.dart index 4d99f7a..96cfdb7 100644 --- a/lib/utils/apicall.dart +++ b/lib/utils/apicall.dart @@ -139,13 +139,13 @@ class ApiCall { "order_by": "7", "type": "1" }); - response = - await dio.post('${Constants.stagingUrl}${Constants.eventslistapi}', - options: Options(), - queryParameters: { - "user_email": "vinodh@aissel.com", - }, - data: formData); + response = await dio.post( + '${EventsConstants.stagingUrl}${EventsConstants.eventslistapi}', + options: Options(), + queryParameters: { + "user_email": "vinodh@aissel.com", + }, + data: formData); print("response user eventssssss here!!!!!!!!!!!!!!!!!!!!! "); print(response.data.toString()); Map jsondata = json.decode(response.data); @@ -168,7 +168,7 @@ class ApiCall { var formData = FormData.fromMap({ "email": email, }); - response = await dio.post('${Constants.getTokenApi}', + response = await dio.post('${EventsConstants.getTokenApi}', options: Options(), queryParameters: { "email": email, @@ -198,7 +198,7 @@ class ApiCall { var formData = FormData.fromMap({ "email": email, }); - response = await dio.post('${Constants.validateTokenApi}', + response = await dio.post('${EventsConstants.validateTokenApi}', options: Options(), queryParameters: { "email": email, @@ -226,7 +226,7 @@ class ApiCall { // "email": email, // }); response = await dio.post( - '${Constants.logoutApi}', + '${EventsConstants.logoutApi}', options: Options(headers: {"Authorization": "Bearer $token"}), // queryParameters: { // "token": token, @@ -254,13 +254,13 @@ class ApiCall { "end": endDate, "event_id": eventid, }); - response = - await dio.post('${Constants.stagingUrl}${Constants.eventslistapi}', - options: Options(), - queryParameters: { - "user_email": "vinodh@aissel.com", - }, - data: formData); + response = await dio.post( + '${EventsConstants.stagingUrl}${EventsConstants.eventslistapi}', + options: Options(), + queryParameters: { + "user_email": "vinodh@aissel.com", + }, + data: formData); print("response user eventssssss here!!!!!!!!!!!!!!!!!!!!! "); print(response.data.toString()); Map jsondata = json.decode(response.data); @@ -310,7 +310,7 @@ class ApiCall { Response response; response = await dio.post( - '${Constants.domainUrl}eventsdetail?eventid=$eventid', + '${EventsConstants.domainUrl}eventsdetail?eventid=$eventid', options: Options(), ); print("response user keywords here########## "); @@ -335,7 +335,7 @@ class ApiCall { Response response; response = await dio.post( - '${Constants.domainUrl}eventsapi.api.addEventsToFav?eventid=$eventid', + '${EventsConstants.domainUrl}eventsapi.api.addEventsToFav?eventid=$eventid', options: Options(), ); print("response user keywords here########## "); @@ -358,7 +358,7 @@ class ApiCall { Response response; response = await dio.post( - '${Constants.domainUrl}eventsapi.api.attendingEvents?eventid=$eventid', + '${EventsConstants.domainUrl}eventsapi.api.attendingEvents?eventid=$eventid', options: Options(), ); print("response user keywords here########## "); @@ -450,7 +450,7 @@ class ApiCall { Response response; response = await dio.post( - '${Constants.domainUrl}eventsapi.api.addEventsToFav?eventid=$eventid', + '${EventsConstants.domainUrl}eventsapi.api.addEventsToFav?eventid=$eventid', options: Options(), ); print("response user keywords here########## "); @@ -473,7 +473,7 @@ class ApiCall { Response response; response = await dio.post( - '${Constants.domainUrl}eventsapi.api.attendingEvents?eventid=$eventid', + '${EventsConstants.domainUrl}eventsapi.api.attendingEvents?eventid=$eventid', options: Options(), ); print("response user keywords here########## "); diff --git a/lib/utils/constants.dart b/lib/utils/constants.dart index 5965074..418d016 100644 --- a/lib/utils/constants.dart +++ b/lib/utils/constants.dart @@ -1,7 +1,7 @@ import 'package:flutter/cupertino.dart'; import 'package:flutter/material.dart'; -class Constants { +class EventsConstants { //static const Color bgcolor = Color.fromARGB(255, 246, 248, 252); static const Color bgcolor = Color(0xFFF2F3F8); static const Color oldbgcolor = Color.fromARGB(255, 222, 237, 247); diff --git a/lib/view/eventdetailstab.dart b/lib/view/eventdetailstab.dart index ee378cb..6346179 100644 --- a/lib/view/eventdetailstab.dart +++ b/lib/view/eventdetailstab.dart @@ -129,7 +129,7 @@ class _EventsDetailTabState extends State { child: Align( alignment: Alignment.center, child: Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, // height: isTablet ? height * 0.50 : height * 0.30, // padding: const EdgeInsets.only(top: 5.0), // width: double.maxFinite, @@ -280,7 +280,7 @@ class _EventsDetailTabState extends State { height: 40, child: FloatingActionButton.extended( elevation: 1, - backgroundColor: Constants.oldbgcolor, + backgroundColor: EventsConstants.oldbgcolor, onPressed: () { setState(() { isExtended = !isExtended; @@ -326,7 +326,7 @@ class _EventsDetailTabState extends State { height: 40, child: FloatingActionButton.extended( elevation: 1, - backgroundColor: Constants.oldbgcolor, + backgroundColor: EventsConstants.oldbgcolor, onPressed: () { setState(() { isExtendedInterested = !isExtendedInterested; diff --git a/lib/view/eventslist.dart b/lib/view/eventslist.dart index 666a22c..532996b 100644 --- a/lib/view/eventslist.dart +++ b/lib/view/eventslist.dart @@ -163,11 +163,11 @@ class _EventsListingScreenState extends State //return SafeArea( return Container( child: Scaffold( - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, appBar: AppBar( // title: Text(""), automaticallyImplyLeading: false, - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, centerTitle: false, flexibleSpace: Row( crossAxisAlignment: CrossAxisAlignment.center, @@ -207,7 +207,7 @@ class _EventsListingScreenState extends State style: TextStyle( // decoration: TextDecoration.underline, // decorationColor: Colors.blue, - color: Constants.blueColor, + color: EventsConstants.blueColor, //fontWeight: FontWeight.bold, fontSize: isTablet ? 22 : 14, @@ -267,7 +267,7 @@ class _EventsListingScreenState extends State floatingActionButtonLocation: FloatingActionButtonLocation.miniEndFloat, floatingActionButton: FloatingActionButton( // backgroundColor: const Color.fromARGB(255, 222, 237, 247), - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, tooltip: 'Actions', // heroTag: "floatbtn232342", onPressed: () { @@ -275,7 +275,7 @@ class _EventsListingScreenState extends State context: context, builder: (BuildContext context) { return Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, width: MediaQuery.of(context).size.width, height: 240, child: Center( @@ -411,7 +411,7 @@ class _EventsListingScreenState extends State return Column( children: [ Container( - color: Constants.blueColor, + color: EventsConstants.blueColor, child: Column( children: [ buildCardView( @@ -449,7 +449,7 @@ class _EventsListingScreenState extends State indicatorSize: TabBarIndicatorSize.tab, labelColor: Colors.black, tabAlignment: TabAlignment.fill, - indicatorColor: Constants.blueColor, + indicatorColor: EventsConstants.blueColor, unselectedLabelColor: Colors.grey, labelStyle: TextStyle( fontWeight: FontWeight.bold, @@ -494,7 +494,7 @@ class _EventsListingScreenState extends State padding: const EdgeInsets.only(right: 16, top: 8, bottom: 8), child: Container( decoration: BoxDecoration( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, borderRadius: const BorderRadius.all( Radius.circular(38.0), ), @@ -561,7 +561,7 @@ class _EventsListingScreenState extends State Widget getAppBarUI(EventsList eventsList) { return Container( decoration: BoxDecoration( - color: Constants.blueColor, + color: EventsConstants.blueColor, boxShadow: [ BoxShadow( color: Colors.grey.withOpacity(0.2), @@ -1019,7 +1019,7 @@ class _EventsListingScreenState extends State child: FloatingActionButton.extended( elevation: 1, // heroTag: "following45", - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, //backgroundColor: Colors.red, onPressed: () async { // String msg = await provider @@ -1129,7 +1129,7 @@ class _EventsListingScreenState extends State height: 45, child: FloatingActionButton.extended( elevation: 1, - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, onPressed: () async { if (!event.isfav) { event.isfav = !event.isfav; @@ -1217,7 +1217,7 @@ class _EventsListingScreenState extends State // : Container( height: MediaQuery.of(context).size.height, - color: Constants.bgcolor, + color: EventsConstants.bgcolor, padding: EdgeInsets.only(left: 8, right: 8), child: SingleChildScrollView( child: Column(children: [ @@ -1321,7 +1321,7 @@ class _EventsListingScreenState extends State padding: EdgeInsets.only(left: 8), decoration: BoxDecoration( // color: Color.fromARGB(179, 248, 238, 238), - color: Constants.bgcolor, + color: EventsConstants.bgcolor, ), child: Column( children: [ @@ -1658,7 +1658,7 @@ class _SliverAppBarDelegate extends SliverPersistentHeaderDelegate { @override Widget build( BuildContext context, double shrinkOffset, bool overlapsContent) { - return Container(color: Constants.tabbgColor, child: _tabBar); + return Container(color: EventsConstants.tabbgColor, child: _tabBar); } @override diff --git a/lib/view/eventstab.dart b/lib/view/eventstab.dart index 4bb79a8..cd58ddd 100644 --- a/lib/view/eventstab.dart +++ b/lib/view/eventstab.dart @@ -119,7 +119,7 @@ class _EventsTabState extends State { top: false, child: Scaffold( bottomNavigationBar: BottomNavigationBar( - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, type: BottomNavigationBarType.fixed, currentIndex: _selectedIndex, //backgroundColor: Color.fromARGB(255, 35, 79, 150), diff --git a/lib/view/home.dart b/lib/view/home.dart index 5fa38b1..5528224 100644 --- a/lib/view/home.dart +++ b/lib/view/home.dart @@ -216,7 +216,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { endDrawer: populateDrawer(provider), appBar: AppBar( automaticallyImplyLeading: false, - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, centerTitle: true, title: _isSearch ? Padding( @@ -237,7 +237,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { } }, decoration: InputDecoration( - fillColor: Constants.blueColor, + fillColor: EventsConstants.blueColor, contentPadding: EdgeInsets.symmetric(vertical: 9.0), border: OutlineInputBorder(), hintText: "Search for events...", @@ -320,7 +320,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { ]; }, body: Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, child: buildListView(context, provider)), ), ), @@ -341,7 +341,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { child: Container( height: 24, decoration: BoxDecoration( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, boxShadow: [ BoxShadow( color: Colors.grey.withOpacity(0.2), @@ -352,7 +352,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { ), ), Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, child: Padding( padding: const EdgeInsets.only(left: 16, right: 16, top: 8, bottom: 4), @@ -534,7 +534,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { padding: const EdgeInsets.only(right: 12, top: 8, bottom: 8), child: Container( decoration: BoxDecoration( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, borderRadius: const BorderRadius.all( Radius.circular(24.0), ), @@ -761,10 +761,10 @@ class _HomeScreenState extends State with TickerProviderStateMixin { populateDrawer(EventsProvider provider) { return Theme( - data: Theme.of(context).copyWith(canvasColor: Constants.bgcolor), + data: Theme.of(context).copyWith(canvasColor: EventsConstants.bgcolor), child: Container( width: MediaQuery.of(context).size.width * 0.60, - color: Constants.bgcolor, + color: EventsConstants.bgcolor, child: Drawer( child: SingleChildScrollView( scrollDirection: Axis.vertical, @@ -1409,7 +1409,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { }, child: Card( elevation: 2, - shadowColor: Constants.bgcolor, + shadowColor: EventsConstants.bgcolor, child: buildCardView( context, provider.eventList[index], provider))); }, @@ -1541,7 +1541,7 @@ class _HomeScreenState extends State with TickerProviderStateMixin { child: FloatingActionButton.extended( elevation: 1, shape: CircleBorder(), - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, onPressed: () async { // String msg = await provider // .addEventsToFavs(event.eventId!); diff --git a/lib/view/insights.dart b/lib/view/insights.dart index 85ac4c2..9264cee 100644 --- a/lib/view/insights.dart +++ b/lib/view/insights.dart @@ -78,7 +78,7 @@ class _EventsInsightsState extends State { widgets.add(ScatterItem(widget.kFlutterHashtags[i], i)); } return Scaffold( - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, body: Padding( padding: const EdgeInsets.symmetric(horizontal: 12.0), child: SingleChildScrollView( diff --git a/lib/view/login.dart b/lib/view/login.dart index aa65cd2..af3b2b9 100644 --- a/lib/view/login.dart +++ b/lib/view/login.dart @@ -84,7 +84,7 @@ class _LoginScreenState extends State { builder: (BuildContext context, Orientation orientation) { return Scaffold( appBar: CustomAppBar( - backgroundcolor: Constants.blueColor, + backgroundcolor: EventsConstants.blueColor, title: "Sign In", ), // resizeToAvoidBottomInset: true, @@ -231,7 +231,7 @@ class _LoginScreenState extends State { height: isTablet ? 40 : 20, ), CustomButton( - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, onPressed: () async { setState(() { print("loading"); diff --git a/lib/view/navigation_home_screen.dart b/lib/view/navigation_home_screen.dart index 930ccd0..52c1068 100644 --- a/lib/view/navigation_home_screen.dart +++ b/lib/view/navigation_home_screen.dart @@ -1,4 +1,5 @@ import 'package:flutter/material.dart'; +import 'package:konectar_events/contacts_module/ui_screen/new_contacts.dart'; import 'package:konectar_events/utils/app_theme.dart'; import 'package:konectar_events/view/home.dart'; import 'package:konectar_events/widgets/drawerusercontroller.dart'; @@ -55,7 +56,7 @@ class _NavigationHomeScreenState extends State { break; case DrawerIndex.Help: setState(() { - screenView = HomeScreen(); + screenView = Contacts1(); }); break; case DrawerIndex.FeedBack: diff --git a/lib/view/profileview.dart b/lib/view/profileview.dart index ca568cf..8cc0a79 100644 --- a/lib/view/profileview.dart +++ b/lib/view/profileview.dart @@ -165,7 +165,7 @@ class _HCPProfileScreenState extends State { appBar: AppBar( // title: Text(""), automaticallyImplyLeading: false, - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, centerTitle: false, flexibleSpace: FlexibleSpaceBar( background: Padding( @@ -217,7 +217,7 @@ class _HCPProfileScreenState extends State { SliverAppBar( expandedHeight: 280.0, // expandedHeight: MediaQuery.of(context).size.height * 0.25, - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, automaticallyImplyLeading: false, floating: false, pinned: false, @@ -309,9 +309,9 @@ class _HCPProfileScreenState extends State { begin: Alignment.bottomCenter, end: Alignment.topCenter, colors: [ - Constants.blueColor, - Constants.blueColor, - Constants.blueColor, + EventsConstants.blueColor, + EventsConstants.blueColor, + EventsConstants.blueColor, // const Color.fromARGB(255, 222, 237, 247), // const Color.fromARGB(255, 222, 237, 247), // Color(0xff006df1) @@ -535,7 +535,7 @@ class _HCPProfileScreenState extends State { HcpProfileProvider provider) { sessionList = eventsdetail.sessionName!.split(","); return Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, child: Column( children: [ Container( @@ -731,7 +731,7 @@ class _HCPProfileScreenState extends State { padding: EdgeInsets.only(left: 8), decoration: BoxDecoration( // color: Color.fromARGB(179, 248, 238, 238), - color: Constants.bgcolor, + color: EventsConstants.bgcolor, ), child: ListView.separated( padding: EdgeInsets.only(top: 10.0, left: 4.0), @@ -827,7 +827,7 @@ class _HCPProfileScreenState extends State { // minWidth: MediaQuery.of(context).size.width * 0.34, maxWidth: MediaQuery.of(context).size.width), decoration: BoxDecoration( - color: Constants.bgtopic, + color: EventsConstants.bgtopic, border: Border.all(color: Colors.grey), borderRadius: BorderRadius.all( Radius.circular(10.0), @@ -846,7 +846,7 @@ class _HCPProfileScreenState extends State { style: TextStyle( overflow: TextOverflow.clip, - color: Constants.fonttopic, + color: EventsConstants.fonttopic, fontSize: isTablet ? 16 : 14), ), ); @@ -857,7 +857,7 @@ class _HCPProfileScreenState extends State { Widget medicalInsights() { return Container( - color: Constants.bgcolor, + color: EventsConstants.bgcolor, child: Center( child: FloatingActionButton.extended( backgroundColor: Colors.green, @@ -906,8 +906,8 @@ class _SliverAppBarDelegate extends SliverPersistentHeaderDelegate { end: Alignment.topCenter, colors: [ // Constants.blueColor, - Constants.tabbgColor, - Constants.blueColor, + EventsConstants.tabbgColor, + EventsConstants.blueColor, // Constants.tabbgColor, // const Color.fromARGB(255, 222, 237, 247), // const Color.fromARGB(255, 222, 237, 247), @@ -1004,9 +1004,9 @@ class _TopPortion extends StatelessWidget { begin: Alignment.bottomCenter, end: Alignment.topCenter, colors: [ - Constants.blueColor, - Constants.blueColor, - Constants.blueColor, + EventsConstants.blueColor, + EventsConstants.blueColor, + EventsConstants.blueColor, // const Color.fromARGB(255, 222, 237, 247), // const Color.fromARGB(255, 222, 237, 247), // Color(0xff006df1) diff --git a/lib/view/socialmedia.dart b/lib/view/socialmedia.dart index f75978b..590a2f9 100644 --- a/lib/view/socialmedia.dart +++ b/lib/view/socialmedia.dart @@ -12,7 +12,7 @@ import 'package:konectar_events/widgets/flutter_hashtags.dart'; import 'package:konectar_events/widgets/heatmapcalendar.dart'; import 'package:konectar_events/widgets/timelinechart.dart'; import 'package:konectar_events/widgets/word_cloud.dart'; -import 'package:theta/theta.dart'; + import 'package:word_cloud/word_cloud_data.dart'; import 'package:word_cloud/word_cloud_view.dart'; @@ -36,7 +36,7 @@ class _SocialMediaState extends State { final screenSize = MediaQuery.of(context).size; final ratio = screenSize.width / (screenSize.height / 2); return Scaffold( - backgroundColor: Constants.bgcolor, + backgroundColor: EventsConstants.bgcolor, // appBar: CustomAppBar( // title: "Social Media", // fontColor: Colors.black, diff --git a/lib/widgets/chartline.dart b/lib/widgets/chartline.dart index 807a5a0..1f82e67 100644 --- a/lib/widgets/chartline.dart +++ b/lib/widgets/chartline.dart @@ -45,7 +45,7 @@ class ChartLine extends StatelessWidget { ), Container( //constraints: BoxConstraints(maxWidth: lineWidget), - color: Constants.blueColor, + color: EventsConstants.blueColor, height: 40, width: lineWidget, padding: const EdgeInsets.all(8.0), diff --git a/lib/widgets/home_drawer.dart b/lib/widgets/home_drawer.dart index 8207f5f..7aac0f4 100644 --- a/lib/widgets/home_drawer.dart +++ b/lib/widgets/home_drawer.dart @@ -47,12 +47,12 @@ class _HomeDrawerState extends State { labelName: 'Events', //icon: Icon(Icons.home), ), - // DrawerList( - // index: DrawerIndex.Help, - // labelName: 'Help', - // isAssetsImage: true, - // imageName: 'assets/images/supportIcon.png', - // ), + DrawerList( + index: DrawerIndex.Help, + labelName: 'Contacts', + // isAssetsImage: true, + // imageName: 'assets/images/supportIcon.png', + ), // DrawerList( // index: DrawerIndex.FeedBack, // labelName: 'FeedBack', @@ -126,7 +126,7 @@ class _HomeDrawerState extends State { const BorderRadius.all(Radius.circular(60.0)), child: CircleAvatar( radius: 24, - backgroundColor: Constants.blueColor, + backgroundColor: EventsConstants.blueColor, // child: Icon( // Icons.person, // size: 18, diff --git a/lib/widgets/snackbar.dart b/lib/widgets/snackbar.dart index 248f142..4021b91 100644 --- a/lib/widgets/snackbar.dart +++ b/lib/widgets/snackbar.dart @@ -8,7 +8,7 @@ class SnackBarWidget { msg, style: TextStyle(color: Colors.black), ), - backgroundColor: Constants.oldbgcolor, + backgroundColor: EventsConstants.oldbgcolor, duration: Durations.long1, ); ScaffoldMessenger.of(context).showSnackBar(snackBar); diff --git a/macos/Flutter/GeneratedPluginRegistrant.swift b/macos/Flutter/GeneratedPluginRegistrant.swift index 497e15a..bde3d2b 100644 --- a/macos/Flutter/GeneratedPluginRegistrant.swift +++ b/macos/Flutter/GeneratedPluginRegistrant.swift @@ -6,23 +6,21 @@ import FlutterMacOS import Foundation import connectivity_plus -import device_info_plus import file_selector_macos import firebase_core import firebase_remote_config -import package_info_plus import path_provider_foundation import shared_preferences_foundation +import sqflite import url_launcher_macos func RegisterGeneratedPlugins(registry: FlutterPluginRegistry) { - ConnectivityPlugin.register(with: registry.registrar(forPlugin: "ConnectivityPlugin")) - DeviceInfoPlusMacosPlugin.register(with: registry.registrar(forPlugin: "DeviceInfoPlusMacosPlugin")) + ConnectivityPlusPlugin.register(with: registry.registrar(forPlugin: "ConnectivityPlusPlugin")) FileSelectorPlugin.register(with: registry.registrar(forPlugin: "FileSelectorPlugin")) FLTFirebaseCorePlugin.register(with: registry.registrar(forPlugin: "FLTFirebaseCorePlugin")) FLTFirebaseRemoteConfigPlugin.register(with: registry.registrar(forPlugin: "FLTFirebaseRemoteConfigPlugin")) - FPPPackageInfoPlusPlugin.register(with: registry.registrar(forPlugin: "FPPPackageInfoPlusPlugin")) PathProviderPlugin.register(with: registry.registrar(forPlugin: "PathProviderPlugin")) SharedPreferencesPlugin.register(with: registry.registrar(forPlugin: "SharedPreferencesPlugin")) + SqflitePlugin.register(with: registry.registrar(forPlugin: "SqflitePlugin")) UrlLauncherPlugin.register(with: registry.registrar(forPlugin: "UrlLauncherPlugin")) } diff --git a/pubspec.lock b/pubspec.lock index 96626a9..bda8eb4 100644 --- a/pubspec.lock +++ b/pubspec.lock @@ -25,14 +25,14 @@ packages: url: "https://pub.dev" source: hosted version: "3.0.1" - after_layout: - dependency: transitive + adoptive_calendar: + dependency: "direct main" description: - name: after_layout - sha256: "95a1cb2ca1464f44f14769329fbf15987d20ab6c88f8fc5d359bd362be625f29" + name: adoptive_calendar + sha256: "3f049b91715f66e3c68219c26f461b0d6c7ae9fe32a9a5b0129f4cbd4fb980a3" url: "https://pub.dev" source: hosted - version: "1.2.0" + version: "0.1.9" analyzer: dependency: transitive description: @@ -89,14 +89,6 @@ packages: url: "https://pub.dev" source: hosted version: "2.1.1" - box_transform: - dependency: transitive - description: - name: box_transform - sha256: ca3f90f4924d63ce69ef02b8fd251512b44bbac5ad4f454087cbde04754344dc - url: "https://pub.dev" - source: hosted - version: "0.2.1" build: dependency: transitive description: @@ -161,6 +153,38 @@ packages: url: "https://pub.dev" source: hosted version: "8.9.1" + cached_network_image: + dependency: "direct main" + description: + name: cached_network_image + sha256: "4a5d8d2c728b0f3d0245f69f921d7be90cae4c2fd5288f773088672c0893f819" + url: "https://pub.dev" + source: hosted + version: "3.4.0" + cached_network_image_platform_interface: + dependency: transitive + description: + name: cached_network_image_platform_interface + sha256: "35814b016e37fbdc91f7ae18c8caf49ba5c88501813f73ce8a07027a395e2829" + url: "https://pub.dev" + source: hosted + version: "4.1.1" + cached_network_image_web: + dependency: transitive + description: + name: cached_network_image_web + sha256: "6322dde7a5ad92202e64df659241104a43db20ed594c41ca18de1014598d7996" + url: "https://pub.dev" + source: hosted + version: "1.3.0" + carousel_slider: + dependency: "direct main" + description: + name: carousel_slider + sha256: "9c695cc963bf1d04a47bd6021f68befce8970bcd61d24938e1fb0918cf5d9c42" + url: "https://pub.dev" + source: hosted + version: "4.2.1" characters: dependency: transitive description: @@ -169,6 +193,30 @@ packages: url: "https://pub.dev" source: hosted version: "1.3.0" + charcode: + dependency: transitive + description: + name: charcode + sha256: fb98c0f6d12c920a02ee2d998da788bca066ca5f148492b7085ee23372b12306 + url: "https://pub.dev" + source: hosted + version: "1.3.1" + charts_common: + dependency: transitive + description: + name: charts_common + sha256: "7b8922f9b0d9b134122756a787dab1c3946ae4f3fc5022ff323ba0014998ea02" + url: "https://pub.dev" + source: hosted + version: "0.12.0" + charts_flutter: + dependency: "direct main" + description: + name: charts_flutter + sha256: "4172c3f4b85322fdffe1896ffbed79ae4689ae72cb6fe6690dcaaea620a9c558" + url: "https://pub.dev" + source: hosted + version: "0.12.0" checked_yaml: dependency: transitive description: @@ -202,21 +250,21 @@ packages: source: hosted version: "1.18.0" connectivity_plus: - dependency: "direct dev" + dependency: "direct main" description: name: connectivity_plus - sha256: b74247fad72c171381dbe700ca17da24deac637ab6d43c343b42867acb95c991 + sha256: "2056db5241f96cdc0126bd94459fc4cdc13876753768fc7a31c425e50a7177d0" url: "https://pub.dev" source: hosted - version: "3.0.6" + version: "6.0.5" connectivity_plus_platform_interface: dependency: transitive description: name: connectivity_plus_platform_interface - sha256: cf1d1c28f4416f8c654d7dc3cd638ec586076255d407cef3ddbdaf178272a71a + sha256: "42657c1715d48b167930d5f34d00222ac100475f73d10162ddf43e714932f204" url: "https://pub.dev" source: hosted - version: "1.2.4" + version: "2.0.1" convert: dependency: transitive description: @@ -249,6 +297,14 @@ packages: url: "https://pub.dev" source: hosted version: "0.3.0+1" + csslib: + dependency: transitive + description: + name: csslib + sha256: "706b5707578e0c1b4b7550f64078f0a0f19dec3f50a178ffae7006b0a9ca58fb" + url: "https://pub.dev" + source: hosted + version: "1.0.0" cupertino_icons: dependency: "direct main" description: @@ -265,6 +321,14 @@ packages: url: "https://pub.dev" source: hosted version: "2.3.6" + data_table_2: + dependency: "direct main" + description: + name: data_table_2 + sha256: f02ec9b24f44420816a87370ff4f4e533e15b274f6267e4c9a88a585ad1a0473 + url: "https://pub.dev" + source: hosted + version: "2.5.15" dbus: dependency: transitive description: @@ -273,78 +337,46 @@ packages: url: "https://pub.dev" source: hosted version: "0.7.10" - defer_pointer: - dependency: transitive - description: - name: defer_pointer - sha256: d69e6f8c1d0f052d2616cc1db3782e0ea73f42e4c6f6122fd1a548dfe79faf02 - url: "https://pub.dev" - source: hosted - version: "0.0.2" - device_frame: - dependency: transitive - description: - name: device_frame - sha256: afe76182aec178d171953d9b4a50a43c57c7cf3c77d8b09a48bf30c8fa04dd9d - url: "https://pub.dev" - source: hosted - version: "1.1.0" - device_info_plus: - dependency: transitive - description: - name: device_info_plus - sha256: "77f757b789ff68e4eaf9c56d1752309bd9f7ad557cb105b938a7f8eb89e59110" - url: "https://pub.dev" - source: hosted - version: "9.1.2" - device_info_plus_platform_interface: - dependency: transitive - description: - name: device_info_plus_platform_interface - sha256: d3b01d5868b50ae571cd1dc6e502fc94d956b665756180f7b16ead09e836fd64 - url: "https://pub.dev" - source: hosted - version: "7.0.0" dio: dependency: "direct main" description: name: dio - sha256: "0978e9a3e45305a80a7210dbeaf79d6ee8bee33f70c8e542dc654c952070217f" + sha256: "5598aa796bbf4699afd5c67c0f5f6e2ed542afc956884b9cd58c306966efc260" url: "https://pub.dev" source: hosted - version: "5.4.2+1" + version: "5.7.0" + dio_web_adapter: + dependency: transitive + description: + name: dio_web_adapter + sha256: "33259a9276d6cea88774a0000cfae0d861003497755969c92faa223108620dc8" + url: "https://pub.dev" + source: hosted + version: "2.0.0" dropdown_button2: - dependency: "direct dev" + dependency: "direct main" description: name: dropdown_button2 sha256: b0fe8d49a030315e9eef6c7ac84ca964250155a6224d491c1365061bc974a9e1 url: "https://pub.dev" source: hosted version: "2.3.9" - either_dart: - dependency: transitive + dropdown_search: + dependency: "direct main" description: - name: either_dart - sha256: "0b57f6a9410ce0ba2cc340220109f545bf4bad1b06b242219f0af11ab9e84f0e" + name: dropdown_search + sha256: "55106e8290acaa97ed15bea1fdad82c3cf0c248dd410e651f5a8ac6870f783ab" url: "https://pub.dev" source: hosted - version: "1.0.0" - encrypt: - dependency: transitive + version: "5.0.6" + dropdownfield2: + dependency: "direct main" description: - name: encrypt - sha256: "62d9aa4670cc2a8798bab89b39fc71b6dfbacf615de6cf5001fb39f7e4a996a2" + name: dropdownfield2 + sha256: "83d7c25c253f64d86d3541543b5a118b150acd2810e0f57330c970e81032db35" url: "https://pub.dev" source: hosted - version: "5.0.3" - enum_to_string: - dependency: transitive - description: - name: enum_to_string - sha256: bd9e83a33b754cb43a75b36a9af2a0b92a757bfd9847d2621ca0b1bed45f8e7a - url: "https://pub.dev" - source: hosted - version: "2.0.1" + version: "1.0.7" equatable: dependency: transitive description: @@ -353,6 +385,14 @@ packages: url: "https://pub.dev" source: hosted version: "2.0.5" + expandable: + dependency: "direct main" + description: + name: expandable + sha256: "9604d612d4d1146dafa96c6d8eec9c2ff0994658d6d09fed720ab788c7f5afc2" + url: "https://pub.dev" + source: hosted + version: "5.0.1" fake_async: dependency: transitive description: @@ -361,14 +401,6 @@ packages: url: "https://pub.dev" source: hosted version: "1.3.1" - feather_icons: - dependency: transitive - description: - name: feather_icons - sha256: "9fe1e52305fc363c3ee08cabaef32526e2e8ce53091c7b70f9c774460a1f03ae" - url: "https://pub.dev" - source: hosted - version: "1.2.0" ffi: dependency: transitive description: @@ -386,13 +418,13 @@ packages: source: hosted version: "7.0.0" file_picker: - dependency: "direct dev" + dependency: "direct main" description: name: file_picker - sha256: "1bbf65dd997458a08b531042ec3794112a6c39c07c37ff22113d2e7e4f81d4e4" + sha256: "2ca051989f69d1b2ca012b2cf3ccf78c70d40144f0861ff2c063493f7c8c3d45" url: "https://pub.dev" source: hosted - version: "6.2.1" + version: "8.0.5" file_selector_linux: dependency: transitive description: @@ -494,14 +526,22 @@ packages: description: flutter source: sdk version: "0.0.0" - flutter_box_transform: + flutter_cache_manager: dependency: transitive description: - name: flutter_box_transform - sha256: "1e25647db0246bac10e330b5bcddc836f5eb9573e0b8846676a518f0a90527a4" + name: flutter_cache_manager + sha256: "400b6592f16a4409a7f2bb929a9a7e38c72cceb8ffb99ee57bbf2cb2cecf8386" url: "https://pub.dev" source: hosted - version: "0.2.1" + version: "3.4.1" + flutter_carousel_widget: + dependency: "direct main" + description: + name: flutter_carousel_widget + sha256: "9476c39f1fcff57fb387a1a3c379a01f7c73eca4179ac1b41c07b7181fadec14" + url: "https://pub.dev" + source: hosted + version: "2.3.0" flutter_heatmap_calendar: dependency: "direct main" description: @@ -518,6 +558,14 @@ packages: url: "https://pub.dev" source: hosted version: "2.0.17" + flutter_profile_picture: + dependency: "direct main" + description: + name: flutter_profile_picture + sha256: "067caecef0d7162d3858eaca3c5859cbbb21b3e5704c2bc5b96b50ffe267f45d" + url: "https://pub.dev" + source: hosted + version: "2.0.0" flutter_scatter: dependency: "direct main" description: @@ -526,22 +574,14 @@ packages: url: "https://pub.dev" source: hosted version: "0.2.0" - flutter_staggered_animations: - dependency: transitive - description: - name: flutter_staggered_animations - sha256: "81d3c816c9bb0dca9e8a5d5454610e21ffb068aedb2bde49d2f8d04f75538351" - url: "https://pub.dev" - source: hosted - version: "1.1.1" flutter_svg: dependency: "direct main" description: name: flutter_svg - sha256: d39e7f95621fc84376bc0f7d504f05c3a41488c562f4a8ad410569127507402c + sha256: "7b4ca6cf3304575fe9c8ec64813c8d02ee41d2afe60bcfe0678bcb5375d596a2" url: "https://pub.dev" source: hosted - version: "2.0.9" + version: "2.0.10+1" flutter_test: dependency: "direct dev" description: flutter @@ -560,22 +600,6 @@ packages: url: "https://pub.dev" source: hosted version: "10.7.0" - font_awesome_flutter_named: - dependency: transitive - description: - name: font_awesome_flutter_named - sha256: ed0a376065c70d0ea538b6e19aa1a602f1ae033c6ac8e5961433f9e8b119fcff - url: "https://pub.dev" - source: hosted - version: "1.1.2+1" - freezed_annotation: - dependency: transitive - description: - name: freezed_annotation - sha256: c3fd9336eb55a38cc1bbd79ab17573113a8deccd0ecbbf926cca3c62803b5c2d - url: "https://pub.dev" - source: hosted - version: "2.4.1" frontend_server_client: dependency: transitive description: @@ -584,22 +608,6 @@ packages: url: "https://pub.dev" source: hosted version: "4.0.0" - gap: - dependency: transitive - description: - name: gap - sha256: f19387d4e32f849394758b91377f9153a1b41d79513ef7668c088c77dbc6955d - url: "https://pub.dev" - source: hosted - version: "3.0.1" - get_it: - dependency: transitive - description: - name: get_it - sha256: e6017ce7fdeaf218dc51a100344d8cb70134b80e28b760f8bb23c242437bafd7 - url: "https://pub.dev" - source: hosted - version: "7.6.7" glob: dependency: transitive description: @@ -616,14 +624,6 @@ packages: url: "https://pub.dev" source: hosted version: "10.2.0" - google_fonts: - dependency: transitive - description: - name: google_fonts - sha256: "6b6f10f0ce3c42f6552d1c70d2c28d764cf22bb487f50f66cca31dcd5194f4d6" - url: "https://pub.dev" - source: hosted - version: "4.0.4" graphs: dependency: transitive description: @@ -656,14 +656,22 @@ packages: url: "https://pub.dev" source: hosted version: "2.0.1" + html: + dependency: transitive + description: + name: html + sha256: "3a7812d5bcd2894edf53dfaf8cd640876cf6cef50a8f238745c8b8120ea74d3a" + url: "https://pub.dev" + source: hosted + version: "0.15.4" http: dependency: transitive description: name: http - sha256: "5895291c13fa8a3bd82e76d5627f69e0d85ca6a30dcac95c4ea19a5d555879c2" + sha256: b9c29a161230ee03d3ccf545097fccd9b87a5264228c5d348202e0f0c28f9010 url: "https://pub.dev" source: hosted - version: "0.13.6" + version: "1.2.2" http_mock_adapter: dependency: "direct main" description: @@ -688,6 +696,14 @@ packages: url: "https://pub.dev" source: hosted version: "4.0.2" + image: + dependency: transitive + description: + name: image + sha256: "2237616a36c0d69aef7549ab439b833fb7f9fb9fc861af2cc9ac3eedddd69ca8" + url: "https://pub.dev" + source: hosted + version: "4.2.0" image_picker: dependency: "direct main" description: @@ -764,10 +780,10 @@ packages: dependency: "direct main" description: name: intl - sha256: "3bc132a9dbce73a7e4a21a17d06e1878839ffbf975568bc875c60537824b0c4d" + sha256: "910f85bce16fb5c6f614e117efa303e85a1731bb0081edf3604a2ae6e9a3cc91" url: "https://pub.dev" source: hosted - version: "0.18.1" + version: "0.17.0" io: dependency: transitive description: @@ -776,6 +792,14 @@ packages: url: "https://pub.dev" source: hosted version: "1.0.4" + jiffy: + dependency: transitive + description: + name: jiffy + sha256: "85172c4fc975a50224521c05bf43abc845288863b19d91bd3c221a96a8785dd3" + url: "https://pub.dev" + source: hosted + version: "5.0.0" jose: dependency: transitive description: @@ -824,22 +848,6 @@ packages: url: "https://pub.dev" source: hosted version: "2.0.1" - light_logger: - dependency: transitive - description: - name: light_logger - sha256: e4d1ed16750a41e20d87b6feb367d6fd96d0dffac6dc4b6a76f685b3d79de56f - url: "https://pub.dev" - source: hosted - version: "0.0.3" - line_icons: - dependency: transitive - description: - name: line_icons - sha256: "249d781d922f5437ac763d9c8f5a02cf5b499a6dc3f85e4b92e074cff0a932ab" - url: "https://pub.dev" - source: hosted - version: "2.0.3" logger: dependency: transitive description: @@ -856,14 +864,6 @@ packages: url: "https://pub.dev" source: hosted version: "1.2.0" - lottie: - dependency: transitive - description: - name: lottie - sha256: a93542cc2d60a7057255405f62252533f8e8956e7e06754955669fd32fb4b216 - url: "https://pub.dev" - source: hosted - version: "2.7.0" matcher: dependency: transitive description: @@ -880,14 +880,6 @@ packages: url: "https://pub.dev" source: hosted version: "0.8.0" - material_design_icons_flutter: - dependency: transitive - description: - name: material_design_icons_flutter - sha256: "4c81ebf55b9661d1eb94652884a7b098af63153ea75b9070caedaddfae308e02" - url: "https://pub.dev" - source: hosted - version: "6.0.7296" meta: dependency: transitive description: @@ -912,6 +904,14 @@ packages: url: "https://pub.dev" source: hosted version: "0.0.2" + multi_dropdown: + dependency: "direct main" + description: + name: multi_dropdown + sha256: b63ff339fcc875d667f8688c8ef62853545b580dd2b6fe78b73339783268afd8 + url: "https://pub.dev" + source: hosted + version: "2.1.4" nested: dependency: transitive description: @@ -928,6 +928,22 @@ packages: url: "https://pub.dev" source: hosted version: "0.5.0" + octo_image: + dependency: transitive + description: + name: octo_image + sha256: "34faa6639a78c7e3cbe79be6f9f96535867e879748ade7d17c9b1ae7536293bd" + url: "https://pub.dev" + source: hosted + version: "2.1.0" + open_file: + dependency: "direct main" + description: + name: open_file + sha256: a5a32d44acb7c899987d0999e1e3cbb0a0f1adebbf41ac813ec6d2d8faa0af20 + url: "https://pub.dev" + source: hosted + version: "3.3.2" openid_client: dependency: "direct dev" description: @@ -944,22 +960,6 @@ packages: url: "https://pub.dev" source: hosted version: "2.1.0" - package_info_plus: - dependency: transitive - description: - name: package_info_plus - sha256: "7e76fad405b3e4016cd39d08f455a4eb5199723cf594cd1b8916d47140d93017" - url: "https://pub.dev" - source: hosted - version: "4.2.0" - package_info_plus_platform_interface: - dependency: transitive - description: - name: package_info_plus_platform_interface - sha256: "9bc8ba46813a4cc42c66ab781470711781940780fd8beddd0c3da62506d3a6c6" - url: "https://pub.dev" - source: hosted - version: "2.0.1" path: dependency: transitive description: @@ -980,10 +980,10 @@ packages: dependency: "direct main" description: name: path_provider - sha256: b27217933eeeba8ff24845c34003b003b2b22151de3c908d0e679e8fe1aa078b + sha256: fec0d61223fba3154d87759e3cc27fe2c8dc498f6386c6d6fc80d1afdd1bf378 url: "https://pub.dev" source: hosted - version: "2.1.2" + version: "2.1.4" path_provider_android: dependency: transitive description: @@ -1025,7 +1025,7 @@ packages: source: hosted version: "2.2.1" permission_handler: - dependency: "direct dev" + dependency: "direct main" description: name: permission_handler sha256: "18bf33f7fefbd812f37e72091a15575e72d5318854877e0e4035a24ac1113ecb" @@ -1112,6 +1112,22 @@ packages: url: "https://pub.dev" source: hosted version: "1.5.1" + popover: + dependency: "direct main" + description: + name: popover + sha256: "5cba40e04115cbbf15c35e00767b91e8bf3f769763a34beb2f8a1b9e8b5fc876" + url: "https://pub.dev" + source: hosted + version: "0.3.0+1" + popup_menu: + dependency: "direct main" + description: + name: popup_menu + sha256: "85fe2b7a0c43989307000d89f736718ebb2821eb11c7cf9bd409a1a4be39c3eb" + url: "https://pub.dev" + source: hosted + version: "2.1.0" provider: dependency: "direct main" description: @@ -1144,14 +1160,22 @@ packages: url: "https://pub.dev" source: hosted version: "3.2.1" - recase: - dependency: transitive + responsive_grid: + dependency: "direct main" description: - name: recase - sha256: e4eb4ec2dcdee52dcf99cb4ceabaffc631d7424ee55e56f280bc039737f89213 + name: responsive_grid + sha256: "852b4d46ae4a530e0d54a1dc59964f3d2cd8d6ca1f6fc4e5790cc0580e367e24" url: "https://pub.dev" source: hosted - version: "4.1.0" + version: "2.4.4" + rfw: + dependency: "direct main" + description: + name: rfw + sha256: b7c5f9b24b69e3581dc1cf70ec366e53b0b4f73d60ed05886f3726cf4abebe0b + url: "https://pub.dev" + source: hosted + version: "1.0.29" riverpod: dependency: "direct main" description: @@ -1160,14 +1184,22 @@ packages: url: "https://pub.dev" source: hosted version: "2.5.1" + rxdart: + dependency: transitive + description: + name: rxdart + sha256: "5c3004a4a8dbb94bd4bf5412a4def4acdaa12e12f269737a5751369e12d1a962" + url: "https://pub.dev" + source: hosted + version: "0.28.0" shared_preferences: dependency: "direct main" description: name: shared_preferences - sha256: "81429e4481e1ccfb51ede496e916348668fd0921627779233bd24cc3ff6abd02" + sha256: d3bbe5553a986e83980916ded2f0b435ef2e1893dfaa29d5a7a790d0eca12180 url: "https://pub.dev" source: hosted - version: "2.2.2" + version: "2.2.3" shared_preferences_android: dependency: transitive description: @@ -1261,6 +1293,30 @@ packages: url: "https://pub.dev" source: hosted version: "1.10.0" + sprintf: + dependency: transitive + description: + name: sprintf + sha256: "1fc9ffe69d4df602376b52949af107d8f5703b77cda567c4d7d86a0693120f23" + url: "https://pub.dev" + source: hosted + version: "7.0.0" + sqflite: + dependency: transitive + description: + name: sqflite + sha256: a43e5a27235518c03ca238e7b4732cf35eabe863a369ceba6cbefa537a66f16d + url: "https://pub.dev" + source: hosted + version: "2.3.3+1" + sqflite_common: + dependency: transitive + description: + name: sqflite_common + sha256: "3da423ce7baf868be70e2c0976c28a1bb2f73644268b7ffa7d2e08eab71f16a4" + url: "https://pub.dev" + source: hosted + version: "2.5.4" stack_trace: dependency: transitive description: @@ -1301,6 +1357,46 @@ packages: url: "https://pub.dev" source: hosted version: "1.2.0" + syncfusion_flutter_charts: + dependency: "direct main" + description: + name: syncfusion_flutter_charts + sha256: bdb7cc5814ceb187793cea587f4a5946afcffd96726b219cee79df8460f44b7b + url: "https://pub.dev" + source: hosted + version: "21.2.4" + syncfusion_flutter_core: + dependency: transitive + description: + name: syncfusion_flutter_core + sha256: "8db8f55c77f56968681447d3837c10f27a9e861e238a898fda116c7531def979" + url: "https://pub.dev" + source: hosted + version: "21.2.10" + syncfusion_flutter_xlsio: + dependency: "direct main" + description: + name: syncfusion_flutter_xlsio + sha256: "182bb1320cf102528fecf039a93245c8a59af4e062584b4039d44cb6410341bb" + url: "https://pub.dev" + source: hosted + version: "21.2.3" + syncfusion_officecore: + dependency: transitive + description: + name: syncfusion_officecore + sha256: "78a68bf204b0ebe904ac1a79f7800f719bb90a680d886c894a2f3047220a7b14" + url: "https://pub.dev" + source: hosted + version: "21.2.10" + synchronized: + dependency: transitive + description: + name: synchronized + sha256: "539ef412b170d65ecdafd780f924e5be3f60032a1128df156adad6c5b373d558" + url: "https://pub.dev" + source: hosted + version: "3.1.0+1" term_glyph: dependency: transitive description: @@ -1325,54 +1421,6 @@ packages: url: "https://pub.dev" source: hosted version: "3.0.1" - theta: - dependency: "direct main" - description: - name: theta - sha256: "4774f8b21ed42cffdf512837eecd09379c3f9b1c9734949d3df5236b60967eeb" - url: "https://pub.dev" - source: hosted - version: "0.8.7" - theta_analytics: - dependency: transitive - description: - name: theta_analytics - sha256: "983a84cdb590368610de14ade218cc55df655ec4ff503f14e6ea99d72d6c1a8b" - url: "https://pub.dev" - source: hosted - version: "0.1.4" - theta_design_system: - dependency: transitive - description: - name: theta_design_system - sha256: "1a9999582fabe15eb0fef5dcdea881b365801b2bc11069d3f3e4867e81c8024a" - url: "https://pub.dev" - source: hosted - version: "0.3.6" - theta_models: - dependency: transitive - description: - name: theta_models - sha256: "2271892f23cb49fa929e1ef3c5e40c139df1c10c36000d15f6acd9ad6eb0d33b" - url: "https://pub.dev" - source: hosted - version: "0.7.8" - theta_open_widgets: - dependency: transitive - description: - name: theta_open_widgets - sha256: "06b4b7e098272c2b1f1e88f9e2bf16f90ed5637f236a282aaae15ad42eed4a95" - url: "https://pub.dev" - source: hosted - version: "0.7.12" - theta_rendering: - dependency: transitive - description: - name: theta_rendering - sha256: bccf2d8c0e31678259611994d5076d66ef214aa1d589122018c17dc9a2b2cea3 - url: "https://pub.dev" - source: hosted - version: "0.2.3" timing: dependency: transitive description: @@ -1389,14 +1437,30 @@ packages: url: "https://pub.dev" source: hosted version: "1.3.2" - url_launcher: - dependency: "direct dev" + universal_html: + dependency: "direct main" description: - name: url_launcher - sha256: "0ecc004c62fd3ed36a2ffcbe0dd9700aee63bd7532d0b642a488b1ec310f492e" + name: universal_html + sha256: "56536254004e24d9d8cfdb7dbbf09b74cf8df96729f38a2f5c238163e3d58971" url: "https://pub.dev" source: hosted - version: "6.2.5" + version: "2.2.4" + universal_io: + dependency: transitive + description: + name: universal_io + sha256: "1722b2dcc462b4b2f3ee7d188dad008b6eb4c40bbd03a3de451d82c78bba9aad" + url: "https://pub.dev" + source: hosted + version: "2.2.2" + url_launcher: + dependency: "direct main" + description: + name: url_launcher + sha256: "21b704ce5fa560ea9f3b525b43601c678728ba46725bab9b01187b4831377ed3" + url: "https://pub.dev" + source: hosted + version: "6.3.0" url_launcher_android: dependency: transitive description: @@ -1457,34 +1521,34 @@ packages: dependency: transitive description: name: uuid - sha256: "648e103079f7c64a36dc7d39369cabb358d377078a051d6ae2ad3aa539519313" + sha256: a5be9ef6618a7ac1e964353ef476418026db906c4facdedaa299b7a2e71690ff url: "https://pub.dev" source: hosted - version: "3.0.7" + version: "4.5.1" vector_graphics: dependency: transitive description: name: vector_graphics - sha256: "4ac59808bbfca6da38c99f415ff2d3a5d7ca0a6b4809c71d9cf30fba5daf9752" + sha256: "32c3c684e02f9bc0afb0ae0aa653337a2fe022e8ab064bcd7ffda27a74e288e3" url: "https://pub.dev" source: hosted - version: "1.1.10+1" + version: "1.1.11+1" vector_graphics_codec: dependency: transitive description: name: vector_graphics_codec - sha256: f3247e7ab0ec77dc759263e68394990edc608fb2b480b80db8aa86ed09279e33 + sha256: c86987475f162fadff579e7320c7ddda04cd2fdeffbe1129227a85d9ac9e03da url: "https://pub.dev" source: hosted - version: "1.1.10+1" + version: "1.1.11+1" vector_graphics_compiler: dependency: transitive description: name: vector_graphics_compiler - sha256: "18489bdd8850de3dd7ca8a34e0c446f719ec63e2bab2e7a8cc66a9028dd76c5a" + sha256: "12faff3f73b1741a36ca7e31b292ddeb629af819ca9efe9953b70bd63fc8cd81" url: "https://pub.dev" source: hosted - version: "1.1.10+1" + version: "1.1.11+1" vector_math: dependency: transitive description: @@ -1533,14 +1597,6 @@ packages: url: "https://pub.dev" source: hosted version: "5.4.0" - win32_registry: - dependency: transitive - description: - name: win32_registry - sha256: "41fd8a189940d8696b1b810efb9abcf60827b6cbfab90b0c43e8439e3a39d85a" - url: "https://pub.dev" - source: hosted - version: "1.1.2" word_cloud: dependency: "direct main" description: diff --git a/pubspec.yaml b/pubspec.yaml index 68ecb31..a29e31f 100644 --- a/pubspec.yaml +++ b/pubspec.yaml @@ -33,20 +33,20 @@ dependencies: sdk: flutter # The following adds the Cupertino Icons font to your application. # Use with the CupertinoIcons class for iOS style icons. - cupertino_icons: ^1.0.2 - dio: ^5.3.2 - shared_preferences: ^2.2.0 - provider: ^6.0.5 + + + + image_picker: ^1.0.4 - flutter_svg: ^2.0.7 + riverpod: ^2.4.0 - theta: ^0.8.5 - intl: ^0.18.1 + # theta: ^0.8.5 + intl: ^0.17.0 hive_generator: ^2.0.1 hive_flutter: ^1.1.0 build_runner: ^2.4.6 - path_provider: ^2.1.1 - http_mock_adapter: ^0.6.0 + + info_popup: ^3.0.0 word_cloud: ^1.0.1 firebase_core: ^2.31.0 @@ -55,18 +55,53 @@ dependencies: fl_chart: ^0.68.0 flutter_heatmap_calendar: ^1.0.5 avatar_stack: ^1.2.0 + cupertino_icons: ^1.0.6 + flutter_svg: ^2.0.10+1 + flutter_profile_picture: ^2.0.0 + + charts_flutter: ^0.12.0 + syncfusion_flutter_charts: ^21.2.4 + dropdown_search: ^5.0.6 + dropdownfield2: ^1.0.7 + path_provider: ^2.1.3 + provider: ^6.1.2 + dropdown_button2: ^2.3.9 + file_picker: ^8.0.2 + permission_handler: ^11.3.1 + + connectivity_plus: ^6.0.3 + shared_preferences: ^2.2.3 + dio: ^5.4.3+1 + http_mock_adapter: ^0.6.1 + syncfusion_flutter_xlsio: ^21.2.3 + universal_html: ^2.2.4 + open_file: ^3.3.2 + rfw: ^1.0.26 + + responsive_grid: ^2.4.4 + popover: ^0.3.0+1 + data_table_2: ^2.5.15 + expandable: ^5.0.1 + flutter_carousel_widget: ^2.2.0 + carousel_slider: ^4.2.1 + popup_menu: ^2.0.0 + adoptive_calendar: ^0.1.8 + multi_dropdown: ^2.1.4 + + cached_network_image: ^3.4.0 + url_launcher: ^6.3.0 dev_dependencies: - connectivity_plus: ^3.0.2 - url_launcher: ^6.1.6 + # connectivity_plus: ^3.0.2 + # url_launcher: ^6.1.6 openid_client: ^0.4.7 go_router: ^10.0.0 hive: ^2.2.3 dropdown_button2: ^2.3.9 - file_picker: ^6.1.1 - permission_handler: ^11.1.0 + # file_picker: ^6.1.1 + # permission_handler: ^11.1.0 textfield_tags: ^3.0.1 add_2_calendar: ^3.0.1 font_awesome_flutter: ^10.1.0 @@ -101,6 +136,10 @@ flutter: # To add assets to your application, add an assets section, like this: assets: + - assets/konectar_white_logo.svg + - assets/interactionform.json + - assets/contact.json + - assets/section.json - assets/images/ - assets/response.json - shorebird.yaml